PatientID,Text_Genetate,Raw_Data
TCGA-EW-A2FS,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting. All values fall within non-significant ranges per defined criteria.","mRNA_MLPH: 0.6181024310277528, mRNA_C2orf54: -1.0786005466382416, mRNA_CITED4: -1.0426780049444144, mRNA_ESR1: 0.2360953017338898, mRNA_SPDEF: -0.0741370059575423, mRNA_AGR3: 0.21634028548497, mRNA_FOXC1: -0.1297250788884059, mRNA_GATA3: 0.4056144745315068, mRNA_AGR2: 0.1232667069410107, mRNA_XBP1: 0.2231952426565022, mRNA_PRR15: 0.3425739768512676, mRNA_SLC44A4: -0.1311533457581483, mRNA_CA12: 0.3821746425333253, mRNA_DTL: -0.3913768905655766, mRNA_C5AR2: -0.3572944192317596, mRNA_TBC1D9: -0.1542610559769485, mRNA_AR: -0.4302855975820674, mRNA_CCDC170: 0.1909659831325164, mRNA_DEGS2: -1.0064749972108795, mRNA_TFF3: 0.0275663260891661, mRNA_DNALI1: 0.9324974557547188, mRNA_LINC00504: -1.236255479159051, mRNA_CLCA2: -0.6139197110725955, mRNA_PPP1R14C: 0.1350314260092639, mRNA_THSD4: 0.5923254178193356, mRNA_SPAG5: -0.1071138193393432, mRNA_FBP1: -0.5554143089759751, mRNA_SLC7A8: -1.6066340983081566, mRNA_EN1: -0.3340803167209136, mRNA_ZNF552: 0.3319888608276327, Methylation_LRRC6: 0.4671073056875414, Methylation_chr2 66218712 LINC02934 (29533): 0.2946033750594284, Methylation_HOXB13: -1.056444168500135, Methylation_chr10 3949206 LINC02660 (4871): -0.5502044795822976, Methylation_chr5 179517140 RNF130 (18026): 0.3673696972743727, Methylation_LOC727677: 0.731299862746585, Methylation_LETM1: -0.5401000265245387, Methylation_CDC42BPB: 0.873239349182782, Methylation_C8orf38: 1.5689950689602767, Methylation_chr14 100504766 EVL (18852): 0.7722406251944185, Methylation_chr5 72594851 LOC340090 (24088): 0.340458734160401, Methylation_chr2 242904738 LINC01238 (3421): 1.3970717136281927, Methylation_ARFGEF1: 0.2743516005661519, Methylation_MAPT: 0.6975149132958388, Methylation_ZFAT: 0.6475652530323177, Methylation_KCNQ4: -0.6200955300953592, Methylation_chr1 232684368 SIPA1L2 (12934): 0.5227198312343838, Methylation_CRNKL1: 0.3172209904449466, Methylation_PRKAG2: -0.5570452431331689, Methylation_MICB: -0.1998381086205376, miRNA_hsa-mir-934: 0.3172337012633984, miRNA_hsa-mir-4728: 0.6452206762870737, miRNA_hsa-mir-5695: 0.3158456092687287, miRNA_hsa-mir-18a: -0.0238445208631355, miRNA_hsa-mir-190b: 0.2388443503255751, miRNA_hsa-mir-577: -0.49890683757464, miRNA_hsa-mir-135b: 0.0494178051030154, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.5584673339273338, miRNA_hsa-mir-130b: 0.2072705086398402, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-OL-A6VR,"No features meet the strict diagnostic thresholds for mRNA (Z > 1.30 or Z < -1.92), methylation (Z > 1.50 or Z < -1.47), miRNA (Z > 1.99 or Z < -1.25), or CNV (deletion, gain, amplification, or high-level amplification). All values fall within non-actionable ranges.","mRNA_MLPH: 0.975493169538961, mRNA_C2orf54: 0.1532640184021074, mRNA_CITED4: -0.0053410414872026, mRNA_ESR1: 0.1886190944572528, mRNA_SPDEF: 0.8938134834142489, mRNA_AGR3: 0.3280906905414427, mRNA_FOXC1: -0.7688631890153161, mRNA_GATA3: 0.6336337567203326, mRNA_AGR2: 0.4996133017657714, mRNA_XBP1: 1.0957553772724982, mRNA_PRR15: 0.6852386247140381, mRNA_SLC44A4: 0.8238820523293223, mRNA_CA12: 0.7791914425750447, mRNA_DTL: -1.4960714428281656, mRNA_C5AR2: 1.2340176644524012, mRNA_TBC1D9: 0.8669197178769507, mRNA_AR: 0.62095302370996, mRNA_CCDC170: 0.3901531504566224, mRNA_DEGS2: 0.2502554630470001, mRNA_TFF3: 1.36144565916084, mRNA_DNALI1: 1.0616383339442066, mRNA_LINC00504: 1.026818318413728, mRNA_CLCA2: 1.1869686636780974, mRNA_PPP1R14C: -0.3256627685470898, mRNA_THSD4: 0.5605972829301716, mRNA_SPAG5: -1.1200844739697615, mRNA_FBP1: 1.286987607319392, mRNA_SLC7A8: 1.744641331489444, mRNA_EN1: -0.968908779967167, mRNA_ZNF552: 0.2848330017967349, Methylation_LRRC6: -1.2025428035301855, Methylation_chr2 66218712 LINC02934 (29533): 1.276937166730504, Methylation_HOXB13: -0.6534129834877352, Methylation_chr10 3949206 LINC02660 (4871): -1.1425982914795627, Methylation_chr5 179517140 RNF130 (18026): 0.4676429244544105, Methylation_LOC727677: -1.2711058990702844, Methylation_LETM1: -1.4407405261385304, Methylation_CDC42BPB: 1.1963468420571923, Methylation_C8orf38: -0.8760590775097117, Methylation_chr14 100504766 EVL (18852): -0.6468052139816832, Methylation_chr5 72594851 LOC340090 (24088): 1.0989970161731468, Methylation_chr2 242904738 LINC01238 (3421): -0.5624167912151292, Methylation_ARFGEF1: -0.7568903941600421, Methylation_MAPT: -1.4123397914243312, Methylation_ZFAT: -0.0283256947650064, Methylation_KCNQ4: -1.0587360355317967, Methylation_chr1 232684368 SIPA1L2 (12934): -0.9693877679844256, Methylation_CRNKL1: -0.2898330955226627, Methylation_PRKAG2: -1.3810959745809066, Methylation_MICB: -0.4810419782073937, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.6753963518011998, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.738804673802833, miRNA_hsa-mir-190b: 0.5555202050570341, miRNA_hsa-mir-577: -0.4716339860402296, miRNA_hsa-mir-135b: -0.8892512462706431, miRNA_hsa-mir-2115: -0.4180318379793543, miRNA_hsa-mir-17: 0.7673661394084902, miRNA_hsa-mir-130b: -1.3626953060680973, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A226,High mRNA_C2orf54 (Z=1.48) and mRNA_DTL (Z=1.66) indicate overexpression. No methylation or miRNA alterations meet diagnostic thresholds. All CNVs fall within normal range (−1.10 to −0.10). These features collectively suggest luminal A phenotype with cell cycle dysregulation.,"mRNA_MLPH: 0.0128963841741569, mRNA_C2orf54: 1.482182873902829, mRNA_CITED4: -0.7913906727913459, mRNA_ESR1: 0.6396729136772492, mRNA_SPDEF: -0.0182201577454958, mRNA_AGR3: 0.6740775790295608, mRNA_FOXC1: 0.0972049121972523, mRNA_GATA3: 0.3662960657604587, mRNA_AGR2: 0.3927445274071107, mRNA_XBP1: 1.1588916632299395, mRNA_PRR15: 0.8207065294860116, mRNA_SLC44A4: 0.8368510919740916, mRNA_CA12: 0.3645197533393498, mRNA_DTL: 1.6576404596850645, mRNA_C5AR2: 0.4044476077951163, mRNA_TBC1D9: 0.1145651800779984, mRNA_AR: 1.247491736538604, mRNA_CCDC170: 0.6640983452473554, mRNA_DEGS2: 0.0070349678755262, mRNA_TFF3: -0.2745403635155895, mRNA_DNALI1: 0.7899627108963692, mRNA_LINC00504: 0.6616708519807655, mRNA_CLCA2: -0.1604056092027345, mRNA_PPP1R14C: 0.0783755378400385, mRNA_THSD4: 0.3705636021263733, mRNA_SPAG5: 1.0520304113442416, mRNA_FBP1: 0.5442148060535599, mRNA_SLC7A8: 1.054983297314586, mRNA_EN1: 0.346382429018629, mRNA_ZNF552: 0.652596165626754, Methylation_LRRC6: 0.012564050195312, Methylation_chr2 66218712 LINC02934 (29533): -0.1208012683703076, Methylation_HOXB13: 0.2739125676331831, Methylation_chr10 3949206 LINC02660 (4871): -1.2376408436207358, Methylation_chr5 179517140 RNF130 (18026): -0.0224238761470558, Methylation_LOC727677: 0.606672158587251, Methylation_LETM1: -0.2619692925726744, Methylation_CDC42BPB: -0.5114287132669031, Methylation_C8orf38: -0.2533341725894769, Methylation_chr14 100504766 EVL (18852): 0.1733209609070947, Methylation_chr5 72594851 LOC340090 (24088): 0.2930675912024694, Methylation_chr2 242904738 LINC01238 (3421): -0.371020049941736, Methylation_ARFGEF1: -0.3764139665800478, Methylation_MAPT: -0.2160838891666527, Methylation_ZFAT: 0.1086348599735929, Methylation_KCNQ4: -1.0078654867912258, Methylation_chr1 232684368 SIPA1L2 (12934): -0.9813663073018556, Methylation_CRNKL1: -0.5337704892115128, Methylation_PRKAG2: 0.5920854248649848, Methylation_MICB: -0.5862657583288957, miRNA_hsa-mir-934: -0.0675461180096044, miRNA_hsa-mir-4728: -0.4333388701294693, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.7771080189927488, miRNA_hsa-mir-190b: 0.6296610125842427, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.2916577044923605, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.8572173981417863, miRNA_hsa-mir-130b: -0.5648396339715689, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A27H,"High-level Amplification of EN1 and PPP1R14C drives significant mRNA overexpression. Promoter hypermethylation of LRRC6, LOC727677, C8orf38, EVL, ARFGEF1, SIPA1L2, and ZFAT mediates epigenetic silencing. miRNA hsa-mir-934, hsa-mir-135b, and hsa-mir-577 are upregulated; hsa-mir-190b is downregulated. These features indicate a luminal B phenotype with ER signaling dysregulation.","mRNA_MLPH: -1.750404084955143, mRNA_C2orf54: -0.24916405810815, mRNA_CITED4: 0.5521528842497708, mRNA_ESR1: -1.9076203470059832, mRNA_SPDEF: -3.0774050444735765, mRNA_AGR3: -1.996779389179844, mRNA_FOXC1: 1.3464912674422738, mRNA_GATA3: -2.806173072717152, mRNA_AGR2: -2.5256282073128355, mRNA_XBP1: -1.5471662280995375, mRNA_PRR15: -1.7892540048735308, mRNA_SLC44A4: -0.3059617183374375, mRNA_CA12: -1.738730007829793, mRNA_DTL: 0.6928779066370307, mRNA_C5AR2: -1.838234938738612, mRNA_TBC1D9: -1.40665930611984, mRNA_AR: -1.590853575133318, mRNA_CCDC170: -1.1941882759213114, mRNA_DEGS2: -1.971487864465722, mRNA_TFF3: -2.1720872178794752, mRNA_DNALI1: -1.590227059258309, mRNA_LINC00504: -1.5652275986469122, mRNA_CLCA2: -0.7308821089096369, mRNA_PPP1R14C: 2.445901288278289, mRNA_THSD4: -0.8786045228171632, mRNA_SPAG5: -0.4030730080425797, mRNA_FBP1: -2.5246758738413595, mRNA_SLC7A8: -1.167664465806331, mRNA_EN1: 2.7444069826318622, mRNA_ZNF552: -1.4514930559555428, Methylation_LRRC6: 1.5242586060147003, Methylation_chr2 66218712 LINC02934 (29533): 1.1340910405890778, Methylation_HOXB13: 0.602149542695383, Methylation_chr10 3949206 LINC02660 (4871): 1.212425492927335, Methylation_chr5 179517140 RNF130 (18026): -0.4300919483705538, Methylation_LOC727677: 1.5481097142150086, Methylation_LETM1: 1.3491804074856506, Methylation_CDC42BPB: 1.309728555759833, Methylation_C8orf38: 1.6679709810298249, Methylation_chr14 100504766 EVL (18852): 1.558423707283448, Methylation_chr5 72594851 LOC340090 (24088): -1.5345860990757796, Methylation_chr2 242904738 LINC01238 (3421): 1.4761201949194225, Methylation_ARFGEF1: 1.5782104931338232, Methylation_MAPT: 1.4622004252102718, Methylation_ZFAT: 1.4512185637856747, Methylation_KCNQ4: 0.9700255993698996, Methylation_chr1 232684368 SIPA1L2 (12934): 1.676660946531659, Methylation_CRNKL1: 1.3448387549620893, Methylation_PRKAG2: -1.1168330757551168, Methylation_MICB: 1.4633106475045463, miRNA_hsa-mir-934: 4.444022153659287, miRNA_hsa-mir-4728: 0.1945959242174597, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.0917952052306885, miRNA_hsa-mir-190b: -1.7943798165638982, miRNA_hsa-mir-577: 1.7700234125231211, miRNA_hsa-mir-135b: 2.64508114773899, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.0623920809031579, miRNA_hsa-mir-130b: 0.298263623613119, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-D8-A3Z6,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.9197228717878834, mRNA_C2orf54: 0.8779153080898608, mRNA_CITED4: 0.0545077839385268, mRNA_ESR1: 0.1782280867356017, mRNA_SPDEF: 0.7595866664783189, mRNA_AGR3: 1.1352854155148306, mRNA_FOXC1: -0.1616174798297796, mRNA_GATA3: 0.2776810422898565, mRNA_AGR2: 0.5687601340094026, mRNA_XBP1: 0.9726913262996778, mRNA_PRR15: 0.308150092546208, mRNA_SLC44A4: 0.790213534056164, mRNA_CA12: 0.68199211777631, mRNA_DTL: -0.6202779711515971, mRNA_C5AR2: 0.843390302635683, mRNA_TBC1D9: 0.5323880709689399, mRNA_AR: 0.4884678453074508, mRNA_CCDC170: 0.5463188750601468, mRNA_DEGS2: 1.1600815184391908, mRNA_TFF3: 1.277744929598791, mRNA_DNALI1: 0.5780579014395403, mRNA_LINC00504: 0.0717742308375056, mRNA_CLCA2: -0.16022750585265, mRNA_PPP1R14C: 0.0949025337673818, mRNA_THSD4: 0.4838659683516813, mRNA_SPAG5: -1.182877515166657, mRNA_FBP1: 1.058620906106904, mRNA_SLC7A8: -0.1174760074151124, mRNA_EN1: -0.3735300311656007, mRNA_ZNF552: 0.4644246208223155, Methylation_LRRC6: -0.6587165480014231, Methylation_chr2 66218712 LINC02934 (29533): 0.0115057137605363, Methylation_HOXB13: -0.3790944910594027, Methylation_chr10 3949206 LINC02660 (4871): -0.654874051447948, Methylation_chr5 179517140 RNF130 (18026): 0.7583415189387679, Methylation_LOC727677: 0.5755984532056642, Methylation_LETM1: 0.5366803196025286, Methylation_CDC42BPB: -0.783394719969926, Methylation_C8orf38: -0.585039772281145, Methylation_chr14 100504766 EVL (18852): -0.4560690660208678, Methylation_chr5 72594851 LOC340090 (24088): 0.6205333471632439, Methylation_chr2 242904738 LINC01238 (3421): -0.5595889508713304, Methylation_ARFGEF1: -0.2077122951148582, Methylation_MAPT: -0.5433124596682801, Methylation_ZFAT: -0.4876486154113214, Methylation_KCNQ4: -1.164120715903185, Methylation_chr1 232684368 SIPA1L2 (12934): -0.4174661152451367, Methylation_CRNKL1: -0.0592777429519442, Methylation_PRKAG2: -0.7841895832266109, Methylation_MICB: -0.3831834953348492, miRNA_hsa-mir-934: -0.4387405597214021, miRNA_hsa-mir-4728: -0.7177509775649819, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.2937925487996223, miRNA_hsa-mir-190b: 0.6524825150669696, miRNA_hsa-mir-577: -0.6141329721741471, miRNA_hsa-mir-135b: -0.6315643755991456, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.7242591174470647, miRNA_hsa-mir-130b: -0.6599444262336075, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-B6-A1KN,High-level Amplification of LINC01867 drives mRNA overexpression. ZFAT promoter hypermethylation mediates epigenetic silencing. miR-4728 and miR-2115 are markedly upregulated. These features collectively indicate a luminal-like phenotype with PI3K/AKT pathway dysregulation.,"mRNA_MLPH: 0.9211122307735622, mRNA_C2orf54: -0.0873079938946271, mRNA_CITED4: 0.4982258294396497, mRNA_ESR1: 0.4476140866097051, mRNA_SPDEF: 0.6098089012985378, mRNA_AGR3: 0.793662515514894, mRNA_FOXC1: 0.1304933512799025, mRNA_GATA3: 0.6574249682962509, mRNA_AGR2: 0.5149621297242726, mRNA_XBP1: 0.8315844222908378, mRNA_PRR15: 1.1673118517975332, mRNA_SLC44A4: 0.890199476511491, mRNA_CA12: 0.201546365137911, mRNA_DTL: 0.7778208282317669, mRNA_C5AR2: -0.003127423703289, mRNA_TBC1D9: 0.8224370254501241, mRNA_AR: -1.4786299911168268, mRNA_CCDC170: 0.1753430164243906, mRNA_DEGS2: -0.242877704541421, mRNA_TFF3: 0.3600188377659579, mRNA_DNALI1: -0.6369590965041412, mRNA_LINC00504: -0.026247279108658, mRNA_CLCA2: 0.7571338449208568, mRNA_PPP1R14C: 0.6206208123803963, mRNA_THSD4: 0.0624687918580412, mRNA_SPAG5: 1.3775632765089958, mRNA_FBP1: 0.8663975498903946, mRNA_SLC7A8: -0.3018799210345613, mRNA_EN1: -0.8337495932302791, mRNA_ZNF552: 0.766714627993117, Methylation_LRRC6: -1.1193579487721592, Methylation_chr2 66218712 LINC02934 (29533): -0.2002287019015855, Methylation_HOXB13: 1.0107064462013282, Methylation_chr10 3949206 LINC02660 (4871): -0.6119312498244376, Methylation_chr5 179517140 RNF130 (18026): 1.0311507830152815, Methylation_LOC727677: -0.95263335517357, Methylation_LETM1: -0.0394640738434402, Methylation_CDC42BPB: 1.2894875143115525, Methylation_C8orf38: -1.4387049156405478, Methylation_chr14 100504766 EVL (18852): -0.456059560584747, Methylation_chr5 72594851 LOC340090 (24088): 0.9866759105157564, Methylation_chr2 242904738 LINC01238 (3421): 0.5424376104496249, Methylation_ARFGEF1: -0.7208268755222496, Methylation_MAPT: 0.6850123136915001, Methylation_ZFAT: -1.5394673031391035, Methylation_KCNQ4: -0.3684472326340162, Methylation_chr1 232684368 SIPA1L2 (12934): -0.9608314205155664, Methylation_CRNKL1: -1.1203447099470112, Methylation_PRKAG2: -1.13737482669208, Methylation_MICB: -1.3704249206808643, miRNA_hsa-mir-934: 0.1860554840938413, miRNA_hsa-mir-4728: 3.111396807779545, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.6480044423764123, miRNA_hsa-mir-190b: -0.2527838813464089, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: 0.4522134085180914, miRNA_hsa-mir-2115: 2.4751337217025484, miRNA_hsa-mir-17: 0.1068185424569315, miRNA_hsa-mir-130b: 0.2045036004555842, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-BH-A2L8,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.2070250505994422, mRNA_C2orf54: 0.5897323140994014, mRNA_CITED4: 0.713693647768815, mRNA_ESR1: -0.3259542086503949, mRNA_SPDEF: 0.3349674224962722, mRNA_AGR3: 0.3298384916061861, mRNA_FOXC1: -0.0771955077396101, mRNA_GATA3: -0.1605492454654277, mRNA_AGR2: 0.4270506548808718, mRNA_XBP1: 0.327145134949346, mRNA_PRR15: 0.4589012934027237, mRNA_SLC44A4: 0.6631230900249332, mRNA_CA12: -0.1289971209908725, mRNA_DTL: -0.8222595184168349, mRNA_C5AR2: 0.2456715695605987, mRNA_TBC1D9: 0.023398275883205, mRNA_AR: 0.2336160784482738, mRNA_CCDC170: 1.2918780619465122, mRNA_DEGS2: 0.482927454671655, mRNA_TFF3: -0.0295604530720784, mRNA_DNALI1: 1.426805580017264, mRNA_LINC00504: 0.0966628015494477, mRNA_CLCA2: -0.3028865616771888, mRNA_PPP1R14C: 0.6595047041634642, mRNA_THSD4: -0.9272256060235692, mRNA_SPAG5: -0.2596004215544503, mRNA_FBP1: 0.0170627423878986, mRNA_SLC7A8: 0.3358211062346724, mRNA_EN1: -0.4882549684478474, mRNA_ZNF552: -0.3386655202332144, Methylation_LRRC6: 0.9322840794017224, Methylation_chr2 66218712 LINC02934 (29533): 1.1607599071301284, Methylation_HOXB13: -0.9584971632975396, Methylation_chr10 3949206 LINC02660 (4871): -0.0052871135882847, Methylation_chr5 179517140 RNF130 (18026): 0.2062039295006519, Methylation_LOC727677: 0.3247740962379473, Methylation_LETM1: 0.2165876322459316, Methylation_CDC42BPB: -0.1874235554150988, Methylation_C8orf38: 0.6656102108193678, Methylation_chr14 100504766 EVL (18852): 0.1998231449248618, Methylation_chr5 72594851 LOC340090 (24088): 0.3126755594008393, Methylation_chr2 242904738 LINC01238 (3421): 0.1741129709821101, Methylation_ARFGEF1: 0.7659787841930292, Methylation_MAPT: 0.323021651197481, Methylation_ZFAT: 0.4454267249070449, Methylation_KCNQ4: -1.197630026102762, Methylation_chr1 232684368 SIPA1L2 (12934): 0.5950839770567041, Methylation_CRNKL1: 0.7429286873851378, Methylation_PRKAG2: 0.5216645718387924, Methylation_MICB: 0.7530225787356023, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.959335009840516, miRNA_hsa-mir-190b: -0.0135359464453083, miRNA_hsa-mir-577: -0.1963310018226772, miRNA_hsa-mir-135b: -0.9015641272770688, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.1793586940758996, miRNA_hsa-mir-130b: -1.022803195713653, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A8-A075,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression.  
mRNA_C2orf54 is highly expressed (Z=1.66).  
mRNA_CITED4 is low (Z=-1.58).  
Methylation_C8orf38 is hypermethylated (Z=-1.50).  
Methylation_chr5 72594851 LOC340090 is hypomethylated (Z=-1.46).  
miRNA_hsa-mir-190b and miRNA_hsa-mir-2115 are upregulated (Z>1.99).","mRNA_MLPH: 0.1671481878983873, mRNA_C2orf54: 1.658262487481113, mRNA_CITED4: -1.5774195053701, mRNA_ESR1: -0.3761520670529455, mRNA_SPDEF: 0.801273240410644, mRNA_AGR3: 0.3119600456450191, mRNA_FOXC1: -0.9871709334694032, mRNA_GATA3: 0.2968467862567971, mRNA_AGR2: 0.3891203179897176, mRNA_XBP1: 0.1337319349217748, mRNA_PRR15: 0.5614002876619429, mRNA_SLC44A4: 0.7509770575358203, mRNA_CA12: 0.247474447227691, mRNA_DTL: 0.1624316149569969, mRNA_C5AR2: 0.533876277059418, mRNA_TBC1D9: -0.7481303203193208, mRNA_AR: 0.604513438261321, mRNA_CCDC170: -0.2551548431262506, mRNA_DEGS2: 0.31466204135278, mRNA_TFF3: 0.2510117017834015, mRNA_DNALI1: -0.098276358128776, mRNA_LINC00504: 0.6673698627759591, mRNA_CLCA2: 0.4462978442443928, mRNA_PPP1R14C: -0.6694609305273852, mRNA_THSD4: 0.0855519061017122, mRNA_SPAG5: 0.0387362025594913, mRNA_FBP1: 0.0851080250920602, mRNA_SLC7A8: 0.096018141238793, mRNA_EN1: 0.092152900992832, mRNA_ZNF552: -0.182850303338151, Methylation_LRRC6: -1.0812606005875842, Methylation_chr2 66218712 LINC02934 (29533): -0.5008555597201009, Methylation_HOXB13: -0.9792409523172932, Methylation_chr10 3949206 LINC02660 (4871): -0.6172326077197059, Methylation_chr5 179517140 RNF130 (18026): -0.3182706077983721, Methylation_LOC727677: -1.1210180565256247, Methylation_LETM1: -0.016810843002063, Methylation_CDC42BPB: -1.281480718631039, Methylation_C8orf38: -1.5024996653371097, Methylation_chr14 100504766 EVL (18852): -0.909897858312166, Methylation_chr5 72594851 LOC340090 (24088): -1.46308141942494, Methylation_chr2 242904738 LINC01238 (3421): 0.6465546048429547, Methylation_ARFGEF1: -0.6872800563987193, Methylation_MAPT: -0.4609329228392649, Methylation_ZFAT: -1.3772761948963217, Methylation_KCNQ4: -1.1324789610764965, Methylation_chr1 232684368 SIPA1L2 (12934): -0.7344650891736589, Methylation_CRNKL1: -0.6240698768034174, Methylation_PRKAG2: -1.0235703805634258, Methylation_MICB: -0.917171348282412, miRNA_hsa-mir-934: 0.0685775932923923, miRNA_hsa-mir-4728: -0.0626210981555154, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.4265725056705162, miRNA_hsa-mir-190b: 1.0641946466400631, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: 0.1556933284283048, miRNA_hsa-mir-2115: 0.9553141437211656, miRNA_hsa-mir-17: 0.0967347171632831, miRNA_hsa-mir-130b: 0.3503218383289249, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-JL-A3YX,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives transcriptional activation.  
Promoter hypomethylation at LINC02934 (Z = -1.61) and ARFGEF1 (Z = -1.24) suggests epigenetic derepression.  
No mRNA or miRNA alterations meet diagnostic thresholds for dysregulation.","mRNA_MLPH: 0.299228386346918, mRNA_C2orf54: 0.478283148265768, mRNA_CITED4: 0.8203012731147461, mRNA_ESR1: 0.073951979603843, mRNA_SPDEF: 0.8069956161174567, mRNA_AGR3: 0.3664665272455829, mRNA_FOXC1: -0.6026379748465942, mRNA_GATA3: 0.7611923210919475, mRNA_AGR2: 0.5209435958243964, mRNA_XBP1: 0.4094179149315077, mRNA_PRR15: 0.3536643613542576, mRNA_SLC44A4: 0.5775130923146814, mRNA_CA12: 0.5592326062838957, mRNA_DTL: 0.4149248333024017, mRNA_C5AR2: 0.6311107187838925, mRNA_TBC1D9: 0.1477673897901946, mRNA_AR: 0.3416112299953863, mRNA_CCDC170: 0.3647639201019209, mRNA_DEGS2: 1.151596662918511, mRNA_TFF3: 0.6893505062699682, mRNA_DNALI1: 0.3290044611532877, mRNA_LINC00504: 0.3211339945419105, mRNA_CLCA2: -0.288870628925079, mRNA_PPP1R14C: -0.4212092537396337, mRNA_THSD4: 0.2530963422679375, mRNA_SPAG5: 0.2901127048868554, mRNA_FBP1: 0.7827060281642892, mRNA_SLC7A8: 0.2908442775106515, mRNA_EN1: -0.490993422027975, mRNA_ZNF552: 0.0659849390394225, Methylation_LRRC6: -0.9117313623548544, Methylation_chr2 66218712 LINC02934 (29533): -1.611676102766466, Methylation_HOXB13: 0.6914971694853609, Methylation_chr10 3949206 LINC02660 (4871): -1.0812780818375596, Methylation_chr5 179517140 RNF130 (18026): 0.985529865516306, Methylation_LOC727677: -1.029072933542327, Methylation_LETM1: -0.781047871889428, Methylation_CDC42BPB: -0.8276701504987246, Methylation_C8orf38: -1.2014163477800397, Methylation_chr14 100504766 EVL (18852): -0.5892522796410348, Methylation_chr5 72594851 LOC340090 (24088): 0.9162520597821264, Methylation_chr2 242904738 LINC01238 (3421): -1.025872311901416, Methylation_ARFGEF1: -1.242213825741023, Methylation_MAPT: -1.143461930772928, Methylation_ZFAT: -1.2414714593692553, Methylation_KCNQ4: 1.1689215692414383, Methylation_chr1 232684368 SIPA1L2 (12934): -0.6339437365857041, Methylation_CRNKL1: -0.6557584602226474, Methylation_PRKAG2: 0.3298946009676352, Methylation_MICB: -1.3761747910561808, miRNA_hsa-mir-934: 0.0382765472713236, miRNA_hsa-mir-4728: -0.2894201129153217, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.3614171149872041, miRNA_hsa-mir-190b: 0.5042214867472529, miRNA_hsa-mir-577: -0.5098520099164843, miRNA_hsa-mir-135b: -0.5123866176154079, miRNA_hsa-mir-2115: 1.5904044606435648, miRNA_hsa-mir-17: 0.9710215415183864, miRNA_hsa-mir-130b: -0.648274993127831, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-D8-A3Z5,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.8259516820482935, mRNA_C2orf54: 0.0912360896746748, mRNA_CITED4: 0.6839013883130792, mRNA_ESR1: 0.2427505036952841, mRNA_SPDEF: 0.7609898413157509, mRNA_AGR3: 0.6041091469536278, mRNA_FOXC1: 0.2923899038874205, mRNA_GATA3: 0.5207168986537061, mRNA_AGR2: 0.5278535903782585, mRNA_XBP1: 0.1830598919992941, mRNA_PRR15: 0.6297169025702501, mRNA_SLC44A4: 0.8465169677931167, mRNA_CA12: 0.4643935187390644, mRNA_DTL: -1.2653034464821264, mRNA_C5AR2: 0.0842412376916909, mRNA_TBC1D9: 0.2690946639099925, mRNA_AR: 0.3895011879092148, mRNA_CCDC170: 0.5012544849118147, mRNA_DEGS2: 0.4762088907672193, mRNA_TFF3: 1.0825282417988566, mRNA_DNALI1: 0.6520744598615662, mRNA_LINC00504: -0.4219142436072142, mRNA_CLCA2: -0.5765824042964787, mRNA_PPP1R14C: -0.2069107059352626, mRNA_THSD4: 0.8109058057476842, mRNA_SPAG5: -1.088300097616647, mRNA_FBP1: 0.4314398477697265, mRNA_SLC7A8: -0.4345216083244989, mRNA_EN1: -0.1117132952624423, mRNA_ZNF552: 0.703391196040608, Methylation_LRRC6: 0.2317149919879351, Methylation_chr2 66218712 LINC02934 (29533): -0.1291720039876777, Methylation_HOXB13: -1.0692584249659258, Methylation_chr10 3949206 LINC02660 (4871): -0.1644619315890954, Methylation_chr5 179517140 RNF130 (18026): -0.1856279597511802, Methylation_LOC727677: -0.0848342914353422, Methylation_LETM1: -0.0703552445320749, Methylation_CDC42BPB: -0.5139588849123627, Methylation_C8orf38: 0.1473844835754149, Methylation_chr14 100504766 EVL (18852): 0.3964641940333649, Methylation_chr5 72594851 LOC340090 (24088): 0.6840152579993203, Methylation_chr2 242904738 LINC01238 (3421): -0.4558116565035413, Methylation_ARFGEF1: 0.8019280774707118, Methylation_MAPT: 0.0109679804372249, Methylation_ZFAT: 0.1175989521467705, Methylation_KCNQ4: -1.0122903418595357, Methylation_chr1 232684368 SIPA1L2 (12934): 0.0774395018257411, Methylation_CRNKL1: 0.2171885882734593, Methylation_PRKAG2: -0.2366380621199551, Methylation_MICB: 0.2055745484460172, miRNA_hsa-mir-934: -0.4017704875726841, miRNA_hsa-mir-4728: 0.4460451846911258, miRNA_hsa-mir-5695: -0.021552777132804, miRNA_hsa-mir-18a: 0.1109352126035734, miRNA_hsa-mir-190b: 1.0630512226856177, miRNA_hsa-mir-577: -0.3143671507970455, miRNA_hsa-mir-135b: -0.0848050933858948, miRNA_hsa-mir-2115: -0.3805200523460392, miRNA_hsa-mir-17: 0.2685145963873814, miRNA_hsa-mir-130b: -1.6421919289273876, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-OL-A66J,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.6542368211954366, mRNA_C2orf54: -1.2399390837024282, mRNA_CITED4: 1.0382863713139878, mRNA_ESR1: 0.501047045526041, mRNA_SPDEF: 0.2343544176802258, mRNA_AGR3: 0.7542155442757245, mRNA_FOXC1: 0.1789870677411779, mRNA_GATA3: 0.6886034100520075, mRNA_AGR2: 0.1658850346844544, mRNA_XBP1: 0.780922154547874, mRNA_PRR15: 0.8526995383290501, mRNA_SLC44A4: 0.3181887936471548, mRNA_CA12: 0.8101550853098408, mRNA_DTL: -1.049863352622812, mRNA_C5AR2: 0.9443199501567175, mRNA_TBC1D9: 0.3539297143343436, mRNA_AR: -0.4070325004393846, mRNA_CCDC170: 0.8798886049160329, mRNA_DEGS2: 1.392458518770989, mRNA_TFF3: 1.1601003827567244, mRNA_DNALI1: 0.7094600513743823, mRNA_LINC00504: 1.2176395168545948, mRNA_CLCA2: -0.608848273096824, mRNA_PPP1R14C: -0.5585392269784248, mRNA_THSD4: 0.2973829934682209, mRNA_SPAG5: -1.2327054868449911, mRNA_FBP1: 0.8124666246364582, mRNA_SLC7A8: 0.2977611563708129, mRNA_EN1: -0.5132320343053934, mRNA_ZNF552: 0.8382295147396219, Methylation_LRRC6: 0.244067102171394, Methylation_chr2 66218712 LINC02934 (29533): -0.9451029259817402, Methylation_HOXB13: -1.074581526820073, Methylation_chr10 3949206 LINC02660 (4871): -0.5758836667902095, Methylation_chr5 179517140 RNF130 (18026): 0.6139151368422638, Methylation_LOC727677: -0.5392851616473086, Methylation_LETM1: -0.6206543269893732, Methylation_CDC42BPB: 1.4376915754256152, Methylation_C8orf38: -0.6438260605380676, Methylation_chr14 100504766 EVL (18852): -0.3944862234630295, Methylation_chr5 72594851 LOC340090 (24088): -1.5818189699214995, Methylation_chr2 242904738 LINC01238 (3421): -0.7067678904143101, Methylation_ARFGEF1: 0.0885045043430405, Methylation_MAPT: -0.6138559788096479, Methylation_ZFAT: -0.6867620376630913, Methylation_KCNQ4: 0.5366343914350991, Methylation_chr1 232684368 SIPA1L2 (12934): 0.3941483977394172, Methylation_CRNKL1: 0.312416594584525, Methylation_PRKAG2: -0.5225184790628198, Methylation_MICB: -0.4808865309763031, miRNA_hsa-mir-934: -0.2928489207749257, miRNA_hsa-mir-4728: 0.4165380920387218, miRNA_hsa-mir-5695: 0.3975906634636725, miRNA_hsa-mir-18a: -0.2406527458858371, miRNA_hsa-mir-190b: -0.0347397514778726, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.6070910428867135, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.4942377115697455, miRNA_hsa-mir-130b: -0.9470527605962328, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A73U,High-level Amplification of none; Deletion absent. mRNA_TFF3 (Z=1.45) is highly expressed. mRNA_SPAG5 (Z=−2.02) is low. No methylation or miRNA alterations meet diagnostic thresholds. CNVs are all normal (−1.10 ≤ Z < −0.10). Isolated TFF3 overexpression and SPAG5 suppression without genomic/epigenetic drivers.,"mRNA_MLPH: 0.2780340463899687, mRNA_C2orf54: -0.7091628869052555, mRNA_CITED4: -0.9031406853473124, mRNA_ESR1: -0.0148711662855128, mRNA_SPDEF: 0.0068378899984525, mRNA_AGR3: 0.6329013684927454, mRNA_FOXC1: -0.534189542531906, mRNA_GATA3: -0.2435502411543519, mRNA_AGR2: 0.8703678320984551, mRNA_XBP1: -0.0382025761775191, mRNA_PRR15: 0.1427346813750366, mRNA_SLC44A4: 0.5471623107590265, mRNA_CA12: -0.4789063125020904, mRNA_DTL: -1.741238764012231, mRNA_C5AR2: 0.7173028603573899, mRNA_TBC1D9: -0.7038921829780787, mRNA_AR: 0.1037012721370675, mRNA_CCDC170: -0.6083964670615284, mRNA_DEGS2: 0.0418805536242314, mRNA_TFF3: 1.4453914136374688, mRNA_DNALI1: -0.6633523915168288, mRNA_LINC00504: -0.8190585374523112, mRNA_CLCA2: -0.6069780766104984, mRNA_PPP1R14C: -1.0109222601360668, mRNA_THSD4: -0.526081916745144, mRNA_SPAG5: -2.02369345019562, mRNA_FBP1: 0.2958303770455846, mRNA_SLC7A8: 0.3783924856937225, mRNA_EN1: 0.1137714758223122, mRNA_ZNF552: 0.4075678431372596, Methylation_LRRC6: 0.9659137201273088, Methylation_chr2 66218712 LINC02934 (29533): 1.2840622150246943, Methylation_HOXB13: -0.0937916856521705, Methylation_chr10 3949206 LINC02660 (4871): 1.052027988930336, Methylation_chr5 179517140 RNF130 (18026): -1.1822592458661252, Methylation_LOC727677: 0.93143068874544, Methylation_LETM1: 0.9781308748568786, Methylation_CDC42BPB: -0.5565327023236882, Methylation_C8orf38: 1.27804269395998, Methylation_chr14 100504766 EVL (18852): 0.9158281882913956, Methylation_chr5 72594851 LOC340090 (24088): 0.2150719878862296, Methylation_chr2 242904738 LINC01238 (3421): -0.0353527307950216, Methylation_ARFGEF1: 1.0392312739072616, Methylation_MAPT: 0.8517326167583747, Methylation_ZFAT: 0.5356366494860353, Methylation_KCNQ4: -1.0462422006125605, Methylation_chr1 232684368 SIPA1L2 (12934): 0.6140183169841765, Methylation_CRNKL1: 0.8428377456133535, Methylation_PRKAG2: 0.2675676409161254, Methylation_MICB: 1.0320743828620798, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.7782653876121126, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.9308550909934992, miRNA_hsa-mir-190b: -0.9024743416539248, miRNA_hsa-mir-577: -0.3279145638549224, miRNA_hsa-mir-135b: -0.22362555490358, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.8206217750068997, miRNA_hsa-mir-130b: -1.322550417787432, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AC-A3QQ,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: -0.0724530511588217, mRNA_C2orf54: -1.2943230935752186, mRNA_CITED4: -0.1489047698785386, mRNA_ESR1: 0.2340098278552045, mRNA_SPDEF: -1.4273110120621326, mRNA_AGR3: -0.5059805608399102, mRNA_FOXC1: -0.2699619011555833, mRNA_GATA3: 0.2773228500696204, mRNA_AGR2: -0.1893655718806012, mRNA_XBP1: -0.4499406548872875, mRNA_PRR15: -0.6293821970713465, mRNA_SLC44A4: -0.4683673870748002, mRNA_CA12: -0.0973207981005734, mRNA_DTL: -0.0713342678813026, mRNA_C5AR2: -0.7741449724679061, mRNA_TBC1D9: -0.26894379997734, mRNA_AR: 0.3789511474712603, mRNA_CCDC170: -0.3285611763785618, mRNA_DEGS2: -1.6486313545428837, mRNA_TFF3: -0.4757744748855373, mRNA_DNALI1: 0.211793286075293, mRNA_LINC00504: 0.117400137040596, mRNA_CLCA2: 0.7725055448687318, mRNA_PPP1R14C: -0.9122389674205909, mRNA_THSD4: 0.3935793144264054, mRNA_SPAG5: -0.4353343120496739, mRNA_FBP1: -1.7485284392869809, mRNA_SLC7A8: -0.1363970007955471, mRNA_EN1: -0.3894180184779168, mRNA_ZNF552: 0.5373415879460481, Methylation_LRRC6: -0.5859779099455668, Methylation_chr2 66218712 LINC02934 (29533): -1.1601389335846477, Methylation_HOXB13: -1.0516713463352578, Methylation_chr10 3949206 LINC02660 (4871): -0.5190721907200306, Methylation_chr5 179517140 RNF130 (18026): 1.0114092668663874, Methylation_LOC727677: -0.663768073252406, Methylation_LETM1: -0.9204256629546854, Methylation_CDC42BPB: 1.3343836696056282, Methylation_C8orf38: -0.3082901268552758, Methylation_chr14 100504766 EVL (18852): -0.4152579054677308, Methylation_chr5 72594851 LOC340090 (24088): -0.5256320720693013, Methylation_chr2 242904738 LINC01238 (3421): -0.8340505556093485, Methylation_ARFGEF1: -0.5625968659481005, Methylation_MAPT: -0.9188142713256224, Methylation_ZFAT: -0.7418815035765853, Methylation_KCNQ4: -1.118993676411432, Methylation_chr1 232684368 SIPA1L2 (12934): -1.0744542308995428, Methylation_CRNKL1: -1.109131991999433, Methylation_PRKAG2: -0.3511756259323658, Methylation_MICB: -0.9651596951215452, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 1.3646450117322542, miRNA_hsa-mir-5695: 0.1440711231179719, miRNA_hsa-mir-18a: -0.2075368338933061, miRNA_hsa-mir-190b: 1.1166686854974803, miRNA_hsa-mir-577: -0.1157290560990998, miRNA_hsa-mir-135b: -0.6223655142479453, miRNA_hsa-mir-2115: -0.3114293046384607, miRNA_hsa-mir-17: 0.3048136180497022, miRNA_hsa-mir-130b: 0.0256837858333008, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AN-A0XS,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. No mRNA, methylation, or miRNA alterations meet diagnostic thresholds for dysregulation. These features collectively indicate a luminal phenotype with potential vesicular trafficking dysregulation.","mRNA_MLPH: 0.6790137220888646, mRNA_C2orf54: 1.3346096825791638, mRNA_CITED4: 1.1601792083328168, mRNA_ESR1: 0.577023315742255, mRNA_SPDEF: 0.5263959487033173, mRNA_AGR3: 0.4346023112769241, mRNA_FOXC1: -0.4114739572521315, mRNA_GATA3: 0.1800480288951347, mRNA_AGR2: 1.114071298638463, mRNA_XBP1: 0.3909750972749304, mRNA_PRR15: -0.3242186828586492, mRNA_SLC44A4: -0.9645602035132396, mRNA_CA12: 0.0292753829739254, mRNA_DTL: -1.4085190128115954, mRNA_C5AR2: 0.4845050576753517, mRNA_TBC1D9: 0.2194414333396431, mRNA_AR: 0.7129159068145202, mRNA_CCDC170: 0.1665736805854601, mRNA_DEGS2: 0.8475135568228108, mRNA_TFF3: 0.2762323896487028, mRNA_DNALI1: 0.5278815343293893, mRNA_LINC00504: 0.6619054702342241, mRNA_CLCA2: -0.5922444425961984, mRNA_PPP1R14C: -0.5451787972691696, mRNA_THSD4: 0.1151076018074585, mRNA_SPAG5: -0.8185807300643617, mRNA_FBP1: 0.2008198961826524, mRNA_SLC7A8: 0.7746971098568566, mRNA_EN1: 0.1725699716431367, mRNA_ZNF552: 0.4591505045933422, Methylation_LRRC6: -1.0798362679395537, Methylation_chr2 66218712 LINC02934 (29533): -0.3955743058873192, Methylation_HOXB13: 0.7899327067456539, Methylation_chr10 3949206 LINC02660 (4871): -0.5457701491502895, Methylation_chr5 179517140 RNF130 (18026): 1.1092352331742652, Methylation_LOC727677: -0.8484989784416705, Methylation_LETM1: -0.1775695849504624, Methylation_CDC42BPB: 0.9759549350945602, Methylation_C8orf38: -1.0671421363977498, Methylation_chr14 100504766 EVL (18852): -0.7543709744258926, Methylation_chr5 72594851 LOC340090 (24088): 0.9129374438310772, Methylation_chr2 242904738 LINC01238 (3421): -0.4650933455486237, Methylation_ARFGEF1: -1.2984836618414588, Methylation_MAPT: -0.5715768836322654, Methylation_ZFAT: -1.0081206229474926, Methylation_KCNQ4: 0.0570948963561556, Methylation_chr1 232684368 SIPA1L2 (12934): -0.1763694887117668, Methylation_CRNKL1: -0.4983938216469634, Methylation_PRKAG2: 1.2111894089755448, Methylation_MICB: -0.1794007694815184, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.1253007845476713, miRNA_hsa-mir-5695: 0.663882490931996, miRNA_hsa-mir-18a: -0.1648691230223609, miRNA_hsa-mir-190b: 0.5906987260380229, miRNA_hsa-mir-577: -0.1799652576040017, miRNA_hsa-mir-135b: -0.4359896275620952, miRNA_hsa-mir-2115: 0.8770573144673037, miRNA_hsa-mir-17: 0.3083219637913051, miRNA_hsa-mir-130b: -0.1177174253866476, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-A2-A0T5,High mRNA_CITED4 (Z=1.33) indicates overexpression. No methylation sites meet hyper/hypo thresholds. miRNA_hsa-mir-135b upregulated (Z=1.74). All CNVs fall within normal range (−1.10 to −0.10). These features suggest luminal transcriptional activity without strong genomic or epigenetic drivers.,"mRNA_MLPH: 0.380450903097812, mRNA_C2orf54: 0.076149091335114, mRNA_CITED4: 1.33493032384169, mRNA_ESR1: 0.2591767514654783, mRNA_SPDEF: 0.2896291016562309, mRNA_AGR3: 0.6462057449729246, mRNA_FOXC1: 0.0846264552754222, mRNA_GATA3: 0.5616552658763913, mRNA_AGR2: -0.1836778283084658, mRNA_XBP1: 0.7480687248248697, mRNA_PRR15: 0.3779377814500471, mRNA_SLC44A4: 0.4550516367708126, mRNA_CA12: 0.4536049125153815, mRNA_DTL: 0.534800497379524, mRNA_C5AR2: 0.0085212084646604, mRNA_TBC1D9: 0.1833155289854461, mRNA_AR: 0.0531876503889062, mRNA_CCDC170: 0.3026252655234628, mRNA_DEGS2: -0.2597683473974616, mRNA_TFF3: 0.4930543991333075, mRNA_DNALI1: 0.8476610816034263, mRNA_LINC00504: 0.4119385071507053, mRNA_CLCA2: 0.3358086299491357, mRNA_PPP1R14C: 1.1263514324396988, mRNA_THSD4: -0.2493390852706313, mRNA_SPAG5: -0.56839084722113, mRNA_FBP1: 0.0335427732038786, mRNA_SLC7A8: 0.3672195653368564, mRNA_EN1: -0.6019057139816505, mRNA_ZNF552: -0.0962550693985989, Methylation_LRRC6: -0.3637710554259696, Methylation_chr2 66218712 LINC02934 (29533): 0.2521199406533245, Methylation_HOXB13: -0.9683870465146722, Methylation_chr10 3949206 LINC02660 (4871): -0.4563334774793933, Methylation_chr5 179517140 RNF130 (18026): -1.1036671612860558, Methylation_LOC727677: -0.6644004421395432, Methylation_LETM1: -0.1049906293971122, Methylation_CDC42BPB: 1.28840612241808, Methylation_C8orf38: -0.6187344955131048, Methylation_chr14 100504766 EVL (18852): -0.2153889460522567, Methylation_chr5 72594851 LOC340090 (24088): 0.1083842420710678, Methylation_chr2 242904738 LINC01238 (3421): -0.7995281928486324, Methylation_ARFGEF1: -0.7736243770057877, Methylation_MAPT: -0.4223466093541906, Methylation_ZFAT: 0.3069649485978361, Methylation_KCNQ4: -1.108646001531995, Methylation_chr1 232684368 SIPA1L2 (12934): -0.5423685511462916, Methylation_CRNKL1: -0.2047823391847431, Methylation_PRKAG2: 0.1447848278611618, Methylation_MICB: -0.6171328159939399, miRNA_hsa-mir-934: -0.2167641267825507, miRNA_hsa-mir-4728: -0.1084782692928061, miRNA_hsa-mir-5695: 0.6903742073347516, miRNA_hsa-mir-18a: -0.4262354385218573, miRNA_hsa-mir-190b: 0.8223778792117413, miRNA_hsa-mir-577: 0.0103526640625629, miRNA_hsa-mir-135b: 1.7351656745261494, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.0382715533073176, miRNA_hsa-mir-130b: -0.6406137313196437, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A1Y1,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.1777942034736106, mRNA_C2orf54: -0.4845865682835686, mRNA_CITED4: 0.2910455029453159, mRNA_ESR1: 0.5246515095411642, mRNA_SPDEF: 0.0591340335649486, mRNA_AGR3: 0.6527050945583092, mRNA_FOXC1: -0.9121728523421372, mRNA_GATA3: 0.4521937442039291, mRNA_AGR2: 0.7942356848837514, mRNA_XBP1: -0.2425082527183931, mRNA_PRR15: 0.5686840445194261, mRNA_SLC44A4: 0.7044997543613899, mRNA_CA12: 0.3904506851727446, mRNA_DTL: 0.951957285579065, mRNA_C5AR2: 0.6757112360361599, mRNA_TBC1D9: -0.4392703946030001, mRNA_AR: 0.574713622090802, mRNA_CCDC170: 0.2816346702070357, mRNA_DEGS2: 0.9429758304949712, mRNA_TFF3: 0.1933130120648102, mRNA_DNALI1: 0.4045941286380679, mRNA_LINC00504: 0.1054825492189607, mRNA_CLCA2: -0.8950940779111158, mRNA_PPP1R14C: -0.8412844339075287, mRNA_THSD4: 0.1158175317305208, mRNA_SPAG5: 0.7577098662708767, mRNA_FBP1: 0.6034552542262465, mRNA_SLC7A8: 0.474479823901264, mRNA_EN1: 0.3687964163767141, mRNA_ZNF552: -0.6475952825839058, Methylation_LRRC6: -1.0973133695512851, Methylation_chr2 66218712 LINC02934 (29533): -0.3308544864134997, Methylation_HOXB13: -1.0200595220001143, Methylation_chr10 3949206 LINC02660 (4871): -1.2010172002006014, Methylation_chr5 179517140 RNF130 (18026): 0.5401011209390754, Methylation_LOC727677: -1.1394282760633216, Methylation_LETM1: -0.697970521906861, Methylation_CDC42BPB: -1.2657802836324457, Methylation_C8orf38: -1.1132866548792788, Methylation_chr14 100504766 EVL (18852): -0.5367356746708917, Methylation_chr5 72594851 LOC340090 (24088): 0.5000113299641537, Methylation_chr2 242904738 LINC01238 (3421): -0.2891748318077807, Methylation_ARFGEF1: -1.223059319792875, Methylation_MAPT: -0.6921625794959136, Methylation_ZFAT: -1.2124014408883657, Methylation_KCNQ4: 0.052132921905425, Methylation_chr1 232684368 SIPA1L2 (12934): -0.4914156900433529, Methylation_CRNKL1: -1.0984884716084924, Methylation_PRKAG2: 0.8227114364125666, Methylation_MICB: -0.6690255074097481, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.2581573782426533, miRNA_hsa-mir-5695: 1.307288643984209, miRNA_hsa-mir-18a: 0.551336563113047, miRNA_hsa-mir-190b: 0.7700844052538771, miRNA_hsa-mir-577: -0.4694512985201919, miRNA_hsa-mir-135b: -0.986809676833296, miRNA_hsa-mir-2115: -0.1886223295201914, miRNA_hsa-mir-17: 0.4696462030869757, miRNA_hsa-mir-130b: 0.9178335958521092, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-OL-A66I,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression of PPP1R14C and EN1. Promoter hypermethylation of LRRC6, LINC02660, RNF130, LOC727677, C8orf38, EVL, ARFGEF1, SIPA1L2, CRNKL1, and MICB mediates epigenetic silencing. miR-190b downregulation and miR-577 upregulation suggest post-transcriptional dysregulation. These features indicate a luminal B-like phenotype with ER-pathway suppression.","mRNA_MLPH: -2.137953964924792, mRNA_C2orf54: 0.2460336665169532, mRNA_CITED4: 0.6274268133442168, mRNA_ESR1: -1.7179248094108492, mRNA_SPDEF: -2.8391592600042403, mRNA_AGR3: -1.6029941594099224, mRNA_FOXC1: 1.087336595879975, mRNA_GATA3: -1.6375517468576624, mRNA_AGR2: -2.020609107204134, mRNA_XBP1: -2.1693478789694804, mRNA_PRR15: -1.6366461057789508, mRNA_SLC44A4: -2.0741881126766284, mRNA_CA12: -2.708984391579793, mRNA_DTL: 0.1621026650375912, mRNA_C5AR2: -0.9970518334058148, mRNA_TBC1D9: -1.876098941868028, mRNA_AR: -1.80593885634791, mRNA_CCDC170: -1.3818298551606687, mRNA_DEGS2: -2.221820283932016, mRNA_TFF3: -1.4584758047367778, mRNA_DNALI1: -1.7571165070736772, mRNA_LINC00504: -1.719976756955786, mRNA_CLCA2: -0.8844846909764366, mRNA_PPP1R14C: 2.4665753074426333, mRNA_THSD4: -1.7537905459901628, mRNA_SPAG5: 0.4823128887132051, mRNA_FBP1: -1.448173797783024, mRNA_SLC7A8: -1.624095913201605, mRNA_EN1: 2.8429202894691605, mRNA_ZNF552: -1.7764914703982322, Methylation_LRRC6: 1.5060598719125484, Methylation_chr2 66218712 LINC02934 (29533): 0.0973668195986932, Methylation_HOXB13: 0.3005811491356733, Methylation_chr10 3949206 LINC02660 (4871): 1.5674592956102558, Methylation_chr5 179517140 RNF130 (18026): -1.6364018230440671, Methylation_LOC727677: 1.563651342380703, Methylation_LETM1: 1.2975104240720798, Methylation_CDC42BPB: 0.49385174955779, Methylation_C8orf38: 1.6531395505037876, Methylation_chr14 100504766 EVL (18852): 1.5531480856819682, Methylation_chr5 72594851 LOC340090 (24088): -1.3540143394691588, Methylation_chr2 242904738 LINC01238 (3421): 1.4060339402703066, Methylation_ARFGEF1: 1.6177053777339443, Methylation_MAPT: 1.4372088510931147, Methylation_ZFAT: 1.3522963465056437, Methylation_KCNQ4: -0.0833081076712305, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5456703910041083, Methylation_CRNKL1: 1.403512601496023, Methylation_PRKAG2: 0.5363193416587746, Methylation_MICB: 1.520929551792228, miRNA_hsa-mir-934: 1.3881468352704238, miRNA_hsa-mir-4728: -0.922267760190366, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.4490269497142203, miRNA_hsa-mir-190b: -2.052137242410604, miRNA_hsa-mir-577: 1.7428567455620196, miRNA_hsa-mir-135b: 1.3491037010362377, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.217343303212253, miRNA_hsa-mir-130b: -0.1732582798882168, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-EW-A1OX,"High-level Amplification of none; DTL mRNA overexpression (Z=2.37) and PRR15 upregulation (Z=1.70) exceed thresholds. CITED4 (Z=-2.34) and SLC7A8 (Z=-2.94) are significantly downregulated. HOXB13 promoter hypermethylation (Z=1.79) and LETM1 hypomethylation (Z=-1.98) meet epigenetic criteria. miR-18a, miR-17, and miR-135b are downregulated (Z < -1.25). No CNVs meet amplification/deletion thresholds.","mRNA_MLPH: 1.083947001689321, mRNA_C2orf54: -1.2735059190792268, mRNA_CITED4: -2.34142914362812, mRNA_ESR1: 0.7361809727339401, mRNA_SPDEF: 0.6944157776763046, mRNA_AGR3: 0.6821344813226736, mRNA_FOXC1: -1.2498921045222944, mRNA_GATA3: 1.1137124995722203, mRNA_AGR2: 0.6291425711350781, mRNA_XBP1: 0.9930444581380486, mRNA_PRR15: 1.7047480868124132, mRNA_SLC44A4: 0.7307455690923438, mRNA_CA12: -2.001899698023799, mRNA_DTL: 2.374644690608529, mRNA_C5AR2: 0.6693781988235111, mRNA_TBC1D9: 1.431249471360579, mRNA_AR: 0.8637764288831151, mRNA_CCDC170: 1.5576617727413296, mRNA_DEGS2: 0.2351107829615333, mRNA_TFF3: 1.3784243393930902, mRNA_DNALI1: 1.2443616806306808, mRNA_LINC00504: 0.0605437802801133, mRNA_CLCA2: -0.8574107404477758, mRNA_PPP1R14C: -1.1632488817667417, mRNA_THSD4: 0.9821635092996168, mRNA_SPAG5: -0.1270609954763199, mRNA_FBP1: 0.3558353904109259, mRNA_SLC7A8: -2.9442816740361084, mRNA_EN1: -1.108599181307411, mRNA_ZNF552: -0.1741238457890823, Methylation_LRRC6: -1.4843364969598607, Methylation_chr2 66218712 LINC02934 (29533): -2.025931482951555, Methylation_HOXB13: 1.7875637633211507, Methylation_chr10 3949206 LINC02660 (4871): -1.0170974055166808, Methylation_chr5 179517140 RNF130 (18026): 1.0651727570925644, Methylation_LOC727677: -0.7717863841105626, Methylation_LETM1: -1.9755461157301737, Methylation_CDC42BPB: 1.4260263236055557, Methylation_C8orf38: 1.6577984730116624, Methylation_chr14 100504766 EVL (18852): -1.4787022508397518, Methylation_chr5 72594851 LOC340090 (24088): 1.2423096911624176, Methylation_chr2 242904738 LINC01238 (3421): 1.4939628100490066, Methylation_ARFGEF1: -0.8818595035568815, Methylation_MAPT: 1.0113467991850045, Methylation_ZFAT: -0.9508591672817528, Methylation_KCNQ4: -1.1719138648641136, Methylation_chr1 232684368 SIPA1L2 (12934): -1.7193160792798368, Methylation_CRNKL1: -1.9153720682958568, Methylation_PRKAG2: -1.719574249220523, Methylation_MICB: -1.2057343250120391, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.4037157444387313, miRNA_hsa-mir-5695: 0.1229038070972958, miRNA_hsa-mir-18a: -1.3033402026869036, miRNA_hsa-mir-190b: 0.4258341289644789, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.347205685420266, miRNA_hsa-mir-130b: -0.8881201242226303, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A1XQ,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives genomic instability. FOXC1 and EN1 mRNA overexpression (Z > 1.30) aligns with aggressive transcriptional activity. ESR1, AGR3, GATA3, AGR2, TFF3, and AR show significant mRNA downregulation (Z < -1.92). Promoter hypermethylation (Z > 1.50) at LRRC6, LINC02660, C8orf38, EVL, ARFGEF1, and SIPA1L2 mediates epigenetic silencing. miR-934 and miR-5695 are upregulated (Z > 1.99); miR-190b is downregulated (Z < -1.25).","mRNA_MLPH: -1.1208238040881429, mRNA_C2orf54: 0.102351830317021, mRNA_CITED4: -0.3785773821875079, mRNA_ESR1: -1.9311080264809937, mRNA_SPDEF: -0.011043589528646, mRNA_AGR3: -2.0260634665434747, mRNA_FOXC1: 2.424773123993792, mRNA_GATA3: -2.9783111595501137, mRNA_AGR2: -2.1817369832396465, mRNA_XBP1: -0.982582281698252, mRNA_PRR15: -2.196607085161545, mRNA_SLC44A4: -1.431667363348794, mRNA_CA12: -1.5389093240209315, mRNA_DTL: 0.2488011655380189, mRNA_C5AR2: -1.4216155425375276, mRNA_TBC1D9: -1.4623800084646768, mRNA_AR: -2.1809291472741377, mRNA_CCDC170: -1.4968419667221662, mRNA_DEGS2: -1.59821210087838, mRNA_TFF3: -2.2100647087344347, mRNA_DNALI1: -1.220717059575806, mRNA_LINC00504: -1.7393570628291055, mRNA_CLCA2: -0.8596254839660936, mRNA_PPP1R14C: 0.6624776046492756, mRNA_THSD4: -1.8329515962764285, mRNA_SPAG5: 0.0191921206395833, mRNA_FBP1: -0.626314493805849, mRNA_SLC7A8: -1.9017007065441025, mRNA_EN1: 2.169673989285548, mRNA_ZNF552: -1.888552218902687, Methylation_LRRC6: 1.5191466807248597, Methylation_chr2 66218712 LINC02934 (29533): -0.2120977899895013, Methylation_HOXB13: -1.0901717421732906, Methylation_chr10 3949206 LINC02660 (4871): 1.5327797245045982, Methylation_chr5 179517140 RNF130 (18026): -1.584983157988503, Methylation_LOC727677: 1.4123416442712131, Methylation_LETM1: 1.37380292452196, Methylation_CDC42BPB: 0.8331072477944482, Methylation_C8orf38: 1.635682136911901, Methylation_chr14 100504766 EVL (18852): 1.5356724932448735, Methylation_chr5 72594851 LOC340090 (24088): -1.3957523892952326, Methylation_chr2 242904738 LINC01238 (3421): 1.4407247872556472, Methylation_ARFGEF1: 1.6690013913913853, Methylation_MAPT: 1.3200343923816638, Methylation_ZFAT: 1.2616146637426713, Methylation_KCNQ4: 1.0469867450331756, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5240276609223569, Methylation_CRNKL1: 1.4223653525453774, Methylation_PRKAG2: -1.2679566730166898, Methylation_MICB: 1.472786285370656, miRNA_hsa-mir-934: 2.288651902824135, miRNA_hsa-mir-4728: 0.0468520976119163, miRNA_hsa-mir-5695: 3.857931664888072, miRNA_hsa-mir-18a: 0.7478532208657839, miRNA_hsa-mir-190b: -1.7809532832277828, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: 1.494336233751774, miRNA_hsa-mir-2115: -0.455153741363866, miRNA_hsa-mir-17: 1.45160676653657, miRNA_hsa-mir-130b: 1.7244027909329178, CNV_VPS54: 2.3735003872816955, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 2.464291317721031, CNV_WDPCP: 2.38809584879993, CNV_CEP68: 2.464291317721031"
TCGA-OL-A6VO,"High-level Amplification absent; no CNVs meet amplification thresholds.  
mRNA_EN1 (Z=3.00) and mRNA_FOXC1 (Z=2.59) significantly overexpressed.  
mRNA_GATA3 (Z=-3.29), mRNA_MLPH (Z=-3.08), and mRNA_AGR2 (Z=-2.52) strongly downregulated.  
Methylation_chr10:3949206, ARFGEF1, KCNQ4, and chr14:100504766 hypermethylated (Z>1.50).  
Methylation_chr5:72594851 hypomethylated (Z=-1.58).  
miRNA_hsa-mir-18a, -17, -934, and -577 upregulated (Z>1.99); miRNA_hsa-mir-190b downregulated (Z<-1.25).","mRNA_MLPH: -3.0786342974892764, mRNA_C2orf54: 1.841073177602312, mRNA_CITED4: 0.3379161237589395, mRNA_ESR1: -1.4150105218328517, mRNA_SPDEF: -1.652356746553146, mRNA_AGR3: -1.9176614813034127, mRNA_FOXC1: 2.5991459699160195, mRNA_GATA3: -3.2883967527112405, mRNA_AGR2: -2.521642215436944, mRNA_XBP1: -2.262130193460966, mRNA_PRR15: -0.604511090740165, mRNA_SLC44A4: -2.223185496894956, mRNA_CA12: -1.925510217257551, mRNA_DTL: 1.4019646052749737, mRNA_C5AR2: -1.8576279303082504, mRNA_TBC1D9: -2.2695177121545416, mRNA_AR: -1.7148815507527797, mRNA_CCDC170: -1.5929293975793044, mRNA_DEGS2: -1.289019599887337, mRNA_TFF3: -1.418174675695011, mRNA_DNALI1: -1.9030726841021464, mRNA_LINC00504: -1.660052690910251, mRNA_CLCA2: -0.8295099534902286, mRNA_PPP1R14C: 1.398081491314026, mRNA_THSD4: -2.267268890425496, mRNA_SPAG5: 1.4580563324120122, mRNA_FBP1: -2.2691854070420225, mRNA_SLC7A8: -2.3314433596974258, mRNA_EN1: 3.002114579985267, mRNA_ZNF552: -1.5086587281603123, Methylation_LRRC6: 1.4968511529667492, Methylation_chr2 66218712 LINC02934 (29533): -1.1602908996667245, Methylation_HOXB13: -0.9785283247152984, Methylation_chr10 3949206 LINC02660 (4871): 1.6342554874374142, Methylation_chr5 179517140 RNF130 (18026): -1.4407104907760018, Methylation_LOC727677: 1.485352687998324, Methylation_LETM1: 1.3136507568523776, Methylation_CDC42BPB: -0.2443176031255259, Methylation_C8orf38: 1.2971338229718754, Methylation_chr14 100504766 EVL (18852): 1.5207359648723833, Methylation_chr5 72594851 LOC340090 (24088): -1.5829502412090333, Methylation_chr2 242904738 LINC01238 (3421): 1.3520618315311312, Methylation_ARFGEF1: 1.6832054920413029, Methylation_MAPT: 1.4757032611698342, Methylation_ZFAT: 1.3353492198760493, Methylation_KCNQ4: 1.6433711841975658, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5033074444419698, Methylation_CRNKL1: 1.3192297685993524, Methylation_PRKAG2: 0.8453389844659728, Methylation_MICB: 1.4503112368705533, miRNA_hsa-mir-934: 2.518524076570039, miRNA_hsa-mir-4728: -0.4790086700778431, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 2.9683560146404577, miRNA_hsa-mir-190b: -1.7187281350852832, miRNA_hsa-mir-577: 2.066690234950831, miRNA_hsa-mir-135b: 1.6783170063192347, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 2.830939893715997, miRNA_hsa-mir-130b: 1.4740118091702326, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-LD-A74U,"No mRNA, methylation, miRNA, or CNV features meet the specified diagnostic thresholds. All values fall within non-significant ranges per the defined criteria.","mRNA_MLPH: 0.7781535901337793, mRNA_C2orf54: 0.9194676871105556, mRNA_CITED4: 0.8214597398296939, mRNA_ESR1: 0.5161050581670134, mRNA_SPDEF: 0.7093084136760002, mRNA_AGR3: 0.3480098657958766, mRNA_FOXC1: 0.4081124192118072, mRNA_GATA3: 0.2599529026499989, mRNA_AGR2: 0.7171070537777419, mRNA_XBP1: 0.295474932105378, mRNA_PRR15: 0.5600446130382735, mRNA_SLC44A4: 1.1601879343313577, mRNA_CA12: 0.1602057071534259, mRNA_DTL: -0.3653274082378221, mRNA_C5AR2: 0.9191199515719252, mRNA_TBC1D9: 0.1337175241913173, mRNA_AR: 0.2454954932918945, mRNA_CCDC170: 0.4792611780478607, mRNA_DEGS2: 0.3394781969547466, mRNA_TFF3: 1.081841392116822, mRNA_DNALI1: 0.1633804564879411, mRNA_LINC00504: 0.1367499020624726, mRNA_CLCA2: 1.2281951609603885, mRNA_PPP1R14C: 0.1751826322117775, mRNA_THSD4: -0.1313013530198486, mRNA_SPAG5: -0.7895059423966962, mRNA_FBP1: 0.5476763187834367, mRNA_SLC7A8: 0.4181972608134268, mRNA_EN1: -0.1439164363360935, mRNA_ZNF552: 0.7277004422658925, Methylation_LRRC6: 0.7108473389540905, Methylation_chr2 66218712 LINC02934 (29533): 0.0478490366966551, Methylation_HOXB13: 0.3975180895033475, Methylation_chr10 3949206 LINC02660 (4871): -0.04799820574979, Methylation_chr5 179517140 RNF130 (18026): 0.2298957710324276, Methylation_LOC727677: 0.4461783694662817, Methylation_LETM1: 0.4650506862668029, Methylation_CDC42BPB: -0.6015441929773286, Methylation_C8orf38: 0.0730267506088712, Methylation_chr14 100504766 EVL (18852): 0.6252237689692771, Methylation_chr5 72594851 LOC340090 (24088): 0.4344626534068314, Methylation_chr2 242904738 LINC01238 (3421): 0.5245111830971391, Methylation_ARFGEF1: 0.7882164846779521, Methylation_MAPT: 0.5281695332891335, Methylation_ZFAT: -0.1930800442953449, Methylation_KCNQ4: -0.8951794910301858, Methylation_chr1 232684368 SIPA1L2 (12934): 0.7319634333134252, Methylation_CRNKL1: 0.5160387663508705, Methylation_PRKAG2: -0.1986415521649686, Methylation_MICB: 0.3652123054358005, miRNA_hsa-mir-934: -0.4070256103232638, miRNA_hsa-mir-4728: -1.017669911925391, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.912625642443895, miRNA_hsa-mir-190b: -0.420064440641482, miRNA_hsa-mir-577: -0.6666784216001485, miRNA_hsa-mir-135b: -0.7227636867685879, miRNA_hsa-mir-2115: 0.5388426670746261, miRNA_hsa-mir-17: -0.7274254931950669, miRNA_hsa-mir-130b: -0.980309520704575, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-EW-A1IY,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-significant ranges per specified Z-score and CNV cutoffs.","mRNA_MLPH: -0.0031669913233423, mRNA_C2orf54: -0.5689484411203984, mRNA_CITED4: -0.0960217676973609, mRNA_ESR1: 0.290720060275649, mRNA_SPDEF: -0.3657541568942624, mRNA_AGR3: 1.1621089685732209, mRNA_FOXC1: 0.1459177942055539, mRNA_GATA3: 0.4158498978865511, mRNA_AGR2: 0.8135891759533901, mRNA_XBP1: 0.7191362011375337, mRNA_PRR15: -0.1835712251462834, mRNA_SLC44A4: 0.945864674630278, mRNA_CA12: 0.4376130271277593, mRNA_DTL: 1.1405837134354735, mRNA_C5AR2: 0.1300510597528467, mRNA_TBC1D9: 0.7007922063454054, mRNA_AR: 0.93051806799491, mRNA_CCDC170: 0.600594401443197, mRNA_DEGS2: 0.012469328474518, mRNA_TFF3: -0.151247768767942, mRNA_DNALI1: -0.676473428724863, mRNA_LINC00504: 0.5983054510381696, mRNA_CLCA2: -0.3792890484748922, mRNA_PPP1R14C: 1.3713934017750378, mRNA_THSD4: 0.0922071203131837, mRNA_SPAG5: -0.1777283048362068, mRNA_FBP1: 0.0822306920888377, mRNA_SLC7A8: 1.1039593258146412, mRNA_EN1: -0.0114241151980881, mRNA_ZNF552: 0.4245654542549239, Methylation_LRRC6: 0.5130790770700236, Methylation_chr2 66218712 LINC02934 (29533): 0.3658815924059104, Methylation_HOXB13: 0.266636974382364, Methylation_chr10 3949206 LINC02660 (4871): 0.3034594370838482, Methylation_chr5 179517140 RNF130 (18026): 0.379724547569601, Methylation_LOC727677: 0.6404156488012007, Methylation_LETM1: 0.2811547219670386, Methylation_CDC42BPB: -1.3031721847261053, Methylation_C8orf38: 0.0764732727781169, Methylation_chr14 100504766 EVL (18852): 0.2751742757970429, Methylation_chr5 72594851 LOC340090 (24088): 0.3847605900415705, Methylation_chr2 242904738 LINC01238 (3421): -0.1757698180654736, Methylation_ARFGEF1: 0.3568100653412231, Methylation_MAPT: 0.1005832821114018, Methylation_ZFAT: 0.6517234919116723, Methylation_KCNQ4: 0.3458127520831897, Methylation_chr1 232684368 SIPA1L2 (12934): 0.3748865604147069, Methylation_CRNKL1: 0.3987617478853207, Methylation_PRKAG2: 0.4177244324457756, Methylation_MICB: 0.7584342841680167, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.564219565439143, miRNA_hsa-mir-5695: 0.3642414503585853, miRNA_hsa-mir-18a: -0.4997844118557535, miRNA_hsa-mir-190b: 0.4870419144658816, miRNA_hsa-mir-577: 0.2083194603479968, miRNA_hsa-mir-135b: -0.3784664703835602, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.6785192930035194, miRNA_hsa-mir-130b: 0.5640837829288159, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-GM-A4E0,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified Z-score and CNV cutoffs.","mRNA_MLPH: -0.4020512065015074, mRNA_C2orf54: 0.1187667183393252, mRNA_CITED4: 0.0764430282771898, mRNA_ESR1: -0.1532983274653901, mRNA_SPDEF: 0.0769238784103425, mRNA_AGR3: -0.2395011508726162, mRNA_FOXC1: 0.5591154162638212, mRNA_GATA3: -0.1121065058899743, mRNA_AGR2: 0.0581798947452992, mRNA_XBP1: -0.5429294438107777, mRNA_PRR15: -0.3929930056504137, mRNA_SLC44A4: -0.0747038498429852, mRNA_CA12: -0.0468328055590397, mRNA_DTL: -2.1042152712463262, mRNA_C5AR2: -0.2865773715921093, mRNA_TBC1D9: -0.7399776001980097, mRNA_AR: -0.5545409758425346, mRNA_CCDC170: -0.2318824344693237, mRNA_DEGS2: 0.3175518860823879, mRNA_TFF3: -0.1602846723915208, mRNA_DNALI1: -0.1672879443593769, mRNA_LINC00504: -0.7691922519087318, mRNA_CLCA2: 0.2207477498138855, mRNA_PPP1R14C: -0.2552408477428939, mRNA_THSD4: -0.4121652134751807, mRNA_SPAG5: -2.15544219727361, mRNA_FBP1: -0.9199749941728232, mRNA_SLC7A8: -0.1866094055869596, mRNA_EN1: -0.2320673430359268, mRNA_ZNF552: -0.3716388042551271, Methylation_LRRC6: 1.1578810902789949, Methylation_chr2 66218712 LINC02934 (29533): 0.301244391751759, Methylation_HOXB13: -0.9057511719877764, Methylation_chr10 3949206 LINC02660 (4871): 0.1006773709694757, Methylation_chr5 179517140 RNF130 (18026): -1.284260743279389, Methylation_LOC727677: 1.098978247501509, Methylation_LETM1: 0.8101976842517626, Methylation_CDC42BPB: -0.3664133485293979, Methylation_C8orf38: 0.8540367943868713, Methylation_chr14 100504766 EVL (18852): 0.9926697763435172, Methylation_chr5 72594851 LOC340090 (24088): 0.0381051546747289, Methylation_chr2 242904738 LINC01238 (3421): 0.9850174437678044, Methylation_ARFGEF1: 1.0198051289361154, Methylation_MAPT: 0.6610413113497676, Methylation_ZFAT: 0.5543425837286937, Methylation_KCNQ4: -0.6680349026457921, Methylation_chr1 232684368 SIPA1L2 (12934): 0.7520024888442107, Methylation_CRNKL1: 0.7990071265627059, Methylation_PRKAG2: 0.2643627676040833, Methylation_MICB: 0.9725121666594712, miRNA_hsa-mir-934: 0.0931203500651524, miRNA_hsa-mir-4728: 0.099389209414465, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.221553481929765, miRNA_hsa-mir-190b: -0.2011093728623151, miRNA_hsa-mir-577: -0.5431176513661835, miRNA_hsa-mir-135b: -0.5850706369594022, miRNA_hsa-mir-2115: -0.3165463009612704, miRNA_hsa-mir-17: 0.0815618057918984, miRNA_hsa-mir-130b: -0.981790985712624, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E2-A573,"High-level Amplification absent; no CNV alterations meet diagnostic thresholds.  
FOXC1, PPP1R14C, and EN1 show high mRNA expression (Z > 1.30).  
ESR1, GATA3, AR, SLC7A8, and THSD4 exhibit low mRNA levels (Z < -1.92).  
HOXB13 and RNF130 promoters are hypomethylated (Z < -1.47); multiple loci hypermethylated (Z > 1.50).  
hsa-mir-934 and hsa-mir-18a upregulated (Z > 1.99); hsa-mir-190b downregulated (Z < -1.25).","mRNA_MLPH: -1.6589764438443422, mRNA_C2orf54: 0.5426775305535045, mRNA_CITED4: 0.5062033439307595, mRNA_ESR1: -1.985134408638476, mRNA_SPDEF: -1.080955893422847, mRNA_AGR3: -1.7751636149289176, mRNA_FOXC1: 2.711171783922204, mRNA_GATA3: -2.4181859266786025, mRNA_AGR2: -1.7678387011029064, mRNA_XBP1: -1.277262521723025, mRNA_PRR15: -1.329582074949252, mRNA_SLC44A4: -2.189662331455461, mRNA_CA12: -1.95674184534915, mRNA_DTL: 0.6229042174094158, mRNA_C5AR2: -1.838168486577313, mRNA_TBC1D9: -2.126021301364964, mRNA_AR: -2.4165150965181903, mRNA_CCDC170: -1.6269504634319127, mRNA_DEGS2: -0.6877439906780091, mRNA_TFF3: -1.5199938062925018, mRNA_DNALI1: -1.8788728966681905, mRNA_LINC00504: -1.647852500595778, mRNA_CLCA2: 0.2956023901940111, mRNA_PPP1R14C: 2.333574155204386, mRNA_THSD4: -2.185701346727467, mRNA_SPAG5: 0.5661355922641877, mRNA_FBP1: -1.7734631889521253, mRNA_SLC7A8: -2.393479189325144, mRNA_EN1: 2.2309485670094107, mRNA_ZNF552: -2.0472441882418373, Methylation_LRRC6: 1.4717291093787137, Methylation_chr2 66218712 LINC02934 (29533): 0.4273347626914647, Methylation_HOXB13: -1.0469244262176238, Methylation_chr10 3949206 LINC02660 (4871): 1.6050243521337997, Methylation_chr5 179517140 RNF130 (18026): -1.5717567515765372, Methylation_LOC727677: 1.50338002436179, Methylation_LETM1: 1.3326792540108383, Methylation_CDC42BPB: -0.5587240156577696, Methylation_C8orf38: 1.4942820176840577, Methylation_chr14 100504766 EVL (18852): 1.4569967490161408, Methylation_chr5 72594851 LOC340090 (24088): -1.4889509829445362, Methylation_chr2 242904738 LINC01238 (3421): 1.3318389195895624, Methylation_ARFGEF1: 1.5367906262829143, Methylation_MAPT: 1.4236347751811618, Methylation_ZFAT: 1.4090799045070703, Methylation_KCNQ4: 0.8209007667730687, Methylation_chr1 232684368 SIPA1L2 (12934): 1.527406703103939, Methylation_CRNKL1: 1.3599859346356924, Methylation_PRKAG2: -0.7170835209792936, Methylation_MICB: 1.4381110533588737, miRNA_hsa-mir-934: 3.029362895268357, miRNA_hsa-mir-4728: -0.7039619109457691, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 2.421251474670675, miRNA_hsa-mir-190b: -1.450603061389146, miRNA_hsa-mir-577: 1.179186297635401, miRNA_hsa-mir-135b: 1.7338097446027911, miRNA_hsa-mir-2115: -0.4328062292851264, miRNA_hsa-mir-17: 1.977171765691473, miRNA_hsa-mir-130b: 1.8566260013079288, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-E9-A228,High-level Amplification of SPAG5 drives significant mRNA overexpression. AGR2 and PRR15 show high mRNA expression (Z > 1.30). CITED4 is low (Z < -1.92). PRKAG2 promoter hypermethylation (Z > 1.50) suggests silencing; CRNKL1 and MICB are hypomethylated (Z < -1.47). miR-4728 is upregulated (Z > 1.99); no downregulated miRNAs meet threshold. CNV shows no amplifications/deletions per criteria.,"mRNA_MLPH: -0.0859473267834488, mRNA_C2orf54: -1.2693107405048325, mRNA_CITED4: -2.863503301479708, mRNA_ESR1: 1.1013657544525168, mRNA_SPDEF: 0.3113884318540935, mRNA_AGR3: 0.3419706379041807, mRNA_FOXC1: -0.5225653148973994, mRNA_GATA3: 0.8701723124498664, mRNA_AGR2: 1.641889233544783, mRNA_XBP1: 0.9834627260418596, mRNA_PRR15: 1.826733333859761, mRNA_SLC44A4: 0.441788343741493, mRNA_CA12: -0.3637865220018316, mRNA_DTL: 0.9807284635783138, mRNA_C5AR2: 0.5160989819428762, mRNA_TBC1D9: 1.0095371446672876, mRNA_AR: 0.8740016142399203, mRNA_CCDC170: 0.4766682669690555, mRNA_DEGS2: -0.3534176204075123, mRNA_TFF3: 1.5060755380511217, mRNA_DNALI1: 0.4772649842889268, mRNA_LINC00504: 0.3471693758859802, mRNA_CLCA2: -0.8873855244009909, mRNA_PPP1R14C: -0.8020824321799953, mRNA_THSD4: 1.3640382073989092, mRNA_SPAG5: 2.5271193370421696, mRNA_FBP1: 1.2261401825569989, mRNA_SLC7A8: -0.3220090214414247, mRNA_EN1: -0.6185466491001372, mRNA_ZNF552: 0.3661579740112161, Methylation_LRRC6: -1.078924687171426, Methylation_chr2 66218712 LINC02934 (29533): 0.3049660412069799, Methylation_HOXB13: 1.401505073243373, Methylation_chr10 3949206 LINC02660 (4871): -1.1597705813959314, Methylation_chr5 179517140 RNF130 (18026): 0.6561750982229401, Methylation_LOC727677: -0.9793427877475956, Methylation_LETM1: -1.1536209809164275, Methylation_CDC42BPB: 1.05317915561365, Methylation_C8orf38: 1.3332547949302862, Methylation_chr14 100504766 EVL (18852): -0.9822289680625376, Methylation_chr5 72594851 LOC340090 (24088): 0.3645210916282351, Methylation_chr2 242904738 LINC01238 (3421): 1.28520074287071, Methylation_ARFGEF1: -0.8448017083459213, Methylation_MAPT: 0.8396374829261207, Methylation_ZFAT: -1.073665818015777, Methylation_KCNQ4: -0.1958208117617045, Methylation_chr1 232684368 SIPA1L2 (12934): -1.0552906848191606, Methylation_CRNKL1: -1.2277093322344512, Methylation_PRKAG2: -1.70498963673898, Methylation_MICB: -1.375476495590357, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 2.111112172720517, miRNA_hsa-mir-5695: 0.5940448197522263, miRNA_hsa-mir-18a: 0.2691728527002587, miRNA_hsa-mir-190b: 0.2534780564680642, miRNA_hsa-mir-577: -0.2731735576695209, miRNA_hsa-mir-135b: -0.592391829344173, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.0756779260338891, miRNA_hsa-mir-130b: 1.7731046133805568, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A1AI,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression of PPP1R14C and FOXC1. Promoter hypermethylation of chr10:3949206 (LINC02660), chr14:100504766 (EVL), and chr1:232684368 (SIPA1L2) mediates epigenetic silencing. Hypomethylation of RNF130 correlates with transcriptional downregulation. Upregulated miR-577 and miR-934 suggest post-transcriptional dysregulation. These features indicate a basal-like phenotype with PI3K/AKT pathway activation.","mRNA_MLPH: -2.382860506552987, mRNA_C2orf54: -0.0908346927162191, mRNA_CITED4: -0.0690828240235003, mRNA_ESR1: -1.026931623794348, mRNA_SPDEF: -1.6037505237270773, mRNA_AGR3: -2.060531268628111, mRNA_FOXC1: 2.417838318144629, mRNA_GATA3: -1.1508357742873792, mRNA_AGR2: -2.403228993679574, mRNA_XBP1: -1.271157120089378, mRNA_PRR15: -2.5087547907151366, mRNA_SLC44A4: -2.1861045692100056, mRNA_CA12: -2.431088548299624, mRNA_DTL: -0.0916465725274746, mRNA_C5AR2: -1.756429223635285, mRNA_TBC1D9: -1.7051948132051928, mRNA_AR: -2.3677926278405725, mRNA_CCDC170: -1.6116639232332104, mRNA_DEGS2: -1.898563294227321, mRNA_TFF3: -2.291788040378579, mRNA_DNALI1: -2.0695838625630145, mRNA_LINC00504: -1.74684500546988, mRNA_CLCA2: -0.6243577906684893, mRNA_PPP1R14C: 2.7297676570613474, mRNA_THSD4: -1.80156008890855, mRNA_SPAG5: 1.449399158696868, mRNA_FBP1: 0.2132307282719801, mRNA_SLC7A8: -2.196188518197902, mRNA_EN1: -1.0822907253856886, mRNA_ZNF552: -1.686664427898794, Methylation_LRRC6: 1.4971098839890804, Methylation_chr2 66218712 LINC02934 (29533): 0.0130662733769972, Methylation_HOXB13: 0.7585735205181897, Methylation_chr10 3949206 LINC02660 (4871): 1.6071978781499765, Methylation_chr5 179517140 RNF130 (18026): -1.5047885839617257, Methylation_LOC727677: 1.4922297392263526, Methylation_LETM1: 1.362191789147033, Methylation_CDC42BPB: 0.5095064492979225, Methylation_C8orf38: 1.4229983496597018, Methylation_chr14 100504766 EVL (18852): 1.505834301051648, Methylation_chr5 72594851 LOC340090 (24088): -1.3378917363563283, Methylation_chr2 242904738 LINC01238 (3421): 1.475794256079594, Methylation_ARFGEF1: 1.484159298857394, Methylation_MAPT: 1.4034911916769417, Methylation_ZFAT: 1.3832049919360614, Methylation_KCNQ4: 0.7378499355472923, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5151783391283011, Methylation_CRNKL1: 1.4354378969284716, Methylation_PRKAG2: -1.059355423772459, Methylation_MICB: 1.426422577025522, miRNA_hsa-mir-934: 2.170249978973175, miRNA_hsa-mir-4728: 0.4636933955040512, miRNA_hsa-mir-5695: 1.2273481312108734, miRNA_hsa-mir-18a: 1.677168226655149, miRNA_hsa-mir-190b: -1.2189332108158817, miRNA_hsa-mir-577: 3.954953070754875, miRNA_hsa-mir-135b: 0.1717598440549338, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.4296897725886584, miRNA_hsa-mir-130b: 0.9799596036814974, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-OL-A5RU,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.8135136570972805, mRNA_C2orf54: -1.046690978827124, mRNA_CITED4: -0.0685271248643581, mRNA_ESR1: 0.934114871538808, mRNA_SPDEF: 0.7187939666025461, mRNA_AGR3: 0.5364050771819457, mRNA_FOXC1: -0.1381640263013204, mRNA_GATA3: 0.143370760788874, mRNA_AGR2: -0.1445226481633372, mRNA_XBP1: 0.9930866377761404, mRNA_PRR15: 0.1694154921440583, mRNA_SLC44A4: 0.6714610311658218, mRNA_CA12: 0.4960104734230018, mRNA_DTL: -1.2367294168715437, mRNA_C5AR2: 0.6216941968209114, mRNA_TBC1D9: 1.0997914974186844, mRNA_AR: 0.6303116952151596, mRNA_CCDC170: 0.6527033658573876, mRNA_DEGS2: 0.3183867445004201, mRNA_TFF3: 0.3332639545392907, mRNA_DNALI1: -0.0272014839310419, mRNA_LINC00504: 0.3780077993748054, mRNA_CLCA2: -0.3161899809586903, mRNA_PPP1R14C: -0.1918653438261296, mRNA_THSD4: 0.6422052984122332, mRNA_SPAG5: -1.2332644796480476, mRNA_FBP1: 0.4454864646301073, mRNA_SLC7A8: 0.0427773042046143, mRNA_EN1: -0.5626633418779478, mRNA_ZNF552: 1.1244916175462505, Methylation_LRRC6: 0.6519425433957418, Methylation_chr2 66218712 LINC02934 (29533): 0.7838268776815919, Methylation_HOXB13: -0.9251321029104644, Methylation_chr10 3949206 LINC02660 (4871): -0.0094452693210897, Methylation_chr5 179517140 RNF130 (18026): -0.2593822489113893, Methylation_LOC727677: 0.0902935783339973, Methylation_LETM1: 0.2557958763982564, Methylation_CDC42BPB: -0.8225136855492762, Methylation_C8orf38: 0.2695714658307879, Methylation_chr14 100504766 EVL (18852): 0.3592849509477349, Methylation_chr5 72594851 LOC340090 (24088): -0.0873461249262018, Methylation_chr2 242904738 LINC01238 (3421): -0.5571253811466973, Methylation_ARFGEF1: 0.5620188526744962, Methylation_MAPT: 0.4476856080482961, Methylation_ZFAT: -0.1271476805754987, Methylation_KCNQ4: 0.3348885300866883, Methylation_chr1 232684368 SIPA1L2 (12934): 0.5754240557982336, Methylation_CRNKL1: 0.5778333846955535, Methylation_PRKAG2: 0.2905976955779765, Methylation_MICB: 0.542981370297743, miRNA_hsa-mir-934: -0.5049445572386813, miRNA_hsa-mir-4728: -0.455604405071268, miRNA_hsa-mir-5695: -0.4185791495172725, miRNA_hsa-mir-18a: -1.1482103448223222, miRNA_hsa-mir-190b: -0.1784878662142381, miRNA_hsa-mir-577: -0.6753323670692152, miRNA_hsa-mir-135b: -0.9351993292251016, miRNA_hsa-mir-2115: 0.8413604747915918, miRNA_hsa-mir-17: -0.5910431610375049, miRNA_hsa-mir-130b: -1.4618104862125618, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A7-A6VW,"High-level Amplification absent; no CNVs meet amplification thresholds.  
mRNA_C2orf54 (Z=1.35) and mRNA_FOXC1 (Z=1.53) are overexpressed; mRNA_PPP1R14C (Z=2.45) highly overexpressed.  
mRNA_TBC1D9 (Z=−2.01) is downregulated.  
Methylation_KCNQ4 (Z=1.79), Methylation_C8orf38 (Z=1.58), and Methylation_ARFGEF1 (Z=1.50) hypermethylated.  
Methylation_RNF130 (Z=−1.67) and Methylation_LOC340090 (Z=−1.53) hypomethylated.  
miRNA_hsa-mir-934 (Z=2.72) and miRNA_hsa-mir-135b (Z=2.08) upregulated; miRNA_hsa-mir-190b (Z=−1.65) downregulated.","mRNA_MLPH: -0.8659868374425171, mRNA_C2orf54: 1.3481583935548211, mRNA_CITED4: 0.6440636658600707, mRNA_ESR1: -1.3822868246561175, mRNA_SPDEF: -0.4613539619625976, mRNA_AGR3: -0.556018345809364, mRNA_FOXC1: 1.5299557999227282, mRNA_GATA3: -1.433805929766052, mRNA_AGR2: -0.0837039204075515, mRNA_XBP1: -1.83388965158306, mRNA_PRR15: 0.3271596576644331, mRNA_SLC44A4: -1.7916231307362018, mRNA_CA12: -1.793212505057181, mRNA_DTL: 0.074010931317314, mRNA_C5AR2: -1.7832302573244163, mRNA_TBC1D9: -2.0089885450493843, mRNA_AR: -1.7050629482853497, mRNA_CCDC170: -1.762310074215096, mRNA_DEGS2: -1.303154350475079, mRNA_TFF3: -1.2340926250651831, mRNA_DNALI1: -1.8882311041251163, mRNA_LINC00504: -1.5765478551805827, mRNA_CLCA2: 0.4862655516704411, mRNA_PPP1R14C: 2.44661810626268, mRNA_THSD4: -1.7471031865038391, mRNA_SPAG5: 0.7222436654112224, mRNA_FBP1: -1.816770039152351, mRNA_SLC7A8: -1.880312296414753, mRNA_EN1: 0.2812762172821645, mRNA_ZNF552: -1.4014076792703656, Methylation_LRRC6: 1.2871659241468705, Methylation_chr2 66218712 LINC02934 (29533): 0.4875135888820731, Methylation_HOXB13: 0.7564046983106468, Methylation_chr10 3949206 LINC02660 (4871): 1.4220217534179245, Methylation_chr5 179517140 RNF130 (18026): -1.6684314778463325, Methylation_LOC727677: 1.4366888974012668, Methylation_LETM1: 1.2952629091533308, Methylation_CDC42BPB: 0.9523076284433392, Methylation_C8orf38: 1.5823535741188557, Methylation_chr14 100504766 EVL (18852): 1.4891611426728355, Methylation_chr5 72594851 LOC340090 (24088): -1.5335137622311017, Methylation_chr2 242904738 LINC01238 (3421): 1.3169502666400668, Methylation_ARFGEF1: 1.502531647932139, Methylation_MAPT: 1.4582379447237632, Methylation_ZFAT: 1.401557802050273, Methylation_KCNQ4: 1.7930957619666317, Methylation_chr1 232684368 SIPA1L2 (12934): 1.544453807217689, Methylation_CRNKL1: 1.4187979008020326, Methylation_PRKAG2: -1.6199636990851105, Methylation_MICB: 1.449559914687447, miRNA_hsa-mir-934: 2.7172870368529467, miRNA_hsa-mir-4728: -0.502118515962289, miRNA_hsa-mir-5695: 0.1135981029949128, miRNA_hsa-mir-18a: 1.0725601767554438, miRNA_hsa-mir-190b: -1.6452172082606045, miRNA_hsa-mir-577: 1.331402447267394, miRNA_hsa-mir-135b: 2.07630218897069, miRNA_hsa-mir-2115: 0.3964062798651571, miRNA_hsa-mir-17: 0.7736497407438024, miRNA_hsa-mir-130b: -0.013772098349316, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-C8-A1HF,"High-level Amplification of *VPS54*, *LINC01867*, *LINC02576*, *WDPCP*, and *CEP68* drives mRNA overexpression. *C2orf54* and *CLCA2* show high mRNA (Z > 1.30). *AGR3* is low mRNA (Z < -1.92). Promoter hypermethylation at *HOXB13*, *LINC02660*, and *LOC727677* (Z > 1.50) suggests epigenetic silencing. miR-4728 is upregulated (Z > 1.99); no downregulated miRNAs meet threshold.","mRNA_MLPH: -0.548850771463315, mRNA_C2orf54: 3.3320224635013087, mRNA_CITED4: -1.286314307304582, mRNA_ESR1: -0.7272075265548955, mRNA_SPDEF: 0.5841851923208705, mRNA_AGR3: -1.6559240726406983, mRNA_FOXC1: -0.8100098947376897, mRNA_GATA3: 0.2387669807404441, mRNA_AGR2: -0.4896104064151191, mRNA_XBP1: 0.3556735387644393, mRNA_PRR15: 0.577831270474806, mRNA_SLC44A4: 0.2111574349223363, mRNA_CA12: -0.8053879480427395, mRNA_DTL: 0.7530476495639911, mRNA_C5AR2: -1.0771496601947297, mRNA_TBC1D9: -1.1455461770446476, mRNA_AR: 0.1437254536518638, mRNA_CCDC170: -1.412842794061458, mRNA_DEGS2: -0.2008259875070526, mRNA_TFF3: -0.100509956188909, mRNA_DNALI1: 1.170535790994404, mRNA_LINC00504: -0.2752461470604234, mRNA_CLCA2: 1.9557933314837777, mRNA_PPP1R14C: -0.0463453886907003, mRNA_THSD4: -1.2252154362865109, mRNA_SPAG5: 1.3679581797457303, mRNA_FBP1: -0.7506919878319601, mRNA_SLC7A8: 0.0189586051288715, mRNA_EN1: -0.0389521280539393, mRNA_ZNF552: -0.7125741514877663, Methylation_LRRC6: -0.2421561005836179, Methylation_chr2 66218712 LINC02934 (29533): -1.238678222434033, Methylation_HOXB13: 1.3341127263230674, Methylation_chr10 3949206 LINC02660 (4871): 1.639715276366105, Methylation_chr5 179517140 RNF130 (18026): 0.8012213930069757, Methylation_LOC727677: 1.4666897325803667, Methylation_LETM1: 1.3458831272970229, Methylation_CDC42BPB: -1.2448565115133772, Methylation_C8orf38: 0.886232589259292, Methylation_chr14 100504766 EVL (18852): 0.0551052222779013, Methylation_chr5 72594851 LOC340090 (24088): 0.2521710612158211, Methylation_chr2 242904738 LINC01238 (3421): 1.2329534890479894, Methylation_ARFGEF1: -0.5843003249346754, Methylation_MAPT: 1.0170317964184268, Methylation_ZFAT: 0.534689662299326, Methylation_KCNQ4: -0.9593600515218608, Methylation_chr1 232684368 SIPA1L2 (12934): 0.0296667154298801, Methylation_CRNKL1: 0.0594084735606469, Methylation_PRKAG2: -1.0352782671004976, Methylation_MICB: 0.7492926921813455, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 2.8797155135042813, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.7598728173948891, miRNA_hsa-mir-190b: 0.708680871094201, miRNA_hsa-mir-577: 0.7628891819386133, miRNA_hsa-mir-135b: -0.2664307373076442, miRNA_hsa-mir-2115: -0.1247398802009866, miRNA_hsa-mir-17: 1.1554815412807726, miRNA_hsa-mir-130b: 1.844042607237424, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-BH-A204,"mRNA_CITED4 is low (Z = -2.39).  
Methylation_HOXB13 is hyper-methylated (Z = 1.55); Methylation_ZFAT, LETM1, and LINC02934 are hypo-methylated (Z < -1.47).  
No miRNAs meet up/downregulation thresholds.  
All CNVs fall within normal range (−1.10 to −0.10).  
HOXB13 hypermethylation suggests epigenetic silencing; CITED4 downregulation may reflect transcriptional suppression.","mRNA_MLPH: 0.0587047811392656, mRNA_C2orf54: -1.2943230935752186, mRNA_CITED4: -2.3867290261079925, mRNA_ESR1: 1.2443608695813535, mRNA_SPDEF: -0.0656044044048456, mRNA_AGR3: 0.8335437129621338, mRNA_FOXC1: -0.4402333489219781, mRNA_GATA3: 0.8455491635184743, mRNA_AGR2: 1.049626589986185, mRNA_XBP1: 1.0532687182536324, mRNA_PRR15: 0.8405268447451583, mRNA_SLC44A4: 0.2017735920554289, mRNA_CA12: 0.8902161814110097, mRNA_DTL: 1.3804921128951606, mRNA_C5AR2: 0.5277677138383647, mRNA_TBC1D9: 1.170747770584494, mRNA_AR: 0.3365482153725747, mRNA_CCDC170: 0.8680608782558656, mRNA_DEGS2: -0.102134344193382, mRNA_TFF3: 0.9912129033735868, mRNA_DNALI1: 0.2625308462856586, mRNA_LINC00504: 1.226966057112559, mRNA_CLCA2: -0.8890393515007246, mRNA_PPP1R14C: -1.0968157816223627, mRNA_THSD4: 1.344900694615996, mRNA_SPAG5: 1.0075752912484524, mRNA_FBP1: 1.1470639053876612, mRNA_SLC7A8: 1.307652491430396, mRNA_EN1: -0.5078401561173362, mRNA_ZNF552: 0.3299863606208031, Methylation_LRRC6: -1.564193605062372, Methylation_chr2 66218712 LINC02934 (29533): -1.9344692563157404, Methylation_HOXB13: 1.5535219680071748, Methylation_chr10 3949206 LINC02660 (4871): -1.3422921991847263, Methylation_chr5 179517140 RNF130 (18026): 1.2543027444520782, Methylation_LOC727677: -1.1382344906579511, Methylation_LETM1: -1.9156488955283573, Methylation_CDC42BPB: 1.113058270063043, Methylation_C8orf38: -0.8484028368699327, Methylation_chr14 100504766 EVL (18852): -1.20995051655677, Methylation_chr5 72594851 LOC340090 (24088): 1.3033769724216184, Methylation_chr2 242904738 LINC01238 (3421): -1.4690309765220226, Methylation_ARFGEF1: -1.3175232229593872, Methylation_MAPT: -1.4845769374824394, Methylation_ZFAT: -1.9482783566990065, Methylation_KCNQ4: 1.0855449953158085, Methylation_chr1 232684368 SIPA1L2 (12934): -1.3997479136291957, Methylation_CRNKL1: -1.2985337571925202, Methylation_PRKAG2: -1.4270602775505978, Methylation_MICB: -1.5658156829432317, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.4632638459466765, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.3841264794235993, miRNA_hsa-mir-190b: 1.256603313351244, miRNA_hsa-mir-577: -0.3938009417960782, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: 0.1004549556716104, miRNA_hsa-mir-17: 1.1105324139990642, miRNA_hsa-mir-130b: 0.55337892684331, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-C8-A1HJ,"High-level Amplification absent; no CNVs meet amplification thresholds.  
mRNA_PPP1R14C (Z=2.74) and mRNA_EN1 (Z=2.26) overexpressed; mRNA_CITED4 (Z=1.31) and mRNA_FOXC1 (Z=1.91) elevated per mRNA high threshold.  
Multiple mRNAs downregulated (e.g., SPDEF, GATA3, ESR1; Z < -1.92).  
Methylation hypermethylated at ARFGEF1, C8orf38, KCNQ4, and chr10:3949206 (Z > 1.50); hypomethylated at RNF130 and chr5:72594851 (Z < -1.47).  
miR-130b, miR-135b, miR-17, miR-18a, miR-577, miR-934 upregulated (Z > 1.99); miR-190b downregulated (Z < -1.25).","mRNA_MLPH: -2.5103630675369444, mRNA_C2orf54: -0.7210947603455982, mRNA_CITED4: 1.3109170564475887, mRNA_ESR1: -1.9703473696357667, mRNA_SPDEF: -2.912349449672575, mRNA_AGR3: -1.7511717625422594, mRNA_FOXC1: 1.91250561320748, mRNA_GATA3: -2.825960024265336, mRNA_AGR2: -1.9116578352439184, mRNA_XBP1: -2.0156067222717047, mRNA_PRR15: -2.124985841619685, mRNA_SLC44A4: -2.2238272724367576, mRNA_CA12: -1.5638440529837567, mRNA_DTL: 0.8027052865640119, mRNA_C5AR2: -2.0908198383018086, mRNA_TBC1D9: -2.4658286772942235, mRNA_AR: -2.0894330044356297, mRNA_CCDC170: -1.847604684387741, mRNA_DEGS2: -1.2988219085613564, mRNA_TFF3: -2.109033410219915, mRNA_DNALI1: -1.775718376325764, mRNA_LINC00504: -1.6448091236741884, mRNA_CLCA2: -0.8241991168626476, mRNA_PPP1R14C: 2.7388049064706874, mRNA_THSD4: -2.153465074261073, mRNA_SPAG5: -0.0648180107295863, mRNA_FBP1: -2.704837936764856, mRNA_SLC7A8: -2.042599701260346, mRNA_EN1: 2.2565319177821546, mRNA_ZNF552: -2.118811590720384, Methylation_LRRC6: 1.4639636984191384, Methylation_chr2 66218712 LINC02934 (29533): -1.868862611099344, Methylation_HOXB13: -1.094089015636153, Methylation_chr10 3949206 LINC02660 (4871): 1.590195073777557, Methylation_chr5 179517140 RNF130 (18026): -1.6437235205842131, Methylation_LOC727677: 1.4715266896899035, Methylation_LETM1: 1.3125979297738284, Methylation_CDC42BPB: 1.2768784899273264, Methylation_C8orf38: 1.6231957527096883, Methylation_chr14 100504766 EVL (18852): 1.5972684272332012, Methylation_chr5 72594851 LOC340090 (24088): -1.5679256717941867, Methylation_chr2 242904738 LINC01238 (3421): 1.405586018929556, Methylation_ARFGEF1: 1.6497147346176146, Methylation_MAPT: 1.432052396429738, Methylation_ZFAT: 1.4333498668960396, Methylation_KCNQ4: 1.607122256843521, Methylation_chr1 232684368 SIPA1L2 (12934): 1.4946005195230323, Methylation_CRNKL1: 1.4703847466769333, Methylation_PRKAG2: -0.3161519501655376, Methylation_MICB: 1.5486804160309309, miRNA_hsa-mir-934: 3.806226927856376, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 3.840472202800104, miRNA_hsa-mir-190b: -2.052137242410604, miRNA_hsa-mir-577: 3.309941877251568, miRNA_hsa-mir-135b: 3.9046900370173, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 3.446698645372781, miRNA_hsa-mir-130b: 4.291996841703456, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-BH-A1EY,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.4352515626663073, mRNA_C2orf54: -0.0629992489943242, mRNA_CITED4: -1.3725992681742711, mRNA_ESR1: 0.6159631503374047, mRNA_SPDEF: -0.1140069638856337, mRNA_AGR3: 0.6033146367637358, mRNA_FOXC1: -0.5102367084675138, mRNA_GATA3: -0.060687279081019, mRNA_AGR2: 0.6176786199653542, mRNA_XBP1: 0.3562305608070397, mRNA_PRR15: 0.1361672318246326, mRNA_SLC44A4: 0.7885155754818425, mRNA_CA12: 0.830657823605125, mRNA_DTL: -0.7407652142806415, mRNA_C5AR2: -0.4254002411928962, mRNA_TBC1D9: -0.1011666773756026, mRNA_AR: 0.7926013380634951, mRNA_CCDC170: 0.7972468881558631, mRNA_DEGS2: 0.5491544337406326, mRNA_TFF3: 0.8143644393870112, mRNA_DNALI1: 0.8423572557247364, mRNA_LINC00504: -0.2017919976065265, mRNA_CLCA2: -0.2729783536555185, mRNA_PPP1R14C: 0.6827013935024369, mRNA_THSD4: 0.2832155423927698, mRNA_SPAG5: -0.2864689760940115, mRNA_FBP1: 0.0349387601026281, mRNA_SLC7A8: 0.4009243349046378, mRNA_EN1: 0.1132217054110366, mRNA_ZNF552: -0.2645419573351476, Methylation_LRRC6: -0.2443530582605204, Methylation_chr2 66218712 LINC02934 (29533): 0.7698697811020396, Methylation_HOXB13: 0.2692816031167646, Methylation_chr10 3949206 LINC02660 (4871): -0.1588782353423185, Methylation_chr5 179517140 RNF130 (18026): -0.1447173246810117, Methylation_LOC727677: -0.4448433325293702, Methylation_LETM1: -0.5119606619396525, Methylation_CDC42BPB: -0.97911486046973, Methylation_C8orf38: -0.7486005093528538, Methylation_chr14 100504766 EVL (18852): 1.2479249817723728, Methylation_chr5 72594851 LOC340090 (24088): 0.393607848102029, Methylation_chr2 242904738 LINC01238 (3421): -0.3704043039507796, Methylation_ARFGEF1: 0.411703576107166, Methylation_MAPT: -0.2560391408650048, Methylation_ZFAT: -0.4904320480384515, Methylation_KCNQ4: 0.1333638120526647, Methylation_chr1 232684368 SIPA1L2 (12934): -0.0726924009761228, Methylation_CRNKL1: 0.5406274637765832, Methylation_PRKAG2: -0.7382229536467478, Methylation_MICB: 0.1209169288252292, miRNA_hsa-mir-934: -0.2429422935137649, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: 0.5896374368786078, miRNA_hsa-mir-18a: -1.1403554384504353, miRNA_hsa-mir-190b: -0.5693032330033347, miRNA_hsa-mir-577: -0.5784748638140006, miRNA_hsa-mir-135b: -0.8448025466646991, miRNA_hsa-mir-2115: 1.501454302157626, miRNA_hsa-mir-17: -1.4009659769624752, miRNA_hsa-mir-130b: -0.0840743974860293, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A0W4,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.4384368055396152, mRNA_C2orf54: 0.143799554860605, mRNA_CITED4: 0.4252699030248114, mRNA_ESR1: 0.207984356400362, mRNA_SPDEF: 0.4542495200952191, mRNA_AGR3: 0.5291386719524204, mRNA_FOXC1: -0.0494368427488376, mRNA_GATA3: 0.964527308849268, mRNA_AGR2: 0.4714051010133432, mRNA_XBP1: 1.154081847006412, mRNA_PRR15: 0.7954431998793915, mRNA_SLC44A4: 0.3888306121827764, mRNA_CA12: 0.7980891639491304, mRNA_DTL: -0.3901449510825168, mRNA_C5AR2: 0.8433094082262491, mRNA_TBC1D9: 0.8138601152165356, mRNA_AR: 1.2745025422044465, mRNA_CCDC170: 1.2480624795472568, mRNA_DEGS2: 0.9040053812340416, mRNA_TFF3: 0.4235070095637033, mRNA_DNALI1: 0.7703686381260384, mRNA_LINC00504: 1.4771329143428278, mRNA_CLCA2: 0.3028003265534118, mRNA_PPP1R14C: 0.2214442594797137, mRNA_THSD4: 0.9925407980111648, mRNA_SPAG5: -0.1013066626382008, mRNA_FBP1: 0.30376376313107, mRNA_SLC7A8: 0.984348918739426, mRNA_EN1: -0.5830091808359819, mRNA_ZNF552: 0.6622322966184729, Methylation_LRRC6: -0.0026423432328204, Methylation_chr2 66218712 LINC02934 (29533): -0.1860276433210518, Methylation_HOXB13: -0.9469125098199858, Methylation_chr10 3949206 LINC02660 (4871): -0.47840201160455, Methylation_chr5 179517140 RNF130 (18026): 0.8959238908265901, Methylation_LOC727677: -0.3689047324059687, Methylation_LETM1: -0.3375289876706842, Methylation_CDC42BPB: -0.8850521906565352, Methylation_C8orf38: -0.2168109227379517, Methylation_chr14 100504766 EVL (18852): -0.1947985325044553, Methylation_chr5 72594851 LOC340090 (24088): 0.7339978436486015, Methylation_chr2 242904738 LINC01238 (3421): -0.5467751872111212, Methylation_ARFGEF1: -0.2349329601272922, Methylation_MAPT: -0.2779090211868891, Methylation_ZFAT: -0.0339561326772278, Methylation_KCNQ4: -1.138900134681048, Methylation_chr1 232684368 SIPA1L2 (12934): -0.4302440970547859, Methylation_CRNKL1: -0.3604495497645453, Methylation_PRKAG2: -0.2658816176490409, Methylation_MICB: -0.1731227143744635, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.8230867846242282, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.5821359611496716, miRNA_hsa-mir-190b: 0.0013823956928475, miRNA_hsa-mir-577: -0.4574389412522414, miRNA_hsa-mir-135b: 0.399508224184962, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.3743295556444406, miRNA_hsa-mir-130b: -1.4737256535057148, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-B6-A0WZ,High mRNA_CITED4 (Z=1.90) and mRNA_SLC7A8 (Z=1.56) indicate overexpression. miRNA_hsa-mir-5695 is upregulated (Z=2.52). No methylation or CNV alterations meet diagnostic thresholds. These features suggest luminal transcriptional activity without clear genomic or epigenetic drivers.,"mRNA_MLPH: 0.6276790398763927, mRNA_C2orf54: 0.5479958999578309, mRNA_CITED4: 1.8981899012781207, mRNA_ESR1: 0.5876754308712243, mRNA_SPDEF: 0.7045378490819275, mRNA_AGR3: 1.0024580184826417, mRNA_FOXC1: -1.0606655858291725, mRNA_GATA3: 0.3672584437739009, mRNA_AGR2: 1.0570231539446509, mRNA_XBP1: 0.6138904849508143, mRNA_PRR15: 0.469683350412865, mRNA_SLC44A4: 0.4992349450033105, mRNA_CA12: 0.491719928051082, mRNA_DTL: -0.0247631383242365, mRNA_C5AR2: 1.2823618197400957, mRNA_TBC1D9: 0.1886311316188956, mRNA_AR: 0.5606597155397728, mRNA_CCDC170: 0.597318301519663, mRNA_DEGS2: 1.333502097829124, mRNA_TFF3: 0.6183487291550599, mRNA_DNALI1: -0.2809370945390911, mRNA_LINC00504: 0.7823187007904567, mRNA_CLCA2: 1.1892898627249826, mRNA_PPP1R14C: -0.4782215638606679, mRNA_THSD4: 0.0064182396517365, mRNA_SPAG5: -0.145509886061176, mRNA_FBP1: 0.9489538453385156, mRNA_SLC7A8: 1.5618696639096608, mRNA_EN1: -0.3315448118077718, mRNA_ZNF552: 0.4285232285944693, Methylation_LRRC6: -0.6019510043735581, Methylation_chr2 66218712 LINC02934 (29533): 0.4131778967388452, Methylation_HOXB13: -0.3951319189521263, Methylation_chr10 3949206 LINC02660 (4871): -0.0684392309935696, Methylation_chr5 179517140 RNF130 (18026): 0.9688301652337435, Methylation_LOC727677: 0.1566102712429526, Methylation_LETM1: 0.4815657719531362, Methylation_CDC42BPB: -1.2359986590572276, Methylation_C8orf38: -0.9281525251657984, Methylation_chr14 100504766 EVL (18852): -0.4770151227624494, Methylation_chr5 72594851 LOC340090 (24088): 0.8337367874432456, Methylation_chr2 242904738 LINC01238 (3421): -0.853746246691973, Methylation_ARFGEF1: -0.551270555651846, Methylation_MAPT: -0.8433668729357757, Methylation_ZFAT: 0.1232021471934703, Methylation_KCNQ4: -0.2269000685640051, Methylation_chr1 232684368 SIPA1L2 (12934): -0.8396667334615895, Methylation_CRNKL1: -0.9837377942095366, Methylation_PRKAG2: 1.155913925464089, Methylation_MICB: -0.7175226535719087, miRNA_hsa-mir-934: -0.3388365556693982, miRNA_hsa-mir-4728: -0.6462719208852061, miRNA_hsa-mir-5695: 2.520318492053102, miRNA_hsa-mir-18a: -0.1747075767797241, miRNA_hsa-mir-190b: 0.2242668851864059, miRNA_hsa-mir-577: -0.3416937364618465, miRNA_hsa-mir-135b: -0.455161763872378, miRNA_hsa-mir-2115: 0.4974788674854784, miRNA_hsa-mir-17: -0.9042007542819426, miRNA_hsa-mir-130b: -0.0771085472671959, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-AR-A5QN,High mRNA_AGR3 (Z=1.35) and mRNA_AGR2 (Z=1.31) indicate luminal overexpression. mRNA_TFF3 (Z=1.33) elevated. No methylation or miRNA alterations meet significance thresholds. All CNVs fall within normal range. These features collectively indicate a luminal A phenotype with estrogen signaling activation.,"mRNA_MLPH: 1.001795718267436, mRNA_C2orf54: -0.966721048634292, mRNA_CITED4: -0.9921614641923174, mRNA_ESR1: 0.944348363701528, mRNA_SPDEF: 0.6489958578787042, mRNA_AGR3: 1.3541962974156003, mRNA_FOXC1: 0.5129667585182627, mRNA_GATA3: 0.2198301130576921, mRNA_AGR2: 1.3141871289920226, mRNA_XBP1: 0.1275826044698322, mRNA_PRR15: 1.071228820605724, mRNA_SLC44A4: 0.7439221916516043, mRNA_CA12: 0.5975050345954379, mRNA_DTL: 0.7023009769712177, mRNA_C5AR2: 1.139577385665072, mRNA_TBC1D9: 1.214258659520078, mRNA_AR: 0.0305951827629023, mRNA_CCDC170: 0.9264666557415836, mRNA_DEGS2: 0.8641677747326457, mRNA_TFF3: 1.3295946097437985, mRNA_DNALI1: -0.3898506448559473, mRNA_LINC00504: -0.2275024213167921, mRNA_CLCA2: -0.5799524861221425, mRNA_PPP1R14C: -0.1114675618975657, mRNA_THSD4: 0.8991602126788513, mRNA_SPAG5: -0.2107202708217698, mRNA_FBP1: 1.150541302212952, mRNA_SLC7A8: 0.2971953839112977, mRNA_EN1: 0.0226723843698453, mRNA_ZNF552: 0.7728762256407036, Methylation_LRRC6: -0.4861194228625797, Methylation_chr2 66218712 LINC02934 (29533): 1.2141350313593284, Methylation_HOXB13: 0.8936049129062122, Methylation_chr10 3949206 LINC02660 (4871): -0.5987551444262733, Methylation_chr5 179517140 RNF130 (18026): 0.4873592489102265, Methylation_LOC727677: -0.74418811946027, Methylation_LETM1: 0.0814648315604647, Methylation_CDC42BPB: -0.1339791738780088, Methylation_C8orf38: -0.7993171110330655, Methylation_chr14 100504766 EVL (18852): -0.2885884069099425, Methylation_chr5 72594851 LOC340090 (24088): 0.6031520014670454, Methylation_chr2 242904738 LINC01238 (3421): -0.8870106225174917, Methylation_ARFGEF1: -0.1475479476394126, Methylation_MAPT: -0.5870843414134161, Methylation_ZFAT: -0.647535228342806, Methylation_KCNQ4: 0.3750967059637359, Methylation_chr1 232684368 SIPA1L2 (12934): -0.6479657938204095, Methylation_CRNKL1: -0.0066552868302907, Methylation_PRKAG2: -0.4289546288569907, Methylation_MICB: -0.3305770250626549, miRNA_hsa-mir-934: -0.2719663391013575, miRNA_hsa-mir-4728: 0.0086133369785599, miRNA_hsa-mir-5695: 0.4779493783492946, miRNA_hsa-mir-18a: -0.5906382084552056, miRNA_hsa-mir-190b: 0.001836325579866, miRNA_hsa-mir-577: -0.459965825645277, miRNA_hsa-mir-135b: -0.746058778491402, miRNA_hsa-mir-2115: 0.6692476350249082, miRNA_hsa-mir-17: 0.2345176478485527, miRNA_hsa-mir-130b: -1.4155266749764894, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A2-A0T6,"No mRNA, methylation, miRNA, or CNV features meet the specified diagnostic thresholds. All values fall within non-actionable ranges per the defined criteria.","mRNA_MLPH: 0.2180105447526388, mRNA_C2orf54: 1.2926044363859457, mRNA_CITED4: 0.9680300258828228, mRNA_ESR1: -0.0796926405583271, mRNA_SPDEF: 0.3968023521290311, mRNA_AGR3: -0.1123385700440772, mRNA_FOXC1: -0.1261524160945391, mRNA_GATA3: 0.5959973618803827, mRNA_AGR2: 0.1609917185477371, mRNA_XBP1: -0.426532578588507, mRNA_PRR15: 0.0888586007455629, mRNA_SLC44A4: 0.6602871834769578, mRNA_CA12: 0.3065731258427402, mRNA_DTL: -1.2932810344753252, mRNA_C5AR2: -0.4353034117221141, mRNA_TBC1D9: 0.2640750593498344, mRNA_AR: 1.0272006046655493, mRNA_CCDC170: 0.0121169672897575, mRNA_DEGS2: 0.6875107769533979, mRNA_TFF3: 0.0384266675302954, mRNA_DNALI1: 0.7212371633876683, mRNA_LINC00504: 0.5780610491960316, mRNA_CLCA2: -0.3087819712089852, mRNA_PPP1R14C: -1.0263723953951382, mRNA_THSD4: 0.6029591799738341, mRNA_SPAG5: -1.6393744415476303, mRNA_FBP1: 0.3013275726483859, mRNA_SLC7A8: 1.0527037299467854, mRNA_EN1: 0.2734173336793252, mRNA_ZNF552: 0.0974816918802474, Methylation_LRRC6: -0.212838774347719, Methylation_chr2 66218712 LINC02934 (29533): 1.0509680166538098, Methylation_HOXB13: -0.8659125323595276, Methylation_chr10 3949206 LINC02660 (4871): 0.6693362117174867, Methylation_chr5 179517140 RNF130 (18026): 0.730705148527739, Methylation_LOC727677: -0.4404554454143476, Methylation_LETM1: 0.1759823887010222, Methylation_CDC42BPB: -1.1327321107603257, Methylation_C8orf38: 0.1387042798799985, Methylation_chr14 100504766 EVL (18852): -0.0779355465740259, Methylation_chr5 72594851 LOC340090 (24088): 0.8290239738582609, Methylation_chr2 242904738 LINC01238 (3421): -0.5637714610774773, Methylation_ARFGEF1: 0.876220583310891, Methylation_MAPT: 0.1556108407130343, Methylation_ZFAT: 1.354702822340245, Methylation_KCNQ4: -0.540224460652859, Methylation_chr1 232684368 SIPA1L2 (12934): 0.4973939225999984, Methylation_CRNKL1: 0.6678440749446964, Methylation_PRKAG2: 1.2440379289556929, Methylation_MICB: 0.6156559994986187, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.4189468965302309, miRNA_hsa-mir-5695: 0.2279029400502502, miRNA_hsa-mir-18a: -1.022724067568621, miRNA_hsa-mir-190b: -0.608872273748816, miRNA_hsa-mir-577: -0.1928839534970828, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: 0.0380174289879235, miRNA_hsa-mir-17: -1.6411127028296189, miRNA_hsa-mir-130b: -1.9821881517181523, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-B6-A0RE,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. FOXC1 and PPP1R14C show significant mRNA upregulation (Z > 1.30). SPDEF, AGR3, PRR15, SLC44A4, CA12, THSD4, FBP1, SLC7A8, and DEGS2 are transcriptionally downregulated (Z < -1.92). HOXB13 and LOC727677 promoters are hypermethylated (Z > 1.50); RNF130 and LOC340090 are hypomethylated (Z < -1.47). miR-934, miR-577, and miR-135b are upregulated; miR-190b is downregulated.","mRNA_MLPH: -1.7600563299809155, mRNA_C2orf54: 0.7297579435340493, mRNA_CITED4: 0.0265622498611092, mRNA_ESR1: -1.3859907036806614, mRNA_SPDEF: -2.656338629629792, mRNA_AGR3: -1.915290918541432, mRNA_FOXC1: 2.578627645951044, mRNA_GATA3: -0.4541297958302106, mRNA_AGR2: -1.8187539300051423, mRNA_XBP1: -1.7925568096348845, mRNA_PRR15: -2.3521459397022544, mRNA_SLC44A4: -2.2470750602072624, mRNA_CA12: -2.1514053595490568, mRNA_DTL: 0.6312206058365528, mRNA_C5AR2: -1.7694914373869968, mRNA_TBC1D9: -1.8214521019961087, mRNA_AR: -1.427716468833618, mRNA_CCDC170: -1.8669983750654413, mRNA_DEGS2: -2.0713573770205675, mRNA_TFF3: -2.111860390144206, mRNA_DNALI1: -0.9328517606561898, mRNA_LINC00504: -1.7003486150656622, mRNA_CLCA2: -0.2704534923153408, mRNA_PPP1R14C: 2.962298533623151, mRNA_THSD4: -2.0467556266904827, mRNA_SPAG5: 1.1247945921075968, mRNA_FBP1: -1.910562829383452, mRNA_SLC7A8: -1.913590451568751, mRNA_EN1: 1.7937562960100115, mRNA_ZNF552: -1.757096459087632, Methylation_LRRC6: 1.4961031921224155, Methylation_chr2 66218712 LINC02934 (29533): 0.4950212263300442, Methylation_HOXB13: 1.6115917906856556, Methylation_chr10 3949206 LINC02660 (4871): 0.5786001695778606, Methylation_chr5 179517140 RNF130 (18026): -1.5532020526915409, Methylation_LOC727677: 1.5110625410520735, Methylation_LETM1: 1.3860343162362012, Methylation_CDC42BPB: 1.164053684226916, Methylation_C8orf38: 1.56783185778118, Methylation_chr14 100504766 EVL (18852): 1.292395836461033, Methylation_chr5 72594851 LOC340090 (24088): -1.5371125910685624, Methylation_chr2 242904738 LINC01238 (3421): 1.354276151701459, Methylation_ARFGEF1: 1.4300951491391918, Methylation_MAPT: 1.3553269284363851, Methylation_ZFAT: 1.455930709317825, Methylation_KCNQ4: 1.3314387312738718, Methylation_chr1 232684368 SIPA1L2 (12934): 1.4928778882513838, Methylation_CRNKL1: 1.072619084841834, Methylation_PRKAG2: -1.233399390579666, Methylation_MICB: 1.3117682789707787, miRNA_hsa-mir-934: 2.759287246825759, miRNA_hsa-mir-4728: -0.5193390472386534, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.3460148399648717, miRNA_hsa-mir-190b: -2.052137242410604, miRNA_hsa-mir-577: 2.6250671149253013, miRNA_hsa-mir-135b: 2.115651066425972, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.3285604759505262, miRNA_hsa-mir-130b: 0.1263963554570604, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-A1-A0SQ,"mRNA_DTL (Z=2.397) and mRNA_TFF3 (Z=1.885) are highly overexpressed; mRNA_XBP1 (Z=1.322) and mRNA_ZNF552 (Z=1.417) exceed the high-expression threshold. mRNA_SLC7A8 (Z=-1.874) is low. LETM1, MAPT, PRKAG2, and others show promoter hypomethylation (Z < -1.47). miR-17 is downregulated (Z=-1.945). No CNVs meet deletion/amplification thresholds. These features suggest luminal breast cancer with ER pathway activity and potential immune modulation.","mRNA_MLPH: 0.9943627900615802, mRNA_C2orf54: 0.339253077560758, mRNA_CITED4: -1.0376680928289177, mRNA_ESR1: 0.610684208418569, mRNA_SPDEF: 1.0753092667282844, mRNA_AGR3: 0.5042125466293862, mRNA_FOXC1: -0.6372421422177174, mRNA_GATA3: 0.8295605619004908, mRNA_AGR2: 0.5374960156848668, mRNA_XBP1: 1.322056966647145, mRNA_PRR15: 1.0346336024509466, mRNA_SLC44A4: 0.9815139554380128, mRNA_CA12: 0.1366143199577442, mRNA_DTL: 2.397265137751192, mRNA_C5AR2: 0.8121253661380698, mRNA_TBC1D9: 1.104601576692012, mRNA_AR: -0.5547412456427037, mRNA_CCDC170: -1.448846499634587, mRNA_DEGS2: 0.0031014507352391, mRNA_TFF3: 1.884849274500662, mRNA_DNALI1: 0.4677871043055425, mRNA_LINC00504: 0.8471640855538275, mRNA_CLCA2: -0.8655462821168831, mRNA_PPP1R14C: -0.9447448164814342, mRNA_THSD4: 1.2558743691780367, mRNA_SPAG5: 0.2679577400960312, mRNA_FBP1: 1.090958097712022, mRNA_SLC7A8: -1.8735501246933444, mRNA_EN1: -1.0056764615042135, mRNA_ZNF552: 1.4165523047452626, Methylation_LRRC6: -1.1714448073441874, Methylation_chr2 66218712 LINC02934 (29533): -0.4209366729342139, Methylation_HOXB13: -0.4943651386566198, Methylation_chr10 3949206 LINC02660 (4871): -1.1426797222007847, Methylation_chr5 179517140 RNF130 (18026): 0.9022629054351228, Methylation_LOC727677: -1.2906931917787043, Methylation_LETM1: -1.6858708809539429, Methylation_CDC42BPB: -1.3602656220597964, Methylation_C8orf38: -0.7510669523443314, Methylation_chr14 100504766 EVL (18852): -1.2837017182544546, Methylation_chr5 72594851 LOC340090 (24088): -0.6558745176477225, Methylation_chr2 242904738 LINC01238 (3421): -1.1391026110180051, Methylation_ARFGEF1: -1.035787479941477, Methylation_MAPT: -1.5338250697733624, Methylation_ZFAT: -1.1594212753602615, Methylation_KCNQ4: -1.2244270975564928, Methylation_chr1 232684368 SIPA1L2 (12934): -1.3697462649557164, Methylation_CRNKL1: -1.338287383663014, Methylation_PRKAG2: -1.476895744158798, Methylation_MICB: -1.1354891353962475, miRNA_hsa-mir-934: -0.1806480182090281, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: 0.8293533870647818, miRNA_hsa-mir-18a: -1.1060546380825005, miRNA_hsa-mir-190b: 1.5943980878051107, miRNA_hsa-mir-577: -0.3755505910518434, miRNA_hsa-mir-135b: -0.5052576065666029, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.94452145595765, miRNA_hsa-mir-130b: 1.0623676950047725, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-GM-A3XN,High mRNA_CITED4 (Z=1.30) indicates overexpression. No methylation or miRNA alterations meet diagnostic thresholds. All CNVs fall within normal range (−1.10 to −0.10). Isolated CITED4 upregulation suggests limited transcriptional dysregulation without clear genomic or epigenetic drivers.,"mRNA_MLPH: 0.2871697417500451, mRNA_C2orf54: -0.4875445845760541, mRNA_CITED4: 1.3024485921801172, mRNA_ESR1: -0.3705721536023519, mRNA_SPDEF: -0.053447129000146, mRNA_AGR3: 0.3758158997949447, mRNA_FOXC1: 0.5968736595420533, mRNA_GATA3: 0.3513747354578675, mRNA_AGR2: 0.4718848738139652, mRNA_XBP1: -0.4673627108901169, mRNA_PRR15: 0.2145772047878897, mRNA_SLC44A4: 0.3709554447002396, mRNA_CA12: 0.3447116950357204, mRNA_DTL: -0.6831297126139794, mRNA_C5AR2: 0.784901707802447, mRNA_TBC1D9: -0.0710837794043966, mRNA_AR: -0.2193505439309708, mRNA_CCDC170: -0.1728942943832613, mRNA_DEGS2: 0.4397120710513051, mRNA_TFF3: 0.7227872482113824, mRNA_DNALI1: 0.7615819296450931, mRNA_LINC00504: -0.8471546090237269, mRNA_CLCA2: -0.3619078187600717, mRNA_PPP1R14C: -0.0632637497494029, mRNA_THSD4: -0.2309370024561221, mRNA_SPAG5: -0.725217106885003, mRNA_FBP1: 0.1381160865967975, mRNA_SLC7A8: -0.4889960775943685, mRNA_EN1: -0.1035658218091206, mRNA_ZNF552: 0.2917647848810004, Methylation_LRRC6: 0.8988448647560028, Methylation_chr2 66218712 LINC02934 (29533): 1.0179642116296796, Methylation_HOXB13: -0.9773812827894394, Methylation_chr10 3949206 LINC02660 (4871): 0.2548933972744837, Methylation_chr5 179517140 RNF130 (18026): 0.6369988959340919, Methylation_LOC727677: 0.283587885484588, Methylation_LETM1: 0.430083606334435, Methylation_CDC42BPB: -0.4400370328464676, Methylation_C8orf38: 0.7964444684720923, Methylation_chr14 100504766 EVL (18852): 0.8872466187141446, Methylation_chr5 72594851 LOC340090 (24088): 0.4189965807682255, Methylation_chr2 242904738 LINC01238 (3421): 0.044688871956125, Methylation_ARFGEF1: 1.334282171202151, Methylation_MAPT: 0.1234480393767409, Methylation_ZFAT: 0.5475665870061702, Methylation_KCNQ4: -1.1390163818185977, Methylation_chr1 232684368 SIPA1L2 (12934): 0.8561269924340131, Methylation_CRNKL1: 0.8884529928022081, Methylation_PRKAG2: 1.1222392531690666, Methylation_MICB: 0.7725408400625615, miRNA_hsa-mir-934: -0.4094121729249778, miRNA_hsa-mir-4728: -0.4715978244153075, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.1526377702556138, miRNA_hsa-mir-190b: 0.8800872810545814, miRNA_hsa-mir-577: -0.3860427415624086, miRNA_hsa-mir-135b: -0.6517969313231388, miRNA_hsa-mir-2115: -0.3927869525139991, miRNA_hsa-mir-17: -0.3301374381902527, miRNA_hsa-mir-130b: -0.2505699304787884, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E2-A1LL,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. CLCA2 and PPP1R14C show significant mRNA upregulation (Z > 1.30). FBP1 is low (Z < -1.92). Promoter hypermethylation in ARFGEF1, EVL, C8orf38, and LRRC6 (Z > 1.50) suggests epigenetic silencing. miR-135b and miR-18a are upregulated (Z > 1.99); miR-4728 is downregulated (Z < -1.25).","mRNA_MLPH: -0.9699215234727064, mRNA_C2orf54: -0.6575074367410414, mRNA_CITED4: 0.7017685914133334, mRNA_ESR1: -1.1306569854637432, mRNA_SPDEF: -1.340693596254334, mRNA_AGR3: -1.123377806700512, mRNA_FOXC1: 1.145723192158809, mRNA_GATA3: -1.0064257834399668, mRNA_AGR2: 0.1646064889332726, mRNA_XBP1: -1.5698387921987005, mRNA_PRR15: -1.6812833314047928, mRNA_SLC44A4: -1.2969796748631384, mRNA_CA12: 0.1895463733259796, mRNA_DTL: 1.5516257684675856, mRNA_C5AR2: -1.8134917030791189, mRNA_TBC1D9: -1.2794689905457022, mRNA_AR: -1.4035732054890238, mRNA_CCDC170: -1.7852844784564037, mRNA_DEGS2: -1.1418147768884153, mRNA_TFF3: -1.5858747115706129, mRNA_DNALI1: -1.0711347689387278, mRNA_LINC00504: -1.3972983199744833, mRNA_CLCA2: 3.31379050591747, mRNA_PPP1R14C: 2.4023208872032336, mRNA_THSD4: -0.7033071085196821, mRNA_SPAG5: 0.7602339843728757, mRNA_FBP1: -2.259950017459425, mRNA_SLC7A8: 0.349013665958378, mRNA_EN1: -0.8042501704307511, mRNA_ZNF552: -1.815662066610929, Methylation_LRRC6: 1.5144714024251282, Methylation_chr2 66218712 LINC02934 (29533): -1.0566697123619928, Methylation_HOXB13: -1.061436750030932, Methylation_chr10 3949206 LINC02660 (4871): 0.1759299265965093, Methylation_chr5 179517140 RNF130 (18026): 0.1847416006288232, Methylation_LOC727677: 1.4789958353774433, Methylation_LETM1: 1.210462274554902, Methylation_CDC42BPB: 1.1617788011156986, Methylation_C8orf38: 1.5467190108497813, Methylation_chr14 100504766 EVL (18852): 1.5992487066955134, Methylation_chr5 72594851 LOC340090 (24088): 0.5620195159117283, Methylation_chr2 242904738 LINC01238 (3421): 1.3046973596149956, Methylation_ARFGEF1: 1.7260476003815857, Methylation_MAPT: 0.8014741409108742, Methylation_ZFAT: 1.3033100010371703, Methylation_KCNQ4: -1.2155964238322712, Methylation_chr1 232684368 SIPA1L2 (12934): 1.1510688042790929, Methylation_CRNKL1: 1.399703158657162, Methylation_PRKAG2: -0.6055098987897775, Methylation_MICB: 1.2193173447109302, miRNA_hsa-mir-934: 0.2758431657782481, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.9309114349856693, miRNA_hsa-mir-190b: -1.180640349545791, miRNA_hsa-mir-577: 0.4278734539596365, miRNA_hsa-mir-135b: 2.2743433291297745, miRNA_hsa-mir-2115: 0.1858273096987412, miRNA_hsa-mir-17: 0.5930882424666927, miRNA_hsa-mir-130b: 1.4193351516887278, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-BH-AB28,High mRNA_CITED4 (Z=1.96) indicates overexpression. No methylation or miRNA alterations meet diagnostic thresholds. All CNVs fall within normal range (−1.10 to −0.10). Isolated CITED4 upregulation suggests potential HIF-pathway activation without genomic or epigenetic drivers.,"mRNA_MLPH: 0.9595454541471536, mRNA_C2orf54: -1.0449155967877, mRNA_CITED4: 1.9620993646804248, mRNA_ESR1: 0.8305471813531281, mRNA_SPDEF: 0.7386208983240311, mRNA_AGR3: 0.4943767873388496, mRNA_FOXC1: -0.3428077330161244, mRNA_GATA3: 0.5741120138088939, mRNA_AGR2: 0.8423010531355991, mRNA_XBP1: 0.9427620579356908, mRNA_PRR15: 0.5909382097470228, mRNA_SLC44A4: 0.4649584170861531, mRNA_CA12: -0.4552131321246548, mRNA_DTL: 0.4813787678654853, mRNA_C5AR2: 0.6583991088432046, mRNA_TBC1D9: 0.0508665410515471, mRNA_AR: 0.5885017441019177, mRNA_CCDC170: 0.9992882776642203, mRNA_DEGS2: 0.3585364781221372, mRNA_TFF3: 0.5226343734944732, mRNA_DNALI1: 0.9912483998055472, mRNA_LINC00504: 0.5282525467336805, mRNA_CLCA2: 0.3590435737931533, mRNA_PPP1R14C: -0.6967694483979996, mRNA_THSD4: 0.8930395179217516, mRNA_SPAG5: -0.1356558555852104, mRNA_FBP1: 0.4005846000310153, mRNA_SLC7A8: 0.5501256293390001, mRNA_EN1: -0.3448318335307842, mRNA_ZNF552: 0.9646661198791386, Methylation_LRRC6: 0.009867508882959, Methylation_chr2 66218712 LINC02934 (29533): 0.7743267473746066, Methylation_HOXB13: 0.7413609516924795, Methylation_chr10 3949206 LINC02660 (4871): -0.5235710542909309, Methylation_chr5 179517140 RNF130 (18026): 0.3906680629808213, Methylation_LOC727677: -0.1686817035122261, Methylation_LETM1: 0.1592502108326826, Methylation_CDC42BPB: 0.6872761144539595, Methylation_C8orf38: 1.3446423912186438, Methylation_chr14 100504766 EVL (18852): -0.4493791542837341, Methylation_chr5 72594851 LOC340090 (24088): 0.4591379865885571, Methylation_chr2 242904738 LINC01238 (3421): -0.5633387858988619, Methylation_ARFGEF1: -0.2468941393603069, Methylation_MAPT: -1.1905413117004948, Methylation_ZFAT: -0.1456117347790702, Methylation_KCNQ4: -0.85405158225825, Methylation_chr1 232684368 SIPA1L2 (12934): -0.6210534240090712, Methylation_CRNKL1: -0.7576620807668704, Methylation_PRKAG2: -0.0001744113004598, Methylation_MICB: -0.5269589236867679, miRNA_hsa-mir-934: -0.3351674001280358, miRNA_hsa-mir-4728: 0.0766394224375273, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.5795610242279816, miRNA_hsa-mir-190b: 0.7040466089147162, miRNA_hsa-mir-577: -0.2594756621481826, miRNA_hsa-mir-135b: 1.760763639445952, miRNA_hsa-mir-2115: -0.2736047075109924, miRNA_hsa-mir-17: 0.3147613378324727, miRNA_hsa-mir-130b: -1.2207825103399632, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A2-A0YD,"No mRNA, methylation, miRNA, or CNV features meet the specified diagnostic thresholds. All values fall within non-significant ranges per the defined criteria.","mRNA_MLPH: 0.6024107075407623, mRNA_C2orf54: 0.1244974059740781, mRNA_CITED4: 0.4610015649583254, mRNA_ESR1: 0.7765645763498299, mRNA_SPDEF: 0.0286064410303099, mRNA_AGR3: 0.5375090537455719, mRNA_FOXC1: 0.4375291955617519, mRNA_GATA3: 0.5557260651626419, mRNA_AGR2: 0.605728925164949, mRNA_XBP1: 0.3220716627941329, mRNA_PRR15: 0.4289330091669595, mRNA_SLC44A4: 0.6292237804973461, mRNA_CA12: 0.8642965324937452, mRNA_DTL: 0.1789540618885411, mRNA_C5AR2: 0.7074042233084125, mRNA_TBC1D9: 0.5297914811177333, mRNA_AR: 0.3690196499688504, mRNA_CCDC170: 0.9481091268231376, mRNA_DEGS2: 0.7561005878692862, mRNA_TFF3: 0.2455722265822167, mRNA_DNALI1: 0.7536669835757488, mRNA_LINC00504: 0.4757001574691334, mRNA_CLCA2: 0.2873810515771583, mRNA_PPP1R14C: 0.0145756369935879, mRNA_THSD4: 0.2703857544396823, mRNA_SPAG5: -0.7434945509428904, mRNA_FBP1: 0.224080917855516, mRNA_SLC7A8: 0.4660103781452561, mRNA_EN1: 0.2839408186294043, mRNA_ZNF552: 1.0071375778033642, Methylation_LRRC6: 0.2545866693025157, Methylation_chr2 66218712 LINC02934 (29533): 1.2272785684575065, Methylation_HOXB13: -0.6943276043607498, Methylation_chr10 3949206 LINC02660 (4871): -0.2021775212808579, Methylation_chr5 179517140 RNF130 (18026): 0.2956829703122666, Methylation_LOC727677: 0.0540173794776855, Methylation_LETM1: -0.1701438924149157, Methylation_CDC42BPB: -0.9360750582338352, Methylation_C8orf38: 0.7941690010110541, Methylation_chr14 100504766 EVL (18852): 0.3339007573473768, Methylation_chr5 72594851 LOC340090 (24088): 0.5697869310325326, Methylation_chr2 242904738 LINC01238 (3421): -0.1158576302958878, Methylation_ARFGEF1: 0.1667393753928044, Methylation_MAPT: 0.5610927982050259, Methylation_ZFAT: 0.363585914720999, Methylation_KCNQ4: -0.8412823082986322, Methylation_chr1 232684368 SIPA1L2 (12934): -0.2094498632875467, Methylation_CRNKL1: 0.4869803390863165, Methylation_PRKAG2: -0.4920099331216001, Methylation_MICB: -0.0749733184764809, miRNA_hsa-mir-934: -0.2750463127680125, miRNA_hsa-mir-4728: 0.8382992519075562, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.1287306842254552, miRNA_hsa-mir-190b: 0.2601453788032432, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: 0.0001313381729476, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.408466749461031, miRNA_hsa-mir-130b: -0.6693056405612092, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A7-A13F,"High-level Amplification of none; CA12 (Z=1.61), DTL (Z=1.77), and SPAG5 (Z=1.79) show high mRNA expression. No promoter hyper/hypomethylation meets thresholds. miRNA hsa-mir-5695 is upregulated (Z=1.62). CNVs show only gains (e.g., VPS54, WDPCP). These features suggest luminal breast cancer with ER pathway activity.","mRNA_MLPH: 0.3817277773680684, mRNA_C2orf54: -0.4296322624232194, mRNA_CITED4: 0.9789816676422362, mRNA_ESR1: 0.2963220253431593, mRNA_SPDEF: 0.4592479400786051, mRNA_AGR3: 0.7341493585906046, mRNA_FOXC1: -0.5280819099130518, mRNA_GATA3: 0.4697305232758007, mRNA_AGR2: 0.319459558029745, mRNA_XBP1: 0.8479065014530681, mRNA_PRR15: 0.3201381197417641, mRNA_SLC44A4: 0.3989548850934922, mRNA_CA12: 1.6138857728163098, mRNA_DTL: 1.766745918623632, mRNA_C5AR2: 0.7662409739973709, mRNA_TBC1D9: 0.1606435523381449, mRNA_AR: 0.538848592759895, mRNA_CCDC170: -0.2223972126272847, mRNA_DEGS2: 0.6862803322170367, mRNA_TFF3: 0.5858747840721036, mRNA_DNALI1: 0.0837462350572953, mRNA_LINC00504: 0.4239819252156627, mRNA_CLCA2: 0.8823973340134336, mRNA_PPP1R14C: -0.9356747533624716, mRNA_THSD4: 0.9117612922861692, mRNA_SPAG5: 1.7925987050881316, mRNA_FBP1: 0.6979530318447983, mRNA_SLC7A8: 0.9098790534754598, mRNA_EN1: -0.804293686193707, mRNA_ZNF552: 0.8444134054236231, Methylation_LRRC6: -1.2192871974536683, Methylation_chr2 66218712 LINC02934 (29533): 0.6224211801552857, Methylation_HOXB13: -0.7155070286873457, Methylation_chr10 3949206 LINC02660 (4871): -1.0140236606834143, Methylation_chr5 179517140 RNF130 (18026): 1.1678465119659591, Methylation_LOC727677: -0.4949393797450266, Methylation_LETM1: -1.125957426027531, Methylation_CDC42BPB: 1.3465537967542482, Methylation_C8orf38: 1.309050070916742, Methylation_chr14 100504766 EVL (18852): -0.7691435337135102, Methylation_chr5 72594851 LOC340090 (24088): 1.2529209530680174, Methylation_chr2 242904738 LINC01238 (3421): -0.8479851026825619, Methylation_ARFGEF1: -0.9083881818145584, Methylation_MAPT: -0.9749848374390506, Methylation_ZFAT: -0.9349909115702156, Methylation_KCNQ4: 0.96198174685509, Methylation_chr1 232684368 SIPA1L2 (12934): -1.2463719872575278, Methylation_CRNKL1: -0.957288213753657, Methylation_PRKAG2: 1.3521148387221038, Methylation_MICB: -1.0129085593070473, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.2112488337948307, miRNA_hsa-mir-5695: 1.6198542534802125, miRNA_hsa-mir-18a: 0.2070307792946291, miRNA_hsa-mir-190b: 1.078842171411449, miRNA_hsa-mir-577: -0.185654305210668, miRNA_hsa-mir-135b: -0.4426545590476142, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.0038773009576417, miRNA_hsa-mir-130b: 0.8024704586914749, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-A2-A3KC,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.862972438075462, mRNA_C2orf54: 1.0987849707341926, mRNA_CITED4: -0.4696215569588039, mRNA_ESR1: 0.554121038709943, mRNA_SPDEF: 0.6751122418455944, mRNA_AGR3: 0.5962513581900595, mRNA_FOXC1: 0.8749598370834744, mRNA_GATA3: 0.5695753746774767, mRNA_AGR2: 1.0884456603401935, mRNA_XBP1: 0.672024555958202, mRNA_PRR15: 0.3882890759323003, mRNA_SLC44A4: 0.3266806672080594, mRNA_CA12: 0.9536814878820252, mRNA_DTL: 1.188987515911029, mRNA_C5AR2: 0.1372933944668287, mRNA_TBC1D9: 0.5569466060283518, mRNA_AR: 0.7147615013168905, mRNA_CCDC170: 0.4034043110583882, mRNA_DEGS2: 1.2244482695658476, mRNA_TFF3: 0.9621961305175764, mRNA_DNALI1: 0.1717688182683376, mRNA_LINC00504: 0.4324870591092423, mRNA_CLCA2: -0.5237384351243192, mRNA_PPP1R14C: -0.03001985259387, mRNA_THSD4: 0.6584859238285814, mRNA_SPAG5: 0.2289810870679475, mRNA_FBP1: 0.368134443296552, mRNA_SLC7A8: 0.6314977578254556, mRNA_EN1: -0.3238955747266491, mRNA_ZNF552: 1.3259697276388576, Methylation_LRRC6: 0.8735390837420445, Methylation_chr2 66218712 LINC02934 (29533): 1.0871717126709108, Methylation_HOXB13: -0.8188042587879645, Methylation_chr10 3949206 LINC02660 (4871): -0.242245335066528, Methylation_chr5 179517140 RNF130 (18026): 0.2985310864623645, Methylation_LOC727677: -0.3855156925100901, Methylation_LETM1: -0.3846879167878325, Methylation_CDC42BPB: 1.066697978103353, Methylation_C8orf38: 0.5728515343343078, Methylation_chr14 100504766 EVL (18852): -0.1355797441570087, Methylation_chr5 72594851 LOC340090 (24088): 0.5096861675481753, Methylation_chr2 242904738 LINC01238 (3421): -0.4359556665645242, Methylation_ARFGEF1: 0.3829696773023204, Methylation_MAPT: -0.136362782130574, Methylation_ZFAT: 0.5851928563677153, Methylation_KCNQ4: -0.6850740883556131, Methylation_chr1 232684368 SIPA1L2 (12934): -0.1356527406334348, Methylation_CRNKL1: 0.3802682076783162, Methylation_PRKAG2: -0.2714458063218625, Methylation_MICB: 0.3563946251183174, miRNA_hsa-mir-934: 0.0342243610202132, miRNA_hsa-mir-4728: -0.4748091453835937, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.28936315027058, miRNA_hsa-mir-190b: 0.3713535843260953, miRNA_hsa-mir-577: -0.346888966387697, miRNA_hsa-mir-135b: 0.9094996841856788, miRNA_hsa-mir-2115: 0.1301243030101611, miRNA_hsa-mir-17: 0.2114669460983421, miRNA_hsa-mir-130b: -0.6290570018597512, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-EW-A1P3,"SLC7A8 mRNA overexpression (Z=1.56) exceeds the high-expression threshold. No methylation or miRNA alterations meet diagnostic criteria. All CNVs fall within the normal range (−1.10 to −0.10). Isolated SLC7A8 upregulation may indicate amino acid transport dysregulation, but insufficient genomic/epigenetic drivers preclude definitive subtype classification.","mRNA_MLPH: 0.5651880035949811, mRNA_C2orf54: -0.1448704105146885, mRNA_CITED4: 1.2614568269483064, mRNA_ESR1: 0.5022765889609512, mRNA_SPDEF: 0.5967276699319713, mRNA_AGR3: 0.9588476514827056, mRNA_FOXC1: -0.1966109274862111, mRNA_GATA3: 0.884720718916604, mRNA_AGR2: 1.28472441287579, mRNA_XBP1: -0.0950507391610228, mRNA_PRR15: 0.4779806620700668, mRNA_SLC44A4: 0.260371969605585, mRNA_CA12: 0.7997345594284023, mRNA_DTL: 0.3526651331811822, mRNA_C5AR2: 0.454097215638448, mRNA_TBC1D9: 0.0313286156641908, mRNA_AR: -0.0652459301454879, mRNA_CCDC170: 0.7727136771131229, mRNA_DEGS2: 1.2176389856423728, mRNA_TFF3: 0.3926685461275535, mRNA_DNALI1: 0.9419254192898064, mRNA_LINC00504: 0.7878927407975322, mRNA_CLCA2: 0.823426871732622, mRNA_PPP1R14C: -0.2849241032738031, mRNA_THSD4: 0.3127980441206627, mRNA_SPAG5: 0.5824188073132017, mRNA_FBP1: -0.0463162385887497, mRNA_SLC7A8: 1.5591592834522163, mRNA_EN1: -0.4559163455107002, mRNA_ZNF552: 0.7755363864801575, Methylation_LRRC6: -0.3159495792066035, Methylation_chr2 66218712 LINC02934 (29533): 1.0504573174036902, Methylation_HOXB13: -0.705112300837025, Methylation_chr10 3949206 LINC02660 (4871): 0.3443891381060517, Methylation_chr5 179517140 RNF130 (18026): 0.61390592605775, Methylation_LOC727677: 0.1482559652643798, Methylation_LETM1: -0.7211865882972336, Methylation_CDC42BPB: -1.1032543631296814, Methylation_C8orf38: 0.7839768642806665, Methylation_chr14 100504766 EVL (18852): -1.157358261882834, Methylation_chr5 72594851 LOC340090 (24088): -0.0183579437739525, Methylation_chr2 242904738 LINC01238 (3421): -0.4556540977563035, Methylation_ARFGEF1: -0.3418356183186731, Methylation_MAPT: -1.0069789531455071, Methylation_ZFAT: -0.2640998790276438, Methylation_KCNQ4: -1.1831564067840166, Methylation_chr1 232684368 SIPA1L2 (12934): -0.9581625295887256, Methylation_CRNKL1: -0.6437909237807979, Methylation_PRKAG2: 0.6493687876460712, Methylation_MICB: -1.15519192593342, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.177704855544769, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.1021377528591724, miRNA_hsa-mir-190b: -0.1070497848138532, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.3112446405208385, miRNA_hsa-mir-2115: 0.1146930117161529, miRNA_hsa-mir-17: -1.2722909626820804, miRNA_hsa-mir-130b: -0.5038693881865854, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E2-A14U,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.8025609786605093, mRNA_C2orf54: 0.2211967167339887, mRNA_CITED4: 0.694920877906219, mRNA_ESR1: 0.7036092217451997, mRNA_SPDEF: 0.8837434201201915, mRNA_AGR3: 0.3849547290293753, mRNA_FOXC1: 0.1365850706958661, mRNA_GATA3: 0.2843954323404183, mRNA_AGR2: 0.3877170182171978, mRNA_XBP1: 0.8971367689044494, mRNA_PRR15: 0.2710925800495068, mRNA_SLC44A4: 0.2721952111407326, mRNA_CA12: 0.5098662490148523, mRNA_DTL: -2.8422608844676662, mRNA_C5AR2: 0.6730484803347688, mRNA_TBC1D9: 0.5541901120694666, mRNA_AR: 0.6730624493200934, mRNA_CCDC170: 0.7624593622940941, mRNA_DEGS2: 0.5928048178927375, mRNA_TFF3: 0.2269526331983131, mRNA_DNALI1: 0.8084903343793988, mRNA_LINC00504: 0.4643889278953779, mRNA_CLCA2: 0.2545474497919718, mRNA_PPP1R14C: 0.6060255395547923, mRNA_THSD4: 0.8645374182734558, mRNA_SPAG5: -1.982774710965933, mRNA_FBP1: 0.7000387134298599, mRNA_SLC7A8: 0.2966210278204304, mRNA_EN1: -0.3799455095292428, mRNA_ZNF552: 0.6013940950165872, Methylation_LRRC6: 0.2824761146570746, Methylation_chr2 66218712 LINC02934 (29533): -0.1328168017168892, Methylation_HOXB13: -1.0661427924600448, Methylation_chr10 3949206 LINC02660 (4871): 0.1192130603553602, Methylation_chr5 179517140 RNF130 (18026): -0.4654222470625624, Methylation_LOC727677: -0.1384605104614663, Methylation_LETM1: -0.0048882441098236, Methylation_CDC42BPB: -0.3073615729588806, Methylation_C8orf38: -0.1324728471489005, Methylation_chr14 100504766 EVL (18852): 0.392828597382134, Methylation_chr5 72594851 LOC340090 (24088): 0.2359690742588093, Methylation_chr2 242904738 LINC01238 (3421): -0.0516403482792525, Methylation_ARFGEF1: 0.4723886548692292, Methylation_MAPT: -0.0486693462021246, Methylation_ZFAT: 0.7396354012186966, Methylation_KCNQ4: -0.6632585996417174, Methylation_chr1 232684368 SIPA1L2 (12934): 0.8009731172116319, Methylation_CRNKL1: 0.6516188401571353, Methylation_PRKAG2: 1.172875632900609, Methylation_MICB: 0.3135955468993625, miRNA_hsa-mir-934: 0.4769306358098774, miRNA_hsa-mir-4728: -0.2033764516358096, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.0776287719817124, miRNA_hsa-mir-190b: 0.359982613340168, miRNA_hsa-mir-577: -0.0517688641690201, miRNA_hsa-mir-135b: 0.2692941025782568, miRNA_hsa-mir-2115: 0.8852062035728596, miRNA_hsa-mir-17: 0.2957785870743208, miRNA_hsa-mir-130b: -0.2663948105025929, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-S3-AA10,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression.  
Promoter hypermethylation of chr10:3949206 (LINC02660), C8orf38, and chr14:100504766 (EVL) mediates epigenetic silencing.  
miR-18a, miR-577, and miR-17 are upregulated; miR-190b is downregulated.  
These features indicate a basal-like phenotype with PI3K/AKT/mTOR dysregulation.","mRNA_MLPH: -2.2742656528732854, mRNA_C2orf54: 0.614046201782654, mRNA_CITED4: 0.3363878565015897, mRNA_ESR1: -1.819523800784091, mRNA_SPDEF: -2.869972702055728, mRNA_AGR3: -1.973841217445852, mRNA_FOXC1: 2.362673482047502, mRNA_GATA3: -1.762117054063557, mRNA_AGR2: -1.7389955084325144, mRNA_XBP1: -1.556474825710343, mRNA_PRR15: -2.4352411489694528, mRNA_SLC44A4: -1.3510338620333162, mRNA_CA12: -2.1932398995116955, mRNA_DTL: 0.6888099799147519, mRNA_C5AR2: -1.5104270323081816, mRNA_TBC1D9: -1.8649211025521368, mRNA_AR: -2.161148061520359, mRNA_CCDC170: -1.6831071643615727, mRNA_DEGS2: -1.96081576979491, mRNA_TFF3: -1.496305599278176, mRNA_DNALI1: -1.8986706281394017, mRNA_LINC00504: -1.6708979346674018, mRNA_CLCA2: -0.8480012371810041, mRNA_PPP1R14C: 2.3182863814502626, mRNA_THSD4: -2.279085054196618, mRNA_SPAG5: 0.666630665434566, mRNA_FBP1: -1.1032407756746414, mRNA_SLC7A8: -1.9164655443472256, mRNA_EN1: 2.129174550264432, mRNA_ZNF552: -2.395586576603593, Methylation_LRRC6: 1.3953710790364244, Methylation_chr2 66218712 LINC02934 (29533): -0.1117043484945932, Methylation_HOXB13: -1.0055351220027384, Methylation_chr10 3949206 LINC02660 (4871): 1.5032679322137668, Methylation_chr5 179517140 RNF130 (18026): -1.3915202017072006, Methylation_LOC727677: 1.4514862254973708, Methylation_LETM1: 1.3343746213794438, Methylation_CDC42BPB: -0.2491521454958819, Methylation_C8orf38: 1.5598751030914446, Methylation_chr14 100504766 EVL (18852): 1.411869623589688, Methylation_chr5 72594851 LOC340090 (24088): -0.951706209123924, Methylation_chr2 242904738 LINC01238 (3421): 1.3794128029960864, Methylation_ARFGEF1: 0.8050939461367704, Methylation_MAPT: 0.7219042338428544, Methylation_ZFAT: 1.272135057942385, Methylation_KCNQ4: -0.3277690740190803, Methylation_chr1 232684368 SIPA1L2 (12934): 1.009425572516927, Methylation_CRNKL1: 1.2236198686891069, Methylation_PRKAG2: -0.8674095064525276, Methylation_MICB: 1.0539630082116127, miRNA_hsa-mir-934: -0.0004373386132412, miRNA_hsa-mir-4728: -0.1779328675808692, miRNA_hsa-mir-5695: -0.0199755498780595, miRNA_hsa-mir-18a: 2.6205871653227826, miRNA_hsa-mir-190b: -2.052137242410604, miRNA_hsa-mir-577: 2.4429461790506712, miRNA_hsa-mir-135b: 1.2184309722269788, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 3.263010029648567, miRNA_hsa-mir-130b: 1.0346291535221368, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-A1-A0SJ,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.0638694246917292, mRNA_C2orf54: -0.3085699216862237, mRNA_CITED4: -1.6168574436221896, mRNA_ESR1: 0.0760076248652399, mRNA_SPDEF: 0.0345187627106104, mRNA_AGR3: -0.5239325189971064, mRNA_FOXC1: 0.0982658313456566, mRNA_GATA3: 0.3004949723303757, mRNA_AGR2: 0.4626293842785804, mRNA_XBP1: 0.6642914525412124, mRNA_PRR15: 0.7288948457171295, mRNA_SLC44A4: 0.5106482048215966, mRNA_CA12: 0.5177533528083222, mRNA_DTL: 0.1136003585845265, mRNA_C5AR2: -0.7322092029122397, mRNA_TBC1D9: -0.0081599041986871, mRNA_AR: 0.1197890889719165, mRNA_CCDC170: 0.2138163704573056, mRNA_DEGS2: -0.3337417648721973, mRNA_TFF3: -0.0418775647023466, mRNA_DNALI1: 0.7172199762552972, mRNA_LINC00504: -0.8556586478109574, mRNA_CLCA2: -0.3873699704024852, mRNA_PPP1R14C: 0.0426522081131458, mRNA_THSD4: 0.8617958233930184, mRNA_SPAG5: 0.4509827792426169, mRNA_FBP1: 0.3639167411658686, mRNA_SLC7A8: -0.1299118053434918, mRNA_EN1: -0.64503784819739, mRNA_ZNF552: 0.1070605879335589, Methylation_LRRC6: -0.9148296010091004, Methylation_chr2 66218712 LINC02934 (29533): 1.2777503474396594, Methylation_HOXB13: -0.8776621668299477, Methylation_chr10 3949206 LINC02660 (4871): -0.8398621502249481, Methylation_chr5 179517140 RNF130 (18026): 0.764759918611232, Methylation_LOC727677: -1.0671718896215137, Methylation_LETM1: -0.8556952488466708, Methylation_CDC42BPB: 1.3430613355856975, Methylation_C8orf38: 1.2067905160993146, Methylation_chr14 100504766 EVL (18852): -0.6771390136546437, Methylation_chr5 72594851 LOC340090 (24088): 0.4557816308104652, Methylation_chr2 242904738 LINC01238 (3421): -0.1174598348089959, Methylation_ARFGEF1: -1.113400280684074, Methylation_MAPT: 0.3443314876813155, Methylation_ZFAT: -0.8812281745498124, Methylation_KCNQ4: -0.9714394884597868, Methylation_chr1 232684368 SIPA1L2 (12934): -0.7923466373365228, Methylation_CRNKL1: -0.7317905847110542, Methylation_PRKAG2: 0.0197877292531994, Methylation_MICB: -0.6062309187873212, miRNA_hsa-mir-934: -0.1079674355495014, miRNA_hsa-mir-4728: 0.4961839332804656, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.8380885226783426, miRNA_hsa-mir-190b: 0.0628122373520155, miRNA_hsa-mir-577: 0.0810568921609401, miRNA_hsa-mir-135b: 0.3146054264857325, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.391709088718501, miRNA_hsa-mir-130b: 1.7527059474938964, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-E9-A248,"mRNA_AGR3 (Z = -1.97) and mRNA_CA12 (Z = -2.12) are significantly downregulated. Methylation_chr10 3949206 (Z = 1.66), Methylation_CRNKL1 (Z = 1.51), and Methylation_MICB (Z = 1.42) are hypermethylated. No CNVs meet amplification/deletion thresholds. These features suggest luminal B-like phenotype with ER-pathway suppression.","mRNA_MLPH: -0.437986942371496, mRNA_C2orf54: 0.6587894258516993, mRNA_CITED4: -0.898649481323363, mRNA_ESR1: -1.407052420569071, mRNA_SPDEF: -0.1273840560019408, mRNA_AGR3: -1.9689443870373504, mRNA_FOXC1: -0.3725798591375909, mRNA_GATA3: -1.5507313762224737, mRNA_AGR2: -0.4453237441713529, mRNA_XBP1: -0.4940800759558474, mRNA_PRR15: 0.1694669985844976, mRNA_SLC44A4: -0.2653060477741988, mRNA_CA12: -2.122629783973057, mRNA_DTL: 0.1112936421936379, mRNA_C5AR2: -1.8518847874120827, mRNA_TBC1D9: -0.7250980958051, mRNA_AR: -1.085099019757592, mRNA_CCDC170: -1.28140928343224, mRNA_DEGS2: -0.8135780458096736, mRNA_TFF3: 0.2277813164890693, mRNA_DNALI1: -0.5457337683453215, mRNA_LINC00504: -1.2167999041362434, mRNA_CLCA2: -0.6987823987791336, mRNA_PPP1R14C: 1.1619130377146298, mRNA_THSD4: -1.6094033856778711, mRNA_SPAG5: 0.9172996271779726, mRNA_FBP1: -0.5194082721971957, mRNA_SLC7A8: -1.780239808420597, mRNA_EN1: -1.013476065401214, mRNA_ZNF552: -1.0904649083822904, Methylation_LRRC6: 1.2229941999053306, Methylation_chr2 66218712 LINC02934 (29533): 0.730989922726937, Methylation_HOXB13: -1.092983330976229, Methylation_chr10 3949206 LINC02660 (4871): 1.6614368064251477, Methylation_chr5 179517140 RNF130 (18026): -1.370609038516191, Methylation_LOC727677: -0.2612148735963436, Methylation_LETM1: 1.3710227028726798, Methylation_CDC42BPB: -0.3006811208310403, Methylation_C8orf38: 0.1620227939918725, Methylation_chr14 100504766 EVL (18852): 1.2204739990388718, Methylation_chr5 72594851 LOC340090 (24088): -1.3372470500576514, Methylation_chr2 242904738 LINC01238 (3421): 1.350901161089118, Methylation_ARFGEF1: 0.5907832612195103, Methylation_MAPT: 0.6459016347831055, Methylation_ZFAT: 0.5059471296218297, Methylation_KCNQ4: 0.4054167391833537, Methylation_chr1 232684368 SIPA1L2 (12934): 1.1337067893166757, Methylation_CRNKL1: 1.5124449751954814, Methylation_PRKAG2: -0.1159395191015075, Methylation_MICB: 1.4157703298379187, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.8513102425488231, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.3912548090526862, miRNA_hsa-mir-190b: -0.9876099605961288, miRNA_hsa-mir-577: 1.3866486265893412, miRNA_hsa-mir-135b: 1.1571751724816794, miRNA_hsa-mir-2115: 1.0168156399862498, miRNA_hsa-mir-17: 0.9416370539505384, miRNA_hsa-mir-130b: 0.6931681128636835, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-BH-A0BT,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.2650422058195481, mRNA_C2orf54: 1.2861555937456317, mRNA_CITED4: 1.0185832127898071, mRNA_ESR1: 0.2520785669291019, mRNA_SPDEF: 1.1262473818803538, mRNA_AGR3: 0.112353106015937, mRNA_FOXC1: -0.5112069918624849, mRNA_GATA3: 0.3088878985969369, mRNA_AGR2: 0.2141328738686572, mRNA_XBP1: 0.1427608115321773, mRNA_PRR15: -0.1062238753482134, mRNA_SLC44A4: -1.293618993137612, mRNA_CA12: -0.0513627717632703, mRNA_DTL: -0.6375304441700484, mRNA_C5AR2: -0.1354222527342575, mRNA_TBC1D9: -1.2376266183417846, mRNA_AR: 0.8003327324189075, mRNA_CCDC170: -0.4248178277632506, mRNA_DEGS2: 0.9725613373321814, mRNA_TFF3: 0.9910414655383534, mRNA_DNALI1: 0.8168992490107506, mRNA_LINC00504: -0.2564720106447647, mRNA_CLCA2: 0.4362425123360242, mRNA_PPP1R14C: -0.1986517210371933, mRNA_THSD4: -0.2319155200095957, mRNA_SPAG5: -1.265331282778959, mRNA_FBP1: 0.0260900502685182, mRNA_SLC7A8: 0.9246794687898476, mRNA_EN1: -0.4452073230312359, mRNA_ZNF552: 0.4087411888812772, Methylation_LRRC6: -1.251488473422987, Methylation_chr2 66218712 LINC02934 (29533): -0.7361204852883638, Methylation_HOXB13: -1.0443827254996416, Methylation_chr10 3949206 LINC02660 (4871): -1.120833636431716, Methylation_chr5 179517140 RNF130 (18026): 0.6046891026618604, Methylation_LOC727677: 0.0302721097314922, Methylation_LETM1: -0.7637788949095441, Methylation_CDC42BPB: -1.168993828035147, Methylation_C8orf38: -0.9525496741107944, Methylation_chr14 100504766 EVL (18852): -1.27384509560746, Methylation_chr5 72594851 LOC340090 (24088): 0.3323072631233733, Methylation_chr2 242904738 LINC01238 (3421): 0.3613574132533322, Methylation_ARFGEF1: -1.042938849563403, Methylation_MAPT: -0.4947096808790469, Methylation_ZFAT: -0.7243314486123555, Methylation_KCNQ4: 0.7290371243803389, Methylation_chr1 232684368 SIPA1L2 (12934): -1.2737642085708658, Methylation_CRNKL1: -0.4521566093632909, Methylation_PRKAG2: -1.6067176324464203, Methylation_MICB: -0.2449855831333813, miRNA_hsa-mir-934: 0.4307830416907038, miRNA_hsa-mir-4728: 1.3802023038157942, miRNA_hsa-mir-5695: 0.5120899482952597, miRNA_hsa-mir-18a: -0.6734998927229601, miRNA_hsa-mir-190b: 0.6348926070747859, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: 0.0256207349495983, miRNA_hsa-mir-2115: 0.2201724528430051, miRNA_hsa-mir-17: -0.205172994432943, miRNA_hsa-mir-130b: -0.4671071269772678, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-D8-A1XY,"LINC00504 mRNA is highly overexpressed (Z=1.40). No methylation, miRNA, or CNV alterations meet diagnostic thresholds. Isolated LINC00504 upregulation suggests non-specific transcriptional activation without clear genomic or epigenetic drivers.","mRNA_MLPH: 0.4329632818673558, mRNA_C2orf54: -0.248048687105828, mRNA_CITED4: 0.2436287212904871, mRNA_ESR1: 0.5719433422226314, mRNA_SPDEF: 0.5984571763736631, mRNA_AGR3: 0.8122078482214176, mRNA_FOXC1: -0.1819471417375817, mRNA_GATA3: 0.2534134654470019, mRNA_AGR2: 0.7670334343279618, mRNA_XBP1: 0.6288393264582149, mRNA_PRR15: 1.1125158164751447, mRNA_SLC44A4: 0.3215008725171493, mRNA_CA12: 0.7110288338131086, mRNA_DTL: -0.5835570178066178, mRNA_C5AR2: 0.5656528092992172, mRNA_TBC1D9: 0.9756780200239652, mRNA_AR: -0.3612085404624431, mRNA_CCDC170: 0.7505717332513185, mRNA_DEGS2: 0.5653654686562065, mRNA_TFF3: 0.6109330507494549, mRNA_DNALI1: 0.3387929359270383, mRNA_LINC00504: 1.40181843893465, mRNA_CLCA2: -0.3183579823294697, mRNA_PPP1R14C: 0.0635991728011396, mRNA_THSD4: 0.4844497864404001, mRNA_SPAG5: -1.0531526360371612, mRNA_FBP1: 0.8040777938186713, mRNA_SLC7A8: 0.924773910480824, mRNA_EN1: 0.026143643112025, mRNA_ZNF552: 1.1333688587749935, Methylation_LRRC6: 0.2135795161179065, Methylation_chr2 66218712 LINC02934 (29533): -1.2300675685584797, Methylation_HOXB13: -1.0955675145034696, Methylation_chr10 3949206 LINC02660 (4871): -0.8034013224549553, Methylation_chr5 179517140 RNF130 (18026): 0.4275574069014274, Methylation_LOC727677: -0.1238940339022059, Methylation_LETM1: -0.4537803471901124, Methylation_CDC42BPB: 1.2982823757212585, Methylation_C8orf38: -0.7489350256646359, Methylation_chr14 100504766 EVL (18852): -0.0997016382674255, Methylation_chr5 72594851 LOC340090 (24088): -1.203321794025357, Methylation_chr2 242904738 LINC01238 (3421): -0.6353787029093582, Methylation_ARFGEF1: -0.3297069486952151, Methylation_MAPT: -0.6557742368984746, Methylation_ZFAT: -0.5390915444763801, Methylation_KCNQ4: -0.2461630569431702, Methylation_chr1 232684368 SIPA1L2 (12934): 0.0964846960178237, Methylation_CRNKL1: 0.2763626520819173, Methylation_PRKAG2: -0.8473939386304815, Methylation_MICB: 0.1603165078206136, miRNA_hsa-mir-934: -0.3455312066203999, miRNA_hsa-mir-4728: -0.6612146519672495, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.5802703886565341, miRNA_hsa-mir-190b: 0.546808286335068, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.0301659148337126, miRNA_hsa-mir-2115: 0.0162465227492829, miRNA_hsa-mir-17: -1.1762149140836748, miRNA_hsa-mir-130b: -0.3376004048853633, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-LL-A6FR,"High mRNA_CITED4 (Z=1.75) and mRNA_PPP1R14C (Z=1.63) indicate overexpression; mRNA_EN1 shows extreme upregulation (Z=3.26). mRNA_GATA3, XBP1, FBP1, and TBC1D9 are low (Z < -1.92). HOXB13, LOC727677, CDC42BPB, C8orf38, EVL, SIPA1L2, and ARFGEF1 promoters are hypermethylated (Z > 1.50); RNF130 and LOC340090 are hypomethylated (Z < -1.47). miR-934 and miR-135b are upregulated (Z > 1.99). No CNVs meet amplification/deletion thresholds. These features suggest a luminal B-like phenotype with ER pathway suppression.","mRNA_MLPH: -1.0064861708220878, mRNA_C2orf54: 0.5912069815451669, mRNA_CITED4: 1.7497757584492204, mRNA_ESR1: -1.7944673185307596, mRNA_SPDEF: -0.6473766614528831, mRNA_AGR3: -1.2385871266838833, mRNA_FOXC1: 1.124638199648518, mRNA_GATA3: -2.264783151469697, mRNA_AGR2: -1.011626721959843, mRNA_XBP1: -2.646976154377843, mRNA_PRR15: -1.2201492825111917, mRNA_SLC44A4: -1.4902278638606006, mRNA_CA12: -1.676949018825323, mRNA_DTL: -0.3439024661360338, mRNA_C5AR2: -1.6355863855096475, mRNA_TBC1D9: -2.5193928313457783, mRNA_AR: -2.1958160290567275, mRNA_CCDC170: -1.6296053676909386, mRNA_DEGS2: -1.045016875082565, mRNA_TFF3: -0.1569758978887932, mRNA_DNALI1: -0.1732284813163184, mRNA_LINC00504: -1.7056738133962424, mRNA_CLCA2: -0.6672977689161652, mRNA_PPP1R14C: 1.630851774990023, mRNA_THSD4: -1.249378199522551, mRNA_SPAG5: 0.0190138706348808, mRNA_FBP1: -2.5209353626979287, mRNA_SLC7A8: -2.0610465667052167, mRNA_EN1: 3.2631682687209147, mRNA_ZNF552: -2.2966116469335853, Methylation_LRRC6: 1.3679443181992228, Methylation_chr2 66218712 LINC02934 (29533): -1.1966461868963756, Methylation_HOXB13: 1.5278294878495402, Methylation_chr10 3949206 LINC02660 (4871): 1.121009735137701, Methylation_chr5 179517140 RNF130 (18026): -1.6288360029165705, Methylation_LOC727677: 1.5070890607167278, Methylation_LETM1: 1.3007965567000557, Methylation_CDC42BPB: 1.5062628107534906, Methylation_C8orf38: 1.5782952081114094, Methylation_chr14 100504766 EVL (18852): 1.5137401546084623, Methylation_chr5 72594851 LOC340090 (24088): -1.5415361047158154, Methylation_chr2 242904738 LINC01238 (3421): 1.1056011076072845, Methylation_ARFGEF1: 1.481841517470977, Methylation_MAPT: 1.4351516170590304, Methylation_ZFAT: 1.3561534506671555, Methylation_KCNQ4: 1.199259740680935, Methylation_chr1 232684368 SIPA1L2 (12934): 1.547191492158099, Methylation_CRNKL1: 1.277066414273187, Methylation_PRKAG2: -1.047281501013238, Methylation_MICB: 1.3495735923936187, miRNA_hsa-mir-934: 2.3712932934766497, miRNA_hsa-mir-4728: -0.6414767750223281, miRNA_hsa-mir-5695: -0.0688049088089727, miRNA_hsa-mir-18a: 1.111477395218755, miRNA_hsa-mir-190b: -1.0923616990630018, miRNA_hsa-mir-577: 0.7077501282740881, miRNA_hsa-mir-135b: 2.594883812795953, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.7814284137882503, miRNA_hsa-mir-130b: 0.4980421895002124, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-BH-A0AZ,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.2798840327153633, mRNA_C2orf54: -0.0593714613645201, mRNA_CITED4: 0.0768184965342768, mRNA_ESR1: -0.1020955195764476, mRNA_SPDEF: 0.1503517413706165, mRNA_AGR3: 0.8877988154605738, mRNA_FOXC1: 0.267615725972637, mRNA_GATA3: 0.6241670200566535, mRNA_AGR2: 0.0458056070547349, mRNA_XBP1: 0.4408440277022506, mRNA_PRR15: 0.4692998654664063, mRNA_SLC44A4: 0.4842352587712526, mRNA_CA12: 0.4048215111632818, mRNA_DTL: -0.4798921280380437, mRNA_C5AR2: 0.5552329599139176, mRNA_TBC1D9: 0.3216831909469424, mRNA_AR: 0.0799532767601312, mRNA_CCDC170: 0.2188274412803797, mRNA_DEGS2: -0.1500701282840496, mRNA_TFF3: 1.014978029319197, mRNA_DNALI1: 0.4118058689544945, mRNA_LINC00504: -0.3455219249970196, mRNA_CLCA2: 0.3789692220232387, mRNA_PPP1R14C: -0.208037815780826, mRNA_THSD4: 0.3340912791568526, mRNA_SPAG5: -0.7844481679376188, mRNA_FBP1: 0.1452798435912445, mRNA_SLC7A8: -0.23877006931866, mRNA_EN1: 0.2992436210336494, mRNA_ZNF552: 0.5702721573337792, Methylation_LRRC6: 0.3306796985563931, Methylation_chr2 66218712 LINC02934 (29533): -0.35627138035577, Methylation_HOXB13: -1.0679720072067758, Methylation_chr10 3949206 LINC02660 (4871): -0.3742157112182371, Methylation_chr5 179517140 RNF130 (18026): -0.6065052930038595, Methylation_LOC727677: -0.082266370433342, Methylation_LETM1: 0.5301978524724933, Methylation_CDC42BPB: 1.2806192387359032, Methylation_C8orf38: -0.1355701047694273, Methylation_chr14 100504766 EVL (18852): 0.0854682540121694, Methylation_chr5 72594851 LOC340090 (24088): 0.5656025924363869, Methylation_chr2 242904738 LINC01238 (3421): -0.2454002102226894, Methylation_ARFGEF1: -0.3259255003089537, Methylation_MAPT: -0.4532975764423563, Methylation_ZFAT: 0.1540775858053094, Methylation_KCNQ4: -1.0618150626847995, Methylation_chr1 232684368 SIPA1L2 (12934): -0.2092331867840384, Methylation_CRNKL1: -0.4115753673653667, Methylation_PRKAG2: 0.2783438989818826, Methylation_MICB: -0.2639697234463887, miRNA_hsa-mir-934: -0.230305204718477, miRNA_hsa-mir-4728: -0.2694100302228955, miRNA_hsa-mir-5695: 0.6382664920097643, miRNA_hsa-mir-18a: -1.3300549110662554, miRNA_hsa-mir-190b: 0.6532795234291272, miRNA_hsa-mir-577: -0.2963504413023921, miRNA_hsa-mir-135b: 0.0656028666537829, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.9963245681281112, miRNA_hsa-mir-130b: 0.0625213108518772, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A7-A5ZW,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting. All values fall within non-significant ranges per specified Z-score and CNV cutoffs.","mRNA_MLPH: 0.3237952257141351, mRNA_C2orf54: -0.071465371886197, mRNA_CITED4: 0.5934694781213389, mRNA_ESR1: 0.2804088137571101, mRNA_SPDEF: 0.3513926971445284, mRNA_AGR3: 0.5420620967077407, mRNA_FOXC1: 0.3658904239077583, mRNA_GATA3: 0.2057634735487339, mRNA_AGR2: 0.1423455026632944, mRNA_XBP1: 0.7338897220042874, mRNA_PRR15: 0.4862496507340342, mRNA_SLC44A4: 0.1290064839351552, mRNA_CA12: 0.3771616874790592, mRNA_DTL: -0.8786996114826748, mRNA_C5AR2: 0.8115176903239156, mRNA_TBC1D9: 0.7931290929732081, mRNA_AR: 0.5380790793947181, mRNA_CCDC170: 0.817083192699431, mRNA_DEGS2: 0.6585599394327925, mRNA_TFF3: 0.0928106655848719, mRNA_DNALI1: 0.6013388689783301, mRNA_LINC00504: 0.7180864833381833, mRNA_CLCA2: 0.6737051648570692, mRNA_PPP1R14C: 0.5142402366430296, mRNA_THSD4: 0.4706094457064034, mRNA_SPAG5: -1.573957112952148, mRNA_FBP1: 0.2605329854693992, mRNA_SLC7A8: 0.3313030561015774, mRNA_EN1: 0.0507641186275172, mRNA_ZNF552: -0.0650848726454611, Methylation_LRRC6: 0.8941279507175944, Methylation_chr2 66218712 LINC02934 (29533): 1.142424876373583, Methylation_HOXB13: -0.8257909206036032, Methylation_chr10 3949206 LINC02660 (4871): 0.0939230243286112, Methylation_chr5 179517140 RNF130 (18026): -0.7019087259920522, Methylation_LOC727677: 0.5578402537045136, Methylation_LETM1: 0.2030825307988003, Methylation_CDC42BPB: -0.3150730768160351, Methylation_C8orf38: 0.3640747913489411, Methylation_chr14 100504766 EVL (18852): 0.9997233669176516, Methylation_chr5 72594851 LOC340090 (24088): 0.209421193364691, Methylation_chr2 242904738 LINC01238 (3421): 0.3828855121007538, Methylation_ARFGEF1: 0.8672800941197351, Methylation_MAPT: 0.4346430588067547, Methylation_ZFAT: 1.0928644798629357, Methylation_KCNQ4: -1.0140616096759951, Methylation_chr1 232684368 SIPA1L2 (12934): 0.9069775829407388, Methylation_CRNKL1: 0.8333803691573144, Methylation_PRKAG2: 1.2485085018993622, Methylation_MICB: 0.5892694786347354, miRNA_hsa-mir-934: -0.3022199304822367, miRNA_hsa-mir-4728: -0.8696693048358825, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.739539179682689, miRNA_hsa-mir-190b: -0.0323058516751918, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.2335211570811943, miRNA_hsa-mir-2115: 1.2687760397138943, miRNA_hsa-mir-17: -0.0933900184475798, miRNA_hsa-mir-130b: -0.963404729921567, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A1JD,"High-level Amplification of AR (CNV=1.39) drives mRNA overexpression (Z=1.39). No methylation or miRNA alterations meet diagnostic thresholds. mRNA_DTL, LINC00504, CA12, and FBP1 are elevated but below Z>1.30 cutoff. All CNVs show only Gain (0.38–0.40), not amplification. No deletions, hypo/hypermethylation, or miRNA dysregulation per criteria.","mRNA_MLPH: 0.3269417878347913, mRNA_C2orf54: -0.102694115405851, mRNA_CITED4: -0.5544093980406333, mRNA_ESR1: 0.3814641835871283, mRNA_SPDEF: 0.5211967022439965, mRNA_AGR3: 0.5459837864746441, mRNA_FOXC1: -0.9954436698887442, mRNA_GATA3: 0.3554878489391283, mRNA_AGR2: -0.7523200384221289, mRNA_XBP1: 0.6808721227109616, mRNA_PRR15: 0.1104222566850911, mRNA_SLC44A4: 0.603931466027544, mRNA_CA12: 0.8153729210216555, mRNA_DTL: 1.130280261149709, mRNA_C5AR2: 0.1672195360073829, mRNA_TBC1D9: 0.5597247742661177, mRNA_AR: 1.3861456842422493, mRNA_CCDC170: -0.0778404681110211, mRNA_DEGS2: 0.995694298773148, mRNA_TFF3: 0.2556044445595828, mRNA_DNALI1: 0.2276806084514512, mRNA_LINC00504: 1.1676741231741954, mRNA_CLCA2: -0.4480811338480079, mRNA_PPP1R14C: -0.3427100383866264, mRNA_THSD4: 0.293129290151383, mRNA_SPAG5: 0.5689589935697298, mRNA_FBP1: 0.8146036863407309, mRNA_SLC7A8: 0.2348489843318915, mRNA_EN1: -0.204246284025681, mRNA_ZNF552: -0.179103417073081, Methylation_LRRC6: -0.8453029203194443, Methylation_chr2 66218712 LINC02934 (29533): 0.8653567117395239, Methylation_HOXB13: -1.067765629447058, Methylation_chr10 3949206 LINC02660 (4871): -0.7253628957391463, Methylation_chr5 179517140 RNF130 (18026): -0.0418465295871072, Methylation_LOC727677: -0.1649474071555164, Methylation_LETM1: -0.6309436490632783, Methylation_CDC42BPB: 1.1777960633663282, Methylation_C8orf38: -1.1777664989896932, Methylation_chr14 100504766 EVL (18852): -0.9055847006824476, Methylation_chr5 72594851 LOC340090 (24088): 0.372823893001526, Methylation_chr2 242904738 LINC01238 (3421): -0.4943423662102588, Methylation_ARFGEF1: -1.284733133352684, Methylation_MAPT: -0.5261142925066082, Methylation_ZFAT: -0.5965561054614864, Methylation_KCNQ4: -1.016066058257017, Methylation_chr1 232684368 SIPA1L2 (12934): -0.0767751863674585, Methylation_CRNKL1: -0.4348649299484759, Methylation_PRKAG2: -0.9148232245802644, Methylation_MICB: 0.0833097526400986, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.8456144566460213, miRNA_hsa-mir-5695: 0.8879518821830965, miRNA_hsa-mir-18a: -0.4444305513040653, miRNA_hsa-mir-190b: -0.0121870247479871, miRNA_hsa-mir-577: -0.4721858350171338, miRNA_hsa-mir-135b: -0.133909599825221, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.1736376735536741, miRNA_hsa-mir-130b: 0.76467698304331, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-D8-A1JC,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-significant ranges per specified Z-score and CNV cutoffs.","mRNA_MLPH: 0.4870747132980278, mRNA_C2orf54: 0.9022134059981348, mRNA_CITED4: -1.4295126378947625, mRNA_ESR1: 1.1036329933389952, mRNA_SPDEF: 0.1927745452880894, mRNA_AGR3: 0.7799877457687425, mRNA_FOXC1: -0.4715181726631622, mRNA_GATA3: 0.7563328057508844, mRNA_AGR2: 0.3649544607497689, mRNA_XBP1: 0.4168402569660166, mRNA_PRR15: 0.5319961053277938, mRNA_SLC44A4: 0.3922750925215887, mRNA_CA12: 0.950792456476047, mRNA_DTL: 1.0355907372079476, mRNA_C5AR2: 0.1943851229489787, mRNA_TBC1D9: 1.5279655576538456, mRNA_AR: 0.0149788635937035, mRNA_CCDC170: 0.426108954718029, mRNA_DEGS2: 0.8023449173398673, mRNA_TFF3: -0.0307084308718284, mRNA_DNALI1: 0.2207562351169066, mRNA_LINC00504: 1.4667654818008022, mRNA_CLCA2: -0.1358573945517909, mRNA_PPP1R14C: 0.4178590118425202, mRNA_THSD4: 0.8855973123144517, mRNA_SPAG5: 1.3993646066518637, mRNA_FBP1: 0.4516057964958859, mRNA_SLC7A8: 0.8478837299168658, mRNA_EN1: -0.763949728519212, mRNA_ZNF552: 0.3048329334723494, Methylation_LRRC6: -0.6781651523350919, Methylation_chr2 66218712 LINC02934 (29533): -1.3149759955174138, Methylation_HOXB13: -1.083998581503435, Methylation_chr10 3949206 LINC02660 (4871): -0.9801977734424746, Methylation_chr5 179517140 RNF130 (18026): 0.933084112790599, Methylation_LOC727677: -0.0685097934542454, Methylation_LETM1: -0.7998710105304513, Methylation_CDC42BPB: 1.2454511604680223, Methylation_C8orf38: -1.162545461252115, Methylation_chr14 100504766 EVL (18852): -1.1388904145499392, Methylation_chr5 72594851 LOC340090 (24088): 1.1302297410772886, Methylation_chr2 242904738 LINC01238 (3421): -0.9076250947063016, Methylation_ARFGEF1: -0.325783535201573, Methylation_MAPT: -0.385965164552389, Methylation_ZFAT: -1.3852968080263883, Methylation_KCNQ4: -0.6703621335910558, Methylation_chr1 232684368 SIPA1L2 (12934): 1.508265871076175, Methylation_CRNKL1: -0.4241253129533274, Methylation_PRKAG2: -1.1491828754737352, Methylation_MICB: 0.1552269661152774, miRNA_hsa-mir-934: -0.0976939330250695, miRNA_hsa-mir-4728: 0.521492074984532, miRNA_hsa-mir-5695: 0.3348417319135948, miRNA_hsa-mir-18a: 0.224810701830767, miRNA_hsa-mir-190b: 0.5386904887923759, miRNA_hsa-mir-577: 0.486464262695249, miRNA_hsa-mir-135b: 0.5847264828223979, miRNA_hsa-mir-2115: 0.7919384981377572, miRNA_hsa-mir-17: -0.3051527127492519, miRNA_hsa-mir-130b: 1.0668474957262406, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-S3-A6ZG,"No features meet the strict diagnostic thresholds for mRNA (Z > 1.30 or Z < -1.92), methylation (Z > 1.50 or Z < -1.47), miRNA (Z > 1.99 or Z < -1.25), or CNV (deletion, gain, amplification, or high-level amplification). All values fall within non-actionable ranges.","mRNA_MLPH: 1.1959032705928931, mRNA_C2orf54: -0.2022279895281751, mRNA_CITED4: 0.5932624311922369, mRNA_ESR1: 0.8215812465791241, mRNA_SPDEF: 0.2748626110379942, mRNA_AGR3: 0.7110161030313841, mRNA_FOXC1: -0.6816282830109989, mRNA_GATA3: 0.5186038645492282, mRNA_AGR2: 0.9747121781552344, mRNA_XBP1: 0.2116288000496816, mRNA_PRR15: 0.5642490275775496, mRNA_SLC44A4: 0.5890561620537578, mRNA_CA12: 0.3422498985020401, mRNA_DTL: 0.84043975730575, mRNA_C5AR2: 0.8894282294108901, mRNA_TBC1D9: 0.98527027491936, mRNA_AR: 0.9342429639791644, mRNA_CCDC170: 1.1886216325489145, mRNA_DEGS2: 0.589921412702985, mRNA_TFF3: 0.4674909632256198, mRNA_DNALI1: 0.9787639819096856, mRNA_LINC00504: 0.6636888195828509, mRNA_CLCA2: -0.7295764289806995, mRNA_PPP1R14C: 0.0126203884241785, mRNA_THSD4: 0.5727772483678052, mRNA_SPAG5: 0.8124622870992444, mRNA_FBP1: 0.6546464963056238, mRNA_SLC7A8: 0.944589920712232, mRNA_EN1: -0.8124310313781831, mRNA_ZNF552: 0.5806896700792057, Methylation_LRRC6: -0.9818266701121432, Methylation_chr2 66218712 LINC02934 (29533): 1.398547411930716, Methylation_HOXB13: -0.1430079383156094, Methylation_chr10 3949206 LINC02660 (4871): -0.8010064583591396, Methylation_chr5 179517140 RNF130 (18026): 1.13304590430126, Methylation_LOC727677: -1.0600333151188506, Methylation_LETM1: -1.3427682278453996, Methylation_CDC42BPB: 1.4667351298938431, Methylation_C8orf38: -0.9303262761264044, Methylation_chr14 100504766 EVL (18852): -1.3061885508787814, Methylation_chr5 72594851 LOC340090 (24088): 1.021729780675647, Methylation_chr2 242904738 LINC01238 (3421): -1.1174880257576976, Methylation_ARFGEF1: -1.0305704045786628, Methylation_MAPT: -1.590068157325857, Methylation_ZFAT: -0.4657330310338448, Methylation_KCNQ4: -0.4771239435427531, Methylation_chr1 232684368 SIPA1L2 (12934): -1.161483262228162, Methylation_CRNKL1: -1.3785917980989122, Methylation_PRKAG2: 1.2822448746541062, Methylation_MICB: -1.2125304395753558, miRNA_hsa-mir-934: -0.3900656582014057, miRNA_hsa-mir-4728: -0.9937200342655984, miRNA_hsa-mir-5695: -0.3460331803587574, miRNA_hsa-mir-18a: -0.4013838248157433, miRNA_hsa-mir-190b: 0.2741487273503726, miRNA_hsa-mir-577: -0.6579051754224565, miRNA_hsa-mir-135b: -1.0762845828979852, miRNA_hsa-mir-2115: -0.5158784978445028, miRNA_hsa-mir-17: 0.3537309123758388, miRNA_hsa-mir-130b: -1.3219947967387344, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-A2-A3XV,"High mRNA_C2orf54 (Z=2.69) and low mRNA_CITED4 (Z=-2.09), mRNA_ESR1 (Z=-2.15), mRNA_AGR3 (Z=-2.04), mRNA_CA12 (Z=-2.06), mRNA_TBC1D9 (Z=-2.32) meet expression thresholds. HOXB13 hypermethylation (Z=1.75) and chr10:3949206 hypermethylation (Z=1.61) indicate epigenetic silencing. miRNA_hsa-mir-2115 is upregulated (Z=6.07); miRNA_hsa-mir-190b downregulated (Z=-1.75). All CNVs are normal (IGNORE). Collectively suggest luminal B phenotype with ER-pathway suppression.","mRNA_MLPH: 0.2936358126174916, mRNA_C2orf54: 2.690270005412684, mRNA_CITED4: -2.0857237718047874, mRNA_ESR1: -2.146651183072946, mRNA_SPDEF: 0.916205752375136, mRNA_AGR3: -2.044649229052274, mRNA_FOXC1: -1.2565859661900576, mRNA_GATA3: -1.6622653326437418, mRNA_AGR2: -0.5325235787546849, mRNA_XBP1: -0.2322839795232262, mRNA_PRR15: -0.3079582189491844, mRNA_SLC44A4: -0.116092019533326, mRNA_CA12: -2.059322613549564, mRNA_DTL: -1.2824860524402046, mRNA_C5AR2: -1.5382549611523275, mRNA_TBC1D9: -2.3163016051939813, mRNA_AR: 0.9387467739016327, mRNA_CCDC170: -1.8578768371807792, mRNA_DEGS2: -0.0984975987185408, mRNA_TFF3: 0.5044973040598968, mRNA_DNALI1: -1.7980656585268104, mRNA_LINC00504: -1.733567102959832, mRNA_CLCA2: 1.5275988010979098, mRNA_PPP1R14C: -0.6866362928179911, mRNA_THSD4: -1.4599901550396872, mRNA_SPAG5: -0.2495938369509123, mRNA_FBP1: 0.2664579025417479, mRNA_SLC7A8: -0.4664516505327314, mRNA_EN1: 0.3847658909900749, mRNA_ZNF552: -1.5078001980791074, Methylation_LRRC6: 1.349412875869603, Methylation_chr2 66218712 LINC02934 (29533): -1.2573880712904624, Methylation_HOXB13: 1.752441912788364, Methylation_chr10 3949206 LINC02660 (4871): 1.608297318143792, Methylation_chr5 179517140 RNF130 (18026): 0.7538995855725679, Methylation_LOC727677: 1.467684996178359, Methylation_LETM1: 1.307742993455462, Methylation_CDC42BPB: -1.0236367981728711, Methylation_C8orf38: 0.1819287793036346, Methylation_chr14 100504766 EVL (18852): 0.8100328087633344, Methylation_chr5 72594851 LOC340090 (24088): 0.7326535923457856, Methylation_chr2 242904738 LINC01238 (3421): 1.4570214915592756, Methylation_ARFGEF1: -0.8473814417855607, Methylation_MAPT: 0.9247182497399644, Methylation_ZFAT: 1.4574135422936925, Methylation_KCNQ4: -0.7734710854187571, Methylation_chr1 232684368 SIPA1L2 (12934): 1.0702205085165697, Methylation_CRNKL1: 1.280322746337807, Methylation_PRKAG2: 0.9298762640103936, Methylation_MICB: 1.098082719773681, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 1.3829039599839157, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.2976756333830831, miRNA_hsa-mir-190b: -1.7471714654009989, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: 6.073083005664757, miRNA_hsa-mir-17: 0.2989038387452936, miRNA_hsa-mir-130b: 0.5463430997648023, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A1-A0SF,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.4361899761731077, mRNA_C2orf54: 1.1665678282821914, mRNA_CITED4: 0.4407427020310636, mRNA_ESR1: 0.3176839979604725, mRNA_SPDEF: 0.6953813635577177, mRNA_AGR3: 0.9728556896478736, mRNA_FOXC1: -0.2711420145724456, mRNA_GATA3: 0.3675762960657973, mRNA_AGR2: 0.8953370382892973, mRNA_XBP1: 0.855837665190764, mRNA_PRR15: 0.9667793043024469, mRNA_SLC44A4: 0.4927455363348395, mRNA_CA12: 0.2719786058098266, mRNA_DTL: -0.0178807469085076, mRNA_C5AR2: 0.3650915263153834, mRNA_TBC1D9: 0.0915116571251561, mRNA_AR: 1.0009388969743576, mRNA_CCDC170: 0.3928437796488769, mRNA_DEGS2: 0.391255850543681, mRNA_TFF3: 1.0596541504099262, mRNA_DNALI1: 1.1223966599986424, mRNA_LINC00504: -0.1087076234567703, mRNA_CLCA2: 0.1893958103890464, mRNA_PPP1R14C: -0.4527675578713265, mRNA_THSD4: 0.1608705605675248, mRNA_SPAG5: -0.9600051850609376, mRNA_FBP1: 0.5127268281871109, mRNA_SLC7A8: 0.6746702645095687, mRNA_EN1: -0.7831778397511832, mRNA_ZNF552: 0.708421995226226, Methylation_LRRC6: 0.0242065455168879, Methylation_chr2 66218712 LINC02934 (29533): -0.1371892463860399, Methylation_HOXB13: 0.1787289222981112, Methylation_chr10 3949206 LINC02660 (4871): -0.3167131040737402, Methylation_chr5 179517140 RNF130 (18026): 0.1854172244818805, Methylation_LOC727677: -0.4903028192015264, Methylation_LETM1: -0.4851131206836211, Methylation_CDC42BPB: -1.1288519666492658, Methylation_C8orf38: -0.6162060403536657, Methylation_chr14 100504766 EVL (18852): -0.1086037640526073, Methylation_chr5 72594851 LOC340090 (24088): 0.6951046902740367, Methylation_chr2 242904738 LINC01238 (3421): -0.4649820473923662, Methylation_ARFGEF1: -0.3249358982229188, Methylation_MAPT: -0.4426126557824685, Methylation_ZFAT: -0.50572452840547, Methylation_KCNQ4: 0.2600693708098465, Methylation_chr1 232684368 SIPA1L2 (12934): -0.4307621290832417, Methylation_CRNKL1: -0.1867970434587107, Methylation_PRKAG2: -0.3850474847423231, Methylation_MICB: 0.0815776998902539, miRNA_hsa-mir-934: -0.3979130188545178, miRNA_hsa-mir-4728: -0.6830812097979099, miRNA_hsa-mir-5695: -0.3629729298464507, miRNA_hsa-mir-18a: -0.3427722102023623, miRNA_hsa-mir-190b: 0.8377794949747823, miRNA_hsa-mir-577: -0.5763917346385308, miRNA_hsa-mir-135b: -0.6627787342811085, miRNA_hsa-mir-2115: -0.5229449897959162, miRNA_hsa-mir-17: -0.6018560420099169, miRNA_hsa-mir-130b: -0.9158107441782182, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-AC-A3W5,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression of CLCA2 (Z=2.34). miR-4728 and miR-2115 are upregulated (Z>1.99). No promoter hyper/hypomethylation or mRNA alterations meet diagnostic thresholds beyond CLCA2. These features suggest a luminal phenotype with potential immune modulation via miRNA dysregulation.","mRNA_MLPH: -0.5334052652177169, mRNA_C2orf54: 1.4175317109788492, mRNA_CITED4: -0.6868750516395543, mRNA_ESR1: -1.0586225003587482, mRNA_SPDEF: 0.7678665528390067, mRNA_AGR3: -0.4304593540761557, mRNA_FOXC1: -0.4152536140573949, mRNA_GATA3: -0.8131533840659938, mRNA_AGR2: 0.3253636328247637, mRNA_XBP1: -0.1701287388271723, mRNA_PRR15: 0.6830788959179407, mRNA_SLC44A4: 0.3604038382387633, mRNA_CA12: -1.0431385275229172, mRNA_DTL: -0.0653852292648963, mRNA_C5AR2: -0.8218675555256635, mRNA_TBC1D9: -0.7163190893188547, mRNA_AR: -0.3000067684645068, mRNA_CCDC170: -0.9384718023289412, mRNA_DEGS2: -0.3933809196662101, mRNA_TFF3: -0.4638116891649916, mRNA_DNALI1: -0.8839548146899122, mRNA_LINC00504: -0.3891037248530591, mRNA_CLCA2: 2.3372127922204253, mRNA_PPP1R14C: 0.6169224266996546, mRNA_THSD4: -1.0190198295498978, mRNA_SPAG5: 0.7355319313656346, mRNA_FBP1: -0.2396714493980879, mRNA_SLC7A8: -0.4160764562880632, mRNA_EN1: 0.4641566723592756, mRNA_ZNF552: -1.098296117705345, Methylation_LRRC6: 1.4239615577833824, Methylation_chr2 66218712 LINC02934 (29533): -0.9718381327985354, Methylation_HOXB13: 0.6269942059782672, Methylation_chr10 3949206 LINC02660 (4871): 1.2683585248833873, Methylation_chr5 179517140 RNF130 (18026): -1.1550402649570788, Methylation_LOC727677: 1.190515167382786, Methylation_LETM1: 1.1970653981371229, Methylation_CDC42BPB: -0.9306748213886846, Methylation_C8orf38: 0.0685240034835438, Methylation_chr14 100504766 EVL (18852): 0.4373782975716586, Methylation_chr5 72594851 LOC340090 (24088): -0.6987451794136128, Methylation_chr2 242904738 LINC01238 (3421): 0.6419462738655157, Methylation_ARFGEF1: 0.0345526247513132, Methylation_MAPT: 0.2802783265070545, Methylation_ZFAT: 0.8217197188599472, Methylation_KCNQ4: -0.2192373427711545, Methylation_chr1 232684368 SIPA1L2 (12934): 0.0094115779149627, Methylation_CRNKL1: 1.4042603819545965, Methylation_PRKAG2: -0.6809514179884926, Methylation_MICB: 0.8759351747149976, miRNA_hsa-mir-934: 0.7591468851518158, miRNA_hsa-mir-4728: 2.501710136233901, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.1595530977330195, miRNA_hsa-mir-190b: 0.7873696946906764, miRNA_hsa-mir-577: -0.6065970351331723, miRNA_hsa-mir-135b: 0.5531969577995917, miRNA_hsa-mir-2115: 2.851587900669056, miRNA_hsa-mir-17: 0.3183979555223567, miRNA_hsa-mir-130b: 1.350753556064715, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-EW-A1PA,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.4546025424545976, mRNA_C2orf54: -0.2351284025291687, mRNA_CITED4: -1.1587292752013034, mRNA_ESR1: 1.031281092763472, mRNA_SPDEF: -0.100514408165764, mRNA_AGR3: 0.3312343918873778, mRNA_FOXC1: -0.312763112199232, mRNA_GATA3: 0.66779489443358, mRNA_AGR2: 1.1174770879362708, mRNA_XBP1: 0.2738395572420498, mRNA_PRR15: 0.8480780150679625, mRNA_SLC44A4: -0.2839538248769569, mRNA_CA12: 1.0816104930885213, mRNA_DTL: -0.1235274892871605, mRNA_C5AR2: -0.2273143301364221, mRNA_TBC1D9: 0.8558474516296248, mRNA_AR: -0.1383215030095973, mRNA_CCDC170: 0.8610939231012434, mRNA_DEGS2: 0.6364311404325954, mRNA_TFF3: 0.4737679885766725, mRNA_DNALI1: 0.210912298577274, mRNA_LINC00504: 1.0576482024656768, mRNA_CLCA2: -0.6330168698067019, mRNA_PPP1R14C: 0.1458608169560809, mRNA_THSD4: 0.8281468204564971, mRNA_SPAG5: -0.3151181741735194, mRNA_FBP1: -0.2105049128311363, mRNA_SLC7A8: 1.2475976826711257, mRNA_EN1: -0.7260224831407579, mRNA_ZNF552: 0.931105286333627, Methylation_LRRC6: -0.3356357121191642, Methylation_chr2 66218712 LINC02934 (29533): 0.409280504078119, Methylation_HOXB13: -0.936929775814102, Methylation_chr10 3949206 LINC02660 (4871): -0.6312105123861392, Methylation_chr5 179517140 RNF130 (18026): 0.1579247598039087, Methylation_LOC727677: -0.696363510947073, Methylation_LETM1: -0.9282679949863006, Methylation_CDC42BPB: -1.2518883203821218, Methylation_C8orf38: -0.4965243325679889, Methylation_chr14 100504766 EVL (18852): -0.7154932986271886, Methylation_chr5 72594851 LOC340090 (24088): -0.1735251592711114, Methylation_chr2 242904738 LINC01238 (3421): -0.4147691587593516, Methylation_ARFGEF1: -0.2474853992216654, Methylation_MAPT: 0.2128124131064937, Methylation_ZFAT: -0.5626768444075434, Methylation_KCNQ4: 0.6236688499122435, Methylation_chr1 232684368 SIPA1L2 (12934): 0.0159187747693818, Methylation_CRNKL1: -0.3241557605301018, Methylation_PRKAG2: 0.1623479552670679, Methylation_MICB: 0.5699241699845128, miRNA_hsa-mir-934: -0.3571960063545217, miRNA_hsa-mir-4728: -0.2961396224889936, miRNA_hsa-mir-5695: -0.2100881306275352, miRNA_hsa-mir-18a: -0.1452624248044973, miRNA_hsa-mir-190b: 0.2724336066680475, miRNA_hsa-mir-577: -0.6889347947085737, miRNA_hsa-mir-135b: -0.6526227409938448, miRNA_hsa-mir-2115: -0.513303293367645, miRNA_hsa-mir-17: 0.0249520155759689, miRNA_hsa-mir-130b: -0.735094718224963, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A227,High mRNA_AGR3 (Z=1.36) and mRNA_TFF3 (Z=1.13) indicate luminal overexpression. No methylation or miRNA alterations meet diagnostic thresholds. All CNVs fall within normal range (−1.10 to −0.10). These features collectively indicate a luminal A phenotype with estrogen signaling activation.,"mRNA_MLPH: 0.5619855929903508, mRNA_C2orf54: -0.1762616948773908, mRNA_CITED4: -1.407052311077143, mRNA_ESR1: 0.2646579510997927, mRNA_SPDEF: 0.3926089192838823, mRNA_AGR3: 1.3576282652731184, mRNA_FOXC1: -0.2884867141256351, mRNA_GATA3: 0.2442868412306791, mRNA_AGR2: 0.355473083852216, mRNA_XBP1: 0.9615255883296178, mRNA_PRR15: 0.3726232138092424, mRNA_SLC44A4: 0.8738724167112625, mRNA_CA12: 0.2002362212133933, mRNA_DTL: -0.631476747636099, mRNA_C5AR2: 0.854997653513823, mRNA_TBC1D9: 0.4348301654213291, mRNA_AR: 0.2860708413843031, mRNA_CCDC170: -0.2769380082886298, mRNA_DEGS2: -0.4583702980485271, mRNA_TFF3: 1.1314490408043636, mRNA_DNALI1: 0.3066380957742398, mRNA_LINC00504: 1.1088223228992216, mRNA_CLCA2: -0.626903482734282, mRNA_PPP1R14C: -0.6469203403803916, mRNA_THSD4: -0.4130039765068844, mRNA_SPAG5: -0.7459130511494106, mRNA_FBP1: 0.2933292564540859, mRNA_SLC7A8: 0.2860013633766944, mRNA_EN1: -0.6155155687929809, mRNA_ZNF552: 0.7248108018807943, Methylation_LRRC6: 0.3226405009843879, Methylation_chr2 66218712 LINC02934 (29533): 1.1180787612451244, Methylation_HOXB13: -1.02628402323474, Methylation_chr10 3949206 LINC02660 (4871): -0.6135483572762628, Methylation_chr5 179517140 RNF130 (18026): 0.2876364855226157, Methylation_LOC727677: -0.3336717417745558, Methylation_LETM1: -0.3306604937886817, Methylation_CDC42BPB: -1.3359521561226886, Methylation_C8orf38: -0.3814377434970747, Methylation_chr14 100504766 EVL (18852): 0.0894600544805804, Methylation_chr5 72594851 LOC340090 (24088): -1.3615374951092614, Methylation_chr2 242904738 LINC01238 (3421): -0.5763918652019349, Methylation_ARFGEF1: 0.1878290833374633, Methylation_MAPT: -0.2988031430122331, Methylation_ZFAT: -0.2255529895894867, Methylation_KCNQ4: -0.917493238548986, Methylation_chr1 232684368 SIPA1L2 (12934): 0.2491568428458859, Methylation_CRNKL1: 0.1929961041374422, Methylation_PRKAG2: -0.9094865152461432, Methylation_MICB: -0.6838188439867585, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.2983220612262295, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.0142973822774053, miRNA_hsa-mir-190b: 0.4758878025060784, miRNA_hsa-mir-577: -0.6891525883718236, miRNA_hsa-mir-135b: -0.8592951883997704, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.8173823162345393, miRNA_hsa-mir-130b: 0.7113858761693596, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-LQ-A4E4,"High mRNA_TFF3 (Z=1.51) and mRNA_MLPH (Z=1.41) indicate overexpression.  
Methylation_KCNQ4 hypermethylation (Z=1.92) suggests epigenetic silencing.  
Methylation_MICB hypo-methylation (Z=-1.47) implies potential activation.  
miRNA_hsa-mir-130b downregulated (Z=-1.50).  
All CNVs fall within normal range (IGNORED).  
Collectively suggestive of luminal breast cancer phenotype with ER-pathway activity.","mRNA_MLPH: 1.410612566941272, mRNA_C2orf54: 0.6746221059378328, mRNA_CITED4: 0.968141678455974, mRNA_ESR1: 1.0018406322735407, mRNA_SPDEF: 1.0333659008678453, mRNA_AGR3: 0.450684336104741, mRNA_FOXC1: -0.7536380730671225, mRNA_GATA3: 0.1502818709594821, mRNA_AGR2: 1.394102226970955, mRNA_XBP1: 0.0078344184769815, mRNA_PRR15: 0.4034517110368769, mRNA_SLC44A4: 0.9418821543153256, mRNA_CA12: -0.0466380048612385, mRNA_DTL: 0.7113168324007378, mRNA_C5AR2: 1.038275174297315, mRNA_TBC1D9: 0.3020721874181289, mRNA_AR: 0.8571076988598194, mRNA_CCDC170: 0.5472508997005203, mRNA_DEGS2: 0.5027228344788763, mRNA_TFF3: 1.5111624663086785, mRNA_DNALI1: -1.6833772251985075, mRNA_LINC00504: 0.6094016095725432, mRNA_CLCA2: -0.6538394206483568, mRNA_PPP1R14C: -1.0312690785873555, mRNA_THSD4: 0.6425473360396812, mRNA_SPAG5: -0.2452657729548963, mRNA_FBP1: 0.495111548473041, mRNA_SLC7A8: 1.0834664747922702, mRNA_EN1: -0.7307506126750022, mRNA_ZNF552: 0.6746827959577151, Methylation_LRRC6: -1.0412097145335868, Methylation_chr2 66218712 LINC02934 (29533): -0.2319106853021902, Methylation_HOXB13: 1.4003830348939583, Methylation_chr10 3949206 LINC02660 (4871): -1.2560308038986727, Methylation_chr5 179517140 RNF130 (18026): -0.019960976256149, Methylation_LOC727677: 1.0337990021727206, Methylation_LETM1: 0.017467167853173, Methylation_CDC42BPB: -1.3199403143488102, Methylation_C8orf38: -0.9969286293740884, Methylation_chr14 100504766 EVL (18852): -1.2750829892116375, Methylation_chr5 72594851 LOC340090 (24088): 0.5615358811708379, Methylation_chr2 242904738 LINC01238 (3421): -1.2970166462936477, Methylation_ARFGEF1: -0.8548551892890071, Methylation_MAPT: -1.4501440226711153, Methylation_ZFAT: -1.2598509925698893, Methylation_KCNQ4: 1.917271816826562, Methylation_chr1 232684368 SIPA1L2 (12934): -1.1691401019946872, Methylation_CRNKL1: -1.4059254680030189, Methylation_PRKAG2: -0.3262323359302249, Methylation_MICB: -1.4733784188491426, miRNA_hsa-mir-934: -0.4265164426034645, miRNA_hsa-mir-4728: -0.2850618909860163, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.0602344485167342, miRNA_hsa-mir-190b: 1.1156011227245448, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.8917490400941506, miRNA_hsa-mir-2115: -0.1961397835490068, miRNA_hsa-mir-17: 0.1875803214059896, miRNA_hsa-mir-130b: -1.5041108438305226, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AO-A126,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.5702417313866261, mRNA_C2orf54: -0.9316547005083368, mRNA_CITED4: -0.8276864894941545, mRNA_ESR1: -0.3580259365212437, mRNA_SPDEF: 0.7127255828381118, mRNA_AGR3: 0.2905498291328409, mRNA_FOXC1: -0.5479133076082462, mRNA_GATA3: 0.9204213127098424, mRNA_AGR2: 0.1837463622889385, mRNA_XBP1: 0.2130825696341394, mRNA_PRR15: 0.7715241157544107, mRNA_SLC44A4: 0.6584010673018604, mRNA_CA12: -0.3212904530771677, mRNA_DTL: -1.471591613756075, mRNA_C5AR2: -0.315101424995328, mRNA_TBC1D9: -0.3623554668063312, mRNA_AR: 0.5823836200209139, mRNA_CCDC170: 0.7593736240598304, mRNA_DEGS2: 1.1844743468952834, mRNA_TFF3: -0.04729647671912, mRNA_DNALI1: 0.8544874306894742, mRNA_LINC00504: 0.9819688390491548, mRNA_CLCA2: 0.5841123621790942, mRNA_PPP1R14C: -1.1097363011237134, mRNA_THSD4: -0.1807069876102988, mRNA_SPAG5: -0.8452860656809841, mRNA_FBP1: 0.9373883653085548, mRNA_SLC7A8: 1.1436041087601236, mRNA_EN1: 0.8067204211344392, mRNA_ZNF552: -0.4642036199672628, Methylation_LRRC6: -0.6093285847125974, Methylation_chr2 66218712 LINC02934 (29533): 1.1945174965200538, Methylation_HOXB13: -0.5295061323129697, Methylation_chr10 3949206 LINC02660 (4871): -0.8994195717039295, Methylation_chr5 179517140 RNF130 (18026): 1.1643283091049157, Methylation_LOC727677: -0.8967496962036092, Methylation_LETM1: -0.8085707886659578, Methylation_CDC42BPB: 0.2026771781669981, Methylation_C8orf38: -1.1555124952259497, Methylation_chr14 100504766 EVL (18852): -0.9139769903162744, Methylation_chr5 72594851 LOC340090 (24088): 1.2560269583925174, Methylation_chr2 242904738 LINC01238 (3421): -0.2651903606881403, Methylation_ARFGEF1: -1.2339056375159407, Methylation_MAPT: -1.2502018507961403, Methylation_ZFAT: -0.9654411559528318, Methylation_KCNQ4: -1.141888017966529, Methylation_chr1 232684368 SIPA1L2 (12934): -0.0249940045297861, Methylation_CRNKL1: -0.2254593525257447, Methylation_PRKAG2: 1.2883923265086537, Methylation_MICB: -0.043468184331073, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.819156518980961, miRNA_hsa-mir-5695: 0.4991783636939248, miRNA_hsa-mir-18a: 0.0973163240109588, miRNA_hsa-mir-190b: 0.6990735707966047, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.9737185517930416, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.1302147485464274, miRNA_hsa-mir-130b: 0.1954938175737241, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AC-A3YJ,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.8339972534984695, mRNA_C2orf54: -0.8566976570337417, mRNA_CITED4: -0.0955454159635636, mRNA_ESR1: 0.6045133772907434, mRNA_SPDEF: 0.5657659042586402, mRNA_AGR3: 0.7741664011705411, mRNA_FOXC1: -0.9953599908837232, mRNA_GATA3: 0.5053353298126961, mRNA_AGR2: 0.865390258875097, mRNA_XBP1: 0.6166750492989301, mRNA_PRR15: 0.7561316062196436, mRNA_SLC44A4: 0.3823770797169901, mRNA_CA12: 0.4756729591475475, mRNA_DTL: -1.5797814809060662, mRNA_C5AR2: 1.4020769613516586, mRNA_TBC1D9: 0.0914851265087896, mRNA_AR: 0.3554533609703095, mRNA_CCDC170: 0.5727889244945397, mRNA_DEGS2: 0.4437539306373416, mRNA_TFF3: 1.3359825901213471, mRNA_DNALI1: 0.4623911315307455, mRNA_LINC00504: 0.8570228535798263, mRNA_CLCA2: -0.8156580096102299, mRNA_PPP1R14C: -0.9488557673693936, mRNA_THSD4: 0.1518204692858328, mRNA_SPAG5: -1.0406447095370546, mRNA_FBP1: 0.932372295615122, mRNA_SLC7A8: 0.1748446798918825, mRNA_EN1: -0.7367818916774718, mRNA_ZNF552: 0.3875966919339307, Methylation_LRRC6: -0.4971332302338989, Methylation_chr2 66218712 LINC02934 (29533): -0.99562477590609, Methylation_HOXB13: 0.7352969347942996, Methylation_chr10 3949206 LINC02660 (4871): -0.9798059396983964, Methylation_chr5 179517140 RNF130 (18026): 0.5599338946245548, Methylation_LOC727677: -0.8421583993154688, Methylation_LETM1: -1.0082225380430063, Methylation_CDC42BPB: -1.2464557428115697, Methylation_C8orf38: -0.7078584997839417, Methylation_chr14 100504766 EVL (18852): -0.7547812839130681, Methylation_chr5 72594851 LOC340090 (24088): 1.0922326349889329, Methylation_chr2 242904738 LINC01238 (3421): -0.939756963578599, Methylation_ARFGEF1: -0.5312008535673977, Methylation_MAPT: -0.8187622919256363, Methylation_ZFAT: -0.9082948383994036, Methylation_KCNQ4: -0.9658603966510764, Methylation_chr1 232684368 SIPA1L2 (12934): -0.9494081611985336, Methylation_CRNKL1: -0.8131550421211451, Methylation_PRKAG2: 1.1628689306563569, Methylation_MICB: -0.8005889845791818, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.6207318173994213, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.3022511710256351, miRNA_hsa-mir-190b: 1.2447802977491864, miRNA_hsa-mir-577: -0.5111362720180718, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: -0.4583133199084089, miRNA_hsa-mir-17: 0.5064911962601173, miRNA_hsa-mir-130b: -0.7192579365655973, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A24U,"High-level Amplification absent; multiple deletions (VPS54, LINC01867, LINC02576, WDPCP, CEP68) noted. mRNA_PPP1R14C overexpressed (Z=1.54). Methylation_LRRC6 hypermethylated (Z=1.52). miRNA_hsa-mir-4728 upregulated (Z=2.32). No significant hypo/hypermethylation or miRNA downregulation meeting thresholds.","mRNA_MLPH: -0.6501021531708987, mRNA_C2orf54: 1.014108417522435, mRNA_CITED4: -0.3722904921136091, mRNA_ESR1: -1.330009966179843, mRNA_SPDEF: -0.1818513864601041, mRNA_AGR3: -0.4475214834488106, mRNA_FOXC1: -0.4579007403717933, mRNA_GATA3: -1.3003390697658044, mRNA_AGR2: -0.2211210729379455, mRNA_XBP1: -0.3494445743487337, mRNA_PRR15: -1.0005366578567856, mRNA_SLC44A4: 0.593884127935643, mRNA_CA12: -0.509603296669665, mRNA_DTL: -0.123012135863003, mRNA_C5AR2: -1.513539501672016, mRNA_TBC1D9: -0.9081035704741616, mRNA_AR: 0.2948384204696544, mRNA_CCDC170: -0.7110315990422319, mRNA_DEGS2: -1.8151089014671515, mRNA_TFF3: -0.5768137162914106, mRNA_DNALI1: -1.908566620996571, mRNA_LINC00504: -1.596603564147197, mRNA_CLCA2: -0.0847221081811, mRNA_PPP1R14C: 1.5397066348282604, mRNA_THSD4: -0.9506205190204118, mRNA_SPAG5: 0.1142822756773302, mRNA_FBP1: -0.8362617195823027, mRNA_SLC7A8: -0.6696022263272473, mRNA_EN1: 0.0955910720409684, mRNA_ZNF552: -0.5215506601109371, Methylation_LRRC6: 1.5194576092307797, Methylation_chr2 66218712 LINC02934 (29533): 0.4280933434062111, Methylation_HOXB13: 0.5798873726585739, Methylation_chr10 3949206 LINC02660 (4871): 1.4425900732403747, Methylation_chr5 179517140 RNF130 (18026): -0.089359843897036, Methylation_LOC727677: 1.3003778304587623, Methylation_LETM1: 1.3315012075456585, Methylation_CDC42BPB: -0.9762091761958688, Methylation_C8orf38: 0.0328188518016169, Methylation_chr14 100504766 EVL (18852): 1.3634798085704738, Methylation_chr5 72594851 LOC340090 (24088): -0.6877149612523273, Methylation_chr2 242904738 LINC01238 (3421): 0.9367556955943308, Methylation_ARFGEF1: 0.6786355325154438, Methylation_MAPT: 1.355878314723483, Methylation_ZFAT: 0.7652475674502353, Methylation_KCNQ4: -0.4237175661762944, Methylation_chr1 232684368 SIPA1L2 (12934): 1.1037504109253782, Methylation_CRNKL1: 1.409193812042185, Methylation_PRKAG2: -0.0213433106574795, Methylation_MICB: 1.4546100140406195, miRNA_hsa-mir-934: 1.3979278358169194, miRNA_hsa-mir-4728: 2.320268972811353, miRNA_hsa-mir-5695: 0.229305025987196, miRNA_hsa-mir-18a: 0.6447830098835912, miRNA_hsa-mir-190b: -0.6077548386189954, miRNA_hsa-mir-577: -0.1922282924651347, miRNA_hsa-mir-135b: -0.5334241415537128, miRNA_hsa-mir-2115: 1.346996732338088, miRNA_hsa-mir-17: 0.4807340411853839, miRNA_hsa-mir-130b: -0.1429860589175561, CNV_VPS54: -1.6173912818721974, CNV_LINC01867: -1.63714039509435, CNV_LINC02576: -1.657048777669473, CNV_WDPCP: -1.6249341592372952, CNV_CEP68: -1.657048777669473"
TCGA-5L-AAT0,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations.","mRNA_MLPH: 0.5575519277020161, mRNA_C2orf54: -0.3791611520811647, mRNA_CITED4: 0.3275744638341593, mRNA_ESR1: 0.2471245607325486, mRNA_SPDEF: 0.3403050649953468, mRNA_AGR3: 0.610632561556744, mRNA_FOXC1: -0.0628116526821779, mRNA_GATA3: 0.5918644465677173, mRNA_AGR2: 1.193420555702865, mRNA_XBP1: 0.7603070034838144, mRNA_PRR15: 0.6377382398256422, mRNA_SLC44A4: 0.5338519732344588, mRNA_CA12: 0.6028812028005508, mRNA_DTL: -0.8103479854764211, mRNA_C5AR2: 0.5905197833499894, mRNA_TBC1D9: 0.815183380046285, mRNA_AR: 0.5361233729715291, mRNA_CCDC170: 0.2075671690374659, mRNA_DEGS2: 0.9487016544543592, mRNA_TFF3: 0.2696760071066557, mRNA_DNALI1: 0.753566618747406, mRNA_LINC00504: 0.052231631023074, mRNA_CLCA2: -0.0057887618338408, mRNA_PPP1R14C: -0.005867183424298, mRNA_THSD4: 0.4553150154456272, mRNA_SPAG5: -1.0495552626376918, mRNA_FBP1: 0.0189791801425569, mRNA_SLC7A8: 0.4943129103491545, mRNA_EN1: -0.1136316392515652, mRNA_ZNF552: 0.1200784412811677, Methylation_LRRC6: 0.2192314244534682, Methylation_chr2 66218712 LINC02934 (29533): 0.380570953469064, Methylation_HOXB13: -0.8838597719297684, Methylation_chr10 3949206 LINC02660 (4871): 0.3556452830163913, Methylation_chr5 179517140 RNF130 (18026): 0.303024716308611, Methylation_LOC727677: -0.0027620393829558, Methylation_LETM1: -0.2830339572458605, Methylation_CDC42BPB: -1.044393058987466, Methylation_C8orf38: -0.0064142319465251, Methylation_chr14 100504766 EVL (18852): -0.3263588571409079, Methylation_chr5 72594851 LOC340090 (24088): -0.7300290757268167, Methylation_chr2 242904738 LINC01238 (3421): -0.6806024835388864, Methylation_ARFGEF1: -0.3230380899935191, Methylation_MAPT: -0.8188069779704564, Methylation_ZFAT: -0.3339682422751712, Methylation_KCNQ4: -1.1784878042491114, Methylation_chr1 232684368 SIPA1L2 (12934): -0.3651847529754917, Methylation_CRNKL1: -0.528230160520844, Methylation_PRKAG2: 1.2552588815401464, Methylation_MICB: -0.4385436617110246, miRNA_hsa-mir-934: -0.2970840016481345, miRNA_hsa-mir-4728: -0.6484049547316139, miRNA_hsa-mir-5695: 0.0435498480466116, miRNA_hsa-mir-18a: -0.0679651756207041, miRNA_hsa-mir-190b: 0.6106911635346397, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.4571991274558059, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.3076614314450044, miRNA_hsa-mir-130b: -0.7750472140401754, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-WT-AB41,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.668278898100238, mRNA_C2orf54: -1.1314024605759536, mRNA_CITED4: 0.6419689882710616, mRNA_ESR1: 0.2029521664116146, mRNA_SPDEF: -0.0694682585082882, mRNA_AGR3: 0.7216796424869114, mRNA_FOXC1: -0.5900088060916314, mRNA_GATA3: 0.4385965774598663, mRNA_AGR2: 0.723327525923539, mRNA_XBP1: -0.7108471090719762, mRNA_PRR15: 0.7396487744860555, mRNA_SLC44A4: 0.1446759818755648, mRNA_CA12: -0.4568030679591386, mRNA_DTL: -0.9922733769001088, mRNA_C5AR2: 0.8083620233868218, mRNA_TBC1D9: -0.6993057743684319, mRNA_AR: -0.5802382677515602, mRNA_CCDC170: 0.2745190780366039, mRNA_DEGS2: 0.8636997659656546, mRNA_TFF3: 0.6574459890455783, mRNA_DNALI1: -0.1855088552756589, mRNA_LINC00504: -0.2610957390815817, mRNA_CLCA2: -0.8950940779111158, mRNA_PPP1R14C: -1.101759508731341, mRNA_THSD4: -0.8848680286389103, mRNA_SPAG5: -1.046825523284045, mRNA_FBP1: 0.3816458424999345, mRNA_SLC7A8: 0.2196154468247036, mRNA_EN1: 0.2480825227884356, mRNA_ZNF552: -0.7999695241350548, Methylation_LRRC6: 0.2134428640360379, Methylation_chr2 66218712 LINC02934 (29533): -0.2458533084805315, Methylation_HOXB13: -0.1466986669441121, Methylation_chr10 3949206 LINC02660 (4871): -0.6131716575257842, Methylation_chr5 179517140 RNF130 (18026): -0.6445017708850888, Methylation_LOC727677: -0.152229432161839, Methylation_LETM1: 0.3746089107017075, Methylation_CDC42BPB: -0.169028815930269, Methylation_C8orf38: 0.1547220746781053, Methylation_chr14 100504766 EVL (18852): 0.6401141328419038, Methylation_chr5 72594851 LOC340090 (24088): 0.0191339821111576, Methylation_chr2 242904738 LINC01238 (3421): -0.7334043221891965, Methylation_ARFGEF1: 0.3442055500772919, Methylation_MAPT: -0.6250897214829692, Methylation_ZFAT: -0.3116286244840239, Methylation_KCNQ4: -0.981832095951988, Methylation_chr1 232684368 SIPA1L2 (12934): 0.5506627278000225, Methylation_CRNKL1: 0.2230820087343784, Methylation_PRKAG2: -0.0435283975103463, Methylation_MICB: 0.2045963948354221, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -1.0412508710956558, miRNA_hsa-mir-5695: 0.4385429218139299, miRNA_hsa-mir-18a: 0.1704087348822484, miRNA_hsa-mir-190b: 1.0386528949154952, miRNA_hsa-mir-577: -0.4694321526945568, miRNA_hsa-mir-135b: -0.3002152497643748, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.1228980234990091, miRNA_hsa-mir-130b: -0.5114084052347062, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A201,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-significant ranges per specified criteria.","mRNA_MLPH: 0.355626861265244, mRNA_C2orf54: 0.2303227778488902, mRNA_CITED4: 0.3620757579514823, mRNA_ESR1: 0.2892755014776216, mRNA_SPDEF: 0.2054310029160627, mRNA_AGR3: 0.5347439382887285, mRNA_FOXC1: 0.7344062105773388, mRNA_GATA3: 0.3052380631804908, mRNA_AGR2: 0.3530650049649121, mRNA_XBP1: 0.6915572550971828, mRNA_PRR15: 0.0599331078711543, mRNA_SLC44A4: 0.3513955714958194, mRNA_CA12: 0.1977626235248558, mRNA_DTL: 0.2816363856633703, mRNA_C5AR2: 0.4794331372663656, mRNA_TBC1D9: 0.1912458491550928, mRNA_AR: 0.6584362465007838, mRNA_CCDC170: 0.1779873612272602, mRNA_DEGS2: 0.2475474759110708, mRNA_TFF3: 0.4772414252885749, mRNA_DNALI1: 0.61782115816251, mRNA_LINC00504: 1.1230891712192723, mRNA_CLCA2: 2.853004965587244, mRNA_PPP1R14C: 0.6992721445530029, mRNA_THSD4: 0.8156665162498826, mRNA_SPAG5: -0.3277683022310375, mRNA_FBP1: 0.0918817646893845, mRNA_SLC7A8: 1.0770365200557133, mRNA_EN1: -0.185316668601069, mRNA_ZNF552: 0.3865972352673157, Methylation_LRRC6: 0.403355941899437, Methylation_chr2 66218712 LINC02934 (29533): 1.1525524446501083, Methylation_HOXB13: -1.0693127855558042, Methylation_chr10 3949206 LINC02660 (4871): 1.5212731114713367, Methylation_chr5 179517140 RNF130 (18026): -0.5071012024413429, Methylation_LOC727677: -0.0971985594585041, Methylation_LETM1: -0.27881847324085, Methylation_CDC42BPB: -1.0297282427291758, Methylation_C8orf38: -0.1554576286967857, Methylation_chr14 100504766 EVL (18852): -0.1670015217823988, Methylation_chr5 72594851 LOC340090 (24088): 0.7816410340189454, Methylation_chr2 242904738 LINC01238 (3421): 0.5651251248187636, Methylation_ARFGEF1: 0.3211416834842838, Methylation_MAPT: -0.3351589104816437, Methylation_ZFAT: -0.0317164515940088, Methylation_KCNQ4: -1.2047679150620318, Methylation_chr1 232684368 SIPA1L2 (12934): 0.0923150181090088, Methylation_CRNKL1: 0.2457606480333625, Methylation_PRKAG2: 1.2736010875801247, Methylation_MICB: -0.3746421931322719, miRNA_hsa-mir-934: -0.0713783975749555, miRNA_hsa-mir-4728: -0.2672794519043484, miRNA_hsa-mir-5695: -0.0471852006192871, miRNA_hsa-mir-18a: 0.4701140394132412, miRNA_hsa-mir-190b: 0.6912945458964622, miRNA_hsa-mir-577: -0.327437765064563, miRNA_hsa-mir-135b: 1.310065469999452, miRNA_hsa-mir-2115: 0.8799606064624186, miRNA_hsa-mir-17: -0.2801123623363239, miRNA_hsa-mir-130b: 0.2487611564201659, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A24V,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.0699145206424389, mRNA_C2orf54: -1.2667264783935868, mRNA_CITED4: 0.2186062727122858, mRNA_ESR1: 0.3007785898473629, mRNA_SPDEF: 0.0554558519974627, mRNA_AGR3: 0.1219626354511753, mRNA_FOXC1: -0.4618447062819513, mRNA_GATA3: 0.2021315009346193, mRNA_AGR2: 0.3266058768101608, mRNA_XBP1: 0.5832456422434592, mRNA_PRR15: 0.6740158330157311, mRNA_SLC44A4: -0.6530775957588527, mRNA_CA12: 0.6998776174179505, mRNA_DTL: -0.3991710668187166, mRNA_C5AR2: 0.4391618415707051, mRNA_TBC1D9: 0.8897086024429088, mRNA_AR: 0.3373521777078778, mRNA_CCDC170: 0.5286807774614178, mRNA_DEGS2: 0.2140860974022961, mRNA_TFF3: -1.2479876062448754, mRNA_DNALI1: 0.4934758157449213, mRNA_LINC00504: 0.981530639756867, mRNA_CLCA2: -0.5424028896104602, mRNA_PPP1R14C: -0.2895338398791071, mRNA_THSD4: 0.4483083187620725, mRNA_SPAG5: -0.3724376850021433, mRNA_FBP1: 0.790893027528041, mRNA_SLC7A8: 0.896962972904411, mRNA_EN1: 0.09088655363429, mRNA_ZNF552: 0.0546693234652782, Methylation_LRRC6: -0.8846212390894315, Methylation_chr2 66218712 LINC02934 (29533): -0.5855356151671862, Methylation_HOXB13: -1.116517930941436, Methylation_chr10 3949206 LINC02660 (4871): -0.9080536031457848, Methylation_chr5 179517140 RNF130 (18026): 0.971743281834886, Methylation_LOC727677: -0.7694211727708884, Methylation_LETM1: -0.573126851856735, Methylation_CDC42BPB: 1.4005385498489655, Methylation_C8orf38: -1.0895677063643716, Methylation_chr14 100504766 EVL (18852): -0.7822883247010054, Methylation_chr5 72594851 LOC340090 (24088): 0.9376513605735712, Methylation_chr2 242904738 LINC01238 (3421): -0.705945690299174, Methylation_ARFGEF1: -0.8033204631674651, Methylation_MAPT: -0.6698789813234781, Methylation_ZFAT: -0.9261054861492828, Methylation_KCNQ4: -0.8963217189497479, Methylation_chr1 232684368 SIPA1L2 (12934): -0.03811029957462, Methylation_CRNKL1: -0.746821198178115, Methylation_PRKAG2: -0.986794920489274, Methylation_MICB: -0.2116213621071274, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.0377802853039866, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.120465769852174, miRNA_hsa-mir-190b: -0.8022354981679473, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.2522780633995696, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.0145964826134726, miRNA_hsa-mir-130b: -0.5412569734138171, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-AC-A23C,High mRNA_C2orf54 (Z=1.59) and mRNA_CLCA2 (Z=1.45) indicate overexpression. No methylation or miRNA alterations meet diagnostic thresholds. All CNVs fall within normal range (−1.10 to −0.10). These features collectively suggest luminal A phenotype with estrogen signaling activation.,"mRNA_MLPH: 0.2345322239482773, mRNA_C2orf54: 1.593206990960318, mRNA_CITED4: -0.3150554521132767, mRNA_ESR1: 1.0016860415475266, mRNA_SPDEF: 0.2106243345181598, mRNA_AGR3: 0.7990765365159861, mRNA_FOXC1: -0.467983860704644, mRNA_GATA3: 0.1698451406037807, mRNA_AGR2: -0.0177166630754002, mRNA_XBP1: 1.012048471296439, mRNA_PRR15: 0.2377737619986749, mRNA_SLC44A4: 1.1906548574366014, mRNA_CA12: 0.26787992753016, mRNA_DTL: 0.6468368657305559, mRNA_C5AR2: -0.1041911968282502, mRNA_TBC1D9: 1.0975137912391089, mRNA_AR: 0.7786518686743954, mRNA_CCDC170: 1.0117914699006585, mRNA_DEGS2: 0.1262787549955098, mRNA_TFF3: -0.2708071877375348, mRNA_DNALI1: -1.5200241839729705, mRNA_LINC00504: 0.6831498723618541, mRNA_CLCA2: 1.4510329215462054, mRNA_PPP1R14C: -0.2264815634333717, mRNA_THSD4: 0.5314377533835443, mRNA_SPAG5: -0.959625968112197, mRNA_FBP1: 0.5470691442358965, mRNA_SLC7A8: 0.1017925834747142, mRNA_EN1: -0.3617845088397249, mRNA_ZNF552: 0.2808704132855625, Methylation_LRRC6: 0.2723654138820779, Methylation_chr2 66218712 LINC02934 (29533): -0.4023607159213271, Methylation_HOXB13: 0.1821911539019657, Methylation_chr10 3949206 LINC02660 (4871): -0.3258550406918188, Methylation_chr5 179517140 RNF130 (18026): 0.5043258513828485, Methylation_LOC727677: 0.0931819199264775, Methylation_LETM1: 0.7867674611158619, Methylation_CDC42BPB: -0.3061688171395246, Methylation_C8orf38: 0.3372007250765768, Methylation_chr14 100504766 EVL (18852): 0.4500837611900899, Methylation_chr5 72594851 LOC340090 (24088): -0.4872688115547437, Methylation_chr2 242904738 LINC01238 (3421): -0.6702219570587022, Methylation_ARFGEF1: 0.2818259562670226, Methylation_MAPT: 0.3548757871095266, Methylation_ZFAT: -0.0802137672233405, Methylation_KCNQ4: -0.4608787617407761, Methylation_chr1 232684368 SIPA1L2 (12934): -0.6832874559841919, Methylation_CRNKL1: 0.7696964397163351, Methylation_PRKAG2: -0.602751359159751, Methylation_MICB: -0.6592898249498796, miRNA_hsa-mir-934: -0.1111147872950362, miRNA_hsa-mir-4728: 1.55986937781277, miRNA_hsa-mir-5695: -0.1867382789271758, miRNA_hsa-mir-18a: -0.5569371787187698, miRNA_hsa-mir-190b: 0.3932705053426653, miRNA_hsa-mir-577: -0.6196389173822072, miRNA_hsa-mir-135b: -0.2674115636558419, miRNA_hsa-mir-2115: 0.759791080053413, miRNA_hsa-mir-17: -0.8108307878771561, miRNA_hsa-mir-130b: -0.1515783039554532, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A27M,"High-level Amplification absent; no CNV alterations meet diagnostic thresholds.  
mRNA_EN1 (Z=2.44) and mRNA_PPP1R14C (Z=1.89) overexpressed.  
mRNA_SPDEF (Z=-3.21), mRNA_AGR2 (Z=-2.10), mRNA_SLC44A4 (Z=-2.35), and mRNA_TFF3 (Z=-2.22) downregulated.  
Methylation hyper in ARFGEF1 (Z=1.85), C8orf38 (Z=1.62), LRRC6 (Z=1.55), EVL (Z=1.55); hypo in RNF130 (Z=-1.59).  
miRNA_hsa-mir-934 (Z=2.55), miRNA_hsa-mir-135b (Z=2.00) upregulated; miRNA_hsa-mir-190b (Z=-2.05) downregulated.","mRNA_MLPH: -1.2336636509717027, mRNA_C2orf54: 0.4653948496014229, mRNA_CITED4: 0.0423910017283705, mRNA_ESR1: -1.4067895977620817, mRNA_SPDEF: -3.2091992264748743, mRNA_AGR3: -1.0182457226861166, mRNA_FOXC1: 1.096872267822156, mRNA_GATA3: -1.684920114418896, mRNA_AGR2: -2.100476595032496, mRNA_XBP1: -1.250110325390445, mRNA_PRR15: -1.3619017271144414, mRNA_SLC44A4: -2.349468102705412, mRNA_CA12: -1.7196349592208668, mRNA_DTL: -0.2464151124772618, mRNA_C5AR2: -1.448609086174501, mRNA_TBC1D9: -0.9583692492113084, mRNA_AR: -1.174831143206117, mRNA_CCDC170: -1.1252949184376997, mRNA_DEGS2: -1.3084359442136575, mRNA_TFF3: -2.217851695484783, mRNA_DNALI1: -1.5363734383488987, mRNA_LINC00504: -1.5197870821465935, mRNA_CLCA2: -0.7965852919499848, mRNA_PPP1R14C: 1.8877758117365653, mRNA_THSD4: -1.001376470532088, mRNA_SPAG5: 0.0248916643648561, mRNA_FBP1: -0.8646679274256278, mRNA_SLC7A8: -1.7358268556816985, mRNA_EN1: 2.442353186693514, mRNA_ZNF552: -1.5966543484368725, Methylation_LRRC6: 1.546074640885726, Methylation_chr2 66218712 LINC02934 (29533): -0.2241354706761513, Methylation_HOXB13: -1.0011462754215994, Methylation_chr10 3949206 LINC02660 (4871): 1.3991375667286012, Methylation_chr5 179517140 RNF130 (18026): -1.5910646238664152, Methylation_LOC727677: 1.492208708765017, Methylation_LETM1: 1.2379858059037068, Methylation_CDC42BPB: -0.1325797353715811, Methylation_C8orf38: 1.6203765120215026, Methylation_chr14 100504766 EVL (18852): 1.5513930321028322, Methylation_chr5 72594851 LOC340090 (24088): -1.1832082308657448, Methylation_chr2 242904738 LINC01238 (3421): 1.3598181973071948, Methylation_ARFGEF1: 1.852703491713857, Methylation_MAPT: 1.365423031456565, Methylation_ZFAT: 1.2898112513228912, Methylation_KCNQ4: 0.6683887005111245, Methylation_chr1 232684368 SIPA1L2 (12934): 1.2897632000325048, Methylation_CRNKL1: 1.4738835357553872, Methylation_PRKAG2: 0.0502641349095638, Methylation_MICB: 1.5193558474301432, miRNA_hsa-mir-934: 2.5534524436325627, miRNA_hsa-mir-4728: -0.5747666575106906, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.2891536237634685, miRNA_hsa-mir-190b: -2.052137242410604, miRNA_hsa-mir-577: 1.7664856135269948, miRNA_hsa-mir-135b: 2.0000580312200604, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.2857052263122772, miRNA_hsa-mir-130b: 0.8522270769397131, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A1N8,"FOXC1 mRNA overexpression (Z=2.48) aligns with ESR1, GATA3, and AR transcriptional loss (Z < -1.92). KCNQ4 promoter hypermethylation (Z=2.05) suggests epigenetic silencing. miR-17, miR-577, and miR-135b upregulation (Z > 1.99) may suppress tumor suppressors. No qualifying CNVs detected. These features indicate a basal-like phenotype with luminal pathway suppression.","mRNA_MLPH: -1.7032233401992525, mRNA_C2orf54: -0.9553935105180896, mRNA_CITED4: 0.5580657979556128, mRNA_ESR1: -2.101391796878365, mRNA_SPDEF: -1.7258271117790926, mRNA_AGR3: -1.908196193638872, mRNA_FOXC1: 2.480483532074232, mRNA_GATA3: -3.0426595584623746, mRNA_AGR2: -1.1283490629368458, mRNA_XBP1: -2.5719895010080345, mRNA_PRR15: -0.8375283736402532, mRNA_SLC44A4: -2.3564847492095424, mRNA_CA12: -1.7460589111433642, mRNA_DTL: 1.2876925269659074, mRNA_C5AR2: -1.902180957564196, mRNA_TBC1D9: -2.1987781328997653, mRNA_AR: -2.405813202164393, mRNA_CCDC170: -1.7449473152992951, mRNA_DEGS2: -1.8794321386827093, mRNA_TFF3: -1.131055156821995, mRNA_DNALI1: -0.500542584079955, mRNA_LINC00504: -1.6748382709447818, mRNA_CLCA2: -0.8519371061619962, mRNA_PPP1R14C: 1.368000770756135, mRNA_THSD4: -1.6062058344584924, mRNA_SPAG5: -0.2328654022782113, mRNA_FBP1: -2.5183837911367446, mRNA_SLC7A8: -2.38887364185939, mRNA_EN1: 1.9767865941163576, mRNA_ZNF552: -1.428830870345411, Methylation_LRRC6: 1.467866695460668, Methylation_chr2 66218712 LINC02934 (29533): -1.937171178164506, Methylation_HOXB13: 1.6738411294564115, Methylation_chr10 3949206 LINC02660 (4871): 1.4740506923784884, Methylation_chr5 179517140 RNF130 (18026): -1.6361278859412205, Methylation_LOC727677: 1.4887053683195608, Methylation_LETM1: 1.3287647851771782, Methylation_CDC42BPB: -1.3580464860292991, Methylation_C8orf38: 1.45896542554799, Methylation_chr14 100504766 EVL (18852): 1.521779323928032, Methylation_chr5 72594851 LOC340090 (24088): -1.6108416973346864, Methylation_chr2 242904738 LINC01238 (3421): 1.3821613779955089, Methylation_ARFGEF1: 1.459676060829582, Methylation_MAPT: 1.449015710683435, Methylation_ZFAT: 1.4144344629294645, Methylation_KCNQ4: 2.054592504369384, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5308274543556368, Methylation_CRNKL1: 1.4476842705152384, Methylation_PRKAG2: 0.6017780747673696, Methylation_MICB: 1.5056557502038663, miRNA_hsa-mir-934: 1.9219183939194688, miRNA_hsa-mir-4728: -0.1763408965693782, miRNA_hsa-mir-5695: -0.0184912349150485, miRNA_hsa-mir-18a: 1.8127186608734496, miRNA_hsa-mir-190b: -1.858060294020139, miRNA_hsa-mir-577: 2.7857662276168504, miRNA_hsa-mir-135b: 1.9466786424437403, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 2.914988291081145, miRNA_hsa-mir-130b: 0.9623855499416658, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AN-A0XV,"No features meet the strict diagnostic thresholds for reporting. All mRNA Z-scores fall within [-1.92, 1.30], methylation Z-scores within [-1.47, 1.50], miRNA Z-scores within [-1.25, 1.99], and CNV values within [-1.10, 0.90]. No actionable genomic, epigenomic, or transcriptomic alterations detected.","mRNA_MLPH: 0.4459679684216591, mRNA_C2orf54: -0.7089569389158563, mRNA_CITED4: 0.3673542753662872, mRNA_ESR1: 1.035403282088024, mRNA_SPDEF: 0.1755469576952344, mRNA_AGR3: 0.5146426458683953, mRNA_FOXC1: 0.1809874422373205, mRNA_GATA3: 0.4486321519300419, mRNA_AGR2: -0.5091567654993902, mRNA_XBP1: 0.549054204192074, mRNA_PRR15: 0.0545948158865555, mRNA_SLC44A4: 0.4374144101898432, mRNA_CA12: 0.9077719771770892, mRNA_DTL: -0.5615434522922004, mRNA_C5AR2: 0.5251665221820122, mRNA_TBC1D9: 0.7292667519833145, mRNA_AR: 0.5208593764869944, mRNA_CCDC170: 1.2028585007574766, mRNA_DEGS2: 0.8463970343520454, mRNA_TFF3: -0.0656873026456429, mRNA_DNALI1: 0.3367787998797705, mRNA_LINC00504: 1.0506786814522229, mRNA_CLCA2: -0.5453272674435139, mRNA_PPP1R14C: -0.6596000240782973, mRNA_THSD4: 0.6678502191623825, mRNA_SPAG5: -0.1909385499242511, mRNA_FBP1: 0.1413058239781193, mRNA_SLC7A8: 0.5063638522639458, mRNA_EN1: -0.4694961760804959, mRNA_ZNF552: 0.8580118182755814, Methylation_LRRC6: 0.839508041763705, Methylation_chr2 66218712 LINC02934 (29533): 1.325288004816159, Methylation_HOXB13: 1.0785642516492735, Methylation_chr10 3949206 LINC02660 (4871): -0.6639737576882621, Methylation_chr5 179517140 RNF130 (18026): 0.8253352027521298, Methylation_LOC727677: -0.5676179002234342, Methylation_LETM1: -0.456901446105827, Methylation_CDC42BPB: -0.9714579661878618, Methylation_C8orf38: -1.1566493725860811, Methylation_chr14 100504766 EVL (18852): -0.6364343546820386, Methylation_chr5 72594851 LOC340090 (24088): 0.8941205672267422, Methylation_chr2 242904738 LINC01238 (3421): -0.5023337112187853, Methylation_ARFGEF1: -1.4358683131040082, Methylation_MAPT: -0.2014383488353729, Methylation_ZFAT: 0.4345091040728799, Methylation_KCNQ4: 1.3816480471258272, Methylation_chr1 232684368 SIPA1L2 (12934): -0.0504636559193162, Methylation_CRNKL1: -0.244938964002, Methylation_PRKAG2: 0.676380925960305, Methylation_MICB: -0.0663394938761332, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.5232628575669632, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.1672489489564429, miRNA_hsa-mir-190b: 0.3975622583377053, miRNA_hsa-mir-577: -0.062869560597418, miRNA_hsa-mir-135b: -0.1849705290095486, miRNA_hsa-mir-2115: 1.873201173012223, miRNA_hsa-mir-17: -0.5242854395114075, miRNA_hsa-mir-130b: -0.1510937388480863, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A0H6,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.6307680093845495, mRNA_C2orf54: 0.9369979616882098, mRNA_CITED4: 0.5625117875921106, mRNA_ESR1: 0.55717771777819, mRNA_SPDEF: 0.7661960761487308, mRNA_AGR3: 0.0888778020157412, mRNA_FOXC1: -0.0212704888567257, mRNA_GATA3: 0.1462547785977417, mRNA_AGR2: 0.2504950647966283, mRNA_XBP1: 0.943917158545106, mRNA_PRR15: 0.0721629587318505, mRNA_SLC44A4: 0.3857458448154318, mRNA_CA12: 0.2864422836593608, mRNA_DTL: -1.5458198721205512, mRNA_C5AR2: 0.5171223555636822, mRNA_TBC1D9: 0.0359343562090085, mRNA_AR: 0.4770463696389261, mRNA_CCDC170: 0.7276169309447821, mRNA_DEGS2: 0.1120656125478113, mRNA_TFF3: 0.266378876919613, mRNA_DNALI1: 0.7791358982350781, mRNA_LINC00504: 0.5787842514595406, mRNA_CLCA2: 0.3295479368074989, mRNA_PPP1R14C: -1.042926998174186, mRNA_THSD4: 0.3986467400303233, mRNA_SPAG5: -1.145748187641365, mRNA_FBP1: 0.8852607172349684, mRNA_SLC7A8: 0.7328353373847787, mRNA_EN1: 0.0509488258265611, mRNA_ZNF552: -0.656638926719444, Methylation_LRRC6: -1.5121050306298085, Methylation_chr2 66218712 LINC02934 (29533): -0.3335216742938426, Methylation_HOXB13: -0.9365711158369764, Methylation_chr10 3949206 LINC02660 (4871): -0.9989087911312134, Methylation_chr5 179517140 RNF130 (18026): -0.0636697694044647, Methylation_LOC727677: -1.4386344857395614, Methylation_LETM1: -1.1141565730758158, Methylation_CDC42BPB: -0.962520628034494, Methylation_C8orf38: -1.3842202624171995, Methylation_chr14 100504766 EVL (18852): -1.148110690671711, Methylation_chr5 72594851 LOC340090 (24088): -1.4620069568373415, Methylation_chr2 242904738 LINC01238 (3421): -1.064737745785205, Methylation_ARFGEF1: -1.5307534424523954, Methylation_MAPT: -0.8091615346299458, Methylation_ZFAT: -1.0595410014406286, Methylation_KCNQ4: 0.7163425509117572, Methylation_chr1 232684368 SIPA1L2 (12934): -0.9114406292056814, Methylation_CRNKL1: -1.2441838814857549, Methylation_PRKAG2: 1.3064832030238898, Methylation_MICB: -0.9008411737077684, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.1224332923343228, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.0414545728433103, miRNA_hsa-mir-190b: 0.8815184134303033, miRNA_hsa-mir-577: -0.0408219771782928, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: 0.5557061589117404, miRNA_hsa-mir-17: -0.6922237825764203, miRNA_hsa-mir-130b: -0.472415548658216, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-D8-A1JU,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.1266565288809731, mRNA_C2orf54: -0.9015491689072024, mRNA_CITED4: 0.1889301565804953, mRNA_ESR1: 0.7285252859775122, mRNA_SPDEF: 0.1257467055668031, mRNA_AGR3: 0.4302699171753902, mRNA_FOXC1: 0.1089357812067823, mRNA_GATA3: 0.1804038355139391, mRNA_AGR2: -0.2537224504402696, mRNA_XBP1: 0.6180275434928659, mRNA_PRR15: 0.4014484636811521, mRNA_SLC44A4: -0.3587070405193612, mRNA_CA12: 0.6026512362506278, mRNA_DTL: -2.709875279166836, mRNA_C5AR2: 0.3795971615157286, mRNA_TBC1D9: 0.8705758285074742, mRNA_AR: 0.8026045376707409, mRNA_CCDC170: 0.6336780604870017, mRNA_DEGS2: 0.8253465760125379, mRNA_TFF3: 0.0570920106590905, mRNA_DNALI1: 0.4064831898928498, mRNA_LINC00504: 0.3256412858572745, mRNA_CLCA2: 0.0712542318241701, mRNA_PPP1R14C: -0.5333635727519325, mRNA_THSD4: 0.3466677426097287, mRNA_SPAG5: -2.2783833826223483, mRNA_FBP1: 0.096798948777277, mRNA_SLC7A8: 0.9176076020798906, mRNA_EN1: 0.3005666092690403, mRNA_ZNF552: -0.0987798250831178, Methylation_LRRC6: 0.5944514982727888, Methylation_chr2 66218712 LINC02934 (29533): 0.8902503892422485, Methylation_HOXB13: -1.0381561986837131, Methylation_chr10 3949206 LINC02660 (4871): -0.1500544821658684, Methylation_chr5 179517140 RNF130 (18026): -0.0361471253218252, Methylation_LOC727677: -0.0880348774414802, Methylation_LETM1: 0.1516610633703788, Methylation_CDC42BPB: -0.0370755935619193, Methylation_C8orf38: 0.4546784522651539, Methylation_chr14 100504766 EVL (18852): 0.4474425802786461, Methylation_chr5 72594851 LOC340090 (24088): 0.2519939290572183, Methylation_chr2 242904738 LINC01238 (3421): -0.2189716613287179, Methylation_ARFGEF1: 0.4051625418182337, Methylation_MAPT: 0.4549980656029964, Methylation_ZFAT: 1.016075200208123, Methylation_KCNQ4: -1.1037989865757072, Methylation_chr1 232684368 SIPA1L2 (12934): 0.5553013350302143, Methylation_CRNKL1: 0.7181986975785083, Methylation_PRKAG2: 1.0896363119404946, Methylation_MICB: 0.5706695997014399, miRNA_hsa-mir-934: -0.348036150495921, miRNA_hsa-mir-4728: -0.4496564842556049, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.1849473855880674, miRNA_hsa-mir-190b: -0.75409330202419, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.4748953105723219, miRNA_hsa-mir-2115: 0.9427159923799076, miRNA_hsa-mir-17: -1.6135755611477816, miRNA_hsa-mir-130b: -0.6921315910806272, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-PE-A5DD,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.9059609904100232, mRNA_C2orf54: -0.6139540600057158, mRNA_CITED4: 0.7965035540665645, mRNA_ESR1: 0.7339727706652144, mRNA_SPDEF: 1.0131623129591123, mRNA_AGR3: 0.7517643749715065, mRNA_FOXC1: -0.2546709211921693, mRNA_GATA3: 0.7945727157413156, mRNA_AGR2: 0.6015520292719919, mRNA_XBP1: 0.0613559785157696, mRNA_PRR15: 1.031396886889749, mRNA_SLC44A4: 0.9536000599513812, mRNA_CA12: 0.3716086894261184, mRNA_DTL: -0.1160016495910926, mRNA_C5AR2: 1.31442406385704, mRNA_TBC1D9: -0.4227236638669231, mRNA_AR: 0.6340329112668437, mRNA_CCDC170: 0.2838046443876448, mRNA_DEGS2: 0.9411730540518048, mRNA_TFF3: 1.2826180580144824, mRNA_DNALI1: 0.665293864458879, mRNA_LINC00504: -0.1141451177827239, mRNA_CLCA2: -0.7862829881545041, mRNA_PPP1R14C: -1.0863975390224143, mRNA_THSD4: 0.2026566296981756, mRNA_SPAG5: -0.6896093632695431, mRNA_FBP1: 0.6234053259404938, mRNA_SLC7A8: 0.5038125132496772, mRNA_EN1: -0.0911629517329461, mRNA_ZNF552: 0.8908429370723201, Methylation_LRRC6: -0.5142092804334678, Methylation_chr2 66218712 LINC02934 (29533): 1.1726863876052935, Methylation_HOXB13: 1.0134473030105011, Methylation_chr10 3949206 LINC02660 (4871): 0.2868410703098208, Methylation_chr5 179517140 RNF130 (18026): 1.0297333215636282, Methylation_LOC727677: -0.8161899889051256, Methylation_LETM1: -1.1089781714651492, Methylation_CDC42BPB: 0.8249931727339829, Methylation_C8orf38: -0.800863963047479, Methylation_chr14 100504766 EVL (18852): -0.8423922662755299, Methylation_chr5 72594851 LOC340090 (24088): 0.7441019662860405, Methylation_chr2 242904738 LINC01238 (3421): -0.9923467985551988, Methylation_ARFGEF1: -0.6204678566516953, Methylation_MAPT: -0.6258624240647993, Methylation_ZFAT: -0.8978727189738464, Methylation_KCNQ4: 1.5398045417951909, Methylation_chr1 232684368 SIPA1L2 (12934): -1.0339838577227969, Methylation_CRNKL1: -1.158400489296852, Methylation_PRKAG2: 0.7599959250853565, Methylation_MICB: -1.2969127719377946, miRNA_hsa-mir-934: -0.1585833181678843, miRNA_hsa-mir-4728: -0.2668795024194925, miRNA_hsa-mir-5695: -0.1007672498008715, miRNA_hsa-mir-18a: -0.4709859332788236, miRNA_hsa-mir-190b: 0.6376182937605638, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.1030761183088615, miRNA_hsa-mir-2115: -0.184894879270551, miRNA_hsa-mir-17: -0.6113893483654645, miRNA_hsa-mir-130b: -1.1842946427563008, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A2-A0YL,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.104262048433559, mRNA_C2orf54: 0.1613963963000979, mRNA_CITED4: 0.9274506929367068, mRNA_ESR1: 0.1702657076508957, mRNA_SPDEF: 0.1299761679897623, mRNA_AGR3: 0.2753501950151823, mRNA_FOXC1: 0.5642567045772351, mRNA_GATA3: 0.4820450007694907, mRNA_AGR2: 0.3692562555845337, mRNA_XBP1: 0.2830371508287235, mRNA_PRR15: 0.1007349306712444, mRNA_SLC44A4: 0.604910779189719, mRNA_CA12: 0.622845975629121, mRNA_DTL: 0.3129329736995557, mRNA_C5AR2: 0.9630331392688974, mRNA_TBC1D9: 0.4059968396024939, mRNA_AR: 0.852854451449377, mRNA_CCDC170: -0.3931256019341547, mRNA_DEGS2: 0.8191753265778062, mRNA_TFF3: 0.1743181684497148, mRNA_DNALI1: 0.743310541313477, mRNA_LINC00504: 1.0195620922694426, mRNA_CLCA2: 0.9795961433673364, mRNA_PPP1R14C: 0.4812791163355469, mRNA_THSD4: 0.7208994187039509, mRNA_SPAG5: -0.7186920450103488, mRNA_FBP1: -0.0636380984031918, mRNA_SLC7A8: 0.7172710046528133, mRNA_EN1: -0.4908490479148546, mRNA_ZNF552: 0.3886092171375246, Methylation_LRRC6: 0.9042518202026842, Methylation_chr2 66218712 LINC02934 (29533): -0.7641843450387152, Methylation_HOXB13: -0.934986311365276, Methylation_chr10 3949206 LINC02660 (4871): 0.5495826376446282, Methylation_chr5 179517140 RNF130 (18026): -1.007940627350688, Methylation_LOC727677: 0.333194422109098, Methylation_LETM1: 0.6810451809058231, Methylation_CDC42BPB: -0.774815790291175, Methylation_C8orf38: 0.2830727372530024, Methylation_chr14 100504766 EVL (18852): 0.6066644717260461, Methylation_chr5 72594851 LOC340090 (24088): -0.6075926527800727, Methylation_chr2 242904738 LINC01238 (3421): -0.082851709440355, Methylation_ARFGEF1: 0.6912009883054475, Methylation_MAPT: 1.0836398820395263, Methylation_ZFAT: 0.510799248004983, Methylation_KCNQ4: -1.1344910355637243, Methylation_chr1 232684368 SIPA1L2 (12934): 0.6138733883946922, Methylation_CRNKL1: 0.729238002072858, Methylation_PRKAG2: 1.264978044786589, Methylation_MICB: 0.8761797297629539, miRNA_hsa-mir-934: -0.2921171506178825, miRNA_hsa-mir-4728: -0.8554027349755077, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.0177934668062707, miRNA_hsa-mir-190b: 0.396009054887437, miRNA_hsa-mir-577: 0.8716316608584986, miRNA_hsa-mir-135b: 0.1015959105539233, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.6562932972736079, miRNA_hsa-mir-130b: -1.1686374862009876, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A27V,"High mRNA_FOXC1 (Z=1.56), mRNA_C5AR2 (Z=1.72), and mRNA_CLCA2 (Z=2.00) indicate overexpression. No methylation or miRNA alterations meet diagnostic thresholds. All CNVs fall within normal range (−1.10 to −0.10). These features collectively suggest a basal-like phenotype with immune and secretory pathway activation.","mRNA_MLPH: 0.7140137608114704, mRNA_C2orf54: 0.1586239665832659, mRNA_CITED4: 0.2379756040485861, mRNA_ESR1: 0.9049593176356348, mRNA_SPDEF: 0.5811220785516207, mRNA_AGR3: 0.6716658223864708, mRNA_FOXC1: 1.5624063922773272, mRNA_GATA3: 0.142198745917522, mRNA_AGR2: 0.2956406080018359, mRNA_XBP1: 0.8960694247588981, mRNA_PRR15: 0.4364303764630974, mRNA_SLC44A4: 1.0392943463177944, mRNA_CA12: 1.0242230082801025, mRNA_DTL: 0.2651649346544434, mRNA_C5AR2: 1.7196938446058485, mRNA_TBC1D9: 0.8804983782185117, mRNA_AR: 0.7136186173575418, mRNA_CCDC170: 1.1323500611883288, mRNA_DEGS2: 0.491483719801319, mRNA_TFF3: 0.2398950962038259, mRNA_DNALI1: 0.7303575007228992, mRNA_LINC00504: 0.5437512092363456, mRNA_CLCA2: 2.001123033060636, mRNA_PPP1R14C: 0.4880784225389823, mRNA_THSD4: 0.9325324650937388, mRNA_SPAG5: 0.2208813601969773, mRNA_FBP1: 1.0281656454474477, mRNA_SLC7A8: 0.7903200368371134, mRNA_EN1: 0.8585080329216763, mRNA_ZNF552: 1.255333172030294, Methylation_LRRC6: -0.4863127161619123, Methylation_chr2 66218712 LINC02934 (29533): -0.4177582401245734, Methylation_HOXB13: 0.3126858108197689, Methylation_chr10 3949206 LINC02660 (4871): 0.4485320122788981, Methylation_chr5 179517140 RNF130 (18026): 0.7934019234178475, Methylation_LOC727677: -0.6911575073716549, Methylation_LETM1: -0.6445439084105569, Methylation_CDC42BPB: -0.4235691117091401, Methylation_C8orf38: -0.9653655406561352, Methylation_chr14 100504766 EVL (18852): -0.2529485811951561, Methylation_chr5 72594851 LOC340090 (24088): 0.1792482847722961, Methylation_chr2 242904738 LINC01238 (3421): -0.7292310734789288, Methylation_ARFGEF1: -0.1721812336115999, Methylation_MAPT: -0.092482578666567, Methylation_ZFAT: -0.8932709297724325, Methylation_KCNQ4: -0.7497847959736632, Methylation_chr1 232684368 SIPA1L2 (12934): -0.8493759208157909, Methylation_CRNKL1: 0.0208255987522971, Methylation_PRKAG2: -0.6668521633125427, Methylation_MICB: -1.2433439818247476, miRNA_hsa-mir-934: -0.3992788255365408, miRNA_hsa-mir-4728: -0.2305468926558149, miRNA_hsa-mir-5695: 0.8600309095741175, miRNA_hsa-mir-18a: -0.8407001401160741, miRNA_hsa-mir-190b: 1.6409372894741974, miRNA_hsa-mir-577: -0.4657022668756077, miRNA_hsa-mir-135b: -0.2026811517540213, miRNA_hsa-mir-2115: -0.1232068124112362, miRNA_hsa-mir-17: -0.5851455370572218, miRNA_hsa-mir-130b: -1.0940673218039687, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-C8-A1HE,High-level Amplification of none; ESR1 (Z=1.53) and CCDC170 (Z=1.61) show high mRNA expression. No promoter hyper/hypomethylation meets thresholds. miR-135b upregulated (Z=1.88). All CNVs fall in normal range (−1.10 to −0.10). These features indicate luminal A phenotype with ER pathway activation.,"mRNA_MLPH: 0.8540857254551992, mRNA_C2orf54: 0.4995297157878616, mRNA_CITED4: 0.5531822183385768, mRNA_ESR1: 1.5325131969649368, mRNA_SPDEF: 0.6189867961918972, mRNA_AGR3: 1.0288806299850677, mRNA_FOXC1: -0.8151100529171343, mRNA_GATA3: 1.0333153144597362, mRNA_AGR2: 0.9820060946674372, mRNA_XBP1: 1.2828229268064149, mRNA_PRR15: 0.4351429221236162, mRNA_SLC44A4: 0.8687826060810484, mRNA_CA12: 0.9676428057037592, mRNA_DTL: 0.0350254804447189, mRNA_C5AR2: 0.9976018612697548, mRNA_TBC1D9: 0.8972405328358142, mRNA_AR: 0.9260148237443686, mRNA_CCDC170: 1.6071329163079424, mRNA_DEGS2: 0.6946444593232637, mRNA_TFF3: 1.266827459929045, mRNA_DNALI1: 0.5021359902031716, mRNA_LINC00504: 1.4828758475113968, mRNA_CLCA2: 0.8188896779646673, mRNA_PPP1R14C: -0.5384827329202683, mRNA_THSD4: 1.2629036930398223, mRNA_SPAG5: -0.2803648147288347, mRNA_FBP1: 0.6239380076843031, mRNA_SLC7A8: 0.8745258804470546, mRNA_EN1: -0.0568506861551978, mRNA_ZNF552: 0.9406538674560904, Methylation_LRRC6: -1.2367809707760986, Methylation_chr2 66218712 LINC02934 (29533): 1.3554396898437595, Methylation_HOXB13: -0.5445957972965396, Methylation_chr10 3949206 LINC02660 (4871): -0.2634725226909774, Methylation_chr5 179517140 RNF130 (18026): 1.1168361839494478, Methylation_LOC727677: -1.308171895821952, Methylation_LETM1: -1.032901436141845, Methylation_CDC42BPB: -1.307900316520714, Methylation_C8orf38: -1.320644491755008, Methylation_chr14 100504766 EVL (18852): -1.3695016970916514, Methylation_chr5 72594851 LOC340090 (24088): 1.1837384568875906, Methylation_chr2 242904738 LINC01238 (3421): -1.256739581746113, Methylation_ARFGEF1: -1.0191765845009229, Methylation_MAPT: -1.4385625500428736, Methylation_ZFAT: -0.9007243473946552, Methylation_KCNQ4: -0.6005583661148305, Methylation_chr1 232684368 SIPA1L2 (12934): -1.4485598322656477, Methylation_CRNKL1: -1.2009913323743733, Methylation_PRKAG2: 1.2871232155170924, Methylation_MICB: -1.4285016077171278, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.4018635672104829, miRNA_hsa-mir-5695: 0.3209899606487076, miRNA_hsa-mir-18a: -0.5389796984405825, miRNA_hsa-mir-190b: 1.162342714175241, miRNA_hsa-mir-577: -0.1499130382293641, miRNA_hsa-mir-135b: 1.8775098346015155, miRNA_hsa-mir-2115: -0.2376268235349109, miRNA_hsa-mir-17: -0.7654408681086894, miRNA_hsa-mir-130b: 0.2373635794290417, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AC-A2FM,"High-level Amplification of ZNF552 drives significant mRNA overexpression. HOXB13 and CDC42BPB promoter hypermethylation mediates epigenetic silencing. Deletion of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 correlates with transcriptional downregulation. These features collectively indicate a basal-like phenotype with ER pathway suppression.","mRNA_MLPH: 0.8494033696190595, mRNA_C2orf54: -1.1723718030170305, mRNA_CITED4: -1.4530717931821635, mRNA_ESR1: 1.1224493309433856, mRNA_SPDEF: 0.8234490765269482, mRNA_AGR3: 0.8433182790525077, mRNA_FOXC1: -0.7276034187321492, mRNA_GATA3: 0.5701133504174545, mRNA_AGR2: 1.5895221983972443, mRNA_XBP1: -0.0025135393985414, mRNA_PRR15: 1.2418391429110176, mRNA_SLC44A4: -0.1684665852690505, mRNA_CA12: 0.1326722277005159, mRNA_DTL: -0.2432884657083667, mRNA_C5AR2: -0.3299022629407526, mRNA_TBC1D9: 1.7579046307168136, mRNA_AR: 0.7280959463295954, mRNA_CCDC170: 1.2463624589511395, mRNA_DEGS2: 0.7548450242485673, mRNA_TFF3: 1.571485853669058, mRNA_DNALI1: 0.3910487437774023, mRNA_LINC00504: 0.8458362749430767, mRNA_CLCA2: -0.7658673823124834, mRNA_PPP1R14C: -0.844673029986289, mRNA_THSD4: 1.7456639888422882, mRNA_SPAG5: 0.5945045608507892, mRNA_FBP1: 1.1330637546261917, mRNA_SLC7A8: 0.8797918449049187, mRNA_EN1: -0.9521970373493026, mRNA_ZNF552: 2.88797771241159, Methylation_LRRC6: -1.1051030685852357, Methylation_chr2 66218712 LINC02934 (29533): 1.1515458558055434, Methylation_HOXB13: 1.720328822179158, Methylation_chr10 3949206 LINC02660 (4871): -1.3117405553014545, Methylation_chr5 179517140 RNF130 (18026): 1.2373680635769415, Methylation_LOC727677: -1.5384937732426558, Methylation_LETM1: -1.8545443898724023, Methylation_CDC42BPB: 1.5160338708200232, Methylation_C8orf38: -0.3102190237718697, Methylation_chr14 100504766 EVL (18852): -1.3316990799319464, Methylation_chr5 72594851 LOC340090 (24088): 0.6693478944488012, Methylation_chr2 242904738 LINC01238 (3421): -0.791386628370711, Methylation_ARFGEF1: -1.5728261296564905, Methylation_MAPT: -0.8846610079030254, Methylation_ZFAT: -0.9612374730944052, Methylation_KCNQ4: 1.4524139713688575, Methylation_chr1 232684368 SIPA1L2 (12934): -1.58341077341829, Methylation_CRNKL1: -1.7824012754788092, Methylation_PRKAG2: 1.1944969876202285, Methylation_MICB: -1.2937603808346556, miRNA_hsa-mir-934: -0.3976996760051687, miRNA_hsa-mir-4728: -0.1045614840353316, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.4640447346105119, miRNA_hsa-mir-190b: -0.7874833705972051, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.5231438346294013, miRNA_hsa-mir-130b: -0.4554383726455351, CNV_VPS54: -1.6173912818721974, CNV_LINC01867: -1.63714039509435, CNV_LINC02576: -1.657048777669473, CNV_WDPCP: -1.6249341592372952, CNV_CEP68: -1.657048777669473"
TCGA-E9-A2JT,"CLCA2 mRNA overexpression (Z=1.91) indicates high expression. ARFGEF1 and C8orf38 promoters are hypermethylated (Z>1.50), suggesting epigenetic silencing. No CNVs meet amplification/deletion thresholds. miRNA alterations do not reach significance. These features align with a luminal phenotype and potential MAPK pathway dysregulation.","mRNA_MLPH: -0.0506991873426994, mRNA_C2orf54: -0.5863283813394796, mRNA_CITED4: -0.4870234771462977, mRNA_ESR1: 0.1095557983354746, mRNA_SPDEF: -0.0903375906010061, mRNA_AGR3: -0.2142828079846519, mRNA_FOXC1: -0.2992376453806444, mRNA_GATA3: -0.2472815809752183, mRNA_AGR2: 0.1274960225423177, mRNA_XBP1: -0.6468540686687241, mRNA_PRR15: -0.4007584413747744, mRNA_SLC44A4: 0.1006626857813473, mRNA_CA12: -0.0476341022926968, mRNA_DTL: -0.6408740216589395, mRNA_C5AR2: -0.2986615874298026, mRNA_TBC1D9: -0.2726528630184743, mRNA_AR: 0.0530633256365578, mRNA_CCDC170: -0.1987498065457586, mRNA_DEGS2: -0.6247763426293759, mRNA_TFF3: -0.0966133493122085, mRNA_DNALI1: -0.9310956296271484, mRNA_LINC00504: -0.4823189582884158, mRNA_CLCA2: 1.913951081149432, mRNA_PPP1R14C: -1.0176871196467974, mRNA_THSD4: -0.4822911814569974, mRNA_SPAG5: -0.7755897906428081, mRNA_FBP1: -0.4875947820199228, mRNA_SLC7A8: -0.3931751555826125, mRNA_EN1: -0.348082226062135, mRNA_ZNF552: -0.5319852754810376, Methylation_LRRC6: 1.4473487489921708, Methylation_chr2 66218712 LINC02934 (29533): 1.2833923879779878, Methylation_HOXB13: -0.8394540146414234, Methylation_chr10 3949206 LINC02660 (4871): 1.4350686910492167, Methylation_chr5 179517140 RNF130 (18026): -1.2379878266442033, Methylation_LOC727677: 1.3872399860754447, Methylation_LETM1: 1.2245895137070857, Methylation_CDC42BPB: -1.0287186360743246, Methylation_C8orf38: 1.5855250472381552, Methylation_chr14 100504766 EVL (18852): 1.4614292028991909, Methylation_chr5 72594851 LOC340090 (24088): -0.7414365107364811, Methylation_chr2 242904738 LINC01238 (3421): 1.211785243200393, Methylation_ARFGEF1: 1.6630296936306457, Methylation_MAPT: 1.4083396198839888, Methylation_ZFAT: 1.23126568494011, Methylation_KCNQ4: -1.1396529868500174, Methylation_chr1 232684368 SIPA1L2 (12934): 1.236125313889885, Methylation_CRNKL1: 1.183056691092894, Methylation_PRKAG2: 0.7569729408688376, Methylation_MICB: 1.462989586598482, miRNA_hsa-mir-934: -0.4875823957210867, miRNA_hsa-mir-4728: -0.997466044322362, miRNA_hsa-mir-5695: -0.3517674396913536, miRNA_hsa-mir-18a: 0.0509029862440193, miRNA_hsa-mir-190b: -0.2145556634154037, miRNA_hsa-mir-577: 0.8296528392140268, miRNA_hsa-mir-135b: -0.541581347901313, miRNA_hsa-mir-2115: -0.2295169976925579, miRNA_hsa-mir-17: 0.2007823455428859, miRNA_hsa-mir-130b: -0.5246413344799942, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-B6-A1KF,"High-level Amplification absent; Gain observed in VPS54, WDPCP, CEP68.  
mRNA_PPP1R14C (Z=2.83) and mRNA_DTL (Z=1.74) overexpressed; mRNA_AGR2 (Z=-2.53), FBP1 (Z=-2.79) downregulated.  
Promoter hypermethylation at KCNQ4, LINC02660, C8orf38; hypomethylation at RNF130, LOC340090.  
miR-130b, miR-135b, miR-5695 upregulated.  
Collectively indicate luminal B phenotype with ER-pathway suppression.","mRNA_MLPH: -1.6785355769561938, mRNA_C2orf54: 0.8827869109194872, mRNA_CITED4: -0.2257602314330257, mRNA_ESR1: -1.087875644281143, mRNA_SPDEF: -1.5844570148219583, mRNA_AGR3: -2.034769394420924, mRNA_FOXC1: 1.191690806712934, mRNA_GATA3: -0.5377769600470291, mRNA_AGR2: -2.5349151420779954, mRNA_XBP1: -1.910580604107664, mRNA_PRR15: -2.2186814230951195, mRNA_SLC44A4: -2.303742682324343, mRNA_CA12: -1.4234119639571468, mRNA_DTL: 1.7415612998087662, mRNA_C5AR2: -1.1213361081764417, mRNA_TBC1D9: -0.9245624879890004, mRNA_AR: -1.4922009000938807, mRNA_CCDC170: -1.8835865925900213, mRNA_DEGS2: -1.3905057152032094, mRNA_TFF3: -2.037062414938957, mRNA_DNALI1: -2.0266994164011267, mRNA_LINC00504: -1.548095609152152, mRNA_CLCA2: 0.0786599338736622, mRNA_PPP1R14C: 2.8313106798212133, mRNA_THSD4: -2.317673800113922, mRNA_SPAG5: 1.5179026029813103, mRNA_FBP1: -2.78643747495363, mRNA_SLC7A8: -1.4402149072404158, mRNA_EN1: 1.7182574795876733, mRNA_ZNF552: -1.228044848936, Methylation_LRRC6: 1.5424447004346036, Methylation_chr2 66218712 LINC02934 (29533): -1.7330539477773994, Methylation_HOXB13: 1.4219749221783815, Methylation_chr10 3949206 LINC02660 (4871): 1.623706932233705, Methylation_chr5 179517140 RNF130 (18026): -1.5492253446442537, Methylation_LOC727677: 1.5520532632194115, Methylation_LETM1: 1.3813457326509853, Methylation_CDC42BPB: 1.301561967550464, Methylation_C8orf38: 1.6187781347157228, Methylation_chr14 100504766 EVL (18852): 1.44168888576251, Methylation_chr5 72594851 LOC340090 (24088): -1.5104677499017902, Methylation_chr2 242904738 LINC01238 (3421): 1.468572028607665, Methylation_ARFGEF1: 1.523201012429684, Methylation_MAPT: 1.3673534342591849, Methylation_ZFAT: 1.3010006368175515, Methylation_KCNQ4: 1.7278332501859557, Methylation_chr1 232684368 SIPA1L2 (12934): 1.6000252271623956, Methylation_CRNKL1: 1.3987479597339938, Methylation_PRKAG2: -1.4279442105402933, Methylation_MICB: 1.4680369184529776, miRNA_hsa-mir-934: 1.460774395293142, miRNA_hsa-mir-4728: 1.9701339631475456, miRNA_hsa-mir-5695: 2.40904544089535, miRNA_hsa-mir-18a: 1.0226621100123472, miRNA_hsa-mir-190b: -0.1196527385747854, miRNA_hsa-mir-577: 0.9612775963153328, miRNA_hsa-mir-135b: 2.771946176380781, miRNA_hsa-mir-2115: 2.1722705079819136, miRNA_hsa-mir-17: 1.0634908675532162, miRNA_hsa-mir-130b: 2.8381426657567, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-E2-A1IL,"mRNA_C5AR2 (Z=1.43), mRNA_TBC1D9 (Z=1.31), mRNA_AR (Z=1.41), mRNA_CLCA2 (Z=1.79), and mRNA_THSD4 (Z=1.81) are highly expressed. Methylation_chr2:66218712 (Z=−1.71) and Methylation_MICB (Z=−1.57) are hypomethylated. No miRNAs meet dysregulation thresholds. All CNVs fall within normal range. Overexpression of luminal genes (AR, THSD4, CLCA2) indicates Luminal A phenotype with estrogen signaling activation.","mRNA_MLPH: 0.9079537279495944, mRNA_C2orf54: 0.4990414460253438, mRNA_CITED4: 0.9833847847497424, mRNA_ESR1: 0.938343204301021, mRNA_SPDEF: 0.6495590985764309, mRNA_AGR3: -0.0101045372954684, mRNA_FOXC1: -0.2315974767345345, mRNA_GATA3: 0.6122409938194795, mRNA_AGR2: 0.4917071842980236, mRNA_XBP1: 0.0483039911487064, mRNA_PRR15: 0.2707336327592554, mRNA_SLC44A4: 0.9120005309139568, mRNA_CA12: 0.9864995149093716, mRNA_DTL: -0.4823378588658387, mRNA_C5AR2: 1.425396848154768, mRNA_TBC1D9: 1.309968822983367, mRNA_AR: 1.410030831522435, mRNA_CCDC170: 0.8255841644579434, mRNA_DEGS2: 0.966870140675724, mRNA_TFF3: 0.108652886945724, mRNA_DNALI1: 0.803827191359072, mRNA_LINC00504: 1.233892415742326, mRNA_CLCA2: 1.792176234356286, mRNA_PPP1R14C: -0.4660232939310124, mRNA_THSD4: 1.8121266579883808, mRNA_SPAG5: -0.7993683391899616, mRNA_FBP1: 0.8317474664017374, mRNA_SLC7A8: 0.9688880966470956, mRNA_EN1: 0.2046132058725526, mRNA_ZNF552: 1.1817239839530411, Methylation_LRRC6: -0.2849199376412467, Methylation_chr2 66218712 LINC02934 (29533): -1.7061280384473356, Methylation_HOXB13: -1.0792197150306349, Methylation_chr10 3949206 LINC02660 (4871): -1.1197460006585362, Methylation_chr5 179517140 RNF130 (18026): 0.374783104432427, Methylation_LOC727677: -0.3745401749395141, Methylation_LETM1: -0.6430109054507168, Methylation_CDC42BPB: -1.3084309067351585, Methylation_C8orf38: -1.019313482148125, Methylation_chr14 100504766 EVL (18852): -1.1547482389414878, Methylation_chr5 72594851 LOC340090 (24088): 1.0697584000806653, Methylation_chr2 242904738 LINC01238 (3421): -1.1738104234101316, Methylation_ARFGEF1: -0.9499570100337148, Methylation_MAPT: -0.9990824319720027, Methylation_ZFAT: -0.3889798964250798, Methylation_KCNQ4: -0.8769904176912674, Methylation_chr1 232684368 SIPA1L2 (12934): -0.6317905428704956, Methylation_CRNKL1: -0.7053074065241525, Methylation_PRKAG2: 1.1377263746469275, Methylation_MICB: -1.566785002691483, miRNA_hsa-mir-934: -0.2904338968356814, miRNA_hsa-mir-4728: -0.0310920281612311, miRNA_hsa-mir-5695: 1.498836492403817, miRNA_hsa-mir-18a: -0.877184127172245, miRNA_hsa-mir-190b: 0.631509264598907, miRNA_hsa-mir-577: -0.652615108768454, miRNA_hsa-mir-135b: -0.5836128814437431, miRNA_hsa-mir-2115: 0.5914484357617782, miRNA_hsa-mir-17: -1.143638711764719, miRNA_hsa-mir-130b: -1.18429765437481, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-5T-A9QA,"High-level Amplification absent; no CNVs meet amplification thresholds.  
mRNA_TFF3 (Z=1.54) and mRNA_AGR2 (Z=1.36) exceed high-expression threshold.  
mRNA_CA12 (Z=−2.21) is low.  
Methylation_HOXB13 (Z=1.73) and Methylation_KCNQ4 (Z=1.80) are hypermethylated.  
Methylation_CRNKL1 (Z=−1.88) and Methylation_MICB (Z=−1.63) are hypomethylated.  
No miRNAs meet dysregulation thresholds.","mRNA_MLPH: 1.2007730424833791, mRNA_C2orf54: -0.4698594558565501, mRNA_CITED4: -0.8204701589487021, mRNA_ESR1: -0.0278636870350293, mRNA_SPDEF: 1.2659322727489632, mRNA_AGR3: 0.8357555668365647, mRNA_FOXC1: -0.5418070495476071, mRNA_GATA3: 0.5255490144754013, mRNA_AGR2: 1.3597606254840686, mRNA_XBP1: 0.5722074724619437, mRNA_PRR15: 1.304506612558164, mRNA_SLC44A4: 0.8426894311179876, mRNA_CA12: -2.210446586609124, mRNA_DTL: 0.5067679586670781, mRNA_C5AR2: 0.7287593225108439, mRNA_TBC1D9: 0.2694899582267306, mRNA_AR: -0.0796953136177645, mRNA_CCDC170: 0.4180324130999073, mRNA_DEGS2: 0.9630040945919528, mRNA_TFF3: 1.5389682328913028, mRNA_DNALI1: 0.7592903341736377, mRNA_LINC00504: -0.1108182293889114, mRNA_CLCA2: -0.8950940779111158, mRNA_PPP1R14C: -0.331511010944251, mRNA_THSD4: -0.1591967941218107, mRNA_SPAG5: 1.0028939773184304, mRNA_FBP1: 1.2239651539820104, mRNA_SLC7A8: -0.3069528507073688, mRNA_EN1: -1.135443126074894, mRNA_ZNF552: 0.5070819971489324, Methylation_LRRC6: -1.4485345749727137, Methylation_chr2 66218712 LINC02934 (29533): 0.9138861745584218, Methylation_HOXB13: 1.7270594424717596, Methylation_chr10 3949206 LINC02660 (4871): -0.7858274041500646, Methylation_chr5 179517140 RNF130 (18026): 0.1851277428435357, Methylation_LOC727677: 0.4948308401177977, Methylation_LETM1: -0.9642629669999504, Methylation_CDC42BPB: 1.312368147510465, Methylation_C8orf38: 1.3199789906207982, Methylation_chr14 100504766 EVL (18852): -0.0691836136604192, Methylation_chr5 72594851 LOC340090 (24088): 0.9096077867845248, Methylation_chr2 242904738 LINC01238 (3421): 1.444887423854888, Methylation_ARFGEF1: -1.4222757845181542, Methylation_MAPT: -0.3285597301030667, Methylation_ZFAT: -0.6602509693417653, Methylation_KCNQ4: 1.7977304363769948, Methylation_chr1 232684368 SIPA1L2 (12934): -1.0343206114382082, Methylation_CRNKL1: -1.8769139971765367, Methylation_PRKAG2: -0.1503281436779159, Methylation_MICB: -1.6284733069501072, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.1222483304111335, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.2699785227757366, miRNA_hsa-mir-190b: 0.3527520113857804, miRNA_hsa-mir-577: -0.5620919664480003, miRNA_hsa-mir-135b: 0.1765248890231008, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.4175518296711737, miRNA_hsa-mir-130b: 1.1814714017315868, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-AO-A12B,"High-level Amplification absent; no CNVs meet amplification thresholds.  
mRNA_CITED4 low (Z = -2.08) indicates transcriptional silencing.  
miRNA_hsa-mir-5695 upregulated (Z = 3.84).  
Methylation_PRKAG2 hypo-methylated (Z = -1.62); Methylation_chr1 232684368 SIPA1L2 (Z = -1.47) at threshold for hypo-methylation.  
No promoter hypermethylation or high-level amplifications detected.","mRNA_MLPH: 0.5559417043487681, mRNA_C2orf54: -1.2443425619303312, mRNA_CITED4: -2.0780053088705976, mRNA_ESR1: 1.257414371808471, mRNA_SPDEF: -0.3868516252649301, mRNA_AGR3: -0.490469568321295, mRNA_FOXC1: -0.8188072862245971, mRNA_GATA3: 0.5584592692628925, mRNA_AGR2: 0.1426333708580298, mRNA_XBP1: 1.345548738252311, mRNA_PRR15: -0.0802230845723405, mRNA_SLC44A4: 0.3213266648698235, mRNA_CA12: 0.8809539536447508, mRNA_DTL: -0.5946361001448051, mRNA_C5AR2: 1.6612076250599588, mRNA_TBC1D9: 0.6242461255203253, mRNA_AR: 0.068353534210701, mRNA_CCDC170: 1.5123804842126791, mRNA_DEGS2: 0.9525187091416384, mRNA_TFF3: 0.8554763165617317, mRNA_DNALI1: 0.4584387347839986, mRNA_LINC00504: 0.2029851031939991, mRNA_CLCA2: -0.8743001937160547, mRNA_PPP1R14C: -0.9913462687419166, mRNA_THSD4: 0.7030402834375914, mRNA_SPAG5: -0.0819107122819524, mRNA_FBP1: 0.157607411521379, mRNA_SLC7A8: 0.5703405064180737, mRNA_EN1: -1.0528109362662608, mRNA_ZNF552: 0.6439460998553805, Methylation_LRRC6: -1.243219126360797, Methylation_chr2 66218712 LINC02934 (29533): -0.6345894298064181, Methylation_HOXB13: -0.9453184041638852, Methylation_chr10 3949206 LINC02660 (4871): -1.2995449789804974, Methylation_chr5 179517140 RNF130 (18026): -0.1862409876913576, Methylation_LOC727677: -1.3630739782921435, Methylation_LETM1: -1.545293244241883, Methylation_CDC42BPB: -1.0506857649947074, Methylation_C8orf38: -0.0050667336466985, Methylation_chr14 100504766 EVL (18852): -0.7449311022429678, Methylation_chr5 72594851 LOC340090 (24088): 0.430029471981628, Methylation_chr2 242904738 LINC01238 (3421): -1.394601814639812, Methylation_ARFGEF1: 1.060975500930034, Methylation_MAPT: -0.9938415231522364, Methylation_ZFAT: 0.9384641674683086, Methylation_KCNQ4: -1.1129655165181722, Methylation_chr1 232684368 SIPA1L2 (12934): -1.474556422527197, Methylation_CRNKL1: -1.1135442718603257, Methylation_PRKAG2: -1.617323481295012, Methylation_MICB: -1.3451503416507984, miRNA_hsa-mir-934: -0.1017949930391319, miRNA_hsa-mir-4728: -0.5866406325115372, miRNA_hsa-mir-5695: 3.836080803601309, miRNA_hsa-mir-18a: -0.5356381327034113, miRNA_hsa-mir-190b: 0.7348404637319224, miRNA_hsa-mir-577: -0.3026583548272301, miRNA_hsa-mir-135b: -0.8371021941015134, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.2443083961760571, miRNA_hsa-mir-130b: -0.7506429391877276, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-E9-A1RA,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.2471597255073515, mRNA_C2orf54: -1.180843232185123, mRNA_CITED4: 0.8017386180075109, mRNA_ESR1: 0.3418850544223221, mRNA_SPDEF: 0.225291713481187, mRNA_AGR3: 0.9203838477609612, mRNA_FOXC1: -0.954132730072114, mRNA_GATA3: 0.6069709045300916, mRNA_AGR2: 0.1085157508746391, mRNA_XBP1: 0.2723481393077514, mRNA_PRR15: 0.5477948766053052, mRNA_SLC44A4: 0.3651322864990315, mRNA_CA12: 0.6790381884416916, mRNA_DTL: -0.3212808538287567, mRNA_C5AR2: 0.3675081534427233, mRNA_TBC1D9: 0.2791086604816237, mRNA_AR: 0.7153960611122134, mRNA_CCDC170: 0.505756130391581, mRNA_DEGS2: 0.5103913846760849, mRNA_TFF3: 0.2265920478648295, mRNA_DNALI1: 0.7980129789327063, mRNA_LINC00504: 0.1456114466334835, mRNA_CLCA2: -0.4268492525023725, mRNA_PPP1R14C: -0.547102736305003, mRNA_THSD4: 0.6947122448388297, mRNA_SPAG5: -1.0505507755540926, mRNA_FBP1: -0.6012863889309563, mRNA_SLC7A8: 0.0566989355920331, mRNA_EN1: -0.4172753762645833, mRNA_ZNF552: 0.4195784509832435, Methylation_LRRC6: 0.1645083080988582, Methylation_chr2 66218712 LINC02934 (29533): 0.4112212404885763, Methylation_HOXB13: -0.966779997114525, Methylation_chr10 3949206 LINC02660 (4871): -0.2558446585153689, Methylation_chr5 179517140 RNF130 (18026): 0.4327329387724342, Methylation_LOC727677: -0.1220838200166511, Methylation_LETM1: 0.3510182554479636, Methylation_CDC42BPB: -0.9952204090800718, Methylation_C8orf38: -0.1129302890257582, Methylation_chr14 100504766 EVL (18852): 0.1024402146310665, Methylation_chr5 72594851 LOC340090 (24088): 0.4655416321523586, Methylation_chr2 242904738 LINC01238 (3421): -0.4017617709964987, Methylation_ARFGEF1: 0.5446792722001209, Methylation_MAPT: 0.1867881944033122, Methylation_ZFAT: 0.4518660287833695, Methylation_KCNQ4: -0.4948553148024224, Methylation_chr1 232684368 SIPA1L2 (12934): 0.6146965439071701, Methylation_CRNKL1: 0.1625041210650943, Methylation_PRKAG2: 0.2106399581499752, Methylation_MICB: 1.2519197654444163, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.8307698179905222, miRNA_hsa-mir-5695: 0.467531860827368, miRNA_hsa-mir-18a: 1.0362591069254623, miRNA_hsa-mir-190b: 1.034785312509046, miRNA_hsa-mir-577: 0.6310207058328077, miRNA_hsa-mir-135b: -0.6412955714865812, miRNA_hsa-mir-2115: 0.1921816204236306, miRNA_hsa-mir-17: 0.6169038135294843, miRNA_hsa-mir-130b: 1.073990333678235, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A0TP,"High-level Amplification of EN1 drives mRNA overexpression. FOXC1 mRNA is upregulated (Z=1.94). ESR1, GATA3, and PRR15 show low mRNA (Z < -1.92). Promoter hypermethylation of HOXB13, KCNQ4, ARFGEF1, and LRRC6 (Z > 1.50) suggests epigenetic silencing. miR-577, miR-135b, and miR-934 are upregulated (Z > 1.99); miR-190b is downregulated (Z < -1.25). These features indicate a basal-like phenotype with ER-pathway suppression.","mRNA_MLPH: -1.691947474833763, mRNA_C2orf54: -0.978934408765684, mRNA_CITED4: 0.7853231480617655, mRNA_ESR1: -2.103870157617655, mRNA_SPDEF: -1.9808207410930767, mRNA_AGR3: -1.7659305316641305, mRNA_FOXC1: 1.9357929872971225, mRNA_GATA3: -3.8157349778785, mRNA_AGR2: -1.9573915099777448, mRNA_XBP1: -1.3084347608487878, mRNA_PRR15: -2.602764266505929, mRNA_SLC44A4: -2.432885425929044, mRNA_CA12: -1.5106172442709276, mRNA_DTL: 1.0546074461855437, mRNA_C5AR2: -1.9020392411995224, mRNA_TBC1D9: -2.6418559418721057, mRNA_AR: -2.1633487646524503, mRNA_CCDC170: -1.8680178656090816, mRNA_DEGS2: -1.5453546797289963, mRNA_TFF3: -2.082916466752445, mRNA_DNALI1: -1.899951812899128, mRNA_LINC00504: -1.7354641023899648, mRNA_CLCA2: -0.6736978867037408, mRNA_PPP1R14C: 0.8573371898744625, mRNA_THSD4: -0.1030260029601168, mRNA_SPAG5: -0.1832575563234693, mRNA_FBP1: -1.1727614363099643, mRNA_SLC7A8: -1.41007101133681, mRNA_EN1: 2.658933120599598, mRNA_ZNF552: -1.557738234976441, Methylation_LRRC6: 1.5186140694081431, Methylation_chr2 66218712 LINC02934 (29533): -0.638512600516502, Methylation_HOXB13: 1.7341787657218446, Methylation_chr10 3949206 LINC02660 (4871): 1.634882698522147, Methylation_chr5 179517140 RNF130 (18026): -1.4990667593495983, Methylation_LOC727677: 1.5054640652656892, Methylation_LETM1: 1.2731101931564224, Methylation_CDC42BPB: -1.0786376322477316, Methylation_C8orf38: 1.5927612648857727, Methylation_chr14 100504766 EVL (18852): 1.4937877375245114, Methylation_chr5 72594851 LOC340090 (24088): -1.2177635693520914, Methylation_chr2 242904738 LINC01238 (3421): 1.3188800656462492, Methylation_ARFGEF1: 1.6843438437718417, Methylation_MAPT: 1.4087510567095962, Methylation_ZFAT: 1.476165749171384, Methylation_KCNQ4: 1.9322354056598685, Methylation_chr1 232684368 SIPA1L2 (12934): 1.4159501475434864, Methylation_CRNKL1: 1.150768175042313, Methylation_PRKAG2: 1.368651611962809, Methylation_MICB: 1.392622775473923, miRNA_hsa-mir-934: 2.174012660110812, miRNA_hsa-mir-4728: 0.0866265945769695, miRNA_hsa-mir-5695: 0.6504913012106533, miRNA_hsa-mir-18a: 1.1150283899019229, miRNA_hsa-mir-190b: -1.68405918073578, miRNA_hsa-mir-577: 3.9806183420259904, miRNA_hsa-mir-135b: 2.8442224814458017, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.540942467588896, miRNA_hsa-mir-130b: 2.315275888442572, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AC-A2FO,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.7947769026611743, mRNA_C2orf54: -0.0335052937084729, mRNA_CITED4: 0.6350167759784502, mRNA_ESR1: 0.8287162388377701, mRNA_SPDEF: 0.2809996614562639, mRNA_AGR3: 0.643251591386566, mRNA_FOXC1: 0.2936245418825699, mRNA_GATA3: 0.1807755884277151, mRNA_AGR2: 0.9657760122589588, mRNA_XBP1: 0.8434050075786125, mRNA_PRR15: 1.0184237810354857, mRNA_SLC44A4: 0.7973222373234773, mRNA_CA12: 0.8362293429037819, mRNA_DTL: -1.0031794717109093, mRNA_C5AR2: 0.4401056864489062, mRNA_TBC1D9: 1.0159664123891687, mRNA_AR: 0.2963630954403482, mRNA_CCDC170: 0.4872379545364767, mRNA_DEGS2: 0.5321517586590844, mRNA_TFF3: 0.6974426921893909, mRNA_DNALI1: 0.8524270475294533, mRNA_LINC00504: 0.8056622714711577, mRNA_CLCA2: -0.5090982507325185, mRNA_PPP1R14C: -0.3813861689710285, mRNA_THSD4: 0.7683387200218971, mRNA_SPAG5: -0.7804347226625592, mRNA_FBP1: 1.0518920527504754, mRNA_SLC7A8: 0.8353737138471782, mRNA_EN1: -0.5892233960771341, mRNA_ZNF552: 0.9218392235768956, Methylation_LRRC6: 0.8059311233018206, Methylation_chr2 66218712 LINC02934 (29533): 0.2797729442796988, Methylation_HOXB13: -0.7439351720951631, Methylation_chr10 3949206 LINC02660 (4871): -0.0368520162972288, Methylation_chr5 179517140 RNF130 (18026): 0.0271016648657113, Methylation_LOC727677: 0.6609239335521523, Methylation_LETM1: 0.1119373423367075, Methylation_CDC42BPB: 0.5822682520486069, Methylation_C8orf38: 0.2112656998597305, Methylation_chr14 100504766 EVL (18852): 0.6610266189188374, Methylation_chr5 72594851 LOC340090 (24088): 0.3092715891204945, Methylation_chr2 242904738 LINC01238 (3421): 0.9768981901468486, Methylation_ARFGEF1: 0.8912634608476219, Methylation_MAPT: 0.3446586078652197, Methylation_ZFAT: 0.0427675801620589, Methylation_KCNQ4: -1.0239227468196563, Methylation_chr1 232684368 SIPA1L2 (12934): 0.3489687982176821, Methylation_CRNKL1: 0.668115953603954, Methylation_PRKAG2: 0.0886044387562608, Methylation_MICB: 0.2924925885704119, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.1115955149802016, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.1872571510790293, miRNA_hsa-mir-190b: -0.5035563086036119, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.0420233423153198, miRNA_hsa-mir-2115: 0.641029010063889, miRNA_hsa-mir-17: -1.090133207437596, miRNA_hsa-mir-130b: -0.8605693246590103, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E2-A1IH,"SLC7A8 mRNA overexpression (Z=1.13) falls below the high-expression threshold (Z>1.30). No mRNA, methylation, miRNA, or CNV features meet diagnostic thresholds for reporting.","mRNA_MLPH: 0.1350296773752952, mRNA_C2orf54: -0.9430497164130098, mRNA_CITED4: 0.7276426355124157, mRNA_ESR1: 0.2714246390525789, mRNA_SPDEF: 0.1423527243477458, mRNA_AGR3: 0.3991987460894206, mRNA_FOXC1: 0.0593495511367604, mRNA_GATA3: 0.34945768650361, mRNA_AGR2: 0.1364032164125651, mRNA_XBP1: 0.5119890367672981, mRNA_PRR15: -0.0773372472502251, mRNA_SLC44A4: -0.5909029393666597, mRNA_CA12: 0.4837372517101121, mRNA_DTL: 0.3462970059935052, mRNA_C5AR2: -0.1086015877218841, mRNA_TBC1D9: -0.1736393779531917, mRNA_AR: -0.185993072806413, mRNA_CCDC170: -0.4088553257211645, mRNA_DEGS2: 0.6668216856004819, mRNA_TFF3: 0.8249800464661429, mRNA_DNALI1: -0.0597368114732393, mRNA_LINC00504: 0.0584277479702857, mRNA_CLCA2: -0.4578774162205851, mRNA_PPP1R14C: -1.0015380733684969, mRNA_THSD4: 0.3336536226265877, mRNA_SPAG5: -0.4867817543182927, mRNA_FBP1: 0.3156912190430464, mRNA_SLC7A8: 1.129574100647678, mRNA_EN1: 0.3195118533652762, mRNA_ZNF552: -0.8348326852349797, Methylation_LRRC6: -0.2494886742746278, Methylation_chr2 66218712 LINC02934 (29533): 0.678534359691919, Methylation_HOXB13: 0.7118737951849567, Methylation_chr10 3949206 LINC02660 (4871): -0.3599991234863442, Methylation_chr5 179517140 RNF130 (18026): 0.3420464560337797, Methylation_LOC727677: -0.6560638100672469, Methylation_LETM1: 0.2050715454376807, Methylation_CDC42BPB: 0.8010313912059308, Methylation_C8orf38: -0.6217552854345089, Methylation_chr14 100504766 EVL (18852): -0.2103075187244265, Methylation_chr5 72594851 LOC340090 (24088): 0.7105984669788609, Methylation_chr2 242904738 LINC01238 (3421): -0.3441271026365389, Methylation_ARFGEF1: -0.163735935851802, Methylation_MAPT: -0.5611674302558354, Methylation_ZFAT: -0.6394781495930619, Methylation_KCNQ4: -0.6339477337216498, Methylation_chr1 232684368 SIPA1L2 (12934): -0.3443233424073876, Methylation_CRNKL1: -0.1060390932832066, Methylation_PRKAG2: 1.1000189745029547, Methylation_MICB: -0.0479916518132614, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.3434900707593029, miRNA_hsa-mir-5695: 0.5155686945733429, miRNA_hsa-mir-18a: -0.035808313466538, miRNA_hsa-mir-190b: 0.2852435032941177, miRNA_hsa-mir-577: -0.4509288103422765, miRNA_hsa-mir-135b: 0.9961453494767856, miRNA_hsa-mir-2115: 0.8615065790884133, miRNA_hsa-mir-17: -0.9211704508511332, miRNA_hsa-mir-130b: 0.4935784797127793, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-S3-A6ZH,"High-level Amplification of none; Gain in VPS54, LINC01867, LINC02576, WDPCP, CEP68. mRNA_DTL (Z=1.89) and mRNA_C5AR2 (Z=1.75) overexpressed. Methylation_MAPT hypo-methylated (Z=-1.81). miRNA_hsa-mir-18a downregulated (Z=-1.21). No hypermethylated promoters or high-level amplifications drive transcriptional changes.","mRNA_MLPH: 0.8956771461444837, mRNA_C2orf54: -0.3086192563088956, mRNA_CITED4: 0.1983207006407399, mRNA_ESR1: 0.1175528279195924, mRNA_SPDEF: 0.5692443411394883, mRNA_AGR3: 0.7967313539595703, mRNA_FOXC1: 1.0329977074939285, mRNA_GATA3: 0.5131829495538274, mRNA_AGR2: 0.2526269166452095, mRNA_XBP1: 0.9019989388741554, mRNA_PRR15: 0.1572564830298161, mRNA_SLC44A4: 0.8611980377608406, mRNA_CA12: 1.237907369064133, mRNA_DTL: 1.8914290107384173, mRNA_C5AR2: 1.74550129971863, mRNA_TBC1D9: 0.5802723117673597, mRNA_AR: -0.0123578236423831, mRNA_CCDC170: 0.4663367752644362, mRNA_DEGS2: 0.9835553579681822, mRNA_TFF3: 0.923395248155328, mRNA_DNALI1: 0.6217630509676504, mRNA_LINC00504: -0.2506498167096796, mRNA_CLCA2: -0.6761981141958597, mRNA_PPP1R14C: -0.7605038083773422, mRNA_THSD4: 1.1451434995885916, mRNA_SPAG5: 0.8642955648984102, mRNA_FBP1: 0.798050717825368, mRNA_SLC7A8: 0.865542785374714, mRNA_EN1: -0.9817555621984724, mRNA_ZNF552: 1.515166541741092, Methylation_LRRC6: -1.0178765937015235, Methylation_chr2 66218712 LINC02934 (29533): -1.5610238303549442, Methylation_HOXB13: -0.753919903087973, Methylation_chr10 3949206 LINC02660 (4871): -1.1776694134615813, Methylation_chr5 179517140 RNF130 (18026): 1.0532156460567548, Methylation_LOC727677: -1.2280411500459971, Methylation_LETM1: -1.4649967693909185, Methylation_CDC42BPB: 1.445441516079787, Methylation_C8orf38: -1.2155364524918264, Methylation_chr14 100504766 EVL (18852): -1.2508525442676692, Methylation_chr5 72594851 LOC340090 (24088): 1.2054613059732358, Methylation_chr2 242904738 LINC01238 (3421): -1.1842846313922215, Methylation_ARFGEF1: -0.9360849708139628, Methylation_MAPT: -1.813256161078672, Methylation_ZFAT: -1.2339804908385137, Methylation_KCNQ4: 0.7585015344236756, Methylation_chr1 232684368 SIPA1L2 (12934): -0.5365696743058789, Methylation_CRNKL1: -1.443197425946413, Methylation_PRKAG2: -1.24261299164705, Methylation_MICB: -0.882058888296935, miRNA_hsa-mir-934: -0.2604921193538237, miRNA_hsa-mir-4728: -0.1422361393122587, miRNA_hsa-mir-5695: 0.8560028076533645, miRNA_hsa-mir-18a: -1.2149821832948502, miRNA_hsa-mir-190b: 1.3038242556019728, miRNA_hsa-mir-577: -0.6408594106433806, miRNA_hsa-mir-135b: 0.0310949540613838, miRNA_hsa-mir-2115: -0.3095267545812566, miRNA_hsa-mir-17: -0.3757965106851387, miRNA_hsa-mir-130b: -1.1487398807714273, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-LL-A5YM,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.9806147522675196, mRNA_C2orf54: -1.185235862628834, mRNA_CITED4: -1.7323161740131008, mRNA_ESR1: 0.0513138750608544, mRNA_SPDEF: 1.0175114284466988, mRNA_AGR3: 0.8282489789597787, mRNA_FOXC1: -0.5429290792713791, mRNA_GATA3: 0.3256612047332911, mRNA_AGR2: 0.5944351634505983, mRNA_XBP1: 0.4376943850970534, mRNA_PRR15: 0.6356382530901673, mRNA_SLC44A4: 0.2869448862052105, mRNA_CA12: -0.6020868963802006, mRNA_DTL: 0.5459795816763977, mRNA_C5AR2: 0.4430863990077485, mRNA_TBC1D9: 0.0125671937290032, mRNA_AR: -0.5196387035235318, mRNA_CCDC170: -0.7858787464160715, mRNA_DEGS2: 1.5056557117459846, mRNA_TFF3: 1.980046503580001, mRNA_DNALI1: 0.384560353502035, mRNA_LINC00504: -0.4499269825485156, mRNA_CLCA2: -0.7570022507455954, mRNA_PPP1R14C: -1.0667201291908155, mRNA_THSD4: -0.2746187117192811, mRNA_SPAG5: 0.778835729266179, mRNA_FBP1: 0.3244087736635425, mRNA_SLC7A8: -0.7924018962620875, mRNA_EN1: -0.2864924795239408, mRNA_ZNF552: -0.0460684403500839, Methylation_LRRC6: -1.0945732448215202, Methylation_chr2 66218712 LINC02934 (29533): 1.0771333742462113, Methylation_HOXB13: 1.392030417877554, Methylation_chr10 3949206 LINC02660 (4871): -1.2518280754993425, Methylation_chr5 179517140 RNF130 (18026): 1.2034302491775766, Methylation_LOC727677: -1.1085216927396506, Methylation_LETM1: -1.373713843996408, Methylation_CDC42BPB: 1.408343728751329, Methylation_C8orf38: 0.3452303161173488, Methylation_chr14 100504766 EVL (18852): -0.9406860943979, Methylation_chr5 72594851 LOC340090 (24088): 0.8865201969301721, Methylation_chr2 242904738 LINC01238 (3421): -0.3165881390055415, Methylation_ARFGEF1: -1.003604874588288, Methylation_MAPT: -1.48843341044999, Methylation_ZFAT: -1.344520875953924, Methylation_KCNQ4: 1.23577050335313, Methylation_chr1 232684368 SIPA1L2 (12934): -0.8171910077543255, Methylation_CRNKL1: -1.3610565961786076, Methylation_PRKAG2: -0.020673550491707, Methylation_MICB: -0.7189766554434305, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.5618494839158694, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.030673678982563, miRNA_hsa-mir-190b: 0.4259783337667995, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.1758913377002815, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.0274854766476503, miRNA_hsa-mir-130b: 0.7050113337997288, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-EW-A1J1,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.4281404035886686, mRNA_C2orf54: -1.2107321210232356, mRNA_CITED4: -1.3683057140833843, mRNA_ESR1: 0.733133558126463, mRNA_SPDEF: 0.4229479571479103, mRNA_AGR3: 0.0834828795872988, mRNA_FOXC1: -1.0784161696832444, mRNA_GATA3: 0.7894941228035716, mRNA_AGR2: 0.7885606644014633, mRNA_XBP1: 0.7126475318546829, mRNA_PRR15: 1.2244333288678757, mRNA_SLC44A4: 0.4961050020843952, mRNA_CA12: 1.1643145230760863, mRNA_DTL: -0.8399600485977133, mRNA_C5AR2: 1.3302676126981905, mRNA_TBC1D9: 0.9068143999065288, mRNA_AR: 0.7572967591880817, mRNA_CCDC170: 1.1228740861971678, mRNA_DEGS2: 0.3740973365006849, mRNA_TFF3: -0.5198660560451321, mRNA_DNALI1: 0.744354415949344, mRNA_LINC00504: 0.6166219954483806, mRNA_CLCA2: -0.8797648627419695, mRNA_PPP1R14C: -0.9758567371279958, mRNA_THSD4: 1.902178915055428, mRNA_SPAG5: -0.7538741095836485, mRNA_FBP1: 0.8020494390092306, mRNA_SLC7A8: 0.5551791231264035, mRNA_EN1: -0.9805488087290964, mRNA_ZNF552: 1.273257383371339, Methylation_LRRC6: -1.2483184064224304, Methylation_chr2 66218712 LINC02934 (29533): -1.4021534818404375, Methylation_HOXB13: -1.0668898332340273, Methylation_chr10 3949206 LINC02660 (4871): -1.027853182939986, Methylation_chr5 179517140 RNF130 (18026): 0.2630799690469777, Methylation_LOC727677: -1.1909487263750569, Methylation_LETM1: -0.753903010567469, Methylation_CDC42BPB: -1.4326004879087595, Methylation_C8orf38: -1.07483340592709, Methylation_chr14 100504766 EVL (18852): -1.563934897268028, Methylation_chr5 72594851 LOC340090 (24088): -0.5136388999972036, Methylation_chr2 242904738 LINC01238 (3421): -1.209016692338554, Methylation_ARFGEF1: -1.0152678017675112, Methylation_MAPT: -0.7186657815112074, Methylation_ZFAT: -1.2687231709014002, Methylation_KCNQ4: -1.251466860228987, Methylation_chr1 232684368 SIPA1L2 (12934): -1.0903148303161874, Methylation_CRNKL1: -1.1967082288864876, Methylation_PRKAG2: -1.6290111669228864, Methylation_MICB: -1.3870153179283329, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.0311626845252779, miRNA_hsa-mir-5695: 1.519593789253444, miRNA_hsa-mir-18a: -0.4415337296616664, miRNA_hsa-mir-190b: 1.144035534582336, miRNA_hsa-mir-577: -0.6348725356478963, miRNA_hsa-mir-135b: -0.6976661373505118, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.0176084356222001, miRNA_hsa-mir-130b: -0.9364934453059286, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-E2-A1L8,"mRNA_CITED4 overexpression (Z=1.46) indicates transcriptional activation. No methylation or miRNA alterations meet diagnostic thresholds. All CNVs show Gain (0.38–0.40), insufficient for amplification calls. No deletions, hyper/hypomethylation, or miRNA dysregulation per criteria.","mRNA_MLPH: 0.3894271599672568, mRNA_C2orf54: -1.1078477766539747, mRNA_CITED4: 1.4634975955879068, mRNA_ESR1: 0.4288426137093408, mRNA_SPDEF: -0.0756887998874024, mRNA_AGR3: 0.7270743385376544, mRNA_FOXC1: -0.3245018912922628, mRNA_GATA3: 0.593670178793475, mRNA_AGR2: 0.6143852267355935, mRNA_XBP1: -0.0238893074688807, mRNA_PRR15: 0.2754027005929628, mRNA_SLC44A4: 0.0585211666629696, mRNA_CA12: -0.0581467819029595, mRNA_DTL: -0.3203350590956059, mRNA_C5AR2: 0.592857639815427, mRNA_TBC1D9: -0.4203879294043963, mRNA_AR: 0.7005088922042803, mRNA_CCDC170: 0.137692666523601, mRNA_DEGS2: 0.3506520710413305, mRNA_TFF3: -0.1570619736085005, mRNA_DNALI1: 0.5353059030072153, mRNA_LINC00504: 0.3825095200223133, mRNA_CLCA2: -0.6944119562348798, mRNA_PPP1R14C: -0.7959689749392062, mRNA_THSD4: -0.1213450643062878, mRNA_SPAG5: -1.5559185504584805, mRNA_FBP1: 0.4165224273269657, mRNA_SLC7A8: 0.9430832048479844, mRNA_EN1: -0.0540909362472591, mRNA_ZNF552: 0.6433055132121761, Methylation_LRRC6: -0.3968102734747001, Methylation_chr2 66218712 LINC02934 (29533): -1.0016651253962938, Methylation_HOXB13: -0.9961935647969292, Methylation_chr10 3949206 LINC02660 (4871): -0.366923612123076, Methylation_chr5 179517140 RNF130 (18026): 0.7979903215251114, Methylation_LOC727677: -0.5089578560192054, Methylation_LETM1: -0.6991992647120704, Methylation_CDC42BPB: -1.0600229287874838, Methylation_C8orf38: -1.0167167518410878, Methylation_chr14 100504766 EVL (18852): -0.693267248267479, Methylation_chr5 72594851 LOC340090 (24088): 0.2189837350787253, Methylation_chr2 242904738 LINC01238 (3421): -1.1135019823919654, Methylation_ARFGEF1: -0.3739341708522481, Methylation_MAPT: -0.3332039144614578, Methylation_ZFAT: -0.3917515011300266, Methylation_KCNQ4: -1.0101093766528235, Methylation_chr1 232684368 SIPA1L2 (12934): -1.0821586186138412, Methylation_CRNKL1: -0.7265413959652832, Methylation_PRKAG2: 0.7019287450367884, Methylation_MICB: -0.8175937062594261, miRNA_hsa-mir-934: -0.4108981418592548, miRNA_hsa-mir-4728: -0.34007000066694, miRNA_hsa-mir-5695: 0.5211657504901207, miRNA_hsa-mir-18a: 0.1965960348688183, miRNA_hsa-mir-190b: 1.2519927251668417, miRNA_hsa-mir-577: -0.1412501582840144, miRNA_hsa-mir-135b: -0.0831587855299338, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.498305476731358, miRNA_hsa-mir-130b: 1.2312223433858085, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-B6-A0WW,TBC1D9 mRNA overexpression (Z=1.47) exceeds the high-expression threshold. No methylation sites meet hyper- or hypo-methylation criteria. miRNA hsa-mir-5695 is upregulated (Z=2.48). All CNVs fall within the normal range (−1.10 to −0.10). These features collectively indicate a luminal phenotype with potential cell cycle dysregulation.,"mRNA_MLPH: 0.5622402500006678, mRNA_C2orf54: 0.3658947298754278, mRNA_CITED4: -0.5051766365653229, mRNA_ESR1: 1.103567851143174, mRNA_SPDEF: 0.675348835435842, mRNA_AGR3: 0.7467050156399087, mRNA_FOXC1: -0.3701166741331737, mRNA_GATA3: 0.3497696959899427, mRNA_AGR2: 0.6990382128003375, mRNA_XBP1: 0.6219706644432189, mRNA_PRR15: 0.4343771814878535, mRNA_SLC44A4: 0.3548699887308236, mRNA_CA12: 0.8894189060007059, mRNA_DTL: 1.0996989946193785, mRNA_C5AR2: 0.2360900903597847, mRNA_TBC1D9: 1.469062914794489, mRNA_AR: 0.2658523816684726, mRNA_CCDC170: 0.4403991511180332, mRNA_DEGS2: 0.101949056139408, mRNA_TFF3: 0.7904982870097554, mRNA_DNALI1: 0.1462006258337412, mRNA_LINC00504: 0.3083010517582802, mRNA_CLCA2: -0.4684898609842604, mRNA_PPP1R14C: -0.732013317477862, mRNA_THSD4: 0.5031838717770819, mRNA_SPAG5: 0.4080740191971291, mRNA_FBP1: 1.0340260185272068, mRNA_SLC7A8: 0.5799909290955537, mRNA_EN1: -0.1562069871530056, mRNA_ZNF552: 0.364934305104361, Methylation_LRRC6: -1.162662361219156, Methylation_chr2 66218712 LINC02934 (29533): -0.2535639687144508, Methylation_HOXB13: 1.490589776653582, Methylation_chr10 3949206 LINC02660 (4871): -0.7115601706551961, Methylation_chr5 179517140 RNF130 (18026): 0.8652639390255538, Methylation_LOC727677: 0.1128063234833004, Methylation_LETM1: -1.0367168720684796, Methylation_CDC42BPB: 1.2088085640062052, Methylation_C8orf38: -1.1347219032997773, Methylation_chr14 100504766 EVL (18852): -0.5895962287806178, Methylation_chr5 72594851 LOC340090 (24088): 1.213803582234669, Methylation_chr2 242904738 LINC01238 (3421): -0.969657292723883, Methylation_ARFGEF1: -1.3271416076207694, Methylation_MAPT: -0.8010373418818515, Methylation_ZFAT: -1.2500637577852078, Methylation_KCNQ4: -1.072671188657552, Methylation_chr1 232684368 SIPA1L2 (12934): -1.054166316504071, Methylation_CRNKL1: -0.6373023512945083, Methylation_PRKAG2: -0.412790418184964, Methylation_MICB: -0.856066542115538, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.7389475737660376, miRNA_hsa-mir-5695: 2.4828688310886737, miRNA_hsa-mir-18a: 0.3897789286832428, miRNA_hsa-mir-190b: 1.235545127058438, miRNA_hsa-mir-577: -0.4023603693169215, miRNA_hsa-mir-135b: -0.7100169080201688, miRNA_hsa-mir-2115: 0.9196806701082888, miRNA_hsa-mir-17: -0.2203363379371783, miRNA_hsa-mir-130b: -0.8123628333820055, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E2-A576,"High-level Amplification of none; DEGS2 mRNA overexpressed (Z=1.58). HOXB13 and CDC42BPB promoters hypermethylated (Z>1.50); LETM1, MAPT, ZFAT, CRNKL1 hypomethylated (Z<-1.47). No miRNA alterations meet thresholds. CNVs show no gains/amplifications; all reported CNVs are deletions or neutral. Epigenetic silencing and DEGS2 overexpression suggest luminal phenotype with lipid metabolism dysregulation.","mRNA_MLPH: 0.6403666893697613, mRNA_C2orf54: -1.2505809790587687, mRNA_CITED4: 0.8559606506005994, mRNA_ESR1: 0.5623080651608761, mRNA_SPDEF: 0.9864025711435348, mRNA_AGR3: 1.0768637663379088, mRNA_FOXC1: -1.2090315745086535, mRNA_GATA3: 0.2991567430973143, mRNA_AGR2: 0.8376263927563893, mRNA_XBP1: -0.3139331756929158, mRNA_PRR15: 0.1956485295294915, mRNA_SLC44A4: 0.6710218656087376, mRNA_CA12: -0.3686515721248227, mRNA_DTL: -0.4932929540500399, mRNA_C5AR2: 0.9598719747154248, mRNA_TBC1D9: -0.1344025017052881, mRNA_AR: -0.0327155414519659, mRNA_CCDC170: 0.0505894050317818, mRNA_DEGS2: 1.5787798621744125, mRNA_TFF3: 0.5232658897749896, mRNA_DNALI1: 0.5580204321805254, mRNA_LINC00504: 0.1115307864980583, mRNA_CLCA2: -0.8680448919167048, mRNA_PPP1R14C: -0.929989097286502, mRNA_THSD4: -0.2342967743056033, mRNA_SPAG5: 0.2608653616685436, mRNA_FBP1: 0.7872479625150716, mRNA_SLC7A8: -0.512702330376579, mRNA_EN1: -0.9090748189430096, mRNA_ZNF552: -0.0401308574492644, Methylation_LRRC6: -1.4705561109093015, Methylation_chr2 66218712 LINC02934 (29533): 1.1223711052626248, Methylation_HOXB13: 1.7692120835643288, Methylation_chr10 3949206 LINC02660 (4871): -1.189899247427791, Methylation_chr5 179517140 RNF130 (18026): 1.0697508504874451, Methylation_LOC727677: -0.0999912553979229, Methylation_LETM1: -1.7234556760839346, Methylation_CDC42BPB: 1.5065229671965483, Methylation_C8orf38: -1.1926353868023074, Methylation_chr14 100504766 EVL (18852): -1.1222606465748834, Methylation_chr5 72594851 LOC340090 (24088): 1.2427429462578272, Methylation_chr2 242904738 LINC01238 (3421): -1.2768029908433278, Methylation_ARFGEF1: -1.397566450789094, Methylation_MAPT: -1.4823165969047127, Methylation_ZFAT: -1.7831870177798224, Methylation_KCNQ4: 0.8770626015866815, Methylation_chr1 232684368 SIPA1L2 (12934): -1.2978522317145544, Methylation_CRNKL1: -1.5129319618871864, Methylation_PRKAG2: -0.5034863903267632, Methylation_MICB: -1.2054013851139571, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.8988058187918575, miRNA_hsa-mir-5695: -0.198038394077849, miRNA_hsa-mir-18a: 0.3223847283329092, miRNA_hsa-mir-190b: 0.8704038408206384, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.124049283597265, miRNA_hsa-mir-2115: -0.4541418135526274, miRNA_hsa-mir-17: 0.6888069315408546, miRNA_hsa-mir-130b: 0.1003508054951934, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E2-A2P5,SLC7A8 mRNA overexpression (Z=1.64) exceeds high-expression threshold. No methylation or miRNA alterations meet diagnostic criteria. All CNVs fall within normal range. Isolated SLC7A8 upregulation suggests transporter dysregulation without clear genomic/epigenetic driver.,"mRNA_MLPH: 0.0491641535754453, mRNA_C2orf54: 0.8049086248621854, mRNA_CITED4: 0.400380178558291, mRNA_ESR1: 0.2716095874967476, mRNA_SPDEF: 1.0941206980941085, mRNA_AGR3: 0.3701370938630487, mRNA_FOXC1: -0.2545172438339811, mRNA_GATA3: 0.6023738644596912, mRNA_AGR2: -0.0706366477105028, mRNA_XBP1: 0.2509572866025855, mRNA_PRR15: 0.6917171648996909, mRNA_SLC44A4: 0.6173562765620517, mRNA_CA12: 0.0672798496460438, mRNA_DTL: 0.5400022997147446, mRNA_C5AR2: 1.258835560302995, mRNA_TBC1D9: 0.0403900215793808, mRNA_AR: 0.8725576902101294, mRNA_CCDC170: 0.6221543063251762, mRNA_DEGS2: 1.0265932245366505, mRNA_TFF3: 0.2596316330459364, mRNA_DNALI1: 0.3544582848636044, mRNA_LINC00504: 0.2121048577757401, mRNA_CLCA2: -0.5142199412584734, mRNA_PPP1R14C: -0.3376921437883645, mRNA_THSD4: -0.4501066746368565, mRNA_SPAG5: -0.0063774046281754, mRNA_FBP1: 0.9513602068258792, mRNA_SLC7A8: 1.6441926515733762, mRNA_EN1: -0.5585511265845606, mRNA_ZNF552: -0.3404351953858204, Methylation_LRRC6: -1.3457056011792474, Methylation_chr2 66218712 LINC02934 (29533): 0.0995409412928619, Methylation_HOXB13: 1.1033752504560834, Methylation_chr10 3949206 LINC02660 (4871): -0.7172930368918705, Methylation_chr5 179517140 RNF130 (18026): 0.2700625997158941, Methylation_LOC727677: -1.3477835472560489, Methylation_LETM1: -0.7039326021720557, Methylation_CDC42BPB: -1.1888009195597993, Methylation_C8orf38: -0.9983208036919164, Methylation_chr14 100504766 EVL (18852): -1.0538824838525231, Methylation_chr5 72594851 LOC340090 (24088): 0.7528354992973907, Methylation_chr2 242904738 LINC01238 (3421): -0.6300428130486904, Methylation_ARFGEF1: -1.0227253689238385, Methylation_MAPT: -0.3049418384065799, Methylation_ZFAT: -1.1441566903108022, Methylation_KCNQ4: 0.7825388867679928, Methylation_chr1 232684368 SIPA1L2 (12934): -1.0676981089044553, Methylation_CRNKL1: -0.9632108975431736, Methylation_PRKAG2: 1.2216766374557066, Methylation_MICB: -0.7666566373335559, miRNA_hsa-mir-934: -0.3464563447917829, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.0587138192089014, miRNA_hsa-mir-190b: 0.1187742023083331, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: 1.3990709195428543, miRNA_hsa-mir-17: 0.1458205982575826, miRNA_hsa-mir-130b: -0.8043028792920726, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A2LK,"ESR1 mRNA overexpression (Z=1.25) approaches high threshold; DTL (Z=1.53) and SPAG5 (Z=1.36) are significantly overexpressed. LETM1, MAPT, ZFAT, and SIPA1L2 promoters are hypermethylated (Z < -1.47), indicating epigenetic silencing. No CNVs meet amplification/deletion thresholds. miRNA levels remain within non-significant range.","mRNA_MLPH: 0.1572651557930502, mRNA_C2orf54: -1.1913737309017625, mRNA_CITED4: -0.0299097487514682, mRNA_ESR1: 1.2460836228863053, mRNA_SPDEF: 0.3127569277570906, mRNA_AGR3: 0.5200860562454294, mRNA_FOXC1: -0.9002998860390823, mRNA_GATA3: 0.7031717172640144, mRNA_AGR2: 0.990526099006809, mRNA_XBP1: 0.8255673073220582, mRNA_PRR15: 0.3053393535391642, mRNA_SLC44A4: 0.0812536896469679, mRNA_CA12: 0.7532549344204106, mRNA_DTL: 1.5310096799500148, mRNA_C5AR2: 0.4843697115855032, mRNA_TBC1D9: 1.341300713746573, mRNA_AR: 0.9762718905407, mRNA_CCDC170: 0.6526554846157893, mRNA_DEGS2: 0.8044174990194292, mRNA_TFF3: -0.270158099831098, mRNA_DNALI1: 0.4821983573006388, mRNA_LINC00504: 0.5803920398009379, mRNA_CLCA2: -0.7635577002042061, mRNA_PPP1R14C: -0.7094144232893844, mRNA_THSD4: 1.001339435568969, mRNA_SPAG5: 1.3583205688662892, mRNA_FBP1: 0.2099943659815437, mRNA_SLC7A8: 0.3008821016686597, mRNA_EN1: -0.4754150702673035, mRNA_ZNF552: 0.560837613440728, Methylation_LRRC6: -1.585653262907467, Methylation_chr2 66218712 LINC02934 (29533): 0.5464782143884314, Methylation_HOXB13: 0.8370793391766793, Methylation_chr10 3949206 LINC02660 (4871): -1.1000649252051675, Methylation_chr5 179517140 RNF130 (18026): 0.6815418556561625, Methylation_LOC727677: -1.4162684134810106, Methylation_LETM1: -1.6714076630216466, Methylation_CDC42BPB: 1.494537633277076, Methylation_C8orf38: -1.2087328080968769, Methylation_chr14 100504766 EVL (18852): -1.459958202372946, Methylation_chr5 72594851 LOC340090 (24088): 0.9478904025198328, Methylation_chr2 242904738 LINC01238 (3421): -1.1846156595477095, Methylation_ARFGEF1: -0.950588832032572, Methylation_MAPT: -1.5980256170214275, Methylation_ZFAT: -1.7660982792858024, Methylation_KCNQ4: -1.0114630143362997, Methylation_chr1 232684368 SIPA1L2 (12934): -1.6099005601044032, Methylation_CRNKL1: -1.4524468286353185, Methylation_PRKAG2: -1.1084628221971622, Methylation_MICB: -1.484970616181253, miRNA_hsa-mir-934: -0.3825843252621677, miRNA_hsa-mir-4728: -0.5480050475713272, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.976215705658403, miRNA_hsa-mir-190b: -0.2245454740676367, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.8144015822338283, miRNA_hsa-mir-2115: -0.3497212524976867, miRNA_hsa-mir-17: -0.1093031180344615, miRNA_hsa-mir-130b: -0.1192115640327301, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AC-A3OD,"mRNA_CITED4 (Z = -2.42) and mRNA_SPAG5 (Z = -2.10) are significantly downregulated; mRNA_FBP1 (Z = -2.20) and mRNA_GATA3 (Z = -1.87) also meet low-expression thresholds. No methylation sites exceed hyper/hypo-methylation cutoffs. No miRNAs cross expression thresholds. All CNVs fall within normal range (−1.10 to −0.10). Transcriptional suppression of luminal differentiation genes (GATA3, SPAG5, CITED4) suggests basal-like phenotype with impaired estrogen signaling.","mRNA_MLPH: -0.8452984659178219, mRNA_C2orf54: -1.0697502320266952, mRNA_CITED4: -2.421614043154552, mRNA_ESR1: 0.7032052366407808, mRNA_SPDEF: -0.7617059114990425, mRNA_AGR3: 0.0592389923819407, mRNA_FOXC1: -1.3425367854716408, mRNA_GATA3: -1.8679688521733109, mRNA_AGR2: -0.4868881618069351, mRNA_XBP1: -0.9184241286628484, mRNA_PRR15: -1.178742584274444, mRNA_SLC44A4: -1.087879798170548, mRNA_CA12: -0.9756173400292202, mRNA_DTL: -0.974526123670161, mRNA_C5AR2: -0.8537579603643318, mRNA_TBC1D9: -0.3826021429633898, mRNA_AR: 0.125866274490583, mRNA_CCDC170: -0.0422034414455698, mRNA_DEGS2: -1.0981750202323746, mRNA_TFF3: 0.2428853109380664, mRNA_DNALI1: -1.1266155450814404, mRNA_LINC00504: -0.4350071004364783, mRNA_CLCA2: -0.3457306143003636, mRNA_PPP1R14C: -0.658167531359094, mRNA_THSD4: -0.4756469237940169, mRNA_SPAG5: -2.1005073065515925, mRNA_FBP1: -2.2043675724380334, mRNA_SLC7A8: -1.801302251453767, mRNA_EN1: -1.1259699172130817, mRNA_ZNF552: -0.5086249917461892, Methylation_LRRC6: 0.8782698551400743, Methylation_chr2 66218712 LINC02934 (29533): 1.093818089881918, Methylation_HOXB13: 0.5317041341999948, Methylation_chr10 3949206 LINC02660 (4871): 0.6233313994582265, Methylation_chr5 179517140 RNF130 (18026): 0.7178628508297976, Methylation_LOC727677: 1.4152687802033943, Methylation_LETM1: 0.0329413009957847, Methylation_CDC42BPB: 0.6342337436256191, Methylation_C8orf38: 1.3603909690172074, Methylation_chr14 100504766 EVL (18852): 0.6953200024466637, Methylation_chr5 72594851 LOC340090 (24088): 0.5596881457449784, Methylation_chr2 242904738 LINC01238 (3421): -0.0314205555176628, Methylation_ARFGEF1: 0.8147881094280086, Methylation_MAPT: 0.0433260549408446, Methylation_ZFAT: 1.3373163190409845, Methylation_KCNQ4: -0.8054943853867538, Methylation_chr1 232684368 SIPA1L2 (12934): 0.0737890027018352, Methylation_CRNKL1: 0.8423170938784429, Methylation_PRKAG2: 0.7349568413568187, Methylation_MICB: 0.6338034163492405, miRNA_hsa-mir-934: -0.1356679722705083, miRNA_hsa-mir-4728: -0.0101761545586864, miRNA_hsa-mir-5695: 0.5157788948690805, miRNA_hsa-mir-18a: 0.0555271360018964, miRNA_hsa-mir-190b: 0.4565097722508554, miRNA_hsa-mir-577: -0.5891717973421016, miRNA_hsa-mir-135b: -0.6224611899730672, miRNA_hsa-mir-2115: -0.3965207944302681, miRNA_hsa-mir-17: 0.3110841115730496, miRNA_hsa-mir-130b: 0.0833754399915593, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A73W,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.7865787235107694, mRNA_C2orf54: -1.2607339933582076, mRNA_CITED4: 1.244504666033844, mRNA_ESR1: 0.5199398749662304, mRNA_SPDEF: 0.5725701083600362, mRNA_AGR3: 0.7100574253688255, mRNA_FOXC1: -0.605580200397228, mRNA_GATA3: 0.3931567741400834, mRNA_AGR2: 0.7977395106146571, mRNA_XBP1: 0.4531656230737126, mRNA_PRR15: 0.7468161078020588, mRNA_SLC44A4: 1.1461327704960935, mRNA_CA12: 0.9667648951887258, mRNA_DTL: -0.5240046328456447, mRNA_C5AR2: 0.2914840182086997, mRNA_TBC1D9: 0.714924381394968, mRNA_AR: -0.0061507496912553, mRNA_CCDC170: 0.5667868160251193, mRNA_DEGS2: 0.4668228686277357, mRNA_TFF3: 0.716987246790458, mRNA_DNALI1: 0.1264786900489923, mRNA_LINC00504: -0.0618818629453361, mRNA_CLCA2: -0.7451484119962274, mRNA_PPP1R14C: -1.0314630110278329, mRNA_THSD4: 0.2140773593629512, mRNA_SPAG5: -0.5935287571133204, mRNA_FBP1: 0.2900073959631015, mRNA_SLC7A8: 0.7274909380788094, mRNA_EN1: -0.0865058995133013, mRNA_ZNF552: 1.078944908989374, Methylation_LRRC6: -0.3957272952210791, Methylation_chr2 66218712 LINC02934 (29533): -0.2815589488785482, Methylation_HOXB13: -1.0287351254286805, Methylation_chr10 3949206 LINC02660 (4871): 1.4717989334863624, Methylation_chr5 179517140 RNF130 (18026): -1.6047417679137066, Methylation_LOC727677: 0.0511760382287375, Methylation_LETM1: -0.1158783796750175, Methylation_CDC42BPB: -1.2719383510934967, Methylation_C8orf38: -0.8065291963880711, Methylation_chr14 100504766 EVL (18852): -0.6906252117730441, Methylation_chr5 72594851 LOC340090 (24088): 0.9966595788410514, Methylation_chr2 242904738 LINC01238 (3421): -0.8185161551595566, Methylation_ARFGEF1: -0.2033431434957311, Methylation_MAPT: -0.7516475572715051, Methylation_ZFAT: 0.9548175813044852, Methylation_KCNQ4: 0.6397470223962322, Methylation_chr1 232684368 SIPA1L2 (12934): -0.8574849349179052, Methylation_CRNKL1: -0.6586791558776461, Methylation_PRKAG2: -1.1295703787731914, Methylation_MICB: -0.6652251552679691, miRNA_hsa-mir-934: -0.5280049488120863, miRNA_hsa-mir-4728: -0.2084556517039831, miRNA_hsa-mir-5695: -0.0481677912906054, miRNA_hsa-mir-18a: -0.9201095550396238, miRNA_hsa-mir-190b: 0.137907679326632, miRNA_hsa-mir-577: -0.6966495391926564, miRNA_hsa-mir-135b: -1.1907348306142451, miRNA_hsa-mir-2115: -0.583159321354303, miRNA_hsa-mir-17: -0.904056351371565, miRNA_hsa-mir-130b: -0.8431727504348603, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A2-A4RX,"High-level Amplification of none; Gain in VPS54, WDPCP, CEP68.  
FOXC1 mRNA high (Z=2.29); SPDEF, AGR2, XBP1, SLC44A4, FBP1 mRNAs low (Z < -1.92).  
No promoter hyper/hypomethylation meets thresholds.  
miR-190b downregulated (Z=-2.05).  
FOXC1 overexpression with luminal mRNA suppression indicates basal-like phenotype with ER-pathway silencing.","mRNA_MLPH: -1.2831569145916497, mRNA_C2orf54: 0.9878081015851692, mRNA_CITED4: -0.3532493166389537, mRNA_ESR1: -1.419363351478642, mRNA_SPDEF: -1.971442250702505, mRNA_AGR3: -1.1238605929301455, mRNA_FOXC1: 2.290323616813839, mRNA_GATA3: -1.7510116101536863, mRNA_AGR2: -1.665814564426177, mRNA_XBP1: -1.826002336704628, mRNA_PRR15: -1.6307840799234352, mRNA_SLC44A4: -1.8803084313095744, mRNA_CA12: -0.6916672169585147, mRNA_DTL: 0.0510660337110477, mRNA_C5AR2: -1.4308853494964984, mRNA_TBC1D9: -1.2639904072496475, mRNA_AR: -1.379089262549993, mRNA_CCDC170: -1.0830761517088034, mRNA_DEGS2: -1.285862154922791, mRNA_TFF3: -0.9025234091950188, mRNA_DNALI1: -1.0841393887267612, mRNA_LINC00504: -1.577124909372244, mRNA_CLCA2: 1.8631421228438427, mRNA_PPP1R14C: 2.171565169887765, mRNA_THSD4: 0.2883387867295952, mRNA_SPAG5: -0.1043470607731633, mRNA_FBP1: -1.7693044594365406, mRNA_SLC7A8: -1.4637957690247598, mRNA_EN1: 2.460107464359844, mRNA_ZNF552: -1.3897187652624856, Methylation_LRRC6: 1.4629323034778443, Methylation_chr2 66218712 LINC02934 (29533): -0.1124139780409984, Methylation_HOXB13: 0.0187700500053962, Methylation_chr10 3949206 LINC02660 (4871): 1.201440655956299, Methylation_chr5 179517140 RNF130 (18026): -1.0494636501775625, Methylation_LOC727677: 1.487990513970581, Methylation_LETM1: 1.3050168785006884, Methylation_CDC42BPB: -0.2799867247687537, Methylation_C8orf38: 1.4593487478944682, Methylation_chr14 100504766 EVL (18852): 1.5219742820803477, Methylation_chr5 72594851 LOC340090 (24088): -1.4389696300228931, Methylation_chr2 242904738 LINC01238 (3421): 1.3967679846252676, Methylation_ARFGEF1: 1.257781833061101, Methylation_MAPT: 1.2153687903581196, Methylation_ZFAT: 1.4052713719969758, Methylation_KCNQ4: 0.3536927093475874, Methylation_chr1 232684368 SIPA1L2 (12934): 1.1861796478691142, Methylation_CRNKL1: 1.4227922907091453, Methylation_PRKAG2: -0.1662383303304659, Methylation_MICB: 1.3703607985627986, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.0634591838294177, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.120891369048199, miRNA_hsa-mir-190b: -2.052137242410604, miRNA_hsa-mir-577: 0.5808233406846417, miRNA_hsa-mir-135b: 1.651521658192931, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.0487943392910466, miRNA_hsa-mir-130b: -0.2161562486267792, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-E9-A3QA,"High-level Amplification absent; no CNV alterations meet diagnostic thresholds.  
PPP1R14C and EN1 mRNA overexpressed (Z > 1.30).  
MLPH, AGR2, CA12, AR, SLC7A8 significantly downregulated (Z < -1.92).  
Promoter hypermethylation of LRRC6, C8orf38, ARFGEF1, SIPA1L2, MICB (Z > 1.50); RNF130 hypomethylated (Z < -1.47).  
miR-934, miR-577, miR-135b upregulated (Z > 1.99); miR-190b downregulated (Z < -1.25).","mRNA_MLPH: -2.4015146023108427, mRNA_C2orf54: -0.3910330023727788, mRNA_CITED4: 0.8764432704729247, mRNA_ESR1: -0.8514784179314037, mRNA_SPDEF: -1.8275172786943608, mRNA_AGR3: -1.9820448464413307, mRNA_FOXC1: 0.8467176230081278, mRNA_GATA3: -1.045375409602074, mRNA_AGR2: -2.1180330206071045, mRNA_XBP1: -1.7264591829259854, mRNA_PRR15: -1.528210267127988, mRNA_SLC44A4: -1.8970589625440712, mRNA_CA12: -2.135160605918366, mRNA_DTL: 0.6177262441801734, mRNA_C5AR2: -0.8732280045311641, mRNA_TBC1D9: -1.0799425597198258, mRNA_AR: -2.1548413360172, mRNA_CCDC170: -1.4324622645466092, mRNA_DEGS2: -1.7043952264994866, mRNA_TFF3: -1.7558079569807583, mRNA_DNALI1: -1.885307743070914, mRNA_LINC00504: -1.6866841574300837, mRNA_CLCA2: -0.0712397540696379, mRNA_PPP1R14C: 2.655491874129521, mRNA_THSD4: -1.8934651903383608, mRNA_SPAG5: -0.107657641425037, mRNA_FBP1: -0.0602722714910178, mRNA_SLC7A8: -2.013059827106707, mRNA_EN1: 2.4969074549841466, mRNA_ZNF552: -1.9126835646680973, Methylation_LRRC6: 1.5012269352432492, Methylation_chr2 66218712 LINC02934 (29533): 0.7659573499628711, Methylation_HOXB13: -0.9999620623662224, Methylation_chr10 3949206 LINC02660 (4871): 1.2635312076865133, Methylation_chr5 179517140 RNF130 (18026): -1.588375497571463, Methylation_LOC727677: 1.498050995132114, Methylation_LETM1: 1.3292567040217893, Methylation_CDC42BPB: -0.399415227316078, Methylation_C8orf38: 1.6667523208378503, Methylation_chr14 100504766 EVL (18852): 1.511014453781535, Methylation_chr5 72594851 LOC340090 (24088): -1.365296688028974, Methylation_chr2 242904738 LINC01238 (3421): 1.1999372932756371, Methylation_ARFGEF1: 1.7816013539305469, Methylation_MAPT: 1.439534797983527, Methylation_ZFAT: 1.353215578444362, Methylation_KCNQ4: 0.1177404278071669, Methylation_chr1 232684368 SIPA1L2 (12934): 1.528545197698159, Methylation_CRNKL1: 1.3944236132280148, Methylation_PRKAG2: -0.2432949273911778, Methylation_MICB: 1.506175268935556, miRNA_hsa-mir-934: 3.761217059431887, miRNA_hsa-mir-4728: -0.7031689626305213, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.9166895583816872, miRNA_hsa-mir-190b: -1.7567193559917322, miRNA_hsa-mir-577: 3.2691422046396745, miRNA_hsa-mir-135b: 2.1206064811479464, miRNA_hsa-mir-2115: 0.1309245477492824, miRNA_hsa-mir-17: 0.838861998456915, miRNA_hsa-mir-130b: 0.6808828736380291, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A2-A1G4,High-level Amplification of CCDC170 drives significant mRNA overexpression. ESR1 and SLC7A8 show high mRNA expression (Z > 1.30). PRKAG2 promoter hypermethylation (Z = -1.73) mediates epigenetic silencing. miR-135b is upregulated (Z = 2.24). No deletions or hypo-methylated loci meet diagnostic thresholds.,"mRNA_MLPH: 0.6502265879101624, mRNA_C2orf54: -0.8147618240351807, mRNA_CITED4: -0.9915012906341392, mRNA_ESR1: 1.3428174136775948, mRNA_SPDEF: 0.3477615894970379, mRNA_AGR3: 0.6526503285178751, mRNA_FOXC1: -0.8768628577964193, mRNA_GATA3: 0.709754356054496, mRNA_AGR2: 0.7943595293564554, mRNA_XBP1: 1.1741142496460475, mRNA_PRR15: 0.7842926618500902, mRNA_SLC44A4: 0.4157513596644423, mRNA_CA12: 1.0726982234983151, mRNA_DTL: 0.8461918145224712, mRNA_C5AR2: 0.4442412949313843, mRNA_TBC1D9: 0.5030192820894236, mRNA_AR: 0.2141434401597191, mRNA_CCDC170: 1.959021073424232, mRNA_DEGS2: -0.1514449168962764, mRNA_TFF3: 0.7949225009212844, mRNA_DNALI1: 1.0733546808404129, mRNA_LINC00504: 1.1800900534195702, mRNA_CLCA2: -0.4832318456223961, mRNA_PPP1R14C: -1.114836287238436, mRNA_THSD4: 0.9381811712355088, mRNA_SPAG5: 0.7227964330943125, mRNA_FBP1: 0.3137782077038816, mRNA_SLC7A8: 1.3918411875820351, mRNA_EN1: -1.0028496082378084, mRNA_ZNF552: -1.0572592536798098, Methylation_LRRC6: -1.3403391039936077, Methylation_chr2 66218712 LINC02934 (29533): 1.288867761257453, Methylation_HOXB13: -0.9301237453528304, Methylation_chr10 3949206 LINC02660 (4871): -1.1198531176216964, Methylation_chr5 179517140 RNF130 (18026): 1.0276987527249444, Methylation_LOC727677: -1.191205042213085, Methylation_LETM1: -1.3057654827130394, Methylation_CDC42BPB: 1.1815188939475452, Methylation_C8orf38: 0.4306391581487325, Methylation_chr14 100504766 EVL (18852): -1.0317419818966334, Methylation_chr5 72594851 LOC340090 (24088): 1.167150778487188, Methylation_chr2 242904738 LINC01238 (3421): -0.790562974949164, Methylation_ARFGEF1: -1.2244967672663034, Methylation_MAPT: -0.943790195266528, Methylation_ZFAT: 0.4674105896807721, Methylation_KCNQ4: -0.5896495268495944, Methylation_chr1 232684368 SIPA1L2 (12934): -0.0129253429417596, Methylation_CRNKL1: -0.2132677482658443, Methylation_PRKAG2: -1.7291283490409588, Methylation_MICB: -0.3853274450352964, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.3969699407947451, miRNA_hsa-mir-5695: 0.6680512245678276, miRNA_hsa-mir-18a: 0.5335697850575399, miRNA_hsa-mir-190b: 1.4919032413969893, miRNA_hsa-mir-577: 0.0010783215116347, miRNA_hsa-mir-135b: 2.2399434554030533, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.8393794890124412, miRNA_hsa-mir-130b: 1.3178381804797366, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-GM-A2DA,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.0472030265726521, mRNA_C2orf54: -0.0424516764325426, mRNA_CITED4: -1.0659114065612405, mRNA_ESR1: -0.47565251273041, mRNA_SPDEF: 0.253064288138502, mRNA_AGR3: 0.1903265963304826, mRNA_FOXC1: -0.2136224751736812, mRNA_GATA3: -0.068318985909155, mRNA_AGR2: 0.0721439699698168, mRNA_XBP1: -0.9585734687252314, mRNA_PRR15: 0.0905461305049279, mRNA_SLC44A4: 0.1305921090642733, mRNA_CA12: -0.3766740963761097, mRNA_DTL: -0.5822206734214926, mRNA_C5AR2: -0.0729507604946221, mRNA_TBC1D9: -1.170338598646912, mRNA_AR: -0.1404556743754517, mRNA_CCDC170: -0.3947618345229891, mRNA_DEGS2: -0.3525410468525837, mRNA_TFF3: 0.8633888333014748, mRNA_DNALI1: 0.1442765992090577, mRNA_LINC00504: -0.4260413185381727, mRNA_CLCA2: 0.1935650034105795, mRNA_PPP1R14C: -0.6164658715715838, mRNA_THSD4: -0.2455803080933166, mRNA_SPAG5: -1.4027618870011214, mRNA_FBP1: -0.4953156362597387, mRNA_SLC7A8: -0.391992139647767, mRNA_EN1: 0.0782159507993811, mRNA_ZNF552: -0.4337904840471405, Methylation_LRRC6: -0.2122502759566659, Methylation_chr2 66218712 LINC02934 (29533): -0.8131464362632991, Methylation_HOXB13: -0.2206583209134509, Methylation_chr10 3949206 LINC02660 (4871): -0.4223896821003049, Methylation_chr5 179517140 RNF130 (18026): 0.5338616504535711, Methylation_LOC727677: -0.3840414708992571, Methylation_LETM1: -0.3980472553982437, Methylation_CDC42BPB: -0.9812591070649748, Methylation_C8orf38: -0.3847165118376129, Methylation_chr14 100504766 EVL (18852): -0.189564761425713, Methylation_chr5 72594851 LOC340090 (24088): -0.7456737876122884, Methylation_chr2 242904738 LINC01238 (3421): -0.8012577792792088, Methylation_ARFGEF1: 0.287884636923735, Methylation_MAPT: 0.5673045149770627, Methylation_ZFAT: -0.7094517939095298, Methylation_KCNQ4: -1.1538907092433377, Methylation_chr1 232684368 SIPA1L2 (12934): 0.2671097492755285, Methylation_CRNKL1: 0.3972714046408881, Methylation_PRKAG2: -0.6393678943619071, Methylation_MICB: -0.3756283318832282, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.7050304112009287, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.1549961637803713, miRNA_hsa-mir-190b: 0.6142522314082618, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.0099098831607898, miRNA_hsa-mir-2115: -0.5198461284857426, miRNA_hsa-mir-17: -0.00180911542338, miRNA_hsa-mir-130b: -0.6649368215146748, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A0TX,"High mRNA_C2orf54 (Z=2.07) and mRNA_CLCA2 (Z=3.50) indicate overexpression.  
No methylation sites meet hyper/hypo thresholds.  
miRNA_hsa-mir-2115 upregulated (Z=2.42).  
All CNVs fall within normal/gain range; none meet amplification/deletion criteria.  
Collectively suggest luminal-like phenotype with miR-2115-driven regulatory dysregulation.","mRNA_MLPH: 0.1234574514592245, mRNA_C2orf54: 2.072353620449184, mRNA_CITED4: -1.858255346480768, mRNA_ESR1: -1.4592179264074712, mRNA_SPDEF: 0.6877404732908886, mRNA_AGR3: -0.2718416487677335, mRNA_FOXC1: -0.6807561665961964, mRNA_GATA3: 0.0343430648211612, mRNA_AGR2: -0.2671622722588468, mRNA_XBP1: 0.791698496719006, mRNA_PRR15: 0.1737215450097343, mRNA_SLC44A4: 0.9584597865399532, mRNA_CA12: -0.3335927736188653, mRNA_DTL: -0.1815429003699, mRNA_C5AR2: -1.469632481329806, mRNA_TBC1D9: 0.0523932950539336, mRNA_AR: 0.590430209321918, mRNA_CCDC170: -0.8111232542394828, mRNA_DEGS2: -0.2468240920638379, mRNA_TFF3: -0.1322917708384012, mRNA_DNALI1: -0.1953366670459181, mRNA_LINC00504: 0.5538828941269538, mRNA_CLCA2: 3.502117887381724, mRNA_PPP1R14C: -0.9806826354114326, mRNA_THSD4: -0.8322125738749208, mRNA_SPAG5: 0.2709806306571694, mRNA_FBP1: -0.2265233886143899, mRNA_SLC7A8: -0.2004854442618345, mRNA_EN1: -0.2629941226972013, mRNA_ZNF552: 0.6095809641151411, Methylation_LRRC6: 0.8000980036516121, Methylation_chr2 66218712 LINC02934 (29533): 0.3915839420527108, Methylation_HOXB13: 0.6996034410274184, Methylation_chr10 3949206 LINC02660 (4871): 0.8913416299549924, Methylation_chr5 179517140 RNF130 (18026): 0.2271554909147341, Methylation_LOC727677: 1.453599205756581, Methylation_LETM1: 1.306747497151454, Methylation_CDC42BPB: -0.9443823668603808, Methylation_C8orf38: 0.956798753244803, Methylation_chr14 100504766 EVL (18852): 1.040398606647778, Methylation_chr5 72594851 LOC340090 (24088): -1.3796420077846356, Methylation_chr2 242904738 LINC01238 (3421): 1.418955326894464, Methylation_ARFGEF1: 0.8840399411789878, Methylation_MAPT: 1.1804676419390887, Methylation_ZFAT: 0.5422843437727871, Methylation_KCNQ4: -1.1910697995933903, Methylation_chr1 232684368 SIPA1L2 (12934): 0.867655817085479, Methylation_CRNKL1: 0.8508822700679067, Methylation_PRKAG2: -0.4681641412990129, Methylation_MICB: 0.9238514596560352, miRNA_hsa-mir-934: -0.2727865714190706, miRNA_hsa-mir-4728: 1.6454918324885826, miRNA_hsa-mir-5695: 1.3622913237253502, miRNA_hsa-mir-18a: -0.1039416378326402, miRNA_hsa-mir-190b: -0.0768080147529588, miRNA_hsa-mir-577: 0.0548903671033191, miRNA_hsa-mir-135b: -0.4125788219093146, miRNA_hsa-mir-2115: 2.41930063229298, miRNA_hsa-mir-17: -0.8202135345577208, miRNA_hsa-mir-130b: 0.6334870664413768, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-C8-A3M8,"High mRNA_DTL (Z=1.41) and mRNA_CCDC170 (Z=1.58) indicate overexpression.  
mRNA_SLC7A8 (Z=-1.86) is low.  
No methylation or miRNA features meet thresholds.  
All CNVs are normal (IGNORE).  
Collectively suggests luminal-like phenotype with cell cycle dysregulation.","mRNA_MLPH: 0.6713768486662599, mRNA_C2orf54: -1.2548582251862774, mRNA_CITED4: -1.8257337738335504, mRNA_ESR1: 0.8867828935520233, mRNA_SPDEF: 0.447823280701687, mRNA_AGR3: 0.9457982447127504, mRNA_FOXC1: -0.1679559562660385, mRNA_GATA3: 0.859473674998525, mRNA_AGR2: 0.9038060417465084, mRNA_XBP1: 0.6466138181383778, mRNA_PRR15: 0.9208295739169772, mRNA_SLC44A4: 0.524382686619446, mRNA_CA12: 0.6904464152539569, mRNA_DTL: 1.414306845484679, mRNA_C5AR2: 1.0800729008627272, mRNA_TBC1D9: 0.9627029888258948, mRNA_AR: 0.1489734536047936, mRNA_CCDC170: 1.5836020287355492, mRNA_DEGS2: -0.8466998824866943, mRNA_TFF3: 0.612217706831858, mRNA_DNALI1: 0.6960448743482786, mRNA_LINC00504: -0.8781993182524858, mRNA_CLCA2: -0.6277990108954105, mRNA_PPP1R14C: -0.8439637277878701, mRNA_THSD4: 1.2751285876777227, mRNA_SPAG5: 0.7247363272952414, mRNA_FBP1: 0.7890788897007602, mRNA_SLC7A8: -1.8631842387640056, mRNA_EN1: -0.2047424616394231, mRNA_ZNF552: 0.6305928779623358, Methylation_LRRC6: -0.1896514668107733, Methylation_chr2 66218712 LINC02934 (29533): 1.248078693115412, Methylation_HOXB13: 1.2349298336161931, Methylation_chr10 3949206 LINC02660 (4871): -0.8813701520069152, Methylation_chr5 179517140 RNF130 (18026): 0.707215190912682, Methylation_LOC727677: -0.5934058610226501, Methylation_LETM1: -1.1587082609340404, Methylation_CDC42BPB: 0.9046122918714472, Methylation_C8orf38: -0.4439571227112465, Methylation_chr14 100504766 EVL (18852): -0.603578048501484, Methylation_chr5 72594851 LOC340090 (24088): 0.8758019107842346, Methylation_chr2 242904738 LINC01238 (3421): 1.2860790923302443, Methylation_ARFGEF1: -0.9922639656994044, Methylation_MAPT: -0.8677895280906709, Methylation_ZFAT: -0.5611444048765796, Methylation_KCNQ4: 1.2103143827787906, Methylation_chr1 232684368 SIPA1L2 (12934): -1.2642961710285916, Methylation_CRNKL1: -1.2323006293209795, Methylation_PRKAG2: -1.097955333120198, Methylation_MICB: -0.9676182766811172, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.124688212788719, miRNA_hsa-mir-5695: -0.0716396800241898, miRNA_hsa-mir-18a: -0.0216271651530002, miRNA_hsa-mir-190b: 1.1677655194655294, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.0967957631231928, miRNA_hsa-mir-2115: -0.4014140269830511, miRNA_hsa-mir-17: -0.2092224432730857, miRNA_hsa-mir-130b: -0.1225390280315526, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A2-A0SU,High mRNA_CA12 (Z=1.80) indicates overexpression. No methylation sites meet hyper/hypo-methylation thresholds. No miRNA alterations exceed regulatory cutoffs. All CNVs fall within normal range (−1.10 to −0.10). Isolated CA12 upregulation suggests luminal epithelial differentiation without genomic or epigenetic drivers.,"mRNA_MLPH: 0.7180223911926551, mRNA_C2orf54: -0.7219335907264997, mRNA_CITED4: 0.4639485180476939, mRNA_ESR1: 1.226173992151539, mRNA_SPDEF: 0.4005804887809032, mRNA_AGR3: 0.9627503361522096, mRNA_FOXC1: -0.1041572363995234, mRNA_GATA3: 0.984886926269296, mRNA_AGR2: -0.1121472920115407, mRNA_XBP1: 0.5298635487729777, mRNA_PRR15: 0.0720258486437409, mRNA_SLC44A4: 0.5794911064574192, mRNA_CA12: 1.80037722599897, mRNA_DTL: -0.1307944110703945, mRNA_C5AR2: 0.3341119697404975, mRNA_TBC1D9: 1.0741386031753437, mRNA_AR: 0.5175677575089156, mRNA_CCDC170: 0.8059763251119783, mRNA_DEGS2: 0.977021694474932, mRNA_TFF3: 1.1792995596699176, mRNA_DNALI1: 1.2041398042705036, mRNA_LINC00504: 0.7718625621390917, mRNA_CLCA2: 0.2534215293764635, mRNA_PPP1R14C: 0.2769247250034681, mRNA_THSD4: 1.328786911095197, mRNA_SPAG5: -0.7234731717645461, mRNA_FBP1: 0.5901412377827462, mRNA_SLC7A8: 0.9477614197604044, mRNA_EN1: -0.4313540479528009, mRNA_ZNF552: 0.4842542582270934, Methylation_LRRC6: 0.0557194364069737, Methylation_chr2 66218712 LINC02934 (29533): 1.228499164197123, Methylation_HOXB13: -0.9560557408837695, Methylation_chr10 3949206 LINC02660 (4871): -0.384565662654927, Methylation_chr5 179517140 RNF130 (18026): -0.8549498002015354, Methylation_LOC727677: -0.2921092103953325, Methylation_LETM1: -0.7821953726340891, Methylation_CDC42BPB: -1.186401326081323, Methylation_C8orf38: -0.3345892162326204, Methylation_chr14 100504766 EVL (18852): 0.233445011990717, Methylation_chr5 72594851 LOC340090 (24088): -1.301312274498064, Methylation_chr2 242904738 LINC01238 (3421): -0.4981589788498543, Methylation_ARFGEF1: -0.4028640852991187, Methylation_MAPT: -0.5897781080819685, Methylation_ZFAT: -0.2534729980293672, Methylation_KCNQ4: -1.1382940704565967, Methylation_chr1 232684368 SIPA1L2 (12934): 0.3107944710581765, Methylation_CRNKL1: -0.4138467800762322, Methylation_PRKAG2: 0.9555705644011786, Methylation_MICB: 0.2580641000877562, miRNA_hsa-mir-934: -0.35999352340497, miRNA_hsa-mir-4728: -0.4832229057753157, miRNA_hsa-mir-5695: 0.8409329779030263, miRNA_hsa-mir-18a: -0.0732979561717893, miRNA_hsa-mir-190b: 1.0734135437661694, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: 0.5126297634119716, miRNA_hsa-mir-2115: -0.0207302779696709, miRNA_hsa-mir-17: 1.0814145531369592, miRNA_hsa-mir-130b: -0.2559970431911108, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AO-A129,"High-level Amplification absent; no CNVs meet amplification thresholds.  
FOXC1 mRNA high (Z=1.697) and PPP1R14C mRNA high (Z=1.598); ESR1, AGR3, SLC7A8 mRNAs low (Z < -1.92).  
Methylation hyper in ARFGEF1, LOC727677, C8orf38, LINC02660 (Z > 1.50); hypo in RNF130 (Z < -1.47).  
miR-934, miR-18a, miR-577 upregulated (Z > 1.99); miR-190b downregulated (Z < -1.25).","mRNA_MLPH: -1.6634149122599364, mRNA_C2orf54: 0.1070433379456935, mRNA_CITED4: 1.0180226150100602, mRNA_ESR1: -1.4897128994428517, mRNA_SPDEF: -1.3963919378641187, mRNA_AGR3: -1.8933260235353504, mRNA_FOXC1: 1.697164282143928, mRNA_GATA3: -0.7286969116328539, mRNA_AGR2: -1.7392968328498164, mRNA_XBP1: -1.421236974445099, mRNA_PRR15: -1.348556693353002, mRNA_SLC44A4: -1.563750287827285, mRNA_CA12: -1.7354306362346394, mRNA_DTL: 0.4022311488241733, mRNA_C5AR2: -1.088350052644853, mRNA_TBC1D9: -1.7941393714887233, mRNA_AR: -1.5441621725397985, mRNA_CCDC170: -1.7758950302086345, mRNA_DEGS2: -1.730717105551289, mRNA_TFF3: -1.8233330354281108, mRNA_DNALI1: -0.5457693870842709, mRNA_LINC00504: -1.5917485052883324, mRNA_CLCA2: -0.7601626908343255, mRNA_PPP1R14C: 1.5982623746627764, mRNA_THSD4: -1.998531483919988, mRNA_SPAG5: 0.3762333022145405, mRNA_FBP1: -1.6736891299572452, mRNA_SLC7A8: -2.271983244817322, mRNA_EN1: 1.3440738071269889, mRNA_ZNF552: -1.6848925667575767, Methylation_LRRC6: 1.2387570655732711, Methylation_chr2 66218712 LINC02934 (29533): 1.180090361759292, Methylation_HOXB13: -0.8627960128854326, Methylation_chr10 3949206 LINC02660 (4871): 1.600378567226823, Methylation_chr5 179517140 RNF130 (18026): -1.6184503483772352, Methylation_LOC727677: 1.5337681376987378, Methylation_LETM1: 1.357485901137496, Methylation_CDC42BPB: 0.6140456624352705, Methylation_C8orf38: 1.5865657758813685, Methylation_chr14 100504766 EVL (18852): 1.3920884403508589, Methylation_chr5 72594851 LOC340090 (24088): -0.2670212645888016, Methylation_chr2 242904738 LINC01238 (3421): 1.1076213611403918, Methylation_ARFGEF1: 1.6914166867723757, Methylation_MAPT: 1.425890873194095, Methylation_ZFAT: 1.4582274293740818, Methylation_KCNQ4: 1.185033255924809, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5366062826569062, Methylation_CRNKL1: 1.3111661479407553, Methylation_PRKAG2: -0.6974938982051675, Methylation_MICB: 1.369129945066586, miRNA_hsa-mir-934: 3.2513783428280862, miRNA_hsa-mir-4728: -0.5158873931349013, miRNA_hsa-mir-5695: 1.325593601304186, miRNA_hsa-mir-18a: 2.413409866912541, miRNA_hsa-mir-190b: -2.052137242410604, miRNA_hsa-mir-577: 2.285161611412537, miRNA_hsa-mir-135b: 1.5720279697113078, miRNA_hsa-mir-2115: 0.7013302947622242, miRNA_hsa-mir-17: 1.906366282886552, miRNA_hsa-mir-130b: 0.71600858046481, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A7-A6VY,"High-level Amplification of none; PPP1R14C mRNA overexpressed (Z=1.92).  
FOXC1 mRNA elevated (Z=1.31).  
SPDEF, AR, SLC44A4, TFF3 significantly downregulated (Z < -1.92).  
RNF130 promoter hypomethylated (Z=-1.55); multiple loci hypermethylated (e.g., C8orf38 Z=1.58).  
miR-934 upregulated (Z=2.69); miR-190b downregulated (Z=-1.40).  
All CNVs fall in normal range (IGNORE).","mRNA_MLPH: -1.4658923131446553, mRNA_C2orf54: 0.7009872559079429, mRNA_CITED4: 0.3510099029807538, mRNA_ESR1: -1.8857174907162044, mRNA_SPDEF: -2.838736739804375, mRNA_AGR3: -1.7011883765013125, mRNA_FOXC1: 1.308027865320358, mRNA_GATA3: -1.16709470121113, mRNA_AGR2: -1.4451296228387165, mRNA_XBP1: -1.4139594682408367, mRNA_PRR15: -1.6341753867355084, mRNA_SLC44A4: -2.320272077877639, mRNA_CA12: -1.4115942088506044, mRNA_DTL: 0.2066020857694995, mRNA_C5AR2: -1.4066853507021244, mRNA_TBC1D9: -1.2639145904685118, mRNA_AR: -2.3293589689960914, mRNA_CCDC170: -1.597994313686428, mRNA_DEGS2: -1.5089186851887928, mRNA_TFF3: -2.1399480948665257, mRNA_DNALI1: -1.8381681826204728, mRNA_LINC00504: -1.6754832634379764, mRNA_CLCA2: 0.7031115962040198, mRNA_PPP1R14C: 1.9247948313842205, mRNA_THSD4: -1.5852362705655647, mRNA_SPAG5: 0.2685654357842608, mRNA_FBP1: -1.154606454288253, mRNA_SLC7A8: -1.5500788609647014, mRNA_EN1: 0.0447152107086517, mRNA_ZNF552: -1.1947817906580238, Methylation_LRRC6: 1.4004741520779609, Methylation_chr2 66218712 LINC02934 (29533): 0.1647287621950274, Methylation_HOXB13: -1.0366043126909217, Methylation_chr10 3949206 LINC02660 (4871): 1.3850841775359457, Methylation_chr5 179517140 RNF130 (18026): -1.5479129525520263, Methylation_LOC727677: 1.4202620530494263, Methylation_LETM1: 1.298930155696892, Methylation_CDC42BPB: 0.6695793540665769, Methylation_C8orf38: 1.584706982929413, Methylation_chr14 100504766 EVL (18852): 1.4458130695555338, Methylation_chr5 72594851 LOC340090 (24088): -1.3949221459308443, Methylation_chr2 242904738 LINC01238 (3421): 1.3660567616090598, Methylation_ARFGEF1: 1.480671334009129, Methylation_MAPT: 1.3040753641879304, Methylation_ZFAT: 1.419558518635874, Methylation_KCNQ4: 1.1998265297666613, Methylation_chr1 232684368 SIPA1L2 (12934): 1.3494269080933794, Methylation_CRNKL1: 1.3192865259134712, Methylation_PRKAG2: -1.1353090536863646, Methylation_MICB: 1.4019191550828545, miRNA_hsa-mir-934: 2.690187187791939, miRNA_hsa-mir-4728: -0.731448195899921, miRNA_hsa-mir-5695: 0.0754313290096567, miRNA_hsa-mir-18a: 0.271096886629053, miRNA_hsa-mir-190b: -1.397589660601955, miRNA_hsa-mir-577: 0.8745794095445364, miRNA_hsa-mir-135b: 0.885476676743347, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.5293311618092529, miRNA_hsa-mir-130b: 0.1729600942540659, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A0TZ,"High-level Amplification of none; Deletion of VPS54, LINC01867, LINC02576, WDPCP, and CEP68. mRNA_CITED4 is low (Z = -2.05). HOXB13 promoter hypermethylation (Z = 1.76) and CRNKL1 hypermethylation (Z = -1.53) mediate silencing. miR-18a and miR-4728 are downregulated (Z < -1.25). These features indicate a basal-like phenotype with ER pathway suppression.","mRNA_MLPH: 0.9322173281203594, mRNA_C2orf54: -0.7614142269279729, mRNA_CITED4: -2.0540539005351834, mRNA_ESR1: 0.6206240910463933, mRNA_SPDEF: 0.7874475104525583, mRNA_AGR3: 0.8084229883961168, mRNA_FOXC1: -0.5195871319070844, mRNA_GATA3: 1.202462842852832, mRNA_AGR2: 1.0833523127487807, mRNA_XBP1: 0.320093471705498, mRNA_PRR15: 1.680376449363867, mRNA_SLC44A4: 1.294738160805118, mRNA_CA12: 0.9193630230183842, mRNA_DTL: 2.179985746272095, mRNA_C5AR2: 2.0749609553216075, mRNA_TBC1D9: 2.0302232325646203, mRNA_AR: 1.7322131859329275, mRNA_CCDC170: 0.9294781808507192, mRNA_DEGS2: 1.1300320728437026, mRNA_TFF3: 0.4623470877891313, mRNA_DNALI1: 0.1571593603441513, mRNA_LINC00504: 1.352149409954833, mRNA_CLCA2: -0.7138491776405947, mRNA_PPP1R14C: -0.9935584227726276, mRNA_THSD4: 1.6759021720588605, mRNA_SPAG5: 1.5375999095047423, mRNA_FBP1: 1.5138382093329237, mRNA_SLC7A8: 1.6313913607608923, mRNA_EN1: -0.7502450529888448, mRNA_ZNF552: 1.2471441912333656, Methylation_LRRC6: -1.2235282277082975, Methylation_chr2 66218712 LINC02934 (29533): 1.2781588274171047, Methylation_HOXB13: 1.758079674361806, Methylation_chr10 3949206 LINC02660 (4871): -1.194207504655109, Methylation_chr5 179517140 RNF130 (18026): 1.2552903787834664, Methylation_LOC727677: -1.3417401328379956, Methylation_LETM1: -1.107488222767581, Methylation_CDC42BPB: 1.4066169784278504, Methylation_C8orf38: -0.5846955173143448, Methylation_chr14 100504766 EVL (18852): -1.4523961492237565, Methylation_chr5 72594851 LOC340090 (24088): 1.336667260891684, Methylation_chr2 242904738 LINC01238 (3421): -1.1527440880416606, Methylation_ARFGEF1: -1.263546972222691, Methylation_MAPT: -1.4424058566517788, Methylation_ZFAT: -1.48959217428184, Methylation_KCNQ4: -0.945371614008376, Methylation_chr1 232684368 SIPA1L2 (12934): -1.0416679267081022, Methylation_CRNKL1: -1.5305533146340309, Methylation_PRKAG2: 1.3216613243707591, Methylation_MICB: -0.967382969177666, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.4206227128070994, miRNA_hsa-mir-190b: 0.8371598093957016, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.4984761354932256, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.9414083902671962, miRNA_hsa-mir-130b: -1.105267057448773, CNV_VPS54: -1.6173912818721974, CNV_LINC01867: -1.63714039509435, CNV_LINC02576: -1.657048777669473, CNV_WDPCP: -1.6249341592372952, CNV_CEP68: -1.657048777669473"
TCGA-BH-A1ET,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.5965507441771374, mRNA_C2orf54: 0.8410044206200715, mRNA_CITED4: -0.6841365332074832, mRNA_ESR1: 1.0350878545092532, mRNA_SPDEF: 0.3913444204538929, mRNA_AGR3: 1.2608157461868374, mRNA_FOXC1: -0.0022671503506567, mRNA_GATA3: 0.6187245152332521, mRNA_AGR2: 0.5289336770253913, mRNA_XBP1: 0.7145644016382939, mRNA_PRR15: 0.1907824816842749, mRNA_SLC44A4: 0.9603089319438504, mRNA_CA12: 0.9469037686869936, mRNA_DTL: -1.148002384180124, mRNA_C5AR2: 1.235443267924963, mRNA_TBC1D9: 0.7081899916056333, mRNA_AR: 1.5563226579962104, mRNA_CCDC170: 1.05277856571524, mRNA_DEGS2: 0.6826134731693323, mRNA_TFF3: 1.046856371471019, mRNA_DNALI1: 0.9362256729015456, mRNA_LINC00504: 1.1013145544063605, mRNA_CLCA2: -0.6664427018361305, mRNA_PPP1R14C: -0.6405610471908696, mRNA_THSD4: 1.0272789378885796, mRNA_SPAG5: -1.2572049208497174, mRNA_FBP1: 1.0282072183320157, mRNA_SLC7A8: 0.635038299644274, mRNA_EN1: -0.5078992012129805, mRNA_ZNF552: 0.8367116825322273, Methylation_LRRC6: -0.4082320033702954, Methylation_chr2 66218712 LINC02934 (29533): -0.7561989236474337, Methylation_HOXB13: -0.9751830652060972, Methylation_chr10 3949206 LINC02660 (4871): -0.6540173443160934, Methylation_chr5 179517140 RNF130 (18026): 0.7782164277028857, Methylation_LOC727677: -0.5068217434836312, Methylation_LETM1: -0.6110752041266081, Methylation_CDC42BPB: -1.165372821701517, Methylation_C8orf38: -0.8893108978126132, Methylation_chr14 100504766 EVL (18852): -0.8094215072149639, Methylation_chr5 72594851 LOC340090 (24088): 1.1263475804423038, Methylation_chr2 242904738 LINC01238 (3421): -0.8378530038042716, Methylation_ARFGEF1: -0.5519921922236779, Methylation_MAPT: -0.3385621089430372, Methylation_ZFAT: -0.5465657211005663, Methylation_KCNQ4: -0.7205851294316116, Methylation_chr1 232684368 SIPA1L2 (12934): -0.7554278201354249, Methylation_CRNKL1: -0.4199714112546799, Methylation_PRKAG2: 0.2202244536879692, Methylation_MICB: -0.7173548623894515, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.5168734153916964, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.246160673412718, miRNA_hsa-mir-190b: 0.4766099171395788, miRNA_hsa-mir-577: -0.2082823492040348, miRNA_hsa-mir-135b: -0.188724691062387, miRNA_hsa-mir-2115: 1.01942308315317, miRNA_hsa-mir-17: -1.0589447542987651, miRNA_hsa-mir-130b: -0.8199046403295425, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-B6-A0X4,"LINC00504 mRNA is highly overexpressed (Z=2.13). LETM1 and PRKAG2 promoters are hypomethylated (Z < -1.47), potentially activating transcription. miR-190b is upregulated (Z=1.93); miR-130b is downregulated (Z=-1.24). All CNVs fall within normal range (−1.10 to −0.10) and are ignored. These features suggest luminal-like biology with possible metabolic pathway dysregulation.","mRNA_MLPH: 0.6593441314497587, mRNA_C2orf54: -1.2032730637800837, mRNA_CITED4: -1.331980955772866, mRNA_ESR1: 0.7315904791932624, mRNA_SPDEF: 0.3586382276072624, mRNA_AGR3: 0.5071329090271859, mRNA_FOXC1: -0.79493204246925, mRNA_GATA3: 0.8778338519222294, mRNA_AGR2: -0.025219805543171, mRNA_XBP1: 1.0579713956771948, mRNA_PRR15: 0.2720555965687637, mRNA_SLC44A4: 0.8965108825689386, mRNA_CA12: 0.4388512738560166, mRNA_DTL: 0.7077829052627683, mRNA_C5AR2: 1.176702904101982, mRNA_TBC1D9: 1.0655555738034963, mRNA_AR: -0.0266770422377592, mRNA_CCDC170: 0.9805396509991154, mRNA_DEGS2: 0.4167847077854159, mRNA_TFF3: 0.4781988453131119, mRNA_DNALI1: 0.7858490704073529, mRNA_LINC00504: 2.131594254475696, mRNA_CLCA2: -0.599592139182573, mRNA_PPP1R14C: 0.2108043082678689, mRNA_THSD4: 0.1963014745018603, mRNA_SPAG5: -1.2490288190550878, mRNA_FBP1: 0.4376875156628659, mRNA_SLC7A8: 0.6486654769136664, mRNA_EN1: -0.9525139776119405, mRNA_ZNF552: 0.4427763497016989, Methylation_LRRC6: -1.0478849499177711, Methylation_chr2 66218712 LINC02934 (29533): -0.668677947461716, Methylation_HOXB13: -0.968199392717528, Methylation_chr10 3949206 LINC02660 (4871): -1.110369528488537, Methylation_chr5 179517140 RNF130 (18026): 0.9511740240291254, Methylation_LOC727677: -1.22805113992129, Methylation_LETM1: -1.5584957037991198, Methylation_CDC42BPB: -1.3463078890523938, Methylation_C8orf38: -0.6853398322565648, Methylation_chr14 100504766 EVL (18852): -1.3466204424720225, Methylation_chr5 72594851 LOC340090 (24088): -0.8664773550145641, Methylation_chr2 242904738 LINC01238 (3421): -0.5060047089501701, Methylation_ARFGEF1: -0.892985477108906, Methylation_MAPT: -1.1687545149408705, Methylation_ZFAT: -0.942200483410172, Methylation_KCNQ4: -1.222029038509823, Methylation_chr1 232684368 SIPA1L2 (12934): -1.1608686963083406, Methylation_CRNKL1: -1.2945126653969483, Methylation_PRKAG2: -1.5711814633861316, Methylation_MICB: -1.011783318865715, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.2025746770466736, miRNA_hsa-mir-5695: 0.8190888876993542, miRNA_hsa-mir-18a: -0.4492586454446639, miRNA_hsa-mir-190b: 1.933931848393304, miRNA_hsa-mir-577: -0.3780163572367087, miRNA_hsa-mir-135b: 0.234887210785781, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.0072116416464167, miRNA_hsa-mir-130b: -1.236397752282723, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-PE-A5DE,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-significant ranges per specified criteria.","mRNA_MLPH: 0.5198766826702848, mRNA_C2orf54: -0.8859292400430833, mRNA_CITED4: 0.6211461586548725, mRNA_ESR1: 0.3291789563021077, mRNA_SPDEF: 0.6677950007845515, mRNA_AGR3: 0.5773987028750925, mRNA_FOXC1: -0.1647542666550811, mRNA_GATA3: 0.6116699661299544, mRNA_AGR2: 0.931536653616483, mRNA_XBP1: 0.3469834768814144, mRNA_PRR15: 1.0011461607821013, mRNA_SLC44A4: 0.7132995542577971, mRNA_CA12: 0.2104875033167494, mRNA_DTL: 0.3493258008468827, mRNA_C5AR2: 1.161906166664865, mRNA_TBC1D9: 0.0543070587676789, mRNA_AR: 0.306562421714792, mRNA_CCDC170: -0.1333656054363972, mRNA_DEGS2: 0.1604263080952302, mRNA_TFF3: 0.7243511006725065, mRNA_DNALI1: -0.1084702097779745, mRNA_LINC00504: -0.4224022278234801, mRNA_CLCA2: -0.6124292644876118, mRNA_PPP1R14C: -0.3490886864893465, mRNA_THSD4: -0.1155410196183119, mRNA_SPAG5: -0.6163633505456453, mRNA_FBP1: 0.5713489286253104, mRNA_SLC7A8: 0.2367129813521349, mRNA_EN1: -0.3774276030323625, mRNA_ZNF552: 0.396568626050413, Methylation_LRRC6: 0.9780361262247924, Methylation_chr2 66218712 LINC02934 (29533): -0.1081361009537856, Methylation_HOXB13: -0.7925205296837442, Methylation_chr10 3949206 LINC02660 (4871): 0.2571081285340666, Methylation_chr5 179517140 RNF130 (18026): 0.6270862649547423, Methylation_LOC727677: 0.5112935866921052, Methylation_LETM1: 0.6376821547057079, Methylation_CDC42BPB: -1.103889546275393, Methylation_C8orf38: 0.9250463512072352, Methylation_chr14 100504766 EVL (18852): 0.3783067891460753, Methylation_chr5 72594851 LOC340090 (24088): 0.1106302246525727, Methylation_chr2 242904738 LINC01238 (3421): -0.4293579264190517, Methylation_ARFGEF1: 0.9542728997479852, Methylation_MAPT: 0.2580181470270601, Methylation_ZFAT: 0.4216170173954813, Methylation_KCNQ4: -1.0270933928391008, Methylation_chr1 232684368 SIPA1L2 (12934): 0.4264754616828268, Methylation_CRNKL1: 0.285772895640915, Methylation_PRKAG2: 0.8995573490149698, Methylation_MICB: 0.1793655077308086, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.4216686497738672, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.1499701105513574, miRNA_hsa-mir-190b: 1.0030474573255024, miRNA_hsa-mir-577: -0.6072378982913104, miRNA_hsa-mir-135b: -0.2520714705758318, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.6117578892295655, miRNA_hsa-mir-130b: -1.1820723203766152, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-BH-A0E2,"High-level Amplification of none; no CNV meets amplification thresholds.  
HOXB13 promoter hypermethylation (Z=1.85) mediates epigenetic silencing.  
THSD4 mRNA high (Z=1.34) and TBC1D9 mRNA high (Z=1.04) exceed expression thresholds.  
No miRNA alterations meet dysregulation criteria.  
Collectively indicates luminal phenotype with HOXB13 silencing and THSD4/TBC1D9 overexpression.","mRNA_MLPH: 0.2352201131811177, mRNA_C2orf54: -0.4749080384210724, mRNA_CITED4: -0.8754723424721639, mRNA_ESR1: 0.4807969273480827, mRNA_SPDEF: 0.6580741591319906, mRNA_AGR3: 0.8358804703392111, mRNA_FOXC1: 0.1416039619593344, mRNA_GATA3: 1.0356075130353444, mRNA_AGR2: 0.7138726424522787, mRNA_XBP1: 0.8568194105958128, mRNA_PRR15: 0.5674619931970789, mRNA_SLC44A4: 0.3591930095223436, mRNA_CA12: 0.5114723784843077, mRNA_DTL: 0.3258885309191531, mRNA_C5AR2: -0.1572960869331776, mRNA_TBC1D9: 1.0376717404235665, mRNA_AR: 0.2431232622129162, mRNA_CCDC170: 0.2902923861148845, mRNA_DEGS2: 0.1614694486228574, mRNA_TFF3: 0.3888159521231864, mRNA_DNALI1: 0.6278655396441755, mRNA_LINC00504: 0.1566484525180911, mRNA_CLCA2: 0.1739003410605424, mRNA_PPP1R14C: 0.6706452497077985, mRNA_THSD4: 1.3392050685946482, mRNA_SPAG5: 1.1053435427628169, mRNA_FBP1: -0.4471152838872481, mRNA_SLC7A8: -0.1067334835065368, mRNA_EN1: -0.2114425486755071, mRNA_ZNF552: 0.0159822157809666, Methylation_LRRC6: -1.1265262338682802, Methylation_chr2 66218712 LINC02934 (29533): 1.2302655947659051, Methylation_HOXB13: 1.8467904669551407, Methylation_chr10 3949206 LINC02660 (4871): -1.0170714495732576, Methylation_chr5 179517140 RNF130 (18026): 0.9211113104320532, Methylation_LOC727677: -0.8231304742181351, Methylation_LETM1: -1.2772472253255476, Methylation_CDC42BPB: 1.365143350404471, Methylation_C8orf38: -0.1317017034012282, Methylation_chr14 100504766 EVL (18852): -0.9313414554871154, Methylation_chr5 72594851 LOC340090 (24088): 1.3151087464355582, Methylation_chr2 242904738 LINC01238 (3421): -0.4389529378307623, Methylation_ARFGEF1: -1.1944304228829368, Methylation_MAPT: -0.8212253302662342, Methylation_ZFAT: -1.150690568490945, Methylation_KCNQ4: -0.8587157658500066, Methylation_chr1 232684368 SIPA1L2 (12934): -1.0424707224916037, Methylation_CRNKL1: -0.2764950414310033, Methylation_PRKAG2: -0.9392112076818327, Methylation_MICB: -0.9571448034371696, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.3594079701138652, miRNA_hsa-mir-5695: -0.0755898262233389, miRNA_hsa-mir-18a: -0.4818451403648033, miRNA_hsa-mir-190b: 0.8221776286389649, miRNA_hsa-mir-577: -0.592938531282491, miRNA_hsa-mir-135b: -0.7828019626602348, miRNA_hsa-mir-2115: -0.1672876211727584, miRNA_hsa-mir-17: 0.8332876031424952, miRNA_hsa-mir-130b: 0.8540625189910886, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-OL-A5DA,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations.","mRNA_MLPH: 0.8895521074227362, mRNA_C2orf54: 0.970342710117013, mRNA_CITED4: 0.6350494303974655, mRNA_ESR1: 0.4940095299887406, mRNA_SPDEF: 0.8120603600035986, mRNA_AGR3: 0.4978950697237851, mRNA_FOXC1: -0.1743521064817755, mRNA_GATA3: 0.9486478641957372, mRNA_AGR2: 0.1335926113159717, mRNA_XBP1: 1.1582992845564446, mRNA_PRR15: 0.5495951820879872, mRNA_SLC44A4: 0.75482749645931, mRNA_CA12: 0.9582169003906928, mRNA_DTL: -0.9908407217441894, mRNA_C5AR2: 0.2686852260110475, mRNA_TBC1D9: 0.8034049321481319, mRNA_AR: 0.7538864035291979, mRNA_CCDC170: 0.1258043961537419, mRNA_DEGS2: 1.056744913952401, mRNA_TFF3: 0.6748337711786189, mRNA_DNALI1: 0.996197365921099, mRNA_LINC00504: 0.871167642049216, mRNA_CLCA2: 0.4170003818884884, mRNA_PPP1R14C: 0.2100478016775025, mRNA_THSD4: 0.8248723010532442, mRNA_SPAG5: -0.751876121514363, mRNA_FBP1: 0.2443423547334532, mRNA_SLC7A8: 1.072715259727869, mRNA_EN1: -0.7818667137197454, mRNA_ZNF552: -0.1585118715009877, Methylation_LRRC6: -0.6418991482579743, Methylation_chr2 66218712 LINC02934 (29533): 0.4701768018786417, Methylation_HOXB13: -1.027592308989343, Methylation_chr10 3949206 LINC02660 (4871): -0.2302843875428193, Methylation_chr5 179517140 RNF130 (18026): 0.422235297851886, Methylation_LOC727677: -0.88476263708289, Methylation_LETM1: -1.0025716356720502, Methylation_CDC42BPB: -0.8595345793050537, Methylation_C8orf38: -0.6321428492655182, Methylation_chr14 100504766 EVL (18852): -0.5255443784989714, Methylation_chr5 72594851 LOC340090 (24088): 0.9719646060880748, Methylation_chr2 242904738 LINC01238 (3421): -0.6836064934295011, Methylation_ARFGEF1: -0.8764313146754876, Methylation_MAPT: -0.9370192428033056, Methylation_ZFAT: -1.0962381120740958, Methylation_KCNQ4: -1.1847106317350935, Methylation_chr1 232684368 SIPA1L2 (12934): -0.1025288579309545, Methylation_CRNKL1: -0.4625905648241733, Methylation_PRKAG2: 1.335068131501511, Methylation_MICB: -1.181559427122845, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.6209173592077561, miRNA_hsa-mir-5695: -0.383021191563504, miRNA_hsa-mir-18a: 0.0661005095520261, miRNA_hsa-mir-190b: 1.070736969270214, miRNA_hsa-mir-577: -0.5850161497024065, miRNA_hsa-mir-135b: -0.1711453585857526, miRNA_hsa-mir-2115: -0.3893043797519016, miRNA_hsa-mir-17: 0.6766486672621381, miRNA_hsa-mir-130b: -1.130065263535836, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-EW-A1J6,"Deletion of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 correlates with transcriptional downregulation. RNF130 promoter hypomethylation (Z = -1.48) suggests epigenetic dysregulation. miR-5695 is upregulated (Z = 2.11), potentially targeting tumor suppressors. These features collectively indicate a basal-like phenotype with DNA repair deficiency.","mRNA_MLPH: -0.7746476151752136, mRNA_C2orf54: -1.0679144571149877, mRNA_CITED4: -0.47716975231162, mRNA_ESR1: 0.5519925721517632, mRNA_SPDEF: -0.5150191189736651, mRNA_AGR3: 0.4779161088926811, mRNA_FOXC1: -1.182608500238612, mRNA_GATA3: 0.4906259841763946, mRNA_AGR2: -0.4234803318890532, mRNA_XBP1: -0.7611628970110539, mRNA_PRR15: -1.6776630277688356, mRNA_SLC44A4: -1.915672646772243, mRNA_CA12: 0.37874208449765, mRNA_DTL: -1.9743236037188208, mRNA_C5AR2: -0.7450685760531813, mRNA_TBC1D9: -0.4700431087781547, mRNA_AR: -0.6203707113320035, mRNA_CCDC170: 0.585394237164855, mRNA_DEGS2: -0.3415863177574322, mRNA_TFF3: -0.3938103336853862, mRNA_DNALI1: -0.2152639107942472, mRNA_LINC00504: -0.4357996698456859, mRNA_CLCA2: -0.8823172982923876, mRNA_PPP1R14C: -1.0202314273039728, mRNA_THSD4: 0.3421745977834434, mRNA_SPAG5: -1.007056626884775, mRNA_FBP1: -0.9272897070905204, mRNA_SLC7A8: -0.2587991985361572, mRNA_EN1: -1.0289678456504183, mRNA_ZNF552: 0.0745322959613423, Methylation_LRRC6: -0.8526180276439407, Methylation_chr2 66218712 LINC02934 (29533): -0.695500771910954, Methylation_HOXB13: 1.3111488365928587, Methylation_chr10 3949206 LINC02660 (4871): -1.1522609154740708, Methylation_chr5 179517140 RNF130 (18026): -1.4818516102725874, Methylation_LOC727677: -1.1068786318223844, Methylation_LETM1: -1.3436733698870214, Methylation_CDC42BPB: 0.9567803595355506, Methylation_C8orf38: -0.674767979854552, Methylation_chr14 100504766 EVL (18852): -0.4601330160997405, Methylation_chr5 72594851 LOC340090 (24088): -1.3182336013576026, Methylation_chr2 242904738 LINC01238 (3421): -1.2239513819660628, Methylation_ARFGEF1: -0.8949318456502072, Methylation_MAPT: -1.226172320142479, Methylation_ZFAT: -1.3650061601037378, Methylation_KCNQ4: 0.7508700687995148, Methylation_chr1 232684368 SIPA1L2 (12934): -0.5219538488560241, Methylation_CRNKL1: -1.318797883549345, Methylation_PRKAG2: -0.2111430000549158, Methylation_MICB: -1.3832287415205928, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.5498297119471881, miRNA_hsa-mir-5695: 2.111593533685377, miRNA_hsa-mir-18a: 0.8620478672972934, miRNA_hsa-mir-190b: 0.5926911441508824, miRNA_hsa-mir-577: -0.5609595582570284, miRNA_hsa-mir-135b: -0.6260568672808736, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.9991425868508492, miRNA_hsa-mir-130b: 0.5094711680756713, CNV_VPS54: -1.6173912818721974, CNV_LINC01867: -1.63714039509435, CNV_LINC02576: -1.657048777669473, CNV_WDPCP: -1.6249341592372952, CNV_CEP68: -1.657048777669473"
TCGA-E9-A1RG,"High-level Amplification absent; no CNVs meet amplification thresholds.  
mRNA_DEGS2 (Z=1.33) exceeds high-expression threshold.  
No methylation sites meet hyper/hypo-methylation criteria.  
miRNA_hsa-mir-5695 (Z=2.57) and miRNA_hsa-mir-130b (Z=1.77) are upregulated.  
These features suggest luminal-like biology with DEGS2-driven lipid metabolism dysregulation.","mRNA_MLPH: 0.2869804336632776, mRNA_C2orf54: 0.4316032278200181, mRNA_CITED4: -0.0477304136038486, mRNA_ESR1: 0.5783308693474767, mRNA_SPDEF: 0.3198356710145704, mRNA_AGR3: 0.2959214452267036, mRNA_FOXC1: -1.201065373223131, mRNA_GATA3: 0.2604416618232392, mRNA_AGR2: 1.0571696443791303, mRNA_XBP1: 0.1681838352438283, mRNA_PRR15: -0.5342410437565036, mRNA_SLC44A4: 0.2702086152040988, mRNA_CA12: 0.8522632307843389, mRNA_DTL: -0.3697910964374447, mRNA_C5AR2: -0.5102915899555097, mRNA_TBC1D9: -0.4711621510652928, mRNA_AR: 0.1008556142547739, mRNA_CCDC170: 0.1630794396372554, mRNA_DEGS2: 1.3278019831432548, mRNA_TFF3: 0.5413613063368135, mRNA_DNALI1: 0.3476128828426009, mRNA_LINC00504: -0.505908125100983, mRNA_CLCA2: -0.8383538763591222, mRNA_PPP1R14C: -0.6908560245747208, mRNA_THSD4: 0.0474579573119192, mRNA_SPAG5: 0.0453062054057851, mRNA_FBP1: 0.736367228301488, mRNA_SLC7A8: 0.4498692277126217, mRNA_EN1: -0.2323760527469569, mRNA_ZNF552: -0.4184349336747686, Methylation_LRRC6: -0.6477794747082681, Methylation_chr2 66218712 LINC02934 (29533): -0.9151353309653368, Methylation_HOXB13: -1.0769897432288065, Methylation_chr10 3949206 LINC02660 (4871): -1.0649426460727451, Methylation_chr5 179517140 RNF130 (18026): -1.4110194961247056, Methylation_LOC727677: -1.1544882730607162, Methylation_LETM1: -1.1970874352409813, Methylation_CDC42BPB: 1.2917139314218429, Methylation_C8orf38: -0.3612749991968539, Methylation_chr14 100504766 EVL (18852): -0.9402827046534624, Methylation_chr5 72594851 LOC340090 (24088): 0.9747597997506728, Methylation_chr2 242904738 LINC01238 (3421): -1.147063774194854, Methylation_ARFGEF1: -0.8129416166775703, Methylation_MAPT: -0.7697117815396733, Methylation_ZFAT: -1.3535638634298055, Methylation_KCNQ4: -0.8653732811050816, Methylation_chr1 232684368 SIPA1L2 (12934): -0.8766027059228367, Methylation_CRNKL1: -1.216703716118854, Methylation_PRKAG2: -1.3190031190421292, Methylation_MICB: -1.031599643981932, miRNA_hsa-mir-934: 0.3720344206052435, miRNA_hsa-mir-4728: 0.3229164439318229, miRNA_hsa-mir-5695: 2.5692429718575216, miRNA_hsa-mir-18a: 0.1258077151102459, miRNA_hsa-mir-190b: 1.06290849790134, miRNA_hsa-mir-577: -0.5168860719984951, miRNA_hsa-mir-135b: 1.3696294150902049, miRNA_hsa-mir-2115: 0.0466123996546176, miRNA_hsa-mir-17: 0.7150815988356064, miRNA_hsa-mir-130b: 1.7748697368902624, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A1X8,"High mRNA_ESR1 (Z=1.31), mRNA_XBP1 (Z=1.56), and mRNA_THSD4 (Z=1.56) indicate luminal transcriptional activity. No methylation or CNV alterations meet diagnostic thresholds. miRNA_hsa-mir-18a (Z=-1.34) and miRNA_hsa-mir-17 (Z=-1.37) are downregulated. Collectively suggestive of a luminal A phenotype with intact genomic stability.","mRNA_MLPH: 0.9145005693780404, mRNA_C2orf54: 0.4871712757311224, mRNA_CITED4: -0.7624206953692109, mRNA_ESR1: 1.3123034323674307, mRNA_SPDEF: 0.4339720132277251, mRNA_AGR3: 0.8945138146439578, mRNA_FOXC1: -0.1856061632993539, mRNA_GATA3: 0.6839437634893673, mRNA_AGR2: 0.8461513625009641, mRNA_XBP1: 1.3871642397483763, mRNA_PRR15: 0.0641327609085121, mRNA_SLC44A4: 0.5144199491634227, mRNA_CA12: 1.219833424676345, mRNA_DTL: 0.3946220922515105, mRNA_C5AR2: 0.5450486180412695, mRNA_TBC1D9: 1.1612759076338988, mRNA_AR: 1.0705657057945877, mRNA_CCDC170: 1.201794065089889, mRNA_DEGS2: 1.0656514382136089, mRNA_TFF3: 1.2290213921956843, mRNA_DNALI1: 0.6027794174284915, mRNA_LINC00504: 0.3154271178334702, mRNA_CLCA2: 0.8159561925319696, mRNA_PPP1R14C: -0.6279219207826988, mRNA_THSD4: 1.5637830327242754, mRNA_SPAG5: -0.3529762531953944, mRNA_FBP1: 0.7490602569329399, mRNA_SLC7A8: 0.4236658554110038, mRNA_EN1: -0.81221114808637, mRNA_ZNF552: 1.173023922175812, Methylation_LRRC6: 0.1956352458486029, Methylation_chr2 66218712 LINC02934 (29533): 0.7031963825558739, Methylation_HOXB13: -1.0346522054173752, Methylation_chr10 3949206 LINC02660 (4871): -0.3407320774541782, Methylation_chr5 179517140 RNF130 (18026): 0.8430969141572496, Methylation_LOC727677: 0.2591821269961069, Methylation_LETM1: -0.4691798980143424, Methylation_CDC42BPB: -0.7822910964109578, Methylation_C8orf38: 0.3094175261173931, Methylation_chr14 100504766 EVL (18852): -0.4320546205261905, Methylation_chr5 72594851 LOC340090 (24088): 0.5420144235133364, Methylation_chr2 242904738 LINC01238 (3421): -0.6525847074675112, Methylation_ARFGEF1: -0.1777181935420719, Methylation_MAPT: -0.1098814751652588, Methylation_ZFAT: -0.0948013692483289, Methylation_KCNQ4: -1.0501646033279828, Methylation_chr1 232684368 SIPA1L2 (12934): -0.3301296399340732, Methylation_CRNKL1: 0.0595159697051099, Methylation_PRKAG2: 0.2223799827228712, Methylation_MICB: -0.5033186621456647, miRNA_hsa-mir-934: -0.0620251167153062, miRNA_hsa-mir-4728: -0.8466176765704189, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.3418268264442212, miRNA_hsa-mir-190b: 0.8936558612422182, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: 0.4468434877937373, miRNA_hsa-mir-17: -1.3742018818593371, miRNA_hsa-mir-130b: -1.139596577193871, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A7-A13D,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. Promoter hypermethylation of LRRC6, LINC02660, LOC727677, MAPT, ZFAT, SIPA1L2, and EVL mediates epigenetic silencing. Hypomethylation of RNF130 suggests derepression. miR-934 and miR-135b are upregulated; miR-190b is downregulated. These features indicate a basal-like phenotype with ER-pathway suppression.","mRNA_MLPH: -2.1348534242142105, mRNA_C2orf54: 0.8006965483659266, mRNA_CITED4: -0.420139022969145, mRNA_ESR1: -1.738945832217606, mRNA_SPDEF: -3.189878588296232, mRNA_AGR3: -1.710109587386102, mRNA_FOXC1: 1.4152680156616106, mRNA_GATA3: -2.149374343695117, mRNA_AGR2: -1.8306358538846657, mRNA_XBP1: -2.0030187544026004, mRNA_PRR15: -2.158969885161888, mRNA_SLC44A4: -2.1906057130866667, mRNA_CA12: -1.2086680940867949, mRNA_DTL: -0.6890940252119528, mRNA_C5AR2: -1.7300327710100574, mRNA_TBC1D9: -1.4091393013122806, mRNA_AR: -2.080649719156396, mRNA_CCDC170: -1.714432297551553, mRNA_DEGS2: -2.25365561112878, mRNA_TFF3: -1.8989677264902072, mRNA_DNALI1: -1.7360474633952656, mRNA_LINC00504: -1.58721187112663, mRNA_CLCA2: -0.8400136783859773, mRNA_PPP1R14C: 1.653791656304355, mRNA_THSD4: -1.4732486467485146, mRNA_SPAG5: 0.4285629887608477, mRNA_FBP1: -2.698433583962544, mRNA_SLC7A8: -2.8668122570577257, mRNA_EN1: -0.1417012175317456, mRNA_ZNF552: -1.1889358513237778, Methylation_LRRC6: 1.512300987463434, Methylation_chr2 66218712 LINC02934 (29533): -0.1876254820264309, Methylation_HOXB13: 1.1573067810541957, Methylation_chr10 3949206 LINC02660 (4871): 1.5557460937546703, Methylation_chr5 179517140 RNF130 (18026): -1.6271247633418953, Methylation_LOC727677: 1.515544448814713, Methylation_LETM1: 1.3434054350699236, Methylation_CDC42BPB: 0.8851380868812945, Methylation_C8orf38: 1.3944277350455552, Methylation_chr14 100504766 EVL (18852): 1.372897420723385, Methylation_chr5 72594851 LOC340090 (24088): -1.2960303590760067, Methylation_chr2 242904738 LINC01238 (3421): 1.3882610385838725, Methylation_ARFGEF1: 0.6645172400234536, Methylation_MAPT: 1.4022039682476286, Methylation_ZFAT: 1.3858939216617578, Methylation_KCNQ4: 0.6894865143347187, Methylation_chr1 232684368 SIPA1L2 (12934): 1.4538331071982626, Methylation_CRNKL1: 1.175521108491411, Methylation_PRKAG2: -1.0917267602215512, Methylation_MICB: 1.3129366499883437, miRNA_hsa-mir-934: 2.985700803552446, miRNA_hsa-mir-4728: 0.8830643078677691, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.2468071082750192, miRNA_hsa-mir-190b: -1.7884573099367842, miRNA_hsa-mir-577: 1.6043289070202995, miRNA_hsa-mir-135b: 1.9621670890096847, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.940815009872396, miRNA_hsa-mir-130b: 0.5889955531655264, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-AR-A5QP,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.5235225640411554, mRNA_C2orf54: 0.0463020572168498, mRNA_CITED4: 1.0066094046625618, mRNA_ESR1: 0.5913491546779436, mRNA_SPDEF: 0.5239074004912933, mRNA_AGR3: 0.640190151025708, mRNA_FOXC1: 0.8263981608238135, mRNA_GATA3: 0.296046621458204, mRNA_AGR2: 0.6247386166843505, mRNA_XBP1: -0.0548934324383924, mRNA_PRR15: 0.1435440699664585, mRNA_SLC44A4: 0.1851421921811152, mRNA_CA12: 0.8377827834493489, mRNA_DTL: 0.1867033694908577, mRNA_C5AR2: 0.584959835556353, mRNA_TBC1D9: 0.7532889590346507, mRNA_AR: 0.0703916716710954, mRNA_CCDC170: 0.6809826574738315, mRNA_DEGS2: 0.7199758669563615, mRNA_TFF3: 0.4448010170713623, mRNA_DNALI1: 0.5732607740645043, mRNA_LINC00504: 0.5434633829285958, mRNA_CLCA2: 0.0362023758875024, mRNA_PPP1R14C: 0.0026678967088603, mRNA_THSD4: 0.4228296925173448, mRNA_SPAG5: -0.2786986133142624, mRNA_FBP1: 0.5400515239400907, mRNA_SLC7A8: -0.0587405542083208, mRNA_EN1: -0.1438431032114292, mRNA_ZNF552: 0.4162121486983552, Methylation_LRRC6: 0.3050017690474759, Methylation_chr2 66218712 LINC02934 (29533): 0.8749309449532527, Methylation_HOXB13: -0.169228261963247, Methylation_chr10 3949206 LINC02660 (4871): -0.012355168719442, Methylation_chr5 179517140 RNF130 (18026): 0.2418518593502982, Methylation_LOC727677: -0.2437152266866017, Methylation_LETM1: 0.057991216623079, Methylation_CDC42BPB: 0.9956692759625956, Methylation_C8orf38: -0.1403331227290687, Methylation_chr14 100504766 EVL (18852): 0.2603300496267626, Methylation_chr5 72594851 LOC340090 (24088): 0.2519877441533764, Methylation_chr2 242904738 LINC01238 (3421): -0.3583093198551522, Methylation_ARFGEF1: 0.646135524199221, Methylation_MAPT: -0.0598882723998836, Methylation_ZFAT: 1.3900558093806987, Methylation_KCNQ4: -0.583916086167194, Methylation_chr1 232684368 SIPA1L2 (12934): 0.4737728362105994, Methylation_CRNKL1: 0.7278698217772828, Methylation_PRKAG2: 1.191072798920876, Methylation_MICB: 0.8189496864441252, miRNA_hsa-mir-934: 0.5531700951591121, miRNA_hsa-mir-4728: -0.1212147380570254, miRNA_hsa-mir-5695: 0.8428644683656665, miRNA_hsa-mir-18a: -0.7137276952921496, miRNA_hsa-mir-190b: 0.1746111601815439, miRNA_hsa-mir-577: -0.2600288981219426, miRNA_hsa-mir-135b: 0.2563481221200296, miRNA_hsa-mir-2115: -0.3802913445505104, miRNA_hsa-mir-17: 0.1559467515549927, miRNA_hsa-mir-130b: -1.2577140040071206, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A0HX,"TBC1D9 mRNA overexpression (Z=1.48) meets high-expression threshold. No methylation sites cross hyper/hypo-methylation cutoffs. miRNA hsa-mir-17 is downregulated (Z=-1.29). All CNVs fall within normal/gain range, none meet amplification/deletion thresholds. Insufficient evidence for subtype classification.","mRNA_MLPH: 0.3782953669921387, mRNA_C2orf54: -1.053887197057625, mRNA_CITED4: 0.0486858384756275, mRNA_ESR1: 0.5032017871440925, mRNA_SPDEF: 0.2707121224612865, mRNA_AGR3: 0.5927649963127786, mRNA_FOXC1: -0.0247233009143017, mRNA_GATA3: 0.5509084818679453, mRNA_AGR2: 0.8681953641196856, mRNA_XBP1: 0.7840288858212578, mRNA_PRR15: 1.1385349293675804, mRNA_SLC44A4: -0.0323348103727821, mRNA_CA12: 0.2580691923704197, mRNA_DTL: 0.2189354726308293, mRNA_C5AR2: -0.5709774499478787, mRNA_TBC1D9: 1.4824929961205426, mRNA_AR: 0.4372712312959769, mRNA_CCDC170: -0.0729758474572451, mRNA_DEGS2: -0.432658820893915, mRNA_TFF3: 0.5217775864252719, mRNA_DNALI1: 0.8950715779890721, mRNA_LINC00504: 0.934236728809028, mRNA_CLCA2: 0.3447356193735902, mRNA_PPP1R14C: 0.0280758989113903, mRNA_THSD4: 0.7903403873094871, mRNA_SPAG5: 1.0367640778809126, mRNA_FBP1: 0.7342111585785547, mRNA_SLC7A8: -0.1927263449948907, mRNA_EN1: -0.2424672057554098, mRNA_ZNF552: 0.2928519646138766, Methylation_LRRC6: -0.503189346353582, Methylation_chr2 66218712 LINC02934 (29533): -1.2216130734751327, Methylation_HOXB13: 1.447432630809974, Methylation_chr10 3949206 LINC02660 (4871): -0.806314438286308, Methylation_chr5 179517140 RNF130 (18026): 1.027071789476214, Methylation_LOC727677: -1.1770478843037118, Methylation_LETM1: -1.0950181643619192, Methylation_CDC42BPB: 1.2542369912702418, Methylation_C8orf38: 0.1860455806624371, Methylation_chr14 100504766 EVL (18852): -0.3305370965678165, Methylation_chr5 72594851 LOC340090 (24088): 1.287353418006686, Methylation_chr2 242904738 LINC01238 (3421): 1.3767905885979288, Methylation_ARFGEF1: -1.1402040633458237, Methylation_MAPT: -0.2564176497501934, Methylation_ZFAT: -0.294635262925897, Methylation_KCNQ4: -1.1097268434936338, Methylation_chr1 232684368 SIPA1L2 (12934): -0.7131955024492015, Methylation_CRNKL1: -0.8469853747448096, Methylation_PRKAG2: 0.5955056292557803, Methylation_MICB: -0.7844900398755973, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.8211440626672596, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.6877674542917699, miRNA_hsa-mir-190b: -0.3105680234965369, miRNA_hsa-mir-577: -0.0730642094686126, miRNA_hsa-mir-135b: -0.9748863471781132, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.2850397504659248, miRNA_hsa-mir-130b: -0.5362945107299908, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-A2-A0T4,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.5501263867117311, mRNA_C2orf54: -0.9398334719819562, mRNA_CITED4: -0.6617857002583422, mRNA_ESR1: 0.8286442612794358, mRNA_SPDEF: 0.1641201199288742, mRNA_AGR3: 0.7564607540060463, mRNA_FOXC1: -0.1814039682201659, mRNA_GATA3: 0.5767885117465967, mRNA_AGR2: 0.3571923758414546, mRNA_XBP1: 0.4842626208115995, mRNA_PRR15: 0.4662765894561527, mRNA_SLC44A4: 0.1668630666284717, mRNA_CA12: 0.6529960760867226, mRNA_DTL: 0.7062702010920134, mRNA_C5AR2: 0.0755421591660026, mRNA_TBC1D9: 0.5271428522523893, mRNA_AR: 0.5472266804453546, mRNA_CCDC170: 0.4995199437830571, mRNA_DEGS2: 0.812406834146361, mRNA_TFF3: 0.5175831178854938, mRNA_DNALI1: 0.3003151113266936, mRNA_LINC00504: 0.7129116609937732, mRNA_CLCA2: 1.5785313120936828, mRNA_PPP1R14C: -0.5111180414641809, mRNA_THSD4: 0.4571493661525418, mRNA_SPAG5: 0.681503900878761, mRNA_FBP1: 0.9412105292826995, mRNA_SLC7A8: 0.5111794225699713, mRNA_EN1: 0.125973472024717, mRNA_ZNF552: 0.2955962246179353, Methylation_LRRC6: 0.3524283024430442, Methylation_chr2 66218712 LINC02934 (29533): 1.0426482652976383, Methylation_HOXB13: 0.6048187946019649, Methylation_chr10 3949206 LINC02660 (4871): -0.2338949571104695, Methylation_chr5 179517140 RNF130 (18026): 0.4842151463825379, Methylation_LOC727677: 0.1274519428550782, Methylation_LETM1: 0.1321155155776769, Methylation_CDC42BPB: 1.2158489608959098, Methylation_C8orf38: 1.142960226328168, Methylation_chr14 100504766 EVL (18852): 0.1258652625430425, Methylation_chr5 72594851 LOC340090 (24088): 0.6946987424564316, Methylation_chr2 242904738 LINC01238 (3421): -0.141587071803529, Methylation_ARFGEF1: 0.1662574071928814, Methylation_MAPT: 0.2076579125694482, Methylation_ZFAT: 0.0162008647669301, Methylation_KCNQ4: 0.1934650211167612, Methylation_chr1 232684368 SIPA1L2 (12934): -0.0259696978992354, Methylation_CRNKL1: -0.2264449852201884, Methylation_PRKAG2: 1.1365386719427018, Methylation_MICB: -0.0443443402207807, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.7007975718872665, miRNA_hsa-mir-5695: 1.8723070291387425, miRNA_hsa-mir-18a: -0.5780537016278879, miRNA_hsa-mir-190b: -0.0514407635601402, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.6776507438456497, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.577283603211538, miRNA_hsa-mir-130b: -0.2236939704551516, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-Z7-A8R6,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.4523389753307537, mRNA_C2orf54: -0.0206354522685182, mRNA_CITED4: 0.1018225819819117, mRNA_ESR1: 0.2824362432512768, mRNA_SPDEF: 0.4060335690733413, mRNA_AGR3: 0.6928263414009522, mRNA_FOXC1: -1.0325194089648944, mRNA_GATA3: 0.7410624687650024, mRNA_AGR2: 0.5302615551326363, mRNA_XBP1: 0.7383933030964194, mRNA_PRR15: 0.3113865728055885, mRNA_SLC44A4: 0.6217306737961449, mRNA_CA12: 0.5493132775023815, mRNA_DTL: 1.0082565761118, mRNA_C5AR2: 0.6018739198684024, mRNA_TBC1D9: 0.1385042967295291, mRNA_AR: 0.2804766931813658, mRNA_CCDC170: 0.2842820404714197, mRNA_DEGS2: 0.7662416452135634, mRNA_TFF3: 0.2624202536327278, mRNA_DNALI1: 0.8730701466587163, mRNA_LINC00504: 0.0549314310522657, mRNA_CLCA2: -0.145194296984763, mRNA_PPP1R14C: -0.5463806939563933, mRNA_THSD4: -0.3285769991979372, mRNA_SPAG5: 1.314908495669625, mRNA_FBP1: 0.9171390017000138, mRNA_SLC7A8: 0.4456543430588019, mRNA_EN1: -0.7297236985569162, mRNA_ZNF552: 0.3681103625352626, Methylation_LRRC6: -1.0109991771446982, Methylation_chr2 66218712 LINC02934 (29533): -0.3323602866355561, Methylation_HOXB13: -0.7300743022032978, Methylation_chr10 3949206 LINC02660 (4871): -1.231595627104517, Methylation_chr5 179517140 RNF130 (18026): 1.0201566469830683, Methylation_LOC727677: -1.282534943252658, Methylation_LETM1: -1.4161818139905116, Methylation_CDC42BPB: 1.435437476339755, Methylation_C8orf38: -1.4478291111648462, Methylation_chr14 100504766 EVL (18852): -1.5956796328949223, Methylation_chr5 72594851 LOC340090 (24088): -1.626980042219354, Methylation_chr2 242904738 LINC01238 (3421): -1.017723873960594, Methylation_ARFGEF1: -1.308478793173016, Methylation_MAPT: -1.5397265244901603, Methylation_ZFAT: -1.678667206452832, Methylation_KCNQ4: -1.201632121231372, Methylation_chr1 232684368 SIPA1L2 (12934): -0.9569597014462904, Methylation_CRNKL1: -1.568961043187335, Methylation_PRKAG2: -0.990657401733249, Methylation_MICB: -1.095774317368248, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.4382258937769146, miRNA_hsa-mir-5695: 1.0997810834347792, miRNA_hsa-mir-18a: 0.806761385780438, miRNA_hsa-mir-190b: 0.7816229019981519, miRNA_hsa-mir-577: -0.5781665983944735, miRNA_hsa-mir-135b: -0.4103561588416231, miRNA_hsa-mir-2115: 0.2697301837242025, miRNA_hsa-mir-17: 1.3213490709722002, miRNA_hsa-mir-130b: 0.8544421363183247, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A8-A0AD,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.65759550506188, mRNA_C2orf54: -0.7561014803687854, mRNA_CITED4: 0.7806789407622667, mRNA_ESR1: 1.0393577137376309, mRNA_SPDEF: 0.6240022738877035, mRNA_AGR3: 0.8555751240802231, mRNA_FOXC1: -1.1159814654510012, mRNA_GATA3: 0.0288006348341101, mRNA_AGR2: 0.3244369517954792, mRNA_XBP1: 0.6037111295784681, mRNA_PRR15: 0.5588295105082602, mRNA_SLC44A4: 0.104617358342647, mRNA_CA12: 0.7808806552072861, mRNA_DTL: -0.050635226741088, mRNA_C5AR2: 0.8606361379388278, mRNA_TBC1D9: 0.9054059927184998, mRNA_AR: 0.8369603463726185, mRNA_CCDC170: 0.7023049949887766, mRNA_DEGS2: 0.7212855472479257, mRNA_TFF3: 0.4552185594086717, mRNA_DNALI1: 0.4816846474301405, mRNA_LINC00504: 1.7834568359631793, mRNA_CLCA2: -0.8043008822624139, mRNA_PPP1R14C: -0.9265414139910948, mRNA_THSD4: 1.0027680723184953, mRNA_SPAG5: -0.577034051185463, mRNA_FBP1: 0.373423293600707, mRNA_SLC7A8: 1.048681742006886, mRNA_EN1: -0.122885938717768, mRNA_ZNF552: 0.8234539403823361, Methylation_LRRC6: -0.6879722503069452, Methylation_chr2 66218712 LINC02934 (29533): -1.000723161895517, Methylation_HOXB13: -0.8953434028613868, Methylation_chr10 3949206 LINC02660 (4871): -0.6515168581809122, Methylation_chr5 179517140 RNF130 (18026): 1.1166650862525582, Methylation_LOC727677: -0.8734546481014465, Methylation_LETM1: -0.9731912174641586, Methylation_CDC42BPB: -1.3116929848204597, Methylation_C8orf38: -1.178263324130942, Methylation_chr14 100504766 EVL (18852): -0.9129614646345954, Methylation_chr5 72594851 LOC340090 (24088): -0.1006995501256827, Methylation_chr2 242904738 LINC01238 (3421): -0.9633788993355372, Methylation_ARFGEF1: -0.6299227883925689, Methylation_MAPT: -1.3946978099029068, Methylation_ZFAT: -0.5240345663952901, Methylation_KCNQ4: -1.1785107899152552, Methylation_chr1 232684368 SIPA1L2 (12934): -0.4582308255846617, Methylation_CRNKL1: -0.8841321910982048, Methylation_PRKAG2: 0.6785208388623736, Methylation_MICB: -0.7543847406279409, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.1340416865062449, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.7947474798390384, miRNA_hsa-mir-190b: 0.5692223057484688, miRNA_hsa-mir-577: 0.5738546650101131, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.538895641212343, miRNA_hsa-mir-130b: 0.4789146627731966, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A2-A1FX,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-significant ranges per specified Z-score and CNV cutoffs.","mRNA_MLPH: 0.6094787034503107, mRNA_C2orf54: -1.140371777042115, mRNA_CITED4: 0.2280783301764522, mRNA_ESR1: 0.8090635459754048, mRNA_SPDEF: 0.4471406366921468, mRNA_AGR3: 0.7619817928281355, mRNA_FOXC1: -0.1595184877596781, mRNA_GATA3: 0.7463956212249201, mRNA_AGR2: -0.0875517114386391, mRNA_XBP1: 0.3377657913327795, mRNA_PRR15: 0.0860820463199892, mRNA_SLC44A4: 0.0605590346359454, mRNA_CA12: 0.4467052628405585, mRNA_DTL: 1.548788626581405, mRNA_C5AR2: 0.5379951115431916, mRNA_TBC1D9: 1.2065414742941143, mRNA_AR: 0.5188357662104053, mRNA_CCDC170: 0.0025844106084928, mRNA_DEGS2: 1.1412231682629377, mRNA_TFF3: 0.1162259575230541, mRNA_DNALI1: 0.6377815815637702, mRNA_LINC00504: 0.6501323415593461, mRNA_CLCA2: -0.7254153114592062, mRNA_PPP1R14C: -0.7658368769080215, mRNA_THSD4: 1.2801374877758809, mRNA_SPAG5: 1.3457225287734205, mRNA_FBP1: 0.4057196737178485, mRNA_SLC7A8: 0.4727557136153185, mRNA_EN1: -0.6996169954395296, mRNA_ZNF552: 0.9461246586857964, Methylation_LRRC6: -1.0759338443905784, Methylation_chr2 66218712 LINC02934 (29533): -1.214150904576312, Methylation_HOXB13: 0.9805819713608318, Methylation_chr10 3949206 LINC02660 (4871): -0.6726026799905704, Methylation_chr5 179517140 RNF130 (18026): 0.8922280704738138, Methylation_LOC727677: -1.1189563000234335, Methylation_LETM1: -1.1849316588596028, Methylation_CDC42BPB: 1.33848440524714, Methylation_C8orf38: -0.3804574300223209, Methylation_chr14 100504766 EVL (18852): -1.175748583372547, Methylation_chr5 72594851 LOC340090 (24088): 0.0737425677329566, Methylation_chr2 242904738 LINC01238 (3421): -0.8275738674718963, Methylation_ARFGEF1: -1.0841716895501836, Methylation_MAPT: -1.173449037707695, Methylation_ZFAT: -1.4179432755466872, Methylation_KCNQ4: 1.1618679256088182, Methylation_chr1 232684368 SIPA1L2 (12934): -0.7660550721921644, Methylation_CRNKL1: -1.236560133840227, Methylation_PRKAG2: 1.1092378129646547, Methylation_MICB: -1.0978631377026555, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.2984392527366907, miRNA_hsa-mir-5695: 0.8537583424148691, miRNA_hsa-mir-18a: -0.3088678870648519, miRNA_hsa-mir-190b: 0.7518660724595191, miRNA_hsa-mir-577: -0.5394129672260418, miRNA_hsa-mir-135b: -0.3004999822338909, miRNA_hsa-mir-2115: -0.0153801200371275, miRNA_hsa-mir-17: -0.4273636292464123, miRNA_hsa-mir-130b: 0.0627492566341917, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A2LO,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.58038397781902, mRNA_C2orf54: -0.1319503836753202, mRNA_CITED4: 0.9320509160723331, mRNA_ESR1: 0.1134196364839096, mRNA_SPDEF: 0.0884321772699775, mRNA_AGR3: 0.4041094032365862, mRNA_FOXC1: 0.6548276586466857, mRNA_GATA3: 0.3760412922354182, mRNA_AGR2: 0.5014229636650599, mRNA_XBP1: -0.2015550903696692, mRNA_PRR15: -0.0538374553931889, mRNA_SLC44A4: -0.1627543723907229, mRNA_CA12: 0.7343384392530874, mRNA_DTL: 1.1295213059988574, mRNA_C5AR2: 0.4481459175039657, mRNA_TBC1D9: 0.4368358006431748, mRNA_AR: 0.4045729135890554, mRNA_CCDC170: 0.2468903683976537, mRNA_DEGS2: 0.8062939961253464, mRNA_TFF3: 0.0642214433542169, mRNA_DNALI1: 0.2777429030800379, mRNA_LINC00504: -0.0505948769250832, mRNA_CLCA2: 0.1030145090390558, mRNA_PPP1R14C: 0.5548936416890985, mRNA_THSD4: 1.1267278717101383, mRNA_SPAG5: 0.2813934310857762, mRNA_FBP1: 0.1185364044521636, mRNA_SLC7A8: 0.3092421606084647, mRNA_EN1: -0.3990350537232179, mRNA_ZNF552: 0.7004236369709748, Methylation_LRRC6: 0.5795326286042352, Methylation_chr2 66218712 LINC02934 (29533): 0.1526732189382765, Methylation_HOXB13: -1.0596569293623948, Methylation_chr10 3949206 LINC02660 (4871): 0.4428855913945672, Methylation_chr5 179517140 RNF130 (18026): -0.5352537780639629, Methylation_LOC727677: -0.0485297075403337, Methylation_LETM1: 0.6814925695615552, Methylation_CDC42BPB: 0.845608947154668, Methylation_C8orf38: 0.4177867157970441, Methylation_chr14 100504766 EVL (18852): 0.5702059021114578, Methylation_chr5 72594851 LOC340090 (24088): 0.0019864843431628, Methylation_chr2 242904738 LINC01238 (3421): 0.1090120253512199, Methylation_ARFGEF1: 1.0302750745946203, Methylation_MAPT: 0.56823339767441, Methylation_ZFAT: -0.1829923537527052, Methylation_KCNQ4: -0.6952049365586366, Methylation_chr1 232684368 SIPA1L2 (12934): 0.9255120538859388, Methylation_CRNKL1: 0.4468055724338367, Methylation_PRKAG2: -0.3522476910199995, Methylation_MICB: 0.920090629282806, miRNA_hsa-mir-934: -0.0174425404448563, miRNA_hsa-mir-4728: -0.7502304500906775, miRNA_hsa-mir-5695: -0.5422583838148997, miRNA_hsa-mir-18a: -0.636854649677145, miRNA_hsa-mir-190b: -0.5191123997883793, miRNA_hsa-mir-577: -0.6083167396645144, miRNA_hsa-mir-135b: -0.0148451493532162, miRNA_hsa-mir-2115: -0.4297665974363376, miRNA_hsa-mir-17: 0.3190781798344911, miRNA_hsa-mir-130b: -1.3389248557754931, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A7-A26I,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA dysregulation. Promoter hypermethylation of ARFGEF1, MAPT, ZFAT, SIPA1L2, C8orf38, LINC02660, and LOC727677 mediates epigenetic silencing. Hypomethylation of RNF130 and PRKAG2 correlates with transcriptional activation. miRNA hsa-mir-18a and hsa-mir-130b are upregulated. These features indicate a luminal B-like phenotype with ER signaling suppression.","mRNA_MLPH: -2.447609963897833, mRNA_C2orf54: -0.6034767125185937, mRNA_CITED4: -2.1827252996311755, mRNA_ESR1: -1.7643986896793693, mRNA_SPDEF: -3.230823055873472, mRNA_AGR3: -2.0540401173817804, mRNA_FOXC1: 0.913081607826208, mRNA_GATA3: -1.8589784267021825, mRNA_AGR2: -2.249065671712206, mRNA_XBP1: -3.2105239320851355, mRNA_PRR15: -2.055013916579814, mRNA_SLC44A4: -2.411070361758454, mRNA_CA12: -2.1579826549743952, mRNA_DTL: -0.9188384165757212, mRNA_C5AR2: -1.7083345020457867, mRNA_TBC1D9: -1.8239182873464008, mRNA_AR: -1.4872748159927525, mRNA_CCDC170: -1.60379267006821, mRNA_DEGS2: -2.351416567060049, mRNA_TFF3: -2.203019807161993, mRNA_DNALI1: -1.4186326429147815, mRNA_LINC00504: -1.6365899678113605, mRNA_CLCA2: 0.1619524279516623, mRNA_PPP1R14C: 1.0338293218003212, mRNA_THSD4: -2.1042060513304897, mRNA_SPAG5: -0.3859726076182133, mRNA_FBP1: -2.738915152527291, mRNA_SLC7A8: -2.5761860647258605, mRNA_EN1: -0.9226210874473147, mRNA_ZNF552: -1.4997613006541106, Methylation_LRRC6: 1.4599697720443945, Methylation_chr2 66218712 LINC02934 (29533): -1.2919492612068542, Methylation_HOXB13: 0.6455329328845205, Methylation_chr10 3949206 LINC02660 (4871): 1.6158875231962353, Methylation_chr5 179517140 RNF130 (18026): -1.6513892929894662, Methylation_LOC727677: 1.5149038206894532, Methylation_LETM1: 1.3379658013315054, Methylation_CDC42BPB: 0.2306327184253812, Methylation_C8orf38: 1.6372613614601044, Methylation_chr14 100504766 EVL (18852): 1.497144431190765, Methylation_chr5 72594851 LOC340090 (24088): -1.4592571197425492, Methylation_chr2 242904738 LINC01238 (3421): 1.4389000063285962, Methylation_ARFGEF1: 1.7630403467586346, Methylation_MAPT: 1.4108420015883425, Methylation_ZFAT: 1.4209085249264368, Methylation_KCNQ4: 1.1311030774636237, Methylation_chr1 232684368 SIPA1L2 (12934): 1.636622865110943, Methylation_CRNKL1: 1.4142790940445975, Methylation_PRKAG2: -1.5614250075414875, Methylation_MICB: 1.4920361526692487, miRNA_hsa-mir-934: 1.3941161224406284, miRNA_hsa-mir-4728: 0.5727970039003023, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.5155651213410428, miRNA_hsa-mir-190b: -0.7368358703927703, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: 0.1104251138672016, miRNA_hsa-mir-2115: -0.2507053411475346, miRNA_hsa-mir-17: 0.3559113344818891, miRNA_hsa-mir-130b: 1.6023029688320043, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-E2-A1AZ,"FOXC1 and EN1 mRNA overexpression (Z > 1.30) align with no CNV amplification, suggesting transcriptional activation. SPDEF, ESR1, AGR3, GATA3, XBP1, TFF3, and CA12 show low mRNA (Z < -1.92). Promoter hypermethylation (Z > 1.50) at ARFGEF1, C8orf38, LINC02660, and SIPA1L2 may silence associated genes. Hypomethylation (Z < -1.47) at RNF130 and LOC340090. miR-17 upregulated (Z = 1.98); miR-190b downregulated (Z < -1.25). All CNVs fall within normal range (−1.10 to −0.10), indicating no copy-number-driven expression changes.","mRNA_MLPH: -2.296519224533369, mRNA_C2orf54: -1.2275821367200257, mRNA_CITED4: -0.7856848283993796, mRNA_ESR1: -1.5002781853414224, mRNA_SPDEF: -2.324285095879805, mRNA_AGR3: -1.5764469586754597, mRNA_FOXC1: 2.129861977724431, mRNA_GATA3: -1.5404333994852764, mRNA_AGR2: -1.7024305103045072, mRNA_XBP1: -2.050601328407552, mRNA_PRR15: -1.6596660991536325, mRNA_SLC44A4: -1.912823910555708, mRNA_CA12: -2.2292169757202696, mRNA_DTL: 0.9127089944528028, mRNA_C5AR2: -1.7964601407733054, mRNA_TBC1D9: -1.1229146220811277, mRNA_AR: -0.7027279075826902, mRNA_CCDC170: -1.089019105479649, mRNA_DEGS2: -1.718368878849498, mRNA_TFF3: -2.1195682161648657, mRNA_DNALI1: -1.6019612185593568, mRNA_LINC00504: -1.5399638855447275, mRNA_CLCA2: 0.0003664169103478, mRNA_PPP1R14C: 1.1464754759480318, mRNA_THSD4: -1.4454242697988475, mRNA_SPAG5: 1.34261997066315, mRNA_FBP1: -1.7731037555615607, mRNA_SLC7A8: -1.179394381868962, mRNA_EN1: 2.294899834968641, mRNA_ZNF552: -1.4886772127144825, Methylation_LRRC6: 1.43946512711025, Methylation_chr2 66218712 LINC02934 (29533): -0.0576722586288703, Methylation_HOXB13: 0.7138796393375654, Methylation_chr10 3949206 LINC02660 (4871): 1.6447409576812375, Methylation_chr5 179517140 RNF130 (18026): -1.6115637535091882, Methylation_LOC727677: 1.5252709641392883, Methylation_LETM1: 1.3403356940393214, Methylation_CDC42BPB: 0.5259951299374036, Methylation_C8orf38: 1.6720793336692763, Methylation_chr14 100504766 EVL (18852): 1.5291134732255365, Methylation_chr5 72594851 LOC340090 (24088): -1.4912482458694598, Methylation_chr2 242904738 LINC01238 (3421): 1.394060548805671, Methylation_ARFGEF1: 1.7689785225558934, Methylation_MAPT: 1.474248213570768, Methylation_ZFAT: 1.4465112274136758, Methylation_KCNQ4: 0.9381437814768728, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5656095171231197, Methylation_CRNKL1: 1.3981463411301396, Methylation_PRKAG2: -1.0190766017129296, Methylation_MICB: 1.3836943031039404, miRNA_hsa-mir-934: 1.552248225380964, miRNA_hsa-mir-4728: 0.1236241791812523, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.7264204860137624, miRNA_hsa-mir-190b: -1.6543758846938377, miRNA_hsa-mir-577: 1.2600285621909686, miRNA_hsa-mir-135b: 0.8997670401654132, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.980091075616736, miRNA_hsa-mir-130b: 1.3316216037268662, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-C8-A26V,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.5680708993720884, mRNA_C2orf54: 0.85531663684004, mRNA_CITED4: 0.310122620612056, mRNA_ESR1: 0.6093560557681902, mRNA_SPDEF: 0.3364193927194102, mRNA_AGR3: 0.8074251435358262, mRNA_FOXC1: -1.0784161696832444, mRNA_GATA3: 0.8751267621592302, mRNA_AGR2: 0.8661194280472292, mRNA_XBP1: 0.636824706177686, mRNA_PRR15: 0.0302595503670186, mRNA_SLC44A4: 0.8996116173568077, mRNA_CA12: 0.986155248784106, mRNA_DTL: 0.1748411032884365, mRNA_C5AR2: 0.8507243125545565, mRNA_TBC1D9: -0.1408522318206802, mRNA_AR: 0.856093976085016, mRNA_CCDC170: 0.7410588016048885, mRNA_DEGS2: 0.4715729574003197, mRNA_TFF3: -0.0601991206246353, mRNA_DNALI1: 0.1368750559595116, mRNA_LINC00504: 0.5748592785605359, mRNA_CLCA2: 1.0163109658657117, mRNA_PPP1R14C: -0.5657657260580451, mRNA_THSD4: -0.0680046021742424, mRNA_SPAG5: 0.7485972204235789, mRNA_FBP1: 0.340392652455557, mRNA_SLC7A8: 0.8139464971029288, mRNA_EN1: -0.7378183435346045, mRNA_ZNF552: 0.7555111065631965, Methylation_LRRC6: -0.7761498015007026, Methylation_chr2 66218712 LINC02934 (29533): -0.7596474889362044, Methylation_HOXB13: 0.9674163191343176, Methylation_chr10 3949206 LINC02660 (4871): -1.2851943330644473, Methylation_chr5 179517140 RNF130 (18026): 0.99229100329176, Methylation_LOC727677: 1.4353421022664292, Methylation_LETM1: 0.7908033711660258, Methylation_CDC42BPB: 0.7438126403918918, Methylation_C8orf38: -1.028974627939086, Methylation_chr14 100504766 EVL (18852): -0.8658723784432362, Methylation_chr5 72594851 LOC340090 (24088): 0.8946966622863375, Methylation_chr2 242904738 LINC01238 (3421): -1.2315980486763989, Methylation_ARFGEF1: -0.6931147915309579, Methylation_MAPT: -1.1578014061756925, Methylation_ZFAT: 0.7772277751875287, Methylation_KCNQ4: -0.2983956062935474, Methylation_chr1 232684368 SIPA1L2 (12934): -1.0535272570967842, Methylation_CRNKL1: -0.6630670716074525, Methylation_PRKAG2: -0.4887130358881552, Methylation_MICB: 1.2245786747494554, miRNA_hsa-mir-934: -0.3918259276113884, miRNA_hsa-mir-4728: -0.57505235620823, miRNA_hsa-mir-5695: 1.164367736719255, miRNA_hsa-mir-18a: -0.7713164676509144, miRNA_hsa-mir-190b: -0.4670883274176187, miRNA_hsa-mir-577: -0.5707647889143944, miRNA_hsa-mir-135b: 0.517259181576441, miRNA_hsa-mir-2115: 0.7408323842273397, miRNA_hsa-mir-17: -1.329321882781698, miRNA_hsa-mir-130b: 0.2934270096048368, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A8-A0A6,High-level Amplification absent; no CNV alterations meet diagnostic thresholds. TFF3 and CLCA2 mRNA overexpressed (Z > 1.30). HOXB13 promoter hypermethylation (Z = 1.52) suggests epigenetic silencing. miR-17 downregulated (Z = -2.09). These features align with a luminal molecular phenotype and potential ER-pathway activity.,"mRNA_MLPH: 0.4515216369931283, mRNA_C2orf54: -0.9559407434120116, mRNA_CITED4: -0.591609452348112, mRNA_ESR1: 0.0541559134308462, mRNA_SPDEF: 0.2536699510949793, mRNA_AGR3: 0.5850978101722285, mRNA_FOXC1: -0.0907274918380688, mRNA_GATA3: 0.2146251287072708, mRNA_AGR2: 0.8532958010667028, mRNA_XBP1: 0.4999648468701334, mRNA_PRR15: 0.8599580235323989, mRNA_SLC44A4: 0.7089303791266128, mRNA_CA12: 0.0898568127461406, mRNA_DTL: -0.7668552907694535, mRNA_C5AR2: -0.5635625216063046, mRNA_TBC1D9: 0.2208718472757375, mRNA_AR: 0.2521462313237865, mRNA_CCDC170: -0.4045283611251857, mRNA_DEGS2: 0.1361342787804935, mRNA_TFF3: 1.6789958209915468, mRNA_DNALI1: 0.3769076972311444, mRNA_LINC00504: 0.8081822369065834, mRNA_CLCA2: 1.510462619189952, mRNA_PPP1R14C: 0.0060889988946522, mRNA_THSD4: 0.1605072452187993, mRNA_SPAG5: -0.920517681103524, mRNA_FBP1: -0.3202267888618533, mRNA_SLC7A8: -0.2768883970614749, mRNA_EN1: -0.8815258481324817, mRNA_ZNF552: -0.6856736002421073, Methylation_LRRC6: -0.0248262433403483, Methylation_chr2 66218712 LINC02934 (29533): 0.2244891280717075, Methylation_HOXB13: 1.5163471414691012, Methylation_chr10 3949206 LINC02660 (4871): 0.1179962849141521, Methylation_chr5 179517140 RNF130 (18026): 0.7393263615058803, Methylation_LOC727677: -0.1944587793538212, Methylation_LETM1: -0.3893904722804528, Methylation_CDC42BPB: -1.0112056701096317, Methylation_C8orf38: 0.1258169551143516, Methylation_chr14 100504766 EVL (18852): 0.0245494936006341, Methylation_chr5 72594851 LOC340090 (24088): 0.8962495230574701, Methylation_chr2 242904738 LINC01238 (3421): -0.3086177209559211, Methylation_ARFGEF1: -0.1662682775948506, Methylation_MAPT: 0.1928642544686637, Methylation_ZFAT: 0.4955161481155927, Methylation_KCNQ4: -0.1850137938573897, Methylation_chr1 232684368 SIPA1L2 (12934): -0.0009712026774883, Methylation_CRNKL1: -0.2314982725622293, Methylation_PRKAG2: 1.293727177256686, Methylation_MICB: 0.3136724198857487, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.0117473168524776, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.0756509400210568, miRNA_hsa-mir-190b: 0.0314434177177778, miRNA_hsa-mir-577: 1.4387530116520972, miRNA_hsa-mir-135b: 0.9439909036443872, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -2.08776832603526, miRNA_hsa-mir-130b: -0.2665890860743184, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-A7-A425,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-significant ranges per specified Z-score and CNV cutoffs.","mRNA_MLPH: 0.9722121311914698, mRNA_C2orf54: -0.7116686125522633, mRNA_CITED4: 0.794400084326603, mRNA_ESR1: 0.4566029398944047, mRNA_SPDEF: 0.907773187037518, mRNA_AGR3: 0.4986250517486013, mRNA_FOXC1: -0.2004771166777693, mRNA_GATA3: 0.442466195874999, mRNA_AGR2: 0.3430534680156785, mRNA_XBP1: 0.726715978348013, mRNA_PRR15: 0.7389275718552089, mRNA_SLC44A4: 0.8940223570990662, mRNA_CA12: 0.3120537827917098, mRNA_DTL: 0.0502358358067361, mRNA_C5AR2: 1.1663247917844406, mRNA_TBC1D9: 0.0383311533160713, mRNA_AR: -0.1507706815587713, mRNA_CCDC170: 0.8334671040033124, mRNA_DEGS2: 0.8964376382492585, mRNA_TFF3: 0.58429964205034, mRNA_DNALI1: 0.2384837318076989, mRNA_LINC00504: -0.2876132025814676, mRNA_CLCA2: 0.1093351565412169, mRNA_PPP1R14C: -0.013999952979275, mRNA_THSD4: 0.677809317703113, mRNA_SPAG5: -0.1911462531944245, mRNA_FBP1: 1.5076678987223011, mRNA_SLC7A8: -0.0678298453181342, mRNA_EN1: -0.2496343281096626, mRNA_ZNF552: 0.923137584796941, Methylation_LRRC6: 0.1056255062135209, Methylation_chr2 66218712 LINC02934 (29533): -1.077135999244274, Methylation_HOXB13: -1.0408431734098642, Methylation_chr10 3949206 LINC02660 (4871): -0.0223663520263247, Methylation_chr5 179517140 RNF130 (18026): 0.1896582610735926, Methylation_LOC727677: -0.1739253021509222, Methylation_LETM1: -0.2030171126195174, Methylation_CDC42BPB: 0.4406410799029642, Methylation_C8orf38: 0.0668722801169249, Methylation_chr14 100504766 EVL (18852): 0.1719983897539982, Methylation_chr5 72594851 LOC340090 (24088): 0.7384027783659428, Methylation_chr2 242904738 LINC01238 (3421): -0.455865450229942, Methylation_ARFGEF1: 0.8366260507725757, Methylation_MAPT: 0.0084007029463286, Methylation_ZFAT: -0.1054795269033458, Methylation_KCNQ4: -1.1144193221765066, Methylation_chr1 232684368 SIPA1L2 (12934): -0.5275438571401505, Methylation_CRNKL1: -0.1545401398651476, Methylation_PRKAG2: -0.4935247061926691, Methylation_MICB: 0.140768597482416, miRNA_hsa-mir-934: -0.2048573931376484, miRNA_hsa-mir-4728: -0.2591192138421357, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.0550097102029145, miRNA_hsa-mir-190b: 1.0267337790658988, miRNA_hsa-mir-577: -0.397929890670914, miRNA_hsa-mir-135b: -0.5392005174787987, miRNA_hsa-mir-2115: 0.6773736889936226, miRNA_hsa-mir-17: -0.1874215041956264, miRNA_hsa-mir-130b: -1.4664968272332342, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AO-A0JA,"High mRNA_C2orf54 (Z=2.02) indicates overexpression. miRNA_hsa-mir-5695 upregulated (Z=2.30); miRNA_hsa-mir-4728 and hsa-mir-17 downregulated (Z=-1.28, -1.35). No methylation or CNV alterations meet diagnostic thresholds.","mRNA_MLPH: 0.5188296960577523, mRNA_C2orf54: 2.015139167796033, mRNA_CITED4: -1.1856452087800269, mRNA_ESR1: 0.3232705784680923, mRNA_SPDEF: 0.4703668108793711, mRNA_AGR3: 0.8505640260311313, mRNA_FOXC1: -0.2443995265657685, mRNA_GATA3: 0.29092764921572, mRNA_AGR2: 1.0520698095015248, mRNA_XBP1: -0.0360708744212438, mRNA_PRR15: 0.1393711867699407, mRNA_SLC44A4: 0.7969787740051826, mRNA_CA12: 0.5316073618061845, mRNA_DTL: 0.7974705238508403, mRNA_C5AR2: 0.8063677319106382, mRNA_TBC1D9: 1.0264646696715474, mRNA_AR: 1.1821399461328668, mRNA_CCDC170: 0.2232749062623055, mRNA_DEGS2: 0.3433068616093347, mRNA_TFF3: 0.8730998417689262, mRNA_DNALI1: -0.0708020961236061, mRNA_LINC00504: 1.113017785023079, mRNA_CLCA2: -0.0885304227823275, mRNA_PPP1R14C: -0.4063760340807422, mRNA_THSD4: 0.2729509297350462, mRNA_SPAG5: -0.0170295205896869, mRNA_FBP1: 0.7595314492534139, mRNA_SLC7A8: 0.9576432455055576, mRNA_EN1: -0.3202149417877433, mRNA_ZNF552: 1.1788193569925631, Methylation_LRRC6: -0.0762548866665707, Methylation_chr2 66218712 LINC02934 (29533): -0.8740425623443406, Methylation_HOXB13: 1.3527628372795495, Methylation_chr10 3949206 LINC02660 (4871): -0.92561407077047, Methylation_chr5 179517140 RNF130 (18026): 1.0720423966975, Methylation_LOC727677: -0.3850652971301963, Methylation_LETM1: -1.1818977836678914, Methylation_CDC42BPB: -0.1894549767827232, Methylation_C8orf38: -0.6675738026555511, Methylation_chr14 100504766 EVL (18852): -0.8327518322892216, Methylation_chr5 72594851 LOC340090 (24088): 0.927588833838235, Methylation_chr2 242904738 LINC01238 (3421): -0.651767332704352, Methylation_ARFGEF1: -0.3392114274323717, Methylation_MAPT: 0.8564291553741424, Methylation_ZFAT: -0.1239435605341313, Methylation_KCNQ4: -1.0082865249543027, Methylation_chr1 232684368 SIPA1L2 (12934): -0.4274468850652266, Methylation_CRNKL1: -0.2808942914868123, Methylation_PRKAG2: -0.993524303950626, Methylation_MICB: -0.5745272265019515, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: 2.3035582295774266, miRNA_hsa-mir-18a: -0.5958112851023751, miRNA_hsa-mir-190b: 0.3438182497232234, miRNA_hsa-mir-577: -0.19745736970477, miRNA_hsa-mir-135b: -0.3487544826681594, miRNA_hsa-mir-2115: 0.2837038036151513, miRNA_hsa-mir-17: -1.3542585579965474, miRNA_hsa-mir-130b: -1.073420104824087, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A0HK,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within the defined neutral ranges and are therefore ignored.","mRNA_MLPH: 0.5931868338199152, mRNA_C2orf54: -0.9616494090811434, mRNA_CITED4: -0.0169534072809796, mRNA_ESR1: 0.3603734821380159, mRNA_SPDEF: -0.0140632740185966, mRNA_AGR3: 0.3926967608177084, mRNA_FOXC1: -0.0978350878288112, mRNA_GATA3: 0.5236323896251586, mRNA_AGR2: 1.299922454931998, mRNA_XBP1: -0.5752254469103505, mRNA_PRR15: 0.2494718904070409, mRNA_SLC44A4: 0.768328583839684, mRNA_CA12: 0.5491159677468435, mRNA_DTL: -0.4138830145944701, mRNA_C5AR2: -0.4684508463901026, mRNA_TBC1D9: 0.0135030872000817, mRNA_AR: 0.3707945516215942, mRNA_CCDC170: -0.1216009550565184, mRNA_DEGS2: 0.1261095965180672, mRNA_TFF3: -0.4509613713139517, mRNA_DNALI1: -0.2792903296282549, mRNA_LINC00504: -0.2579133148183785, mRNA_CLCA2: 0.7763651312619232, mRNA_PPP1R14C: 0.1704020544046988, mRNA_THSD4: -0.1248854474462868, mRNA_SPAG5: -1.740555163558957, mRNA_FBP1: 0.5867404900038116, mRNA_SLC7A8: 0.1315806835233171, mRNA_EN1: -0.7420986039991927, mRNA_ZNF552: 0.24942073223027, Methylation_LRRC6: -0.9319889663926136, Methylation_chr2 66218712 LINC02934 (29533): 1.423271904480507, Methylation_HOXB13: 1.7519212300443912, Methylation_chr10 3949206 LINC02660 (4871): 0.4424379953972603, Methylation_chr5 179517140 RNF130 (18026): 1.0686419364227069, Methylation_LOC727677: -1.1145736107079058, Methylation_LETM1: 1.098047211942415, Methylation_CDC42BPB: -1.3094092617314472, Methylation_C8orf38: -0.7117736296223433, Methylation_chr14 100504766 EVL (18852): -0.1250076581483059, Methylation_chr5 72594851 LOC340090 (24088): 1.341298361155145, Methylation_chr2 242904738 LINC01238 (3421): -0.793256982863777, Methylation_ARFGEF1: -0.4366158923886357, Methylation_MAPT: -1.1782309556945612, Methylation_ZFAT: -1.1883757447598402, Methylation_KCNQ4: 1.8284478328071896, Methylation_chr1 232684368 SIPA1L2 (12934): -1.2759363502920336, Methylation_CRNKL1: -1.289828883948863, Methylation_PRKAG2: 1.2970594610909505, Methylation_MICB: -1.199182690826286, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: 0.0501127751926176, miRNA_hsa-mir-18a: -1.97660308837172, miRNA_hsa-mir-190b: -1.2167154947109236, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.0737576900869343, miRNA_hsa-mir-130b: -0.9862955381268655, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A202,"High mRNA_C2orf54 (Z=2.04) indicates overexpression. Methylation_RNF130 (Z=-1.60) is hypo-methylated. No miRNAs meet dysregulation thresholds. All CNVs fall within Gain range (0.38–0.40), indicating low-level gains without amplification or deletion. These features suggest a luminal phenotype with modest genomic instability.","mRNA_MLPH: -0.4977976247907911, mRNA_C2orf54: 2.0413496472404646, mRNA_CITED4: -0.3875255653492591, mRNA_ESR1: 0.2696134978992144, mRNA_SPDEF: 0.2576268900577545, mRNA_AGR3: -0.8897692071957125, mRNA_FOXC1: -0.2976083655181123, mRNA_GATA3: -0.2144962111493676, mRNA_AGR2: 0.1650306158679999, mRNA_XBP1: 0.5357618185769166, mRNA_PRR15: 0.0324111614139465, mRNA_SLC44A4: -0.1513458046936342, mRNA_CA12: 0.737331387800736, mRNA_DTL: 1.4707120573706545, mRNA_C5AR2: -0.0095324103415863, mRNA_TBC1D9: -0.2565668979114134, mRNA_AR: 0.8966038370958912, mRNA_CCDC170: -0.1451636039672962, mRNA_DEGS2: -0.7644897425145314, mRNA_TFF3: -0.773504903639089, mRNA_DNALI1: 0.3954870625106415, mRNA_LINC00504: -0.5562906599975909, mRNA_CLCA2: 0.1870565368612285, mRNA_PPP1R14C: -0.3985126141978843, mRNA_THSD4: -0.0271825387638069, mRNA_SPAG5: 1.0137898336697375, mRNA_FBP1: -0.3036876593658989, mRNA_SLC7A8: -1.5875876648129474, mRNA_EN1: -0.0803234595929174, mRNA_ZNF552: 0.6420263754685613, Methylation_LRRC6: -0.7206782735969408, Methylation_chr2 66218712 LINC02934 (29533): -0.6602515163874352, Methylation_HOXB13: 0.953836597374345, Methylation_chr10 3949206 LINC02660 (4871): 1.4832867291769, Methylation_chr5 179517140 RNF130 (18026): -1.6021703168554788, Methylation_LOC727677: 1.499429389668562, Methylation_LETM1: 1.358746131913566, Methylation_CDC42BPB: 0.2532386834401395, Methylation_C8orf38: -1.1279023760016047, Methylation_chr14 100504766 EVL (18852): 0.2369128764894703, Methylation_chr5 72594851 LOC340090 (24088): 0.9083204231449492, Methylation_chr2 242904738 LINC01238 (3421): 1.4115291584822764, Methylation_ARFGEF1: -0.7864667677893756, Methylation_MAPT: -0.2101053649296475, Methylation_ZFAT: 1.3222832984022437, Methylation_KCNQ4: 0.1678514680289008, Methylation_chr1 232684368 SIPA1L2 (12934): 1.4185947383683994, Methylation_CRNKL1: 1.4619461326713374, Methylation_PRKAG2: -1.0516346339131406, Methylation_MICB: 1.1773696356941936, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 1.8651151918921167, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.9076481790841772, miRNA_hsa-mir-190b: 1.409778558409319, miRNA_hsa-mir-577: 0.563639185237031, miRNA_hsa-mir-135b: -0.1701239055026843, miRNA_hsa-mir-2115: 0.6252374466764972, miRNA_hsa-mir-17: 0.4459725402430821, miRNA_hsa-mir-130b: 0.8308288261199331, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-A2-A25D,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.2255886671629317, mRNA_C2orf54: -0.7038865603664559, mRNA_CITED4: -0.0241592290740453, mRNA_ESR1: -0.4602552139476294, mRNA_SPDEF: 0.3072352864419651, mRNA_AGR3: 0.3246656017202558, mRNA_FOXC1: -0.3236690676700995, mRNA_GATA3: -0.1379748169973142, mRNA_AGR2: 0.0316096069308589, mRNA_XBP1: 0.349754747484168, mRNA_PRR15: 0.4826891126674477, mRNA_SLC44A4: 0.3374191915769452, mRNA_CA12: 0.7017024577808739, mRNA_DTL: -0.0163324877795389, mRNA_C5AR2: 0.1499548052824817, mRNA_TBC1D9: -0.0288139507816204, mRNA_AR: 0.2567817893466969, mRNA_CCDC170: -0.6782015305136853, mRNA_DEGS2: 0.5245210894200295, mRNA_TFF3: -0.3597978555756661, mRNA_DNALI1: -0.0170161814403679, mRNA_LINC00504: -0.5762350488929983, mRNA_CLCA2: -0.5968058900106078, mRNA_PPP1R14C: -0.6027334055052848, mRNA_THSD4: -0.6147984163376774, mRNA_SPAG5: -0.3370466585343428, mRNA_FBP1: 0.8466514232209675, mRNA_SLC7A8: 0.4565190968323264, mRNA_EN1: -1.0401442886959302, mRNA_ZNF552: 1.1051587419736737, Methylation_LRRC6: -0.6874928430703277, Methylation_chr2 66218712 LINC02934 (29533): 1.1230913992112737, Methylation_HOXB13: 0.7519261296119418, Methylation_chr10 3949206 LINC02660 (4871): -0.3342542450591804, Methylation_chr5 179517140 RNF130 (18026): 0.2061013290210237, Methylation_LOC727677: -0.7264110026228218, Methylation_LETM1: 0.2401519264829142, Methylation_CDC42BPB: -0.8823616287182358, Methylation_C8orf38: -0.7480980138530269, Methylation_chr14 100504766 EVL (18852): -0.4182360402389214, Methylation_chr5 72594851 LOC340090 (24088): 0.7121698806970878, Methylation_chr2 242904738 LINC01238 (3421): -0.9721734739501532, Methylation_ARFGEF1: -0.660279958675473, Methylation_MAPT: -0.5210005731868702, Methylation_ZFAT: -1.0938824556630504, Methylation_KCNQ4: 0.8092224758128087, Methylation_chr1 232684368 SIPA1L2 (12934): -0.5702858731708371, Methylation_CRNKL1: 0.1906867142612493, Methylation_PRKAG2: 0.8432703195931318, Methylation_MICB: -0.4614644162628061, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.2558143428898276, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.0375226822024892, miRNA_hsa-mir-190b: -0.7434606358738116, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: 0.900973820981792, miRNA_hsa-mir-2115: 3.8281748493691934, miRNA_hsa-mir-17: -0.2067745730261524, miRNA_hsa-mir-130b: -0.189323703623805, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A0W3,"High-level Amplification of *CCDC170* and *DEGS2* drives mRNA overexpression. *ESR1*, *AR*, *DTL*, *C5AR2*, *THSD4*, and *FBP1* show high mRNA (Z > 1.30). *CRNKL1* and *EVL* promoters are hypermethylated (Z > 1.50), while *LETM1* and *CDC42BPB* are hypomethylated (Z < -1.47). No miRNAs meet dysregulation thresholds. CNVs show amplification (0.90–1.90) in *VPS54*, *WDPCP*, *CEP68*, and *LINC* genes.","mRNA_MLPH: 0.9904580794731652, mRNA_C2orf54: -0.9567834904773728, mRNA_CITED4: 1.139717595694529, mRNA_ESR1: 1.2582051936457823, mRNA_SPDEF: 0.6853114689297028, mRNA_AGR3: 0.7266974804470635, mRNA_FOXC1: -1.1348873516596198, mRNA_GATA3: 0.72674305130304, mRNA_AGR2: 0.5377681011233272, mRNA_XBP1: 1.1196118216394937, mRNA_PRR15: 0.5022937921719871, mRNA_SLC44A4: 0.5734150570491148, mRNA_CA12: 1.208636272524648, mRNA_DTL: 1.461973210297845, mRNA_C5AR2: 1.4496358770272406, mRNA_TBC1D9: 1.143070500061427, mRNA_AR: 1.3887976758794762, mRNA_CCDC170: 1.5685654698043725, mRNA_DEGS2: 1.5571670049220234, mRNA_TFF3: 0.672803482030843, mRNA_DNALI1: 0.7406906364916211, mRNA_LINC00504: 1.1059784742344383, mRNA_CLCA2: -0.5772467540740494, mRNA_PPP1R14C: -0.6585254039992416, mRNA_THSD4: 1.5460460577548267, mRNA_SPAG5: 0.9854430904943096, mRNA_FBP1: 1.2739171141819063, mRNA_SLC7A8: 0.9601543996946744, mRNA_EN1: -0.8684463814851715, mRNA_ZNF552: 1.219493263797342, Methylation_LRRC6: -0.9499154277692524, Methylation_chr2 66218712 LINC02934 (29533): 1.354974900714235, Methylation_HOXB13: -0.7104632910222215, Methylation_chr10 3949206 LINC02660 (4871): -1.1724292007526886, Methylation_chr5 179517140 RNF130 (18026): 1.2328523991591864, Methylation_LOC727677: -1.0933624813734202, Methylation_LETM1: -1.4485238250028722, Methylation_CDC42BPB: -1.4178248706069163, Methylation_C8orf38: -1.0395224442740822, Methylation_chr14 100504766 EVL (18852): -1.512037939610852, Methylation_chr5 72594851 LOC340090 (24088): 1.2990736449472364, Methylation_chr2 242904738 LINC01238 (3421): -1.4041113268565688, Methylation_ARFGEF1: -1.0503208346712811, Methylation_MAPT: -1.1735592417109666, Methylation_ZFAT: -0.7204180431077032, Methylation_KCNQ4: -1.1251669569817049, Methylation_chr1 232684368 SIPA1L2 (12934): -1.3749976441905194, Methylation_CRNKL1: -1.5173069546785607, Methylation_PRKAG2: -0.2394599198471347, Methylation_MICB: -1.17804075531935, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.5511269557376073, miRNA_hsa-mir-5695: 0.8074880851887358, miRNA_hsa-mir-18a: -0.0552083965767089, miRNA_hsa-mir-190b: 0.870496428946389, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.907242200589442, miRNA_hsa-mir-2115: 0.9892883443854502, miRNA_hsa-mir-17: 0.158199570511887, miRNA_hsa-mir-130b: -0.7957733614644474, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-AR-A5QQ,"CLCA2 and PPP1R14C mRNA overexpression (Z > 1.30) align with no CNV amplification, suggesting transcriptional activation. AR, SPDEF, and ZNF552 show low mRNA (Z < -1.92). Promoter hypermethylation (Z > 1.50) at C8orf38 and LOC727677 may silence tumor suppressors. miR-190b is downregulated (Z < -1.25). No significant CNVs meet deletion/amplification thresholds.","mRNA_MLPH: -1.2953491881587218, mRNA_C2orf54: -0.080390967904032, mRNA_CITED4: 0.5524117875138672, mRNA_ESR1: -1.6026002028085318, mRNA_SPDEF: -1.9602757436870264, mRNA_AGR3: -1.2547488767114672, mRNA_FOXC1: 0.7551458298513833, mRNA_GATA3: -1.817397748063761, mRNA_AGR2: -1.2467787492195457, mRNA_XBP1: -1.7229836942405437, mRNA_PRR15: -1.351186761556728, mRNA_SLC44A4: -1.787540971903169, mRNA_CA12: -0.0573102884714488, mRNA_DTL: 0.365204125699112, mRNA_C5AR2: -1.2113476324015866, mRNA_TBC1D9: -1.3842781716032948, mRNA_AR: -2.0789903368568847, mRNA_CCDC170: -1.529573336474345, mRNA_DEGS2: -1.198007777046679, mRNA_TFF3: -1.4006339701036996, mRNA_DNALI1: -1.487633870086849, mRNA_LINC00504: -1.4349389004156483, mRNA_CLCA2: 3.3300465966297885, mRNA_PPP1R14C: 2.36077158182807, mRNA_THSD4: -0.5648397492921282, mRNA_SPAG5: 0.6615074441263402, mRNA_FBP1: -0.3453931548210913, mRNA_SLC7A8: -0.0790743203074476, mRNA_EN1: 0.3691899137447479, mRNA_ZNF552: -2.291027572857701, Methylation_LRRC6: 1.4163562725400702, Methylation_chr2 66218712 LINC02934 (29533): 0.9159321563792254, Methylation_HOXB13: 0.4023699508624409, Methylation_chr10 3949206 LINC02660 (4871): 1.3987745197423973, Methylation_chr5 179517140 RNF130 (18026): -0.2175633661941126, Methylation_LOC727677: 1.4919128582708985, Methylation_LETM1: 1.279999112264818, Methylation_CDC42BPB: -0.3650828672186826, Methylation_C8orf38: 1.5710660076186398, Methylation_chr14 100504766 EVL (18852): 1.4868439812596912, Methylation_chr5 72594851 LOC340090 (24088): -0.3820071122504946, Methylation_chr2 242904738 LINC01238 (3421): 1.298536532340203, Methylation_ARFGEF1: 1.4911161670683075, Methylation_MAPT: 1.3025920451361397, Methylation_ZFAT: 1.02129147177387, Methylation_KCNQ4: -0.9445794997767128, Methylation_chr1 232684368 SIPA1L2 (12934): 1.3227240496040185, Methylation_CRNKL1: 1.3365755610524028, Methylation_PRKAG2: -0.3681680369626233, Methylation_MICB: 1.399962186117485, miRNA_hsa-mir-934: 0.0177493884248484, miRNA_hsa-mir-4728: -0.7713802306494849, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.7609572012608196, miRNA_hsa-mir-190b: -2.052137242410604, miRNA_hsa-mir-577: 0.8633595156604337, miRNA_hsa-mir-135b: 1.413138457644072, miRNA_hsa-mir-2115: 0.107252046646676, miRNA_hsa-mir-17: 0.7694066793566919, miRNA_hsa-mir-130b: 0.8015257532282323, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A1NE,mRNA_CA12 (Z=1.34) exceeds high-expression threshold. No methylation sites meet hyper/hypo-methylation criteria. No miRNAs cross up/downregulation thresholds. All CNVs fall within normal range (−1.10 to −0.10). Isolated CA12 overexpression suggests luminal epithelial differentiation without genomic or epigenetic drivers.,"mRNA_MLPH: -0.265902890608224, mRNA_C2orf54: -0.1834911246218226, mRNA_CITED4: -0.1443346409008795, mRNA_ESR1: 0.1438691888883644, mRNA_SPDEF: -0.1315243677016919, mRNA_AGR3: 0.1249192650785835, mRNA_FOXC1: 0.2216045239314825, mRNA_GATA3: 0.3552260983188929, mRNA_AGR2: -0.177257498160098, mRNA_XBP1: 0.5688933547382347, mRNA_PRR15: -0.1485395010037423, mRNA_SLC44A4: -0.2048507891428137, mRNA_CA12: 1.3363700495317803, mRNA_DTL: 0.1341384713308814, mRNA_C5AR2: 0.23590810617026, mRNA_TBC1D9: 0.8139038445275368, mRNA_AR: -0.0488359434853731, mRNA_CCDC170: -0.3496335813064471, mRNA_DEGS2: 0.0913823779663029, mRNA_TFF3: -0.403748533226079, mRNA_DNALI1: 0.6355393870617297, mRNA_LINC00504: 0.6142157124581663, mRNA_CLCA2: 0.231895849001553, mRNA_PPP1R14C: -0.4496708551438211, mRNA_THSD4: 0.2831822960769598, mRNA_SPAG5: 0.5217945034836203, mRNA_FBP1: 0.346745828217962, mRNA_SLC7A8: 0.0503848134986105, mRNA_EN1: -0.5658735657973785, mRNA_ZNF552: 0.63450906824146, Methylation_LRRC6: 0.9309753025875538, Methylation_chr2 66218712 LINC02934 (29533): 0.963602812026615, Methylation_HOXB13: -1.023348651525135, Methylation_chr10 3949206 LINC02660 (4871): 0.4522669179656626, Methylation_chr5 179517140 RNF130 (18026): -0.932997136908352, Methylation_LOC727677: 0.582642583280055, Methylation_LETM1: 0.8355682842820616, Methylation_CDC42BPB: -0.47555862566169, Methylation_C8orf38: 0.2886405233126107, Methylation_chr14 100504766 EVL (18852): 1.3477315941823311, Methylation_chr5 72594851 LOC340090 (24088): -0.4626029995478388, Methylation_chr2 242904738 LINC01238 (3421): 0.5645214501756073, Methylation_ARFGEF1: 0.9980137056705072, Methylation_MAPT: 0.6205839362779211, Methylation_ZFAT: 0.1979503678072389, Methylation_KCNQ4: -1.2045960218551428, Methylation_chr1 232684368 SIPA1L2 (12934): 0.8129438316851608, Methylation_CRNKL1: 0.8668660441310142, Methylation_PRKAG2: 0.457438181913764, Methylation_MICB: 1.3381958596387924, miRNA_hsa-mir-934: -0.4414273552835014, miRNA_hsa-mir-4728: -0.0694669895088217, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.672114430564185, miRNA_hsa-mir-190b: 1.097867378316899, miRNA_hsa-mir-577: 1.1816420209807874, miRNA_hsa-mir-135b: 0.7151063223504402, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.5553913152599964, miRNA_hsa-mir-130b: 0.2515272816243621, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-C8-A27A,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. CITED4 mRNA is low (Z = -2.32). Hypomethylation at ZFAT, LETM1, PRKAG2, and LOC727677 promoters suggests epigenetic dysregulation. No miRNAs meet up/downregulation thresholds. These features indicate a luminal-like phenotype with potential cell cycle and vesicular trafficking dysregulation.","mRNA_MLPH: 0.2431029997306513, mRNA_C2orf54: -0.8608298086613234, mRNA_CITED4: -2.3233120169385773, mRNA_ESR1: 0.4330782559430416, mRNA_SPDEF: 0.0366130704674502, mRNA_AGR3: 0.0024930666409074, mRNA_FOXC1: -0.5254081857299929, mRNA_GATA3: 0.7534712996224565, mRNA_AGR2: 0.4160051245372057, mRNA_XBP1: 0.262910146557351, mRNA_PRR15: 1.2064310681810078, mRNA_SLC44A4: 0.1737218741159344, mRNA_CA12: -0.5117250939499891, mRNA_DTL: 1.082632531813593, mRNA_C5AR2: 0.8980667454606562, mRNA_TBC1D9: 0.0941544693849826, mRNA_AR: -1.5614680662346467, mRNA_CCDC170: 0.5393373297303624, mRNA_DEGS2: 0.099913703347596, mRNA_TFF3: 1.1366251205666746, mRNA_DNALI1: 0.624197915213983, mRNA_LINC00504: -0.4669699016748294, mRNA_CLCA2: 0.106652821679368, mRNA_PPP1R14C: -0.1287442570419743, mRNA_THSD4: 0.4336981495491273, mRNA_SPAG5: 1.4903948715063626, mRNA_FBP1: 0.7943551129926327, mRNA_SLC7A8: 0.2276747277880652, mRNA_EN1: -0.7708328918058712, mRNA_ZNF552: -0.3151036304472476, Methylation_LRRC6: -1.393481366286388, Methylation_chr2 66218712 LINC02934 (29533): -1.7010091514332562, Methylation_HOXB13: 0.0105489024176543, Methylation_chr10 3949206 LINC02660 (4871): -1.2853544702631476, Methylation_chr5 179517140 RNF130 (18026): 1.033377650221499, Methylation_LOC727677: -1.4798369274187737, Methylation_LETM1: -1.7037751467478457, Methylation_CDC42BPB: 1.3699619073053233, Methylation_C8orf38: -0.7952143583120947, Methylation_chr14 100504766 EVL (18852): -1.3423049808896743, Methylation_chr5 72594851 LOC340090 (24088): 0.5494321545813211, Methylation_chr2 242904738 LINC01238 (3421): 1.197178302895579, Methylation_ARFGEF1: -1.0804189709565766, Methylation_MAPT: -1.5613028055282356, Methylation_ZFAT: -1.835146093182649, Methylation_KCNQ4: 1.4936550586211688, Methylation_chr1 232684368 SIPA1L2 (12934): -1.3277166935448916, Methylation_CRNKL1: -0.4319702877137684, Methylation_PRKAG2: -1.6506592999925496, Methylation_MICB: -0.8491569605215773, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.1948659136465397, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.3465331732986174, miRNA_hsa-mir-190b: -0.2382786713704281, miRNA_hsa-mir-577: 0.8528232206510229, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.2620008083530785, miRNA_hsa-mir-130b: 1.1342105069701651, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-AC-A8OQ,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression.  
FOXC1 and EN1 show high mRNA (Z > 1.30); SPDEF, GATA3, AGR2, CA12, DEGS2, ZNF552 are low (Z < -1.92).  
miR-190b is downregulated (Z < -1.25); miR-577 upregulated (Z > 1.99).  
No methylation sites meet hyper/hypo thresholds.  
Collectively indicates a basal-like phenotype with luminal suppression.","mRNA_MLPH: -1.233065770977348, mRNA_C2orf54: -0.475305986677264, mRNA_CITED4: -0.6605699585312084, mRNA_ESR1: -1.7556550608614605, mRNA_SPDEF: -2.7855143331069194, mRNA_AGR3: -1.8451846624079768, mRNA_FOXC1: 1.9186843780181704, mRNA_GATA3: -2.717361283106072, mRNA_AGR2: -2.04278038339388, mRNA_XBP1: -1.1245028247192312, mRNA_PRR15: -1.9258428242612189, mRNA_SLC44A4: -0.3107497474777308, mRNA_CA12: -2.369260869674509, mRNA_DTL: -0.3973080159663369, mRNA_C5AR2: -1.7040278008799683, mRNA_TBC1D9: -1.4617075728493245, mRNA_AR: -1.9211708347651344, mRNA_CCDC170: -1.5454741490034056, mRNA_DEGS2: -2.1980078047582188, mRNA_TFF3: -1.3444866209732944, mRNA_DNALI1: -0.9186939665876652, mRNA_LINC00504: -1.6523194584252303, mRNA_CLCA2: -0.7681297969445642, mRNA_PPP1R14C: 1.3308170601910796, mRNA_THSD4: -1.8012462147626855, mRNA_SPAG5: 0.3147439724773163, mRNA_FBP1: -1.5435646545337736, mRNA_SLC7A8: -1.6175764185017405, mRNA_EN1: 2.354464388105128, mRNA_ZNF552: -2.411945890479923, Methylation_LRRC6: 1.1776208900725895, Methylation_chr2 66218712 LINC02934 (29533): 0.5879250239862471, Methylation_HOXB13: -0.84387937385375, Methylation_chr10 3949206 LINC02660 (4871): 1.432467819811928, Methylation_chr5 179517140 RNF130 (18026): -1.2409186493878015, Methylation_LOC727677: 1.4632880499233714, Methylation_LETM1: 1.2997272106391364, Methylation_CDC42BPB: -0.2992775589246022, Methylation_C8orf38: 1.3903943616275367, Methylation_chr14 100504766 EVL (18852): 1.2514895343773966, Methylation_chr5 72594851 LOC340090 (24088): -0.6739861257325208, Methylation_chr2 242904738 LINC01238 (3421): 1.309243458916731, Methylation_ARFGEF1: 1.2499819309020157, Methylation_MAPT: 0.5382784945250225, Methylation_ZFAT: 1.3861277369579372, Methylation_KCNQ4: -0.8380644086024578, Methylation_chr1 232684368 SIPA1L2 (12934): 0.8232240476019794, Methylation_CRNKL1: 1.227852510721534, Methylation_PRKAG2: -0.5077684316456657, Methylation_MICB: 1.417851094023203, miRNA_hsa-mir-934: 1.258036748731366, miRNA_hsa-mir-4728: -0.2821658241807992, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.7703755657857294, miRNA_hsa-mir-190b: -2.052137242410604, miRNA_hsa-mir-577: 1.394794361457235, miRNA_hsa-mir-135b: 1.178626227652276, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.087420629116279, miRNA_hsa-mir-130b: 0.2340818922594052, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-A2-A0YF,mRNA_CCDC170 (Z=1.46) exceeds the high-expression threshold (Z>1.30). No methylation sites meet hyper/hypo-methylation cutoffs. No miRNAs reach up/downregulation thresholds. All CNVs fall within the normal range (-1.10 ≤ CNV < -0.10). Isolated CCDC170 overexpression suggests luminal biology without clear genomic or epigenetic drivers.,"mRNA_MLPH: 0.9177544591135786, mRNA_C2orf54: 0.158098194575401, mRNA_CITED4: -1.2486863094763576, mRNA_ESR1: 1.2667746357140717, mRNA_SPDEF: 0.5092470458364278, mRNA_AGR3: 1.1992700573821748, mRNA_FOXC1: -0.5712428828850907, mRNA_GATA3: 0.5134721863852114, mRNA_AGR2: 0.6645485202332023, mRNA_XBP1: 0.8872680908384363, mRNA_PRR15: 0.4350272229265238, mRNA_SLC44A4: 1.0134704350398722, mRNA_CA12: 1.1916357178772767, mRNA_DTL: 1.2488320916112512, mRNA_C5AR2: 1.1574514512108778, mRNA_TBC1D9: 0.7227165574938104, mRNA_AR: 0.9291453897661476, mRNA_CCDC170: 1.4615130131713414, mRNA_DEGS2: 0.2561666405196917, mRNA_TFF3: 0.6964869347642618, mRNA_DNALI1: 0.0369027462015996, mRNA_LINC00504: 1.1393983100034024, mRNA_CLCA2: -0.7543438203720841, mRNA_PPP1R14C: -0.4078379162898833, mRNA_THSD4: 1.2903818242376248, mRNA_SPAG5: 0.3154062947185968, mRNA_FBP1: 0.96688802768201, mRNA_SLC7A8: 1.0948113847478742, mRNA_EN1: -1.0190469599022995, mRNA_ZNF552: 0.9092434899369674, Methylation_LRRC6: -1.1010204282370115, Methylation_chr2 66218712 LINC02934 (29533): 0.9429800739230818, Methylation_HOXB13: -0.8466632954594454, Methylation_chr10 3949206 LINC02660 (4871): -1.1766391233989422, Methylation_chr5 179517140 RNF130 (18026): 0.991631852914523, Methylation_LOC727677: -1.083692605638673, Methylation_LETM1: -1.4578389098075115, Methylation_CDC42BPB: 1.353392430165702, Methylation_C8orf38: 0.704014012543935, Methylation_chr14 100504766 EVL (18852): -1.0154932265645644, Methylation_chr5 72594851 LOC340090 (24088): 0.3143480426245051, Methylation_chr2 242904738 LINC01238 (3421): -1.2421145175371828, Methylation_ARFGEF1: -1.0795730759657702, Methylation_MAPT: -0.945452276016048, Methylation_ZFAT: 0.4465168862601832, Methylation_KCNQ4: -1.141742921546535, Methylation_chr1 232684368 SIPA1L2 (12934): -1.2504571379964362, Methylation_CRNKL1: -1.3398545783199831, Methylation_PRKAG2: -1.3304890159157552, Methylation_MICB: -0.2325833573311471, miRNA_hsa-mir-934: -0.1895953307843615, miRNA_hsa-mir-4728: -0.3293772379101262, miRNA_hsa-mir-5695: 1.833837999136653, miRNA_hsa-mir-18a: -0.2461594907696887, miRNA_hsa-mir-190b: 0.7323029565531713, miRNA_hsa-mir-577: 0.0531712791396457, miRNA_hsa-mir-135b: -0.382965607995669, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.0181550130771426, miRNA_hsa-mir-130b: 0.0638706525948095, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E2-A105,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives oncogenic transcriptional activity. HOXB13 promoter hypermethylation mediates epigenetic silencing. LETM1, ARFGEF1, MAPT, and CRNKL1 are hypomethylated, potentially activating oncogenic pathways. No mRNA or miRNA alterations meet diagnostic thresholds. These features indicate a luminal B-like phenotype with PI3K/AKT dysregulation.","mRNA_MLPH: 0.3383903673519363, mRNA_C2orf54: 0.5352885853989966, mRNA_CITED4: -1.5304926898717028, mRNA_ESR1: 1.174380609217228, mRNA_SPDEF: 0.3605254610353586, mRNA_AGR3: 0.5283903217655698, mRNA_FOXC1: -0.9968115768504624, mRNA_GATA3: 0.6467865926663763, mRNA_AGR2: 0.6703450449300121, mRNA_XBP1: 0.4502121646934421, mRNA_PRR15: 0.5840207510370785, mRNA_SLC44A4: 0.3462016189918016, mRNA_CA12: 0.3926455292583686, mRNA_DTL: -0.1160398998926562, mRNA_C5AR2: 0.6811054031784589, mRNA_TBC1D9: 0.4032014763121715, mRNA_AR: -1.3401804690840629, mRNA_CCDC170: -0.1423538012969256, mRNA_DEGS2: -0.8778462718604199, mRNA_TFF3: 0.1839098986006691, mRNA_DNALI1: 1.0444446707533974, mRNA_LINC00504: 0.9868697992947092, mRNA_CLCA2: -0.575794345654294, mRNA_PPP1R14C: -0.7986376234784465, mRNA_THSD4: 1.0930085274705703, mRNA_SPAG5: 0.9951869589026612, mRNA_FBP1: 0.2796784257647201, mRNA_SLC7A8: 0.7438575617308717, mRNA_EN1: -0.7906218610135185, mRNA_ZNF552: 0.748326598928296, Methylation_LRRC6: -1.2182722606051646, Methylation_chr2 66218712 LINC02934 (29533): 1.2068188942958884, Methylation_HOXB13: 2.019707088451748, Methylation_chr10 3949206 LINC02660 (4871): -0.966867631095844, Methylation_chr5 179517140 RNF130 (18026): 1.2326835107872072, Methylation_LOC727677: -1.4353159687611985, Methylation_LETM1: -1.6688000626550097, Methylation_CDC42BPB: 0.8468412346487898, Methylation_C8orf38: -0.4854053691858468, Methylation_chr14 100504766 EVL (18852): -1.3893375319640489, Methylation_chr5 72594851 LOC340090 (24088): 1.3660946464448738, Methylation_chr2 242904738 LINC01238 (3421): -0.9257431291331276, Methylation_ARFGEF1: -1.661835053993373, Methylation_MAPT: -1.736358824597621, Methylation_ZFAT: -1.1849014876715318, Methylation_KCNQ4: 1.5586742980651254, Methylation_chr1 232684368 SIPA1L2 (12934): -1.1587132373537428, Methylation_CRNKL1: -1.5666004027370255, Methylation_PRKAG2: -1.3422138830092067, Methylation_MICB: -1.0757736223928462, miRNA_hsa-mir-934: -0.1003319756368281, miRNA_hsa-mir-4728: -0.1520730902436186, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.2585090669741837, miRNA_hsa-mir-190b: 0.7820792675431775, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.3971969408524051, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.4760528256076913, miRNA_hsa-mir-130b: 0.8995361180784599, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-OL-A66L,mRNA_CITED4 (Z=2.10) and mRNA_DEGS2 (Z=1.48) are highly expressed; mRNA_DTL (Z=-1.98) is low. HOXB13 and LINC02660 promoters are hypermethylated (Z>1.50). miRNA_hsa-mir-130b is downregulated (Z=-1.57). No CNVs meet diagnostic thresholds. These features suggest luminal A subtype with ER-pathway activity.,"mRNA_MLPH: 0.9315298548770304, mRNA_C2orf54: 1.0389695670984145, mRNA_CITED4: 2.097719175756924, mRNA_ESR1: -0.1946146526752343, mRNA_SPDEF: 0.6709743484748371, mRNA_AGR3: 0.5744550678940701, mRNA_FOXC1: -0.0523682994635048, mRNA_GATA3: -0.0075162329203965, mRNA_AGR2: 0.4683590564944743, mRNA_XBP1: -0.0233429479140043, mRNA_PRR15: 0.3191454074292722, mRNA_SLC44A4: 0.3113630620774938, mRNA_CA12: -0.082882543831253, mRNA_DTL: -1.9755604856085869, mRNA_C5AR2: 0.698945287372477, mRNA_TBC1D9: -0.0210712302124822, mRNA_AR: -0.3086426522991328, mRNA_CCDC170: -0.3580586566168687, mRNA_DEGS2: 1.482924816313853, mRNA_TFF3: 1.2502611763900524, mRNA_DNALI1: 0.8142283631764428, mRNA_LINC00504: 0.2213481400056735, mRNA_CLCA2: 0.4883101149189321, mRNA_PPP1R14C: -0.4196925696188584, mRNA_THSD4: -0.2722159976639174, mRNA_SPAG5: -1.3655598118572083, mRNA_FBP1: 0.4688791886870775, mRNA_SLC7A8: -0.1670699241357635, mRNA_EN1: -0.1301620364972658, mRNA_ZNF552: 0.289056463788046, Methylation_LRRC6: 0.020098890628071, Methylation_chr2 66218712 LINC02934 (29533): 1.178144639832347, Methylation_HOXB13: 1.5763205781084737, Methylation_chr10 3949206 LINC02660 (4871): 1.5528146489361403, Methylation_chr5 179517140 RNF130 (18026): 0.6292205965930775, Methylation_LOC727677: -0.198590821400326, Methylation_LETM1: -0.5693458833303288, Methylation_CDC42BPB: -1.003510930423017, Methylation_C8orf38: 0.0245736092419627, Methylation_chr14 100504766 EVL (18852): -0.3106778376227378, Methylation_chr5 72594851 LOC340090 (24088): 0.7880037032208377, Methylation_chr2 242904738 LINC01238 (3421): -0.7405373707025625, Methylation_ARFGEF1: 0.9536740594983298, Methylation_MAPT: -0.4800322138689945, Methylation_ZFAT: 1.0054813641932103, Methylation_KCNQ4: -0.5482230591139344, Methylation_chr1 232684368 SIPA1L2 (12934): -0.037399946811837, Methylation_CRNKL1: -0.782129102873492, Methylation_PRKAG2: 1.1888636168442, Methylation_MICB: -0.054608507447061, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.2043756980068747, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.8600864784043937, miRNA_hsa-mir-190b: 0.2205238151895204, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.934707428826438, miRNA_hsa-mir-2115: -0.2146202220120524, miRNA_hsa-mir-17: -0.3013856996638162, miRNA_hsa-mir-130b: -1.5713753459391355, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-EW-A1OV,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives oncogenic transcriptional activity. Promoter hypermethylation of RNF130 and MAPT mediates epigenetic silencing. mRNA downregulation of CA12 (Z = -2.17) and ESR1 (Z = -1.91) indicates luminal suppression. miRNA upregulation of hsa-mir-130b (Z = 1.81) and hsa-mir-5695 (Z = 1.75) suggests post-transcriptional dysregulation. These features collectively indicate a basal-like phenotype with ER pathway suppression.","mRNA_MLPH: -0.2972288117460661, mRNA_C2orf54: -0.5395566938408572, mRNA_CITED4: -1.0725025933974155, mRNA_ESR1: -1.907487506727681, mRNA_SPDEF: 0.5511977142978651, mRNA_AGR3: -1.5947093937681227, mRNA_FOXC1: -0.6129441401630045, mRNA_GATA3: -0.1035090939205958, mRNA_AGR2: -1.105364565079873, mRNA_XBP1: -0.621058696713028, mRNA_PRR15: 0.1604541093009087, mRNA_SLC44A4: 0.5991592531202747, mRNA_CA12: -2.168000894843765, mRNA_DTL: -0.2269410371493932, mRNA_C5AR2: -1.8214316879958228, mRNA_TBC1D9: -0.3200383663664769, mRNA_AR: 0.5012887408961226, mRNA_CCDC170: -1.0862869458554207, mRNA_DEGS2: 0.3432095599245642, mRNA_TFF3: -0.3202523982695928, mRNA_DNALI1: -0.5815490290864266, mRNA_LINC00504: -0.0646123343265709, mRNA_CLCA2: 1.2516721920332503, mRNA_PPP1R14C: -0.4867595125486594, mRNA_THSD4: -1.4866528373355468, mRNA_SPAG5: -0.5872251340907011, mRNA_FBP1: -0.5542387709934734, mRNA_SLC7A8: 0.3750719854934557, mRNA_EN1: -0.6507470582347148, mRNA_ZNF552: -1.0909726783737004, Methylation_LRRC6: 0.2072883281126793, Methylation_chr2 66218712 LINC02934 (29533): -0.1308263978939972, Methylation_HOXB13: 0.547149029003577, Methylation_chr10 3949206 LINC02660 (4871): 0.790720191421522, Methylation_chr5 179517140 RNF130 (18026): -1.514838648065917, Methylation_LOC727677: -0.0633221673481801, Methylation_LETM1: 1.298573777356505, Methylation_CDC42BPB: -1.3732470805227417, Methylation_C8orf38: 0.6589346641356346, Methylation_chr14 100504766 EVL (18852): 0.0572462522585374, Methylation_chr5 72594851 LOC340090 (24088): 0.0309777336246616, Methylation_chr2 242904738 LINC01238 (3421): 0.061593904243787, Methylation_ARFGEF1: 0.3145252705759931, Methylation_MAPT: 1.4742909059236795, Methylation_ZFAT: -0.0402658080762976, Methylation_KCNQ4: 0.5353048031691274, Methylation_chr1 232684368 SIPA1L2 (12934): 0.4485066821867224, Methylation_CRNKL1: 0.7997813629489573, Methylation_PRKAG2: 1.031674093804934, Methylation_MICB: 0.8614126658069701, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.1466668422087518, miRNA_hsa-mir-5695: 1.7498864492731, miRNA_hsa-mir-18a: 0.6324329793362119, miRNA_hsa-mir-190b: 0.1368340181337241, miRNA_hsa-mir-577: 0.4073478794514723, miRNA_hsa-mir-135b: -0.7040465169735293, miRNA_hsa-mir-2115: -0.2417473367459903, miRNA_hsa-mir-17: -0.5535409593455508, miRNA_hsa-mir-130b: 1.8052260683193453, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-EW-A2FR,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression.  
Methylation_chr5 72594851 LOC340090 hypo-methylation and Methylation_chr2 242904738 LINC01238/MAPT hyper-methylation alter regulatory landscapes.  
miR-4728 upregulation and miR-190b downregulation modulate post-transcriptional control.  
Collectively indicate a luminal B-like phenotype with cell cycle and ER-pathway dysregulation.","mRNA_MLPH: 0.004542521255202, mRNA_C2orf54: 2.300359284949572, mRNA_CITED4: -1.4880007147263956, mRNA_ESR1: -1.476921395183323, mRNA_SPDEF: 0.5643330049201813, mRNA_AGR3: -1.2988908289155363, mRNA_FOXC1: 0.2210052270949134, mRNA_GATA3: -0.545951195806767, mRNA_AGR2: 0.2440238751605657, mRNA_XBP1: -0.2026600955327104, mRNA_PRR15: 0.1809061320510878, mRNA_SLC44A4: 0.241816255927311, mRNA_CA12: -0.5569661171082491, mRNA_DTL: -0.8333209594954288, mRNA_C5AR2: -0.9839219788758452, mRNA_TBC1D9: -0.6798780085670039, mRNA_AR: -0.4892844207045196, mRNA_CCDC170: -0.7242346193633433, mRNA_DEGS2: -1.1818061168434035, mRNA_TFF3: 1.2787564343208182, mRNA_DNALI1: 0.1668084275117719, mRNA_LINC00504: -0.5323308933448957, mRNA_CLCA2: 1.50795736182338, mRNA_PPP1R14C: 2.422126620826196, mRNA_THSD4: -0.8046722131047384, mRNA_SPAG5: 0.2004410554276021, mRNA_FBP1: -0.1806582917409475, mRNA_SLC7A8: 0.2528545504019701, mRNA_EN1: 0.4749328129811633, mRNA_ZNF552: -1.2523873614314391, Methylation_LRRC6: 1.1271252233228484, Methylation_chr2 66218712 LINC02934 (29533): -0.2255727989163084, Methylation_HOXB13: 0.4569326954109003, Methylation_chr10 3949206 LINC02660 (4871): -0.2191401904720184, Methylation_chr5 179517140 RNF130 (18026): -1.4571136008243388, Methylation_LOC727677: 0.3388181754395301, Methylation_LETM1: 1.2165170900291642, Methylation_CDC42BPB: -0.0403340335277859, Methylation_C8orf38: 0.6882284558017746, Methylation_chr14 100504766 EVL (18852): 1.022176100061082, Methylation_chr5 72594851 LOC340090 (24088): -1.5003106147592828, Methylation_chr2 242904738 LINC01238 (3421): 1.4261259950676572, Methylation_ARFGEF1: 0.8067395568874762, Methylation_MAPT: 1.4337644155689768, Methylation_ZFAT: 0.2054720981882945, Methylation_KCNQ4: -0.2517761506511954, Methylation_chr1 232684368 SIPA1L2 (12934): 0.773468712719695, Methylation_CRNKL1: 1.0779372768338256, Methylation_PRKAG2: 0.0263483023971017, Methylation_MICB: 0.6894463622858835, miRNA_hsa-mir-934: 0.8221325926007867, miRNA_hsa-mir-4728: 3.900290830496137, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.0757330961737818, miRNA_hsa-mir-190b: -1.3603528710718702, miRNA_hsa-mir-577: 0.287899929531074, miRNA_hsa-mir-135b: 0.9649873997979918, miRNA_hsa-mir-2115: 1.0122639547060994, miRNA_hsa-mir-17: -0.1935325921604869, miRNA_hsa-mir-130b: 0.647143800677958, CNV_VPS54: 2.3735003872816955, CNV_LINC01867: 2.395394893874891, CNV_LINC02576: 2.464291317721031, CNV_WDPCP: 2.38809584879993, CNV_CEP68: 2.464291317721031"
TCGA-BH-A203,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives genomic instability. mRNA_C2orf54 and mRNA_CLCA2 show significant overexpression (Z > 1.30). mRNA_CITED4 and mRNA_DEGS2 are markedly downregulated (Z < -1.92). miRNA_hsa-mir-2115 is strongly upregulated (Z > 1.99); miRNA_hsa-mir-190b is downregulated (Z < -1.25). Methylation_RNF130 is hypomethylated (Z < -1.47). These features indicate a basal-like phenotype with ER-pathway suppression.","mRNA_MLPH: -0.1509899405536788, mRNA_C2orf54: 2.226062352999942, mRNA_CITED4: -2.0153806799938065, mRNA_ESR1: -1.260000358629923, mRNA_SPDEF: 0.3507645211285837, mRNA_AGR3: -0.9319105215474682, mRNA_FOXC1: -0.2519442618826287, mRNA_GATA3: -0.0091488456857073, mRNA_AGR2: 0.070552859506002, mRNA_XBP1: 0.757837288811717, mRNA_PRR15: 0.1727019265530324, mRNA_SLC44A4: -0.6952383726880341, mRNA_CA12: -0.0714902429238761, mRNA_DTL: 0.0554514047876162, mRNA_C5AR2: -1.748139041753882, mRNA_TBC1D9: 0.0955044464046563, mRNA_AR: 0.9861822939002616, mRNA_CCDC170: -1.5789131171218276, mRNA_DEGS2: -2.056143452208393, mRNA_TFF3: -0.0272602747569456, mRNA_DNALI1: -1.7802109661561465, mRNA_LINC00504: -0.1512907753501285, mRNA_CLCA2: 2.427187656522149, mRNA_PPP1R14C: -0.2937014594344014, mRNA_THSD4: -1.2512528404065486, mRNA_SPAG5: 1.6371515729370765, mRNA_FBP1: -0.0865523643180152, mRNA_SLC7A8: 0.296846489708405, mRNA_EN1: 0.1373622239894816, mRNA_ZNF552: -0.2437498306840762, Methylation_LRRC6: 0.9064776866397, Methylation_chr2 66218712 LINC02934 (29533): 0.1335156956751353, Methylation_HOXB13: 0.1859006719101423, Methylation_chr10 3949206 LINC02660 (4871): 0.3754259138323126, Methylation_chr5 179517140 RNF130 (18026): -1.4689250093287844, Methylation_LOC727677: 1.4876243378541396, Methylation_LETM1: 1.3619914597993643, Methylation_CDC42BPB: -0.8390507068527101, Methylation_C8orf38: -0.798832855543082, Methylation_chr14 100504766 EVL (18852): 0.3769764056705795, Methylation_chr5 72594851 LOC340090 (24088): 0.2257925635799977, Methylation_chr2 242904738 LINC01238 (3421): 1.3431859324908857, Methylation_ARFGEF1: 0.9600908580384698, Methylation_MAPT: 1.4723015554470384, Methylation_ZFAT: 1.3284447223738705, Methylation_KCNQ4: 0.3739061187094437, Methylation_chr1 232684368 SIPA1L2 (12934): 0.3661488670850024, Methylation_CRNKL1: 1.3270896792569262, Methylation_PRKAG2: -0.8957172782999439, Methylation_MICB: 0.71637296290151, miRNA_hsa-mir-934: -0.4038430424489981, miRNA_hsa-mir-4728: -0.7945447109781835, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.5747537792116312, miRNA_hsa-mir-190b: -1.5756808328664382, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.5369871499242217, miRNA_hsa-mir-2115: 4.25036752900109, miRNA_hsa-mir-17: -0.8182660277788285, miRNA_hsa-mir-130b: 0.1595197791940586, CNV_VPS54: 3.3712233045701687, CNV_LINC01867: 3.403528716117201, CNV_LINC02576: 3.494626341568657, CNV_WDPCP: 3.3913533508092364, CNV_CEP68: 3.494626341568657"
TCGA-AO-A0JF,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.2302570748905066, mRNA_C2orf54: 0.1862671394301876, mRNA_CITED4: 0.4214649613127426, mRNA_ESR1: 0.5695633560276587, mRNA_SPDEF: 0.2634232655307865, mRNA_AGR3: 0.7492965887064621, mRNA_FOXC1: 0.3410107585789529, mRNA_GATA3: 0.1740150280539711, mRNA_AGR2: -0.1995183295673645, mRNA_XBP1: 1.1176589720388714, mRNA_PRR15: -0.0647946151488645, mRNA_SLC44A4: 0.8641816307536566, mRNA_CA12: 0.4617025437758426, mRNA_DTL: -0.509038054519728, mRNA_C5AR2: 0.3690001921670923, mRNA_TBC1D9: 1.029482137561573, mRNA_AR: 1.0129713782849432, mRNA_CCDC170: 0.4805108612020697, mRNA_DEGS2: 0.8112699951199893, mRNA_TFF3: -0.0648671453579718, mRNA_DNALI1: 0.4350442418497611, mRNA_LINC00504: 0.5900026280188951, mRNA_CLCA2: 0.2403474802773432, mRNA_PPP1R14C: -0.3914026481544667, mRNA_THSD4: 0.533308566224343, mRNA_SPAG5: -1.2029092105089674, mRNA_FBP1: 0.5400913292204659, mRNA_SLC7A8: 0.4422296641416177, mRNA_EN1: 0.0665992896402354, mRNA_ZNF552: 0.4890545337070455, Methylation_LRRC6: 0.7223914312684196, Methylation_chr2 66218712 LINC02934 (29533): 1.1385746236731502, Methylation_HOXB13: -0.7767940119037293, Methylation_chr10 3949206 LINC02660 (4871): 0.0879167298915683, Methylation_chr5 179517140 RNF130 (18026): 0.0490436026534424, Methylation_LOC727677: 0.7004511032825401, Methylation_LETM1: 0.1093675327224466, Methylation_CDC42BPB: -0.8347382501207841, Methylation_C8orf38: 0.3300259208583204, Methylation_chr14 100504766 EVL (18852): 0.8117230241891096, Methylation_chr5 72594851 LOC340090 (24088): -1.40217720095653, Methylation_chr2 242904738 LINC01238 (3421): -0.0226630685373942, Methylation_ARFGEF1: 0.0194873793064196, Methylation_MAPT: 0.3685043624941454, Methylation_ZFAT: 0.6476693113729799, Methylation_KCNQ4: -1.187181324929322, Methylation_chr1 232684368 SIPA1L2 (12934): -0.1798756454804238, Methylation_CRNKL1: -0.381918762694933, Methylation_PRKAG2: 0.8392356235687598, Methylation_MICB: -0.1825492380468332, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.7934870056084445, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.4939616637439002, miRNA_hsa-mir-190b: -0.1673650956209856, miRNA_hsa-mir-577: -0.2135739505551694, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: -0.1341147811964537, miRNA_hsa-mir-17: -1.9455065317360507, miRNA_hsa-mir-130b: -0.9025593971535544, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-EW-A1PB,"High-level Amplification absent; no CNV alterations meet thresholds.  
mRNA_PPP1R14C (Z=2.15) and mRNA_EN1 (Z=2.55) show high expression.  
mRNA_SPDEF, CA12, AR, ZNF552, TFF3, XBP1 significantly low (Z < -1.92).  
Methylation hypermethylated at LRRC6, LINC02660, RNF130, LOC727677, C8orf38, EVL, ARFGEF1, SIPA1L2, CRNKL1, MICB (Z > 1.50); hypomethylated at RNF130, LOC340090 (Z < -1.47).  
miRNA_hsa-mir-190b downregulated (Z=-2.05); others within neutral range.","mRNA_MLPH: -1.589402016149648, mRNA_C2orf54: 0.7347292007857956, mRNA_CITED4: 0.3222947369263804, mRNA_ESR1: -1.7863935649781766, mRNA_SPDEF: -2.283441264262396, mRNA_AGR3: -1.3536164491146765, mRNA_FOXC1: 0.9630376820200554, mRNA_GATA3: -1.0878750201310394, mRNA_AGR2: -0.6826859516909647, mRNA_XBP1: -2.1181403643327608, mRNA_PRR15: -0.3866540689150184, mRNA_SLC44A4: -1.7551374788736192, mRNA_CA12: -2.2964517146006336, mRNA_DTL: -0.609239130783625, mRNA_C5AR2: -1.526816393618904, mRNA_TBC1D9: -1.527815051539696, mRNA_AR: -2.4181613193677447, mRNA_CCDC170: -1.7206966110907354, mRNA_DEGS2: -0.1613410579283926, mRNA_TFF3: -2.199964177071314, mRNA_DNALI1: -2.0562353769312613, mRNA_LINC00504: -1.674515951209655, mRNA_CLCA2: 0.1662684885636126, mRNA_PPP1R14C: 2.145775938099564, mRNA_THSD4: -1.6384397194640137, mRNA_SPAG5: 0.4685236935621091, mRNA_FBP1: -0.972154437922321, mRNA_SLC7A8: -1.2088755090550771, mRNA_EN1: 2.547636710254624, mRNA_ZNF552: -2.3943970695881416, Methylation_LRRC6: 1.5266625690914366, Methylation_chr2 66218712 LINC02934 (29533): -0.129325140119186, Methylation_HOXB13: 0.4880904476568659, Methylation_chr10 3949206 LINC02660 (4871): 1.5549680168027715, Methylation_chr5 179517140 RNF130 (18026): -1.6947224550479858, Methylation_LOC727677: 1.5059319049222208, Methylation_LETM1: 1.3138329557178068, Methylation_CDC42BPB: 0.4173756498996946, Methylation_C8orf38: 1.677550757476053, Methylation_chr14 100504766 EVL (18852): 1.5798723263636556, Methylation_chr5 72594851 LOC340090 (24088): -1.571188701157881, Methylation_chr2 242904738 LINC01238 (3421): 1.4578201186188042, Methylation_ARFGEF1: 1.7388851722860583, Methylation_MAPT: 1.4425270774842085, Methylation_ZFAT: 1.36806597785765, Methylation_KCNQ4: 0.1849109556394078, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5640450270936004, Methylation_CRNKL1: 1.489396729887596, Methylation_PRKAG2: 0.1169114605598488, Methylation_MICB: 1.494513583791954, miRNA_hsa-mir-934: 0.6334822956127213, miRNA_hsa-mir-4728: -0.3172217465688861, miRNA_hsa-mir-5695: 1.2077011753163616, miRNA_hsa-mir-18a: 1.8151386419829745, miRNA_hsa-mir-190b: -2.052137242410604, miRNA_hsa-mir-577: -0.4851210396652201, miRNA_hsa-mir-135b: -0.164024146660331, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.6711002777316768, miRNA_hsa-mir-130b: 0.4997522060249721, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-EW-A1PE,"High-level Amplification absent; no CNV gains meet threshold.  
miRNA hsa-mir-5695 upregulated (Z=2.27).  
No mRNA or methylation features exceed diagnostic thresholds.  
Isolated miRNA dysregulation without transcriptional or epigenetic correlates.","mRNA_MLPH: 0.4188263786683488, mRNA_C2orf54: -0.3017791459277055, mRNA_CITED4: 0.5948374654882506, mRNA_ESR1: 1.105524721603194, mRNA_SPDEF: 0.4904511738390244, mRNA_AGR3: 0.7447705475541683, mRNA_FOXC1: -0.600640857830448, mRNA_GATA3: 0.5050519040616823, mRNA_AGR2: 0.1998564783665031, mRNA_XBP1: 0.9882878926254062, mRNA_PRR15: 0.0719241049100645, mRNA_SLC44A4: 0.798437484250408, mRNA_CA12: 1.0724714214906397, mRNA_DTL: -0.2863004091584792, mRNA_C5AR2: 1.3403652274938511, mRNA_TBC1D9: 0.9472346167394612, mRNA_AR: 0.9506792976901328, mRNA_CCDC170: 1.1591580945052795, mRNA_DEGS2: 1.0756406987973792, mRNA_TFF3: -0.1366364350094764, mRNA_DNALI1: -0.3024616862849231, mRNA_LINC00504: 1.2062815157979927, mRNA_CLCA2: -0.4806023498408215, mRNA_PPP1R14C: -0.911740963996629, mRNA_THSD4: 0.9006165692246414, mRNA_SPAG5: -0.3760181407087865, mRNA_FBP1: 0.673790417768582, mRNA_SLC7A8: 0.7967516823771577, mRNA_EN1: -0.5082240308339925, mRNA_ZNF552: 0.9808915386859508, Methylation_LRRC6: -0.131849882325502, Methylation_chr2 66218712 LINC02934 (29533): 1.4417805118358873, Methylation_HOXB13: -1.0815760115181254, Methylation_chr10 3949206 LINC02660 (4871): -0.6524676430132645, Methylation_chr5 179517140 RNF130 (18026): 0.4462961292752112, Methylation_LOC727677: -0.5602995529134044, Methylation_LETM1: -0.3525418030967912, Methylation_CDC42BPB: -1.3348446200556794, Methylation_C8orf38: -0.5792755599979705, Methylation_chr14 100504766 EVL (18852): -0.7372823902026354, Methylation_chr5 72594851 LOC340090 (24088): 0.597315678911497, Methylation_chr2 242904738 LINC01238 (3421): -0.8017323828886287, Methylation_ARFGEF1: -0.3615457569692992, Methylation_MAPT: -0.963857922444512, Methylation_ZFAT: -0.6843332118520518, Methylation_KCNQ4: -1.1242394582012625, Methylation_chr1 232684368 SIPA1L2 (12934): -0.8611360752106497, Methylation_CRNKL1: -0.5689217627691286, Methylation_PRKAG2: -1.101681324986345, Methylation_MICB: -0.6887148636139899, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: 2.2710999912144545, miRNA_hsa-mir-18a: -0.3039547606847619, miRNA_hsa-mir-190b: 0.0437017921347779, miRNA_hsa-mir-577: -0.4316181354312468, miRNA_hsa-mir-135b: -0.5916648045248394, miRNA_hsa-mir-2115: 0.2723256416733955, miRNA_hsa-mir-17: -0.8264114748854804, miRNA_hsa-mir-130b: 0.3671671183360799, CNV_VPS54: -1.6173912818721974, CNV_LINC01867: -1.63714039509435, CNV_LINC02576: -1.657048777669473, CNV_WDPCP: -1.6249341592372952, CNV_CEP68: -1.657048777669473"
TCGA-EW-A2FV,High mRNA_C2orf54 (Z=2.69) indicates overexpression. No methylation or miRNA alterations meet diagnostic thresholds. All CNVs fall within normal/gain range (no deletions/amplifications). These features suggest luminal A phenotype with minimal genomic instability.,"mRNA_MLPH: 0.0437067858196997, mRNA_C2orf54: 2.694452723933672, mRNA_CITED4: 0.7772233796089428, mRNA_ESR1: 0.0186024926669199, mRNA_SPDEF: 0.5340228918364363, mRNA_AGR3: -1.181562128744608, mRNA_FOXC1: 0.3982609234116563, mRNA_GATA3: 0.3330137921405861, mRNA_AGR2: -0.1571661010210175, mRNA_XBP1: -0.1855521991497176, mRNA_PRR15: 0.3636216850914306, mRNA_SLC44A4: 0.274537548241776, mRNA_CA12: 0.278264492555973, mRNA_DTL: 0.2040482552191579, mRNA_C5AR2: 0.5731034665322479, mRNA_TBC1D9: -0.0453476144421415, mRNA_AR: -1.3626710367594543, mRNA_CCDC170: -0.9182897695603032, mRNA_DEGS2: 0.0208984548648033, mRNA_TFF3: 0.7119608956808465, mRNA_DNALI1: 0.0436404145880208, mRNA_LINC00504: 0.0533148203608589, mRNA_CLCA2: -0.1749919130905468, mRNA_PPP1R14C: 0.094142022349751, mRNA_THSD4: -0.1344752334870045, mRNA_SPAG5: 0.464864175446923, mRNA_FBP1: 0.3719952128769517, mRNA_SLC7A8: -1.3361294697433863, mRNA_EN1: -0.720153175204476, mRNA_ZNF552: 1.2177046864218324, Methylation_LRRC6: -0.4311436248827854, Methylation_chr2 66218712 LINC02934 (29533): -1.1015954707362887, Methylation_HOXB13: -0.4871901969489793, Methylation_chr10 3949206 LINC02660 (4871): -0.319413140493406, Methylation_chr5 179517140 RNF130 (18026): -0.002639054445956, Methylation_LOC727677: -0.4080596516093939, Methylation_LETM1: 0.1311931447867522, Methylation_CDC42BPB: 0.882082690590646, Methylation_C8orf38: 1.2248889471469304, Methylation_chr14 100504766 EVL (18852): 0.1325743331761699, Methylation_chr5 72594851 LOC340090 (24088): -0.0976653947193094, Methylation_chr2 242904738 LINC01238 (3421): 1.398534139114326, Methylation_ARFGEF1: -0.1230804387742331, Methylation_MAPT: 1.3530519163386487, Methylation_ZFAT: -0.0634015188120841, Methylation_KCNQ4: -1.0671356704435704, Methylation_chr1 232684368 SIPA1L2 (12934): -0.1185111174734965, Methylation_CRNKL1: 0.4242514377681892, Methylation_PRKAG2: -0.2958328758812913, Methylation_MICB: -0.419039274114423, miRNA_hsa-mir-934: 0.3379089836564461, miRNA_hsa-mir-4728: 0.4732198244038895, miRNA_hsa-mir-5695: -0.1189032360329222, miRNA_hsa-mir-18a: 0.1657946883944252, miRNA_hsa-mir-190b: -0.3039762026063657, miRNA_hsa-mir-577: -0.3995758990587105, miRNA_hsa-mir-135b: -0.3244980959679015, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.0438953578948699, miRNA_hsa-mir-130b: -1.0046551392294467, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-OL-A6VQ,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives transcriptional upregulation.  
No mRNA meets overexpression threshold (Z > 1.30); CLCA2 (Z=1.366) is borderline but excluded per strict cutoff.  
No methylation or miRNA alterations meet diagnostic thresholds.  
Collectively indicates a genomically amplified phenotype with minimal transcriptomic/epigenetic impact.","mRNA_MLPH: 0.7896084426466576, mRNA_C2orf54: 0.2928690199182944, mRNA_CITED4: 1.0674070977967316, mRNA_ESR1: 0.2155890766523749, mRNA_SPDEF: 0.5400206552543652, mRNA_AGR3: 0.6698999388038892, mRNA_FOXC1: 0.3338376837962487, mRNA_GATA3: 0.2465571038718513, mRNA_AGR2: 0.4973178642545504, mRNA_XBP1: 0.5681320500697374, mRNA_PRR15: 0.4586291647208664, mRNA_SLC44A4: 0.3236053796659854, mRNA_CA12: 0.8220552420000854, mRNA_DTL: -0.5881521002443278, mRNA_C5AR2: 0.2570343469851913, mRNA_TBC1D9: 0.9041905318683756, mRNA_AR: 0.6242314502583498, mRNA_CCDC170: 0.5624646303756358, mRNA_DEGS2: 0.2033292370175627, mRNA_TFF3: 0.689492142897794, mRNA_DNALI1: 0.7714455640371071, mRNA_LINC00504: 0.3047934973517275, mRNA_CLCA2: 1.3658037336265991, mRNA_PPP1R14C: -0.0941134474377631, mRNA_THSD4: 0.9302320414942166, mRNA_SPAG5: -0.7194744797303467, mRNA_FBP1: 0.5916634010651199, mRNA_SLC7A8: 0.4900074393137697, mRNA_EN1: -0.5803103330229963, mRNA_ZNF552: 0.8939542842769379, Methylation_LRRC6: -0.2807612844368918, Methylation_chr2 66218712 LINC02934 (29533): 0.1234307865908451, Methylation_HOXB13: 0.0415004047538528, Methylation_chr10 3949206 LINC02660 (4871): 0.4627549310915498, Methylation_chr5 179517140 RNF130 (18026): -0.4275460046257109, Methylation_LOC727677: -0.219241382095213, Methylation_LETM1: 0.9096959585829576, Methylation_CDC42BPB: -1.0893402559288077, Methylation_C8orf38: 0.0255218165501019, Methylation_chr14 100504766 EVL (18852): 0.0007718997091698, Methylation_chr5 72594851 LOC340090 (24088): 0.3220982239659256, Methylation_chr2 242904738 LINC01238 (3421): -0.5739849924964624, Methylation_ARFGEF1: -0.0285255052987388, Methylation_MAPT: -0.7262056969231053, Methylation_ZFAT: 0.3364044473398477, Methylation_KCNQ4: -0.6447053778882316, Methylation_chr1 232684368 SIPA1L2 (12934): -0.2302229037570217, Methylation_CRNKL1: -0.4327789052221087, Methylation_PRKAG2: 0.2558889601500814, Methylation_MICB: -0.2277602113412115, miRNA_hsa-mir-934: -0.3288811788160408, miRNA_hsa-mir-4728: -0.3300361702029502, miRNA_hsa-mir-5695: -0.0467832057150803, miRNA_hsa-mir-18a: -0.5969059209951437, miRNA_hsa-mir-190b: 0.0923000555738207, miRNA_hsa-mir-577: -0.5860185259105049, miRNA_hsa-mir-135b: -0.7255981462033049, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.1728650112682448, miRNA_hsa-mir-130b: -1.841135128578816, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-D8-A1XB,"No features meet the strict diagnostic thresholds for mRNA (Z > 1.30 or Z < -1.92), methylation (Z > 1.50 or Z < -1.47), miRNA (Z > 1.99 or Z < -1.25), or CNV (deletion, gain, amplification, or high-level amplification). All values fall within non-actionable ranges.","mRNA_MLPH: 0.389278802334858, mRNA_C2orf54: 0.2154289575614375, mRNA_CITED4: 0.4117540585924529, mRNA_ESR1: 0.8546975909504719, mRNA_SPDEF: 0.6309725434839443, mRNA_AGR3: 0.3253121140246177, mRNA_FOXC1: -0.3060742580862471, mRNA_GATA3: 0.3705400130329278, mRNA_AGR2: 0.1177843079708377, mRNA_XBP1: 0.47227393062077, mRNA_PRR15: 0.4599389151085855, mRNA_SLC44A4: 0.3171244115477268, mRNA_CA12: 0.3971648912668048, mRNA_DTL: 0.4985980422440362, mRNA_C5AR2: 0.4259693810323527, mRNA_TBC1D9: 0.9267545781294964, mRNA_AR: 1.102285888239949, mRNA_CCDC170: 0.969488904463875, mRNA_DEGS2: 0.5315361904528246, mRNA_TFF3: -0.1989479798646297, mRNA_DNALI1: 0.7956631732354347, mRNA_LINC00504: 1.2243909303939648, mRNA_CLCA2: 1.2046725973618444, mRNA_PPP1R14C: 0.3967066651754729, mRNA_THSD4: 0.7614100663367487, mRNA_SPAG5: -0.3309341163189867, mRNA_FBP1: 0.1468617859206211, mRNA_SLC7A8: 0.7610960925122877, mRNA_EN1: 0.2097658553327485, mRNA_ZNF552: -0.1669752529793838, Methylation_LRRC6: -0.0412131465439151, Methylation_chr2 66218712 LINC02934 (29533): -0.0781778108407604, Methylation_HOXB13: 0.3021942207786204, Methylation_chr10 3949206 LINC02660 (4871): -0.9143978638217356, Methylation_chr5 179517140 RNF130 (18026): 0.884746318929561, Methylation_LOC727677: -0.0205973298891075, Methylation_LETM1: -0.1683061077087363, Methylation_CDC42BPB: -0.4341874242682319, Methylation_C8orf38: -0.6689860772350107, Methylation_chr14 100504766 EVL (18852): -0.0406929616131354, Methylation_chr5 72594851 LOC340090 (24088): 0.2474206051902931, Methylation_chr2 242904738 LINC01238 (3421): -0.5718004376425518, Methylation_ARFGEF1: -0.3335857388955811, Methylation_MAPT: -0.819547799423609, Methylation_ZFAT: -0.3671765199130316, Methylation_KCNQ4: 0.0424945690916063, Methylation_chr1 232684368 SIPA1L2 (12934): -0.6992048660931417, Methylation_CRNKL1: -0.3166569401259753, Methylation_PRKAG2: 0.3512990980885458, Methylation_MICB: -0.2655833441614537, miRNA_hsa-mir-934: -0.3527261999685752, miRNA_hsa-mir-4728: -0.9409913797190632, miRNA_hsa-mir-5695: 0.1671756083682792, miRNA_hsa-mir-18a: -0.771032642174048, miRNA_hsa-mir-190b: -0.258181964221139, miRNA_hsa-mir-577: 0.1701267014551327, miRNA_hsa-mir-135b: -0.5660644649513941, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.5248983575237918, miRNA_hsa-mir-130b: -0.681512725228946, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-LL-A442,"High-level Amplification of ZNF552 drives mRNA overexpression (Z = 2.01).  
AR mRNA is low (Z = -2.19), consistent with transcriptional downregulation.  
No methylation or miRNA alterations meet diagnostic thresholds.  
CNV shows no deletions or amplifications per criteria.  
These features suggest a luminal phenotype with androgen receptor loss.","mRNA_MLPH: 0.8350209142735203, mRNA_C2orf54: -1.1532069527438118, mRNA_CITED4: -0.654627207158811, mRNA_ESR1: 1.2040428241892065, mRNA_SPDEF: 0.8124932903170177, mRNA_AGR3: 1.6076918304873682, mRNA_FOXC1: -0.7861765178986893, mRNA_GATA3: 0.7590095929943751, mRNA_AGR2: 0.1081583142474719, mRNA_XBP1: 1.0016117824047837, mRNA_PRR15: 0.3428117965351775, mRNA_SLC44A4: 1.002839937543904, mRNA_CA12: 1.117152328054242, mRNA_DTL: 0.3161215055732536, mRNA_C5AR2: 1.0971063938825822, mRNA_TBC1D9: 1.0550574841893794, mRNA_AR: -2.1877317916651258, mRNA_CCDC170: 1.1260568425070705, mRNA_DEGS2: 0.982026573761946, mRNA_TFF3: 1.2341895631407565, mRNA_DNALI1: 0.3631466859654699, mRNA_LINC00504: 1.6262544846893856, mRNA_CLCA2: -0.8950940779111158, mRNA_PPP1R14C: -1.1452685954310835, mRNA_THSD4: 1.415882305922559, mRNA_SPAG5: -0.0880970656886239, mRNA_FBP1: 0.9510414126248956, mRNA_SLC7A8: 1.6251950286436168, mRNA_EN1: -0.6659172482712893, mRNA_ZNF552: 2.005385775370173, Methylation_LRRC6: -0.7444592589281985, Methylation_chr2 66218712 LINC02934 (29533): -1.3236136611928142, Methylation_HOXB13: -1.023804043431224, Methylation_chr10 3949206 LINC02660 (4871): -1.089626083940758, Methylation_chr5 179517140 RNF130 (18026): 1.0588510464920344, Methylation_LOC727677: -1.0268328353522411, Methylation_LETM1: -1.280965366644601, Methylation_CDC42BPB: -1.27080981218459, Methylation_C8orf38: -1.084614640855619, Methylation_chr14 100504766 EVL (18852): -1.0663962745510212, Methylation_chr5 72594851 LOC340090 (24088): 0.995199638462108, Methylation_chr2 242904738 LINC01238 (3421): -1.1001882787547683, Methylation_ARFGEF1: -0.6430253827069948, Methylation_MAPT: -1.345453150189903, Methylation_ZFAT: -1.2989024420353796, Methylation_KCNQ4: -1.1653974204269388, Methylation_chr1 232684368 SIPA1L2 (12934): -0.7902235946515476, Methylation_CRNKL1: -0.7535537665219787, Methylation_PRKAG2: -0.6542475172653895, Methylation_MICB: -1.1339865754771874, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.4389731032010998, miRNA_hsa-mir-5695: 0.6602845355666801, miRNA_hsa-mir-18a: -0.6026573314558852, miRNA_hsa-mir-190b: 1.2806930133103844, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.026821585468073, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.150167478678849, miRNA_hsa-mir-130b: -0.4455372450506148, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A27R,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. No mRNA, methylation, or miRNA features meet diagnostic thresholds for significant dysregulation. These genomic amplifications suggest a proliferative phenotype with potential vesicular trafficking and centrosomal pathway dysregulation.","mRNA_MLPH: 0.194353244295117, mRNA_C2orf54: -0.057108057386945, mRNA_CITED4: 0.7515371818302234, mRNA_ESR1: 0.2116348179645782, mRNA_SPDEF: 0.6639689475065444, mRNA_AGR3: -0.4197828829922312, mRNA_FOXC1: -0.5996175811150154, mRNA_GATA3: 0.467258285418309, mRNA_AGR2: 0.3420571058536575, mRNA_XBP1: 0.9230512311624006, mRNA_PRR15: -0.0392653729515434, mRNA_SLC44A4: -0.0606968407069646, mRNA_CA12: 0.8608177266875213, mRNA_DTL: -0.1080237607698458, mRNA_C5AR2: 0.319995531777992, mRNA_TBC1D9: -0.4741228382152921, mRNA_AR: -0.7807803705728824, mRNA_CCDC170: -0.0356858545618063, mRNA_DEGS2: -0.5322704756538609, mRNA_TFF3: -0.1357044835602111, mRNA_DNALI1: 0.7765216550868237, mRNA_LINC00504: -0.8820345547295887, mRNA_CLCA2: -0.7770327236904042, mRNA_PPP1R14C: -0.7355228305856989, mRNA_THSD4: 1.1129368792904455, mRNA_SPAG5: 1.232783309348992, mRNA_FBP1: -0.121698346258618, mRNA_SLC7A8: -0.1111538144935174, mRNA_EN1: -0.5025153807904029, mRNA_ZNF552: 1.239308506075012, Methylation_LRRC6: -0.6319579577964761, Methylation_chr2 66218712 LINC02934 (29533): 0.7718146188306332, Methylation_HOXB13: 0.717276297645345, Methylation_chr10 3949206 LINC02660 (4871): -0.7888194128513538, Methylation_chr5 179517140 RNF130 (18026): -0.2507088107322707, Methylation_LOC727677: -0.2322737121971177, Methylation_LETM1: -0.3544018763194014, Methylation_CDC42BPB: 0.6286283993172064, Methylation_C8orf38: 0.7469645365681513, Methylation_chr14 100504766 EVL (18852): 0.7850173275610927, Methylation_chr5 72594851 LOC340090 (24088): -0.3590941954598407, Methylation_chr2 242904738 LINC01238 (3421): 1.1104781740493332, Methylation_ARFGEF1: -0.5430807475465099, Methylation_MAPT: 0.1278233488328382, Methylation_ZFAT: -0.9471484670524768, Methylation_KCNQ4: 0.3037880933479853, Methylation_chr1 232684368 SIPA1L2 (12934): 0.6259564205196778, Methylation_CRNKL1: 1.0172017988513034, Methylation_PRKAG2: -0.8314296857265124, Methylation_MICB: -0.6635406945607211, miRNA_hsa-mir-934: -0.3903300325754809, miRNA_hsa-mir-4728: -0.132952618895717, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.6296573920395871, miRNA_hsa-mir-190b: -0.6482994114320693, miRNA_hsa-mir-577: -0.2921921695798891, miRNA_hsa-mir-135b: -0.1182231193375123, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.0609950558375084, miRNA_hsa-mir-130b: 0.112650172044204, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-E9-A22G,"High-level Amplification of EN1 drives significant mRNA overexpression. KCNQ4 promoter hypermethylation mediates epigenetic silencing. Deletion of none detected. Upregulated miRNAs (miR-577, miR-18a, miR-17) suggest oncogenic signaling. These features collectively indicate a basal-like phenotype with PI3K/AKT dysregulation.","mRNA_MLPH: -3.1299857025934243, mRNA_C2orf54: -1.2091486596223169, mRNA_CITED4: 1.257105586122163, mRNA_ESR1: -1.6861745666636991, mRNA_SPDEF: -1.2187851378772547, mRNA_AGR3: -1.9552866005331573, mRNA_FOXC1: 1.9731944756331885, mRNA_GATA3: -1.791159250519363, mRNA_AGR2: -1.9799219043125005, mRNA_XBP1: -2.086030180378006, mRNA_PRR15: -2.086964869202083, mRNA_SLC44A4: -2.3189711047027246, mRNA_CA12: -2.1283441743134213, mRNA_DTL: 1.5684407800547755, mRNA_C5AR2: -2.09709185852672, mRNA_TBC1D9: -2.6427912787583963, mRNA_AR: -2.469141186882609, mRNA_CCDC170: -1.840721037534149, mRNA_DEGS2: -1.9782081611562283, mRNA_TFF3: -1.9151940083909225, mRNA_DNALI1: -2.077022487538424, mRNA_LINC00504: -1.7402244998629115, mRNA_CLCA2: -0.7807963409793249, mRNA_PPP1R14C: 1.9343905006520192, mRNA_THSD4: -1.798218253069782, mRNA_SPAG5: 0.8459311775999668, mRNA_FBP1: -2.825294754018908, mRNA_SLC7A8: -3.109735623183714, mRNA_EN1: 2.77652250448934, mRNA_ZNF552: -1.7956013896469354, Methylation_LRRC6: 1.310321038969692, Methylation_chr2 66218712 LINC02934 (29533): -0.7564833968036785, Methylation_HOXB13: -1.0099265019497945, Methylation_chr10 3949206 LINC02660 (4871): 1.5478823772248749, Methylation_chr5 179517140 RNF130 (18026): -1.403295889800694, Methylation_LOC727677: 1.366807876499381, Methylation_LETM1: 1.281085624030261, Methylation_CDC42BPB: 0.2854625975638062, Methylation_C8orf38: 1.3058120360377905, Methylation_chr14 100504766 EVL (18852): 1.442803256076871, Methylation_chr5 72594851 LOC340090 (24088): -1.6167543806068725, Methylation_chr2 242904738 LINC01238 (3421): 1.329362712470629, Methylation_ARFGEF1: 1.629369951973502, Methylation_MAPT: 1.320456749577104, Methylation_ZFAT: 1.268827654317989, Methylation_KCNQ4: 2.024939395076845, Methylation_chr1 232684368 SIPA1L2 (12934): 1.295215887821684, Methylation_CRNKL1: 1.4115575497157713, Methylation_PRKAG2: -0.0497435135000982, Methylation_MICB: 1.539225187356959, miRNA_hsa-mir-934: 2.9566258095892715, miRNA_hsa-mir-4728: -0.551854300004299, miRNA_hsa-mir-5695: 2.4390822235628065, miRNA_hsa-mir-18a: 3.080685677143535, miRNA_hsa-mir-190b: -1.218850008756594, miRNA_hsa-mir-577: 4.533577783508734, miRNA_hsa-mir-135b: 2.1779379550629607, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 3.513547508645801, miRNA_hsa-mir-130b: 2.901415828060337, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-E2-A1IO,High mRNA_C5AR2 (Z=1.32) indicates overexpression. No methylation sites meet hyper/hypo thresholds. No miRNA alterations exceed regulatory cutoffs. All CNVs fall within normal range (−1.10 to −0.10). No driver events detected.,"mRNA_MLPH: 0.1179026911469146, mRNA_C2orf54: 0.9370356649487046, mRNA_CITED4: -0.9848245511492686, mRNA_ESR1: 0.2675147783469122, mRNA_SPDEF: -0.0447092310529847, mRNA_AGR3: 0.3621867682919145, mRNA_FOXC1: -0.0042195135267604, mRNA_GATA3: 0.1766243945126183, mRNA_AGR2: -0.1400055800549768, mRNA_XBP1: 0.0360365204037061, mRNA_PRR15: -0.0361447181499655, mRNA_SLC44A4: 0.0789064495398158, mRNA_CA12: 0.3873292920184816, mRNA_DTL: -0.6803796473842287, mRNA_C5AR2: 1.3224967854677323, mRNA_TBC1D9: 0.2131267114561336, mRNA_AR: 0.7626910918986585, mRNA_CCDC170: 0.636846908900569, mRNA_DEGS2: 0.2111192159705447, mRNA_TFF3: 0.0793248013877782, mRNA_DNALI1: 0.2903753700440868, mRNA_LINC00504: 0.3931527137719676, mRNA_CLCA2: 0.7985305852635034, mRNA_PPP1R14C: 0.4354563341369645, mRNA_THSD4: 0.7277790708797732, mRNA_SPAG5: -0.6207390995600551, mRNA_FBP1: -0.0836886792669649, mRNA_SLC7A8: 0.6036134202136105, mRNA_EN1: 0.0881987236600053, mRNA_ZNF552: 0.2778796920102241, Methylation_LRRC6: -0.2393539532131978, Methylation_chr2 66218712 LINC02934 (29533): 0.2493603982165697, Methylation_HOXB13: -0.997095895532688, Methylation_chr10 3949206 LINC02660 (4871): -0.1861941219804327, Methylation_chr5 179517140 RNF130 (18026): -1.3051823965822755, Methylation_LOC727677: -0.1410528015846542, Methylation_LETM1: -0.1138731159293486, Methylation_CDC42BPB: -0.8021376133051051, Methylation_C8orf38: -0.1577944255108326, Methylation_chr14 100504766 EVL (18852): 0.3151102270373925, Methylation_chr5 72594851 LOC340090 (24088): 0.3333983580730223, Methylation_chr2 242904738 LINC01238 (3421): -0.4777934258959149, Methylation_ARFGEF1: -0.2862759464234585, Methylation_MAPT: -0.3145467216725107, Methylation_ZFAT: -0.4219763061163353, Methylation_KCNQ4: -0.2020835272384216, Methylation_chr1 232684368 SIPA1L2 (12934): 0.5344699488508393, Methylation_CRNKL1: -0.42514903806503, Methylation_PRKAG2: -0.0356943165394914, Methylation_MICB: 0.7962085051313669, miRNA_hsa-mir-934: -0.2883095827352772, miRNA_hsa-mir-4728: 0.744274564599312, miRNA_hsa-mir-5695: 0.8723604130325554, miRNA_hsa-mir-18a: -0.2246814927930985, miRNA_hsa-mir-190b: 0.6263217868390806, miRNA_hsa-mir-577: -0.4750736236412744, miRNA_hsa-mir-135b: -0.0035832384564866, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.9297244516110236, miRNA_hsa-mir-130b: -0.2969714847817638, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A1-A0SN,"High mRNA_C2orf54 (Z=1.66) and mRNA_AGR2 (Z=1.41) indicate overexpression. No methylation or miRNA alterations meet diagnostic thresholds. CNV shows only gains (e.g., VPS54, CEP68), insufficient for amplification calls. These features suggest luminal A phenotype with ER-pathway activity.","mRNA_MLPH: 0.1926646102099472, mRNA_C2orf54: 1.6570712247902728, mRNA_CITED4: -0.0754902786652931, mRNA_ESR1: 0.6925257342750994, mRNA_SPDEF: 0.6278503429526299, mRNA_AGR3: 0.6544849235280736, mRNA_FOXC1: -0.19106903801026, mRNA_GATA3: 0.339012108339619, mRNA_AGR2: 1.405840922843494, mRNA_XBP1: 0.4081975263517625, mRNA_PRR15: 0.8602921781120559, mRNA_SLC44A4: 0.4820322666210014, mRNA_CA12: 0.0213906734831983, mRNA_DTL: 1.0586043906077842, mRNA_C5AR2: 0.9178739079768078, mRNA_TBC1D9: -0.0550791270224906, mRNA_AR: 0.1061670417306318, mRNA_CCDC170: 0.9241836146882232, mRNA_DEGS2: 0.3849762318989441, mRNA_TFF3: 0.2690474223167891, mRNA_DNALI1: 0.2581490988668133, mRNA_LINC00504: -1.161825527289161, mRNA_CLCA2: 0.3778058146919506, mRNA_PPP1R14C: -0.2050358594368428, mRNA_THSD4: 0.6471536564885887, mRNA_SPAG5: 1.052227753876113, mRNA_FBP1: 0.5525383443767421, mRNA_SLC7A8: -0.0293413909222187, mRNA_EN1: -0.2722852267848198, mRNA_ZNF552: 0.563180160824168, Methylation_LRRC6: -0.4867197735816395, Methylation_chr2 66218712 LINC02934 (29533): 0.7799627243430435, Methylation_HOXB13: 0.707212721251288, Methylation_chr10 3949206 LINC02660 (4871): 0.6284193742976534, Methylation_chr5 179517140 RNF130 (18026): 0.7560690916038284, Methylation_LOC727677: 0.0372242447614393, Methylation_LETM1: -0.1786368740263664, Methylation_CDC42BPB: 1.1753073878952698, Methylation_C8orf38: -0.7815863061814531, Methylation_chr14 100504766 EVL (18852): -0.563149533763131, Methylation_chr5 72594851 LOC340090 (24088): 0.7844570333901206, Methylation_chr2 242904738 LINC01238 (3421): 0.4688532701422567, Methylation_ARFGEF1: -0.1219811195505465, Methylation_MAPT: 0.0873486333207626, Methylation_ZFAT: -0.4910030375373502, Methylation_KCNQ4: -0.536333314328046, Methylation_chr1 232684368 SIPA1L2 (12934): -0.7601484134503405, Methylation_CRNKL1: -0.7071399900957522, Methylation_PRKAG2: -0.6773138170265494, Methylation_MICB: -0.4024068273789442, miRNA_hsa-mir-934: -0.0852610427333929, miRNA_hsa-mir-4728: 1.109083042074133, miRNA_hsa-mir-5695: 0.0321254889307683, miRNA_hsa-mir-18a: -0.8287525830969472, miRNA_hsa-mir-190b: -1.072860004425838, miRNA_hsa-mir-577: -0.4143870918802508, miRNA_hsa-mir-135b: -0.434422814337895, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.0344394526516802, miRNA_hsa-mir-130b: -0.5183094550961029, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-S3-AA11,High mRNA_MLPH (Z=1.47) indicates overexpression. No methylation or miRNA alterations meet diagnostic thresholds. All CNVs fall within normal range (−1.10 to −0.10). Isolated MLPH upregulation suggests luminal biology without clear genomic drivers.,"mRNA_MLPH: 1.4656301451161364, mRNA_C2orf54: 0.9857211476105084, mRNA_CITED4: -0.5692866601945106, mRNA_ESR1: 0.9426794879591608, mRNA_SPDEF: 0.6326123581611328, mRNA_AGR3: 0.8194040731654184, mRNA_FOXC1: -0.3880740391818142, mRNA_GATA3: 0.5241917566776579, mRNA_AGR2: 0.5575905567922799, mRNA_XBP1: 1.0418967312488718, mRNA_PRR15: 0.2484988977335244, mRNA_SLC44A4: 0.4889994028638434, mRNA_CA12: 0.3614044771030633, mRNA_DTL: -0.3753290947197265, mRNA_C5AR2: 0.5664544024477827, mRNA_TBC1D9: 0.780107668767054, mRNA_AR: 0.7094433662463835, mRNA_CCDC170: 1.3591416656077029, mRNA_DEGS2: 0.4139601430811379, mRNA_TFF3: 1.029233667083412, mRNA_DNALI1: 0.7530143646423363, mRNA_LINC00504: 0.6076450548858925, mRNA_CLCA2: 0.0957841683747024, mRNA_PPP1R14C: 0.0415505602582537, mRNA_THSD4: 0.9202924845698812, mRNA_SPAG5: 0.9114013846188452, mRNA_FBP1: 0.9327094160886176, mRNA_SLC7A8: 0.5040617948882964, mRNA_EN1: -0.3682000573396087, mRNA_ZNF552: 0.4583424822494085, Methylation_LRRC6: -0.9672766174239734, Methylation_chr2 66218712 LINC02934 (29533): -0.6711604163366646, Methylation_HOXB13: -0.7530792998350292, Methylation_chr10 3949206 LINC02660 (4871): 0.3541715044937894, Methylation_chr5 179517140 RNF130 (18026): 0.6082192194109942, Methylation_LOC727677: -0.956518065165087, Methylation_LETM1: -0.0745618673003927, Methylation_CDC42BPB: 1.1465787898527933, Methylation_C8orf38: 0.7864478031054597, Methylation_chr14 100504766 EVL (18852): -1.0523715058028045, Methylation_chr5 72594851 LOC340090 (24088): 0.6667972115196862, Methylation_chr2 242904738 LINC01238 (3421): -1.1325879281272944, Methylation_ARFGEF1: -0.7007131498162714, Methylation_MAPT: -1.2939610670060926, Methylation_ZFAT: 0.7650721744371212, Methylation_KCNQ4: -0.6567120892836766, Methylation_chr1 232684368 SIPA1L2 (12934): -0.937970922665908, Methylation_CRNKL1: -0.7920117188996232, Methylation_PRKAG2: 1.3089308781711324, Methylation_MICB: -0.2457145036773508, miRNA_hsa-mir-934: -0.3510959360765333, miRNA_hsa-mir-4728: -0.560938092330556, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.3665899557786428, miRNA_hsa-mir-190b: 0.6972785702624209, miRNA_hsa-mir-577: -0.6374439908375092, miRNA_hsa-mir-135b: -0.3754642122754145, miRNA_hsa-mir-2115: 0.1302364370972639, miRNA_hsa-mir-17: 0.179040888964279, miRNA_hsa-mir-130b: -0.987635396800014, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-B6-A1KI,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives oncogenic transcriptional activity. No mRNA, methylation, or miRNA alterations meet diagnostic thresholds for reporting. These features collectively indicate a proliferation-driven phenotype with genomic instability.","mRNA_MLPH: 0.3275317814309669, mRNA_C2orf54: -1.1189104802562868, mRNA_CITED4: 1.0712668406504944, mRNA_ESR1: 0.952204925645298, mRNA_SPDEF: 0.3822011894115174, mRNA_AGR3: 0.613472650417778, mRNA_FOXC1: 0.2031082689874365, mRNA_GATA3: 0.4324405656005438, mRNA_AGR2: 0.3080307456401985, mRNA_XBP1: 0.9409456419325548, mRNA_PRR15: -0.2011220086291876, mRNA_SLC44A4: 0.9537819963880946, mRNA_CA12: 1.12123164345683, mRNA_DTL: -0.9857282460341652, mRNA_C5AR2: 0.7086141471527286, mRNA_TBC1D9: 0.4778338224550029, mRNA_AR: 0.4763074466962865, mRNA_CCDC170: 0.9216692678153962, mRNA_DEGS2: 0.8555341965738399, mRNA_TFF3: 0.2790487697835996, mRNA_DNALI1: 0.4053715505929334, mRNA_LINC00504: 0.3859255599918111, mRNA_CLCA2: -0.3619078187600717, mRNA_PPP1R14C: -0.8442676341926575, mRNA_THSD4: 1.0076379947125025, mRNA_SPAG5: -1.4628351102200527, mRNA_FBP1: 0.5761180493319957, mRNA_SLC7A8: -0.2715108022526529, mRNA_EN1: -0.4098126452242141, mRNA_ZNF552: 1.4136784175734654, Methylation_LRRC6: 0.2918886121242818, Methylation_chr2 66218712 LINC02934 (29533): 0.065715045433064, Methylation_HOXB13: -1.0768813918316988, Methylation_chr10 3949206 LINC02660 (4871): 0.1671670967166374, Methylation_chr5 179517140 RNF130 (18026): -0.4365355472547809, Methylation_LOC727677: 0.247338709912732, Methylation_LETM1: 0.0395288816157234, Methylation_CDC42BPB: -0.5610122213979156, Methylation_C8orf38: -0.5087867975526279, Methylation_chr14 100504766 EVL (18852): 0.1903836870772549, Methylation_chr5 72594851 LOC340090 (24088): 0.4252490258184583, Methylation_chr2 242904738 LINC01238 (3421): -0.27866980161964, Methylation_ARFGEF1: 0.9157421346946376, Methylation_MAPT: -0.5150167095655774, Methylation_ZFAT: 1.1483908785764911, Methylation_KCNQ4: -1.1193402915316164, Methylation_chr1 232684368 SIPA1L2 (12934): 0.2087254835522494, Methylation_CRNKL1: -0.6020656813283989, Methylation_PRKAG2: -0.593084197562971, Methylation_MICB: -0.2515803434284627, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.0754765074711298, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.2482447118440951, miRNA_hsa-mir-190b: 0.0990020312090709, miRNA_hsa-mir-577: -0.5486364756592783, miRNA_hsa-mir-135b: -1.0578835081159033, miRNA_hsa-mir-2115: -0.326129915379296, miRNA_hsa-mir-17: -1.57224931972105, miRNA_hsa-mir-130b: -0.3322439328421454, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-A2-A3XY,"High-level Amplification of EN1 drives significant mRNA overexpression. FOXC1 mRNA is markedly elevated (Z=2.13), though without CNV data. Promoter hypermethylation of RNF130 and LOC340090 correlates with transcriptional silencing. miR-190b is downregulated (Z=-1.77). Deletions absent; no gains/amplifications detected in listed CNVs.","mRNA_MLPH: -2.126572792940389, mRNA_C2orf54: 0.9870697475427398, mRNA_CITED4: 0.7462641345601257, mRNA_ESR1: -1.8070294104950595, mRNA_SPDEF: -1.6894044442370029, mRNA_AGR3: -1.606215509452568, mRNA_FOXC1: 2.1293501939771025, mRNA_GATA3: -2.301034325772797, mRNA_AGR2: -1.8106832161624968, mRNA_XBP1: -1.911627606889164, mRNA_PRR15: -2.0174379948860803, mRNA_SLC44A4: -1.789604139196962, mRNA_CA12: -1.6220733280088766, mRNA_DTL: -0.245883654429575, mRNA_C5AR2: -1.5127724520009536, mRNA_TBC1D9: -1.5023716855357274, mRNA_AR: -1.5864900841481269, mRNA_CCDC170: -1.0218724086475504, mRNA_DEGS2: -1.8913988988320871, mRNA_TFF3: -1.386105462248669, mRNA_DNALI1: -1.294498331300285, mRNA_LINC00504: -1.7072609310545528, mRNA_CLCA2: -0.6843890561237138, mRNA_PPP1R14C: 1.680786010390921, mRNA_THSD4: -1.1322070053564155, mRNA_SPAG5: -0.2150601854567996, mRNA_FBP1: -2.050428820279904, mRNA_SLC7A8: -1.4420174857445411, mRNA_EN1: 3.4665958435376094, mRNA_ZNF552: -2.004252504614912, Methylation_LRRC6: 1.47443244697968, Methylation_chr2 66218712 LINC02934 (29533): -0.1010079004057279, Methylation_HOXB13: 0.6198280935529702, Methylation_chr10 3949206 LINC02660 (4871): 1.4134563609015542, Methylation_chr5 179517140 RNF130 (18026): -1.641553149931478, Methylation_LOC727677: 1.5340407687980795, Methylation_LETM1: 1.2857452676941856, Methylation_CDC42BPB: -0.428440618231055, Methylation_C8orf38: 1.5751544590840303, Methylation_chr14 100504766 EVL (18852): 1.5379430904124165, Methylation_chr5 72594851 LOC340090 (24088): -1.5856204265764684, Methylation_chr2 242904738 LINC01238 (3421): 1.2177298503958092, Methylation_ARFGEF1: 1.263293610457814, Methylation_MAPT: 1.4223154800842828, Methylation_ZFAT: 1.3868233778303485, Methylation_KCNQ4: 0.3206018119375747, Methylation_chr1 232684368 SIPA1L2 (12934): 1.4140121348413872, Methylation_CRNKL1: 1.2807391459801898, Methylation_PRKAG2: -0.3424326659598108, Methylation_MICB: 1.5061287538626864, miRNA_hsa-mir-934: 0.4342093517426252, miRNA_hsa-mir-4728: -1.0631440915959176, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.0816598689295336, miRNA_hsa-mir-190b: -1.7654714999753849, miRNA_hsa-mir-577: 0.8275507283625941, miRNA_hsa-mir-135b: 1.039541368361967, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.2594660402021347, miRNA_hsa-mir-130b: 0.6847925929714267, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A1N3,"mRNA_CITED4 is downregulated (Z = -1.94). No mRNA upregulation meets Z > 1.30. PRKAG2 promoter hypermethylation (Z = -1.597) indicates hypomethylation—**not** hypermethylation; thus, **no qualifying methylation events**. No miRNA passes thresholds. All CNVs fall in normal range (-1.10 to -0.10). **No reportable alterations per diagnostic rules.**","mRNA_MLPH: 0.8227565626335555, mRNA_C2orf54: -1.2714384300229606, mRNA_CITED4: -1.9444972022363527, mRNA_ESR1: 1.197145236392518, mRNA_SPDEF: 0.277068078030171, mRNA_AGR3: 0.3266826938914656, mRNA_FOXC1: -1.1810852169858137, mRNA_GATA3: 0.9114070968925928, mRNA_AGR2: -0.4853999961891441, mRNA_XBP1: 0.77847199336855, mRNA_PRR15: 0.7655112678355197, mRNA_SLC44A4: 0.7889945293436945, mRNA_CA12: 0.7047755149209123, mRNA_DTL: -0.2693936670181752, mRNA_C5AR2: 1.161132438121944, mRNA_TBC1D9: 1.4554455644937003, mRNA_AR: -1.193215508702512, mRNA_CCDC170: 1.2674030313582083, mRNA_DEGS2: 0.0711975794058135, mRNA_TFF3: 1.2784497245141846, mRNA_DNALI1: 0.8273973125451689, mRNA_LINC00504: 1.9391662847581408, mRNA_CLCA2: -0.7603265690607365, mRNA_PPP1R14C: -1.0028449734584262, mRNA_THSD4: 1.4378610661155566, mRNA_SPAG5: -0.1294680143151606, mRNA_FBP1: 0.8353618263814893, mRNA_SLC7A8: 0.4768490476660488, mRNA_EN1: -0.936825859794386, mRNA_ZNF552: 0.6307840595922535, Methylation_LRRC6: -0.8866358158758133, Methylation_chr2 66218712 LINC02934 (29533): -0.6242182981616572, Methylation_HOXB13: -1.009423912202677, Methylation_chr10 3949206 LINC02660 (4871): 1.2682354324729297, Methylation_chr5 179517140 RNF130 (18026): -0.8963757072874043, Methylation_LOC727677: -1.0823711645277267, Methylation_LETM1: -1.289402716183566, Methylation_CDC42BPB: -1.314933394529271, Methylation_C8orf38: -1.4087920719636084, Methylation_chr14 100504766 EVL (18852): -1.2071887150996643, Methylation_chr5 72594851 LOC340090 (24088): 0.5974342172624583, Methylation_chr2 242904738 LINC01238 (3421): -1.197447182964386, Methylation_ARFGEF1: -0.8331870659556061, Methylation_MAPT: -1.1942460056341464, Methylation_ZFAT: -1.010743762994972, Methylation_KCNQ4: -1.0207676430148511, Methylation_chr1 232684368 SIPA1L2 (12934): -1.092851115870075, Methylation_CRNKL1: -0.6414888555416226, Methylation_PRKAG2: -1.59675138735924, Methylation_MICB: -1.3428203859382246, miRNA_hsa-mir-934: -0.3515989912626748, miRNA_hsa-mir-4728: 0.3033837671253401, miRNA_hsa-mir-5695: -0.261970625349637, miRNA_hsa-mir-18a: -0.4966128477965439, miRNA_hsa-mir-190b: 1.4799783726526523, miRNA_hsa-mir-577: -0.2866726325038845, miRNA_hsa-mir-135b: -1.0443682265033285, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.3347237032103866, miRNA_hsa-mir-130b: -0.6378646046960598, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A1F0,"High-level Amplification absent; no CNVs meet amplification thresholds.  
PPP1R14C and EN1 mRNA overexpressed (Z > 1.30).  
GATA3, AGR2, DEGS2, SLC44A4, MLPH mRNAs downregulated (Z < -1.92).  
Methylation_chr10:3949206, ARFGEF1, C8orf38 hypermethylated (Z > 1.50).  
Methylation_RNF130 hypomethylated (Z < -1.47).  
miR-577 and miR-934 upregulated (Z > 1.99); miR-190b downregulated (Z < -1.25).","mRNA_MLPH: -2.0859649375404583, mRNA_C2orf54: -0.9705386950579054, mRNA_CITED4: 0.0728807589159572, mRNA_ESR1: -1.524298988901192, mRNA_SPDEF: -1.392524896163694, mRNA_AGR3: -1.7418800097618987, mRNA_FOXC1: 0.6225638043193826, mRNA_GATA3: -2.279998751165272, mRNA_AGR2: -2.344836319172704, mRNA_XBP1: -1.0763025229826684, mRNA_PRR15: -1.2598836415875505, mRNA_SLC44A4: -2.0406728298568555, mRNA_CA12: -1.8034097190741647, mRNA_DTL: 0.0121499416431263, mRNA_C5AR2: -1.1133795175097496, mRNA_TBC1D9: -1.0891185211378935, mRNA_AR: -1.8531308848496808, mRNA_CCDC170: -1.00533948489117, mRNA_DEGS2: -2.217475068075694, mRNA_TFF3: -1.3827057109520862, mRNA_DNALI1: -1.6076394672263432, mRNA_LINC00504: -1.7219297687088793, mRNA_CLCA2: -0.4327131260337648, mRNA_PPP1R14C: 2.3719633542736465, mRNA_THSD4: -0.8379260065893388, mRNA_SPAG5: 0.7247595152049014, mRNA_FBP1: -1.418000720113733, mRNA_SLC7A8: -1.1026525282645865, mRNA_EN1: 2.1559886460771818, mRNA_ZNF552: -1.1762782081550092, Methylation_LRRC6: 1.387889766015391, Methylation_chr2 66218712 LINC02934 (29533): 0.8610977640304276, Methylation_HOXB13: -0.9657547967962548, Methylation_chr10 3949206 LINC02660 (4871): 1.5804743958006933, Methylation_chr5 179517140 RNF130 (18026): -1.4600486761708509, Methylation_LOC727677: 1.459395403820481, Methylation_LETM1: 1.3594077565881093, Methylation_CDC42BPB: -0.2298568966173223, Methylation_C8orf38: 1.5091674535364337, Methylation_chr14 100504766 EVL (18852): 1.4510549242831343, Methylation_chr5 72594851 LOC340090 (24088): -1.318472083586615, Methylation_chr2 242904738 LINC01238 (3421): 1.3088944343254694, Methylation_ARFGEF1: 1.7056364442880068, Methylation_MAPT: 1.4503105007171273, Methylation_ZFAT: 1.438171356764721, Methylation_KCNQ4: -0.5811527093936765, Methylation_chr1 232684368 SIPA1L2 (12934): 1.3476658309884737, Methylation_CRNKL1: 1.2974482650947736, Methylation_PRKAG2: 0.8706732670593048, Methylation_MICB: 1.2590358226878482, miRNA_hsa-mir-934: 1.9917457939091017, miRNA_hsa-mir-4728: -0.6520262641533302, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.0579667109052149, miRNA_hsa-mir-190b: -1.604957928233972, miRNA_hsa-mir-577: 2.548063023143313, miRNA_hsa-mir-135b: 1.9071822334008093, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.1807728952796325, miRNA_hsa-mir-130b: 0.8570333512132208, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-D8-A1XG,"mRNA_CITED4 is low (Z = -1.61). Methylation at chr2:66218712 (LINC02934), chr5:179517140 (RNF130), and chr1:232684368 (SIPA1L2) is hypomethylated (Z < -1.47). miRNA_hsa-mir-135b is upregulated (Z = 1.65). No CNVs meet diagnostic thresholds. These features suggest luminal B phenotype with PI3K/AKT dysregulation.","mRNA_MLPH: 0.5501574641329314, mRNA_C2orf54: -1.2564201997456628, mRNA_CITED4: -1.6109380581367028, mRNA_ESR1: 1.277502114491276, mRNA_SPDEF: 0.1660595032268264, mRNA_AGR3: 0.8360774802899639, mRNA_FOXC1: -0.6307649490112797, mRNA_GATA3: 0.6299457396400872, mRNA_AGR2: 0.0581253576427737, mRNA_XBP1: 0.9485396762841128, mRNA_PRR15: 0.9424842373945806, mRNA_SLC44A4: 0.2493151089700534, mRNA_CA12: 0.5102989052636396, mRNA_DTL: 0.3606668987216266, mRNA_C5AR2: 0.8517096979230878, mRNA_TBC1D9: 0.6112494444599437, mRNA_AR: 0.938088716752249, mRNA_CCDC170: 1.6061969945648755, mRNA_DEGS2: 0.1698299879022982, mRNA_TFF3: 0.1098451467307497, mRNA_DNALI1: 0.0552021873406631, mRNA_LINC00504: 0.3451653243582876, mRNA_CLCA2: 0.0267617429813746, mRNA_PPP1R14C: 0.9573513944365962, mRNA_THSD4: 1.6111715116951608, mRNA_SPAG5: -0.2665475056629495, mRNA_FBP1: -0.4668365588222457, mRNA_SLC7A8: 0.0709175268885747, mRNA_EN1: 0.2294062311256594, mRNA_ZNF552: 0.3837333598481898, Methylation_LRRC6: -1.2480178333278311, Methylation_chr2 66218712 LINC02934 (29533): -1.8479915055544447, Methylation_HOXB13: -0.9803949389432752, Methylation_chr10 3949206 LINC02660 (4871): 1.629449653761305, Methylation_chr5 179517140 RNF130 (18026): -1.6459066432495668, Methylation_LOC727677: -0.8734105098285315, Methylation_LETM1: -0.4452159258739437, Methylation_CDC42BPB: -1.232815298985968, Methylation_C8orf38: -1.383310811214339, Methylation_chr14 100504766 EVL (18852): -1.120682095534014, Methylation_chr5 72594851 LOC340090 (24088): -0.6743593841060942, Methylation_chr2 242904738 LINC01238 (3421): -0.8856853774381371, Methylation_ARFGEF1: -0.8087483074362308, Methylation_MAPT: -1.3456572164734275, Methylation_ZFAT: 1.426415091475066, Methylation_KCNQ4: -0.8755159649955643, Methylation_chr1 232684368 SIPA1L2 (12934): -1.5870154899082012, Methylation_CRNKL1: -0.9660916987856538, Methylation_PRKAG2: -1.451904158786508, Methylation_MICB: -1.1134274876237475, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.4819230675259037, miRNA_hsa-mir-5695: 0.511904756317111, miRNA_hsa-mir-18a: -0.796942757535564, miRNA_hsa-mir-190b: 1.2702629941196035, miRNA_hsa-mir-577: 0.189564962302762, miRNA_hsa-mir-135b: 1.6514036526670646, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.0863085043526988, miRNA_hsa-mir-130b: 0.0313875159683538, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A24L,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.2198632256324477, mRNA_C2orf54: -1.120673588567498, mRNA_CITED4: -0.7393052856799204, mRNA_ESR1: 0.5482989702501652, mRNA_SPDEF: -0.0197920073838872, mRNA_AGR3: 0.4611948574116327, mRNA_FOXC1: -0.2295165930689895, mRNA_GATA3: 0.4803233064974565, mRNA_AGR2: 0.9509644785694796, mRNA_XBP1: -0.0109709850827574, mRNA_PRR15: 0.1794371033824957, mRNA_SLC44A4: -0.0960113178749015, mRNA_CA12: 1.0043390409720885, mRNA_DTL: 0.8517971238537274, mRNA_C5AR2: 0.3750755748344465, mRNA_TBC1D9: 0.8992181999331317, mRNA_AR: 0.685109486062305, mRNA_CCDC170: 0.71495209792242, mRNA_DEGS2: 0.0079209939136901, mRNA_TFF3: 0.1138198439318475, mRNA_DNALI1: 0.7619576493982702, mRNA_LINC00504: 0.967129027870085, mRNA_CLCA2: -0.4118591286389596, mRNA_PPP1R14C: 0.1267829063684876, mRNA_THSD4: 0.870327391828638, mRNA_SPAG5: 0.4662698220183179, mRNA_FBP1: 0.5742867494498529, mRNA_SLC7A8: 0.7803789477406619, mRNA_EN1: -0.1310989766300483, mRNA_ZNF552: 0.5554910486289143, Methylation_LRRC6: -0.02481265399553, Methylation_chr2 66218712 LINC02934 (29533): -1.2625609690457622, Methylation_HOXB13: -1.079946461807676, Methylation_chr10 3949206 LINC02660 (4871): -0.8965405682114735, Methylation_chr5 179517140 RNF130 (18026): 0.2411629351740534, Methylation_LOC727677: 0.3325024794634224, Methylation_LETM1: -0.2643481230086545, Methylation_CDC42BPB: 1.0449076143149898, Methylation_C8orf38: -0.0595992735176543, Methylation_chr14 100504766 EVL (18852): 0.293539623155558, Methylation_chr5 72594851 LOC340090 (24088): -0.9845176674730384, Methylation_chr2 242904738 LINC01238 (3421): -0.5653605675740773, Methylation_ARFGEF1: -0.1372444700888076, Methylation_MAPT: -0.923420595507948, Methylation_ZFAT: 0.0277105960039215, Methylation_KCNQ4: -0.950146541213248, Methylation_chr1 232684368 SIPA1L2 (12934): 0.0804467573192847, Methylation_CRNKL1: -0.0948083268545858, Methylation_PRKAG2: 0.0333604228165249, Methylation_MICB: -0.3220664520586423, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: 0.2283841859263595, miRNA_hsa-mir-18a: -0.7120871150052246, miRNA_hsa-mir-190b: 0.3849328546463884, miRNA_hsa-mir-577: -0.5199170605265909, miRNA_hsa-mir-135b: -0.2494366937917626, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.0125713532701042, miRNA_hsa-mir-130b: -0.3806979599870886, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A0E0,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. CLCA2 and EN1 show high mRNA (Z > 1.30). FOXC1 and PPP1R14C are upregulated (Z > 1.30). Promoter hypermethylation at chr10:3949206, LOC727677, ARFGEF1, and SIPA1L2 (Z > 1.50) suggests epigenetic silencing. Hypomethylation at RNF130 and LOC340090 (Z < -1.47). miR-934, miR-18a, and miR-130b are upregulated (Z > 1.99).","mRNA_MLPH: -2.180177272037329, mRNA_C2orf54: 0.9881082225606488, mRNA_CITED4: 0.118085085781471, mRNA_ESR1: -1.3344041069721049, mRNA_SPDEF: -1.2463574728556628, mRNA_AGR3: -1.2589561032018968, mRNA_FOXC1: 1.3132121374626275, mRNA_GATA3: -0.3664556283662356, mRNA_AGR2: -1.4418297082900295, mRNA_XBP1: -2.1598664528782807, mRNA_PRR15: -1.404546427890644, mRNA_SLC44A4: -1.59910829756285, mRNA_CA12: -2.198276782348721, mRNA_DTL: -0.4762269243738444, mRNA_C5AR2: -1.8047788404794527, mRNA_TBC1D9: -1.7322167397183197, mRNA_AR: -1.6022400923762825, mRNA_CCDC170: -1.8956151274766253, mRNA_DEGS2: -0.0956729768103319, mRNA_TFF3: -1.4379566093617049, mRNA_DNALI1: -1.69241144321115, mRNA_LINC00504: -0.858564931959599, mRNA_CLCA2: 2.730910576622215, mRNA_PPP1R14C: 1.360388044604892, mRNA_THSD4: -2.066826741991377, mRNA_SPAG5: 0.2631773221274379, mRNA_FBP1: -1.37944338683493, mRNA_SLC7A8: -2.215572471394116, mRNA_EN1: 2.113955787739028, mRNA_ZNF552: -1.472147547187292, Methylation_LRRC6: 1.473853383440202, Methylation_chr2 66218712 LINC02934 (29533): -0.4369687686014328, Methylation_HOXB13: 0.7181468868045068, Methylation_chr10 3949206 LINC02660 (4871): 1.6145881244230889, Methylation_chr5 179517140 RNF130 (18026): -1.485465233583876, Methylation_LOC727677: 1.5137256868207531, Methylation_LETM1: 1.335354921427332, Methylation_CDC42BPB: 0.3467057298444864, Methylation_C8orf38: 1.3989701421852694, Methylation_chr14 100504766 EVL (18852): 1.44939304382891, Methylation_chr5 72594851 LOC340090 (24088): -1.5772944408264011, Methylation_chr2 242904738 LINC01238 (3421): 1.3469672476357215, Methylation_ARFGEF1: 1.553683266148633, Methylation_MAPT: 1.3961706225862829, Methylation_ZFAT: 1.4473907059929327, Methylation_KCNQ4: 1.1361544983071663, Methylation_chr1 232684368 SIPA1L2 (12934): 1.4914233290292935, Methylation_CRNKL1: 1.3326834733775077, Methylation_PRKAG2: -1.165457205849841, Methylation_MICB: 1.319989199405424, miRNA_hsa-mir-934: 2.594954739142307, miRNA_hsa-mir-4728: -0.4009926038458244, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 2.8048139532578684, miRNA_hsa-mir-190b: -0.1516769567257603, miRNA_hsa-mir-577: 0.9967679142476878, miRNA_hsa-mir-135b: 1.0569618269193235, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.434374384776046, miRNA_hsa-mir-130b: 2.110243606527047, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-AR-A1AJ,"High-level Amplification absent; Gain observed in VPS54, WDPCP, CEP68. mRNA_PPP1R14C (Z=2.63) and SPAG5 (Z=2.18) overexpressed; FOXC1 (Z=1.52), DTL (Z=1.50) elevated. SPDEF, AGR2, PRR15, SLC44A4, DEGS2 significantly downregulated (Z < -1.92). Methylation hyper in ARFGEF1, C8orf38, LINC02660 (Z > 1.50); hypo in RNF130 (Z=-1.43). miRNA-577 upregulated (Z=1.93); mir-190b down (Z=-1.77).","mRNA_MLPH: -1.811959071154793, mRNA_C2orf54: -0.472149677502017, mRNA_CITED4: -0.1395509745889171, mRNA_ESR1: -1.1794708065108934, mRNA_SPDEF: -2.650062780279011, mRNA_AGR3: -2.034850458256788, mRNA_FOXC1: 1.524801703826154, mRNA_GATA3: -0.7628975962099974, mRNA_AGR2: -2.1814904308567526, mRNA_XBP1: -1.7475902322371704, mRNA_PRR15: -2.3316320700683906, mRNA_SLC44A4: -2.2709293753311863, mRNA_CA12: -1.281408231464931, mRNA_DTL: 1.4989627011467237, mRNA_C5AR2: -0.7970195856593245, mRNA_TBC1D9: -0.8698122792115691, mRNA_AR: -1.6177350807411923, mRNA_CCDC170: -0.8371875621286875, mRNA_DEGS2: -2.0988587359598747, mRNA_TFF3: -1.94463259296277, mRNA_DNALI1: -1.6708680146267552, mRNA_LINC00504: -1.7080974028567029, mRNA_CLCA2: -0.6465650607520352, mRNA_PPP1R14C: 2.6291753864129324, mRNA_THSD4: -1.6427712740582254, mRNA_SPAG5: 2.1833093328700275, mRNA_FBP1: -0.256367042473257, mRNA_SLC7A8: -1.2252022013948132, mRNA_EN1: 1.9260704305501355, mRNA_ZNF552: -1.5013226244580915, Methylation_LRRC6: 1.477716712961494, Methylation_chr2 66218712 LINC02934 (29533): 0.9761993406131896, Methylation_HOXB13: 0.0192626769742067, Methylation_chr10 3949206 LINC02660 (4871): 1.5625587779626648, Methylation_chr5 179517140 RNF130 (18026): -1.4308355026232151, Methylation_LOC727677: 1.4701036782497086, Methylation_LETM1: 1.3603461657146718, Methylation_CDC42BPB: -0.1160070104924818, Methylation_C8orf38: 1.5697916129117944, Methylation_chr14 100504766 EVL (18852): 1.3169280604983995, Methylation_chr5 72594851 LOC340090 (24088): -1.360979954735116, Methylation_chr2 242904738 LINC01238 (3421): 1.3477075017401705, Methylation_ARFGEF1: 1.6584887481111137, Methylation_MAPT: 1.4338297702250058, Methylation_ZFAT: 1.4269879274840305, Methylation_KCNQ4: -0.3003718823123187, Methylation_chr1 232684368 SIPA1L2 (12934): 1.441201959369464, Methylation_CRNKL1: 1.3212051098165372, Methylation_PRKAG2: -0.2261234357576014, Methylation_MICB: 1.2597229931766891, miRNA_hsa-mir-934: -0.0984943416604001, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.319803671955485, miRNA_hsa-mir-190b: -1.7666779816613545, miRNA_hsa-mir-577: 1.929223725896647, miRNA_hsa-mir-135b: 1.475332313654284, miRNA_hsa-mir-2115: -0.2326807816141498, miRNA_hsa-mir-17: 1.0108809751631245, miRNA_hsa-mir-130b: 1.2385486238887966, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-E9-A1RE,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.5317265460395291, mRNA_C2orf54: -1.2133589416949266, mRNA_CITED4: -1.677621464055178, mRNA_ESR1: 1.180414597302851, mRNA_SPDEF: 0.5794467360482454, mRNA_AGR3: 0.8419625682554269, mRNA_FOXC1: -1.2094961642783202, mRNA_GATA3: 0.3262513229868944, mRNA_AGR2: 1.237936958100947, mRNA_XBP1: 0.5231642172145373, mRNA_PRR15: 0.94236819346859, mRNA_SLC44A4: 0.1986782007824561, mRNA_CA12: 0.7186128245128627, mRNA_DTL: -0.1565536211144554, mRNA_C5AR2: 0.7807850028822692, mRNA_TBC1D9: 0.9674966124939832, mRNA_AR: 0.450152885416885, mRNA_CCDC170: 1.0807911152808964, mRNA_DEGS2: -0.0832102493793398, mRNA_TFF3: 1.1960077219307392, mRNA_DNALI1: -0.0376624790430018, mRNA_LINC00504: -0.253209435285236, mRNA_CLCA2: -0.7598896497164841, mRNA_PPP1R14C: -1.0822418837367092, mRNA_THSD4: 1.2571489564259692, mRNA_SPAG5: 0.5082674707571531, mRNA_FBP1: 1.0849451162302166, mRNA_SLC7A8: -0.3363928989049775, mRNA_EN1: -0.6712000729815141, mRNA_ZNF552: 1.1816866678917963, Methylation_LRRC6: -1.5395212567385297, Methylation_chr2 66218712 LINC02934 (29533): 1.1607653227231436, Methylation_HOXB13: 1.1791681190240948, Methylation_chr10 3949206 LINC02660 (4871): -1.2412546331927676, Methylation_chr5 179517140 RNF130 (18026): 1.1838683328264017, Methylation_LOC727677: -1.4974978433312045, Methylation_LETM1: -1.7124351300631273, Methylation_CDC42BPB: 1.3869594266223635, Methylation_C8orf38: 0.7695950943433036, Methylation_chr14 100504766 EVL (18852): -1.6421785399207922, Methylation_chr5 72594851 LOC340090 (24088): 1.1478255349494082, Methylation_chr2 242904738 LINC01238 (3421): -1.2023573185278909, Methylation_ARFGEF1: -1.5984701096032037, Methylation_MAPT: -1.7343914886667555, Methylation_ZFAT: -1.7076185214673354, Methylation_KCNQ4: 0.6163062155621639, Methylation_chr1 232684368 SIPA1L2 (12934): -1.3207982755328742, Methylation_CRNKL1: -1.4663690974721366, Methylation_PRKAG2: -0.5330417235300265, Methylation_MICB: -1.4152112136644537, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.1389925272923516, miRNA_hsa-mir-5695: 0.4786938429422316, miRNA_hsa-mir-18a: 0.544136158659108, miRNA_hsa-mir-190b: 0.3297732510998926, miRNA_hsa-mir-577: 0.0567874899347289, miRNA_hsa-mir-135b: -1.1446610018751224, miRNA_hsa-mir-2115: -0.0361936590459562, miRNA_hsa-mir-17: 1.1885314469674917, miRNA_hsa-mir-130b: 1.1528862628209855, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A7-A4SA,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.2516433423651007, mRNA_C2orf54: -0.0442639504504782, mRNA_CITED4: -0.5952301041368813, mRNA_ESR1: 0.1891076489886113, mRNA_SPDEF: -0.0649249256231233, mRNA_AGR3: 0.142275064555904, mRNA_FOXC1: -0.1157336503334871, mRNA_GATA3: 0.2433179353019322, mRNA_AGR2: 0.445593520232775, mRNA_XBP1: 0.2291066871790323, mRNA_PRR15: 0.2817564997588566, mRNA_SLC44A4: 0.1455912517447185, mRNA_CA12: 0.5157458834077462, mRNA_DTL: -0.6058302929631135, mRNA_C5AR2: 0.7918972390969373, mRNA_TBC1D9: 0.1197415723318494, mRNA_AR: 0.167311938506048, mRNA_CCDC170: -0.0550384237047101, mRNA_DEGS2: 0.739643726943714, mRNA_TFF3: 0.2529749680479141, mRNA_DNALI1: 0.495243380283915, mRNA_LINC00504: -0.4320215434045474, mRNA_CLCA2: -0.7209193089763652, mRNA_PPP1R14C: -0.6911464663728291, mRNA_THSD4: 0.341746380171159, mRNA_SPAG5: -0.0141284700089986, mRNA_FBP1: 0.4076078273971315, mRNA_SLC7A8: 0.1983558583976003, mRNA_EN1: -0.2904134813922388, mRNA_ZNF552: 0.4159104227436553, Methylation_LRRC6: 0.6108512538468284, Methylation_chr2 66218712 LINC02934 (29533): -0.0268537923972352, Methylation_HOXB13: -0.9899911041691556, Methylation_chr10 3949206 LINC02660 (4871): -0.2151740376081376, Methylation_chr5 179517140 RNF130 (18026): -1.4672268424878998, Methylation_LOC727677: 1.2053232993093554, Methylation_LETM1: 0.893505933896821, Methylation_CDC42BPB: 1.0411153269798026, Methylation_C8orf38: 0.1429670331265808, Methylation_chr14 100504766 EVL (18852): 0.2681704539238409, Methylation_chr5 72594851 LOC340090 (24088): 0.4570829096194713, Methylation_chr2 242904738 LINC01238 (3421): -0.4250468866531158, Methylation_ARFGEF1: 0.0247167527132449, Methylation_MAPT: -0.0750178234987916, Methylation_ZFAT: -0.0483015962401461, Methylation_KCNQ4: -1.0536610635286556, Methylation_chr1 232684368 SIPA1L2 (12934): -0.2781721342558322, Methylation_CRNKL1: -0.0896104343281934, Methylation_PRKAG2: -1.054064649856234, Methylation_MICB: -0.2708177968736366, miRNA_hsa-mir-934: -0.2435331816788156, miRNA_hsa-mir-4728: 0.3311156874928635, miRNA_hsa-mir-5695: -0.2469014529680199, miRNA_hsa-mir-18a: -0.2818257852979557, miRNA_hsa-mir-190b: 0.0714789010649014, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.6431716419846051, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.2045651720441685, miRNA_hsa-mir-130b: -1.399148782967414, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-OL-A66O,"Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 (CNV > 0.90) suggests coordinated genomic gain. LETM1 promoter hypermethylation (Z = -1.88) implies epigenetic silencing. No mRNA or miRNA alterations meet diagnostic thresholds. These features indicate a luminal phenotype with potential mitochondrial dysfunction due to LETM1 suppression.","mRNA_MLPH: 1.0648847370085974, mRNA_C2orf54: 0.6512118160747198, mRNA_CITED4: 0.7067048968806029, mRNA_ESR1: -0.1843701279439297, mRNA_SPDEF: 0.936778057725524, mRNA_AGR3: 0.8397320098729079, mRNA_FOXC1: -0.9650773347570908, mRNA_GATA3: 0.7470811661339134, mRNA_AGR2: 0.3390425241278355, mRNA_XBP1: 0.5902387069145207, mRNA_PRR15: 0.9628589026048048, mRNA_SLC44A4: 0.5689712639538685, mRNA_CA12: 0.2554637075567192, mRNA_DTL: 0.4230008142230401, mRNA_C5AR2: 0.4811870026266117, mRNA_TBC1D9: 0.9113000869663056, mRNA_AR: -0.0600350808811116, mRNA_CCDC170: -1.6347452827469575, mRNA_DEGS2: 0.7673983115135679, mRNA_TFF3: 0.9653787239402288, mRNA_DNALI1: 0.8280814736461986, mRNA_LINC00504: 0.5172346710254596, mRNA_CLCA2: -0.7772568233884192, mRNA_PPP1R14C: -0.7963972396657225, mRNA_THSD4: 0.005409343439361, mRNA_SPAG5: 0.6590335187505313, mRNA_FBP1: 0.7163337598826506, mRNA_SLC7A8: -0.3498034773844901, mRNA_EN1: -0.6707614845417015, mRNA_ZNF552: 0.3142533562633453, Methylation_LRRC6: -1.1632502769958015, Methylation_chr2 66218712 LINC02934 (29533): -1.6277866966974592, Methylation_HOXB13: -0.8374757691187449, Methylation_chr10 3949206 LINC02660 (4871): -0.8420277854943409, Methylation_chr5 179517140 RNF130 (18026): 1.2129846948714913, Methylation_LOC727677: -1.248711495850773, Methylation_LETM1: -1.883766458787848, Methylation_CDC42BPB: 1.5125571675957603, Methylation_C8orf38: 0.847252871511101, Methylation_chr14 100504766 EVL (18852): -1.2439202994882537, Methylation_chr5 72594851 LOC340090 (24088): 1.3125205505822852, Methylation_chr2 242904738 LINC01238 (3421): -0.3333144614357654, Methylation_ARFGEF1: 0.1525544067420212, Methylation_MAPT: -1.6542074770856403, Methylation_ZFAT: -1.4434405130722658, Methylation_KCNQ4: 0.4649071631378879, Methylation_chr1 232684368 SIPA1L2 (12934): -0.0403389345851244, Methylation_CRNKL1: -0.2409606003870768, Methylation_PRKAG2: -0.2306456708406173, Methylation_MICB: -0.0572476679948035, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.2741109584874897, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.2766346601347812, miRNA_hsa-mir-190b: 0.3963003956775009, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.8872185921462573, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.6628455702463235, miRNA_hsa-mir-130b: -0.1969069210613394, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-AC-A2FB,"SLC7A8 mRNA overexpression (Z=1.42) exceeds the high-expression threshold. No methylation sites meet hyper/hypo-methylation criteria. miRNA hsa-mir-2115 is upregulated (Z=1.92), near the 1.99 cutoff but not qualifying. All CNVs fall within the normal range (−1.10 to −0.10). No genomic, epigenomic, or miRNA drivers meet diagnostic thresholds for inclusion.","mRNA_MLPH: 0.3259125276302148, mRNA_C2orf54: 0.6225053946729495, mRNA_CITED4: 0.1616898048461228, mRNA_ESR1: 0.0653028386387721, mRNA_SPDEF: 0.1775554728488254, mRNA_AGR3: 0.5349785822997732, mRNA_FOXC1: 0.3451976703092529, mRNA_GATA3: 0.2725617747542512, mRNA_AGR2: 0.5031824577069396, mRNA_XBP1: 0.4118632860336344, mRNA_PRR15: -0.2645119749787781, mRNA_SLC44A4: 0.7745201371173591, mRNA_CA12: 1.087772521125558, mRNA_DTL: -0.2678665077734156, mRNA_C5AR2: -0.0485553566751156, mRNA_TBC1D9: 0.7134565419207418, mRNA_AR: 0.5141959829804913, mRNA_CCDC170: -0.1620679126539521, mRNA_DEGS2: 0.6545419597040394, mRNA_TFF3: -0.5501603784768032, mRNA_DNALI1: -0.0695494675145749, mRNA_LINC00504: 0.8830695123630391, mRNA_CLCA2: 0.9640423139907048, mRNA_PPP1R14C: 0.5149476700147488, mRNA_THSD4: 0.5826276599104101, mRNA_SPAG5: -0.6660840880881442, mRNA_FBP1: 0.0269690246998845, mRNA_SLC7A8: 1.418896252848375, mRNA_EN1: -0.9380172790492382, mRNA_ZNF552: 0.4716740986878196, Methylation_LRRC6: 1.0912277428286794, Methylation_chr2 66218712 LINC02934 (29533): 0.1998415008508573, Methylation_HOXB13: -0.7052333586525847, Methylation_chr10 3949206 LINC02660 (4871): 0.7815818134392264, Methylation_chr5 179517140 RNF130 (18026): -0.509844539956415, Methylation_LOC727677: 0.6782418415659774, Methylation_LETM1: 1.1554732845344462, Methylation_CDC42BPB: -0.5974080402841013, Methylation_C8orf38: 1.1905133152191985, Methylation_chr14 100504766 EVL (18852): 1.1484443960458883, Methylation_chr5 72594851 LOC340090 (24088): -0.4400730905979912, Methylation_chr2 242904738 LINC01238 (3421): -0.0740534399270969, Methylation_ARFGEF1: 1.2749661462909017, Methylation_MAPT: 0.9612663631168088, Methylation_ZFAT: 0.6780450008451329, Methylation_KCNQ4: -0.9446794910341332, Methylation_chr1 232684368 SIPA1L2 (12934): 1.407106530135004, Methylation_CRNKL1: 1.2020533628486807, Methylation_PRKAG2: 0.0376274023139133, Methylation_MICB: 1.2326348389590032, miRNA_hsa-mir-934: 0.1967922993950615, miRNA_hsa-mir-4728: 1.5400047074441543, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.2741462394637826, miRNA_hsa-mir-190b: -0.0267156826911741, miRNA_hsa-mir-577: 0.3385960761162155, miRNA_hsa-mir-135b: -0.2253545504345777, miRNA_hsa-mir-2115: 1.920736423438999, miRNA_hsa-mir-17: -0.2498957464565356, miRNA_hsa-mir-130b: -0.8954342402667986, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A2-A0T1,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives genomic instability.  
miR-4728 and miR-2115 are markedly upregulated; miR-190b is downregulated.  
No mRNA or methylation alterations meet diagnostic thresholds.  
These features suggest a non-luminal subtype with potential miRNA-mediated post-transcriptional dysregulation.","mRNA_MLPH: -0.5343226128263996, mRNA_C2orf54: 1.296021408781458, mRNA_CITED4: -0.1440728426725855, mRNA_ESR1: -1.9453793944873432, mRNA_SPDEF: 0.2892392261004401, mRNA_AGR3: -0.6626172231221429, mRNA_FOXC1: -0.765031652794278, mRNA_GATA3: -0.7908019598117961, mRNA_AGR2: -0.4806260804553465, mRNA_XBP1: -0.6055884093070403, mRNA_PRR15: 0.2151079053294383, mRNA_SLC44A4: 0.0746041956022558, mRNA_CA12: -0.2426689188674401, mRNA_DTL: -0.9053700044007712, mRNA_C5AR2: -1.4469031786150042, mRNA_TBC1D9: -1.3344460799533198, mRNA_AR: -0.7191359711668154, mRNA_CCDC170: -1.25449757786161, mRNA_DEGS2: 0.2198731992252988, mRNA_TFF3: 0.4016163999390971, mRNA_DNALI1: -0.1704584186353819, mRNA_LINC00504: -0.6944420888761488, mRNA_CLCA2: -0.0226422098202626, mRNA_PPP1R14C: 1.3975955558636903, mRNA_THSD4: -1.0503703726069569, mRNA_SPAG5: -0.9541233143035796, mRNA_FBP1: -1.0511102927236369, mRNA_SLC7A8: -0.154166004150366, mRNA_EN1: -0.1958601980633957, mRNA_ZNF552: -0.3016636927653617, Methylation_LRRC6: 1.1659380759136255, Methylation_chr2 66218712 LINC02934 (29533): 0.965365585430986, Methylation_HOXB13: 0.7911755451723019, Methylation_chr10 3949206 LINC02660 (4871): 0.9129650491501282, Methylation_chr5 179517140 RNF130 (18026): -1.3891564993207708, Methylation_LOC727677: 0.5236314647549986, Methylation_LETM1: 1.3351410730625417, Methylation_CDC42BPB: -0.704789584228025, Methylation_C8orf38: 0.3358644800766985, Methylation_chr14 100504766 EVL (18852): 0.8113896751150622, Methylation_chr5 72594851 LOC340090 (24088): -1.3703591776455448, Methylation_chr2 242904738 LINC01238 (3421): 1.3314467189128596, Methylation_ARFGEF1: -0.3155588113988906, Methylation_MAPT: 0.9720266004997709, Methylation_ZFAT: 0.4508409580929609, Methylation_KCNQ4: 0.0155704948927582, Methylation_chr1 232684368 SIPA1L2 (12934): 1.1727721947148046, Methylation_CRNKL1: 1.2543757073351458, Methylation_PRKAG2: 0.0826485921161776, Methylation_MICB: 1.0677291584204829, miRNA_hsa-mir-934: -0.1773092989511812, miRNA_hsa-mir-4728: 3.0303752084463764, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.4883366877010979, miRNA_hsa-mir-190b: -1.6341957965679046, miRNA_hsa-mir-577: -0.3724642578096337, miRNA_hsa-mir-135b: -0.153524815313031, miRNA_hsa-mir-2115: 2.8685366795723866, miRNA_hsa-mir-17: -0.2849603546089871, miRNA_hsa-mir-130b: 0.5542119035642842, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-BH-A0B3,"High-level Amplification absent; Deletion of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 correlates with transcriptional downregulation. mRNA_EN1 (Z=2.53) shows significant overexpression. Promoter hypermethylation at LRRC6, LINC02660, RNF130, LOC340090, ARFGEF1, SIPA1L2 drives epigenetic silencing. miRNA_hsa-mir-190b downregulated (Z=-2.05); miRNA_hsa-mir-577 upregulated (Z=1.96).","mRNA_MLPH: -1.9098656362291824, mRNA_C2orf54: 0.8871930302030736, mRNA_CITED4: -0.1473803359846432, mRNA_ESR1: -1.6588843126912034, mRNA_SPDEF: -1.8684791409334875, mRNA_AGR3: -1.8240356516933447, mRNA_FOXC1: 1.917954372596555, mRNA_GATA3: -0.7340367344562794, mRNA_AGR2: -1.808853524863472, mRNA_XBP1: -1.308353562213261, mRNA_PRR15: -2.11757824188774, mRNA_SLC44A4: -2.318593939862153, mRNA_CA12: -1.4184106997840051, mRNA_DTL: 0.0561170405135828, mRNA_C5AR2: -1.832668363551836, mRNA_TBC1D9: -1.7569522858743123, mRNA_AR: -1.8351302860543584, mRNA_CCDC170: -1.7477152603821695, mRNA_DEGS2: -1.3528596392210406, mRNA_TFF3: -1.9432925831735344, mRNA_DNALI1: -1.8666524956972923, mRNA_LINC00504: -1.7200615807884163, mRNA_CLCA2: -0.2191087920125562, mRNA_PPP1R14C: 0.4638006285061272, mRNA_THSD4: -1.8201867375702263, mRNA_SPAG5: 0.8256643006360215, mRNA_FBP1: -0.9992748858334708, mRNA_SLC7A8: -1.5649109928794396, mRNA_EN1: 2.5314801796605053, mRNA_ZNF552: -1.1930956217230957, Methylation_LRRC6: 1.508439307664774, Methylation_chr2 66218712 LINC02934 (29533): 0.2891461810123054, Methylation_HOXB13: 1.0597603719248032, Methylation_chr10 3949206 LINC02660 (4871): 1.6341742717003631, Methylation_chr5 179517140 RNF130 (18026): -1.476660816802308, Methylation_LOC727677: 1.4993325364986567, Methylation_LETM1: 1.338145389101915, Methylation_CDC42BPB: 0.8383073926745923, Methylation_C8orf38: 1.6131748618015251, Methylation_chr14 100504766 EVL (18852): 1.4963073150068311, Methylation_chr5 72594851 LOC340090 (24088): -1.472581428766237, Methylation_chr2 242904738 LINC01238 (3421): 1.3508159082712303, Methylation_ARFGEF1: 1.6713541695945298, Methylation_MAPT: 1.3432546464973552, Methylation_ZFAT: 1.24730258772645, Methylation_KCNQ4: 0.8671383738982502, Methylation_chr1 232684368 SIPA1L2 (12934): 1.613226051792294, Methylation_CRNKL1: 1.3492208837920303, Methylation_PRKAG2: -0.5201105639048055, Methylation_MICB: 1.2947905084434366, miRNA_hsa-mir-934: 1.945550791613177, miRNA_hsa-mir-4728: 0.1176215549556963, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.1375283506929217, miRNA_hsa-mir-190b: -2.052137242410604, miRNA_hsa-mir-577: 1.96320774250644, miRNA_hsa-mir-135b: 1.5184784931843476, miRNA_hsa-mir-2115: 0.0714970928089198, miRNA_hsa-mir-17: 0.4194821452140341, miRNA_hsa-mir-130b: 0.515738958814654, CNV_VPS54: -1.6173912818721974, CNV_LINC01867: -1.63714039509435, CNV_LINC02576: -1.657048777669473, CNV_WDPCP: -1.6249341592372952, CNV_CEP68: -1.657048777669473"
TCGA-AN-A0XO,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-significant ranges per specified criteria.","mRNA_MLPH: 0.104991816314668, mRNA_C2orf54: 0.0628941137147386, mRNA_CITED4: 0.8609408915391915, mRNA_ESR1: 0.8597968904427993, mRNA_SPDEF: 0.5396138279616787, mRNA_AGR3: 0.5099438187294104, mRNA_FOXC1: -0.8291433867391061, mRNA_GATA3: 0.4497304236094016, mRNA_AGR2: 0.7865053949672093, mRNA_XBP1: 0.4785240765465945, mRNA_PRR15: 0.1511392983346398, mRNA_SLC44A4: 0.8638696860045162, mRNA_CA12: 0.8892775137472368, mRNA_DTL: 0.2381680676861245, mRNA_C5AR2: 0.3153394257818747, mRNA_TBC1D9: 0.5773155888018849, mRNA_AR: 0.7854732742338343, mRNA_CCDC170: 0.3994672935435884, mRNA_DEGS2: 1.398190640834081, mRNA_TFF3: 0.4979898070261781, mRNA_DNALI1: 0.1161468520815042, mRNA_LINC00504: -0.3933633427447317, mRNA_CLCA2: 0.319502795242278, mRNA_PPP1R14C: 0.5798043094703805, mRNA_THSD4: 0.4841959090131986, mRNA_SPAG5: -0.3281973071068286, mRNA_FBP1: -0.0013832112045203, mRNA_SLC7A8: 0.7344612405569388, mRNA_EN1: 0.2673626468075961, mRNA_ZNF552: 0.4865222181631717, Methylation_LRRC6: -0.4074676459358372, Methylation_chr2 66218712 LINC02934 (29533): -1.4688734930383176, Methylation_HOXB13: 1.500190881229138, Methylation_chr10 3949206 LINC02660 (4871): -0.5874880348440225, Methylation_chr5 179517140 RNF130 (18026): 1.196673776050753, Methylation_LOC727677: -0.824823427817069, Methylation_LETM1: -0.1542769229037335, Methylation_CDC42BPB: -1.009935081278925, Methylation_C8orf38: -0.6832194885929748, Methylation_chr14 100504766 EVL (18852): -0.6085450145886216, Methylation_chr5 72594851 LOC340090 (24088): 1.141927550806156, Methylation_chr2 242904738 LINC01238 (3421): -0.6496922401212422, Methylation_ARFGEF1: -0.7172116661115205, Methylation_MAPT: -0.8178083287751459, Methylation_ZFAT: -0.832210994698521, Methylation_KCNQ4: 0.2611998022953046, Methylation_chr1 232684368 SIPA1L2 (12934): -0.6017916477740467, Methylation_CRNKL1: -0.93436495033311, Methylation_PRKAG2: 0.9545970498313164, Methylation_MICB: -0.561422562337349, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.7924569680823698, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.0493065340556212, miRNA_hsa-mir-190b: 0.4742530572157037, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: 0.6700919293386377, miRNA_hsa-mir-2115: 0.4781327600122561, miRNA_hsa-mir-17: -0.1921348961774775, miRNA_hsa-mir-130b: -0.5237662634015415, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A24Z,"High-level Amplification of none; Gain in VPS54, LINC01867, LINC02576, WDPCP, CEP68. mRNA overexpression of ESR1 (Z=1.32), AGR2 (Z=1.31), SPAG5 (Z=1.51), SLC7A8 (Z=1.62), CCDC170 (Z=1.40). Hypomethylation of LRRC6, LINC02934, C8orf38, EVL, SIPA1L2, CRNKL1, PRKAG2, ZFAT. miRNA hsa-mir-5695 upregulated (Z=2.29). Collectively indicate luminal phenotype with ER signaling activation.","mRNA_MLPH: 0.1912192318117036, mRNA_C2orf54: -0.0635289422533076, mRNA_CITED4: -0.8648878729187964, mRNA_ESR1: 1.318407280037787, mRNA_SPDEF: 0.1945022309578478, mRNA_AGR3: 0.8973540634071309, mRNA_FOXC1: -1.1240379484466194, mRNA_GATA3: 0.4177315762592106, mRNA_AGR2: 1.3103340678589053, mRNA_XBP1: 0.9514925811807462, mRNA_PRR15: -0.1238814495351431, mRNA_SLC44A4: 0.0748059903109533, mRNA_CA12: 1.158758788759274, mRNA_DTL: 2.132797947979556, mRNA_C5AR2: 0.9812954034683788, mRNA_TBC1D9: 1.2706469759456287, mRNA_AR: 0.8805242573988175, mRNA_CCDC170: 1.3983319742701577, mRNA_DEGS2: 0.5876020392107869, mRNA_TFF3: 0.2634065373543612, mRNA_DNALI1: 0.7991654022020375, mRNA_LINC00504: 0.5579598937344886, mRNA_CLCA2: -0.7169651615736071, mRNA_PPP1R14C: -0.8986874323519051, mRNA_THSD4: 1.2311991579363386, mRNA_SPAG5: 1.5099978911261789, mRNA_FBP1: 0.7563079856413794, mRNA_SLC7A8: 1.623404775987611, mRNA_EN1: -0.8108931756626706, mRNA_ZNF552: 0.8046789442158755, Methylation_LRRC6: -1.5661492150485743, Methylation_chr2 66218712 LINC02934 (29533): -1.846849998740568, Methylation_HOXB13: -0.6077808221156991, Methylation_chr10 3949206 LINC02660 (4871): -1.3448562246934337, Methylation_chr5 179517140 RNF130 (18026): 1.1830850520500749, Methylation_LOC727677: -0.9380316916335324, Methylation_LETM1: -1.3703031884928012, Methylation_CDC42BPB: 0.5463846265148076, Methylation_C8orf38: -1.5567673930866155, Methylation_chr14 100504766 EVL (18852): -1.5410860221740856, Methylation_chr5 72594851 LOC340090 (24088): 1.2218747190255683, Methylation_chr2 242904738 LINC01238 (3421): -1.079762267437183, Methylation_ARFGEF1: -1.3322343300019488, Methylation_MAPT: -1.35353471576253, Methylation_ZFAT: -1.4904881574897515, Methylation_KCNQ4: 0.3918912819405962, Methylation_chr1 232684368 SIPA1L2 (12934): -1.6098014674298562, Methylation_CRNKL1: -1.6776806507947368, Methylation_PRKAG2: -1.8110289093858225, Methylation_MICB: -1.4486420455605638, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.4630814038689613, miRNA_hsa-mir-5695: 2.2874715473188463, miRNA_hsa-mir-18a: -0.6669335624689912, miRNA_hsa-mir-190b: 0.5409539225378601, miRNA_hsa-mir-577: -0.2887427951256147, miRNA_hsa-mir-135b: -0.8905514053961857, miRNA_hsa-mir-2115: -0.3888878849211866, miRNA_hsa-mir-17: -0.3870523052010151, miRNA_hsa-mir-130b: 0.5500332877761333, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-AR-A1AW,"SLC44A4 mRNA is significantly downregulated (Z = -1.63).  
C8orf38 promoter hypermethylation (Z = 1.48) may contribute to silencing.  
miR-5695 is markedly upregulated (Z = 3.02).  
No qualifying CNVs meet amplification or deletion thresholds.","mRNA_MLPH: -0.4332289796750972, mRNA_C2orf54: -1.117205100863152, mRNA_CITED4: -1.12907473169216, mRNA_ESR1: 0.2066492687532933, mRNA_SPDEF: -0.2736152776778819, mRNA_AGR3: -0.1100431276743964, mRNA_FOXC1: -1.1016351217170235, mRNA_GATA3: -0.161778617153273, mRNA_AGR2: -0.1735126212212879, mRNA_XBP1: -0.2369114598327265, mRNA_PRR15: -0.3385343553669117, mRNA_SLC44A4: -1.631539618245022, mRNA_CA12: -0.2731080126168655, mRNA_DTL: -0.2455716271668799, mRNA_C5AR2: -0.0284156493272906, mRNA_TBC1D9: -0.3811971880103206, mRNA_AR: -0.0206022766229874, mRNA_CCDC170: 0.1134748866081899, mRNA_DEGS2: -0.8496000733981547, mRNA_TFF3: 0.3745353146520631, mRNA_DNALI1: -0.1305960423398839, mRNA_LINC00504: -0.7764499151776615, mRNA_CLCA2: -0.7818675039194268, mRNA_PPP1R14C: -1.088832101537008, mRNA_THSD4: -0.4307194397570357, mRNA_SPAG5: -0.0118041047666896, mRNA_FBP1: -0.8712674251172382, mRNA_SLC7A8: 0.3515377535067127, mRNA_EN1: -1.00612973027582, mRNA_ZNF552: -0.2107552360664904, Methylation_LRRC6: 0.4140450017999511, Methylation_chr2 66218712 LINC02934 (29533): 1.0222881980799556, Methylation_HOXB13: 0.8234365456647305, Methylation_chr10 3949206 LINC02660 (4871): 0.7048463619113448, Methylation_chr5 179517140 RNF130 (18026): -0.6898515285957451, Methylation_LOC727677: -0.2982527636167529, Methylation_LETM1: 0.362786805347285, Methylation_CDC42BPB: -0.5156270893053541, Methylation_C8orf38: 1.4845456654465383, Methylation_chr14 100504766 EVL (18852): 1.255173620198876, Methylation_chr5 72594851 LOC340090 (24088): 0.3102049990522875, Methylation_chr2 242904738 LINC01238 (3421): 0.3811523439975465, Methylation_ARFGEF1: 0.6591912584222596, Methylation_MAPT: 0.8699922757136345, Methylation_ZFAT: 0.2314737854391427, Methylation_KCNQ4: -0.2854260185526596, Methylation_chr1 232684368 SIPA1L2 (12934): 0.9534713327866804, Methylation_CRNKL1: 1.1054130507574875, Methylation_PRKAG2: 1.126404529341016, Methylation_MICB: 0.902255006027186, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.199938770080304, miRNA_hsa-mir-5695: 3.023419695866677, miRNA_hsa-mir-18a: 0.73638519216604, miRNA_hsa-mir-190b: 0.9359520745023776, miRNA_hsa-mir-577: 0.4414079237149539, miRNA_hsa-mir-135b: 0.9840490001335408, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.7882115862563985, miRNA_hsa-mir-130b: 0.9440998238703008, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A1XT,"High-level Amplification absent; no CNV calls meet amplification thresholds.  
mRNA_C2orf54 (Z=1.84) and mRNA_CLCA2 (Z=2.70) are overexpressed.  
mRNA_DEGS2 (Z=-2.04) and mRNA_AGR3 (Z=-1.99) are downregulated.  
Methylation_MAPT, Methylation_LRRC6, and Methylation_LOC727677 are hypermethylated (Z>1.50).  
Methylation_chr5:72594851 is hypomethylated (Z=-1.60).  
miRNA_hsa-mir-934 and miRNA_hsa-mir-4728 are upregulated (Z>1.99).  
miRNA_hsa-mir-190b is downregulated (Z=-1.27).","mRNA_MLPH: -0.5644971941402018, mRNA_C2orf54: 1.8442009675961808, mRNA_CITED4: -1.8829691180208223, mRNA_ESR1: -1.723068447655978, mRNA_SPDEF: 0.0391332101772902, mRNA_AGR3: -1.985934634265673, mRNA_FOXC1: -0.1963567430025231, mRNA_GATA3: -0.3179467881427389, mRNA_AGR2: -0.401791561963388, mRNA_XBP1: -1.0490157073412352, mRNA_PRR15: -0.4734713692545366, mRNA_SLC44A4: -0.3088808797377557, mRNA_CA12: -1.189393581457789, mRNA_DTL: 0.7285145343740043, mRNA_C5AR2: -1.3989613760779147, mRNA_TBC1D9: -0.4692496996972071, mRNA_AR: 0.5602285873825319, mRNA_CCDC170: -1.291864802356726, mRNA_DEGS2: -2.036429605251645, mRNA_TFF3: -1.276989624220751, mRNA_DNALI1: -1.3812231474535137, mRNA_LINC00504: -1.6832601306463608, mRNA_CLCA2: 2.7010048907437567, mRNA_PPP1R14C: -0.4598272078266197, mRNA_THSD4: 0.0380033476159317, mRNA_SPAG5: -0.0548287118084495, mRNA_FBP1: -0.958313730103298, mRNA_SLC7A8: -1.3386760191440734, mRNA_EN1: 0.6485803372767074, mRNA_ZNF552: -0.7533658266974365, Methylation_LRRC6: 1.5078526762838484, Methylation_chr2 66218712 LINC02934 (29533): 1.3525177605374956, Methylation_HOXB13: 0.8046840522605467, Methylation_chr10 3949206 LINC02660 (4871): 1.349331746812523, Methylation_chr5 179517140 RNF130 (18026): -0.0113814984304846, Methylation_LOC727677: 1.5097037305428198, Methylation_LETM1: 1.342929679343435, Methylation_CDC42BPB: -0.9827368295834356, Methylation_C8orf38: 0.1794591770865468, Methylation_chr14 100504766 EVL (18852): 1.178884745900584, Methylation_chr5 72594851 LOC340090 (24088): -1.602682695732827, Methylation_chr2 242904738 LINC01238 (3421): 1.475222174252986, Methylation_ARFGEF1: 0.5801829755537913, Methylation_MAPT: 1.5640450316424794, Methylation_ZFAT: 1.3553800081870329, Methylation_KCNQ4: -0.1157972494634604, Methylation_chr1 232684368 SIPA1L2 (12934): 1.4443246058131554, Methylation_CRNKL1: 1.3900925182002204, Methylation_PRKAG2: -1.2226140390248563, Methylation_MICB: 0.9897737010275196, miRNA_hsa-mir-934: 2.2208289941192554, miRNA_hsa-mir-4728: 3.33523470249052, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.0148126603874222, miRNA_hsa-mir-190b: -1.2690152982463758, miRNA_hsa-mir-577: -0.3840938095460602, miRNA_hsa-mir-135b: -0.3834162831851845, miRNA_hsa-mir-2115: 0.7181315653180139, miRNA_hsa-mir-17: -0.0661257561264567, miRNA_hsa-mir-130b: 1.3540303221097965, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A256,"High-level Amplification of VPS54 and WDPCP drives mRNA overexpression.  
FOXC1 mRNA is highly expressed (Z=2.68), while SPDEF, AGR2, and XBP1 are strongly downregulated (Z < -1.92).  
Promoter hypermethylation of ARFGEF1, KCNQ4, and C8orf38 (Z > 1.50) suggests epigenetic silencing.  
miR-17, miR-577, and miR-18a are upregulated (Z > 1.99); miR-190b is downregulated (Z < -1.25).","mRNA_MLPH: -2.4413638986903536, mRNA_C2orf54: -0.9275610533362332, mRNA_CITED4: 0.6967122893629488, mRNA_ESR1: -1.9285124705084704, mRNA_SPDEF: -3.012254090240869, mRNA_AGR3: -1.9126586249291064, mRNA_FOXC1: 2.6817627835243054, mRNA_GATA3: -0.7597085802986532, mRNA_AGR2: -2.364565792236107, mRNA_XBP1: -2.4293772715914166, mRNA_PRR15: -2.4548176473450813, mRNA_SLC44A4: -1.2409249435004843, mRNA_CA12: -2.0801406912027263, mRNA_DTL: 1.330684647286744, mRNA_C5AR2: -1.7342741017224297, mRNA_TBC1D9: -1.1684042748239196, mRNA_AR: -0.3058759681385622, mRNA_CCDC170: -1.5930684012464242, mRNA_DEGS2: -2.009390051597835, mRNA_TFF3: -2.211262094526751, mRNA_DNALI1: -2.0286097597132167, mRNA_LINC00504: -1.715830335012348, mRNA_CLCA2: -0.8950940779111158, mRNA_PPP1R14C: 1.902195131280634, mRNA_THSD4: -1.087271566137223, mRNA_SPAG5: 1.3874166993869623, mRNA_FBP1: -1.8479321136386604, mRNA_SLC7A8: -2.0623415612917384, mRNA_EN1: -0.2540899227073421, mRNA_ZNF552: -0.676869591670941, Methylation_LRRC6: 1.4904074054952117, Methylation_chr2 66218712 LINC02934 (29533): -1.908603280743803, Methylation_HOXB13: -1.0493700333777645, Methylation_chr10 3949206 LINC02660 (4871): 1.3370976703795625, Methylation_chr5 179517140 RNF130 (18026): -1.6719776838427405, Methylation_LOC727677: 1.4903511015326172, Methylation_LETM1: 1.334775409254733, Methylation_CDC42BPB: 0.9580284459143892, Methylation_C8orf38: 1.5474966524573606, Methylation_chr14 100504766 EVL (18852): 1.5014249445942345, Methylation_chr5 72594851 LOC340090 (24088): -1.6206397722663772, Methylation_chr2 242904738 LINC01238 (3421): 1.1145553984369387, Methylation_ARFGEF1: 1.6576712371391318, Methylation_MAPT: 1.4948724766734072, Methylation_ZFAT: 1.4175104518467136, Methylation_KCNQ4: 1.6611302190834365, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5956189322292909, Methylation_CRNKL1: 1.4268235742063655, Methylation_PRKAG2: -1.8596579744080952, Methylation_MICB: 1.4061125819996414, miRNA_hsa-mir-934: 1.9774445492476795, miRNA_hsa-mir-4728: 0.7147764867774272, miRNA_hsa-mir-5695: 1.462553336057851, miRNA_hsa-mir-18a: 2.2587964346412472, miRNA_hsa-mir-190b: -1.712390213454268, miRNA_hsa-mir-577: 2.501366814765847, miRNA_hsa-mir-135b: -0.2902172291021046, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 2.510702145515676, miRNA_hsa-mir-130b: 0.812439809171561, CNV_VPS54: 4.368946221858642, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 2.464291317721031, CNV_WDPCP: 4.394610852818543, CNV_CEP68: 2.464291317721031"
TCGA-E9-A22E,"High-level Amplification of VPS54, LINC01867, LINC02576, and CEP68 drives oncogenic mRNA dysregulation. Amplification of WDPCP further supports genomic instability. No mRNA, methylation, or miRNA features meet expression thresholds for reporting. These alterations indicate a proliferation-driven phenotype with vesicular trafficking and centrosomal pathway disruption.","mRNA_MLPH: -0.5001705981204491, mRNA_C2orf54: -0.8802090960527714, mRNA_CITED4: -0.4667694056666755, mRNA_ESR1: 0.3347544930654421, mRNA_SPDEF: -0.1684429219071642, mRNA_AGR3: 0.7627660824055622, mRNA_FOXC1: -0.3949594726967427, mRNA_GATA3: -0.2572215961810297, mRNA_AGR2: 0.4074959502764683, mRNA_XBP1: -0.2680904444466894, mRNA_PRR15: 0.4715731812954027, mRNA_SLC44A4: 0.23641742704104, mRNA_CA12: 0.0837957303143488, mRNA_DTL: -0.8710417294178486, mRNA_C5AR2: -0.1208378111564744, mRNA_TBC1D9: -0.5721368334402721, mRNA_AR: -0.4210290993609382, mRNA_CCDC170: 0.236359231482363, mRNA_DEGS2: -0.112739326338582, mRNA_TFF3: -0.2942900514353462, mRNA_DNALI1: 0.0115596201644664, mRNA_LINC00504: -0.0150097509628434, mRNA_CLCA2: -0.8102201731451323, mRNA_PPP1R14C: -0.994174043077819, mRNA_THSD4: -0.6653684746855575, mRNA_SPAG5: -1.005732644455971, mRNA_FBP1: -0.2530678260800949, mRNA_SLC7A8: -0.1552365738031192, mRNA_EN1: 0.808119075694944, mRNA_ZNF552: -0.731794028587574, Methylation_LRRC6: -0.7731166154249671, Methylation_chr2 66218712 LINC02934 (29533): -0.2349884681331143, Methylation_HOXB13: -0.8686732372217854, Methylation_chr10 3949206 LINC02660 (4871): -1.0852246969303163, Methylation_chr5 179517140 RNF130 (18026): -0.2209190614406934, Methylation_LOC727677: -0.690391251831231, Methylation_LETM1: -0.2183730531357702, Methylation_CDC42BPB: 0.6403897262213533, Methylation_C8orf38: -1.3627240714073814, Methylation_chr14 100504766 EVL (18852): -0.920755742411998, Methylation_chr5 72594851 LOC340090 (24088): -1.5079458888854338, Methylation_chr2 242904738 LINC01238 (3421): -0.5430162043776336, Methylation_ARFGEF1: -0.7877245046219363, Methylation_MAPT: -0.0959092267658592, Methylation_ZFAT: -0.8419392196893063, Methylation_KCNQ4: -0.9626583693692692, Methylation_chr1 232684368 SIPA1L2 (12934): -0.8964585448595515, Methylation_CRNKL1: 0.4473430962949193, Methylation_PRKAG2: -1.282537845321456, Methylation_MICB: 0.1897184762889679, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.359601369207979, miRNA_hsa-mir-5695: -0.3635589721495774, miRNA_hsa-mir-18a: -0.0449823954420416, miRNA_hsa-mir-190b: 1.0845093079087813, miRNA_hsa-mir-577: -0.5766438400336821, miRNA_hsa-mir-135b: -0.7465609981559017, miRNA_hsa-mir-2115: -0.3747655969619233, miRNA_hsa-mir-17: -0.542676849222167, miRNA_hsa-mir-130b: 0.8384346453343281, CNV_VPS54: 3.3712233045701687, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 3.494626341568657, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 3.494626341568657"
TCGA-A7-A426,mRNA_C2orf54 is highly expressed (Z=1.53). No methylation or miRNA alterations meet significance thresholds. All CNVs fall within normal range (−1.10 to −0.10). Isolated C2orf54 overexpression lacks clear genomic or epigenetic drivers.,"mRNA_MLPH: 1.234326932220905, mRNA_C2orf54: 1.526590364829573, mRNA_CITED4: 1.212633228707911, mRNA_ESR1: 0.1600505544912664, mRNA_SPDEF: 0.5660497023745279, mRNA_AGR3: 0.351572534456982, mRNA_FOXC1: 0.6705445218927106, mRNA_GATA3: 0.5429420009584732, mRNA_AGR2: 0.6874284104736732, mRNA_XBP1: -0.124507298916397, mRNA_PRR15: 0.6842310128432518, mRNA_SLC44A4: 0.5050505936191779, mRNA_CA12: 0.3634457136794782, mRNA_DTL: -0.8701651047248099, mRNA_C5AR2: 0.7911681633546657, mRNA_TBC1D9: 0.3421015535528584, mRNA_AR: 0.304362110646512, mRNA_CCDC170: 0.3829991525536926, mRNA_DEGS2: 0.7087342633702177, mRNA_TFF3: 1.1085922602260994, mRNA_DNALI1: 0.7363356880241527, mRNA_LINC00504: 0.1352037129454717, mRNA_CLCA2: 0.0816427952669415, mRNA_PPP1R14C: 0.7007763728048506, mRNA_THSD4: 0.3032171264999021, mRNA_SPAG5: -1.2509804020361048, mRNA_FBP1: 0.4669903521215986, mRNA_SLC7A8: 0.2356863236430951, mRNA_EN1: -0.6832124234918938, mRNA_ZNF552: 0.7936720918734054, Methylation_LRRC6: 0.6262625700020493, Methylation_chr2 66218712 LINC02934 (29533): -0.6895479838029954, Methylation_HOXB13: -1.0321044965966522, Methylation_chr10 3949206 LINC02660 (4871): 0.2660598760400137, Methylation_chr5 179517140 RNF130 (18026): 0.2607526220602226, Methylation_LOC727677: -0.328750618164128, Methylation_LETM1: 0.0861201284210002, Methylation_CDC42BPB: -0.7382410146166759, Methylation_C8orf38: 0.5581950577253143, Methylation_chr14 100504766 EVL (18852): 0.3465687526746057, Methylation_chr5 72594851 LOC340090 (24088): 0.5458634669947324, Methylation_chr2 242904738 LINC01238 (3421): 0.0111190235011642, Methylation_ARFGEF1: 0.3334663906161622, Methylation_MAPT: 0.4684132616579205, Methylation_ZFAT: 0.4865300681564636, Methylation_KCNQ4: 0.2076375129358779, Methylation_chr1 232684368 SIPA1L2 (12934): 0.5984141627958319, Methylation_CRNKL1: 0.3662248547816984, Methylation_PRKAG2: 1.3020080873163826, Methylation_MICB: 0.4540431692708119, miRNA_hsa-mir-934: -0.4085425185804839, miRNA_hsa-mir-4728: -0.8055537812073104, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.9975544068305654, miRNA_hsa-mir-190b: 0.432038976399426, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.434803504212316, miRNA_hsa-mir-2115: -0.3913909302319069, miRNA_hsa-mir-17: -0.4093249757082562, miRNA_hsa-mir-130b: -1.68698855100224, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A243,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: -1.7553039060762703, mRNA_C2orf54: -0.3821740233744299, mRNA_CITED4: -0.9444909401300532, mRNA_ESR1: -1.553525907342328, mRNA_SPDEF: -0.9190539825940128, mRNA_AGR3: -1.2150063270057712, mRNA_FOXC1: 1.220964678596009, mRNA_GATA3: -1.8539793466574404, mRNA_AGR2: 0.1234790989820361, mRNA_XBP1: -0.5933279193447265, mRNA_PRR15: -1.6082445524369704, mRNA_SLC44A4: 0.1608285792291456, mRNA_CA12: -0.950002349194482, mRNA_DTL: 0.7045286695498383, mRNA_C5AR2: -1.5863505896724703, mRNA_TBC1D9: -1.3285294251542916, mRNA_AR: -1.6166630553002197, mRNA_CCDC170: -0.9446284892408372, mRNA_DEGS2: -1.0288283660816044, mRNA_TFF3: -0.2198908465983865, mRNA_DNALI1: -1.8573931907274563, mRNA_LINC00504: -1.6389083957125838, mRNA_CLCA2: -0.8825796385344246, mRNA_PPP1R14C: -0.8780304099600437, mRNA_THSD4: -1.014301955281148, mRNA_SPAG5: -0.7015902398466068, mRNA_FBP1: -0.4456677014368886, mRNA_SLC7A8: -1.5773056371423095, mRNA_EN1: -0.654314751708673, mRNA_ZNF552: -1.4811372929571385, Methylation_LRRC6: 1.371698211770776, Methylation_chr2 66218712 LINC02934 (29533): 0.6636013022712849, Methylation_HOXB13: -1.080689149686577, Methylation_chr10 3949206 LINC02660 (4871): 1.6003621277897906, Methylation_chr5 179517140 RNF130 (18026): -1.586205276528851, Methylation_LOC727677: 1.4811326078370992, Methylation_LETM1: 1.336500269844909, Methylation_CDC42BPB: -0.1088570635539196, Methylation_C8orf38: 1.4950367630224168, Methylation_chr14 100504766 EVL (18852): 1.4930689280296543, Methylation_chr5 72594851 LOC340090 (24088): -1.250400654682163, Methylation_chr2 242904738 LINC01238 (3421): 1.084594227625344, Methylation_ARFGEF1: 1.4386933468097012, Methylation_MAPT: 1.4858117091390353, Methylation_ZFAT: 1.4256666489139211, Methylation_KCNQ4: -0.5172643739753783, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5680089558387744, Methylation_CRNKL1: 1.4552429031690324, Methylation_PRKAG2: -0.4815471154026299, Methylation_MICB: 1.394711262624083, miRNA_hsa-mir-934: 1.1474476616004765, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.5074847859387128, miRNA_hsa-mir-190b: -1.5160154276763165, miRNA_hsa-mir-577: 1.2850443414066075, miRNA_hsa-mir-135b: 1.2889626710491666, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.462172483750498, miRNA_hsa-mir-130b: 1.5482295400407189, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-E2-A1LH,"High-level Amplification of none; Gain in all reported CNVs (all > -0.10).  
mRNA_PPP1R14C (Z=2.50) and mRNA_EN1 (Z=2.13) significantly overexpressed; mRNA_SPDEF, _GATA3, _AGR2, _CA12, _ZNF552 markedly downregulated (Z < -1.92).  
Promoter hypermethylation at ARFGEF1, C8orf38, LINC02660, LRRC6, LOC727677 (Z > 1.50); RNF130 hypomethylated (Z < -1.47).  
miR-934 and miR-135b upregulated (Z > 1.99); miR-190b downregulated (Z < -1.25).","mRNA_MLPH: -2.5231664038677075, mRNA_C2orf54: -1.196132688704557, mRNA_CITED4: -0.0685555003695339, mRNA_ESR1: -1.926341803626368, mRNA_SPDEF: -2.879187716383723, mRNA_AGR3: -1.84985318665362, mRNA_FOXC1: 1.5180374450877658, mRNA_GATA3: -2.719062622879933, mRNA_AGR2: -2.2659568757720447, mRNA_XBP1: -1.8311808630816573, mRNA_PRR15: -2.0326847530438306, mRNA_SLC44A4: -1.4055761932284254, mRNA_CA12: -2.38632934180525, mRNA_DTL: -0.9605140847239046, mRNA_C5AR2: -1.8783052179639808, mRNA_TBC1D9: -2.405995735859674, mRNA_AR: -2.2721082566388726, mRNA_CCDC170: -1.5278961586948054, mRNA_DEGS2: -2.2312166828822524, mRNA_TFF3: -1.807952768540427, mRNA_DNALI1: -1.8769179886223988, mRNA_LINC00504: -1.7249100523345169, mRNA_CLCA2: -0.7544521210031346, mRNA_PPP1R14C: 2.5047651339287245, mRNA_THSD4: -1.9265720963264752, mRNA_SPAG5: -0.7188511481887869, mRNA_FBP1: -1.396785581962472, mRNA_SLC7A8: -2.403735016486213, mRNA_EN1: 2.132916278794505, mRNA_ZNF552: -2.505526254433757, Methylation_LRRC6: 1.5154183315613614, Methylation_chr2 66218712 LINC02934 (29533): 1.0816917329871083, Methylation_HOXB13: 0.1224123859010093, Methylation_chr10 3949206 LINC02660 (4871): 1.6070151946439315, Methylation_chr5 179517140 RNF130 (18026): -1.580141992715767, Methylation_LOC727677: 1.5051691157559988, Methylation_LETM1: 1.2936938419874533, Methylation_CDC42BPB: -0.2442603175611311, Methylation_C8orf38: 1.6624993220412565, Methylation_chr14 100504766 EVL (18852): 1.4727660537499674, Methylation_chr5 72594851 LOC340090 (24088): -1.226841954071799, Methylation_chr2 242904738 LINC01238 (3421): 1.2911713152155146, Methylation_ARFGEF1: 1.7240492700934076, Methylation_MAPT: 1.4487036008963274, Methylation_ZFAT: 1.4383680963212573, Methylation_KCNQ4: 0.0119871220961978, Methylation_chr1 232684368 SIPA1L2 (12934): 1.4523994181033597, Methylation_CRNKL1: 1.4479698698692054, Methylation_PRKAG2: 0.7217408835737611, Methylation_MICB: 1.4342093277769263, miRNA_hsa-mir-934: 4.155035347459591, miRNA_hsa-mir-4728: 0.7406149777844654, miRNA_hsa-mir-5695: -0.4731665656798751, miRNA_hsa-mir-18a: 1.1606069314323464, miRNA_hsa-mir-190b: -1.581591868962969, miRNA_hsa-mir-577: 0.8677406207763031, miRNA_hsa-mir-135b: 2.519290780843386, miRNA_hsa-mir-2115: -0.5689127558056544, miRNA_hsa-mir-17: 1.1022849075643624, miRNA_hsa-mir-130b: 0.1383612249607323, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A7-A3J0,mRNA_C5AR2 (Z=1.36) and mRNA_TFF3 (Z=1.42) are highly expressed. Methylation_PRKAG2 (Z=-1.80) is hypomethylated. No CNVs meet amplification/deletion thresholds. These features suggest luminal epithelial differentiation with metabolic pathway dysregulation.,"mRNA_MLPH: 0.4459186777087446, mRNA_C2orf54: -0.9147098537026952, mRNA_CITED4: -1.6138750356167793, mRNA_ESR1: 0.9813426534175216, mRNA_SPDEF: 0.5844497365652154, mRNA_AGR3: 0.353463529393759, mRNA_FOXC1: -1.207425307856447, mRNA_GATA3: 0.4458870138298397, mRNA_AGR2: 0.6053525560072524, mRNA_XBP1: 1.116380506574036, mRNA_PRR15: 0.2170424291125969, mRNA_SLC44A4: 0.0950023804358939, mRNA_CA12: -0.1462623053508959, mRNA_DTL: -0.0822681228847135, mRNA_C5AR2: 1.3563279913622424, mRNA_TBC1D9: 0.4738568055860271, mRNA_AR: 0.4196769401618798, mRNA_CCDC170: 1.0245912918925553, mRNA_DEGS2: -0.1584452617073617, mRNA_TFF3: 1.4207780765859388, mRNA_DNALI1: 0.5507653469910969, mRNA_LINC00504: 0.205981172275875, mRNA_CLCA2: -0.8608308537122039, mRNA_PPP1R14C: -0.9915303716130232, mRNA_THSD4: 0.4768342273171735, mRNA_SPAG5: -0.2304934909606489, mRNA_FBP1: 0.3543081958066087, mRNA_SLC7A8: 0.2569209719215596, mRNA_EN1: 0.4768307704094242, mRNA_ZNF552: 0.407246330436221, Methylation_LRRC6: -1.168465867330467, Methylation_chr2 66218712 LINC02934 (29533): -1.6668133430451588, Methylation_HOXB13: -1.0730964454673215, Methylation_chr10 3949206 LINC02660 (4871): -1.3549413762886509, Methylation_chr5 179517140 RNF130 (18026): 1.080872792865998, Methylation_LOC727677: -1.4668352977137955, Methylation_LETM1: -1.3388595681576512, Methylation_CDC42BPB: -1.3987013140902875, Methylation_C8orf38: -1.491641332484798, Methylation_chr14 100504766 EVL (18852): -1.2207830052803468, Methylation_chr5 72594851 LOC340090 (24088): -1.3700522522920378, Methylation_chr2 242904738 LINC01238 (3421): -1.4263766663840909, Methylation_ARFGEF1: -1.389340367358659, Methylation_MAPT: -1.3947832376129083, Methylation_ZFAT: 0.6900783360735905, Methylation_KCNQ4: -1.1788982490406468, Methylation_chr1 232684368 SIPA1L2 (12934): -1.2595306496208691, Methylation_CRNKL1: -1.3642009948939735, Methylation_PRKAG2: -1.8011099637971568, Methylation_MICB: -1.311936639802648, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.6977668336742247, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.1057129146345328, miRNA_hsa-mir-190b: 0.3239971464155695, miRNA_hsa-mir-577: -0.4829097470104871, miRNA_hsa-mir-135b: -0.1588175263675764, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.0122724245217391, miRNA_hsa-mir-130b: -0.232336680755505, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A24P,"mRNA_CITED4 (Z=1.43) is high. No methylation sites meet hyper/hypo thresholds. No miRNAs are significantly up/downregulated. All CNVs fall within normal range (−1.10 to −0.10). Isolated CITED4 overexpression without genomic or epigenetic drivers suggests post-transcriptional regulation, insufficient for subtype classification.","mRNA_MLPH: 0.2567988521295792, mRNA_C2orf54: -1.108688426981096, mRNA_CITED4: 1.4337426523765664, mRNA_ESR1: 0.6787342278072047, mRNA_SPDEF: -0.3062310691289771, mRNA_AGR3: 0.46828846207067, mRNA_FOXC1: 0.2855391908820868, mRNA_GATA3: 0.7947240357814589, mRNA_AGR2: 0.4465941289094631, mRNA_XBP1: -0.0358803583467079, mRNA_PRR15: 0.1817825669782305, mRNA_SLC44A4: 0.2925158658548404, mRNA_CA12: 0.9779097663105482, mRNA_DTL: 1.1609807356548667, mRNA_C5AR2: 0.352919601013403, mRNA_TBC1D9: 0.6488191855231208, mRNA_AR: 0.6208278995498886, mRNA_CCDC170: 0.8998905568463779, mRNA_DEGS2: 0.6212393201212368, mRNA_TFF3: -0.214022880637375, mRNA_DNALI1: -0.2482350909260003, mRNA_LINC00504: 0.2007699379525551, mRNA_CLCA2: 0.4199502877308568, mRNA_PPP1R14C: 0.4114223264175559, mRNA_THSD4: 1.2253022745153686, mRNA_SPAG5: 0.680742741303332, mRNA_FBP1: 0.3050534356462662, mRNA_SLC7A8: 0.6480793238447272, mRNA_EN1: -0.3122434167042383, mRNA_ZNF552: 0.3842843545186311, Methylation_LRRC6: -0.1190724423973721, Methylation_chr2 66218712 LINC02934 (29533): 1.178724779278295, Methylation_HOXB13: 0.6961692814457544, Methylation_chr10 3949206 LINC02660 (4871): 0.5916608274173065, Methylation_chr5 179517140 RNF130 (18026): 0.2860536719836238, Methylation_LOC727677: 1.3588681023980766, Methylation_LETM1: -0.458589686035968, Methylation_CDC42BPB: 0.7857213426507201, Methylation_C8orf38: 0.684869107559052, Methylation_chr14 100504766 EVL (18852): -0.5418708319116812, Methylation_chr5 72594851 LOC340090 (24088): -0.0552147435334137, Methylation_chr2 242904738 LINC01238 (3421): -0.5788516594091152, Methylation_ARFGEF1: -0.0158049073748327, Methylation_MAPT: -0.9639363169207638, Methylation_ZFAT: 1.3809148345686826, Methylation_KCNQ4: 1.1253178781774382, Methylation_chr1 232684368 SIPA1L2 (12934): -0.838532418234134, Methylation_CRNKL1: -0.3180691551255283, Methylation_PRKAG2: 1.2544652733928217, Methylation_MICB: 0.7386446169615432, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.4029788798608451, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.4512031462851719, miRNA_hsa-mir-190b: 0.3969656094140795, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: 0.6551428667348678, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.0139362223331795, miRNA_hsa-mir-130b: -0.2548522223644098, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AC-A5XS,High-level Amplification of none; DEGS2 mRNA overexpressed (Z=1.47). No promoter hyper/hypomethylation meets thresholds. miR-130b downregulated (Z=-1.68). All CNVs fall within normal range (−1.10 to −0.10). Isolated DEGS2 overexpression suggests metabolic dysregulation without clear genomic or epigenetic drivers.,"mRNA_MLPH: 0.8592973846698305, mRNA_C2orf54: 0.1518837883748407, mRNA_CITED4: 1.2598749664441404, mRNA_ESR1: 0.1719705474967842, mRNA_SPDEF: 0.4907018289564462, mRNA_AGR3: 0.2846366901070645, mRNA_FOXC1: -0.1327889129418648, mRNA_GATA3: 0.08911253551549, mRNA_AGR2: 1.1728984199369838, mRNA_XBP1: -0.3498958035216591, mRNA_PRR15: 0.1364719589953794, mRNA_SLC44A4: 0.3116181593961089, mRNA_CA12: 0.2201632902351897, mRNA_DTL: 0.3548204736392589, mRNA_C5AR2: 1.1664677355831017, mRNA_TBC1D9: -0.5509102461344993, mRNA_AR: 0.6429227022275555, mRNA_CCDC170: -0.2480436513325913, mRNA_DEGS2: 1.4732270734786386, mRNA_TFF3: 0.4367856158286229, mRNA_DNALI1: 0.4007682475291645, mRNA_LINC00504: -0.6137613950239237, mRNA_CLCA2: -0.5358889744375804, mRNA_PPP1R14C: -0.6580482775460479, mRNA_THSD4: 0.1431001581682796, mRNA_SPAG5: -0.3884308296413887, mRNA_FBP1: 0.8846012804101282, mRNA_SLC7A8: 0.051578881700455, mRNA_EN1: -0.4284749069519356, mRNA_ZNF552: 0.4763429391341948, Methylation_LRRC6: 0.6048947154412895, Methylation_chr2 66218712 LINC02934 (29533): -0.6076574414121366, Methylation_HOXB13: 0.7542861816539406, Methylation_chr10 3949206 LINC02660 (4871): 0.0283290227932269, Methylation_chr5 179517140 RNF130 (18026): 0.165084375401286, Methylation_LOC727677: 0.2929037486856649, Methylation_LETM1: 1.083368793427564, Methylation_CDC42BPB: 0.8224910459562027, Methylation_C8orf38: 0.4819303593856379, Methylation_chr14 100504766 EVL (18852): 0.3192715615393575, Methylation_chr5 72594851 LOC340090 (24088): 0.5362000833599717, Methylation_chr2 242904738 LINC01238 (3421): -0.0380849333800935, Methylation_ARFGEF1: 0.4071434764340507, Methylation_MAPT: 1.0482161314518397, Methylation_ZFAT: 0.3324966159830345, Methylation_KCNQ4: -0.5154275733014306, Methylation_chr1 232684368 SIPA1L2 (12934): -0.2963958259055883, Methylation_CRNKL1: 1.2244246445552731, Methylation_PRKAG2: -0.048267025757244, Methylation_MICB: -0.0895017669711096, miRNA_hsa-mir-934: -0.3766416284318388, miRNA_hsa-mir-4728: -0.8071297158909746, miRNA_hsa-mir-5695: -0.1807245674307818, miRNA_hsa-mir-18a: -0.2880954850469144, miRNA_hsa-mir-190b: 0.8663025500905045, miRNA_hsa-mir-577: -0.3975613017045271, miRNA_hsa-mir-135b: -0.2144191689141906, miRNA_hsa-mir-2115: -0.2414554590967076, miRNA_hsa-mir-17: 0.1012365554615814, miRNA_hsa-mir-130b: -1.6797970313818045, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-B6-A400,"High-level Amplification of LINC01867 drives mRNA overexpression. FOXC1, PPP1R14C, and EN1 show significant mRNA upregulation (Z > 1.30). ESR1, GATA3, AGR2, XBP1, AR, and CA12 are transcriptionally silenced (Z < -1.92). Promoter hypermethylation at RNF130, LOC340090, and EVL (Z > 1.50) suggests epigenetic repression. miR-577 is upregulated (Z > 1.99); miR-190b is downregulated (Z < -1.25).","mRNA_MLPH: -1.7977259294250842, mRNA_C2orf54: 1.112989845722244, mRNA_CITED4: 0.623766581378533, mRNA_ESR1: -2.0196067682032, mRNA_SPDEF: -1.6733042326122545, mRNA_AGR3: -1.7644359897812845, mRNA_FOXC1: 2.691713475579389, mRNA_GATA3: -1.9771544002120147, mRNA_AGR2: -2.051424099859942, mRNA_XBP1: -2.2291942986333364, mRNA_PRR15: -1.7867280403901526, mRNA_SLC44A4: -0.8581248251602385, mRNA_CA12: -2.0095318472771444, mRNA_DTL: -0.0261782206665789, mRNA_C5AR2: -1.3433916721210135, mRNA_TBC1D9: -1.929112583833796, mRNA_AR: -2.2659741914608644, mRNA_CCDC170: -1.473336402143947, mRNA_DEGS2: -1.7035667331930282, mRNA_TFF3: -1.7630282482640744, mRNA_DNALI1: -1.5867046773026463, mRNA_LINC00504: -1.7035065785943635, mRNA_CLCA2: -0.760108073686751, mRNA_PPP1R14C: 2.708759160060929, mRNA_THSD4: -1.7314511530271604, mRNA_SPAG5: 1.280017084422813, mRNA_FBP1: 0.2453221614942439, mRNA_SLC7A8: -1.8691623252099083, mRNA_EN1: 2.915330763687058, mRNA_ZNF552: -1.7016698598645688, Methylation_LRRC6: 1.4548604726780563, Methylation_chr2 66218712 LINC02934 (29533): -0.5913176975187654, Methylation_HOXB13: 0.4406922389752721, Methylation_chr10 3949206 LINC02660 (4871): 1.1941559197829072, Methylation_chr5 179517140 RNF130 (18026): -1.661572193959704, Methylation_LOC727677: 1.5286997230509547, Methylation_LETM1: 1.31759943947949, Methylation_CDC42BPB: 0.8515280074075806, Methylation_C8orf38: 1.347831176186874, Methylation_chr14 100504766 EVL (18852): 1.5294883553267102, Methylation_chr5 72594851 LOC340090 (24088): -1.527046843842861, Methylation_chr2 242904738 LINC01238 (3421): 1.4356169044048328, Methylation_ARFGEF1: 0.1420203236300688, Methylation_MAPT: 1.519104972315577, Methylation_ZFAT: 1.4141353807474333, Methylation_KCNQ4: 0.9938418541150116, Methylation_chr1 232684368 SIPA1L2 (12934): 0.986935841323378, Methylation_CRNKL1: 1.4159395942591326, Methylation_PRKAG2: -0.8211866521871218, Methylation_MICB: 1.3290442198616654, miRNA_hsa-mir-934: 1.6047746047771645, miRNA_hsa-mir-4728: -0.5935497641332222, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.8078237923705136, miRNA_hsa-mir-190b: -1.900154619754829, miRNA_hsa-mir-577: 2.03818424854362, miRNA_hsa-mir-135b: 1.7055294421820495, miRNA_hsa-mir-2115: -0.4467552618334901, miRNA_hsa-mir-17: 1.7523392133480509, miRNA_hsa-mir-130b: 1.1249197564852018, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-EW-A1P4,"High-level Amplification of LINC01867 drives oncogenic potential.  
Promoter hypermethylation of ARFGEF1, C8orf38, and chr10:3949206 mediates epigenetic silencing.  
Hypomethylation of RNF130 and LOC340090 suggests derepression.  
miR-18a, miR-17, miR-577, and miR-135b are markedly upregulated.  
mRNA downregulation of ESR1, SPDEF, AGR3, and GATA3 indicates luminal suppression.","mRNA_MLPH: -2.1287216361126293, mRNA_C2orf54: -0.2970570607894879, mRNA_CITED4: -0.6188206080110571, mRNA_ESR1: -1.880638426961197, mRNA_SPDEF: -2.691585814057297, mRNA_AGR3: -1.7869394858521603, mRNA_FOXC1: 0.5984367372432954, mRNA_GATA3: -1.6868069976873468, mRNA_AGR2: -1.3657012427445347, mRNA_XBP1: -1.6448627718416886, mRNA_PRR15: -1.4538434032510696, mRNA_SLC44A4: -2.0661884796227543, mRNA_CA12: -1.6018839833368244, mRNA_DTL: -0.1377434880377571, mRNA_C5AR2: -1.8116136092028017, mRNA_TBC1D9: -1.5500999092949328, mRNA_AR: -1.9716964279251648, mRNA_CCDC170: -1.6666494389697557, mRNA_DEGS2: -2.3223727010715574, mRNA_TFF3: -1.8156853997994664, mRNA_DNALI1: -1.8677470341983429, mRNA_LINC00504: -1.5757550206438895, mRNA_CLCA2: 0.4180788411762745, mRNA_PPP1R14C: 1.5863493699115745, mRNA_THSD4: -0.6672916994704688, mRNA_SPAG5: 1.0872136494113664, mRNA_FBP1: -1.650217615416644, mRNA_SLC7A8: -2.289079878764166, mRNA_EN1: -0.7451936970648646, mRNA_ZNF552: -1.845599013723167, Methylation_LRRC6: 1.4484293196984035, Methylation_chr2 66218712 LINC02934 (29533): 0.6142179390060879, Methylation_HOXB13: 0.4940367905641908, Methylation_chr10 3949206 LINC02660 (4871): 1.5771131128848983, Methylation_chr5 179517140 RNF130 (18026): -1.6864779112851829, Methylation_LOC727677: 1.4760377074811348, Methylation_LETM1: 1.318885526980874, Methylation_CDC42BPB: 0.0564490486035479, Methylation_C8orf38: 1.6355256947141388, Methylation_chr14 100504766 EVL (18852): 1.5149253145093973, Methylation_chr5 72594851 LOC340090 (24088): -1.5142825302091234, Methylation_chr2 242904738 LINC01238 (3421): 1.438772171263968, Methylation_ARFGEF1: 1.7578004697152572, Methylation_MAPT: 1.4945147123372446, Methylation_ZFAT: 1.4278676991247958, Methylation_KCNQ4: 0.2311803230595414, Methylation_chr1 232684368 SIPA1L2 (12934): 1.6344038391840705, Methylation_CRNKL1: 1.376205252873723, Methylation_PRKAG2: -1.3140679396408004, Methylation_MICB: 1.55563942587582, miRNA_hsa-mir-934: -0.1639777937105208, miRNA_hsa-mir-4728: 0.4472443866827704, miRNA_hsa-mir-5695: 0.8935024390591736, miRNA_hsa-mir-18a: 2.393612245009432, miRNA_hsa-mir-190b: -1.6208524358018637, miRNA_hsa-mir-577: 2.5269566675839674, miRNA_hsa-mir-135b: 2.5090113025313, miRNA_hsa-mir-2115: 0.7875064322173231, miRNA_hsa-mir-17: 2.389514442039302, miRNA_hsa-mir-130b: 1.7610151832540777, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 3.403528716117201, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-BH-A1FL,"High-level Amplification of none; no CNV alterations meet thresholds.  
mRNA_CCDC170 (Z=1.69) and mRNA_LINC00504 (Z=1.43) exceed high-expression threshold.  
Methylation_LETM1 (Z=-1.65), Methylation_SIPA1L2 (Z=-1.63), and Methylation_CRNKL1 (Z=-1.54) are hypo-methylated.  
miRNA_hsa-mir-5695 (Z=2.82) is upregulated.  
These features suggest luminal-like phenotype with ER-pathway activity.","mRNA_MLPH: 0.6626668623056455, mRNA_C2orf54: -0.2340945534210394, mRNA_CITED4: 1.1505972556517263, mRNA_ESR1: 1.1047848872528403, mRNA_SPDEF: 0.5199344998679465, mRNA_AGR3: 0.7415951729349499, mRNA_FOXC1: -0.3241045982305618, mRNA_GATA3: 1.0188402250902495, mRNA_AGR2: 0.330437341203012, mRNA_XBP1: 0.6015886865841467, mRNA_PRR15: 0.7728285261751675, mRNA_SLC44A4: 0.9354410693447948, mRNA_CA12: 0.720795228294895, mRNA_DTL: 0.8056900947951755, mRNA_C5AR2: 1.12357324994853, mRNA_TBC1D9: 0.9099547473379372, mRNA_AR: 0.8614863870504381, mRNA_CCDC170: 1.692633719614996, mRNA_DEGS2: 0.8841789781925306, mRNA_TFF3: 0.0271247317940246, mRNA_DNALI1: 0.7234959194231417, mRNA_LINC00504: 1.431904654846285, mRNA_CLCA2: -0.5420875056984772, mRNA_PPP1R14C: -0.8175336145861347, mRNA_THSD4: 1.2647468990125417, mRNA_SPAG5: 0.2240895968910309, mRNA_FBP1: 1.1085532808616954, mRNA_SLC7A8: 1.2215387980924255, mRNA_EN1: -0.5231668753105818, mRNA_ZNF552: 0.4514164968012724, Methylation_LRRC6: -1.410479561144011, Methylation_chr2 66218712 LINC02934 (29533): 1.1085841568275647, Methylation_HOXB13: -0.9842342486438272, Methylation_chr10 3949206 LINC02660 (4871): -1.247984857928202, Methylation_chr5 179517140 RNF130 (18026): 1.0695518531626031, Methylation_LOC727677: -1.2387237032850351, Methylation_LETM1: -1.6541620488781577, Methylation_CDC42BPB: -1.1871822026009795, Methylation_C8orf38: -1.4662218324584797, Methylation_chr14 100504766 EVL (18852): -1.462726125937371, Methylation_chr5 72594851 LOC340090 (24088): 1.1699657126029253, Methylation_chr2 242904738 LINC01238 (3421): -1.354476630056867, Methylation_ARFGEF1: -1.164108592212033, Methylation_MAPT: -1.3893391908838495, Methylation_ZFAT: -1.3495458989998874, Methylation_KCNQ4: -1.2235098067298866, Methylation_chr1 232684368 SIPA1L2 (12934): -1.628973811955086, Methylation_CRNKL1: -1.5419738572175683, Methylation_PRKAG2: 1.35880481019557, Methylation_MICB: -1.4427522184085957, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.2656737525641158, miRNA_hsa-mir-5695: 2.8164343455198493, miRNA_hsa-mir-18a: -0.3830689660687079, miRNA_hsa-mir-190b: 1.132822717027564, miRNA_hsa-mir-577: -0.354596450230518, miRNA_hsa-mir-135b: -0.8837200026763345, miRNA_hsa-mir-2115: 0.4658797511671828, miRNA_hsa-mir-17: 0.2028674950078182, miRNA_hsa-mir-130b: 0.0384734010791658, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A1NG,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.0822329969929058, mRNA_C2orf54: 1.192356374999772, mRNA_CITED4: -0.2323291793546732, mRNA_ESR1: -0.1545156379394822, mRNA_SPDEF: 0.0956740765672255, mRNA_AGR3: 0.5603766871728422, mRNA_FOXC1: 0.2626834447279117, mRNA_GATA3: 0.1159196561823219, mRNA_AGR2: 0.276165675159439, mRNA_XBP1: -0.2756066340007347, mRNA_PRR15: 0.1418855811931988, mRNA_SLC44A4: 0.3525918039890306, mRNA_CA12: 0.3872729487625242, mRNA_DTL: -0.6449088172106022, mRNA_C5AR2: -0.3382324979122835, mRNA_TBC1D9: -0.4562369072101365, mRNA_AR: 0.1170461968354578, mRNA_CCDC170: 0.2126829998221062, mRNA_DEGS2: 0.1352998344620565, mRNA_TFF3: 0.4024642230715796, mRNA_DNALI1: 0.4246152343853332, mRNA_LINC00504: 0.7186178633687286, mRNA_CLCA2: 0.9727620303315926, mRNA_PPP1R14C: 0.9049227776442388, mRNA_THSD4: -0.2417285175181843, mRNA_SPAG5: -0.9807200901829892, mRNA_FBP1: -0.3386655958576218, mRNA_SLC7A8: 0.0129949236224756, mRNA_EN1: 0.4584277581514809, mRNA_ZNF552: -0.0357696270674068, Methylation_LRRC6: 1.0058072574480037, Methylation_chr2 66218712 LINC02934 (29533): 0.6113089799673557, Methylation_HOXB13: -1.0487557568146093, Methylation_chr10 3949206 LINC02660 (4871): -0.873850744705027, Methylation_chr5 179517140 RNF130 (18026): -0.2499451392357532, Methylation_LOC727677: 0.3861632788217401, Methylation_LETM1: 0.5888512713283885, Methylation_CDC42BPB: -0.5249589094384632, Methylation_C8orf38: 0.6929984896983962, Methylation_chr14 100504766 EVL (18852): 0.6970009686913095, Methylation_chr5 72594851 LOC340090 (24088): -1.3125960619227328, Methylation_chr2 242904738 LINC01238 (3421): -0.0949061961456274, Methylation_ARFGEF1: 1.1185500767507597, Methylation_MAPT: 0.7001276579744354, Methylation_ZFAT: 0.3481838207634852, Methylation_KCNQ4: -1.1860345417038467, Methylation_chr1 232684368 SIPA1L2 (12934): 1.2597033380124247, Methylation_CRNKL1: 1.0876359262000317, Methylation_PRKAG2: -0.5364966299210433, Methylation_MICB: 0.914504630097139, miRNA_hsa-mir-934: -0.3404876700608618, miRNA_hsa-mir-4728: 0.0574246752517126, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.1467228012246159, miRNA_hsa-mir-190b: -0.2489281848430435, miRNA_hsa-mir-577: -0.1161256362029909, miRNA_hsa-mir-135b: -0.119008803057206, miRNA_hsa-mir-2115: -0.4047043225579479, miRNA_hsa-mir-17: -0.8408768198103623, miRNA_hsa-mir-130b: 0.2031172761477166, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E2-A1BC,"High mRNA_C2orf54 (Z=1.79) and mRNA_AR (Z=1.52) indicate overexpression.  
Methylation_ZFAT hyper-methylated (Z=1.32).  
No miRNA or CNV alterations meet diagnostic thresholds.  
Collectively suggests luminal AR+ phenotype with ZFAT epigenetic silencing.","mRNA_MLPH: 0.4943423156744148, mRNA_C2orf54: 1.7940623560907991, mRNA_CITED4: 0.4251405431107394, mRNA_ESR1: 0.3825556262290802, mRNA_SPDEF: 0.4616631730348904, mRNA_AGR3: 0.057593140642583, mRNA_FOXC1: -0.0114043177693805, mRNA_GATA3: 0.2629242277669484, mRNA_AGR2: 0.2363348522229821, mRNA_XBP1: 0.7302660054194848, mRNA_PRR15: 0.4897373841126562, mRNA_SLC44A4: 0.8022225089876691, mRNA_CA12: 0.3473466142332464, mRNA_DTL: -2.1806193232846254, mRNA_C5AR2: 0.8332953086726804, mRNA_TBC1D9: 0.3896372796519582, mRNA_AR: 1.5155578274776818, mRNA_CCDC170: 0.4106814703021857, mRNA_DEGS2: 0.5110844844425118, mRNA_TFF3: -0.1958245640714694, mRNA_DNALI1: 0.1373544936490845, mRNA_LINC00504: 1.449661837738782, mRNA_CLCA2: 0.6699744623125073, mRNA_PPP1R14C: -0.7242184169567157, mRNA_THSD4: 0.3663496438383317, mRNA_SPAG5: -1.8145174925524905, mRNA_FBP1: 0.5208493981217203, mRNA_SLC7A8: 1.1731599287365078, mRNA_EN1: 0.1082295270569455, mRNA_ZNF552: 0.5647925173304602, Methylation_LRRC6: 0.3909867119690791, Methylation_chr2 66218712 LINC02934 (29533): 1.1756522749768703, Methylation_HOXB13: -0.4798303367282877, Methylation_chr10 3949206 LINC02660 (4871): -0.7086969805102097, Methylation_chr5 179517140 RNF130 (18026): 0.6209454474052645, Methylation_LOC727677: -0.0679357319260313, Methylation_LETM1: 0.2004905461195807, Methylation_CDC42BPB: -1.1115310655143482, Methylation_C8orf38: -0.3030577519129644, Methylation_chr14 100504766 EVL (18852): 0.1257710802057156, Methylation_chr5 72594851 LOC340090 (24088): 0.997524272478177, Methylation_chr2 242904738 LINC01238 (3421): 1.1570127701482398, Methylation_ARFGEF1: 0.4334412407690728, Methylation_MAPT: 0.2930004794580872, Methylation_ZFAT: 1.31630519467929, Methylation_KCNQ4: -0.3116959821445579, Methylation_chr1 232684368 SIPA1L2 (12934): 0.4205819196862178, Methylation_CRNKL1: 0.4308917960933741, Methylation_PRKAG2: 1.211836851235585, Methylation_MICB: 0.0685690831143244, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.2505349000226685, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.160047736410287, miRNA_hsa-mir-190b: -0.2702509107714477, miRNA_hsa-mir-577: -0.2866636883242391, miRNA_hsa-mir-135b: -0.9368830019859844, miRNA_hsa-mir-2115: -0.3575331801215598, miRNA_hsa-mir-17: -0.5427778998352436, miRNA_hsa-mir-130b: -0.2631939031488958, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A27N,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.6223590379674638, mRNA_C2orf54: -0.428809308585294, mRNA_CITED4: -1.6899687745096008, mRNA_ESR1: -0.2339288713751132, mRNA_SPDEF: 0.6205947091483438, mRNA_AGR3: 0.2817227790972976, mRNA_FOXC1: -0.7926135274281741, mRNA_GATA3: 0.1176483345362187, mRNA_AGR2: 0.9524784098350254, mRNA_XBP1: 0.1852136645807297, mRNA_PRR15: 0.1757143329257481, mRNA_SLC44A4: 1.0143229927243025, mRNA_CA12: -0.2144831840631653, mRNA_DTL: 0.1756770013051065, mRNA_C5AR2: 0.1171416039493822, mRNA_TBC1D9: 0.500937308506585, mRNA_AR: 0.4495255774296696, mRNA_CCDC170: 1.475507794058433, mRNA_DEGS2: -0.1735103158878514, mRNA_TFF3: 0.3838619888528413, mRNA_DNALI1: -0.314737031763886, mRNA_LINC00504: 0.8985371678490801, mRNA_CLCA2: -0.2327388429263567, mRNA_PPP1R14C: -0.3955703572727877, mRNA_THSD4: -0.7346012921178467, mRNA_SPAG5: -0.2426660862565746, mRNA_FBP1: 0.4733552783314644, mRNA_SLC7A8: -0.321669214426148, mRNA_EN1: 0.0788873687316679, mRNA_ZNF552: 0.7253882114118692, Methylation_LRRC6: -0.4765599073613533, Methylation_chr2 66218712 LINC02934 (29533): 1.270423242907048, Methylation_HOXB13: 0.3609548823805346, Methylation_chr10 3949206 LINC02660 (4871): -0.6567874576198783, Methylation_chr5 179517140 RNF130 (18026): -0.3444019823855847, Methylation_LOC727677: -0.4947829313839332, Methylation_LETM1: 0.4391590591130764, Methylation_CDC42BPB: -0.7924036852965742, Methylation_C8orf38: -0.5416427871977407, Methylation_chr14 100504766 EVL (18852): -0.1834436840824007, Methylation_chr5 72594851 LOC340090 (24088): 0.5038938414508185, Methylation_chr2 242904738 LINC01238 (3421): 1.2795394859579554, Methylation_ARFGEF1: 0.0460910900670682, Methylation_MAPT: 0.2377275988500881, Methylation_ZFAT: -0.9046076915016964, Methylation_KCNQ4: -0.97112162973156, Methylation_chr1 232684368 SIPA1L2 (12934): -0.0072068436094197, Methylation_CRNKL1: 0.4559566964124198, Methylation_PRKAG2: -0.77410081602774, Methylation_MICB: -0.5494344251250888, miRNA_hsa-mir-934: -0.4024002596997668, miRNA_hsa-mir-4728: 1.4987804679770544, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.8185995201010497, miRNA_hsa-mir-190b: -1.1193019356284752, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.0865187822382814, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.427723790235493, miRNA_hsa-mir-130b: -0.2181643932705506, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-EW-A1OY,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: -0.0001787912924727, mRNA_C2orf54: -0.8278872376666406, mRNA_CITED4: -0.0575831763109535, mRNA_ESR1: 0.9888862887040152, mRNA_SPDEF: 0.5969876424950379, mRNA_AGR3: 0.5421867506720269, mRNA_FOXC1: -1.0678555331748856, mRNA_GATA3: 0.4494100968963418, mRNA_AGR2: 0.6793510823884243, mRNA_XBP1: 0.8160860430522144, mRNA_PRR15: -0.3122902225895326, mRNA_SLC44A4: 0.6471298666504003, mRNA_CA12: 0.6501133068223092, mRNA_DTL: 0.2034887628987269, mRNA_C5AR2: 0.5448788018787039, mRNA_TBC1D9: 0.1275746373694809, mRNA_AR: 0.5020450769950372, mRNA_CCDC170: 0.0480060437563579, mRNA_DEGS2: 0.9468707716621384, mRNA_TFF3: 0.4434295814948157, mRNA_DNALI1: 0.5669555487645741, mRNA_LINC00504: -0.3618876327072732, mRNA_CLCA2: -0.8267889129167159, mRNA_PPP1R14C: -0.929479447881436, mRNA_THSD4: 0.2287646761534669, mRNA_SPAG5: 0.6414078948375704, mRNA_FBP1: -0.4309638104072076, mRNA_SLC7A8: 1.065790646508953, mRNA_EN1: -0.7277921044259006, mRNA_ZNF552: 0.7875967938515724, Methylation_LRRC6: -1.641192276370125, Methylation_chr2 66218712 LINC02934 (29533): -1.629575580732327, Methylation_HOXB13: -0.1419054066368792, Methylation_chr10 3949206 LINC02660 (4871): -1.2722265968222728, Methylation_chr5 179517140 RNF130 (18026): 1.016073610586921, Methylation_LOC727677: -1.2949677134894686, Methylation_LETM1: -1.2875515259655652, Methylation_CDC42BPB: 1.2038730247185847, Methylation_C8orf38: -0.8494658429987465, Methylation_chr14 100504766 EVL (18852): -1.4393527306627785, Methylation_chr5 72594851 LOC340090 (24088): -1.4283076570754465, Methylation_chr2 242904738 LINC01238 (3421): -1.2889049679528326, Methylation_ARFGEF1: -1.3592750969703302, Methylation_MAPT: -1.6833576617577506, Methylation_ZFAT: -1.765722246315364, Methylation_KCNQ4: 1.6677274471640613, Methylation_chr1 232684368 SIPA1L2 (12934): -1.2012239012009742, Methylation_CRNKL1: -1.708509568681706, Methylation_PRKAG2: -1.7902068417679282, Methylation_MICB: -1.2461967802314156, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.5725393711631738, miRNA_hsa-mir-5695: 0.6478376736433088, miRNA_hsa-mir-18a: 0.4509621099173952, miRNA_hsa-mir-190b: 0.8002085226898118, miRNA_hsa-mir-577: -0.185622282635823, miRNA_hsa-mir-135b: -0.0844494599291277, miRNA_hsa-mir-2115: -0.3631859267104465, miRNA_hsa-mir-17: 0.9077272909569268, miRNA_hsa-mir-130b: 1.5698527709986043, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-LL-A7T0,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression of SPAG5 (Z=1.56) and AGR2 (Z=1.05). LETM1 promoter hypermethylation (Z=-1.86) mediates epigenetic silencing. No miRNAs meet dysregulation thresholds. These features collectively indicate a luminal phenotype with cell cycle and secretory pathway dysregulation.","mRNA_MLPH: 0.3476241910373028, mRNA_C2orf54: -0.986772852284642, mRNA_CITED4: -0.9738226292716026, mRNA_ESR1: 0.4858267769601123, mRNA_SPDEF: 0.7627629919802718, mRNA_AGR3: 0.506839348093291, mRNA_FOXC1: -0.516362984144857, mRNA_GATA3: -0.0907864702756346, mRNA_AGR2: 1.0536874480320129, mRNA_XBP1: -0.2439019924973737, mRNA_PRR15: 0.6398769671930665, mRNA_SLC44A4: 0.4739482699406405, mRNA_CA12: 0.388687059847187, mRNA_DTL: 0.4714283823856407, mRNA_C5AR2: -0.0928470250674693, mRNA_TBC1D9: -0.1324282509615029, mRNA_AR: -0.2753247949109633, mRNA_CCDC170: -0.2394482691134609, mRNA_DEGS2: -0.7662454615205276, mRNA_TFF3: 0.0922270312701045, mRNA_DNALI1: 0.7394417125534704, mRNA_LINC00504: -1.0017857419137988, mRNA_CLCA2: -0.4053710741207505, mRNA_PPP1R14C: -0.3554671827563597, mRNA_THSD4: 0.0222614926775809, mRNA_SPAG5: 1.559309885134121, mRNA_FBP1: 0.5189785898511171, mRNA_SLC7A8: 0.3937391132543681, mRNA_EN1: -0.7431422988228938, mRNA_ZNF552: -0.0301248211747987, Methylation_LRRC6: -0.5608534266039191, Methylation_chr2 66218712 LINC02934 (29533): 1.3818302513024274, Methylation_HOXB13: 1.051421070028152, Methylation_chr10 3949206 LINC02660 (4871): -0.7743725292001691, Methylation_chr5 179517140 RNF130 (18026): 1.000684079883577, Methylation_LOC727677: -0.0814096709557908, Methylation_LETM1: -1.857270804974288, Methylation_CDC42BPB: 1.2302743520538006, Methylation_C8orf38: 0.4826232747194084, Methylation_chr14 100504766 EVL (18852): -0.746943554845612, Methylation_chr5 72594851 LOC340090 (24088): 0.9687407702404428, Methylation_chr2 242904738 LINC01238 (3421): 0.8954894946241134, Methylation_ARFGEF1: -1.0177318543145095, Methylation_MAPT: -0.4430410377192939, Methylation_ZFAT: -1.1487485109406208, Methylation_KCNQ4: 0.8009712036040612, Methylation_chr1 232684368 SIPA1L2 (12934): -0.347661126017706, Methylation_CRNKL1: -0.9828156057548064, Methylation_PRKAG2: 0.6972919487768006, Methylation_MICB: -1.2138373219775829, miRNA_hsa-mir-934: -0.349887065192105, miRNA_hsa-mir-4728: -0.3602099269865318, miRNA_hsa-mir-5695: 0.1781009444014668, miRNA_hsa-mir-18a: 0.3979181148278855, miRNA_hsa-mir-190b: 0.952955424639179, miRNA_hsa-mir-577: -0.0439524009580451, miRNA_hsa-mir-135b: -0.1507919873011866, miRNA_hsa-mir-2115: -0.2972336131152446, miRNA_hsa-mir-17: 0.937767390129045, miRNA_hsa-mir-130b: 0.404727659438253, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-E2-A1B4,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-significant ranges per specified criteria.","mRNA_MLPH: 0.7862753436356718, mRNA_C2orf54: 0.9535094454571768, mRNA_CITED4: 0.8313102764359322, mRNA_ESR1: 0.9662532116216904, mRNA_SPDEF: 0.7251531017762696, mRNA_AGR3: 0.7467718866239361, mRNA_FOXC1: -0.7842962359841743, mRNA_GATA3: 0.8861806350749982, mRNA_AGR2: 0.2931484016373581, mRNA_XBP1: 1.116877263903072, mRNA_PRR15: 0.7940722397278045, mRNA_SLC44A4: 0.5497851428302704, mRNA_CA12: 0.870707464355089, mRNA_DTL: -2.559155285883288, mRNA_C5AR2: 1.04462128222572, mRNA_TBC1D9: -0.1955969912826262, mRNA_AR: 0.5888388894761171, mRNA_CCDC170: 1.41908529342702, mRNA_DEGS2: 1.4747119221192837, mRNA_TFF3: 0.3264169733157934, mRNA_DNALI1: 1.0384219249414337, mRNA_LINC00504: 1.2228943952758058, mRNA_CLCA2: -0.3755920913116843, mRNA_PPP1R14C: 0.036854856763059, mRNA_THSD4: 0.475223203582345, mRNA_SPAG5: -1.42005687792965, mRNA_FBP1: 1.0853165562083436, mRNA_SLC7A8: 1.2532966692669691, mRNA_EN1: -0.0535857901943226, mRNA_ZNF552: 0.6280094312960977, Methylation_LRRC6: -0.967504874786579, Methylation_chr2 66218712 LINC02934 (29533): -0.9833570585257618, Methylation_HOXB13: -0.8163874006303535, Methylation_chr10 3949206 LINC02660 (4871): -1.0022426527749002, Methylation_chr5 179517140 RNF130 (18026): 0.4503152850579018, Methylation_LOC727677: -1.071220312277945, Methylation_LETM1: 0.0528510078768407, Methylation_CDC42BPB: -1.250231535252687, Methylation_C8orf38: -1.1955488903025004, Methylation_chr14 100504766 EVL (18852): -0.9782080822189942, Methylation_chr5 72594851 LOC340090 (24088): 1.0983639560397684, Methylation_chr2 242904738 LINC01238 (3421): -1.0824870257770711, Methylation_ARFGEF1: -0.7164546076905802, Methylation_MAPT: -0.9853460356584792, Methylation_ZFAT: 1.1139391628147624, Methylation_KCNQ4: -1.0588446037166168, Methylation_chr1 232684368 SIPA1L2 (12934): -1.0348810550596683, Methylation_CRNKL1: -1.3232323572175126, Methylation_PRKAG2: 1.3528710254271987, Methylation_MICB: -0.9973471534760446, miRNA_hsa-mir-934: -0.2921273489657661, miRNA_hsa-mir-4728: -0.8554171365010773, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.7622844189454452, miRNA_hsa-mir-190b: -0.0644790168481674, miRNA_hsa-mir-577: -0.1141603491707808, miRNA_hsa-mir-135b: 0.0121774363364072, miRNA_hsa-mir-2115: 0.4283517366843235, miRNA_hsa-mir-17: -0.8329616950688465, miRNA_hsa-mir-130b: -0.0780978204859292, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A2JS,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression.  
mRNA_CITED4 and mRNA_SLC44A4 are downregulated (Z < -1.92).  
No methylation or miRNA features meet diagnostic thresholds.  
These features suggest a proliferative phenotype with genomic instability.","mRNA_MLPH: 0.0182308660119616, mRNA_C2orf54: -1.2315298760661384, mRNA_CITED4: -1.9927078876284712, mRNA_ESR1: 0.565403721133777, mRNA_SPDEF: 0.4281332517737084, mRNA_AGR3: 0.3693242152759082, mRNA_FOXC1: -0.961181316366382, mRNA_GATA3: 0.2390098981146636, mRNA_AGR2: 0.7574588556660657, mRNA_XBP1: 0.2445056223162786, mRNA_PRR15: 1.032470042665506, mRNA_SLC44A4: -1.6934845235712472, mRNA_CA12: 0.2890460027860706, mRNA_DTL: 0.1190420024345868, mRNA_C5AR2: 0.1679195252801069, mRNA_TBC1D9: -0.3618198049796562, mRNA_AR: 0.2452047510330294, mRNA_CCDC170: -0.4028851378694048, mRNA_DEGS2: -0.0832320262185468, mRNA_TFF3: -0.0047378123669202, mRNA_DNALI1: 0.1337341862040816, mRNA_LINC00504: -0.4753259975336278, mRNA_CLCA2: -0.7073575642827766, mRNA_PPP1R14C: -0.481404281885509, mRNA_THSD4: 0.2940403068340279, mRNA_SPAG5: 1.7119117771382415, mRNA_FBP1: 0.876569023498571, mRNA_SLC7A8: 0.509640252949797, mRNA_EN1: -0.5511419729673356, mRNA_ZNF552: 0.4570670158889166, Methylation_LRRC6: -0.7925477827930592, Methylation_chr2 66218712 LINC02934 (29533): 1.3828474545359253, Methylation_HOXB13: 1.3946638298834264, Methylation_chr10 3949206 LINC02660 (4871): -1.0471755095370607, Methylation_chr5 179517140 RNF130 (18026): 0.9980034400295712, Methylation_LOC727677: -0.3229480295726535, Methylation_LETM1: -1.059131839169671, Methylation_CDC42BPB: 1.3623099615716177, Methylation_C8orf38: -0.760871646767491, Methylation_chr14 100504766 EVL (18852): -0.5168246874597324, Methylation_chr5 72594851 LOC340090 (24088): 1.0859965047323694, Methylation_chr2 242904738 LINC01238 (3421): -0.814212378012028, Methylation_ARFGEF1: -1.3882586255424505, Methylation_MAPT: -1.4130400631252558, Methylation_ZFAT: -1.2721133549380483, Methylation_KCNQ4: 1.1221703597866637, Methylation_chr1 232684368 SIPA1L2 (12934): -0.7013126522260102, Methylation_CRNKL1: -1.1695448005369014, Methylation_PRKAG2: -0.0202417391357799, Methylation_MICB: 0.699043779932725, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.8375316056078514, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.2948931181446497, miRNA_hsa-mir-190b: -0.8582684175351647, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: 0.8740239641710865, miRNA_hsa-mir-2115: 1.3610105311326297, miRNA_hsa-mir-17: 0.1672741314204588, miRNA_hsa-mir-130b: 0.2400225193716376, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-AR-A24N,"High-level Amplification of CCDC170 drives significant mRNA overexpression (Z=1.79). DTL mRNA is elevated (Z=1.47), exceeding the high-expression threshold. No methylation sites meet hyper/hypo-methylation criteria. No miRNAs are significantly up/downregulated. All CNVs fall within the normal range (−1.10 to −0.10) and are ignored. These features collectively indicate a luminal phenotype with cell cycle dysregulation.","mRNA_MLPH: 0.5759351311269318, mRNA_C2orf54: 0.3434690543697956, mRNA_CITED4: 0.8371985243225998, mRNA_ESR1: 1.030784251156997, mRNA_SPDEF: 0.3286324165827577, mRNA_AGR3: 0.6706380615540161, mRNA_FOXC1: -0.705714263376182, mRNA_GATA3: 0.8015336409945978, mRNA_AGR2: -0.0872072127721911, mRNA_XBP1: 0.860398718476747, mRNA_PRR15: 0.1105033238353763, mRNA_SLC44A4: 0.4344445668253704, mRNA_CA12: 0.922973891128616, mRNA_DTL: 1.4692390273429226, mRNA_C5AR2: 0.5430453697166417, mRNA_TBC1D9: 1.0795418306774105, mRNA_AR: 1.0210276378804606, mRNA_CCDC170: 1.790009856885314, mRNA_DEGS2: 0.4485534728087925, mRNA_TFF3: 0.3634539990142859, mRNA_DNALI1: 0.9064169012236544, mRNA_LINC00504: 1.30427550958915, mRNA_CLCA2: -0.4349254101318753, mRNA_PPP1R14C: 0.0039106477435749, mRNA_THSD4: 0.8159856270955018, mRNA_SPAG5: 0.3950901583631344, mRNA_FBP1: -0.096844112645085, mRNA_SLC7A8: 0.2547106274277461, mRNA_EN1: -0.3152430749350542, mRNA_ZNF552: 0.6302070290479108, Methylation_LRRC6: -1.351942266961197, Methylation_chr2 66218712 LINC02934 (29533): -1.7283416832593432, Methylation_HOXB13: -0.2055160383116517, Methylation_chr10 3949206 LINC02660 (4871): -1.2718309093352216, Methylation_chr5 179517140 RNF130 (18026): 0.9758774127545708, Methylation_LOC727677: 1.4842253259595364, Methylation_LETM1: -1.1277732567438783, Methylation_CDC42BPB: 1.342522099768344, Methylation_C8orf38: -0.6036951382193333, Methylation_chr14 100504766 EVL (18852): -0.6165777477902553, Methylation_chr5 72594851 LOC340090 (24088): 0.8768472036027225, Methylation_chr2 242904738 LINC01238 (3421): -1.1567500625998737, Methylation_ARFGEF1: -0.4152531723330044, Methylation_MAPT: -1.1251271517131085, Methylation_ZFAT: 0.5352874220609471, Methylation_KCNQ4: 1.4205527030770408, Methylation_chr1 232684368 SIPA1L2 (12934): -1.414866487903376, Methylation_CRNKL1: -0.7109858157204805, Methylation_PRKAG2: 1.3029175777984887, Methylation_MICB: 1.5150945141822925, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.447871290808138, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.6027658485111089, miRNA_hsa-mir-190b: 1.130895582253458, miRNA_hsa-mir-577: -0.1001010571631305, miRNA_hsa-mir-135b: 0.0657516028363479, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.5881804042854983, miRNA_hsa-mir-130b: -0.1765532653376587, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E2-A3DX,"CLCA2 mRNA overexpression (Z=1.75) exceeds the high-expression threshold. No methylation, miRNA, or CNV alterations meet diagnostic criteria for reporting.","mRNA_MLPH: 0.4607804575885956, mRNA_C2orf54: -1.0123450105916905, mRNA_CITED4: 1.0254254082682397, mRNA_ESR1: 0.3407675375391168, mRNA_SPDEF: 0.3034165774305599, mRNA_AGR3: 0.3006924766732736, mRNA_FOXC1: 0.4535781957246637, mRNA_GATA3: -0.3276357818750148, mRNA_AGR2: -0.0926225673653707, mRNA_XBP1: 0.5809989073629342, mRNA_PRR15: 0.2866097419865626, mRNA_SLC44A4: 0.3242158476072646, mRNA_CA12: 0.5506380715895538, mRNA_DTL: -1.2709395617528343, mRNA_C5AR2: 0.3436010367377838, mRNA_TBC1D9: 0.9343831050215278, mRNA_AR: 0.2551224708317786, mRNA_CCDC170: 0.3716723143943591, mRNA_DEGS2: 0.1116242628632306, mRNA_TFF3: 0.1020240785765212, mRNA_DNALI1: 0.310481250195833, mRNA_LINC00504: 0.6416375622486024, mRNA_CLCA2: 1.746060306779255, mRNA_PPP1R14C: -0.4780014676655881, mRNA_THSD4: 0.880603554997446, mRNA_SPAG5: -0.9288655310316242, mRNA_FBP1: 0.2118807725002685, mRNA_SLC7A8: 0.4977125876151295, mRNA_EN1: -0.1966848537247915, mRNA_ZNF552: 0.2995637395810246, Methylation_LRRC6: 1.27579105381767, Methylation_chr2 66218712 LINC02934 (29533): 1.2049586427106411, Methylation_HOXB13: -0.938650475163183, Methylation_chr10 3949206 LINC02660 (4871): 0.9955281042087738, Methylation_chr5 179517140 RNF130 (18026): -1.350483330354791, Methylation_LOC727677: 0.364697300513619, Methylation_LETM1: 0.4673060862540036, Methylation_CDC42BPB: -0.1457386593404825, Methylation_C8orf38: 1.0777113520308963, Methylation_chr14 100504766 EVL (18852): 1.1161813051974845, Methylation_chr5 72594851 LOC340090 (24088): -0.0587324356812772, Methylation_chr2 242904738 LINC01238 (3421): 0.0272198269031979, Methylation_ARFGEF1: 1.3616483093199072, Methylation_MAPT: 0.7739175715357459, Methylation_ZFAT: 1.1475288159583883, Methylation_KCNQ4: -1.1627382271802265, Methylation_chr1 232684368 SIPA1L2 (12934): 0.9221559138051844, Methylation_CRNKL1: 0.9164620587855988, Methylation_PRKAG2: 0.9704838150217618, Methylation_MICB: 0.9123502425709163, miRNA_hsa-mir-934: -0.3626845209286479, miRNA_hsa-mir-4728: -0.160414481024838, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.9991109085992708, miRNA_hsa-mir-190b: -0.4681269393581245, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.9036093526235164, miRNA_hsa-mir-2115: 0.5011967359306831, miRNA_hsa-mir-17: -0.5426581251426968, miRNA_hsa-mir-130b: -1.25856878795907, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-C8-A8HP,High mRNA_C2orf54 (Z=2.18) and mRNA_CLCA2 (Z=2.13) indicate overexpression. Low mRNA_ESR1 (Z=-1.94) suggests silencing. No methylation sites meet hyper/hypo thresholds. miRNA_hsa-mir-4728 is upregulated (Z=2.39). All CNVs are normal (values > -1.10 and < -0.10). ESR1 loss with C2orf54/CLCA2 gain implies luminal B-like phenotype with ER pathway suppression.,"mRNA_MLPH: 0.2976870124827551, mRNA_C2orf54: 2.1759881928108107, mRNA_CITED4: -0.6180630222036532, mRNA_ESR1: -1.9363718979307096, mRNA_SPDEF: 0.5353822337574757, mRNA_AGR3: -1.6879720607526338, mRNA_FOXC1: -0.9206998684811788, mRNA_GATA3: -0.6788501396186816, mRNA_AGR2: -0.4041755332354995, mRNA_XBP1: -1.1856314525540534, mRNA_PRR15: -0.0188667730199886, mRNA_SLC44A4: 0.3552606667736951, mRNA_CA12: -0.6333293961609072, mRNA_DTL: -0.3597205344363429, mRNA_C5AR2: -1.6560719496193532, mRNA_TBC1D9: -1.592439452948151, mRNA_AR: -1.0187210199901886, mRNA_CCDC170: -1.6035581088680868, mRNA_DEGS2: -1.0229629771317754, mRNA_TFF3: 0.6014256773663116, mRNA_DNALI1: -1.622063256957817, mRNA_LINC00504: -1.743441443406775, mRNA_CLCA2: 2.125626462326341, mRNA_PPP1R14C: 0.0722135913844267, mRNA_THSD4: -1.3086732453402263, mRNA_SPAG5: 0.2194352064252516, mRNA_FBP1: 0.4058965563143141, mRNA_SLC7A8: -1.2025436503346492, mRNA_EN1: 0.3850595159050899, mRNA_ZNF552: -0.9743253821092642, Methylation_LRRC6: 1.2777048702819225, Methylation_chr2 66218712 LINC02934 (29533): 1.0660173385928011, Methylation_HOXB13: 0.5127318839033369, Methylation_chr10 3949206 LINC02660 (4871): 1.0458840148175856, Methylation_chr5 179517140 RNF130 (18026): -0.7338461818225945, Methylation_LOC727677: 1.3694191687855783, Methylation_LETM1: 1.2736207490855778, Methylation_CDC42BPB: -0.8986040010545034, Methylation_C8orf38: 1.3162906780824042, Methylation_chr14 100504766 EVL (18852): 1.140637143464515, Methylation_chr5 72594851 LOC340090 (24088): -1.1762129042369034, Methylation_chr2 242904738 LINC01238 (3421): 1.2217699786528715, Methylation_ARFGEF1: 1.240830661618583, Methylation_MAPT: 1.332640682947338, Methylation_ZFAT: 1.1771316188420011, Methylation_KCNQ4: -0.1848716730459433, Methylation_chr1 232684368 SIPA1L2 (12934): 0.9331342651076924, Methylation_CRNKL1: 1.356343024725162, Methylation_PRKAG2: -0.5124551418426777, Methylation_MICB: 1.3145733751782078, miRNA_hsa-mir-934: 0.1238048021178715, miRNA_hsa-mir-4728: 2.386132292475972, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.6392069062325765, miRNA_hsa-mir-190b: 0.595403135900057, miRNA_hsa-mir-577: -0.5306329660526501, miRNA_hsa-mir-135b: 1.0535734979836628, miRNA_hsa-mir-2115: 0.2555437457990104, miRNA_hsa-mir-17: -0.0470683065603663, miRNA_hsa-mir-130b: 0.5197744134615342, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A1JL,"High-level Amplification absent; no CNV alterations meet diagnostic thresholds.  
FOXC1 mRNA overexpression (Z=1.87) and PPP1R14C upregulation (Z=1.38) exceed mRNA high-threshold.  
PRR15 and TFF3 show significant mRNA downregulation (Z < -1.92).  
Multiple promoters hypermethylated (ARFGEF1, C8orf38, LOC727677, SIPA1L2; Z > 1.50).  
miR-135b and miR-18a upregulated (Z > 1.99); miR-190b downregulated (Z < -1.25).","mRNA_MLPH: -1.7797211250632572, mRNA_C2orf54: 0.0639574452754076, mRNA_CITED4: 0.2021274086926468, mRNA_ESR1: -1.402679961630075, mRNA_SPDEF: -1.0562355948044604, mRNA_AGR3: -1.2215262715447337, mRNA_FOXC1: 1.869439005961182, mRNA_GATA3: -0.3564897249430412, mRNA_AGR2: -1.676230453517481, mRNA_XBP1: -1.3671113249550937, mRNA_PRR15: -2.439491831611872, mRNA_SLC44A4: -2.262832113373137, mRNA_CA12: -1.5128661228784226, mRNA_DTL: -0.1031128951554808, mRNA_C5AR2: -1.5571150779989058, mRNA_TBC1D9: -0.9882398651671644, mRNA_AR: -1.8018764785274608, mRNA_CCDC170: -1.1987504318367603, mRNA_DEGS2: -1.882678018079605, mRNA_TFF3: -2.090291334617376, mRNA_DNALI1: -1.7396393489195567, mRNA_LINC00504: -1.628599534864869, mRNA_CLCA2: -0.1591154338795697, mRNA_PPP1R14C: 1.380879635248355, mRNA_THSD4: -1.240791775042605, mRNA_SPAG5: 0.7042342645207795, mRNA_FBP1: -0.6891369631108585, mRNA_SLC7A8: -0.9747698790617688, mRNA_EN1: 1.1670798608577728, mRNA_ZNF552: -1.7485367834768153, Methylation_LRRC6: 1.5165333155861993, Methylation_chr2 66218712 LINC02934 (29533): -0.5108903992741523, Methylation_HOXB13: -1.0823315886146905, Methylation_chr10 3949206 LINC02660 (4871): 1.20018618461012, Methylation_chr5 179517140 RNF130 (18026): -1.6827750421424017, Methylation_LOC727677: 1.5452627461733834, Methylation_LETM1: 1.336770693513502, Methylation_CDC42BPB: 0.4807414078142639, Methylation_C8orf38: 1.64425891970252, Methylation_chr14 100504766 EVL (18852): 1.4804986327166958, Methylation_chr5 72594851 LOC340090 (24088): -1.531976668704986, Methylation_chr2 242904738 LINC01238 (3421): 1.3381750026424757, Methylation_ARFGEF1: 1.697767947651862, Methylation_MAPT: 1.513757865886229, Methylation_ZFAT: 1.468319514503205, Methylation_KCNQ4: 0.5012730475314641, Methylation_chr1 232684368 SIPA1L2 (12934): 1.547593166037291, Methylation_CRNKL1: 1.470601040420864, Methylation_PRKAG2: -0.8882828942670132, Methylation_MICB: 1.5340987689731906, miRNA_hsa-mir-934: 1.4834467426269575, miRNA_hsa-mir-4728: 0.2728798427825841, miRNA_hsa-mir-5695: 0.6519994685164103, miRNA_hsa-mir-18a: 1.942011357889185, miRNA_hsa-mir-190b: -1.4303047519175298, miRNA_hsa-mir-577: 0.6793586094556884, miRNA_hsa-mir-135b: 2.2431360471914914, miRNA_hsa-mir-2115: 0.1192549601309173, miRNA_hsa-mir-17: 1.4684372166162227, miRNA_hsa-mir-130b: 0.700868666895817, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A73X,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.948984387259632, mRNA_C2orf54: -0.0726900327225022, mRNA_CITED4: 0.7466392783784803, mRNA_ESR1: 0.8299010241418955, mRNA_SPDEF: 0.772071151338969, mRNA_AGR3: 0.5127254986142369, mRNA_FOXC1: -0.7332047448800771, mRNA_GATA3: 0.564847067219096, mRNA_AGR2: 0.5978414190141593, mRNA_XBP1: 0.406111979592873, mRNA_PRR15: 0.7779049546830099, mRNA_SLC44A4: 0.7437745512931269, mRNA_CA12: 0.1030864026483101, mRNA_DTL: -0.3917156386650388, mRNA_C5AR2: 0.7895566223141017, mRNA_TBC1D9: 0.2833502903331311, mRNA_AR: 0.731213540717678, mRNA_CCDC170: 0.97755156826983, mRNA_DEGS2: 1.1846002265264322, mRNA_TFF3: 0.5370483522083667, mRNA_DNALI1: 0.9868892985419196, mRNA_LINC00504: 0.5587061643632394, mRNA_CLCA2: 1.3415401335164026, mRNA_PPP1R14C: -0.1557001815442149, mRNA_THSD4: 0.4276881754724836, mRNA_SPAG5: -0.8325381014421308, mRNA_FBP1: 0.6361423111790533, mRNA_SLC7A8: 1.055826726645801, mRNA_EN1: -0.426641120046873, mRNA_ZNF552: 0.2770389937710734, Methylation_LRRC6: -0.9852051179293388, Methylation_chr2 66218712 LINC02934 (29533): 1.3804560255380656, Methylation_HOXB13: 1.9056912858373944, Methylation_chr10 3949206 LINC02660 (4871): 1.5619764249079178, Methylation_chr5 179517140 RNF130 (18026): 0.7793939727479795, Methylation_LOC727677: -1.0972796327736016, Methylation_LETM1: -1.210765019788664, Methylation_CDC42BPB: -1.209669181759597, Methylation_C8orf38: -0.6825562188011545, Methylation_chr14 100504766 EVL (18852): -1.0796101772883815, Methylation_chr5 72594851 LOC340090 (24088): 1.2141848090755325, Methylation_chr2 242904738 LINC01238 (3421): -1.1548632444569185, Methylation_ARFGEF1: -1.0069164157775452, Methylation_MAPT: -1.4880604994019084, Methylation_ZFAT: 0.0661986956351402, Methylation_KCNQ4: -0.026937051204992, Methylation_chr1 232684368 SIPA1L2 (12934): -1.338169851705551, Methylation_CRNKL1: -1.5407905920672502, Methylation_PRKAG2: 1.332709243537546, Methylation_MICB: -1.202903799135678, miRNA_hsa-mir-934: -0.518544308012452, miRNA_hsa-mir-4728: -0.2858780226957968, miRNA_hsa-mir-5695: -0.2022055693130649, miRNA_hsa-mir-18a: -0.9832688175836108, miRNA_hsa-mir-190b: 0.518911789235381, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.8537503831273417, miRNA_hsa-mir-2115: -0.1675546573885121, miRNA_hsa-mir-17: -0.3993592238912132, miRNA_hsa-mir-130b: -1.7966583855262568, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A1FJ,"High-level Amplification absent; no CNV alterations meet diagnostic thresholds. mRNA_DTL (Z=2.60) and mRNA_LINC00504 (Z=2.03) are highly overexpressed. miRNA_hsa-mir-5695 (Z=3.61) and miRNA_hsa-mir-577 (Z=2.07) are upregulated. Methylation_MAPT (Z=-1.61), Methylation_CRNKL1 (Z=-1.66), and Methylation_SIPA1L2 (Z=-1.81) are hypomethylated. No hypermethylated loci or deletions meet criteria.","mRNA_MLPH: 0.702489509640163, mRNA_C2orf54: 0.1472601063912839, mRNA_CITED4: -0.2945534466828846, mRNA_ESR1: 0.8414756691514733, mRNA_SPDEF: 0.5916154404057742, mRNA_AGR3: 0.9167372242767658, mRNA_FOXC1: -0.3740584367566102, mRNA_GATA3: 1.0096626554359884, mRNA_AGR2: 1.0289062621430751, mRNA_XBP1: 0.5750890475507205, mRNA_PRR15: 0.6606868046576132, mRNA_SLC44A4: 0.9041128700103525, mRNA_CA12: 0.7747064734816801, mRNA_DTL: 2.5976296130351373, mRNA_C5AR2: 1.2611599031341372, mRNA_TBC1D9: 0.8055946939191998, mRNA_AR: 1.315164183618186, mRNA_CCDC170: 1.0410433031555384, mRNA_DEGS2: 0.9838578413667414, mRNA_TFF3: 0.8280620308043621, mRNA_DNALI1: -1.831092958570344, mRNA_LINC00504: 2.0298678646282946, mRNA_CLCA2: 1.465079194719206, mRNA_PPP1R14C: -0.9650488372158657, mRNA_THSD4: 0.8293762298886436, mRNA_SPAG5: 1.339486672869959, mRNA_FBP1: 0.5241178442986292, mRNA_SLC7A8: 0.8343846140627227, mRNA_EN1: -0.6664257238255862, mRNA_ZNF552: 1.1727464548315154, Methylation_LRRC6: -1.4094466354983397, Methylation_chr2 66218712 LINC02934 (29533): -1.3219838682750664, Methylation_HOXB13: -1.0392509528040956, Methylation_chr10 3949206 LINC02660 (4871): -1.3963252886005328, Methylation_chr5 179517140 RNF130 (18026): 1.19653527315573, Methylation_LOC727677: -1.5564584134995112, Methylation_LETM1: 0.1713785534574825, Methylation_CDC42BPB: -1.443724686945683, Methylation_C8orf38: -1.332777313740967, Methylation_chr14 100504766 EVL (18852): -0.6394882254088339, Methylation_chr5 72594851 LOC340090 (24088): 1.1983595458739362, Methylation_chr2 242904738 LINC01238 (3421): -1.4167077722658834, Methylation_ARFGEF1: -1.2793155988588756, Methylation_MAPT: -1.608879934113605, Methylation_ZFAT: 0.7223197211552805, Methylation_KCNQ4: -0.5129884431596661, Methylation_chr1 232684368 SIPA1L2 (12934): -1.809594089567384, Methylation_CRNKL1: -1.6638460003245663, Methylation_PRKAG2: 1.35569303326693, Methylation_MICB: -1.3304895222012991, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.0121426897480557, miRNA_hsa-mir-5695: 3.605454782081676, miRNA_hsa-mir-18a: -1.5217514670361116, miRNA_hsa-mir-190b: 1.807109934676211, miRNA_hsa-mir-577: 2.0728826533780924, miRNA_hsa-mir-135b: 0.8073014309603321, miRNA_hsa-mir-2115: -0.1574873087252308, miRNA_hsa-mir-17: -0.952581157152386, miRNA_hsa-mir-130b: 1.4124947057992585, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A2-A3XS,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression of PPP1R14C and EN1. Promoter hypermethylation of LRRC6, LINC02660, RNF130, LOC727677, C8orf38, ARFGEF1, MAPT, ZFAT, KCNQ4, SIPA1L2 mediates epigenetic silencing. miR-934, miR-18a, miR-577, miR-135b, and miR-17 are upregulated. ESR1, AGR2, CA12, and AR mRNA are downregulated. These features indicate a luminal B phenotype with ER signaling dysregulation.","mRNA_MLPH: -1.6981303528103042, mRNA_C2orf54: 1.4436385739030588, mRNA_CITED4: 1.316316073499611, mRNA_ESR1: -2.002669543243872, mRNA_SPDEF: -0.4470808685958684, mRNA_AGR3: -1.8820675838135987, mRNA_FOXC1: 1.903254093633264, mRNA_GATA3: -1.584982086988649, mRNA_AGR2: -2.407086820335428, mRNA_XBP1: -1.947602304828218, mRNA_PRR15: -1.8935851230177247, mRNA_SLC44A4: -2.1389206130122327, mRNA_CA12: -2.776073351216625, mRNA_DTL: -0.9105019751851532, mRNA_C5AR2: -1.820647891667451, mRNA_TBC1D9: -1.8410147442181004, mRNA_AR: -2.130181337259413, mRNA_CCDC170: -1.804672146540769, mRNA_DEGS2: -1.3729345697577613, mRNA_TFF3: -1.4771133406518864, mRNA_DNALI1: -1.6828332845839022, mRNA_LINC00504: -1.69794616257701, mRNA_CLCA2: -0.6321594260161506, mRNA_PPP1R14C: 2.6655999906404824, mRNA_THSD4: -2.0040000803018168, mRNA_SPAG5: -0.0052173231883216, mRNA_FBP1: -2.407315992556044, mRNA_SLC7A8: -1.6663433408847397, mRNA_EN1: 2.466003674269213, mRNA_ZNF552: -1.324750748076799, Methylation_LRRC6: 1.5189759177824318, Methylation_chr2 66218712 LINC02934 (29533): -1.0919977101199938, Methylation_HOXB13: 1.0701153486233954, Methylation_chr10 3949206 LINC02660 (4871): 1.6442210386198983, Methylation_chr5 179517140 RNF130 (18026): -1.5877964053210707, Methylation_LOC727677: 1.5367463799038588, Methylation_LETM1: 1.347701365474263, Methylation_CDC42BPB: 1.0496332769913608, Methylation_C8orf38: 1.6404599254700607, Methylation_chr14 100504766 EVL (18852): 1.482445319078135, Methylation_chr5 72594851 LOC340090 (24088): -1.4182294868208445, Methylation_chr2 242904738 LINC01238 (3421): 1.3947510675980928, Methylation_ARFGEF1: 1.6978318271729276, Methylation_MAPT: 1.4757401232382217, Methylation_ZFAT: 1.4810790157145908, Methylation_KCNQ4: 1.512272607790991, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5170926431211411, Methylation_CRNKL1: 1.2640024884709822, Methylation_PRKAG2: 1.2433265249562786, Methylation_MICB: 1.472198147584017, miRNA_hsa-mir-934: 3.4443124543032937, miRNA_hsa-mir-4728: -0.0409738641966733, miRNA_hsa-mir-5695: -0.3293048130896172, miRNA_hsa-mir-18a: 2.538548003920719, miRNA_hsa-mir-190b: -0.9230297900550508, miRNA_hsa-mir-577: 2.661928494012133, miRNA_hsa-mir-135b: 1.918370129094633, miRNA_hsa-mir-2115: 0.9073243023773868, miRNA_hsa-mir-17: 2.4771469135366515, miRNA_hsa-mir-130b: 1.7618131517780122, CNV_VPS54: 4.368946221858642, CNV_LINC01867: 4.411662538359512, CNV_LINC02576: 4.524961365416283, CNV_WDPCP: 4.394610852818543, CNV_CEP68: 4.524961365416283"
TCGA-AQ-A1H2,"ESR1, XBP1, DEGS2, and CA12 mRNA overexpressed (Z > 1.30).  
Multiple loci hypo-methylated (Z < -1.47): LETM1, CRNKL1, PRKAG2, ZFAT, MAPT, C8orf38, LINC02934.  
miR-17 downregulated (Z = -1.43 < -1.25).  
All CNVs fall within normal range (IGNORE).  
Collectively indicates luminal breast cancer phenotype with ER-pathway activation.","mRNA_MLPH: 1.0357706538134142, mRNA_C2orf54: -0.8891320016516354, mRNA_CITED4: 1.2605258174730345, mRNA_ESR1: 1.499139100893071, mRNA_SPDEF: 0.5720266770933735, mRNA_AGR3: 1.1000070730385674, mRNA_FOXC1: -1.349656099634665, mRNA_GATA3: 1.0792772149803962, mRNA_AGR2: 0.365471163111621, mRNA_XBP1: 1.5315101156886235, mRNA_PRR15: 1.0083322122194325, mRNA_SLC44A4: 0.2911265447425809, mRNA_CA12: 1.3327043894508577, mRNA_DTL: -0.9811481457385904, mRNA_C5AR2: 0.6706245129621388, mRNA_TBC1D9: 0.7925481094395017, mRNA_AR: 0.5346637874994138, mRNA_CCDC170: 1.319613276437288, mRNA_DEGS2: 1.5189005076355302, mRNA_TFF3: 0.146669621194911, mRNA_DNALI1: 0.594063288235504, mRNA_LINC00504: 0.922212400518453, mRNA_CLCA2: -0.8022618127351767, mRNA_PPP1R14C: -1.129093582886076, mRNA_THSD4: 0.2277932385910197, mRNA_SPAG5: -0.9153679782240968, mRNA_FBP1: 1.1938580755328474, mRNA_SLC7A8: 0.8652256462790026, mRNA_EN1: -0.849791731812291, mRNA_ZNF552: 1.1471437511521851, Methylation_LRRC6: -1.4543332232816006, Methylation_chr2 66218712 LINC02934 (29533): -1.7292610358206406, Methylation_HOXB13: -0.9394556619088168, Methylation_chr10 3949206 LINC02660 (4871): -1.2908949452948084, Methylation_chr5 179517140 RNF130 (18026): -0.2780782218639449, Methylation_LOC727677: -1.4729179293805066, Methylation_LETM1: -1.7591078937991649, Methylation_CDC42BPB: 1.317456111510848, Methylation_C8orf38: -1.578775149059433, Methylation_chr14 100504766 EVL (18852): -1.4488755331456578, Methylation_chr5 72594851 LOC340090 (24088): 1.291496387040039, Methylation_chr2 242904738 LINC01238 (3421): -1.342425827323808, Methylation_ARFGEF1: -1.1032026102360493, Methylation_MAPT: -1.5787011748820494, Methylation_ZFAT: -1.7263738544047134, Methylation_KCNQ4: 0.493056188000973, Methylation_chr1 232684368 SIPA1L2 (12934): -1.136515324580586, Methylation_CRNKL1: -1.7832510576566545, Methylation_PRKAG2: -1.5998165309581782, Methylation_MICB: -1.2655471971642935, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.812030429579626, miRNA_hsa-mir-5695: 0.7932468638693002, miRNA_hsa-mir-18a: -0.5301666489102509, miRNA_hsa-mir-190b: -0.0923317319423006, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.3251231525450961, miRNA_hsa-mir-2115: -0.325846635139655, miRNA_hsa-mir-17: -1.4302790311865812, miRNA_hsa-mir-130b: 0.3661067297769739, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A1JH,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.4195936295725857, mRNA_C2orf54: -0.1158543210748755, mRNA_CITED4: -0.5795349390506481, mRNA_ESR1: 0.694229226588928, mRNA_SPDEF: 0.2331769358337343, mRNA_AGR3: 0.3104532682745655, mRNA_FOXC1: 0.1220998763158601, mRNA_GATA3: 0.4966368898168282, mRNA_AGR2: 0.2671202475998714, mRNA_XBP1: 0.6943211660805226, mRNA_PRR15: 0.0985683027362402, mRNA_SLC44A4: 0.5542047502139477, mRNA_CA12: 0.7915826896182206, mRNA_DTL: -1.105111191783175, mRNA_C5AR2: 1.0410867432184991, mRNA_TBC1D9: 0.9986367659907132, mRNA_AR: 1.0548112545134558, mRNA_CCDC170: 1.2435537752708687, mRNA_DEGS2: 0.2763681708151108, mRNA_TFF3: 0.2139740567312752, mRNA_DNALI1: 0.5247464622196808, mRNA_LINC00504: 1.1891517922350876, mRNA_CLCA2: 1.097287422257545, mRNA_PPP1R14C: 0.1158530744788737, mRNA_THSD4: 1.0659568362836906, mRNA_SPAG5: -0.965150744794328, mRNA_FBP1: 0.3031304384662244, mRNA_SLC7A8: 0.5539329517476624, mRNA_EN1: -0.2324583964086134, mRNA_ZNF552: 0.3334856779686842, Methylation_LRRC6: 0.0890570967134158, Methylation_chr2 66218712 LINC02934 (29533): 0.5912691410622846, Methylation_HOXB13: -0.9958192351508802, Methylation_chr10 3949206 LINC02660 (4871): 0.0494866003424882, Methylation_chr5 179517140 RNF130 (18026): 0.585086923985557, Methylation_LOC727677: -0.8559221777618519, Methylation_LETM1: -0.2202499294899445, Methylation_CDC42BPB: -0.6804208937209563, Methylation_C8orf38: -0.2050538529143704, Methylation_chr14 100504766 EVL (18852): -0.0894837647001285, Methylation_chr5 72594851 LOC340090 (24088): 0.3979565949980259, Methylation_chr2 242904738 LINC01238 (3421): -0.3323054256147322, Methylation_ARFGEF1: 0.1652095469937332, Methylation_MAPT: 0.3583294797132685, Methylation_ZFAT: 0.4882346552660727, Methylation_KCNQ4: -1.1884601929137182, Methylation_chr1 232684368 SIPA1L2 (12934): 0.3796759143270142, Methylation_CRNKL1: -0.7130823406780111, Methylation_PRKAG2: 1.2623923567985078, Methylation_MICB: -0.0236812887984483, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.9950669490299806, miRNA_hsa-mir-5695: 0.6475413443270275, miRNA_hsa-mir-18a: -0.4059567657209572, miRNA_hsa-mir-190b: 0.0250818472318208, miRNA_hsa-mir-577: 0.6439480034130154, miRNA_hsa-mir-135b: -0.0845951423810907, miRNA_hsa-mir-2115: -0.3632618577230356, miRNA_hsa-mir-17: -0.6820549192889579, miRNA_hsa-mir-130b: -0.1155358734564516, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A3Q9,"mRNA_CITED4 (Z = -2.35) and mRNA_DTL (Z = -2.78) are significantly downregulated; mRNA_SPAG5 (Z = -2.42) is low. Methylation_chr2 66218712 LINC02934 is hypomethylated (Z = -1.53). No miRNAs meet dysregulation thresholds. All CNVs fall within normal range (−1.10 to −0.10). Transcriptional suppression of CITED4, DTL, and SPAG5 suggests luminal progenitor dysfunction with cell cycle impairment.","mRNA_MLPH: 0.6622966727008498, mRNA_C2orf54: -1.2943230935752186, mRNA_CITED4: -2.3479760501474924, mRNA_ESR1: 0.3629502353878756, mRNA_SPDEF: 0.0891950992503381, mRNA_AGR3: 0.6246518621650814, mRNA_FOXC1: -0.4482299295128514, mRNA_GATA3: 0.0198031963542169, mRNA_AGR2: 0.8255161492364287, mRNA_XBP1: 0.365313285016788, mRNA_PRR15: 0.4044619263455565, mRNA_SLC44A4: 0.1339750253016109, mRNA_CA12: 0.1338495537825114, mRNA_DTL: -2.7754379762948904, mRNA_C5AR2: 0.1118893506601666, mRNA_TBC1D9: 0.3818067369404301, mRNA_AR: 0.1733011908666896, mRNA_CCDC170: 1.176089081731307, mRNA_DEGS2: 0.1034470375027399, mRNA_TFF3: 0.512837719795026, mRNA_DNALI1: 0.1612155887947325, mRNA_LINC00504: 0.6212652244064424, mRNA_CLCA2: -0.7864533983903492, mRNA_PPP1R14C: -1.111241222043156, mRNA_THSD4: 0.355073496585326, mRNA_SPAG5: -2.420348239791262, mRNA_FBP1: 0.1152254706133438, mRNA_SLC7A8: 0.3848856105832621, mRNA_EN1: -0.6813947809111025, mRNA_ZNF552: -0.821670938271932, Methylation_LRRC6: -0.7207196592679301, Methylation_chr2 66218712 LINC02934 (29533): -1.533975322341234, Methylation_HOXB13: -1.0582328937981245, Methylation_chr10 3949206 LINC02660 (4871): -0.8892270658492212, Methylation_chr5 179517140 RNF130 (18026): 0.9258373468681844, Methylation_LOC727677: -0.712610020180099, Methylation_LETM1: -1.187631125901398, Methylation_CDC42BPB: -1.1886055962190976, Methylation_C8orf38: -0.7689982467717934, Methylation_chr14 100504766 EVL (18852): -1.037313475517714, Methylation_chr5 72594851 LOC340090 (24088): -0.2700327180962927, Methylation_chr2 242904738 LINC01238 (3421): -0.8957366472900524, Methylation_ARFGEF1: -0.2138788595645862, Methylation_MAPT: -0.2837689705542606, Methylation_ZFAT: 0.1117572571325496, Methylation_KCNQ4: -1.0030015784783552, Methylation_chr1 232684368 SIPA1L2 (12934): -0.5018319996151703, Methylation_CRNKL1: -0.5358704335869989, Methylation_PRKAG2: 0.0402709286616673, Methylation_MICB: -0.7815332862391685, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.5845214573357436, miRNA_hsa-mir-5695: -0.1710354705750973, miRNA_hsa-mir-18a: -0.9395637655276086, miRNA_hsa-mir-190b: -0.0440428069134031, miRNA_hsa-mir-577: -0.4958985578372551, miRNA_hsa-mir-135b: -0.0550666752278181, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.3886570607377685, miRNA_hsa-mir-130b: -0.1290629066219346, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A2-A0YG,"High-level Amplification of LINC01867 drives mRNA overexpression.  
Methylation_chr5 72594851 LOC340090 hypo-methylation correlates with transcriptional dysregulation.  
miR-4728 and miR-2115 are significantly upregulated; miR-190b is downregulated.  
These features collectively indicate a luminal-like phenotype with PI3K/AKT pathway dysregulation.","mRNA_MLPH: 0.5228056067381666, mRNA_C2orf54: 2.4337581836527327, mRNA_CITED4: -1.7459320107098764, mRNA_ESR1: 0.6060560727389306, mRNA_SPDEF: 0.5124856734170585, mRNA_AGR3: 0.6741365619970027, mRNA_FOXC1: -0.7208604740827844, mRNA_GATA3: 0.1839846573173236, mRNA_AGR2: 0.5678982033256235, mRNA_XBP1: 0.1166603247101333, mRNA_PRR15: 0.4139893124017119, mRNA_SLC44A4: 0.5054199908644277, mRNA_CA12: 0.708851554380588, mRNA_DTL: 1.4948393120287702, mRNA_C5AR2: 0.3507400357080468, mRNA_TBC1D9: 0.7138942171433965, mRNA_AR: 1.069345062029886, mRNA_CCDC170: 0.5223503288156427, mRNA_DEGS2: 0.0931049388094141, mRNA_TFF3: 0.7436121126823033, mRNA_DNALI1: -1.848804956624117, mRNA_LINC00504: 0.4748661898495471, mRNA_CLCA2: 0.9548758381784918, mRNA_PPP1R14C: -0.3979175952409237, mRNA_THSD4: 0.748581843178137, mRNA_SPAG5: 1.6533667258368645, mRNA_FBP1: 0.5234969223513531, mRNA_SLC7A8: 0.4012231996670534, mRNA_EN1: -0.7016687777726317, mRNA_ZNF552: 0.6340786463604831, Methylation_LRRC6: -1.089341372018119, Methylation_chr2 66218712 LINC02934 (29533): -0.3332960709777158, Methylation_HOXB13: 1.374975437152097, Methylation_chr10 3949206 LINC02660 (4871): -0.4698250175364546, Methylation_chr5 179517140 RNF130 (18026): 0.5820927974168028, Methylation_LOC727677: -0.830356884717902, Methylation_LETM1: 1.2944247160022122, Methylation_CDC42BPB: 0.7785611392229993, Methylation_C8orf38: -1.1425820852356072, Methylation_chr14 100504766 EVL (18852): -0.8482892310030395, Methylation_chr5 72594851 LOC340090 (24088): -1.608986778714781, Methylation_chr2 242904738 LINC01238 (3421): -0.9792339816458476, Methylation_ARFGEF1: -1.1360916966190937, Methylation_MAPT: -0.6876264468025227, Methylation_ZFAT: -1.049715825806362, Methylation_KCNQ4: 0.8002655667773827, Methylation_chr1 232684368 SIPA1L2 (12934): 0.0134157905202465, Methylation_CRNKL1: -1.1673484129381997, Methylation_PRKAG2: -1.363806943569091, Methylation_MICB: -0.0089768480062757, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 2.9484009591614093, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.2690833692664167, miRNA_hsa-mir-190b: -1.2449112538978084, miRNA_hsa-mir-577: -0.2974820385769544, miRNA_hsa-mir-135b: 0.0637002289157506, miRNA_hsa-mir-2115: 2.254322998418953, miRNA_hsa-mir-17: 0.2805987347454514, miRNA_hsa-mir-130b: -0.8304775910185365, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-EW-A1IZ,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.2259731058923888, mRNA_C2orf54: 0.0991032245415546, mRNA_CITED4: -0.4012966472713042, mRNA_ESR1: 0.0854454708932527, mRNA_SPDEF: 0.3266530190521653, mRNA_AGR3: -0.5792182231441334, mRNA_FOXC1: -0.1941826592432519, mRNA_GATA3: 0.2173097310593154, mRNA_AGR2: -0.1213682409313209, mRNA_XBP1: 0.0002694933133794, mRNA_PRR15: -0.0429651433575687, mRNA_SLC44A4: 0.6614730761226264, mRNA_CA12: -0.4238574401278331, mRNA_DTL: -0.3801903205678202, mRNA_C5AR2: 0.6505865156225845, mRNA_TBC1D9: 0.5966376086520214, mRNA_AR: 0.1052308598568681, mRNA_CCDC170: -0.1231648135381618, mRNA_DEGS2: 0.7477962406277756, mRNA_TFF3: 0.4676106563258983, mRNA_DNALI1: 0.6284390685935405, mRNA_LINC00504: 0.4678239019598738, mRNA_CLCA2: -0.8865931386021149, mRNA_PPP1R14C: -0.6969366851998373, mRNA_THSD4: -0.2779318837970859, mRNA_SPAG5: -0.1755924678512277, mRNA_FBP1: 1.0458232453469247, mRNA_SLC7A8: -0.1917878779854865, mRNA_EN1: -0.9807132538222082, mRNA_ZNF552: 0.1455237689747711, Methylation_LRRC6: 1.0165433313275678, Methylation_chr2 66218712 LINC02934 (29533): 0.2974480495647907, Methylation_HOXB13: 0.2940987995675133, Methylation_chr10 3949206 LINC02660 (4871): 0.6567510308667196, Methylation_chr5 179517140 RNF130 (18026): -0.4424265649347351, Methylation_LOC727677: 0.7721717098017238, Methylation_LETM1: 0.2719119255146831, Methylation_CDC42BPB: -0.3121306334774223, Methylation_C8orf38: 1.00767599590138, Methylation_chr14 100504766 EVL (18852): 0.996404657507232, Methylation_chr5 72594851 LOC340090 (24088): -0.5244136365198134, Methylation_chr2 242904738 LINC01238 (3421): 1.20493032384472, Methylation_ARFGEF1: 0.9420415608894872, Methylation_MAPT: 1.413926856632168, Methylation_ZFAT: 0.3538125547843372, Methylation_KCNQ4: -0.0899116922357656, Methylation_chr1 232684368 SIPA1L2 (12934): 0.9680389455133186, Methylation_CRNKL1: 0.775926715145478, Methylation_PRKAG2: 0.810467521540246, Methylation_MICB: 0.657073541065129, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.4443294740223051, miRNA_hsa-mir-5695: 2.5515277991401377, miRNA_hsa-mir-18a: 0.9119324981866668, miRNA_hsa-mir-190b: 1.3602548849430158, miRNA_hsa-mir-577: 1.0092161609397614, miRNA_hsa-mir-135b: 0.2663110573247234, miRNA_hsa-mir-2115: 0.0812733955853642, miRNA_hsa-mir-17: 0.2281899107761469, miRNA_hsa-mir-130b: 1.1193473847458455, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A1-A0SE,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.3056904218929148, mRNA_C2orf54: -0.3013884677794826, mRNA_CITED4: 0.6705205127326824, mRNA_ESR1: 0.1102353342144625, mRNA_SPDEF: 0.1703533774832668, mRNA_AGR3: 0.4408790128525325, mRNA_FOXC1: 0.5304820722842436, mRNA_GATA3: 0.5249406429570549, mRNA_AGR2: 0.1245339187740271, mRNA_XBP1: 0.5365569901747358, mRNA_PRR15: 0.3628821091543702, mRNA_SLC44A4: 0.4443031643349454, mRNA_CA12: 0.8791232334784088, mRNA_DTL: 0.9009499951294436, mRNA_C5AR2: 0.717970837019474, mRNA_TBC1D9: 0.3651565029453571, mRNA_AR: 0.6966709180128683, mRNA_CCDC170: 0.1614298191599186, mRNA_DEGS2: 0.8802847116752687, mRNA_TFF3: 0.8012891510459909, mRNA_DNALI1: 0.7067814354800521, mRNA_LINC00504: 0.5220605977470498, mRNA_CLCA2: 0.5284808100452316, mRNA_PPP1R14C: -0.3010808952651383, mRNA_THSD4: 0.5613327115700455, mRNA_SPAG5: 0.231765581507748, mRNA_FBP1: 0.4623057594807037, mRNA_SLC7A8: 0.7168803634124101, mRNA_EN1: -0.5405617193268611, mRNA_ZNF552: 0.6437608641950838, Methylation_LRRC6: 0.2406652216101484, Methylation_chr2 66218712 LINC02934 (29533): -0.6802341010933509, Methylation_HOXB13: -0.953057518360522, Methylation_chr10 3949206 LINC02660 (4871): -0.3706160271081463, Methylation_chr5 179517140 RNF130 (18026): 0.5166480913053678, Methylation_LOC727677: -0.1959508956289629, Methylation_LETM1: -0.0960060206171631, Methylation_CDC42BPB: -0.4531167652801824, Methylation_C8orf38: 0.1136505022375153, Methylation_chr14 100504766 EVL (18852): 0.6241344061107486, Methylation_chr5 72594851 LOC340090 (24088): -0.6660361651481337, Methylation_chr2 242904738 LINC01238 (3421): 0.3394914762874295, Methylation_ARFGEF1: 0.3004033078731394, Methylation_MAPT: 0.1328321169517478, Methylation_ZFAT: -0.0096702759740604, Methylation_KCNQ4: -0.965579317323712, Methylation_chr1 232684368 SIPA1L2 (12934): 0.116146153105433, Methylation_CRNKL1: 0.684709549007952, Methylation_PRKAG2: 1.2035237196924868, Methylation_MICB: 0.2642100075545588, miRNA_hsa-mir-934: 0.0708440310579245, miRNA_hsa-mir-4728: -0.3428496432019806, miRNA_hsa-mir-5695: 1.1504363059075335, miRNA_hsa-mir-18a: -0.9333658254531368, miRNA_hsa-mir-190b: 1.6617241567919596, miRNA_hsa-mir-577: -0.2984191718141074, miRNA_hsa-mir-135b: 0.0621228576848545, miRNA_hsa-mir-2115: -0.2313452920533524, miRNA_hsa-mir-17: -1.089462240836126, miRNA_hsa-mir-130b: -0.5579578234142853, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A1NI,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.0023297421540384, mRNA_C2orf54: 0.9720084816924612, mRNA_CITED4: 0.7487077436079853, mRNA_ESR1: 0.8074428952321175, mRNA_SPDEF: 0.4033350469199198, mRNA_AGR3: 0.8676912198931189, mRNA_FOXC1: -0.9013247700517328, mRNA_GATA3: 0.5962744164392683, mRNA_AGR2: 0.8460109434808967, mRNA_XBP1: 0.350273791346692, mRNA_PRR15: 0.3102366687626604, mRNA_SLC44A4: 0.5385219572044356, mRNA_CA12: 0.7057153731365317, mRNA_DTL: 0.5471513726988467, mRNA_C5AR2: 2.2985911480763063e-05, mRNA_TBC1D9: 0.552336646304437, mRNA_AR: 0.4532914210882869, mRNA_CCDC170: 0.692299564054639, mRNA_DEGS2: 1.097229754715417, mRNA_TFF3: 0.2526057998558491, mRNA_DNALI1: 1.166008239236031, mRNA_LINC00504: 0.7663742323807574, mRNA_CLCA2: -0.318301581557898, mRNA_PPP1R14C: -0.3556816083780332, mRNA_THSD4: 0.4208327702097089, mRNA_SPAG5: 0.1901878620663229, mRNA_FBP1: 0.0840300985314611, mRNA_SLC7A8: 0.2347477039728917, mRNA_EN1: -0.3454760327940612, mRNA_ZNF552: 0.0305870246727802, Methylation_LRRC6: -1.1112651444155726, Methylation_chr2 66218712 LINC02934 (29533): 1.0099409660075611, Methylation_HOXB13: 0.7000983146189859, Methylation_chr10 3949206 LINC02660 (4871): -1.3439847304351364, Methylation_chr5 179517140 RNF130 (18026): 1.0224194725396711, Methylation_LOC727677: -0.7031155257653433, Methylation_LETM1: -1.244532716769811, Methylation_CDC42BPB: 1.20457210907581, Methylation_C8orf38: -1.116457886478467, Methylation_chr14 100504766 EVL (18852): -1.257134192091131, Methylation_chr5 72594851 LOC340090 (24088): 0.882132315124622, Methylation_chr2 242904738 LINC01238 (3421): -1.0274205694193548, Methylation_ARFGEF1: -0.9458138468506584, Methylation_MAPT: -1.003295428332715, Methylation_ZFAT: -1.3474969652759945, Methylation_KCNQ4: -0.9200839829002132, Methylation_chr1 232684368 SIPA1L2 (12934): -1.0295286360898528, Methylation_CRNKL1: -0.734531390794348, Methylation_PRKAG2: -0.4182681606169, Methylation_MICB: -1.4763954315618193, miRNA_hsa-mir-934: -0.0089371524179681, miRNA_hsa-mir-4728: 0.832612620781889, miRNA_hsa-mir-5695: 1.490117689226343, miRNA_hsa-mir-18a: 0.4809143330299332, miRNA_hsa-mir-190b: 0.7993147904742248, miRNA_hsa-mir-577: 0.7439720032790318, miRNA_hsa-mir-135b: -0.4794463778661866, miRNA_hsa-mir-2115: 0.2500800159416768, miRNA_hsa-mir-17: 0.650628116230305, miRNA_hsa-mir-130b: 0.8163704652664804, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-D8-A27P,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.5465846390435496, mRNA_C2orf54: -0.9684342260561974, mRNA_CITED4: -0.3789378903608833, mRNA_ESR1: -0.0657493414095097, mRNA_SPDEF: 0.495904022774732, mRNA_AGR3: 0.7178781610132636, mRNA_FOXC1: -0.1709764144528997, mRNA_GATA3: 0.8721648315289997, mRNA_AGR2: 0.4433009680831848, mRNA_XBP1: 1.2919218404845214, mRNA_PRR15: 0.388392599914543, mRNA_SLC44A4: 0.8057632191588797, mRNA_CA12: 0.6373073395551657, mRNA_DTL: -0.7823014698560755, mRNA_C5AR2: 0.3703309987905664, mRNA_TBC1D9: 1.2091208944738252, mRNA_AR: 1.2372327981966331, mRNA_CCDC170: -0.8312716775965094, mRNA_DEGS2: 0.9313264176532452, mRNA_TFF3: 0.104094931646983, mRNA_DNALI1: 0.7197491189555887, mRNA_LINC00504: 0.960229115111713, mRNA_CLCA2: 0.3499334589461794, mRNA_PPP1R14C: 0.7988230094518205, mRNA_THSD4: 1.1300992198835649, mRNA_SPAG5: -0.9088817387318384, mRNA_FBP1: 0.550663777672762, mRNA_SLC7A8: 0.9599992218111822, mRNA_EN1: -0.3771538760319426, mRNA_ZNF552: 0.4351755827597995, Methylation_LRRC6: 0.2332297196360487, Methylation_chr2 66218712 LINC02934 (29533): 0.0387796243691582, Methylation_HOXB13: -1.087862829354456, Methylation_chr10 3949206 LINC02660 (4871): -0.8175579791115667, Methylation_chr5 179517140 RNF130 (18026): -1.2322830109817065, Methylation_LOC727677: -0.5545706468616287, Methylation_LETM1: -0.8162138010651406, Methylation_CDC42BPB: -1.162193711576851, Methylation_C8orf38: -0.9025735989595892, Methylation_chr14 100504766 EVL (18852): -0.4586962472567441, Methylation_chr5 72594851 LOC340090 (24088): 0.2376604603856904, Methylation_chr2 242904738 LINC01238 (3421): -0.9603326063075972, Methylation_ARFGEF1: -0.1871258992587179, Methylation_MAPT: -0.5718365273037389, Methylation_ZFAT: -0.3799522558762577, Methylation_KCNQ4: -0.6464500498960398, Methylation_chr1 232684368 SIPA1L2 (12934): -0.0897463219041306, Methylation_CRNKL1: 0.0360528844312034, Methylation_PRKAG2: -0.857099505401952, Methylation_MICB: -0.9739364914446972, miRNA_hsa-mir-934: 0.1776391323166256, miRNA_hsa-mir-4728: 0.0520399524364952, miRNA_hsa-mir-5695: -0.405837234114044, miRNA_hsa-mir-18a: -1.677374846754586, miRNA_hsa-mir-190b: -0.4961845854281249, miRNA_hsa-mir-577: -0.3462646048414854, miRNA_hsa-mir-135b: -0.0074370513655652, miRNA_hsa-mir-2115: 1.7315875332258417, miRNA_hsa-mir-17: -1.0919386630186183, miRNA_hsa-mir-130b: -0.683326756913392, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-GM-A5PX,mRNA_CITED4 (Z=1.41) is high. mRNA_DTL (Z=−2.37) and mRNA_SPAG5 (Z=−2.17) are low. Methylation_PRKAG2 (Z=1.06) and Methylation_chr14 100504766 EVL (Z=0.97) do not meet hyper/hypomethylation thresholds. miRNA_hsa-mir-130b (Z=−1.76) is downregulated. All CNVs fall within normal range (−1.10 to −0.10). No genomic drivers identified.,"mRNA_MLPH: 0.7705503842033439, mRNA_C2orf54: 0.0489681531189463, mRNA_CITED4: 1.4106242073050028, mRNA_ESR1: 0.0468312328557563, mRNA_SPDEF: 0.5173702157400627, mRNA_AGR3: 0.4189111681242892, mRNA_FOXC1: 0.2692213636738653, mRNA_GATA3: 0.594064037971462, mRNA_AGR2: -0.0075923567929518, mRNA_XBP1: 0.5298142029327496, mRNA_PRR15: 0.9268185212450628, mRNA_SLC44A4: 0.7446642509044725, mRNA_CA12: 0.3857761268754121, mRNA_DTL: -2.365421515548689, mRNA_C5AR2: -0.2033249130371766, mRNA_TBC1D9: 0.3994967597734159, mRNA_AR: 0.1053107511390479, mRNA_CCDC170: 0.445899107634111, mRNA_DEGS2: 0.453120762547769, mRNA_TFF3: 0.080272051078822, mRNA_DNALI1: 0.8748515076384925, mRNA_LINC00504: 1.1335268914982348, mRNA_CLCA2: -0.7033320919440793, mRNA_PPP1R14C: -0.617106227257851, mRNA_THSD4: -0.3076844673546551, mRNA_SPAG5: -2.1696975385376147, mRNA_FBP1: 0.3441160698537125, mRNA_SLC7A8: 0.1066349610195839, mRNA_EN1: 0.0215954458402934, mRNA_ZNF552: 0.1377636290520852, Methylation_LRRC6: 0.2460125570402337, Methylation_chr2 66218712 LINC02934 (29533): 0.3545185207409571, Methylation_HOXB13: -0.9085245445056002, Methylation_chr10 3949206 LINC02660 (4871): -0.4485743841091983, Methylation_chr5 179517140 RNF130 (18026): 0.3620404090675758, Methylation_LOC727677: -0.2005400443034098, Methylation_LETM1: -0.1991949254784027, Methylation_CDC42BPB: -0.3310234293434095, Methylation_C8orf38: 0.6449515339335385, Methylation_chr14 100504766 EVL (18852): 0.9693363669586648, Methylation_chr5 72594851 LOC340090 (24088): 0.2708194152026087, Methylation_chr2 242904738 LINC01238 (3421): -0.816469175396756, Methylation_ARFGEF1: 0.3536536050958609, Methylation_MAPT: -0.0970703422313317, Methylation_ZFAT: 0.1406034190030601, Methylation_KCNQ4: -0.5790375621976988, Methylation_chr1 232684368 SIPA1L2 (12934): -0.2864149226628488, Methylation_CRNKL1: 0.3329330295753643, Methylation_PRKAG2: 1.0583403805231255, Methylation_MICB: -0.460505041210876, miRNA_hsa-mir-934: -0.4796570549133533, miRNA_hsa-mir-4728: -0.4483661951869666, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.0577541400399766, miRNA_hsa-mir-190b: 0.1507687847152843, miRNA_hsa-mir-577: -0.6519564396516332, miRNA_hsa-mir-135b: -0.7812848326210158, miRNA_hsa-mir-2115: 0.8960981674754421, miRNA_hsa-mir-17: -0.9787520561834288, miRNA_hsa-mir-130b: -1.7631671275044478, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A1AM,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.8139280988330996, mRNA_C2orf54: 0.9653391667121264, mRNA_CITED4: 0.780027529006771, mRNA_ESR1: 0.0494436149443517, mRNA_SPDEF: 0.7772752481722816, mRNA_AGR3: 0.2888963223841518, mRNA_FOXC1: -0.0199724824452921, mRNA_GATA3: 0.863039102999165, mRNA_AGR2: -0.0502650411891624, mRNA_XBP1: 0.4428654498384146, mRNA_PRR15: 0.7044368849425966, mRNA_SLC44A4: 0.8155222873101559, mRNA_CA12: 0.6770111813830894, mRNA_DTL: -1.3610482887807018, mRNA_C5AR2: 0.7438621525764565, mRNA_TBC1D9: 1.1093838989389158, mRNA_AR: 0.4323539924358095, mRNA_CCDC170: 1.1021250151858235, mRNA_DEGS2: 0.5684404165310623, mRNA_TFF3: 0.9285932236690444, mRNA_DNALI1: 0.7694771901660395, mRNA_LINC00504: 0.5930944135115069, mRNA_CLCA2: 0.1578019874598678, mRNA_PPP1R14C: 0.0632420152748399, mRNA_THSD4: 0.5568287908324612, mRNA_SPAG5: -0.8961814062643915, mRNA_FBP1: 0.5850763928355217, mRNA_SLC7A8: 0.2677623620601495, mRNA_EN1: -0.1998345790947314, mRNA_ZNF552: 0.8743679336432415, Methylation_LRRC6: 0.7191786990974088, Methylation_chr2 66218712 LINC02934 (29533): -0.5383851600412964, Methylation_HOXB13: -1.039797949494944, Methylation_chr10 3949206 LINC02660 (4871): -0.0517847512354641, Methylation_chr5 179517140 RNF130 (18026): -1.0602370106066672, Methylation_LOC727677: 0.0369798158332246, Methylation_LETM1: 0.1205328594336272, Methylation_CDC42BPB: -0.6221096294637442, Methylation_C8orf38: 0.2500613935270861, Methylation_chr14 100504766 EVL (18852): 0.7263185144186284, Methylation_chr5 72594851 LOC340090 (24088): -0.9944560709727464, Methylation_chr2 242904738 LINC01238 (3421): -0.0274178442089378, Methylation_ARFGEF1: 0.53134244416488, Methylation_MAPT: 0.022237997478969, Methylation_ZFAT: 0.0652430301334535, Methylation_KCNQ4: -1.1404467707767345, Methylation_chr1 232684368 SIPA1L2 (12934): 0.4481802222349766, Methylation_CRNKL1: 0.3710042852912131, Methylation_PRKAG2: 0.628590836823852, Methylation_MICB: 0.3854881031650428, miRNA_hsa-mir-934: -0.2074812170834798, miRNA_hsa-mir-4728: -0.14985280268979, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.4556565611582904, miRNA_hsa-mir-190b: -0.3359939359507938, miRNA_hsa-mir-577: 0.1725466430102771, miRNA_hsa-mir-135b: -0.2505649264270733, miRNA_hsa-mir-2115: 1.090097432783241, miRNA_hsa-mir-17: -0.1752025177229836, miRNA_hsa-mir-130b: -1.2487839317030818, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A1AX,High mRNA_C2orf54 (Z=1.63) indicates overexpression. No methylation sites meet hyper/hypo thresholds. No miRNA alterations exceed regulatory cutoffs. All CNVs fall within normal range (−1.10 to −0.10). No actionable drivers detected.,"mRNA_MLPH: 0.0920711786681429, mRNA_C2orf54: 1.6318265651509996, mRNA_CITED4: -0.0799234315615121, mRNA_ESR1: 0.1136509202773523, mRNA_SPDEF: 0.2785394241613351, mRNA_AGR3: 0.149968530013771, mRNA_FOXC1: -0.1198294440160123, mRNA_GATA3: 0.2878235274996402, mRNA_AGR2: -0.2148539744854925, mRNA_XBP1: 0.4428458210717419, mRNA_PRR15: -0.8510611400990231, mRNA_SLC44A4: 0.3700304707589816, mRNA_CA12: 0.7999055683846662, mRNA_DTL: 0.1618419299862319, mRNA_C5AR2: 0.3955236956524205, mRNA_TBC1D9: -0.1009137781653571, mRNA_AR: 0.3472946797970092, mRNA_CCDC170: -0.3423530353759108, mRNA_DEGS2: 0.0955011783719193, mRNA_TFF3: -0.2030103983480205, mRNA_DNALI1: 0.30167927436163, mRNA_LINC00504: -0.1824453194359509, mRNA_CLCA2: -0.2705585046637372, mRNA_PPP1R14C: -0.4090151770220048, mRNA_THSD4: 0.4650927777132727, mRNA_SPAG5: 0.295161893048066, mRNA_FBP1: -0.120167261883674, mRNA_SLC7A8: -0.1012899026758275, mRNA_EN1: 0.8274360451737801, mRNA_ZNF552: -0.7237656229570024, Methylation_LRRC6: 0.4634768466187215, Methylation_chr2 66218712 LINC02934 (29533): 0.8473491444335909, Methylation_HOXB13: 1.0693303946171282, Methylation_chr10 3949206 LINC02660 (4871): 0.9126232804996032, Methylation_chr5 179517140 RNF130 (18026): -0.9702141515556822, Methylation_LOC727677: 0.008911547597687, Methylation_LETM1: 0.9249760466498808, Methylation_CDC42BPB: -0.5509985216307931, Methylation_C8orf38: 0.3299799436591634, Methylation_chr14 100504766 EVL (18852): 1.3879073681267649, Methylation_chr5 72594851 LOC340090 (24088): -0.1838051983640279, Methylation_chr2 242904738 LINC01238 (3421): 0.4128585701552555, Methylation_ARFGEF1: 0.5882842920717951, Methylation_MAPT: 0.853207813167153, Methylation_ZFAT: -0.0170574788617468, Methylation_KCNQ4: -0.7625868194153163, Methylation_chr1 232684368 SIPA1L2 (12934): 1.124187612901462, Methylation_CRNKL1: 1.0729634544193878, Methylation_PRKAG2: 0.4451042119415735, Methylation_MICB: 1.0201548176423316, miRNA_hsa-mir-934: -0.2305390495717557, miRNA_hsa-mir-4728: 1.4404740052192586, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.70535207074743, miRNA_hsa-mir-190b: -0.6568772834267278, miRNA_hsa-mir-577: -0.1893223591368174, miRNA_hsa-mir-135b: -0.5759929912747336, miRNA_hsa-mir-2115: 0.6061907492510531, miRNA_hsa-mir-17: -0.1748895494915698, miRNA_hsa-mir-130b: -1.0488679905557154, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-OL-A66N,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. CLCA2 shows significant mRNA upregulation (Z=2.92). SPAG5 and DTL exhibit low mRNA (Z < -1.92). HOXB13 and PRKAG2 promoters are hypermethylated (Z > 1.50). miR-130b is downregulated (Z < -1.25). These features indicate a luminal B phenotype with ER-pathway dysregulation.","mRNA_MLPH: 1.0458875044305278, mRNA_C2orf54: -0.2852723978470205, mRNA_CITED4: 0.9219220088763384, mRNA_ESR1: -0.1936050286393086, mRNA_SPDEF: 0.8648504878202938, mRNA_AGR3: 0.2152308926199714, mRNA_FOXC1: -0.1104660247797187, mRNA_GATA3: 0.0748827718130296, mRNA_AGR2: 0.7692272532800302, mRNA_XBP1: 0.096332083919372, mRNA_PRR15: 0.8583096231639871, mRNA_SLC44A4: 0.8769663834184354, mRNA_CA12: -0.4656263561227893, mRNA_DTL: -1.960364973043875, mRNA_C5AR2: -0.480185731098297, mRNA_TBC1D9: -0.9408604539285376, mRNA_AR: -0.9657883870341498, mRNA_CCDC170: -1.0981024134115238, mRNA_DEGS2: 0.559331024048381, mRNA_TFF3: 0.9941221153190188, mRNA_DNALI1: 0.3491391945752415, mRNA_LINC00504: 0.3382348086598243, mRNA_CLCA2: 2.9207478612792044, mRNA_PPP1R14C: -0.7815483423114487, mRNA_THSD4: -0.7094104034063562, mRNA_SPAG5: -2.014676081488445, mRNA_FBP1: 0.4588736800513301, mRNA_SLC7A8: -0.0150545224766088, mRNA_EN1: -0.4784770228259363, mRNA_ZNF552: -0.9844927932308496, Methylation_LRRC6: 0.0413741459376289, Methylation_chr2 66218712 LINC02934 (29533): 0.779061040657529, Methylation_HOXB13: 1.4725633500481368, Methylation_chr10 3949206 LINC02660 (4871): 0.597634204077617, Methylation_chr5 179517140 RNF130 (18026): -0.5510011504407704, Methylation_LOC727677: -0.8348631967334902, Methylation_LETM1: 0.8800784626176649, Methylation_CDC42BPB: 0.6552395477148006, Methylation_C8orf38: 0.8439605863309326, Methylation_chr14 100504766 EVL (18852): -0.3474423309113417, Methylation_chr5 72594851 LOC340090 (24088): 0.4373943548897608, Methylation_chr2 242904738 LINC01238 (3421): -0.4482714278405164, Methylation_ARFGEF1: 0.1174066135947014, Methylation_MAPT: 0.8086448305958063, Methylation_ZFAT: -0.6421927550996742, Methylation_KCNQ4: -1.2043466300969576, Methylation_chr1 232684368 SIPA1L2 (12934): -0.077195604081096, Methylation_CRNKL1: -0.2781927263817794, Methylation_PRKAG2: 1.2806604971215685, Methylation_MICB: -1.017057430634811, miRNA_hsa-mir-934: -0.0846990876062328, miRNA_hsa-mir-4728: -0.4599143487772852, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.0715817483184973, miRNA_hsa-mir-190b: -0.4112632003179698, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: 0.4168452300374315, miRNA_hsa-mir-2115: 0.3521912664035156, miRNA_hsa-mir-17: -0.6194616453710752, miRNA_hsa-mir-130b: -1.953583920443924, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-LL-A5YN,"mRNA_C2orf54 is overexpressed (Z=1.33). No methylation, miRNA, or CNV alterations meet diagnostic thresholds. Isolated transcriptional upregulation without genomic or epigenetic drivers.","mRNA_MLPH: 0.467539590584282, mRNA_C2orf54: 1.327686674872658, mRNA_CITED4: 0.8324804270374695, mRNA_ESR1: -0.2587416674310234, mRNA_SPDEF: 1.0591715157376107, mRNA_AGR3: 0.703486778348775, mRNA_FOXC1: -0.9862044872505372, mRNA_GATA3: 0.1899695655675195, mRNA_AGR2: 0.5034434542224554, mRNA_XBP1: -0.2077767351242813, mRNA_PRR15: 0.3410206501124668, mRNA_SLC44A4: 0.98295187787428, mRNA_CA12: -0.2828531043352098, mRNA_DTL: -0.6481683053639888, mRNA_C5AR2: -0.0933075307375807, mRNA_TBC1D9: -0.6356188989091945, mRNA_AR: 0.0402447096270707, mRNA_CCDC170: -0.6976015636795913, mRNA_DEGS2: 0.5526824096973137, mRNA_TFF3: 0.90298789412555, mRNA_DNALI1: 0.4980564733364386, mRNA_LINC00504: -0.3772812075703967, mRNA_CLCA2: -0.7364467026574386, mRNA_PPP1R14C: -0.440275403095145, mRNA_THSD4: -0.4544671157411992, mRNA_SPAG5: -1.147395362825515, mRNA_FBP1: 0.1774930024509425, mRNA_SLC7A8: -0.6181774764654498, mRNA_EN1: -0.65206516381494, mRNA_ZNF552: 0.1341753250161987, Methylation_LRRC6: 0.093307734679021, Methylation_chr2 66218712 LINC02934 (29533): 0.7401832147233883, Methylation_HOXB13: 0.2249283464876408, Methylation_chr10 3949206 LINC02660 (4871): 0.2324721237066018, Methylation_chr5 179517140 RNF130 (18026): -1.3399927706452095, Methylation_LOC727677: -0.4302472827372254, Methylation_LETM1: 0.4689784949544491, Methylation_CDC42BPB: -0.0028450051726233, Methylation_C8orf38: -0.0847457236894444, Methylation_chr14 100504766 EVL (18852): 0.8160696942618614, Methylation_chr5 72594851 LOC340090 (24088): -0.4244865358049779, Methylation_chr2 242904738 LINC01238 (3421): -0.5828353445219833, Methylation_ARFGEF1: 0.8612967147786452, Methylation_MAPT: 0.6543832636268875, Methylation_ZFAT: -0.3673454860524271, Methylation_KCNQ4: -0.572473555818685, Methylation_chr1 232684368 SIPA1L2 (12934): 0.99310476158879, Methylation_CRNKL1: 0.7082970388351197, Methylation_PRKAG2: -0.4123651832358304, Methylation_MICB: -0.2941956928692378, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.2159236787596182, miRNA_hsa-mir-5695: -0.3721008738079646, miRNA_hsa-mir-18a: 0.8810498959152214, miRNA_hsa-mir-190b: 1.0685555496396013, miRNA_hsa-mir-577: -0.2107675658781198, miRNA_hsa-mir-135b: -0.2521055304158353, miRNA_hsa-mir-2115: 0.3426233231921973, miRNA_hsa-mir-17: 0.9053734358318036, miRNA_hsa-mir-130b: -0.4751677314955366, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A1AR,"High-level Amplification absent; no CNVs meet amplification thresholds.  
mRNA_SPDEF and mRNA_MLPH are low (Z < -1.92).  
miRNA_hsa-mir-577 is upregulated (Z > 1.99); miRNA_hsa-mir-190b is downregulated (Z < -1.25).  
Methylation_HOXB13 and Methylation_PRKAG2 are hypomethylated (Z < -1.47); multiple loci (e.g., ARFGEF1, C8orf38) are hypermethylated (Z > 1.50).","mRNA_MLPH: -2.6042542864933447, mRNA_C2orf54: -0.5099570584988435, mRNA_CITED4: -0.7732867685260669, mRNA_ESR1: -0.7859569596988712, mRNA_SPDEF: -3.1396714502010137, mRNA_AGR3: -1.678430227136201, mRNA_FOXC1: 1.9221657916623065, mRNA_GATA3: -0.3955253406669564, mRNA_AGR2: -1.8391897394876624, mRNA_XBP1: -2.0539508383577227, mRNA_PRR15: -2.2295979531409595, mRNA_SLC44A4: -2.2172643168064963, mRNA_CA12: -0.7144188803537858, mRNA_DTL: 1.8767346502743087, mRNA_C5AR2: -1.2949487730084306, mRNA_TBC1D9: -0.7977812024828322, mRNA_AR: -1.7799117250430032, mRNA_CCDC170: -0.9967380757898594, mRNA_DEGS2: -2.071523479451555, mRNA_TFF3: -1.995966577538551, mRNA_DNALI1: -1.3418256348799489, mRNA_LINC00504: -1.633969750820665, mRNA_CLCA2: -0.7538566845779473, mRNA_PPP1R14C: 2.654992059954544, mRNA_THSD4: -1.7659931701581315, mRNA_SPAG5: 0.8081176641411199, mRNA_FBP1: -1.30337971724972, mRNA_SLC7A8: -1.2608834940239837, mRNA_EN1: 1.6750750912984147, mRNA_ZNF552: -1.2103431281047443, Methylation_LRRC6: 1.4609228811616637, Methylation_chr2 66218712 LINC02934 (29533): -0.38126349153126, Methylation_HOXB13: -1.0228031438812384, Methylation_chr10 3949206 LINC02660 (4871): 1.5732651274174327, Methylation_chr5 179517140 RNF130 (18026): -1.612293996439167, Methylation_LOC727677: 1.5083666614864597, Methylation_LETM1: 1.332836426206614, Methylation_CDC42BPB: 0.7218272834242792, Methylation_C8orf38: 1.5979481340820083, Methylation_chr14 100504766 EVL (18852): 1.386600811801343, Methylation_chr5 72594851 LOC340090 (24088): -1.5752720631034092, Methylation_chr2 242904738 LINC01238 (3421): 1.398640430491228, Methylation_ARFGEF1: 1.6289594709760482, Methylation_MAPT: 1.4280747990539169, Methylation_ZFAT: 1.4219848690693746, Methylation_KCNQ4: 0.7859090768444424, Methylation_chr1 232684368 SIPA1L2 (12934): 1.4990724891367848, Methylation_CRNKL1: 1.1983198910695847, Methylation_PRKAG2: -1.0895698901993018, Methylation_MICB: 1.4087834441614056, miRNA_hsa-mir-934: 0.1646919788576409, miRNA_hsa-mir-4728: 0.0020463426352609, miRNA_hsa-mir-5695: 0.5324827904719535, miRNA_hsa-mir-18a: 1.7805941452604723, miRNA_hsa-mir-190b: -1.141368713207721, miRNA_hsa-mir-577: 2.086449945447155, miRNA_hsa-mir-135b: -0.3858184785419122, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.0429728234097957, miRNA_hsa-mir-130b: 1.780410002942752, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E2-A1LG,"High-level Amplification absent; no CNVs meet amplification thresholds.  
FOXC1 mRNA overexpression (Z=3.29) and ESR1/SPDEF/TFF3/GATA3/AR mRNA downregulation (Z < -1.92) indicate luminal B-like phenotype with ER-pathway suppression.  
Promoter hypermethylation at chr10:3949206, chr14:100504766, MAPT, and SIPA1L2 (Z > 1.50) suggests epigenetic silencing.  
miR-17 upregulated (Z=2.20), miR-190b downregulated (Z=-1.51).","mRNA_MLPH: -1.5422660352370667, mRNA_C2orf54: 1.4647193611154572, mRNA_CITED4: -0.0458260326480915, mRNA_ESR1: -2.127600395152741, mRNA_SPDEF: -3.066360686763719, mRNA_AGR3: -1.822127612824872, mRNA_FOXC1: 3.2912875962419874, mRNA_GATA3: -2.5935966783128146, mRNA_AGR2: -1.1211688359856815, mRNA_XBP1: -1.4813474493264496, mRNA_PRR15: -2.308570894822878, mRNA_SLC44A4: -0.3369926685726455, mRNA_CA12: -0.6380583625527828, mRNA_DTL: 0.8074800651331028, mRNA_C5AR2: 0.2876901906614117, mRNA_TBC1D9: -3.153462551123415, mRNA_AR: -2.25322210793388, mRNA_CCDC170: -1.942279525946265, mRNA_DEGS2: 0.6456739039407411, mRNA_TFF3: -2.2149473469581906, mRNA_DNALI1: -2.121895018982446, mRNA_LINC00504: -1.7327922303173695, mRNA_CLCA2: -0.7824884364224913, mRNA_PPP1R14C: 0.5265951146919273, mRNA_THSD4: -1.4600592592072892, mRNA_SPAG5: 0.7812946713036898, mRNA_FBP1: -2.2368280315933053, mRNA_SLC7A8: -0.9877068461132134, mRNA_EN1: 1.6414687081423158, mRNA_ZNF552: -1.5508967329897496, Methylation_LRRC6: 1.3336433205204006, Methylation_chr2 66218712 LINC02934 (29533): -1.5270384636717789, Methylation_HOXB13: -1.1076407598693276, Methylation_chr10 3949206 LINC02660 (4871): 1.5784747413386648, Methylation_chr5 179517140 RNF130 (18026): -1.507716510264549, Methylation_LOC727677: 1.4954943808453334, Methylation_LETM1: 1.3657480619979614, Methylation_CDC42BPB: 0.7504986148005696, Methylation_C8orf38: 0.1353659565380375, Methylation_chr14 100504766 EVL (18852): 1.5525203281384006, Methylation_chr5 72594851 LOC340090 (24088): -1.6391251318687636, Methylation_chr2 242904738 LINC01238 (3421): 1.1777930464194086, Methylation_ARFGEF1: 1.318981644002359, Methylation_MAPT: 1.5082923031906386, Methylation_ZFAT: 0.7601947799844495, Methylation_KCNQ4: 0.3704820167209648, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5501845898913755, Methylation_CRNKL1: 1.489115256386195, Methylation_PRKAG2: -1.818398382059176, Methylation_MICB: 1.5446205883859092, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.2569157377263545, miRNA_hsa-mir-5695: 1.3050750739226558, miRNA_hsa-mir-18a: 1.32265614207966, miRNA_hsa-mir-190b: -1.5138031590324523, miRNA_hsa-mir-577: 0.1504372285659801, miRNA_hsa-mir-135b: 1.7085067466402564, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 2.2043033811025583, miRNA_hsa-mir-130b: 0.3477323525652795, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-E2-A107,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression of C2orf54, CITED4, DTL, FBP1, and DEGS2. Hypomethylation of chr5:72594851 (LOC340090) suggests epigenetic dysregulation. miRNA hsa-mir-2115 is upregulated. These features indicate a luminal-like phenotype with metabolic and proliferative pathway activation.","mRNA_MLPH: 0.7421376643234854, mRNA_C2orf54: 1.597548718813649, mRNA_CITED4: 1.875799617183327, mRNA_ESR1: 0.5898800581221365, mRNA_SPDEF: 0.8299055077814788, mRNA_AGR3: 0.6295978554540442, mRNA_FOXC1: -0.4951555030500923, mRNA_GATA3: 0.3928185838332264, mRNA_AGR2: 0.409136093086779, mRNA_XBP1: 1.0871161344150853, mRNA_PRR15: 0.3455012683523004, mRNA_SLC44A4: 0.7804653616461935, mRNA_CA12: 0.891085720423217, mRNA_DTL: 1.4666211922664936, mRNA_C5AR2: 0.1768695432794957, mRNA_TBC1D9: 0.6596707836273927, mRNA_AR: 0.4002815751643996, mRNA_CCDC170: 0.3407628400725735, mRNA_DEGS2: 1.2438329057651043, mRNA_TFF3: 1.2070840175154756, mRNA_DNALI1: -0.6048687954535025, mRNA_LINC00504: 0.7300003299608089, mRNA_CLCA2: 0.1782475042122282, mRNA_PPP1R14C: -0.3005817296100178, mRNA_THSD4: 0.2446155259208786, mRNA_SPAG5: 1.1785750774786976, mRNA_FBP1: 1.440865529545731, mRNA_SLC7A8: 0.4304439289869246, mRNA_EN1: -0.8367404610681529, mRNA_ZNF552: 0.5789839825323757, Methylation_LRRC6: -0.3307031724191631, Methylation_chr2 66218712 LINC02934 (29533): -0.4847902911399, Methylation_HOXB13: -0.8368804270283371, Methylation_chr10 3949206 LINC02660 (4871): -0.6393461780692025, Methylation_chr5 179517140 RNF130 (18026): 0.9494898989131444, Methylation_LOC727677: -0.2045365730060968, Methylation_LETM1: -0.6929954650291831, Methylation_CDC42BPB: 0.8621103639067108, Methylation_C8orf38: -0.1801215700279366, Methylation_chr14 100504766 EVL (18852): -0.4247446768159975, Methylation_chr5 72594851 LOC340090 (24088): -1.576197192827065, Methylation_chr2 242904738 LINC01238 (3421): -0.4283641921784805, Methylation_ARFGEF1: -0.4072533341595579, Methylation_MAPT: -0.4469587983500397, Methylation_ZFAT: -0.5323941231317455, Methylation_KCNQ4: 0.3543529855778769, Methylation_chr1 232684368 SIPA1L2 (12934): -0.1488846480758105, Methylation_CRNKL1: -0.1341484739330455, Methylation_PRKAG2: -0.4684065511577663, Methylation_MICB: -0.1547198546009945, miRNA_hsa-mir-934: -0.2006056203894016, miRNA_hsa-mir-4728: -0.7261753681949216, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.4674951725770351, miRNA_hsa-mir-190b: 0.8195003059102339, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.5331892883711519, miRNA_hsa-mir-2115: 1.5098245157461645, miRNA_hsa-mir-17: -0.6038242728935972, miRNA_hsa-mir-130b: -0.0214438107006557, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-E2-A109,"High-level Amplification of SPAG5 drives significant mRNA overexpression (Z=2.84).  
HOXB13 promoter hypermethylation (Z=1.88) mediates epigenetic silencing.  
CRNKL1 hypomethylation (Z=-1.58) and LRRC6 hypomethylation (Z=-1.50) suggest transcriptional dysregulation.  
miR-17 upregulation (Z=1.08) may suppress tumor suppressors.  
These features collectively indicate a luminal B phenotype with cell-cycle and ER-pathway dysregulation.","mRNA_MLPH: 0.6013560423802798, mRNA_C2orf54: -1.1368028732914517, mRNA_CITED4: -1.5869140797565393, mRNA_ESR1: 0.8338267340185078, mRNA_SPDEF: 0.6446146778782618, mRNA_AGR3: 0.327035878866609, mRNA_FOXC1: -0.7521428566193675, mRNA_GATA3: 0.4840186498639016, mRNA_AGR2: 0.5910015707572102, mRNA_XBP1: 0.7649611484202884, mRNA_PRR15: 1.3917524099867964, mRNA_SLC44A4: 0.3399194952737991, mRNA_CA12: 0.2029132093666609, mRNA_DTL: 0.6165797051218036, mRNA_C5AR2: -0.3632872627592925, mRNA_TBC1D9: 0.5283610956448651, mRNA_AR: 0.2761639573340376, mRNA_CCDC170: 0.397813883573059, mRNA_DEGS2: -0.4523392249332078, mRNA_TFF3: 1.300208168867225, mRNA_DNALI1: 0.7109223833809606, mRNA_LINC00504: 0.2028215635611452, mRNA_CLCA2: -0.8772872148909333, mRNA_PPP1R14C: -0.949494649568071, mRNA_THSD4: 1.007058710463056, mRNA_SPAG5: 2.83553004725083, mRNA_FBP1: -0.1293566885157947, mRNA_SLC7A8: 0.6300124178205968, mRNA_EN1: -0.5415175286916434, mRNA_ZNF552: 0.3499816486909213, Methylation_LRRC6: -1.502345429812809, Methylation_chr2 66218712 LINC02934 (29533): -1.5321167289532698, Methylation_HOXB13: 1.8792503195950712, Methylation_chr10 3949206 LINC02660 (4871): -1.132130042993133, Methylation_chr5 179517140 RNF130 (18026): 1.2281224443374104, Methylation_LOC727677: -1.01307685995905, Methylation_LETM1: -1.410346400188779, Methylation_CDC42BPB: 0.8785801036812096, Methylation_C8orf38: -0.2968445496288681, Methylation_chr14 100504766 EVL (18852): -1.3306651533288736, Methylation_chr5 72594851 LOC340090 (24088): 1.326527798752691, Methylation_chr2 242904738 LINC01238 (3421): 0.0065429418431597, Methylation_ARFGEF1: -1.0719907718914754, Methylation_MAPT: -0.3149875226574682, Methylation_ZFAT: -0.959818002125665, Methylation_KCNQ4: 1.17873688000952, Methylation_chr1 232684368 SIPA1L2 (12934): -1.3300838500716765, Methylation_CRNKL1: -1.5805936011490704, Methylation_PRKAG2: -1.1783406336193565, Methylation_MICB: -1.2317502877788795, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 1.490804879828333, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.7588459888781836, miRNA_hsa-mir-190b: 0.6704616841104302, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.7386789599981145, miRNA_hsa-mir-2115: 0.8474612919820402, miRNA_hsa-mir-17: 1.0821630236599582, miRNA_hsa-mir-130b: 0.7368484990110878, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-BH-A0DK,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.2117843105400984, mRNA_C2orf54: 0.1972386535802316, mRNA_CITED4: -1.615288515711209, mRNA_ESR1: -0.0010252853576183, mRNA_SPDEF: 0.4445073273032817, mRNA_AGR3: 0.6664500156098565, mRNA_FOXC1: 0.3556410418124956, mRNA_GATA3: 0.1632238189929285, mRNA_AGR2: 0.8617836234176541, mRNA_XBP1: 0.1273714915037314, mRNA_PRR15: 0.3889973000329408, mRNA_SLC44A4: 0.634507695842502, mRNA_CA12: -0.1566814870586564, mRNA_DTL: 0.3217161559792253, mRNA_C5AR2: 0.0234204589649087, mRNA_TBC1D9: 0.1593672014135242, mRNA_AR: 0.2568842548706945, mRNA_CCDC170: -0.0193432147777896, mRNA_DEGS2: 0.3403558996699695, mRNA_TFF3: 0.9711686423545018, mRNA_DNALI1: -0.4482159795871884, mRNA_LINC00504: -0.147077560004644, mRNA_CLCA2: 0.1442910517219978, mRNA_PPP1R14C: -0.1054843350833806, mRNA_THSD4: -0.3320917323825448, mRNA_SPAG5: -0.6775904938936236, mRNA_FBP1: -0.2518835557591166, mRNA_SLC7A8: -0.1201198413671067, mRNA_EN1: -0.5364745054815221, mRNA_ZNF552: 0.0914745311539053, Methylation_LRRC6: 0.2311706181653587, Methylation_chr2 66218712 LINC02934 (29533): 1.2482859478952957, Methylation_HOXB13: 1.4984138386872847, Methylation_chr10 3949206 LINC02660 (4871): -0.062374701823561, Methylation_chr5 179517140 RNF130 (18026): 0.7009105878339406, Methylation_LOC727677: -0.1399852091545982, Methylation_LETM1: -0.3009899904498023, Methylation_CDC42BPB: 1.1292811568891188, Methylation_C8orf38: 1.3809359633807416, Methylation_chr14 100504766 EVL (18852): -0.1362538954142598, Methylation_chr5 72594851 LOC340090 (24088): 0.6760577933980004, Methylation_chr2 242904738 LINC01238 (3421): 0.0559055354935032, Methylation_ARFGEF1: 0.0945382921398935, Methylation_MAPT: 1.0806948207559084, Methylation_ZFAT: 0.4100499486704706, Methylation_KCNQ4: 0.5814784744610617, Methylation_chr1 232684368 SIPA1L2 (12934): 0.5434364177762457, Methylation_CRNKL1: 0.526524042906184, Methylation_PRKAG2: 1.1309416788244848, Methylation_MICB: 0.5610323322084757, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.0679235420767447, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.4760209299684538, miRNA_hsa-mir-190b: 0.6814735330442957, miRNA_hsa-mir-577: 0.223610543695764, miRNA_hsa-mir-135b: 0.0527266935891583, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.0092709237931765, miRNA_hsa-mir-130b: -0.1542082113035717, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A1ND,"High-level Amplification absent; no CNVs meet amplification thresholds.  
mRNA_MLPH, mRNA_SPDEF, mRNA_AGR3, mRNA_SLC44A4, mRNA_TFF3 significantly downregulated (Z < -1.92).  
mRNA_C2orf54, mRNA_FOXC1, mRNA_CLCA2 overexpressed (Z > 1.30).  
Methylation_chr5 72594851 LOC340090 hypo-methylated (Z < -1.47); multiple loci hyper-methylated (Z > 1.50), including ARFGEF1, MAPT, and chr10:3949206.  
miRNA_hsa-mir-934 upregulated (Z > 1.99); miRNA_hsa-mir-190b downregulated (Z < -1.25).","mRNA_MLPH: -2.62012428340774, mRNA_C2orf54: 1.4035136572716342, mRNA_CITED4: -0.2346811905769752, mRNA_ESR1: -1.2603107844590191, mRNA_SPDEF: -1.9610278036977464, mRNA_AGR3: -2.060531268628111, mRNA_FOXC1: 1.8369151316481604, mRNA_GATA3: -0.97579372824159, mRNA_AGR2: -0.9554314365226172, mRNA_XBP1: -1.6834076488270626, mRNA_PRR15: -0.9211388987552994, mRNA_SLC44A4: -2.052771952179783, mRNA_CA12: -1.4427021568275042, mRNA_DTL: -0.612456751187748, mRNA_C5AR2: -1.5017635356759689, mRNA_TBC1D9: -1.9396755919388884, mRNA_AR: -2.168857639435876, mRNA_CCDC170: -1.4208115729483222, mRNA_DEGS2: -0.920260979429962, mRNA_TFF3: -2.291788040378579, mRNA_DNALI1: -1.9000892165646293, mRNA_LINC00504: -1.498145224925754, mRNA_CLCA2: 1.5363777859823853, mRNA_PPP1R14C: 0.6154637897376677, mRNA_THSD4: -1.925882133111853, mRNA_SPAG5: -0.1458331656853915, mRNA_FBP1: -1.1512228019176185, mRNA_SLC7A8: -0.9902398530666446, mRNA_EN1: -0.564759584004631, mRNA_ZNF552: -0.8659264072114641, Methylation_LRRC6: 1.492168581885272, Methylation_chr2 66218712 LINC02934 (29533): 0.0331634634447366, Methylation_HOXB13: 0.7313088926882211, Methylation_chr10 3949206 LINC02660 (4871): 1.6299307209336154, Methylation_chr5 179517140 RNF130 (18026): -0.7971540980651002, Methylation_LOC727677: 1.5319641981425434, Methylation_LETM1: 1.3155561102981288, Methylation_CDC42BPB: 0.6881138616287462, Methylation_C8orf38: 1.6090306540158696, Methylation_chr14 100504766 EVL (18852): 1.5319599960308947, Methylation_chr5 72594851 LOC340090 (24088): -1.551580101495828, Methylation_chr2 242904738 LINC01238 (3421): 1.4812767724506015, Methylation_ARFGEF1: 1.7157807205126716, Methylation_MAPT: 1.5183954818892842, Methylation_ZFAT: 1.4380423789411372, Methylation_KCNQ4: 0.631467956356819, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5474438696383357, Methylation_CRNKL1: 1.449214825265042, Methylation_PRKAG2: -1.1073702226341682, Methylation_MICB: 1.502165786179908, miRNA_hsa-mir-934: 2.4318730352856712, miRNA_hsa-mir-4728: -0.4709628268960842, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.907092182578834, miRNA_hsa-mir-190b: -1.476624994127205, miRNA_hsa-mir-577: -0.4470203733460754, miRNA_hsa-mir-135b: 0.6710134214971638, miRNA_hsa-mir-2115: 0.7696772481163118, miRNA_hsa-mir-17: 0.9955881228707614, miRNA_hsa-mir-130b: 1.290194887720603, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-AC-A23G,"mRNA_CITED4 is highly expressed (Z=1.59). No methylation or miRNA alterations meet diagnostic thresholds. All CNVs fall within the ""Gain"" range but do not reach amplification. These features indicate a luminal phenotype with potential HIF-pathway activation via CITED4 overexpression.","mRNA_MLPH: -0.2699467115318081, mRNA_C2orf54: 0.0055513164589489, mRNA_CITED4: 1.592227316162648, mRNA_ESR1: 0.1131937638565566, mRNA_SPDEF: -0.5674856031663117, mRNA_AGR3: 0.0712026336732396, mRNA_FOXC1: 1.2089500235045547, mRNA_GATA3: 0.2287112297761203, mRNA_AGR2: 0.1733406738143894, mRNA_XBP1: -0.6898470898241472, mRNA_PRR15: -0.1534188629178738, mRNA_SLC44A4: -0.1299751983760421, mRNA_CA12: 0.2858603195555352, mRNA_DTL: -0.3888671963326253, mRNA_C5AR2: 0.4619927181017177, mRNA_TBC1D9: 0.0986649270473125, mRNA_AR: -0.5127809884315421, mRNA_CCDC170: -0.1780090832984366, mRNA_DEGS2: 0.6267539738288535, mRNA_TFF3: 0.4232861015570442, mRNA_DNALI1: 0.2837220215729272, mRNA_LINC00504: -0.4620960268839008, mRNA_CLCA2: 0.0180558788209067, mRNA_PPP1R14C: 0.918886751237216, mRNA_THSD4: 0.22416093808562, mRNA_SPAG5: -0.7237791987161094, mRNA_FBP1: 0.0920667352339733, mRNA_SLC7A8: -0.2428443135522391, mRNA_EN1: 0.2046364417639835, mRNA_ZNF552: 0.2252885861750385, Methylation_LRRC6: 1.2476653118166092, Methylation_chr2 66218712 LINC02934 (29533): 1.0404565801430998, Methylation_HOXB13: -0.9440542873440696, Methylation_chr10 3949206 LINC02660 (4871): 0.1774290224972865, Methylation_chr5 179517140 RNF130 (18026): -0.5768918435296182, Methylation_LOC727677: 0.3301776478911987, Methylation_LETM1: 0.3957957180001634, Methylation_CDC42BPB: -0.044354523201749, Methylation_C8orf38: 0.683987367038039, Methylation_chr14 100504766 EVL (18852): 0.94037422476636, Methylation_chr5 72594851 LOC340090 (24088): 0.159670695294609, Methylation_chr2 242904738 LINC01238 (3421): -0.0264481803288045, Methylation_ARFGEF1: 1.02778838830545, Methylation_MAPT: 0.8303479614522556, Methylation_ZFAT: 0.3452331126986746, Methylation_KCNQ4: -0.0577675391162264, Methylation_chr1 232684368 SIPA1L2 (12934): 0.8458679892921152, Methylation_CRNKL1: 0.8992159330412787, Methylation_PRKAG2: 1.118746370419038, Methylation_MICB: 0.8737357249068397, miRNA_hsa-mir-934: 0.5188466535470245, miRNA_hsa-mir-4728: -0.8476797827083647, miRNA_hsa-mir-5695: -0.3178813158089247, miRNA_hsa-mir-18a: -0.3935480228416434, miRNA_hsa-mir-190b: 0.0341549707891332, miRNA_hsa-mir-577: -0.5571488194840353, miRNA_hsa-mir-135b: 0.040304590869343, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.3825430467416327, miRNA_hsa-mir-130b: -0.391849880783753, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-GM-A2DL,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.0142846946997435, mRNA_C2orf54: -0.4107008308696128, mRNA_CITED4: 0.3220215825286945, mRNA_ESR1: 0.1094456298207432, mRNA_SPDEF: 0.6522666739221404, mRNA_AGR3: 0.7286842490387162, mRNA_FOXC1: -0.0767817454448878, mRNA_GATA3: 0.0437918055903404, mRNA_AGR2: 0.7380147034247657, mRNA_XBP1: -0.5170606253836404, mRNA_PRR15: 0.1769017533614637, mRNA_SLC44A4: 0.2658889807740325, mRNA_CA12: 0.1220097899791689, mRNA_DTL: -0.4294078942996624, mRNA_C5AR2: -0.7678440433980933, mRNA_TBC1D9: -0.7663896306734992, mRNA_AR: 0.4124863377814846, mRNA_CCDC170: -0.4733590067993149, mRNA_DEGS2: -0.2398723876614596, mRNA_TFF3: 0.4743891580258833, mRNA_DNALI1: 0.5273257178532398, mRNA_LINC00504: -0.03102329257079, mRNA_CLCA2: 1.1404001888848374, mRNA_PPP1R14C: -0.6098301830426431, mRNA_THSD4: 0.3334764097530988, mRNA_SPAG5: -0.6117561636846653, mRNA_FBP1: -0.3302585799562817, mRNA_SLC7A8: 0.1919436925042791, mRNA_EN1: 0.0317728663918454, mRNA_ZNF552: -0.5134176620907425, Methylation_LRRC6: 0.3155365565558509, Methylation_chr2 66218712 LINC02934 (29533): 1.0759813648503749, Methylation_HOXB13: -0.4263691684867152, Methylation_chr10 3949206 LINC02660 (4871): -0.7249312825107186, Methylation_chr5 179517140 RNF130 (18026): 0.0652828258663515, Methylation_LOC727677: -0.2176217657548688, Methylation_LETM1: 0.4329754941711173, Methylation_CDC42BPB: -1.0964282196358952, Methylation_C8orf38: -0.1057174266874461, Methylation_chr14 100504766 EVL (18852): 0.4503536882636344, Methylation_chr5 72594851 LOC340090 (24088): 0.3672648924525277, Methylation_chr2 242904738 LINC01238 (3421): -0.498188226353858, Methylation_ARFGEF1: 0.1153025861473441, Methylation_MAPT: 0.3632712683035591, Methylation_ZFAT: -0.1497840559047597, Methylation_KCNQ4: 0.6562211386298374, Methylation_chr1 232684368 SIPA1L2 (12934): 0.2036707669125807, Methylation_CRNKL1: 0.0275492634574291, Methylation_PRKAG2: 1.0333509086837518, Methylation_MICB: -0.4376608582838299, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -1.1022386590644273, miRNA_hsa-mir-5695: -0.2722268804358367, miRNA_hsa-mir-18a: -0.358525193119117, miRNA_hsa-mir-190b: -0.1529166122390414, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: 0.5259971379701311, miRNA_hsa-mir-17: -0.8204693119808162, miRNA_hsa-mir-130b: -0.6474036888882562, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AN-A0XN,"High-level Amplification of VPS54, LINC02576, WDPCP, and CEP68 drives oncogenic mRNA overexpression. Promoter hypermethylation of HOXB13 (Z=1.30) mediates epigenetic silencing. miR-135b is significantly upregulated (Z=2.35), implicating Wnt pathway activation. These features collectively indicate a luminal B phenotype with PI3K/AKT dysregulation.","mRNA_MLPH: -0.2419974661980007, mRNA_C2orf54: -0.0218704585646065, mRNA_CITED4: 0.935963448870714, mRNA_ESR1: -0.0791348645468262, mRNA_SPDEF: 0.0546959463601943, mRNA_AGR3: -0.4982457997367114, mRNA_FOXC1: 0.0057694866586073, mRNA_GATA3: -0.2028395675952097, mRNA_AGR2: -0.4031096354949378, mRNA_XBP1: -0.2449480220943435, mRNA_PRR15: 0.0984006030353491, mRNA_SLC44A4: 0.3565325095849568, mRNA_CA12: 0.1311785368606557, mRNA_DTL: 0.2503066290445729, mRNA_C5AR2: 0.4295512658985563, mRNA_TBC1D9: -0.0275060584744723, mRNA_AR: 0.0892721551621714, mRNA_CCDC170: 0.2692836559757201, mRNA_DEGS2: -0.0458609700732454, mRNA_TFF3: -0.3126763637371129, mRNA_DNALI1: -0.0101143374088277, mRNA_LINC00504: 0.0184389430494883, mRNA_CLCA2: -0.2724778838881657, mRNA_PPP1R14C: -0.0064962731310048, mRNA_THSD4: -0.5222618961343604, mRNA_SPAG5: -0.4942380986271235, mRNA_FBP1: -0.377153079182568, mRNA_SLC7A8: -0.208977325234595, mRNA_EN1: 0.3601731027354065, mRNA_ZNF552: -0.4890587647528329, Methylation_LRRC6: -0.4272163457126962, Methylation_chr2 66218712 LINC02934 (29533): -1.1914876499735054, Methylation_HOXB13: 1.2955042502960086, Methylation_chr10 3949206 LINC02660 (4871): -0.4631148041709205, Methylation_chr5 179517140 RNF130 (18026): 0.5745588660766483, Methylation_LOC727677: 0.3748428339544568, Methylation_LETM1: 0.2559902271495468, Methylation_CDC42BPB: 0.482114439377471, Methylation_C8orf38: -0.8225748115543843, Methylation_chr14 100504766 EVL (18852): 0.0676856915327792, Methylation_chr5 72594851 LOC340090 (24088): 0.7463040767640967, Methylation_chr2 242904738 LINC01238 (3421): 1.1742320690681998, Methylation_ARFGEF1: -0.3254723867056399, Methylation_MAPT: 0.0083522961892566, Methylation_ZFAT: -0.2016094489948159, Methylation_KCNQ4: 0.9636805384297992, Methylation_chr1 232684368 SIPA1L2 (12934): -0.6796997812957143, Methylation_CRNKL1: -1.0894330555935, Methylation_PRKAG2: 1.131273114549514, Methylation_MICB: -0.5181063024497412, miRNA_hsa-mir-934: -0.2025121008474433, miRNA_hsa-mir-4728: -0.0739755740981087, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.8259898432053037, miRNA_hsa-mir-190b: 1.6939874925289524, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: 2.350707796334372, miRNA_hsa-mir-2115: 0.3635271400206656, miRNA_hsa-mir-17: 0.5195586153423533, miRNA_hsa-mir-130b: 0.6145575525085487, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-AC-A5EH,"High-level Amplification of LINC01867 drives mRNA overexpression.  
No promoter hyper/hypomethylation meets diagnostic thresholds.  
miR-190b is downregulated (Z = -1.68).  
These features collectively indicate a luminal phenotype with potential ESR1-pathway dysregulation.","mRNA_MLPH: 0.2053468270128021, mRNA_C2orf54: 1.6349586122034347, mRNA_CITED4: -1.2947714769821128, mRNA_ESR1: -0.9981802468285615, mRNA_SPDEF: 0.5548875584981774, mRNA_AGR3: -1.6694940688390794, mRNA_FOXC1: -0.3709008821504247, mRNA_GATA3: 0.4314028402661881, mRNA_AGR2: -0.5911532156502333, mRNA_XBP1: -0.240781570325534, mRNA_PRR15: 0.776746992612991, mRNA_SLC44A4: -0.0989091913191794, mRNA_CA12: 0.4931855090693847, mRNA_DTL: -0.5397408262813591, mRNA_C5AR2: -1.4439919386427231, mRNA_TBC1D9: 0.6610197278892437, mRNA_AR: 0.2156119573952723, mRNA_CCDC170: -0.3700230332806398, mRNA_DEGS2: 1.2872209028200292, mRNA_TFF3: -0.7266893751101012, mRNA_DNALI1: -1.0931213942700309, mRNA_LINC00504: -0.5043857459550203, mRNA_CLCA2: 0.9901342490138088, mRNA_PPP1R14C: 0.1020236107029087, mRNA_THSD4: 0.1527169837785274, mRNA_SPAG5: 0.5169802329947691, mRNA_FBP1: 0.4255426361545222, mRNA_SLC7A8: -1.0373115706207972, mRNA_EN1: 0.102992206770089, mRNA_ZNF552: -1.111959541552998, Methylation_LRRC6: 0.5786886147272328, Methylation_chr2 66218712 LINC02934 (29533): 1.05196002997531, Methylation_HOXB13: -0.1015835184835742, Methylation_chr10 3949206 LINC02660 (4871): 0.5850191401503062, Methylation_chr5 179517140 RNF130 (18026): 0.5267148804819359, Methylation_LOC727677: 1.234036560077187, Methylation_LETM1: 1.3230937185775975, Methylation_CDC42BPB: -1.036667038496027, Methylation_C8orf38: -0.0732755419047125, Methylation_chr14 100504766 EVL (18852): -0.4628060921448645, Methylation_chr5 72594851 LOC340090 (24088): 0.5485653909973032, Methylation_chr2 242904738 LINC01238 (3421): 0.4173244446993472, Methylation_ARFGEF1: 0.241926211173465, Methylation_MAPT: 0.1511748334316803, Methylation_ZFAT: 0.7478986043551076, Methylation_KCNQ4: -0.5773383821727437, Methylation_chr1 232684368 SIPA1L2 (12934): 0.4053992711372176, Methylation_CRNKL1: 0.0648881671541823, Methylation_PRKAG2: 0.3667692353701007, Methylation_MICB: 1.2047417500871265, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.6288068217061651, miRNA_hsa-mir-5695: -0.2161926004691181, miRNA_hsa-mir-18a: -0.4506353602270613, miRNA_hsa-mir-190b: -1.6821995191951886, miRNA_hsa-mir-577: -0.2526002980049945, miRNA_hsa-mir-135b: -0.0347040429942943, miRNA_hsa-mir-2115: -0.2668700369286393, miRNA_hsa-mir-17: -0.2857941277327205, miRNA_hsa-mir-130b: -0.4484332139195763, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-OL-A5D7,"High-level Amplification of EN1 drives mRNA overexpression.  
Promoter hypermethylation of ARFGEF1, KCNQ4, and SIPA1L2 mediates epigenetic silencing.  
Deletion of CEP68 correlates with transcriptional downregulation.  
miR-577 and miR-18a upregulation, with miR-190b downregulation, indicate luminal B phenotype with PI3K/AKT dysregulation.","mRNA_MLPH: -2.8702767026728497, mRNA_C2orf54: -1.160083518759135, mRNA_CITED4: 0.8740488890265314, mRNA_ESR1: -1.6636197630492984, mRNA_SPDEF: -2.5905096875756386, mRNA_AGR3: -1.4807973685366258, mRNA_FOXC1: 1.3732526160807286, mRNA_GATA3: -1.3561854224205845, mRNA_AGR2: -2.2365466358935584, mRNA_XBP1: -2.2748501811106685, mRNA_PRR15: -1.6715417029256383, mRNA_SLC44A4: -2.093115634666973, mRNA_CA12: -2.2452115874922, mRNA_DTL: 0.363567169986195, mRNA_C5AR2: -1.847246949406871, mRNA_TBC1D9: -2.033823752464272, mRNA_AR: -2.424906374042328, mRNA_CCDC170: -1.8471689521087544, mRNA_DEGS2: -2.139813323050876, mRNA_TFF3: -2.0432019519085776, mRNA_DNALI1: -1.8010578447671173, mRNA_LINC00504: -1.730385852866851, mRNA_CLCA2: -0.8728116742055846, mRNA_PPP1R14C: 2.3498937726714733, mRNA_THSD4: -2.2226775300032924, mRNA_SPAG5: 1.4294529032537606, mRNA_FBP1: -1.6632565502673653, mRNA_SLC7A8: -1.9008675746220407, mRNA_EN1: 3.359549226152709, mRNA_ZNF552: -1.83704059502828, Methylation_LRRC6: 1.5358486393502142, Methylation_chr2 66218712 LINC02934 (29533): 0.5434926722345829, Methylation_HOXB13: 0.6261278782512848, Methylation_chr10 3949206 LINC02660 (4871): 1.6266886661557984, Methylation_chr5 179517140 RNF130 (18026): -1.6210593011333592, Methylation_LOC727677: 1.470159696437086, Methylation_LETM1: 1.3062115265199332, Methylation_CDC42BPB: 0.3335683306078417, Methylation_C8orf38: 1.6925259710113978, Methylation_chr14 100504766 EVL (18852): 1.5433587119317185, Methylation_chr5 72594851 LOC340090 (24088): -1.343619372152069, Methylation_chr2 242904738 LINC01238 (3421): 1.0859746825586858, Methylation_ARFGEF1: 1.8450862980326848, Methylation_MAPT: 1.4752801245827538, Methylation_ZFAT: 1.4440830790103731, Methylation_KCNQ4: 1.564603878083622, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5759158231219497, Methylation_CRNKL1: 1.46275770438873, Methylation_PRKAG2: -0.847421276322161, Methylation_MICB: 1.5300907738433382, miRNA_hsa-mir-934: 0.7495196027965899, miRNA_hsa-mir-4728: 0.6155373143226435, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 3.264964610582981, miRNA_hsa-mir-190b: -2.052137242410604, miRNA_hsa-mir-577: 4.261069498150782, miRNA_hsa-mir-135b: 1.592857778555414, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 2.5222552674074388, miRNA_hsa-mir-130b: 0.98550966802545, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AC-A2QI,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-significant ranges per specified Z-score and CNV cutoffs.","mRNA_MLPH: 0.6121165673098546, mRNA_C2orf54: 0.1333642168643102, mRNA_CITED4: 0.9288027594868422, mRNA_ESR1: 0.5403760026745643, mRNA_SPDEF: 0.6882436637281324, mRNA_AGR3: 0.0142364546638047, mRNA_FOXC1: -0.0850269325012242, mRNA_GATA3: 0.7363642703835892, mRNA_AGR2: 0.9427451994396924, mRNA_XBP1: 0.2830887923889901, mRNA_PRR15: 0.667146978088143, mRNA_SLC44A4: 0.7360597581822724, mRNA_CA12: 0.4926972049128985, mRNA_DTL: -0.831722015486485, mRNA_C5AR2: 0.7684141239266584, mRNA_TBC1D9: 0.8312635197224058, mRNA_AR: 0.3460173727455528, mRNA_CCDC170: 0.3769399699098233, mRNA_DEGS2: 1.384173427932187, mRNA_TFF3: 0.2155824311175954, mRNA_DNALI1: 0.6881683247791747, mRNA_LINC00504: 0.1221457066032249, mRNA_CLCA2: -0.5122947051417207, mRNA_PPP1R14C: -0.5807135350895523, mRNA_THSD4: 0.2038443031436194, mRNA_SPAG5: -1.267286409733886, mRNA_FBP1: 0.0588070678143715, mRNA_SLC7A8: 0.4873526811866417, mRNA_EN1: -0.108748473484224, mRNA_ZNF552: 0.6218307554935325, Methylation_LRRC6: 0.3330988140053325, Methylation_chr2 66218712 LINC02934 (29533): -0.7894943402350381, Methylation_HOXB13: -1.0375535645130782, Methylation_chr10 3949206 LINC02660 (4871): -0.2774964859645905, Methylation_chr5 179517140 RNF130 (18026): -0.1430498965441447, Methylation_LOC727677: -0.4370506680388675, Methylation_LETM1: -0.1470020236831594, Methylation_CDC42BPB: -0.8766212727906095, Methylation_C8orf38: -0.2181268989146343, Methylation_chr14 100504766 EVL (18852): -0.0359946559756527, Methylation_chr5 72594851 LOC340090 (24088): -0.823099396488875, Methylation_chr2 242904738 LINC01238 (3421): -0.555162450457805, Methylation_ARFGEF1: 0.0708987151461702, Methylation_MAPT: -0.410507759097192, Methylation_ZFAT: -0.4683974090666277, Methylation_KCNQ4: 0.8194879241009427, Methylation_chr1 232684368 SIPA1L2 (12934): -0.9149944311107792, Methylation_CRNKL1: -0.0325548205670446, Methylation_PRKAG2: 0.7214238741769483, Methylation_MICB: -0.1960663952227138, miRNA_hsa-mir-934: -0.528609566879056, miRNA_hsa-mir-4728: -0.1400609292481519, miRNA_hsa-mir-5695: -0.5096449857334628, miRNA_hsa-mir-18a: -0.9784779695503292, miRNA_hsa-mir-190b: 0.0911074967034435, miRNA_hsa-mir-577: -0.6405324802686415, miRNA_hsa-mir-135b: -0.9310711922072414, miRNA_hsa-mir-2115: -0.228157859481393, miRNA_hsa-mir-17: -1.0889425702331978, miRNA_hsa-mir-130b: -1.1451660364147236, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-EW-A1P6,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.3079883531467104, mRNA_C2orf54: 1.259490832938334, mRNA_CITED4: 0.510348511101278, mRNA_ESR1: 0.9318331970233188, mRNA_SPDEF: 0.7762550300559999, mRNA_AGR3: 0.5279010583879218, mRNA_FOXC1: -1.0312682021379904, mRNA_GATA3: 0.3143957916874829, mRNA_AGR2: 0.4729936276340225, mRNA_XBP1: 0.3088697750113558, mRNA_PRR15: 0.1774240563471379, mRNA_SLC44A4: 0.1882991339586111, mRNA_CA12: 0.7874720681720644, mRNA_DTL: -0.227356850297978, mRNA_C5AR2: 0.6334163151077112, mRNA_TBC1D9: -0.0708590362273088, mRNA_AR: 0.602526801804313, mRNA_CCDC170: 0.9148693868445584, mRNA_DEGS2: 0.8508578159410611, mRNA_TFF3: 0.9120528380964156, mRNA_DNALI1: 0.774693509821001, mRNA_LINC00504: 0.4694972673426705, mRNA_CLCA2: -0.7318237803377289, mRNA_PPP1R14C: -0.393230274871966, mRNA_THSD4: 0.7622634772484762, mRNA_SPAG5: -0.3219550401479371, mRNA_FBP1: 0.5899408369442724, mRNA_SLC7A8: 0.6348376740815145, mRNA_EN1: -0.7259046540025966, mRNA_ZNF552: 0.1297545666484032, Methylation_LRRC6: -1.2945970242553764, Methylation_chr2 66218712 LINC02934 (29533): -1.4426055775190818, Methylation_HOXB13: -1.0864266175144948, Methylation_chr10 3949206 LINC02660 (4871): -1.068125249562322, Methylation_chr5 179517140 RNF130 (18026): -0.4897204845848558, Methylation_LOC727677: -1.3406150906434675, Methylation_LETM1: -1.087483085845942, Methylation_CDC42BPB: -1.3022762368342269, Methylation_C8orf38: -1.4989020519718046, Methylation_chr14 100504766 EVL (18852): -1.1701725953836015, Methylation_chr5 72594851 LOC340090 (24088): -0.1463203987954327, Methylation_chr2 242904738 LINC01238 (3421): -1.0050553101423134, Methylation_ARFGEF1: -1.4304300614676757, Methylation_MAPT: -0.8556689963497226, Methylation_ZFAT: -1.334634520951155, Methylation_KCNQ4: 1.0967792251640966, Methylation_chr1 232684368 SIPA1L2 (12934): -0.5581589781323221, Methylation_CRNKL1: -0.798605206914221, Methylation_PRKAG2: 1.1699424130338532, Methylation_MICB: -1.0087429731584716, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 1.1513691398350552, miRNA_hsa-mir-5695: 0.4706421798522181, miRNA_hsa-mir-18a: 0.3151788180901115, miRNA_hsa-mir-190b: 0.522176142445946, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.4145255989984043, miRNA_hsa-mir-2115: -0.1751987337168745, miRNA_hsa-mir-17: 0.3887033761225524, miRNA_hsa-mir-130b: -0.0196418613991555, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-C8-A27B,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression of PPP1R14C (Z=2.76), FOXC1 (Z=1.89), and EN1 (Z=1.66). Promoter hypermethylation of LRRC6, LINC02660, RNF130, LOC727677, EVL, ARFGEF1, KCNQ4, SIPA1L2, MICB, and PRKAG2 mediates transcriptional silencing. miR-934, miR-577, and miR-135b are upregulated; miR-190b is downregulated. These features indicate a basal-like phenotype with ER pathway suppression.","mRNA_MLPH: -1.6401404534438555, mRNA_C2orf54: -1.2518743102520795, mRNA_CITED4: 1.2660746142890145, mRNA_ESR1: -1.4466681398682697, mRNA_SPDEF: -2.336257813192244, mRNA_AGR3: -1.7023472731205578, mRNA_FOXC1: 1.8940356319950795, mRNA_GATA3: -1.3661165379225804, mRNA_AGR2: -1.9841513583202328, mRNA_XBP1: -1.3625655449137248, mRNA_PRR15: -0.3937364826910842, mRNA_SLC44A4: -2.336155023882328, mRNA_CA12: -1.832827743264848, mRNA_DTL: 1.3503840652360777, mRNA_C5AR2: -1.931521316926075, mRNA_TBC1D9: -1.4385167149084002, mRNA_AR: -2.386909030290332, mRNA_CCDC170: -0.8970394599977094, mRNA_DEGS2: -1.7922286456667844, mRNA_TFF3: -2.244976579921297, mRNA_DNALI1: -2.076321877604971, mRNA_LINC00504: -1.7185359965585048, mRNA_CLCA2: -0.875337644204626, mRNA_PPP1R14C: 2.76006521482778, mRNA_THSD4: -0.3590748232864129, mRNA_SPAG5: 0.8183190376768392, mRNA_FBP1: -1.1044124574535343, mRNA_SLC7A8: -1.1281457584429335, mRNA_EN1: 1.656258377445026, mRNA_ZNF552: -1.9165560512810664, Methylation_LRRC6: 1.543979409113318, Methylation_chr2 66218712 LINC02934 (29533): -0.2271206852999457, Methylation_HOXB13: 0.2240439508944729, Methylation_chr10 3949206 LINC02660 (4871): 1.5840968724721, Methylation_chr5 179517140 RNF130 (18026): -1.601957642940816, Methylation_LOC727677: 1.515519750970051, Methylation_LETM1: 1.380199558051422, Methylation_CDC42BPB: 0.8570018887549057, Methylation_C8orf38: 1.4922358867664598, Methylation_chr14 100504766 EVL (18852): 1.512794799306695, Methylation_chr5 72594851 LOC340090 (24088): -1.5896201815984778, Methylation_chr2 242904738 LINC01238 (3421): 1.4345626804545533, Methylation_ARFGEF1: 1.729627026994199, Methylation_MAPT: 1.3691281541151867, Methylation_ZFAT: 1.3302974687440683, Methylation_KCNQ4: 1.7701409324559558, Methylation_chr1 232684368 SIPA1L2 (12934): 1.6110104251234982, Methylation_CRNKL1: 1.4237997981450652, Methylation_PRKAG2: -1.694729121023128, Methylation_MICB: 1.5746708215594991, miRNA_hsa-mir-934: 3.894677819543573, miRNA_hsa-mir-4728: -0.888788471079422, miRNA_hsa-mir-5695: 0.3094297169163231, miRNA_hsa-mir-18a: 1.2794453694403136, miRNA_hsa-mir-190b: -1.7727686644084444, miRNA_hsa-mir-577: 2.341752541262257, miRNA_hsa-mir-135b: 2.828346336306755, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.7613387404175755, miRNA_hsa-mir-130b: 0.6776230548153303, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-AC-A3W6,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-significant ranges per specified Z-score and CNV cutoffs.","mRNA_MLPH: 0.515922240728367, mRNA_C2orf54: 0.5242382750285246, mRNA_CITED4: -0.0884046093967318, mRNA_ESR1: 0.3582610908945834, mRNA_SPDEF: 0.5994352523955134, mRNA_AGR3: 0.5584557122321056, mRNA_FOXC1: -0.0768875727306437, mRNA_GATA3: 0.4562149335926573, mRNA_AGR2: 0.3657790993922333, mRNA_XBP1: -0.2463733116934709, mRNA_PRR15: 0.6599046488044378, mRNA_SLC44A4: 0.7233487781136688, mRNA_CA12: 0.1699140964065224, mRNA_DTL: -0.4614579447063269, mRNA_C5AR2: 0.9315076901311712, mRNA_TBC1D9: -0.024100640141898, mRNA_AR: 0.5425251641516079, mRNA_CCDC170: 0.0047707315070249, mRNA_DEGS2: -0.0501245672729707, mRNA_TFF3: 0.9279594268071898, mRNA_DNALI1: -0.2209906927570123, mRNA_LINC00504: 0.1427738789452989, mRNA_CLCA2: -0.2925506235928274, mRNA_PPP1R14C: -1.0930236859459068, mRNA_THSD4: 0.2349572228192361, mRNA_SPAG5: -0.8016619470797548, mRNA_FBP1: -0.0495597190145028, mRNA_SLC7A8: -0.0998181695194936, mRNA_EN1: 0.4641566723592756, mRNA_ZNF552: 0.2121553943123043, Methylation_LRRC6: 0.9462837695757534, Methylation_chr2 66218712 LINC02934 (29533): 1.2532648579089682, Methylation_HOXB13: 0.3664630469547528, Methylation_chr10 3949206 LINC02660 (4871): 0.1938473086747329, Methylation_chr5 179517140 RNF130 (18026): 0.0533255782137665, Methylation_LOC727677: 0.5258849123826616, Methylation_LETM1: 0.5114132144058893, Methylation_CDC42BPB: -0.5076670780864622, Methylation_C8orf38: 0.1717442756026524, Methylation_chr14 100504766 EVL (18852): 0.9384464281779218, Methylation_chr5 72594851 LOC340090 (24088): -0.0075211115389442, Methylation_chr2 242904738 LINC01238 (3421): -0.0661109166394109, Methylation_ARFGEF1: 0.7857051538009371, Methylation_MAPT: 0.956817164135265, Methylation_ZFAT: 0.2218758715372175, Methylation_KCNQ4: -0.3952346007278944, Methylation_chr1 232684368 SIPA1L2 (12934): 1.0120813778406046, Methylation_CRNKL1: 0.5768371369501811, Methylation_PRKAG2: 1.2499666605141455, Methylation_MICB: 0.4998743058502076, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.905420030576514, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.2270138951004584, miRNA_hsa-mir-190b: 1.2609251696921355, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.183626085196401, miRNA_hsa-mir-2115: -0.458514079376736, miRNA_hsa-mir-17: -0.5806573344187049, miRNA_hsa-mir-130b: 0.1613081948590156, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A7-A56D,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.2731907793679238, mRNA_C2orf54: 1.1835502682678778, mRNA_CITED4: 0.8426160762269653, mRNA_ESR1: -0.1302607133468756, mRNA_SPDEF: 0.6295714564751453, mRNA_AGR3: 0.3976061405363905, mRNA_FOXC1: -0.8086833844500514, mRNA_GATA3: 0.1547084673454099, mRNA_AGR2: 0.4681695425443314, mRNA_XBP1: -0.9341265864857118, mRNA_PRR15: -0.1700836080823206, mRNA_SLC44A4: 0.1563964480181265, mRNA_CA12: -0.3631837642636371, mRNA_DTL: -1.491031838008456, mRNA_C5AR2: -0.1271795705960116, mRNA_TBC1D9: -1.6169407445726158, mRNA_AR: -0.6022322517118526, mRNA_CCDC170: -0.2416759920299177, mRNA_DEGS2: 1.9196967914788945, mRNA_TFF3: 1.2635876432688546, mRNA_DNALI1: 0.0452993189873062, mRNA_LINC00504: -1.0960656578799417, mRNA_CLCA2: -0.7035327907949439, mRNA_PPP1R14C: -0.5568651106333056, mRNA_THSD4: -1.010370938090942, mRNA_SPAG5: 1.1048582934327122, mRNA_FBP1: -0.9006957467956435, mRNA_SLC7A8: -0.4573383698166551, mRNA_EN1: 0.9511901606301568, mRNA_ZNF552: -1.252527152529182, Methylation_LRRC6: -0.0898730869738622, Methylation_chr2 66218712 LINC02934 (29533): -0.0976398149044996, Methylation_HOXB13: 0.7610990962999329, Methylation_chr10 3949206 LINC02660 (4871): 0.1324727303720935, Methylation_chr5 179517140 RNF130 (18026): 0.8667370142078473, Methylation_LOC727677: 0.3615030142500994, Methylation_LETM1: 0.4086587619857068, Methylation_CDC42BPB: 1.4261859262461627, Methylation_C8orf38: -0.4671917087973565, Methylation_chr14 100504766 EVL (18852): -0.6326309713899124, Methylation_chr5 72594851 LOC340090 (24088): -1.365263456928904, Methylation_chr2 242904738 LINC01238 (3421): -0.7323206944613, Methylation_ARFGEF1: -0.0725840445955828, Methylation_MAPT: 1.300524327700036, Methylation_ZFAT: -0.4773963768098422, Methylation_KCNQ4: -1.0258347597386952, Methylation_chr1 232684368 SIPA1L2 (12934): 0.33211887851179, Methylation_CRNKL1: -0.4042596133498295, Methylation_PRKAG2: 0.7117298694995454, Methylation_MICB: -0.2716780693582106, miRNA_hsa-mir-934: 0.1621405898479601, miRNA_hsa-mir-4728: -0.6860550288607831, miRNA_hsa-mir-5695: 0.1523111665300652, miRNA_hsa-mir-18a: -0.1258102069921584, miRNA_hsa-mir-190b: -0.4872722737573728, miRNA_hsa-mir-577: -0.6403535067222585, miRNA_hsa-mir-135b: -0.0021065459452008, miRNA_hsa-mir-2115: 0.4334689348399241, miRNA_hsa-mir-17: -0.5381380349781004, miRNA_hsa-mir-130b: -0.6494237580664798, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A1R0,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.5115141336902479, mRNA_C2orf54: -1.1900115970486729, mRNA_CITED4: 0.8936164708941219, mRNA_ESR1: 0.4079293914463254, mRNA_SPDEF: 0.2958082017914251, mRNA_AGR3: 0.3817327769479772, mRNA_FOXC1: -0.2989389211063915, mRNA_GATA3: 0.7507496268284074, mRNA_AGR2: 0.3800925281086282, mRNA_XBP1: 0.5492139667754402, mRNA_PRR15: 0.4813642704599993, mRNA_SLC44A4: 0.1662397864568962, mRNA_CA12: 0.9192316612390812, mRNA_DTL: -0.4668140651186698, mRNA_C5AR2: 0.9961728453467904, mRNA_TBC1D9: 0.7115496070595584, mRNA_AR: 0.7931881190885166, mRNA_CCDC170: 0.0111526017013139, mRNA_DEGS2: 1.0231982010458356, mRNA_TFF3: 0.3127965380825512, mRNA_DNALI1: 0.9598954983060256, mRNA_LINC00504: 1.208222707685587, mRNA_CLCA2: -0.6380482512738695, mRNA_PPP1R14C: -0.4128754518741273, mRNA_THSD4: 0.9295286570554953, mRNA_SPAG5: -0.4191942785253336, mRNA_FBP1: 0.1945725391378774, mRNA_SLC7A8: 1.005473732683876, mRNA_EN1: -0.0655045643044387, mRNA_ZNF552: 0.2490223032746138, Methylation_LRRC6: 0.3016116732750934, Methylation_chr2 66218712 LINC02934 (29533): -0.5051277284804954, Methylation_HOXB13: -1.0082513220534228, Methylation_chr10 3949206 LINC02660 (4871): -0.2845537391180136, Methylation_chr5 179517140 RNF130 (18026): 0.4074300707592214, Methylation_LOC727677: -0.0838550556701875, Methylation_LETM1: -0.338255768834147, Methylation_CDC42BPB: -1.075051108744271, Methylation_C8orf38: 0.0875630668174918, Methylation_chr14 100504766 EVL (18852): 0.4364882611467421, Methylation_chr5 72594851 LOC340090 (24088): -0.5394757405396815, Methylation_chr2 242904738 LINC01238 (3421): 1.344421419086498, Methylation_ARFGEF1: 0.6751574023126717, Methylation_MAPT: -0.0289924072936612, Methylation_ZFAT: 0.2226801573221682, Methylation_KCNQ4: -0.9143480775255532, Methylation_chr1 232684368 SIPA1L2 (12934): 0.5046545367236296, Methylation_CRNKL1: 0.3772785041681094, Methylation_PRKAG2: 0.1696007074033196, Methylation_MICB: -0.0855438084779017, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.3722061860492844, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.545808780845754, miRNA_hsa-mir-190b: -0.7628230937018934, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: -0.3273654906798185, miRNA_hsa-mir-17: -0.9166826227159244, miRNA_hsa-mir-130b: -0.364280665201587, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-LL-A73Y,"High-level Amplification of VPS54, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. FOXC1 and EN1 show significant mRNA upregulation (Z > 1.30). GATA3, AGR2, CA12, and ESR1 are transcriptionally silenced (Z < -1.92). Promoter hypermethylation at C8orf38 and SIPA1L2 (Z > 1.50) and hypomethylation at RNF130 and LOC340090 (Z < -1.47) mediate epigenetic dysregulation. miR-934 and miR-135b are upregulated; miR-190b is downregulated.","mRNA_MLPH: -1.9535040033829527, mRNA_C2orf54: 1.0887975362611089, mRNA_CITED4: 0.7973627083953059, mRNA_ESR1: -1.8385031941710368, mRNA_SPDEF: -0.946258333041766, mRNA_AGR3: -1.8855489340874951, mRNA_FOXC1: 2.284465955969648, mRNA_GATA3: -2.4653184876832843, mRNA_AGR2: -2.4703732034805923, mRNA_XBP1: -1.8770954776215445, mRNA_PRR15: -1.644494442252342, mRNA_SLC44A4: -0.7913262051203501, mRNA_CA12: -2.4212974765325708, mRNA_DTL: -0.5320429186245237, mRNA_C5AR2: -1.3100407157606286, mRNA_TBC1D9: -1.434484092975561, mRNA_AR: -1.4058145021271775, mRNA_CCDC170: -1.1741232758581917, mRNA_DEGS2: -1.7438488442345204, mRNA_TFF3: -1.7543500188654757, mRNA_DNALI1: -1.6133005918341377, mRNA_LINC00504: -1.5394797371959694, mRNA_CLCA2: -0.8126380935537969, mRNA_PPP1R14C: 0.8645786016165989, mRNA_THSD4: -1.8186183149102304, mRNA_SPAG5: -0.475494822230826, mRNA_FBP1: 0.4804453914316625, mRNA_SLC7A8: -0.7983767020550248, mRNA_EN1: 2.9603723521592595, mRNA_ZNF552: -0.9336670310853864, Methylation_LRRC6: 1.481967658264307, Methylation_chr2 66218712 LINC02934 (29533): -0.6110013708717525, Methylation_HOXB13: 0.4756685342420855, Methylation_chr10 3949206 LINC02660 (4871): 1.3684694519291691, Methylation_chr5 179517140 RNF130 (18026): -1.5958504870104375, Methylation_LOC727677: 1.4683410713363496, Methylation_LETM1: 1.2553683243263072, Methylation_CDC42BPB: 0.6154739558621751, Methylation_C8orf38: 1.620982419450078, Methylation_chr14 100504766 EVL (18852): 1.4272328494626272, Methylation_chr5 72594851 LOC340090 (24088): -1.5136021270322888, Methylation_chr2 242904738 LINC01238 (3421): 1.2840615692403594, Methylation_ARFGEF1: 1.402492379926103, Methylation_MAPT: 1.4259491151540753, Methylation_ZFAT: 1.3314701256340051, Methylation_KCNQ4: 0.5653000325138143, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5249641868113566, Methylation_CRNKL1: 1.3187289582420911, Methylation_PRKAG2: -0.6893230726027113, Methylation_MICB: 1.4379823679962709, miRNA_hsa-mir-934: 2.3137082117277177, miRNA_hsa-mir-4728: -0.7731464938298618, miRNA_hsa-mir-5695: -0.3559544437434679, miRNA_hsa-mir-18a: 1.0920103962298162, miRNA_hsa-mir-190b: -2.052137242410604, miRNA_hsa-mir-577: 0.2181103343119762, miRNA_hsa-mir-135b: 1.9659875766836032, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.0688443369859897, miRNA_hsa-mir-130b: 0.0113007118892048, CNV_VPS54: 1.375777469993222, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-AR-A0TR,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. CRNKL1 promoter hypermethylation (Z = -1.60) mediates epigenetic silencing. miR-18a downregulation (Z = -1.69) and miR-130b downregulation (Z = -1.27) suggest loss of tumor-suppressive regulation. These features collectively indicate a luminal B phenotype with PI3K/AKT/mTOR dysregulation.","mRNA_MLPH: 1.2025466235560824, mRNA_C2orf54: -1.2943230935752186, mRNA_CITED4: 0.6841252705188605, mRNA_ESR1: 1.292834778975836, mRNA_SPDEF: 0.8509906686167604, mRNA_AGR3: 0.8126321738305106, mRNA_FOXC1: -1.1894268937209054, mRNA_GATA3: 1.2374594524117783, mRNA_AGR2: 1.709968949456536, mRNA_XBP1: 0.3971909533423728, mRNA_PRR15: 1.0381583143235156, mRNA_SLC44A4: 0.4828758680880394, mRNA_CA12: 0.9523811761198928, mRNA_DTL: -1.3153821570402788, mRNA_C5AR2: 1.394600955643027, mRNA_TBC1D9: 1.4481489576998048, mRNA_AR: 0.8553152420953052, mRNA_CCDC170: 1.263109183643578, mRNA_DEGS2: 0.465757783599404, mRNA_TFF3: 1.129504592448628, mRNA_DNALI1: 0.8612637405270399, mRNA_LINC00504: 0.6822053875425862, mRNA_CLCA2: -0.8856039755636942, mRNA_PPP1R14C: -1.1208415211411225, mRNA_THSD4: 1.6759679784022592, mRNA_SPAG5: -0.292512866768822, mRNA_FBP1: 1.186113322466164, mRNA_SLC7A8: 1.2771147508222076, mRNA_EN1: -0.642780146619155, mRNA_ZNF552: 2.126371229769093, Methylation_LRRC6: -1.2655110506445575, Methylation_chr2 66218712 LINC02934 (29533): 1.2697038565523306, Methylation_HOXB13: -0.7376998272939284, Methylation_chr10 3949206 LINC02660 (4871): -1.1965497249092258, Methylation_chr5 179517140 RNF130 (18026): 1.185584220008886, Methylation_LOC727677: -1.2487212515999842, Methylation_LETM1: -1.0989770396804108, Methylation_CDC42BPB: -1.3497614503802724, Methylation_C8orf38: -1.066510041249897, Methylation_chr14 100504766 EVL (18852): -1.1144680345094031, Methylation_chr5 72594851 LOC340090 (24088): 0.8923489907715378, Methylation_chr2 242904738 LINC01238 (3421): -1.0535802872192312, Methylation_ARFGEF1: -1.261441012877074, Methylation_MAPT: -1.46313396196767, Methylation_ZFAT: -1.12976747003375, Methylation_KCNQ4: -0.4856546131393965, Methylation_chr1 232684368 SIPA1L2 (12934): -1.3613226747193947, Methylation_CRNKL1: -1.6039681702634487, Methylation_PRKAG2: 1.364002294900991, Methylation_MICB: -1.2434683807377354, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.2731608257851974, miRNA_hsa-mir-5695: 0.1776026057697867, miRNA_hsa-mir-18a: -1.6936735855830478, miRNA_hsa-mir-190b: 1.1868929711872198, miRNA_hsa-mir-577: 0.434777137007874, miRNA_hsa-mir-135b: 0.3464724423514413, miRNA_hsa-mir-2115: 0.4573687807242373, miRNA_hsa-mir-17: -1.197885852995768, miRNA_hsa-mir-130b: -1.2716463396190154, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-D8-A1X5,High mRNA_C2orf54 (Z=2.02) indicates overexpression; mRNA_CITED4 (Z=-1.94) is downregulated. Methylation_chr2 66218712 LINC02934 (Z=-1.51) and Methylation_ZFAT (Z=-1.29) are hypomethylated. miRNA_hsa-mir-4728 (Z=2.89) is upregulated. All CNVs show Gain (0.38–0.40). No high-level amplifications or deletions.,"mRNA_MLPH: 0.7952076996493525, mRNA_C2orf54: 2.019190230280953, mRNA_CITED4: -1.9411891110535515, mRNA_ESR1: 1.066003541046536, mRNA_SPDEF: 0.2102809880416103, mRNA_AGR3: 0.81916155116095, mRNA_FOXC1: -0.8854391823211486, mRNA_GATA3: 0.3561767402931898, mRNA_AGR2: 0.4781352169858838, mRNA_XBP1: 0.662553578977398, mRNA_PRR15: 1.0466755016224498, mRNA_SLC44A4: 0.93800588099028, mRNA_CA12: 0.7713371431754223, mRNA_DTL: 1.1671995275006672, mRNA_C5AR2: 0.6973541308259255, mRNA_TBC1D9: 0.65006801506865, mRNA_AR: 0.8089035415616941, mRNA_CCDC170: 0.9099002444640404, mRNA_DEGS2: 0.7993655510022492, mRNA_TFF3: 0.002073783329287, mRNA_DNALI1: -0.0950134216937514, mRNA_LINC00504: 0.5382532460324764, mRNA_CLCA2: -0.8722947043698387, mRNA_PPP1R14C: -1.112102503387258, mRNA_THSD4: 1.081132078019054, mRNA_SPAG5: 0.1540663764814739, mRNA_FBP1: 0.3038193652096901, mRNA_SLC7A8: 0.8042606504027616, mRNA_EN1: -0.0443244736811969, mRNA_ZNF552: -0.1630460231422046, Methylation_LRRC6: -1.1847644439866998, Methylation_chr2 66218712 LINC02934 (29533): -1.5081907850868808, Methylation_HOXB13: 0.8083117356127331, Methylation_chr10 3949206 LINC02660 (4871): -1.0839822673657715, Methylation_chr5 179517140 RNF130 (18026): 1.014387754772508, Methylation_LOC727677: -1.1123458815591758, Methylation_LETM1: -0.4634367581026099, Methylation_CDC42BPB: 1.3206291340326983, Methylation_C8orf38: -0.7874870818502461, Methylation_chr14 100504766 EVL (18852): -1.1202265781607688, Methylation_chr5 72594851 LOC340090 (24088): 0.7231678372165191, Methylation_chr2 242904738 LINC01238 (3421): -0.9784114583832094, Methylation_ARFGEF1: -0.954314423068631, Methylation_MAPT: 0.268958118243788, Methylation_ZFAT: -1.287994777505105, Methylation_KCNQ4: 0.5534899540478498, Methylation_chr1 232684368 SIPA1L2 (12934): -0.8482316189109976, Methylation_CRNKL1: -0.4205233896468018, Methylation_PRKAG2: -1.1834583648373154, Methylation_MICB: -0.9066772356478824, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 2.894047634203936, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.2878931494000912, miRNA_hsa-mir-190b: 0.9177420496866784, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.6894466640531955, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.129659172892945, miRNA_hsa-mir-130b: -0.0306296054423091, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-E9-A5FL,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives oncogenic genomic instability.  
mRNA_CLCA2 overexpression (Z=2.09) indicates luminal differentiation.  
Promoter hypermethylation of RNF130 and LOC340090 mediates transcriptional silencing.  
miR-18a upregulation (Z=2.45) and miR-190b downregulation (Z=-1.75) suggest ESR1-pathway suppression.  
Collectively indicative of a luminal B subtype with PI3K/AKT dysregulation.","mRNA_MLPH: -2.447431995286036, mRNA_C2orf54: -0.6142616281381861, mRNA_CITED4: -0.5326020544180855, mRNA_ESR1: -1.2461834623129098, mRNA_SPDEF: -3.0695720150428785, mRNA_AGR3: -1.8805072869878752, mRNA_FOXC1: 0.2957137581853795, mRNA_GATA3: -1.0908671567978738, mRNA_AGR2: -1.6534190162074538, mRNA_XBP1: -3.251140014250855, mRNA_PRR15: -1.6288040232182404, mRNA_SLC44A4: -2.2478920079800946, mRNA_CA12: -1.039942159197717, mRNA_DTL: -1.2234601249721269, mRNA_C5AR2: -1.9135124590683843, mRNA_TBC1D9: -2.3660075874610107, mRNA_AR: -2.0553580982003687, mRNA_CCDC170: -1.5826590760590946, mRNA_DEGS2: -1.8057261973734096, mRNA_TFF3: -1.8270266696975503, mRNA_DNALI1: -1.5531553113939254, mRNA_LINC00504: -0.4288690108143128, mRNA_CLCA2: 2.091570874399173, mRNA_PPP1R14C: 0.2994031147473242, mRNA_THSD4: -2.0661048604765417, mRNA_SPAG5: -0.0129300979752054, mRNA_FBP1: -2.339722888205257, mRNA_SLC7A8: -0.3650071608147536, mRNA_EN1: 0.3900430648745627, mRNA_ZNF552: -1.6040797942902063, Methylation_LRRC6: 1.3757251148115357, Methylation_chr2 66218712 LINC02934 (29533): -0.2844915484009543, Methylation_HOXB13: 1.0223152355863183, Methylation_chr10 3949206 LINC02660 (4871): 1.25243220762991, Methylation_chr5 179517140 RNF130 (18026): -1.6993906216867274, Methylation_LOC727677: 1.5383512252657412, Methylation_LETM1: 1.3377199040236138, Methylation_CDC42BPB: 0.9163301802723528, Methylation_C8orf38: 1.5520029188071642, Methylation_chr14 100504766 EVL (18852): 1.123097832692865, Methylation_chr5 72594851 LOC340090 (24088): -1.532094941749678, Methylation_chr2 242904738 LINC01238 (3421): 1.3123212087194294, Methylation_ARFGEF1: 1.5144134662391189, Methylation_MAPT: 1.5253438446036192, Methylation_ZFAT: 1.3814132669936747, Methylation_KCNQ4: -1.0846629175687543, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5259887024775085, Methylation_CRNKL1: 1.4556626602040157, Methylation_PRKAG2: -0.4994541732885502, Methylation_MICB: 1.4163081562711604, miRNA_hsa-mir-934: 0.4715058807829231, miRNA_hsa-mir-4728: -0.0986592364923174, miRNA_hsa-mir-5695: 0.3974684588645699, miRNA_hsa-mir-18a: 2.4513692747391547, miRNA_hsa-mir-190b: -1.7498699513869271, miRNA_hsa-mir-577: 0.8696091343130872, miRNA_hsa-mir-135b: 0.5661069662562819, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.3905868081845585, miRNA_hsa-mir-130b: 1.0368122718823274, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-E9-A1RF,"No mRNA, methylation, or miRNA features meet diagnostic thresholds. CNV shows amplification (not high-level) of VPS54, LINC01867, LINC02576, WDPCP, and CEP68. Insufficient evidence for subtype classification or pathway dysregulation.","mRNA_MLPH: 0.216085772403972, mRNA_C2orf54: 0.4227930274609123, mRNA_CITED4: 0.996525123993922, mRNA_ESR1: 0.2985604896714058, mRNA_SPDEF: 0.3668443747961755, mRNA_AGR3: 0.0508315031666351, mRNA_FOXC1: -0.744100645716926, mRNA_GATA3: 0.7760691470882659, mRNA_AGR2: -0.0118319355308945, mRNA_XBP1: -0.5436837963503728, mRNA_PRR15: -0.6758739384666743, mRNA_SLC44A4: -0.0143492115635961, mRNA_CA12: -0.4361843847365169, mRNA_DTL: -0.3718755767440906, mRNA_C5AR2: -0.8899028712420355, mRNA_TBC1D9: 0.5302962037140195, mRNA_AR: -0.0733684427709157, mRNA_CCDC170: -0.6715921291039318, mRNA_DEGS2: -0.0105858793198623, mRNA_TFF3: 0.542203198470322, mRNA_DNALI1: 0.3379938725631098, mRNA_LINC00504: 0.3022697226469132, mRNA_CLCA2: -0.524544194526389, mRNA_PPP1R14C: 0.002079407470908, mRNA_THSD4: -0.3615391918639631, mRNA_SPAG5: 0.3928600811939469, mRNA_FBP1: 0.2405735924038816, mRNA_SLC7A8: -0.9626911417421866, mRNA_EN1: -0.1057427894077675, mRNA_ZNF552: 0.7134835101666457, Methylation_LRRC6: -0.4796465224505231, Methylation_chr2 66218712 LINC02934 (29533): -0.3048581195336233, Methylation_HOXB13: 1.359214825812193, Methylation_chr10 3949206 LINC02660 (4871): -0.6697607405572548, Methylation_chr5 179517140 RNF130 (18026): 0.3274875968760737, Methylation_LOC727677: -0.3642572823982404, Methylation_LETM1: -0.3250037163027883, Methylation_CDC42BPB: 1.0274745349115926, Methylation_C8orf38: -1.1088386915010375, Methylation_chr14 100504766 EVL (18852): -1.1853099457164271, Methylation_chr5 72594851 LOC340090 (24088): 0.4694265752763706, Methylation_chr2 242904738 LINC01238 (3421): -0.652500254740391, Methylation_ARFGEF1: -0.7214612536254479, Methylation_MAPT: -0.3670884514847112, Methylation_ZFAT: 0.1472724318306121, Methylation_KCNQ4: -0.1649539468259896, Methylation_chr1 232684368 SIPA1L2 (12934): -1.127307756866818, Methylation_CRNKL1: -1.0891692270074669, Methylation_PRKAG2: -1.115799333153563, Methylation_MICB: -0.983243179062601, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.2951860716618839, miRNA_hsa-mir-5695: -0.3729031254701367, miRNA_hsa-mir-18a: 0.6267312721125126, miRNA_hsa-mir-190b: -0.3727504953992233, miRNA_hsa-mir-577: -0.3738883855192558, miRNA_hsa-mir-135b: -0.1208045198312613, miRNA_hsa-mir-2115: -0.0226742829389322, miRNA_hsa-mir-17: 0.2302039381698193, miRNA_hsa-mir-130b: 0.6267924773828489, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-BH-A0AW,"High-level Amplification of *VPS54*, *LINC01867*, *LINC02576*, *WDPCP*, and *CEP68* drives mRNA overexpression. *CLCA2* mRNA is highly overexpressed (Z=2.36). *AGR3* mRNA is low (Z=-2.01). *HOXB13* and *chr10:3949206* promoters are hypermethylated (Z>1.50). miR-4728 and miR-2115 are upregulated (Z>1.99). These features indicate a basal-like phenotype with ER-pathway suppression.","mRNA_MLPH: -0.4267931948022937, mRNA_C2orf54: 1.3637894932705703, mRNA_CITED4: -1.6266152718240043, mRNA_ESR1: -1.3993912972117726, mRNA_SPDEF: 0.6825265591963671, mRNA_AGR3: -2.0113834135344595, mRNA_FOXC1: -0.4985678213550109, mRNA_GATA3: -0.6078234601539962, mRNA_AGR2: -0.2401190592452443, mRNA_XBP1: 0.3942376395622282, mRNA_PRR15: 0.4353128771879944, mRNA_SLC44A4: 0.1587669053671345, mRNA_CA12: -0.9305393272326792, mRNA_DTL: -0.5105806683807981, mRNA_C5AR2: -1.8827428614848816, mRNA_TBC1D9: -1.0662758797525442, mRNA_AR: -0.0622498338810936, mRNA_CCDC170: -1.5985071097735557, mRNA_DEGS2: 0.0650498372364304, mRNA_TFF3: 0.711410532792535, mRNA_DNALI1: -1.177489515438337, mRNA_LINC00504: -1.3096139268792877, mRNA_CLCA2: 2.36118546773836, mRNA_PPP1R14C: 0.6550919065960785, mRNA_THSD4: -1.7039815983998712, mRNA_SPAG5: 0.7637590772189325, mRNA_FBP1: 0.4441954804000698, mRNA_SLC7A8: -0.0301226381054227, mRNA_EN1: -0.8142364654687818, mRNA_ZNF552: -1.3956971580966984, Methylation_LRRC6: 1.4562858869244366, Methylation_chr2 66218712 LINC02934 (29533): 1.327867091315493, Methylation_HOXB13: 1.802985691921818, Methylation_chr10 3949206 LINC02660 (4871): 1.518190811857587, Methylation_chr5 179517140 RNF130 (18026): 0.0559526154044545, Methylation_LOC727677: 1.0407105093469826, Methylation_LETM1: 1.294240783315854, Methylation_CDC42BPB: -1.155454187951393, Methylation_C8orf38: -0.2363375936314667, Methylation_chr14 100504766 EVL (18852): 0.5917266465292079, Methylation_chr5 72594851 LOC340090 (24088): -1.3674134619159553, Methylation_chr2 242904738 LINC01238 (3421): 0.1365057143983058, Methylation_ARFGEF1: -0.1953061417919609, Methylation_MAPT: 1.1979712127770437, Methylation_ZFAT: 0.32836275984458, Methylation_KCNQ4: 0.7985727909739788, Methylation_chr1 232684368 SIPA1L2 (12934): 0.4850355813497113, Methylation_CRNKL1: -0.3273765984459539, Methylation_PRKAG2: -0.5843879861249993, Methylation_MICB: 0.7500089265284205, miRNA_hsa-mir-934: 0.3549345855667755, miRNA_hsa-mir-4728: 4.153499837614957, miRNA_hsa-mir-5695: 2.071209712886388, miRNA_hsa-mir-18a: 1.6627665499826343, miRNA_hsa-mir-190b: -0.392758646919019, miRNA_hsa-mir-577: 0.1195453623133499, miRNA_hsa-mir-135b: 0.0604155442203658, miRNA_hsa-mir-2115: 4.023903285876089, miRNA_hsa-mir-17: 0.7348742871349029, miRNA_hsa-mir-130b: 1.157680311585668, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-A7-A26E,LINC00504 mRNA overexpression (Z=1.63) and ZNF552 high mRNA (Z=2.40) exceed the high-expression threshold. TBC1D9 mRNA elevated (Z=1.32). No methylation sites meet hyper/hypo thresholds. miRNA hsa-mir-17 downregulated (Z=-1.37). All CNVs fall within normal range. These features suggest luminal transcriptional activity without clear genomic or epigenetic drivers.,"mRNA_MLPH: 0.8954290959307142, mRNA_C2orf54: 0.4487282430326588, mRNA_CITED4: -0.4561036103014463, mRNA_ESR1: 1.0280034976554226, mRNA_SPDEF: -0.5007471441461867, mRNA_AGR3: 0.558783247176225, mRNA_FOXC1: -0.9802365589695418, mRNA_GATA3: 0.086140623613824, mRNA_AGR2: -0.0093197550232495, mRNA_XBP1: 0.4001066217029547, mRNA_PRR15: -0.5012208444853319, mRNA_SLC44A4: -0.0161892668588488, mRNA_CA12: 0.2281392062058154, mRNA_DTL: -0.6387648894603921, mRNA_C5AR2: 0.0755130023496593, mRNA_TBC1D9: 1.321736508540834, mRNA_AR: 0.938268949729362, mRNA_CCDC170: 0.7792051735573661, mRNA_DEGS2: -0.4359227379811252, mRNA_TFF3: -0.6039481970382904, mRNA_DNALI1: 0.002151764470762, mRNA_LINC00504: 1.6337511945115872, mRNA_CLCA2: -0.7151244639329863, mRNA_PPP1R14C: -0.5189701246445342, mRNA_THSD4: 1.2042081648900185, mRNA_SPAG5: -0.2793821856726497, mRNA_FBP1: -0.5557475720979921, mRNA_SLC7A8: -0.2915443943249146, mRNA_EN1: -0.5776209855951924, mRNA_ZNF552: 2.3980557232471265, Methylation_LRRC6: -0.0987737329269829, Methylation_chr2 66218712 LINC02934 (29533): 1.3065898872173658, Methylation_HOXB13: -0.8709676575744024, Methylation_chr10 3949206 LINC02660 (4871): -0.4355840635514068, Methylation_chr5 179517140 RNF130 (18026): 0.976827407772607, Methylation_LOC727677: 1.307338259405075, Methylation_LETM1: -0.7964237209783965, Methylation_CDC42BPB: -0.6663992696795297, Methylation_C8orf38: -0.4359578260457054, Methylation_chr14 100504766 EVL (18852): 0.3944387400617246, Methylation_chr5 72594851 LOC340090 (24088): 0.2257386070363169, Methylation_chr2 242904738 LINC01238 (3421): -0.7539492834377068, Methylation_ARFGEF1: -0.0643008986788465, Methylation_MAPT: -0.4537988837064635, Methylation_ZFAT: -0.9300687455225538, Methylation_KCNQ4: -0.936904978061862, Methylation_chr1 232684368 SIPA1L2 (12934): -0.2997127785643016, Methylation_CRNKL1: -0.4676255352552899, Methylation_PRKAG2: 1.3073576249505268, Methylation_MICB: -0.6037053797391814, miRNA_hsa-mir-934: -0.3108682059710927, miRNA_hsa-mir-4728: -0.3482571088875467, miRNA_hsa-mir-5695: 1.1383813309265085, miRNA_hsa-mir-18a: -1.223900059620855, miRNA_hsa-mir-190b: -0.0894531453555777, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.5817799632035084, miRNA_hsa-mir-2115: 0.8714819962269668, miRNA_hsa-mir-17: -1.3666193224127832, miRNA_hsa-mir-130b: -1.158512055323673, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-LL-A5YL,"High mRNA_C2orf54 (Z=1.36), mRNA_C5AR2 (Z=1.30), mRNA_TFF3 (Z=1.95), and mRNA_CLCA2 (Z=1.77) indicate overexpression. Methylation_ZFAT (Z=1.43) and Methylation_chr2:242904738 (Z=1.37) are hypermethylated. miRNA_hsa-mir-135b is upregulated (Z=2.04). No CNVs meet deletion/amplification thresholds. These features suggest luminal breast cancer with ER-pathway activity.","mRNA_MLPH: 1.1040028938441584, mRNA_C2orf54: 1.3612173154061873, mRNA_CITED4: 1.0222663726712942, mRNA_ESR1: -0.2997632965763382, mRNA_SPDEF: 0.9027117704829966, mRNA_AGR3: 0.1533083523163552, mRNA_FOXC1: -0.3467711156116266, mRNA_GATA3: -0.0634891697118049, mRNA_AGR2: 1.089493770438986, mRNA_XBP1: 0.0461653611341658, mRNA_PRR15: 0.4190915809371606, mRNA_SLC44A4: 0.5854416123061308, mRNA_CA12: -0.9213653538681806, mRNA_DTL: 0.3358459148074361, mRNA_C5AR2: 1.304952075962012, mRNA_TBC1D9: -1.1870368151514672, mRNA_AR: -0.6485787293792561, mRNA_CCDC170: 0.1457990657267769, mRNA_DEGS2: 1.035787208282141, mRNA_TFF3: 1.9465467437977144, mRNA_DNALI1: 0.5406215865383772, mRNA_LINC00504: 0.4436769240726866, mRNA_CLCA2: 1.7688220765916574, mRNA_PPP1R14C: -0.1218342880535312, mRNA_THSD4: -0.6049914126334672, mRNA_SPAG5: -0.2563293917653591, mRNA_FBP1: -0.4265754737592989, mRNA_SLC7A8: -0.0529221821024101, mRNA_EN1: -0.4628709008519567, mRNA_ZNF552: 0.331513993822057, Methylation_LRRC6: 0.4173080301949941, Methylation_chr2 66218712 LINC02934 (29533): 1.1876059037705975, Methylation_HOXB13: 1.1934784262980451, Methylation_chr10 3949206 LINC02660 (4871): 0.0372968512721445, Methylation_chr5 179517140 RNF130 (18026): 0.8656811580753174, Methylation_LOC727677: 1.247587591374442, Methylation_LETM1: 1.2467216432819574, Methylation_CDC42BPB: 1.013332116584394, Methylation_C8orf38: 0.9636637318951368, Methylation_chr14 100504766 EVL (18852): 0.0047230601243655, Methylation_chr5 72594851 LOC340090 (24088): 0.6784199389685525, Methylation_chr2 242904738 LINC01238 (3421): 1.3676602364312311, Methylation_ARFGEF1: 0.0946384161145199, Methylation_MAPT: 1.2951042345843524, Methylation_ZFAT: 1.4294817659848331, Methylation_KCNQ4: 0.4578308037769529, Methylation_chr1 232684368 SIPA1L2 (12934): 0.0656301663977246, Methylation_CRNKL1: -0.1189974102090427, Methylation_PRKAG2: -0.6759750388992684, Methylation_MICB: 0.0379107648287723, miRNA_hsa-mir-934: 0.8006862503409684, miRNA_hsa-mir-4728: -0.4486690670955707, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.316361610155565, miRNA_hsa-mir-190b: 0.5981047325435651, miRNA_hsa-mir-577: -0.4372329249661561, miRNA_hsa-mir-135b: 2.0423293271378307, miRNA_hsa-mir-2115: 1.009482491583931, miRNA_hsa-mir-17: -0.0750648841410916, miRNA_hsa-mir-130b: -0.4195966514668086, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A7-A3IZ,High-level Amplification of CCDC170 drives significant mRNA overexpression. LETM1 and CRNKL1 promoter hypermethylation mediates epigenetic silencing. Deletion of LINC01867 correlates with transcriptional downregulation. These features collectively indicate a luminal phenotype with ER signaling dysregulation.,"mRNA_MLPH: 0.984013591928008, mRNA_C2orf54: -1.2943230935752186, mRNA_CITED4: -1.5626745746636856, mRNA_ESR1: 1.4271144024657212, mRNA_SPDEF: 0.5827216759582452, mRNA_AGR3: 0.3935154943146198, mRNA_FOXC1: -0.170225668308628, mRNA_GATA3: 1.4659420091482436, mRNA_AGR2: 1.2044302279322432, mRNA_XBP1: 1.0788627600462952, mRNA_PRR15: 1.3263666715821605, mRNA_SLC44A4: 0.4020100992756859, mRNA_CA12: 0.9224893906929452, mRNA_DTL: 0.8371470110025004, mRNA_C5AR2: 1.2910273670070358, mRNA_TBC1D9: 1.1599227090905848, mRNA_AR: 0.8317186548802449, mRNA_CCDC170: 2.478795279050504, mRNA_DEGS2: 1.086094126707673, mRNA_TFF3: 1.134319465245709, mRNA_DNALI1: 0.7988353621484757, mRNA_LINC00504: 1.7257166616365012, mRNA_CLCA2: -0.8538823450729867, mRNA_PPP1R14C: -1.0507763824174683, mRNA_THSD4: 1.9478325954753848, mRNA_SPAG5: 0.6819967541703289, mRNA_FBP1: 0.9818251586609924, mRNA_SLC7A8: 0.4061986364373012, mRNA_EN1: -1.0372462600523846, mRNA_ZNF552: 0.7094786324534899, Methylation_LRRC6: -1.439865022028321, Methylation_chr2 66218712 LINC02934 (29533): 0.4020894229880013, Methylation_HOXB13: -0.9981657137842876, Methylation_chr10 3949206 LINC02660 (4871): -0.8904439440735897, Methylation_chr5 179517140 RNF130 (18026): 1.230072699606375, Methylation_LOC727677: -1.59285031945465, Methylation_LETM1: -1.8019354282135187, Methylation_CDC42BPB: -1.299575166985483, Methylation_C8orf38: -1.2247381668644608, Methylation_chr14 100504766 EVL (18852): -1.4590111427214478, Methylation_chr5 72594851 LOC340090 (24088): 1.3134525112940925, Methylation_chr2 242904738 LINC01238 (3421): -1.471669260345643, Methylation_ARFGEF1: -1.2172098637010946, Methylation_MAPT: -1.2814079087191097, Methylation_ZFAT: -1.3308951946450955, Methylation_KCNQ4: -0.1541408293351246, Methylation_chr1 232684368 SIPA1L2 (12934): -1.4784820353079668, Methylation_CRNKL1: -1.6204443059276337, Methylation_PRKAG2: 1.2700199678617037, Methylation_MICB: -1.3287912381239515, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.5634632936989654, miRNA_hsa-mir-5695: -0.1491861955677622, miRNA_hsa-mir-18a: -0.3410274376306108, miRNA_hsa-mir-190b: 0.5644229824552701, miRNA_hsa-mir-577: -0.4869590172134503, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.5525048149611423, miRNA_hsa-mir-130b: -0.1556817495992036, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -1.63714039509435, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AO-A1KT,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.6121657678331995, mRNA_C2orf54: -1.107113048738214, mRNA_CITED4: 0.0428233435809412, mRNA_ESR1: 0.2238788317927105, mRNA_SPDEF: 0.6649911868804737, mRNA_AGR3: 0.4883213657581807, mRNA_FOXC1: -0.3631577163547697, mRNA_GATA3: 0.7346399460512435, mRNA_AGR2: 0.3957046732567957, mRNA_XBP1: 0.5595138036791631, mRNA_PRR15: 0.8813403896293805, mRNA_SLC44A4: 0.4908452707578924, mRNA_CA12: -0.0505378626013795, mRNA_DTL: 0.2988086037984613, mRNA_C5AR2: -0.4431436620863048, mRNA_TBC1D9: -0.308300377549644, mRNA_AR: -0.4860325291881245, mRNA_CCDC170: 0.2310756834284691, mRNA_DEGS2: 0.6011840054950696, mRNA_TFF3: 0.5557544819946858, mRNA_DNALI1: 0.956516564141238, mRNA_LINC00504: 0.8321547201922087, mRNA_CLCA2: -0.3231411227689272, mRNA_PPP1R14C: -0.4481574143590046, mRNA_THSD4: -0.0076622913310459, mRNA_SPAG5: 0.8056101019060053, mRNA_FBP1: 1.1100949992758713, mRNA_SLC7A8: 0.9675809266292767, mRNA_EN1: -0.4279163317913693, mRNA_ZNF552: 0.1779717089329401, Methylation_LRRC6: -1.453061121690449, Methylation_chr2 66218712 LINC02934 (29533): -0.4216717237258267, Methylation_HOXB13: -1.0765536277959755, Methylation_chr10 3949206 LINC02660 (4871): -1.1664532844165283, Methylation_chr5 179517140 RNF130 (18026): 0.9124861762734132, Methylation_LOC727677: -1.2423533546723264, Methylation_LETM1: -0.609910309992849, Methylation_CDC42BPB: 1.3092918611332476, Methylation_C8orf38: 1.3472499524803074, Methylation_chr14 100504766 EVL (18852): -0.8900179924754061, Methylation_chr5 72594851 LOC340090 (24088): 1.2509736229473511, Methylation_chr2 242904738 LINC01238 (3421): -0.9578292781299862, Methylation_ARFGEF1: -1.2054947152239133, Methylation_MAPT: -0.6326908147000327, Methylation_ZFAT: -1.5006617456000653, Methylation_KCNQ4: -1.1914804606185847, Methylation_chr1 232684368 SIPA1L2 (12934): -1.004286033921833, Methylation_CRNKL1: -1.0151421096350042, Methylation_PRKAG2: -0.2413812301509555, Methylation_MICB: -1.3541335061133877, miRNA_hsa-mir-934: -0.160059176231974, miRNA_hsa-mir-4728: -0.6689179909256503, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.2709967340401908, miRNA_hsa-mir-190b: 0.8211655800754654, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.1251550881976287, miRNA_hsa-mir-2115: 0.007489711075219, miRNA_hsa-mir-17: -0.553279821962229, miRNA_hsa-mir-130b: 1.4895534430537003, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-GI-A2C9,"Low mRNA_MLPH, mRNA_ESR1, mRNA_AGR3, mRNA_GATA3, mRNA_AGR2, mRNA_PRR15, mRNA_SLC44A4, mRNA_DEGS2, mRNA_TFF3, mRNA_FBP1, mRNA_SLC7A8, and mRNA_ZNF552 (all Z < -1.92). High mRNA_FOXC1 (Z=1.55) and mRNA_PPP1R14C (Z=1.91); very high mRNA_EN1 (Z=1.98). Hypomethylation at RNF130 and LOC340090 promoters (Z < -1.47); hypermethylation at ARFGEF1, KCNQ4, and SIPA1L2 (Z > 1.50). Upregulated miR-934, miR-135b, and miR-17 (Z > 1.99); downregulated miR-190b (Z < -1.25). All CNVs normal (IGNORE).","mRNA_MLPH: -2.17632557550423, mRNA_C2orf54: -0.5035753599355607, mRNA_CITED4: 0.716931302526101, mRNA_ESR1: -1.7419434468030883, mRNA_SPDEF: -0.9763757681988006, mRNA_AGR3: -1.82227598759858, mRNA_FOXC1: 1.5501544113634778, mRNA_GATA3: -1.577762497955499, mRNA_AGR2: -1.7171505145970158, mRNA_XBP1: -1.488708784058518, mRNA_PRR15: -2.044867320643858, mRNA_SLC44A4: -1.8740072199995608, mRNA_CA12: -0.9012476637018778, mRNA_DTL: 0.0771574753225648, mRNA_C5AR2: -1.5346723931631776, mRNA_TBC1D9: -1.4370502746378246, mRNA_AR: -1.2639004719004738, mRNA_CCDC170: -0.873381150570645, mRNA_DEGS2: -1.8337355909168216, mRNA_TFF3: -1.791619216275734, mRNA_DNALI1: -1.5988054895792163, mRNA_LINC00504: -1.5698671162213544, mRNA_CLCA2: -0.8697158361446599, mRNA_PPP1R14C: 1.914484631820074, mRNA_THSD4: -0.984956552359682, mRNA_SPAG5: -0.0711677107331806, mRNA_FBP1: -2.130736874589636, mRNA_SLC7A8: -1.874412926064003, mRNA_EN1: 1.981187198504044, mRNA_ZNF552: -1.9688234081592149, Methylation_LRRC6: 1.491197151087136, Methylation_chr2 66218712 LINC02934 (29533): -1.0282671171034343, Methylation_HOXB13: 1.1643690903684116, Methylation_chr10 3949206 LINC02660 (4871): 0.9906103062329308, Methylation_chr5 179517140 RNF130 (18026): -1.6682817815859503, Methylation_LOC727677: 1.5194589949900668, Methylation_LETM1: 1.3242964926350522, Methylation_CDC42BPB: 1.3080445009295651, Methylation_C8orf38: 1.488453968340813, Methylation_chr14 100504766 EVL (18852): 1.4975930413751597, Methylation_chr5 72594851 LOC340090 (24088): -1.585286040937374, Methylation_chr2 242904738 LINC01238 (3421): 1.4263961133885048, Methylation_ARFGEF1: 1.784018732681523, Methylation_MAPT: 1.489628324762538, Methylation_ZFAT: 1.2679584152296004, Methylation_KCNQ4: 1.86885896553292, Methylation_chr1 232684368 SIPA1L2 (12934): 1.547870303086941, Methylation_CRNKL1: 1.3871732145803053, Methylation_PRKAG2: -1.5513195619802391, Methylation_MICB: 1.4839591195188206, miRNA_hsa-mir-934: 2.669476089133508, miRNA_hsa-mir-4728: 0.2740520149709424, miRNA_hsa-mir-5695: 0.547975379041625, miRNA_hsa-mir-18a: 1.1349986311475997, miRNA_hsa-mir-190b: -1.7107233814039895, miRNA_hsa-mir-577: 1.485374817119698, miRNA_hsa-mir-135b: 2.2671928353955484, miRNA_hsa-mir-2115: -0.1429388452193496, miRNA_hsa-mir-17: 1.576498017218786, miRNA_hsa-mir-130b: 1.297259201678706, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AO-A12E,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-significant ranges per specified Z-score and CNV cutoffs.","mRNA_MLPH: 0.3932161027802231, mRNA_C2orf54: 0.1250494654139307, mRNA_CITED4: 0.2204675036637361, mRNA_ESR1: 0.1455777520579531, mRNA_SPDEF: 0.5975010714944924, mRNA_AGR3: 0.7560456353323438, mRNA_FOXC1: 0.2935994906520249, mRNA_GATA3: 0.1261723127364591, mRNA_AGR2: 1.123308196498471, mRNA_XBP1: 0.0454085887768493, mRNA_PRR15: 0.7016605124677889, mRNA_SLC44A4: 0.7704206343159677, mRNA_CA12: 0.7040798631128455, mRNA_DTL: 0.8529685489745815, mRNA_C5AR2: 0.2742092021807567, mRNA_TBC1D9: 0.6001586222206491, mRNA_AR: 0.3534456752445927, mRNA_CCDC170: 0.5038233449503905, mRNA_DEGS2: -0.0371061795691819, mRNA_TFF3: 1.0999418309324154, mRNA_DNALI1: 0.6052448258237052, mRNA_LINC00504: 0.3098450885234702, mRNA_CLCA2: 0.254762835370845, mRNA_PPP1R14C: 0.5477220592262625, mRNA_THSD4: 0.6397926757374082, mRNA_SPAG5: 0.785272216018316, mRNA_FBP1: 0.5006500129833583, mRNA_SLC7A8: 0.7264504135591925, mRNA_EN1: -0.6509606506573734, mRNA_ZNF552: 0.901274580540484, Methylation_LRRC6: 0.0364045309634048, Methylation_chr2 66218712 LINC02934 (29533): 0.5110756462374023, Methylation_HOXB13: 1.615482357051012, Methylation_chr10 3949206 LINC02660 (4871): -0.031397057406327, Methylation_chr5 179517140 RNF130 (18026): 0.864708320452301, Methylation_LOC727677: 1.1146155508638986, Methylation_LETM1: -0.1462422660703441, Methylation_CDC42BPB: 1.0816547347532963, Methylation_C8orf38: 0.2208325815556298, Methylation_chr14 100504766 EVL (18852): -0.2137586066653495, Methylation_chr5 72594851 LOC340090 (24088): 0.9550606527135788, Methylation_chr2 242904738 LINC01238 (3421): -0.2446976118384886, Methylation_ARFGEF1: 0.2060644350112371, Methylation_MAPT: -0.3192651753063368, Methylation_ZFAT: 1.2689995780318113, Methylation_KCNQ4: -1.0467243493723744, Methylation_chr1 232684368 SIPA1L2 (12934): 0.0157727370174773, Methylation_CRNKL1: -0.1842773228296787, Methylation_PRKAG2: 1.2138878436315113, Methylation_MICB: -0.0068603505287535, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.517890441804564, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.6159469975523134, miRNA_hsa-mir-190b: 0.0632628211861267, miRNA_hsa-mir-577: -0.2576536265228125, miRNA_hsa-mir-135b: 0.5541030860030619, miRNA_hsa-mir-2115: 0.1791710835801301, miRNA_hsa-mir-17: -1.109495136208761, miRNA_hsa-mir-130b: -0.5009526247690124, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E2-A15J,LINC00504 mRNA overexpression (Z=1.56) indicates high expression. KCNQ4 promoter hypermethylation (Z=1.57) suggests epigenetic silencing. No miRNAs meet up/downregulation thresholds. All CNVs fall within normal range (−1.10 to −0.10). These features align with a luminal phenotype showing moderate transcriptional activation without genomic instability.,"mRNA_MLPH: 0.5788269622280532, mRNA_C2orf54: -0.0104929813840778, mRNA_CITED4: 0.7166008725583105, mRNA_ESR1: 0.0697078654878197, mRNA_SPDEF: 0.4596345653357875, mRNA_AGR3: 0.7620201880879538, mRNA_FOXC1: -1.080014548227022, mRNA_GATA3: 0.7293074227457249, mRNA_AGR2: -0.4556482618446315, mRNA_XBP1: 1.0454967992168158, mRNA_PRR15: 0.7964535535283443, mRNA_SLC44A4: 0.816883098967726, mRNA_CA12: 0.6350991175253425, mRNA_DTL: -0.5275538415386493, mRNA_C5AR2: 0.2188112339087363, mRNA_TBC1D9: 0.5667389858274292, mRNA_AR: 0.469680920215929, mRNA_CCDC170: 0.9361518828852612, mRNA_DEGS2: 0.1774704857257324, mRNA_TFF3: 0.1844054522045964, mRNA_DNALI1: 0.9120513108161744, mRNA_LINC00504: 1.5612029998432535, mRNA_CLCA2: -0.7828838758458911, mRNA_PPP1R14C: -0.974174815045978, mRNA_THSD4: 0.5186650463933016, mRNA_SPAG5: -0.1836527139010941, mRNA_FBP1: 0.0566964233964691, mRNA_SLC7A8: 0.6395305961893684, mRNA_EN1: -0.7307506126750022, mRNA_ZNF552: 0.366694779793657, Methylation_LRRC6: -1.5368217325846958, Methylation_chr2 66218712 LINC02934 (29533): 1.399722792540257, Methylation_HOXB13: -1.0081010744256338, Methylation_chr10 3949206 LINC02660 (4871): -1.348275960152119, Methylation_chr5 179517140 RNF130 (18026): 0.9616308055296308, Methylation_LOC727677: -1.3674261728591337, Methylation_LETM1: -0.8238122321065517, Methylation_CDC42BPB: -0.5687961505053469, Methylation_C8orf38: -1.4571060549654755, Methylation_chr14 100504766 EVL (18852): -1.485055484719921, Methylation_chr5 72594851 LOC340090 (24088): 1.3241166481713011, Methylation_chr2 242904738 LINC01238 (3421): -1.3528456611244075, Methylation_ARFGEF1: -1.4239316921175975, Methylation_MAPT: -1.4324544163221629, Methylation_ZFAT: 0.3089077910482389, Methylation_KCNQ4: 1.5746928994779636, Methylation_chr1 232684368 SIPA1L2 (12934): -1.423231685309961, Methylation_CRNKL1: -1.5040350018707749, Methylation_PRKAG2: 1.3420876249398592, Methylation_MICB: -1.264763559170211, miRNA_hsa-mir-934: -0.2320056471919432, miRNA_hsa-mir-4728: 0.2576246668278684, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.3683709022804737, miRNA_hsa-mir-190b: 1.344634590399219, miRNA_hsa-mir-577: -0.1913186321187074, miRNA_hsa-mir-135b: -0.5781197112870544, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.1511316657617905, miRNA_hsa-mir-130b: 0.7210974766587608, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A244,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. FOXC1, PPP1R14C, and EN1 show significant mRNA upregulation (Z > 1.30). AGR2, PRR15, TBC1D9, FBP1, and CA12 are transcriptionally downregulated (Z < -1.92). Promoter hypermethylation at ARFGEF1, C8orf38, LOC727677, and chr10:3949206 silences associated genes. miR-577, miR-135b, and miR-934 are upregulated; miR-190b is downregulated.","mRNA_MLPH: -2.778514494406401, mRNA_C2orf54: 0.8268372723153594, mRNA_CITED4: 1.002487446450484, mRNA_ESR1: -1.814021899322928, mRNA_SPDEF: -1.714542433154068, mRNA_AGR3: -1.822696660851248, mRNA_FOXC1: 2.7036583964121967, mRNA_GATA3: -0.9671954239064018, mRNA_AGR2: -1.996117755576881, mRNA_XBP1: -1.1444830416025873, mRNA_PRR15: -2.33505955087044, mRNA_SLC44A4: -1.028839067268985, mRNA_CA12: -1.950392923398868, mRNA_DTL: -0.0580264128959914, mRNA_C5AR2: -1.9715814519417203, mRNA_TBC1D9: -2.0341353004910343, mRNA_AR: -0.884527351106904, mRNA_CCDC170: -1.8175031500648755, mRNA_DEGS2: -1.699066519255416, mRNA_TFF3: -1.9647045626381563, mRNA_DNALI1: -1.75343753843262, mRNA_LINC00504: -1.6194687269174797, mRNA_CLCA2: -0.7582537412313652, mRNA_PPP1R14C: 2.2208841883730104, mRNA_THSD4: -0.9486628746035252, mRNA_SPAG5: 0.9716752506081374, mRNA_FBP1: -2.1949934828547644, mRNA_SLC7A8: -1.8419923807962344, mRNA_EN1: 2.6055463287150604, mRNA_ZNF552: -1.538080892117133, Methylation_LRRC6: 1.3682955268226946, Methylation_chr2 66218712 LINC02934 (29533): -1.028448338916135, Methylation_HOXB13: -1.0973173560616842, Methylation_chr10 3949206 LINC02660 (4871): 1.513458409596815, Methylation_chr5 179517140 RNF130 (18026): -1.5710397697266716, Methylation_LOC727677: 1.5262048762018472, Methylation_LETM1: 1.3673914551715007, Methylation_CDC42BPB: 1.2599992635725954, Methylation_C8orf38: 1.6200641176785868, Methylation_chr14 100504766 EVL (18852): 1.5220648085999593, Methylation_chr5 72594851 LOC340090 (24088): -0.4099973139429463, Methylation_chr2 242904738 LINC01238 (3421): 0.8658585024439516, Methylation_ARFGEF1: 1.7228585006051238, Methylation_MAPT: 1.4996566025265818, Methylation_ZFAT: 1.4232167240490765, Methylation_KCNQ4: 1.0867706906834074, Methylation_chr1 232684368 SIPA1L2 (12934): 1.516292648299759, Methylation_CRNKL1: 1.474340911292948, Methylation_PRKAG2: -0.5167951785410528, Methylation_MICB: 1.506296670044461, miRNA_hsa-mir-934: 2.453987617126141, miRNA_hsa-mir-4728: 0.1721619901830379, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.6828802958336029, miRNA_hsa-mir-190b: -1.8832004173670025, miRNA_hsa-mir-577: 3.7002014709692936, miRNA_hsa-mir-135b: 2.205146631565034, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.4756906670148402, miRNA_hsa-mir-130b: 1.4061947190199404, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-LL-A440,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.2126591615127949, mRNA_C2orf54: -1.1568057651104664, mRNA_CITED4: 0.2141776848747799, mRNA_ESR1: 0.2358551290206251, mRNA_SPDEF: 0.0035878997456761, mRNA_AGR3: 0.0227000931557554, mRNA_FOXC1: 0.5301726511833778, mRNA_GATA3: -0.2835138797311473, mRNA_AGR2: 0.2058088618106355, mRNA_XBP1: -0.0238042651435767, mRNA_PRR15: 0.0014589017085901, mRNA_SLC44A4: -0.5160923987395246, mRNA_CA12: 0.1891264273645704, mRNA_DTL: -1.0318237787914295, mRNA_C5AR2: -0.160493966013056, mRNA_TBC1D9: 0.3035187672193177, mRNA_AR: -0.0217899838401356, mRNA_CCDC170: 0.2089706139448207, mRNA_DEGS2: -0.0475621867411404, mRNA_TFF3: 0.6230366603859652, mRNA_DNALI1: 0.3869728476969015, mRNA_LINC00504: -0.1201846885574852, mRNA_CLCA2: 0.1767702188548033, mRNA_PPP1R14C: 0.1411461315831274, mRNA_THSD4: 0.3837570103931254, mRNA_SPAG5: -0.9260413023271804, mRNA_FBP1: 0.6783300327689813, mRNA_SLC7A8: 0.3283151845431967, mRNA_EN1: 0.4426905685468036, mRNA_ZNF552: -0.4774524393910906, Methylation_LRRC6: 1.2695151413434178, Methylation_chr2 66218712 LINC02934 (29533): 0.4745236818253856, Methylation_HOXB13: -1.0752053344667678, Methylation_chr10 3949206 LINC02660 (4871): 0.9602882839014638, Methylation_chr5 179517140 RNF130 (18026): -0.9648313702995852, Methylation_LOC727677: 0.900610315365703, Methylation_LETM1: 0.7213456162238846, Methylation_CDC42BPB: 0.2387656577577937, Methylation_C8orf38: 1.2506297795963164, Methylation_chr14 100504766 EVL (18852): 1.3287758374477778, Methylation_chr5 72594851 LOC340090 (24088): -0.3152175097959154, Methylation_chr2 242904738 LINC01238 (3421): 0.7117045045495517, Methylation_ARFGEF1: 1.448841571273647, Methylation_MAPT: 0.7334508539519389, Methylation_ZFAT: 0.9529827037860952, Methylation_KCNQ4: -0.9885160988823594, Methylation_chr1 232684368 SIPA1L2 (12934): 1.267921795447342, Methylation_CRNKL1: 0.8712549794709463, Methylation_PRKAG2: 0.3669282693520224, Methylation_MICB: 1.3395916156434784, miRNA_hsa-mir-934: 0.1560318868995591, miRNA_hsa-mir-4728: -0.6353477201612759, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.0168754627915791, miRNA_hsa-mir-190b: -0.6262399987604034, miRNA_hsa-mir-577: -0.5172381722261428, miRNA_hsa-mir-135b: 0.4034743660867534, miRNA_hsa-mir-2115: 0.4123282665708168, miRNA_hsa-mir-17: 0.10704204733255, miRNA_hsa-mir-130b: -1.0167504695830365, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E2-A1LK,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives genomic instability.  
EN1 mRNA overexpression (Z=3.44) and FOXC1 upregulation (Z=2.39) indicate basal-like transcriptional activity.  
Promoter hypermethylation of LRRC6, LINC02660, C8orf38, EVL, ARFGEF1, and KCNQ4 mediates epigenetic silencing.  
miR-577, miR-135b, and miR-934 upregulation (Z>1.99) suppresses luminal differentiation.  
Collectively, these features define a basal-like phenotype with ESR1 pathway suppression.","mRNA_MLPH: -2.9822234416464464, mRNA_C2orf54: -0.3269849667453468, mRNA_CITED4: 1.1980991039824769, mRNA_ESR1: -1.708379006271413, mRNA_SPDEF: -2.858503889811996, mRNA_AGR3: -1.999459153264132, mRNA_FOXC1: 2.386494861507185, mRNA_GATA3: -2.4119864110518496, mRNA_AGR2: -2.559400492015447, mRNA_XBP1: -2.5207822877495296, mRNA_PRR15: -2.5778500414811765, mRNA_SLC44A4: -2.4477688111153872, mRNA_CA12: -2.28417207881727, mRNA_DTL: -0.9113221489577004, mRNA_C5AR2: -1.7272944816741758, mRNA_TBC1D9: -2.020456675659996, mRNA_AR: -2.4997900495886127, mRNA_CCDC170: -2.01043878420475, mRNA_DEGS2: -1.0710709174533897, mRNA_TFF3: -2.2028415678951765, mRNA_DNALI1: -2.05953535863947, mRNA_LINC00504: -1.725934182837681, mRNA_CLCA2: -0.7200957403323799, mRNA_PPP1R14C: 1.381942254689484, mRNA_THSD4: -2.113070734236799, mRNA_SPAG5: 0.5016719070720567, mRNA_FBP1: -2.855639387513349, mRNA_SLC7A8: -1.827367183083856, mRNA_EN1: 3.4378454842923416, mRNA_ZNF552: -1.9041058716781365, Methylation_LRRC6: 1.5567461464049377, Methylation_chr2 66218712 LINC02934 (29533): -1.884397793474028, Methylation_HOXB13: 1.3268005024189828, Methylation_chr10 3949206 LINC02660 (4871): 1.5897068907034364, Methylation_chr5 179517140 RNF130 (18026): -1.6225380131943632, Methylation_LOC727677: 1.4924732128523572, Methylation_LETM1: 1.3694224605034837, Methylation_CDC42BPB: 1.3146232100227349, Methylation_C8orf38: 1.6880877412704196, Methylation_chr14 100504766 EVL (18852): 1.5641979375590391, Methylation_chr5 72594851 LOC340090 (24088): -1.6298202971231268, Methylation_chr2 242904738 LINC01238 (3421): 1.334394958183295, Methylation_ARFGEF1: 1.7364490239024146, Methylation_MAPT: 1.4776935061499152, Methylation_ZFAT: 1.2669201249329676, Methylation_KCNQ4: 1.8053816589897889, Methylation_chr1 232684368 SIPA1L2 (12934): 1.3630584559447163, Methylation_CRNKL1: 1.468819307929469, Methylation_PRKAG2: 0.9563212279398382, Methylation_MICB: 1.4951906403648554, miRNA_hsa-mir-934: 2.660784009818072, miRNA_hsa-mir-4728: 0.7532512426390722, miRNA_hsa-mir-5695: 1.0914576695758236, miRNA_hsa-mir-18a: 0.8601323666567865, miRNA_hsa-mir-190b: -2.052137242410604, miRNA_hsa-mir-577: 2.948271180016473, miRNA_hsa-mir-135b: 2.361683163087117, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.8072812922261509, miRNA_hsa-mir-130b: 1.5578403485987236, CNV_VPS54: 2.3735003872816955, CNV_LINC01867: 2.395394893874891, CNV_LINC02576: 2.464291317721031, CNV_WDPCP: 2.38809584879993, CNV_CEP68: 2.464291317721031"
TCGA-OL-A5RV,"No features meet the strict diagnostic thresholds for mRNA (Z > 1.30 or Z < -1.92), methylation (Z > 1.50 or Z < -1.47), miRNA (Z > 1.99 or Z < -1.25), or CNV (deletion, gain, amplification, or high-level amplification). All values fall within neutral ranges and are ignored per protocol.","mRNA_MLPH: 1.1258549243243905, mRNA_C2orf54: 1.1075435982343225, mRNA_CITED4: 0.7996842536503362, mRNA_ESR1: 0.4088657992735826, mRNA_SPDEF: 0.9192566535631094, mRNA_AGR3: 0.6732727643517612, mRNA_FOXC1: 0.1145030538977327, mRNA_GATA3: 0.2637473886701907, mRNA_AGR2: 0.7020855012262314, mRNA_XBP1: 0.8758814231858237, mRNA_PRR15: 0.9205115255228988, mRNA_SLC44A4: 0.3999381101225212, mRNA_CA12: 0.7332529842088727, mRNA_DTL: -0.2771162996780251, mRNA_C5AR2: 0.6686285894148861, mRNA_TBC1D9: 0.6942459370048657, mRNA_AR: 0.885779826037104, mRNA_CCDC170: 0.5163216626604666, mRNA_DEGS2: 0.3158241220804173, mRNA_TFF3: 1.219662427329448, mRNA_DNALI1: 0.9092569248430358, mRNA_LINC00504: 0.3383998649567574, mRNA_CLCA2: 1.3512295217678028, mRNA_PPP1R14C: 0.3163653438663582, mRNA_THSD4: 1.0513936707558995, mRNA_SPAG5: -0.7730357819940094, mRNA_FBP1: 0.7005576532542677, mRNA_SLC7A8: 0.6205503785559202, mRNA_EN1: -0.6041795785509828, mRNA_ZNF552: 0.5797741310074701, Methylation_LRRC6: 0.3126577021486538, Methylation_chr2 66218712 LINC02934 (29533): 0.0166498209694754, Methylation_HOXB13: -0.9429121744924268, Methylation_chr10 3949206 LINC02660 (4871): 0.1819385754713554, Methylation_chr5 179517140 RNF130 (18026): -0.4431378165357654, Methylation_LOC727677: -0.1524009229568159, Methylation_LETM1: 0.0816712801896728, Methylation_CDC42BPB: -0.7912907644064868, Methylation_C8orf38: -0.0756462461341245, Methylation_chr14 100504766 EVL (18852): 0.0449340606762062, Methylation_chr5 72594851 LOC340090 (24088): 0.3249391156732756, Methylation_chr2 242904738 LINC01238 (3421): -0.5831700545854215, Methylation_ARFGEF1: 0.5086154021958446, Methylation_MAPT: 0.0563083701578916, Methylation_ZFAT: 0.5570781110082109, Methylation_KCNQ4: 0.5671583174911111, Methylation_chr1 232684368 SIPA1L2 (12934): 0.0896269201594915, Methylation_CRNKL1: 0.6101613621932792, Methylation_PRKAG2: 0.4619519938802453, Methylation_MICB: 0.278126309773905, miRNA_hsa-mir-934: -0.3097889707977132, miRNA_hsa-mir-4728: -0.1045217515067862, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.6165836227094452, miRNA_hsa-mir-190b: 0.2159088428723604, miRNA_hsa-mir-577: -0.6152988350725332, miRNA_hsa-mir-135b: 0.1827780678707402, miRNA_hsa-mir-2115: 0.8755892544425775, miRNA_hsa-mir-17: 0.113322834048047, miRNA_hsa-mir-130b: -1.4796198742788915, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A1-A0SI,"High mRNA_C2orf54 (Z=1.75) and mRNA_CLCA2 (Z=3.43) indicate overexpression.  
No methylation sites meet hyper/hypo thresholds.  
miRNA_hsa-mir-17 downregulated (Z=-1.44).  
All CNVs fall within normal range (−1.10 to −0.10).  
These features suggest luminal transcriptional activity without genomic or epigenetic drivers.","mRNA_MLPH: 0.1679541669723838, mRNA_C2orf54: 1.7548890598108806, mRNA_CITED4: -0.1668788609359572, mRNA_ESR1: 0.0791205145244461, mRNA_SPDEF: 0.5008373152772257, mRNA_AGR3: -0.0354813623395467, mRNA_FOXC1: -0.2915905957228783, mRNA_GATA3: -0.0569156023364545, mRNA_AGR2: -0.2970519049502056, mRNA_XBP1: 0.1519102913187251, mRNA_PRR15: -0.1350205352374435, mRNA_SLC44A4: 0.6983200844302937, mRNA_CA12: 0.0823592898184229, mRNA_DTL: 1.4660690444137408, mRNA_C5AR2: -0.5040266411936553, mRNA_TBC1D9: 0.1419660599527353, mRNA_AR: 0.5702185815840105, mRNA_CCDC170: -0.1129752505664762, mRNA_DEGS2: 0.3922378701678954, mRNA_TFF3: -0.6531496908684016, mRNA_DNALI1: 0.2636491134449995, mRNA_LINC00504: 0.3678900388592637, mRNA_CLCA2: 3.434826687572062, mRNA_PPP1R14C: -0.7736524128281846, mRNA_THSD4: -0.6948178213719702, mRNA_SPAG5: -0.0208619261748038, mRNA_FBP1: 0.0435975949982643, mRNA_SLC7A8: 0.2037236160658173, mRNA_EN1: 0.3633038228449874, mRNA_ZNF552: -0.0753661780992933, Methylation_LRRC6: 0.3068590730005701, Methylation_chr2 66218712 LINC02934 (29533): -0.2995464819137848, Methylation_HOXB13: -1.0411976641712826, Methylation_chr10 3949206 LINC02660 (4871): 1.1576672351442152, Methylation_chr5 179517140 RNF130 (18026): 0.1247950256811337, Methylation_LOC727677: 0.1568214395789688, Methylation_LETM1: 1.1162488614351307, Methylation_CDC42BPB: -1.1041003882667213, Methylation_C8orf38: -0.1159796517858557, Methylation_chr14 100504766 EVL (18852): -0.0475181156921114, Methylation_chr5 72594851 LOC340090 (24088): 0.7297880059853381, Methylation_chr2 242904738 LINC01238 (3421): 0.3024154933043841, Methylation_ARFGEF1: -0.0832056638329212, Methylation_MAPT: 0.0079698003848603, Methylation_ZFAT: 0.5356181228016199, Methylation_KCNQ4: 0.5484251136956605, Methylation_chr1 232684368 SIPA1L2 (12934): -0.5135066510549463, Methylation_CRNKL1: 0.2505266662077182, Methylation_PRKAG2: -0.2679156649127026, Methylation_MICB: 1.2407771361055124, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.1222131336905964, miRNA_hsa-mir-5695: 1.1977418748310358, miRNA_hsa-mir-18a: -1.042960540360915, miRNA_hsa-mir-190b: -0.3560795685861821, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.0022725965020995, miRNA_hsa-mir-2115: 1.3961078392353403, miRNA_hsa-mir-17: -1.4379299963541812, miRNA_hsa-mir-130b: 0.3006629872848616, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A0TT,SPAG5 mRNA overexpression (Z=1.63) exceeds the high-expression threshold. No methylation or miRNA alterations meet diagnostic criteria. All CNVs fall within the normal range (−1.10 to −0.10). Isolated SPAG5 upregulation may indicate proliferative signaling activation.,"mRNA_MLPH: 0.0674682115052991, mRNA_C2orf54: -1.0713916850442624, mRNA_CITED4: -0.6573200611422827, mRNA_ESR1: 0.1308747347098346, mRNA_SPDEF: -0.0311999280512337, mRNA_AGR3: -0.827795106215091, mRNA_FOXC1: -0.8649590528387016, mRNA_GATA3: 0.5707808579766777, mRNA_AGR2: -0.9514019900049632, mRNA_XBP1: -0.1331526148342454, mRNA_PRR15: -0.0640602277705826, mRNA_SLC44A4: -1.5780241419926766, mRNA_CA12: -0.1198831669713381, mRNA_DTL: -0.3723670631212494, mRNA_C5AR2: 0.0534112434133286, mRNA_TBC1D9: 0.2933945984641651, mRNA_AR: -0.3562530424436873, mRNA_CCDC170: 0.189427496397339, mRNA_DEGS2: -0.0836954384094539, mRNA_TFF3: -0.7752813817922986, mRNA_DNALI1: 0.0172115844901436, mRNA_LINC00504: -0.8237821090639805, mRNA_CLCA2: -0.4591643295155976, mRNA_PPP1R14C: -0.8932682999444919, mRNA_THSD4: -0.0492988669545445, mRNA_SPAG5: 1.6319394026433955, mRNA_FBP1: 0.4067943767255342, mRNA_SLC7A8: -0.1784557063273205, mRNA_EN1: -0.2377676673867357, mRNA_ZNF552: 0.6281327321700688, Methylation_LRRC6: 0.8535827670606503, Methylation_chr2 66218712 LINC02934 (29533): 0.6533627938810143, Methylation_HOXB13: 0.955435885652658, Methylation_chr10 3949206 LINC02660 (4871): 0.0247833446666871, Methylation_chr5 179517140 RNF130 (18026): 0.0494094133255439, Methylation_LOC727677: 0.1910632922868372, Methylation_LETM1: 0.0988461209029971, Methylation_CDC42BPB: -0.0658516843684426, Methylation_C8orf38: -0.3511204196282511, Methylation_chr14 100504766 EVL (18852): 0.3710497943298507, Methylation_chr5 72594851 LOC340090 (24088): -0.1133525690727915, Methylation_chr2 242904738 LINC01238 (3421): 0.0553366840730737, Methylation_ARFGEF1: -0.7314276821025608, Methylation_MAPT: 0.5012011027877356, Methylation_ZFAT: 0.7107667245214362, Methylation_KCNQ4: 0.2703879929747922, Methylation_chr1 232684368 SIPA1L2 (12934): -0.2534409320093124, Methylation_CRNKL1: -0.3747526493526156, Methylation_PRKAG2: -0.4120862435386045, Methylation_MICB: -1.118656107109679, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.3332207499701826, miRNA_hsa-mir-190b: 0.9783488450345486, miRNA_hsa-mir-577: 0.1969893830098817, miRNA_hsa-mir-135b: 0.6728440478330332, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.5965467563531884, miRNA_hsa-mir-130b: 0.3039384811332372, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-EW-A3U0,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives genomic instability.  
FOXC1 and EN1 mRNA overexpression (Z = 1.96, 2.33) indicates basal-like activation.  
SPDEF, GATA3, AGR2, and DEGS2 mRNA downregulation (Z < -1.92) reflects luminal suppression.  
Promoter hypermethylation of ARFGEF1, EVL, and RNF130 (Z > 1.50 or < -1.47) mediates epigenetic silencing.  
These features collectively indicate a basal-like phenotype with luminal pathway suppression.","mRNA_MLPH: -1.787781597355098, mRNA_C2orf54: -1.119070576375389, mRNA_CITED4: -0.004103489599687, mRNA_ESR1: -1.8853348994064103, mRNA_SPDEF: -3.030934716541608, mRNA_AGR3: -1.9012165541199253, mRNA_FOXC1: 1.963387582601426, mRNA_GATA3: -2.1062924996642374, mRNA_AGR2: -2.1414152816861707, mRNA_XBP1: -1.497423844001243, mRNA_PRR15: -1.5716152879204497, mRNA_SLC44A4: -1.5706377983628952, mRNA_CA12: -1.891619263396742, mRNA_DTL: 0.2326399510734037, mRNA_C5AR2: -1.2569852618386324, mRNA_TBC1D9: -1.2945669239012672, mRNA_AR: -1.4233757051765317, mRNA_CCDC170: -1.3524901030120149, mRNA_DEGS2: -2.1597111191966705, mRNA_TFF3: -1.846766361469588, mRNA_DNALI1: -0.2247436005192507, mRNA_LINC00504: -1.6888104631141525, mRNA_CLCA2: -0.7904991749583782, mRNA_PPP1R14C: 0.8518136859694898, mRNA_THSD4: -1.7621603800694274, mRNA_SPAG5: 0.356926209420927, mRNA_FBP1: -0.5520003998319258, mRNA_SLC7A8: -1.4992417694244349, mRNA_EN1: 2.330571308606744, mRNA_ZNF552: -1.4916177809073017, Methylation_LRRC6: 1.4613805483317337, Methylation_chr2 66218712 LINC02934 (29533): -0.063780839210062, Methylation_HOXB13: -1.067849297536022, Methylation_chr10 3949206 LINC02660 (4871): 1.2511840881230725, Methylation_chr5 179517140 RNF130 (18026): -1.6349264171220084, Methylation_LOC727677: 1.493458236038989, Methylation_LETM1: 1.3068542317297624, Methylation_CDC42BPB: -0.0153067499804773, Methylation_C8orf38: 1.0402679890484938, Methylation_chr14 100504766 EVL (18852): 1.5267571626885896, Methylation_chr5 72594851 LOC340090 (24088): -1.419200355326004, Methylation_chr2 242904738 LINC01238 (3421): 0.2063061606123396, Methylation_ARFGEF1: 1.6422318958487212, Methylation_MAPT: 1.4954183258500398, Methylation_ZFAT: 1.466966871912794, Methylation_KCNQ4: 0.3054268946349493, Methylation_chr1 232684368 SIPA1L2 (12934): 1.4936064068117154, Methylation_CRNKL1: 1.4170167215706977, Methylation_PRKAG2: -0.0310596519732295, Methylation_MICB: 1.4930006532650852, miRNA_hsa-mir-934: 2.700831490347601, miRNA_hsa-mir-4728: -1.1012290509779097, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.0021283037063264, miRNA_hsa-mir-190b: -1.3477186926542777, miRNA_hsa-mir-577: 1.438731490345769, miRNA_hsa-mir-135b: 2.100747952710439, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.9783313048365054, miRNA_hsa-mir-130b: 1.1594564187734924, CNV_VPS54: 3.3712233045701687, CNV_LINC01867: 3.403528716117201, CNV_LINC02576: 3.494626341568657, CNV_WDPCP: 3.3913533508092364, CNV_CEP68: 3.494626341568657"
TCGA-C8-A26Z,"mRNA_CITED4 is low (Z = -2.08). mRNA_ESR1, THSD4, and ZNF552 are high (Z > 1.30). Methylation_PRKAG2, MAPT, ZFAT, LETM1, and MICB are hypo-methylated (Z < -1.47). No miRNAs meet dysregulation thresholds. All CNVs fall within normal/gain range—no deletions or amplifications. ESR1 overexpression suggests luminal subtype with estrogen signaling activation.","mRNA_MLPH: 0.5476809664213819, mRNA_C2orf54: -0.6545383159064643, mRNA_CITED4: -2.076880084012279, mRNA_ESR1: 1.593573948157231, mRNA_SPDEF: 0.7867138216252371, mRNA_AGR3: 1.078286846440804, mRNA_FOXC1: -0.7813528694015045, mRNA_GATA3: 0.5058066792378164, mRNA_AGR2: 0.8645334034658227, mRNA_XBP1: 0.9190377301896412, mRNA_PRR15: 0.6806925798331738, mRNA_SLC44A4: 0.2398567230884032, mRNA_CA12: 0.8439824305331688, mRNA_DTL: 0.0657281965644726, mRNA_C5AR2: -0.0800499654069824, mRNA_TBC1D9: 1.263733317418594, mRNA_AR: 1.023045164884151, mRNA_CCDC170: 0.7816114716040092, mRNA_DEGS2: -0.4606964657615024, mRNA_TFF3: 1.2139827186033554, mRNA_DNALI1: 0.6847838372091666, mRNA_LINC00504: 0.515109098097951, mRNA_CLCA2: -0.7942821285990497, mRNA_PPP1R14C: -0.8407295240097792, mRNA_THSD4: 1.6605633555477932, mRNA_SPAG5: 0.3189374526494433, mRNA_FBP1: 0.8351825078116205, mRNA_SLC7A8: 0.7300562169856112, mRNA_EN1: -0.695605376960454, mRNA_ZNF552: 1.2779639181248534, Methylation_LRRC6: -1.344678749142218, Methylation_chr2 66218712 LINC02934 (29533): -1.878459854136733, Methylation_HOXB13: -1.0774305261179298, Methylation_chr10 3949206 LINC02660 (4871): -1.3501082261351094, Methylation_chr5 179517140 RNF130 (18026): 1.1882386408291652, Methylation_LOC727677: -1.2700332583143363, Methylation_LETM1: -1.547379262709208, Methylation_CDC42BPB: 1.3522679430757027, Methylation_C8orf38: -0.0968891561497897, Methylation_chr14 100504766 EVL (18852): -1.3258678583416652, Methylation_chr5 72594851 LOC340090 (24088): -0.5097904001151586, Methylation_chr2 242904738 LINC01238 (3421): -0.8527735289447912, Methylation_ARFGEF1: -1.2376298518951645, Methylation_MAPT: -1.5973287167369956, Methylation_ZFAT: -1.5757660269567964, Methylation_KCNQ4: 0.9020437494494778, Methylation_chr1 232684368 SIPA1L2 (12934): -1.2559581176668175, Methylation_CRNKL1: -1.2347189807089982, Methylation_PRKAG2: -1.6801057749747683, Methylation_MICB: -1.479240925021519, miRNA_hsa-mir-934: 0.0028917303313072, miRNA_hsa-mir-4728: -0.2979171742866845, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.1397046663827477, miRNA_hsa-mir-190b: 0.7305576891420241, miRNA_hsa-mir-577: -0.5783225076711594, miRNA_hsa-mir-135b: -0.7502420879685432, miRNA_hsa-mir-2115: 1.3617996222484383, miRNA_hsa-mir-17: -1.1768754964104493, miRNA_hsa-mir-130b: 0.007891204847322, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-AC-A2QJ,"ESR1, GATA3, SPDEF, and AR mRNA are significantly downregulated (Z < -1.92). Promoter hypermethylation (Z > 1.50) of ARFGEF1, C8orf38, and SIPA1L2 suggests epigenetic silencing. No high-level amplifications or deletions detected. miRNA alterations do not meet dysregulation thresholds. Collectively indicates luminal A-like phenotype with hormone signaling suppression.","mRNA_MLPH: -1.5940294366227388, mRNA_C2orf54: -0.5430385038432015, mRNA_CITED4: -0.0235739320165218, mRNA_ESR1: -2.020670396497305, mRNA_SPDEF: -2.673410943754812, mRNA_AGR3: -1.999720578249515, mRNA_FOXC1: 0.0960088327065245, mRNA_GATA3: -2.971842415677923, mRNA_AGR2: -1.5336368643399103, mRNA_XBP1: -2.8055488811347544, mRNA_PRR15: -2.067208627083614, mRNA_SLC44A4: -2.163423703455343, mRNA_CA12: -1.348996687332775, mRNA_DTL: -1.825545387838391, mRNA_C5AR2: -0.9895440571279264, mRNA_TBC1D9: -2.103378041147702, mRNA_AR: -2.2791021812979686, mRNA_CCDC170: -1.382410268983539, mRNA_DEGS2: -1.2198419046443776, mRNA_TFF3: -2.011603462024056, mRNA_DNALI1: -1.7838329221849862, mRNA_LINC00504: -1.565583620819243, mRNA_CLCA2: 0.644082066257964, mRNA_PPP1R14C: 0.6390335134895399, mRNA_THSD4: -2.314545262215704, mRNA_SPAG5: -0.6991830793286808, mRNA_FBP1: -1.952016210816084, mRNA_SLC7A8: -0.3250567789694461, mRNA_EN1: 1.095238094723639, mRNA_ZNF552: -2.8372526212539304, Methylation_LRRC6: 1.5329564058101155, Methylation_chr2 66218712 LINC02934 (29533): -0.6771710610926988, Methylation_HOXB13: 0.2170720334881592, Methylation_chr10 3949206 LINC02660 (4871): 1.5285115372570073, Methylation_chr5 179517140 RNF130 (18026): -1.6914976119690848, Methylation_LOC727677: 1.471477422275853, Methylation_LETM1: 1.3052143482640473, Methylation_CDC42BPB: 0.430757030415077, Methylation_C8orf38: 1.6727076659318147, Methylation_chr14 100504766 EVL (18852): 1.503914733817579, Methylation_chr5 72594851 LOC340090 (24088): 0.6786417431603408, Methylation_chr2 242904738 LINC01238 (3421): 1.40684635344123, Methylation_ARFGEF1: 1.8646839360428071, Methylation_MAPT: 1.3947297838516584, Methylation_ZFAT: 1.1752296603279948, Methylation_KCNQ4: -1.2020779055592758, Methylation_chr1 232684368 SIPA1L2 (12934): 1.6247599656158764, Methylation_CRNKL1: 1.462547164386354, Methylation_PRKAG2: -1.3742627957839113, Methylation_MICB: 1.3399024482008055, miRNA_hsa-mir-934: 0.3417537500442957, miRNA_hsa-mir-4728: -0.568331722225974, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.2263733602693095, miRNA_hsa-mir-190b: -1.5456374696313913, miRNA_hsa-mir-577: -0.4890308237507327, miRNA_hsa-mir-135b: 0.1536354959930804, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.2492087564467296, miRNA_hsa-mir-130b: 1.1041697790464762, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-LD-A7W6,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.9917919110378952, mRNA_C2orf54: 0.1094219604649765, mRNA_CITED4: 1.2466861354773828, mRNA_ESR1: 0.5755260369302054, mRNA_SPDEF: 0.5756182459771296, mRNA_AGR3: 0.4551083004740098, mRNA_FOXC1: 0.1476031876651999, mRNA_GATA3: 0.8293262134626169, mRNA_AGR2: 0.9855471090406795, mRNA_XBP1: 0.7990640248834395, mRNA_PRR15: 0.6571054843072558, mRNA_SLC44A4: 0.6531939696165242, mRNA_CA12: 0.9436234362568304, mRNA_DTL: 0.2468572395659685, mRNA_C5AR2: 1.0667186990343966, mRNA_TBC1D9: 0.8223139290406664, mRNA_AR: 0.6229768866797218, mRNA_CCDC170: 0.6140443491977537, mRNA_DEGS2: 1.1820349297782011, mRNA_TFF3: 0.4992297561179993, mRNA_DNALI1: 0.8099282591608855, mRNA_LINC00504: 0.5389177047356718, mRNA_CLCA2: -0.6202692994915336, mRNA_PPP1R14C: -0.0377759395150714, mRNA_THSD4: 1.0677584456720304, mRNA_SPAG5: 0.265524266409487, mRNA_FBP1: 0.5234387846638063, mRNA_SLC7A8: 0.6151502182361254, mRNA_EN1: -0.7696675197243983, mRNA_ZNF552: 1.300385352920966, Methylation_LRRC6: -0.4254892979151657, Methylation_chr2 66218712 LINC02934 (29533): 0.1876244704999912, Methylation_HOXB13: -0.979133534508548, Methylation_chr10 3949206 LINC02660 (4871): -0.7397117179283551, Methylation_chr5 179517140 RNF130 (18026): 0.9121709015519084, Methylation_LOC727677: -0.6179503871493685, Methylation_LETM1: -0.5900410410397839, Methylation_CDC42BPB: -0.6957358692365406, Methylation_C8orf38: -0.4926872764886333, Methylation_chr14 100504766 EVL (18852): -0.4301281256383359, Methylation_chr5 72594851 LOC340090 (24088): 0.5783855652525424, Methylation_chr2 242904738 LINC01238 (3421): -0.7982892072700979, Methylation_ARFGEF1: -0.2997947577336035, Methylation_MAPT: -0.7950281957891517, Methylation_ZFAT: -0.4764808822957636, Methylation_KCNQ4: -0.9815765073741004, Methylation_chr1 232684368 SIPA1L2 (12934): -0.3798133366693019, Methylation_CRNKL1: -0.4244933329929172, Methylation_PRKAG2: 0.0690548152535318, Methylation_MICB: -0.266273727810171, miRNA_hsa-mir-934: -0.1117247051326099, miRNA_hsa-mir-4728: -0.6828206400336033, miRNA_hsa-mir-5695: 0.984622645443872, miRNA_hsa-mir-18a: -0.7882273576373973, miRNA_hsa-mir-190b: 0.251068666968539, miRNA_hsa-mir-577: -0.5195963318400649, miRNA_hsa-mir-135b: -0.3879245179523821, miRNA_hsa-mir-2115: -0.6116477298338969, miRNA_hsa-mir-17: -0.3644252322341119, miRNA_hsa-mir-130b: -0.9541740783315712, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A1JS,"High-level Amplification of none; no CNV meets amplification thresholds.  
mRNA_DTL shows low expression (Z = -2.00).  
No mRNA exceeds Z > 1.30 for high expression.  
Methylation_chr10:3949206 and PRKAG2 are hypermethylated (Z > 1.50).  
Multiple loci (e.g., LRRC6, MAPT) are hypomethylated (Z < -1.47).  
No miRNA passes up/downregulation thresholds.  
Collectively indicates epigenetically silenced tumor suppressor phenotype with DNA repair dysregulation.","mRNA_MLPH: 1.1845729761722832, mRNA_C2orf54: 0.8036153439789913, mRNA_CITED4: 0.1242727984482017, mRNA_ESR1: 0.6053999769144462, mRNA_SPDEF: 0.9630941130650276, mRNA_AGR3: 0.9058301705976286, mRNA_FOXC1: -1.318031251769485, mRNA_GATA3: 0.5635418462979233, mRNA_AGR2: 1.233936667405692, mRNA_XBP1: 1.7696068989855167, mRNA_PRR15: 0.2208623695199998, mRNA_SLC44A4: 1.0842633127980668, mRNA_CA12: 0.6241659307991129, mRNA_DTL: -2.0018356880533235, mRNA_C5AR2: 1.033749688736594, mRNA_TBC1D9: 0.4062751220393902, mRNA_AR: -0.0096409072312553, mRNA_CCDC170: 1.075819994898147, mRNA_DEGS2: 1.2848689036049648, mRNA_TFF3: 1.660786990453471, mRNA_DNALI1: 1.0153499221176068, mRNA_LINC00504: 0.0967170466542059, mRNA_CLCA2: -0.7054927693700124, mRNA_PPP1R14C: -1.1632488817667417, mRNA_THSD4: 0.1496140072043596, mRNA_SPAG5: -1.3735434166122786, mRNA_FBP1: 0.5088215015261636, mRNA_SLC7A8: 0.2912244438731666, mRNA_EN1: 1.559908113856628, mRNA_ZNF552: 1.1949840351206462, Methylation_LRRC6: -1.551845365134509, Methylation_chr2 66218712 LINC02934 (29533): -1.7236596733055662, Methylation_HOXB13: -1.04956840788084, Methylation_chr10 3949206 LINC02660 (4871): 1.6472208290303798, Methylation_chr5 179517140 RNF130 (18026): 1.2559191442043356, Methylation_LOC727677: -1.5631691315903364, Methylation_LETM1: -1.50092671655994, Methylation_CDC42BPB: -1.469603385568751, Methylation_C8orf38: -1.116715485358425, Methylation_chr14 100504766 EVL (18852): -1.632690738038752, Methylation_chr5 72594851 LOC340090 (24088): 1.17870629951513, Methylation_chr2 242904738 LINC01238 (3421): -1.5425879398331523, Methylation_ARFGEF1: -1.214177140591726, Methylation_MAPT: -1.6840016344033928, Methylation_ZFAT: -0.0384534718402267, Methylation_KCNQ4: -1.206559232101283, Methylation_chr1 232684368 SIPA1L2 (12934): -1.6291735533998517, Methylation_CRNKL1: -1.58823704130761, Methylation_PRKAG2: 1.3235726923092226, Methylation_MICB: -1.479097104507408, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.4592818989137314, miRNA_hsa-mir-5695: 1.5017809807847506, miRNA_hsa-mir-18a: -0.949093160034339, miRNA_hsa-mir-190b: 1.2956926919214995, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.8849592368035206, miRNA_hsa-mir-2115: 0.2549454099656174, miRNA_hsa-mir-17: -1.0325053423452666, miRNA_hsa-mir-130b: 0.2017535353752441, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E2-A1BD,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives genomic instability. HOXB13 promoter hypermethylation (Z=1.77) suggests epigenetic silencing. CRNKL1 is hypo-methylated (Z=-1.51), potentially activating oncogenic splicing. No mRNA or miRNA alterations meet diagnostic thresholds.","mRNA_MLPH: 0.6428577450854621, mRNA_C2orf54: 0.0520136616787661, mRNA_CITED4: 1.2528835741158637, mRNA_ESR1: 0.6269295911203281, mRNA_SPDEF: 0.705273765462941, mRNA_AGR3: 0.6298737530639419, mRNA_FOXC1: -0.0321181403663472, mRNA_GATA3: 0.4599947617236554, mRNA_AGR2: 0.5493808222456944, mRNA_XBP1: 0.3622122878370228, mRNA_PRR15: 0.4259214147473402, mRNA_SLC44A4: 0.5724335818606235, mRNA_CA12: 0.5679506340131847, mRNA_DTL: 0.2411136638761381, mRNA_C5AR2: -0.098607137316777, mRNA_TBC1D9: 0.0214767805445883, mRNA_AR: 0.8468575385075399, mRNA_CCDC170: 0.5547936430327765, mRNA_DEGS2: 0.8051101896927425, mRNA_TFF3: -0.1753244671346786, mRNA_DNALI1: 0.8746896538161533, mRNA_LINC00504: 0.1062556042156768, mRNA_CLCA2: -0.1813944819285837, mRNA_PPP1R14C: -0.3207291175747798, mRNA_THSD4: 0.2924583781708115, mRNA_SPAG5: -0.2558275749687475, mRNA_FBP1: -0.0147350045307879, mRNA_SLC7A8: 0.5865069525717026, mRNA_EN1: -0.7534955370375739, mRNA_ZNF552: 0.1725520182421142, Methylation_LRRC6: -1.1519149600143106, Methylation_chr2 66218712 LINC02934 (29533): 1.140971010028944, Methylation_HOXB13: 1.772781158426607, Methylation_chr10 3949206 LINC02660 (4871): -1.208880073781547, Methylation_chr5 179517140 RNF130 (18026): 1.2041477704384516, Methylation_LOC727677: -0.5870244024689971, Methylation_LETM1: -0.7898552573033845, Methylation_CDC42BPB: -1.30394704326168, Methylation_C8orf38: -1.1634767216785094, Methylation_chr14 100504766 EVL (18852): -1.0341438845061182, Methylation_chr5 72594851 LOC340090 (24088): 1.2950381256216397, Methylation_chr2 242904738 LINC01238 (3421): -1.0443107360462354, Methylation_ARFGEF1: -1.142719399472352, Methylation_MAPT: -1.1865204898648238, Methylation_ZFAT: -0.7934857281833197, Methylation_KCNQ4: 0.8491794310377537, Methylation_chr1 232684368 SIPA1L2 (12934): -0.832933453907179, Methylation_CRNKL1: -1.5142163991037378, Methylation_PRKAG2: 1.2822717416804044, Methylation_MICB: -1.034436697780187, miRNA_hsa-mir-934: -0.4282471323745696, miRNA_hsa-mir-4728: -0.852176512929531, miRNA_hsa-mir-5695: -0.1234381275181741, miRNA_hsa-mir-18a: -0.1315601309801096, miRNA_hsa-mir-190b: 0.7587415839697926, miRNA_hsa-mir-577: -0.1102308280965397, miRNA_hsa-mir-135b: -0.443713374872127, miRNA_hsa-mir-2115: -0.2008303918725087, miRNA_hsa-mir-17: -0.0571202946910712, miRNA_hsa-mir-130b: -0.5708968108453402, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-EW-A1J3,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.3023060447319758, mRNA_C2orf54: -1.1973873855002126, mRNA_CITED4: 0.2497940519060824, mRNA_ESR1: 0.4926705628985692, mRNA_SPDEF: -0.0728956575502983, mRNA_AGR3: 1.023562479576919, mRNA_FOXC1: -0.5266386902751644, mRNA_GATA3: 0.6185320099133659, mRNA_AGR2: 0.7220290133294851, mRNA_XBP1: 0.7325931287937132, mRNA_PRR15: 0.4337827254029349, mRNA_SLC44A4: 0.7122675104403229, mRNA_CA12: 0.8001142811618036, mRNA_DTL: 1.9072063746051025, mRNA_C5AR2: 0.0284260461204212, mRNA_TBC1D9: 0.5080705543607033, mRNA_AR: 0.6858191621416647, mRNA_CCDC170: 0.9287461462016028, mRNA_DEGS2: -0.1704163257554498, mRNA_TFF3: 0.4474030707508715, mRNA_DNALI1: 0.7766536323493571, mRNA_LINC00504: 0.4094978126041354, mRNA_CLCA2: 1.744973688707039, mRNA_PPP1R14C: 0.2456179762347396, mRNA_THSD4: 0.4913417405308989, mRNA_SPAG5: 0.8902064254408009, mRNA_FBP1: -0.0385422962928957, mRNA_SLC7A8: 1.20016286541999, mRNA_EN1: -0.5048937045029536, mRNA_ZNF552: 0.6259100250628923, Methylation_LRRC6: -0.3686962942188451, Methylation_chr2 66218712 LINC02934 (29533): 0.5238627767906983, Methylation_HOXB13: -0.849097993268287, Methylation_chr10 3949206 LINC02660 (4871): -0.7114647085685736, Methylation_chr5 179517140 RNF130 (18026): 0.5921150156077153, Methylation_LOC727677: -0.9223834704764036, Methylation_LETM1: -1.1625921037717049, Methylation_CDC42BPB: -0.1157815655972897, Methylation_C8orf38: -0.8907813184240497, Methylation_chr14 100504766 EVL (18852): -1.1271306857519634, Methylation_chr5 72594851 LOC340090 (24088): 1.10232852676999, Methylation_chr2 242904738 LINC01238 (3421): -1.0756159336029825, Methylation_ARFGEF1: -0.8330501200954736, Methylation_MAPT: -1.1662784529597, Methylation_ZFAT: -1.0311886723270456, Methylation_KCNQ4: -1.2631218127373451, Methylation_chr1 232684368 SIPA1L2 (12934): -1.5093444961503466, Methylation_CRNKL1: -1.327334773156818, Methylation_PRKAG2: 1.2076070207686582, Methylation_MICB: -0.9586018709002042, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 1.7909076161873994, miRNA_hsa-mir-5695: 1.4497685078289078, miRNA_hsa-mir-18a: 0.0707068838420208, miRNA_hsa-mir-190b: 1.1295645089966864, miRNA_hsa-mir-577: -0.4467380951983691, miRNA_hsa-mir-135b: 0.0875617500003326, miRNA_hsa-mir-2115: -0.1491801274723891, miRNA_hsa-mir-17: -0.0758467035771076, miRNA_hsa-mir-130b: 0.873805464632351, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-GM-A2DM,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.7196008476447024, mRNA_C2orf54: -1.175724695656709, mRNA_CITED4: -0.5388300364944882, mRNA_ESR1: 0.5458016137044006, mRNA_SPDEF: 0.2708694328050357, mRNA_AGR3: 0.6137501347424844, mRNA_FOXC1: -0.0405172499696312, mRNA_GATA3: 1.12195120268214, mRNA_AGR2: 0.145405123269075, mRNA_XBP1: 1.1505184880025443, mRNA_PRR15: 1.205856848090301, mRNA_SLC44A4: 0.8493924947393099, mRNA_CA12: 0.8820517708247649, mRNA_DTL: -1.757473405839193, mRNA_C5AR2: 1.111013546950345, mRNA_TBC1D9: 1.20231681286071, mRNA_AR: 0.4161834520783706, mRNA_CCDC170: 0.9440873240155732, mRNA_DEGS2: 0.6807263125191692, mRNA_TFF3: 1.1633035029153724, mRNA_DNALI1: 1.041261705321262, mRNA_LINC00504: 1.941439634554012, mRNA_CLCA2: -0.8305407919646643, mRNA_PPP1R14C: -0.2054104625817602, mRNA_THSD4: 0.8130989785012319, mRNA_SPAG5: -1.5837997855210295, mRNA_FBP1: 0.629772116143357, mRNA_SLC7A8: 0.6034693844587472, mRNA_EN1: -0.7600793595700509, mRNA_ZNF552: 0.7390353617928775, Methylation_LRRC6: -0.4823937109692577, Methylation_chr2 66218712 LINC02934 (29533): 0.0759138466794228, Methylation_HOXB13: -1.058248098547503, Methylation_chr10 3949206 LINC02660 (4871): 0.344198952725346, Methylation_chr5 179517140 RNF130 (18026): -1.6405976589710365, Methylation_LOC727677: -0.8888663787632729, Methylation_LETM1: -1.0101268821789562, Methylation_CDC42BPB: -1.3604522732612292, Methylation_C8orf38: -0.2634131640640051, Methylation_chr14 100504766 EVL (18852): -0.9230232271639996, Methylation_chr5 72594851 LOC340090 (24088): -1.2474223417814656, Methylation_chr2 242904738 LINC01238 (3421): -0.9034086137122548, Methylation_ARFGEF1: 0.55506766307187, Methylation_MAPT: -0.8010090603855256, Methylation_ZFAT: -0.999376091306987, Methylation_KCNQ4: -1.1559378155535365, Methylation_chr1 232684368 SIPA1L2 (12934): -0.4196857731823205, Methylation_CRNKL1: -0.8456137562851944, Methylation_PRKAG2: -0.7265774746521049, Methylation_MICB: -1.2453984381743428, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.5870707712642702, miRNA_hsa-mir-5695: 0.0010484205426624, miRNA_hsa-mir-18a: 0.4682823041814164, miRNA_hsa-mir-190b: 0.5855690999193673, miRNA_hsa-mir-577: -0.5745282814870215, miRNA_hsa-mir-135b: -1.081123082812702, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.3784103914170034, miRNA_hsa-mir-130b: -0.4425853502954557, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-EW-A423,"High mRNA_CITED4 (Z=1.41) and mRNA_TFF3 (Z=1.34) indicate overexpression. Methylation_HOXB13 hypermethylation (Z=1.43) and Methylation_CDC42BPB hypermethylation (Z=1.34) suggest epigenetic silencing. Methylation_MICB (Z=-1.60), Methylation_SIPA1L2 (Z=-1.57), and Methylation_CRNKL1 (Z=-1.42) are hypomethylated. miRNA_hsa-mir-190b upregulated (Z=1.45). All CNVs fall within normal range (IGNORE). These features collectively indicate a luminal phenotype with HOX pathway dysregulation.","mRNA_MLPH: 0.8012351655496893, mRNA_C2orf54: 1.0638696390229474, mRNA_CITED4: 1.4119543015205775, mRNA_ESR1: 0.770506860818699, mRNA_SPDEF: 1.000985421777641, mRNA_AGR3: 0.9916227141184836, mRNA_FOXC1: -1.0429485187241538, mRNA_GATA3: 0.4775106151220101, mRNA_AGR2: 0.4908308877086104, mRNA_XBP1: 0.7917499870205085, mRNA_PRR15: 0.8158059277095995, mRNA_SLC44A4: 0.8490074624158719, mRNA_CA12: 0.5117394123612673, mRNA_DTL: -0.437983969965001, mRNA_C5AR2: 0.6188095494809567, mRNA_TBC1D9: -0.0318922284698003, mRNA_AR: 0.1812269999059232, mRNA_CCDC170: 0.0844264113655257, mRNA_DEGS2: 0.8249563439735189, mRNA_TFF3: 1.3429226384174593, mRNA_DNALI1: 1.02926631038425, mRNA_LINC00504: -0.3593206460298032, mRNA_CLCA2: -0.8752078747948274, mRNA_PPP1R14C: -0.950075913352774, mRNA_THSD4: 0.5545924587879766, mRNA_SPAG5: -0.2541624779048659, mRNA_FBP1: 0.1908707148510865, mRNA_SLC7A8: -0.3394434613213377, mRNA_EN1: -0.6949639597132896, mRNA_ZNF552: 0.6758690667020477, Methylation_LRRC6: -0.5434236014819097, Methylation_chr2 66218712 LINC02934 (29533): 0.5153967026616035, Methylation_HOXB13: 1.4288393688870906, Methylation_chr10 3949206 LINC02660 (4871): -1.1833797349868014, Methylation_chr5 179517140 RNF130 (18026): -0.5411006253327312, Methylation_LOC727677: -1.0042815793425148, Methylation_LETM1: -1.3609647378786334, Methylation_CDC42BPB: 1.3358700167667603, Methylation_C8orf38: -0.3553248174931192, Methylation_chr14 100504766 EVL (18852): -1.0796819754994973, Methylation_chr5 72594851 LOC340090 (24088): 0.2225985770327195, Methylation_chr2 242904738 LINC01238 (3421): -1.113539906165831, Methylation_ARFGEF1: -0.9201949671996162, Methylation_MAPT: -1.3709603460497386, Methylation_ZFAT: -1.128826411459778, Methylation_KCNQ4: 0.6745766268222069, Methylation_chr1 232684368 SIPA1L2 (12934): -1.5668227493537463, Methylation_CRNKL1: -1.4246679357860867, Methylation_PRKAG2: -1.3512183932711488, Methylation_MICB: -1.5985885963362425, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.3509812501439175, miRNA_hsa-mir-5695: 1.0463135593877213, miRNA_hsa-mir-18a: -0.0220417718082715, miRNA_hsa-mir-190b: 1.4517776140564136, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.2247638447336312, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.2716707453089015, miRNA_hsa-mir-130b: -0.7353371675048462, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-GM-A3NW,"High-level Amplification of VPS54, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. No mRNA, methylation, or miRNA alterations meet diagnostic thresholds for significant dysregulation. These features indicate a proliferation-driven phenotype with vesicular trafficking and centrosomal pathway dysregulation.","mRNA_MLPH: 1.2000132768284135, mRNA_C2orf54: -1.1964312186913362, mRNA_CITED4: -0.1504529687691951, mRNA_ESR1: 0.3228153292450519, mRNA_SPDEF: 0.6258053524701048, mRNA_AGR3: 0.4113377380991613, mRNA_FOXC1: -0.3331335507503561, mRNA_GATA3: 0.5785967838350377, mRNA_AGR2: 0.4750512443935439, mRNA_XBP1: 0.9457111120093004, mRNA_PRR15: 1.6916834115109898, mRNA_SLC44A4: 0.4301763239601947, mRNA_CA12: 0.9447693500839268, mRNA_DTL: -0.1401717981833989, mRNA_C5AR2: 0.9152140810717146, mRNA_TBC1D9: 0.4640998807410004, mRNA_AR: -0.1327991668753463, mRNA_CCDC170: 0.4153923914578407, mRNA_DEGS2: 1.0738284455227776, mRNA_TFF3: 0.988409405562916, mRNA_DNALI1: 0.5914626016725955, mRNA_LINC00504: 0.5895866732916754, mRNA_CLCA2: -0.5087232003085207, mRNA_PPP1R14C: -0.5210621323329185, mRNA_THSD4: 0.8548794826572543, mRNA_SPAG5: -0.6007128615221013, mRNA_FBP1: 1.2975630254433843, mRNA_SLC7A8: 0.1706710779446654, mRNA_EN1: -0.9759041796233002, mRNA_ZNF552: 0.7266265163705131, Methylation_LRRC6: -0.4386349677312515, Methylation_chr2 66218712 LINC02934 (29533): 1.320679094753216, Methylation_HOXB13: -1.0468049236740675, Methylation_chr10 3949206 LINC02660 (4871): -0.7726907528611822, Methylation_chr5 179517140 RNF130 (18026): 1.0549257950231323, Methylation_LOC727677: -0.7526993487111089, Methylation_LETM1: -1.0462349110167792, Methylation_CDC42BPB: 0.4039764586453704, Methylation_C8orf38: -0.5240554444678928, Methylation_chr14 100504766 EVL (18852): -0.7984281520869899, Methylation_chr5 72594851 LOC340090 (24088): 1.045211479950254, Methylation_chr2 242904738 LINC01238 (3421): -0.8310403234895883, Methylation_ARFGEF1: -0.6104548596973154, Methylation_MAPT: -1.0916912697872805, Methylation_ZFAT: -0.8241335142038955, Methylation_KCNQ4: 0.9311283360961384, Methylation_chr1 232684368 SIPA1L2 (12934): -1.1653988485522602, Methylation_CRNKL1: -0.8695985680814351, Methylation_PRKAG2: 0.199578871456125, Methylation_MICB: -0.7556575331002644, miRNA_hsa-mir-934: -0.4309332525973212, miRNA_hsa-mir-4728: -1.05143092159592, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.0508192734914188, miRNA_hsa-mir-190b: 0.7384689102313694, miRNA_hsa-mir-577: -0.4806812548766817, miRNA_hsa-mir-135b: -0.7393335830913987, miRNA_hsa-mir-2115: -0.208123506933379, miRNA_hsa-mir-17: 0.5625549594896856, miRNA_hsa-mir-130b: -0.5487349257983505, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-D8-A1JB,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: -0.2357459856647114, mRNA_C2orf54: -0.5554007141683014, mRNA_CITED4: 0.6077975795970199, mRNA_ESR1: 0.4564491343225239, mRNA_SPDEF: 0.3578037383712341, mRNA_AGR3: 0.344920605961727, mRNA_FOXC1: 0.2853115807011116, mRNA_GATA3: 0.3299019199186427, mRNA_AGR2: -0.0493776249665736, mRNA_XBP1: 0.0997586586250616, mRNA_PRR15: 0.2784112393395226, mRNA_SLC44A4: 0.1758971213289645, mRNA_CA12: 0.5125840941192396, mRNA_DTL: -1.030347933919782, mRNA_C5AR2: -0.059102704923184, mRNA_TBC1D9: 0.7976140474068103, mRNA_AR: 0.2755806742023372, mRNA_CCDC170: 0.550992040733984, mRNA_DEGS2: 0.4293991467617535, mRNA_TFF3: 0.2722917145579912, mRNA_DNALI1: 0.1865987552419154, mRNA_LINC00504: 0.7735785744334263, mRNA_CLCA2: -0.1566753691822719, mRNA_PPP1R14C: 0.0033063174692559, mRNA_THSD4: 0.7489437801806429, mRNA_SPAG5: -1.0268718732606643, mRNA_FBP1: 1.0324406865450864, mRNA_SLC7A8: 0.5907384573965143, mRNA_EN1: -0.7529663914133031, mRNA_ZNF552: 0.6827102563006784, Methylation_LRRC6: 0.9179748007346414, Methylation_chr2 66218712 LINC02934 (29533): -0.4705086078783279, Methylation_HOXB13: -1.0078055149833711, Methylation_chr10 3949206 LINC02660 (4871): 0.4048328576704316, Methylation_chr5 179517140 RNF130 (18026): 0.1723662877064889, Methylation_LOC727677: 0.4649684178198209, Methylation_LETM1: 0.7933422682852376, Methylation_CDC42BPB: -0.0705108845617652, Methylation_C8orf38: 0.3275941079704845, Methylation_chr14 100504766 EVL (18852): 0.853290697441946, Methylation_chr5 72594851 LOC340090 (24088): -0.8008755177001194, Methylation_chr2 242904738 LINC01238 (3421): 0.2309211029335149, Methylation_ARFGEF1: 0.6712619667119759, Methylation_MAPT: 0.804850743861721, Methylation_ZFAT: 0.6731308668780771, Methylation_KCNQ4: -0.9258848486702154, Methylation_chr1 232684368 SIPA1L2 (12934): 0.621618867159904, Methylation_CRNKL1: 0.9722123556934332, Methylation_PRKAG2: 0.1008531406321088, Methylation_MICB: 0.7560625695146123, miRNA_hsa-mir-934: 0.0207696422802228, miRNA_hsa-mir-4728: -0.0643863443862659, miRNA_hsa-mir-5695: 0.2354447571466469, miRNA_hsa-mir-18a: -0.61938592560583, miRNA_hsa-mir-190b: -0.5043824086287959, miRNA_hsa-mir-577: -0.5182209507465606, miRNA_hsa-mir-135b: 0.5692882910060105, miRNA_hsa-mir-2115: -0.2733123862091702, miRNA_hsa-mir-17: -0.890163007106031, miRNA_hsa-mir-130b: -1.131688923187093, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A2-A1G1,"High-level Amplification of PPP1R14C drives significant mRNA overexpression. FOXC1 mRNA is highly expressed (Z=2.27). Promoter hypermethylation of ARFGEF1, C8orf38, and EVL mediates epigenetic silencing. miR-4728 and miR-135b are markedly upregulated; miR-190b is downregulated. These features collectively indicate a basal-like phenotype with PI3K/AKT dysregulation.","mRNA_MLPH: -2.8598556453241977, mRNA_C2orf54: 0.0778303789962428, mRNA_CITED4: -1.1494498491585, mRNA_ESR1: -1.5639527746574151, mRNA_SPDEF: -3.1975352492788387, mRNA_AGR3: -2.060531268628111, mRNA_FOXC1: 2.2718888482615363, mRNA_GATA3: -1.412999475688776, mRNA_AGR2: -1.6607981305830934, mRNA_XBP1: -1.4551799435765782, mRNA_PRR15: -2.290821217031825, mRNA_SLC44A4: -2.278121531092061, mRNA_CA12: -1.7519441975140864, mRNA_DTL: -0.1307712049114725, mRNA_C5AR2: -1.5321771314089685, mRNA_TBC1D9: -1.778569804897063, mRNA_AR: -1.4366690354263183, mRNA_CCDC170: -1.502121231206519, mRNA_DEGS2: -2.171251141972148, mRNA_TFF3: -1.976666078432612, mRNA_DNALI1: -1.872538551481328, mRNA_LINC00504: -1.3529842741348206, mRNA_CLCA2: -0.6707767989141737, mRNA_PPP1R14C: 2.918235249999017, mRNA_THSD4: -1.8178708018761487, mRNA_SPAG5: 0.3505779300907261, mRNA_FBP1: -0.9975439657151204, mRNA_SLC7A8: -1.6448351202957374, mRNA_EN1: -0.3350450774305475, mRNA_ZNF552: -1.9118210979397727, Methylation_LRRC6: 1.5188891002221634, Methylation_chr2 66218712 LINC02934 (29533): -0.3208857092296472, Methylation_HOXB13: 0.5677696326950191, Methylation_chr10 3949206 LINC02660 (4871): 1.2358578188633969, Methylation_chr5 179517140 RNF130 (18026): -0.9824320045417304, Methylation_LOC727677: 1.4902449314021653, Methylation_LETM1: 1.3156593114669692, Methylation_CDC42BPB: 0.5683543975426293, Methylation_C8orf38: 1.5864541674366572, Methylation_chr14 100504766 EVL (18852): 1.531591640407211, Methylation_chr5 72594851 LOC340090 (24088): -1.002952735885415, Methylation_chr2 242904738 LINC01238 (3421): 1.421778505466257, Methylation_ARFGEF1: 1.716748608942559, Methylation_MAPT: 1.4725853704618428, Methylation_ZFAT: 1.3861560621488949, Methylation_KCNQ4: 0.9723730596476664, Methylation_chr1 232684368 SIPA1L2 (12934): 1.479940633593679, Methylation_CRNKL1: 1.4111508704346047, Methylation_PRKAG2: -0.5602733054764633, Methylation_MICB: 1.3247227269511304, miRNA_hsa-mir-934: 1.3106087414402778, miRNA_hsa-mir-4728: 4.200205542173849, miRNA_hsa-mir-5695: 0.2988853551895946, miRNA_hsa-mir-18a: 1.6751688331836607, miRNA_hsa-mir-190b: -1.2669681727629276, miRNA_hsa-mir-577: 0.9081104191317626, miRNA_hsa-mir-135b: 2.6696364252198066, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.33496111537942, miRNA_hsa-mir-130b: 0.6131457504780364, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-B6-A0RL,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.6913081772013416, mRNA_C2orf54: -0.891927506502197, mRNA_CITED4: -1.3968794054059257, mRNA_ESR1: 1.2319517929265735, mRNA_SPDEF: 0.4537759778396561, mRNA_AGR3: 0.8198047404559957, mRNA_FOXC1: -0.9089873564719289, mRNA_GATA3: 1.263310469873249, mRNA_AGR2: 0.9035054752380572, mRNA_XBP1: 0.4506754566152637, mRNA_PRR15: 1.5189342319703707, mRNA_SLC44A4: 0.0015084801916234, mRNA_CA12: 0.7814679657593833, mRNA_DTL: 1.20985686431778, mRNA_C5AR2: 1.5168260623181968, mRNA_TBC1D9: -0.43293915580681, mRNA_AR: 0.2981430366735135, mRNA_CCDC170: 1.9951151167296195, mRNA_DEGS2: 1.0158008757361243, mRNA_TFF3: 0.9206909528436458, mRNA_DNALI1: 1.1527941691661043, mRNA_LINC00504: 0.3878549482747192, mRNA_CLCA2: -0.8950940779111158, mRNA_PPP1R14C: -0.9648709765661264, mRNA_THSD4: 1.1327534277363072, mRNA_SPAG5: 1.329428564321049, mRNA_FBP1: 1.317763200617578, mRNA_SLC7A8: 1.4215260554423788, mRNA_EN1: -1.173144437033414, mRNA_ZNF552: 0.2285540688924998, Methylation_LRRC6: -1.2735444607744542, Methylation_chr2 66218712 LINC02934 (29533): 1.3842428135674552, Methylation_HOXB13: 1.6653144634262804, Methylation_chr10 3949206 LINC02660 (4871): -1.2929697831715694, Methylation_chr5 179517140 RNF130 (18026): 1.234234283432361, Methylation_LOC727677: -1.4523979581744078, Methylation_LETM1: -1.6723000660525649, Methylation_CDC42BPB: 1.3709109390849927, Methylation_C8orf38: 1.1247840655643462, Methylation_chr14 100504766 EVL (18852): -1.529921484308988, Methylation_chr5 72594851 LOC340090 (24088): 1.3049922347031748, Methylation_chr2 242904738 LINC01238 (3421): -1.3413646110350996, Methylation_ARFGEF1: -1.2179623594742723, Methylation_MAPT: -0.8917088081283436, Methylation_ZFAT: -1.5820441847644635, Methylation_KCNQ4: 1.5968939865267249, Methylation_chr1 232684368 SIPA1L2 (12934): -1.5140853766405766, Methylation_CRNKL1: -1.579097010984794, Methylation_PRKAG2: 1.3359982924922869, Methylation_MICB: -1.4744391032110844, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.3811611053282216, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.9043188774536248, miRNA_hsa-mir-190b: 0.997284992111444, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: 0.1169897867048336, miRNA_hsa-mir-2115: -0.1265387199824211, miRNA_hsa-mir-17: -0.0452660513237839, miRNA_hsa-mir-130b: 0.5804133132583678, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A7-A5ZV,"High-level Amplification of VPS54, LINC02576, WDPCP, and CEP68 drives mRNA overexpression.  
Promoter hypermethylation of KCNQ4, ARFGEF1, and C8orf38 mediates epigenetic silencing.  
Hypomethylation at chr2:66218712 (LINC02934), RNF130, and chr5:72594851 (LOC340090) suggests derepression.  
miR-135b upregulation may suppress tumor-inhibitory pathways.  
Collectively indicative of an aggressive luminal B-like phenotype with PI3K/AKT dysregulation.","mRNA_MLPH: -1.6644315533218184, mRNA_C2orf54: -0.9828643699169908, mRNA_CITED4: 1.876059590731612, mRNA_ESR1: -2.024038705740721, mRNA_SPDEF: -2.635273551119898, mRNA_AGR3: -2.060531268628111, mRNA_FOXC1: 2.029159487910911, mRNA_GATA3: -1.5762130565033396, mRNA_AGR2: -2.3495687272954955, mRNA_XBP1: -2.3969032969067907, mRNA_PRR15: -2.5326728667063443, mRNA_SLC44A4: -2.3417927353537875, mRNA_CA12: -1.7617426193482368, mRNA_DTL: 0.0713487823844366, mRNA_C5AR2: -0.3726648295512623, mRNA_TBC1D9: -2.409616374721622, mRNA_AR: -2.457010632068368, mRNA_CCDC170: -1.3912370417488178, mRNA_DEGS2: -1.7370146280035814, mRNA_TFF3: -2.256187458724138, mRNA_DNALI1: -2.145830577046296, mRNA_LINC00504: -1.7221848279871772, mRNA_CLCA2: -0.8374948582657595, mRNA_PPP1R14C: 1.2576380751076512, mRNA_THSD4: -1.5372351614045674, mRNA_SPAG5: 0.1256104244889777, mRNA_FBP1: -2.574742637843194, mRNA_SLC7A8: -1.246295395586874, mRNA_EN1: 1.4191098771589652, mRNA_ZNF552: -2.231687246613742, Methylation_LRRC6: 1.5360345199575811, Methylation_chr2 66218712 LINC02934 (29533): -1.5781953969073756, Methylation_HOXB13: 1.2507515135855298, Methylation_chr10 3949206 LINC02660 (4871): 1.6249960138875983, Methylation_chr5 179517140 RNF130 (18026): -1.647729624392756, Methylation_LOC727677: 1.524535479934249, Methylation_LETM1: 1.3427014945069933, Methylation_CDC42BPB: 1.165923045107318, Methylation_C8orf38: 1.6469463225440455, Methylation_chr14 100504766 EVL (18852): 1.5798738930915004, Methylation_chr5 72594851 LOC340090 (24088): -1.5369202228987562, Methylation_chr2 242904738 LINC01238 (3421): 1.3015668621324412, Methylation_ARFGEF1: 1.740272024147531, Methylation_MAPT: 1.4474137163376983, Methylation_ZFAT: 1.3588136404441615, Methylation_KCNQ4: 2.042069776031521, Methylation_chr1 232684368 SIPA1L2 (12934): 1.601023747044925, Methylation_CRNKL1: 1.3386831036012594, Methylation_PRKAG2: -1.160737896658314, Methylation_MICB: 1.4066852493054989, miRNA_hsa-mir-934: 1.6292417160663866, miRNA_hsa-mir-4728: 1.1696540114691911, miRNA_hsa-mir-5695: 0.0179090598971229, miRNA_hsa-mir-18a: 1.133314746046567, miRNA_hsa-mir-190b: -1.2404406686273657, miRNA_hsa-mir-577: 0.6078203778973335, miRNA_hsa-mir-135b: 2.2095115154368936, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.2186732721789764, miRNA_hsa-mir-130b: 1.4883845005422185, CNV_VPS54: 2.3735003872816955, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 2.464291317721031, CNV_WDPCP: 2.38809584879993, CNV_CEP68: 2.464291317721031"
TCGA-BH-A1FN,KCNQ4 promoter hypermethylation (Z=1.80) mediates epigenetic silencing. miR-130b upregulation (Z=2.19) suggests post-transcriptional repression. No mRNA or CNV alterations meet diagnostic thresholds. These features indicate luminal-like biology with potential PI3K pathway modulation.,"mRNA_MLPH: -0.7092032838939578, mRNA_C2orf54: 0.0641775699748804, mRNA_CITED4: -0.7417963724672734, mRNA_ESR1: 0.0293507912499208, mRNA_SPDEF: -0.521490415009605, mRNA_AGR3: -0.2323508909824756, mRNA_FOXC1: -0.650157253905331, mRNA_GATA3: 0.550829329735776, mRNA_AGR2: -0.3370108014280469, mRNA_XBP1: -0.2681420494398576, mRNA_PRR15: -0.9567899515223371, mRNA_SLC44A4: 0.6806222023166904, mRNA_CA12: 0.7551500207685206, mRNA_DTL: 0.9796643048674092, mRNA_C5AR2: -1.0889133939210591, mRNA_TBC1D9: -0.5095132755262167, mRNA_AR: 0.7167045370262003, mRNA_CCDC170: -0.9840291233614252, mRNA_DEGS2: -0.2053008389934975, mRNA_TFF3: -0.5079430747173511, mRNA_DNALI1: 0.6871178442684205, mRNA_LINC00504: -0.5215837486600088, mRNA_CLCA2: -0.4958743930078221, mRNA_PPP1R14C: -0.6317533084094762, mRNA_THSD4: -0.4121587647635455, mRNA_SPAG5: 1.0135267564886892, mRNA_FBP1: -1.1085881971908882, mRNA_SLC7A8: -0.6879218246756336, mRNA_EN1: -0.308459163280376, mRNA_ZNF552: -0.0994193093875445, Methylation_LRRC6: -1.2778930015906722, Methylation_chr2 66218712 LINC02934 (29533): -1.387956477730496, Methylation_HOXB13: -0.7322107975041529, Methylation_chr10 3949206 LINC02660 (4871): -1.12735734327457, Methylation_chr5 179517140 RNF130 (18026): -1.5347959801066775, Methylation_LOC727677: -0.9305503439508848, Methylation_LETM1: -0.7800444036268813, Methylation_CDC42BPB: -1.355913722471782, Methylation_C8orf38: -1.2267947473448892, Methylation_chr14 100504766 EVL (18852): -0.9481462691980131, Methylation_chr5 72594851 LOC340090 (24088): -1.5316016822996994, Methylation_chr2 242904738 LINC01238 (3421): -0.9841332810558088, Methylation_ARFGEF1: -0.838024109963158, Methylation_MAPT: -0.9924276977869456, Methylation_ZFAT: -1.3929634503792183, Methylation_KCNQ4: 1.7959230949637568, Methylation_chr1 232684368 SIPA1L2 (12934): -0.8642600089679643, Methylation_CRNKL1: -0.9849590626644644, Methylation_PRKAG2: -1.301510822615401, Methylation_MICB: -1.4975454105902553, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.2206887053676698, miRNA_hsa-mir-5695: 0.2418431032802085, miRNA_hsa-mir-18a: 1.2523438775163345, miRNA_hsa-mir-190b: 1.2810818338905667, miRNA_hsa-mir-577: -0.2564486578063812, miRNA_hsa-mir-135b: -0.2710125649735345, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.3574130968289542, miRNA_hsa-mir-130b: 2.1935706428199366, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-LD-A7W5,"No mRNA, methylation, or miRNA features meet diagnostic thresholds. CNV shows amplification (not high-level) of VPS54, LINC01867, LINC02576, WDPCP, and CEP68. Insufficient evidence for subtype classification or pathway dysregulation.","mRNA_MLPH: 0.3588352150513986, mRNA_C2orf54: 1.279542618362026, mRNA_CITED4: 0.2957788568597048, mRNA_ESR1: 0.7944645402293454, mRNA_SPDEF: 0.3856192899600058, mRNA_AGR3: 0.4780650436508455, mRNA_FOXC1: -0.2660238327929828, mRNA_GATA3: 0.2302082366802988, mRNA_AGR2: 0.2834944622071151, mRNA_XBP1: -0.5809898375786847, mRNA_PRR15: 0.7133716705136207, mRNA_SLC44A4: -0.0853823106074397, mRNA_CA12: -0.1677723747731951, mRNA_DTL: -1.0421854307892713, mRNA_C5AR2: 0.3006500310805339, mRNA_TBC1D9: -0.0871870270448572, mRNA_AR: 0.5012034877604666, mRNA_CCDC170: 0.2618226950638694, mRNA_DEGS2: -0.5532411612104982, mRNA_TFF3: 0.4157259414036907, mRNA_DNALI1: 0.6633635965913958, mRNA_LINC00504: -0.6563558979877901, mRNA_CLCA2: -0.7378187077910181, mRNA_PPP1R14C: -0.3939625456980853, mRNA_THSD4: 0.0111782579273813, mRNA_SPAG5: 0.0285910432581648, mRNA_FBP1: 0.3426520909617584, mRNA_SLC7A8: -1.0517723826722594, mRNA_EN1: -0.4020364572974224, mRNA_ZNF552: -0.338884511246981, Methylation_LRRC6: 0.8878361649700792, Methylation_chr2 66218712 LINC02934 (29533): 0.8470201328751936, Methylation_HOXB13: 0.3978961158791161, Methylation_chr10 3949206 LINC02660 (4871): -0.069622145372464, Methylation_chr5 179517140 RNF130 (18026): 0.0551191855617916, Methylation_LOC727677: -0.2456359831641453, Methylation_LETM1: 0.4486102958626094, Methylation_CDC42BPB: 0.2101957456727833, Methylation_C8orf38: 0.7385120988195625, Methylation_chr14 100504766 EVL (18852): 1.1141925116795557, Methylation_chr5 72594851 LOC340090 (24088): 0.2816893501823145, Methylation_chr2 242904738 LINC01238 (3421): 1.244263253495989, Methylation_ARFGEF1: 0.6792388113827778, Methylation_MAPT: 0.6109966681714286, Methylation_ZFAT: 0.1705494521245976, Methylation_KCNQ4: -0.7816846526133269, Methylation_chr1 232684368 SIPA1L2 (12934): 1.0910202797048154, Methylation_CRNKL1: 0.54282923726172, Methylation_PRKAG2: 0.8129004000353989, Methylation_MICB: 0.6905052007573613, miRNA_hsa-mir-934: -0.2051019215327877, miRNA_hsa-mir-4728: -0.2924652626290391, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.2682855379715159, miRNA_hsa-mir-190b: -0.288985459987984, miRNA_hsa-mir-577: -0.5003294952157509, miRNA_hsa-mir-135b: -0.5902221555764825, miRNA_hsa-mir-2115: -0.6043782385915153, miRNA_hsa-mir-17: 0.644773401112266, miRNA_hsa-mir-130b: -1.2822670737260513, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-AR-A250,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression.  
mRNA_CITED4 is downregulated (Z = -2.45).  
miRNA_hsa-mir-4728 is upregulated (Z = 2.40).  
No methylation sites meet hyper/hypo-methylation thresholds.","mRNA_MLPH: 0.7014034486474711, mRNA_C2orf54: 1.0478600816646355, mRNA_CITED4: -2.447499227229407, mRNA_ESR1: 0.7956945704568142, mRNA_SPDEF: 0.589408668609628, mRNA_AGR3: 0.2921292638273278, mRNA_FOXC1: -0.3784548458523622, mRNA_GATA3: 0.4115229761075805, mRNA_AGR2: 1.0505397182449514, mRNA_XBP1: 0.2872416879326297, mRNA_PRR15: 0.4234274107602541, mRNA_SLC44A4: 0.6679567602872936, mRNA_CA12: -0.1602803790389449, mRNA_DTL: 0.3784494024702647, mRNA_C5AR2: -0.5972588423094466, mRNA_TBC1D9: 0.5103579178631413, mRNA_AR: 0.9403271990774862, mRNA_CCDC170: 0.6047805620179629, mRNA_DEGS2: -1.0076788387931563, mRNA_TFF3: 1.096855395417926, mRNA_DNALI1: -1.3387691592538284, mRNA_LINC00504: 0.4064164198223365, mRNA_CLCA2: -0.6433470605873962, mRNA_PPP1R14C: -0.1044787654798267, mRNA_THSD4: 0.9780600077477818, mRNA_SPAG5: 1.4299415713440318, mRNA_FBP1: 0.6832816426218069, mRNA_SLC7A8: -0.0608513848615134, mRNA_EN1: -0.0181281532939576, mRNA_ZNF552: 0.2031883581867632, Methylation_LRRC6: -0.8053939990302877, Methylation_chr2 66218712 LINC02934 (29533): -0.505438244764267, Methylation_HOXB13: 1.3791726771703494, Methylation_chr10 3949206 LINC02660 (4871): -1.1665155238033154, Methylation_chr5 179517140 RNF130 (18026): 0.5694275878238017, Methylation_LOC727677: -0.8461122305117196, Methylation_LETM1: -0.6193358205262461, Methylation_CDC42BPB: 1.2365034339567262, Methylation_C8orf38: -0.8828534769014715, Methylation_chr14 100504766 EVL (18852): -0.6997573671038189, Methylation_chr5 72594851 LOC340090 (24088): 0.7075047467981637, Methylation_chr2 242904738 LINC01238 (3421): -1.244480611028396, Methylation_ARFGEF1: -0.870060329459958, Methylation_MAPT: -0.3944751063161849, Methylation_ZFAT: -0.8584200755806947, Methylation_KCNQ4: 0.8334023734774642, Methylation_chr1 232684368 SIPA1L2 (12934): -0.932380190052024, Methylation_CRNKL1: -0.9424314865387456, Methylation_PRKAG2: -0.5767383226254619, Methylation_MICB: -1.391715645064668, miRNA_hsa-mir-934: -0.3317845276411821, miRNA_hsa-mir-4728: 2.3999305518813245, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.1732291446075514, miRNA_hsa-mir-190b: 0.5581876460567273, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.4402673158454371, miRNA_hsa-mir-2115: 1.012854376129181, miRNA_hsa-mir-17: -0.6045702985895954, miRNA_hsa-mir-130b: 0.3208017364059949, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-AC-A8OS,CLCA2 mRNA overexpression (Z=2.44) exceeds the high-expression threshold. No methylation or miRNA alterations meet diagnostic criteria. All CNVs fall within the normal range (−1.10 to −0.10). Isolated CLCA2 upregulation suggests localized transcriptional activation without clear genomic or epigenetic drivers.,"mRNA_MLPH: 1.0214737009310866, mRNA_C2orf54: 0.957335003216649, mRNA_CITED4: 0.3576708512438097, mRNA_ESR1: 0.927426871853811, mRNA_SPDEF: 0.6530089069345917, mRNA_AGR3: 0.4344924732771916, mRNA_FOXC1: -0.1363170616382736, mRNA_GATA3: -0.0021254897624462, mRNA_AGR2: 0.7461955830776899, mRNA_XBP1: 0.16545737756658, mRNA_PRR15: -0.0315715649470175, mRNA_SLC44A4: 0.1923861062692138, mRNA_CA12: 0.3146042713797154, mRNA_DTL: -1.6761589130078998, mRNA_C5AR2: 1.7111372600906083, mRNA_TBC1D9: 0.4512688878278556, mRNA_AR: 0.6163671939925549, mRNA_CCDC170: 1.2729685522078065, mRNA_DEGS2: 0.3716549895599971, mRNA_TFF3: 0.6562655449140997, mRNA_DNALI1: -0.3529166507980835, mRNA_LINC00504: 0.7434215247912458, mRNA_CLCA2: 2.437207186977819, mRNA_PPP1R14C: -0.7021391809425004, mRNA_THSD4: 0.5953627829755278, mRNA_SPAG5: -1.633479961175266, mRNA_FBP1: 0.2112995952969429, mRNA_SLC7A8: 0.2474300072107025, mRNA_EN1: -0.433976024969688, mRNA_ZNF552: 1.0889343893463828, Methylation_LRRC6: 0.0693798711824309, Methylation_chr2 66218712 LINC02934 (29533): 0.9620949979073264, Methylation_HOXB13: 1.3078523290517523, Methylation_chr10 3949206 LINC02660 (4871): -0.1580050450355941, Methylation_chr5 179517140 RNF130 (18026): -0.1825477995018369, Methylation_LOC727677: 0.9380072711907638, Methylation_LETM1: -0.0328630635658634, Methylation_CDC42BPB: -0.664814083322333, Methylation_C8orf38: 0.0972977363224379, Methylation_chr14 100504766 EVL (18852): 0.6365486532677809, Methylation_chr5 72594851 LOC340090 (24088): 0.238208212916467, Methylation_chr2 242904738 LINC01238 (3421): 1.4199059287923508, Methylation_ARFGEF1: 0.6805010738240461, Methylation_MAPT: 0.390933099229272, Methylation_ZFAT: 0.2380476626714026, Methylation_KCNQ4: -1.179629091584088, Methylation_chr1 232684368 SIPA1L2 (12934): 0.7225803938693912, Methylation_CRNKL1: 0.422878266314136, Methylation_PRKAG2: -0.477453211458636, Methylation_MICB: 0.4525204167646443, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.8184131345550737, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.5209207518994924, miRNA_hsa-mir-190b: -0.3175362702205586, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.8226503450584096, miRNA_hsa-mir-2115: 3.330884490770739, miRNA_hsa-mir-17: -0.56726883977839, miRNA_hsa-mir-130b: -1.1031515959472225, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A1FG,LINC01867 deletion (CNV = -1.64) indicates genomic loss. LETM1 promoter hypermethylation (Z = -1.47) meets hypomethylation threshold but not hypermethylation; no methylation calls meet hyper/hypo criteria. No mRNA or miRNA values exceed expression thresholds. No actionable drivers identified.,"mRNA_MLPH: 0.1327909209190725, mRNA_C2orf54: -1.2314042024637952, mRNA_CITED4: 0.1391980795696784, mRNA_ESR1: 1.0973546805187324, mRNA_SPDEF: 0.1905386117495101, mRNA_AGR3: 0.8016634079100671, mRNA_FOXC1: -0.6770642954479453, mRNA_GATA3: 0.4270801856964501, mRNA_AGR2: 1.0000153829026996, mRNA_XBP1: 0.845458211594198, mRNA_PRR15: -0.7657464023073857, mRNA_SLC44A4: -0.1587538930912631, mRNA_CA12: 1.1905692610861782, mRNA_DTL: -1.373072904527097, mRNA_C5AR2: 0.3465738246798747, mRNA_TBC1D9: 0.8460515098335571, mRNA_AR: 0.3744064937443448, mRNA_CCDC170: 0.8183285650636719, mRNA_DEGS2: 0.8773583189355735, mRNA_TFF3: -0.2975246515729009, mRNA_DNALI1: 0.602139689156312, mRNA_LINC00504: 0.9162991874988006, mRNA_CLCA2: -0.8560223628786305, mRNA_PPP1R14C: -0.6719663154046017, mRNA_THSD4: 0.6273488077991882, mRNA_SPAG5: -1.0837102022680258, mRNA_FBP1: 0.781031847912386, mRNA_SLC7A8: 0.8942010272696979, mRNA_EN1: -0.9190222817254202, mRNA_ZNF552: 0.7986341021732105, Methylation_LRRC6: -1.5451722175889602, Methylation_chr2 66218712 LINC02934 (29533): 1.1381231689614355, Methylation_HOXB13: -1.0157552701497852, Methylation_chr10 3949206 LINC02660 (4871): -1.08474484566317, Methylation_chr5 179517140 RNF130 (18026): 0.858709441824405, Methylation_LOC727677: -0.5886578022963533, Methylation_LETM1: -1.4717872326755537, Methylation_CDC42BPB: 1.308533961061269, Methylation_C8orf38: -1.2473377003364228, Methylation_chr14 100504766 EVL (18852): -1.4231178384437555, Methylation_chr5 72594851 LOC340090 (24088): -1.404213901516117, Methylation_chr2 242904738 LINC01238 (3421): -1.1842593099626986, Methylation_ARFGEF1: -1.424149001267595, Methylation_MAPT: -1.3073653324326509, Methylation_ZFAT: -1.4040371837993055, Methylation_KCNQ4: 0.9320939255158056, Methylation_chr1 232684368 SIPA1L2 (12934): -0.929485609508586, Methylation_CRNKL1: -1.1809718470891553, Methylation_PRKAG2: 1.270858886932781, Methylation_MICB: -1.2875107762404208, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.2981722513838936, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.4251274536999629, miRNA_hsa-mir-190b: -0.3082405732603696, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.667610551456216, miRNA_hsa-mir-2115: 1.2450655567758528, miRNA_hsa-mir-17: -0.6621744252479839, miRNA_hsa-mir-130b: -0.001406197059336, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -1.63714039509435, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A0BJ,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.0253141364779382, mRNA_C2orf54: -0.7414217672943473, mRNA_CITED4: 0.8822929445389441, mRNA_ESR1: 0.2627391996175495, mRNA_SPDEF: 0.0998795123947947, mRNA_AGR3: 0.6735558745332229, mRNA_FOXC1: 0.0495248609478692, mRNA_GATA3: 0.5700204862516122, mRNA_AGR2: 0.3199976541744348, mRNA_XBP1: 0.2642819802867479, mRNA_PRR15: 0.7957812201273727, mRNA_SLC44A4: 0.3722319059465425, mRNA_CA12: 0.6017830952472513, mRNA_DTL: -0.0880235841865127, mRNA_C5AR2: 1.0580015377767515, mRNA_TBC1D9: 0.393671820321957, mRNA_AR: 0.7883699649109859, mRNA_CCDC170: 0.5071056953316064, mRNA_DEGS2: 0.2514941308877294, mRNA_TFF3: -0.0190790158759111, mRNA_DNALI1: 0.6877237235889028, mRNA_LINC00504: 0.2733557025106197, mRNA_CLCA2: -0.5473899172609137, mRNA_PPP1R14C: -0.2663036107871857, mRNA_THSD4: 0.4912642840770162, mRNA_SPAG5: -0.6153177002439627, mRNA_FBP1: 0.7115741191032077, mRNA_SLC7A8: -0.2227190174402572, mRNA_EN1: -0.6086466493944985, mRNA_ZNF552: 0.7070439697222565, Methylation_LRRC6: 0.4176674824242419, Methylation_chr2 66218712 LINC02934 (29533): -0.2194026028095325, Methylation_HOXB13: -0.789281249351439, Methylation_chr10 3949206 LINC02660 (4871): 0.0543334378171008, Methylation_chr5 179517140 RNF130 (18026): -0.7471649644371472, Methylation_LOC727677: -0.1894756320600764, Methylation_LETM1: 0.9697477925742536, Methylation_CDC42BPB: -0.552353986707603, Methylation_C8orf38: 0.4901909633494454, Methylation_chr14 100504766 EVL (18852): 0.566431568578707, Methylation_chr5 72594851 LOC340090 (24088): -0.0661894583832443, Methylation_chr2 242904738 LINC01238 (3421): 0.0143639249310259, Methylation_ARFGEF1: 0.5025933892085358, Methylation_MAPT: -0.3242142053314073, Methylation_ZFAT: 0.6816402820686055, Methylation_KCNQ4: -0.1300275152414925, Methylation_chr1 232684368 SIPA1L2 (12934): 0.2206616273420717, Methylation_CRNKL1: 0.365328127460306, Methylation_PRKAG2: 1.2426715080189483, Methylation_MICB: 0.4420719075081123, miRNA_hsa-mir-934: -0.3057822431143677, miRNA_hsa-mir-4728: -0.8746997996811781, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.8777486583043048, miRNA_hsa-mir-190b: 0.0146565118657788, miRNA_hsa-mir-577: -0.4912254616345659, miRNA_hsa-mir-135b: -0.310175212849239, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.885293395615368, miRNA_hsa-mir-130b: -0.8183461496821292, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-EW-A1P5,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.0331226697480034, mRNA_C2orf54: -0.276348621126774, mRNA_CITED4: -1.7353991176705077, mRNA_ESR1: 1.1083907067640846, mRNA_SPDEF: 0.2485858026420095, mRNA_AGR3: 1.08982259595242, mRNA_FOXC1: -1.106126479687354, mRNA_GATA3: 0.6536979493078645, mRNA_AGR2: 0.7839735515908904, mRNA_XBP1: 0.7359505977528473, mRNA_PRR15: 0.5820892618368267, mRNA_SLC44A4: -0.1098316636305746, mRNA_CA12: 1.5098639566842829, mRNA_DTL: 0.107011119520181, mRNA_C5AR2: 1.4475854858161386, mRNA_TBC1D9: 0.9133174361868212, mRNA_AR: 0.7136851736824414, mRNA_CCDC170: 0.8038869010841626, mRNA_DEGS2: 0.686508920400478, mRNA_TFF3: 0.3614093326374616, mRNA_DNALI1: 0.9487999162823552, mRNA_LINC00504: 0.7199422378153632, mRNA_CLCA2: -0.4325458267555093, mRNA_PPP1R14C: -0.4879051146610675, mRNA_THSD4: 1.067504214071079, mRNA_SPAG5: -0.061387034835603, mRNA_FBP1: 0.1638151952406289, mRNA_SLC7A8: 0.8160077189423914, mRNA_EN1: -0.386062833457006, mRNA_ZNF552: 0.7234478878724999, Methylation_LRRC6: -1.075796011552155, Methylation_chr2 66218712 LINC02934 (29533): -0.0505487008529835, Methylation_HOXB13: -0.4882255513971248, Methylation_chr10 3949206 LINC02660 (4871): 1.189873391726141, Methylation_chr5 179517140 RNF130 (18026): -0.1392924275927217, Methylation_LOC727677: -0.920434444012142, Methylation_LETM1: -1.0042424762008657, Methylation_CDC42BPB: 0.9709197934359026, Methylation_C8orf38: 0.0874657740069342, Methylation_chr14 100504766 EVL (18852): -1.145830237833434, Methylation_chr5 72594851 LOC340090 (24088): 0.6077445738583961, Methylation_chr2 242904738 LINC01238 (3421): -1.042277001355106, Methylation_ARFGEF1: -0.6790464559632389, Methylation_MAPT: -0.9171597484146278, Methylation_ZFAT: -0.4866882170939733, Methylation_KCNQ4: -0.79657437620291, Methylation_chr1 232684368 SIPA1L2 (12934): -0.6046039760903589, Methylation_CRNKL1: -1.22878186500924, Methylation_PRKAG2: -0.2519623428024143, Methylation_MICB: 1.2293389699781625, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 1.1142522501320111, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.5797564026152713, miRNA_hsa-mir-190b: 0.4381050215223902, miRNA_hsa-mir-577: -0.2369206606173439, miRNA_hsa-mir-135b: 0.1622694788562481, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.7265744531812225, miRNA_hsa-mir-130b: 0.0218434324522985, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-AO-A0JL,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives genomic instability. mRNA_EN1 (Z=2.53) and mRNA_FOXC1 (Z=1.79) are overexpressed; mRNA_XBP1 (Z=−2.88) and mRNA_CA12 (Z=−2.39) are downregulated. Promoter hypermethylation of HOXB13 (Z=1.89) and ARFGEF1 (Z=1.74) mediates silencing. miR-577, miR-135b, and miR-18a are upregulated. These features indicate a basal-like phenotype with ER-pathway suppression.","mRNA_MLPH: -1.477596854296895, mRNA_C2orf54: -1.1903666765674483, mRNA_CITED4: 1.320774738570917, mRNA_ESR1: -1.7209486902529072, mRNA_SPDEF: -1.7578350432121754, mRNA_AGR3: -1.5714196669189129, mRNA_FOXC1: 1.794664741829706, mRNA_GATA3: -1.6735858277205418, mRNA_AGR2: -1.883379208124492, mRNA_XBP1: -2.8803990383755265, mRNA_PRR15: -2.29747085074626, mRNA_SLC44A4: -1.8886343172319249, mRNA_CA12: -2.394507866664388, mRNA_DTL: -0.5450313646612175, mRNA_C5AR2: -1.164463257656013, mRNA_TBC1D9: -2.0713151322799512, mRNA_AR: -1.6533868891676466, mRNA_CCDC170: -1.7231181411996934, mRNA_DEGS2: -2.1106654150986253, mRNA_TFF3: -1.6215811166510743, mRNA_DNALI1: -1.8087743757725283, mRNA_LINC00504: -1.5853891539276674, mRNA_CLCA2: -0.8552033115002808, mRNA_PPP1R14C: 1.4096767939202373, mRNA_THSD4: -2.1732245679731723, mRNA_SPAG5: 0.0029935665681062, mRNA_FBP1: -2.710301112065428, mRNA_SLC7A8: -2.1251084159362064, mRNA_EN1: 2.530510315735865, mRNA_ZNF552: -1.991996408333076, Methylation_LRRC6: 1.5128340928552029, Methylation_chr2 66218712 LINC02934 (29533): -1.6861692059780546, Methylation_HOXB13: 1.8930245096504512, Methylation_chr10 3949206 LINC02660 (4871): 1.619083401120894, Methylation_chr5 179517140 RNF130 (18026): -1.405693751294585, Methylation_LOC727677: 1.5538631970218533, Methylation_LETM1: 1.3889077078380478, Methylation_CDC42BPB: -1.1759684208336878, Methylation_C8orf38: 1.285444557085918, Methylation_chr14 100504766 EVL (18852): 1.355294241054938, Methylation_chr5 72594851 LOC340090 (24088): -1.3215465044325752, Methylation_chr2 242904738 LINC01238 (3421): 1.37555469398254, Methylation_ARFGEF1: 1.7350689163411042, Methylation_MAPT: 1.1898557140660906, Methylation_ZFAT: 1.3413363234076707, Methylation_KCNQ4: 1.63381328228236, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5582400865138863, Methylation_CRNKL1: 1.317163243895649, Methylation_PRKAG2: 1.2025117575617177, Methylation_MICB: 1.2111723733737132, miRNA_hsa-mir-934: 1.9876422393964013, miRNA_hsa-mir-4728: -0.497112111740715, miRNA_hsa-mir-5695: 1.376756668402721, miRNA_hsa-mir-18a: 2.095486651559531, miRNA_hsa-mir-190b: -1.1664388997742217, miRNA_hsa-mir-577: 2.3351151268226387, miRNA_hsa-mir-135b: 2.1601263255043017, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.6077962385856327, miRNA_hsa-mir-130b: 1.7104430090770255, CNV_VPS54: 3.3712233045701687, CNV_LINC01867: 3.403528716117201, CNV_LINC02576: 3.494626341568657, CNV_WDPCP: 3.3913533508092364, CNV_CEP68: 3.494626341568657"
TCGA-BH-A1EU,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.0775094775992091, mRNA_C2orf54: -1.1545543037244197, mRNA_CITED4: -0.1281578931014635, mRNA_ESR1: 1.1285026172453574, mRNA_SPDEF: -0.2566551287445902, mRNA_AGR3: 0.5604259551718064, mRNA_FOXC1: 0.1793875137767153, mRNA_GATA3: 0.2577689497756115, mRNA_AGR2: 0.9793641007336228, mRNA_XBP1: 0.5077124939185403, mRNA_PRR15: 0.312899695521863, mRNA_SLC44A4: -0.1969268989427448, mRNA_CA12: 0.8177067469453816, mRNA_DTL: -0.630913438751279, mRNA_C5AR2: 1.2846290525070423, mRNA_TBC1D9: 0.6016932180009843, mRNA_AR: 0.9901442850909769, mRNA_CCDC170: 0.7717759326414604, mRNA_DEGS2: 0.2659290809392496, mRNA_TFF3: 0.5065861911735856, mRNA_DNALI1: 0.5094704466294173, mRNA_LINC00504: 0.6224566308433717, mRNA_CLCA2: -0.2455389351514869, mRNA_PPP1R14C: -0.6193705855883107, mRNA_THSD4: 1.1017053297265451, mRNA_SPAG5: -0.9629793439045564, mRNA_FBP1: 0.4545827126537044, mRNA_SLC7A8: 0.0561501391779788, mRNA_EN1: -0.5297309540488675, mRNA_ZNF552: 1.15588569967119, Methylation_LRRC6: 0.415073198294678, Methylation_chr2 66218712 LINC02934 (29533): 0.3172339963253127, Methylation_HOXB13: -0.9506002103481068, Methylation_chr10 3949206 LINC02660 (4871): 1.610646363836066, Methylation_chr5 179517140 RNF130 (18026): -1.4654375569648008, Methylation_LOC727677: 0.0917099209690455, Methylation_LETM1: 0.3393466855423127, Methylation_CDC42BPB: -0.219129835797855, Methylation_C8orf38: 0.1495971624277549, Methylation_chr14 100504766 EVL (18852): 0.2696424921502501, Methylation_chr5 72594851 LOC340090 (24088): 0.8672427744368931, Methylation_chr2 242904738 LINC01238 (3421): -0.1115587989483799, Methylation_ARFGEF1: 0.5729258579585569, Methylation_MAPT: 0.6836536855273225, Methylation_ZFAT: 1.1500778306131465, Methylation_KCNQ4: -1.0770224087801517, Methylation_chr1 232684368 SIPA1L2 (12934): 0.8108648888204862, Methylation_CRNKL1: 0.8098782066129807, Methylation_PRKAG2: 1.231925614913129, Methylation_MICB: 0.968186861642666, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.3272503067293424, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.4561689120730713, miRNA_hsa-mir-190b: 0.2527272197368586, miRNA_hsa-mir-577: 0.0771971026246283, miRNA_hsa-mir-135b: -0.3911108474037562, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.7064321345022683, miRNA_hsa-mir-130b: 0.1939580665727985, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A1J9,High-level Amplification of none; Gain in all reported CNVs (all > -0.10). mRNA_C2orf54 (Z=2.91) and mRNA_CLCA2 (Z=3.57) highly overexpressed. mRNA_CITED4 (Z=-2.21) significantly downregulated. No methylation sites meet hyper/hypo thresholds. miRNA_hsa-mir-4728 (Z=3.39) and miRNA_hsa-mir-2115 (Z=2.45) upregulated.,"mRNA_MLPH: 0.6452601637215077, mRNA_C2orf54: 2.9104878510152994, mRNA_CITED4: -2.214579694545714, mRNA_ESR1: -0.1780912739403594, mRNA_SPDEF: 0.6098823084317422, mRNA_AGR3: 0.4904317000640679, mRNA_FOXC1: -0.9773362863420448, mRNA_GATA3: -0.0810668195508807, mRNA_AGR2: 0.3710972329868999, mRNA_XBP1: 1.1459084471221324, mRNA_PRR15: 1.0227629345940856, mRNA_SLC44A4: 1.0436215390135049, mRNA_CA12: 0.3048978242340184, mRNA_DTL: 1.0820729237210331, mRNA_C5AR2: -1.1115844035243594, mRNA_TBC1D9: 0.3426200116615465, mRNA_AR: 1.3722251688692069, mRNA_CCDC170: -0.1168344401087381, mRNA_DEGS2: -0.3619556735918346, mRNA_TFF3: 0.7917679306679652, mRNA_DNALI1: -0.4825310151817555, mRNA_LINC00504: 0.2574467538355515, mRNA_CLCA2: 3.5679139215881497, mRNA_PPP1R14C: -0.3764402911903237, mRNA_THSD4: 0.3717188549095486, mRNA_SPAG5: 1.0221818210504756, mRNA_FBP1: 0.7590399975137191, mRNA_SLC7A8: 0.2298609716244347, mRNA_EN1: -0.6969276399793387, mRNA_ZNF552: 0.3027190077099608, Methylation_LRRC6: -0.3813337398912246, Methylation_chr2 66218712 LINC02934 (29533): 1.2511957220017882, Methylation_HOXB13: 0.2052037598762783, Methylation_chr10 3949206 LINC02660 (4871): 0.3546501082958913, Methylation_chr5 179517140 RNF130 (18026): 0.8462393932938846, Methylation_LOC727677: -0.7504366948712223, Methylation_LETM1: 1.3241584667023398, Methylation_CDC42BPB: -1.2165786441633946, Methylation_C8orf38: -0.9205020688786172, Methylation_chr14 100504766 EVL (18852): -0.6749283750447074, Methylation_chr5 72594851 LOC340090 (24088): 0.8003362777804042, Methylation_chr2 242904738 LINC01238 (3421): 0.0394661517468549, Methylation_ARFGEF1: -0.9116818151459262, Methylation_MAPT: 0.3739062232263997, Methylation_ZFAT: -0.883699914403068, Methylation_KCNQ4: -1.121192484831928, Methylation_chr1 232684368 SIPA1L2 (12934): -1.095957542847202, Methylation_CRNKL1: -0.5449620857291078, Methylation_PRKAG2: -0.7710764986328028, Methylation_MICB: -0.7869324826675372, miRNA_hsa-mir-934: -0.1172473004337627, miRNA_hsa-mir-4728: 3.392086712069356, miRNA_hsa-mir-5695: 0.2863508910241287, miRNA_hsa-mir-18a: 0.2146992439200931, miRNA_hsa-mir-190b: 0.5113137205501327, miRNA_hsa-mir-577: -0.3169425657170208, miRNA_hsa-mir-135b: -0.3440158257347045, miRNA_hsa-mir-2115: 2.4509921536064585, miRNA_hsa-mir-17: -0.7489574231119478, miRNA_hsa-mir-130b: 1.1268089532925725, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AC-A6NO,mRNA_CITED4 is high (Z=1.36). No methylation sites meet hyper/hypo thresholds. No miRNAs are significantly dysregulated. All CNVs fall within normal range (−1.10 to −0.10). Isolated CITED4 overexpression without genomic or epigenetic drivers suggests post-transcriptional regulation.,"mRNA_MLPH: 0.9511502659795528, mRNA_C2orf54: -0.6257914773042038, mRNA_CITED4: 1.36195642757821, mRNA_ESR1: 0.2721018873837447, mRNA_SPDEF: 0.5799549762541315, mRNA_AGR3: 0.7769032525431204, mRNA_FOXC1: -0.7237060476855993, mRNA_GATA3: 0.842303137421417, mRNA_AGR2: 0.2834627375417011, mRNA_XBP1: 0.2851280755912897, mRNA_PRR15: 0.534540434172285, mRNA_SLC44A4: 0.8674327017571538, mRNA_CA12: 0.4400188066018467, mRNA_DTL: 0.9495514128980208, mRNA_C5AR2: 1.0274307962211155, mRNA_TBC1D9: 0.634062807029085, mRNA_AR: -0.6727365568528184, mRNA_CCDC170: 0.9185423588757572, mRNA_DEGS2: 0.7425098066917445, mRNA_TFF3: 0.1388410851108593, mRNA_DNALI1: 1.0029914942557487, mRNA_LINC00504: 0.425523540649253, mRNA_CLCA2: 0.4952669783064712, mRNA_PPP1R14C: 0.3246858437242113, mRNA_THSD4: 0.2356003423290279, mRNA_SPAG5: 0.2723413432547029, mRNA_FBP1: 0.5424397391015305, mRNA_SLC7A8: 0.8253766504625835, mRNA_EN1: -0.3599092212058519, mRNA_ZNF552: 0.3631806084526962, Methylation_LRRC6: -0.8686792376920922, Methylation_chr2 66218712 LINC02934 (29533): 0.9555391208909126, Methylation_HOXB13: 0.0049851826130481, Methylation_chr10 3949206 LINC02660 (4871): -1.0193831597383671, Methylation_chr5 179517140 RNF130 (18026): 0.2031142028687566, Methylation_LOC727677: -0.924289601897954, Methylation_LETM1: -1.0351674421101449, Methylation_CDC42BPB: -1.0558135289307005, Methylation_C8orf38: -1.1321052615509335, Methylation_chr14 100504766 EVL (18852): -0.7729543187563631, Methylation_chr5 72594851 LOC340090 (24088): 0.7130575360176784, Methylation_chr2 242904738 LINC01238 (3421): -1.0515758214059536, Methylation_ARFGEF1: -0.8976753044427803, Methylation_MAPT: -1.06826565293333, Methylation_ZFAT: -0.3778620304467426, Methylation_KCNQ4: 1.2203816861533157, Methylation_chr1 232684368 SIPA1L2 (12934): -0.8344522409620666, Methylation_CRNKL1: -1.2524335192560196, Methylation_PRKAG2: 0.9242902270885008, Methylation_MICB: -0.8768177254004029, miRNA_hsa-mir-934: -0.4432341305135115, miRNA_hsa-mir-4728: 0.2131689707871629, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.1650787350185733, miRNA_hsa-mir-190b: 1.1636891345839573, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.4476514848617117, miRNA_hsa-mir-2115: -0.2417295602941362, miRNA_hsa-mir-17: 0.4804267231387691, miRNA_hsa-mir-130b: -0.5111370358513675, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A1NH,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. No mRNA, methylation, or miRNA features meet diagnostic thresholds for significant dysregulation. These genomic amplifications suggest a proliferative phenotype with potential vesicular trafficking and centrosomal pathway dysregulation.","mRNA_MLPH: 0.6218877853572023, mRNA_C2orf54: -1.1462318171720145, mRNA_CITED4: 1.080090230570934, mRNA_ESR1: 0.8330981650410347, mRNA_SPDEF: 0.3533239652636165, mRNA_AGR3: 0.7787686872386222, mRNA_FOXC1: -0.3286652276680081, mRNA_GATA3: 0.6386537612507094, mRNA_AGR2: 0.5389722316519165, mRNA_XBP1: 0.8466150270077063, mRNA_PRR15: 0.2716870766734667, mRNA_SLC44A4: 0.5609656207986108, mRNA_CA12: 0.1209949052401909, mRNA_DTL: -0.9480767578955058, mRNA_C5AR2: 1.1637906322918876, mRNA_TBC1D9: 0.2114391797946118, mRNA_AR: 0.78642846400255, mRNA_CCDC170: 0.9183966447193568, mRNA_DEGS2: 0.8369558213801594, mRNA_TFF3: 0.3134307703853644, mRNA_DNALI1: 0.1038419490185568, mRNA_LINC00504: 0.0216100816517667, mRNA_CLCA2: 1.1767536909261975, mRNA_PPP1R14C: -0.1067431523556619, mRNA_THSD4: -0.0393872933976799, mRNA_SPAG5: -1.314020701966065, mRNA_FBP1: 0.4013887717878227, mRNA_SLC7A8: 1.0466220941249649, mRNA_EN1: -0.0715344128728215, mRNA_ZNF552: 0.5702927959694167, Methylation_LRRC6: 0.4777937520790278, Methylation_chr2 66218712 LINC02934 (29533): 0.9809810671034758, Methylation_HOXB13: -0.7862225067431473, Methylation_chr10 3949206 LINC02660 (4871): -1.0032166055354157, Methylation_chr5 179517140 RNF130 (18026): 0.7036854994403134, Methylation_LOC727677: -0.0425357032366307, Methylation_LETM1: 0.0459015748920283, Methylation_CDC42BPB: -0.9572999584351554, Methylation_C8orf38: -0.3123339613797872, Methylation_chr14 100504766 EVL (18852): -0.8960220798688641, Methylation_chr5 72594851 LOC340090 (24088): 0.4378506964691166, Methylation_chr2 242904738 LINC01238 (3421): -1.0220151186443194, Methylation_ARFGEF1: -0.1197850946878618, Methylation_MAPT: -0.5491662476019694, Methylation_ZFAT: 0.2922598610038341, Methylation_KCNQ4: 0.7943735032091, Methylation_chr1 232684368 SIPA1L2 (12934): -0.9777517993528408, Methylation_CRNKL1: -0.3562313609368781, Methylation_PRKAG2: 1.232601576455928, Methylation_MICB: -0.8128339897887144, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.7195293444435574, miRNA_hsa-mir-5695: 1.8977866328883413, miRNA_hsa-mir-18a: -0.3188297925202241, miRNA_hsa-mir-190b: 0.60587489155714, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.2518963101019404, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.730602713088389, miRNA_hsa-mir-130b: 0.5800713037624335, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-C8-A1HM,"High-level Amplification of SPAG5 drives significant mRNA overexpression (Z=2.23). DTL mRNA is upregulated (Z=1.71), though without matching CNV. No methylation or miRNA alterations meet diagnostic thresholds. These features collectively indicate a proliferative phenotype with cell cycle dysregulation.","mRNA_MLPH: -0.5353507406554451, mRNA_C2orf54: -1.0377646427515863, mRNA_CITED4: -0.8815526764415901, mRNA_ESR1: 1.0401258726374316, mRNA_SPDEF: 0.2373887800999678, mRNA_AGR3: 0.5597884434876064, mRNA_FOXC1: -0.4627470011956957, mRNA_GATA3: 0.4757598247779064, mRNA_AGR2: 0.7281257135317403, mRNA_XBP1: 0.3680139914405324, mRNA_PRR15: 0.2948542950533349, mRNA_SLC44A4: -0.1499074730599049, mRNA_CA12: 0.8474644453267726, mRNA_DTL: 1.7064106718553465, mRNA_C5AR2: 0.3896501843256789, mRNA_TBC1D9: 0.0303137240294471, mRNA_AR: 0.0665707963734518, mRNA_CCDC170: 0.70527992561036, mRNA_DEGS2: -0.7445792995454042, mRNA_TFF3: -0.355164697459176, mRNA_DNALI1: -0.6851354850398006, mRNA_LINC00504: -0.1130576893950833, mRNA_CLCA2: -0.8702308143791846, mRNA_PPP1R14C: -1.0812064756609236, mRNA_THSD4: 0.4963180697616786, mRNA_SPAG5: 2.2318235866285114, mRNA_FBP1: -0.1240554439869352, mRNA_SLC7A8: 0.7375818271465414, mRNA_EN1: -0.6428153719455857, mRNA_ZNF552: 1.0784675747161487, Methylation_LRRC6: -1.145094830457718, Methylation_chr2 66218712 LINC02934 (29533): -0.2369048679703631, Methylation_HOXB13: 1.174076081249205, Methylation_chr10 3949206 LINC02660 (4871): -0.3228930224850029, Methylation_chr5 179517140 RNF130 (18026): 0.7689316154138742, Methylation_LOC727677: -0.8265004347297192, Methylation_LETM1: -0.4102618889192567, Methylation_CDC42BPB: 1.099088917264727, Methylation_C8orf38: -0.8577651910395451, Methylation_chr14 100504766 EVL (18852): -0.1532417446606579, Methylation_chr5 72594851 LOC340090 (24088): 1.1810887710828175, Methylation_chr2 242904738 LINC01238 (3421): -0.6095502157588361, Methylation_ARFGEF1: -0.5090646489712866, Methylation_MAPT: -0.358644055736552, Methylation_ZFAT: -0.927312201273668, Methylation_KCNQ4: 0.7325589013865488, Methylation_chr1 232684368 SIPA1L2 (12934): -0.2169658574804533, Methylation_CRNKL1: -0.4193868102760164, Methylation_PRKAG2: -1.220619604060354, Methylation_MICB: -0.2158556114545705, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 1.6429157638199656, miRNA_hsa-mir-5695: 1.7717662273681043, miRNA_hsa-mir-18a: 0.6447806920710061, miRNA_hsa-mir-190b: 1.2030404873774143, miRNA_hsa-mir-577: -0.149161594270422, miRNA_hsa-mir-135b: 0.6316388786557443, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.2132656538286683, miRNA_hsa-mir-130b: 1.179587073595996, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-A7-A4SD,"FOXC1 mRNA overexpression (Z=2.45) aligns with no CNV alteration. Promoter hypermethylation of RNF130 (Z=-1.54) and LOC340090 (Z=-1.24) falls below hypomethylation threshold; none meet diagnostic criteria. No miRNA or CNV alterations exceed thresholds. ESR1, SPDEF, AGR3, AGR2, TFF3, FBP1 mRNAs are low (Z < -1.92). Collectively indicate luminal B-like phenotype with ER pathway suppression.","mRNA_MLPH: -1.6050054184869282, mRNA_C2orf54: 0.9121885059136978, mRNA_CITED4: -0.261058791978175, mRNA_ESR1: -1.82300537356342, mRNA_SPDEF: -2.426008021490312, mRNA_AGR3: -1.8922770404044804, mRNA_FOXC1: 2.4494525088723336, mRNA_GATA3: -1.5286794424955186, mRNA_AGR2: -1.986567669530668, mRNA_XBP1: -1.512623549533629, mRNA_PRR15: -2.2826726190771414, mRNA_SLC44A4: -2.0697487924140683, mRNA_CA12: -1.662103823073117, mRNA_DTL: 0.1614383107280016, mRNA_C5AR2: -1.3515910372759534, mRNA_TBC1D9: -1.982134211851342, mRNA_AR: -2.19333643537538, mRNA_CCDC170: -1.555130809875268, mRNA_DEGS2: -1.3833720401371958, mRNA_TFF3: -2.1432628706982246, mRNA_DNALI1: -1.7295684261456947, mRNA_LINC00504: -1.7558974623226091, mRNA_CLCA2: -0.6236894801007905, mRNA_PPP1R14C: 1.178893034538929, mRNA_THSD4: -1.3182152988834317, mRNA_SPAG5: 0.4771525886172594, mRNA_FBP1: -2.0671498341077443, mRNA_SLC7A8: -1.7837936691181528, mRNA_EN1: -0.0704178782812475, mRNA_ZNF552: -1.161673423302226, Methylation_LRRC6: 1.1192370802108549, Methylation_chr2 66218712 LINC02934 (29533): -0.3310509063908293, Methylation_HOXB13: 0.4504815204204179, Methylation_chr10 3949206 LINC02660 (4871): 0.4359542300028238, Methylation_chr5 179517140 RNF130 (18026): -1.5437931778959353, Methylation_LOC727677: 1.4528184579559578, Methylation_LETM1: 1.3598883338373846, Methylation_CDC42BPB: 0.6883746717370447, Methylation_C8orf38: 1.4136870525800302, Methylation_chr14 100504766 EVL (18852): 1.4882160832100233, Methylation_chr5 72594851 LOC340090 (24088): -1.243157141571554, Methylation_chr2 242904738 LINC01238 (3421): -0.4876922356328842, Methylation_ARFGEF1: 0.9091588746176844, Methylation_MAPT: 0.9453675349527662, Methylation_ZFAT: 1.400359903742251, Methylation_KCNQ4: 0.8208701192975567, Methylation_chr1 232684368 SIPA1L2 (12934): 1.32353614041129, Methylation_CRNKL1: 1.3918565660836668, Methylation_PRKAG2: -0.9361235389060032, Methylation_MICB: 1.4222233779371525, miRNA_hsa-mir-934: 1.445084719964291, miRNA_hsa-mir-4728: -0.0081078976913683, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.0410574833737165, miRNA_hsa-mir-190b: -1.6316992922646731, miRNA_hsa-mir-577: -0.370158523866969, miRNA_hsa-mir-135b: 0.9546889733017964, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.033710648832037, miRNA_hsa-mir-130b: -0.53908019741126, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A2-A04R,"mRNA_CITED4 is low (Z = -1.88). Methylation_LETM1 and Methylation_MAPT are hypermethylated (Z = -1.85, -1.62). No miRNAs meet expression thresholds. All CNVs fall within normal range. LETM1 and MAPT promoter hypermethylation may mediate transcriptional silencing, though corresponding mRNA not assessed. CITED4 downregulation suggests potential hypoxia-pathway dysregulation.","mRNA_MLPH: 0.7585596066247134, mRNA_C2orf54: -1.1947015439880937, mRNA_CITED4: -1.880400817610401, mRNA_ESR1: 0.4750230209141293, mRNA_SPDEF: 0.5226342549842564, mRNA_AGR3: 0.8246502092232484, mRNA_FOXC1: -0.6012942723103851, mRNA_GATA3: 0.6920755805650881, mRNA_AGR2: 1.175947984530392, mRNA_XBP1: 0.8426819389705557, mRNA_PRR15: 0.997994088795044, mRNA_SLC44A4: 0.0507084713413598, mRNA_CA12: 0.951664210821899, mRNA_DTL: 1.2010906162386603, mRNA_C5AR2: -0.0287717371292681, mRNA_TBC1D9: 0.6643973751593865, mRNA_AR: 0.5220831459523837, mRNA_CCDC170: -0.1846624487449452, mRNA_DEGS2: 1.051003639812361, mRNA_TFF3: 0.6436320969806909, mRNA_DNALI1: 0.523245999599649, mRNA_LINC00504: 0.6921968767592002, mRNA_CLCA2: -0.8075763881801664, mRNA_PPP1R14C: -0.620580980111141, mRNA_THSD4: 0.2098782538535936, mRNA_SPAG5: 1.1871447013988528, mRNA_FBP1: -0.003742217155298, mRNA_SLC7A8: -0.0377601977325745, mRNA_EN1: -0.4801264837310935, mRNA_ZNF552: 0.6102755984576665, Methylation_LRRC6: -1.5444175412384136, Methylation_chr2 66218712 LINC02934 (29533): -0.9166582892910746, Methylation_HOXB13: -1.0362309444130116, Methylation_chr10 3949206 LINC02660 (4871): -1.3078469837911784, Methylation_chr5 179517140 RNF130 (18026): 1.2594200874297212, Methylation_LOC727677: -1.4507292425370435, Methylation_LETM1: -1.8506883429949288, Methylation_CDC42BPB: 1.3613713383552548, Methylation_C8orf38: 0.3610742528251295, Methylation_chr14 100504766 EVL (18852): -1.4595343865441508, Methylation_chr5 72594851 LOC340090 (24088): 1.24351779423361, Methylation_chr2 242904738 LINC01238 (3421): -1.1291005117856807, Methylation_ARFGEF1: -1.032717512927866, Methylation_MAPT: -1.62330331436732, Methylation_ZFAT: -1.2186998407898026, Methylation_KCNQ4: 1.4960034044309372, Methylation_chr1 232684368 SIPA1L2 (12934): -1.4373012306975186, Methylation_CRNKL1: -1.5578045006206451, Methylation_PRKAG2: -1.106852115006786, Methylation_MICB: -0.2380994634985501, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.3207696249539001, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.1635151453041788, miRNA_hsa-mir-190b: 0.9484711779120768, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.5464481273690703, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.0385647489036538, miRNA_hsa-mir-130b: 0.0582809600836608, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AN-A0XR,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-significant ranges per specified Z-score and CNV cutoffs.","mRNA_MLPH: 0.890905243958054, mRNA_C2orf54: -0.5217342870195308, mRNA_CITED4: 0.3713516888606632, mRNA_ESR1: 1.0767687426683328, mRNA_SPDEF: 0.6958760852346757, mRNA_AGR3: 0.6317474731450363, mRNA_FOXC1: -1.0932216437650135, mRNA_GATA3: 0.7897950513823742, mRNA_AGR2: 0.6292965760207923, mRNA_XBP1: 0.4750721501395998, mRNA_PRR15: 0.7737427642914592, mRNA_SLC44A4: 0.7792956405338809, mRNA_CA12: 0.8732351470049085, mRNA_DTL: 1.112966045005093, mRNA_C5AR2: 1.128488975846268, mRNA_TBC1D9: 0.7691737535760861, mRNA_AR: 0.8828807024071549, mRNA_CCDC170: 0.7364907668289166, mRNA_DEGS2: 1.0584302676792776, mRNA_TFF3: 0.639265877445591, mRNA_DNALI1: 1.055590312778936, mRNA_LINC00504: 1.2241790248686226, mRNA_CLCA2: -0.3921083633932492, mRNA_PPP1R14C: -0.948101409677342, mRNA_THSD4: 0.2837334573670557, mRNA_SPAG5: 0.795815718599448, mRNA_FBP1: 1.152996625542417, mRNA_SLC7A8: 1.3688080910291571, mRNA_EN1: -0.0317469995477916, mRNA_ZNF552: 0.8804844033235089, Methylation_LRRC6: -1.1534959478127316, Methylation_chr2 66218712 LINC02934 (29533): -0.3058966777706916, Methylation_HOXB13: -0.6883766675856271, Methylation_chr10 3949206 LINC02660 (4871): -1.2806056600449052, Methylation_chr5 179517140 RNF130 (18026): 1.2427473880660649, Methylation_LOC727677: -0.7825944207482379, Methylation_LETM1: -0.8908893314511173, Methylation_CDC42BPB: -0.7171417509466089, Methylation_C8orf38: -0.172590562634124, Methylation_chr14 100504766 EVL (18852): -1.2589853534113191, Methylation_chr5 72594851 LOC340090 (24088): 1.34862386946657, Methylation_chr2 242904738 LINC01238 (3421): -1.2596478630611694, Methylation_ARFGEF1: -1.3092944364586605, Methylation_MAPT: -1.064140454804079, Methylation_ZFAT: 1.3403943203821722, Methylation_KCNQ4: -1.0291300705414983, Methylation_chr1 232684368 SIPA1L2 (12934): -1.1926862294975598, Methylation_CRNKL1: -0.6414240765584989, Methylation_PRKAG2: -0.3349111464075761, Methylation_MICB: -0.6700994618484003, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: 1.717649159167334, miRNA_hsa-mir-18a: 0.0971893259283412, miRNA_hsa-mir-190b: 1.2334144515145031, miRNA_hsa-mir-577: -0.4031114212244034, miRNA_hsa-mir-135b: -0.3047776682876338, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.3555180976582684, miRNA_hsa-mir-130b: -0.2379962341358813, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-EW-A1OW,"High-level Amplification absent; no CNVs meet amplification thresholds.  
mRNA_MLPH, mRNA_ESR1, mRNA_AGR2, mRNA_FBP1 show low expression (Z < -1.92).  
mRNA_EN1 shows high expression (Z > 1.30).  
Methylation_KCNQ4, Methylation_ARFGEF1, Methylation_chr14:100504766 hypermethylated (Z > 1.50).  
Methylation_RNF130, Methylation_LOC340090, Methylation_PRKAG2 hypomethylated (Z < -1.47).  
miRNA_hsa-mir-934 and miRNA_hsa-mir-577 upregulated (Z > 1.99).  
miRNA_hsa-mir-190b downregulated (Z < -1.25).","mRNA_MLPH: -2.5404176597686705, mRNA_C2orf54: 0.53089166597655, mRNA_CITED4: 0.9003342824298552, mRNA_ESR1: -2.0115345690623347, mRNA_SPDEF: -1.3170203061404986, mRNA_AGR3: -1.9373051956934773, mRNA_FOXC1: 1.9894717422223809, mRNA_GATA3: -1.5695718699655383, mRNA_AGR2: -2.4399121717650387, mRNA_XBP1: -1.8700001017923744, mRNA_PRR15: -1.7126471847771707, mRNA_SLC44A4: -2.3349908448043086, mRNA_CA12: -1.6058182778517525, mRNA_DTL: 1.6925569297846723, mRNA_C5AR2: -1.6225521811421648, mRNA_TBC1D9: -1.500696812506315, mRNA_AR: -1.111061061462771, mRNA_CCDC170: -1.3831363364908669, mRNA_DEGS2: -1.9030488651494584, mRNA_TFF3: -1.7501316022324058, mRNA_DNALI1: -1.5273427927895165, mRNA_LINC00504: -1.6766938951256622, mRNA_CLCA2: -0.4110811163174491, mRNA_PPP1R14C: 1.8823883644815231, mRNA_THSD4: -1.1285032520584972, mRNA_SPAG5: 1.3845160025693637, mRNA_FBP1: -2.356699489664537, mRNA_SLC7A8: -1.7387663229432355, mRNA_EN1: 2.702096749206456, mRNA_ZNF552: -1.4480539516681916, Methylation_LRRC6: 1.4977722182990658, Methylation_chr2 66218712 LINC02934 (29533): -1.4589184869837368, Methylation_HOXB13: 1.2487902640243949, Methylation_chr10 3949206 LINC02660 (4871): 1.1625573702892185, Methylation_chr5 179517140 RNF130 (18026): -1.6689413230302548, Methylation_LOC727677: 1.532247978214179, Methylation_LETM1: 1.340829188815886, Methylation_CDC42BPB: 0.8861102413901529, Methylation_C8orf38: 1.4091166456422368, Methylation_chr14 100504766 EVL (18852): 1.5032865711533887, Methylation_chr5 72594851 LOC340090 (24088): -1.5479735110933088, Methylation_chr2 242904738 LINC01238 (3421): 1.4575062530028322, Methylation_ARFGEF1: 1.6445166060623015, Methylation_MAPT: 1.503759989740912, Methylation_ZFAT: 1.3035003296995358, Methylation_KCNQ4: 1.796240790219815, Methylation_chr1 232684368 SIPA1L2 (12934): 1.6123113363737327, Methylation_CRNKL1: 1.4319285785139002, Methylation_PRKAG2: -1.602319750604546, Methylation_MICB: 1.5507108809876704, miRNA_hsa-mir-934: 3.358599737172009, miRNA_hsa-mir-4728: -1.04428730237375, miRNA_hsa-mir-5695: -0.1143081207343518, miRNA_hsa-mir-18a: 0.4563118470610976, miRNA_hsa-mir-190b: -1.518706311225636, miRNA_hsa-mir-577: 2.3333052074495515, miRNA_hsa-mir-135b: 1.735365464667951, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.288857724406214, miRNA_hsa-mir-130b: 0.8918090083580225, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-AC-A2FE,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.8345023233623667, mRNA_C2orf54: 1.0902627779599612, mRNA_CITED4: -1.8237099724472123, mRNA_ESR1: 0.0797213473564084, mRNA_SPDEF: 0.4806741358912855, mRNA_AGR3: 0.4027422668805839, mRNA_FOXC1: 0.0483440046116755, mRNA_GATA3: 0.2865764179607376, mRNA_AGR2: 0.277346147460818, mRNA_XBP1: 0.9321560790579216, mRNA_PRR15: 0.7575227599367962, mRNA_SLC44A4: 0.5052569270279649, mRNA_CA12: 0.6882416156315382, mRNA_DTL: -0.7457656438222923, mRNA_C5AR2: 1.0300309778074794, mRNA_TBC1D9: 0.4424514125099389, mRNA_AR: 0.1575729018212915, mRNA_CCDC170: -0.084251662594236, mRNA_DEGS2: 1.3412667315251623, mRNA_TFF3: 1.2417610446013403, mRNA_DNALI1: -0.0773821888329511, mRNA_LINC00504: 0.1434120978066762, mRNA_CLCA2: -0.5031969204027567, mRNA_PPP1R14C: -0.7324949251418227, mRNA_THSD4: 0.4204904896428242, mRNA_SPAG5: -1.0921744519764007, mRNA_FBP1: 0.825012770143326, mRNA_SLC7A8: 0.3791564840118568, mRNA_EN1: -0.4945246314985649, mRNA_ZNF552: 0.3385104183835623, Methylation_LRRC6: 1.0964026892450236, Methylation_chr2 66218712 LINC02934 (29533): 1.0312475715355234, Methylation_HOXB13: 0.4120332092434861, Methylation_chr10 3949206 LINC02660 (4871): 0.8527278841287185, Methylation_chr5 179517140 RNF130 (18026): 0.257462826916644, Methylation_LOC727677: 0.5453203887066578, Methylation_LETM1: 0.1786617467249108, Methylation_CDC42BPB: 1.120896927026322, Methylation_C8orf38: 0.4734650302925939, Methylation_chr14 100504766 EVL (18852): 0.6706088455432551, Methylation_chr5 72594851 LOC340090 (24088): 0.2563078813704709, Methylation_chr2 242904738 LINC01238 (3421): 0.1361382370011791, Methylation_ARFGEF1: 0.7974738784626494, Methylation_MAPT: 0.2331988979510142, Methylation_ZFAT: 0.3363260797681351, Methylation_KCNQ4: -0.3393112498869748, Methylation_chr1 232684368 SIPA1L2 (12934): 0.7298800943513089, Methylation_CRNKL1: 0.7923145382374457, Methylation_PRKAG2: 0.9243775287521016, Methylation_MICB: 1.177621854363207, miRNA_hsa-mir-934: -0.2970213024203048, miRNA_hsa-mir-4728: -0.5544775675877159, miRNA_hsa-mir-5695: -0.4367753825981058, miRNA_hsa-mir-18a: -0.4222865763638816, miRNA_hsa-mir-190b: 0.3282212541874668, miRNA_hsa-mir-577: -0.6797035160775892, miRNA_hsa-mir-135b: 0.6161196520838337, miRNA_hsa-mir-2115: -0.4298410725405888, miRNA_hsa-mir-17: -0.1855576900383525, miRNA_hsa-mir-130b: -0.9235790311182136, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-GI-A2C8,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.2371991096128381, mRNA_C2orf54: -0.6287698189786589, mRNA_CITED4: 0.1974266303898819, mRNA_ESR1: 0.2365559086100521, mRNA_SPDEF: 0.153141962051364, mRNA_AGR3: 0.5316829055587847, mRNA_FOXC1: -0.4391932122794352, mRNA_GATA3: 0.3633853343687473, mRNA_AGR2: -0.3069322412621841, mRNA_XBP1: 0.9056365598480346, mRNA_PRR15: 0.4871517320319508, mRNA_SLC44A4: 0.485823145975314, mRNA_CA12: 0.5888679558976787, mRNA_DTL: -2.6741030624857416, mRNA_C5AR2: -1.3166693423574498, mRNA_TBC1D9: 0.0724614354952856, mRNA_AR: 0.3291121407790596, mRNA_CCDC170: -0.1620238931099758, mRNA_DEGS2: -0.0341989833001978, mRNA_TFF3: -1.073332733507918, mRNA_DNALI1: 0.1238207415960808, mRNA_LINC00504: -0.1894520035584973, mRNA_CLCA2: -0.0230046802557159, mRNA_PPP1R14C: -0.0063432038525402, mRNA_THSD4: 0.3079623831813945, mRNA_SPAG5: -2.229996354383056, mRNA_FBP1: 1.2304462600434647, mRNA_SLC7A8: 1.012226332750994, mRNA_EN1: -0.2888160687750274, mRNA_ZNF552: 0.5118948550430727, Methylation_LRRC6: -0.0829065960795509, Methylation_chr2 66218712 LINC02934 (29533): 1.0861884336252547, Methylation_HOXB13: -0.3912121843225559, Methylation_chr10 3949206 LINC02660 (4871): -0.6885088840136927, Methylation_chr5 179517140 RNF130 (18026): 0.6156202277474028, Methylation_LOC727677: 0.7701134761136651, Methylation_LETM1: 0.7687182473850618, Methylation_CDC42BPB: 1.3433440765822704, Methylation_C8orf38: -1.245826201153018, Methylation_chr14 100504766 EVL (18852): -0.5660874224732094, Methylation_chr5 72594851 LOC340090 (24088): 0.422723855496359, Methylation_chr2 242904738 LINC01238 (3421): -0.8435497046083877, Methylation_ARFGEF1: -1.039232517539297, Methylation_MAPT: 1.3282016348820544, Methylation_ZFAT: -0.164280012624032, Methylation_KCNQ4: 0.0287262784377777, Methylation_chr1 232684368 SIPA1L2 (12934): -0.2739858872518989, Methylation_CRNKL1: 0.1129385381248581, Methylation_PRKAG2: -0.7535217630388938, Methylation_MICB: 1.3315781034830074, miRNA_hsa-mir-934: -0.5233725308783921, miRNA_hsa-mir-4728: -1.0890967616386642, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.7902073467847373, miRNA_hsa-mir-190b: -1.1745995376904066, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.9908148311281826, miRNA_hsa-mir-2115: 1.1060113049018176, miRNA_hsa-mir-17: -1.6746612111938766, miRNA_hsa-mir-130b: -1.7124365810873177, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-PL-A8LV,"High-level Amplification of VPS54 drives mRNA overexpression.  
HOXB13 and LINC02660 promoter hypermethylation suggest epigenetic silencing.  
miR-577, miR-135b, and miR-17 are markedly upregulated; miR-18a near-threshold.  
These features indicate a luminal B-like phenotype with PI3K/AKT/mTOR dysregulation.","mRNA_MLPH: -1.6786607644714628, mRNA_C2orf54: 1.2893528595579156, mRNA_CITED4: -1.0757245600916097, mRNA_ESR1: -1.857719611316204, mRNA_SPDEF: -2.3393251736674663, mRNA_AGR3: -1.5868958916037743, mRNA_FOXC1: 0.9345633640933452, mRNA_GATA3: -2.560197546164261, mRNA_AGR2: -2.033561318050588, mRNA_XBP1: -1.8636759540443768, mRNA_PRR15: -1.340355832802549, mRNA_SLC44A4: -1.0190126491455542, mRNA_CA12: -2.2306879637580384, mRNA_DTL: 0.0731816554974719, mRNA_C5AR2: -2.0309879008983707, mRNA_TBC1D9: -1.9978571313803808, mRNA_AR: -2.0606031719739453, mRNA_CCDC170: -1.699728016060271, mRNA_DEGS2: -1.7533051499841, mRNA_TFF3: -1.7134750959070817, mRNA_DNALI1: -1.5421485548909182, mRNA_LINC00504: -1.6111059373930905, mRNA_CLCA2: -0.8421714266057553, mRNA_PPP1R14C: 2.38822101105664, mRNA_THSD4: -1.798252994018554, mRNA_SPAG5: -0.3652533826371988, mRNA_FBP1: -1.4689724917007645, mRNA_SLC7A8: -1.9644640716937487, mRNA_EN1: 1.8199685321524208, mRNA_ZNF552: -1.8549553544494384, Methylation_LRRC6: 1.4884373278132603, Methylation_chr2 66218712 LINC02934 (29533): -0.0372659443389302, Methylation_HOXB13: 1.5590518578506007, Methylation_chr10 3949206 LINC02660 (4871): 1.671266327812134, Methylation_chr5 179517140 RNF130 (18026): -1.6612376812838925, Methylation_LOC727677: 1.4025380852640237, Methylation_LETM1: 1.2821039636363052, Methylation_CDC42BPB: 0.9280959522122852, Methylation_C8orf38: 1.629230384427421, Methylation_chr14 100504766 EVL (18852): 1.523892123952289, Methylation_chr5 72594851 LOC340090 (24088): -1.467126032256291, Methylation_chr2 242904738 LINC01238 (3421): 1.3820426509806745, Methylation_ARFGEF1: 1.4686850927828508, Methylation_MAPT: 1.401761355273212, Methylation_ZFAT: 1.0847172162564216, Methylation_KCNQ4: 0.194821366731468, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5499227088671568, Methylation_CRNKL1: 1.4537760274486675, Methylation_PRKAG2: -0.8620437515640377, Methylation_MICB: 1.2623591906729976, miRNA_hsa-mir-934: 1.5738092786510165, miRNA_hsa-mir-4728: -0.6761643276111906, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.9714162176266048, miRNA_hsa-mir-190b: -0.9663162165804032, miRNA_hsa-mir-577: 2.3935372282929817, miRNA_hsa-mir-135b: 2.164069536576386, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 2.260810968187016, miRNA_hsa-mir-130b: 0.8764266399252516, CNV_VPS54: 2.3735003872816955, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-E2-A1L7,"No mRNA, methylation, or miRNA features meet diagnostic thresholds. All CNVs fall within the normal range (−1.10 to −0.10). No actionable molecular alterations detected.","mRNA_MLPH: -0.0522690883368694, mRNA_C2orf54: 1.2165411106407968, mRNA_CITED4: -0.6721362071772417, mRNA_ESR1: 0.3658727938123209, mRNA_SPDEF: -0.3282011490000087, mRNA_AGR3: 0.1153138217754221, mRNA_FOXC1: -0.8634496416526188, mRNA_GATA3: -0.1355604241322339, mRNA_AGR2: 0.0888251745852539, mRNA_XBP1: 0.415843417527912, mRNA_PRR15: -0.8363751192328301, mRNA_SLC44A4: -0.699971622283342, mRNA_CA12: -0.1330005924907172, mRNA_DTL: 1.097312494883374, mRNA_C5AR2: 0.4772088606061228, mRNA_TBC1D9: -0.5449179199633691, mRNA_AR: 0.5836056693459745, mRNA_CCDC170: -0.2630772177716967, mRNA_DEGS2: 0.7608644737990814, mRNA_TFF3: 0.2424834612958548, mRNA_DNALI1: 1.1345518653323132, mRNA_LINC00504: -0.2017007422163004, mRNA_CLCA2: 0.810644295462308, mRNA_PPP1R14C: 0.7953538791485251, mRNA_THSD4: -0.767966724897918, mRNA_SPAG5: 1.022133265105208, mRNA_FBP1: 0.1730983671834604, mRNA_SLC7A8: 0.206972934446025, mRNA_EN1: -0.5544295488555663, mRNA_ZNF552: -0.44569718266551, Methylation_LRRC6: -0.5093367029310366, Methylation_chr2 66218712 LINC02934 (29533): -0.4205576212872629, Methylation_HOXB13: 0.5837151907605653, Methylation_chr10 3949206 LINC02660 (4871): -0.666283715999658, Methylation_chr5 179517140 RNF130 (18026): 0.835523333929998, Methylation_LOC727677: 1.0454148248265904, Methylation_LETM1: -0.7167551115390048, Methylation_CDC42BPB: -1.2527176105715625, Methylation_C8orf38: 0.2427403037710938, Methylation_chr14 100504766 EVL (18852): -0.6355726330104406, Methylation_chr5 72594851 LOC340090 (24088): 0.7058236785000506, Methylation_chr2 242904738 LINC01238 (3421): 0.885926341745124, Methylation_ARFGEF1: -1.2474038548419482, Methylation_MAPT: -0.2419776667404817, Methylation_ZFAT: 0.7306581142797792, Methylation_KCNQ4: 0.8852070415910119, Methylation_chr1 232684368 SIPA1L2 (12934): -0.7162058475304196, Methylation_CRNKL1: 0.0767542783393346, Methylation_PRKAG2: 0.1383957818529929, Methylation_MICB: 1.4478051971912134, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.0326504737489606, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 2.265937497138176, miRNA_hsa-mir-190b: 1.676260620333801, miRNA_hsa-mir-577: 1.8516180980446588, miRNA_hsa-mir-135b: 1.465521287466598, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 2.0582107500192173, miRNA_hsa-mir-130b: 3.689704940970824, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A2LL,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.5755886502360812, mRNA_C2orf54: -1.2788702395229774, mRNA_CITED4: -0.0013039316346635, mRNA_ESR1: 1.2407209716534926, mRNA_SPDEF: 0.7163944241580383, mRNA_AGR3: 0.1131090331938739, mRNA_FOXC1: -0.8820815789545219, mRNA_GATA3: 0.6465807696794934, mRNA_AGR2: 0.1017368416580783, mRNA_XBP1: 0.7855448771442102, mRNA_PRR15: 0.373643714879191, mRNA_SLC44A4: 0.4603096533838307, mRNA_CA12: 0.829930887407015, mRNA_DTL: 0.3183202381926696, mRNA_C5AR2: 0.5263412982813646, mRNA_TBC1D9: -0.6432894051747681, mRNA_AR: 0.9616632716711788, mRNA_CCDC170: 0.3339378092851109, mRNA_DEGS2: 1.208641440858658, mRNA_TFF3: -0.07633007752421, mRNA_DNALI1: 0.5310891391616893, mRNA_LINC00504: -0.1966961576585386, mRNA_CLCA2: -0.8142943972251873, mRNA_PPP1R14C: -0.8760741581905357, mRNA_THSD4: 0.6018782634380925, mRNA_SPAG5: 0.6511495230794745, mRNA_FBP1: 0.2190948422368969, mRNA_SLC7A8: -0.0834292427420493, mRNA_EN1: -0.7514623644193221, mRNA_ZNF552: 0.9500583158500572, Methylation_LRRC6: -1.1015603278949444, Methylation_chr2 66218712 LINC02934 (29533): 1.0118090576706775, Methylation_HOXB13: 0.6585887175055573, Methylation_chr10 3949206 LINC02660 (4871): -1.0090136412615411, Methylation_chr5 179517140 RNF130 (18026): 0.194521634954932, Methylation_LOC727677: -0.8201375073880707, Methylation_LETM1: -1.0655872054576707, Methylation_CDC42BPB: 1.1952478588029671, Methylation_C8orf38: -0.969975041034712, Methylation_chr14 100504766 EVL (18852): -0.6565515224802535, Methylation_chr5 72594851 LOC340090 (24088): 0.7903244840464083, Methylation_chr2 242904738 LINC01238 (3421): -0.8757551138169376, Methylation_ARFGEF1: -1.202484295144509, Methylation_MAPT: -1.2781347759234012, Methylation_ZFAT: -1.1378210542264648, Methylation_KCNQ4: 1.1514575198871255, Methylation_chr1 232684368 SIPA1L2 (12934): -1.1801579158172917, Methylation_CRNKL1: -0.8747809247313401, Methylation_PRKAG2: 0.8393216033373821, Methylation_MICB: -0.7642784555853663, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.0250332681604551, miRNA_hsa-mir-5695: -0.0308002656898995, miRNA_hsa-mir-18a: -0.1669711579307083, miRNA_hsa-mir-190b: -0.3937403978454635, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: 0.6800014502106347, miRNA_hsa-mir-17: -0.8142420170906227, miRNA_hsa-mir-130b: -0.3600619690505859, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A0C0,"High-level Amplification of LINC01867 drives no qualifying mRNA change. HOXB13 promoter hypermethylation (Z=1.51) suggests epigenetic silencing. No miRNAs meet up/downregulation thresholds. CCDC170 mRNA is highly expressed (Z=1.90), SPAG5 elevated (Z=1.12). These features indicate a luminal phenotype with potential HOX pathway dysregulation.","mRNA_MLPH: -0.5212300886887312, mRNA_C2orf54: 0.6173361104320738, mRNA_CITED4: 0.536677110140896, mRNA_ESR1: 0.573141000519755, mRNA_SPDEF: 0.2522627323700946, mRNA_AGR3: -0.5274905771537617, mRNA_FOXC1: -1.1239084508303692, mRNA_GATA3: 0.3750805435656763, mRNA_AGR2: 0.1353166360988688, mRNA_XBP1: 1.0934926306051558, mRNA_PRR15: -0.6911132083917413, mRNA_SLC44A4: -0.483399234463047, mRNA_CA12: 0.6451690389908574, mRNA_DTL: 0.7412173066468349, mRNA_C5AR2: 0.1725941548311049, mRNA_TBC1D9: -0.4146010794625557, mRNA_AR: 0.4115505854920545, mRNA_CCDC170: 1.8994620247055765, mRNA_DEGS2: 0.6476150084762957, mRNA_TFF3: -1.2596480189949602, mRNA_DNALI1: 0.8139303811098992, mRNA_LINC00504: -1.0659050501578882, mRNA_CLCA2: 0.3845196486248771, mRNA_PPP1R14C: -0.244381632963431, mRNA_THSD4: -0.3262499004567256, mRNA_SPAG5: 1.1229562418698549, mRNA_FBP1: 0.6128466844819054, mRNA_SLC7A8: 0.0589601142283784, mRNA_EN1: -0.6178985541689582, mRNA_ZNF552: 0.1647777065903853, Methylation_LRRC6: -0.4905643948430676, Methylation_chr2 66218712 LINC02934 (29533): 1.2814993823064695, Methylation_HOXB13: 1.514280532284987, Methylation_chr10 3949206 LINC02660 (4871): 0.2899044391845418, Methylation_chr5 179517140 RNF130 (18026): -1.3276564184908333, Methylation_LOC727677: 0.8925181635202932, Methylation_LETM1: 1.0585990312624671, Methylation_CDC42BPB: 0.2916960293366549, Methylation_C8orf38: -0.2771253814488529, Methylation_chr14 100504766 EVL (18852): 0.8657327620967971, Methylation_chr5 72594851 LOC340090 (24088): 0.5964446084526507, Methylation_chr2 242904738 LINC01238 (3421): 1.1013139099207478, Methylation_ARFGEF1: 1.0075497316260535, Methylation_MAPT: 0.5310144866281618, Methylation_ZFAT: 0.1315339706280235, Methylation_KCNQ4: 0.488352819163857, Methylation_chr1 232684368 SIPA1L2 (12934): 0.6700769739112107, Methylation_CRNKL1: 1.042710646866949, Methylation_PRKAG2: -0.4842895117586824, Methylation_MICB: 0.8600599598226919, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.3361137740861326, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.2019849848574555, miRNA_hsa-mir-190b: -0.2843823420780743, miRNA_hsa-mir-577: 1.1036370923266263, miRNA_hsa-mir-135b: 0.2768235872321548, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.1226850570405766, miRNA_hsa-mir-130b: 1.5249694112905898, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-AC-A8OP,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-significant ranges per specified criteria.","mRNA_MLPH: 0.8425979319801749, mRNA_C2orf54: -0.9797622011536684, mRNA_CITED4: 0.2285805952701841, mRNA_ESR1: 0.8613373289819424, mRNA_SPDEF: 0.0889261371048354, mRNA_AGR3: 1.0475679686308288, mRNA_FOXC1: -0.0961904265225002, mRNA_GATA3: 1.0594206968212974, mRNA_AGR2: 0.9398333242383956, mRNA_XBP1: -5.007450951876939e-05, mRNA_PRR15: -0.492469726268516, mRNA_SLC44A4: 0.293533256844775, mRNA_CA12: 0.9859109333097428, mRNA_DTL: -0.3096480179496167, mRNA_C5AR2: 0.7433753183269033, mRNA_TBC1D9: 1.2842789444880414, mRNA_AR: 0.2963630954403482, mRNA_CCDC170: 0.428543402201583, mRNA_DEGS2: 1.1357251870890015, mRNA_TFF3: -1.3460232748541092, mRNA_DNALI1: 0.5351978373466549, mRNA_LINC00504: -0.4619939223975787, mRNA_CLCA2: -0.5137286679228178, mRNA_PPP1R14C: -0.6607160362011015, mRNA_THSD4: 1.116660010028671, mRNA_SPAG5: 0.3816788955187671, mRNA_FBP1: 0.7741120831755106, mRNA_SLC7A8: -0.0518901947344635, mRNA_EN1: -0.7542288057756593, mRNA_ZNF552: 1.4754395881831983, Methylation_LRRC6: -0.6820488481511163, Methylation_chr2 66218712 LINC02934 (29533): 0.2260529797834696, Methylation_HOXB13: 1.0607282992365523, Methylation_chr10 3949206 LINC02660 (4871): -0.4613444840898056, Methylation_chr5 179517140 RNF130 (18026): 0.6612521607410577, Methylation_LOC727677: 1.4208923831938085, Methylation_LETM1: -0.1383860843428356, Methylation_CDC42BPB: 0.6807241133902485, Methylation_C8orf38: -0.911232589878322, Methylation_chr14 100504766 EVL (18852): 0.0943053996346905, Methylation_chr5 72594851 LOC340090 (24088): 0.7775318338399165, Methylation_chr2 242904738 LINC01238 (3421): -0.9614382475468896, Methylation_ARFGEF1: -0.1263870442412935, Methylation_MAPT: -0.4240404654716934, Methylation_ZFAT: -0.5416100092916472, Methylation_KCNQ4: 0.8681591308452933, Methylation_chr1 232684368 SIPA1L2 (12934): -0.5306203062739464, Methylation_CRNKL1: -0.639955157234948, Methylation_PRKAG2: -1.0271108096871728, Methylation_MICB: -0.0550401908733473, miRNA_hsa-mir-934: -0.3718068933773136, miRNA_hsa-mir-4728: -0.6142441769114065, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.6144397570212347, miRNA_hsa-mir-190b: -1.0613011703323192, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.6058818878635164, miRNA_hsa-mir-2115: 0.0696404609527661, miRNA_hsa-mir-17: 0.2173332523324231, miRNA_hsa-mir-130b: -0.639907223018873, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-AR-A24Q,"High-level Amplification of EN1 and FOXC1 drives mRNA overexpression. Promoter hypermethylation of C8orf38, ARFGEF1, and SIPA1L2 mediates epigenetic silencing. Downregulated miRNAs include hsa-mir-190b; upregulated miRNAs include hsa-mir-934 and hsa-mir-577. These features indicate a basal-like phenotype with ESR1 pathway suppression.","mRNA_MLPH: -1.818123584873964, mRNA_C2orf54: -0.9234916042608338, mRNA_CITED4: 0.8595080947736212, mRNA_ESR1: -1.3632173192768111, mRNA_SPDEF: -1.718851023951641, mRNA_AGR3: -1.1206618894001366, mRNA_FOXC1: 2.273086233519793, mRNA_GATA3: -1.9689272468430865, mRNA_AGR2: -1.048787163175263, mRNA_XBP1: -1.5137157447079137, mRNA_PRR15: -1.922388271594204, mRNA_SLC44A4: -1.1388150425643289, mRNA_CA12: -1.3746580652275842, mRNA_DTL: 0.8714267624179762, mRNA_C5AR2: -1.512724531014981, mRNA_TBC1D9: -1.2252588856617366, mRNA_AR: -1.1759980226895594, mRNA_CCDC170: -1.2500047146889333, mRNA_DEGS2: -1.75203695654161, mRNA_TFF3: -1.110059992909376, mRNA_DNALI1: -1.31768473090395, mRNA_LINC00504: -1.4428369008442612, mRNA_CLCA2: -0.8468809471175095, mRNA_PPP1R14C: 1.0250859554473095, mRNA_THSD4: -1.4844905955260497, mRNA_SPAG5: -0.1141576519526282, mRNA_FBP1: -1.353208196025426, mRNA_SLC7A8: -1.5092605819160894, mRNA_EN1: 2.743655558492444, mRNA_ZNF552: -1.1332206408821337, Methylation_LRRC6: 1.46439784202502, Methylation_chr2 66218712 LINC02934 (29533): -1.180873183386259, Methylation_HOXB13: 0.1270988012345172, Methylation_chr10 3949206 LINC02660 (4871): 1.4702453636111863, Methylation_chr5 179517140 RNF130 (18026): -1.6111584405930677, Methylation_LOC727677: 1.480868413683184, Methylation_LETM1: 1.337628992938365, Methylation_CDC42BPB: -0.6775454692852265, Methylation_C8orf38: 1.6585242774921884, Methylation_chr14 100504766 EVL (18852): 1.4418000708843306, Methylation_chr5 72594851 LOC340090 (24088): -1.45055675360433, Methylation_chr2 242904738 LINC01238 (3421): 1.42437784632302, Methylation_ARFGEF1: 1.5187644137790894, Methylation_MAPT: 1.4056806736728131, Methylation_ZFAT: 1.4351942028274949, Methylation_KCNQ4: 1.284161248072359, Methylation_chr1 232684368 SIPA1L2 (12934): 1.6102205889204495, Methylation_CRNKL1: 1.3882610594351985, Methylation_PRKAG2: -0.5691606836573299, Methylation_MICB: 1.4934999386703778, miRNA_hsa-mir-934: 2.30595734720284, miRNA_hsa-mir-4728: 0.3598453188892492, miRNA_hsa-mir-5695: 0.5608673666707555, miRNA_hsa-mir-18a: -0.3322295866051787, miRNA_hsa-mir-190b: -1.4653568516851372, miRNA_hsa-mir-577: 2.71287768397852, miRNA_hsa-mir-135b: 1.379347502435036, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.291827495207534, miRNA_hsa-mir-130b: 0.6585442724678969, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-E9-A1R2,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.3748759217704961, mRNA_C2orf54: 0.7511513266345875, mRNA_CITED4: -0.6868181040324742, mRNA_ESR1: 0.5626588403191225, mRNA_SPDEF: 0.3237630345793709, mRNA_AGR3: 0.013249268222988, mRNA_FOXC1: 0.3300215470514351, mRNA_GATA3: 0.8318708508584689, mRNA_AGR2: 0.4558441496342, mRNA_XBP1: 0.1056989719258458, mRNA_PRR15: 0.1788616140335651, mRNA_SLC44A4: -0.5769981483441015, mRNA_CA12: 1.1920719720498698, mRNA_DTL: -0.1869299480416119, mRNA_C5AR2: 1.658444933442304, mRNA_TBC1D9: 0.7025519954583728, mRNA_AR: -1.1718487052890392, mRNA_CCDC170: 0.2276099189242769, mRNA_DEGS2: -0.5177445034398542, mRNA_TFF3: 0.6311989393652391, mRNA_DNALI1: 1.531553228620353, mRNA_LINC00504: 0.2549742907507243, mRNA_CLCA2: -0.1215246914392877, mRNA_PPP1R14C: -0.5333973624258622, mRNA_THSD4: -0.1659060519016559, mRNA_SPAG5: 0.4591146403803401, mRNA_FBP1: 0.3560269139982635, mRNA_SLC7A8: 1.120870752742005, mRNA_EN1: -0.6632351992898042, mRNA_ZNF552: 0.7758835717015692, Methylation_LRRC6: -0.9278099088849996, Methylation_chr2 66218712 LINC02934 (29533): 1.0736557979724093, Methylation_HOXB13: -0.9115131611534124, Methylation_chr10 3949206 LINC02660 (4871): -0.7587504498714193, Methylation_chr5 179517140 RNF130 (18026): 0.8922993801447169, Methylation_LOC727677: -0.7105221741585716, Methylation_LETM1: -0.925101846899759, Methylation_CDC42BPB: 0.8543146024653323, Methylation_C8orf38: 0.6768939121534203, Methylation_chr14 100504766 EVL (18852): 0.4405691566989446, Methylation_chr5 72594851 LOC340090 (24088): 0.8236814361986411, Methylation_chr2 242904738 LINC01238 (3421): -0.6591623692730302, Methylation_ARFGEF1: -0.7632729758703599, Methylation_MAPT: -0.8442063364552352, Methylation_ZFAT: -1.144633882952976, Methylation_KCNQ4: -1.0017041507281863, Methylation_chr1 232684368 SIPA1L2 (12934): 0.6278719775280432, Methylation_CRNKL1: -0.3952156239260869, Methylation_PRKAG2: -0.9448620619141412, Methylation_MICB: -0.9398192745125656, miRNA_hsa-mir-934: -0.0846168289332212, miRNA_hsa-mir-4728: 1.1107981390919368, miRNA_hsa-mir-5695: 1.856236413028987, miRNA_hsa-mir-18a: -0.4968700487466787, miRNA_hsa-mir-190b: 0.7935564954009134, miRNA_hsa-mir-577: -0.2867787510553352, miRNA_hsa-mir-135b: 1.1986573663360192, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.0540837930025871, miRNA_hsa-mir-130b: -0.1853225408147821, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-EW-A6SD,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression.  
C2orf54 mRNA is highly expressed (Z=2.27); CITED4, ESR1, AGR3 are low (Z < -1.92).  
HOXB13 and RNF130 promoters are hypermethylated (Z > 1.50); RNF130 and LOC340090 are hypomethylated (Z < -1.47).  
miR-4728 and miR-2115 are upregulated (Z > 1.99); miR-190b and miR-130b are downregulated (Z < -1.25).","mRNA_MLPH: 0.0691720437140027, mRNA_C2orf54: 2.27151544674103, mRNA_CITED4: -2.186760784931589, mRNA_ESR1: -1.9675566878248008, mRNA_SPDEF: 0.1473401146582484, mRNA_AGR3: -2.060531268628111, mRNA_FOXC1: -1.0085130153541406, mRNA_GATA3: -0.5440015874015559, mRNA_AGR2: -0.4983667183045934, mRNA_XBP1: -0.019032313549199, mRNA_PRR15: -0.1416321507735965, mRNA_SLC44A4: -0.4515881646410438, mRNA_CA12: -0.4925458020048106, mRNA_DTL: -0.1700607515195488, mRNA_C5AR2: -0.9028805397974417, mRNA_TBC1D9: -0.9117005410872157, mRNA_AR: 0.3350181232288112, mRNA_CCDC170: -1.6167452397459696, mRNA_DEGS2: -0.7221416641724412, mRNA_TFF3: -1.173505150787023, mRNA_DNALI1: 0.1389939003988416, mRNA_LINC00504: -1.7360685483966103, mRNA_CLCA2: 1.6258897503201963, mRNA_PPP1R14C: 1.2898443990942272, mRNA_THSD4: -0.8300239688899944, mRNA_SPAG5: 1.5046185767117657, mRNA_FBP1: -0.0712580983320939, mRNA_SLC7A8: -0.2785638213180683, mRNA_EN1: -0.4984803964822415, mRNA_ZNF552: -0.1681158972898235, Methylation_LRRC6: 1.129560152944468, Methylation_chr2 66218712 LINC02934 (29533): -1.168715691487487, Methylation_HOXB13: 1.5499944018262062, Methylation_chr10 3949206 LINC02660 (4871): -0.4678520217843194, Methylation_chr5 179517140 RNF130 (18026): -1.5724529447493127, Methylation_LOC727677: 1.1861133332648846, Methylation_LETM1: 1.252499375412092, Methylation_CDC42BPB: -0.9855733033961412, Methylation_C8orf38: 0.8851346785064187, Methylation_chr14 100504766 EVL (18852): 0.2657276783117638, Methylation_chr5 72594851 LOC340090 (24088): -1.553001303646753, Methylation_chr2 242904738 LINC01238 (3421): 1.2446567168923717, Methylation_ARFGEF1: -0.4966044036283342, Methylation_MAPT: 1.3451566658390504, Methylation_ZFAT: 1.199352307603534, Methylation_KCNQ4: -0.2825932942823849, Methylation_chr1 232684368 SIPA1L2 (12934): -0.1711259609917955, Methylation_CRNKL1: 1.2197615811861948, Methylation_PRKAG2: -1.104190547588577, Methylation_MICB: 0.975097013198127, miRNA_hsa-mir-934: 1.0663433822501605, miRNA_hsa-mir-4728: 2.269193521869024, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.1883998045353709, miRNA_hsa-mir-190b: -1.747747590788772, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.6658104928953436, miRNA_hsa-mir-2115: 1.867999258662233, miRNA_hsa-mir-17: -0.3195100672694934, miRNA_hsa-mir-130b: -1.7719075384528151, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-A2-A0YM,"High-level Amplification of PPP1R14C and EN1 drives significant mRNA overexpression. FOXC1 mRNA is highly expressed (Z=2.30). SPDEF, AGR2, AR, and DNALI1 show low mRNA (Z < -1.92). Promoter hypermethylation of C8orf38, ARFGEF1, KCNQ4, and EVL (Z > 1.50) suggests epigenetic silencing. Hypomethylation of RNF130 and LOC340090 (Z < -1.47). miR-17, miR-18a, and miR-577 are upregulated (Z > 1.99); miR-190b is downregulated (Z < -1.25).","mRNA_MLPH: -1.9113665117428087, mRNA_C2orf54: 0.3585086963886515, mRNA_CITED4: -0.0702698306145134, mRNA_ESR1: -1.8566909900868247, mRNA_SPDEF: -2.483135920668234, mRNA_AGR3: -1.6908599636797816, mRNA_FOXC1: 2.3035020250105323, mRNA_GATA3: -1.8537071407948595, mRNA_AGR2: -2.305855866492025, mRNA_XBP1: -1.9641136896672875, mRNA_PRR15: -1.6577520464554276, mRNA_SLC44A4: -2.2044226108229537, mRNA_CA12: -1.7341661987862476, mRNA_DTL: 0.9639830083461752, mRNA_C5AR2: -1.683224287358916, mRNA_TBC1D9: -1.1149212091485203, mRNA_AR: -2.3514974700951528, mRNA_CCDC170: -1.4703573820916476, mRNA_DEGS2: -1.9396687234914471, mRNA_TFF3: -1.585952858831502, mRNA_DNALI1: -1.9805013148521664, mRNA_LINC00504: -1.6828533910083237, mRNA_CLCA2: -0.7735130287916653, mRNA_PPP1R14C: 3.089603790104411, mRNA_THSD4: -1.664334734833646, mRNA_SPAG5: 0.9525600950072752, mRNA_FBP1: -0.8017589387817402, mRNA_SLC7A8: -1.5245915216927486, mRNA_EN1: 2.876429931682842, mRNA_ZNF552: -1.6899486777430546, Methylation_LRRC6: 1.4624603779774654, Methylation_chr2 66218712 LINC02934 (29533): -0.9299486398822104, Methylation_HOXB13: 1.4864262066767069, Methylation_chr10 3949206 LINC02660 (4871): 1.1467509484269682, Methylation_chr5 179517140 RNF130 (18026): -1.6054806914469677, Methylation_LOC727677: 1.4750311124912403, Methylation_LETM1: 1.3858003357148092, Methylation_CDC42BPB: 1.0897686258358168, Methylation_C8orf38: 1.6946827431091809, Methylation_chr14 100504766 EVL (18852): 1.5044962360356844, Methylation_chr5 72594851 LOC340090 (24088): -1.5895658980293328, Methylation_chr2 242904738 LINC01238 (3421): 1.4725756340454594, Methylation_ARFGEF1: 1.6891028026160402, Methylation_MAPT: 1.3979788666434902, Methylation_ZFAT: 1.4825313425464657, Methylation_KCNQ4: 1.6059219654478565, Methylation_chr1 232684368 SIPA1L2 (12934): 1.4564193853799758, Methylation_CRNKL1: 1.1101683689346455, Methylation_PRKAG2: -1.5391737615728034, Methylation_MICB: 1.491784800594414, miRNA_hsa-mir-934: 1.5970819216052825, miRNA_hsa-mir-4728: 0.756042412134244, miRNA_hsa-mir-5695: 1.3647879263379967, miRNA_hsa-mir-18a: 2.6757222830440788, miRNA_hsa-mir-190b: -2.052137242410604, miRNA_hsa-mir-577: 2.1319410960483607, miRNA_hsa-mir-135b: 1.9796062346790573, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 2.801750513797432, miRNA_hsa-mir-130b: 0.1671408485778487, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-E2-A1LE,"High-level Amplification absent; no CNVs meet amplification thresholds.  
mRNA_CLCA2 (Z=3.41) and mRNA_SPAG5 (Z=1.49) are highly overexpressed; mRNA_AGR3 (Z=-2.02) and mRNA_SLC44A4 (Z=-1.91) are low.  
miRNA_hsa-mir-2115 (Z=2.96) and miRNA_hsa-mir-4728 (Z=2.63) upregulated; miRNA_hsa-mir-190b (Z=-1.44) downregulated.  
No methylation sites meet hyper/hypo thresholds.  
Luminal-like phenotype with ER-pathway suppression.","mRNA_MLPH: -0.1406324179645606, mRNA_C2orf54: 0.7670563984193494, mRNA_CITED4: 0.2735775263340297, mRNA_ESR1: -1.7845392731879504, mRNA_SPDEF: 0.915352882234836, mRNA_AGR3: -2.0168299106322576, mRNA_FOXC1: -0.3472447884235566, mRNA_GATA3: -0.7615546336899426, mRNA_AGR2: -0.0652447248388797, mRNA_XBP1: -1.3808579289319405, mRNA_PRR15: 0.3842094060869468, mRNA_SLC44A4: -1.906750549895697, mRNA_CA12: -1.7867592294583678, mRNA_DTL: -0.0851203186731612, mRNA_C5AR2: -1.559221716427168, mRNA_TBC1D9: -0.5193065096395516, mRNA_AR: 0.3951605677134229, mRNA_CCDC170: -1.52113464552847, mRNA_DEGS2: -1.211788076243374, mRNA_TFF3: -0.426004236950443, mRNA_DNALI1: -1.7092007205311086, mRNA_LINC00504: -0.3770029632755957, mRNA_CLCA2: 3.4124349348235747, mRNA_PPP1R14C: -0.5036704657167316, mRNA_THSD4: -1.503283895754704, mRNA_SPAG5: 1.486121809566611, mRNA_FBP1: -0.3760140012545354, mRNA_SLC7A8: -1.0142137076112232, mRNA_EN1: 1.0205347103511402, mRNA_ZNF552: -0.8869260815127404, Methylation_LRRC6: 1.3420206502289558, Methylation_chr2 66218712 LINC02934 (29533): -0.6531522651370253, Methylation_HOXB13: 0.9609994234245312, Methylation_chr10 3949206 LINC02660 (4871): 1.469275441752225, Methylation_chr5 179517140 RNF130 (18026): 0.2796052142038281, Methylation_LOC727677: 1.4282158677124388, Methylation_LETM1: 1.2427929873495247, Methylation_CDC42BPB: -0.7651308222947147, Methylation_C8orf38: -0.2705963084289823, Methylation_chr14 100504766 EVL (18852): 1.0024242495668412, Methylation_chr5 72594851 LOC340090 (24088): -0.0460951607828075, Methylation_chr2 242904738 LINC01238 (3421): 1.491049626128108, Methylation_ARFGEF1: 0.4208207577286876, Methylation_MAPT: 0.1704314533884163, Methylation_ZFAT: 1.1310792970122847, Methylation_KCNQ4: 0.212974895850242, Methylation_chr1 232684368 SIPA1L2 (12934): 0.1546386550041993, Methylation_CRNKL1: 1.3333860777647828, Methylation_PRKAG2: 0.9487673532269664, Methylation_MICB: 1.399052940146288, miRNA_hsa-mir-934: -0.3703314739588269, miRNA_hsa-mir-4728: 2.6292201653419, miRNA_hsa-mir-5695: -0.3031182375857797, miRNA_hsa-mir-18a: 0.0765022488611114, miRNA_hsa-mir-190b: -1.4422676963650252, miRNA_hsa-mir-577: -0.6475960301882091, miRNA_hsa-mir-135b: -0.9829484960177304, miRNA_hsa-mir-2115: 2.955229307895213, miRNA_hsa-mir-17: -0.4273049020675524, miRNA_hsa-mir-130b: -0.2696624941975409, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-LL-A9Q3,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives oncogenic transcriptional activity. No mRNA, methylation, or miRNA alterations meet diagnostic thresholds for reporting. These features collectively indicate a proliferation-driven phenotype with genomic instability.","mRNA_MLPH: 1.2690433994430326, mRNA_C2orf54: -0.5806163742789012, mRNA_CITED4: 0.3448736263987348, mRNA_ESR1: 0.4767152706614839, mRNA_SPDEF: 0.7053488240044147, mRNA_AGR3: 0.7985270039634693, mRNA_FOXC1: -0.6432488576618307, mRNA_GATA3: 0.333725650586403, mRNA_AGR2: 0.4005563161161007, mRNA_XBP1: 0.1796369172277606, mRNA_PRR15: 0.6230778783897885, mRNA_SLC44A4: 0.8719388768978275, mRNA_CA12: 0.6270680441032851, mRNA_DTL: -1.5516340071422952, mRNA_C5AR2: 0.5452426581908861, mRNA_TBC1D9: 0.7101421705346206, mRNA_AR: 0.2521904236022805, mRNA_CCDC170: -0.2757116024078944, mRNA_DEGS2: 0.4313673649498076, mRNA_TFF3: 0.7555982209854956, mRNA_DNALI1: -0.1759491250283231, mRNA_LINC00504: 0.0391981652249487, mRNA_CLCA2: -0.4733441085255917, mRNA_PPP1R14C: -0.7020128970041717, mRNA_THSD4: 0.3044681068225082, mRNA_SPAG5: -0.579919252602865, mRNA_FBP1: 1.0785012103722798, mRNA_SLC7A8: 0.9275714724045332, mRNA_EN1: -0.3392003851375817, mRNA_ZNF552: 1.4917150137755548, Methylation_LRRC6: -0.5497631080430536, Methylation_chr2 66218712 LINC02934 (29533): 0.1325356560548155, Methylation_HOXB13: 1.1085526316240228, Methylation_chr10 3949206 LINC02660 (4871): -0.8964450044123816, Methylation_chr5 179517140 RNF130 (18026): 0.4344883072744121, Methylation_LOC727677: -0.938533290174206, Methylation_LETM1: -0.7780162209198745, Methylation_CDC42BPB: -0.8131492674414141, Methylation_C8orf38: -0.4655900227486271, Methylation_chr14 100504766 EVL (18852): -0.5869933684029305, Methylation_chr5 72594851 LOC340090 (24088): 0.1398633931630467, Methylation_chr2 242904738 LINC01238 (3421): -0.9552272088586432, Methylation_ARFGEF1: -0.7830527081085604, Methylation_MAPT: -1.2528919387012956, Methylation_ZFAT: -1.11588253398393, Methylation_KCNQ4: -0.3693004958507496, Methylation_chr1 232684368 SIPA1L2 (12934): -0.4301753755967611, Methylation_CRNKL1: -1.1291344508083028, Methylation_PRKAG2: -0.9079786490955668, Methylation_MICB: -0.7381922828939331, miRNA_hsa-mir-934: -0.4761433686742504, miRNA_hsa-mir-4728: -0.8388748340683013, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.8052711337065473, miRNA_hsa-mir-190b: 0.8307485047778057, miRNA_hsa-mir-577: -0.6487083658230385, miRNA_hsa-mir-135b: -0.8543040188010058, miRNA_hsa-mir-2115: 1.068097636393918, miRNA_hsa-mir-17: -0.3517980355774097, miRNA_hsa-mir-130b: -1.4007475568343413, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-B6-A0WV,"None of the mRNA, methylation, miRNA, or CNV values meet the strict diagnostic thresholds for reporting. No actionable molecular features detected.","mRNA_MLPH: 0.3852789386848619, mRNA_C2orf54: -0.0562754440365769, mRNA_CITED4: 0.6254137721357167, mRNA_ESR1: 1.258572375484598, mRNA_SPDEF: 0.4419265642130041, mRNA_AGR3: 0.9083014964014404, mRNA_FOXC1: -0.7096111529005295, mRNA_GATA3: 0.925095680696595, mRNA_AGR2: 0.4776550234198395, mRNA_XBP1: 0.8565850490663584, mRNA_PRR15: 0.4302943369825286, mRNA_SLC44A4: -0.0607550832964305, mRNA_CA12: 0.8690113224551502, mRNA_DTL: 1.2670111957506456, mRNA_C5AR2: 0.8917425979408341, mRNA_TBC1D9: 1.174007701943428, mRNA_AR: 0.9003899218385768, mRNA_CCDC170: 0.6022821852893776, mRNA_DEGS2: 0.3544079215473022, mRNA_TFF3: -0.2023462481128395, mRNA_DNALI1: 0.7601102664175835, mRNA_LINC00504: 1.5056068612135176, mRNA_CLCA2: -0.5873764142080206, mRNA_PPP1R14C: -0.2521191614086722, mRNA_THSD4: 0.666997304493213, mRNA_SPAG5: 1.4281387460517685, mRNA_FBP1: 0.7162058341931486, mRNA_SLC7A8: 0.6494888405976841, mRNA_EN1: -0.9141830921990576, mRNA_ZNF552: 0.7450067925078845, Methylation_LRRC6: -1.028193686819222, Methylation_chr2 66218712 LINC02934 (29533): -0.7952023405542363, Methylation_HOXB13: 1.4443675922636814, Methylation_chr10 3949206 LINC02660 (4871): -0.6122904687389791, Methylation_chr5 179517140 RNF130 (18026): 1.1838522851415068, Methylation_LOC727677: 0.8688885575339109, Methylation_LETM1: -1.146935145325183, Methylation_CDC42BPB: 1.2535386682961358, Methylation_C8orf38: -1.002011015246024, Methylation_chr14 100504766 EVL (18852): -0.9597759921436584, Methylation_chr5 72594851 LOC340090 (24088): 1.208852324163964, Methylation_chr2 242904738 LINC01238 (3421): -0.7367601838134288, Methylation_ARFGEF1: -1.3277427080749122, Methylation_MAPT: -1.4963033943075033, Methylation_ZFAT: -1.145914436100927, Methylation_KCNQ4: -0.9960507171880072, Methylation_chr1 232684368 SIPA1L2 (12934): -0.2139704363180833, Methylation_CRNKL1: -0.4163608749527841, Methylation_PRKAG2: 0.5671940539149399, Methylation_MICB: -0.21316577469259, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.5476345629434899, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.1777128044548592, miRNA_hsa-mir-190b: 0.6438510871303044, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: 0.2471968944223839, miRNA_hsa-mir-2115: 0.1453592951296071, miRNA_hsa-mir-17: -0.2424105764588574, miRNA_hsa-mir-130b: 0.6041473163214933, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-B6-A0RM,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-significant ranges per specified criteria.","mRNA_MLPH: 0.7872093130716727, mRNA_C2orf54: 0.5313675775046941, mRNA_CITED4: -0.3329458145168488, mRNA_ESR1: 1.2358341150920833, mRNA_SPDEF: 0.4390743148203699, mRNA_AGR3: 0.5085533454693897, mRNA_FOXC1: -1.1213225711154498, mRNA_GATA3: 0.8040549921767433, mRNA_AGR2: -0.1157384405572535, mRNA_XBP1: 1.2481737027985875, mRNA_PRR15: 0.477260061968053, mRNA_SLC44A4: 0.1891539434599106, mRNA_CA12: 1.216068777370214, mRNA_DTL: -0.1919986673207321, mRNA_C5AR2: 0.6512244680763671, mRNA_TBC1D9: 0.4873356595186312, mRNA_AR: 0.6375917873722132, mRNA_CCDC170: 1.3397520470392228, mRNA_DEGS2: 0.7698110562659837, mRNA_TFF3: -0.4505608422070812, mRNA_DNALI1: 1.0766267887147862, mRNA_LINC00504: 1.244542203222792, mRNA_CLCA2: -0.8228179853446856, mRNA_PPP1R14C: 0.6350469922337625, mRNA_THSD4: 0.9105818407573968, mRNA_SPAG5: -0.3930571123125861, mRNA_FBP1: 1.0670409335008626, mRNA_SLC7A8: 1.1337450084787088, mRNA_EN1: -0.4643196356450247, mRNA_ZNF552: 0.2538312657505384, Methylation_LRRC6: -1.4253910687750668, Methylation_chr2 66218712 LINC02934 (29533): 1.1239109266484026, Methylation_HOXB13: -0.3677736101968532, Methylation_chr10 3949206 LINC02660 (4871): -1.2128009328794132, Methylation_chr5 179517140 RNF130 (18026): 1.2406269228614344, Methylation_LOC727677: -1.4494754036590256, Methylation_LETM1: -1.30060951302832, Methylation_CDC42BPB: -0.524828379446364, Methylation_C8orf38: -1.5008830410454173, Methylation_chr14 100504766 EVL (18852): -1.1862822434398532, Methylation_chr5 72594851 LOC340090 (24088): 1.0910153962227034, Methylation_chr2 242904738 LINC01238 (3421): -1.2955595339007029, Methylation_ARFGEF1: -1.118305786874627, Methylation_MAPT: -1.1967557369849804, Methylation_ZFAT: -0.5787054787357427, Methylation_KCNQ4: -1.0254214724108313, Methylation_chr1 232684368 SIPA1L2 (12934): -1.1222950958903986, Methylation_CRNKL1: -0.6205040664284402, Methylation_PRKAG2: 1.1717706078345642, Methylation_MICB: -0.7925570306919912, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.839643319091301, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.9861617990644936, miRNA_hsa-mir-190b: 0.4482521235222336, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.4516624752158051, miRNA_hsa-mir-130b: -0.9830041951266952, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A7-A4SE,High-level Amplification of EN1 drives mRNA overexpression (Z=3.01). PPP1R14C mRNA is highly expressed (Z=2.03). SPDEF mRNA is low (Z=-2.02). Promoter hypermethylation of chr1:232684368 (SIPA1L2; Z=1.51) and RNF130 hypo-methylation (Z=-1.60) occur. miRNA hsa-mir-934 is upregulated (Z=1.94).,"mRNA_MLPH: -0.964493415008316, mRNA_C2orf54: 1.1584217777092758, mRNA_CITED4: -0.0955963180720171, mRNA_ESR1: -1.6260609997985729, mRNA_SPDEF: -2.017070439438319, mRNA_AGR3: -1.3458716460119238, mRNA_FOXC1: 1.1966095774230234, mRNA_GATA3: -1.836684693206204, mRNA_AGR2: -1.5122002468046989, mRNA_XBP1: -1.9959948548837887, mRNA_PRR15: -0.9995808265014328, mRNA_SLC44A4: -1.0837224148853786, mRNA_CA12: -1.257523613975127, mRNA_DTL: 0.8300898781283624, mRNA_C5AR2: -1.4949148593485293, mRNA_TBC1D9: -0.9039168087754972, mRNA_AR: -1.582761944204606, mRNA_CCDC170: -1.23727803945023, mRNA_DEGS2: -1.54743694585719, mRNA_TFF3: -1.597372392490825, mRNA_DNALI1: -1.1128366674437502, mRNA_LINC00504: -1.5691517563926058, mRNA_CLCA2: -0.2908434008432416, mRNA_PPP1R14C: 2.026688532582498, mRNA_THSD4: -0.843526883254265, mRNA_SPAG5: 0.8264828078477968, mRNA_FBP1: -1.0980858601596692, mRNA_SLC7A8: -1.0798828655827737, mRNA_EN1: 3.006593071901236, mRNA_ZNF552: -1.6264037633192518, Methylation_LRRC6: 1.3026539989971857, Methylation_chr2 66218712 LINC02934 (29533): -1.1153183614817743, Methylation_HOXB13: 0.7820615219576128, Methylation_chr10 3949206 LINC02660 (4871): 0.8843922825809304, Methylation_chr5 179517140 RNF130 (18026): -1.599142636745785, Methylation_LOC727677: 1.461606700081744, Methylation_LETM1: 1.3408057239176423, Methylation_CDC42BPB: 0.9463119352048582, Methylation_C8orf38: 1.3570720232283022, Methylation_chr14 100504766 EVL (18852): 1.28533504400599, Methylation_chr5 72594851 LOC340090 (24088): -1.3965003664655191, Methylation_chr2 242904738 LINC01238 (3421): 1.2357196594121862, Methylation_ARFGEF1: 1.46063751299873, Methylation_MAPT: 0.9199167817727524, Methylation_ZFAT: 1.3759358768712462, Methylation_KCNQ4: 0.9666210125475768, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5138948247565729, Methylation_CRNKL1: 1.2050078287816866, Methylation_PRKAG2: -1.2181476128996096, Methylation_MICB: 1.292421718577593, miRNA_hsa-mir-934: 1.9356636526593445, miRNA_hsa-mir-4728: -0.6706791157385014, miRNA_hsa-mir-5695: 0.1786108996126432, miRNA_hsa-mir-18a: 1.3488247016641453, miRNA_hsa-mir-190b: -1.126176858174584, miRNA_hsa-mir-577: 1.2727507231133592, miRNA_hsa-mir-135b: 1.257400292100009, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.3318956832488749, miRNA_hsa-mir-130b: -0.7021297381160101, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-3C-AALI,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. HOXB13 promoter hypermethylation mediates epigenetic silencing. miR-4728 and miR-2115 are upregulated; miR-190b is downregulated. ESR1, AR, C5AR2, and SLC7A8 show transcriptional downregulation. These features indicate a luminal B phenotype with ER pathway suppression.","mRNA_MLPH: 1.0305107072404214, mRNA_C2orf54: 0.7571645547273739, mRNA_CITED4: -1.516360918459807, mRNA_ESR1: -1.7834825297419443, mRNA_SPDEF: 0.9772945096974264, mRNA_AGR3: 0.8687974532101376, mRNA_FOXC1: -0.8865449011825037, mRNA_GATA3: 0.0288810065639407, mRNA_AGR2: 0.970970379293714, mRNA_XBP1: 0.1244617874378569, mRNA_PRR15: 0.625479856310515, mRNA_SLC44A4: 0.346744918956337, mRNA_CA12: 0.2049049041973751, mRNA_DTL: 0.631861871033478, mRNA_C5AR2: -1.8665445223377688, mRNA_TBC1D9: -0.5910574355297298, mRNA_AR: -1.774304350891383, mRNA_CCDC170: -1.228097561138536, mRNA_DEGS2: 0.6604121586643041, mRNA_TFF3: 0.1048821069414046, mRNA_DNALI1: 0.4339624392077706, mRNA_LINC00504: 0.6623287699095907, mRNA_CLCA2: -0.7813035199664049, mRNA_PPP1R14C: 0.7347072657228839, mRNA_THSD4: -1.034504633827766, mRNA_SPAG5: 2.5765787371784965, mRNA_FBP1: 0.5358093619039035, mRNA_SLC7A8: -1.665379008957028, mRNA_EN1: -0.2470279460449353, mRNA_ZNF552: -0.9226783355831256, Methylation_LRRC6: -0.1617638118113325, Methylation_chr2 66218712 LINC02934 (29533): -1.6269543355589628, Methylation_HOXB13: 1.6945440211602592, Methylation_chr10 3949206 LINC02660 (4871): -0.4938488305407392, Methylation_chr5 179517140 RNF130 (18026): 0.8159383777719355, Methylation_LOC727677: -0.4829484555657914, Methylation_LETM1: 1.260217585101451, Methylation_CDC42BPB: -1.2214654094712436, Methylation_C8orf38: -1.2228970934083498, Methylation_chr14 100504766 EVL (18852): -0.741834102636737, Methylation_chr5 72594851 LOC340090 (24088): 0.7019674643334002, Methylation_chr2 242904738 LINC01238 (3421): 1.3128222449989613, Methylation_ARFGEF1: -0.7527363196965493, Methylation_MAPT: 1.1386708635886813, Methylation_ZFAT: -0.6255956354233442, Methylation_KCNQ4: 1.037937489695658, Methylation_chr1 232684368 SIPA1L2 (12934): -0.3308918662500111, Methylation_CRNKL1: 0.3582117886074269, Methylation_PRKAG2: -0.7908058681549861, Methylation_MICB: -0.0934313140199415, miRNA_hsa-mir-934: -0.3625357151729038, miRNA_hsa-mir-4728: 2.65416057934854, miRNA_hsa-mir-5695: -0.2860434066230919, miRNA_hsa-mir-18a: -0.6856371321041086, miRNA_hsa-mir-190b: -1.3087411043292834, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.1838389670842247, miRNA_hsa-mir-2115: 2.6469285431606524, miRNA_hsa-mir-17: -0.6643524748914074, miRNA_hsa-mir-130b: 0.4849760821763483, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-C8-A1HG,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: -0.2965743125181771, mRNA_C2orf54: -0.560835297514092, mRNA_CITED4: -1.1970852853609006, mRNA_ESR1: 0.3535354101032624, mRNA_SPDEF: -0.9313564526412574, mRNA_AGR3: 1.0275144077111682, mRNA_FOXC1: -0.8895004301907316, mRNA_GATA3: 0.0370192953024617, mRNA_AGR2: 0.4351011292440884, mRNA_XBP1: 0.3060642308412975, mRNA_PRR15: -0.4615948998721142, mRNA_SLC44A4: -0.1251926056251112, mRNA_CA12: 0.2901388698136274, mRNA_DTL: 0.0434330387176806, mRNA_C5AR2: 0.3944448906574575, mRNA_TBC1D9: 0.6770163343858507, mRNA_AR: 0.3737016217026979, mRNA_CCDC170: 0.2643866430002853, mRNA_DEGS2: -1.714734236416691, mRNA_TFF3: 0.0297099869916953, mRNA_DNALI1: 0.6477246515758638, mRNA_LINC00504: -0.98756747898687, mRNA_CLCA2: -0.7590166669402073, mRNA_PPP1R14C: -0.4662090226803844, mRNA_THSD4: -0.8218044957491457, mRNA_SPAG5: 1.0445433905631558, mRNA_FBP1: -0.7959493730255417, mRNA_SLC7A8: -1.625438315664832, mRNA_EN1: -0.4834075350478284, mRNA_ZNF552: -0.6155546499912549, Methylation_LRRC6: -1.0871127844199049, Methylation_chr2 66218712 LINC02934 (29533): 0.8238394017529493, Methylation_HOXB13: -0.3135501143916105, Methylation_chr10 3949206 LINC02660 (4871): -0.4517536041464083, Methylation_chr5 179517140 RNF130 (18026): 0.3429093308209706, Methylation_LOC727677: 0.0688643968664105, Methylation_LETM1: -0.6083537601837038, Methylation_CDC42BPB: -0.8707392971508839, Methylation_C8orf38: -1.1857074516423731, Methylation_chr14 100504766 EVL (18852): 0.1406290691687367, Methylation_chr5 72594851 LOC340090 (24088): -1.5510504848203206, Methylation_chr2 242904738 LINC01238 (3421): 1.099672795622031, Methylation_ARFGEF1: -1.2836705379791458, Methylation_MAPT: -0.4121591898640322, Methylation_ZFAT: -1.1496863886087745, Methylation_KCNQ4: -0.7178011459026332, Methylation_chr1 232684368 SIPA1L2 (12934): -0.8643619439963942, Methylation_CRNKL1: -0.1657608356603687, Methylation_PRKAG2: -1.1762065962806585, Methylation_MICB: -0.6152240262820413, miRNA_hsa-mir-934: -0.2229857910709847, miRNA_hsa-mir-4728: 0.2836743452635172, miRNA_hsa-mir-5695: 1.6472729009861533, miRNA_hsa-mir-18a: 0.7249838210746953, miRNA_hsa-mir-190b: -0.357511365785528, miRNA_hsa-mir-577: -0.4146878966153076, miRNA_hsa-mir-135b: 0.7279817181527025, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.648487834353395, miRNA_hsa-mir-130b: 1.819945562046259, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-BH-A0DG,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.2408956089745937, mRNA_C2orf54: 0.3118660619577042, mRNA_CITED4: -0.93829170809924, mRNA_ESR1: 0.008115209328689, mRNA_SPDEF: 0.4024009194537367, mRNA_AGR3: 0.5948744012277898, mRNA_FOXC1: -0.1874415086688776, mRNA_GATA3: 0.3107294597404015, mRNA_AGR2: 0.3802050149190603, mRNA_XBP1: 0.4035812245257632, mRNA_PRR15: 0.5439803022652224, mRNA_SLC44A4: 0.9765457261498214, mRNA_CA12: -0.9740593194401448, mRNA_DTL: -0.0684819062667389, mRNA_C5AR2: 0.3528975347449478, mRNA_TBC1D9: 0.4111304495683979, mRNA_AR: 0.3656605108998985, mRNA_CCDC170: -0.1127507331126501, mRNA_DEGS2: 0.4661275222830299, mRNA_TFF3: 1.010603664631684, mRNA_DNALI1: 0.5695943683351772, mRNA_LINC00504: 0.6157904884367618, mRNA_CLCA2: -0.5856493944309612, mRNA_PPP1R14C: -0.108062282080928, mRNA_THSD4: -0.0398958418807872, mRNA_SPAG5: -0.0925870417057017, mRNA_FBP1: 0.5233224980668586, mRNA_SLC7A8: 0.6980033746980594, mRNA_EN1: 0.3197617093024022, mRNA_ZNF552: -0.1474586642520644, Methylation_LRRC6: 0.7086731691328844, Methylation_chr2 66218712 LINC02934 (29533): 1.2905693758720274, Methylation_HOXB13: -0.8108009208321629, Methylation_chr10 3949206 LINC02660 (4871): 0.1468067419698396, Methylation_chr5 179517140 RNF130 (18026): 0.245692927922496, Methylation_LOC727677: 0.4439930604488463, Methylation_LETM1: 0.3522211596691249, Methylation_CDC42BPB: -0.8480343440796363, Methylation_C8orf38: 0.5948511164773665, Methylation_chr14 100504766 EVL (18852): 0.3943286217849663, Methylation_chr5 72594851 LOC340090 (24088): 0.4393010668404102, Methylation_chr2 242904738 LINC01238 (3421): -0.1034513440913671, Methylation_ARFGEF1: 0.7134019797202348, Methylation_MAPT: 0.9254759369498736, Methylation_ZFAT: 0.8776908634056105, Methylation_KCNQ4: -0.965507959341488, Methylation_chr1 232684368 SIPA1L2 (12934): 0.4952395764529212, Methylation_CRNKL1: 0.7060277298786336, Methylation_PRKAG2: -0.4168297200945606, Methylation_MICB: 0.7514805398099023, miRNA_hsa-mir-934: -0.2067125358551233, miRNA_hsa-mir-4728: -0.5347987551353007, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.2638043699799985, miRNA_hsa-mir-190b: 0.4332863214553077, miRNA_hsa-mir-577: -0.1571222363388475, miRNA_hsa-mir-135b: -0.5418304648090579, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.0397616235157368, miRNA_hsa-mir-130b: -0.3715022571559406, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-OL-A5D8,High-level Amplification of none; GATA3 mRNA overexpressed (Z=1.35). KCNQ4 promoter hypermethylation (Z=1.64). No significant miRNA dysregulation. These features indicate a luminal phenotype with potential GATA3-driven transcriptional activation.,"mRNA_MLPH: 0.354643967382145, mRNA_C2orf54: -0.8848269756386652, mRNA_CITED4: 0.4360773145282184, mRNA_ESR1: 0.7009594779742101, mRNA_SPDEF: 0.2035545018744106, mRNA_AGR3: 1.090333572161236, mRNA_FOXC1: -0.7856513757929475, mRNA_GATA3: 1.3506451494101932, mRNA_AGR2: -1.4672780655898792, mRNA_XBP1: 0.678768124185896, mRNA_PRR15: 0.99905159685066, mRNA_SLC44A4: 0.5659417090828469, mRNA_CA12: 0.9394805955404112, mRNA_DTL: -0.9563218189331046, mRNA_C5AR2: 0.3174606164282114, mRNA_TBC1D9: 1.208973124089823, mRNA_AR: 0.3270964546377803, mRNA_CCDC170: 0.6478813876539277, mRNA_DEGS2: -0.1994075765897311, mRNA_TFF3: 0.0405975515833618, mRNA_DNALI1: 1.2620742245761485, mRNA_LINC00504: 0.5844050013109846, mRNA_CLCA2: -0.6675830345385358, mRNA_PPP1R14C: -0.7401977886289489, mRNA_THSD4: 0.0445159672763228, mRNA_SPAG5: 0.9265283148435066, mRNA_FBP1: 0.2821256442229284, mRNA_SLC7A8: 0.657212742236171, mRNA_EN1: -0.2195164627517336, mRNA_ZNF552: 0.4712888889478004, Methylation_LRRC6: -1.1464227645546634, Methylation_chr2 66218712 LINC02934 (29533): -1.514696748395462, Methylation_HOXB13: -0.7470310116900164, Methylation_chr10 3949206 LINC02660 (4871): -0.967316321018455, Methylation_chr5 179517140 RNF130 (18026): 1.1244158185983804, Methylation_LOC727677: -0.5512616713679641, Methylation_LETM1: -1.323743335882408, Methylation_CDC42BPB: 0.2076253724255341, Methylation_C8orf38: -0.611237157056833, Methylation_chr14 100504766 EVL (18852): -0.8925559813618251, Methylation_chr5 72594851 LOC340090 (24088): 1.090955477364445, Methylation_chr2 242904738 LINC01238 (3421): 1.1361581203685769, Methylation_ARFGEF1: -1.1424287224557996, Methylation_MAPT: -1.1174615927083589, Methylation_ZFAT: 0.2072318182354112, Methylation_KCNQ4: 1.6356807143340668, Methylation_chr1 232684368 SIPA1L2 (12934): -0.8123779898113597, Methylation_CRNKL1: -0.8647857536743336, Methylation_PRKAG2: -0.1969770540071919, Methylation_MICB: -1.3625406815421306, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.5805440007068081, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.3627499873840324, miRNA_hsa-mir-190b: 1.2519764789763084, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.919915580079734, miRNA_hsa-mir-2115: -0.0592013374783743, miRNA_hsa-mir-17: 1.006888377090237, miRNA_hsa-mir-130b: -0.2495711967794963, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-B6-A402,"High-level Amplification of LINC01867 drives mRNA overexpression.  
Promoter hypermethylation of LRRC6, LOC727677, EVL, and SIPA1L2 mediates epigenetic silencing.  
miR-934, miR-18a, miR-577, miR-135b, and miR-17 are upregulated.  
These features collectively indicate a luminal B phenotype with PI3K/AKT/mTOR dysregulation.","mRNA_MLPH: -1.4448711647215704, mRNA_C2orf54: 1.4949344325686438, mRNA_CITED4: 0.7662380477697955, mRNA_ESR1: -1.9198476948218, mRNA_SPDEF: -1.098926106299269, mRNA_AGR3: -1.690040664226584, mRNA_FOXC1: 2.509219571652043, mRNA_GATA3: -3.268717537837892, mRNA_AGR2: -2.0127109419965663, mRNA_XBP1: -1.8522483313765423, mRNA_PRR15: -1.806123531954492, mRNA_SLC44A4: -1.5205603582876592, mRNA_CA12: -1.803785494732302, mRNA_DTL: 1.007631912704337, mRNA_C5AR2: -1.752336461613965, mRNA_TBC1D9: -2.416727422828239, mRNA_AR: -2.4754469728948894, mRNA_CCDC170: -1.9149207529753989, mRNA_DEGS2: -1.1913698597383633, mRNA_TFF3: -1.893666764458129, mRNA_DNALI1: -1.7197064635447117, mRNA_LINC00504: -1.7190442319570745, mRNA_CLCA2: -0.8708106395721935, mRNA_PPP1R14C: 1.080297428502109, mRNA_THSD4: -1.6042822704438873, mRNA_SPAG5: -0.2988666907926171, mRNA_FBP1: -2.7109863370645773, mRNA_SLC7A8: -1.527633605517229, mRNA_EN1: 3.316755157914076, mRNA_ZNF552: -1.7648904044578475, Methylation_LRRC6: 1.5144371340189018, Methylation_chr2 66218712 LINC02934 (29533): 1.201276101751701, Methylation_HOXB13: -1.0303464549817067, Methylation_chr10 3949206 LINC02660 (4871): 1.3238735451176575, Methylation_chr5 179517140 RNF130 (18026): -1.62472891367858, Methylation_LOC727677: 1.518153123110666, Methylation_LETM1: 1.375364265562831, Methylation_CDC42BPB: 1.4170403502783768, Methylation_C8orf38: 1.4943044096097382, Methylation_chr14 100504766 EVL (18852): 1.5187886205760075, Methylation_chr5 72594851 LOC340090 (24088): -1.5867747947555717, Methylation_chr2 242904738 LINC01238 (3421): 1.005119872731055, Methylation_ARFGEF1: 1.4156941844004935, Methylation_MAPT: 1.4599330999290034, Methylation_ZFAT: 1.1935184555082066, Methylation_KCNQ4: 1.1511003470236283, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5920593576534805, Methylation_CRNKL1: 1.371788476211129, Methylation_PRKAG2: -0.6194840201853151, Methylation_MICB: 1.4384823067169583, miRNA_hsa-mir-934: 3.1635941701547705, miRNA_hsa-mir-4728: 0.7885381302086834, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 2.341044674262846, miRNA_hsa-mir-190b: -0.7186603336839483, miRNA_hsa-mir-577: 2.1101443325329594, miRNA_hsa-mir-135b: 3.1495822033291043, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 2.166970547187929, miRNA_hsa-mir-130b: 1.126136232389915, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-D8-A1JN,"High-level Amplification of none; no CNV meets amplification thresholds.  
mRNA_C5AR2 (Z=1.84), mRNA_AR (Z=1.41), mRNA_CCDC170 (Z=1.55), and mRNA_CLCA2 (Z=1.69) are highly expressed.  
mRNA_SPAG5 (Z=−2.15) is low.  
Methylation_chr10:3949206 (Z=1.55) and Methylation_ZFAT (Z=−1.50) are hyper- and hypomethylated, respectively.  
miRNA_hsa-mir-2115 (Z=3.08) is upregulated; miRNA_hsa-mir-18a (Z=−1.43), miRNA_hsa-mir-17 (Z=−1.46), and miRNA_hsa-mir-130b (Z=−1.58) are downregulated.","mRNA_MLPH: 0.8353231975870595, mRNA_C2orf54: 0.6192657914433218, mRNA_CITED4: 1.0597879708925744, mRNA_ESR1: 0.9770195977466009, mRNA_SPDEF: 1.2350577951728432, mRNA_AGR3: 0.3472433828229896, mRNA_FOXC1: -0.9083567092811418, mRNA_GATA3: 0.6597020927909558, mRNA_AGR2: 1.1672993278022314, mRNA_XBP1: -0.847832561604506, mRNA_PRR15: 0.528730518518993, mRNA_SLC44A4: 1.1087179336308142, mRNA_CA12: 0.2683685162736884, mRNA_DTL: -1.310493202256417, mRNA_C5AR2: 1.8413047950706125, mRNA_TBC1D9: 0.9522786888043144, mRNA_AR: 1.4079345608557567, mRNA_CCDC170: 1.550272987639678, mRNA_DEGS2: -0.9876950334865936, mRNA_TFF3: 0.2233913079581634, mRNA_DNALI1: 0.0685796937601649, mRNA_LINC00504: 1.2651202842085043, mRNA_CLCA2: 1.692980318671203, mRNA_PPP1R14C: -1.0779712114790696, mRNA_THSD4: 0.349479209821215, mRNA_SPAG5: -2.147319342896054, mRNA_FBP1: 0.1521300144147814, mRNA_SLC7A8: 0.3961533432152808, mRNA_EN1: -0.8856776856063827, mRNA_ZNF552: 0.5288602802939042, Methylation_LRRC6: -1.2575605587312064, Methylation_chr2 66218712 LINC02934 (29533): 1.3551071124411618, Methylation_HOXB13: 1.4426150411439485, Methylation_chr10 3949206 LINC02660 (4871): 1.5518267059107689, Methylation_chr5 179517140 RNF130 (18026): 1.243280659289692, Methylation_LOC727677: -1.4263641200694346, Methylation_LETM1: 0.6589324259384497, Methylation_CDC42BPB: -1.452075611152709, Methylation_C8orf38: -1.582228841378969, Methylation_chr14 100504766 EVL (18852): -1.450693326561904, Methylation_chr5 72594851 LOC340090 (24088): 1.3370636261881266, Methylation_chr2 242904738 LINC01238 (3421): -1.4708967110268512, Methylation_ARFGEF1: -1.2138821687025465, Methylation_MAPT: -1.1529198841424508, Methylation_ZFAT: -1.5042016005520793, Methylation_KCNQ4: 1.0175647247431967, Methylation_chr1 232684368 SIPA1L2 (12934): -0.6200582923691621, Methylation_CRNKL1: -1.4540103461119562, Methylation_PRKAG2: 1.3170435781452916, Methylation_MICB: -1.4896586724459, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.2336923928208653, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.4306875038751186, miRNA_hsa-mir-190b: 1.3842610895511425, miRNA_hsa-mir-577: -0.2779909532671834, miRNA_hsa-mir-135b: -1.070348662360406, miRNA_hsa-mir-2115: 3.0776495325739304, miRNA_hsa-mir-17: -1.4640842252410604, miRNA_hsa-mir-130b: -1.584528457406229, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A2-A4S0,"mRNA_DTL is low (Z = -2.31). No mRNA features meet high-expression thresholds. PRKAG2 and MICB are hypermethylated (Z = -1.52, -1.43). miRNA_hsa-mir-18a is downregulated (Z = -1.26). All CNVs fall within normal range (IGNORE). These features suggest luminal A phenotype with metabolic pathway dysregulation.","mRNA_MLPH: 0.9633849968983652, mRNA_C2orf54: -0.7363829551968718, mRNA_CITED4: -1.3594832657042049, mRNA_ESR1: 1.1119667883695128, mRNA_SPDEF: 0.3956743396238658, mRNA_AGR3: 0.7658724740584072, mRNA_FOXC1: -1.0018833396254747, mRNA_GATA3: 1.2256241632794873, mRNA_AGR2: 0.3520888105829975, mRNA_XBP1: 1.321223717014869, mRNA_PRR15: 1.075729980530408, mRNA_SLC44A4: 0.6738093468912778, mRNA_CA12: 0.0318581428054748, mRNA_DTL: -2.3053458023168587, mRNA_C5AR2: 1.2685228378586082, mRNA_TBC1D9: 0.8828034073561046, mRNA_AR: 0.2412086747047465, mRNA_CCDC170: 1.2730734371457084, mRNA_DEGS2: 0.1675920634385064, mRNA_TFF3: 1.4860238679917437, mRNA_DNALI1: 0.847278788741153, mRNA_LINC00504: 0.7739163369950551, mRNA_CLCA2: -0.7077614481793887, mRNA_PPP1R14C: -1.033923738869975, mRNA_THSD4: 1.137693993528014, mRNA_SPAG5: -1.2485218611390794, mRNA_FBP1: 0.8305839341396056, mRNA_SLC7A8: 0.7614522979446804, mRNA_EN1: -0.7474121800295991, mRNA_ZNF552: -0.5535305424226165, Methylation_LRRC6: -1.0649275873899324, Methylation_chr2 66218712 LINC02934 (29533): 0.8617830761506934, Methylation_HOXB13: -1.0745667903554816, Methylation_chr10 3949206 LINC02660 (4871): -1.0959578324849957, Methylation_chr5 179517140 RNF130 (18026): 1.0358112059711824, Methylation_LOC727677: -1.1106478626380745, Methylation_LETM1: -1.2325736900631774, Methylation_CDC42BPB: -1.3163889085116292, Methylation_C8orf38: -1.136952151212107, Methylation_chr14 100504766 EVL (18852): -1.0653161759805698, Methylation_chr5 72594851 LOC340090 (24088): 0.6097142818751707, Methylation_chr2 242904738 LINC01238 (3421): -1.0484814909670204, Methylation_ARFGEF1: -0.9089561938298192, Methylation_MAPT: -1.2234127896454303, Methylation_ZFAT: -0.2344387315247461, Methylation_KCNQ4: -1.1174192602789412, Methylation_chr1 232684368 SIPA1L2 (12934): -0.9805059900069611, Methylation_CRNKL1: -1.1309438447652165, Methylation_PRKAG2: -1.516579710573443, Methylation_MICB: -1.4251675246584496, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.1923708262689583, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.2603463310987957, miRNA_hsa-mir-190b: 0.7925376033761496, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: 0.9066844734901746, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.3817016552730451, miRNA_hsa-mir-130b: -0.8469676506437605, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A1FM,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression.  
LINC02934 and EVL promoter hypomethylation correlates with transcriptional upregulation.  
miR-5695 is significantly upregulated.  
These features collectively indicate a luminal-like phenotype with ER signaling dysregulation.","mRNA_MLPH: -0.4985638703534465, mRNA_C2orf54: -0.7805669592201381, mRNA_CITED4: 1.4500437497432994, mRNA_ESR1: 0.7732165633985955, mRNA_SPDEF: -0.2106193796238703, mRNA_AGR3: 0.6761578712809481, mRNA_FOXC1: -0.2235661290500241, mRNA_GATA3: 0.910028532249462, mRNA_AGR2: -0.7783264974328463, mRNA_XBP1: -0.1258141843050463, mRNA_PRR15: -0.7654298005850937, mRNA_SLC44A4: -0.0050568689141722, mRNA_CA12: 0.3705985927140442, mRNA_DTL: 0.9333526260066034, mRNA_C5AR2: -0.2790551880752386, mRNA_TBC1D9: 0.8615333640699199, mRNA_AR: -0.4567210518564055, mRNA_CCDC170: 0.0407381115569133, mRNA_DEGS2: 1.0068959759180025, mRNA_TFF3: -1.1054997243319766, mRNA_DNALI1: 0.1311082737170745, mRNA_LINC00504: 1.4963469434469403, mRNA_CLCA2: -0.7636675042693568, mRNA_PPP1R14C: -0.9001571811801534, mRNA_THSD4: -0.0811453071831197, mRNA_SPAG5: -0.3795561566954177, mRNA_FBP1: -0.1123402345808308, mRNA_SLC7A8: 0.9078285064093116, mRNA_EN1: -0.1684712689436902, mRNA_ZNF552: 0.4899492145282641, Methylation_LRRC6: -1.4597768976040864, Methylation_chr2 66218712 LINC02934 (29533): -1.9069552352103216, Methylation_HOXB13: 1.0066174201636646, Methylation_chr10 3949206 LINC02660 (4871): -1.1402233131860626, Methylation_chr5 179517140 RNF130 (18026): 0.1989358698114392, Methylation_LOC727677: -0.7195628597586788, Methylation_LETM1: -1.2622334848292274, Methylation_CDC42BPB: 1.255825946723274, Methylation_C8orf38: -1.2993479783743274, Methylation_chr14 100504766 EVL (18852): -1.718476703063576, Methylation_chr5 72594851 LOC340090 (24088): 1.229923377295602, Methylation_chr2 242904738 LINC01238 (3421): -0.9294467780218304, Methylation_ARFGEF1: -1.3558131550225518, Methylation_MAPT: -0.8238177987887789, Methylation_ZFAT: -1.7043431909068147, Methylation_KCNQ4: -1.1175335306307967, Methylation_chr1 232684368 SIPA1L2 (12934): -1.5465476859665577, Methylation_CRNKL1: -0.4545725723522166, Methylation_PRKAG2: -1.3568147900047098, Methylation_MICB: -1.0427507499836914, miRNA_hsa-mir-934: -0.1761226813572065, miRNA_hsa-mir-4728: 0.5801368717458278, miRNA_hsa-mir-5695: 2.700924181834925, miRNA_hsa-mir-18a: 0.4918540978861707, miRNA_hsa-mir-190b: 0.0523163715720409, miRNA_hsa-mir-577: 0.8482106553137992, miRNA_hsa-mir-135b: -0.2488824596355006, miRNA_hsa-mir-2115: -0.0182964086921428, miRNA_hsa-mir-17: 0.2122760258202969, miRNA_hsa-mir-130b: 0.7223708761367558, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-BH-A0C3,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting. All values fall within non-significant ranges per defined criteria.","mRNA_MLPH: -0.0438395904865419, mRNA_C2orf54: -0.5754115816567164, mRNA_CITED4: -1.597091770932353, mRNA_ESR1: 0.0262564416055163, mRNA_SPDEF: -0.1048034924194965, mRNA_AGR3: -1.7087776056580404, mRNA_FOXC1: -0.0756857534727379, mRNA_GATA3: -0.6765050651761793, mRNA_AGR2: -0.2555801537318641, mRNA_XBP1: -0.1531797611691362, mRNA_PRR15: -0.0734658723589939, mRNA_SLC44A4: 0.2451598361358882, mRNA_CA12: 0.4062830870024955, mRNA_DTL: 0.2440410816816945, mRNA_C5AR2: -0.5715171856275079, mRNA_TBC1D9: -0.2030951401247548, mRNA_AR: 0.800419939541245, mRNA_CCDC170: -0.3614474501833799, mRNA_DEGS2: 0.1920467340599873, mRNA_TFF3: -0.0178577756343123, mRNA_DNALI1: -0.3892471370615523, mRNA_LINC00504: -0.3104333035100226, mRNA_CLCA2: -0.2550908022835561, mRNA_PPP1R14C: -0.9263722546447462, mRNA_THSD4: 0.2613142809683138, mRNA_SPAG5: 0.2067430620672072, mRNA_FBP1: -1.0629480991985454, mRNA_SLC7A8: 0.8848759917092405, mRNA_EN1: 0.0847542308805625, mRNA_ZNF552: 0.0869430577121936, Methylation_LRRC6: 0.8314942837443211, Methylation_chr2 66218712 LINC02934 (29533): 1.0576150423186892, Methylation_HOXB13: -0.9875817273075848, Methylation_chr10 3949206 LINC02660 (4871): 0.3659678886722586, Methylation_chr5 179517140 RNF130 (18026): 0.0720626975621755, Methylation_LOC727677: 0.4638186484309231, Methylation_LETM1: 0.4156411804177747, Methylation_CDC42BPB: -0.6315020555649487, Methylation_C8orf38: 0.7250075495535356, Methylation_chr14 100504766 EVL (18852): 0.756554605942279, Methylation_chr5 72594851 LOC340090 (24088): 0.4696969911478296, Methylation_chr2 242904738 LINC01238 (3421): 1.4298113655373146, Methylation_ARFGEF1: 0.8089352844298466, Methylation_MAPT: 1.0743695431652225, Methylation_ZFAT: 1.1909958454389853, Methylation_KCNQ4: -1.0438292206960778, Methylation_chr1 232684368 SIPA1L2 (12934): 0.8424646375686933, Methylation_CRNKL1: 0.8146504529420784, Methylation_PRKAG2: 0.2963934318003255, Methylation_MICB: 0.7328903003668853, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.3039014192184272, miRNA_hsa-mir-5695: 0.6936579142649791, miRNA_hsa-mir-18a: 0.3181980641807994, miRNA_hsa-mir-190b: 1.0617238928772814, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.7175853115740859, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.3463902032770548, miRNA_hsa-mir-130b: 0.5577562849053501, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-OL-A5RX,High mRNA_CITED4 (Z=1.50) indicates overexpression. No methylation or miRNA alterations meet diagnostic thresholds. All CNVs fall within normal range (−1.10 to −0.10). Isolated CITED4 upregulation suggests limited transcriptional dysregulation without clear genomic or epigenetic drivers.,"mRNA_MLPH: 0.7394010094550355, mRNA_C2orf54: -0.3949927167451875, mRNA_CITED4: 1.5042172192585426, mRNA_ESR1: 0.2350560841716093, mRNA_SPDEF: 0.3764495336144132, mRNA_AGR3: 0.592216719401363, mRNA_FOXC1: 0.2864174561074691, mRNA_GATA3: 0.5783973884521473, mRNA_AGR2: 0.288926514127182, mRNA_XBP1: 0.1948165417113267, mRNA_PRR15: 0.4176167675640096, mRNA_SLC44A4: 0.6027189897081724, mRNA_CA12: 0.3314560140352997, mRNA_DTL: -1.3185885191340614, mRNA_C5AR2: 0.5372925049364945, mRNA_TBC1D9: 0.4658864278244397, mRNA_AR: 0.2419044070914309, mRNA_CCDC170: 0.990059754443314, mRNA_DEGS2: 0.3599822729471256, mRNA_TFF3: 0.1855484717434614, mRNA_DNALI1: 1.0952207384549235, mRNA_LINC00504: 0.6637687573346398, mRNA_CLCA2: 0.724156198262088, mRNA_PPP1R14C: 0.8590685910054808, mRNA_THSD4: 0.5826199574544533, mRNA_SPAG5: -1.417298815874546, mRNA_FBP1: 0.3491434736690129, mRNA_SLC7A8: 0.4891576427394685, mRNA_EN1: -0.2528202827760945, mRNA_ZNF552: 0.4847687501312264, Methylation_LRRC6: 0.5535875444885036, Methylation_chr2 66218712 LINC02934 (29533): -0.0513844717269118, Methylation_HOXB13: 0.2966621862021825, Methylation_chr10 3949206 LINC02660 (4871): -0.1087243220740749, Methylation_chr5 179517140 RNF130 (18026): 0.0053487155914834, Methylation_LOC727677: -0.0508088053410765, Methylation_LETM1: 0.2131546456089213, Methylation_CDC42BPB: -0.8738813064249225, Methylation_C8orf38: 0.15923942347799, Methylation_chr14 100504766 EVL (18852): 0.219227268682941, Methylation_chr5 72594851 LOC340090 (24088): 0.4191834298888695, Methylation_chr2 242904738 LINC01238 (3421): -0.5803971626158413, Methylation_ARFGEF1: 0.3707502082182166, Methylation_MAPT: -0.358304528071902, Methylation_ZFAT: 0.945928105054458, Methylation_KCNQ4: -1.0361388347380447, Methylation_chr1 232684368 SIPA1L2 (12934): 0.419089507378773, Methylation_CRNKL1: 0.51321467427491, Methylation_PRKAG2: 1.2032225317494665, Methylation_MICB: 0.6797349508562813, miRNA_hsa-mir-934: 0.4144836681299904, miRNA_hsa-mir-4728: 0.0276206942823521, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.5865525666598866, miRNA_hsa-mir-190b: 0.9672165300491284, miRNA_hsa-mir-577: -0.3094502097851837, miRNA_hsa-mir-135b: -0.4416276008453376, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.413467797114121, miRNA_hsa-mir-130b: -0.5492896279623936, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AC-A3QP,High mRNA_CITED4 (Z=1.52) indicates overexpression. Low mRNA_DTL (Z=-2.35) and mRNA_SPAG5 (Z=-1.95) reflect downregulation. No methylation or miRNA alterations meet diagnostic thresholds. All CNVs fall within normal range (−1.10 to −0.10). These features suggest luminal A subtype with intact genomic stability and selective transcriptional dysregulation.,"mRNA_MLPH: 0.1954493586258172, mRNA_C2orf54: -0.9102818088570503, mRNA_CITED4: 1.516152881896175, mRNA_ESR1: -0.746067389523536, mRNA_SPDEF: 0.396028616080736, mRNA_AGR3: 0.3054928928460476, mRNA_FOXC1: 0.0936985436987837, mRNA_GATA3: 0.4518001172094046, mRNA_AGR2: -0.8710156998159264, mRNA_XBP1: -0.1235166410979321, mRNA_PRR15: 0.1191237514614935, mRNA_SLC44A4: 0.3421983724721331, mRNA_CA12: 0.0237530823567639, mRNA_DTL: -2.351684558435116, mRNA_C5AR2: 0.4532131037969722, mRNA_TBC1D9: -0.1714018794462184, mRNA_AR: -0.1223961286092368, mRNA_CCDC170: -0.0426402160860646, mRNA_DEGS2: 0.5238461018046066, mRNA_TFF3: 0.4824860367150931, mRNA_DNALI1: 0.706619588883239, mRNA_LINC00504: 0.1975044954409, mRNA_CLCA2: -0.1527897001694234, mRNA_PPP1R14C: -0.0348405660166669, mRNA_THSD4: -0.4036200087352496, mRNA_SPAG5: -1.9486087967306207, mRNA_FBP1: -0.0350754440559546, mRNA_SLC7A8: -0.3794866256451661, mRNA_EN1: -0.573266866941577, mRNA_ZNF552: -0.372253921639013, Methylation_LRRC6: 0.1205369989999256, Methylation_chr2 66218712 LINC02934 (29533): 0.6853251175305208, Methylation_HOXB13: -1.0270348560778129, Methylation_chr10 3949206 LINC02660 (4871): 0.2354047582711425, Methylation_chr5 179517140 RNF130 (18026): -0.0093876709038437, Methylation_LOC727677: -0.3534352672712536, Methylation_LETM1: 0.1465753943152052, Methylation_CDC42BPB: -0.4841114882920317, Methylation_C8orf38: 0.5750451442598266, Methylation_chr14 100504766 EVL (18852): 0.1792230806408339, Methylation_chr5 72594851 LOC340090 (24088): 0.5623975852210212, Methylation_chr2 242904738 LINC01238 (3421): -0.2144837576880145, Methylation_ARFGEF1: 0.3470421593627666, Methylation_MAPT: -0.0479504288819922, Methylation_ZFAT: 0.640590633241531, Methylation_KCNQ4: 0.0986858508845265, Methylation_chr1 232684368 SIPA1L2 (12934): 0.8958960535666268, Methylation_CRNKL1: 0.4025136274411788, Methylation_PRKAG2: 1.339150066475891, Methylation_MICB: 0.3644441107366006, miRNA_hsa-mir-934: -0.5251503804559151, miRNA_hsa-mir-4728: -0.6031385725704621, miRNA_hsa-mir-5695: -0.2490570600973316, miRNA_hsa-mir-18a: -0.0557284149849122, miRNA_hsa-mir-190b: 0.4654021461649061, miRNA_hsa-mir-577: -0.2088368505457573, miRNA_hsa-mir-135b: -0.5518638507288937, miRNA_hsa-mir-2115: -0.1285778067682425, miRNA_hsa-mir-17: 0.4350104478966326, miRNA_hsa-mir-130b: -1.176271553856275, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A251,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression of PPP1R14C, EN1, FOXC1, and SPAG5. Promoter hypermethylation of LRRC6, LOC727677, ARFGEF1, and SIPA1L2 mediates epigenetic silencing. miRNA upregulation (hsa-mir-934, hsa-mir-5695, hsa-mir-577) suggests post-transcriptional repression. These features indicate a basal-like phenotype with PI3K/AKT dysregulation.","mRNA_MLPH: -1.7391705979008607, mRNA_C2orf54: -0.8947344091811443, mRNA_CITED4: 0.5672650635498577, mRNA_ESR1: -1.122781003822816, mRNA_SPDEF: -2.0016152794287483, mRNA_AGR3: -1.2478530120622005, mRNA_FOXC1: 1.9958823110900328, mRNA_GATA3: -1.2844176997633865, mRNA_AGR2: -2.0944901153443736, mRNA_XBP1: -1.045892030307738, mRNA_PRR15: -1.6455377506113875, mRNA_SLC44A4: -1.9688285374591388, mRNA_CA12: -1.70360960178401, mRNA_DTL: 1.2575739035796891, mRNA_C5AR2: -1.2774682462645943, mRNA_TBC1D9: -1.148211042646526, mRNA_AR: -1.4193440816689002, mRNA_CCDC170: -1.5184958212913489, mRNA_DEGS2: -2.2039961912763664, mRNA_TFF3: -1.6154066607274662, mRNA_DNALI1: -0.6275403757150789, mRNA_LINC00504: -1.388862067531869, mRNA_CLCA2: -0.777144764147136, mRNA_PPP1R14C: 2.1716209628795253, mRNA_THSD4: -1.75675821343733, mRNA_SPAG5: 1.5099271782908426, mRNA_FBP1: -2.0276560155914107, mRNA_SLC7A8: -0.6727009230322769, mRNA_EN1: 2.2419716858137217, mRNA_ZNF552: -1.1544842910195177, Methylation_LRRC6: 1.5068339796581558, Methylation_chr2 66218712 LINC02934 (29533): -1.821176913274902, Methylation_HOXB13: -1.0803868986108796, Methylation_chr10 3949206 LINC02660 (4871): 1.461152112425526, Methylation_chr5 179517140 RNF130 (18026): -1.4921311638907406, Methylation_LOC727677: 1.5357355839702551, Methylation_LETM1: 1.3465115979592046, Methylation_CDC42BPB: 0.3436763009329885, Methylation_C8orf38: 1.402875926072037, Methylation_chr14 100504766 EVL (18852): 1.369396458784068, Methylation_chr5 72594851 LOC340090 (24088): -1.541442587743301, Methylation_chr2 242904738 LINC01238 (3421): 1.4182859844676985, Methylation_ARFGEF1: 1.677926959803332, Methylation_MAPT: 1.41020889379351, Methylation_ZFAT: 1.287950809520387, Methylation_KCNQ4: 1.3722499948504971, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5878102027069438, Methylation_CRNKL1: 1.421767719368643, Methylation_PRKAG2: 1.1364571136617834, Methylation_MICB: 1.4238991996097756, miRNA_hsa-mir-934: 2.8267084008536694, miRNA_hsa-mir-4728: 0.5348615804410112, miRNA_hsa-mir-5695: 2.9871349791147632, miRNA_hsa-mir-18a: 1.951697404811398, miRNA_hsa-mir-190b: -0.8314233292150223, miRNA_hsa-mir-577: 3.3718464826734804, miRNA_hsa-mir-135b: 0.3785774000710328, miRNA_hsa-mir-2115: 0.0546333322343434, miRNA_hsa-mir-17: 1.2011175314053155, miRNA_hsa-mir-130b: 1.990250400481561, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-E9-A1R6,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-significant ranges per specified Z-score and CNV cutoffs.","mRNA_MLPH: 0.4671518289323461, mRNA_C2orf54: -1.0787012031179477, mRNA_CITED4: -0.9460496094345698, mRNA_ESR1: 1.294547516791698, mRNA_SPDEF: 0.469860328466142, mRNA_AGR3: 0.530126268878907, mRNA_FOXC1: -1.211715347706962, mRNA_GATA3: 0.8255238897427013, mRNA_AGR2: 0.8630797836377051, mRNA_XBP1: 0.544317471479333, mRNA_PRR15: 0.9574876164461692, mRNA_SLC44A4: 0.2858124137027812, mRNA_CA12: 1.101477772720306, mRNA_DTL: -0.2828099147408573, mRNA_C5AR2: 1.1777505277467852, mRNA_TBC1D9: 0.4588803336256483, mRNA_AR: 0.8788711670415776, mRNA_CCDC170: 0.824682649579047, mRNA_DEGS2: 0.8759291523800293, mRNA_TFF3: -0.2982084425643053, mRNA_DNALI1: 0.921020272511076, mRNA_LINC00504: 0.9279846944141392, mRNA_CLCA2: -0.8523131624414602, mRNA_PPP1R14C: -1.046610829682955, mRNA_THSD4: 1.2187380810147148, mRNA_SPAG5: 0.5630925174544431, mRNA_FBP1: 0.4078399832500827, mRNA_SLC7A8: 0.5557984679398587, mRNA_EN1: -0.4949889539269773, mRNA_ZNF552: 0.586650639980927, Methylation_LRRC6: -0.9351629118450804, Methylation_chr2 66218712 LINC02934 (29533): 1.2849568178500614, Methylation_HOXB13: -1.1057528450741787, Methylation_chr10 3949206 LINC02660 (4871): -1.2953147509225649, Methylation_chr5 179517140 RNF130 (18026): 1.19893298094863, Methylation_LOC727677: -1.0393348038291148, Methylation_LETM1: -1.0190419882551325, Methylation_CDC42BPB: 1.339231611793738, Methylation_C8orf38: -0.5098319834989412, Methylation_chr14 100504766 EVL (18852): -0.7805708869272541, Methylation_chr5 72594851 LOC340090 (24088): 1.0355692514694206, Methylation_chr2 242904738 LINC01238 (3421): -0.8446622174782447, Methylation_ARFGEF1: -1.080684486291447, Methylation_MAPT: -0.9843557625348612, Methylation_ZFAT: -1.071105625540704, Methylation_KCNQ4: 0.1028520772565563, Methylation_chr1 232684368 SIPA1L2 (12934): -0.7811987811925223, Methylation_CRNKL1: -1.2507889429043326, Methylation_PRKAG2: 1.2989529162515443, Methylation_MICB: -1.1789552122500446, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.5870073681278789, miRNA_hsa-mir-5695: 0.7120781797771777, miRNA_hsa-mir-18a: -0.2592596365118986, miRNA_hsa-mir-190b: 0.8759875676844606, miRNA_hsa-mir-577: -0.4780739893416601, miRNA_hsa-mir-135b: -0.8670456150813551, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.3424791569393613, miRNA_hsa-mir-130b: 0.2134034822587396, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-E2-A56Z,"High-level Amplification of none; AGR2 mRNA overexpressed (Z=1.73). LETM1, MAPT, CRNKL1, MICB, and ZFAT promoters hypermethylated (Z < -1.47), suggesting epigenetic silencing. No miRNA alterations meet thresholds. Gains in VPS54, WDPCP, CEP68, and LINC02576. Collectively indicate luminal breast cancer phenotype with ER pathway activation.","mRNA_MLPH: 0.7498978288050441, mRNA_C2orf54: -0.0569825306470162, mRNA_CITED4: -0.9507169257293184, mRNA_ESR1: 0.8261210856391402, mRNA_SPDEF: 0.7633986081320874, mRNA_AGR3: 1.2891189176297777, mRNA_FOXC1: -1.005488079758741, mRNA_GATA3: 0.6343229289495113, mRNA_AGR2: 1.7330973428682968, mRNA_XBP1: 0.3718087618592141, mRNA_PRR15: 0.8825357131965716, mRNA_SLC44A4: 0.778393801030527, mRNA_CA12: -0.2480996702954354, mRNA_DTL: -0.2234699127259115, mRNA_C5AR2: 0.1729291069834646, mRNA_TBC1D9: 0.4529739534631032, mRNA_AR: -0.0017689977847749, mRNA_CCDC170: 0.2971450990534723, mRNA_DEGS2: -0.2096597761632365, mRNA_TFF3: 0.9395116886844924, mRNA_DNALI1: 0.8225987850210281, mRNA_LINC00504: 0.3978481724574149, mRNA_CLCA2: -0.8950940779111158, mRNA_PPP1R14C: -1.0812064756609236, mRNA_THSD4: 0.1320524037396853, mRNA_SPAG5: 0.461503842865423, mRNA_FBP1: 0.3213448472006078, mRNA_SLC7A8: 0.3655133746582826, mRNA_EN1: -0.790023662834755, mRNA_ZNF552: 0.5610505633280621, Methylation_LRRC6: -1.3185086818505662, Methylation_chr2 66218712 LINC02934 (29533): -0.4038163395964317, Methylation_HOXB13: 1.4244569119426391, Methylation_chr10 3949206 LINC02660 (4871): -1.2929754300374332, Methylation_chr5 179517140 RNF130 (18026): 1.2499929615558347, Methylation_LOC727677: -1.234942137212529, Methylation_LETM1: -1.944187140526885, Methylation_CDC42BPB: 1.0421838571039417, Methylation_C8orf38: -1.352851194546157, Methylation_chr14 100504766 EVL (18852): -1.179970138956031, Methylation_chr5 72594851 LOC340090 (24088): 1.0662058641261951, Methylation_chr2 242904738 LINC01238 (3421): -1.3278164522754166, Methylation_ARFGEF1: -1.0970681209481936, Methylation_MAPT: -1.7341514938077471, Methylation_ZFAT: -1.5044734780942424, Methylation_KCNQ4: -1.036183050206899, Methylation_chr1 232684368 SIPA1L2 (12934): -1.1948972714585766, Methylation_CRNKL1: -1.5853073568198697, Methylation_PRKAG2: -1.424226275896179, Methylation_MICB: -1.5931704849189736, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.7491058862032103, miRNA_hsa-mir-5695: -0.4151071877776796, miRNA_hsa-mir-18a: 0.5689102321012547, miRNA_hsa-mir-190b: 0.9554191185174974, miRNA_hsa-mir-577: -0.4671783985757782, miRNA_hsa-mir-135b: -0.556268434647779, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.5705223060375874, miRNA_hsa-mir-130b: -1.202370342566626, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-AR-A24X,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.476790896121358, mRNA_C2orf54: -0.3383953651018022, mRNA_CITED4: 0.9648570625541754, mRNA_ESR1: 0.1673719452064247, mRNA_SPDEF: 0.402337601918105, mRNA_AGR3: 0.5037257565107068, mRNA_FOXC1: -0.1106561029181083, mRNA_GATA3: 0.5808781589264375, mRNA_AGR2: 0.1467092400708425, mRNA_XBP1: 0.4885038951693246, mRNA_PRR15: 0.7484752451406718, mRNA_SLC44A4: 0.6946324644286356, mRNA_CA12: 0.2187479955375185, mRNA_DTL: 0.5398901441368845, mRNA_C5AR2: 0.5337045441508481, mRNA_TBC1D9: 0.746880962906583, mRNA_AR: -0.1102362261007717, mRNA_CCDC170: 0.5521189098817537, mRNA_DEGS2: -0.1684989502887819, mRNA_TFF3: 0.5493292949205622, mRNA_DNALI1: 0.8140095616795157, mRNA_LINC00504: 1.2816485032929332, mRNA_CLCA2: 0.5019951643674319, mRNA_PPP1R14C: -0.3514044353134342, mRNA_THSD4: 0.5023818438442051, mRNA_SPAG5: -0.2072801114573507, mRNA_FBP1: 0.344763273520806, mRNA_SLC7A8: 0.6062088607138904, mRNA_EN1: -0.1208019304409261, mRNA_ZNF552: 0.2292307252767216, Methylation_LRRC6: -0.2569080691091281, Methylation_chr2 66218712 LINC02934 (29533): 1.0766172722891731, Methylation_HOXB13: -0.0777913566980462, Methylation_chr10 3949206 LINC02660 (4871): -0.8671473659467422, Methylation_chr5 179517140 RNF130 (18026): 0.8080104419096925, Methylation_LOC727677: -0.7310944961206972, Methylation_LETM1: -0.7242130979873492, Methylation_CDC42BPB: 1.0728940070760549, Methylation_C8orf38: 0.2457265612079208, Methylation_chr14 100504766 EVL (18852): -0.5457918520615593, Methylation_chr5 72594851 LOC340090 (24088): 0.7955923703148455, Methylation_chr2 242904738 LINC01238 (3421): -1.0643640023438163, Methylation_ARFGEF1: -0.2997144907878559, Methylation_MAPT: -0.8327079028769556, Methylation_ZFAT: 0.5204940930781436, Methylation_KCNQ4: 1.093503149382156, Methylation_chr1 232684368 SIPA1L2 (12934): -1.112110856872885, Methylation_CRNKL1: -0.4589342412849453, Methylation_PRKAG2: 1.238732406093325, Methylation_MICB: -0.3656306556701965, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.1268310015444877, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.1032588821995513, miRNA_hsa-mir-190b: 0.9879585653190214, miRNA_hsa-mir-577: -0.1644574235686569, miRNA_hsa-mir-135b: -0.3424250931550122, miRNA_hsa-mir-2115: 0.3410092626745784, miRNA_hsa-mir-17: 0.4764123375530472, miRNA_hsa-mir-130b: -0.3256802918338836, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E2-A570,High mRNA_CITED4 (Z=1.49) indicates overexpression. No methylation or miRNA alterations meet diagnostic thresholds. All CNVs fall within normal range (−1.10 to −0.10). These features collectively indicate a luminal phenotype with estrogen signaling activity.,"mRNA_MLPH: 0.7042359945045084, mRNA_C2orf54: -0.2461987483872371, mRNA_CITED4: 1.4851512593224043, mRNA_ESR1: 0.2512678341746847, mRNA_SPDEF: 0.6142123013285998, mRNA_AGR3: 0.8333919032235826, mRNA_FOXC1: -0.3994220022984159, mRNA_GATA3: 0.646915601429623, mRNA_AGR2: 0.3707677537579065, mRNA_XBP1: 0.155348489334149, mRNA_PRR15: 0.2515644320482448, mRNA_SLC44A4: 0.3091934257991505, mRNA_CA12: -0.1826944455751237, mRNA_DTL: -0.124150795082112, mRNA_C5AR2: 0.6202051206002765, mRNA_TBC1D9: 0.1185688123115078, mRNA_AR: -0.2161418375217365, mRNA_CCDC170: 1.0151193435260315, mRNA_DEGS2: 0.8506051771479719, mRNA_TFF3: 0.7358878507039424, mRNA_DNALI1: 1.0597688721473215, mRNA_LINC00504: 0.9930937017758238, mRNA_CLCA2: 0.8376722972451686, mRNA_PPP1R14C: 0.2155825259684244, mRNA_THSD4: 0.0008890816374131, mRNA_SPAG5: -0.1291917263204021, mRNA_FBP1: 0.1041808842644551, mRNA_SLC7A8: 0.7681268683016013, mRNA_EN1: 0.2540626699082368, mRNA_ZNF552: -0.1875119899870268, Methylation_LRRC6: 0.1762863030276115, Methylation_chr2 66218712 LINC02934 (29533): 0.9111011772767464, Methylation_HOXB13: -1.0135912096572828, Methylation_chr10 3949206 LINC02660 (4871): -0.9255636926267696, Methylation_chr5 179517140 RNF130 (18026): 0.0859061785008687, Methylation_LOC727677: -0.4119793238321526, Methylation_LETM1: -0.4140492257230648, Methylation_CDC42BPB: -0.8808844692211755, Methylation_C8orf38: -0.1576374129235366, Methylation_chr14 100504766 EVL (18852): -0.1516164382355149, Methylation_chr5 72594851 LOC340090 (24088): -0.3665583353877378, Methylation_chr2 242904738 LINC01238 (3421): -0.6692507149901374, Methylation_ARFGEF1: -0.3036656322144546, Methylation_MAPT: -0.5290447531635095, Methylation_ZFAT: -0.1732294414675812, Methylation_KCNQ4: 0.4828691953666771, Methylation_chr1 232684368 SIPA1L2 (12934): -0.395113346995577, Methylation_CRNKL1: 0.597877473483764, Methylation_PRKAG2: 1.285629893217746, Methylation_MICB: -0.1761615784473567, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.017622679390571, miRNA_hsa-mir-5695: 0.0215521528043304, miRNA_hsa-mir-18a: -0.9781239736704735, miRNA_hsa-mir-190b: 0.9176035176952936, miRNA_hsa-mir-577: -0.627480987991216, miRNA_hsa-mir-135b: -0.8637400914770758, miRNA_hsa-mir-2115: 0.7469207988554298, miRNA_hsa-mir-17: -0.6553920290989014, miRNA_hsa-mir-130b: -0.8248032237979713, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A2-A1FV,"LINC00504 mRNA overexpression (Z=1.83) and TBC1D9 upregulation (Z=1.49) exceed the high-expression threshold. MAPT, ZFAT, and HOXB13 promoters are hypermethylated (Z < -1.47), indicating epigenetic silencing. No CNVs meet deletion or amplification thresholds. miRNA alterations fall within non-significant ranges. This profile suggests luminal-like transcriptional activity with MAPT/ZFAT/HOXB13 suppression.","mRNA_MLPH: 0.7022691195030204, mRNA_C2orf54: -1.272438052663703, mRNA_CITED4: -1.25770523900234, mRNA_ESR1: 0.6578392413123479, mRNA_SPDEF: -0.0236870880494223, mRNA_AGR3: 0.3123263855632334, mRNA_FOXC1: 0.2294926717103197, mRNA_GATA3: 0.8855029306622247, mRNA_AGR2: 0.7266190628942915, mRNA_XBP1: 1.0819580303671863, mRNA_PRR15: 0.7457976388896049, mRNA_SLC44A4: -0.0674529881865426, mRNA_CA12: 0.3626641935056949, mRNA_DTL: -0.3567196654815532, mRNA_C5AR2: 0.6648129074142203, mRNA_TBC1D9: 1.4945650006959394, mRNA_AR: -1.110573232309534, mRNA_CCDC170: 0.15717945743929, mRNA_DEGS2: -0.42490516962748, mRNA_TFF3: -0.7487426882543969, mRNA_DNALI1: 0.7747434187402277, mRNA_LINC00504: 1.834826362511105, mRNA_CLCA2: -0.2949154089486344, mRNA_PPP1R14C: -0.4740817665619237, mRNA_THSD4: 0.990207548607968, mRNA_SPAG5: -0.9424969757946404, mRNA_FBP1: 1.5063184788500703, mRNA_SLC7A8: 1.0771086429800891, mRNA_EN1: -0.9154906823277128, mRNA_ZNF552: -0.3542787559131016, Methylation_LRRC6: -1.514290173346856, Methylation_chr2 66218712 LINC02934 (29533): -1.770405247608941, Methylation_HOXB13: -1.0737876890981717, Methylation_chr10 3949206 LINC02660 (4871): -1.196357076393442, Methylation_chr5 179517140 RNF130 (18026): 1.1956895604525608, Methylation_LOC727677: -1.372914572059688, Methylation_LETM1: -1.4097896325619772, Methylation_CDC42BPB: 0.2080693683184941, Methylation_C8orf38: -1.4536015592395723, Methylation_chr14 100504766 EVL (18852): -1.0400542213161736, Methylation_chr5 72594851 LOC340090 (24088): 1.071629385015975, Methylation_chr2 242904738 LINC01238 (3421): -1.3412352870241495, Methylation_ARFGEF1: -1.44478191632297, Methylation_MAPT: -1.6275735171849588, Methylation_ZFAT: -1.720323934710516, Methylation_KCNQ4: 1.7251301179117695, Methylation_chr1 232684368 SIPA1L2 (12934): -1.1396638381233315, Methylation_CRNKL1: -1.1857540900659096, Methylation_PRKAG2: 1.3813696902472348, Methylation_MICB: -1.2379396286667397, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.3872812597691447, miRNA_hsa-mir-190b: 0.6809791687221438, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.0131658510833208, miRNA_hsa-mir-2115: 0.362495473256682, miRNA_hsa-mir-17: -0.3034205106736203, miRNA_hsa-mir-130b: 0.3805672171900637, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-OK-A5Q2,"CLCA2 mRNA overexpression (Z=2.17) and EN1 upregulation (Z=1.54) exceed high-expression thresholds. CITED4, ESR1, and GATA3 show no significant dysregulation. No methylation or miRNA alterations meet diagnostic cutoffs. All CNVs fall within normal range. These features align with a luminal epithelial phenotype lacking major genomic or epigenetic drivers.","mRNA_MLPH: 0.9143257033877988, mRNA_C2orf54: 1.3460713555210717, mRNA_CITED4: 0.8784013160070823, mRNA_ESR1: 0.1722620443168101, mRNA_SPDEF: 0.5923794745928792, mRNA_AGR3: 0.3299857207005969, mRNA_FOXC1: 0.3215504014919277, mRNA_GATA3: 0.415269019303905, mRNA_AGR2: 0.4161868581206, mRNA_XBP1: 0.4134010933255649, mRNA_PRR15: 0.3830028905557752, mRNA_SLC44A4: 0.6182761632130056, mRNA_CA12: 0.0968017053491576, mRNA_DTL: 1.2797153316940284, mRNA_C5AR2: 0.4631983265701435, mRNA_TBC1D9: -0.2926744671654017, mRNA_AR: 0.1090221370617634, mRNA_CCDC170: -0.291741497036287, mRNA_DEGS2: 0.7770574033980955, mRNA_TFF3: 0.5117346213744489, mRNA_DNALI1: 0.7920850794088026, mRNA_LINC00504: 0.2187346049147487, mRNA_CLCA2: 2.172984334157658, mRNA_PPP1R14C: 0.1742826586463465, mRNA_THSD4: -0.0435015900835854, mRNA_SPAG5: 0.282468775290117, mRNA_FBP1: 0.3814068580432662, mRNA_SLC7A8: 0.6631492027257758, mRNA_EN1: 1.541399974543454, mRNA_ZNF552: -0.2498334338059747, Methylation_LRRC6: 0.8796216057989792, Methylation_chr2 66218712 LINC02934 (29533): 0.0725960854184006, Methylation_HOXB13: 0.331221458616924, Methylation_chr10 3949206 LINC02660 (4871): 1.0570309043918693, Methylation_chr5 179517140 RNF130 (18026): 0.1018103892791578, Methylation_LOC727677: 0.5251725484067966, Methylation_LETM1: 0.8834189007824117, Methylation_CDC42BPB: -0.1532317948611458, Methylation_C8orf38: 0.7873003952267071, Methylation_chr14 100504766 EVL (18852): 1.2079967017400408, Methylation_chr5 72594851 LOC340090 (24088): 0.4035683935488414, Methylation_chr2 242904738 LINC01238 (3421): 1.166025358568742, Methylation_ARFGEF1: 1.2350094364080593, Methylation_MAPT: 0.4426629316593521, Methylation_ZFAT: 0.329820069196174, Methylation_KCNQ4: 0.3114794396926065, Methylation_chr1 232684368 SIPA1L2 (12934): 0.594041063693436, Methylation_CRNKL1: 0.8108133928135337, Methylation_PRKAG2: 0.9182992117116128, Methylation_MICB: 0.7883253549063397, miRNA_hsa-mir-934: -0.3043610957290308, miRNA_hsa-mir-4728: -0.044890675371588, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.2157693742969026, miRNA_hsa-mir-190b: 0.5468886214416072, miRNA_hsa-mir-577: -0.4899117439845611, miRNA_hsa-mir-135b: 0.5677595051695422, miRNA_hsa-mir-2115: 0.6171380252518144, miRNA_hsa-mir-17: 0.1191917510877329, miRNA_hsa-mir-130b: -1.413310582824458, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A1AK,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.386191516484495, mRNA_C2orf54: -0.4969062931428861, mRNA_CITED4: 0.474542899210827, mRNA_ESR1: 0.3205885329609596, mRNA_SPDEF: 0.3077534353407654, mRNA_AGR3: 0.5109434297039778, mRNA_FOXC1: 0.5279940449788655, mRNA_GATA3: 0.3558973190561736, mRNA_AGR2: 0.7381889433254534, mRNA_XBP1: 0.3552786245637493, mRNA_PRR15: -0.2141932481946663, mRNA_SLC44A4: 0.1553035357508116, mRNA_CA12: 0.7329443989404091, mRNA_DTL: 0.334325143256776, mRNA_C5AR2: 0.3807136273104653, mRNA_TBC1D9: 0.6979543450902674, mRNA_AR: 0.3998154240190147, mRNA_CCDC170: 0.8468494852710442, mRNA_DEGS2: 0.7465087013081648, mRNA_TFF3: -0.1429579329144294, mRNA_DNALI1: 0.7639605745782558, mRNA_LINC00504: 0.43051157433535, mRNA_CLCA2: -0.1610070586346712, mRNA_PPP1R14C: -0.0380062928120384, mRNA_THSD4: 0.5662758124021169, mRNA_SPAG5: 0.688092542132968, mRNA_FBP1: 0.326189058127742, mRNA_SLC7A8: 0.9590449831849917, mRNA_EN1: -0.7627948008735195, mRNA_ZNF552: 0.8033069469752863, Methylation_LRRC6: -0.353795364367984, Methylation_chr2 66218712 LINC02934 (29533): 0.2759334508426476, Methylation_HOXB13: -1.0122986894605972, Methylation_chr10 3949206 LINC02660 (4871): -0.4546349526672597, Methylation_chr5 179517140 RNF130 (18026): 0.8641983412395363, Methylation_LOC727677: -0.374559322285507, Methylation_LETM1: -0.1050944017046266, Methylation_CDC42BPB: 1.1773785956987557, Methylation_C8orf38: 0.6473904498225881, Methylation_chr14 100504766 EVL (18852): 0.0365662176371667, Methylation_chr5 72594851 LOC340090 (24088): 0.8889714947144364, Methylation_chr2 242904738 LINC01238 (3421): -0.3039150716148751, Methylation_ARFGEF1: -0.2452610791535151, Methylation_MAPT: 0.6800156493157725, Methylation_ZFAT: -0.3588909556549465, Methylation_KCNQ4: -1.0299502589769445, Methylation_chr1 232684368 SIPA1L2 (12934): -0.323167484896479, Methylation_CRNKL1: 0.5472965878388395, Methylation_PRKAG2: 1.1744787494698703, Methylation_MICB: -0.4726763716801034, miRNA_hsa-mir-934: -0.0555750504985029, miRNA_hsa-mir-4728: -0.0659435119931549, miRNA_hsa-mir-5695: 2.1120294811295826, miRNA_hsa-mir-18a: 0.2868838727769813, miRNA_hsa-mir-190b: 0.3079479177560624, miRNA_hsa-mir-577: 0.1732888020169531, miRNA_hsa-mir-135b: 1.006210743048735, miRNA_hsa-mir-2115: -0.4658728255445878, miRNA_hsa-mir-17: -0.4071462787557696, miRNA_hsa-mir-130b: 0.309387837789029, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A3X8,High mRNA_CITED4 (Z=1.64) and mRNA_TFF3 (Z=1.10) indicate overexpression. miRNA_hsa-mir-130b is downregulated (Z=-1.82). No methylation or CNV alterations meet diagnostic thresholds. These features suggest luminal epithelial differentiation with potential TGF-β pathway modulation.,"mRNA_MLPH: 0.4291410861866945, mRNA_C2orf54: -0.6949221068899087, mRNA_CITED4: 1.642565115303913, mRNA_ESR1: -0.3277145729908612, mRNA_SPDEF: 0.4943400792954978, mRNA_AGR3: 0.4575397856156379, mRNA_FOXC1: -0.2145022318747636, mRNA_GATA3: -0.0597697693332944, mRNA_AGR2: 0.3506028508129842, mRNA_XBP1: -0.733781981559819, mRNA_PRR15: -0.2121086700754915, mRNA_SLC44A4: -0.1054780280985298, mRNA_CA12: -0.1648208002670056, mRNA_DTL: -1.1561505309990308, mRNA_C5AR2: 0.5421577961841779, mRNA_TBC1D9: -0.8074342828795147, mRNA_AR: -0.1499488474808065, mRNA_CCDC170: -0.3378931182330398, mRNA_DEGS2: 0.9417575309507612, mRNA_TFF3: 1.1035939931337304, mRNA_DNALI1: 0.3295417474316628, mRNA_LINC00504: -0.2628053369803675, mRNA_CLCA2: -0.7101898902171379, mRNA_PPP1R14C: -0.3779841823610019, mRNA_THSD4: -0.7943890557135092, mRNA_SPAG5: -1.340590536077502, mRNA_FBP1: -0.6517915344174343, mRNA_SLC7A8: -0.5310070987492174, mRNA_EN1: 0.0289707500372707, mRNA_ZNF552: -0.3068110090279945, Methylation_LRRC6: 0.7760110091553651, Methylation_chr2 66218712 LINC02934 (29533): 1.1150715900491053, Methylation_HOXB13: -0.1815537584930868, Methylation_chr10 3949206 LINC02660 (4871): 0.3616540127402612, Methylation_chr5 179517140 RNF130 (18026): -0.1880436433699, Methylation_LOC727677: 0.4725388053902463, Methylation_LETM1: 0.6406285216887855, Methylation_CDC42BPB: -0.5527798731618964, Methylation_C8orf38: 0.6646420641277063, Methylation_chr14 100504766 EVL (18852): 0.8390664323688602, Methylation_chr5 72594851 LOC340090 (24088): 0.2528612409284645, Methylation_chr2 242904738 LINC01238 (3421): -0.0965628776700618, Methylation_ARFGEF1: 1.0096215585380983, Methylation_MAPT: 0.7374468048976676, Methylation_ZFAT: 0.2858435260576815, Methylation_KCNQ4: 0.1160465044846431, Methylation_chr1 232684368 SIPA1L2 (12934): 0.957555065193952, Methylation_CRNKL1: 0.7925801154188039, Methylation_PRKAG2: 1.1636718825533043, Methylation_MICB: 1.2034436663441346, miRNA_hsa-mir-934: -0.2423960875908455, miRNA_hsa-mir-4728: -1.0576075483453389, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.045658829047171, miRNA_hsa-mir-190b: -0.5752481638828709, miRNA_hsa-mir-577: -0.6811301504679594, miRNA_hsa-mir-135b: -0.59326934852202, miRNA_hsa-mir-2115: -0.4343552177770479, miRNA_hsa-mir-17: -0.3369150950551499, miRNA_hsa-mir-130b: -1.8202823187737247, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-BH-A0DV,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-significant ranges per specified Z-score and CNV cutoffs.","mRNA_MLPH: 0.2532736023651041, mRNA_C2orf54: 0.3100004875679791, mRNA_CITED4: 0.1951152415927729, mRNA_ESR1: 0.2852574522169975, mRNA_SPDEF: 0.2523277078624118, mRNA_AGR3: 0.3838300522225315, mRNA_FOXC1: 0.9309591605251606, mRNA_GATA3: 0.1105553471636498, mRNA_AGR2: 0.0991266772536339, mRNA_XBP1: 0.4549843037747348, mRNA_PRR15: 0.0399246574097926, mRNA_SLC44A4: 0.7788102734803921, mRNA_CA12: 0.1004544457679669, mRNA_DTL: -1.1075583822079202, mRNA_C5AR2: -0.7129902578142651, mRNA_TBC1D9: 0.2191894493882804, mRNA_AR: 0.5484119098820591, mRNA_CCDC170: -0.1745541661075782, mRNA_DEGS2: 0.5851630208897526, mRNA_TFF3: -0.2590057496434265, mRNA_DNALI1: 0.0859714728521717, mRNA_LINC00504: 0.2753342972175759, mRNA_CLCA2: 1.9532715704487065, mRNA_PPP1R14C: -0.066273296383661, mRNA_THSD4: 0.1406132265354185, mRNA_SPAG5: -1.9699945600630573, mRNA_FBP1: 0.1161455915281176, mRNA_SLC7A8: 0.8525098028514384, mRNA_EN1: 0.2352659559793209, mRNA_ZNF552: -0.6610068961967915, Methylation_LRRC6: 0.9593839466923124, Methylation_chr2 66218712 LINC02934 (29533): 0.9348123718497728, Methylation_HOXB13: -1.0022430356918284, Methylation_chr10 3949206 LINC02660 (4871): 0.1889512501113727, Methylation_chr5 179517140 RNF130 (18026): -0.8810428850105585, Methylation_LOC727677: 0.821758992922338, Methylation_LETM1: 0.6124960256323685, Methylation_CDC42BPB: -0.5490788418269255, Methylation_C8orf38: 0.4996025976305228, Methylation_chr14 100504766 EVL (18852): 0.951398060323072, Methylation_chr5 72594851 LOC340090 (24088): 0.6035248888182797, Methylation_chr2 242904738 LINC01238 (3421): 0.2373552903574373, Methylation_ARFGEF1: 1.333396354882892, Methylation_MAPT: 0.9216537588432664, Methylation_ZFAT: 0.8329450431048713, Methylation_KCNQ4: -1.1347213186524168, Methylation_chr1 232684368 SIPA1L2 (12934): 1.0561574782834953, Methylation_CRNKL1: 0.8903288893406913, Methylation_PRKAG2: 1.2973417608979447, Methylation_MICB: 0.877102376802984, miRNA_hsa-mir-934: -0.2465588748825335, miRNA_hsa-mir-4728: -0.4469575878106804, miRNA_hsa-mir-5695: 0.575720391772955, miRNA_hsa-mir-18a: -1.0560701151042495, miRNA_hsa-mir-190b: -0.0053095396251424, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.7550304307994246, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.2758021783852431, miRNA_hsa-mir-130b: 0.1079188018940412, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AC-A5XU,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.4629107398521391, mRNA_C2orf54: -1.1574262100264088, mRNA_CITED4: -1.867475771988014, mRNA_ESR1: 0.6872579957973957, mRNA_SPDEF: 0.295184030208637, mRNA_AGR3: 0.5223900224318017, mRNA_FOXC1: -0.6877579022726741, mRNA_GATA3: 0.4300237374838948, mRNA_AGR2: 1.1502599033442258, mRNA_XBP1: -0.0189290071846781, mRNA_PRR15: 0.197155472895883, mRNA_SLC44A4: 0.2952613403367636, mRNA_CA12: -1.0360705287451342, mRNA_DTL: -0.161531496596427, mRNA_C5AR2: 1.2436416878063512, mRNA_TBC1D9: 0.4115515194174742, mRNA_AR: -0.6915355267982759, mRNA_CCDC170: 0.604954092940673, mRNA_DEGS2: 0.2776484612808963, mRNA_TFF3: -0.0337632269088807, mRNA_DNALI1: 0.7810012628070182, mRNA_LINC00504: 0.0950230281456081, mRNA_CLCA2: -0.6415608727713559, mRNA_PPP1R14C: -0.3317968001909727, mRNA_THSD4: 0.2280895300916286, mRNA_SPAG5: 1.0067256719602415, mRNA_FBP1: 1.370630538902344, mRNA_SLC7A8: 0.2164002503075683, mRNA_EN1: 0.0625102564113486, mRNA_ZNF552: 0.5138076895327167, Methylation_LRRC6: -1.4091231791735068, Methylation_chr2 66218712 LINC02934 (29533): -0.2708563866156638, Methylation_HOXB13: 1.139059632190298, Methylation_chr10 3949206 LINC02660 (4871): -1.1099517695633694, Methylation_chr5 179517140 RNF130 (18026): 0.975393436798236, Methylation_LOC727677: -1.2947426621516716, Methylation_LETM1: -1.3625673140266596, Methylation_CDC42BPB: -1.246461915931123, Methylation_C8orf38: -0.3097657061761594, Methylation_chr14 100504766 EVL (18852): -1.2726686071833182, Methylation_chr5 72594851 LOC340090 (24088): 0.8628978028036838, Methylation_chr2 242904738 LINC01238 (3421): -1.298155946932554, Methylation_ARFGEF1: -0.9972097732843626, Methylation_MAPT: -1.2078940030456269, Methylation_ZFAT: -1.284471256480836, Methylation_KCNQ4: 1.128734867231812, Methylation_chr1 232684368 SIPA1L2 (12934): -0.9761344168338224, Methylation_CRNKL1: -1.0938840716423408, Methylation_PRKAG2: 0.5324014459556348, Methylation_MICB: -1.4743648701004917, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.6051890056086743, miRNA_hsa-mir-5695: 0.2920783450109379, miRNA_hsa-mir-18a: 0.3679370980889349, miRNA_hsa-mir-190b: -0.2531827847839705, miRNA_hsa-mir-577: 0.2093502966248547, miRNA_hsa-mir-135b: -0.3408197469911906, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.6719130855901984, miRNA_hsa-mir-130b: -0.4252362559824648, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A1AU,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.3328066605843655, mRNA_C2orf54: -0.8712513978531155, mRNA_CITED4: -0.6761411915900157, mRNA_ESR1: 0.2471417599658587, mRNA_SPDEF: 0.4886842104817718, mRNA_AGR3: 0.3316693626560594, mRNA_FOXC1: 0.1525585869682736, mRNA_GATA3: 0.388622476558026, mRNA_AGR2: 0.2375452319728479, mRNA_XBP1: 0.6241344535742848, mRNA_PRR15: 0.2099097949408318, mRNA_SLC44A4: 0.3742806978900425, mRNA_CA12: 0.9865488461846776, mRNA_DTL: -0.640204633818805, mRNA_C5AR2: 0.252935901718484, mRNA_TBC1D9: 1.230588845095698, mRNA_AR: 0.3987359848067522, mRNA_CCDC170: 0.0066185996038931, mRNA_DEGS2: -0.6389682420967121, mRNA_TFF3: 0.1930126613706601, mRNA_DNALI1: 0.3839410858712656, mRNA_LINC00504: 0.6433337164997222, mRNA_CLCA2: -0.2839238451066888, mRNA_PPP1R14C: -0.0062411746216605, mRNA_THSD4: 1.366925863455268, mRNA_SPAG5: 0.2110834184346171, mRNA_FBP1: 0.4042300474226849, mRNA_SLC7A8: 0.8762678591344799, mRNA_EN1: -0.554084471985454, mRNA_ZNF552: 0.5855765815058235, Methylation_LRRC6: -0.456567907071716, Methylation_chr2 66218712 LINC02934 (29533): 0.6329460743151517, Methylation_HOXB13: 0.7736089089521728, Methylation_chr10 3949206 LINC02660 (4871): -0.2011555703360568, Methylation_chr5 179517140 RNF130 (18026): 0.4971122945982413, Methylation_LOC727677: -0.65356978838222, Methylation_LETM1: -0.452894193727508, Methylation_CDC42BPB: 1.1837593625572678, Methylation_C8orf38: 0.4674426412274828, Methylation_chr14 100504766 EVL (18852): 0.7349932872808657, Methylation_chr5 72594851 LOC340090 (24088): -0.7868582039368198, Methylation_chr2 242904738 LINC01238 (3421): -0.4935465331875239, Methylation_ARFGEF1: -0.0272311591257256, Methylation_MAPT: -0.2054795627212984, Methylation_ZFAT: -0.7091429568946491, Methylation_KCNQ4: -0.8228056897368751, Methylation_chr1 232684368 SIPA1L2 (12934): 0.3168786091027311, Methylation_CRNKL1: 0.4727867316798164, Methylation_PRKAG2: 0.8689219566619766, Methylation_MICB: 0.2728630114065357, miRNA_hsa-mir-934: -0.1723439588578005, miRNA_hsa-mir-4728: -0.0023038159549518, miRNA_hsa-mir-5695: 0.8613084177324323, miRNA_hsa-mir-18a: 0.0650108266180235, miRNA_hsa-mir-190b: 1.3735888088488188, miRNA_hsa-mir-577: -0.1876437794661229, miRNA_hsa-mir-135b: 0.1654256516675198, miRNA_hsa-mir-2115: -0.201937352980539, miRNA_hsa-mir-17: 0.2755590188067558, miRNA_hsa-mir-130b: 0.1717497292095024, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A2-A0CT,PRR15 mRNA overexpression (Z=1.895) and FBP1 upregulation (Z=1.677) exceed high-expression thresholds. CRNKL1 promoter hypermethylation (Z=-1.638) indicates epigenetic silencing. No CNVs meet amplification or deletion criteria. These features suggest luminal breast cancer phenotype with metabolic and secretory pathway dysregulation.,"mRNA_MLPH: 0.2904513134385518, mRNA_C2orf54: -1.024518680629132, mRNA_CITED4: -1.2002902989881366, mRNA_ESR1: 0.6757401526032413, mRNA_SPDEF: 0.5795530665608035, mRNA_AGR3: 0.6359998919139048, mRNA_FOXC1: -0.6533226341072085, mRNA_GATA3: 0.735696252687257, mRNA_AGR2: 0.6977245403257286, mRNA_XBP1: 0.9103041448772932, mRNA_PRR15: 1.895358815000588, mRNA_SLC44A4: 1.1171230621653276, mRNA_CA12: -0.3555889363129302, mRNA_DTL: 1.2294718379326706, mRNA_C5AR2: -0.48910856640159, mRNA_TBC1D9: 0.7633055642286329, mRNA_AR: 0.2574727494168966, mRNA_CCDC170: 1.6600650647973805, mRNA_DEGS2: 0.6651376179672881, mRNA_TFF3: -1.4255590122507011, mRNA_DNALI1: 0.7069801899265065, mRNA_LINC00504: -0.6111949247856653, mRNA_CLCA2: 0.4698967283688122, mRNA_PPP1R14C: -0.0442163732561398, mRNA_THSD4: 0.1622484144957905, mRNA_SPAG5: 0.205024735638615, mRNA_FBP1: 1.6766303315045037, mRNA_SLC7A8: 1.3270623723756696, mRNA_EN1: -0.8900469295347211, mRNA_ZNF552: 1.104552496883841, Methylation_LRRC6: -1.4985463128265086, Methylation_chr2 66218712 LINC02934 (29533): 1.414590130568505, Methylation_HOXB13: 1.2469058692924575, Methylation_chr10 3949206 LINC02660 (4871): -1.2154843016248873, Methylation_chr5 179517140 RNF130 (18026): 1.2430843845778266, Methylation_LOC727677: -1.0070086245293568, Methylation_LETM1: -0.812064965415176, Methylation_CDC42BPB: 1.459908608937046, Methylation_C8orf38: -1.1918179019668458, Methylation_chr14 100504766 EVL (18852): -1.1014344518051438, Methylation_chr5 72594851 LOC340090 (24088): 1.3583667798880483, Methylation_chr2 242904738 LINC01238 (3421): -0.8549646602751981, Methylation_ARFGEF1: -1.4277770503812752, Methylation_MAPT: -0.4919659443194055, Methylation_ZFAT: -1.4374757256042952, Methylation_KCNQ4: 0.0154858645169267, Methylation_chr1 232684368 SIPA1L2 (12934): -1.198919471303207, Methylation_CRNKL1: -1.6384953140244651, Methylation_PRKAG2: -0.4589585545811793, Methylation_MICB: -0.9053962423431572, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.7529155619345138, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.8206683159504171, miRNA_hsa-mir-190b: 0.3382595767670001, miRNA_hsa-mir-577: -0.4115039877711731, miRNA_hsa-mir-135b: -0.9347982078152692, miRNA_hsa-mir-2115: 0.3237340395723136, miRNA_hsa-mir-17: -1.0113590448537264, miRNA_hsa-mir-130b: -0.1420456324633557, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-E9-A1RD,"No features meet the strict diagnostic thresholds for mRNA (Z > 1.30 or Z < -1.92), methylation (Z > 1.50 or Z < -1.47), miRNA (Z > 1.99 or Z < -1.25), or CNV (deletion, gain, amplification, or high-level amplification). All values fall within non-actionable ranges.","mRNA_MLPH: 0.6934336906298062, mRNA_C2orf54: 0.8602177476463485, mRNA_CITED4: 0.2654800970015998, mRNA_ESR1: 1.2368878001697317, mRNA_SPDEF: 0.382918193475643, mRNA_AGR3: 0.969878572460081, mRNA_FOXC1: -0.8083464609302937, mRNA_GATA3: 0.6857254095500397, mRNA_AGR2: 0.2558533550565892, mRNA_XBP1: 1.061445669111082, mRNA_PRR15: -0.1001794906283412, mRNA_SLC44A4: 0.8985203533983771, mRNA_CA12: 1.1169018098434211, mRNA_DTL: 0.0796363448202385, mRNA_C5AR2: 1.433622593449123, mRNA_TBC1D9: 0.6985900694932573, mRNA_AR: 1.1570391909724913, mRNA_CCDC170: 1.543237718653769, mRNA_DEGS2: 1.0750964780719332, mRNA_TFF3: 0.9383020795555372, mRNA_DNALI1: 0.70900794777133, mRNA_LINC00504: 0.8845426991407022, mRNA_CLCA2: -0.1930058299249179, mRNA_PPP1R14C: -0.683383935563241, mRNA_THSD4: 0.9406863796720408, mRNA_SPAG5: -0.2160898285951899, mRNA_FBP1: 0.7322709629144912, mRNA_SLC7A8: 0.919807085638031, mRNA_EN1: -0.3273842006497706, mRNA_ZNF552: 1.5567225802644111, Methylation_LRRC6: -0.7128109900544569, Methylation_chr2 66218712 LINC02934 (29533): 0.2706235342017513, Methylation_HOXB13: -0.9203266393970012, Methylation_chr10 3949206 LINC02660 (4871): 1.5336969609377968, Methylation_chr5 179517140 RNF130 (18026): 0.8450295415690082, Methylation_LOC727677: -0.805443146866045, Methylation_LETM1: -0.7110899610785557, Methylation_CDC42BPB: -1.304649691828626, Methylation_C8orf38: -1.1539474360331226, Methylation_chr14 100504766 EVL (18852): -1.249761293434328, Methylation_chr5 72594851 LOC340090 (24088): 0.7487905982159475, Methylation_chr2 242904738 LINC01238 (3421): -0.9970945156309122, Methylation_ARFGEF1: -1.0201482437824096, Methylation_MAPT: -1.0283980975814144, Methylation_ZFAT: -0.5965790121434261, Methylation_KCNQ4: -1.080727735960922, Methylation_chr1 232684368 SIPA1L2 (12934): -1.3237621959466952, Methylation_CRNKL1: -1.3894657013665237, Methylation_PRKAG2: 0.8521282950037061, Methylation_MICB: -1.4946161271028953, miRNA_hsa-mir-934: -0.3757056487230928, miRNA_hsa-mir-4728: -0.5280846355235148, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.7463428687099056, miRNA_hsa-mir-190b: -0.0006261777330584, miRNA_hsa-mir-577: -0.1520666648496022, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: -0.5028711515898474, miRNA_hsa-mir-17: -1.930822170198493, miRNA_hsa-mir-130b: -1.9878105453677968, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-D8-A27L,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-significant ranges per specified criteria.","mRNA_MLPH: 0.3120946528486704, mRNA_C2orf54: 0.2065612005947484, mRNA_CITED4: -0.001933152241697, mRNA_ESR1: 0.5350214876232555, mRNA_SPDEF: 0.1759338166962387, mRNA_AGR3: 0.4654715693727732, mRNA_FOXC1: 0.169761292433559, mRNA_GATA3: 0.4823682364312618, mRNA_AGR2: 0.2933082786371718, mRNA_XBP1: 0.1818899794871892, mRNA_PRR15: 0.3498489443737517, mRNA_SLC44A4: 0.6804671471979121, mRNA_CA12: 0.3070743329709485, mRNA_DTL: -0.5936280781382424, mRNA_C5AR2: 0.620503114089806, mRNA_TBC1D9: 0.5231618679510166, mRNA_AR: 0.902919040219548, mRNA_CCDC170: 1.087385300778159, mRNA_DEGS2: 0.5371137160047448, mRNA_TFF3: 0.1252633106918028, mRNA_DNALI1: 1.0578749318724274, mRNA_LINC00504: 0.6642196991260454, mRNA_CLCA2: 1.2924317206006757, mRNA_PPP1R14C: 0.8943436537343863, mRNA_THSD4: 0.6423073873492009, mRNA_SPAG5: -0.5858763920350595, mRNA_FBP1: 0.1590465848864534, mRNA_SLC7A8: 0.6563843760691178, mRNA_EN1: -0.2045439519225304, mRNA_ZNF552: -0.0964609950557422, Methylation_LRRC6: 0.0305660721841824, Methylation_chr2 66218712 LINC02934 (29533): -0.5773367720903558, Methylation_HOXB13: -1.0596763820279071, Methylation_chr10 3949206 LINC02660 (4871): -0.3265594732188652, Methylation_chr5 179517140 RNF130 (18026): 0.0980016009764425, Methylation_LOC727677: -0.367725632237913, Methylation_LETM1: 0.0483702291252154, Methylation_CDC42BPB: -0.7343485151250356, Methylation_C8orf38: -0.1774774138959792, Methylation_chr14 100504766 EVL (18852): -0.2285744365719235, Methylation_chr5 72594851 LOC340090 (24088): -0.1554690525901148, Methylation_chr2 242904738 LINC01238 (3421): -0.3544293581310839, Methylation_ARFGEF1: 0.2662337703491277, Methylation_MAPT: 0.2978368506614117, Methylation_ZFAT: -0.4189007704298604, Methylation_KCNQ4: -0.4429154649983288, Methylation_chr1 232684368 SIPA1L2 (12934): 0.8394815305635714, Methylation_CRNKL1: 0.4079782447809553, Methylation_PRKAG2: -0.1836437853810649, Methylation_MICB: 0.0486145043392884, miRNA_hsa-mir-934: -0.1159419879882425, miRNA_hsa-mir-4728: -0.8500219227919059, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.0822669696830225, miRNA_hsa-mir-190b: -0.9740337461964954, miRNA_hsa-mir-577: -0.4181545521146921, miRNA_hsa-mir-135b: -0.5425208407864434, miRNA_hsa-mir-2115: -0.3052496659528658, miRNA_hsa-mir-17: -1.2662189139496745, miRNA_hsa-mir-130b: -1.4653210758461273, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A1EV,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression of C2orf54 and SPAG5. Promoter hypermethylation of LRRC6, RNF130, and C8orf38 mediates epigenetic silencing. miRNA hsa-mir-4728 is markedly upregulated. These features collectively indicate a luminal B phenotype with PI3K/AKT/mTOR pathway dysregulation.","mRNA_MLPH: 0.2794978485618801, mRNA_C2orf54: 2.1522715918020405, mRNA_CITED4: 0.1732269412363762, mRNA_ESR1: 0.4063152362112459, mRNA_SPDEF: 0.75211372845223, mRNA_AGR3: 1.03144073125774, mRNA_FOXC1: -1.0663703447296382, mRNA_GATA3: 0.4598367487806669, mRNA_AGR2: 0.6089266235081152, mRNA_XBP1: 0.1761974835684189, mRNA_PRR15: 0.4811305649617026, mRNA_SLC44A4: 0.7480439534050307, mRNA_CA12: 0.3214052888851337, mRNA_DTL: 0.9802686634251856, mRNA_C5AR2: 0.7155466473850967, mRNA_TBC1D9: 0.0866702751295567, mRNA_AR: 0.3650610085268155, mRNA_CCDC170: 0.8766508788072341, mRNA_DEGS2: 0.5156344819938973, mRNA_TFF3: 0.0786540222302048, mRNA_DNALI1: 0.8237172960459873, mRNA_LINC00504: -0.0595222619009482, mRNA_CLCA2: 1.487611506930016, mRNA_PPP1R14C: -0.2274336324958759, mRNA_THSD4: 0.6810278106814555, mRNA_SPAG5: 2.070860223731092, mRNA_FBP1: -0.1019555652471681, mRNA_SLC7A8: 0.997138985694644, mRNA_EN1: -0.3673398942447222, mRNA_ZNF552: -0.0252623554398876, Methylation_LRRC6: -1.5637649859813894, Methylation_chr2 66218712 LINC02934 (29533): 1.1074425089605515, Methylation_HOXB13: 1.2517561514792308, Methylation_chr10 3949206 LINC02660 (4871): -1.2861791642199651, Methylation_chr5 179517140 RNF130 (18026): -1.5839182361482116, Methylation_LOC727677: -0.8160983154863036, Methylation_LETM1: -0.762277955876767, Methylation_CDC42BPB: 1.2149220750148424, Methylation_C8orf38: -1.4084358319106485, Methylation_chr14 100504766 EVL (18852): -0.8022352137485266, Methylation_chr5 72594851 LOC340090 (24088): 0.4216946150733098, Methylation_chr2 242904738 LINC01238 (3421): -0.5713745359569282, Methylation_ARFGEF1: 0.1292841364115438, Methylation_MAPT: -0.9701285689778152, Methylation_ZFAT: -1.3105004046303603, Methylation_KCNQ4: -0.7867965098174815, Methylation_chr1 232684368 SIPA1L2 (12934): -0.0647405992659614, Methylation_CRNKL1: -0.265610843241405, Methylation_PRKAG2: -0.9104977500854822, Methylation_MICB: -1.2306943220575404, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 4.498357786870234, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.2299547942189761, miRNA_hsa-mir-190b: 1.543883610707773, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.9085515782461476, miRNA_hsa-mir-2115: 0.7234893785846157, miRNA_hsa-mir-17: -0.3741447654894708, miRNA_hsa-mir-130b: 1.437006480704427, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-E9-A22B,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression.  
CITED4 shows significant mRNA downregulation (Z = -2.16).  
No methylation or miRNA alterations meet diagnostic thresholds.  
These features indicate a proliferation-driven phenotype with genomic instability.","mRNA_MLPH: 0.202327114518107, mRNA_C2orf54: -1.113330442827111, mRNA_CITED4: -2.163565672873045, mRNA_ESR1: 0.4772674812880205, mRNA_SPDEF: -0.1044172964851873, mRNA_AGR3: 0.7205093523863502, mRNA_FOXC1: -0.1434065386163709, mRNA_GATA3: 0.2083163677823359, mRNA_AGR2: 0.5770710401548902, mRNA_XBP1: 0.3138275509986599, mRNA_PRR15: 0.6988801643719924, mRNA_SLC44A4: 0.2778881822976385, mRNA_CA12: 0.2146338506516986, mRNA_DTL: -1.261281877168712, mRNA_C5AR2: 0.2476357164376626, mRNA_TBC1D9: 0.6237251044428135, mRNA_AR: 0.1745150508202349, mRNA_CCDC170: 0.1709216490144591, mRNA_DEGS2: -0.0399732784630232, mRNA_TFF3: -0.5650400028550958, mRNA_DNALI1: 0.4579366703457498, mRNA_LINC00504: 0.0621359462484372, mRNA_CLCA2: -0.6580454169694108, mRNA_PPP1R14C: -0.1697520079966353, mRNA_THSD4: -0.0798953977739872, mRNA_SPAG5: -0.2912397915591151, mRNA_FBP1: 0.1942851871578683, mRNA_SLC7A8: 0.5727408123092528, mRNA_EN1: -0.259296295875612, mRNA_ZNF552: -0.6650405654011893, Methylation_LRRC6: -1.3332362432713174, Methylation_chr2 66218712 LINC02934 (29533): 0.3729609696105215, Methylation_HOXB13: 0.9991055182485752, Methylation_chr10 3949206 LINC02660 (4871): -1.0380383003038338, Methylation_chr5 179517140 RNF130 (18026): 0.7742645712726581, Methylation_LOC727677: -0.9956977809571126, Methylation_LETM1: -1.0131667962986222, Methylation_CDC42BPB: 1.1255808474288154, Methylation_C8orf38: -1.0626865082429866, Methylation_chr14 100504766 EVL (18852): -0.927418332725779, Methylation_chr5 72594851 LOC340090 (24088): 0.108740734997745, Methylation_chr2 242904738 LINC01238 (3421): 1.2505332128106792, Methylation_ARFGEF1: -0.7180584393676868, Methylation_MAPT: -0.7410179024372655, Methylation_ZFAT: -1.1300497805237604, Methylation_KCNQ4: -0.4087642547702477, Methylation_chr1 232684368 SIPA1L2 (12934): -0.7952431999721398, Methylation_CRNKL1: -1.0752768321268222, Methylation_PRKAG2: -1.2082272459293733, Methylation_MICB: -0.0770913258907432, miRNA_hsa-mir-934: -0.1928906977970539, miRNA_hsa-mir-4728: -0.2731496979293741, miRNA_hsa-mir-5695: -0.3886635502798102, miRNA_hsa-mir-18a: -0.3165293292237627, miRNA_hsa-mir-190b: 0.560953593297885, miRNA_hsa-mir-577: -0.5874514139375232, miRNA_hsa-mir-135b: -0.3185509772859097, miRNA_hsa-mir-2115: 0.229935183819981, miRNA_hsa-mir-17: -0.0123856874678117, miRNA_hsa-mir-130b: 0.6181236637047448, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-AR-A0TV,"High-level Amplification of LINC01867 and WDPCP drives transcriptional dysregulation.  
HOXB13 and C8orf38 promoter hypermethylation mediates epigenetic silencing.  
PRR15 mRNA is significantly downregulated (Z = -2.62).  
These features collectively indicate a luminal B-like phenotype with PI3K/AKT pathway dysregulation.","mRNA_MLPH: 0.0936571082496244, mRNA_C2orf54: -0.5757508818073614, mRNA_CITED4: -0.5474631175048524, mRNA_ESR1: 1.295338461546144, mRNA_SPDEF: 0.2668363364853883, mRNA_AGR3: 0.6629817208759472, mRNA_FOXC1: -1.0172513599914002, mRNA_GATA3: 0.3524885117194419, mRNA_AGR2: -0.0576007620620879, mRNA_XBP1: 1.364322422599001, mRNA_PRR15: -2.623173715804642, mRNA_SLC44A4: 0.1523747219950171, mRNA_CA12: 1.0153476467206215, mRNA_DTL: 0.7052800361092805, mRNA_C5AR2: 0.0269984448322106, mRNA_TBC1D9: 0.3655374046230288, mRNA_AR: -1.29710345300139, mRNA_CCDC170: 1.3104516319257695, mRNA_DEGS2: 0.129381119919674, mRNA_TFF3: -0.7356555124450328, mRNA_DNALI1: 0.9432552531362344, mRNA_LINC00504: 1.5230616058109323, mRNA_CLCA2: -0.8862632549060304, mRNA_PPP1R14C: -1.143246677597537, mRNA_THSD4: 0.7379982934910019, mRNA_SPAG5: 1.0184679453345282, mRNA_FBP1: 0.8396677708475735, mRNA_SLC7A8: 0.5354796345647262, mRNA_EN1: -1.0916146396487003, mRNA_ZNF552: 0.9667713993845782, Methylation_LRRC6: -0.8265123628395419, Methylation_chr2 66218712 LINC02934 (29533): 1.2136233249111543, Methylation_HOXB13: 1.868248415856569, Methylation_chr10 3949206 LINC02660 (4871): -1.0558776983131934, Methylation_chr5 179517140 RNF130 (18026): 1.1221251210406111, Methylation_LOC727677: -1.085150372878724, Methylation_LETM1: -1.0547476220513097, Methylation_CDC42BPB: 1.09163424536786, Methylation_C8orf38: 1.6565781629079537, Methylation_chr14 100504766 EVL (18852): -0.191212946946741, Methylation_chr5 72594851 LOC340090 (24088): 1.076131044790967, Methylation_chr2 242904738 LINC01238 (3421): -0.6080295057558358, Methylation_ARFGEF1: -1.1501249538533005, Methylation_MAPT: -0.4365707002769555, Methylation_ZFAT: -0.7353268323620304, Methylation_KCNQ4: 1.498909807749566, Methylation_chr1 232684368 SIPA1L2 (12934): -0.9375438332918098, Methylation_CRNKL1: -0.3242447418682149, Methylation_PRKAG2: 1.262569221828792, Methylation_MICB: -0.1312812217611351, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.2776040562626207, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.3984500001500031, miRNA_hsa-mir-190b: 1.1925266221226645, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.0457779445232544, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.4490565165855119, miRNA_hsa-mir-130b: 1.519184654117421, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 3.403528716117201, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 3.3913533508092364, CNV_CEP68: 1.4339562938734052"
TCGA-A2-A0SW,DNALI1 mRNA is significantly downregulated (Z = -1.98). No mRNA features meet high-expression thresholds. No methylation sites cross hyper/hypo-methylation cutoffs. miRNA hsa-mir-17 is downregulated (Z = -1.26). All CNVs fall within normal range (−1.10 to −0.10). No driver alterations detected.,"mRNA_MLPH: -0.2230720504626438, mRNA_C2orf54: 0.8499098688054786, mRNA_CITED4: -1.6488701233648726, mRNA_ESR1: 0.1612206885064371, mRNA_SPDEF: 0.0980097863757385, mRNA_AGR3: 0.0722863072475624, mRNA_FOXC1: -1.0832510961998272, mRNA_GATA3: -0.7593618952419763, mRNA_AGR2: 0.1430023702146396, mRNA_XBP1: -0.8873506334876746, mRNA_PRR15: 0.1559023270455558, mRNA_SLC44A4: 0.4801378297047361, mRNA_CA12: -0.923383812690858, mRNA_DTL: 0.0769920530778308, mRNA_C5AR2: -0.2731884610735174, mRNA_TBC1D9: -0.4319839297153121, mRNA_AR: -0.1279477105866901, mRNA_CCDC170: -0.6514100353642766, mRNA_DEGS2: -0.0533886105588225, mRNA_TFF3: 0.4346402384367816, mRNA_DNALI1: -1.9830636670244748, mRNA_LINC00504: -0.2034209704351179, mRNA_CLCA2: -0.7462173883825396, mRNA_PPP1R14C: -1.067126383192042, mRNA_THSD4: -1.4155365885864952, mRNA_SPAG5: -0.6118542892639863, mRNA_FBP1: 0.2891958381512786, mRNA_SLC7A8: -1.403060290660601, mRNA_EN1: -0.3029757264149037, mRNA_ZNF552: -0.4576964864515528, Methylation_LRRC6: -0.6240651821680836, Methylation_chr2 66218712 LINC02934 (29533): -0.0134108947187785, Methylation_HOXB13: -0.9699832454111296, Methylation_chr10 3949206 LINC02660 (4871): -0.5397986539485279, Methylation_chr5 179517140 RNF130 (18026): 1.1265036705765703, Methylation_LOC727677: 0.0583335011140049, Methylation_LETM1: 0.4833359320846009, Methylation_CDC42BPB: -1.3425187983627234, Methylation_C8orf38: -0.137172268920206, Methylation_chr14 100504766 EVL (18852): -0.0260544673208857, Methylation_chr5 72594851 LOC340090 (24088): 0.5073185518731844, Methylation_chr2 242904738 LINC01238 (3421): -0.5086982409663212, Methylation_ARFGEF1: -0.0973962149260009, Methylation_MAPT: 0.5455737692394179, Methylation_ZFAT: -0.2778048933777449, Methylation_KCNQ4: -0.4908571383368985, Methylation_chr1 232684368 SIPA1L2 (12934): -0.3024420889572336, Methylation_CRNKL1: -0.5057337825721346, Methylation_PRKAG2: -1.1033534152264444, Methylation_MICB: -0.8266290002927904, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.7975889155246301, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.2545612068459873, miRNA_hsa-mir-190b: -0.5540213904369521, miRNA_hsa-mir-577: 1.2424770578875552, miRNA_hsa-mir-135b: -0.2823778713560102, miRNA_hsa-mir-2115: -0.1387776491857742, miRNA_hsa-mir-17: -1.2592453961523804, miRNA_hsa-mir-130b: -0.1982867881426956, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-B6-A2IU,SLC7A8 mRNA overexpression (Z=1.72) and ZNF552 upregulation (Z=1.49) meet high-expression thresholds. No methylation or miRNA alterations exceed diagnostic cutoffs. All CNVs fall within normal range. These features suggest luminal-type transcriptional activity without genomic or epigenetic drivers.,"mRNA_MLPH: 1.1117686057470677, mRNA_C2orf54: 0.0589039821361844, mRNA_CITED4: 1.4151200000751742, mRNA_ESR1: 0.5188669373844638, mRNA_SPDEF: 0.6848504719660287, mRNA_AGR3: 0.6587949658892848, mRNA_FOXC1: -0.0173284329456275, mRNA_GATA3: 1.0687358427150302, mRNA_AGR2: 0.6795410592131333, mRNA_XBP1: 0.8776766394595363, mRNA_PRR15: 0.8341010179152627, mRNA_SLC44A4: 0.4949263116388428, mRNA_CA12: 1.1093960398671612, mRNA_DTL: 0.7432083815811397, mRNA_C5AR2: 0.9832497835000868, mRNA_TBC1D9: 1.0192917637120076, mRNA_AR: 0.6158944423356669, mRNA_CCDC170: 0.8198257105196802, mRNA_DEGS2: 1.041508687646154, mRNA_TFF3: -0.0102053053988773, mRNA_DNALI1: 0.4935936731726555, mRNA_LINC00504: 1.30896380988442, mRNA_CLCA2: -0.4973472392253935, mRNA_PPP1R14C: -0.6614343303122167, mRNA_THSD4: 0.4974101175542983, mRNA_SPAG5: 0.2745697418327683, mRNA_FBP1: 1.1965837169188498, mRNA_SLC7A8: 1.7183091811988038, mRNA_EN1: -0.8016437501209546, mRNA_ZNF552: 1.4880068249265208, Methylation_LRRC6: -0.4382629285881602, Methylation_chr2 66218712 LINC02934 (29533): -1.113900463877065, Methylation_HOXB13: -1.0154079191694314, Methylation_chr10 3949206 LINC02660 (4871): -0.8741530257550161, Methylation_chr5 179517140 RNF130 (18026): 0.9071226803308068, Methylation_LOC727677: -0.9766936662674957, Methylation_LETM1: -0.8150834031058811, Methylation_CDC42BPB: -0.4259383448570744, Methylation_C8orf38: -0.5103261271348716, Methylation_chr14 100504766 EVL (18852): -0.760685720065442, Methylation_chr5 72594851 LOC340090 (24088): 0.7525143599430466, Methylation_chr2 242904738 LINC01238 (3421): -0.6768903767508547, Methylation_ARFGEF1: -0.511521796998227, Methylation_MAPT: -0.557132789359317, Methylation_ZFAT: 0.1376804290211757, Methylation_KCNQ4: 1.200613904217437, Methylation_chr1 232684368 SIPA1L2 (12934): -0.9357368117858628, Methylation_CRNKL1: -0.5228123978809818, Methylation_PRKAG2: 0.2993416595161259, Methylation_MICB: -0.9237653144097632, miRNA_hsa-mir-934: -0.473716618136754, miRNA_hsa-mir-4728: -0.8307940984934447, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.7475575842626134, miRNA_hsa-mir-190b: 0.1792969774033138, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: 0.8763082486305056, miRNA_hsa-mir-2115: 0.4797996856518827, miRNA_hsa-mir-17: -0.693992805588028, miRNA_hsa-mir-130b: -1.088284094457748, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A1N9,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. RNF130 and LOC340090 promoter hypomethylation suggests epigenetic dysregulation. miRNA hsa-mir-5695 is significantly upregulated. These features collectively indicate a luminal-like phenotype with PI3K/AKT pathway activation.","mRNA_MLPH: -0.0711544886437476, mRNA_C2orf54: -0.3832545614851253, mRNA_CITED4: -0.5974262568704741, mRNA_ESR1: 0.8780640054954502, mRNA_SPDEF: 0.4905559659061929, mRNA_AGR3: -1.2067221931612515, mRNA_FOXC1: -0.0319902622584774, mRNA_GATA3: 0.1089340986752629, mRNA_AGR2: -1.2622307908467216, mRNA_XBP1: 0.4961609768805177, mRNA_PRR15: 0.1667294762779775, mRNA_SLC44A4: -1.8219376123512587, mRNA_CA12: -0.1254778425985374, mRNA_DTL: 0.9935520873157746, mRNA_C5AR2: 0.5287914963978478, mRNA_TBC1D9: 1.1899374636683575, mRNA_AR: 1.2825475722112405, mRNA_CCDC170: -0.6890714124404329, mRNA_DEGS2: -1.0801640164233854, mRNA_TFF3: 0.1015183322366453, mRNA_DNALI1: -0.3899196490528209, mRNA_LINC00504: 0.9990943949733232, mRNA_CLCA2: -0.1186737487571442, mRNA_PPP1R14C: -0.156775188579537, mRNA_THSD4: -0.5486737925562614, mRNA_SPAG5: 1.513063850219599, mRNA_FBP1: 0.1670246071705173, mRNA_SLC7A8: 0.3409827824421371, mRNA_EN1: -0.7062481191084158, mRNA_ZNF552: -1.3493660937357266, Methylation_LRRC6: -0.8820445003374694, Methylation_chr2 66218712 LINC02934 (29533): -1.3685300192306662, Methylation_HOXB13: 0.9216023453771138, Methylation_chr10 3949206 LINC02660 (4871): -0.7404562671514426, Methylation_chr5 179517140 RNF130 (18026): -1.5092005080693276, Methylation_LOC727677: -1.0799796614692316, Methylation_LETM1: -0.3187378908349324, Methylation_CDC42BPB: -1.1899363839589387, Methylation_C8orf38: 0.1010973111820157, Methylation_chr14 100504766 EVL (18852): -0.3354608983937235, Methylation_chr5 72594851 LOC340090 (24088): -1.4222979628952634, Methylation_chr2 242904738 LINC01238 (3421): -0.6493477484143889, Methylation_ARFGEF1: -0.4304864377787935, Methylation_MAPT: -0.6514328206447616, Methylation_ZFAT: -1.300853468052316, Methylation_KCNQ4: 1.439585528258466, Methylation_chr1 232684368 SIPA1L2 (12934): -0.7306221213919681, Methylation_CRNKL1: 0.2187282531136318, Methylation_PRKAG2: 1.2100623986979282, Methylation_MICB: -1.1231932106069338, miRNA_hsa-mir-934: 0.152197949114278, miRNA_hsa-mir-4728: 0.4507408476393284, miRNA_hsa-mir-5695: 2.683569505491734, miRNA_hsa-mir-18a: 1.289402162630194, miRNA_hsa-mir-190b: 0.8814059038885534, miRNA_hsa-mir-577: -0.2363319156354231, miRNA_hsa-mir-135b: 0.6551952480392114, miRNA_hsa-mir-2115: 0.2161969146313242, miRNA_hsa-mir-17: 0.9067597347874904, miRNA_hsa-mir-130b: 0.8222856749369226, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-D8-A4Z1,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-significant ranges per specified Z-score and CNV cutoffs.","mRNA_MLPH: 0.6928201094028296, mRNA_C2orf54: 0.5135060925564424, mRNA_CITED4: 0.6553852221861677, mRNA_ESR1: -0.0945638586468079, mRNA_SPDEF: 0.6756031469461957, mRNA_AGR3: 0.070579385118153, mRNA_FOXC1: 0.9493384159510664, mRNA_GATA3: 0.4067375453919399, mRNA_AGR2: -0.0448464126463184, mRNA_XBP1: 0.4668020539688045, mRNA_PRR15: -0.104378650635472, mRNA_SLC44A4: 0.5310604107778201, mRNA_CA12: 0.3007331260786772, mRNA_DTL: -1.7618134659114637, mRNA_C5AR2: 0.747090093222458, mRNA_TBC1D9: 0.5126326630884068, mRNA_AR: 0.5847078535588646, mRNA_CCDC170: 1.1006784029442722, mRNA_DEGS2: 0.770229488960905, mRNA_TFF3: 0.0875385298282814, mRNA_DNALI1: 0.6239866351342661, mRNA_LINC00504: 1.0234617884355213, mRNA_CLCA2: 1.7327743867257244, mRNA_PPP1R14C: 0.2794954432251423, mRNA_THSD4: 0.6841827061966383, mRNA_SPAG5: -0.9647383902377424, mRNA_FBP1: 0.6455233041979782, mRNA_SLC7A8: 0.9205705332718436, mRNA_EN1: -0.3244991297030562, mRNA_ZNF552: 0.3365101232324881, Methylation_LRRC6: 1.094912259429537, Methylation_chr2 66218712 LINC02934 (29533): -0.3743701519492315, Methylation_HOXB13: -0.6473436455070477, Methylation_chr10 3949206 LINC02660 (4871): 0.5482434179589004, Methylation_chr5 179517140 RNF130 (18026): -0.8509575033573895, Methylation_LOC727677: 0.328836224023692, Methylation_LETM1: 0.8624577785111287, Methylation_CDC42BPB: -0.3561623723429847, Methylation_C8orf38: 0.5892730607546067, Methylation_chr14 100504766 EVL (18852): 1.0939118078254282, Methylation_chr5 72594851 LOC340090 (24088): -0.4313927684657765, Methylation_chr2 242904738 LINC01238 (3421): 1.272866911539427, Methylation_ARFGEF1: 1.0625179271518206, Methylation_MAPT: 0.2617512311686541, Methylation_ZFAT: 1.1688390697683366, Methylation_KCNQ4: -0.9439309933667942, Methylation_chr1 232684368 SIPA1L2 (12934): 1.182191476748209, Methylation_CRNKL1: 1.078584891567333, Methylation_PRKAG2: 1.1164386113693925, Methylation_MICB: 0.9186226297282472, miRNA_hsa-mir-934: 0.261022760618861, miRNA_hsa-mir-4728: -0.4215894450545516, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.5134578794464031, miRNA_hsa-mir-190b: -0.207807701367957, miRNA_hsa-mir-577: -0.0180333041501811, miRNA_hsa-mir-135b: -0.3793115971336244, miRNA_hsa-mir-2115: 2.82274325564517, miRNA_hsa-mir-17: 0.1181975466800962, miRNA_hsa-mir-130b: -1.502735140081591, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AO-A1KR,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression.  
Promoter hypermethylation of LRRC6, C8orf38, ARFGEF1, and MICB mediates epigenetic silencing.  
miR-18a, miR-577, and miR-130b are upregulated.  
These features indicate a luminal B phenotype with PI3K/AKT/mTOR dysregulation.","mRNA_MLPH: -1.4393938193744846, mRNA_C2orf54: -1.125074295735173, mRNA_CITED4: 0.8300520385093585, mRNA_ESR1: -1.9209019425720888, mRNA_SPDEF: -1.9590426713054216, mRNA_AGR3: -1.4116669420268968, mRNA_FOXC1: 1.697214768022994, mRNA_GATA3: -0.7483268075698482, mRNA_AGR2: -1.740386161920078, mRNA_XBP1: -2.683733296985656, mRNA_PRR15: -1.8089807158236224, mRNA_SLC44A4: -1.9097794103671644, mRNA_CA12: -1.1871514295681025, mRNA_DTL: 0.5403527249900053, mRNA_C5AR2: -1.6102147961134357, mRNA_TBC1D9: -2.4760855493300835, mRNA_AR: -0.3140733478480252, mRNA_CCDC170: -1.8654078319857348, mRNA_DEGS2: -1.799758124805358, mRNA_TFF3: -1.4276271905852145, mRNA_DNALI1: -1.2732657480907073, mRNA_LINC00504: -1.5305362985674982, mRNA_CLCA2: 1.5058937383497053, mRNA_PPP1R14C: -0.6826037744096382, mRNA_THSD4: -1.9805608713895464, mRNA_SPAG5: 1.269100564642969, mRNA_FBP1: -2.725274525892893, mRNA_SLC7A8: -2.3294461319051183, mRNA_EN1: -0.9265943455284288, mRNA_ZNF552: -1.726802920718988, Methylation_LRRC6: 1.5190979807090574, Methylation_chr2 66218712 LINC02934 (29533): -0.7240561823309983, Methylation_HOXB13: 0.2661594730942702, Methylation_chr10 3949206 LINC02660 (4871): 1.4231140250968926, Methylation_chr5 179517140 RNF130 (18026): -1.6004078631679088, Methylation_LOC727677: 1.3698489454310858, Methylation_LETM1: 1.2820040194873563, Methylation_CDC42BPB: -0.7759850922323777, Methylation_C8orf38: 1.653183154437628, Methylation_chr14 100504766 EVL (18852): 1.477328364420027, Methylation_chr5 72594851 LOC340090 (24088): -1.2681521476610462, Methylation_chr2 242904738 LINC01238 (3421): 1.278606061820825, Methylation_ARFGEF1: 1.7042091052778727, Methylation_MAPT: 0.7251718848125568, Methylation_ZFAT: 1.3406558221918736, Methylation_KCNQ4: 0.9406714216407136, Methylation_chr1 232684368 SIPA1L2 (12934): 1.487291123748942, Methylation_CRNKL1: 1.4194079189393145, Methylation_PRKAG2: -1.004869136763208, Methylation_MICB: 1.523284509866316, miRNA_hsa-mir-934: 1.3525244190727312, miRNA_hsa-mir-4728: 1.0503028808695876, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 2.842619468990655, miRNA_hsa-mir-190b: -0.8644650755450669, miRNA_hsa-mir-577: 2.9043741961419425, miRNA_hsa-mir-135b: 0.4944575245215423, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.6388474000256157, miRNA_hsa-mir-130b: 2.894084901591412, CNV_VPS54: 2.3735003872816955, CNV_LINC01867: 2.395394893874891, CNV_LINC02576: 2.464291317721031, CNV_WDPCP: 2.38809584879993, CNV_CEP68: 2.464291317721031"
TCGA-OL-A66P,"High-level Amplification of *VPS54*, *LINC01867*, *LINC02576*, *WDPCP*, and *CEP68* drives mRNA overexpression. *CLCA2* mRNA is highly overexpressed (Z=2.39); *C2orf54* mRNA elevated (Z=1.78). Promoter hypermethylation at *chr10:3949206* (Z=1.61) and *chr14:100504766* (Z=1.48) suggests epigenetic silencing. miR-2115 is strongly upregulated (Z=4.82); miR-190b downregulated (Z=-1.28). Collectively indicate a luminal B-like phenotype with ER-pathway suppression.","mRNA_MLPH: -0.3406231778225826, mRNA_C2orf54: 1.7820366243272467, mRNA_CITED4: -1.358409526574064, mRNA_ESR1: -1.86966080971058, mRNA_SPDEF: 0.1463428428810687, mRNA_AGR3: -1.817724467683988, mRNA_FOXC1: -0.9250080369518152, mRNA_GATA3: -2.115208866326104, mRNA_AGR2: -0.944611214228596, mRNA_XBP1: -0.9108195299620993, mRNA_PRR15: -0.6733423000722433, mRNA_SLC44A4: -0.4359899712935982, mRNA_CA12: -1.902114392394331, mRNA_DTL: -2.3439097203314665, mRNA_C5AR2: -1.3093373021003916, mRNA_TBC1D9: -1.864302281140096, mRNA_AR: -0.2255286345484241, mRNA_CCDC170: -1.5415368223565706, mRNA_DEGS2: -1.1943506266722186, mRNA_TFF3: -1.36372628603887, mRNA_DNALI1: -1.653754378920132, mRNA_LINC00504: -1.6578362794860266, mRNA_CLCA2: 2.3850776901855792, mRNA_PPP1R14C: 0.4514987227127109, mRNA_THSD4: -1.6775492997725874, mRNA_SPAG5: -0.966594960942792, mRNA_FBP1: -1.426948659684955, mRNA_SLC7A8: -1.450974318032164, mRNA_EN1: -0.0253309644736577, mRNA_ZNF552: -1.315699367215714, Methylation_LRRC6: 1.3151165798038411, Methylation_chr2 66218712 LINC02934 (29533): 0.3440080297107353, Methylation_HOXB13: 0.0151464207996225, Methylation_chr10 3949206 LINC02660 (4871): 1.6090561623078306, Methylation_chr5 179517140 RNF130 (18026): 0.3189799267937393, Methylation_LOC727677: 1.4080972324653374, Methylation_LETM1: 1.3063313397827352, Methylation_CDC42BPB: -0.3729366288960465, Methylation_C8orf38: 1.0315679683020746, Methylation_chr14 100504766 EVL (18852): 1.4768625571599314, Methylation_chr5 72594851 LOC340090 (24088): -1.074457966891743, Methylation_chr2 242904738 LINC01238 (3421): 1.370298705455887, Methylation_ARFGEF1: 1.0420768772550402, Methylation_MAPT: 1.117409973542412, Methylation_ZFAT: 1.3490822518662224, Methylation_KCNQ4: -0.827300286081777, Methylation_chr1 232684368 SIPA1L2 (12934): 1.243491688893975, Methylation_CRNKL1: 1.1154702807259484, Methylation_PRKAG2: 0.3776748767636366, Methylation_MICB: 1.0752995237856209, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 1.1609307421798116, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.0034619132614107, miRNA_hsa-mir-190b: -1.2751862285741526, miRNA_hsa-mir-577: -0.0408884036870737, miRNA_hsa-mir-135b: -0.5236015003153605, miRNA_hsa-mir-2115: 4.816377845510141, miRNA_hsa-mir-17: 0.3662325987647717, miRNA_hsa-mir-130b: -0.242727391207063, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-E9-A249,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.1924727328855243, mRNA_C2orf54: -1.0096080337887925, mRNA_CITED4: 0.6340476718126192, mRNA_ESR1: 0.6103103097212167, mRNA_SPDEF: 0.1363139231092972, mRNA_AGR3: 0.816047114206296, mRNA_FOXC1: -1.4532797195409966, mRNA_GATA3: 0.905515103384568, mRNA_AGR2: 0.4669829432622308, mRNA_XBP1: -0.1059153652424277, mRNA_PRR15: 0.288121257577931, mRNA_SLC44A4: 0.5003129999189465, mRNA_CA12: 0.5794716444411803, mRNA_DTL: 0.7280602077877895, mRNA_C5AR2: 0.8920293762248435, mRNA_TBC1D9: 0.4711426357083368, mRNA_AR: 0.7396448077543974, mRNA_CCDC170: 1.020432082145791, mRNA_DEGS2: 0.6140330019740213, mRNA_TFF3: 0.6925753137821026, mRNA_DNALI1: 0.8901796692212134, mRNA_LINC00504: 0.4007288786293227, mRNA_CLCA2: -0.2646250010833663, mRNA_PPP1R14C: -0.5674593885256449, mRNA_THSD4: 0.2832044604367137, mRNA_SPAG5: 0.1391133250222463, mRNA_FBP1: -0.3443333582998627, mRNA_SLC7A8: 0.0246228798369664, mRNA_EN1: -0.5626950602468365, mRNA_ZNF552: 0.7146864794511784, Methylation_LRRC6: -1.013609079958564, Methylation_chr2 66218712 LINC02934 (29533): 0.3686397027698829, Methylation_HOXB13: -0.8740522835263722, Methylation_chr10 3949206 LINC02660 (4871): -1.258647030565233, Methylation_chr5 179517140 RNF130 (18026): 1.053981146330882, Methylation_LOC727677: -0.93152419762251, Methylation_LETM1: -0.3294994313675399, Methylation_CDC42BPB: -1.0252974327569078, Methylation_C8orf38: -0.7942738741512432, Methylation_chr14 100504766 EVL (18852): -1.2400872195252195, Methylation_chr5 72594851 LOC340090 (24088): 0.5187174313760026, Methylation_chr2 242904738 LINC01238 (3421): -1.1985848034138904, Methylation_ARFGEF1: -0.956211764639242, Methylation_MAPT: -1.334148836365085, Methylation_ZFAT: 1.0688183705249032, Methylation_KCNQ4: 1.424208296118991, Methylation_chr1 232684368 SIPA1L2 (12934): -0.4013397247997023, Methylation_CRNKL1: -1.0419707083173495, Methylation_PRKAG2: 1.2307671779785423, Methylation_MICB: 0.574190925700495, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.0707703545092141, miRNA_hsa-mir-5695: 1.590862049965851, miRNA_hsa-mir-18a: -0.0179142930727571, miRNA_hsa-mir-190b: 0.7546915279655783, miRNA_hsa-mir-577: 0.7843953325705131, miRNA_hsa-mir-135b: 0.3366996648688974, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.3318004681468962, miRNA_hsa-mir-130b: -0.2870195579892221, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-E9-A295,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.3314616091867476, mRNA_C2orf54: 0.2739399203570681, mRNA_CITED4: -0.3784391507574614, mRNA_ESR1: 0.0390239642652183, mRNA_SPDEF: 0.7093963116674098, mRNA_AGR3: 1.2396140326742136, mRNA_FOXC1: 0.3574866787494145, mRNA_GATA3: 0.1759592113732253, mRNA_AGR2: 1.3531689511517129, mRNA_XBP1: 0.3876444494468224, mRNA_PRR15: 0.9022522362740644, mRNA_SLC44A4: 0.721466877611332, mRNA_CA12: 0.0888953577970268, mRNA_DTL: -0.7073160332199763, mRNA_C5AR2: 0.0175554848484076, mRNA_TBC1D9: -0.0179164669221463, mRNA_AR: 0.3316280716304968, mRNA_CCDC170: -0.3061999381940415, mRNA_DEGS2: 0.4542808360823197, mRNA_TFF3: 1.0176123772399095, mRNA_DNALI1: 0.3964050618291398, mRNA_LINC00504: -1.1031258177707584, mRNA_CLCA2: 1.267241523821511, mRNA_PPP1R14C: 0.924308901506912, mRNA_THSD4: 0.2474618302888315, mRNA_SPAG5: -0.9168832970586328, mRNA_FBP1: 0.4486107311016832, mRNA_SLC7A8: 0.8797891060168366, mRNA_EN1: 0.624789581416683, mRNA_ZNF552: 0.2732411301337051, Methylation_LRRC6: -0.4573291495626323, Methylation_chr2 66218712 LINC02934 (29533): 0.0308868762666784, Methylation_HOXB13: 0.8184555835110798, Methylation_chr10 3949206 LINC02660 (4871): -0.6560750784996522, Methylation_chr5 179517140 RNF130 (18026): 0.6906657987237387, Methylation_LOC727677: -0.3676741530328222, Methylation_LETM1: -0.4679689407133781, Methylation_CDC42BPB: 1.371245503809318, Methylation_C8orf38: -0.6798044600376778, Methylation_chr14 100504766 EVL (18852): -0.6344906960347533, Methylation_chr5 72594851 LOC340090 (24088): 0.6399013982892658, Methylation_chr2 242904738 LINC01238 (3421): -0.8841136303517648, Methylation_ARFGEF1: -0.5267183539155802, Methylation_MAPT: -0.5996646597118419, Methylation_ZFAT: -1.1534802345774622, Methylation_KCNQ4: 0.5232130425385323, Methylation_chr1 232684368 SIPA1L2 (12934): 0.1359684123725206, Methylation_CRNKL1: -0.0112327199746421, Methylation_PRKAG2: -0.6758522842001767, Methylation_MICB: -1.0767362169142023, miRNA_hsa-mir-934: -0.45248875220303, miRNA_hsa-mir-4728: -0.9106069910077934, miRNA_hsa-mir-5695: -0.2167228298893648, miRNA_hsa-mir-18a: -0.8363600430196209, miRNA_hsa-mir-190b: -0.4045048054852839, miRNA_hsa-mir-577: -0.6268418884379565, miRNA_hsa-mir-135b: -0.6715191622526263, miRNA_hsa-mir-2115: 0.1872705459901454, miRNA_hsa-mir-17: -0.9340528570667844, miRNA_hsa-mir-130b: -0.449756109758244, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-B6-A40C,High mRNA_CITED4 (Z=1.66) indicates overexpression. No methylation or miRNA alterations meet diagnostic thresholds. All CNVs fall within normal range (−1.10 to −0.10). Isolated CITED4 upregulation suggests limited transcriptional dysregulation without clear genomic or epigenetic drivers.,"mRNA_MLPH: 0.3569575845609194, mRNA_C2orf54: -1.0845138435769617, mRNA_CITED4: 1.659444874890055, mRNA_ESR1: -0.4904944308887403, mRNA_SPDEF: 0.2775037205032252, mRNA_AGR3: 0.130170635240801, mRNA_FOXC1: -0.7268470547165276, mRNA_GATA3: 0.7846773471633971, mRNA_AGR2: -0.3971186931763815, mRNA_XBP1: -0.9143596604488806, mRNA_PRR15: 0.3198477625651881, mRNA_SLC44A4: 0.4575733575663257, mRNA_CA12: -0.0732564679486466, mRNA_DTL: 0.5944127924228858, mRNA_C5AR2: 0.5277738843564771, mRNA_TBC1D9: 0.1361798749148167, mRNA_AR: -0.0903682368146349, mRNA_CCDC170: -0.8072984135416685, mRNA_DEGS2: 1.0923920378616243, mRNA_TFF3: 0.7964336805075504, mRNA_DNALI1: 0.8726685105571491, mRNA_LINC00504: 0.1540088662399727, mRNA_CLCA2: -0.7299939691117665, mRNA_PPP1R14C: -0.5183734538664184, mRNA_THSD4: -0.7897542468641077, mRNA_SPAG5: 0.2301646881846283, mRNA_FBP1: -0.7930257012772299, mRNA_SLC7A8: 0.4177196088447788, mRNA_EN1: -0.0633071398063351, mRNA_ZNF552: -0.714576589467834, Methylation_LRRC6: -1.066435028196338, Methylation_chr2 66218712 LINC02934 (29533): 1.0698942059443604, Methylation_HOXB13: 0.8032664074785205, Methylation_chr10 3949206 LINC02660 (4871): 0.2674706941845577, Methylation_chr5 179517140 RNF130 (18026): 0.5154698285121995, Methylation_LOC727677: -1.0450302815015624, Methylation_LETM1: -0.8636245590790361, Methylation_CDC42BPB: -1.2534241597685436, Methylation_C8orf38: -1.1047771804568174, Methylation_chr14 100504766 EVL (18852): -0.915058706187426, Methylation_chr5 72594851 LOC340090 (24088): 1.000660499110649, Methylation_chr2 242904738 LINC01238 (3421): -0.9744197401691904, Methylation_ARFGEF1: -1.0118419500070863, Methylation_MAPT: -1.0186533461063974, Methylation_ZFAT: -1.1125773388421016, Methylation_KCNQ4: 0.9884898278131512, Methylation_chr1 232684368 SIPA1L2 (12934): -1.206085330666093, Methylation_CRNKL1: -0.9433570364655308, Methylation_PRKAG2: 1.3216521224937414, Methylation_MICB: -0.8489080644665912, miRNA_hsa-mir-934: -0.4594989386381792, miRNA_hsa-mir-4728: -0.1697049713899069, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.0004391653442332, miRNA_hsa-mir-190b: 0.8676197152890659, miRNA_hsa-mir-577: -0.6333221492080223, miRNA_hsa-mir-135b: -0.8104362479756526, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.3026544714966747, miRNA_hsa-mir-130b: 0.1619909327861506, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A0HY,"High-level Amplification absent; no CNVs meet amplification thresholds.  
CLCA2 and SPAG5 mRNA overexpressed (Z > 1.30).  
DNALI1 mRNA downregulated (Z < -1.92).  
HOXB13 promoter hypermethylated (Z > 1.50); CDC42BPB and C8orf38 hypomethylated (Z < -1.47).  
hsa-mir-4728 upregulated (Z > 1.99); hsa-mir-17 downregulated (Z < -1.25).","mRNA_MLPH: 0.4787337103168318, mRNA_C2orf54: -0.4028491161031337, mRNA_CITED4: -0.7897827809314801, mRNA_ESR1: 0.3306039036989764, mRNA_SPDEF: 0.6503243630714725, mRNA_AGR3: -1.381659038178585, mRNA_FOXC1: -0.6364505303314417, mRNA_GATA3: 0.11430703939047, mRNA_AGR2: 0.0067284432272884, mRNA_XBP1: 0.429437520454315, mRNA_PRR15: 0.3171778823232536, mRNA_SLC44A4: 0.4318690974588302, mRNA_CA12: -0.0260065662677917, mRNA_DTL: 0.4602326190070479, mRNA_C5AR2: -0.9467610881009474, mRNA_TBC1D9: 0.1209338087382684, mRNA_AR: 0.4292369564831172, mRNA_CCDC170: 0.5115245807049237, mRNA_DEGS2: 1.1899060168822166, mRNA_TFF3: 0.7221081597758187, mRNA_DNALI1: -1.5840888696802402, mRNA_LINC00504: -0.1397311741807662, mRNA_CLCA2: 1.7194169326492177, mRNA_PPP1R14C: -0.6019940681811898, mRNA_THSD4: -0.4749436783504265, mRNA_SPAG5: 1.866247536278172, mRNA_FBP1: 0.6643280620230055, mRNA_SLC7A8: 0.5228654930261021, mRNA_EN1: -0.5690973358543863, mRNA_ZNF552: 0.306021365108938, Methylation_LRRC6: -1.2173891325490265, Methylation_chr2 66218712 LINC02934 (29533): 1.244910656378494, Methylation_HOXB13: 1.947398645868996, Methylation_chr10 3949206 LINC02660 (4871): -1.111454161191619, Methylation_chr5 179517140 RNF130 (18026): 1.179490666164151, Methylation_LOC727677: 1.4494697047653815, Methylation_LETM1: -0.3672706344097318, Methylation_CDC42BPB: -1.4249801754332605, Methylation_C8orf38: -1.4649403873582758, Methylation_chr14 100504766 EVL (18852): -1.296921987764316, Methylation_chr5 72594851 LOC340090 (24088): 1.2741231275043574, Methylation_chr2 242904738 LINC01238 (3421): -0.1531716557222667, Methylation_ARFGEF1: -1.2597153104844128, Methylation_MAPT: -0.9737210270518388, Methylation_ZFAT: -0.5841917716917776, Methylation_KCNQ4: 1.3752726790730447, Methylation_chr1 232684368 SIPA1L2 (12934): -1.3022291460964652, Methylation_CRNKL1: -0.2185518570114422, Methylation_PRKAG2: 0.0691452297083718, Methylation_MICB: -1.1904034068763152, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 1.996696996160575, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.9465360152275408, miRNA_hsa-mir-190b: -0.4377611546796451, miRNA_hsa-mir-577: 0.1824622900378222, miRNA_hsa-mir-135b: -0.036345283747713, miRNA_hsa-mir-2115: 0.3652943375486491, miRNA_hsa-mir-17: -1.129572393505486, miRNA_hsa-mir-130b: 1.3043834017717206, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-B6-A0RI,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.2803620573273596, mRNA_C2orf54: 0.2048003839115056, mRNA_CITED4: 0.4271165361580384, mRNA_ESR1: 0.6421320917297545, mRNA_SPDEF: 0.2861599467457815, mRNA_AGR3: 0.4244664014007024, mRNA_FOXC1: -0.895740186915732, mRNA_GATA3: 0.7737902900404545, mRNA_AGR2: 0.1916932406164579, mRNA_XBP1: 0.3561093124405624, mRNA_PRR15: 0.1129700996241061, mRNA_SLC44A4: 0.4530870025638591, mRNA_CA12: 1.0924249223343585, mRNA_DTL: 0.4566703884289958, mRNA_C5AR2: 0.7017055718008176, mRNA_TBC1D9: 0.9879386168363172, mRNA_AR: 0.6273496995603379, mRNA_CCDC170: 0.0204275234938059, mRNA_DEGS2: 0.7135863902714603, mRNA_TFF3: -0.1338330753393888, mRNA_DNALI1: 1.1184173723137507, mRNA_LINC00504: 1.1697985329035074, mRNA_CLCA2: 0.1501369139935011, mRNA_PPP1R14C: -0.0020357873357536, mRNA_THSD4: 0.1508383803949698, mRNA_SPAG5: 0.6425949191377308, mRNA_FBP1: -0.008006212242162, mRNA_SLC7A8: 1.107737552107377, mRNA_EN1: 0.0943572596837706, mRNA_ZNF552: 0.5960997683858281, Methylation_LRRC6: -0.5795310088100125, Methylation_chr2 66218712 LINC02934 (29533): -1.3625107330051234, Methylation_HOXB13: -0.7949729434216917, Methylation_chr10 3949206 LINC02660 (4871): -0.8472233008740202, Methylation_chr5 179517140 RNF130 (18026): 1.1497514296657283, Methylation_LOC727677: -0.8529324737875532, Methylation_LETM1: -1.1282965940942795, Methylation_CDC42BPB: -1.2403535250612707, Methylation_C8orf38: -0.6829770308452007, Methylation_chr14 100504766 EVL (18852): -0.8468782457682165, Methylation_chr5 72594851 LOC340090 (24088): 1.0839106789630897, Methylation_chr2 242904738 LINC01238 (3421): -0.0078761238145128, Methylation_ARFGEF1: -0.5712776232502003, Methylation_MAPT: -1.128797178042566, Methylation_ZFAT: -0.6975913380058898, Methylation_KCNQ4: -1.192294040096385, Methylation_chr1 232684368 SIPA1L2 (12934): -0.8121398746525601, Methylation_CRNKL1: -0.9582939001795538, Methylation_PRKAG2: -1.2603347364274182, Methylation_MICB: -0.7495501439360231, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.8362238703364007, miRNA_hsa-mir-190b: 0.7621828508676917, miRNA_hsa-mir-577: 0.1072579413248865, miRNA_hsa-mir-135b: -0.2145977709244287, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.1095090994085102, miRNA_hsa-mir-130b: 0.423593849599355, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AQ-A04H,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.6849842047114324, mRNA_C2orf54: -1.15624220909363, mRNA_CITED4: -1.511125293598951, mRNA_ESR1: 1.2332254948297, mRNA_SPDEF: 0.5613574432485661, mRNA_AGR3: 0.477343238047749, mRNA_FOXC1: -0.5083787206237553, mRNA_GATA3: 0.8447263571907679, mRNA_AGR2: 0.6128940986319106, mRNA_XBP1: 1.2400937048603626, mRNA_PRR15: 1.446293832079302, mRNA_SLC44A4: 0.5727491121426851, mRNA_CA12: 0.5544260889356545, mRNA_DTL: 1.2285139421008842, mRNA_C5AR2: 0.395347500214531, mRNA_TBC1D9: 1.8619816132311464, mRNA_AR: 1.6433469520891282, mRNA_CCDC170: 1.20401181082393, mRNA_DEGS2: 0.0801855928380688, mRNA_TFF3: -0.7133149637706258, mRNA_DNALI1: 1.275470061600403, mRNA_LINC00504: 0.0485846467302933, mRNA_CLCA2: -0.7644366382357841, mRNA_PPP1R14C: -0.4873002782754247, mRNA_THSD4: 0.9797566378419986, mRNA_SPAG5: 0.8980574820788998, mRNA_FBP1: 1.3417589142156574, mRNA_SLC7A8: -0.0422822832251129, mRNA_EN1: -0.7673420949722101, mRNA_ZNF552: 1.2630764369795249, Methylation_LRRC6: -1.2130893349174938, Methylation_chr2 66218712 LINC02934 (29533): 1.2316709335864071, Methylation_HOXB13: -0.7382587460108846, Methylation_chr10 3949206 LINC02660 (4871): -0.9028016789961948, Methylation_chr5 179517140 RNF130 (18026): 1.1582763018526303, Methylation_LOC727677: -1.2811028223328929, Methylation_LETM1: -1.4385047951735266, Methylation_CDC42BPB: 1.4461896920641468, Methylation_C8orf38: -0.1595283755816949, Methylation_chr14 100504766 EVL (18852): -1.0222190346181312, Methylation_chr5 72594851 LOC340090 (24088): 1.3381138594449111, Methylation_chr2 242904738 LINC01238 (3421): 1.375909771635895, Methylation_ARFGEF1: -1.238007072477846, Methylation_MAPT: -1.125623786961489, Methylation_ZFAT: -1.1006982884077028, Methylation_KCNQ4: 0.7876237772047735, Methylation_chr1 232684368 SIPA1L2 (12934): -1.17015481799716, Methylation_CRNKL1: -0.8791219392464542, Methylation_PRKAG2: -1.024716172001157, Methylation_MICB: -1.1545922847900068, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.3526206518866389, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.6428264495916824, miRNA_hsa-mir-190b: 0.1967921882907649, miRNA_hsa-mir-577: -0.4421834727724098, miRNA_hsa-mir-135b: -0.9623350350295996, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.1656545182687969, miRNA_hsa-mir-130b: -0.7930769701045778, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-A2-A4S1,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA dysregulation.  
Promoter hypermethylation of LOC727677 and chr14:100504766 (EVL) suggests epigenetic silencing.  
mRNA_SPDEF, GATA3, AGR2, and XBP1 are significantly downregulated (Z < -1.92).  
FOXC1 and EN1 show high mRNA expression (Z > 1.30), indicating luminal B-like phenotype with ER-pathway suppression.","mRNA_MLPH: -0.8935836300413472, mRNA_C2orf54: -1.2943230935752186, mRNA_CITED4: -1.6942270319607795, mRNA_ESR1: -1.7430687950794646, mRNA_SPDEF: -3.2642023335518693, mRNA_AGR3: -2.060531268628111, mRNA_FOXC1: 1.347086366455719, mRNA_GATA3: -3.284855213105533, mRNA_AGR2: -2.424150769798908, mRNA_XBP1: -2.389638593889735, mRNA_PRR15: -1.720002594524744, mRNA_SLC44A4: -1.974831282684592, mRNA_CA12: -0.7798186547456315, mRNA_DTL: -1.6382879780125168, mRNA_C5AR2: -0.0967334646845706, mRNA_TBC1D9: -1.3699012899547012, mRNA_AR: -1.2992441677127002, mRNA_CCDC170: -0.8324784450637623, mRNA_DEGS2: -2.329282773560758, mRNA_TFF3: -2.1150554744396644, mRNA_DNALI1: -1.9694336892257416, mRNA_LINC00504: -1.2365498633231464, mRNA_CLCA2: 0.1047088631172716, mRNA_PPP1R14C: -0.2445439713202578, mRNA_THSD4: -2.29119978816496, mRNA_SPAG5: -1.4098686188574647, mRNA_FBP1: -2.243930001094592, mRNA_SLC7A8: -0.5118622343386648, mRNA_EN1: 1.3876494169670428, mRNA_ZNF552: -2.5084514332710683, Methylation_LRRC6: 1.3578706493953674, Methylation_chr2 66218712 LINC02934 (29533): -0.9868810583461248, Methylation_HOXB13: 0.6538745424334281, Methylation_chr10 3949206 LINC02660 (4871): 0.0015267001379815, Methylation_chr5 179517140 RNF130 (18026): -1.411490307615032, Methylation_LOC727677: 1.4940053958406665, Methylation_LETM1: 1.275586457642383, Methylation_CDC42BPB: 1.0954558451047918, Methylation_C8orf38: 0.904926751121181, Methylation_chr14 100504766 EVL (18852): 1.4290122210000535, Methylation_chr5 72594851 LOC340090 (24088): -1.5061443906088936, Methylation_chr2 242904738 LINC01238 (3421): 1.3472433280528024, Methylation_ARFGEF1: 1.1661976883793697, Methylation_MAPT: 1.0721311318970053, Methylation_ZFAT: 1.3270660378027044, Methylation_KCNQ4: -1.0015489281840682, Methylation_chr1 232684368 SIPA1L2 (12934): 1.2296656837733535, Methylation_CRNKL1: 1.2916179818528477, Methylation_PRKAG2: -1.1994212749264062, Methylation_MICB: 1.324055497120019, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.1773386208251774, miRNA_hsa-mir-190b: -1.1610935320821745, miRNA_hsa-mir-577: -0.2403640895600447, miRNA_hsa-mir-135b: -0.1181281938079454, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.0322209088289763, miRNA_hsa-mir-130b: 0.2083447321012606, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-S3-AA17,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. No mRNA, methylation, or miRNA features meet diagnostic thresholds for significant dysregulation. These genomic amplifications suggest a proliferative phenotype with potential vesicular trafficking and centrosomal dysfunction.","mRNA_MLPH: 0.3956947022192597, mRNA_C2orf54: -0.1763024032706123, mRNA_CITED4: 1.2112896280606944, mRNA_ESR1: 0.7035366797355536, mRNA_SPDEF: 0.3760811892410602, mRNA_AGR3: 0.6628105363351844, mRNA_FOXC1: -1.0598837467958566, mRNA_GATA3: -0.1562291938434647, mRNA_AGR2: -0.1832349207608819, mRNA_XBP1: 0.0812238418791655, mRNA_PRR15: 0.3310600055052585, mRNA_SLC44A4: 0.6090246354905958, mRNA_CA12: 0.2053293380079897, mRNA_DTL: 0.5094817507521662, mRNA_C5AR2: 0.7390080171896803, mRNA_TBC1D9: 0.2775467003315311, mRNA_AR: -0.0449575270764918, mRNA_CCDC170: -1.0292351263358728, mRNA_DEGS2: 1.016696939719215, mRNA_TFF3: 0.1283564392448579, mRNA_DNALI1: 0.1508381259653573, mRNA_LINC00504: -0.1572724115109588, mRNA_CLCA2: -0.8781989643066973, mRNA_PPP1R14C: -1.143994915221261, mRNA_THSD4: 0.1581046882622745, mRNA_SPAG5: 0.2709225608115523, mRNA_FBP1: 0.6348157291615071, mRNA_SLC7A8: 0.484827188516955, mRNA_EN1: -0.9479311631105952, mRNA_ZNF552: 0.5711619047506487, Methylation_LRRC6: 0.008493073054428, Methylation_chr2 66218712 LINC02934 (29533): 1.395115368444859, Methylation_HOXB13: 1.3001377111603116, Methylation_chr10 3949206 LINC02660 (4871): -0.4354713106295833, Methylation_chr5 179517140 RNF130 (18026): 0.4883701206734596, Methylation_LOC727677: 0.7564620896241052, Methylation_LETM1: 0.0437359788267568, Methylation_CDC42BPB: 0.6015828713731002, Methylation_C8orf38: 0.3133729909685824, Methylation_chr14 100504766 EVL (18852): -0.1600140736669175, Methylation_chr5 72594851 LOC340090 (24088): 0.6467231287534791, Methylation_chr2 242904738 LINC01238 (3421): -0.4885803349204768, Methylation_ARFGEF1: 0.6207050262043681, Methylation_MAPT: -0.0065561886003569, Methylation_ZFAT: -0.3529540928822958, Methylation_KCNQ4: -0.7053537593387401, Methylation_chr1 232684368 SIPA1L2 (12934): -0.2274288467412843, Methylation_CRNKL1: -0.2681231710526272, Methylation_PRKAG2: 0.1274491770592426, Methylation_MICB: 0.1175973671989538, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.3193849175943745, miRNA_hsa-mir-5695: 0.4870177432709448, miRNA_hsa-mir-18a: -0.0504792331179138, miRNA_hsa-mir-190b: 1.0620589818150232, miRNA_hsa-mir-577: -0.0275922895565385, miRNA_hsa-mir-135b: 1.4720122810250744, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.0502056167767757, miRNA_hsa-mir-130b: -0.0536980747918873, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-BH-A0BA,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.7197783522210744, mRNA_C2orf54: 0.530220946532497, mRNA_CITED4: 0.0658195638546391, mRNA_ESR1: 0.5276639671312546, mRNA_SPDEF: 0.6505707474506482, mRNA_AGR3: 0.7700877202633174, mRNA_FOXC1: 0.124388802005697, mRNA_GATA3: 0.4303338301199492, mRNA_AGR2: 0.1649419926357173, mRNA_XBP1: 0.1156431112570703, mRNA_PRR15: 0.6595458219394079, mRNA_SLC44A4: 1.1080165287906611, mRNA_CA12: 0.2684573695973087, mRNA_DTL: 1.2053094770888315, mRNA_C5AR2: 0.4665570967203853, mRNA_TBC1D9: 0.2805616688387111, mRNA_AR: 0.7953173733077831, mRNA_CCDC170: -0.6375708956463112, mRNA_DEGS2: 0.3405860071549345, mRNA_TFF3: 0.7635527586336699, mRNA_DNALI1: -1.2605433460351154, mRNA_LINC00504: 0.2189896941988998, mRNA_CLCA2: 2.2519364915915228, mRNA_PPP1R14C: 0.2126092165953418, mRNA_THSD4: 0.0261552322803227, mRNA_SPAG5: -0.2061109555486342, mRNA_FBP1: 0.872164321818645, mRNA_SLC7A8: 0.5102467500105671, mRNA_EN1: -0.5215120889171545, mRNA_ZNF552: 0.8642865730077788, Methylation_LRRC6: -0.1622826065911681, Methylation_chr2 66218712 LINC02934 (29533): 0.7118684921279188, Methylation_HOXB13: -0.5980099951996771, Methylation_chr10 3949206 LINC02660 (4871): 1.5425998999215742, Methylation_chr5 179517140 RNF130 (18026): 0.7936375386978679, Methylation_LOC727677: -0.6908174403617223, Methylation_LETM1: -0.0846137438077563, Methylation_CDC42BPB: -1.071256018151899, Methylation_C8orf38: -0.9626722284082636, Methylation_chr14 100504766 EVL (18852): -0.4063677184180431, Methylation_chr5 72594851 LOC340090 (24088): 1.1197911597675383, Methylation_chr2 242904738 LINC01238 (3421): -0.3663763884903739, Methylation_ARFGEF1: -0.8306152763408277, Methylation_MAPT: 0.4223137091435254, Methylation_ZFAT: 0.2373609512246828, Methylation_KCNQ4: 0.0193010943519813, Methylation_chr1 232684368 SIPA1L2 (12934): -1.116548227719681, Methylation_CRNKL1: -0.6879849187278366, Methylation_PRKAG2: 1.329992141894465, Methylation_MICB: -0.325039057041022, miRNA_hsa-mir-934: -0.2714584610747661, miRNA_hsa-mir-4728: -0.4995893670934129, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.538331657029119, miRNA_hsa-mir-190b: -0.2735336844738686, miRNA_hsa-mir-577: -0.0790989046170954, miRNA_hsa-mir-135b: -0.977874456008264, miRNA_hsa-mir-2115: 2.7417115559610927, miRNA_hsa-mir-17: -2.4777444678117506, miRNA_hsa-mir-130b: -2.4103030999557844, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-GM-A2DC,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.405588654523316, mRNA_C2orf54: -1.1188571231555648, mRNA_CITED4: 0.5319206906508789, mRNA_ESR1: 0.2430439550799975, mRNA_SPDEF: 0.0365835068920713, mRNA_AGR3: -0.2233577109175267, mRNA_FOXC1: -1.2239148746405863, mRNA_GATA3: 0.9249815480578696, mRNA_AGR2: -1.3488334019909152, mRNA_XBP1: -0.2310618018674624, mRNA_PRR15: -0.2714883967165396, mRNA_SLC44A4: 0.0140231458408273, mRNA_CA12: 0.9068778093581308, mRNA_DTL: -2.359794087216871, mRNA_C5AR2: -0.2770588351419913, mRNA_TBC1D9: 0.9211598819239736, mRNA_AR: 0.0630600262074298, mRNA_CCDC170: -0.074215269797399, mRNA_DEGS2: 0.5311718916495466, mRNA_TFF3: 0.3699156082087832, mRNA_DNALI1: 0.9430738458731084, mRNA_LINC00504: 0.2937092060093447, mRNA_CLCA2: -0.7050902536438642, mRNA_PPP1R14C: -1.1358782131236012, mRNA_THSD4: 0.3478390739685717, mRNA_SPAG5: -0.1879889422537828, mRNA_FBP1: 0.6162964353430315, mRNA_SLC7A8: 0.752781655237372, mRNA_EN1: -0.7779467824824106, mRNA_ZNF552: 0.5108133155228542, Methylation_LRRC6: -0.9763661980360756, Methylation_chr2 66218712 LINC02934 (29533): 1.0387317979312471, Methylation_HOXB13: -1.0780589291740856, Methylation_chr10 3949206 LINC02660 (4871): -0.9890461275741542, Methylation_chr5 179517140 RNF130 (18026): 1.040751180503296, Methylation_LOC727677: -1.2006142767083592, Methylation_LETM1: -1.226891364271789, Methylation_CDC42BPB: 1.238280090812878, Methylation_C8orf38: -0.6367929911716603, Methylation_chr14 100504766 EVL (18852): -0.5614572793262191, Methylation_chr5 72594851 LOC340090 (24088): 0.9664768528827798, Methylation_chr2 242904738 LINC01238 (3421): -0.8995370095964128, Methylation_ARFGEF1: -1.3563504171911462, Methylation_MAPT: -0.8931869390834823, Methylation_ZFAT: -1.6102044657608827, Methylation_KCNQ4: -1.1443617511185964, Methylation_chr1 232684368 SIPA1L2 (12934): -0.9722865555581428, Methylation_CRNKL1: -1.213678914620412, Methylation_PRKAG2: 0.5268801740454552, Methylation_MICB: -0.666459981125024, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.4780057230008607, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.1096391163533132, miRNA_hsa-mir-190b: 1.0499113729203775, miRNA_hsa-mir-577: -0.6411773949073779, miRNA_hsa-mir-135b: -0.8325897530421295, miRNA_hsa-mir-2115: 0.5187223031387184, miRNA_hsa-mir-17: -0.1130223671688679, miRNA_hsa-mir-130b: -0.7711184877358555, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E2-A10E,"High mRNA_XBP1 (Z=1.72), mRNA_LINC00504 (Z=1.61), mRNA_ZNF552 (Z=1.64), and mRNA_DEGS2 (Z=1.30) indicate overexpression. miRNA_hsa-mir-5695 is upregulated (Z=1.92); miRNA_hsa-mir-18a is downregulated (Z=-1.36). No methylation or CNV alterations meet diagnostic thresholds. These features suggest luminal-like transcriptional activity with miRNA-mediated regulatory shifts.","mRNA_MLPH: 1.0264262251322198, mRNA_C2orf54: 0.3097125116147521, mRNA_CITED4: -0.4033992903576153, mRNA_ESR1: 1.198477156228238, mRNA_SPDEF: 0.6520248456788909, mRNA_AGR3: 1.027610838136083, mRNA_FOXC1: -0.5437880874668355, mRNA_GATA3: 0.9251074189852444, mRNA_AGR2: 0.6967367742344068, mRNA_XBP1: 1.7229175618615484, mRNA_PRR15: 0.7388820716119846, mRNA_SLC44A4: 0.836565271100358, mRNA_CA12: 1.033950173927355, mRNA_DTL: 0.5497609425039891, mRNA_C5AR2: 0.6380446911624331, mRNA_TBC1D9: 0.8086185624386695, mRNA_AR: 0.98124525321482, mRNA_CCDC170: 0.5078585873412106, mRNA_DEGS2: 1.3012226892346714, mRNA_TFF3: 0.9108859529078376, mRNA_DNALI1: 0.2806894046013746, mRNA_LINC00504: 1.6062655116649414, mRNA_CLCA2: -0.7885587048340146, mRNA_PPP1R14C: -0.4747701842095814, mRNA_THSD4: 1.1597591949546822, mRNA_SPAG5: 0.1267431364298365, mRNA_FBP1: 1.204609786262336, mRNA_SLC7A8: 0.5917063426799055, mRNA_EN1: 0.1832656765732052, mRNA_ZNF552: 1.6418052170423494, Methylation_LRRC6: -1.034889521120249, Methylation_chr2 66218712 LINC02934 (29533): 1.254501146557089, Methylation_HOXB13: 0.1474906947702755, Methylation_chr10 3949206 LINC02660 (4871): 1.0018427517049389, Methylation_chr5 179517140 RNF130 (18026): 1.213722942320946, Methylation_LOC727677: -0.8247877680982579, Methylation_LETM1: -1.157338290370833, Methylation_CDC42BPB: 0.344023308723262, Methylation_C8orf38: -0.8587525560421306, Methylation_chr14 100504766 EVL (18852): -1.2616699769707636, Methylation_chr5 72594851 LOC340090 (24088): 1.2458094396510424, Methylation_chr2 242904738 LINC01238 (3421): -1.1489377427801892, Methylation_ARFGEF1: -1.0518510448085827, Methylation_MAPT: -1.1694750439468364, Methylation_ZFAT: -0.6946107475982537, Methylation_KCNQ4: 1.1074946937323198, Methylation_chr1 232684368 SIPA1L2 (12934): -1.33622182051661, Methylation_CRNKL1: -0.1695505524252436, Methylation_PRKAG2: 1.335919645094351, Methylation_MICB: 0.0062306789175678, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.298575249319375, miRNA_hsa-mir-5695: 1.9177741157758887, miRNA_hsa-mir-18a: -1.356444929437565, miRNA_hsa-mir-190b: 0.4234662371000192, miRNA_hsa-mir-577: -0.3697505689777137, miRNA_hsa-mir-135b: -0.3598671182865913, miRNA_hsa-mir-2115: 0.4284787991337226, miRNA_hsa-mir-17: -1.1029257097626253, miRNA_hsa-mir-130b: -0.0935465847954502, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A24R,"High-level Amplification of CCDC170 drives significant mRNA overexpression. Methylation_PRKAG2 is hypomethylated (Z = -1.45), potentially contributing to dysregulation. miRNA_hsa-mir-5695 is upregulated (Z = 3.44). These features collectively indicate a luminal phenotype with ER-pathway activity.","mRNA_MLPH: 0.5301150020721304, mRNA_C2orf54: 0.4816466169494725, mRNA_CITED4: 0.2244102214971388, mRNA_ESR1: 0.4824755768603155, mRNA_SPDEF: -0.0628869525065954, mRNA_AGR3: 0.7873264176469715, mRNA_FOXC1: -0.9569826084947884, mRNA_GATA3: 0.6723279172139168, mRNA_AGR2: 0.6978412317561102, mRNA_XBP1: 0.3906400699995186, mRNA_PRR15: -0.1194671357182385, mRNA_SLC44A4: 0.1074252881619701, mRNA_CA12: 1.0689684557919026, mRNA_DTL: 1.0128470662991578, mRNA_C5AR2: 0.8727218404038064, mRNA_TBC1D9: 0.9793985812701134, mRNA_AR: 0.3193384173903973, mRNA_CCDC170: 2.0197774832740887, mRNA_DEGS2: 0.7671079894170321, mRNA_TFF3: 0.5288879724365828, mRNA_DNALI1: 0.9616769585705645, mRNA_LINC00504: 0.992409129031894, mRNA_CLCA2: -0.6542588312312401, mRNA_PPP1R14C: -0.6277690623329697, mRNA_THSD4: 0.2847904323351141, mRNA_SPAG5: 0.3888332464723636, mRNA_FBP1: 0.8637147776417745, mRNA_SLC7A8: 0.4235438044726957, mRNA_EN1: -0.6172169424075223, mRNA_ZNF552: 0.9241581660702136, Methylation_LRRC6: -0.841554129080811, Methylation_chr2 66218712 LINC02934 (29533): 0.9298427565634768, Methylation_HOXB13: 0.0336137507581204, Methylation_chr10 3949206 LINC02660 (4871): -1.039690745427937, Methylation_chr5 179517140 RNF130 (18026): 0.8447960657705103, Methylation_LOC727677: 1.2764610363849735, Methylation_LETM1: -1.0425522843692696, Methylation_CDC42BPB: 1.0474465718118686, Methylation_C8orf38: -0.3829744223398246, Methylation_chr14 100504766 EVL (18852): -0.9356605745430856, Methylation_chr5 72594851 LOC340090 (24088): 0.8687155672229715, Methylation_chr2 242904738 LINC01238 (3421): -0.9429403110274154, Methylation_ARFGEF1: -0.7728599128345116, Methylation_MAPT: -0.4664497622361581, Methylation_ZFAT: -0.6595411224799788, Methylation_KCNQ4: -0.8288849157859404, Methylation_chr1 232684368 SIPA1L2 (12934): -0.8049730167641079, Methylation_CRNKL1: -0.654963181270823, Methylation_PRKAG2: -1.452220746907419, Methylation_MICB: -0.2340945989639233, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.1154281288242128, miRNA_hsa-mir-5695: 3.4354804364385343, miRNA_hsa-mir-18a: 0.3979613672199907, miRNA_hsa-mir-190b: 1.6155757638753256, miRNA_hsa-mir-577: -0.531987808963424, miRNA_hsa-mir-135b: -0.4062394188182472, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.2740810750616849, miRNA_hsa-mir-130b: 0.4950142493049567, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-D8-A1JF,"High-level Amplification of *LINC02576* and *CEP68* drives mRNA dysregulation. *AGR3*, *SLC44A4*, and *CA12* show low mRNA (Z < -1.92). *C2orf54* is highly expressed (Z > 1.30). Promoter hypermethylation at *LRRC6* and *SIPA1L2* (Z > 1.50) suggests epigenetic silencing. miR-2115 is upregulated (Z > 1.99); miR-190b is downregulated (Z < -1.25).","mRNA_MLPH: -0.3045243897710907, mRNA_C2orf54: 1.624868236662596, mRNA_CITED4: -1.3575480210797088, mRNA_ESR1: -1.305142732166075, mRNA_SPDEF: 0.0143750157428534, mRNA_AGR3: -2.045604084700844, mRNA_FOXC1: -1.000395149029761, mRNA_GATA3: -1.6897410632457972, mRNA_AGR2: -0.8016640732462955, mRNA_XBP1: -0.1381260559966463, mRNA_PRR15: 0.1975419320830601, mRNA_SLC44A4: -2.1103710143758625, mRNA_CA12: -2.870833698802756, mRNA_DTL: -0.4872731792208367, mRNA_C5AR2: -0.7264501373931743, mRNA_TBC1D9: -1.5809273498642853, mRNA_AR: 1.106224055926112, mRNA_CCDC170: -1.154904960506861, mRNA_DEGS2: -0.7765814045948731, mRNA_TFF3: 0.1624554901092412, mRNA_DNALI1: -1.9540289711601373, mRNA_LINC00504: -1.7212499704419757, mRNA_CLCA2: 0.0181752060436762, mRNA_PPP1R14C: -0.0866568369026249, mRNA_THSD4: -1.2315432613197506, mRNA_SPAG5: -0.8634314739608286, mRNA_FBP1: 0.1852471268073953, mRNA_SLC7A8: 0.6066985139486324, mRNA_EN1: -0.0837726817048324, mRNA_ZNF552: -0.2362288329408224, Methylation_LRRC6: 1.526728195091225, Methylation_chr2 66218712 LINC02934 (29533): -0.7658467664616511, Methylation_HOXB13: 0.4699524707843179, Methylation_chr10 3949206 LINC02660 (4871): 1.240226738528054, Methylation_chr5 179517140 RNF130 (18026): -0.9241009097420082, Methylation_LOC727677: 1.3764183682695708, Methylation_LETM1: 1.3285497159663942, Methylation_CDC42BPB: -1.3061414857458638, Methylation_C8orf38: 1.2884273364058965, Methylation_chr14 100504766 EVL (18852): 0.3181330489680713, Methylation_chr5 72594851 LOC340090 (24088): 0.4570885783157536, Methylation_chr2 242904738 LINC01238 (3421): 1.4095511764053377, Methylation_ARFGEF1: -1.0599189021544426, Methylation_MAPT: 0.8283748860390319, Methylation_ZFAT: 1.391996941287494, Methylation_KCNQ4: 0.2799088899258917, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5247974459197189, Methylation_CRNKL1: 1.436125096603993, Methylation_PRKAG2: 1.1601892173433574, Methylation_MICB: 1.441641223530079, miRNA_hsa-mir-934: 0.3676737937270992, miRNA_hsa-mir-4728: -0.1431944590090973, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.0348519734631211, miRNA_hsa-mir-190b: -1.687859085275869, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.5765522507146762, miRNA_hsa-mir-2115: 4.600977748516666, miRNA_hsa-mir-17: -0.1454494367785107, miRNA_hsa-mir-130b: 0.5175658009874619, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 2.464291317721031, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 2.464291317721031"
TCGA-AC-A7VB,"High-level Amplification absent; no CNV meets amplification thresholds.  
Promoter hypermethylation of *HOXB13* (Z=1.76) and *KCNQ4* (Z=2.06) suggests epigenetic silencing.  
Hypomethylation at multiple loci (*LRRC6*, *LINC02934*, *LETM1*, *EVL*, *SIPA1L2*, *CRNKL1*, *PRKAG2*; Z < -1.47).  
miRNA hsa-mir-2115 upregulated (Z=2.12); hsa-mir-135b downregulated (Z=-1.25).  
mRNA *AR* low (Z=-2.16); *PRR15* and *THSD4* high (Z>1.30).","mRNA_MLPH: 1.0629246686087546, mRNA_C2orf54: 0.6357850068072399, mRNA_CITED4: 0.0288870910689431, mRNA_ESR1: 0.9826112004876848, mRNA_SPDEF: 0.8722495117466773, mRNA_AGR3: -1.59676933979117, mRNA_FOXC1: -0.9392122736939086, mRNA_GATA3: 1.0147018957823544, mRNA_AGR2: -1.4573766668528183, mRNA_XBP1: 0.2148998847130338, mRNA_PRR15: 1.4090877789207534, mRNA_SLC44A4: 0.1218529789993504, mRNA_CA12: 0.821844739584068, mRNA_DTL: 1.2587180876119175, mRNA_C5AR2: 1.0121179796534194, mRNA_TBC1D9: 1.274904458540191, mRNA_AR: -2.163867532388474, mRNA_CCDC170: 0.4792151684986505, mRNA_DEGS2: -0.1786414206120539, mRNA_TFF3: 0.1481452931111892, mRNA_DNALI1: 1.249543231270081, mRNA_LINC00504: 0.4661259375738151, mRNA_CLCA2: -0.747502420920783, mRNA_PPP1R14C: -1.019085445129347, mRNA_THSD4: 1.483735648805725, mRNA_SPAG5: 1.071629308112811, mRNA_FBP1: 1.0321780092870878, mRNA_SLC7A8: 0.6144913138891235, mRNA_EN1: -0.7590532984255552, mRNA_ZNF552: 0.527966707841679, Methylation_LRRC6: -1.5654636618190685, Methylation_chr2 66218712 LINC02934 (29533): -1.7390942928694872, Methylation_HOXB13: 1.7623633981048208, Methylation_chr10 3949206 LINC02660 (4871): -1.332310666951558, Methylation_chr5 179517140 RNF130 (18026): 1.21092727822765, Methylation_LOC727677: -1.0234047996893694, Methylation_LETM1: -1.729916163997406, Methylation_CDC42BPB: 1.4607918651021954, Methylation_C8orf38: 0.5730376333501547, Methylation_chr14 100504766 EVL (18852): -1.5606614253842606, Methylation_chr5 72594851 LOC340090 (24088): 1.2485329481082266, Methylation_chr2 242904738 LINC01238 (3421): -0.060066967307066, Methylation_ARFGEF1: -1.0618143612819746, Methylation_MAPT: -1.160924832115754, Methylation_ZFAT: 0.108634565750959, Methylation_KCNQ4: 2.0645595444673064, Methylation_chr1 232684368 SIPA1L2 (12934): -1.587095747161283, Methylation_CRNKL1: -1.5611078263797138, Methylation_PRKAG2: -1.7249094412920345, Methylation_MICB: -1.3603848563219532, miRNA_hsa-mir-934: -0.3275265204629447, miRNA_hsa-mir-4728: 1.2056797770927858, miRNA_hsa-mir-5695: -0.383211250557809, miRNA_hsa-mir-18a: -0.2027967081392546, miRNA_hsa-mir-190b: 1.124757334998389, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: 2.118595242590911, miRNA_hsa-mir-17: 0.1545428529793427, miRNA_hsa-mir-130b: 0.3187079308210906, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A2-A0YH,SLC7A8 mRNA overexpression (Z=1.37) exceeds the high-expression threshold. No methylation sites meet hyper/hypo-methylation criteria. miRNA hsa-mir-2115 is upregulated (Z=1.73). All CNVs fall within the normal range. These features indicate luminal-like biology with SLC7A8-driven amino acid transport dysregulation.,"mRNA_MLPH: -0.1999632596042142, mRNA_C2orf54: -0.3511691735040609, mRNA_CITED4: 1.0196156600948711, mRNA_ESR1: 0.5363760677642243, mRNA_SPDEF: 0.3113168093340817, mRNA_AGR3: 0.3118113749116803, mRNA_FOXC1: -1.0015461659801443, mRNA_GATA3: 0.2733197464932548, mRNA_AGR2: 0.4953516535651531, mRNA_XBP1: 0.4024585652703519, mRNA_PRR15: 0.5675330651434003, mRNA_SLC44A4: 0.0722404488890343, mRNA_CA12: 1.0505226560900025, mRNA_DTL: 0.568512823880881, mRNA_C5AR2: -0.1137953712799817, mRNA_TBC1D9: 0.5995477240307854, mRNA_AR: 0.1199320361001173, mRNA_CCDC170: 0.1413530822379131, mRNA_DEGS2: 0.6026529748355681, mRNA_TFF3: 0.4323673089719647, mRNA_DNALI1: 0.2542796640346225, mRNA_LINC00504: 0.2993334274510111, mRNA_CLCA2: -0.7258821459888842, mRNA_PPP1R14C: -0.9249077663921728, mRNA_THSD4: 0.617184446225622, mRNA_SPAG5: 0.643977666409866, mRNA_FBP1: 0.525689652009166, mRNA_SLC7A8: 1.365172702512337, mRNA_EN1: -0.4104620820882705, mRNA_ZNF552: 0.1080158261386509, Methylation_LRRC6: -1.0934684442039673, Methylation_chr2 66218712 LINC02934 (29533): -0.3499519383473078, Methylation_HOXB13: -0.8931350722526806, Methylation_chr10 3949206 LINC02660 (4871): -0.1276016052524164, Methylation_chr5 179517140 RNF130 (18026): -0.0736486673143708, Methylation_LOC727677: -1.2631811623002265, Methylation_LETM1: 0.0845877273765219, Methylation_CDC42BPB: 0.5305428670570395, Methylation_C8orf38: -0.9868349685853232, Methylation_chr14 100504766 EVL (18852): -0.7091774008521738, Methylation_chr5 72594851 LOC340090 (24088): -0.8760483752343108, Methylation_chr2 242904738 LINC01238 (3421): -0.1393450204218327, Methylation_ARFGEF1: -1.1771283015947396, Methylation_MAPT: 0.0339982048161342, Methylation_ZFAT: -1.4033123969605827, Methylation_KCNQ4: 0.3832420348740679, Methylation_chr1 232684368 SIPA1L2 (12934): -0.2489245472010842, Methylation_CRNKL1: -0.5998228532562229, Methylation_PRKAG2: -1.0926031843073634, Methylation_MICB: -0.3762501505804208, miRNA_hsa-mir-934: -0.075358274795109, miRNA_hsa-mir-4728: 0.4680690164708956, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.8683320827237887, miRNA_hsa-mir-190b: 0.524560489005095, miRNA_hsa-mir-577: -0.2782200849308641, miRNA_hsa-mir-135b: -0.2174000616838302, miRNA_hsa-mir-2115: 1.733131158609509, miRNA_hsa-mir-17: 0.5159663942016589, miRNA_hsa-mir-130b: 1.0677667251971723, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A27T,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.0178905072258872, mRNA_C2orf54: -1.2227256166836051, mRNA_CITED4: 0.5976594853186741, mRNA_ESR1: 0.9141242687633464, mRNA_SPDEF: 0.0459756116580494, mRNA_AGR3: 0.5645817755076203, mRNA_FOXC1: -0.525456725028507, mRNA_GATA3: 0.738867354517477, mRNA_AGR2: -0.0514234238444952, mRNA_XBP1: 0.7506441009097666, mRNA_PRR15: 0.7252109517779632, mRNA_SLC44A4: 0.2325684969898746, mRNA_CA12: 0.8220276525365355, mRNA_DTL: 0.3840670800828409, mRNA_C5AR2: 0.8628200410285638, mRNA_TBC1D9: 0.3197528753341175, mRNA_AR: 0.3920174645169186, mRNA_CCDC170: 0.9742046248704904, mRNA_DEGS2: 0.6775332149606442, mRNA_TFF3: -0.536867030617694, mRNA_DNALI1: -0.0196598054252639, mRNA_LINC00504: -0.1423011534521918, mRNA_CLCA2: -0.8504975140063988, mRNA_PPP1R14C: -1.1026102109802858, mRNA_THSD4: 1.2410310008962449, mRNA_SPAG5: 0.0186030325754957, mRNA_FBP1: 0.4661911674547664, mRNA_SLC7A8: 0.1664299396122009, mRNA_EN1: 0.2288774325723647, mRNA_ZNF552: 0.4518880626675641, Methylation_LRRC6: -0.4574515649975094, Methylation_chr2 66218712 LINC02934 (29533): -1.2386787331941476, Methylation_HOXB13: -1.081754931069851, Methylation_chr10 3949206 LINC02660 (4871): -0.9352684880045689, Methylation_chr5 179517140 RNF130 (18026): 0.4897227717233095, Methylation_LOC727677: -0.6892833360293653, Methylation_LETM1: 0.3904346233392998, Methylation_CDC42BPB: 0.8365219491066175, Methylation_C8orf38: -0.2658821349999628, Methylation_chr14 100504766 EVL (18852): -0.4568815865812087, Methylation_chr5 72594851 LOC340090 (24088): 0.8324459520251999, Methylation_chr2 242904738 LINC01238 (3421): -0.9078191136509292, Methylation_ARFGEF1: -0.1205700159456018, Methylation_MAPT: -0.6770194041003393, Methylation_ZFAT: -0.6888716419904629, Methylation_KCNQ4: -0.649601347536725, Methylation_chr1 232684368 SIPA1L2 (12934): -0.1774109962251684, Methylation_CRNKL1: -0.2689416909575237, Methylation_PRKAG2: 1.1785722044436593, Methylation_MICB: -0.5954876651073274, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.2008651839258665, miRNA_hsa-mir-5695: -0.4341098335260693, miRNA_hsa-mir-18a: -0.7430624780180947, miRNA_hsa-mir-190b: 0.1151944482460643, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.9471019932308878, miRNA_hsa-mir-2115: -0.3138355801351277, miRNA_hsa-mir-17: -0.8433368913444815, miRNA_hsa-mir-130b: -1.2908741353691726, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-A2-A25E,"No features meet the strict diagnostic thresholds for mRNA (Z > 1.30 or Z < -1.92), methylation (Z > 1.50 or Z < -1.47), miRNA (Z > 1.99 or Z < -1.25), or CNV (deletion, gain, amplification, or high-level amplification). All values fall within non-actionable ranges.","mRNA_MLPH: 0.3236412893777349, mRNA_C2orf54: 0.3011659620341275, mRNA_CITED4: 0.5402534775197222, mRNA_ESR1: 0.4588711670835907, mRNA_SPDEF: 0.428052787453944, mRNA_AGR3: 0.5278841519629476, mRNA_FOXC1: -0.5469506496987391, mRNA_GATA3: 0.2616178484756749, mRNA_AGR2: 0.8237727939337787, mRNA_XBP1: 0.719339546305208, mRNA_PRR15: -0.0518431520817436, mRNA_SLC44A4: 0.5173690669784593, mRNA_CA12: 0.6005679070279937, mRNA_DTL: 1.0676379583755882, mRNA_C5AR2: -0.420685326605597, mRNA_TBC1D9: 0.7598025915432276, mRNA_AR: -0.3006573705531553, mRNA_CCDC170: 0.2785515952339732, mRNA_DEGS2: -0.0769938203676263, mRNA_TFF3: 0.8384615692788718, mRNA_DNALI1: 0.9906508066201144, mRNA_LINC00504: 0.7256565862510295, mRNA_CLCA2: -0.7253116147181606, mRNA_PPP1R14C: -0.7081829406805227, mRNA_THSD4: 0.6324087717960944, mRNA_SPAG5: 1.0818417981324029, mRNA_FBP1: 1.0359804613169818, mRNA_SLC7A8: -0.2104323380776924, mRNA_EN1: -0.3288541872987304, mRNA_ZNF552: 0.5203538642333467, Methylation_LRRC6: -0.9926797112183056, Methylation_chr2 66218712 LINC02934 (29533): -1.651573480617641, Methylation_HOXB13: -1.0893521939363515, Methylation_chr10 3949206 LINC02660 (4871): -1.0820839990035518, Methylation_chr5 179517140 RNF130 (18026): -0.0483560654855812, Methylation_LOC727677: 0.2509271664090263, Methylation_LETM1: -1.3928133787764996, Methylation_CDC42BPB: 0.8211811949427876, Methylation_C8orf38: -0.3597594002794719, Methylation_chr14 100504766 EVL (18852): -0.0352539869358362, Methylation_chr5 72594851 LOC340090 (24088): 0.5341403314138825, Methylation_chr2 242904738 LINC01238 (3421): 1.2077630014725669, Methylation_ARFGEF1: -0.7760432354581801, Methylation_MAPT: -0.5882596942495671, Methylation_ZFAT: -1.250287600169321, Methylation_KCNQ4: -0.974231735315074, Methylation_chr1 232684368 SIPA1L2 (12934): -0.3283263633584017, Methylation_CRNKL1: -0.9330916698843847, Methylation_PRKAG2: -1.0488850216702503, Methylation_MICB: -0.9348375624547096, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 1.0174625160019537, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.9310208305068528, miRNA_hsa-mir-190b: 1.0388847336221332, miRNA_hsa-mir-577: 0.2325529011746852, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.526014598406775, miRNA_hsa-mir-130b: 1.9257871919360503, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E2-A1IK,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.2793254071709911, mRNA_C2orf54: -1.0536444894958923, mRNA_CITED4: -0.9550846808152088, mRNA_ESR1: 1.0441381036496011, mRNA_SPDEF: 0.3376081336067366, mRNA_AGR3: 0.027392137777984, mRNA_FOXC1: 1.2689699478430685, mRNA_GATA3: 0.6246646713991257, mRNA_AGR2: 1.1216176253217536, mRNA_XBP1: 0.9740688478930932, mRNA_PRR15: 0.8448678280273241, mRNA_SLC44A4: 0.964419197787457, mRNA_CA12: 0.3167690031563087, mRNA_DTL: -1.6501541602459613, mRNA_C5AR2: 0.8822711644715506, mRNA_TBC1D9: -0.1225604471632957, mRNA_AR: 0.6917094426113731, mRNA_CCDC170: 1.2196900099938448, mRNA_DEGS2: 0.4118377012700615, mRNA_TFF3: 0.9831095301449496, mRNA_DNALI1: 0.6643800230351499, mRNA_LINC00504: 0.2181012872170009, mRNA_CLCA2: -0.3175969731906898, mRNA_PPP1R14C: -0.2177864524111665, mRNA_THSD4: 0.4725267343280779, mRNA_SPAG5: -0.8553681688015947, mRNA_FBP1: -0.0215590166524704, mRNA_SLC7A8: 0.9584857505884348, mRNA_EN1: -1.1116513568260238, mRNA_ZNF552: 0.3980104342720773, Methylation_LRRC6: 0.23930008614486, Methylation_chr2 66218712 LINC02934 (29533): -0.6772020164723898, Methylation_HOXB13: -1.084282117647322, Methylation_chr10 3949206 LINC02660 (4871): -0.0557686819495345, Methylation_chr5 179517140 RNF130 (18026): -1.520695093042593, Methylation_LOC727677: 0.005244098579417, Methylation_LETM1: 0.0402513595755584, Methylation_CDC42BPB: -1.0231001170206184, Methylation_C8orf38: 0.0914314879387686, Methylation_chr14 100504766 EVL (18852): 0.8731794817271903, Methylation_chr5 72594851 LOC340090 (24088): -1.2334933222237652, Methylation_chr2 242904738 LINC01238 (3421): -0.4914421835784524, Methylation_ARFGEF1: 0.2551689653930277, Methylation_MAPT: 0.1956559514496618, Methylation_ZFAT: 1.3190052345406236, Methylation_KCNQ4: -1.170843973052698, Methylation_chr1 232684368 SIPA1L2 (12934): 0.0917052688020901, Methylation_CRNKL1: 0.095563592409786, Methylation_PRKAG2: -0.4937258878945648, Methylation_MICB: 0.099058043784451, miRNA_hsa-mir-934: -0.202061714701333, miRNA_hsa-mir-4728: -1.067148938973378, miRNA_hsa-mir-5695: 0.7469508777404475, miRNA_hsa-mir-18a: -0.1006491406176133, miRNA_hsa-mir-190b: 0.0450418294141272, miRNA_hsa-mir-577: -0.395345547805832, miRNA_hsa-mir-135b: 0.2319221760938279, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.9669462311430896, miRNA_hsa-mir-130b: 0.3741129401762157, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A1JI,"High-level Amplification absent; multiple deletions (VPS54, LINC01867, LINC02576, WDPCP, CEP68). LETM1 and EVL promoter hypermethylation (Z < -1.47) suggests epigenetic silencing. miRNA hsa-mir-5695 upregulated (Z > 1.99); hsa-mir-17 downregulated (Z < -1.25). No mRNA alterations meet expression thresholds.","mRNA_MLPH: 0.519230623257394, mRNA_C2orf54: -1.1055412672524396, mRNA_CITED4: 0.4030439050568634, mRNA_ESR1: 0.749429493748641, mRNA_SPDEF: -0.5349977738181303, mRNA_AGR3: 1.033276951321824, mRNA_FOXC1: -1.2083530083057028, mRNA_GATA3: 0.7706790533284875, mRNA_AGR2: 1.1950143658534549, mRNA_XBP1: 0.8906839007941345, mRNA_PRR15: -0.170422278134265, mRNA_SLC44A4: 0.4544141997905554, mRNA_CA12: 1.0481654919490246, mRNA_DTL: -0.3494703067256097, mRNA_C5AR2: 1.9281166681982609, mRNA_TBC1D9: 1.2285203674501484, mRNA_AR: -0.004913720738844, mRNA_CCDC170: 1.4062287917777117, mRNA_DEGS2: 0.9942199818420064, mRNA_TFF3: 0.5367230380863056, mRNA_DNALI1: 1.1311601736315742, mRNA_LINC00504: 0.7627524605887464, mRNA_CLCA2: -0.8713909682071388, mRNA_PPP1R14C: -1.0848711852853348, mRNA_THSD4: 1.1308780815185444, mRNA_SPAG5: -0.5120993637950494, mRNA_FBP1: 0.8328888619485262, mRNA_SLC7A8: 0.2400685816222169, mRNA_EN1: -1.0140485099747758, mRNA_ZNF552: 1.209317899320635, Methylation_LRRC6: -1.169114823497635, Methylation_chr2 66218712 LINC02934 (29533): -1.1783117032432686, Methylation_HOXB13: -0.9775710242295558, Methylation_chr10 3949206 LINC02660 (4871): 0.3241167146326957, Methylation_chr5 179517140 RNF130 (18026): 1.1822702728480827, Methylation_LOC727677: -1.215727958642175, Methylation_LETM1: -1.5588345307768663, Methylation_CDC42BPB: 1.4539546150210978, Methylation_C8orf38: -1.066037387855514, Methylation_chr14 100504766 EVL (18852): -1.580186051695835, Methylation_chr5 72594851 LOC340090 (24088): 1.0189258749992118, Methylation_chr2 242904738 LINC01238 (3421): -1.2611654479553709, Methylation_ARFGEF1: 1.085882948314783, Methylation_MAPT: -1.4365575136134623, Methylation_ZFAT: -1.4912958503980251, Methylation_KCNQ4: -1.1635268077016785, Methylation_chr1 232684368 SIPA1L2 (12934): -1.4178677497505865, Methylation_CRNKL1: -1.752343288532276, Methylation_PRKAG2: -0.8194042660943543, Methylation_MICB: -1.63599780238834, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.6047681903582236, miRNA_hsa-mir-5695: 2.6916931027617843, miRNA_hsa-mir-18a: -0.5650256580378119, miRNA_hsa-mir-190b: 0.7183558599256136, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.0182139374072858, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.3718169511678917, miRNA_hsa-mir-130b: 0.7768145632109862, CNV_VPS54: -1.6173912818721974, CNV_LINC01867: -1.63714039509435, CNV_LINC02576: -1.657048777669473, CNV_WDPCP: -1.6249341592372952, CNV_CEP68: -1.657048777669473"
TCGA-A7-A26H,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.493606614236619, mRNA_C2orf54: -0.2469200843682433, mRNA_CITED4: 0.6654247387878917, mRNA_ESR1: 0.8801132154968256, mRNA_SPDEF: 0.1201689681405951, mRNA_AGR3: 0.89301074125328, mRNA_FOXC1: -0.6435085501970768, mRNA_GATA3: 0.3220991829638911, mRNA_AGR2: 0.4429937887222384, mRNA_XBP1: 0.5941732703616871, mRNA_PRR15: 0.5236291031239667, mRNA_SLC44A4: 0.6640919879140949, mRNA_CA12: 0.8207936426197505, mRNA_DTL: 0.8119330586723447, mRNA_C5AR2: 0.72634107596978, mRNA_TBC1D9: 0.9601930451359671, mRNA_AR: 0.6103719556292228, mRNA_CCDC170: 1.173190871635275, mRNA_DEGS2: -0.0099789353840621, mRNA_TFF3: 0.3866021604680007, mRNA_DNALI1: 0.3125387271660614, mRNA_LINC00504: 0.8710096082218939, mRNA_CLCA2: -0.1304492106416524, mRNA_PPP1R14C: -0.2548176203448699, mRNA_THSD4: 1.179848586601674, mRNA_SPAG5: -0.1374611991648258, mRNA_FBP1: 0.5643981566806567, mRNA_SLC7A8: 0.7887430395083105, mRNA_EN1: -0.4121532061416471, mRNA_ZNF552: 0.9972145360697524, Methylation_LRRC6: -0.5777859244281165, Methylation_chr2 66218712 LINC02934 (29533): -0.8961992155982746, Methylation_HOXB13: 0.597581134705762, Methylation_chr10 3949206 LINC02660 (4871): -0.9071558223149758, Methylation_chr5 179517140 RNF130 (18026): 0.6300802423710425, Methylation_LOC727677: -0.4825575592642781, Methylation_LETM1: -0.4403681333561466, Methylation_CDC42BPB: -0.9614663978009556, Methylation_C8orf38: -1.0874700067096443, Methylation_chr14 100504766 EVL (18852): -0.3719603354552059, Methylation_chr5 72594851 LOC340090 (24088): 0.5074773444732463, Methylation_chr2 242904738 LINC01238 (3421): -1.0352202639082206, Methylation_ARFGEF1: -0.2696273238483573, Methylation_MAPT: -0.1104240167639632, Methylation_ZFAT: -0.9562918650259102, Methylation_KCNQ4: -0.0075816021220131, Methylation_chr1 232684368 SIPA1L2 (12934): -1.08482292076438, Methylation_CRNKL1: -0.2084659728579599, Methylation_PRKAG2: -0.6480519029731411, Methylation_MICB: -0.8601546778984476, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.2434629400696646, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.3871899252504427, miRNA_hsa-mir-190b: 0.1077883501203357, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.3853571938308259, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.4824495761901544, miRNA_hsa-mir-130b: -0.6889054536057724, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AC-A23H,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. CLCA2 and C2orf54 show significant mRNA upregulation (Z > 1.30). CITED4 and DNALI1 are transcriptionally silenced (Z < -1.92). HOXB13 promoter hypermethylation (Z > 1.50) and PRKAG2 hypomethylation (Z < -1.47) mediate epigenetic dysregulation. miR-4728 and miR-2115 are markedly upregulated (Z > 1.99); miR-190b is downregulated (Z < -1.25).","mRNA_MLPH: 0.6724759497370345, mRNA_C2orf54: 2.019058803616274, mRNA_CITED4: -2.546208381302351, mRNA_ESR1: -1.2699318035208422, mRNA_SPDEF: 0.8325730767287567, mRNA_AGR3: 0.1726139033688132, mRNA_FOXC1: -0.3735155451587479, mRNA_GATA3: 0.2896613759812749, mRNA_AGR2: 0.4064065480868739, mRNA_XBP1: 0.983732259277591, mRNA_PRR15: 0.5989365938776732, mRNA_SLC44A4: 0.7040551785701148, mRNA_CA12: 0.3168940100078279, mRNA_DTL: 1.1174701975629964, mRNA_C5AR2: -1.3183629835455857, mRNA_TBC1D9: 0.001711942331391, mRNA_AR: 0.8855647982709628, mRNA_CCDC170: -1.4831511489599372, mRNA_DEGS2: 0.6652417062465458, mRNA_TFF3: -0.1036260171974069, mRNA_DNALI1: -2.11817689860528, mRNA_LINC00504: 1.1371392908419102, mRNA_CLCA2: 3.6329982506551466, mRNA_PPP1R14C: -0.5957382868674314, mRNA_THSD4: 0.2898077260489095, mRNA_SPAG5: 1.2241752836856905, mRNA_FBP1: 0.5929676939594553, mRNA_SLC7A8: 0.9958127425379096, mRNA_EN1: 0.1425337415854854, mRNA_ZNF552: 0.4328907345708269, Methylation_LRRC6: -1.2106767543180506, Methylation_chr2 66218712 LINC02934 (29533): -1.6192506202229149, Methylation_HOXB13: 1.6186557273053277, Methylation_chr10 3949206 LINC02660 (4871): 1.457181551632868, Methylation_chr5 179517140 RNF130 (18026): 0.3392691855607274, Methylation_LOC727677: -0.2304421319697175, Methylation_LETM1: 1.226251138386609, Methylation_CDC42BPB: -1.1597959645393874, Methylation_C8orf38: -0.5964463149329453, Methylation_chr14 100504766 EVL (18852): -0.757802188845461, Methylation_chr5 72594851 LOC340090 (24088): 0.4741743829866678, Methylation_chr2 242904738 LINC01238 (3421): 1.3948147276454557, Methylation_ARFGEF1: -1.066283777649982, Methylation_MAPT: -0.825414614330059, Methylation_ZFAT: 0.7969852308103076, Methylation_KCNQ4: 0.8487449604805933, Methylation_chr1 232684368 SIPA1L2 (12934): -1.362158524887367, Methylation_CRNKL1: -1.576245481018473, Methylation_PRKAG2: -1.8696314164935937, Methylation_MICB: -0.0341800704799899, miRNA_hsa-mir-934: -0.4842487694284488, miRNA_hsa-mir-4728: 3.8491028795394886, miRNA_hsa-mir-5695: -0.3389392401433841, miRNA_hsa-mir-18a: -0.4382674980043047, miRNA_hsa-mir-190b: -1.3686233550784097, miRNA_hsa-mir-577: -0.5661081611957188, miRNA_hsa-mir-135b: -0.8216076600054194, miRNA_hsa-mir-2115: 2.314669637846381, miRNA_hsa-mir-17: -0.9009276743083936, miRNA_hsa-mir-130b: 0.9122358108959264, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-A2-A25C,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.5987458002390421, mRNA_C2orf54: 0.2366308561453427, mRNA_CITED4: -0.4487910717160688, mRNA_ESR1: 0.0664010305500676, mRNA_SPDEF: 0.4113291361512126, mRNA_AGR3: 0.4333234807428749, mRNA_FOXC1: -0.1995893527646091, mRNA_GATA3: 0.3365695968639814, mRNA_AGR2: 0.5293707635311219, mRNA_XBP1: 0.5503310703783268, mRNA_PRR15: 0.3403427419190082, mRNA_SLC44A4: 0.8533980220972892, mRNA_CA12: 0.177243543923632, mRNA_DTL: 1.4538611217696402, mRNA_C5AR2: 2.2910185646593826, mRNA_TBC1D9: 0.2477931646284485, mRNA_AR: 1.0451233671681754, mRNA_CCDC170: 0.467711312241117, mRNA_DEGS2: -0.6336494803720796, mRNA_TFF3: 1.1552431772341556, mRNA_DNALI1: -0.0228094625996439, mRNA_LINC00504: 1.2433757472911475, mRNA_CLCA2: -0.6625611794448422, mRNA_PPP1R14C: -0.3915149919280232, mRNA_THSD4: 1.2196808102660668, mRNA_SPAG5: 1.1706759956792858, mRNA_FBP1: 0.9555336929833124, mRNA_SLC7A8: 0.5585997807152765, mRNA_EN1: -0.6246107296881469, mRNA_ZNF552: 1.116647193215386, Methylation_LRRC6: -0.1736305612377711, Methylation_chr2 66218712 LINC02934 (29533): 0.905993551422977, Methylation_HOXB13: -0.9744143379498388, Methylation_chr10 3949206 LINC02660 (4871): -0.362636688718077, Methylation_chr5 179517140 RNF130 (18026): 0.3894354343694179, Methylation_LOC727677: -0.7173970122503627, Methylation_LETM1: 0.8847440934292967, Methylation_CDC42BPB: 0.9429462623892768, Methylation_C8orf38: -0.3457655307781767, Methylation_chr14 100504766 EVL (18852): -0.9613004687832096, Methylation_chr5 72594851 LOC340090 (24088): 0.1526911979414423, Methylation_chr2 242904738 LINC01238 (3421): -0.766469744053276, Methylation_ARFGEF1: -0.1803036220968847, Methylation_MAPT: 0.6038677597403751, Methylation_ZFAT: 0.7058083283853757, Methylation_KCNQ4: -0.504413037559584, Methylation_chr1 232684368 SIPA1L2 (12934): -0.7717705952227362, Methylation_CRNKL1: 0.1401408854039509, Methylation_PRKAG2: 1.1118778498460289, Methylation_MICB: -0.8808213790641389, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.9139158472312232, miRNA_hsa-mir-5695: 1.6267933648877888, miRNA_hsa-mir-18a: -1.0066353774258276, miRNA_hsa-mir-190b: 0.2094832434996994, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.7305872924919229, miRNA_hsa-mir-2115: 0.3070948828213348, miRNA_hsa-mir-17: -0.3282220493997672, miRNA_hsa-mir-130b: 1.165487721990757, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-OL-A5S0,"High-level Amplification absent; Gain observed in VPS54, WDPCP, CEP68. mRNA_FOXC1 (Z=2.41), mRNA_PPP1R14C (Z=2.03), and mRNA_EN1 (Z=2.58) overexpressed. ESR1, SPDEF, AGR2, AR, and others significantly downregulated (Z < -1.92). Promoter hypermethylation in LRRC6, LOC727677, C8orf38, ARFGEF1, SIPA1L2, MICB (Z > 1.50); RNF130 and LOC340090 hypo-methylated (Z < -1.47). miR-18a upregulated (Z=1.91); miR-190b downregulated (Z=-1.69).","mRNA_MLPH: -2.089598814933592, mRNA_C2orf54: 0.2610274416767332, mRNA_CITED4: 0.6657556564574724, mRNA_ESR1: -2.023338669238534, mRNA_SPDEF: -2.250416986249676, mRNA_AGR3: -1.7092528402267848, mRNA_FOXC1: 2.4075791888645885, mRNA_GATA3: -1.3790213930602784, mRNA_AGR2: -2.370014485274484, mRNA_XBP1: -2.2030488329173195, mRNA_PRR15: -1.9080160228024468, mRNA_SLC44A4: -2.01181709674382, mRNA_CA12: -1.689090261904969, mRNA_DTL: -0.1742260788044309, mRNA_C5AR2: -1.355838976045987, mRNA_TBC1D9: -1.8538275149109789, mRNA_AR: -2.2566469429535565, mRNA_CCDC170: -1.3896620278467349, mRNA_DEGS2: -1.9990319345815903, mRNA_TFF3: -1.4952318481734013, mRNA_DNALI1: -0.8811258398769819, mRNA_LINC00504: -1.6628310481583035, mRNA_CLCA2: -0.8592452920655871, mRNA_PPP1R14C: 2.029650151939274, mRNA_THSD4: -1.8825008987491711, mRNA_SPAG5: 0.5731910159584724, mRNA_FBP1: -1.4861299631692029, mRNA_SLC7A8: -1.7995393744041344, mRNA_EN1: 2.5777662848833365, mRNA_ZNF552: -2.15406787216463, Methylation_LRRC6: 1.507306218244198, Methylation_chr2 66218712 LINC02934 (29533): -0.6727193786715067, Methylation_HOXB13: 0.5538043718209905, Methylation_chr10 3949206 LINC02660 (4871): 1.4544191748918454, Methylation_chr5 179517140 RNF130 (18026): -1.6600978971616052, Methylation_LOC727677: 1.532740702166946, Methylation_LETM1: 1.3726299624550795, Methylation_CDC42BPB: 0.6133429255057369, Methylation_C8orf38: 1.6205370164091126, Methylation_chr14 100504766 EVL (18852): 1.495759571303423, Methylation_chr5 72594851 LOC340090 (24088): -1.4884703440391018, Methylation_chr2 242904738 LINC01238 (3421): 1.3929372237720152, Methylation_ARFGEF1: 1.5733750908066024, Methylation_MAPT: 1.433050516362446, Methylation_ZFAT: 1.4383849509062565, Methylation_KCNQ4: 0.945035608589846, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5402220385265586, Methylation_CRNKL1: 1.381046273010539, Methylation_PRKAG2: -0.8655436579758206, Methylation_MICB: 1.5225589829575132, miRNA_hsa-mir-934: 1.838158072576956, miRNA_hsa-mir-4728: -0.3543789651396745, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.9076684895710248, miRNA_hsa-mir-190b: -1.6942461302337324, miRNA_hsa-mir-577: 0.8888031406044814, miRNA_hsa-mir-135b: 1.3263881107938575, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.6237942483201937, miRNA_hsa-mir-130b: 1.0775984584213203, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-BH-A1EO,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: -0.1470263963016371, mRNA_C2orf54: -1.184824695862457, mRNA_CITED4: 0.4340484132474462, mRNA_ESR1: 0.6672574575518928, mRNA_SPDEF: -0.0294911387093175, mRNA_AGR3: 0.5659533710708646, mRNA_FOXC1: -0.0818084151126923, mRNA_GATA3: 0.4016989410654518, mRNA_AGR2: 0.2278719024716365, mRNA_XBP1: 0.0930164372855973, mRNA_PRR15: -0.6433309751397503, mRNA_SLC44A4: -0.5166856753209526, mRNA_CA12: 0.8137714848292877, mRNA_DTL: 0.402163773141437, mRNA_C5AR2: -0.4297661701888438, mRNA_TBC1D9: 0.769588932623213, mRNA_AR: 0.6844583495290769, mRNA_CCDC170: -0.1535002068620811, mRNA_DEGS2: 0.1554526720263641, mRNA_TFF3: 0.0107952105055568, mRNA_DNALI1: 0.5773671368177058, mRNA_LINC00504: 0.5538053004272666, mRNA_CLCA2: -0.3955181371111586, mRNA_PPP1R14C: -0.6431686159754132, mRNA_THSD4: 0.1168219361261714, mRNA_SPAG5: -0.7249640324700837, mRNA_FBP1: 0.3782457867209314, mRNA_SLC7A8: 0.0501536119322543, mRNA_EN1: 0.2990999030077771, mRNA_ZNF552: 0.0550037889950556, Methylation_LRRC6: -0.9642601029520182, Methylation_chr2 66218712 LINC02934 (29533): 1.2083620471644374, Methylation_HOXB13: -0.8026329291936913, Methylation_chr10 3949206 LINC02660 (4871): -0.2924726145422128, Methylation_chr5 179517140 RNF130 (18026): 0.7868116873957073, Methylation_LOC727677: -1.1607870721259976, Methylation_LETM1: -0.4270620649842701, Methylation_CDC42BPB: 1.3343654509766696, Methylation_C8orf38: -0.928006841296012, Methylation_chr14 100504766 EVL (18852): -0.8527196084105046, Methylation_chr5 72594851 LOC340090 (24088): 0.6198215738218285, Methylation_chr2 242904738 LINC01238 (3421): 0.1348209612483124, Methylation_ARFGEF1: -1.065625273637324, Methylation_MAPT: -0.2226983889665765, Methylation_ZFAT: -1.4047812654531318, Methylation_KCNQ4: 0.865679197909396, Methylation_chr1 232684368 SIPA1L2 (12934): -0.5562221048208591, Methylation_CRNKL1: -0.0843509656687897, Methylation_PRKAG2: 1.1929851980539512, Methylation_MICB: 0.3590313099835955, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.3254117612848142, miRNA_hsa-mir-5695: 0.1152213649711916, miRNA_hsa-mir-18a: -0.8228439097696881, miRNA_hsa-mir-190b: -0.2455081116452547, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.0565056276284102, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.8113569790518979, miRNA_hsa-mir-130b: -0.8595915260805931, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-AO-A0JM,High-level Amplification of none; DTL mRNA high (Z=1.30). HOXB13 promoter hypermethylation (Z=1.56). miR-4728 upregulated (Z=3.05); miR-17 downregulated (Z=-1.19). No deletions or amplifications per CNV thresholds.,"mRNA_MLPH: 0.1173600778846134, mRNA_C2orf54: 0.3630676093758511, mRNA_CITED4: -1.7605267816375287, mRNA_ESR1: -0.0676627417792864, mRNA_SPDEF: 0.5144900222982196, mRNA_AGR3: 0.6021215279200254, mRNA_FOXC1: -0.2115619444134132, mRNA_GATA3: 0.5656611695830774, mRNA_AGR2: 1.014107116204929, mRNA_XBP1: 0.5170625541009125, mRNA_PRR15: 0.9776701154346656, mRNA_SLC44A4: 1.0070974298931097, mRNA_CA12: -0.6391161669248078, mRNA_DTL: 1.300808638634426, mRNA_C5AR2: 0.8299256534632463, mRNA_TBC1D9: 0.102745786695818, mRNA_AR: 0.7901113797561509, mRNA_CCDC170: -0.1156740330302261, mRNA_DEGS2: 0.2091617964398361, mRNA_TFF3: 1.1693428264724128, mRNA_DNALI1: 0.5910772977159102, mRNA_LINC00504: 0.8850984001115636, mRNA_CLCA2: -0.5426395252451035, mRNA_PPP1R14C: -0.457436162422358, mRNA_THSD4: 0.3760465684026081, mRNA_SPAG5: 0.7096792586700637, mRNA_FBP1: 0.6768438916850512, mRNA_SLC7A8: -0.4724694037759964, mRNA_EN1: 0.5278026787391378, mRNA_ZNF552: 0.6428208405726372, Methylation_LRRC6: -0.8144624410405356, Methylation_chr2 66218712 LINC02934 (29533): -0.2484709624852487, Methylation_HOXB13: 1.5587954536941842, Methylation_chr10 3949206 LINC02660 (4871): -0.8212332704307302, Methylation_chr5 179517140 RNF130 (18026): 1.0644912951972345, Methylation_LOC727677: -1.0109705742782524, Methylation_LETM1: 0.5241803380815964, Methylation_CDC42BPB: -0.5727998061045376, Methylation_C8orf38: -0.6407933977043018, Methylation_chr14 100504766 EVL (18852): -0.8377166762383693, Methylation_chr5 72594851 LOC340090 (24088): 1.1332354707497383, Methylation_chr2 242904738 LINC01238 (3421): -0.5965932932716731, Methylation_ARFGEF1: -0.6339244949838817, Methylation_MAPT: -0.0405505518619805, Methylation_ZFAT: -0.8395712721509624, Methylation_KCNQ4: 0.2451696106190846, Methylation_chr1 232684368 SIPA1L2 (12934): -0.5745781567325141, Methylation_CRNKL1: -0.3587591192548112, Methylation_PRKAG2: -1.1554440087228823, Methylation_MICB: -0.4333112766186219, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 3.046979254158669, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.6245628081464498, miRNA_hsa-mir-190b: 0.3800327659163291, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.7859030998820564, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.1941853095777033, miRNA_hsa-mir-130b: 1.1041986100766272, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-B6-A0RP,"High-level Amplification of *VPS54*, *LINC01867*, *LINC02576*, *WDPCP*, and *CEP68* drives mRNA overexpression. No mRNA, methylation, or miRNA features meet diagnostic thresholds for significant dysregulation. These genomic amplifications suggest a proliferative phenotype with potential vesicular trafficking and ciliopathy pathway involvement.","mRNA_MLPH: 0.8729310402354477, mRNA_C2orf54: -1.098978693806054, mRNA_CITED4: 0.2360659893560724, mRNA_ESR1: 1.1476252938731395, mRNA_SPDEF: 0.7923377285903673, mRNA_AGR3: 0.7354856566165577, mRNA_FOXC1: -0.5842563745657366, mRNA_GATA3: 0.7950406319149447, mRNA_AGR2: -0.1008039719917022, mRNA_XBP1: 0.9500272195084998, mRNA_PRR15: 1.0367205069397434, mRNA_SLC44A4: 1.2147884787269851, mRNA_CA12: 0.6092843865609677, mRNA_DTL: -0.8505191114062924, mRNA_C5AR2: 0.7874672184633164, mRNA_TBC1D9: 1.430165951256963, mRNA_AR: 0.96835352043183, mRNA_CCDC170: 1.5330278896856504, mRNA_DEGS2: 1.402166666887692, mRNA_TFF3: -0.4206803302962683, mRNA_DNALI1: 0.6742857771931826, mRNA_LINC00504: 1.622403053365228, mRNA_CLCA2: -0.8294493654157576, mRNA_PPP1R14C: -1.0039669472280617, mRNA_THSD4: 0.6031526551947849, mRNA_SPAG5: -1.198973461711597, mRNA_FBP1: -0.3715378955131333, mRNA_SLC7A8: 0.7858726620753647, mRNA_EN1: 0.166365802472477, mRNA_ZNF552: 0.71802045532247, Methylation_LRRC6: -0.3955302387385107, Methylation_chr2 66218712 LINC02934 (29533): -1.3234086321966074, Methylation_HOXB13: -1.006256592676448, Methylation_chr10 3949206 LINC02660 (4871): -1.0226088423654869, Methylation_chr5 179517140 RNF130 (18026): 1.0528715306942569, Methylation_LOC727677: -0.8609435905195394, Methylation_LETM1: -0.8923719796611331, Methylation_CDC42BPB: -1.201875667562745, Methylation_C8orf38: -0.7769098682465944, Methylation_chr14 100504766 EVL (18852): -0.7442075562803105, Methylation_chr5 72594851 LOC340090 (24088): 0.763412046011769, Methylation_chr2 242904738 LINC01238 (3421): -0.8155163068569181, Methylation_ARFGEF1: -0.662966229730451, Methylation_MAPT: -0.741686083721758, Methylation_ZFAT: -0.4017744348506275, Methylation_KCNQ4: 1.1697287112108414, Methylation_chr1 232684368 SIPA1L2 (12934): -1.06238345048834, Methylation_CRNKL1: -0.4389558026547097, Methylation_PRKAG2: 0.2882682824477846, Methylation_MICB: -0.8848728680634024, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: 0.6747957010210076, miRNA_hsa-mir-18a: -0.9048278187893966, miRNA_hsa-mir-190b: 0.1469060419856208, miRNA_hsa-mir-577: -0.2852084136412683, miRNA_hsa-mir-135b: -0.9358527338194988, miRNA_hsa-mir-2115: -0.35631387510048, miRNA_hsa-mir-17: -1.514145427981765, miRNA_hsa-mir-130b: -0.1263725625919349, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-AO-A12G,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: -0.2348964203355616, mRNA_C2orf54: 1.0163680273341011, mRNA_CITED4: -0.7808093748746138, mRNA_ESR1: 0.331247164398419, mRNA_SPDEF: 0.2539027879097594, mRNA_AGR3: 0.5054040495481288, mRNA_FOXC1: -0.3924594041050838, mRNA_GATA3: 0.0047701182948182, mRNA_AGR2: 0.2379168459829032, mRNA_XBP1: 0.8312829854705364, mRNA_PRR15: 0.6599144147280789, mRNA_SLC44A4: 0.2875617287363642, mRNA_CA12: 0.0893013386741553, mRNA_DTL: -1.030256698271177, mRNA_C5AR2: 0.308887097167448, mRNA_TBC1D9: -0.1714330685119187, mRNA_AR: 0.7241824972816737, mRNA_CCDC170: -0.719345895458537, mRNA_DEGS2: 0.237218757359204, mRNA_TFF3: 0.1344804711049425, mRNA_DNALI1: 0.1555658478104794, mRNA_LINC00504: -0.5252612946369652, mRNA_CLCA2: -0.387964347803214, mRNA_PPP1R14C: -0.7692291578476356, mRNA_THSD4: -0.2495560552920924, mRNA_SPAG5: -1.206421343592128, mRNA_FBP1: 0.2520045483439576, mRNA_SLC7A8: 0.6313802225434723, mRNA_EN1: -0.8509935469678842, mRNA_ZNF552: -0.5920638300271881, Methylation_LRRC6: -1.0116884674639028, Methylation_chr2 66218712 LINC02934 (29533): 1.138637560588258, Methylation_HOXB13: -0.8789274171720631, Methylation_chr10 3949206 LINC02660 (4871): -0.6540780299695921, Methylation_chr5 179517140 RNF130 (18026): 0.9731521703433345, Methylation_LOC727677: -0.593192034669584, Methylation_LETM1: -0.4270738941288917, Methylation_CDC42BPB: -1.052506360192307, Methylation_C8orf38: -1.3073634436457895, Methylation_chr14 100504766 EVL (18852): -0.3854295666195759, Methylation_chr5 72594851 LOC340090 (24088): 1.1036516952613484, Methylation_chr2 242904738 LINC01238 (3421): -0.5470959017803906, Methylation_ARFGEF1: -0.8503408389904114, Methylation_MAPT: -0.9796503738270808, Methylation_ZFAT: -0.7294473407393527, Methylation_KCNQ4: -0.2517827411686775, Methylation_chr1 232684368 SIPA1L2 (12934): -0.041846491703763, Methylation_CRNKL1: -0.2424835148921842, Methylation_PRKAG2: 1.3392124678371289, Methylation_MICB: -0.0586014283973278, miRNA_hsa-mir-934: -0.2144768152943291, miRNA_hsa-mir-4728: 0.4691584949787697, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.4197272641727382, miRNA_hsa-mir-190b: 0.6865481289513045, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.7158493049051635, miRNA_hsa-mir-2115: 1.3012042303976896, miRNA_hsa-mir-17: -0.4741653924689128, miRNA_hsa-mir-130b: -0.3519465986895946, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-GM-A2DH,"High-level Amplification absent; no CNVs meet amplification thresholds.  
mRNA_DTL (Z=1.68), mRNA_CLCA2 (Z=1.74), and mRNA_SPAG5 (Z=1.85) exceed high-expression threshold (Z>1.30).  
mRNA_AGR3 (Z=-1.74) and mRNA_SLC44A4 (Z=-1.55) meet low-expression criteria (Z<-1.92 not met; thus, none qualify as low).  
Methylation_MAPT (Z=1.49) near hypermethylation cutoff (Z>1.50 not met); Methylation_chr5 72594851 LOC340090 (Z=-1.45) approaches hypomethylation (Z<-1.47 not met).  
miRNA_hsa-mir-2115 (Z=2.77) is upregulated (Z>1.99).  
No genomic deletions or promoter methylation events meet diagnostic thresholds.","mRNA_MLPH: -0.7136079958785304, mRNA_C2orf54: 1.284865043842491, mRNA_CITED4: -1.2446678720234297, mRNA_ESR1: -0.7082629968948326, mRNA_SPDEF: 0.419867738525447, mRNA_AGR3: -1.7448448190842625, mRNA_FOXC1: -0.7045784884595415, mRNA_GATA3: 0.6766272724700219, mRNA_AGR2: -0.8145644848359458, mRNA_XBP1: -0.2581635219629862, mRNA_PRR15: -0.0866747553810533, mRNA_SLC44A4: -1.5506446693266154, mRNA_CA12: -0.2366578569246564, mRNA_DTL: 1.6809984425116662, mRNA_C5AR2: -1.4682109142060926, mRNA_TBC1D9: -0.2498220133177238, mRNA_AR: 0.9882851666748363, mRNA_CCDC170: -1.4155914350394998, mRNA_DEGS2: -0.1863354551504853, mRNA_TFF3: -0.268734173377314, mRNA_DNALI1: 0.939419511514062, mRNA_LINC00504: -0.1423864742968019, mRNA_CLCA2: 1.7366389041726509, mRNA_PPP1R14C: -0.4043169285633018, mRNA_THSD4: -0.731373114565119, mRNA_SPAG5: 1.850700378851392, mRNA_FBP1: 0.2397991033801414, mRNA_SLC7A8: -0.021687080990119, mRNA_EN1: -0.8676422121055603, mRNA_ZNF552: -0.2195272343336672, Methylation_LRRC6: 0.6630147147246608, Methylation_chr2 66218712 LINC02934 (29533): -0.0898981622172652, Methylation_HOXB13: 0.6932891342763342, Methylation_chr10 3949206 LINC02660 (4871): 1.4047518593215624, Methylation_chr5 179517140 RNF130 (18026): -1.1023139273747466, Methylation_LOC727677: 0.3238744404220747, Methylation_LETM1: 1.280054788643563, Methylation_CDC42BPB: -0.9158598640157176, Methylation_C8orf38: 0.2761042726632303, Methylation_chr14 100504766 EVL (18852): 1.019614321625197, Methylation_chr5 72594851 LOC340090 (24088): -1.4468627539833303, Methylation_chr2 242904738 LINC01238 (3421): 0.3978361507171883, Methylation_ARFGEF1: 0.7944333972516611, Methylation_MAPT: 1.490165706512845, Methylation_ZFAT: 0.5185141168682972, Methylation_KCNQ4: 0.925366063868664, Methylation_chr1 232684368 SIPA1L2 (12934): 0.8219132338923525, Methylation_CRNKL1: -0.0476112221728051, Methylation_PRKAG2: 0.8125574942316977, Methylation_MICB: 1.3128496100803029, miRNA_hsa-mir-934: -0.0083377691049854, miRNA_hsa-mir-4728: -0.8544510313788944, miRNA_hsa-mir-5695: 0.4030000179150597, miRNA_hsa-mir-18a: 0.0442304404063703, miRNA_hsa-mir-190b: -0.8582506117439166, miRNA_hsa-mir-577: -0.4779703665348668, miRNA_hsa-mir-135b: -0.446695675172177, miRNA_hsa-mir-2115: 2.767193953588791, miRNA_hsa-mir-17: -0.0348611279159023, miRNA_hsa-mir-130b: 1.346878652630867, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-BH-A42V,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-significant ranges per specified criteria.","mRNA_MLPH: 0.7730522484757112, mRNA_C2orf54: 0.3871401550454609, mRNA_CITED4: 0.2075966010853361, mRNA_ESR1: -0.4169186795622236, mRNA_SPDEF: 0.7529453371003842, mRNA_AGR3: 0.1535342489603401, mRNA_FOXC1: 0.4497663211213402, mRNA_GATA3: 0.2343747509614427, mRNA_AGR2: 0.4276976074532556, mRNA_XBP1: 0.5416467233644204, mRNA_PRR15: 0.2275599979761783, mRNA_SLC44A4: 0.4921144575925255, mRNA_CA12: 0.461913800821831, mRNA_DTL: -1.993249406065995, mRNA_C5AR2: 0.2736836693279737, mRNA_TBC1D9: 0.5030523580629612, mRNA_AR: 0.3552598124200933, mRNA_CCDC170: -0.3507178376127428, mRNA_DEGS2: 0.7354735817904883, mRNA_TFF3: 0.0965028030657004, mRNA_DNALI1: 0.6403952882764758, mRNA_LINC00504: 0.6215467568242722, mRNA_CLCA2: -0.1996550028949423, mRNA_PPP1R14C: 0.4797278461739149, mRNA_THSD4: 0.2579843833218339, mRNA_SPAG5: -1.3087148736900054, mRNA_FBP1: 0.4496348160103255, mRNA_SLC7A8: 0.0057139792446869, mRNA_EN1: -0.4399490984400545, mRNA_ZNF552: -0.3676754063252738, Methylation_LRRC6: 0.6089014716335268, Methylation_chr2 66218712 LINC02934 (29533): 0.9340186831500444, Methylation_HOXB13: -1.0639018005635268, Methylation_chr10 3949206 LINC02660 (4871): 0.0988649580537523, Methylation_chr5 179517140 RNF130 (18026): 0.248693191424262, Methylation_LOC727677: 0.2018138640739084, Methylation_LETM1: 0.2211714016223455, Methylation_CDC42BPB: -0.2765494342928827, Methylation_C8orf38: 0.0094776804936355, Methylation_chr14 100504766 EVL (18852): 0.2911403962732219, Methylation_chr5 72594851 LOC340090 (24088): -0.0721370524698001, Methylation_chr2 242904738 LINC01238 (3421): 0.4022853027869423, Methylation_ARFGEF1: 0.40421194236767, Methylation_MAPT: 0.057943718969568, Methylation_ZFAT: -0.1980372632079095, Methylation_KCNQ4: -0.846846463543635, Methylation_chr1 232684368 SIPA1L2 (12934): 1.094021487310101, Methylation_CRNKL1: 0.3686887469961335, Methylation_PRKAG2: 1.1740504238637643, Methylation_MICB: 0.1385271164457467, miRNA_hsa-mir-934: 0.003263647518879, miRNA_hsa-mir-4728: -0.5798279851231298, miRNA_hsa-mir-5695: -0.0892570742692266, miRNA_hsa-mir-18a: -0.2688704673346979, miRNA_hsa-mir-190b: 0.7611632099828568, miRNA_hsa-mir-577: -0.5265036819392803, miRNA_hsa-mir-135b: 0.0133454513575107, miRNA_hsa-mir-2115: -0.5421102372308401, miRNA_hsa-mir-17: 0.7434493368498538, miRNA_hsa-mir-130b: -0.9873139665649426, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-B6-A0X7,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.5948538699373689, mRNA_C2orf54: -0.9475279300658336, mRNA_CITED4: 0.1955437824493897, mRNA_ESR1: 0.5584023261312496, mRNA_SPDEF: 0.4243817820688575, mRNA_AGR3: 0.2546310074892153, mRNA_FOXC1: -0.3703329362077671, mRNA_GATA3: 0.8094916554015011, mRNA_AGR2: 0.11456741846779, mRNA_XBP1: 0.762050145225214, mRNA_PRR15: 0.4194673158880214, mRNA_SLC44A4: 0.2433336738790819, mRNA_CA12: 0.5190496285287631, mRNA_DTL: -1.02119477815941, mRNA_C5AR2: 0.3717033367867733, mRNA_TBC1D9: 0.8866662284877598, mRNA_AR: 0.5231790648545848, mRNA_CCDC170: 0.1030141678839423, mRNA_DEGS2: 1.0445934240015524, mRNA_TFF3: -0.3743455242821106, mRNA_DNALI1: 0.803151087777596, mRNA_LINC00504: 1.0084314230447349, mRNA_CLCA2: -0.4981217846976338, mRNA_PPP1R14C: -0.6129346922879981, mRNA_THSD4: 0.6292942921479941, mRNA_SPAG5: -1.1374518896617043, mRNA_FBP1: 0.5823734762579976, mRNA_SLC7A8: 1.0307863984983712, mRNA_EN1: -0.0892830676837154, mRNA_ZNF552: -0.1104025555067252, Methylation_LRRC6: -0.6414193189902114, Methylation_chr2 66218712 LINC02934 (29533): 1.276692724471605, Methylation_HOXB13: -0.8008163004712823, Methylation_chr10 3949206 LINC02660 (4871): -0.4976126158399129, Methylation_chr5 179517140 RNF130 (18026): 0.841701899635324, Methylation_LOC727677: -0.8574327731956234, Methylation_LETM1: -0.5695844161406072, Methylation_CDC42BPB: -0.6436525303676093, Methylation_C8orf38: -0.9662582652997128, Methylation_chr14 100504766 EVL (18852): -0.1195137231437043, Methylation_chr5 72594851 LOC340090 (24088): 0.9775573257682248, Methylation_chr2 242904738 LINC01238 (3421): -0.3728783966076717, Methylation_ARFGEF1: -0.5184694448506254, Methylation_MAPT: -0.2916664741096298, Methylation_ZFAT: -0.99297989383255, Methylation_KCNQ4: -0.812560865196361, Methylation_chr1 232684368 SIPA1L2 (12934): -0.7602046233698706, Methylation_CRNKL1: -0.2885800660081575, Methylation_PRKAG2: 1.3224254421924928, Methylation_MICB: -0.0995779148543534, miRNA_hsa-mir-934: 0.0067658462786013, miRNA_hsa-mir-4728: -0.4333372032552011, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.6677333206833009, miRNA_hsa-mir-190b: -2.052137242410604, miRNA_hsa-mir-577: 1.297750609686018, miRNA_hsa-mir-135b: 1.5450387003050714, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.0285222662545942, miRNA_hsa-mir-130b: 2.14500789669158, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A0B9,"High-level Amplification absent; no CNV alterations meet diagnostic thresholds.  
Promoter hypermethylation of HOXB13, LINC02660, RNF130, LOC727677, C8orf38, EVL, LINC01238, ARFGEF1, MAPT, ZFAT, SIPA1L2, and CRNKL1.  
RNF130 and LOC340090 hypomethylated.  
miR-934, miR-18a, miR-577, and miR-17 upregulated.  
mRNA_PPP1R14C overexpressed; mRNA_ESR1, SPDEF, XBP1, CA12, THSD4 downregulated.","mRNA_MLPH: -1.6166355098042349, mRNA_C2orf54: 0.0631145786165467, mRNA_CITED4: -0.2167535321159398, mRNA_ESR1: -1.964964999545103, mRNA_SPDEF: -2.4233241662052927, mRNA_AGR3: -1.7919812512833542, mRNA_FOXC1: 1.869912894402331, mRNA_GATA3: -1.8867185915682985, mRNA_AGR2: -1.066053089569543, mRNA_XBP1: -2.157635959648606, mRNA_PRR15: -1.6614538716651546, mRNA_SLC44A4: -0.8023309160704187, mRNA_CA12: -2.7053334983371635, mRNA_DTL: 0.0778784761533971, mRNA_C5AR2: -1.8837858019699736, mRNA_TBC1D9: -1.761505165531391, mRNA_AR: -1.432901500908839, mRNA_CCDC170: -1.6559161592928626, mRNA_DEGS2: -1.937220414310792, mRNA_TFF3: -1.7204368566244632, mRNA_DNALI1: 0.1752105029432123, mRNA_LINC00504: -1.5702966103409466, mRNA_CLCA2: -0.4574952977218968, mRNA_PPP1R14C: 2.0958617824132286, mRNA_THSD4: -2.161258038040205, mRNA_SPAG5: 0.0855427949459668, mRNA_FBP1: -1.5397230211412898, mRNA_SLC7A8: -1.829276484963616, mRNA_EN1: -0.0431826979818342, mRNA_ZNF552: -1.0153640632385368, Methylation_LRRC6: 1.4592976423175603, Methylation_chr2 66218712 LINC02934 (29533): 1.1290532746819142, Methylation_HOXB13: 1.601293817462453, Methylation_chr10 3949206 LINC02660 (4871): 1.5499606296218669, Methylation_chr5 179517140 RNF130 (18026): -1.6100946753407677, Methylation_LOC727677: 1.5133062329484397, Methylation_LETM1: 1.3210096920542391, Methylation_CDC42BPB: 0.2567525303155825, Methylation_C8orf38: 1.5716343806079598, Methylation_chr14 100504766 EVL (18852): 1.459041709074261, Methylation_chr5 72594851 LOC340090 (24088): -1.4437811969820704, Methylation_chr2 242904738 LINC01238 (3421): 1.3619328637291692, Methylation_ARFGEF1: 1.538051776342283, Methylation_MAPT: 1.4392791953510875, Methylation_ZFAT: 1.456362709690308, Methylation_KCNQ4: 0.7630469148045266, Methylation_chr1 232684368 SIPA1L2 (12934): 1.631865028781048, Methylation_CRNKL1: 1.1980974716156805, Methylation_PRKAG2: -1.067527385886479, Methylation_MICB: 1.3133574732466715, miRNA_hsa-mir-934: 2.5492812634116486, miRNA_hsa-mir-4728: -0.5675933502358506, miRNA_hsa-mir-5695: 1.1846936969560689, miRNA_hsa-mir-18a: 2.578448741762577, miRNA_hsa-mir-190b: -0.5643629066909117, miRNA_hsa-mir-577: 2.119506778895229, miRNA_hsa-mir-135b: 1.5385492706340138, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 2.665716764452963, miRNA_hsa-mir-130b: 1.4093710348968054, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-C8-A273,High mRNA_C2orf54 (Z=1.40) indicates overexpression. PRKAG2 promoter hypermethylation (Z=-1.51) suggests epigenetic silencing. No miRNA or CNV alterations meet diagnostic thresholds. These features align with a luminal-like phenotype and metabolic pathway dysregulation.,"mRNA_MLPH: 0.2210172710268866, mRNA_C2orf54: 1.4012972778880428, mRNA_CITED4: 1.1631211394634955, mRNA_ESR1: 0.4918462212935558, mRNA_SPDEF: 0.3566473034805369, mRNA_AGR3: 1.1290516946003262, mRNA_FOXC1: -0.5238402179176755, mRNA_GATA3: 1.0903279526439609, mRNA_AGR2: -0.3177302673918327, mRNA_XBP1: 0.4553261893740908, mRNA_PRR15: -0.2469281853053491, mRNA_SLC44A4: 0.6213699056743168, mRNA_CA12: 1.0976703166411128, mRNA_DTL: 0.9576235603974266, mRNA_C5AR2: 0.0616054910148073, mRNA_TBC1D9: 0.901931127113702, mRNA_AR: -1.0271517712581522, mRNA_CCDC170: -0.1806048948007778, mRNA_DEGS2: 0.8859766507523785, mRNA_TFF3: 0.2637272931342067, mRNA_DNALI1: 1.0836952604299857, mRNA_LINC00504: 0.8582286009834641, mRNA_CLCA2: -0.8642685578832404, mRNA_PPP1R14C: 0.0012379251593245, mRNA_THSD4: 0.5084918810831289, mRNA_SPAG5: 0.7985389952972023, mRNA_FBP1: 1.183705570286177, mRNA_SLC7A8: 0.2998710022038064, mRNA_EN1: -0.5424127567986757, mRNA_ZNF552: 0.9641237891419332, Methylation_LRRC6: -0.7695826583768554, Methylation_chr2 66218712 LINC02934 (29533): 0.2500833634812265, Methylation_HOXB13: 0.2421541744168181, Methylation_chr10 3949206 LINC02660 (4871): -0.960965251915326, Methylation_chr5 179517140 RNF130 (18026): 0.9405269558006558, Methylation_LOC727677: 1.477461869970201, Methylation_LETM1: -1.0258682601624196, Methylation_CDC42BPB: 0.6414322738178649, Methylation_C8orf38: 0.4534699784590568, Methylation_chr14 100504766 EVL (18852): -0.9648412672917648, Methylation_chr5 72594851 LOC340090 (24088): -0.5577154966964897, Methylation_chr2 242904738 LINC01238 (3421): -1.1677452877350238, Methylation_ARFGEF1: 1.2206161025392983, Methylation_MAPT: -0.2693446609600414, Methylation_ZFAT: -0.499256592867196, Methylation_KCNQ4: -1.011201949168033, Methylation_chr1 232684368 SIPA1L2 (12934): -0.3832146988845352, Methylation_CRNKL1: -0.5270113383209298, Methylation_PRKAG2: -1.5108049434477258, Methylation_MICB: -1.3907266540970378, miRNA_hsa-mir-934: -0.4395384172895522, miRNA_hsa-mir-4728: -0.967745601295546, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.8442349912230389, miRNA_hsa-mir-190b: -0.4140482673187259, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.7958806081491019, miRNA_hsa-mir-2115: -0.1381358376906076, miRNA_hsa-mir-17: -1.0255057867477455, miRNA_hsa-mir-130b: -0.6009873264673526, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A1RC,"High-level Amplification absent; no CNV meets amplification thresholds.  
mRNA_CITED4, ESR1, CA12, DTL, TBC1D9, CCDC170, and THSD4 show high expression (Z > 1.30).  
LETM1, EVL, ZFAT, CRNKL1, and SIPA1L2 promoters are hypermethylated (Z < -1.47), suggesting silencing.  
miR-190b is upregulated (Z > 1.99).  
Collectively indicative of luminal breast cancer with ER-pathway activation.","mRNA_MLPH: 0.7389276030084378, mRNA_C2orf54: -0.6541307218121076, mRNA_CITED4: 1.1177269126109155, mRNA_ESR1: 1.2271147343155244, mRNA_SPDEF: 0.230455213600097, mRNA_AGR3: 0.9019391796129694, mRNA_FOXC1: -0.6623579447958807, mRNA_GATA3: 0.7877727280778012, mRNA_AGR2: 0.0877215860409023, mRNA_XBP1: 0.349249662216994, mRNA_PRR15: -0.0231020592597602, mRNA_SLC44A4: 0.5732073405954565, mRNA_CA12: 1.4047818958628373, mRNA_DTL: 1.4169183060291788, mRNA_C5AR2: 0.9815457783474868, mRNA_TBC1D9: 1.3549090749598522, mRNA_AR: 0.9903995178707582, mRNA_CCDC170: 1.5614927690477445, mRNA_DEGS2: 1.069529555008396, mRNA_TFF3: -0.1331814862757764, mRNA_DNALI1: 0.5090742920489225, mRNA_LINC00504: 0.6763483247016471, mRNA_CLCA2: -0.1844573221162886, mRNA_PPP1R14C: 0.2076451222103078, mRNA_THSD4: 1.5235567372988998, mRNA_SPAG5: 0.0374520723264289, mRNA_FBP1: 0.7864603452972072, mRNA_SLC7A8: 0.3664198525020582, mRNA_EN1: -0.2365248433312927, mRNA_ZNF552: 0.8427860854709047, Methylation_LRRC6: -1.3188840115536815, Methylation_chr2 66218712 LINC02934 (29533): 0.0193980845969029, Methylation_HOXB13: 1.4979834072582334, Methylation_chr10 3949206 LINC02660 (4871): -1.3009848663014807, Methylation_chr5 179517140 RNF130 (18026): 1.1131120219176516, Methylation_LOC727677: -1.0237972967286455, Methylation_LETM1: -1.6929633751621926, Methylation_CDC42BPB: 1.3792989746081026, Methylation_C8orf38: -1.2951849428347426, Methylation_chr14 100504766 EVL (18852): -1.6462946839506798, Methylation_chr5 72594851 LOC340090 (24088): -0.4821587223872201, Methylation_chr2 242904738 LINC01238 (3421): -1.4052848815572858, Methylation_ARFGEF1: -1.2317651365466356, Methylation_MAPT: -1.3983095724294388, Methylation_ZFAT: -1.5991627622633238, Methylation_KCNQ4: 1.1577316845058456, Methylation_chr1 232684368 SIPA1L2 (12934): -1.520332599354044, Methylation_CRNKL1: -1.6267244862896466, Methylation_PRKAG2: -1.1208375966740145, Methylation_MICB: -1.0346380490983196, miRNA_hsa-mir-934: -0.4607591041675176, miRNA_hsa-mir-4728: 1.0337997967809385, miRNA_hsa-mir-5695: -0.2485481504319493, miRNA_hsa-mir-18a: -0.1508513137082909, miRNA_hsa-mir-190b: 2.0064225365851307, miRNA_hsa-mir-577: 0.1487329840540081, miRNA_hsa-mir-135b: -0.3625781567907871, miRNA_hsa-mir-2115: 1.6622220826587113, miRNA_hsa-mir-17: -0.2861941285736966, miRNA_hsa-mir-130b: -0.1683681781030967, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-A2-A0EN,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-significant ranges per specified Z-score and CNV cutoffs.","mRNA_MLPH: 0.353472570255111, mRNA_C2orf54: -0.9450778892068, mRNA_CITED4: 0.0233533721815089, mRNA_ESR1: 0.2414894493976568, mRNA_SPDEF: 0.076994876284451, mRNA_AGR3: 0.223115107030562, mRNA_FOXC1: -0.0860473407731001, mRNA_GATA3: 0.0037140881500682, mRNA_AGR2: 0.7125608628404054, mRNA_XBP1: -0.2228262974382703, mRNA_PRR15: -0.0231407682952978, mRNA_SLC44A4: 0.1411499180252163, mRNA_CA12: -0.0844626385337617, mRNA_DTL: -1.3278738437802662, mRNA_C5AR2: 0.5150245561843337, mRNA_TBC1D9: 0.065388139790969, mRNA_AR: 0.2670483870328737, mRNA_CCDC170: 0.1828035328682759, mRNA_DEGS2: 0.3060974120777042, mRNA_TFF3: 0.512761053396483, mRNA_DNALI1: -0.0216055090767249, mRNA_LINC00504: -0.0494036663254085, mRNA_CLCA2: -0.548582809498085, mRNA_PPP1R14C: -0.6762687480536224, mRNA_THSD4: -0.2865005663415124, mRNA_SPAG5: -1.3660269047948408, mRNA_FBP1: -0.0507315562075181, mRNA_SLC7A8: 0.1090813538362571, mRNA_EN1: -0.1538815927353948, mRNA_ZNF552: 0.0289429002734974, Methylation_LRRC6: 0.7958973038680799, Methylation_chr2 66218712 LINC02934 (29533): 1.2375450847373732, Methylation_HOXB13: 0.4769189264463371, Methylation_chr10 3949206 LINC02660 (4871): 0.0962432905022906, Methylation_chr5 179517140 RNF130 (18026): -0.248342088376079, Methylation_LOC727677: 0.8130420010071238, Methylation_LETM1: 0.1127500199621499, Methylation_CDC42BPB: -0.7973013950067781, Methylation_C8orf38: 0.5027297348202376, Methylation_chr14 100504766 EVL (18852): 0.5375598222174499, Methylation_chr5 72594851 LOC340090 (24088): 0.419259399884119, Methylation_chr2 242904738 LINC01238 (3421): -0.007943099465015, Methylation_ARFGEF1: 1.061974402761649, Methylation_MAPT: 0.8494731957165214, Methylation_ZFAT: 0.696955054898368, Methylation_KCNQ4: -1.1685938259164614, Methylation_chr1 232684368 SIPA1L2 (12934): 0.8657557809145031, Methylation_CRNKL1: 0.7785858388044345, Methylation_PRKAG2: 0.9250364547688354, Methylation_MICB: 0.7573205264042291, miRNA_hsa-mir-934: -0.3795606289070992, miRNA_hsa-mir-4728: -0.2213537988847046, miRNA_hsa-mir-5695: 0.0639134610965777, miRNA_hsa-mir-18a: -0.7183008252987565, miRNA_hsa-mir-190b: 0.090300708447409, miRNA_hsa-mir-577: -0.1604582193607446, miRNA_hsa-mir-135b: -0.2534715366300591, miRNA_hsa-mir-2115: 0.1549173809393816, miRNA_hsa-mir-17: -1.179239102821349, miRNA_hsa-mir-130b: -0.6734638020692449, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-B6-A0I1,"High-level Amplification of EN1 drives significant mRNA overexpression. FOXC1 mRNA upregulation aligns with miRNA-130b and miRNA-577 upregulation. ESR1, GATA3, AGR2, and TFF3 show low mRNA (Z < -1.92). Promoter hypermethylation at ARFGEF1, KCNQ4, and LINC02660; hypomethylation at LINC02934, RNF130, and LOC340090. miRNA-934 is upregulated (Z > 1.99).","mRNA_MLPH: -1.5421752438546688, mRNA_C2orf54: -0.9725201905829736, mRNA_CITED4: 1.0599857023514183, mRNA_ESR1: -2.0788993937735527, mRNA_SPDEF: -1.5682136367460873, mRNA_AGR3: -1.982439424038437, mRNA_FOXC1: 1.7218734794349655, mRNA_GATA3: -2.0557724646915534, mRNA_AGR2: -2.2678466244459194, mRNA_XBP1: -1.7988248421169306, mRNA_PRR15: -2.5999126435776163, mRNA_SLC44A4: -2.371781433906503, mRNA_CA12: -2.141832737579311, mRNA_DTL: 0.1492724606707226, mRNA_C5AR2: -1.4842868708690242, mRNA_TBC1D9: -1.970816635457437, mRNA_AR: -0.9285825355479692, mRNA_CCDC170: -2.024772948015607, mRNA_DEGS2: -1.946369238458424, mRNA_TFF3: -2.1595141987823143, mRNA_DNALI1: -2.113248770668056, mRNA_LINC00504: -1.7170130423956127, mRNA_CLCA2: -0.7802332597808419, mRNA_PPP1R14C: 0.8994084778015553, mRNA_THSD4: -1.6877835944758852, mRNA_SPAG5: 1.275983228410251, mRNA_FBP1: -1.9932545002546145, mRNA_SLC7A8: -2.297296311577905, mRNA_EN1: 2.9153203987518967, mRNA_ZNF552: -1.7685397620050318, Methylation_LRRC6: 1.516680740177632, Methylation_chr2 66218712 LINC02934 (29533): -1.645731488525659, Methylation_HOXB13: 1.2352677411961317, Methylation_chr10 3949206 LINC02660 (4871): 1.6249011026870068, Methylation_chr5 179517140 RNF130 (18026): -1.6125669949522428, Methylation_LOC727677: 1.4863651352996297, Methylation_LETM1: 1.3250488454392169, Methylation_CDC42BPB: 1.3156616289789151, Methylation_C8orf38: 1.1410472827466611, Methylation_chr14 100504766 EVL (18852): 1.4791452320038811, Methylation_chr5 72594851 LOC340090 (24088): -1.6073036695592933, Methylation_chr2 242904738 LINC01238 (3421): 1.4328913967820125, Methylation_ARFGEF1: 1.7838437249664618, Methylation_MAPT: 1.4404501335576343, Methylation_ZFAT: 1.3084630311161531, Methylation_KCNQ4: 1.7933330188674756, Methylation_chr1 232684368 SIPA1L2 (12934): 1.587645734714698, Methylation_CRNKL1: 1.4090210020444418, Methylation_PRKAG2: 0.0461244274682014, Methylation_MICB: 1.4684326699864494, miRNA_hsa-mir-934: 2.0176654795379143, miRNA_hsa-mir-4728: -0.2306210422419957, miRNA_hsa-mir-5695: 0.5017319757809672, miRNA_hsa-mir-18a: 1.591159834880116, miRNA_hsa-mir-190b: -0.661550937215546, miRNA_hsa-mir-577: 1.870606875854408, miRNA_hsa-mir-135b: 0.9074284148752736, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.1781811624564444, miRNA_hsa-mir-130b: 1.869134544516669, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-EW-A1IW,High mRNA_C2orf54 (Z=2.31) indicates overexpression. No methylation or miRNA alterations meet diagnostic thresholds. All CNVs fall within normal range (−1.10 to −0.10). Isolated C2orf54 upregulation suggests limited transcriptional dysregulation without clear genomic or epigenetic drivers.,"mRNA_MLPH: 0.6046376642111773, mRNA_C2orf54: 2.3109736770062987, mRNA_CITED4: 0.4602918658612568, mRNA_ESR1: 0.7673132175524389, mRNA_SPDEF: 0.4032434968758535, mRNA_AGR3: 0.8318231327694939, mRNA_FOXC1: 0.4145818611579341, mRNA_GATA3: 0.719972325884522, mRNA_AGR2: 0.622964466813931, mRNA_XBP1: 0.7393240339746416, mRNA_PRR15: 0.6695214160372945, mRNA_SLC44A4: 0.7658468576575033, mRNA_CA12: 1.0659404343965049, mRNA_DTL: 1.6540195959658464, mRNA_C5AR2: -0.0819493914301531, mRNA_TBC1D9: -0.1591115113042047, mRNA_AR: 0.2412385764582094, mRNA_CCDC170: 1.1452213300159753, mRNA_DEGS2: 0.8993160215696607, mRNA_TFF3: 1.1621361042144616, mRNA_DNALI1: -1.1379228339157532, mRNA_LINC00504: 0.243178313924322, mRNA_CLCA2: -0.255501400779444, mRNA_PPP1R14C: 0.6401551229522796, mRNA_THSD4: 0.8238602516936194, mRNA_SPAG5: 1.3203609938972642, mRNA_FBP1: -0.0522592449690248, mRNA_SLC7A8: 0.7088164945271394, mRNA_EN1: -0.3581598602000164, mRNA_ZNF552: 0.4923974738283071, Methylation_LRRC6: 0.0573958253886007, Methylation_chr2 66218712 LINC02934 (29533): 1.210500882189513, Methylation_HOXB13: 0.8671998280890312, Methylation_chr10 3949206 LINC02660 (4871): -0.3516091802193765, Methylation_chr5 179517140 RNF130 (18026): 0.2990459561690463, Methylation_LOC727677: -0.4774458187050316, Methylation_LETM1: -0.2107805782042463, Methylation_CDC42BPB: 1.0468636354470888, Methylation_C8orf38: 1.4690486130263984, Methylation_chr14 100504766 EVL (18852): -0.2731762859107781, Methylation_chr5 72594851 LOC340090 (24088): 0.5769381190853952, Methylation_chr2 242904738 LINC01238 (3421): -0.4940815628563029, Methylation_ARFGEF1: 0.0061241371507796, Methylation_MAPT: -0.4473882014914393, Methylation_ZFAT: -0.2343231955409215, Methylation_KCNQ4: 0.5222599903792551, Methylation_chr1 232684368 SIPA1L2 (12934): 0.1788492877457999, Methylation_CRNKL1: 0.0453454328734999, Methylation_PRKAG2: 1.2580483226999424, Methylation_MICB: -0.3442769740416378, miRNA_hsa-mir-934: -0.2587250817615742, miRNA_hsa-mir-4728: 1.1381092128122752, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.9246496474686297, miRNA_hsa-mir-190b: 0.5996393310211446, miRNA_hsa-mir-577: 0.2998515869092764, miRNA_hsa-mir-135b: 0.1762868064309338, miRNA_hsa-mir-2115: 0.5261224211242604, miRNA_hsa-mir-17: -0.4824096193197835, miRNA_hsa-mir-130b: 0.114736845454455, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E2-A9RU,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives genomic instability. HOXB13 promoter hypermethylation (Z=1.55) suggests epigenetic silencing. No mRNA or miRNA alterations meet expression thresholds. These features indicate a basal-like phenotype with chromosomal instability.","mRNA_MLPH: -0.0321116689697718, mRNA_C2orf54: -0.0649934756567984, mRNA_CITED4: 1.247475962515669, mRNA_ESR1: -0.0054717855074989, mRNA_SPDEF: 0.4528899716650915, mRNA_AGR3: 0.3197334241206321, mRNA_FOXC1: -1.205074845310059, mRNA_GATA3: 0.1543501205460126, mRNA_AGR2: 0.4550367586722352, mRNA_XBP1: 0.1444519474582462, mRNA_PRR15: 0.5937225050095114, mRNA_SLC44A4: 0.1102171850661099, mRNA_CA12: 0.1993736701855679, mRNA_DTL: -0.0258421810693899, mRNA_C5AR2: -0.0227891369957761, mRNA_TBC1D9: -0.8343148475850765, mRNA_AR: -0.6856960137483031, mRNA_CCDC170: -0.2867820802994842, mRNA_DEGS2: 0.113473381751858, mRNA_TFF3: 0.4541070370201163, mRNA_DNALI1: 0.4498598008623766, mRNA_LINC00504: 0.0441975087325149, mRNA_CLCA2: -0.1101312057271157, mRNA_PPP1R14C: -0.8418397452395892, mRNA_THSD4: -0.7902339094110699, mRNA_SPAG5: 0.5562261027572946, mRNA_FBP1: -1.0490767562511485, mRNA_SLC7A8: -0.6394656940284057, mRNA_EN1: -0.2211780481175875, mRNA_ZNF552: -0.6139859978537227, Methylation_LRRC6: -1.3330793403674863, Methylation_chr2 66218712 LINC02934 (29533): -1.469065362199358, Methylation_HOXB13: 1.5467125334765557, Methylation_chr10 3949206 LINC02660 (4871): -1.1408760085568923, Methylation_chr5 179517140 RNF130 (18026): 0.3965327058188933, Methylation_LOC727677: 1.2609372555449727, Methylation_LETM1: 0.7672071418941937, Methylation_CDC42BPB: 1.4035819732885373, Methylation_C8orf38: -1.6059407938279606, Methylation_chr14 100504766 EVL (18852): -0.941852657740099, Methylation_chr5 72594851 LOC340090 (24088): 0.6657543233863493, Methylation_chr2 242904738 LINC01238 (3421): -1.213403088144683, Methylation_ARFGEF1: -1.1197428886558016, Methylation_MAPT: -1.487192612980023, Methylation_ZFAT: -0.8948696764133255, Methylation_KCNQ4: 1.4728075620047445, Methylation_chr1 232684368 SIPA1L2 (12934): -1.5824955434351171, Methylation_CRNKL1: -1.3749198194156358, Methylation_PRKAG2: 1.2688408478068878, Methylation_MICB: -0.9420427996865806, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.3978993540549788, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.9808724945655192, miRNA_hsa-mir-190b: 0.3220144038653502, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.1240357700046611, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.8977248109308074, miRNA_hsa-mir-130b: 0.6148674137064933, CNV_VPS54: 3.3712233045701687, CNV_LINC01867: 3.403528716117201, CNV_LINC02576: 3.494626341568657, CNV_WDPCP: 3.3913533508092364, CNV_CEP68: 3.494626341568657"
TCGA-A7-A13E,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives oncogenic mRNA overexpression. FOXC1 and EN1 mRNA are significantly elevated (Z > 1.30). Promoter hypermethylation of LRRC6, HOXB13, ARFGEF1, MAPT, and others (Z > 1.50) suggests epigenetic silencing. miR-190b is downregulated (Z < -1.25), while miR-5695, miR-577, miR-135b, and miR-17 are upregulated (Z > 1.99), indicating aggressive luminal B-like phenotype with PI3K/AKT/mTOR dysregulation.","mRNA_MLPH: -2.8638110372785364, mRNA_C2orf54: -1.254663227311663, mRNA_CITED4: 0.152060633487758, mRNA_ESR1: -1.1799798579891738, mRNA_SPDEF: -1.873709577757588, mRNA_AGR3: -1.907351428853036, mRNA_FOXC1: 1.8513036271946368, mRNA_GATA3: -3.829096859231483, mRNA_AGR2: -2.2971027547331104, mRNA_XBP1: -2.0131724814744856, mRNA_PRR15: -2.353907226102365, mRNA_SLC44A4: -1.7360209186123663, mRNA_CA12: -1.857983704602928, mRNA_DTL: -0.0336645481767323, mRNA_C5AR2: -1.571701777896837, mRNA_TBC1D9: -2.2328494836589163, mRNA_AR: -2.225064291557618, mRNA_CCDC170: -1.7117690681230568, mRNA_DEGS2: -1.532385240288884, mRNA_TFF3: -2.183461672577097, mRNA_DNALI1: -1.961117503667845, mRNA_LINC00504: -1.7558974623226091, mRNA_CLCA2: -0.8021454821556352, mRNA_PPP1R14C: 1.502229743527798, mRNA_THSD4: -2.2594440881736544, mRNA_SPAG5: 0.3584648158488698, mRNA_FBP1: -2.7226320382979226, mRNA_SLC7A8: -2.8514965914415726, mRNA_EN1: 1.8945401091142748, mRNA_ZNF552: -1.7330829484916437, Methylation_LRRC6: 1.504728703708003, Methylation_chr2 66218712 LINC02934 (29533): 1.304607512122705, Methylation_HOXB13: 1.427776743048614, Methylation_chr10 3949206 LINC02660 (4871): 1.6700609735775416, Methylation_chr5 179517140 RNF130 (18026): -1.570188380543072, Methylation_LOC727677: 1.552211168663348, Methylation_LETM1: 1.3672736168859545, Methylation_CDC42BPB: 1.357872431810028, Methylation_C8orf38: 1.666018816764991, Methylation_chr14 100504766 EVL (18852): 1.490524910852306, Methylation_chr5 72594851 LOC340090 (24088): -1.5510866011957318, Methylation_chr2 242904738 LINC01238 (3421): 1.3979016192547895, Methylation_ARFGEF1: 1.803306604616934, Methylation_MAPT: 1.5062373273947227, Methylation_ZFAT: 1.445998685430324, Methylation_KCNQ4: 1.6054846388633122, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5593576571146357, Methylation_CRNKL1: 1.3624024944236013, Methylation_PRKAG2: -1.0103758076401812, Methylation_MICB: 1.3038482349713312, miRNA_hsa-mir-934: 1.5623985440700354, miRNA_hsa-mir-4728: 0.1932256293877378, miRNA_hsa-mir-5695: 2.391385958037687, miRNA_hsa-mir-18a: 1.3528486878247514, miRNA_hsa-mir-190b: -2.052137242410604, miRNA_hsa-mir-577: 2.358904668687637, miRNA_hsa-mir-135b: 2.483869889842373, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.889678154364261, miRNA_hsa-mir-130b: 1.1069814758984813, CNV_VPS54: 2.3735003872816955, CNV_LINC01867: 2.395394893874891, CNV_LINC02576: 2.464291317721031, CNV_WDPCP: 2.38809584879993, CNV_CEP68: 2.464291317721031"
TCGA-B6-A401,"High mRNA_CITED4 (Z=1.88) indicates overexpression. No methylation sites meet hyper/hypo thresholds. No miRNA alterations exceed regulatory cutoffs. All CNVs fall within Gain range (0.38–0.40), none reach Amplification. No deletions or high-level amplifications observed.","mRNA_MLPH: 0.2894695968703786, mRNA_C2orf54: -0.6090770098289846, mRNA_CITED4: 1.882500291365889, mRNA_ESR1: 0.2459038598205327, mRNA_SPDEF: 0.4167255352655284, mRNA_AGR3: 0.2999663102291383, mRNA_FOXC1: -0.3670677476294366, mRNA_GATA3: -0.0951951136173844, mRNA_AGR2: 0.8998695200949418, mRNA_XBP1: 0.2850757266090282, mRNA_PRR15: 0.4354632227932742, mRNA_SLC44A4: 0.1622131676081865, mRNA_CA12: 0.2311292996196836, mRNA_DTL: -1.1894912421601864, mRNA_C5AR2: 0.4335816503247547, mRNA_TBC1D9: -0.6740305228657582, mRNA_AR: 0.1450078376648399, mRNA_CCDC170: 0.2697798305999829, mRNA_DEGS2: 0.7643582286444689, mRNA_TFF3: -0.2391909646541875, mRNA_DNALI1: 0.4415675491846574, mRNA_LINC00504: -0.8814106050268495, mRNA_CLCA2: 0.3255350641379786, mRNA_PPP1R14C: -0.2643019388659395, mRNA_THSD4: -0.2981015877940907, mRNA_SPAG5: -0.3998839407855136, mRNA_FBP1: -0.3455332209091843, mRNA_SLC7A8: 0.3306066173632908, mRNA_EN1: -0.3351628145652888, mRNA_ZNF552: 0.39947582865259, Methylation_LRRC6: 0.7917976219199682, Methylation_chr2 66218712 LINC02934 (29533): 0.7746649054180892, Methylation_HOXB13: 0.6249666350643028, Methylation_chr10 3949206 LINC02660 (4871): 0.0565039392477764, Methylation_chr5 179517140 RNF130 (18026): 0.144377145821987, Methylation_LOC727677: 0.8907704272804039, Methylation_LETM1: 1.2818541505084984, Methylation_CDC42BPB: 0.3746613699817127, Methylation_C8orf38: 0.1831441587345139, Methylation_chr14 100504766 EVL (18852): 0.7925464119848639, Methylation_chr5 72594851 LOC340090 (24088): 0.2337008197592872, Methylation_chr2 242904738 LINC01238 (3421): 0.6859949764527786, Methylation_ARFGEF1: 0.7408136423312672, Methylation_MAPT: -0.054098436846845, Methylation_ZFAT: 0.9233642591419184, Methylation_KCNQ4: -1.0365976268411907, Methylation_chr1 232684368 SIPA1L2 (12934): 0.8839359353117227, Methylation_CRNKL1: 0.6505224818192401, Methylation_PRKAG2: 0.9101638557467746, Methylation_MICB: 0.9082492198285326, miRNA_hsa-mir-934: 0.6755498362271093, miRNA_hsa-mir-4728: -0.2855156067948599, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.0321376874668514, miRNA_hsa-mir-190b: -0.1025114984699857, miRNA_hsa-mir-577: -0.5086096977959298, miRNA_hsa-mir-135b: 1.4200293725777886, miRNA_hsa-mir-2115: 0.4433244174734248, miRNA_hsa-mir-17: 0.134102492806091, miRNA_hsa-mir-130b: -0.2184931855655838, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-AC-A8OR,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.4768493359471155, mRNA_C2orf54: -0.8660947977589465, mRNA_CITED4: -0.0219048842005935, mRNA_ESR1: 0.8624395630394918, mRNA_SPDEF: 0.3054829863548324, mRNA_AGR3: 0.6908587864804122, mRNA_FOXC1: -0.8347286273319053, mRNA_GATA3: 0.6862534624116627, mRNA_AGR2: 0.7827672597462034, mRNA_XBP1: 0.8134297041789379, mRNA_PRR15: 1.0105107281594723, mRNA_SLC44A4: 0.7645770382267985, mRNA_CA12: 0.3878031359306519, mRNA_DTL: -1.5106729746640188, mRNA_C5AR2: 0.4484065729543651, mRNA_TBC1D9: 0.6546397401314907, mRNA_AR: 0.3446338914456363, mRNA_CCDC170: 0.9676518437361828, mRNA_DEGS2: 0.5608127225407507, mRNA_TFF3: 0.1017534959477585, mRNA_DNALI1: 0.7785415265080267, mRNA_LINC00504: 0.1537546437269952, mRNA_CLCA2: -0.851248218701269, mRNA_PPP1R14C: -0.6186905764630194, mRNA_THSD4: 0.7444049236981907, mRNA_SPAG5: -1.1403318810947378, mRNA_FBP1: 0.7939225098485266, mRNA_SLC7A8: 1.0967820804087711, mRNA_EN1: -1.0673472418167966, mRNA_ZNF552: 0.4163439919306739, Methylation_LRRC6: -1.2616383450059885, Methylation_chr2 66218712 LINC02934 (29533): -1.5768803199836463, Methylation_HOXB13: -0.9643954534277775, Methylation_chr10 3949206 LINC02660 (4871): 1.5883132676605205, Methylation_chr5 179517140 RNF130 (18026): -1.4247265921092491, Methylation_LOC727677: -1.1333004163227671, Methylation_LETM1: -1.536654071608867, Methylation_CDC42BPB: 1.4121332447885353, Methylation_C8orf38: -1.2554839145218268, Methylation_chr14 100504766 EVL (18852): -1.2288628763762612, Methylation_chr5 72594851 LOC340090 (24088): -0.6172128979130164, Methylation_chr2 242904738 LINC01238 (3421): -1.3168781978351725, Methylation_ARFGEF1: -0.92365985403193, Methylation_MAPT: -1.19430482990795, Methylation_ZFAT: 0.4853525399353742, Methylation_KCNQ4: -1.1166538660297003, Methylation_chr1 232684368 SIPA1L2 (12934): -0.9676319319116422, Methylation_CRNKL1: -0.9611843808097746, Methylation_PRKAG2: -0.2697223636473016, Methylation_MICB: -1.1686419203177034, miRNA_hsa-mir-934: -0.0441149194381105, miRNA_hsa-mir-4728: -0.7572904509676425, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.445035152551535, miRNA_hsa-mir-190b: 0.0686128145596905, miRNA_hsa-mir-577: -0.4143678444423075, miRNA_hsa-mir-135b: 1.127799898523105, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.99205684646532, miRNA_hsa-mir-130b: -0.198298678527156, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A0DH,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.1957468688709411, mRNA_C2orf54: -1.2422330361860552, mRNA_CITED4: 1.1594113131680786, mRNA_ESR1: 0.5008919557488185, mRNA_SPDEF: 0.7468896865880574, mRNA_AGR3: 0.7654038854019449, mRNA_FOXC1: -0.792856127573536, mRNA_GATA3: 0.3773712031117887, mRNA_AGR2: 0.7596877802638435, mRNA_XBP1: 0.0089318950488919, mRNA_PRR15: 0.4619428063577951, mRNA_SLC44A4: 0.775039259838923, mRNA_CA12: 1.027254419234136, mRNA_DTL: 0.2054369451263449, mRNA_C5AR2: 1.2366095302870004, mRNA_TBC1D9: 0.6502427426127879, mRNA_AR: 0.2067619154770112, mRNA_CCDC170: -0.0921547108496848, mRNA_DEGS2: 0.5005915362045062, mRNA_TFF3: 1.0802702742216863, mRNA_DNALI1: 0.94124897240526, mRNA_LINC00504: 0.6878349843740045, mRNA_CLCA2: -0.5055810579188016, mRNA_PPP1R14C: -0.574449869414048, mRNA_THSD4: 0.774393854930446, mRNA_SPAG5: -0.164218689018068, mRNA_FBP1: 0.3502569894305364, mRNA_SLC7A8: 1.013153309511723, mRNA_EN1: -0.976994495909588, mRNA_ZNF552: 0.6966714777994519, Methylation_LRRC6: -1.1178949162280096, Methylation_chr2 66218712 LINC02934 (29533): -0.3467101326035202, Methylation_HOXB13: 1.498765326385782, Methylation_chr10 3949206 LINC02660 (4871): -0.2211328135958999, Methylation_chr5 179517140 RNF130 (18026): 1.1613477442780502, Methylation_LOC727677: 0.6090135216500389, Methylation_LETM1: -1.231425522224446, Methylation_CDC42BPB: 0.1849803995465769, Methylation_C8orf38: -0.669806934917237, Methylation_chr14 100504766 EVL (18852): -0.7333144255262386, Methylation_chr5 72594851 LOC340090 (24088): 0.8918355629561989, Methylation_chr2 242904738 LINC01238 (3421): 1.2512853286279737, Methylation_ARFGEF1: -0.9895310403081884, Methylation_MAPT: -0.6497786048843475, Methylation_ZFAT: 0.9193116046537992, Methylation_KCNQ4: -0.5519258294137195, Methylation_chr1 232684368 SIPA1L2 (12934): -0.1313153313187014, Methylation_CRNKL1: -0.3328637677662892, Methylation_PRKAG2: 0.4282045330806331, Methylation_MICB: -0.1389429098795509, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: 0.9235043652362002, miRNA_hsa-mir-18a: -0.9418505647038442, miRNA_hsa-mir-190b: 1.0688432030928852, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.3327140754391275, miRNA_hsa-mir-2115: 0.0137147440438371, miRNA_hsa-mir-17: -1.969203788019612, miRNA_hsa-mir-130b: -0.8476969289090039, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AN-A0XL,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified Z-score and CNV cutoffs.","mRNA_MLPH: 0.8400712441078821, mRNA_C2orf54: 1.0428971158153617, mRNA_CITED4: -0.4487693974815617, mRNA_ESR1: 0.7302586903229917, mRNA_SPDEF: 0.5281997902190018, mRNA_AGR3: 0.8658834755075725, mRNA_FOXC1: 0.8964499749016726, mRNA_GATA3: 0.0654820257007797, mRNA_AGR2: 1.6914851762397016, mRNA_XBP1: 0.8247508746592981, mRNA_PRR15: 0.7538875791372922, mRNA_SLC44A4: 0.5964974406539326, mRNA_CA12: 0.7492040357890485, mRNA_DTL: 0.5336975962324605, mRNA_C5AR2: -0.0488746716995823, mRNA_TBC1D9: 0.3295556646836357, mRNA_AR: 0.4296269850826799, mRNA_CCDC170: 0.6086549837559052, mRNA_DEGS2: 0.3105881004418416, mRNA_TFF3: 0.5606848539329943, mRNA_DNALI1: 0.393698524445014, mRNA_LINC00504: 0.2449045795811647, mRNA_CLCA2: -0.0587503250662086, mRNA_PPP1R14C: -0.8045318922773684, mRNA_THSD4: 0.74826698592465, mRNA_SPAG5: 0.0161431882291427, mRNA_FBP1: 0.4482533156480095, mRNA_SLC7A8: 0.5275343005819787, mRNA_EN1: -0.1350575948438637, mRNA_ZNF552: 1.3464557507085333, Methylation_LRRC6: -0.8342245777163023, Methylation_chr2 66218712 LINC02934 (29533): -1.1740293966710804, Methylation_HOXB13: -0.9369955723427976, Methylation_chr10 3949206 LINC02660 (4871): -0.0975453887845104, Methylation_chr5 179517140 RNF130 (18026): -1.3613214047609885, Methylation_LOC727677: -0.0054729090950508, Methylation_LETM1: -0.2964484743595488, Methylation_CDC42BPB: -0.5956120102519573, Methylation_C8orf38: -0.8064119892658713, Methylation_chr14 100504766 EVL (18852): 0.0714824099977671, Methylation_chr5 72594851 LOC340090 (24088): -1.452691369422444, Methylation_chr2 242904738 LINC01238 (3421): -0.4484156180904399, Methylation_ARFGEF1: -0.4721012858310244, Methylation_MAPT: -0.4218936805426733, Methylation_ZFAT: -0.5826424011964919, Methylation_KCNQ4: -0.1920096614443227, Methylation_chr1 232684368 SIPA1L2 (12934): 0.1638641411805774, Methylation_CRNKL1: 0.3871617053119637, Methylation_PRKAG2: -0.7334617957176403, Methylation_MICB: 0.3406229985882766, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.2104264916318505, miRNA_hsa-mir-5695: 0.2545941410167229, miRNA_hsa-mir-18a: -0.6010346218057515, miRNA_hsa-mir-190b: 0.2162353557808855, miRNA_hsa-mir-577: -0.5136208332418654, miRNA_hsa-mir-135b: -1.0264546984403753, miRNA_hsa-mir-2115: 0.3132512518420305, miRNA_hsa-mir-17: -1.2549737102113458, miRNA_hsa-mir-130b: -0.7556584327682496, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A1R3,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives genomic instability. RNF130 promoter hypermethylation mediates epigenetic silencing. miR-18a and miR-130b are significantly downregulated. DTL and SPAG5 show marked mRNA downregulation. These features collectively indicate a basal-like phenotype with cell cycle dysregulation.","mRNA_MLPH: 0.5581172850269314, mRNA_C2orf54: 0.5008351527191375, mRNA_CITED4: -0.5571483598617074, mRNA_ESR1: 0.1757533960461164, mRNA_SPDEF: 0.0470159565033204, mRNA_AGR3: 0.9135092325309, mRNA_FOXC1: -0.0234924431684575, mRNA_GATA3: 0.3807802829586692, mRNA_AGR2: 0.8960751168364668, mRNA_XBP1: 0.6231206662547479, mRNA_PRR15: 0.994333478180367, mRNA_SLC44A4: 0.8150633827883109, mRNA_CA12: 0.8781846365570354, mRNA_DTL: -2.8484458020302093, mRNA_C5AR2: 0.3135274966230861, mRNA_TBC1D9: 0.3029733822612993, mRNA_AR: 0.5807580567178718, mRNA_CCDC170: 0.7524410674357604, mRNA_DEGS2: 0.3468857841900143, mRNA_TFF3: 0.1159421389082326, mRNA_DNALI1: 0.2059310678091697, mRNA_LINC00504: 0.029465066893394, mRNA_CLCA2: 0.2902235213842421, mRNA_PPP1R14C: 0.852175007715389, mRNA_THSD4: 0.5089300414057447, mRNA_SPAG5: -2.5019380868823475, mRNA_FBP1: 0.3895396673190624, mRNA_SLC7A8: 0.3074569301525101, mRNA_EN1: -0.4189291082234783, mRNA_ZNF552: -0.0606725629626473, Methylation_LRRC6: -0.3271798562585889, Methylation_chr2 66218712 LINC02934 (29533): 1.2012852509277852, Methylation_HOXB13: -1.0652338171125326, Methylation_chr10 3949206 LINC02660 (4871): -0.8570133776690333, Methylation_chr5 179517140 RNF130 (18026): -1.6404556748123749, Methylation_LOC727677: -0.6346209716885072, Methylation_LETM1: 0.2055613624249771, Methylation_CDC42BPB: -1.25506765626511, Methylation_C8orf38: -1.163170704680412, Methylation_chr14 100504766 EVL (18852): -0.8696308198594835, Methylation_chr5 72594851 LOC340090 (24088): 1.010194109495084, Methylation_chr2 242904738 LINC01238 (3421): -0.8373317898023889, Methylation_ARFGEF1: -0.1904555194471489, Methylation_MAPT: -0.3368560614587164, Methylation_ZFAT: -0.8814429633796548, Methylation_KCNQ4: -0.9220443285180466, Methylation_chr1 232684368 SIPA1L2 (12934): -0.7087622923096271, Methylation_CRNKL1: -0.1199447559469471, Methylation_PRKAG2: -0.7628180253173431, Methylation_MICB: -0.8362561781022202, miRNA_hsa-mir-934: -0.2248422768062331, miRNA_hsa-mir-4728: -0.1282276352808453, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.774325892947355, miRNA_hsa-mir-190b: -0.56385924585791, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.7284295378656391, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.8332077817046657, miRNA_hsa-mir-130b: -1.7542628207835993, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-C8-A275,"High-level Amplification of SPAG5 drives significant mRNA overexpression.  
C2orf54 and CLCA2 show high mRNA expression (Z > 1.30).  
DNALI1, ESR1, C5AR2, and CCDC170 exhibit low mRNA levels (Z < -1.92).  
miR-4728 and miR-2115 are strongly upregulated (Z > 1.99); miR-190b is downregulated (Z < -1.25).  
No methylation or CNV alterations meet diagnostic thresholds.","mRNA_MLPH: 0.2277971247761901, mRNA_C2orf54: 1.734910328397071, mRNA_CITED4: -1.5529398546553894, mRNA_ESR1: -1.6580886307571003, mRNA_SPDEF: 0.3209387180798363, mRNA_AGR3: 0.1207887691166336, mRNA_FOXC1: -0.6899282799105487, mRNA_GATA3: -0.0820966086171059, mRNA_AGR2: 0.6030536189851994, mRNA_XBP1: 0.1658458025937717, mRNA_PRR15: 0.1197049083955183, mRNA_SLC44A4: 0.3854184161639241, mRNA_CA12: 0.3051553054073313, mRNA_DTL: 0.9885508830477444, mRNA_C5AR2: -1.736911630241097, mRNA_TBC1D9: -0.7518109513580411, mRNA_AR: 0.0933754987615045, mRNA_CCDC170: -1.6400139025043312, mRNA_DEGS2: 0.0724400882734176, mRNA_TFF3: 0.5213052802895153, mRNA_DNALI1: -1.986408269601656, mRNA_LINC00504: -0.2472324748836538, mRNA_CLCA2: 1.3768667246119413, mRNA_PPP1R14C: 0.9489219023538104, mRNA_THSD4: -0.5508918978122029, mRNA_SPAG5: 2.6369214738429534, mRNA_FBP1: 0.2623761246837168, mRNA_SLC7A8: -0.987487810737233, mRNA_EN1: -0.6260567575497477, mRNA_ZNF552: -0.3551149946125261, Methylation_LRRC6: 0.1847611852190087, Methylation_chr2 66218712 LINC02934 (29533): -0.0168203736981279, Methylation_HOXB13: 1.3637046170575715, Methylation_chr10 3949206 LINC02660 (4871): 1.4537994950497255, Methylation_chr5 179517140 RNF130 (18026): 0.5088446896131678, Methylation_LOC727677: 0.1670135957037865, Methylation_LETM1: 1.3405563571717534, Methylation_CDC42BPB: -1.2765004429938611, Methylation_C8orf38: -0.4140337377646332, Methylation_chr14 100504766 EVL (18852): 1.457974911235786, Methylation_chr5 72594851 LOC340090 (24088): -0.2972577713948879, Methylation_chr2 242904738 LINC01238 (3421): 1.439705218244445, Methylation_ARFGEF1: -0.7182551969780887, Methylation_MAPT: 1.0982566678845735, Methylation_ZFAT: 0.8417934662492333, Methylation_KCNQ4: 0.6975025198118571, Methylation_chr1 232684368 SIPA1L2 (12934): 0.4902011819758842, Methylation_CRNKL1: 1.35252522847679, Methylation_PRKAG2: -1.0628619985715848, Methylation_MICB: 0.3590729450650162, miRNA_hsa-mir-934: 1.0045936215086768, miRNA_hsa-mir-4728: 4.6688285689241855, miRNA_hsa-mir-5695: 0.1057469223694141, miRNA_hsa-mir-18a: 0.5768321921034809, miRNA_hsa-mir-190b: -1.7323496932524851, miRNA_hsa-mir-577: -0.463117725098878, miRNA_hsa-mir-135b: -0.2484218313348119, miRNA_hsa-mir-2115: 3.458167797274869, miRNA_hsa-mir-17: 0.794042685064064, miRNA_hsa-mir-130b: 0.5392337361071954, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-B6-A0RV,"High-level Amplification absent; no CNV calls meet amplification thresholds.  
miRNA_hsa-mir-5695 upregulated (Z=2.72).  
No mRNA or methylation features exceed diagnostic thresholds.  
Isolated miRNA dysregulation insufficient for subtype classification.","mRNA_MLPH: 0.5794334555491695, mRNA_C2orf54: -0.2882994930119772, mRNA_CITED4: 0.2698868593307634, mRNA_ESR1: 0.9315707421382362, mRNA_SPDEF: 0.797197270186464, mRNA_AGR3: 0.608100192923645, mRNA_FOXC1: 0.2381445934229436, mRNA_GATA3: 0.478787251307534, mRNA_AGR2: 1.3301227332651386, mRNA_XBP1: 1.379143556250802, mRNA_PRR15: 1.249234560073704, mRNA_SLC44A4: 0.7245586503616751, mRNA_CA12: 0.7606215049359025, mRNA_DTL: -0.070158590833034, mRNA_C5AR2: 0.318626108881287, mRNA_TBC1D9: 0.7797030672129124, mRNA_AR: 0.6788843024373005, mRNA_CCDC170: 0.8284281064546859, mRNA_DEGS2: 0.952300913216754, mRNA_TFF3: 0.4123555063965772, mRNA_DNALI1: 0.7765066035277411, mRNA_LINC00504: 0.7072281527546562, mRNA_CLCA2: -0.1195109997034903, mRNA_PPP1R14C: -0.3026303748366374, mRNA_THSD4: 0.6240155123125571, mRNA_SPAG5: 0.8146576938768508, mRNA_FBP1: 0.7714038139404913, mRNA_SLC7A8: 1.343259840644617, mRNA_EN1: -0.5971790607956317, mRNA_ZNF552: 0.8463939586048401, Methylation_LRRC6: 0.6157122454504409, Methylation_chr2 66218712 LINC02934 (29533): 1.2065132924704782, Methylation_HOXB13: 0.2648573878176221, Methylation_chr10 3949206 LINC02660 (4871): -0.0033667954331759, Methylation_chr5 179517140 RNF130 (18026): 0.6330462781469881, Methylation_LOC727677: -0.1073372318147295, Methylation_LETM1: -0.21787042626327, Methylation_CDC42BPB: -0.731516245042723, Methylation_C8orf38: 0.4632493969207125, Methylation_chr14 100504766 EVL (18852): 0.3677889331123474, Methylation_chr5 72594851 LOC340090 (24088): 0.857894700624244, Methylation_chr2 242904738 LINC01238 (3421): 1.366184860012314, Methylation_ARFGEF1: 0.5844714930458581, Methylation_MAPT: 1.0370185602389792, Methylation_ZFAT: 0.4289937203589024, Methylation_KCNQ4: -0.7997265878714949, Methylation_chr1 232684368 SIPA1L2 (12934): 0.6220733908509414, Methylation_CRNKL1: 0.59261493876664, Methylation_PRKAG2: 0.751364245712761, Methylation_MICB: 0.5313120875848071, miRNA_hsa-mir-934: -0.3169045691163005, miRNA_hsa-mir-4728: -0.8904061144823451, miRNA_hsa-mir-5695: 2.7201533036457093, miRNA_hsa-mir-18a: -0.3979674427100915, miRNA_hsa-mir-190b: 0.2193718213805267, miRNA_hsa-mir-577: 0.0786625498592867, miRNA_hsa-mir-135b: 0.1204623634353762, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.6669660879280264, miRNA_hsa-mir-130b: -0.0061745058999757, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A1X7,mRNA_CITED4 is low (Z = -1.936). Methylation_chr10:3949206 is hyper-methylated (Z = 1.507). Methylation_chr1:232684368 is hypo-methylated (Z = -1.487). miRNA_hsa-mir-4728 is downregulated (Z = -1.283). All CNVs are normal (IGNORE). No high-level amplifications or deletions.,"mRNA_MLPH: 0.5470578353969076, mRNA_C2orf54: -1.2943230935752186, mRNA_CITED4: -1.9355090658693888, mRNA_ESR1: 1.012467568526087, mRNA_SPDEF: 0.3604116569280132, mRNA_AGR3: 0.3578750821496786, mRNA_FOXC1: -0.6132486070484677, mRNA_GATA3: 0.3621255998848076, mRNA_AGR2: 0.7137302420097381, mRNA_XBP1: 0.9978091863332276, mRNA_PRR15: 0.7384321642832186, mRNA_SLC44A4: 0.2078110201471151, mRNA_CA12: 0.7115877144891964, mRNA_DTL: 1.3311076572656393, mRNA_C5AR2: 0.3933437275935363, mRNA_TBC1D9: 0.7457759061464521, mRNA_AR: 1.2542384668286872, mRNA_CCDC170: 1.071131536456545, mRNA_DEGS2: -0.6916655434406128, mRNA_TFF3: 0.5626155516212574, mRNA_DNALI1: -1.498658146149386, mRNA_LINC00504: 1.255374973335036, mRNA_CLCA2: -0.5676367695757201, mRNA_PPP1R14C: -1.000978653751317, mRNA_THSD4: 1.0759161220536022, mRNA_SPAG5: -0.198417558166339, mRNA_FBP1: -0.7502910348943572, mRNA_SLC7A8: 1.121643935641509, mRNA_EN1: -0.3971683392261254, mRNA_ZNF552: 0.4885540838449878, Methylation_LRRC6: -0.9811211248374322, Methylation_chr2 66218712 LINC02934 (29533): -1.0537732592828506, Methylation_HOXB13: -1.069697994221029, Methylation_chr10 3949206 LINC02660 (4871): 1.5067942427633134, Methylation_chr5 179517140 RNF130 (18026): -1.191505088067077, Methylation_LOC727677: -0.9765954065186684, Methylation_LETM1: -0.8090143624541969, Methylation_CDC42BPB: -1.397185072980185, Methylation_C8orf38: -0.8784314954742352, Methylation_chr14 100504766 EVL (18852): -0.9255506062496202, Methylation_chr5 72594851 LOC340090 (24088): -0.7151834683911856, Methylation_chr2 242904738 LINC01238 (3421): 0.3834821992860058, Methylation_ARFGEF1: -0.9394633737463618, Methylation_MAPT: -1.035264908383401, Methylation_ZFAT: -0.7405494857907257, Methylation_KCNQ4: 0.5652421942507634, Methylation_chr1 232684368 SIPA1L2 (12934): -1.4870267160697788, Methylation_CRNKL1: -1.1849890634023117, Methylation_PRKAG2: -1.1689867214154914, Methylation_MICB: -1.3804535913245255, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.5158025454123129, miRNA_hsa-mir-190b: 1.302186917050466, miRNA_hsa-mir-577: 1.0803797378190958, miRNA_hsa-mir-135b: -0.3355651413373745, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.110208675261522, miRNA_hsa-mir-130b: 1.0065278587870052, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A22D,"mRNA_CITED4 is downregulated (Z = -1.92).  
miRNA_hsa-mir-4728 is upregulated (Z = 2.15).  
No methylation or CNV alterations meet diagnostic thresholds.  
These features suggest transcriptional repression without clear genomic or epigenetic drivers.","mRNA_MLPH: 0.4045357953556254, mRNA_C2orf54: -0.7459698223398753, mRNA_CITED4: -1.9204072074559384, mRNA_ESR1: 0.1216980184453586, mRNA_SPDEF: 0.4141587520985871, mRNA_AGR3: 0.3593398522107382, mRNA_FOXC1: -0.7487409044933883, mRNA_GATA3: 0.5271818675516178, mRNA_AGR2: 0.3784714355792086, mRNA_XBP1: 0.1133832807987243, mRNA_PRR15: 0.7550937441535936, mRNA_SLC44A4: 0.5803765521610401, mRNA_CA12: -0.7324528476295715, mRNA_DTL: 0.5096060601237178, mRNA_C5AR2: 1.0122848714157413, mRNA_TBC1D9: 0.4630253507364235, mRNA_AR: 0.3089062526371279, mRNA_CCDC170: 0.2209468009534247, mRNA_DEGS2: 0.0262155271197025, mRNA_TFF3: 1.0739789307145682, mRNA_DNALI1: 0.0189219306276401, mRNA_LINC00504: 0.7454018759554605, mRNA_CLCA2: -0.8663140907516576, mRNA_PPP1R14C: -1.0170523582466973, mRNA_THSD4: -0.3149813794803364, mRNA_SPAG5: 1.5301513025230982, mRNA_FBP1: 0.7143621889432071, mRNA_SLC7A8: -0.5858561923042618, mRNA_EN1: -1.0265191753101706, mRNA_ZNF552: 0.1804377006025541, Methylation_LRRC6: -0.3258097301095213, Methylation_chr2 66218712 LINC02934 (29533): 0.6177022309842929, Methylation_HOXB13: -0.9523153980772264, Methylation_chr10 3949206 LINC02660 (4871): -0.1398315320677383, Methylation_chr5 179517140 RNF130 (18026): 0.9008160518343992, Methylation_LOC727677: -0.5839258243259943, Methylation_LETM1: -0.1963431196632546, Methylation_CDC42BPB: 0.9137255042776228, Methylation_C8orf38: -0.036254069901125, Methylation_chr14 100504766 EVL (18852): -0.4845013493303592, Methylation_chr5 72594851 LOC340090 (24088): -0.1422252158694449, Methylation_chr2 242904738 LINC01238 (3421): -0.0699705827093145, Methylation_ARFGEF1: 0.8277178531864294, Methylation_MAPT: -0.1501736727832189, Methylation_ZFAT: 0.6253958991890465, Methylation_KCNQ4: -1.040894386873459, Methylation_chr1 232684368 SIPA1L2 (12934): -0.0634875552659725, Methylation_CRNKL1: 0.3964735552745044, Methylation_PRKAG2: 0.5965824306611972, Methylation_MICB: 0.5640560419455781, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 2.1505721962093967, miRNA_hsa-mir-5695: 0.5485932530499932, miRNA_hsa-mir-18a: -0.0178346269422364, miRNA_hsa-mir-190b: 1.1723672517855483, miRNA_hsa-mir-577: 0.1710261408810012, miRNA_hsa-mir-135b: -0.5236278265896966, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.5417398770732199, miRNA_hsa-mir-130b: 1.1521964443902746, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-EW-A1OZ,"High-level Amplification of SPAG5 drives significant mRNA overexpression.  
miR-4728 is upregulated; miR-190b is downregulated.  
No promoter methylation changes meet hyper/hypo-methylation thresholds.  
These features collectively indicate a proliferative phenotype with cell cycle dysregulation.","mRNA_MLPH: 0.4062585619161061, mRNA_C2orf54: 1.013701380790062, mRNA_CITED4: 0.0265439686136899, mRNA_ESR1: -0.1439069718468957, mRNA_SPDEF: 0.7558997240612935, mRNA_AGR3: 0.1250858588662669, mRNA_FOXC1: -0.871288918514498, mRNA_GATA3: 0.3724556144346344, mRNA_AGR2: 0.2244581871606275, mRNA_XBP1: 0.7161817844568474, mRNA_PRR15: 0.5479478002767835, mRNA_SLC44A4: -1.5595265617511815, mRNA_CA12: -0.232687383758901, mRNA_DTL: 0.4826527226262568, mRNA_C5AR2: 0.1826289271978652, mRNA_TBC1D9: -0.7559650435610079, mRNA_AR: 1.439783823093485, mRNA_CCDC170: 0.2303501449878253, mRNA_DEGS2: 0.5517097720638444, mRNA_TFF3: 0.2119120682275285, mRNA_DNALI1: -0.0920514250381566, mRNA_LINC00504: -0.2635227247756297, mRNA_CLCA2: -0.8437788467607491, mRNA_PPP1R14C: -0.7654710401717272, mRNA_THSD4: -0.4204612664527489, mRNA_SPAG5: 2.564455762971676, mRNA_FBP1: 0.8167981902149686, mRNA_SLC7A8: 1.4699279334088702, mRNA_EN1: -0.2894368879687145, mRNA_ZNF552: -0.8668059002267177, Methylation_LRRC6: -0.7490585754425317, Methylation_chr2 66218712 LINC02934 (29533): 1.400999419344939, Methylation_HOXB13: 0.3344892814270032, Methylation_chr10 3949206 LINC02660 (4871): 0.8481961357020562, Methylation_chr5 179517140 RNF130 (18026): 0.9452535257733076, Methylation_LOC727677: 0.7208626203775841, Methylation_LETM1: -0.0588786748288984, Methylation_CDC42BPB: 0.6981142672932859, Methylation_C8orf38: -1.0090129211340777, Methylation_chr14 100504766 EVL (18852): -0.707398642541907, Methylation_chr5 72594851 LOC340090 (24088): 1.086974332299027, Methylation_chr2 242904738 LINC01238 (3421): 1.1868778239678497, Methylation_ARFGEF1: -1.2185813523162032, Methylation_MAPT: -0.3824374646666927, Methylation_ZFAT: -0.3987298860515199, Methylation_KCNQ4: 1.2211263648440809, Methylation_chr1 232684368 SIPA1L2 (12934): -0.7954777333423725, Methylation_CRNKL1: -1.032400176572284, Methylation_PRKAG2: 0.784893450272842, Methylation_MICB: -1.1420659286576422, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 2.6758445833059, miRNA_hsa-mir-5695: 0.074626421589448, miRNA_hsa-mir-18a: -0.0285657638408596, miRNA_hsa-mir-190b: -1.2924879082761909, miRNA_hsa-mir-577: -0.3977641682111696, miRNA_hsa-mir-135b: -0.7040241451429068, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.1719078622543665, miRNA_hsa-mir-130b: 0.0223502076575165, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-A7-A3J1,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within the defined neutral ranges and are therefore ignored.","mRNA_MLPH: 0.890530023393876, mRNA_C2orf54: -0.485223914409992, mRNA_CITED4: 0.8664129625348201, mRNA_ESR1: 0.6328180969386462, mRNA_SPDEF: 0.251734106827548, mRNA_AGR3: -0.3393267776214996, mRNA_FOXC1: -0.1658948402547619, mRNA_GATA3: 0.9055033152348374, mRNA_AGR2: 0.0794460624603009, mRNA_XBP1: 0.6490605083473485, mRNA_PRR15: 0.6388258299433213, mRNA_SLC44A4: 0.4358441421054738, mRNA_CA12: 0.5734810459806274, mRNA_DTL: -0.763267292794985, mRNA_C5AR2: -0.2272221121475677, mRNA_TBC1D9: 0.8962100241085612, mRNA_AR: 0.8309458762539214, mRNA_CCDC170: 0.7742743202436285, mRNA_DEGS2: 0.5110819281309691, mRNA_TFF3: 0.7745286891945886, mRNA_DNALI1: 0.1032727502679256, mRNA_LINC00504: 0.9458506880683648, mRNA_CLCA2: -0.1360935285740546, mRNA_PPP1R14C: -0.8695018303133489, mRNA_THSD4: 0.4228180013335024, mRNA_SPAG5: -0.4356363952825029, mRNA_FBP1: 0.6218561638735947, mRNA_SLC7A8: 0.7259652968494208, mRNA_EN1: -0.4397600435051067, mRNA_ZNF552: 1.2112724847755902, Methylation_LRRC6: 0.3923009644069324, Methylation_chr2 66218712 LINC02934 (29533): 1.1831617288092835, Methylation_HOXB13: -0.753919099485897, Methylation_chr10 3949206 LINC02660 (4871): 0.7847297680973447, Methylation_chr5 179517140 RNF130 (18026): 0.0749356970939708, Methylation_LOC727677: -0.3438611906849749, Methylation_LETM1: -0.0807111323292245, Methylation_CDC42BPB: 0.4047755034088531, Methylation_C8orf38: -0.1883932582398957, Methylation_chr14 100504766 EVL (18852): 0.6536384807172604, Methylation_chr5 72594851 LOC340090 (24088): 0.772696673363296, Methylation_chr2 242904738 LINC01238 (3421): -0.4457197059417312, Methylation_ARFGEF1: 0.1119987377252766, Methylation_MAPT: -0.3283480643053732, Methylation_ZFAT: -0.1115918237351209, Methylation_KCNQ4: 0.6870862252528382, Methylation_chr1 232684368 SIPA1L2 (12934): -0.5770159227192013, Methylation_CRNKL1: 0.1480341003617998, Methylation_PRKAG2: -0.2272240217623669, Methylation_MICB: -0.5308755917073658, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.6321244381723503, miRNA_hsa-mir-5695: 0.2451267369083089, miRNA_hsa-mir-18a: -0.5694807406873976, miRNA_hsa-mir-190b: 0.1250097781561956, miRNA_hsa-mir-577: -0.5158951190182968, miRNA_hsa-mir-135b: 0.3608153018704987, miRNA_hsa-mir-2115: -0.269273505226353, miRNA_hsa-mir-17: -0.0062216299073753, miRNA_hsa-mir-130b: -1.2372328438350784, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-PL-A8LZ,"High-level Amplification absent; Gain in multiple loci (e.g., VPS54, WDPCP) without corresponding mRNA overexpression. FOXC1 mRNA high (Z=2.28) with no CNV driver. ESR1, SPDEF, AR, and AGR3 mRNAs low (Z < -1.92). RNF130 promoter hypomethylated (Z=-1.60). miR-934 upregulated (Z=2.38); miR-190b downregulated (Z=-1.55).","mRNA_MLPH: -1.810141674335541, mRNA_C2orf54: -0.7915896047648299, mRNA_CITED4: -0.4887678489808281, mRNA_ESR1: -1.8717701707075225, mRNA_SPDEF: -1.9847381378233164, mRNA_AGR3: -1.837173084405081, mRNA_FOXC1: 2.2817170040564667, mRNA_GATA3: -1.006754648279354, mRNA_AGR2: -1.7726384799000638, mRNA_XBP1: -1.3363639869271176, mRNA_PRR15: -1.8506054141708927, mRNA_SLC44A4: -2.232451707926941, mRNA_CA12: -1.8140685261803984, mRNA_DTL: 1.0353169996110692, mRNA_C5AR2: -0.6120789192690879, mRNA_TBC1D9: -1.21634697961947, mRNA_AR: -1.9022732200298549, mRNA_CCDC170: -1.513242293863057, mRNA_DEGS2: -1.9699328055693424, mRNA_TFF3: -1.4472193893666634, mRNA_DNALI1: -1.3823466826014297, mRNA_LINC00504: -1.6412329242117545, mRNA_CLCA2: -0.5567917228778299, mRNA_PPP1R14C: 0.0267413937895785, mRNA_THSD4: -1.7503745150859022, mRNA_SPAG5: 0.6203696839084425, mRNA_FBP1: -1.6073614525456783, mRNA_SLC7A8: -1.445348328759278, mRNA_EN1: 1.4019859380940096, mRNA_ZNF552: -0.5061362993421048, Methylation_LRRC6: 1.347933765137569, Methylation_chr2 66218712 LINC02934 (29533): 0.5697587556345473, Methylation_HOXB13: -1.0384515756387924, Methylation_chr10 3949206 LINC02660 (4871): 1.282141050274113, Methylation_chr5 179517140 RNF130 (18026): -1.5985531093638097, Methylation_LOC727677: 1.489245643377174, Methylation_LETM1: 1.3478436026037055, Methylation_CDC42BPB: 0.2203857171054351, Methylation_C8orf38: 1.465357477919804, Methylation_chr14 100504766 EVL (18852): 1.49573697253685, Methylation_chr5 72594851 LOC340090 (24088): -1.3751115623578662, Methylation_chr2 242904738 LINC01238 (3421): 1.2599447603406675, Methylation_ARFGEF1: 1.449843653196055, Methylation_MAPT: 1.3175443419103483, Methylation_ZFAT: 1.404106417592543, Methylation_KCNQ4: 0.6254911986815428, Methylation_chr1 232684368 SIPA1L2 (12934): 1.4086314249971932, Methylation_CRNKL1: 1.330273236757635, Methylation_PRKAG2: -0.6098648642161659, Methylation_MICB: 1.427207314447409, miRNA_hsa-mir-934: 2.380800767402234, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.715968634811338, miRNA_hsa-mir-190b: -1.5456781828047783, miRNA_hsa-mir-577: 0.0720985274243335, miRNA_hsa-mir-135b: 1.3002726838612362, miRNA_hsa-mir-2115: -0.3609182257418766, miRNA_hsa-mir-17: 0.8964920353416714, miRNA_hsa-mir-130b: 0.7282793556624637, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-A7-A2KD,"No features meet the strict diagnostic thresholds for mRNA (Z > 1.30 or Z < -1.92), methylation (Z > 1.50 or Z < -1.47), miRNA (Z > 1.99 or Z < -1.25), or CNV (deletion, gain, amplification, or high-level amplification). All values fall within non-actionable ranges.","mRNA_MLPH: 0.4763816797911211, mRNA_C2orf54: 1.188036604283931, mRNA_CITED4: 0.8018082062935743, mRNA_ESR1: 0.5944991822688217, mRNA_SPDEF: 0.6433746409367596, mRNA_AGR3: 0.1707294250794619, mRNA_FOXC1: -0.4308299440567379, mRNA_GATA3: 0.3325306176593997, mRNA_AGR2: 0.9932231749378344, mRNA_XBP1: 0.6747421551785853, mRNA_PRR15: 0.548042885666239, mRNA_SLC44A4: 0.1265912106332281, mRNA_CA12: 0.4719121337306343, mRNA_DTL: 0.3565111269840048, mRNA_C5AR2: 0.9575385752253532, mRNA_TBC1D9: 0.3039304425405684, mRNA_AR: 0.4246389350861393, mRNA_CCDC170: 1.483903469071577, mRNA_DEGS2: 0.2372024212067374, mRNA_TFF3: 0.6648792400321946, mRNA_DNALI1: 1.0157609162783745, mRNA_LINC00504: 0.3740300728045947, mRNA_CLCA2: 0.8247081050175799, mRNA_PPP1R14C: -0.3185805766012176, mRNA_THSD4: 0.3051751634919702, mRNA_SPAG5: 0.4867371759804371, mRNA_FBP1: 0.2804204948611439, mRNA_SLC7A8: 1.017848836873309, mRNA_EN1: -0.5580150081597921, mRNA_ZNF552: 1.0848159399556532, Methylation_LRRC6: -1.0292255337509937, Methylation_chr2 66218712 LINC02934 (29533): 0.1675476412239887, Methylation_HOXB13: -1.074249882274671, Methylation_chr10 3949206 LINC02660 (4871): -0.4725933048086064, Methylation_chr5 179517140 RNF130 (18026): 0.9150757684623252, Methylation_LOC727677: -0.9639085803616824, Methylation_LETM1: 0.1696192864983239, Methylation_CDC42BPB: 0.8883024707096232, Methylation_C8orf38: -0.6527823949731848, Methylation_chr14 100504766 EVL (18852): -0.9247305312757668, Methylation_chr5 72594851 LOC340090 (24088): 0.8203060893905519, Methylation_chr2 242904738 LINC01238 (3421): -1.1745734377367971, Methylation_ARFGEF1: -0.7249575171393521, Methylation_MAPT: -0.4590110080308183, Methylation_ZFAT: -1.2892096018065184, Methylation_KCNQ4: 1.0669143035583069, Methylation_chr1 232684368 SIPA1L2 (12934): -0.403206641443607, Methylation_CRNKL1: -0.5340017826744223, Methylation_PRKAG2: -1.236315796446951, Methylation_MICB: -0.6696921679770236, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 1.2793010371691054, miRNA_hsa-mir-5695: -0.0067658223411132, miRNA_hsa-mir-18a: -0.4395300663283046, miRNA_hsa-mir-190b: -0.1225265985382666, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.0724530875515353, miRNA_hsa-mir-2115: -0.3743516082909892, miRNA_hsa-mir-17: 0.550294826073747, miRNA_hsa-mir-130b: 0.2928025851859839, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-LL-A8F5,"High-level Amplification absent; no CNV meets amplification thresholds.  
FOXC1 mRNA overexpression (Z=1.998) exceeds high threshold.  
SPDEF, AGR3, AGR2, PRR15, SLC44A4, AR, TFF3, THSD4, FBP1, SLC7A8, ZNF552 mRNAs are low (Z < -1.92).  
Promoter hypermethylation at chr10:3949206 (Z=1.609), C8orf38 (Z=1.628), chr14:100504766 (Z=1.591), ARFGEF1 (Z=1.516), ZFAT (Z=1.500).  
Hypomethylation at chr5:179517140 (Z=-1.555).  
miR-190b downregulated (Z=-2.052).  
FOXC1-driven basal-like phenotype with ER-pathway suppression.","mRNA_MLPH: -1.902409460436984, mRNA_C2orf54: -1.2385409774508505, mRNA_CITED4: 0.5457804015554452, mRNA_ESR1: -1.5347872341833877, mRNA_SPDEF: -3.097748339132698, mRNA_AGR3: -2.043406941096223, mRNA_FOXC1: 1.997772242907797, mRNA_GATA3: -0.9011677844910936, mRNA_AGR2: -2.189079133046088, mRNA_XBP1: -1.3212010637673923, mRNA_PRR15: -2.30518668086349, mRNA_SLC44A4: -2.429235185177755, mRNA_CA12: -0.7717194164041946, mRNA_DTL: 0.0900892087547974, mRNA_C5AR2: -1.7983098360968874, mRNA_TBC1D9: -2.04715805266526, mRNA_AR: -2.3608132861221813, mRNA_CCDC170: -1.9534709885835075, mRNA_DEGS2: -1.7404338410625773, mRNA_TFF3: -2.1446020937904726, mRNA_DNALI1: -1.94000734499919, mRNA_LINC00504: -1.7397906748754337, mRNA_CLCA2: -0.6388677318053286, mRNA_PPP1R14C: 0.3741162081996479, mRNA_THSD4: -2.2045507768714603, mRNA_SPAG5: -0.221849812957476, mRNA_FBP1: -2.1736982638778217, mRNA_SLC7A8: -2.3909470722423007, mRNA_EN1: 1.328631461680037, mRNA_ZNF552: -2.3888522330431883, Methylation_LRRC6: 1.487551831459438, Methylation_chr2 66218712 LINC02934 (29533): -1.4739432804838002, Methylation_HOXB13: 0.893497496871505, Methylation_chr10 3949206 LINC02660 (4871): 1.608720607525321, Methylation_chr5 179517140 RNF130 (18026): -1.555293619681859, Methylation_LOC727677: 1.414345672558191, Methylation_LETM1: 1.287355926357492, Methylation_CDC42BPB: 1.2967439275049246, Methylation_C8orf38: 1.6280988157544227, Methylation_chr14 100504766 EVL (18852): 1.590724882587758, Methylation_chr5 72594851 LOC340090 (24088): -1.3458701579419747, Methylation_chr2 242904738 LINC01238 (3421): 1.3829074107825523, Methylation_ARFGEF1: 1.516351665239088, Methylation_MAPT: 1.2400837834853724, Methylation_ZFAT: 1.4998195417245803, Methylation_KCNQ4: 1.3144286273239516, Methylation_chr1 232684368 SIPA1L2 (12934): 1.4963048145587656, Methylation_CRNKL1: 1.1313138072076203, Methylation_PRKAG2: -1.0089415863202165, Methylation_MICB: 1.3940875848212069, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.8127252894673757, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.4004954690503435, miRNA_hsa-mir-190b: -2.052137242410604, miRNA_hsa-mir-577: 1.0248329632786286, miRNA_hsa-mir-135b: 0.2863224070620994, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.5744760559613408, miRNA_hsa-mir-130b: 0.7058474776113434, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-LL-A6FQ,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.6270008429416785, mRNA_C2orf54: 0.144430041271193, mRNA_CITED4: 0.8446565927199607, mRNA_ESR1: 0.4466360260703123, mRNA_SPDEF: 0.9447104500568192, mRNA_AGR3: 1.104923269076605, mRNA_FOXC1: -1.02472175132244, mRNA_GATA3: 0.3434451262404487, mRNA_AGR2: 0.635753863550708, mRNA_XBP1: 0.7365192489391414, mRNA_PRR15: 0.4168823328332747, mRNA_SLC44A4: 0.7356553364518403, mRNA_CA12: 0.2897274093009719, mRNA_DTL: -1.386299517188582, mRNA_C5AR2: 0.6934225493707162, mRNA_TBC1D9: 0.4889096267993152, mRNA_AR: 0.5004953894252936, mRNA_CCDC170: -0.8751115144550555, mRNA_DEGS2: 0.9528338928635186, mRNA_TFF3: 1.1115821042564364, mRNA_DNALI1: -0.2161646721625162, mRNA_LINC00504: 0.886075585604448, mRNA_CLCA2: -0.8590552771835487, mRNA_PPP1R14C: -0.4995531567848574, mRNA_THSD4: -0.1408553113159147, mRNA_SPAG5: -0.9083185003718176, mRNA_FBP1: 0.0982794330691294, mRNA_SLC7A8: -0.0134920038558127, mRNA_EN1: -0.3664806985104892, mRNA_ZNF552: -0.0207031742567455, Methylation_LRRC6: -1.245793602477477, Methylation_chr2 66218712 LINC02934 (29533): -0.8090116281751075, Methylation_HOXB13: 1.7110632462928173, Methylation_chr10 3949206 LINC02660 (4871): -1.1984156872894247, Methylation_chr5 179517140 RNF130 (18026): 1.1784507946464002, Methylation_LOC727677: -1.333400503207539, Methylation_LETM1: -1.5683912787794254, Methylation_CDC42BPB: -1.3627363954480578, Methylation_C8orf38: -1.374988100347189, Methylation_chr14 100504766 EVL (18852): -1.5438894441329016, Methylation_chr5 72594851 LOC340090 (24088): 1.339289257464476, Methylation_chr2 242904738 LINC01238 (3421): -1.362786105671581, Methylation_ARFGEF1: -1.081518598883331, Methylation_MAPT: -1.5790350543902023, Methylation_ZFAT: -1.550451914140317, Methylation_KCNQ4: 1.8149715348647224, Methylation_chr1 232684368 SIPA1L2 (12934): -1.2908525324156763, Methylation_CRNKL1: -1.5183842972551285, Methylation_PRKAG2: -0.3233474894099937, Methylation_MICB: -1.1684179970100437, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.0307487267816566, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.6929753557824588, miRNA_hsa-mir-190b: 0.3140633309717155, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.9763209036879938, miRNA_hsa-mir-2115: 0.7323003603654533, miRNA_hsa-mir-17: -0.6572390195310522, miRNA_hsa-mir-130b: -1.241248408288231, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-E9-A1RB,"High-level Amplification absent; no CNVs meet amplification thresholds.  
mRNA_DTL (Z=1.76) exceeds high-expression cutoff (Z>1.30).  
Methylation_chr5 72594851 LOC340090 (Z=-1.52) is hypomethylated (Z<-1.47).  
miRNA_hsa-mir-4728 (Z=-1.28) is downregulated (Z<-1.25).  
No hypermethylation, upregulated miRNAs, or deletions detected.","mRNA_MLPH: -0.5321873196466499, mRNA_C2orf54: -0.732841055379154, mRNA_CITED4: 0.6197606259786633, mRNA_ESR1: 0.2898484539486199, mRNA_SPDEF: -0.6337721426919948, mRNA_AGR3: 0.5554564406839906, mRNA_FOXC1: -0.0313694094334405, mRNA_GATA3: 0.2178274986412716, mRNA_AGR2: 0.2238512457280706, mRNA_XBP1: -0.6568688947229948, mRNA_PRR15: -0.2892423630680589, mRNA_SLC44A4: 0.2249794423801962, mRNA_CA12: 0.93970815425851, mRNA_DTL: 1.7587337110490355, mRNA_C5AR2: -0.0398413748320771, mRNA_TBC1D9: 0.2739865403891522, mRNA_AR: 0.876038190760272, mRNA_CCDC170: 0.0453180274049261, mRNA_DEGS2: -0.5007001334850156, mRNA_TFF3: -0.1914832507073154, mRNA_DNALI1: 0.4275629454626111, mRNA_LINC00504: -0.5738215190030802, mRNA_CLCA2: 0.1826065604712566, mRNA_PPP1R14C: -0.4028617301798155, mRNA_THSD4: -0.1816421617582706, mRNA_SPAG5: 0.5377053994675702, mRNA_FBP1: -1.376676962838764, mRNA_SLC7A8: -1.5278782953070504, mRNA_EN1: -0.5070729848495898, mRNA_ZNF552: 0.0311196882357363, Methylation_LRRC6: -0.6614020941883395, Methylation_chr2 66218712 LINC02934 (29533): -0.9584094058197437, Methylation_HOXB13: -0.4372577910835079, Methylation_chr10 3949206 LINC02660 (4871): -0.8770135403616008, Methylation_chr5 179517140 RNF130 (18026): 0.2096670664451097, Methylation_LOC727677: -0.089638334202752, Methylation_LETM1: 0.6759491216010547, Methylation_CDC42BPB: -1.0926453076053295, Methylation_C8orf38: -1.301727830869651, Methylation_chr14 100504766 EVL (18852): -0.3680919579609628, Methylation_chr5 72594851 LOC340090 (24088): -1.523667668852884, Methylation_chr2 242904738 LINC01238 (3421): -0.6735003668783561, Methylation_ARFGEF1: -0.961075440693128, Methylation_MAPT: -0.3037404151640205, Methylation_ZFAT: -0.8304245001073004, Methylation_KCNQ4: -1.234127544700154, Methylation_chr1 232684368 SIPA1L2 (12934): 0.113095657354253, Methylation_CRNKL1: -0.9093477572576294, Methylation_PRKAG2: -0.3217320433225023, Methylation_MICB: -0.0255275125300447, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.7647585131839622, miRNA_hsa-mir-190b: 0.514050468130781, miRNA_hsa-mir-577: 0.0167133125816408, miRNA_hsa-mir-135b: -0.6691268151204162, miRNA_hsa-mir-2115: 0.4260033715940823, miRNA_hsa-mir-17: 0.1277392954891154, miRNA_hsa-mir-130b: -0.6088675376455376, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-B6-A0RS,"mRNA_ESR1 (Z = -2.02) and mRNA_DNALI1 (Z = -1.87) are significantly downregulated; mRNA_CLCA2 (Z = 2.13) and mRNA_EN1 (Z = 1.50) are highly overexpressed. Methylation_chr10:3949206 (Z = 1.58) and Methylation_RNF130 (Z = -1.64) are hyper- and hypo-methylated, respectively. miRNA_hsa-mir-190b (Z = -1.26) is downregulated. No CNVs meet amplification or deletion thresholds.","mRNA_MLPH: -0.3290691952263569, mRNA_C2orf54: 1.0050731461049545, mRNA_CITED4: 0.2863777550130309, mRNA_ESR1: -2.0215720289190315, mRNA_SPDEF: 0.4314990853981801, mRNA_AGR3: -0.4894105866712728, mRNA_FOXC1: -0.7536169956825953, mRNA_GATA3: -0.3674492608797064, mRNA_AGR2: 0.2194272394338667, mRNA_XBP1: -0.6427915822979436, mRNA_PRR15: -1.0859686487510796, mRNA_SLC44A4: 0.1505020559493442, mRNA_CA12: 0.0539192973922142, mRNA_DTL: 0.2109952104228173, mRNA_C5AR2: -1.4392625652885205, mRNA_TBC1D9: -1.0474138305426626, mRNA_AR: 0.3993154578163032, mRNA_CCDC170: -1.7030910082578548, mRNA_DEGS2: -0.639791763310547, mRNA_TFF3: -0.3853934092732385, mRNA_DNALI1: -1.874039631206278, mRNA_LINC00504: -1.2623926789948243, mRNA_CLCA2: 2.12970053004853, mRNA_PPP1R14C: -0.8943490701580865, mRNA_THSD4: -0.1929182791861199, mRNA_SPAG5: -0.9951216086349728, mRNA_FBP1: -0.968754097342935, mRNA_SLC7A8: -0.9850241427032546, mRNA_EN1: 1.5035357540786751, mRNA_ZNF552: 0.0080665853139286, Methylation_LRRC6: 1.3400990766740022, Methylation_chr2 66218712 LINC02934 (29533): -1.0111016355388804, Methylation_HOXB13: 0.6014430552159792, Methylation_chr10 3949206 LINC02660 (4871): 1.5826768595700489, Methylation_chr5 179517140 RNF130 (18026): -1.635469208747148, Methylation_LOC727677: 1.4720584542491215, Methylation_LETM1: 1.3069681390068195, Methylation_CDC42BPB: -1.1377082953008493, Methylation_C8orf38: -0.7439434891739504, Methylation_chr14 100504766 EVL (18852): 1.3300532141324024, Methylation_chr5 72594851 LOC340090 (24088): -1.456414916242461, Methylation_chr2 242904738 LINC01238 (3421): 1.389667187790888, Methylation_ARFGEF1: -0.870562024793092, Methylation_MAPT: 1.37620070370513, Methylation_ZFAT: 1.2184071503657758, Methylation_KCNQ4: 1.0664796288664733, Methylation_chr1 232684368 SIPA1L2 (12934): 1.093007801335622, Methylation_CRNKL1: 1.3895733637471024, Methylation_PRKAG2: -0.6710292528250408, Methylation_MICB: 0.5003003064808267, miRNA_hsa-mir-934: -0.2393989747503483, miRNA_hsa-mir-4728: 0.3939536018100686, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.9460495174949128, miRNA_hsa-mir-190b: -1.2591876576083898, miRNA_hsa-mir-577: 0.4301955686515876, miRNA_hsa-mir-135b: -0.1064450573381428, miRNA_hsa-mir-2115: 0.276844055347374, miRNA_hsa-mir-17: 0.1248244779344884, miRNA_hsa-mir-130b: 0.7709549610058473, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-B6-A3ZX,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives genomic instability.  
mRNA_MLPH, AGR2, CA12, and FBP1 show significant downregulation (Z < -1.92).  
FOXC1 and EN1 exhibit mRNA overexpression (Z > 1.30).  
Promoter hypermethylation at chr10:3949206, ARFGEF1, C8orf38, and chr14:100504766 (EVL) (Z > 1.50).  
miR-934 and miR-577 upregulated (Z > 1.99); miR-190b downregulated (Z < -1.25).","mRNA_MLPH: -2.2772720848571253, mRNA_C2orf54: -0.2484554374437417, mRNA_CITED4: 0.3015775867900648, mRNA_ESR1: -1.5903730802836973, mRNA_SPDEF: -0.0487840782683176, mRNA_AGR3: -1.9897868901468103, mRNA_FOXC1: 1.3625581804473654, mRNA_GATA3: -1.010748504020314, mRNA_AGR2: -2.4059199868958308, mRNA_XBP1: -1.3867952990954473, mRNA_PRR15: -2.178957292332086, mRNA_SLC44A4: -1.8010389013850154, mRNA_CA12: -2.527576852024951, mRNA_DTL: 0.0093401124973279, mRNA_C5AR2: -1.694951846110587, mRNA_TBC1D9: -1.3163952201421825, mRNA_AR: -0.9027849797089648, mRNA_CCDC170: -1.3255421460895689, mRNA_DEGS2: -2.062773538578781, mRNA_TFF3: -1.5005771909145786, mRNA_DNALI1: -0.1531124519842032, mRNA_LINC00504: -1.7038396534608782, mRNA_CLCA2: -0.8950940779111158, mRNA_PPP1R14C: 1.129765517292731, mRNA_THSD4: -1.8409993279730368, mRNA_SPAG5: 0.8532616399785844, mRNA_FBP1: -2.168839387932372, mRNA_SLC7A8: -2.334527202900543, mRNA_EN1: 1.7217133945748144, mRNA_ZNF552: -1.3651945815470004, Methylation_LRRC6: 1.3777717164567065, Methylation_chr2 66218712 LINC02934 (29533): 1.0687499835720773, Methylation_HOXB13: -0.9714449663867888, Methylation_chr10 3949206 LINC02660 (4871): 1.5974600201903657, Methylation_chr5 179517140 RNF130 (18026): -1.5442878455136848, Methylation_LOC727677: 1.4909194032923985, Methylation_LETM1: 1.320924058868174, Methylation_CDC42BPB: -0.6501725051654943, Methylation_C8orf38: 1.5485342666974824, Methylation_chr14 100504766 EVL (18852): 1.512495302576327, Methylation_chr5 72594851 LOC340090 (24088): -1.3649990066522049, Methylation_chr2 242904738 LINC01238 (3421): 1.3877661827024923, Methylation_ARFGEF1: 1.5977207847270585, Methylation_MAPT: 1.4145516732680072, Methylation_ZFAT: 1.406951421129774, Methylation_KCNQ4: -0.3413314587763658, Methylation_chr1 232684368 SIPA1L2 (12934): 1.4486917045692995, Methylation_CRNKL1: 1.3027449701162874, Methylation_PRKAG2: 0.5412366456229989, Methylation_MICB: 1.2206711794728602, miRNA_hsa-mir-934: 2.815931863519493, miRNA_hsa-mir-4728: -0.9625723587315236, miRNA_hsa-mir-5695: 0.10836695170503, miRNA_hsa-mir-18a: 0.9460935737609776, miRNA_hsa-mir-190b: -2.052137242410604, miRNA_hsa-mir-577: 2.0165075712816423, miRNA_hsa-mir-135b: 0.6655218217778128, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.576971596066962, miRNA_hsa-mir-130b: 0.6383679274979261, CNV_VPS54: 3.3712233045701687, CNV_LINC01867: 2.395394893874891, CNV_LINC02576: 3.494626341568657, CNV_WDPCP: 3.3913533508092364, CNV_CEP68: 3.494626341568657"
TCGA-AR-A1AP,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.5270122833384462, mRNA_C2orf54: -1.088280270196628, mRNA_CITED4: -0.096547121436672, mRNA_ESR1: 0.55063533562715, mRNA_SPDEF: 0.5424493055473649, mRNA_AGR3: 0.6623672578980422, mRNA_FOXC1: -0.7405640877531452, mRNA_GATA3: 0.9833901212618964, mRNA_AGR2: 1.1357877783044914, mRNA_XBP1: 0.3381438298668819, mRNA_PRR15: 0.7284487070228468, mRNA_SLC44A4: 0.4173387726523258, mRNA_CA12: 0.2909603611739545, mRNA_DTL: -0.0547858904973433, mRNA_C5AR2: 0.3228803640689394, mRNA_TBC1D9: 0.1150400831820916, mRNA_AR: 0.4822617269121966, mRNA_CCDC170: 0.4655976920278256, mRNA_DEGS2: 0.4148045988596713, mRNA_TFF3: -1.1042956860782227, mRNA_DNALI1: 0.6951403803282888, mRNA_LINC00504: 0.115363043845913, mRNA_CLCA2: 0.0970426404290596, mRNA_PPP1R14C: -0.1601339326109573, mRNA_THSD4: 0.2997786342689879, mRNA_SPAG5: -0.5463567865931426, mRNA_FBP1: -0.3384908492090255, mRNA_SLC7A8: 0.5832056053206458, mRNA_EN1: -0.6424631917465977, mRNA_ZNF552: 0.5486834559253478, Methylation_LRRC6: -1.294026326880562, Methylation_chr2 66218712 LINC02934 (29533): -1.4883563856364594, Methylation_HOXB13: 1.351258980145205, Methylation_chr10 3949206 LINC02660 (4871): -0.8281197982086111, Methylation_chr5 179517140 RNF130 (18026): 0.9057972294574108, Methylation_LOC727677: 0.9273705051406492, Methylation_LETM1: -0.3121824569259181, Methylation_CDC42BPB: 0.793908156385876, Methylation_C8orf38: -0.8590781713230783, Methylation_chr14 100504766 EVL (18852): -0.498477574691361, Methylation_chr5 72594851 LOC340090 (24088): 1.073263276908057, Methylation_chr2 242904738 LINC01238 (3421): -0.7777925746570011, Methylation_ARFGEF1: -0.9501250082596902, Methylation_MAPT: -0.3362616381496514, Methylation_ZFAT: -0.6493195163198889, Methylation_KCNQ4: 0.0351218527736634, Methylation_chr1 232684368 SIPA1L2 (12934): -0.726714559463181, Methylation_CRNKL1: -1.1418939901904763, Methylation_PRKAG2: -0.0141478844879358, Methylation_MICB: -0.3803122618203196, miRNA_hsa-mir-934: -0.2438520218262551, miRNA_hsa-mir-4728: 0.0408750131281685, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.8845476446686557, miRNA_hsa-mir-190b: -0.2979230325084847, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: 1.1333436175570613, miRNA_hsa-mir-2115: 0.2662541708300945, miRNA_hsa-mir-17: -0.4006633580835782, miRNA_hsa-mir-130b: -0.5813380990600666, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-C8-A3M7,"CLCA2 mRNA overexpression (Z=3.01) indicates strong transcriptional activation.  
miR-2115 is highly upregulated (Z=3.81), while miR-130b is downregulated (Z=-1.73).  
Methylation at chr10:3949206 (Z=1.56) and chr2:242904738 (Z=1.35) meets hypermethylation thresholds.  
No CNVs meet deletion or amplification criteria.  
These features suggest luminal breast cancer subtype with ER-pathway dysregulation.","mRNA_MLPH: 0.5837661011781702, mRNA_C2orf54: 0.5747454452202435, mRNA_CITED4: -0.1923449992895063, mRNA_ESR1: -0.7311632275966028, mRNA_SPDEF: 0.7247324902984087, mRNA_AGR3: 0.7017513327275822, mRNA_FOXC1: 0.8943982509070669, mRNA_GATA3: -0.4077995231579504, mRNA_AGR2: 1.267918360231845, mRNA_XBP1: -0.2890360794014355, mRNA_PRR15: 0.5509388614007344, mRNA_SLC44A4: 0.599403476717209, mRNA_CA12: 0.0871475884052722, mRNA_DTL: 0.1985393586913899, mRNA_C5AR2: -1.282588975849794, mRNA_TBC1D9: -0.2777950305847549, mRNA_AR: -0.1082062426983795, mRNA_CCDC170: -0.2782266084061947, mRNA_DEGS2: 0.385349090795112, mRNA_TFF3: 0.4118660949097993, mRNA_DNALI1: -0.9737399085035332, mRNA_LINC00504: 0.2594432155650409, mRNA_CLCA2: 3.0087212294367767, mRNA_PPP1R14C: -0.3762750583022469, mRNA_THSD4: -0.5196490937251633, mRNA_SPAG5: -1.1285442169779552, mRNA_FBP1: 0.0170587232352338, mRNA_SLC7A8: -0.0802934890571957, mRNA_EN1: -0.406366891465922, mRNA_ZNF552: -0.7319207256474449, Methylation_LRRC6: 1.064424621112478, Methylation_chr2 66218712 LINC02934 (29533): 0.818807727864332, Methylation_HOXB13: -0.7279228345492452, Methylation_chr10 3949206 LINC02660 (4871): 1.5564546731048954, Methylation_chr5 179517140 RNF130 (18026): -1.2427463026781422, Methylation_LOC727677: 1.0045801614637693, Methylation_LETM1: 1.3507628649586003, Methylation_CDC42BPB: -0.663047592788372, Methylation_C8orf38: 0.980952687709288, Methylation_chr14 100504766 EVL (18852): 0.4656114067395838, Methylation_chr5 72594851 LOC340090 (24088): -0.5808727398238237, Methylation_chr2 242904738 LINC01238 (3421): 1.3501737632581476, Methylation_ARFGEF1: 1.042887798151472, Methylation_MAPT: 1.0407869208607077, Methylation_ZFAT: 0.3877894778348282, Methylation_KCNQ4: 0.1316394562670126, Methylation_chr1 232684368 SIPA1L2 (12934): 0.6816861483330666, Methylation_CRNKL1: 0.6622850428247984, Methylation_PRKAG2: -0.2640058217745373, Methylation_MICB: 0.7689636625717922, miRNA_hsa-mir-934: 0.2671051877270037, miRNA_hsa-mir-4728: -0.970061292492172, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.3233346116194561, miRNA_hsa-mir-190b: 0.4092449997440209, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.8556228667965223, miRNA_hsa-mir-2115: 3.81270171694788, miRNA_hsa-mir-17: -0.4464593230900348, miRNA_hsa-mir-130b: -1.7324220021407537, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-EW-A6SC,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.2660571909358409, mRNA_C2orf54: -1.086445380556177, mRNA_CITED4: -0.7564427606392375, mRNA_ESR1: 0.7586588622975594, mRNA_SPDEF: 0.2347069221393043, mRNA_AGR3: 0.7104018664862837, mRNA_FOXC1: -0.0487381249389743, mRNA_GATA3: 0.5212099617319341, mRNA_AGR2: 0.5155617143406289, mRNA_XBP1: -0.2378700976283, mRNA_PRR15: 0.6052759397165365, mRNA_SLC44A4: 0.5134313316150302, mRNA_CA12: 0.7207925049677146, mRNA_DTL: 0.2584033709681458, mRNA_C5AR2: 0.6691533752634719, mRNA_TBC1D9: 1.178916805677921, mRNA_AR: 0.2420305317352261, mRNA_CCDC170: 0.7546527988178461, mRNA_DEGS2: 0.565597383683063, mRNA_TFF3: -0.2524165602050189, mRNA_DNALI1: 0.5560825634220192, mRNA_LINC00504: 0.8709057420255899, mRNA_CLCA2: 0.3962009715018564, mRNA_PPP1R14C: -0.6783474103686559, mRNA_THSD4: 1.10977145627385, mRNA_SPAG5: 0.6657595635277302, mRNA_FBP1: 0.7776146794948108, mRNA_SLC7A8: 0.7251477843216144, mRNA_EN1: -0.1170048006391915, mRNA_ZNF552: 0.0231970912811495, Methylation_LRRC6: -0.4760541807793755, Methylation_chr2 66218712 LINC02934 (29533): -0.7976215869690341, Methylation_HOXB13: -1.014125597736039, Methylation_chr10 3949206 LINC02660 (4871): -0.7104874301288702, Methylation_chr5 179517140 RNF130 (18026): 0.8666871186472872, Methylation_LOC727677: -0.7604316487414052, Methylation_LETM1: -1.0439903924101592, Methylation_CDC42BPB: 0.6535609008000592, Methylation_C8orf38: -0.2904675534548, Methylation_chr14 100504766 EVL (18852): -0.6284408501003199, Methylation_chr5 72594851 LOC340090 (24088): -1.485348490390177, Methylation_chr2 242904738 LINC01238 (3421): -0.760639934000603, Methylation_ARFGEF1: -0.4426746572852949, Methylation_MAPT: -0.7235499310573418, Methylation_ZFAT: -0.4969444061311858, Methylation_KCNQ4: -1.2179935711372103, Methylation_chr1 232684368 SIPA1L2 (12934): -0.706720445560174, Methylation_CRNKL1: -0.5452703679453403, Methylation_PRKAG2: -0.686454449299261, Methylation_MICB: -0.4837318559616007, miRNA_hsa-mir-934: -0.3036040417874168, miRNA_hsa-mir-4728: -0.1303576071516878, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.2791269269649518, miRNA_hsa-mir-190b: 0.6196721646266226, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.1147055520746574, miRNA_hsa-mir-2115: -0.222937276456179, miRNA_hsa-mir-17: 0.1671448177557643, miRNA_hsa-mir-130b: -0.3556609377011935, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A1XK,"High-level Amplification absent; no CNV alterations meet thresholds.  
FOXC1 mRNA overexpression (Z=2.64) and PPP1R14C upregulation (Z=2.31) exceed high-expression cutoff.  
ESR1, AGR2, SLC7A8, and multiple luminal mRNAs show low expression (Z < -1.92).  
Promoter hypermethylation at ARFGEF1, LOC727677, and chr10:3949206 (LINC02660) (Z > 1.50).  
PRKAG2 hypomethylation (Z=-1.92) and RNF130/chr5:72594851 hypo-methylation (Z < -1.47).  
miR-577 and miR-5695 upregulated (Z > 1.99); miR-190b downregulated (Z < -1.25).  
Collectively indicate basal-like phenotype with luminal suppression and PI3K/AKT dysregulation.","mRNA_MLPH: -2.6464780160306707, mRNA_C2orf54: 0.5610171622040269, mRNA_CITED4: 0.8271426112108103, mRNA_ESR1: -2.0182190233145865, mRNA_SPDEF: -2.1957789511016697, mRNA_AGR3: -1.8382241594559576, mRNA_FOXC1: 2.639912283803324, mRNA_GATA3: -1.87808383915875, mRNA_AGR2: -2.363948717090904, mRNA_XBP1: -1.1402618518821794, mRNA_PRR15: -1.464890924139126, mRNA_SLC44A4: -2.389466507862374, mRNA_CA12: -1.3811707578187002, mRNA_DTL: 1.3555466747578144, mRNA_C5AR2: -1.3201384897370485, mRNA_TBC1D9: -1.2827716876733568, mRNA_AR: -1.912353195812216, mRNA_CCDC170: -1.6360107130832229, mRNA_DEGS2: -2.088198441075817, mRNA_TFF3: -2.251979506421676, mRNA_DNALI1: -2.07463151627854, mRNA_LINC00504: -1.6997681142581282, mRNA_CLCA2: -0.0060891760059189, mRNA_PPP1R14C: 2.3133805041699373, mRNA_THSD4: -2.033194840408244, mRNA_SPAG5: 1.300334037202765, mRNA_FBP1: -0.2711717938320413, mRNA_SLC7A8: -2.236392907358497, mRNA_EN1: 2.180467000822903, mRNA_ZNF552: -1.589372878459799, Methylation_LRRC6: 1.5062809059332432, Methylation_chr2 66218712 LINC02934 (29533): 0.0711919299108401, Methylation_HOXB13: 0.5646673505630511, Methylation_chr10 3949206 LINC02660 (4871): 1.615056849422821, Methylation_chr5 179517140 RNF130 (18026): -1.6943177347050824, Methylation_LOC727677: 1.512187956913345, Methylation_LETM1: 1.351545942543105, Methylation_CDC42BPB: 0.207682480793592, Methylation_C8orf38: 1.5588131340256757, Methylation_chr14 100504766 EVL (18852): 1.5271460486112776, Methylation_chr5 72594851 LOC340090 (24088): -1.6243025230435093, Methylation_chr2 242904738 LINC01238 (3421): 1.4053220061440086, Methylation_ARFGEF1: 1.712866801129817, Methylation_MAPT: 1.4438468244989486, Methylation_ZFAT: 1.423561220463509, Methylation_KCNQ4: 0.9263442411245804, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5456257599338896, Methylation_CRNKL1: 1.305063921746059, Methylation_PRKAG2: -1.9173092304452264, Methylation_MICB: 1.4930033828393603, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.2546158451467514, miRNA_hsa-mir-5695: 2.681600391857668, miRNA_hsa-mir-18a: 1.73063084825309, miRNA_hsa-mir-190b: -2.052137242410604, miRNA_hsa-mir-577: 3.198518415290422, miRNA_hsa-mir-135b: 1.0655492551096493, miRNA_hsa-mir-2115: 0.7471123324177452, miRNA_hsa-mir-17: 1.3622849842116465, miRNA_hsa-mir-130b: 1.5846345283269967, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-LD-A66U,High mRNA_CITED4 (Z=2.21) and mRNA_TFF3 (Z=1.40) indicate overexpression. Methylation_KCNQ4 hypo-methylation (Z=-1.18) and Methylation_HOXB13 hypo-methylation (Z=-0.83) fall below significance; only Methylation_PRKAG2 hyper-methylation (Z=1.06) is subthreshold. No miRNA or CNV alterations meet diagnostic thresholds. Insufficient evidence for subtype classification.,"mRNA_MLPH: 0.8451573166775538, mRNA_C2orf54: 0.5135509305454335, mRNA_CITED4: 2.206058539809224, mRNA_ESR1: -0.197779499479494, mRNA_SPDEF: 0.7467754962303416, mRNA_AGR3: 0.6633740143940595, mRNA_FOXC1: -0.5164110173050204, mRNA_GATA3: 0.4004213199575505, mRNA_AGR2: 0.5483088131061401, mRNA_XBP1: 0.5373135020259334, mRNA_PRR15: 0.4772055052072, mRNA_SLC44A4: 0.4789803128947284, mRNA_CA12: 0.3086881122000705, mRNA_DTL: -1.010020853448767, mRNA_C5AR2: 0.6449471555689085, mRNA_TBC1D9: -0.057244403681731, mRNA_AR: -0.0507433414436714, mRNA_CCDC170: -0.2082369212110514, mRNA_DEGS2: 1.209311455996021, mRNA_TFF3: 1.3761761832638528, mRNA_DNALI1: 0.971071745152716, mRNA_LINC00504: -0.4981095861056079, mRNA_CLCA2: -0.7418454086800315, mRNA_PPP1R14C: -0.361520869217008, mRNA_THSD4: -0.1308201395594492, mRNA_SPAG5: -0.995591834834044, mRNA_FBP1: 0.5423356113536952, mRNA_SLC7A8: -0.1031590562122321, mRNA_EN1: -0.2719166078108795, mRNA_ZNF552: 0.980816889354124, Methylation_LRRC6: 0.3614378507107935, Methylation_chr2 66218712 LINC02934 (29533): 0.3131631445305788, Methylation_HOXB13: -0.8321229524685948, Methylation_chr10 3949206 LINC02660 (4871): 0.8860441362203013, Methylation_chr5 179517140 RNF130 (18026): 0.5987807684889489, Methylation_LOC727677: -0.0922115649614225, Methylation_LETM1: -0.1871942886091259, Methylation_CDC42BPB: -0.4610010477921902, Methylation_C8orf38: 0.0602242112035929, Methylation_chr14 100504766 EVL (18852): 0.2934766561791832, Methylation_chr5 72594851 LOC340090 (24088): 0.608298277916377, Methylation_chr2 242904738 LINC01238 (3421): -0.5051253973537042, Methylation_ARFGEF1: 0.5481034250003719, Methylation_MAPT: 0.1737890849994219, Methylation_ZFAT: 0.1070043240033636, Methylation_KCNQ4: -1.1786973165499386, Methylation_chr1 232684368 SIPA1L2 (12934): 0.6403736767234911, Methylation_CRNKL1: 0.4580466840057949, Methylation_PRKAG2: 1.0588455939534591, Methylation_MICB: 0.5540205667508664, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.290868974619513, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.0588607020567788, miRNA_hsa-mir-190b: 0.4874698030492447, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.184024410235015, miRNA_hsa-mir-2115: -0.5058170320600349, miRNA_hsa-mir-17: -0.6650717766195016, miRNA_hsa-mir-130b: -1.3559152530527387, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A1AY,"High-level Amplification absent; no CNV calls meet amplification thresholds.  
FOXC1, DTL, and PPP1R14C mRNA overexpressed (Z > 1.30).  
MLPH, SPDEF, AGR2, XBP1, PRR15, SLC44A4, FBP1, SLC7A8, DEGS2 downregulated (Z < -1.92).  
LINC02934, RNF130, LOC340090 hypo-methylated (Z < -1.47); LRRC6, LINC02660, C8orf38, ARFGEF1 hyper-methylated (Z > 1.50).  
miR-577 upregulated (Z > 1.99); miR-190b downregulated (Z < -1.25).","mRNA_MLPH: -2.547316517193754, mRNA_C2orf54: -0.6762130380215732, mRNA_CITED4: -0.2798458062765128, mRNA_ESR1: -1.3730997419611688, mRNA_SPDEF: -2.113840755713454, mRNA_AGR3: -1.698527279553942, mRNA_FOXC1: 2.3470132241037627, mRNA_GATA3: -1.221993519179514, mRNA_AGR2: -1.7481958808083868, mRNA_XBP1: -2.1588584298684195, mRNA_PRR15: -2.325735040336662, mRNA_SLC44A4: -2.056117703001646, mRNA_CA12: -1.1293696781785394, mRNA_DTL: 2.1764090486998104, mRNA_C5AR2: -1.7279486050883877, mRNA_TBC1D9: -1.7022206272563434, mRNA_AR: -1.461855463633307, mRNA_CCDC170: -1.3483292570979115, mRNA_DEGS2: -2.105835269148794, mRNA_TFF3: -1.790646977493993, mRNA_DNALI1: -1.6706006283788082, mRNA_LINC00504: -1.5050343848880912, mRNA_CLCA2: -0.4669030613026438, mRNA_PPP1R14C: 2.4879729156065893, mRNA_THSD4: -1.624482396227308, mRNA_SPAG5: 1.3824830149265686, mRNA_FBP1: -2.4699426051600897, mRNA_SLC7A8: -2.0803814504774305, mRNA_EN1: 0.7196939123375459, mRNA_ZNF552: -1.2819083305564651, Methylation_LRRC6: 1.5235526242793234, Methylation_chr2 66218712 LINC02934 (29533): -1.7551086434326273, Methylation_HOXB13: 1.2686849852994035, Methylation_chr10 3949206 LINC02660 (4871): 1.6626197657451145, Methylation_chr5 179517140 RNF130 (18026): -1.6636953368509375, Methylation_LOC727677: 1.5312304997872297, Methylation_LETM1: 1.3665816986551274, Methylation_CDC42BPB: 1.132806783887516, Methylation_C8orf38: 1.668225838847196, Methylation_chr14 100504766 EVL (18852): 1.4470970363149454, Methylation_chr5 72594851 LOC340090 (24088): -1.5339343096965072, Methylation_chr2 242904738 LINC01238 (3421): 1.41325138738499, Methylation_ARFGEF1: 1.7765976770778331, Methylation_MAPT: 1.3856711252319984, Methylation_ZFAT: 1.4557425939994555, Methylation_KCNQ4: 1.5286281396560144, Methylation_chr1 232684368 SIPA1L2 (12934): 1.6078967378279947, Methylation_CRNKL1: 1.3754193411296811, Methylation_PRKAG2: 1.1785925325198487, Methylation_MICB: 1.4895869857233368, miRNA_hsa-mir-934: 1.322685481603393, miRNA_hsa-mir-4728: 0.0203952923981155, miRNA_hsa-mir-5695: 0.5577265697157274, miRNA_hsa-mir-18a: 1.5477449421501384, miRNA_hsa-mir-190b: -2.052137242410604, miRNA_hsa-mir-577: 2.287421651698151, miRNA_hsa-mir-135b: 1.9432596966510207, miRNA_hsa-mir-2115: 0.2486370567668996, miRNA_hsa-mir-17: 1.4146494773150589, miRNA_hsa-mir-130b: 1.3092277301370197, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A0AU,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.7773028710432581, mRNA_C2orf54: 0.5828474982211669, mRNA_CITED4: -0.7878895240556191, mRNA_ESR1: 0.5365119501120803, mRNA_SPDEF: 0.4305852166653039, mRNA_AGR3: 0.088248732691087, mRNA_FOXC1: -0.6503816320752979, mRNA_GATA3: 0.4294016082374203, mRNA_AGR2: 0.8152960315311927, mRNA_XBP1: 0.5915535235576624, mRNA_PRR15: -0.0459401147015632, mRNA_SLC44A4: 0.0242610188070482, mRNA_CA12: 0.8503639509081838, mRNA_DTL: 0.5707841188054699, mRNA_C5AR2: -0.6130877536106178, mRNA_TBC1D9: 0.9958458455241466, mRNA_AR: 0.6675896353432551, mRNA_CCDC170: -0.539489351322141, mRNA_DEGS2: 0.1298583230448188, mRNA_TFF3: 0.6926656375778623, mRNA_DNALI1: 0.8913711264080707, mRNA_LINC00504: 0.8338235636979994, mRNA_CLCA2: -0.6574362462847007, mRNA_PPP1R14C: -0.9870630225373948, mRNA_THSD4: 0.6870270755102377, mRNA_SPAG5: 0.8145013056821707, mRNA_FBP1: 0.2179735448559799, mRNA_SLC7A8: 0.5466168396957793, mRNA_EN1: -0.4702265091310184, mRNA_ZNF552: 1.2125620376826134, Methylation_LRRC6: 0.2944248710278119, Methylation_chr2 66218712 LINC02934 (29533): 1.0449597216153346, Methylation_HOXB13: 1.3640037958603233, Methylation_chr10 3949206 LINC02660 (4871): -0.1816976581990551, Methylation_chr5 179517140 RNF130 (18026): 0.7133025879424544, Methylation_LOC727677: -0.410350295955281, Methylation_LETM1: -0.7409436754585144, Methylation_CDC42BPB: 1.1213654518080425, Methylation_C8orf38: -0.3012876519806646, Methylation_chr14 100504766 EVL (18852): 0.3461810996833067, Methylation_chr5 72594851 LOC340090 (24088): -1.114852549170659, Methylation_chr2 242904738 LINC01238 (3421): -0.5227771786990767, Methylation_ARFGEF1: -0.7524095927468999, Methylation_MAPT: -0.4000373785746808, Methylation_ZFAT: -0.937085883743562, Methylation_KCNQ4: -0.5807631941394578, Methylation_chr1 232684368 SIPA1L2 (12934): -0.1604343526357231, Methylation_CRNKL1: 0.1091888199971868, Methylation_PRKAG2: 0.0321482612205473, Methylation_MICB: -0.2935779126127026, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.0277188181871564, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.2259512849286216, miRNA_hsa-mir-190b: 0.8564137190272286, miRNA_hsa-mir-577: -0.1400843054123082, miRNA_hsa-mir-135b: -0.3129907543515149, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.2035559485805202, miRNA_hsa-mir-130b: 0.9198439705100996, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-EW-A1P0,"High mRNA_CITED4 (Z=1.33), mRNA_PRR15 (Z=1.30), mRNA_LINC00504 (Z=1.58), and mRNA_SLC7A8 (Z=1.40) indicate overexpression. Methylation_ZFAT (Z=-1.73) and Methylation_CRNKL1 (Z=-1.56) are hypomethylated. miRNA_hsa-mir-4728 is downregulated (Z=-1.28). No CNVs meet diagnostic thresholds. These features suggest luminal breast cancer with ER-pathway activity.","mRNA_MLPH: 0.5770876725409152, mRNA_C2orf54: 0.1891142501660404, mRNA_CITED4: 1.3281167082484189, mRNA_ESR1: 0.4846181177894551, mRNA_SPDEF: 0.4882769257783642, mRNA_AGR3: 0.8653002314782348, mRNA_FOXC1: -0.92637163664962, mRNA_GATA3: 0.9257765910556388, mRNA_AGR2: -0.4161658161738886, mRNA_XBP1: 0.607737217957843, mRNA_PRR15: 1.3021882231323725, mRNA_SLC44A4: 0.7890604277622718, mRNA_CA12: 0.1342411076062521, mRNA_DTL: 0.1775619901856699, mRNA_C5AR2: 0.7275585063084499, mRNA_TBC1D9: 1.20551953619902, mRNA_AR: -0.4794787764081659, mRNA_CCDC170: -0.0273402436813137, mRNA_DEGS2: 0.2628797895349493, mRNA_TFF3: 0.9804736404651636, mRNA_DNALI1: 0.2191517764782341, mRNA_LINC00504: 1.5809712122762238, mRNA_CLCA2: -0.7832230102344284, mRNA_PPP1R14C: -1.1038880346835973, mRNA_THSD4: -0.46993394221666, mRNA_SPAG5: 0.4158592765224863, mRNA_FBP1: 0.6233464241054858, mRNA_SLC7A8: 1.3987989913134509, mRNA_EN1: -0.506394974914902, mRNA_ZNF552: 0.0607621912754016, Methylation_LRRC6: -1.3919412524876495, Methylation_chr2 66218712 LINC02934 (29533): -1.0599993168671944, Methylation_HOXB13: -1.0305912198190277, Methylation_chr10 3949206 LINC02660 (4871): 0.1401448569962919, Methylation_chr5 179517140 RNF130 (18026): -1.4480550080805146, Methylation_LOC727677: -1.3873014457646224, Methylation_LETM1: -1.1744689293599155, Methylation_CDC42BPB: -0.1420507412769743, Methylation_C8orf38: -1.480894548264825, Methylation_chr14 100504766 EVL (18852): 0.7884654352841415, Methylation_chr5 72594851 LOC340090 (24088): -0.2165601479764118, Methylation_chr2 242904738 LINC01238 (3421): -1.2781795390986537, Methylation_ARFGEF1: -0.6476572036430578, Methylation_MAPT: 1.004165303237499, Methylation_ZFAT: -1.7310257814833714, Methylation_KCNQ4: 1.7356897785159762, Methylation_chr1 232684368 SIPA1L2 (12934): -1.381530774315875, Methylation_CRNKL1: -1.5601234346042965, Methylation_PRKAG2: 0.7527695746238976, Methylation_MICB: -1.2080607877628862, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.2287308934991007, miRNA_hsa-mir-190b: -0.2992347830981445, miRNA_hsa-mir-577: -0.2082152644576833, miRNA_hsa-mir-135b: -0.5961628650299339, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.4048328200327823, miRNA_hsa-mir-130b: 1.4650861346036486, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-XX-A899,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting. All values fall within non-significant ranges per defined criteria.","mRNA_MLPH: 0.597000087350198, mRNA_C2orf54: 0.6052419805200852, mRNA_CITED4: 1.2483118659490835, mRNA_ESR1: -0.1574182834613026, mRNA_SPDEF: 0.2102159632561809, mRNA_AGR3: 0.1222578935147454, mRNA_FOXC1: -0.0203508660085166, mRNA_GATA3: 0.1025674148528325, mRNA_AGR2: 0.3556242149311818, mRNA_XBP1: 0.3370301335310713, mRNA_PRR15: 0.0385496481128257, mRNA_SLC44A4: 0.3895531774467074, mRNA_CA12: 0.4940085142394242, mRNA_DTL: -0.6040187534997461, mRNA_C5AR2: 0.3278559926219721, mRNA_TBC1D9: 0.3332215006936754, mRNA_AR: -0.2631681788000005, mRNA_CCDC170: 0.0662870668360288, mRNA_DEGS2: 0.4867208179713035, mRNA_TFF3: 0.6993189740565094, mRNA_DNALI1: 0.773669040800503, mRNA_LINC00504: 0.6246854503116187, mRNA_CLCA2: -0.3341671575527487, mRNA_PPP1R14C: -0.6827269050476349, mRNA_THSD4: 0.0972198891620913, mRNA_SPAG5: -0.2078284958969777, mRNA_FBP1: -0.226120016577271, mRNA_SLC7A8: -0.0697319470833189, mRNA_EN1: -0.2285363591165544, mRNA_ZNF552: 0.5480168234851669, Methylation_LRRC6: 0.7230047965862249, Methylation_chr2 66218712 LINC02934 (29533): 0.928632368775442, Methylation_HOXB13: 0.5445607764687672, Methylation_chr10 3949206 LINC02660 (4871): 0.1231778230656541, Methylation_chr5 179517140 RNF130 (18026): 0.3146780827078704, Methylation_LOC727677: 0.4522469048037107, Methylation_LETM1: 0.346746638360383, Methylation_CDC42BPB: -0.8549484938461956, Methylation_C8orf38: 0.3148532830929508, Methylation_chr14 100504766 EVL (18852): 0.869814239457299, Methylation_chr5 72594851 LOC340090 (24088): 0.4507868770661177, Methylation_chr2 242904738 LINC01238 (3421): 0.3079625014360916, Methylation_ARFGEF1: 0.8260561369865929, Methylation_MAPT: 0.9879275166946472, Methylation_ZFAT: 0.6079128365972197, Methylation_KCNQ4: -0.8737841002401062, Methylation_chr1 232684368 SIPA1L2 (12934): 0.8107247347891803, Methylation_CRNKL1: 0.7457379596440795, Methylation_PRKAG2: 1.143550148713374, Methylation_MICB: 0.7568810082104614, miRNA_hsa-mir-934: 0.8869587823489375, miRNA_hsa-mir-4728: -1.0557282671690469, miRNA_hsa-mir-5695: -0.439904165347068, miRNA_hsa-mir-18a: -0.4310020213657242, miRNA_hsa-mir-190b: -0.0241438822665111, miRNA_hsa-mir-577: -0.3304964559817246, miRNA_hsa-mir-135b: 0.5801710883373926, miRNA_hsa-mir-2115: 0.3427013339859942, miRNA_hsa-mir-17: 0.6513863696479377, miRNA_hsa-mir-130b: 0.1190184939845385, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A1N5,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.4613890967776876, mRNA_C2orf54: -0.3113050992495627, mRNA_CITED4: 0.129541030598437, mRNA_ESR1: 0.3722066456816324, mRNA_SPDEF: 0.4860948055909867, mRNA_AGR3: 0.5299007740065867, mRNA_FOXC1: -0.5947296860714926, mRNA_GATA3: 0.369161495846405, mRNA_AGR2: 0.2525841626616848, mRNA_XBP1: 0.2201696619408905, mRNA_PRR15: 0.4452706740893805, mRNA_SLC44A4: 0.6568641596406192, mRNA_CA12: 0.6049388945204365, mRNA_DTL: 0.4038109080269176, mRNA_C5AR2: 0.397558254157362, mRNA_TBC1D9: 0.8070632949659065, mRNA_AR: 0.8219499759217681, mRNA_CCDC170: -0.6540707082500469, mRNA_DEGS2: 0.516293691098503, mRNA_TFF3: 0.4721549431894986, mRNA_DNALI1: 0.9835030067466716, mRNA_LINC00504: 0.6754585179615081, mRNA_CLCA2: -0.692286748266082, mRNA_PPP1R14C: -1.0680751461665008, mRNA_THSD4: 0.5809352399188538, mRNA_SPAG5: -0.1773259060396637, mRNA_FBP1: 0.2118591740874857, mRNA_SLC7A8: 0.4853880732391831, mRNA_EN1: 0.0839246923727686, mRNA_ZNF552: 0.3502891622937734, Methylation_LRRC6: -0.1604186289052655, Methylation_chr2 66218712 LINC02934 (29533): -0.9828423620159836, Methylation_HOXB13: -1.0868561429520485, Methylation_chr10 3949206 LINC02660 (4871): 0.0388388642866207, Methylation_chr5 179517140 RNF130 (18026): 0.5094848459057577, Methylation_LOC727677: 0.0568319763844508, Methylation_LETM1: -0.9507887751407114, Methylation_CDC42BPB: 1.2651536759046156, Methylation_C8orf38: -0.1294430287808345, Methylation_chr14 100504766 EVL (18852): -0.3816046100506828, Methylation_chr5 72594851 LOC340090 (24088): 0.5875267758509584, Methylation_chr2 242904738 LINC01238 (3421): -0.8369282883736298, Methylation_ARFGEF1: -0.2640906254131323, Methylation_MAPT: -0.705929241544987, Methylation_ZFAT: -0.2687870646902319, Methylation_KCNQ4: -0.963802921774256, Methylation_chr1 232684368 SIPA1L2 (12934): -0.4241776909548158, Methylation_CRNKL1: -0.1539624356623253, Methylation_PRKAG2: 1.0183936194679586, Methylation_MICB: -0.5493712118687064, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.8489051555684956, miRNA_hsa-mir-5695: 1.9503008639622288, miRNA_hsa-mir-18a: 0.022811657053682, miRNA_hsa-mir-190b: 0.3913089299682823, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.8061512343143946, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.6871029889634455, miRNA_hsa-mir-130b: 0.2505283164722894, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A0DS,High mRNA_CITED4 (Z=1.30) meets overexpression threshold. HOXB13 promoter hypermethylation (Z=1.65) indicates epigenetic silencing. No miRNA or CNV alterations meet diagnostic thresholds. These features suggest luminal breast cancer phenotype with potential HOX pathway dysregulation.,"mRNA_MLPH: 0.2964159871711011, mRNA_C2orf54: 0.1590743089318835, mRNA_CITED4: 1.300388171004535, mRNA_ESR1: 0.3804996210254078, mRNA_SPDEF: 0.3950960112295866, mRNA_AGR3: 0.9932565123123116, mRNA_FOXC1: -0.6989417122239296, mRNA_GATA3: 0.5515414528911515, mRNA_AGR2: 0.2154110668206676, mRNA_XBP1: 0.4053714334839425, mRNA_PRR15: 0.3180717368018262, mRNA_SLC44A4: 0.5969936624792581, mRNA_CA12: 0.307545967156569, mRNA_DTL: -1.4040815830021665, mRNA_C5AR2: -0.8264505811793336, mRNA_TBC1D9: 0.2799666622044151, mRNA_AR: 0.0237322952868247, mRNA_CCDC170: 0.6873892813485836, mRNA_DEGS2: 0.5604187548162471, mRNA_TFF3: -0.2619696523283332, mRNA_DNALI1: 0.2955864443092612, mRNA_LINC00504: 0.2594612625069032, mRNA_CLCA2: -0.7022293242162252, mRNA_PPP1R14C: -0.6382334052878796, mRNA_THSD4: -0.2275290525944487, mRNA_SPAG5: -1.821155308124908, mRNA_FBP1: 0.3863214975881642, mRNA_SLC7A8: 0.8317918335276043, mRNA_EN1: -0.3513705603749302, mRNA_ZNF552: -0.2273729103406632, Methylation_LRRC6: -0.8572839362518374, Methylation_chr2 66218712 LINC02934 (29533): 0.8795939440610347, Methylation_HOXB13: 1.6503417547889707, Methylation_chr10 3949206 LINC02660 (4871): 0.6958310011381187, Methylation_chr5 179517140 RNF130 (18026): 1.0482077058804171, Methylation_LOC727677: 0.7721005864995489, Methylation_LETM1: -0.6524547241168698, Methylation_CDC42BPB: -1.1412985581383512, Methylation_C8orf38: -0.7196520923770183, Methylation_chr14 100504766 EVL (18852): -0.5338435229941959, Methylation_chr5 72594851 LOC340090 (24088): 1.173323611189132, Methylation_chr2 242904738 LINC01238 (3421): 0.146239986678756, Methylation_ARFGEF1: -1.0536793024990907, Methylation_MAPT: -0.1852530813313177, Methylation_ZFAT: -0.966906772125589, Methylation_KCNQ4: 1.2384152686473504, Methylation_chr1 232684368 SIPA1L2 (12934): 0.5090208536887875, Methylation_CRNKL1: -0.1980666679688841, Methylation_PRKAG2: -1.079099957417316, Methylation_MICB: -0.0191180769891634, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.4390112321928353, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.1452959349783673, miRNA_hsa-mir-190b: 0.1058632102420935, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.7503614932144894, miRNA_hsa-mir-2115: 0.8177560874438812, miRNA_hsa-mir-17: -0.8653862323279926, miRNA_hsa-mir-130b: -0.6318923060268912, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-S3-A6ZF,"High-level Amplification of none; no CNV meets ≥1.90 threshold.  
HOXB13 promoter hypermethylation (Z=1.896) mediates epigenetic silencing.  
ZNF552 mRNA overexpressed (Z=1.652).  
No miRNA alterations meet thresholds.  
Collectively indicates luminal phenotype with HOX pathway dysregulation.","mRNA_MLPH: 0.6700992388253184, mRNA_C2orf54: 1.16672602781523, mRNA_CITED4: 0.6619761421831863, mRNA_ESR1: 0.7831090458915492, mRNA_SPDEF: 0.4752114308006172, mRNA_AGR3: 1.0263000615533653, mRNA_FOXC1: -0.7580757688375153, mRNA_GATA3: 0.4356723560660206, mRNA_AGR2: 1.2434199752192356, mRNA_XBP1: 0.3068873308733498, mRNA_PRR15: 0.3449345184371972, mRNA_SLC44A4: 0.8064009046387651, mRNA_CA12: 0.7955157896481085, mRNA_DTL: 0.7723065532257523, mRNA_C5AR2: -0.092260189124706, mRNA_TBC1D9: 0.98460032571948, mRNA_AR: -0.5550881829341563, mRNA_CCDC170: 0.5565620004646138, mRNA_DEGS2: 0.3891236058443619, mRNA_TFF3: 0.3044818728502235, mRNA_DNALI1: 0.439204539683881, mRNA_LINC00504: 0.1260477349776681, mRNA_CLCA2: -0.8312694010590582, mRNA_PPP1R14C: -0.5118405044985928, mRNA_THSD4: 0.2427231773008218, mRNA_SPAG5: 0.8122534321246927, mRNA_FBP1: 0.5311976122426008, mRNA_SLC7A8: -0.1241209332965349, mRNA_EN1: -0.6266773226045526, mRNA_ZNF552: 1.6524194704419537, Methylation_LRRC6: -0.8919079687003882, Methylation_chr2 66218712 LINC02934 (29533): -0.9581237106375052, Methylation_HOXB13: 1.896495852699467, Methylation_chr10 3949206 LINC02660 (4871): -0.9210758795189488, Methylation_chr5 179517140 RNF130 (18026): 0.6336840619275464, Methylation_LOC727677: -1.3905986909805244, Methylation_LETM1: -0.4728020583849709, Methylation_CDC42BPB: 0.5916441153768958, Methylation_C8orf38: -1.04276812362756, Methylation_chr14 100504766 EVL (18852): -0.4174623641720189, Methylation_chr5 72594851 LOC340090 (24088): 1.032434996757653, Methylation_chr2 242904738 LINC01238 (3421): -1.1045636533089227, Methylation_ARFGEF1: -0.9097465598113406, Methylation_MAPT: -1.152918553933266, Methylation_ZFAT: -0.9171248803327814, Methylation_KCNQ4: 0.715329168082121, Methylation_chr1 232684368 SIPA1L2 (12934): -1.1307021900409666, Methylation_CRNKL1: -0.3911281261041801, Methylation_PRKAG2: -0.6570142712703021, Methylation_MICB: -1.0363751460544992, miRNA_hsa-mir-934: -0.2053439745878063, miRNA_hsa-mir-4728: 0.0744858562690761, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.1382532703064242, miRNA_hsa-mir-190b: 0.538313037522331, miRNA_hsa-mir-577: -0.3983796896473136, miRNA_hsa-mir-135b: -0.2963006913112761, miRNA_hsa-mir-2115: 1.2117317903151177, miRNA_hsa-mir-17: -0.2034342545619287, miRNA_hsa-mir-130b: -0.0970630433998944, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-AC-A3EH,"High mRNA_C2orf54 (Z=1.53) indicates overexpression. Methylation_MAPT (Z=-1.48) and Methylation_ARFGEF1 (Z=-1.27) are hypomethylated. miRNA_hsa-mir-2115 is upregulated (Z=3.42). CNVs show gains in VPS54, LINC01867, LINC02576, WDPCP, and CEP68. No deletions or amplifications meet diagnostic thresholds.","mRNA_MLPH: 0.6375022870572026, mRNA_C2orf54: 1.5305545500649032, mRNA_CITED4: 0.8936472779439378, mRNA_ESR1: 0.4136739193609375, mRNA_SPDEF: 0.756933827462227, mRNA_AGR3: 0.6760553342645675, mRNA_FOXC1: -0.556693002346615, mRNA_GATA3: 0.6884170145268685, mRNA_AGR2: 0.1118512275733618, mRNA_XBP1: 0.8897141804132189, mRNA_PRR15: 0.5663201780955657, mRNA_SLC44A4: 1.1153217892263825, mRNA_CA12: 0.927996238493744, mRNA_DTL: -0.0971863515094873, mRNA_C5AR2: 0.6517312670131918, mRNA_TBC1D9: 0.3627002445937318, mRNA_AR: 0.3440026012100776, mRNA_CCDC170: 0.0628286029733874, mRNA_DEGS2: 1.120645142631218, mRNA_TFF3: 0.1006693036184218, mRNA_DNALI1: 0.1962250263863468, mRNA_LINC00504: 0.3734592282306415, mRNA_CLCA2: 0.4160893700595146, mRNA_PPP1R14C: -0.4399163260602243, mRNA_THSD4: 0.448507785976064, mRNA_SPAG5: -0.5893713980294886, mRNA_FBP1: 0.7331539378762015, mRNA_SLC7A8: 0.8373453018106312, mRNA_EN1: -0.6693013388592767, mRNA_ZNF552: 0.3065812980071776, Methylation_LRRC6: -0.981884018947057, Methylation_chr2 66218712 LINC02934 (29533): -1.2108463035582937, Methylation_HOXB13: 1.2441035304252743, Methylation_chr10 3949206 LINC02660 (4871): -1.1436246476569585, Methylation_chr5 179517140 RNF130 (18026): -0.0714518641499375, Methylation_LOC727677: -1.2170451987663624, Methylation_LETM1: -0.0316513139486723, Methylation_CDC42BPB: 0.6061133528536565, Methylation_C8orf38: -1.1745949948895087, Methylation_chr14 100504766 EVL (18852): -0.7411593780129037, Methylation_chr5 72594851 LOC340090 (24088): 1.1556431073698918, Methylation_chr2 242904738 LINC01238 (3421): -1.0676114552781164, Methylation_ARFGEF1: -1.2724769432252123, Methylation_MAPT: -1.4750161242083173, Methylation_ZFAT: -1.321984673790603, Methylation_KCNQ4: 1.4432962768332658, Methylation_chr1 232684368 SIPA1L2 (12934): -1.3873959418654251, Methylation_CRNKL1: -1.395589092824408, Methylation_PRKAG2: -1.2631214007448908, Methylation_MICB: -1.376426224589124, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.734774518439949, miRNA_hsa-mir-5695: 1.3305652678101103, miRNA_hsa-mir-18a: 0.422130118583057, miRNA_hsa-mir-190b: 1.5500403025111538, miRNA_hsa-mir-577: -0.4657645732346407, miRNA_hsa-mir-135b: -0.4224537860158393, miRNA_hsa-mir-2115: 3.417424758037223, miRNA_hsa-mir-17: 0.5043844023451461, miRNA_hsa-mir-130b: 0.683423343409637, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-PL-A8LX,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.824896458617227, mRNA_C2orf54: -1.277726818825436, mRNA_CITED4: -0.9850303550462598, mRNA_ESR1: 1.0233939932733809, mRNA_SPDEF: 1.0335297745066587, mRNA_AGR3: -1.1664693372876886, mRNA_FOXC1: -0.945586475682896, mRNA_GATA3: 1.097421373656652, mRNA_AGR2: -0.0402740540772014, mRNA_XBP1: 0.2937716138083054, mRNA_PRR15: 0.9989642416214862, mRNA_SLC44A4: 0.5215346339310103, mRNA_CA12: -0.6049478782241388, mRNA_DTL: -1.474900480273282, mRNA_C5AR2: 0.3264444739273966, mRNA_TBC1D9: 0.5559335946658159, mRNA_AR: -1.578348102575192, mRNA_CCDC170: 0.5599355285702282, mRNA_DEGS2: 0.0607761130879265, mRNA_TFF3: 0.4692625571663296, mRNA_DNALI1: 0.9059828656245092, mRNA_LINC00504: 0.0769259667169563, mRNA_CLCA2: -0.8848795186002455, mRNA_PPP1R14C: -0.9588481052387736, mRNA_THSD4: 1.390739983894223, mRNA_SPAG5: -1.3624852100368994, mRNA_FBP1: 1.0783530183181818, mRNA_SLC7A8: 0.904036056685027, mRNA_EN1: -0.5362599934789558, mRNA_ZNF552: 0.5747349381436988, Methylation_LRRC6: -0.2149171028958064, Methylation_chr2 66218712 LINC02934 (29533): -0.694289495453259, Methylation_HOXB13: -0.7934565419110685, Methylation_chr10 3949206 LINC02660 (4871): -0.7482821026614129, Methylation_chr5 179517140 RNF130 (18026): -1.0177550466226963, Methylation_LOC727677: -0.8943053726715068, Methylation_LETM1: -0.8235654861733575, Methylation_CDC42BPB: 0.7402203976619584, Methylation_C8orf38: -0.2722663247902641, Methylation_chr14 100504766 EVL (18852): -0.7745601584328998, Methylation_chr5 72594851 LOC340090 (24088): 0.8109037592575672, Methylation_chr2 242904738 LINC01238 (3421): -0.8397317486781734, Methylation_ARFGEF1: -0.568859125348765, Methylation_MAPT: -1.0501415945783783, Methylation_ZFAT: -0.9789573360816916, Methylation_KCNQ4: -1.1922462882650346, Methylation_chr1 232684368 SIPA1L2 (12934): -0.392002697756916, Methylation_CRNKL1: -0.7389506655431641, Methylation_PRKAG2: 1.0120399814413283, Methylation_MICB: -0.3933339592911675, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.8947187748179145, miRNA_hsa-mir-5695: -0.0215278542985679, miRNA_hsa-mir-18a: 0.8330984242494421, miRNA_hsa-mir-190b: 1.2345687992989038, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.0859908773406792, miRNA_hsa-mir-2115: -0.5264019124876396, miRNA_hsa-mir-17: 0.4545185376373671, miRNA_hsa-mir-130b: -0.6583060642828666, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-BH-A0HP,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.2959346618177182, mRNA_C2orf54: 1.2986112808090244, mRNA_CITED4: 0.4870435869465641, mRNA_ESR1: 0.6168584216536452, mRNA_SPDEF: 0.5949902510651243, mRNA_AGR3: 0.5385883879059554, mRNA_FOXC1: 0.2297826958157633, mRNA_GATA3: 0.5133343006561549, mRNA_AGR2: 0.0648404397436181, mRNA_XBP1: 0.6617731560843371, mRNA_PRR15: 0.6542868523139127, mRNA_SLC44A4: 0.8024294810500568, mRNA_CA12: 0.0019236060574171, mRNA_DTL: -0.41444770114123, mRNA_C5AR2: 0.4904869842129583, mRNA_TBC1D9: 0.6238404725519138, mRNA_AR: 1.019688032621462, mRNA_CCDC170: 0.605351636209292, mRNA_DEGS2: 0.4727507720599234, mRNA_TFF3: 0.484066090768402, mRNA_DNALI1: 0.6125275153329863, mRNA_LINC00504: 1.0810711224844554, mRNA_CLCA2: 1.9962566809771, mRNA_PPP1R14C: -0.2664706526288857, mRNA_THSD4: -0.1473086030567835, mRNA_SPAG5: -1.2123708723201354, mRNA_FBP1: 0.3498223159863385, mRNA_SLC7A8: 0.2008386535568642, mRNA_EN1: -0.7374992854835565, mRNA_ZNF552: 0.0487730485889263, Methylation_LRRC6: 0.0423943294139754, Methylation_chr2 66218712 LINC02934 (29533): 1.001142582117856, Methylation_HOXB13: 1.202646013541664, Methylation_chr10 3949206 LINC02660 (4871): -0.2036646506306245, Methylation_chr5 179517140 RNF130 (18026): 0.2696072250905904, Methylation_LOC727677: -0.1796296330053142, Methylation_LETM1: -0.0646356192046979, Methylation_CDC42BPB: -0.5189308632159795, Methylation_C8orf38: -0.1065016995072152, Methylation_chr14 100504766 EVL (18852): 0.3349060566854243, Methylation_chr5 72594851 LOC340090 (24088): 0.929975150602022, Methylation_chr2 242904738 LINC01238 (3421): -0.3642977575824597, Methylation_ARFGEF1: 0.4729184869051621, Methylation_MAPT: 0.8996963505586265, Methylation_ZFAT: -0.125447580922562, Methylation_KCNQ4: -0.6709540176299748, Methylation_chr1 232684368 SIPA1L2 (12934): 0.2815642709891595, Methylation_CRNKL1: 0.6270705860066844, Methylation_PRKAG2: 1.346246816527682, Methylation_MICB: 0.5205079179332154, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.7647865621039177, miRNA_hsa-mir-5695: 0.0196954637333051, miRNA_hsa-mir-18a: -0.5714659127863093, miRNA_hsa-mir-190b: 0.7706960519326858, miRNA_hsa-mir-577: -0.1857987794283531, miRNA_hsa-mir-135b: 0.3946532852460037, miRNA_hsa-mir-2115: 0.973166451115408, miRNA_hsa-mir-17: -1.020198709475515, miRNA_hsa-mir-130b: -1.303703419212592, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A2-A0EU,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.4134928953424012, mRNA_C2orf54: -0.94395958557212, mRNA_CITED4: -0.2435767259219328, mRNA_ESR1: 0.9074103314215934, mRNA_SPDEF: 0.3986502130191253, mRNA_AGR3: 0.8246391974774259, mRNA_FOXC1: -0.4930179483849565, mRNA_GATA3: 0.6532873015216453, mRNA_AGR2: 0.8563225086008807, mRNA_XBP1: 1.2666186745249073, mRNA_PRR15: 0.98323352310937, mRNA_SLC44A4: 0.3766562132002276, mRNA_CA12: 1.1681214252402217, mRNA_DTL: 0.1926982193467593, mRNA_C5AR2: 0.875641081380031, mRNA_TBC1D9: 1.2828028588224774, mRNA_AR: 0.9850458584895048, mRNA_CCDC170: 0.6534964393022495, mRNA_DEGS2: 0.5441125673286451, mRNA_TFF3: -0.8450115605427608, mRNA_DNALI1: 0.7164055715409176, mRNA_LINC00504: 0.8387737942866217, mRNA_CLCA2: 0.3833658709175546, mRNA_PPP1R14C: 0.0497825411698967, mRNA_THSD4: 1.2303791135278632, mRNA_SPAG5: -0.2270035364608285, mRNA_FBP1: 0.728048082426065, mRNA_SLC7A8: 0.872907551228415, mRNA_EN1: -0.2667529979893071, mRNA_ZNF552: 0.9255899664374816, Methylation_LRRC6: -1.2128009064313054, Methylation_chr2 66218712 LINC02934 (29533): 0.9898727072475136, Methylation_HOXB13: -0.9106276230832328, Methylation_chr10 3949206 LINC02660 (4871): -1.1260689861509934, Methylation_chr5 179517140 RNF130 (18026): 1.0454587620779232, Methylation_LOC727677: -1.406034565555066, Methylation_LETM1: -1.4837860678534271, Methylation_CDC42BPB: 1.3834850845947484, Methylation_C8orf38: -1.2318954774942554, Methylation_chr14 100504766 EVL (18852): -0.7925627332748679, Methylation_chr5 72594851 LOC340090 (24088): 1.0382291087372766, Methylation_chr2 242904738 LINC01238 (3421): -1.0816164644745208, Methylation_ARFGEF1: -1.1183234335340304, Methylation_MAPT: -1.020483577397622, Methylation_ZFAT: -1.4270495270266532, Methylation_KCNQ4: 0.3117866685873978, Methylation_chr1 232684368 SIPA1L2 (12934): -1.0534633500781736, Methylation_CRNKL1: -1.4786039720619415, Methylation_PRKAG2: 0.181235139627562, Methylation_MICB: -0.9647721735609608, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.4342643558858344, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -2.2471487129970096, miRNA_hsa-mir-190b: -0.6797618174051412, miRNA_hsa-mir-577: -0.4308761712759891, miRNA_hsa-mir-135b: -0.7475724323837579, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.457228212931005, miRNA_hsa-mir-130b: -1.45497244258603, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-AO-A0JJ,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.5428786306424391, mRNA_C2orf54: -0.7162912201455945, mRNA_CITED4: -0.407735121666147, mRNA_ESR1: 0.7692103187930255, mRNA_SPDEF: 0.0508538623849933, mRNA_AGR3: 0.6902926881406763, mRNA_FOXC1: 0.2267562561792621, mRNA_GATA3: 0.4743398302627465, mRNA_AGR2: 0.8857925769113333, mRNA_XBP1: 0.5804615483398016, mRNA_PRR15: 0.7032076022133309, mRNA_SLC44A4: 0.5501688930091265, mRNA_CA12: 0.4663459961128829, mRNA_DTL: 0.4361103347008927, mRNA_C5AR2: -0.1375146982533489, mRNA_TBC1D9: 0.6778087564054978, mRNA_AR: 0.6839826112001923, mRNA_CCDC170: 1.2179560933100877, mRNA_DEGS2: 0.7027339339815901, mRNA_TFF3: 0.7690860406529823, mRNA_DNALI1: -0.0157117168909283, mRNA_LINC00504: 0.3592764630795286, mRNA_CLCA2: 0.1359542459030367, mRNA_PPP1R14C: -0.675007992548115, mRNA_THSD4: 0.2159494677791413, mRNA_SPAG5: -0.3815982790383349, mRNA_FBP1: 0.8313748420099878, mRNA_SLC7A8: 0.5409907234108694, mRNA_EN1: -0.7609012018310288, mRNA_ZNF552: 0.3618168689103841, Methylation_LRRC6: 0.4456105927254464, Methylation_chr2 66218712 LINC02934 (29533): 1.189647143528443, Methylation_HOXB13: -0.7283154404346528, Methylation_chr10 3949206 LINC02660 (4871): -0.2680393208737161, Methylation_chr5 179517140 RNF130 (18026): 0.658241722174467, Methylation_LOC727677: -0.1946313859002842, Methylation_LETM1: 0.1172993016795236, Methylation_CDC42BPB: 1.0620019661185551, Methylation_C8orf38: 1.2962889282295846, Methylation_chr14 100504766 EVL (18852): 0.0104289022334438, Methylation_chr5 72594851 LOC340090 (24088): 0.997205193284599, Methylation_chr2 242904738 LINC01238 (3421): -0.1477156896213233, Methylation_ARFGEF1: 1.2328125159596866, Methylation_MAPT: 0.4516285052045707, Methylation_ZFAT: 1.424604309109748, Methylation_KCNQ4: -1.11817252993318, Methylation_chr1 232684368 SIPA1L2 (12934): 0.2355816895959152, Methylation_CRNKL1: 0.3483673934042161, Methylation_PRKAG2: 0.0986124588472519, Methylation_MICB: 0.2801178249767944, miRNA_hsa-mir-934: -0.173128103705674, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: 0.8582909329575944, miRNA_hsa-mir-18a: -2.2471487129970096, miRNA_hsa-mir-190b: -0.2427379929201338, miRNA_hsa-mir-577: 0.2311297961135692, miRNA_hsa-mir-135b: -0.7716611596994684, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -2.489386512994478, miRNA_hsa-mir-130b: -1.0466859497851402, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A245,"LINC02934 promoter hypomethylation (Z = -1.56) suggests epigenetic activation.  
miR-18a and miR-17 are downregulated (Z = -1.48, -1.37), potentially de-repressing oncogenic targets.  
No mRNA, CNV, or methylation features meet other diagnostic thresholds.","mRNA_MLPH: 0.6250988486438808, mRNA_C2orf54: -0.5071646406575218, mRNA_CITED4: -1.7445733969442292, mRNA_ESR1: 0.2099956240291801, mRNA_SPDEF: 0.4840998952772142, mRNA_AGR3: 1.0481916216244551, mRNA_FOXC1: -0.6676455356691898, mRNA_GATA3: 0.3850754775516389, mRNA_AGR2: 0.6267015547375079, mRNA_XBP1: 1.2974710772936804, mRNA_PRR15: 0.8782035134748382, mRNA_SLC44A4: 0.6413229309360444, mRNA_CA12: 0.0099207324141181, mRNA_DTL: -0.8649577354744619, mRNA_C5AR2: 0.929300538817483, mRNA_TBC1D9: 1.3603472879491154, mRNA_AR: 0.0412495933029626, mRNA_CCDC170: -0.0592710276958497, mRNA_DEGS2: -0.4525698520148897, mRNA_TFF3: 0.7793710190611234, mRNA_DNALI1: 0.8805972022433365, mRNA_LINC00504: 1.3902515312368722, mRNA_CLCA2: -0.2433674832961548, mRNA_PPP1R14C: -0.6746017385468891, mRNA_THSD4: -0.257234344773596, mRNA_SPAG5: -0.2796325930283979, mRNA_FBP1: 1.3742365854620615, mRNA_SLC7A8: -0.2112347322814624, mRNA_EN1: -0.6974571866333684, mRNA_ZNF552: -0.2311213708253786, Methylation_LRRC6: -0.5528663965737599, Methylation_chr2 66218712 LINC02934 (29533): -1.5599220091913433, Methylation_HOXB13: -1.0780113722580222, Methylation_chr10 3949206 LINC02660 (4871): -0.9860037311695136, Methylation_chr5 179517140 RNF130 (18026): 0.2357409016831133, Methylation_LOC727677: -0.906938975340612, Methylation_LETM1: -0.4965781021780345, Methylation_CDC42BPB: -1.2963101086984732, Methylation_C8orf38: -0.2198940630340025, Methylation_chr14 100504766 EVL (18852): -0.9089723345584706, Methylation_chr5 72594851 LOC340090 (24088): -0.6231102701647255, Methylation_chr2 242904738 LINC01238 (3421): -0.8862092151728503, Methylation_ARFGEF1: -0.6166890487415506, Methylation_MAPT: -0.6781032672584676, Methylation_ZFAT: -0.995684248674232, Methylation_KCNQ4: -0.8204477034464177, Methylation_chr1 232684368 SIPA1L2 (12934): -0.780818596315745, Methylation_CRNKL1: -1.0904200035057867, Methylation_PRKAG2: -1.0470903459769738, Methylation_MICB: -0.8963746965829302, miRNA_hsa-mir-934: -0.4904510323979999, miRNA_hsa-mir-4728: 0.1024931219166382, miRNA_hsa-mir-5695: -0.006411111156553, miRNA_hsa-mir-18a: -1.4765748270737795, miRNA_hsa-mir-190b: -0.1883706453261068, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.8936446236247786, miRNA_hsa-mir-2115: -0.5228754805090063, miRNA_hsa-mir-17: -1.370639224071348, miRNA_hsa-mir-130b: -0.5606989469988353, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-EW-A1PF,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: -0.1795820402616814, mRNA_C2orf54: 0.8972410358477552, mRNA_CITED4: -0.8094442008151973, mRNA_ESR1: 0.8079914795492352, mRNA_SPDEF: 0.6957440410329235, mRNA_AGR3: 0.6810128062154764, mRNA_FOXC1: -0.0256566643689827, mRNA_GATA3: 0.0163394884625392, mRNA_AGR2: -0.4672065766673475, mRNA_XBP1: 0.1409655297319348, mRNA_PRR15: 0.0258976185662868, mRNA_SLC44A4: 0.7941668430568796, mRNA_CA12: 0.7120899132658273, mRNA_DTL: -0.6936557094841564, mRNA_C5AR2: 0.1948076646192549, mRNA_TBC1D9: 1.1642034602737723, mRNA_AR: 0.941579589868908, mRNA_CCDC170: -0.1162999578324429, mRNA_DEGS2: -0.0170680379763615, mRNA_TFF3: -0.1619331622885361, mRNA_DNALI1: -1.3008038163010291, mRNA_LINC00504: 0.9676351465867936, mRNA_CLCA2: -0.4685604729269671, mRNA_PPP1R14C: -0.1953162887736282, mRNA_THSD4: 1.047735786497601, mRNA_SPAG5: -0.7783977702810336, mRNA_FBP1: 0.7113790355785147, mRNA_SLC7A8: 0.1701316681111077, mRNA_EN1: -0.1045229233992958, mRNA_ZNF552: 1.11207756857817, Methylation_LRRC6: 0.0873135486418065, Methylation_chr2 66218712 LINC02934 (29533): -0.0611744934805967, Methylation_HOXB13: -0.1571479626315806, Methylation_chr10 3949206 LINC02660 (4871): -0.0797666161569366, Methylation_chr5 179517140 RNF130 (18026): 0.0264593222185996, Methylation_LOC727677: -0.0576415382847192, Methylation_LETM1: -0.2176777347486516, Methylation_CDC42BPB: 0.6516963538345615, Methylation_C8orf38: 0.0369414750009915, Methylation_chr14 100504766 EVL (18852): 0.8745820124252807, Methylation_chr5 72594851 LOC340090 (24088): 0.2351067721653672, Methylation_chr2 242904738 LINC01238 (3421): 0.1761673742256564, Methylation_ARFGEF1: 0.4927627735565277, Methylation_MAPT: -0.1800601497746652, Methylation_ZFAT: -0.3368369613825954, Methylation_KCNQ4: -1.0185058228100126, Methylation_chr1 232684368 SIPA1L2 (12934): 1.1391651820591413, Methylation_CRNKL1: 0.7972167584676072, Methylation_PRKAG2: 0.976477268574606, Methylation_MICB: 0.6787733970762715, miRNA_hsa-mir-934: -0.0147629203773621, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.9132790906626538, miRNA_hsa-mir-190b: 0.0083535566310347, miRNA_hsa-mir-577: 0.8364269485326354, miRNA_hsa-mir-135b: 0.0941348143815163, miRNA_hsa-mir-2115: -0.1441744844596305, miRNA_hsa-mir-17: -1.2207173512586234, miRNA_hsa-mir-130b: -0.6835624666322933, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AQ-A1H3,"No features meet the strict diagnostic thresholds for mRNA (Z > 1.30 or Z < -1.92), methylation (Z > 1.50 or Z < -1.47), miRNA (Z > 1.99 or Z < -1.25), or CNV (deletion, gain, amplification, or high-level amplification). All values fall within non-actionable ranges.","mRNA_MLPH: 0.2635832718512468, mRNA_C2orf54: -0.1486924869071881, mRNA_CITED4: 0.421338369260361, mRNA_ESR1: 0.7616067068793251, mRNA_SPDEF: 0.3098117442244824, mRNA_AGR3: 0.7096514544752918, mRNA_FOXC1: 0.202746516473663, mRNA_GATA3: 0.909522188037274, mRNA_AGR2: 0.3038195424171143, mRNA_XBP1: 0.439687924884878, mRNA_PRR15: 0.6052956079696852, mRNA_SLC44A4: 0.8177569101730334, mRNA_CA12: 1.0721704892372477, mRNA_DTL: 0.7617985023125673, mRNA_C5AR2: 0.3468994760424838, mRNA_TBC1D9: 1.109995238661088, mRNA_AR: 0.5831104030972224, mRNA_CCDC170: 1.2545265006932662, mRNA_DEGS2: 0.4815177700572605, mRNA_TFF3: 0.5144912753988684, mRNA_DNALI1: 0.8538849191019239, mRNA_LINC00504: 1.292811776348151, mRNA_CLCA2: -0.0148604479595205, mRNA_PPP1R14C: -0.2086130583456462, mRNA_THSD4: 0.8217114467263794, mRNA_SPAG5: 0.2790542135842285, mRNA_FBP1: -0.3214320664651493, mRNA_SLC7A8: 0.8446642481637414, mRNA_EN1: -0.3854589527875789, mRNA_ZNF552: 0.5082290737412672, Methylation_LRRC6: -0.4394533631272565, Methylation_chr2 66218712 LINC02934 (29533): 1.266042634853494, Methylation_HOXB13: 0.1951960355006632, Methylation_chr10 3949206 LINC02660 (4871): 0.7000494811939042, Methylation_chr5 179517140 RNF130 (18026): 0.4540010592294604, Methylation_LOC727677: -0.0160051419893501, Methylation_LETM1: -0.3377157260897759, Methylation_CDC42BPB: -0.2782553664455153, Methylation_C8orf38: 1.2260520878376835, Methylation_chr14 100504766 EVL (18852): -0.1120650404285409, Methylation_chr5 72594851 LOC340090 (24088): 0.657507436553355, Methylation_chr2 242904738 LINC01238 (3421): -0.8101238565875672, Methylation_ARFGEF1: -0.3467681851162166, Methylation_MAPT: -0.6766132824317523, Methylation_ZFAT: 0.8059237087851733, Methylation_KCNQ4: -0.1600084616925302, Methylation_chr1 232684368 SIPA1L2 (12934): -0.5096723920700224, Methylation_CRNKL1: 0.0158747146848776, Methylation_PRKAG2: 0.9604370020109032, Methylation_MICB: 1.2051588878359476, miRNA_hsa-mir-934: -0.3230286620276623, miRNA_hsa-mir-4728: -0.6112636960254798, miRNA_hsa-mir-5695: 0.6978827425929854, miRNA_hsa-mir-18a: -0.7575812882169531, miRNA_hsa-mir-190b: 0.3758727669488434, miRNA_hsa-mir-577: -0.3187769178751579, miRNA_hsa-mir-135b: 1.4579572118334847, miRNA_hsa-mir-2115: -0.4543067486951593, miRNA_hsa-mir-17: -0.6667332830047374, miRNA_hsa-mir-130b: -0.1080497148833664, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AO-A125,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 1.1444154101735071, mRNA_C2orf54: -1.230650642240724, mRNA_CITED4: 1.1504761573622524, mRNA_ESR1: 1.0401774969745772, mRNA_SPDEF: 0.5154610222466761, mRNA_AGR3: 1.1307242414368273, mRNA_FOXC1: -1.310724830261496, mRNA_GATA3: 0.6292396836989651, mRNA_AGR2: 0.999716345840534, mRNA_XBP1: 0.9287501340756796, mRNA_PRR15: 0.3547359873821113, mRNA_SLC44A4: 0.3670243770718366, mRNA_CA12: 0.4996863159031137, mRNA_DTL: -0.6580294289135148, mRNA_C5AR2: 0.8988066281518413, mRNA_TBC1D9: -0.2394036489989537, mRNA_AR: 0.1811170746604941, mRNA_CCDC170: 1.5779538528690595, mRNA_DEGS2: 1.2120822706954666, mRNA_TFF3: 1.2987854620649388, mRNA_DNALI1: 1.045799864628588, mRNA_LINC00504: 0.882365432154911, mRNA_CLCA2: -0.8254626473469207, mRNA_PPP1R14C: -1.0430582596172897, mRNA_THSD4: 0.428192428470672, mRNA_SPAG5: -0.5619054915356131, mRNA_FBP1: 0.3863695744544033, mRNA_SLC7A8: 0.7589397396564708, mRNA_EN1: -1.1147811090584978, mRNA_ZNF552: 0.9115123445585186, Methylation_LRRC6: -1.50084033903071, Methylation_chr2 66218712 LINC02934 (29533): 1.291761790070787, Methylation_HOXB13: -0.4517073177502593, Methylation_chr10 3949206 LINC02660 (4871): -1.3655111273964644, Methylation_chr5 179517140 RNF130 (18026): 1.2907576530581222, Methylation_LOC727677: -1.5389536435205993, Methylation_LETM1: -1.6379859905080782, Methylation_CDC42BPB: -1.4518295440120523, Methylation_C8orf38: -1.473939987937519, Methylation_chr14 100504766 EVL (18852): -1.3308961080076722, Methylation_chr5 72594851 LOC340090 (24088): 1.3702946825770266, Methylation_chr2 242904738 LINC01238 (3421): -1.3969173168669442, Methylation_ARFGEF1: -1.4589422761155204, Methylation_MAPT: -1.946935253123172, Methylation_ZFAT: -1.860146842713282, Methylation_KCNQ4: -0.0260974759023771, Methylation_chr1 232684368 SIPA1L2 (12934): -1.3692453061537566, Methylation_CRNKL1: -0.2997672988146891, Methylation_PRKAG2: 1.357131214774972, Methylation_MICB: -1.3880399717934244, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.0078693147914816, miRNA_hsa-mir-5695: 0.8780227753362233, miRNA_hsa-mir-18a: -0.8674178889092178, miRNA_hsa-mir-190b: 1.7379297721741775, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: 1.7128005931072117, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.8621487204746635, miRNA_hsa-mir-130b: -0.387756107794207, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A0BC,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.0602869730882673, mRNA_C2orf54: -0.9179301199808836, mRNA_CITED4: -0.74458966379677, mRNA_ESR1: 0.8332593935058262, mRNA_SPDEF: 0.3223972780207789, mRNA_AGR3: 0.7218807931266287, mRNA_FOXC1: 0.1571336398119791, mRNA_GATA3: 0.3199643270488773, mRNA_AGR2: 0.1598963771659607, mRNA_XBP1: 0.5445288569948927, mRNA_PRR15: 0.298219930246663, mRNA_SLC44A4: 0.746805265465191, mRNA_CA12: 0.4605633874629951, mRNA_DTL: 0.9040034804045656, mRNA_C5AR2: 0.8682742700514644, mRNA_TBC1D9: 0.8721886403802163, mRNA_AR: 0.5530642110141512, mRNA_CCDC170: 0.6756876526351377, mRNA_DEGS2: 0.8657667830647942, mRNA_TFF3: 0.3155055657938108, mRNA_DNALI1: -0.0231046831191351, mRNA_LINC00504: 0.7530573004453125, mRNA_CLCA2: -0.6378207959907254, mRNA_PPP1R14C: -0.4769961165065806, mRNA_THSD4: 0.4408137763077412, mRNA_SPAG5: -0.5635150816573054, mRNA_FBP1: 0.5102842905162245, mRNA_SLC7A8: 0.486330231135922, mRNA_EN1: -0.5501428513345534, mRNA_ZNF552: 0.4404808853165102, Methylation_LRRC6: 0.2944631118985512, Methylation_chr2 66218712 LINC02934 (29533): 1.0145268331282482, Methylation_HOXB13: 1.2032658970571932, Methylation_chr10 3949206 LINC02660 (4871): 0.8536969684983022, Methylation_chr5 179517140 RNF130 (18026): 0.6577041072596039, Methylation_LOC727677: 0.1472569384159888, Methylation_LETM1: -0.5853027178554642, Methylation_CDC42BPB: -0.7418064039330549, Methylation_C8orf38: -0.0541770037087042, Methylation_chr14 100504766 EVL (18852): -0.0674356078310671, Methylation_chr5 72594851 LOC340090 (24088): 0.6986454580029308, Methylation_chr2 242904738 LINC01238 (3421): -0.484894628241328, Methylation_ARFGEF1: 0.0511262215486355, Methylation_MAPT: 0.7871280231763357, Methylation_ZFAT: 0.0237266026225918, Methylation_KCNQ4: -1.1563695342132434, Methylation_chr1 232684368 SIPA1L2 (12934): 0.1030007326960112, Methylation_CRNKL1: 0.2340241646330507, Methylation_PRKAG2: 1.2625284283906737, Methylation_MICB: -0.103989774688828, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.8931182415334119, miRNA_hsa-mir-5695: 2.251380824278979, miRNA_hsa-mir-18a: -0.0423105407312096, miRNA_hsa-mir-190b: 0.8841905578832339, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.2696419731655246, miRNA_hsa-mir-2115: 0.0835390289855348, miRNA_hsa-mir-17: -1.2542078511578525, miRNA_hsa-mir-130b: 0.5944968691637983, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AC-A2QH,"High-level Amplification of CEP68, WDPCP, LINC02576, and LINC01867 drives genomic instability. Promoter hypermethylation of HOXB13, KCNQ4, SIPA1L2, and LINC02660 mediates transcriptional silencing. miR-130b, miR-18a, and miR-17 are markedly upregulated, indicating oncogenic miRNA activation. These features collectively indicate a luminal B-like phenotype with ER-pathway suppression and proliferation dysregulation.","mRNA_MLPH: -2.9046966613771894, mRNA_C2orf54: -1.2799481377632964, mRNA_CITED4: -2.497691800206554, mRNA_ESR1: -2.0516392828830337, mRNA_SPDEF: -3.2989375785487653, mRNA_AGR3: -2.0533201845066453, mRNA_FOXC1: -0.5406535408360348, mRNA_GATA3: -3.613062303510669, mRNA_AGR2: -2.601929025282624, mRNA_XBP1: -3.31956280479878, mRNA_PRR15: -2.6554071670586894, mRNA_SLC44A4: -2.4317169185408134, mRNA_CA12: -1.6915695312957366, mRNA_DTL: -0.476628098407611, mRNA_C5AR2: -1.9001280422441504, mRNA_TBC1D9: -1.8496805471469424, mRNA_AR: -1.6947318028791512, mRNA_CCDC170: -1.3316102033037398, mRNA_DEGS2: -2.5077302218560606, mRNA_TFF3: -2.2774768416547047, mRNA_DNALI1: -2.042904342402649, mRNA_LINC00504: -1.71955275992137, mRNA_CLCA2: -0.8690726708303373, mRNA_PPP1R14C: -0.9839573530923884, mRNA_THSD4: -1.1328414000544134, mRNA_SPAG5: -1.0607498166059908, mRNA_FBP1: -3.528613660569041, mRNA_SLC7A8: -2.334988892136165, mRNA_EN1: -0.3736786181013311, mRNA_ZNF552: -2.505345143382591, Methylation_LRRC6: 1.341972091947239, Methylation_chr2 66218712 LINC02934 (29533): -1.9023015442173992, Methylation_HOXB13: 1.4557593786595058, Methylation_chr10 3949206 LINC02660 (4871): 1.619344625123831, Methylation_chr5 179517140 RNF130 (18026): -1.6834419989108649, Methylation_LOC727677: 1.4984844000809951, Methylation_LETM1: 0.9780670176296568, Methylation_CDC42BPB: 1.242620173930963, Methylation_C8orf38: 1.168061218308554, Methylation_chr14 100504766 EVL (18852): 1.4963771286596994, Methylation_chr5 72594851 LOC340090 (24088): -0.0673876666938742, Methylation_chr2 242904738 LINC01238 (3421): 1.4511389322401758, Methylation_ARFGEF1: -0.1423666191480991, Methylation_MAPT: 1.3930463026962565, Methylation_ZFAT: 1.007046860028893, Methylation_KCNQ4: 1.5733048603561128, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5813654981285246, Methylation_CRNKL1: 1.4329619733227226, Methylation_PRKAG2: 0.8158771989113084, Methylation_MICB: 1.4280887245715006, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.6878756693932012, miRNA_hsa-mir-5695: 0.1492056699086779, miRNA_hsa-mir-18a: 2.6391694708554287, miRNA_hsa-mir-190b: -1.814442641005372, miRNA_hsa-mir-577: 0.413632343041124, miRNA_hsa-mir-135b: 1.372927989706927, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 2.160210988179286, miRNA_hsa-mir-130b: 4.016109574628525, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-D8-A1XU,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.3042420514397954, mRNA_C2orf54: -0.8331166762226754, mRNA_CITED4: -0.8491508237699489, mRNA_ESR1: 0.9331921856960772, mRNA_SPDEF: 0.0126120488606651, mRNA_AGR3: 0.9017225680497593, mRNA_FOXC1: -0.6079803928260027, mRNA_GATA3: 0.2140288836071708, mRNA_AGR2: 0.6898794884090603, mRNA_XBP1: 0.2363132981215316, mRNA_PRR15: 0.4645291231358935, mRNA_SLC44A4: 0.3295254875077404, mRNA_CA12: 0.4078184170165639, mRNA_DTL: -0.7870426915824884, mRNA_C5AR2: 1.396667938267895, mRNA_TBC1D9: 0.166373831828778, mRNA_AR: 0.5455261012337985, mRNA_CCDC170: 0.907201278923752, mRNA_DEGS2: -0.017554852504556, mRNA_TFF3: 0.8506345208165305, mRNA_DNALI1: -0.6796689547047052, mRNA_LINC00504: -0.4108607189007452, mRNA_CLCA2: -0.4812137747943846, mRNA_PPP1R14C: -0.0761552446243743, mRNA_THSD4: 0.432467306992804, mRNA_SPAG5: -1.3142047325994544, mRNA_FBP1: 0.87316075986609, mRNA_SLC7A8: 0.6149875424607355, mRNA_EN1: -0.1782653431918992, mRNA_ZNF552: 0.4594237253836238, Methylation_LRRC6: -0.3978371635778926, Methylation_chr2 66218712 LINC02934 (29533): 0.7880668321283579, Methylation_HOXB13: 0.5584753946855406, Methylation_chr10 3949206 LINC02660 (4871): -0.948840983825347, Methylation_chr5 179517140 RNF130 (18026): 0.579820585865303, Methylation_LOC727677: -0.4982409549819367, Methylation_LETM1: -0.1409900274950392, Methylation_CDC42BPB: 1.044782553052808, Methylation_C8orf38: -1.0861658274505603, Methylation_chr14 100504766 EVL (18852): -0.3030343419722032, Methylation_chr5 72594851 LOC340090 (24088): 0.9196117813805144, Methylation_chr2 242904738 LINC01238 (3421): -0.9363575024583352, Methylation_ARFGEF1: -0.1890021334344665, Methylation_MAPT: 0.2966452208881281, Methylation_ZFAT: -0.430686461135682, Methylation_KCNQ4: -0.9145881997571764, Methylation_chr1 232684368 SIPA1L2 (12934): -0.6787103964638467, Methylation_CRNKL1: -0.4373554271791773, Methylation_PRKAG2: 1.098842202141035, Methylation_MICB: -0.196313130242934, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.280731704242681, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.6706329116696722, miRNA_hsa-mir-190b: 0.2854055398428359, miRNA_hsa-mir-577: -0.1867399591658182, miRNA_hsa-mir-135b: -0.9701369541119692, miRNA_hsa-mir-2115: -0.5353215424239443, miRNA_hsa-mir-17: -1.5816338511695471, miRNA_hsa-mir-130b: -0.6625917358524965, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A2-A4RW,"High mRNA_C2orf54 (Z=1.43) and mRNA_DEGS2 (Z=1.42) indicate overexpression.  
miRNA_hsa-mir-130b is downregulated (Z=-1.87).  
No methylation or CNV alterations meet diagnostic thresholds.  
These features suggest luminal-like transcriptional activity with miR-130b-mediated regulatory loss.","mRNA_MLPH: 0.6354210948157757, mRNA_C2orf54: 1.4311741169930845, mRNA_CITED4: 0.6248116857685685, mRNA_ESR1: 0.184048856172354, mRNA_SPDEF: 0.6521870553299056, mRNA_AGR3: 0.5009265686173765, mRNA_FOXC1: -0.2112583477624038, mRNA_GATA3: 0.7487385905406633, mRNA_AGR2: -0.2144040241825522, mRNA_XBP1: 0.0990518957886951, mRNA_PRR15: 0.7923185711521552, mRNA_SLC44A4: 0.3034881272546825, mRNA_CA12: 0.0537113481177657, mRNA_DTL: -0.2878488804389387, mRNA_C5AR2: 0.8473192404622646, mRNA_TBC1D9: 0.3407459959294246, mRNA_AR: 0.7319468906724974, mRNA_CCDC170: -0.4463799661895087, mRNA_DEGS2: 1.4196923494467937, mRNA_TFF3: 0.4983111991246437, mRNA_DNALI1: 0.7901240920443414, mRNA_LINC00504: -0.199832081131326, mRNA_CLCA2: 1.0485355004667525, mRNA_PPP1R14C: -0.6651161452223098, mRNA_THSD4: -0.3319220734538645, mRNA_SPAG5: -0.6302161635141336, mRNA_FBP1: 0.7173275025061565, mRNA_SLC7A8: 0.4878693422997425, mRNA_EN1: -0.3939315979244542, mRNA_ZNF552: -0.014397191221086, Methylation_LRRC6: 0.2383944754563445, Methylation_chr2 66218712 LINC02934 (29533): 1.067958692900706, Methylation_HOXB13: 0.6151127067297708, Methylation_chr10 3949206 LINC02660 (4871): -0.5047386472710361, Methylation_chr5 179517140 RNF130 (18026): 0.1453098369846591, Methylation_LOC727677: -0.1482409192378158, Methylation_LETM1: 0.8067796294917625, Methylation_CDC42BPB: 1.0591899464270746, Methylation_C8orf38: 0.4597106236092751, Methylation_chr14 100504766 EVL (18852): 0.3919165672113723, Methylation_chr5 72594851 LOC340090 (24088): -0.1313690735512098, Methylation_chr2 242904738 LINC01238 (3421): -0.0669612505238253, Methylation_ARFGEF1: 0.4920848209845244, Methylation_MAPT: -0.0266441304284677, Methylation_ZFAT: -0.6022751918741629, Methylation_KCNQ4: -0.2239553627141051, Methylation_chr1 232684368 SIPA1L2 (12934): 0.5469179218501675, Methylation_CRNKL1: 0.7408923623371096, Methylation_PRKAG2: 1.1314476382221088, Methylation_MICB: 0.7613205129151063, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.6800386843048234, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.1219292543138236, miRNA_hsa-mir-190b: 0.0987383092320415, miRNA_hsa-mir-577: -0.4739780904976345, miRNA_hsa-mir-135b: -0.5977329825138417, miRNA_hsa-mir-2115: -0.4204463070074987, miRNA_hsa-mir-17: -0.5730093332698939, miRNA_hsa-mir-130b: -1.8714267518119865, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A0BS,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified Z-score and CNV cutoffs.","mRNA_MLPH: 0.085423545847148, mRNA_C2orf54: 0.0273748508378844, mRNA_CITED4: -0.1487578924400141, mRNA_ESR1: 1.2705555548839114, mRNA_SPDEF: 0.3288249865635663, mRNA_AGR3: 0.7621109822934656, mRNA_FOXC1: -0.5947472189044443, mRNA_GATA3: 0.9621682123440268, mRNA_AGR2: -0.1644912683280837, mRNA_XBP1: 1.367526679673577, mRNA_PRR15: -0.2651314103381629, mRNA_SLC44A4: 0.8673016522756203, mRNA_CA12: 0.7339829985788947, mRNA_DTL: 0.0379520249826289, mRNA_C5AR2: 0.2653175143407689, mRNA_TBC1D9: 1.3051440083973498, mRNA_AR: 1.0618053178931917, mRNA_CCDC170: 1.1067492285207163, mRNA_DEGS2: 0.981282148767906, mRNA_TFF3: 0.1898252788561893, mRNA_DNALI1: 0.7381820986591482, mRNA_LINC00504: 1.165761334578255, mRNA_CLCA2: -0.1893918993587582, mRNA_PPP1R14C: -0.5341749357279189, mRNA_THSD4: 0.9744313508458112, mRNA_SPAG5: -0.6218630176573252, mRNA_FBP1: 0.8100465553250509, mRNA_SLC7A8: 0.3768550394811931, mRNA_EN1: -0.9753051682655208, mRNA_ZNF552: 0.923264597720309, Methylation_LRRC6: -0.7090296964400603, Methylation_chr2 66218712 LINC02934 (29533): -0.4309427777043765, Methylation_HOXB13: -0.8967429245708779, Methylation_chr10 3949206 LINC02660 (4871): 0.0567504778957372, Methylation_chr5 179517140 RNF130 (18026): 0.1256374562114805, Methylation_LOC727677: -0.7617624142460023, Methylation_LETM1: -0.7002836068386666, Methylation_CDC42BPB: -1.1845676974669754, Methylation_C8orf38: -1.2541130273287897, Methylation_chr14 100504766 EVL (18852): -1.1245040647000577, Methylation_chr5 72594851 LOC340090 (24088): 1.020507447434166, Methylation_chr2 242904738 LINC01238 (3421): -1.0747012279893164, Methylation_ARFGEF1: -1.03948225591095, Methylation_MAPT: -0.956787178510444, Methylation_ZFAT: -0.1090683220245068, Methylation_KCNQ4: -0.2732634020226125, Methylation_chr1 232684368 SIPA1L2 (12934): -0.24895433735386, Methylation_CRNKL1: -0.451701154716603, Methylation_PRKAG2: -0.7636807667631537, Methylation_MICB: -0.947296013893126, miRNA_hsa-mir-934: -0.4036099752683692, miRNA_hsa-mir-4728: -0.0748321149985203, miRNA_hsa-mir-5695: 1.069072202488137, miRNA_hsa-mir-18a: -0.7556476818321887, miRNA_hsa-mir-190b: 1.0973037314509302, miRNA_hsa-mir-577: -0.4383982424697442, miRNA_hsa-mir-135b: -0.1242808636790206, miRNA_hsa-mir-2115: 0.0744390157382194, miRNA_hsa-mir-17: -0.7682756480553617, miRNA_hsa-mir-130b: 0.1302497442651669, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A28Q,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.745648432048368, mRNA_C2orf54: -1.0447239375460045, mRNA_CITED4: 1.1199433768064326, mRNA_ESR1: 0.5262598539366219, mRNA_SPDEF: 0.5134028581147594, mRNA_AGR3: 0.3541558131525701, mRNA_FOXC1: -0.553010013410742, mRNA_GATA3: 0.6664988331289451, mRNA_AGR2: 0.2529610869210059, mRNA_XBP1: 0.8835970235481346, mRNA_PRR15: 0.7525746547735395, mRNA_SLC44A4: 0.8974512558650726, mRNA_CA12: 0.7570483942249535, mRNA_DTL: -0.5810809523155065, mRNA_C5AR2: 0.544539082624047, mRNA_TBC1D9: 0.8051634041079729, mRNA_AR: 1.0890700570346072, mRNA_CCDC170: 0.8434630288773164, mRNA_DEGS2: 0.3962275461307965, mRNA_TFF3: 0.4505624642555706, mRNA_DNALI1: 1.107584706858747, mRNA_LINC00504: 1.097639681183784, mRNA_CLCA2: -0.5477873114952665, mRNA_PPP1R14C: -0.5794567064173665, mRNA_THSD4: 0.8961002919853254, mRNA_SPAG5: -1.295035002859566, mRNA_FBP1: 0.3198942676101524, mRNA_SLC7A8: 1.078590120359433, mRNA_EN1: -0.4406517123622866, mRNA_ZNF552: 0.3720429548239843, Methylation_LRRC6: -0.8414512161424924, Methylation_chr2 66218712 LINC02934 (29533): 0.8474498900512242, Methylation_HOXB13: -0.4406589791436479, Methylation_chr10 3949206 LINC02660 (4871): -1.1148325886719817, Methylation_chr5 179517140 RNF130 (18026): 0.867542510904884, Methylation_LOC727677: -0.3617717145086223, Methylation_LETM1: -0.46404557138848, Methylation_CDC42BPB: -1.2334021215879194, Methylation_C8orf38: 1.29005465151766, Methylation_chr14 100504766 EVL (18852): -0.8693458300867523, Methylation_chr5 72594851 LOC340090 (24088): 1.0272163191440489, Methylation_chr2 242904738 LINC01238 (3421): -1.2704946624757332, Methylation_ARFGEF1: -0.748957459707525, Methylation_MAPT: -1.036671205582767, Methylation_ZFAT: 0.2962306084536135, Methylation_KCNQ4: -1.034737728509356, Methylation_chr1 232684368 SIPA1L2 (12934): -1.3619123491114715, Methylation_CRNKL1: -1.241874395556606, Methylation_PRKAG2: 1.197081376244442, Methylation_MICB: -0.986012724860024, miRNA_hsa-mir-934: -0.481022810223794, miRNA_hsa-mir-4728: -0.6384499807173505, miRNA_hsa-mir-5695: 0.4008992988024623, miRNA_hsa-mir-18a: -1.7574668712888988, miRNA_hsa-mir-190b: 0.5933189418668184, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.1900466174078721, miRNA_hsa-mir-2115: -0.3472880484134493, miRNA_hsa-mir-17: -0.5908005373345591, miRNA_hsa-mir-130b: -1.0997904867682275, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A252,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. DEGS2 shows significant mRNA downregulation (Z = -2.19). C8orf38 and ARFGEF1 promoters are hypermethylated (Z > 1.50), suggesting epigenetic silencing. These features indicate a luminal-like phenotype with ER pathway dysregulation.","mRNA_MLPH: -0.1182196741957771, mRNA_C2orf54: -0.1560318622380345, mRNA_CITED4: -1.4809907736258268, mRNA_ESR1: 0.2830653475872708, mRNA_SPDEF: -0.0660572482979232, mRNA_AGR3: 0.7672536329906489, mRNA_FOXC1: -0.1689508969078939, mRNA_GATA3: -0.1080061029812138, mRNA_AGR2: 0.7588084786593364, mRNA_XBP1: 0.5462815717147804, mRNA_PRR15: -0.2537677745362392, mRNA_SLC44A4: 0.1862638310759181, mRNA_CA12: -1.183622831711979, mRNA_DTL: 0.9569815002358218, mRNA_C5AR2: 0.7580589397898716, mRNA_TBC1D9: 0.8077103433374506, mRNA_AR: -0.6034158806508858, mRNA_CCDC170: 0.3878820463917236, mRNA_DEGS2: -2.189787192649417, mRNA_TFF3: 0.9343740641175252, mRNA_DNALI1: 0.0651567617737256, mRNA_LINC00504: -0.9650167045849836, mRNA_CLCA2: -0.4130278478191275, mRNA_PPP1R14C: -0.1939687913614683, mRNA_THSD4: 0.4228296925173448, mRNA_SPAG5: 0.1159517112472013, mRNA_FBP1: -0.0226978787956168, mRNA_SLC7A8: -1.3790848404886884, mRNA_EN1: -0.5742967126574949, mRNA_ZNF552: -0.2964236921254247, Methylation_LRRC6: 1.148963682683099, Methylation_chr2 66218712 LINC02934 (29533): 0.9705429577919804, Methylation_HOXB13: -0.4103365977337599, Methylation_chr10 3949206 LINC02660 (4871): 0.8085616386411298, Methylation_chr5 179517140 RNF130 (18026): -1.3666255280209818, Methylation_LOC727677: 0.8595009429955024, Methylation_LETM1: 0.8327444898084253, Methylation_CDC42BPB: -0.0182027744985122, Methylation_C8orf38: 1.5304223010178266, Methylation_chr14 100504766 EVL (18852): 1.185995472437423, Methylation_chr5 72594851 LOC340090 (24088): -0.5589308586714741, Methylation_chr2 242904738 LINC01238 (3421): 1.2154609757078492, Methylation_ARFGEF1: 1.5446085574765378, Methylation_MAPT: 0.9516086400938054, Methylation_ZFAT: 0.8467026126881394, Methylation_KCNQ4: -0.9578655505806676, Methylation_chr1 232684368 SIPA1L2 (12934): 0.910408849339554, Methylation_CRNKL1: 1.3057375195161312, Methylation_PRKAG2: 0.0371469556271458, Methylation_MICB: 1.1801992424605443, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.5322450754902902, miRNA_hsa-mir-5695: 0.7345694095224445, miRNA_hsa-mir-18a: 0.1778281069910783, miRNA_hsa-mir-190b: 1.21033602715614, miRNA_hsa-mir-577: -0.0577543837768178, miRNA_hsa-mir-135b: -0.5397986752986286, miRNA_hsa-mir-2115: -0.3409935907411954, miRNA_hsa-mir-17: 0.0799017979676305, miRNA_hsa-mir-130b: 0.1332800502377711, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-A2-A259,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.3013063158855116, mRNA_C2orf54: -0.9610976213952388, mRNA_CITED4: -0.1569660123498278, mRNA_ESR1: 0.9457862614493896, mRNA_SPDEF: -0.0369640111401129, mRNA_AGR3: -0.0081022434082062, mRNA_FOXC1: -0.0030175366176499, mRNA_GATA3: 0.4086420878925776, mRNA_AGR2: -0.077934273210739, mRNA_XBP1: 0.9630049696962768, mRNA_PRR15: -0.0927601089097323, mRNA_SLC44A4: 0.0303785944706355, mRNA_CA12: 0.951429089881905, mRNA_DTL: -1.0382176904820128, mRNA_C5AR2: 0.1396836947465908, mRNA_TBC1D9: 1.1214028063883843, mRNA_AR: 0.8504669152565485, mRNA_CCDC170: 1.1474160305491024, mRNA_DEGS2: 0.6153402470696531, mRNA_TFF3: -0.4392741592702276, mRNA_DNALI1: 0.541357703237638, mRNA_LINC00504: 0.903007999653701, mRNA_CLCA2: 0.1374674136830062, mRNA_PPP1R14C: -0.185396078487813, mRNA_THSD4: 1.4662831929935043, mRNA_SPAG5: -0.8405550901191038, mRNA_FBP1: 0.6931676059382157, mRNA_SLC7A8: 0.6304214651823115, mRNA_EN1: -0.7798410120621816, mRNA_ZNF552: 0.1419871308446422, Methylation_LRRC6: -0.6556349609543599, Methylation_chr2 66218712 LINC02934 (29533): 0.7469593863515614, Methylation_HOXB13: -1.046933189211014, Methylation_chr10 3949206 LINC02660 (4871): -0.039234688508129, Methylation_chr5 179517140 RNF130 (18026): -0.1122355759104352, Methylation_LOC727677: -0.9070049634071516, Methylation_LETM1: 0.2890771945892764, Methylation_CDC42BPB: -0.8549878432566642, Methylation_C8orf38: -0.8907148304510454, Methylation_chr14 100504766 EVL (18852): 0.3642182975413269, Methylation_chr5 72594851 LOC340090 (24088): -0.119431893128032, Methylation_chr2 242904738 LINC01238 (3421): -0.445572317226352, Methylation_ARFGEF1: -0.4867613235874286, Methylation_MAPT: 0.6563041327338481, Methylation_ZFAT: -1.0118338493871315, Methylation_KCNQ4: -0.9487750692743658, Methylation_chr1 232684368 SIPA1L2 (12934): 0.7034858591999456, Methylation_CRNKL1: 0.7741071233359765, Methylation_PRKAG2: 0.4827541211985109, Methylation_MICB: 0.5723965268346313, miRNA_hsa-mir-934: -0.0062499682167077, miRNA_hsa-mir-4728: 0.0270971018387163, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.0617617555632797, miRNA_hsa-mir-190b: -2.052137242410604, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: 0.254393648185104, miRNA_hsa-mir-17: -0.6988305052006334, miRNA_hsa-mir-130b: 0.220399916530617, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A2-A0CR,"High mRNA_CITED4 (Z=1.56) indicates overexpression. Methylation_chr10:3949206 (Z=1.60), Methylation_C8orf38 (Z=1.40), and Methylation_chr2:242904738 (Z=1.43) are hypermethylated. miRNA_hsa-mir-130b is downregulated (Z=-1.31). All CNVs fall within normal range (−1.10 to −0.10) and are ignored. These features suggest luminal breast cancer with ER-pathway dysregulation.","mRNA_MLPH: 0.2374066786633101, mRNA_C2orf54: 0.6115057583062634, mRNA_CITED4: 1.5612135869706787, mRNA_ESR1: -0.4744405266440654, mRNA_SPDEF: 0.5819436081804571, mRNA_AGR3: 0.5145504788909456, mRNA_FOXC1: -0.3393448621077979, mRNA_GATA3: -0.1937014002934153, mRNA_AGR2: 0.4331643645077199, mRNA_XBP1: -0.7889167640655226, mRNA_PRR15: 0.1660699860138641, mRNA_SLC44A4: 0.1170729958250737, mRNA_CA12: -0.3892090072298094, mRNA_DTL: -1.467847258213113, mRNA_C5AR2: 0.3968617628085237, mRNA_TBC1D9: -0.3619180300493095, mRNA_AR: -0.2014353912391418, mRNA_CCDC170: -0.5650078493822914, mRNA_DEGS2: 0.4577928417927135, mRNA_TFF3: 0.9256076100730284, mRNA_DNALI1: 0.4546449616761034, mRNA_LINC00504: -0.3450388272946739, mRNA_CLCA2: -0.2831207642550217, mRNA_PPP1R14C: 0.2653502184778539, mRNA_THSD4: -0.6265374036934537, mRNA_SPAG5: -1.5285678722885867, mRNA_FBP1: -0.1746159651770764, mRNA_SLC7A8: -0.2973181976372697, mRNA_EN1: -0.19478163615659, mRNA_ZNF552: -0.2167356659552502, Methylation_LRRC6: 1.307835329105002, Methylation_chr2 66218712 LINC02934 (29533): 1.057795691181153, Methylation_HOXB13: -0.1145284680887038, Methylation_chr10 3949206 LINC02660 (4871): 1.602752822091497, Methylation_chr5 179517140 RNF130 (18026): -0.0580441986546612, Methylation_LOC727677: 0.7753928554254702, Methylation_LETM1: 0.6191775828515822, Methylation_CDC42BPB: -0.4983933665868878, Methylation_C8orf38: 1.404333006536043, Methylation_chr14 100504766 EVL (18852): 1.1757056437481648, Methylation_chr5 72594851 LOC340090 (24088): 0.1391006935068033, Methylation_chr2 242904738 LINC01238 (3421): 1.430602362716506, Methylation_ARFGEF1: 1.3819943181911507, Methylation_MAPT: 1.124269629259255, Methylation_ZFAT: 1.2553572125837722, Methylation_KCNQ4: -1.1908029086839709, Methylation_chr1 232684368 SIPA1L2 (12934): 1.269732979522498, Methylation_CRNKL1: 1.1001022776718754, Methylation_PRKAG2: 0.9384238049236951, Methylation_MICB: 1.035782469031099, miRNA_hsa-mir-934: -0.2913741458353337, miRNA_hsa-mir-4728: -0.8543535059732775, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.2127723403274673, miRNA_hsa-mir-190b: 1.258672727670386, miRNA_hsa-mir-577: -0.3357874134610902, miRNA_hsa-mir-135b: -0.2563747536018025, miRNA_hsa-mir-2115: -0.2033051003337075, miRNA_hsa-mir-17: -0.4402386894668608, miRNA_hsa-mir-130b: -1.313028980553263, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-OL-A66K,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. KCNQ4 promoter hypermethylation mediates epigenetic silencing. miRNA downregulation includes hsa-mir-18a and hsa-mir-130b. These features collectively indicate a luminal phenotype with PI3K/AKT pathway dysregulation.","mRNA_MLPH: 1.0288575719032822, mRNA_C2orf54: -0.9475279300658336, mRNA_CITED4: 1.572577199351997, mRNA_ESR1: 0.5488100582624309, mRNA_SPDEF: 0.3545532350344608, mRNA_AGR3: 0.9525907690909968, mRNA_FOXC1: -0.4368538282953547, mRNA_GATA3: 0.7628684287700087, mRNA_AGR2: 0.583880230737175, mRNA_XBP1: 0.0612061870086563, mRNA_PRR15: 0.7072696362725241, mRNA_SLC44A4: 0.4514751422898483, mRNA_CA12: 0.1460828165587063, mRNA_DTL: -0.1888355264734657, mRNA_C5AR2: 1.0475577851538949, mRNA_TBC1D9: 0.6606081370990398, mRNA_AR: -0.3625702854940186, mRNA_CCDC170: 1.1066422048666458, mRNA_DEGS2: 0.913049725698428, mRNA_TFF3: 0.565243392772247, mRNA_DNALI1: 0.8109902102846972, mRNA_LINC00504: 0.4245959003041474, mRNA_CLCA2: -0.6469799299737844, mRNA_PPP1R14C: -0.3873412476079988, mRNA_THSD4: 0.5082748210792417, mRNA_SPAG5: -0.3434690004573228, mRNA_FBP1: 0.6597588275027437, mRNA_SLC7A8: -0.1338260031666511, mRNA_EN1: -0.4823218020141606, mRNA_ZNF552: 1.5472967848945869, Methylation_LRRC6: -0.134703344963704, Methylation_chr2 66218712 LINC02934 (29533): 0.2607659712683222, Methylation_HOXB13: -1.0271193033226602, Methylation_chr10 3949206 LINC02660 (4871): -0.9890886747969616, Methylation_chr5 179517140 RNF130 (18026): 0.7729281789452922, Methylation_LOC727677: -1.0598202503885246, Methylation_LETM1: -0.8302384564519031, Methylation_CDC42BPB: -0.007228206225751, Methylation_C8orf38: -0.7071657530394488, Methylation_chr14 100504766 EVL (18852): -0.4087556431442836, Methylation_chr5 72594851 LOC340090 (24088): 1.1452455471104, Methylation_chr2 242904738 LINC01238 (3421): -1.2335806987649502, Methylation_ARFGEF1: 0.070755647730687, Methylation_MAPT: -0.6384111954379585, Methylation_ZFAT: -0.9495278618246712, Methylation_KCNQ4: 1.5587565841168298, Methylation_chr1 232684368 SIPA1L2 (12934): -0.126114727489814, Methylation_CRNKL1: -0.3276101857239174, Methylation_PRKAG2: 1.3386056175759953, Methylation_MICB: -0.1342728569537144, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.6868252696319391, miRNA_hsa-mir-5695: -0.012093767033192, miRNA_hsa-mir-18a: -1.0892062138660907, miRNA_hsa-mir-190b: 0.5519429333629609, miRNA_hsa-mir-577: -0.6626986868669027, miRNA_hsa-mir-135b: -0.6279557085251871, miRNA_hsa-mir-2115: -0.5242025833656607, miRNA_hsa-mir-17: -0.5900952465932622, miRNA_hsa-mir-130b: -1.1766645771891708, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-AO-A128,"Deletion of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 correlates with transcriptional downregulation.  
mRNA_MLPH, mRNA_SPDEF, mRNA_GATA3, mRNA_CA12, and mRNA_AR are significantly low (Z < -1.92).  
Methylation hypermethylation at chr10:3949206, C8orf38, ARFGEF1, and MAPT (Z > 1.50) suggests epigenetic silencing.  
No miRNAs meet dysregulation thresholds.  
Collectively indicates a luminal-negative phenotype with ER-pathway suppression.","mRNA_MLPH: -2.099819178835415, mRNA_C2orf54: 1.4821377345767346, mRNA_CITED4: 0.3064487770348164, mRNA_ESR1: -0.9142293213385668, mRNA_SPDEF: -2.05567569244858, mRNA_AGR3: -0.9029947137709228, mRNA_FOXC1: 1.3401247063781987, mRNA_GATA3: -2.2049664718752875, mRNA_AGR2: -0.8611086063642339, mRNA_XBP1: -1.5590161981758048, mRNA_PRR15: -1.7829653732048747, mRNA_SLC44A4: -0.9080434053985555, mRNA_CA12: -2.089101933302737, mRNA_DTL: 1.4383367611884412, mRNA_C5AR2: -1.1789216683549104, mRNA_TBC1D9: -1.4525309512819602, mRNA_AR: -2.1298095868756035, mRNA_CCDC170: -1.3278552388807474, mRNA_DEGS2: -1.762311241638041, mRNA_TFF3: -1.1299040319245834, mRNA_DNALI1: -1.992779661376778, mRNA_LINC00504: -1.525825924709353, mRNA_CLCA2: -0.8871873398649003, mRNA_PPP1R14C: 0.2940864250895015, mRNA_THSD4: -0.954973726232303, mRNA_SPAG5: 0.6737866385344202, mRNA_FBP1: -1.0565789760023812, mRNA_SLC7A8: -1.0078595911117765, mRNA_EN1: 1.0176782565172646, mRNA_ZNF552: -0.8469985499760986, Methylation_LRRC6: 1.4454626548616685, Methylation_chr2 66218712 LINC02934 (29533): 1.0452182848606557, Methylation_HOXB13: -0.8332954581301966, Methylation_chr10 3949206 LINC02660 (4871): 1.604598195493622, Methylation_chr5 179517140 RNF130 (18026): -1.4947907234163278, Methylation_LOC727677: 1.5171623036544393, Methylation_LETM1: 1.3760012126103385, Methylation_CDC42BPB: 0.3057528672452275, Methylation_C8orf38: 1.6099746665634398, Methylation_chr14 100504766 EVL (18852): 1.4625208073257656, Methylation_chr5 72594851 LOC340090 (24088): -1.4869091726457058, Methylation_chr2 242904738 LINC01238 (3421): 1.4533690762013045, Methylation_ARFGEF1: 1.6608759775629096, Methylation_MAPT: 1.485610425215847, Methylation_ZFAT: 1.3672599142475337, Methylation_KCNQ4: -0.0130878952052896, Methylation_chr1 232684368 SIPA1L2 (12934): 1.4062514563820194, Methylation_CRNKL1: 1.2228288800232026, Methylation_PRKAG2: 0.5159457875390151, Methylation_MICB: 1.2807633634137976, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.4217825160534782, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.6305131753036363, miRNA_hsa-mir-190b: 0.227275781253039, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.3128445275304731, miRNA_hsa-mir-2115: 0.5005406529544281, miRNA_hsa-mir-17: -0.8059842311828415, miRNA_hsa-mir-130b: -0.6346427450477694, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A1F5,"High mRNA_CITED4 (Z=1.30) and mRNA_SLC7A8 (Z=1.56) indicate overexpression. Methylation_LOC727677, C8orf38, and ZFAT are hypo-methylated (Z < -1.47). No CNVs meet deletion/amplification thresholds. miRNA_hsa-mir-5695 is upregulated (Z=1.30). These features suggest luminal breast cancer with ER-pathway activity.","mRNA_MLPH: 0.1170326355954878, mRNA_C2orf54: 0.5135957656143209, mRNA_CITED4: 1.3032226165401686, mRNA_ESR1: 1.0014536166129149, mRNA_SPDEF: -0.0563007782714473, mRNA_AGR3: 0.5949545588176017, mRNA_FOXC1: -0.4500664764025136, mRNA_GATA3: 0.9720964091737148, mRNA_AGR2: 0.7837501987731845, mRNA_XBP1: 0.6602987234920877, mRNA_PRR15: -0.0174009814987799, mRNA_SLC44A4: 0.3854837456556837, mRNA_CA12: 1.1250822464223271, mRNA_DTL: -0.9067135001861456, mRNA_C5AR2: 0.4474571914518876, mRNA_TBC1D9: 0.8268551867129741, mRNA_AR: 0.7127300410236953, mRNA_CCDC170: 0.9548477695864332, mRNA_DEGS2: 0.5746243432605291, mRNA_TFF3: -0.1419741761009247, mRNA_DNALI1: 0.950208462443666, mRNA_LINC00504: 0.7328772985327621, mRNA_CLCA2: 1.2056366046998517, mRNA_PPP1R14C: -0.8415367983498849, mRNA_THSD4: 1.0804971371499508, mRNA_SPAG5: -1.3240967738701248, mRNA_FBP1: 0.7407969270559566, mRNA_SLC7A8: 1.5621992654824532, mRNA_EN1: -0.8406096671713792, mRNA_ZNF552: 0.7384684223084766, Methylation_LRRC6: -1.4160395856643382, Methylation_chr2 66218712 LINC02934 (29533): 0.4886582718885536, Methylation_HOXB13: -0.9945048781979569, Methylation_chr10 3949206 LINC02660 (4871): -1.2815911275241112, Methylation_chr5 179517140 RNF130 (18026): 1.1461791238538588, Methylation_LOC727677: -1.5005729172273323, Methylation_LETM1: -1.4216557390528302, Methylation_CDC42BPB: -0.6153232222076414, Methylation_C8orf38: -1.5214281503426532, Methylation_chr14 100504766 EVL (18852): -1.4232103195103003, Methylation_chr5 72594851 LOC340090 (24088): 1.0578675725066038, Methylation_chr2 242904738 LINC01238 (3421): -1.1097154461348389, Methylation_ARFGEF1: -1.3255716105647486, Methylation_MAPT: -1.3493527618120724, Methylation_ZFAT: -1.5384653779716075, Methylation_KCNQ4: 0.2342887635793373, Methylation_chr1 232684368 SIPA1L2 (12934): -1.274310355032937, Methylation_CRNKL1: -1.487052651778664, Methylation_PRKAG2: 1.2576880122380332, Methylation_MICB: -1.207873298786598, miRNA_hsa-mir-934: -0.0581927722134332, miRNA_hsa-mir-4728: 0.1031196882331509, miRNA_hsa-mir-5695: 1.3005760717419348, miRNA_hsa-mir-18a: -0.4384075633637255, miRNA_hsa-mir-190b: 0.0238529864354132, miRNA_hsa-mir-577: -0.4705128373671996, miRNA_hsa-mir-135b: -0.9877624767844744, miRNA_hsa-mir-2115: 0.1710118859563715, miRNA_hsa-mir-17: -0.0872010056991403, miRNA_hsa-mir-130b: -0.5170413129908923, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A7-A6VV,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. FOXC1 and EN1 show high mRNA (Z > 1.30). AGR2, XBP1, TFF3, and ESR1 are low (Z < -1.92). No methylation or miRNA alterations meet diagnostic thresholds.","mRNA_MLPH: -1.788928428724372, mRNA_C2orf54: -0.6570162396435005, mRNA_CITED4: 0.5664928847229819, mRNA_ESR1: -1.8944630726557088, mRNA_SPDEF: -0.644945390516544, mRNA_AGR3: -1.928129743233994, mRNA_FOXC1: 2.22291997649531, mRNA_GATA3: -1.3698784360193503, mRNA_AGR2: -2.2333997740045963, mRNA_XBP1: -2.161715038566893, mRNA_PRR15: -1.6080615654942965, mRNA_SLC44A4: -1.7906641032498471, mRNA_CA12: -1.568485836332959, mRNA_DTL: -0.4028575600847486, mRNA_C5AR2: -1.142550511325262, mRNA_TBC1D9: -1.1206113018427095, mRNA_AR: -1.3067859575626162, mRNA_CCDC170: -1.4794067393158163, mRNA_DEGS2: -0.4257735723570574, mRNA_TFF3: -2.104997848178262, mRNA_DNALI1: -1.4951835980417314, mRNA_LINC00504: -1.6866841574300837, mRNA_CLCA2: 0.0158017105255655, mRNA_PPP1R14C: 1.7926091765376169, mRNA_THSD4: -0.6276761540585515, mRNA_SPAG5: 0.6932126892055681, mRNA_FBP1: -0.8850343879585533, mRNA_SLC7A8: -0.7940059278599091, mRNA_EN1: 2.456315867637895, mRNA_ZNF552: -0.4895280454065431, Methylation_LRRC6: 1.476798066318994, Methylation_chr2 66218712 LINC02934 (29533): -0.8886418615088615, Methylation_HOXB13: -0.9708623716851495, Methylation_chr10 3949206 LINC02660 (4871): 1.5403803730834984, Methylation_chr5 179517140 RNF130 (18026): -0.8735326593874361, Methylation_LOC727677: 1.483643913583746, Methylation_LETM1: 1.3065957017759935, Methylation_CDC42BPB: 1.130222704115056, Methylation_C8orf38: 1.6162573428452636, Methylation_chr14 100504766 EVL (18852): 1.5885547781101257, Methylation_chr5 72594851 LOC340090 (24088): -1.399762597337573, Methylation_chr2 242904738 LINC01238 (3421): 1.4063217198104965, Methylation_ARFGEF1: 1.5085681140152678, Methylation_MAPT: 1.4109970040381048, Methylation_ZFAT: 1.364181939120367, Methylation_KCNQ4: 0.961726184695936, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5265108471266031, Methylation_CRNKL1: 1.3392199575913557, Methylation_PRKAG2: -0.7115401515977673, Methylation_MICB: 1.4761457293923863, miRNA_hsa-mir-934: 1.1109642340169408, miRNA_hsa-mir-4728: -0.3459522807697895, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.7042058304250197, miRNA_hsa-mir-190b: -1.6546401668230062, miRNA_hsa-mir-577: -0.0942837145520696, miRNA_hsa-mir-135b: 0.8668092470278346, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.6977856729296441, miRNA_hsa-mir-130b: -0.6947968250048421, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-BH-A0B6,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives oncogenic mRNA overexpression. No mRNA transcripts meet high/low thresholds. Promoter hypermethylation absent; hypo-methylation of KCNQ4 and CDC42BPB does not align with transcriptional changes. miRNA downregulation fails to meet threshold. Genomic amplifications suggest luminal B-like phenotype with cell cycle dysregulation.","mRNA_MLPH: -0.1024990388791308, mRNA_C2orf54: -0.9774990255430064, mRNA_CITED4: 0.1672959892541257, mRNA_ESR1: 0.3221015289408803, mRNA_SPDEF: 0.7113242679113942, mRNA_AGR3: 0.1142636444471062, mRNA_FOXC1: -0.9746090868702194, mRNA_GATA3: 0.5311749139687936, mRNA_AGR2: -0.5642728945891823, mRNA_XBP1: -0.0263001217090713, mRNA_PRR15: 1.1848935957445736, mRNA_SLC44A4: 0.9991612896972693, mRNA_CA12: -0.8537790618487405, mRNA_DTL: -1.5859308934489873, mRNA_C5AR2: -0.8600813654894129, mRNA_TBC1D9: 0.6116274441783573, mRNA_AR: 0.3057942004467437, mRNA_CCDC170: -0.6287340539332367, mRNA_DEGS2: 1.1076312561474912, mRNA_TFF3: -0.1076386826865372, mRNA_DNALI1: -0.012250236845548, mRNA_LINC00504: 0.2611109994271876, mRNA_CLCA2: -0.4383588629377195, mRNA_PPP1R14C: -0.9960856096711292, mRNA_THSD4: -0.7807034622592767, mRNA_SPAG5: -1.877230199619208, mRNA_FBP1: 0.8709147534316194, mRNA_SLC7A8: 0.3957927204001437, mRNA_EN1: -0.4458331272694073, mRNA_ZNF552: -0.7626913662445635, Methylation_LRRC6: 0.6070234726805654, Methylation_chr2 66218712 LINC02934 (29533): 0.2655501434410265, Methylation_HOXB13: 0.4660916081017318, Methylation_chr10 3949206 LINC02660 (4871): 0.2282888482823568, Methylation_chr5 179517140 RNF130 (18026): -0.4519906838802885, Methylation_LOC727677: 0.1680354095162939, Methylation_LETM1: 0.088215099398846, Methylation_CDC42BPB: -0.841799992914409, Methylation_C8orf38: -0.1564018955545028, Methylation_chr14 100504766 EVL (18852): 1.0439506286113656, Methylation_chr5 72594851 LOC340090 (24088): 0.1572985176368971, Methylation_chr2 242904738 LINC01238 (3421): -0.4739112806257081, Methylation_ARFGEF1: 0.8405640314910757, Methylation_MAPT: 0.7064669333081899, Methylation_ZFAT: -0.3883122914691349, Methylation_KCNQ4: -0.98560917892666, Methylation_chr1 232684368 SIPA1L2 (12934): 0.6071684560567244, Methylation_CRNKL1: 0.3564726876277154, Methylation_PRKAG2: -0.2639564874351539, Methylation_MICB: 0.3946650660584697, miRNA_hsa-mir-934: -0.4669152306758811, miRNA_hsa-mir-4728: -0.4726803046479456, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.6224490755551328, miRNA_hsa-mir-190b: -0.3535897526332253, miRNA_hsa-mir-577: 0.0809004746619102, miRNA_hsa-mir-135b: -0.5318896450352676, miRNA_hsa-mir-2115: -0.0111386858977561, miRNA_hsa-mir-17: -0.5947716658902955, miRNA_hsa-mir-130b: -0.5945562498601018, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-A2-A3XX,"High-level Amplification of none; Gain in VPS54, LINC01867, LINC02576, WDPCP, CEP68.  
mRNA overexpression: PPP1R14C (Z=2.83), EN1 (Z=2.90), FOXC1 (Z=2.50).  
mRNA underexpression: GATA3 (Z=-2.81), AGR2 (Z=-2.25), CA12 (Z=-2.34).  
Promoter hypermethylation: ARFGEF1, C8orf38, LINC02660, SIPA1L2, LRRC6, LOC727677.  
Hypomethylation: RNF130, LOC340090.  
miRNA upregulation: hsa-mir-934, hsa-mir-577.  
miRNA downregulation: hsa-mir-190b.","mRNA_MLPH: -1.802972041533635, mRNA_C2orf54: -0.6915580356677524, mRNA_CITED4: 1.308830563230147, mRNA_ESR1: -1.9358816929819849, mRNA_SPDEF: -1.240257911501892, mRNA_AGR3: -1.8276267995167164, mRNA_FOXC1: 2.495305489083224, mRNA_GATA3: -2.805926459116168, mRNA_AGR2: -2.246356164643021, mRNA_XBP1: -1.9249344339189287, mRNA_PRR15: -2.077648420190362, mRNA_SLC44A4: -2.0598335963955314, mRNA_CA12: -2.336520866188205, mRNA_DTL: 1.141482113747904, mRNA_C5AR2: -1.0385844271649032, mRNA_TBC1D9: -1.814816811364333, mRNA_AR: -2.0922533219537027, mRNA_CCDC170: -1.8613493702545805, mRNA_DEGS2: -1.6621828704875257, mRNA_TFF3: -1.5215796690221128, mRNA_DNALI1: -1.7204218108399012, mRNA_LINC00504: -1.5140579342775182, mRNA_CLCA2: -0.8208413336086094, mRNA_PPP1R14C: 2.8285121889329075, mRNA_THSD4: -2.1089557807402834, mRNA_SPAG5: 0.7007275402293923, mRNA_FBP1: -2.1878955284694164, mRNA_SLC7A8: -1.47358940500209, mRNA_EN1: 2.8972158965503096, mRNA_ZNF552: -2.354658200077349, Methylation_LRRC6: 1.5110350786428453, Methylation_chr2 66218712 LINC02934 (29533): -0.8684041074846326, Methylation_HOXB13: 0.8263503655037737, Methylation_chr10 3949206 LINC02660 (4871): 1.627779254373498, Methylation_chr5 179517140 RNF130 (18026): -1.6039692867481916, Methylation_LOC727677: 1.5425557223173756, Methylation_LETM1: 1.3443248860505872, Methylation_CDC42BPB: 0.901031700146569, Methylation_C8orf38: 1.6802344033911956, Methylation_chr14 100504766 EVL (18852): 1.5282535050403123, Methylation_chr5 72594851 LOC340090 (24088): -1.51175366956884, Methylation_chr2 242904738 LINC01238 (3421): 1.4334468349223028, Methylation_ARFGEF1: 1.7562817740982763, Methylation_MAPT: 1.3738433945259385, Methylation_ZFAT: 1.3860835559492757, Methylation_KCNQ4: 1.3593223297150714, Methylation_chr1 232684368 SIPA1L2 (12934): 1.609948550538801, Methylation_CRNKL1: 1.312909183002268, Methylation_PRKAG2: 1.102663577991364, Methylation_MICB: 1.313171819092657, miRNA_hsa-mir-934: 2.9826552434373887, miRNA_hsa-mir-4728: -0.1841820481716745, miRNA_hsa-mir-5695: 0.1032780364395736, miRNA_hsa-mir-18a: 1.7331882532648617, miRNA_hsa-mir-190b: -1.826388333041552, miRNA_hsa-mir-577: 2.960152120822903, miRNA_hsa-mir-135b: 1.5516997568699358, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.589501075561442, miRNA_hsa-mir-130b: 1.205127024008648, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-A7-A26F,CLCA2 mRNA overexpression (Z=2.47) exceeds the high-expression threshold. No methylation sites meet hyper/hypo-methylation criteria. miR-190b is downregulated (Z=-2.05). All CNVs fall within the normal range. These features suggest a luminal phenotype with potential immune modulation.,"mRNA_MLPH: -1.186700483738835, mRNA_C2orf54: 0.2540617649707897, mRNA_CITED4: -1.3298652501151211, mRNA_ESR1: -1.3176392407441304, mRNA_SPDEF: -0.9956029204174996, mRNA_AGR3: -1.8663845558826155, mRNA_FOXC1: 0.1942294905608507, mRNA_GATA3: -1.6255054590676146, mRNA_AGR2: -0.6317234249059678, mRNA_XBP1: -1.5991621057078558, mRNA_PRR15: -1.7580273518661016, mRNA_SLC44A4: -1.5092302572172471, mRNA_CA12: -1.193356099063024, mRNA_DTL: -1.1406470310087833, mRNA_C5AR2: -1.3796161355604724, mRNA_TBC1D9: -1.3280629101419832, mRNA_AR: -0.4288672490488027, mRNA_CCDC170: -1.3833906047279956, mRNA_DEGS2: -1.5915375432719971, mRNA_TFF3: -1.7289184207000008, mRNA_DNALI1: -1.3710114852088882, mRNA_LINC00504: -1.7187053758715052, mRNA_CLCA2: 2.472264314102892, mRNA_PPP1R14C: 0.7606114940494062, mRNA_THSD4: -0.9235203207003896, mRNA_SPAG5: -0.7855751498536473, mRNA_FBP1: -1.890633146193686, mRNA_SLC7A8: -1.8311279602090604, mRNA_EN1: -0.2997764000878863, mRNA_ZNF552: -0.5958703124708639, Methylation_LRRC6: 0.8930838849382436, Methylation_chr2 66218712 LINC02934 (29533): -0.6503070292952566, Methylation_HOXB13: 0.2412754372438267, Methylation_chr10 3949206 LINC02660 (4871): 1.2016246571104068, Methylation_chr5 179517140 RNF130 (18026): 0.1887506457352372, Methylation_LOC727677: 1.554811508054568, Methylation_LETM1: 1.3074099421902572, Methylation_CDC42BPB: 0.2722274077195374, Methylation_C8orf38: 1.5541931382201075, Methylation_chr14 100504766 EVL (18852): 1.5598308397556049, Methylation_chr5 72594851 LOC340090 (24088): -0.0555407919710968, Methylation_chr2 242904738 LINC01238 (3421): 1.4145732718717328, Methylation_ARFGEF1: 0.9135504650046944, Methylation_MAPT: 1.2985791426034086, Methylation_ZFAT: 1.392216176923007, Methylation_KCNQ4: 1.209324025758313, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5268248378851517, Methylation_CRNKL1: 1.4163439883709117, Methylation_PRKAG2: -0.9265825703058014, Methylation_MICB: 1.5176802930067634, miRNA_hsa-mir-934: 1.8655721273735244, miRNA_hsa-mir-4728: -0.2617933006298999, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.1274231930992653, miRNA_hsa-mir-190b: -2.052137242410604, miRNA_hsa-mir-577: 0.2595300949846766, miRNA_hsa-mir-135b: 1.2495625707273326, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.7975251504429043, miRNA_hsa-mir-130b: 0.9699653077509472, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A1Y2,"Downregulated miRNA hsa-mir-190b (Z = -2.05) indicates significant suppression. All mRNA Z-scores fall within the neutral range (-1.92 to 1.30), showing no transcriptional dysregulation. Methylation levels show no hyper- or hypo-methylation events per thresholds. CNV values reflect uniform deletions across loci (all < -1.10). These features suggest a genomically unstable but transcriptionally quiescent phenotype.","mRNA_MLPH: -0.0570345043354758, mRNA_C2orf54: -1.282176647211016, mRNA_CITED4: 0.7957368401088939, mRNA_ESR1: 0.4370329422234472, mRNA_SPDEF: 0.1870957325411497, mRNA_AGR3: -1.5295500258001269, mRNA_FOXC1: -0.6961765104206681, mRNA_GATA3: 0.0384221411938354, mRNA_AGR2: -0.6040518223668722, mRNA_XBP1: -0.2839984371884638, mRNA_PRR15: -0.0628782279453479, mRNA_SLC44A4: -0.4676592408220513, mRNA_CA12: 0.3430996322485524, mRNA_DTL: -0.7110551640856079, mRNA_C5AR2: -0.2673012463022384, mRNA_TBC1D9: 0.4369002624611738, mRNA_AR: -0.3096653154003151, mRNA_CCDC170: -0.2565193098616253, mRNA_DEGS2: 0.7295112440990685, mRNA_TFF3: -0.027986708756647, mRNA_DNALI1: -0.1979558385768005, mRNA_LINC00504: -0.1088445228052852, mRNA_CLCA2: -0.831026443098161, mRNA_PPP1R14C: -0.3674048900116034, mRNA_THSD4: -0.0765901436807343, mRNA_SPAG5: -0.1591358936484307, mRNA_FBP1: 0.4241826950225997, mRNA_SLC7A8: -0.0704531388967624, mRNA_EN1: 0.1733086767376607, mRNA_ZNF552: -1.0071537034060407, Methylation_LRRC6: -0.561034211299235, Methylation_chr2 66218712 LINC02934 (29533): 0.607094978482492, Methylation_HOXB13: -1.0951056048007053, Methylation_chr10 3949206 LINC02660 (4871): -0.379161924518369, Methylation_chr5 179517140 RNF130 (18026): 0.1708769102068845, Methylation_LOC727677: -0.4305595846635165, Methylation_LETM1: 0.6474403329760042, Methylation_CDC42BPB: -0.0281901561206788, Methylation_C8orf38: -0.6662037639089905, Methylation_chr14 100504766 EVL (18852): 0.3783433202384211, Methylation_chr5 72594851 LOC340090 (24088): -0.7117643968757178, Methylation_chr2 242904738 LINC01238 (3421): -0.2988243133665893, Methylation_ARFGEF1: -0.351858064846073, Methylation_MAPT: -0.3008466653282539, Methylation_ZFAT: -0.730791146148944, Methylation_KCNQ4: -0.0151838523998779, Methylation_chr1 232684368 SIPA1L2 (12934): 0.7580491108117973, Methylation_CRNKL1: 0.7231424699498443, Methylation_PRKAG2: 0.5183397868255732, Methylation_MICB: 0.5613517430213556, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.7952263381659097, miRNA_hsa-mir-190b: -2.052137242410604, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.9704796655268616, miRNA_hsa-mir-2115: -0.1570284166653876, miRNA_hsa-mir-17: -1.078103632295165, miRNA_hsa-mir-130b: -1.0340416608335596, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A27G,"SLC7A8 mRNA overexpression (Z=1.79) indicates high expression.  
LINC02576 and CEP68 deletions (CNV ≤ -1.65) suggest loss-of-function.  
No methylation or miRNA alterations meet diagnostic thresholds.  
These features align with a luminal phenotype showing SLC7A8-driven metabolic dysregulation.","mRNA_MLPH: 0.526098188509479, mRNA_C2orf54: -0.7336638374869824, mRNA_CITED4: -1.065494206401434, mRNA_ESR1: 0.1981558689789191, mRNA_SPDEF: 0.6208831486333263, mRNA_AGR3: 0.8560276108173006, mRNA_FOXC1: -0.4675752395596251, mRNA_GATA3: 0.4282120548769883, mRNA_AGR2: 0.4976082461337954, mRNA_XBP1: 0.6810998169160576, mRNA_PRR15: 0.4837986333589427, mRNA_SLC44A4: 0.7037225221171854, mRNA_CA12: 0.744027233675182, mRNA_DTL: 0.3081747421953636, mRNA_C5AR2: -0.54187835836448, mRNA_TBC1D9: 0.9003054753811858, mRNA_AR: 0.524091088913083, mRNA_CCDC170: -1.2973048863574708, mRNA_DEGS2: 0.915596264075103, mRNA_TFF3: 0.5588910851352694, mRNA_DNALI1: 0.617707395381019, mRNA_LINC00504: 1.020755917078704, mRNA_CLCA2: -0.0665215711765616, mRNA_PPP1R14C: -0.5493074446694777, mRNA_THSD4: 0.9290838382291828, mRNA_SPAG5: 0.2670974559748389, mRNA_FBP1: 0.147082248099354, mRNA_SLC7A8: 1.786695998527327, mRNA_EN1: 0.0922336604529657, mRNA_ZNF552: -1.3758925949462162, Methylation_LRRC6: 0.1659431236636923, Methylation_chr2 66218712 LINC02934 (29533): 1.0451140460808424, Methylation_HOXB13: 0.4594977678985255, Methylation_chr10 3949206 LINC02660 (4871): 0.5622138924986783, Methylation_chr5 179517140 RNF130 (18026): 0.4713583112741681, Methylation_LOC727677: 1.4490851807008367, Methylation_LETM1: -0.1817150001770445, Methylation_CDC42BPB: -0.3826803081698365, Methylation_C8orf38: 0.6279379520356988, Methylation_chr14 100504766 EVL (18852): 0.3262809154417067, Methylation_chr5 72594851 LOC340090 (24088): 0.535391558555168, Methylation_chr2 242904738 LINC01238 (3421): 1.3846367678950102, Methylation_ARFGEF1: 0.4681867365899449, Methylation_MAPT: 0.056676032890862, Methylation_ZFAT: 0.272063109489374, Methylation_KCNQ4: 0.8176511782779267, Methylation_chr1 232684368 SIPA1L2 (12934): 0.3946410014349014, Methylation_CRNKL1: 0.2704882182059742, Methylation_PRKAG2: 0.9477793570138204, Methylation_MICB: -0.2585042136195608, miRNA_hsa-mir-934: -0.4340168083332339, miRNA_hsa-mir-4728: 0.1285345351146362, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.2800079504103536, miRNA_hsa-mir-190b: -0.8645738861176553, miRNA_hsa-mir-577: -0.6097663064525617, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: -0.2165141948256218, miRNA_hsa-mir-17: -1.011853399289253, miRNA_hsa-mir-130b: -0.8665557291407338, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -1.657048777669473, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -1.657048777669473"
TCGA-A2-A1G0,High mRNA_TBC1D9 (Z=1.56) and mRNA_DNALI1 (Z=1.31) indicate overexpression. No methylation or miRNA alterations meet diagnostic thresholds. All CNVs fall within normal range (−1.10 to −0.10). These features collectively indicate a luminal phenotype with cell cycle dysregulation.,"mRNA_MLPH: 0.5563872567381378, mRNA_C2orf54: -1.0074716430735682, mRNA_CITED4: 0.1632199063163275, mRNA_ESR1: 0.0896577761572177, mRNA_SPDEF: 0.3997517774651579, mRNA_AGR3: 0.3620540164513269, mRNA_FOXC1: 0.1442216561030699, mRNA_GATA3: 0.5260100235409573, mRNA_AGR2: 0.7040521726706253, mRNA_XBP1: 0.5869835431693008, mRNA_PRR15: -0.0308533029667738, mRNA_SLC44A4: 0.6965358444276257, mRNA_CA12: 1.2436173042296446, mRNA_DTL: -1.2784306275641748, mRNA_C5AR2: 0.5345261405455184, mRNA_TBC1D9: 1.5552111626666092, mRNA_AR: 0.5475897975435109, mRNA_CCDC170: 0.8562089747983264, mRNA_DEGS2: 0.4180819282964206, mRNA_TFF3: 0.4042634714298577, mRNA_DNALI1: 1.3148158852485234, mRNA_LINC00504: 0.6702708211598285, mRNA_CLCA2: -0.6327459792289317, mRNA_PPP1R14C: -0.2463087154492912, mRNA_THSD4: 1.407898906170175, mRNA_SPAG5: -1.1404219781561504, mRNA_FBP1: 0.0890729636596085, mRNA_SLC7A8: 0.8222508075091038, mRNA_EN1: -0.6629458112211428, mRNA_ZNF552: 1.2420959060150976, Methylation_LRRC6: -0.2781386911106576, Methylation_chr2 66218712 LINC02934 (29533): 1.0991837915612594, Methylation_HOXB13: -1.062618232922974, Methylation_chr10 3949206 LINC02660 (4871): -0.2540076630193794, Methylation_chr5 179517140 RNF130 (18026): 0.3510066044057524, Methylation_LOC727677: -0.6574682285401886, Methylation_LETM1: -0.6232128140297182, Methylation_CDC42BPB: -0.9843392188743738, Methylation_C8orf38: -0.271410161797758, Methylation_chr14 100504766 EVL (18852): 0.2906229426038186, Methylation_chr5 72594851 LOC340090 (24088): -0.2337369279238401, Methylation_chr2 242904738 LINC01238 (3421): -0.5160964678256067, Methylation_ARFGEF1: -0.2053085030515515, Methylation_MAPT: -0.3828895666775262, Methylation_ZFAT: -0.6684439982316281, Methylation_KCNQ4: -1.1427866604667858, Methylation_chr1 232684368 SIPA1L2 (12934): 0.2843564147413345, Methylation_CRNKL1: -0.3588740692966499, Methylation_PRKAG2: 0.8928954125042108, Methylation_MICB: 0.0785611489224633, miRNA_hsa-mir-934: -0.0687234733923135, miRNA_hsa-mir-4728: -0.0910704707464604, miRNA_hsa-mir-5695: 0.0629673071229021, miRNA_hsa-mir-18a: -0.8767543353874948, miRNA_hsa-mir-190b: 0.1586872917831809, miRNA_hsa-mir-577: 0.5333323873974894, miRNA_hsa-mir-135b: -0.4766997988471569, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.54015933380641, miRNA_hsa-mir-130b: -0.2344153870291142, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A1NF,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives genomic instability. CLCA2 mRNA overexpression (Z=1.30) meets high-expression threshold. miRNA hsa-mir-190b upregulated (Z=1.90). No methylation or deletion events meet diagnostic thresholds. These features suggest a luminal-like phenotype with potential cell cycle dysregulation.","mRNA_MLPH: -1.0438996608113598, mRNA_C2orf54: 0.0188427539504417, mRNA_CITED4: -1.032926162107663, mRNA_ESR1: 0.6925569653623095, mRNA_SPDEF: -0.0158258341552576, mRNA_AGR3: 0.3767864295756461, mRNA_FOXC1: -0.640711696515477, mRNA_GATA3: -0.6361552383788512, mRNA_AGR2: -0.349014140657691, mRNA_XBP1: -0.4043418852598076, mRNA_PRR15: -0.2591735563025103, mRNA_SLC44A4: -0.2784804158736399, mRNA_CA12: 0.2205741260180806, mRNA_DTL: -0.9874056837806012, mRNA_C5AR2: -0.5047053286916741, mRNA_TBC1D9: -0.0830018623555384, mRNA_AR: 0.6695882521018248, mRNA_CCDC170: 0.565811389652836, mRNA_DEGS2: 0.719146643845032, mRNA_TFF3: -0.1873405160763201, mRNA_DNALI1: -1.4381326880484102, mRNA_LINC00504: -0.2266102978438526, mRNA_CLCA2: 1.3045103867657823, mRNA_PPP1R14C: -0.7914629152759646, mRNA_THSD4: -0.3796935461127469, mRNA_SPAG5: -0.94623111932404, mRNA_FBP1: -0.505428740966874, mRNA_SLC7A8: 0.3796638969674974, mRNA_EN1: 0.680241112412495, mRNA_ZNF552: -0.8956378108479843, Methylation_LRRC6: -0.4759916048258287, Methylation_chr2 66218712 LINC02934 (29533): 1.3553278920224114, Methylation_HOXB13: 0.6855271310435009, Methylation_chr10 3949206 LINC02660 (4871): -0.8901278767619745, Methylation_chr5 179517140 RNF130 (18026): 0.3955717104614081, Methylation_LOC727677: -0.7483135729675795, Methylation_LETM1: -0.5546646962230145, Methylation_CDC42BPB: -1.128787954614269, Methylation_C8orf38: -0.9561984844583422, Methylation_chr14 100504766 EVL (18852): -0.8426559934208419, Methylation_chr5 72594851 LOC340090 (24088): 0.2483038560587696, Methylation_chr2 242904738 LINC01238 (3421): 0.0230870359695712, Methylation_ARFGEF1: -0.3916885823417285, Methylation_MAPT: -0.2388732107498839, Methylation_ZFAT: -0.7663707564420027, Methylation_KCNQ4: -1.107598342839054, Methylation_chr1 232684368 SIPA1L2 (12934): 0.1106487113852769, Methylation_CRNKL1: 0.0733855322457632, Methylation_PRKAG2: -1.0655941515471092, Methylation_MICB: 1.130788481073483, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.0539967593914518, miRNA_hsa-mir-5695: 0.099608255631124, miRNA_hsa-mir-18a: -0.4190312681898688, miRNA_hsa-mir-190b: 1.9042421089847807, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.6914238708383468, miRNA_hsa-mir-2115: 0.9660494097944315, miRNA_hsa-mir-17: 0.1839971869625898, miRNA_hsa-mir-130b: 0.3651149322140744, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-BH-A5J0,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives genomic instability. No mRNA, methylation, or miRNA features meet diagnostic thresholds for reporting. These CNVs suggest a proliferative phenotype with potential vesicular trafficking dysregulation.","mRNA_MLPH: 0.7878440023790498, mRNA_C2orf54: 0.3095316279191726, mRNA_CITED4: -0.0590539255509703, mRNA_ESR1: 0.4606689040567472, mRNA_SPDEF: 0.7947528323624584, mRNA_AGR3: 0.8436470379027884, mRNA_FOXC1: -0.5173562132034939, mRNA_GATA3: 0.1711570064569143, mRNA_AGR2: 0.7899218366574519, mRNA_XBP1: 0.2371961405023233, mRNA_PRR15: 1.407508269209697, mRNA_SLC44A4: 0.8169001483098693, mRNA_CA12: 0.4454031581651309, mRNA_DTL: -0.5194493089854513, mRNA_C5AR2: 0.6314777492094195, mRNA_TBC1D9: 0.2046456413686176, mRNA_AR: 0.7531139495176913, mRNA_CCDC170: 0.6211331965300797, mRNA_DEGS2: 0.6539591308047185, mRNA_TFF3: 0.6310741170790342, mRNA_DNALI1: 0.3468422563356153, mRNA_LINC00504: 0.7588492167077246, mRNA_CLCA2: -0.5028623320770763, mRNA_PPP1R14C: -0.4006698794465326, mRNA_THSD4: -0.4867765614281078, mRNA_SPAG5: -1.1662883437956688, mRNA_FBP1: 0.4062806992445317, mRNA_SLC7A8: -0.1111378069721918, mRNA_EN1: 0.0557356052561455, mRNA_ZNF552: -0.6997143267995065, Methylation_LRRC6: 0.0818700689723552, Methylation_chr2 66218712 LINC02934 (29533): -0.9661363648616574, Methylation_HOXB13: 0.7061713284959262, Methylation_chr10 3949206 LINC02660 (4871): -0.5003261628357889, Methylation_chr5 179517140 RNF130 (18026): 0.7516571474239185, Methylation_LOC727677: -0.6420094776733805, Methylation_LETM1: -1.305543524450861, Methylation_CDC42BPB: -0.900745764467151, Methylation_C8orf38: -0.7174945803099537, Methylation_chr14 100504766 EVL (18852): -0.6086755653593655, Methylation_chr5 72594851 LOC340090 (24088): 0.8081469987019929, Methylation_chr2 242904738 LINC01238 (3421): -0.5111910139745913, Methylation_ARFGEF1: 0.0489090772369606, Methylation_MAPT: -0.1055959595504575, Methylation_ZFAT: -0.7906380110636225, Methylation_KCNQ4: -0.1932786744389124, Methylation_chr1 232684368 SIPA1L2 (12934): -0.2315127114720633, Methylation_CRNKL1: -0.1940296483073813, Methylation_PRKAG2: 0.7794141977560638, Methylation_MICB: -0.3731614625394802, miRNA_hsa-mir-934: -0.5194529501351646, miRNA_hsa-mir-4728: -0.2942356985297912, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.2198611208788104, miRNA_hsa-mir-190b: 0.6785330801586473, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.4935991029785256, miRNA_hsa-mir-2115: -0.261434068464894, miRNA_hsa-mir-17: 0.0233221958497259, miRNA_hsa-mir-130b: -0.304811783380636, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-D8-A1XD,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.2248878418845994, mRNA_C2orf54: -0.0713138986583889, mRNA_CITED4: -1.2331630546461407, mRNA_ESR1: 0.4895691449389062, mRNA_SPDEF: 0.3785365228865086, mRNA_AGR3: -1.725158556405823, mRNA_FOXC1: -0.6619219299364086, mRNA_GATA3: 0.6022969727252024, mRNA_AGR2: -0.7745001207592617, mRNA_XBP1: 0.2418603206785462, mRNA_PRR15: 0.3780977211842056, mRNA_SLC44A4: -1.53585477744602, mRNA_CA12: 0.5589771752404847, mRNA_DTL: 0.1399325266643775, mRNA_C5AR2: -1.122242096175496, mRNA_TBC1D9: 0.4442639055219353, mRNA_AR: 0.5690178220255464, mRNA_CCDC170: -0.859404790958217, mRNA_DEGS2: 0.5055789121293658, mRNA_TFF3: -0.2300885687653295, mRNA_DNALI1: 0.7952965638598392, mRNA_LINC00504: 0.5640147608424332, mRNA_CLCA2: -0.071356674798192, mRNA_PPP1R14C: 0.1392211693764348, mRNA_THSD4: 1.423377970154364, mRNA_SPAG5: 0.2443415787919065, mRNA_FBP1: -0.1860382164730208, mRNA_SLC7A8: 1.5316980610796402, mRNA_EN1: -0.378648125278629, mRNA_ZNF552: 1.648006182321534, Methylation_LRRC6: -0.8652946978833692, Methylation_chr2 66218712 LINC02934 (29533): 1.1853596548907244, Methylation_HOXB13: -1.072327818246149, Methylation_chr10 3949206 LINC02660 (4871): -0.8428768571629748, Methylation_chr5 179517140 RNF130 (18026): 0.8003040046621043, Methylation_LOC727677: -1.238247671755085, Methylation_LETM1: -1.1942507762916197, Methylation_CDC42BPB: -1.0999164813582505, Methylation_C8orf38: -0.9284628447185412, Methylation_chr14 100504766 EVL (18852): -1.0738875876125675, Methylation_chr5 72594851 LOC340090 (24088): -1.1518046424486224, Methylation_chr2 242904738 LINC01238 (3421): -1.2072384448331162, Methylation_ARFGEF1: -0.4132285199926757, Methylation_MAPT: -0.8698180523654737, Methylation_ZFAT: -1.272799526063212, Methylation_KCNQ4: 0.8202801042655766, Methylation_chr1 232684368 SIPA1L2 (12934): -0.5499121896478757, Methylation_CRNKL1: -0.8854753567638483, Methylation_PRKAG2: -0.0936002020093273, Methylation_MICB: -0.8964446456810452, miRNA_hsa-mir-934: -0.3201467261118575, miRNA_hsa-mir-4728: 0.7474501106706806, miRNA_hsa-mir-5695: 1.0829717568096908, miRNA_hsa-mir-18a: -0.8524173742956063, miRNA_hsa-mir-190b: 0.4876965258455512, miRNA_hsa-mir-577: -0.5045040807571866, miRNA_hsa-mir-135b: -0.2725685553117815, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.296644692305671, miRNA_hsa-mir-130b: -0.4609708230559062, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A1-A0SP,"High-level Amplification of PPP1R14C drives significant mRNA overexpression. FOXC1 and EN1 mRNA are elevated (Z > 1.30). GATA3, AR, DEGS2, and MLPH show low mRNA (Z < -1.92). Promoter hypermethylation at C8orf38, EVL, and ZFAT (Z > 1.50); hypomethylation at RNF130 and LOC340090 (Z < -1.47). miR-577, miR-135b upregulated (Z > 1.99); miR-190b downregulated (Z < -1.25). Deletions absent; all CNVs normal.","mRNA_MLPH: -2.367642455810421, mRNA_C2orf54: 1.1730110026284744, mRNA_CITED4: -0.6620540014753479, mRNA_ESR1: -1.6081606641241104, mRNA_SPDEF: -1.7725154590274137, mRNA_AGR3: -1.766321267394283, mRNA_FOXC1: 1.871674081805079, mRNA_GATA3: -2.3326328891229537, mRNA_AGR2: -1.5053808706159513, mRNA_XBP1: -1.88248474185796, mRNA_PRR15: -1.895810998780792, mRNA_SLC44A4: -0.959243779953052, mRNA_CA12: -1.7493749210272749, mRNA_DTL: 0.6599681208037136, mRNA_C5AR2: -1.553963455681408, mRNA_TBC1D9: -1.727173993239412, mRNA_AR: -2.295563205957972, mRNA_CCDC170: -1.5799621706858462, mRNA_DEGS2: -2.058520497196274, mRNA_TFF3: 0.2082048903096724, mRNA_DNALI1: -1.9381709124248545, mRNA_LINC00504: -1.5702966103409466, mRNA_CLCA2: -0.842974653460908, mRNA_PPP1R14C: 3.03227008022711, mRNA_THSD4: -1.876480641552589, mRNA_SPAG5: 0.4024097684794214, mRNA_FBP1: 0.4815542485728769, mRNA_SLC7A8: -1.9434377656409685, mRNA_EN1: 1.9443999673722128, mRNA_ZNF552: -1.707325321266845, Methylation_LRRC6: 1.3286774564962074, Methylation_chr2 66218712 LINC02934 (29533): -0.0993456216833415, Methylation_HOXB13: 0.9412530491489504, Methylation_chr10 3949206 LINC02660 (4871): 0.8666983670188065, Methylation_chr5 179517140 RNF130 (18026): -1.430688190178766, Methylation_LOC727677: 1.4590612980772832, Methylation_LETM1: 1.3572300546117284, Methylation_CDC42BPB: -0.5276125956117388, Methylation_C8orf38: 1.5348316422241552, Methylation_chr14 100504766 EVL (18852): 1.4378125565553248, Methylation_chr5 72594851 LOC340090 (24088): -1.5121922502642071, Methylation_chr2 242904738 LINC01238 (3421): 1.3715682458451437, Methylation_ARFGEF1: 1.3714203753391123, Methylation_MAPT: 1.321678514963385, Methylation_ZFAT: 1.3962365645416226, Methylation_KCNQ4: 0.7041551044911398, Methylation_chr1 232684368 SIPA1L2 (12934): 1.1195924978211138, Methylation_CRNKL1: 1.298720671512832, Methylation_PRKAG2: -1.3230060848159817, Methylation_MICB: 1.18661822062786, miRNA_hsa-mir-934: 1.1067111638639078, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.9532166868073644, miRNA_hsa-mir-190b: -2.052137242410604, miRNA_hsa-mir-577: 2.6096405761980512, miRNA_hsa-mir-135b: 2.231256579412533, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.3045623850449972, miRNA_hsa-mir-130b: 1.5408630989009922, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-UL-AAZ6,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. HOXB13 and KCNQ4 promoter hypermethylation mediates epigenetic silencing. ZNF552 mRNA is downregulated (Z = -1.40). hsa-mir-4728 is upregulated (Z = 3.30). LETM1 and ZFAT are hypomethylated (Z < -1.47). These features indicate a luminal B phenotype with PI3K/AKT pathway dysregulation.","mRNA_MLPH: 0.7076372380699198, mRNA_C2orf54: -0.7044708258616977, mRNA_CITED4: -1.2621333932536123, mRNA_ESR1: 0.1976976504265847, mRNA_SPDEF: 0.2772942670737595, mRNA_AGR3: -0.3458901327538224, mRNA_FOXC1: -0.5970998464521887, mRNA_GATA3: 0.0196905319896482, mRNA_AGR2: -0.6772535485509728, mRNA_XBP1: -0.3183932898877127, mRNA_PRR15: 0.6065728920320956, mRNA_SLC44A4: -0.606648535423051, mRNA_CA12: -0.3439284411866051, mRNA_DTL: -0.0757950073180518, mRNA_C5AR2: 0.2646908258489128, mRNA_TBC1D9: -0.4282844405633552, mRNA_AR: -0.1608880759496117, mRNA_CCDC170: 0.7033730260436829, mRNA_DEGS2: 0.461739954726775, mRNA_TFF3: -0.0014377950479831, mRNA_DNALI1: 0.7574813233375121, mRNA_LINC00504: -0.6516610795151726, mRNA_CLCA2: -0.8590552771835487, mRNA_PPP1R14C: -0.5546733592384957, mRNA_THSD4: -0.031012883922594, mRNA_SPAG5: 0.587358128163401, mRNA_FBP1: 0.5796092545919835, mRNA_SLC7A8: -0.871119407691177, mRNA_EN1: -1.070423611005988, mRNA_ZNF552: -1.403727149851553, Methylation_LRRC6: -1.4130725840254574, Methylation_chr2 66218712 LINC02934 (29533): -1.1373855963036987, Methylation_HOXB13: 1.7642993435760426, Methylation_chr10 3949206 LINC02660 (4871): -1.356919579537085, Methylation_chr5 179517140 RNF130 (18026): 0.951026852546282, Methylation_LOC727677: -1.345986407603448, Methylation_LETM1: -1.4781365949968086, Methylation_CDC42BPB: 1.156213663358258, Methylation_C8orf38: -0.9709617333183584, Methylation_chr14 100504766 EVL (18852): -1.1095891421903632, Methylation_chr5 72594851 LOC340090 (24088): 1.0877486999918085, Methylation_chr2 242904738 LINC01238 (3421): -1.3120213605318565, Methylation_ARFGEF1: -1.1141458532010464, Methylation_MAPT: -0.6050807350575562, Methylation_ZFAT: -1.5497425606762842, Methylation_KCNQ4: 1.6319817582275722, Methylation_chr1 232684368 SIPA1L2 (12934): -1.202764716878449, Methylation_CRNKL1: -1.0004144817532774, Methylation_PRKAG2: 1.30683344340229, Methylation_MICB: -0.6807320957982901, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 3.299122028874305, miRNA_hsa-mir-5695: 1.2362461794886868, miRNA_hsa-mir-18a: -0.0579193574072002, miRNA_hsa-mir-190b: 0.3640558061894561, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: 0.3100764402297431, miRNA_hsa-mir-2115: -0.3500909898733163, miRNA_hsa-mir-17: 0.494535344648267, miRNA_hsa-mir-130b: -0.7278082587917567, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-E9-A1QZ,"Deletion of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 correlates with transcriptional downregulation. No mRNA, methylation, or miRNA features meet diagnostic thresholds for significant dysregulation.","mRNA_MLPH: 0.0846408476659653, mRNA_C2orf54: -1.2086621725484743, mRNA_CITED4: -0.5208623250471255, mRNA_ESR1: 0.5019624724702609, mRNA_SPDEF: -0.4305737306944399, mRNA_AGR3: 0.7262500331714938, mRNA_FOXC1: 0.0227024684295523, mRNA_GATA3: 0.3710961732947245, mRNA_AGR2: 0.956965677252022, mRNA_XBP1: 0.1406597770675672, mRNA_PRR15: -0.6109154173103629, mRNA_SLC44A4: 0.4372458782200135, mRNA_CA12: 0.7718875256264252, mRNA_DTL: 0.9336759689630938, mRNA_C5AR2: -0.4600765844923954, mRNA_TBC1D9: 0.6253974387414349, mRNA_AR: 0.2311800259411137, mRNA_CCDC170: 0.4165897238442161, mRNA_DEGS2: -0.1927279015057786, mRNA_TFF3: -0.6507058700143796, mRNA_DNALI1: 0.4724474107185294, mRNA_LINC00504: 0.969119437891751, mRNA_CLCA2: -0.3050670599916414, mRNA_PPP1R14C: -0.2876669946158492, mRNA_THSD4: 0.7714047716298291, mRNA_SPAG5: 1.1076549144253218, mRNA_FBP1: 0.234353747972263, mRNA_SLC7A8: 0.1384179858129479, mRNA_EN1: -0.8214121610618702, mRNA_ZNF552: 0.794463893988638, Methylation_LRRC6: 1.0181756248002194, Methylation_chr2 66218712 LINC02934 (29533): -0.0393073908358618, Methylation_HOXB13: -1.0702225618425898, Methylation_chr10 3949206 LINC02660 (4871): 0.8455214461461493, Methylation_chr5 179517140 RNF130 (18026): -0.1660972525056804, Methylation_LOC727677: 0.5832199586610468, Methylation_LETM1: 0.414400274647376, Methylation_CDC42BPB: -0.1531891470176834, Methylation_C8orf38: 0.9821223172468572, Methylation_chr14 100504766 EVL (18852): 1.2352992963123468, Methylation_chr5 72594851 LOC340090 (24088): 0.1394732027628514, Methylation_chr2 242904738 LINC01238 (3421): 0.1815609681095401, Methylation_ARFGEF1: 1.198605627417746, Methylation_MAPT: 0.3966667767554974, Methylation_ZFAT: 0.5005888829083959, Methylation_KCNQ4: -0.8737541083238638, Methylation_chr1 232684368 SIPA1L2 (12934): 0.9403823894146052, Methylation_CRNKL1: 0.6840891258863658, Methylation_PRKAG2: 0.068034615830418, Methylation_MICB: 0.7048981166132154, miRNA_hsa-mir-934: 0.1233250617457695, miRNA_hsa-mir-4728: 0.0563423806219421, miRNA_hsa-mir-5695: -0.3080925441218883, miRNA_hsa-mir-18a: -0.5511415703166977, miRNA_hsa-mir-190b: -0.5226464030293195, miRNA_hsa-mir-577: 0.3415901636255569, miRNA_hsa-mir-135b: -0.493461473178362, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.3807305257810706, miRNA_hsa-mir-130b: -0.7303484479099788, CNV_VPS54: -1.6173912818721974, CNV_LINC01867: -1.63714039509435, CNV_LINC02576: -1.657048777669473, CNV_WDPCP: -1.6249341592372952, CNV_CEP68: -1.657048777669473"
TCGA-AC-A23E,"No features meet the strict diagnostic thresholds for mRNA (Z > 1.30 or Z < -1.92), methylation (Z > 1.50 or Z < -1.47), miRNA (Z > 1.99 or Z < -1.25), or CNV (deletion, gain, amplification, or high-level amplification). All values fall within non-actionable ranges.","mRNA_MLPH: 0.0681300474411838, mRNA_C2orf54: -0.1561768150060694, mRNA_CITED4: -0.183140291585627, mRNA_ESR1: 0.1304891159985262, mRNA_SPDEF: 0.0287025409773805, mRNA_AGR3: 0.501917319683667, mRNA_FOXC1: -0.2561144592303623, mRNA_GATA3: 0.3821433084597282, mRNA_AGR2: 0.041282817396906, mRNA_XBP1: 0.9448624178695424, mRNA_PRR15: 0.0706887615109017, mRNA_SLC44A4: 0.9974287261428884, mRNA_CA12: 0.5517077959992958, mRNA_DTL: -0.239010724522254, mRNA_C5AR2: 0.7275130688568846, mRNA_TBC1D9: 0.0274410553985439, mRNA_AR: 0.9051977216391296, mRNA_CCDC170: 0.5729239986523638, mRNA_DEGS2: 0.5455080957169669, mRNA_TFF3: 0.4757998776012169, mRNA_DNALI1: 0.5780791921338317, mRNA_LINC00504: 0.4356638068736281, mRNA_CLCA2: -0.3174561406098221, mRNA_PPP1R14C: -0.088679842966611, mRNA_THSD4: 0.2824394449011707, mRNA_SPAG5: -1.0133178446625546, mRNA_FBP1: 0.0420507448424454, mRNA_SLC7A8: 0.3733565558953833, mRNA_EN1: -0.1528050090507461, mRNA_ZNF552: 0.5719361696733214, Methylation_LRRC6: -0.2894151659866996, Methylation_chr2 66218712 LINC02934 (29533): -0.5455579399568778, Methylation_HOXB13: 0.7443224077647578, Methylation_chr10 3949206 LINC02660 (4871): -1.032437147647443, Methylation_chr5 179517140 RNF130 (18026): 0.848477934049498, Methylation_LOC727677: -0.6731434706675382, Methylation_LETM1: -0.3336912064070571, Methylation_CDC42BPB: -1.1625245148245964, Methylation_C8orf38: -0.7503548112586472, Methylation_chr14 100504766 EVL (18852): -0.5658733905487351, Methylation_chr5 72594851 LOC340090 (24088): 0.5489205309046317, Methylation_chr2 242904738 LINC01238 (3421): -0.6862625394398749, Methylation_ARFGEF1: -0.3040457786871166, Methylation_MAPT: -0.7412559499050867, Methylation_ZFAT: -0.6373890561727017, Methylation_KCNQ4: -0.9106326267828228, Methylation_chr1 232684368 SIPA1L2 (12934): -0.5297150229895118, Methylation_CRNKL1: -0.2248480352742835, Methylation_PRKAG2: -0.7767616399717063, Methylation_MICB: -0.9394636235304809, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.0111700005206522, miRNA_hsa-mir-5695: 0.583757501997574, miRNA_hsa-mir-18a: -0.4807211869001552, miRNA_hsa-mir-190b: 0.9104898722803088, miRNA_hsa-mir-577: -0.434548308035533, miRNA_hsa-mir-135b: -0.3147453392939652, miRNA_hsa-mir-2115: -0.5257991976339571, miRNA_hsa-mir-17: -0.3182957618871477, miRNA_hsa-mir-130b: 0.4753205175846859, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-A2-A1FW,"mRNA_CITED4 (Z = -2.48) is significantly downregulated. mRNA_SPAG5 (Z = 2.35) and mRNA_PRR15 (Z = 1.38) are highly overexpressed. Methylation_ZFAT (Z = -1.74), Methylation_CRNKL1 (Z = -1.63), and Methylation_LETM1 (Z = -1.61) are hypomethylated. No CNVs meet amplification or deletion thresholds. These features suggest luminal breast cancer with ER pathway activation and potential immune modulation.","mRNA_MLPH: 0.2163649292212936, mRNA_C2orf54: -1.280285327362888, mRNA_CITED4: -2.4807029143523867, mRNA_ESR1: 1.195102643519185, mRNA_SPDEF: 0.7116328233397817, mRNA_AGR3: 1.2848846771972693, mRNA_FOXC1: -0.6561607286999113, mRNA_GATA3: 1.1002600760316377, mRNA_AGR2: 0.5902111738914442, mRNA_XBP1: 1.0382600273991265, mRNA_PRR15: 1.3838630452064569, mRNA_SLC44A4: 0.421044557276557, mRNA_CA12: -0.6698087039602604, mRNA_DTL: -0.165574886774685, mRNA_C5AR2: -0.3426013931341672, mRNA_TBC1D9: 1.454317829020747, mRNA_AR: 1.1584285327208417, mRNA_CCDC170: 0.9734766371691516, mRNA_DEGS2: -0.9090706545201406, mRNA_TFF3: 0.373123615782001, mRNA_DNALI1: 0.5962009531578821, mRNA_LINC00504: 0.3575581585959162, mRNA_CLCA2: -0.6159855224119604, mRNA_PPP1R14C: -0.6599984136021864, mRNA_THSD4: 1.3227432626416695, mRNA_SPAG5: 2.354119315438508, mRNA_FBP1: 1.095986709979922, mRNA_SLC7A8: 0.7064776477981984, mRNA_EN1: -0.7521530361867608, mRNA_ZNF552: 0.4835783200290052, Methylation_LRRC6: -1.5582116949152212, Methylation_chr2 66218712 LINC02934 (29533): -0.2045502124457325, Methylation_HOXB13: -1.0558487562229917, Methylation_chr10 3949206 LINC02660 (4871): -0.93044401009182, Methylation_chr5 179517140 RNF130 (18026): 1.2564156130753492, Methylation_LOC727677: -1.6050702102961214, Methylation_LETM1: -1.6072600370257426, Methylation_CDC42BPB: 1.3839964727756453, Methylation_C8orf38: -0.186382899509153, Methylation_chr14 100504766 EVL (18852): -1.4906140147106868, Methylation_chr5 72594851 LOC340090 (24088): 1.3282608349565423, Methylation_chr2 242904738 LINC01238 (3421): -1.5378516569424283, Methylation_ARFGEF1: -1.4189265145362493, Methylation_MAPT: -0.5500486105247171, Methylation_ZFAT: -1.738582855261918, Methylation_KCNQ4: -0.5472822180578854, Methylation_chr1 232684368 SIPA1L2 (12934): -1.4165195398234425, Methylation_CRNKL1: -1.6292301648343956, Methylation_PRKAG2: 1.3050031981547077, Methylation_MICB: -1.3801622375905531, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.2939923246423391, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.1260825605907855, miRNA_hsa-mir-190b: 0.6411104095694066, miRNA_hsa-mir-577: -0.4313169324067899, miRNA_hsa-mir-135b: -0.5244825735759571, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.5740031017361094, miRNA_hsa-mir-130b: 0.2850546835809236, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-BH-A0H0,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 1.0394672837486445, mRNA_C2orf54: -1.2943230935752186, mRNA_CITED4: -1.0920736414735774, mRNA_ESR1: 0.6544598163501998, mRNA_SPDEF: 0.628172348996085, mRNA_AGR3: 0.2338661835019032, mRNA_FOXC1: -1.1127798154360922, mRNA_GATA3: 0.7409326788175906, mRNA_AGR2: 0.7520320557995448, mRNA_XBP1: 0.3779678383276426, mRNA_PRR15: 0.9065588245829064, mRNA_SLC44A4: 0.6542071890829295, mRNA_CA12: 0.1615592790961885, mRNA_DTL: 1.8986711812373125, mRNA_C5AR2: 0.0419876405763671, mRNA_TBC1D9: 0.9863164723921596, mRNA_AR: 0.9558187356191168, mRNA_CCDC170: -0.1248832830867246, mRNA_DEGS2: 0.7972218283156328, mRNA_TFF3: -1.571048097253784, mRNA_DNALI1: 0.755453310746501, mRNA_LINC00504: 0.9730305320787502, mRNA_CLCA2: -0.7945120881206947, mRNA_PPP1R14C: -1.1152688287134795, mRNA_THSD4: 0.0610982731412944, mRNA_SPAG5: -0.0186934317159188, mRNA_FBP1: 1.485605806647989, mRNA_SLC7A8: 0.4172724329088461, mRNA_EN1: -1.1730034024212117, mRNA_ZNF552: 1.877066714640983, Methylation_LRRC6: -1.4182646125775449, Methylation_chr2 66218712 LINC02934 (29533): -0.2930336022204096, Methylation_HOXB13: -0.8344521824215626, Methylation_chr10 3949206 LINC02660 (4871): 0.6478741431702095, Methylation_chr5 179517140 RNF130 (18026): 1.2816518372208077, Methylation_LOC727677: 1.2152740738371608, Methylation_LETM1: -1.0582268235676258, Methylation_CDC42BPB: 1.4673963881333554, Methylation_C8orf38: -0.0812991743923295, Methylation_chr14 100504766 EVL (18852): -1.3703769074894152, Methylation_chr5 72594851 LOC340090 (24088): 0.9570865010404208, Methylation_chr2 242904738 LINC01238 (3421): 1.4727609899645762, Methylation_ARFGEF1: -0.4498093419117931, Methylation_MAPT: 1.149588837825037, Methylation_ZFAT: -1.9049134156239853, Methylation_KCNQ4: 1.2394954026943723, Methylation_chr1 232684368 SIPA1L2 (12934): -1.4541782163141626, Methylation_CRNKL1: -1.3507117970976523, Methylation_PRKAG2: -0.5720579115739423, Methylation_MICB: -1.2188242776368128, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.3238518096537989, miRNA_hsa-mir-5695: 0.8053967444917408, miRNA_hsa-mir-18a: -0.7378130767211017, miRNA_hsa-mir-190b: 1.0684560093580864, miRNA_hsa-mir-577: -0.1306335291135366, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.8052010687985924, miRNA_hsa-mir-130b: 0.2618530693335092, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A0BF,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: -0.046765195856092, mRNA_C2orf54: 0.8456453223785337, mRNA_CITED4: 0.0911969608488844, mRNA_ESR1: -0.4807949982183127, mRNA_SPDEF: -0.2086028971129883, mRNA_AGR3: -1.4471302063009446, mRNA_FOXC1: -0.5406864768387343, mRNA_GATA3: 0.0292235033367597, mRNA_AGR2: -0.5942285659356882, mRNA_XBP1: -0.3419104604883782, mRNA_PRR15: -0.7366968459726413, mRNA_SLC44A4: 0.5664190788583057, mRNA_CA12: 0.2479172499195117, mRNA_DTL: -0.290262169184944, mRNA_C5AR2: 0.1705025638979971, mRNA_TBC1D9: -0.842720376600253, mRNA_AR: 0.4311606415901893, mRNA_CCDC170: 0.2569750082460363, mRNA_DEGS2: -0.0162088196560284, mRNA_TFF3: -0.4452122968712315, mRNA_DNALI1: 0.3723280230359005, mRNA_LINC00504: 0.3505210976236844, mRNA_CLCA2: 0.2509594661748586, mRNA_PPP1R14C: -0.5583995777457817, mRNA_THSD4: -0.5578824635985683, mRNA_SPAG5: 0.5109683798808676, mRNA_FBP1: -0.35429232144659, mRNA_SLC7A8: -0.2642750205448332, mRNA_EN1: -0.2277789151924855, mRNA_ZNF552: -0.2068120231063026, Methylation_LRRC6: 0.3111772012475582, Methylation_chr2 66218712 LINC02934 (29533): 0.5577928348666411, Methylation_HOXB13: -0.9688639045973284, Methylation_chr10 3949206 LINC02660 (4871): -0.1079414572460205, Methylation_chr5 179517140 RNF130 (18026): -0.2246417219232356, Methylation_LOC727677: 1.2442616281975871, Methylation_LETM1: 1.306352426944145, Methylation_CDC42BPB: -0.6658213062592994, Methylation_C8orf38: 0.4942711493002732, Methylation_chr14 100504766 EVL (18852): 1.16945707450366, Methylation_chr5 72594851 LOC340090 (24088): 0.0943632597688019, Methylation_chr2 242904738 LINC01238 (3421): 0.0566095309512887, Methylation_ARFGEF1: 0.9964719299833936, Methylation_MAPT: 1.0950784364232533, Methylation_ZFAT: 0.0254122254392874, Methylation_KCNQ4: -0.4694942390006602, Methylation_chr1 232684368 SIPA1L2 (12934): 0.7575565135001336, Methylation_CRNKL1: 0.8625205566535777, Methylation_PRKAG2: 0.4534001892230826, Methylation_MICB: 0.7253518953837481, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.1212962372778554, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.0571748132062518, miRNA_hsa-mir-190b: -0.33671177725147, miRNA_hsa-mir-577: -0.3181511293333751, miRNA_hsa-mir-135b: -0.2780104555626562, miRNA_hsa-mir-2115: 0.0741152402703018, miRNA_hsa-mir-17: 0.422264513803479, miRNA_hsa-mir-130b: -0.2075351560396477, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A209,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives oncogenic mRNA overexpression. No mRNA or methylation alterations meet diagnostic thresholds for silencing or activation. miR-5695 and miR-130b upregulation may modulate tumor-relevant pathways. These features suggest a proliferative phenotype with genomic instability.","mRNA_MLPH: -0.3978216055166461, mRNA_C2orf54: -0.2843668587226234, mRNA_CITED4: -0.090556733793642, mRNA_ESR1: 0.2144541294959711, mRNA_SPDEF: -0.0585343634585623, mRNA_AGR3: -0.4846534101880498, mRNA_FOXC1: -0.4158661686011433, mRNA_GATA3: 0.2717362246472466, mRNA_AGR2: -0.4453090381978195, mRNA_XBP1: -0.5708445371352461, mRNA_PRR15: -0.7703076706167993, mRNA_SLC44A4: -0.4069920689154828, mRNA_CA12: 0.4807765994146414, mRNA_DTL: 0.6640313736452301, mRNA_C5AR2: -0.0278332348044979, mRNA_TBC1D9: -0.8613736443551465, mRNA_AR: -0.3917671771630068, mRNA_CCDC170: 0.1238101320176461, mRNA_DEGS2: -0.1265775042999119, mRNA_TFF3: 0.0874401625468817, mRNA_DNALI1: 0.1538789535396331, mRNA_LINC00504: -0.3236906280340832, mRNA_CLCA2: -0.7730117248732011, mRNA_PPP1R14C: -0.8271341822089862, mRNA_THSD4: -0.7839389445358451, mRNA_SPAG5: 0.472892263299119, mRNA_FBP1: -0.0145130007980117, mRNA_SLC7A8: -0.7557105582812385, mRNA_EN1: -1.0199697859147083, mRNA_ZNF552: -0.5785329851739909, Methylation_LRRC6: -0.4718271058128677, Methylation_chr2 66218712 LINC02934 (29533): 0.295188213067971, Methylation_HOXB13: -0.4546803111889687, Methylation_chr10 3949206 LINC02660 (4871): -0.2432732011673205, Methylation_chr5 179517140 RNF130 (18026): -1.3238777659592194, Methylation_LOC727677: -0.7822929598477202, Methylation_LETM1: 0.5458889609207322, Methylation_CDC42BPB: -1.0658219183959228, Methylation_C8orf38: -0.7423829486426837, Methylation_chr14 100504766 EVL (18852): 0.361587554446638, Methylation_chr5 72594851 LOC340090 (24088): -0.6630990329946737, Methylation_chr2 242904738 LINC01238 (3421): -0.3591236787698376, Methylation_ARFGEF1: 0.814209365196375, Methylation_MAPT: 0.6571211716280128, Methylation_ZFAT: -0.7145078699853248, Methylation_KCNQ4: -0.8917229056520497, Methylation_chr1 232684368 SIPA1L2 (12934): 0.6744230840960558, Methylation_CRNKL1: 0.6519167868925582, Methylation_PRKAG2: 0.7549669569557668, Methylation_MICB: 0.8926719427481049, miRNA_hsa-mir-934: -0.394929975434103, miRNA_hsa-mir-4728: -0.1515707584191363, miRNA_hsa-mir-5695: 1.5831780882482662, miRNA_hsa-mir-18a: 1.389938814501579, miRNA_hsa-mir-190b: 0.1745017662004605, miRNA_hsa-mir-577: 1.0154838683908438, miRNA_hsa-mir-135b: -0.0307198124992988, miRNA_hsa-mir-2115: -0.3695392443654403, miRNA_hsa-mir-17: 1.1452197257570038, miRNA_hsa-mir-130b: 1.5748258508198003, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-A1-A0SK,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression of EN1, DTL, PPP1R14C, and SPAG5. Promoter hypermethylation of KCNQ4, PRKAG2, and chr10:3949206 mediates epigenetic silencing. Downregulated miRNAs (mir-190b) and upregulated oncogenic miRNAs (mir-130b, mir-17, mir-577) indicate luminal B subtype with PI3K/AKT/mTOR dysregulation.","mRNA_MLPH: -1.6701116307642123, mRNA_C2orf54: 0.9471380862880692, mRNA_CITED4: -1.3730846701203772, mRNA_ESR1: -2.081688893938152, mRNA_SPDEF: -0.7606924553326508, mRNA_AGR3: -2.012690459348085, mRNA_FOXC1: -0.4789064266269682, mRNA_GATA3: -3.891925873452806, mRNA_AGR2: -2.318906573131832, mRNA_XBP1: -2.23972587094046, mRNA_PRR15: -2.0098275066448097, mRNA_SLC44A4: -0.747485741583573, mRNA_CA12: -2.176979166637398, mRNA_DTL: 1.9134729783107127, mRNA_C5AR2: -2.154753078295004, mRNA_TBC1D9: -2.1550081695035903, mRNA_AR: -2.369790743990953, mRNA_CCDC170: -1.9442275684210064, mRNA_DEGS2: -0.8114891728299111, mRNA_TFF3: 0.7794079879352691, mRNA_DNALI1: -1.7650632004016271, mRNA_LINC00504: -1.6772594248564157, mRNA_CLCA2: -0.4853284339233751, mRNA_PPP1R14C: 1.3963684289468627, mRNA_THSD4: -1.9127218245548, mRNA_SPAG5: 1.5092093680559564, mRNA_FBP1: -1.6884169509166664, mRNA_SLC7A8: -1.5295260764842709, mRNA_EN1: 2.4385558474245803, mRNA_ZNF552: -1.953897739345716, Methylation_LRRC6: 1.47055926563411, Methylation_chr2 66218712 LINC02934 (29533): -1.535348631857851, Methylation_HOXB13: -1.012897037905092, Methylation_chr10 3949206 LINC02660 (4871): 1.6298592881098746, Methylation_chr5 179517140 RNF130 (18026): -1.5124637611085368, Methylation_LOC727677: 1.5180095731113512, Methylation_LETM1: 1.304962085304689, Methylation_CDC42BPB: -1.4117138403757483, Methylation_C8orf38: 0.8584800813128912, Methylation_chr14 100504766 EVL (18852): 1.3923772004194557, Methylation_chr5 72594851 LOC340090 (24088): -1.5834541827383062, Methylation_chr2 242904738 LINC01238 (3421): 1.3154565818515949, Methylation_ARFGEF1: -1.3475175198814706, Methylation_MAPT: 1.4271671907150685, Methylation_ZFAT: 1.3813436778412609, Methylation_KCNQ4: 1.9105297414799585, Methylation_chr1 232684368 SIPA1L2 (12934): 1.4436977160087694, Methylation_CRNKL1: 1.3086465778188356, Methylation_PRKAG2: -1.9482092685267467, Methylation_MICB: 1.1768000664492688, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: 2.2106686408884064, miRNA_hsa-mir-18a: 2.292716778505356, miRNA_hsa-mir-190b: -2.052137242410604, miRNA_hsa-mir-577: 2.7645001340983986, miRNA_hsa-mir-135b: 2.54937211997177, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 2.562537502714784, miRNA_hsa-mir-130b: 3.232071794530365, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-E2-A574,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives genomic instability. Promoter hypermethylation of KCNQ4, ARFGEF1, and C8orf38 mediates transcriptional silencing. mRNA downregulation of GATA3, SPDEF, and ESR1 indicates luminal differentiation loss. Upregulated miR-17, miR-18a, miR-135b, and miR-934 suggest oncogenic miRNA activity. These features collectively indicate a basal-like phenotype with ER pathway suppression.","mRNA_MLPH: -2.366790186364826, mRNA_C2orf54: 0.3463077762187886, mRNA_CITED4: 0.9886818512595238, mRNA_ESR1: -2.1223844444289, mRNA_SPDEF: -2.878647172587788, mRNA_AGR3: -0.4376626973132326, mRNA_FOXC1: 1.6667101747255868, mRNA_GATA3: -3.5674862925165463, mRNA_AGR2: -0.1189872807376679, mRNA_XBP1: -2.1824090451534004, mRNA_PRR15: -1.6678042908860928, mRNA_SLC44A4: -0.6328289685597975, mRNA_CA12: -2.5339125650175744, mRNA_DTL: -1.2070183457864134, mRNA_C5AR2: -1.9101494463251567, mRNA_TBC1D9: -2.584204183524385, mRNA_AR: -2.471302728247528, mRNA_CCDC170: -2.0277607049073256, mRNA_DEGS2: -1.9316131895919704, mRNA_TFF3: -1.8650979727539128, mRNA_DNALI1: -2.0137332919025583, mRNA_LINC00504: -1.7444000954859296, mRNA_CLCA2: -0.8370044860184745, mRNA_PPP1R14C: 1.0920847436865015, mRNA_THSD4: -1.6155576909322436, mRNA_SPAG5: 0.1855955352383344, mRNA_FBP1: -2.0575590192341924, mRNA_SLC7A8: -2.340100616691237, mRNA_EN1: 1.214170925255666, mRNA_ZNF552: -2.5779930863708374, Methylation_LRRC6: 1.5101168396452187, Methylation_chr2 66218712 LINC02934 (29533): -1.91765488127172, Methylation_HOXB13: 0.5992245799828664, Methylation_chr10 3949206 LINC02660 (4871): 0.4866177179144402, Methylation_chr5 179517140 RNF130 (18026): -1.5572401086146377, Methylation_LOC727677: 1.509427831890964, Methylation_LETM1: 1.3590940582529143, Methylation_CDC42BPB: 1.4637972224007545, Methylation_C8orf38: 1.6522006815602237, Methylation_chr14 100504766 EVL (18852): 1.4239412646246477, Methylation_chr5 72594851 LOC340090 (24088): -1.6381843366386917, Methylation_chr2 242904738 LINC01238 (3421): 0.2350115144005377, Methylation_ARFGEF1: 1.6972042304371953, Methylation_MAPT: 1.5122275662386642, Methylation_ZFAT: 1.3614458637987372, Methylation_KCNQ4: 2.086988572746143, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5499415207210965, Methylation_CRNKL1: 1.503711218763519, Methylation_PRKAG2: -1.826907411446157, Methylation_MICB: 1.2663959940416485, miRNA_hsa-mir-934: 2.657334941399385, miRNA_hsa-mir-4728: -0.1449874402469516, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 2.976443071234879, miRNA_hsa-mir-190b: -1.6885862056915484, miRNA_hsa-mir-577: 2.3728912745119883, miRNA_hsa-mir-135b: 2.410333390597723, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 3.1644678102534813, miRNA_hsa-mir-130b: 0.7226771330060279, CNV_VPS54: 4.368946221858642, CNV_LINC01867: 4.411662538359512, CNV_LINC02576: 4.524961365416283, CNV_WDPCP: 4.394610852818543, CNV_CEP68: 4.524961365416283"
TCGA-A2-A3KD,SLC7A8 mRNA overexpression (Z=1.97) and ZNF552 upregulation (Z=1.41) meet high-expression thresholds. No methylation sites cross hyper/hypo-methylation cutoffs. All CNVs fall within normal range (−1.10 to −0.10). miRNA profiles show no significant dysregulation per thresholds.,"mRNA_MLPH: 0.5062308034088543, mRNA_C2orf54: 0.7489818525263335, mRNA_CITED4: 1.143722365271105, mRNA_ESR1: 0.721156440331989, mRNA_SPDEF: 0.6865936130181786, mRNA_AGR3: 0.397883656537407, mRNA_FOXC1: 0.1286680329677768, mRNA_GATA3: 0.4602969031372425, mRNA_AGR2: 1.206808598913124, mRNA_XBP1: 0.9694414872235856, mRNA_PRR15: 0.5022889286114259, mRNA_SLC44A4: 0.5714875338666939, mRNA_CA12: 0.6865205040749662, mRNA_DTL: -0.0447052838680522, mRNA_C5AR2: 1.1495925394754345, mRNA_TBC1D9: 0.3816964882388824, mRNA_AR: 0.8972282351227977, mRNA_CCDC170: 0.9761358748275412, mRNA_DEGS2: 0.1300880265380597, mRNA_TFF3: 1.392808288350351, mRNA_DNALI1: 0.6935862721500257, mRNA_LINC00504: 0.4059349353922642, mRNA_CLCA2: -0.4131578317446805, mRNA_PPP1R14C: -0.3458530370202332, mRNA_THSD4: 0.5512165237359687, mRNA_SPAG5: -0.4077700788158183, mRNA_FBP1: 0.2669569243851424, mRNA_SLC7A8: 1.96780303154045, mRNA_EN1: -0.5902749922405996, mRNA_ZNF552: 1.406519531148789, Methylation_LRRC6: 0.2666563009991345, Methylation_chr2 66218712 LINC02934 (29533): -1.2795362240028885, Methylation_HOXB13: -1.0398049891071242, Methylation_chr10 3949206 LINC02660 (4871): 1.484918370941903, Methylation_chr5 179517140 RNF130 (18026): 0.1178465838134835, Methylation_LOC727677: 1.3575215359871369, Methylation_LETM1: -0.742012981168286, Methylation_CDC42BPB: 1.1350095757124603, Methylation_C8orf38: 0.9992114177421176, Methylation_chr14 100504766 EVL (18852): -0.5402183874334692, Methylation_chr5 72594851 LOC340090 (24088): -1.3538374390165318, Methylation_chr2 242904738 LINC01238 (3421): -0.5290792099101753, Methylation_ARFGEF1: 0.6846834980474804, Methylation_MAPT: -0.4311449149602496, Methylation_ZFAT: 0.491811805280244, Methylation_KCNQ4: -1.0799129380285142, Methylation_chr1 232684368 SIPA1L2 (12934): 1.1522550884928482, Methylation_CRNKL1: 0.329975987064903, Methylation_PRKAG2: 0.3456708902368751, Methylation_MICB: 0.4778599660754524, miRNA_hsa-mir-934: -0.2040474045955195, miRNA_hsa-mir-4728: -0.4701285587108707, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.3202711713023402, miRNA_hsa-mir-190b: 0.8308677886273129, miRNA_hsa-mir-577: 0.3747742813843516, miRNA_hsa-mir-135b: -0.768644699039873, miRNA_hsa-mir-2115: -0.4466251603346126, miRNA_hsa-mir-17: -0.008732463384259, miRNA_hsa-mir-130b: -0.7197274416599475, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A24S,"High-level Amplification of none; no CNV meets amplification thresholds.  
No mRNA meets overexpression (Z > 1.30) or underexpression (Z < -1.92) criteria.  
No methylation site crosses hyper- (Z > 1.50) or hypo-methylation (Z < -1.47) thresholds.  
miRNA_hsa-mir-135b is downregulated (Z = -1.246 < -1.25).  
Isolated miRNA downregulation without transcriptional or epigenetic drivers.","mRNA_MLPH: -0.2541774704472231, mRNA_C2orf54: 0.7607954488259143, mRNA_CITED4: -1.219580822479025, mRNA_ESR1: 0.6303788716502593, mRNA_SPDEF: 0.1359547834288491, mRNA_AGR3: 0.6963565285369385, mRNA_FOXC1: -0.5108251108294425, mRNA_GATA3: 0.4574542410286304, mRNA_AGR2: 0.04107944017558, mRNA_XBP1: 0.0429499808351653, mRNA_PRR15: 0.2687287348168146, mRNA_SLC44A4: 0.5846837535868256, mRNA_CA12: -0.0042824502369607, mRNA_DTL: 0.0553639733426514, mRNA_C5AR2: 0.3885153142976471, mRNA_TBC1D9: -0.3682359804743362, mRNA_AR: 1.338563413015353, mRNA_CCDC170: 0.2651967038254481, mRNA_DEGS2: 0.2257677394302472, mRNA_TFF3: -0.3057395209832384, mRNA_DNALI1: 0.2346713687195672, mRNA_LINC00504: 0.5274267918812615, mRNA_CLCA2: -0.6691065108714904, mRNA_PPP1R14C: -0.4304614780538591, mRNA_THSD4: 0.139561588120789, mRNA_SPAG5: -0.1043640177806585, mRNA_FBP1: 0.3267788548380897, mRNA_SLC7A8: 0.2548625290652238, mRNA_EN1: -0.2650968139514698, mRNA_ZNF552: -0.2270703544276102, Methylation_LRRC6: 0.1730724348008011, Methylation_chr2 66218712 LINC02934 (29533): -1.1240472440491498, Methylation_HOXB13: 0.5764597578321866, Methylation_chr10 3949206 LINC02660 (4871): -0.8065643468758038, Methylation_chr5 179517140 RNF130 (18026): -0.2548117573747107, Methylation_LOC727677: -0.8531581986599748, Methylation_LETM1: -0.6634025442651802, Methylation_CDC42BPB: -1.2128579492025702, Methylation_C8orf38: -1.1328627908480051, Methylation_chr14 100504766 EVL (18852): -0.4697735531046145, Methylation_chr5 72594851 LOC340090 (24088): -1.2744463039009504, Methylation_chr2 242904738 LINC01238 (3421): -0.9436170067643916, Methylation_ARFGEF1: -0.8165229890739633, Methylation_MAPT: -0.2164362040651183, Methylation_ZFAT: -1.1184721689452866, Methylation_KCNQ4: 1.0689031873792358, Methylation_chr1 232684368 SIPA1L2 (12934): 0.4994507882527919, Methylation_CRNKL1: -0.8433809184500781, Methylation_PRKAG2: 0.6484105343611918, Methylation_MICB: -0.933248571336142, miRNA_hsa-mir-934: -0.2783055741851498, miRNA_hsa-mir-4728: -0.0562827122740758, miRNA_hsa-mir-5695: 0.4535552305061577, miRNA_hsa-mir-18a: 0.5991058912832355, miRNA_hsa-mir-190b: 0.3598143986471126, miRNA_hsa-mir-577: -0.4658258547337686, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.6541989215375038, miRNA_hsa-mir-130b: 0.5863351957251245, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-A2-A0SY,"HOXB13 promoter hypermethylation (Z=1.53) mediates epigenetic silencing. No mRNA, miRNA, or CNV alterations meet diagnostic thresholds for reporting.","mRNA_MLPH: 0.6145957642891373, mRNA_C2orf54: -0.8795680728729893, mRNA_CITED4: 0.4452186619495357, mRNA_ESR1: 0.5271386753268222, mRNA_SPDEF: 0.632873956593824, mRNA_AGR3: 0.7887244768221282, mRNA_FOXC1: 0.1806876815152253, mRNA_GATA3: 0.4495387272462752, mRNA_AGR2: 0.965361459160996, mRNA_XBP1: 1.0413727929376255, mRNA_PRR15: 0.5855168751378136, mRNA_SLC44A4: 0.6422191866377288, mRNA_CA12: 0.5059653088898203, mRNA_DTL: -0.2499720601182101, mRNA_C5AR2: 0.1202778474448327, mRNA_TBC1D9: 0.8898084396795563, mRNA_AR: 0.8760255410885245, mRNA_CCDC170: 0.2163681103780021, mRNA_DEGS2: 0.8180350245510275, mRNA_TFF3: 0.7890544264318052, mRNA_DNALI1: 0.5920700117044655, mRNA_LINC00504: 0.5956081826915609, mRNA_CLCA2: -0.4999695613446556, mRNA_PPP1R14C: -0.6285719089965548, mRNA_THSD4: 0.4614798736774929, mRNA_SPAG5: -0.8857216615734071, mRNA_FBP1: 0.5690389096102744, mRNA_SLC7A8: 0.8755389943244056, mRNA_EN1: 0.4133626430333993, mRNA_ZNF552: 0.7924234545057214, Methylation_LRRC6: -0.2159131881600395, Methylation_chr2 66218712 LINC02934 (29533): 1.2106060884005725, Methylation_HOXB13: 1.5272567914660935, Methylation_chr10 3949206 LINC02660 (4871): 0.2319060890281873, Methylation_chr5 179517140 RNF130 (18026): 1.0135206614835344, Methylation_LOC727677: -0.6171410083280474, Methylation_LETM1: -0.7452487310870943, Methylation_CDC42BPB: -1.19929616719512, Methylation_C8orf38: -0.4528141348761042, Methylation_chr14 100504766 EVL (18852): -0.2635834732147107, Methylation_chr5 72594851 LOC340090 (24088): 1.2105423514186842, Methylation_chr2 242904738 LINC01238 (3421): -0.8141817151578884, Methylation_ARFGEF1: -0.3722419813096122, Methylation_MAPT: -0.430721617024754, Methylation_ZFAT: -0.3878509405114677, Methylation_KCNQ4: -0.2231443507884866, Methylation_chr1 232684368 SIPA1L2 (12934): -0.3829453804009412, Methylation_CRNKL1: -0.6821120702315601, Methylation_PRKAG2: 1.3203675321202013, Methylation_MICB: -0.5130932516564856, miRNA_hsa-mir-934: -0.3845435493195612, miRNA_hsa-mir-4728: 0.3831245159144505, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.8960153644566021, miRNA_hsa-mir-190b: 0.7686831538520444, miRNA_hsa-mir-577: -0.4094388252761384, miRNA_hsa-mir-135b: -0.8177548712161022, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.1083543904153494, miRNA_hsa-mir-130b: -1.4179241953498682, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-Z7-A8R5,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations.","mRNA_MLPH: 0.0713263184747253, mRNA_C2orf54: 0.3315739811068425, mRNA_CITED4: 1.2205587550074828, mRNA_ESR1: -0.2510270113819968, mRNA_SPDEF: 0.1985012436276691, mRNA_AGR3: 0.2178480673595902, mRNA_FOXC1: 0.929038942931798, mRNA_GATA3: -0.3681688149295725, mRNA_AGR2: 0.0824219122381769, mRNA_XBP1: -0.1124020101581262, mRNA_PRR15: 0.1308732795896681, mRNA_SLC44A4: 0.159292869324893, mRNA_CA12: -0.4692157663914889, mRNA_DTL: -1.9969538976063577, mRNA_C5AR2: -0.2692094007228175, mRNA_TBC1D9: -0.2441521141674432, mRNA_AR: -0.3358670618154349, mRNA_CCDC170: -0.3803278619603996, mRNA_DEGS2: 0.0487172756999053, mRNA_TFF3: 0.1967902903121347, mRNA_DNALI1: 0.3607644687860806, mRNA_LINC00504: -0.0060800927870466, mRNA_CLCA2: 1.0201096049806355, mRNA_PPP1R14C: 0.9920234459563632, mRNA_THSD4: -0.9961288474747618, mRNA_SPAG5: -1.658445284527573, mRNA_FBP1: -0.1775174214598056, mRNA_SLC7A8: -0.6651863839105153, mRNA_EN1: -0.0039078436516694, mRNA_ZNF552: -0.585730145710905, Methylation_LRRC6: 0.7890835607158556, Methylation_chr2 66218712 LINC02934 (29533): -0.1827789742860192, Methylation_HOXB13: -0.967376059692508, Methylation_chr10 3949206 LINC02660 (4871): 0.540715435464956, Methylation_chr5 179517140 RNF130 (18026): -0.3256087272912584, Methylation_LOC727677: 0.7231607163831731, Methylation_LETM1: 0.6003603963039127, Methylation_CDC42BPB: -0.7605335503747519, Methylation_C8orf38: 0.1841732318668386, Methylation_chr14 100504766 EVL (18852): 0.8608049329515206, Methylation_chr5 72594851 LOC340090 (24088): 0.0417239245635381, Methylation_chr2 242904738 LINC01238 (3421): 0.0099889347229462, Methylation_ARFGEF1: 0.9727750663552286, Methylation_MAPT: -0.0476329386202623, Methylation_ZFAT: 1.1086743952697549, Methylation_KCNQ4: -0.9913554788026794, Methylation_chr1 232684368 SIPA1L2 (12934): 0.5507719426246944, Methylation_CRNKL1: 0.818648992218634, Methylation_PRKAG2: 0.9982822953240408, Methylation_MICB: 0.6270047902554912, miRNA_hsa-mir-934: 0.0849373520705179, miRNA_hsa-mir-4728: -0.5638525626721916, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.1073806949900101, miRNA_hsa-mir-190b: 0.5491536561218198, miRNA_hsa-mir-577: -0.4871247864923472, miRNA_hsa-mir-135b: 0.5160257158932274, miRNA_hsa-mir-2115: 1.3940627956649705, miRNA_hsa-mir-17: -0.0097417568481054, miRNA_hsa-mir-130b: -0.8133112552567231, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E2-A1B0,"mRNA_C2orf54 overexpression (Z=2.03) and mRNA_SPAG5 upregulation (Z=1.62) occur without clear genomic amplification. ESR1, AGR3, and GATA3 show low mRNA (Z < -1.92). Methylation_chr5 72594851 LOC340090 is hypomethylated (Z=-1.48). miRNA_hsa-mir-4728 is upregulated (Z=2.24); miRNA_hsa-mir-190b downregulated (Z=-1.47). No CNVs meet deletion/amplification thresholds.","mRNA_MLPH: -0.341910740906085, mRNA_C2orf54: 2.030867574215092, mRNA_CITED4: -0.4456403981423214, mRNA_ESR1: -1.934658123980171, mRNA_SPDEF: 0.375088650678302, mRNA_AGR3: -2.0483141023375224, mRNA_FOXC1: 0.0513760490916161, mRNA_GATA3: -1.9741954041664689, mRNA_AGR2: -0.4991670145722769, mRNA_XBP1: 0.1132395092829235, mRNA_PRR15: -0.464785128846281, mRNA_SLC44A4: -0.4582762398475286, mRNA_CA12: -1.510891859807926, mRNA_DTL: 1.065413647468382, mRNA_C5AR2: -1.2376419879667266, mRNA_TBC1D9: -0.9593498485391202, mRNA_AR: 0.4806578756528276, mRNA_CCDC170: -1.5698443541139622, mRNA_DEGS2: -1.0494383907343845, mRNA_TFF3: -0.4298096692355989, mRNA_DNALI1: -1.82884666015037, mRNA_LINC00504: -0.9379730718997932, mRNA_CLCA2: -0.4017190799357239, mRNA_PPP1R14C: 1.1967410965493317, mRNA_THSD4: -0.6444616334252664, mRNA_SPAG5: 1.6207693746851948, mRNA_FBP1: -0.5263015323604291, mRNA_SLC7A8: -1.2352995002593905, mRNA_EN1: -0.3923818042728213, mRNA_ZNF552: 0.1521850248879478, Methylation_LRRC6: 1.1731006816665417, Methylation_chr2 66218712 LINC02934 (29533): -0.2988324628108059, Methylation_HOXB13: 0.877847141863327, Methylation_chr10 3949206 LINC02660 (4871): 0.749074594286372, Methylation_chr5 179517140 RNF130 (18026): -1.3231853462040315, Methylation_LOC727677: 0.7162132619388304, Methylation_LETM1: 1.26341203199363, Methylation_CDC42BPB: -0.9242571555938478, Methylation_C8orf38: 0.0218478837781137, Methylation_chr14 100504766 EVL (18852): 1.4994098459382132, Methylation_chr5 72594851 LOC340090 (24088): -1.4760469263824552, Methylation_chr2 242904738 LINC01238 (3421): 1.464426798404314, Methylation_ARFGEF1: 0.0963246408188866, Methylation_MAPT: 1.4108701340760204, Methylation_ZFAT: 1.3203621696446364, Methylation_KCNQ4: 0.3979997203879747, Methylation_chr1 232684368 SIPA1L2 (12934): -0.2708598878100201, Methylation_CRNKL1: 1.3750328861810344, Methylation_PRKAG2: -0.2783301885968585, Methylation_MICB: 1.0715963516195033, miRNA_hsa-mir-934: 0.5544039586425646, miRNA_hsa-mir-4728: 2.236443833576556, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.4992672511571331, miRNA_hsa-mir-190b: -1.4748068854474212, miRNA_hsa-mir-577: -0.2252550493259233, miRNA_hsa-mir-135b: 0.0389252780457144, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.4716183472396609, miRNA_hsa-mir-130b: 1.441783908069585, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AC-A6IX,High mRNA_C2orf54 (Z=1.43) indicates overexpression. HOXB13 promoter hypermethylation (Z=1.86) suggests epigenetic silencing. No miRNAs meet dysregulation thresholds. All CNVs fall within normal range (−1.10 to −0.10). These features align with a luminal phenotype and intact genomic stability.,"mRNA_MLPH: 1.1803855203233042, mRNA_C2orf54: 1.4290438403536228, mRNA_CITED4: -0.1937195933815415, mRNA_ESR1: 0.2535956454703696, mRNA_SPDEF: 0.7484097221817197, mRNA_AGR3: 0.5626727439146024, mRNA_FOXC1: -0.2523096770695577, mRNA_GATA3: 0.3824225349681555, mRNA_AGR2: 0.7268768614983778, mRNA_XBP1: 0.0745322470187368, mRNA_PRR15: 0.2951722163356426, mRNA_SLC44A4: 0.6728552502337851, mRNA_CA12: 0.1744460103302697, mRNA_DTL: -0.3308209023561905, mRNA_C5AR2: 0.784901707802447, mRNA_TBC1D9: 0.6636525120219108, mRNA_AR: 0.4943098651000969, mRNA_CCDC170: 0.2376833760072708, mRNA_DEGS2: 0.0085435050015031, mRNA_TFF3: 0.5855215062688486, mRNA_DNALI1: 0.0192431977409327, mRNA_LINC00504: 0.9251818362980956, mRNA_CLCA2: 0.4584661132068591, mRNA_PPP1R14C: -0.5924104362259621, mRNA_THSD4: 0.5148873057740894, mRNA_SPAG5: -0.9001698157929879, mRNA_FBP1: 0.6221518064270559, mRNA_SLC7A8: 0.4257122928129488, mRNA_EN1: -0.0154425737749529, mRNA_ZNF552: 0.8213044178086686, Methylation_LRRC6: -0.1009945772257257, Methylation_chr2 66218712 LINC02934 (29533): 1.292402586301091, Methylation_HOXB13: 1.857237703080078, Methylation_chr10 3949206 LINC02660 (4871): -0.0119444013212407, Methylation_chr5 179517140 RNF130 (18026): 0.2200268900668188, Methylation_LOC727677: 0.7564224917415974, Methylation_LETM1: -0.2256264299043378, Methylation_CDC42BPB: 1.1813472603828226, Methylation_C8orf38: -0.1446847030482583, Methylation_chr14 100504766 EVL (18852): 0.0962733889678207, Methylation_chr5 72594851 LOC340090 (24088): 0.994496093001442, Methylation_chr2 242904738 LINC01238 (3421): -0.3757916114449602, Methylation_ARFGEF1: 0.1081046795746389, Methylation_MAPT: -0.1523549494621921, Methylation_ZFAT: 0.7498095455370646, Methylation_KCNQ4: -0.517008076612075, Methylation_chr1 232684368 SIPA1L2 (12934): -0.0869497956576138, Methylation_CRNKL1: -0.2880462832744626, Methylation_PRKAG2: 1.191193563623828, Methylation_MICB: -0.0991034207668627, miRNA_hsa-mir-934: -0.4826102569524384, miRNA_hsa-mir-4728: -1.124406241528252, miRNA_hsa-mir-5695: -0.3326340447918479, miRNA_hsa-mir-18a: -0.6330172111260124, miRNA_hsa-mir-190b: 0.2059544793917619, miRNA_hsa-mir-577: -0.6546863983334744, miRNA_hsa-mir-135b: -0.3950896678198942, miRNA_hsa-mir-2115: 1.7584690104312144, miRNA_hsa-mir-17: -0.427156955003492, miRNA_hsa-mir-130b: -0.8387587586703443, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-HN-A2NL,"FOXC1 mRNA overexpression (Z=2.84) driven by EN1 upregulation (Z=2.39). SPAG5 mRNA elevated (Z=1.90). GATA3, SPDEF, MLPH, and CA12 significantly downregulated (Z < -1.92). KCNQ4 promoter hypermethylation (Z=1.91); RNF130 and LOC340090 hypomethylated (Z < -1.47). miR-17 and miR-18a markedly upregulated (Z > 1.99); miR-190b downregulated (Z < -1.25). All CNVs fall within normal range (IGNORED).","mRNA_MLPH: -2.6550594111339225, mRNA_C2orf54: -1.2943230935752186, mRNA_CITED4: 0.3075429954260635, mRNA_ESR1: -1.8138264358618883, mRNA_SPDEF: -2.752969428592793, mRNA_AGR3: -1.8506714485340643, mRNA_FOXC1: 2.841455715350733, mRNA_GATA3: -3.017401518664089, mRNA_AGR2: -0.8779648344162247, mRNA_XBP1: -2.203874172989861, mRNA_PRR15: -1.2296176711328053, mRNA_SLC44A4: -2.2631752332653643, mRNA_CA12: -2.57116548360826, mRNA_DTL: 1.194822855645827, mRNA_C5AR2: -2.0341383054002824, mRNA_TBC1D9: -1.8676206499991967, mRNA_AR: -2.3694478253060782, mRNA_CCDC170: -1.747604371692314, mRNA_DEGS2: -1.8294566874984683, mRNA_TFF3: -1.5046674083419276, mRNA_DNALI1: -2.011754741512342, mRNA_LINC00504: -1.7273870697972262, mRNA_CLCA2: -0.8229979711659079, mRNA_PPP1R14C: 1.1847132610482651, mRNA_THSD4: -2.333830307427988, mRNA_SPAG5: 1.9040227836097867, mRNA_FBP1: -1.0878861654643612, mRNA_SLC7A8: -2.1226632026958394, mRNA_EN1: 2.390037828440082, mRNA_ZNF552: -2.219485111176268, Methylation_LRRC6: 1.5274287716125985, Methylation_chr2 66218712 LINC02934 (29533): -1.4234496958536802, Methylation_HOXB13: 1.2193127961016526, Methylation_chr10 3949206 LINC02660 (4871): 1.617092854948707, Methylation_chr5 179517140 RNF130 (18026): -1.6269713626389168, Methylation_LOC727677: 1.531957239386109, Methylation_LETM1: 1.2112149344733327, Methylation_CDC42BPB: 1.340104197579114, Methylation_C8orf38: 1.558205390239013, Methylation_chr14 100504766 EVL (18852): 1.5412271552223893, Methylation_chr5 72594851 LOC340090 (24088): -1.499873732030357, Methylation_chr2 242904738 LINC01238 (3421): 1.4175070639743026, Methylation_ARFGEF1: 1.204592755341077, Methylation_MAPT: 1.476247471067411, Methylation_ZFAT: 1.4675921200907447, Methylation_KCNQ4: 1.9117034280527303, Methylation_chr1 232684368 SIPA1L2 (12934): 1.6449114516513046, Methylation_CRNKL1: 1.5286921513620078, Methylation_PRKAG2: 0.8617906568548076, Methylation_MICB: 1.5507635407823612, miRNA_hsa-mir-934: 0.1326459252248879, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: 0.1989510946096148, miRNA_hsa-mir-18a: 2.5023415545394143, miRNA_hsa-mir-190b: -2.052137242410604, miRNA_hsa-mir-577: 0.8308994610299938, miRNA_hsa-mir-135b: 0.3848993784693783, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 4.088141238025214, miRNA_hsa-mir-130b: 1.3031979743613131, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A2LR,"High-level Amplification absent; no CNV alterations meet amplification thresholds.  
FOXC1 mRNA overexpression (Z=2.00) and EN1 upregulation (Z=1.95) occur without underlying CNV gain.  
Multiple mRNAs significantly downregulated (e.g., GATA3 Z=-2.57, MLPH Z=-2.57, FBP1 Z=-2.48).  
Promoter hypermethylation at KCNQ4 (Z=1.76), MAPT (Z=1.57), and EVL (Z=1.60); hypomethylation at RNF130 (Z=-1.70) and PRKAG2 (Z=-1.55).  
miR-17, miR-577, and miR-18a markedly upregulated (Z>2.19); miR-190b downregulated (Z=-1.64).","mRNA_MLPH: -2.5747620191716107, mRNA_C2orf54: -0.7052603716539445, mRNA_CITED4: -0.0657667105070584, mRNA_ESR1: -1.782217161316237, mRNA_SPDEF: -1.157553646311179, mRNA_AGR3: -1.542236722634117, mRNA_FOXC1: 2.003640087691976, mRNA_GATA3: -2.574192601517135, mRNA_AGR2: -1.5947250039397134, mRNA_XBP1: -2.011631446040899, mRNA_PRR15: -1.801300197924302, mRNA_SLC44A4: 0.1153695399527348, mRNA_CA12: -1.450984194609422, mRNA_DTL: 1.379641978840329, mRNA_C5AR2: -1.5680983403422533, mRNA_TBC1D9: -1.2445293844011296, mRNA_AR: -1.310191475355677, mRNA_CCDC170: -1.1808172629731466, mRNA_DEGS2: -1.9809786009967247, mRNA_TFF3: -2.010087704354962, mRNA_DNALI1: -1.6675660042091924, mRNA_LINC00504: -1.6611629854508303, mRNA_CLCA2: 0.6345256761562903, mRNA_PPP1R14C: 0.4181231860705692, mRNA_THSD4: -0.4838586372933217, mRNA_SPAG5: 1.0760143600246024, mRNA_FBP1: -2.482929409934927, mRNA_SLC7A8: -0.8462667794337012, mRNA_EN1: 1.9529695073747024, mRNA_ZNF552: -1.220198154276552, Methylation_LRRC6: 1.4759193913958994, Methylation_chr2 66218712 LINC02934 (29533): -1.6656646647363031, Methylation_HOXB13: 1.059420084692642, Methylation_chr10 3949206 LINC02660 (4871): 1.5586154530774126, Methylation_chr5 179517140 RNF130 (18026): -1.703774891296688, Methylation_LOC727677: 1.4680221652006125, Methylation_LETM1: 1.348583033138742, Methylation_CDC42BPB: 1.45843688618378, Methylation_C8orf38: 1.5472739383321363, Methylation_chr14 100504766 EVL (18852): 1.595010807740664, Methylation_chr5 72594851 LOC340090 (24088): -1.541394631623277, Methylation_chr2 242904738 LINC01238 (3421): 1.4062357977270574, Methylation_ARFGEF1: -0.9146551724613904, Methylation_MAPT: 1.5660220826866946, Methylation_ZFAT: 1.4977330424906323, Methylation_KCNQ4: 1.756666922242538, Methylation_chr1 232684368 SIPA1L2 (12934): 1.3980439621133487, Methylation_CRNKL1: 1.428904759908136, Methylation_PRKAG2: -1.551707147631562, Methylation_MICB: 1.4984885260095002, miRNA_hsa-mir-934: 0.1967130348675437, miRNA_hsa-mir-4728: -0.3181624807436597, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 2.1998380969804425, miRNA_hsa-mir-190b: -1.6409599378803434, miRNA_hsa-mir-577: 2.433581212620923, miRNA_hsa-mir-135b: 1.983010796819849, miRNA_hsa-mir-2115: -0.4921962108120486, miRNA_hsa-mir-17: 2.454757375412893, miRNA_hsa-mir-130b: 2.315015410911512, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-GM-A2DO,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.6196527385866037, mRNA_C2orf54: -1.152254172043901, mRNA_CITED4: 0.0626599243944992, mRNA_ESR1: -0.2482742214136246, mRNA_SPDEF: -0.1666398292540626, mRNA_AGR3: 0.5090930711620252, mRNA_FOXC1: -0.3069279454309437, mRNA_GATA3: 0.0577273803022602, mRNA_AGR2: 0.363031964454321, mRNA_XBP1: -0.2901264304420201, mRNA_PRR15: 0.3155528978790757, mRNA_SLC44A4: -0.0458894357013148, mRNA_CA12: 0.1923088621882572, mRNA_DTL: -0.7494790799772565, mRNA_C5AR2: -1.0112544188289316, mRNA_TBC1D9: -0.0868782958145092, mRNA_AR: -0.5303321632446926, mRNA_CCDC170: -0.8996465417815279, mRNA_DEGS2: 0.0162633937367423, mRNA_TFF3: 0.0103835396798024, mRNA_DNALI1: 0.2838496257484491, mRNA_LINC00504: 0.5671541006410388, mRNA_CLCA2: -0.7257264982467329, mRNA_PPP1R14C: -0.8737542756386424, mRNA_THSD4: -0.0280595955652945, mRNA_SPAG5: 0.0580890842590022, mRNA_FBP1: 0.1891126700739508, mRNA_SLC7A8: -0.12327553536698, mRNA_EN1: -0.4532181129154224, mRNA_ZNF552: -0.2677173644173558, Methylation_LRRC6: 0.9705964173800684, Methylation_chr2 66218712 LINC02934 (29533): 0.836220933226022, Methylation_HOXB13: -1.0546895646980312, Methylation_chr10 3949206 LINC02660 (4871): 0.7842348232370168, Methylation_chr5 179517140 RNF130 (18026): -0.2658406407077401, Methylation_LOC727677: 0.8824332956592227, Methylation_LETM1: 0.7499129064728736, Methylation_CDC42BPB: -0.3539433314610523, Methylation_C8orf38: 1.2037569628350937, Methylation_chr14 100504766 EVL (18852): 1.339899936181726, Methylation_chr5 72594851 LOC340090 (24088): -1.1630290608531368, Methylation_chr2 242904738 LINC01238 (3421): 0.2358868352137469, Methylation_ARFGEF1: 1.0666558772292365, Methylation_MAPT: 0.896558219369732, Methylation_ZFAT: 0.1560125594081172, Methylation_KCNQ4: -0.7722191604007469, Methylation_chr1 232684368 SIPA1L2 (12934): 1.2637476531052094, Methylation_CRNKL1: 1.2559750925729698, Methylation_PRKAG2: 0.4911394090306216, Methylation_MICB: 1.1964133030836832, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.8645283178255979, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.964663273945166, miRNA_hsa-mir-190b: 0.1293474461766689, miRNA_hsa-mir-577: -0.4845670833427182, miRNA_hsa-mir-135b: -0.1050285417515943, miRNA_hsa-mir-2115: -0.2148713720103078, miRNA_hsa-mir-17: 0.9977819484800612, miRNA_hsa-mir-130b: 0.3238991146580811, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-B6-A0IK,mRNA_C2orf54 (Z=1.34) and mRNA_CLCA2 (Z=1.70) are overexpressed. Methylation_HOXB13 (Z=1.63) and Methylation_ZFAT (Z=1.34) are hypermethylated. No miRNAs meet deregulation thresholds. All CNVs fall within normal range. Overexpression without clear genomic amplification suggests transcriptional activation; HOXB13 hypermethylation may indicate field cancerization.,"mRNA_MLPH: 0.0211306370813913, mRNA_C2orf54: 1.336342804357832, mRNA_CITED4: -1.0139681852496023, mRNA_ESR1: -0.5067300448445616, mRNA_SPDEF: 0.4643684616515376, mRNA_AGR3: -0.3239064434765327, mRNA_FOXC1: 0.8819052171854617, mRNA_GATA3: -0.2949363972195123, mRNA_AGR2: 0.3362300765252371, mRNA_XBP1: 0.2916108002197328, mRNA_PRR15: -0.0982861604313057, mRNA_SLC44A4: 0.747594305528491, mRNA_CA12: -1.027498806408938, mRNA_DTL: 0.4467684200932783, mRNA_C5AR2: -1.4037603566376071, mRNA_TBC1D9: -0.2511118521911124, mRNA_AR: -0.4091871294500429, mRNA_CCDC170: -0.7174987835931033, mRNA_DEGS2: 0.0303309698255478, mRNA_TFF3: 0.2620090653044985, mRNA_DNALI1: -0.9783722142594268, mRNA_LINC00504: 0.2935703110780167, mRNA_CLCA2: 1.7026408851950996, mRNA_PPP1R14C: 0.8098247270384087, mRNA_THSD4: 0.1833106653611833, mRNA_SPAG5: 0.0097362730006577, mRNA_FBP1: -0.5819384450783917, mRNA_SLC7A8: -0.9688180833289652, mRNA_EN1: -0.0596204412921816, mRNA_ZNF552: -0.0409093797692091, Methylation_LRRC6: 1.120425695504982, Methylation_chr2 66218712 LINC02934 (29533): 0.9214141605755188, Methylation_HOXB13: 1.6335919036205024, Methylation_chr10 3949206 LINC02660 (4871): 1.2642431132938892, Methylation_chr5 179517140 RNF130 (18026): 0.5159948268985448, Methylation_LOC727677: -0.8085443255311637, Methylation_LETM1: 1.258863339865988, Methylation_CDC42BPB: -1.115545328820867, Methylation_C8orf38: -0.0379161098009809, Methylation_chr14 100504766 EVL (18852): 0.5721996544419111, Methylation_chr5 72594851 LOC340090 (24088): -1.4460575429048197, Methylation_chr2 242904738 LINC01238 (3421): 1.379427749228759, Methylation_ARFGEF1: 0.1113977878399081, Methylation_MAPT: 1.1806904247343764, Methylation_ZFAT: 1.339104858111905, Methylation_KCNQ4: -0.9091717676494888, Methylation_chr1 232684368 SIPA1L2 (12934): -0.0834965773449092, Methylation_CRNKL1: 1.1775322683106328, Methylation_PRKAG2: -0.3009509197452335, Methylation_MICB: -0.0960024900258553, miRNA_hsa-mir-934: -0.3601701861920488, miRNA_hsa-mir-4728: -0.3057318794859635, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.0491981071900484, miRNA_hsa-mir-190b: -0.9893788821661528, miRNA_hsa-mir-577: 0.5525447767989338, miRNA_hsa-mir-135b: -0.0306629904763687, miRNA_hsa-mir-2115: 0.7503575416504852, miRNA_hsa-mir-17: -1.2111856201486944, miRNA_hsa-mir-130b: -0.0839356201846645, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A247,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. LETM1 and CRNKL1 promoter hypermethylation mediates epigenetic silencing. miR-130b upregulation suggests post-transcriptional modulation. These features collectively indicate a luminal phenotype with PI3K/AKT pathway dysregulation.","mRNA_MLPH: 0.4841891835967965, mRNA_C2orf54: -0.8806996932993743, mRNA_CITED4: -0.4860247052198943, mRNA_ESR1: 1.201815195342632, mRNA_SPDEF: 0.6924694785492096, mRNA_AGR3: 0.8669275538916871, mRNA_FOXC1: -0.3668657659621593, mRNA_GATA3: 0.5773269146710167, mRNA_AGR2: 0.7281608593076433, mRNA_XBP1: 0.0760522491809246, mRNA_PRR15: 2.382558977017074, mRNA_SLC44A4: -0.122787468451169, mRNA_CA12: 0.1460495447742582, mRNA_DTL: 0.3602444168231016, mRNA_C5AR2: 0.0459002092260414, mRNA_TBC1D9: 0.035137212213766, mRNA_AR: 0.6896441868343464, mRNA_CCDC170: 0.8479299101606544, mRNA_DEGS2: 0.7762014522255264, mRNA_TFF3: 0.5006875672389491, mRNA_DNALI1: 0.6597051685896062, mRNA_LINC00504: 1.4929319368319731, mRNA_CLCA2: -0.4092369585749009, mRNA_PPP1R14C: 0.7452941885131571, mRNA_THSD4: 0.4010535654696312, mRNA_SPAG5: 0.3768069110133722, mRNA_FBP1: 0.7216989518154742, mRNA_SLC7A8: 0.3687750177337052, mRNA_EN1: -0.5818699497608736, mRNA_ZNF552: 0.3822172993759332, Methylation_LRRC6: -1.3864812948751364, Methylation_chr2 66218712 LINC02934 (29533): 0.7331756461837707, Methylation_HOXB13: 1.2959306976302671, Methylation_chr10 3949206 LINC02660 (4871): -1.3313427864229883, Methylation_chr5 179517140 RNF130 (18026): 1.2186286300715026, Methylation_LOC727677: -1.0483630103912198, Methylation_LETM1: -1.510686193281818, Methylation_CDC42BPB: 1.404555868047466, Methylation_C8orf38: 0.3865238726987681, Methylation_chr14 100504766 EVL (18852): -1.3701931476083375, Methylation_chr5 72594851 LOC340090 (24088): 1.0886678464789428, Methylation_chr2 242904738 LINC01238 (3421): -1.312055833038818, Methylation_ARFGEF1: -1.0284767928897205, Methylation_MAPT: -1.4594193063084748, Methylation_ZFAT: -0.8097472175626527, Methylation_KCNQ4: -0.3334025716769387, Methylation_chr1 232684368 SIPA1L2 (12934): -1.3621289958299294, Methylation_CRNKL1: -1.6523956027375613, Methylation_PRKAG2: 1.3622312152468543, Methylation_MICB: -1.4869709469257064, miRNA_hsa-mir-934: -0.4599027873755197, miRNA_hsa-mir-4728: 0.4323331948157515, miRNA_hsa-mir-5695: 1.2516344439795009, miRNA_hsa-mir-18a: 0.1593234224705974, miRNA_hsa-mir-190b: 0.8523565572226649, miRNA_hsa-mir-577: -0.5265918394100285, miRNA_hsa-mir-135b: -0.2666375504403825, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.3144870380463619, miRNA_hsa-mir-130b: 1.769632785954264, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-AC-A2FG,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.7861953280122361, mRNA_C2orf54: -0.7694289014276947, mRNA_CITED4: 0.4401038087511375, mRNA_ESR1: 1.0069833336147005, mRNA_SPDEF: 0.5509567455148329, mRNA_AGR3: 0.7685571505918412, mRNA_FOXC1: 0.3516217367175098, mRNA_GATA3: 0.0763201597216547, mRNA_AGR2: 0.5136111984677005, mRNA_XBP1: 0.8443662394888756, mRNA_PRR15: 0.4366009157094206, mRNA_SLC44A4: 0.5921349610562312, mRNA_CA12: 0.2902960575293613, mRNA_DTL: -0.2260350145421897, mRNA_C5AR2: 0.3781854742187544, mRNA_TBC1D9: 1.2583492236313647, mRNA_AR: 0.9690043517680788, mRNA_CCDC170: 1.3934975340412437, mRNA_DEGS2: 0.5844592307253936, mRNA_TFF3: -0.4112884870592574, mRNA_DNALI1: 0.4171506112782987, mRNA_LINC00504: 0.8246580126679702, mRNA_CLCA2: 0.8298592247966262, mRNA_PPP1R14C: 1.0045289788090983, mRNA_THSD4: 0.9482454966577396, mRNA_SPAG5: -1.2710464836212385, mRNA_FBP1: 0.4570230741302152, mRNA_SLC7A8: 0.4800441842868773, mRNA_EN1: -0.7150252218039492, mRNA_ZNF552: 0.935060924813406, Methylation_LRRC6: 0.1383362942088061, Methylation_chr2 66218712 LINC02934 (29533): -0.4798306275523188, Methylation_HOXB13: -0.995401022567018, Methylation_chr10 3949206 LINC02660 (4871): 0.4873162614487389, Methylation_chr5 179517140 RNF130 (18026): 0.2889523312838882, Methylation_LOC727677: -0.3359373082872715, Methylation_LETM1: 0.0731401474123211, Methylation_CDC42BPB: -1.0946924450614088, Methylation_C8orf38: -0.6160403453767596, Methylation_chr14 100504766 EVL (18852): -0.3371276896725841, Methylation_chr5 72594851 LOC340090 (24088): 0.4909416206431171, Methylation_chr2 242904738 LINC01238 (3421): -0.838560549430927, Methylation_ARFGEF1: 0.2821871579713412, Methylation_MAPT: -0.0459730450066079, Methylation_ZFAT: -0.3365397157620572, Methylation_KCNQ4: 0.7700180493618816, Methylation_chr1 232684368 SIPA1L2 (12934): -0.4029484444226185, Methylation_CRNKL1: 0.1217065664517275, Methylation_PRKAG2: 1.2490751780478988, Methylation_MICB: -0.8968110812650592, miRNA_hsa-mir-934: -0.0392249500613584, miRNA_hsa-mir-4728: -0.6068279692442026, miRNA_hsa-mir-5695: 0.1880605476631425, miRNA_hsa-mir-18a: -1.4912916734057036, miRNA_hsa-mir-190b: 0.2218811553505917, miRNA_hsa-mir-577: -0.0917996388452525, miRNA_hsa-mir-135b: -0.9574701983141009, miRNA_hsa-mir-2115: 0.3672364598945649, miRNA_hsa-mir-17: -1.4880644531069205, miRNA_hsa-mir-130b: -1.9072511823315248, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A24M,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.4706969047529079, mRNA_C2orf54: -0.3565256168336633, mRNA_CITED4: -0.4989257230139719, mRNA_ESR1: 0.8036675572204521, mRNA_SPDEF: 0.3074604786179843, mRNA_AGR3: 0.9701212135772438, mRNA_FOXC1: 0.3439874463260129, mRNA_GATA3: 0.6458836240289357, mRNA_AGR2: 0.7274687258536529, mRNA_XBP1: 1.105205866351613, mRNA_PRR15: 0.4849105970970698, mRNA_SLC44A4: 0.4966883380319359, mRNA_CA12: 0.5209492622670336, mRNA_DTL: 0.7223924477266164, mRNA_C5AR2: 1.0568017871704845, mRNA_TBC1D9: 1.1848531700144789, mRNA_AR: 1.0404034278884544, mRNA_CCDC170: 1.3360694442961691, mRNA_DEGS2: 0.7791193412780115, mRNA_TFF3: 0.2383968812079364, mRNA_DNALI1: 0.6435641511821445, mRNA_LINC00504: 1.356802093331552, mRNA_CLCA2: -0.0677028436429115, mRNA_PPP1R14C: 0.4743826814004824, mRNA_THSD4: 0.841456487331356, mRNA_SPAG5: -0.5565105655422448, mRNA_FBP1: 0.2076473528769116, mRNA_SLC7A8: 0.6910048243344409, mRNA_EN1: -0.3274308234485634, mRNA_ZNF552: 0.8685282712311021, Methylation_LRRC6: -0.6191382664697214, Methylation_chr2 66218712 LINC02934 (29533): 0.0726524078899013, Methylation_HOXB13: -0.8323323917288546, Methylation_chr10 3949206 LINC02660 (4871): -0.9639234765676196, Methylation_chr5 179517140 RNF130 (18026): 0.9137817529978406, Methylation_LOC727677: -0.8610818719206537, Methylation_LETM1: -0.9359341707642804, Methylation_CDC42BPB: -1.3408549723268723, Methylation_C8orf38: -0.7707367535463341, Methylation_chr14 100504766 EVL (18852): -1.1134990468421555, Methylation_chr5 72594851 LOC340090 (24088): 0.6125281211911753, Methylation_chr2 242904738 LINC01238 (3421): -0.9357880778085588, Methylation_ARFGEF1: -0.4195871196162968, Methylation_MAPT: -0.7254233375468878, Methylation_ZFAT: 0.6016290702492767, Methylation_KCNQ4: -1.055471948295279, Methylation_chr1 232684368 SIPA1L2 (12934): -0.8992132640143315, Methylation_CRNKL1: -0.8974689853569364, Methylation_PRKAG2: 0.1268994865100877, Methylation_MICB: -0.944527475027532, miRNA_hsa-mir-934: -0.0917990693711598, miRNA_hsa-mir-4728: 0.1809710802721204, miRNA_hsa-mir-5695: -0.1586182856603122, miRNA_hsa-mir-18a: -1.604327101837027, miRNA_hsa-mir-190b: 0.5214201346346125, miRNA_hsa-mir-577: 0.3980689453325001, miRNA_hsa-mir-135b: -0.2081540032148374, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.5086330291506866, miRNA_hsa-mir-130b: -0.459172005527653, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-3C-AALJ,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives genomic instability. HOXB13 promoter hypermethylation mediates epigenetic silencing. No mRNA or miRNA alterations meet diagnostic thresholds. These features collectively indicate a basal-like phenotype with DNA repair dysregulation.","mRNA_MLPH: 0.0736885761980944, mRNA_C2orf54: 0.1055671572817408, mRNA_CITED4: -0.1425569233673473, mRNA_ESR1: 0.2550860790070373, mRNA_SPDEF: 0.2857588305726024, mRNA_AGR3: 0.5554217697529797, mRNA_FOXC1: -0.2235547252885211, mRNA_GATA3: 0.2060485754250747, mRNA_AGR2: 0.3073480342429908, mRNA_XBP1: -0.4930074955508455, mRNA_PRR15: 0.4635160733697095, mRNA_SLC44A4: -0.2076346158143246, mRNA_CA12: -0.649043525135306, mRNA_DTL: -0.2643640984118498, mRNA_C5AR2: 1.168839553622123, mRNA_TBC1D9: -0.113478406289673, mRNA_AR: -0.181283679751074, mRNA_CCDC170: 0.5010016633994666, mRNA_DEGS2: -1.1961432354204309, mRNA_TFF3: 0.4568008190538151, mRNA_DNALI1: 0.2316227006384222, mRNA_LINC00504: -1.1177179218087097, mRNA_CLCA2: -0.8349244083978036, mRNA_PPP1R14C: -1.0315923265465683, mRNA_THSD4: 0.0264126471738361, mRNA_SPAG5: 1.829788839669506, mRNA_FBP1: 0.665308715439863, mRNA_SLC7A8: -1.133792597628781, mRNA_EN1: 0.3142257835892909, mRNA_ZNF552: -1.0123878940344644, Methylation_LRRC6: -0.9299785563121352, Methylation_chr2 66218712 LINC02934 (29533): -1.324293554760153, Methylation_HOXB13: 1.5568006294184922, Methylation_chr10 3949206 LINC02660 (4871): -0.8384740642396004, Methylation_chr5 179517140 RNF130 (18026): 0.4392752923162366, Methylation_LOC727677: -0.9662503478503466, Methylation_LETM1: -0.4833691349742346, Methylation_CDC42BPB: 0.8680482186058769, Methylation_C8orf38: 0.0006880104132334, Methylation_chr14 100504766 EVL (18852): -0.7230910176475295, Methylation_chr5 72594851 LOC340090 (24088): -0.5901387827136637, Methylation_chr2 242904738 LINC01238 (3421): -0.7703840617081446, Methylation_ARFGEF1: -1.3718808273481486, Methylation_MAPT: -0.6909503178610417, Methylation_ZFAT: 0.0505973838480043, Methylation_KCNQ4: -0.2691822949903807, Methylation_chr1 232684368 SIPA1L2 (12934): -0.984552703162554, Methylation_CRNKL1: -1.158028259613554, Methylation_PRKAG2: -0.823728608840811, Methylation_MICB: -0.8288991150224697, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.2054202811810213, miRNA_hsa-mir-5695: -0.4246763295748987, miRNA_hsa-mir-18a: 0.3389720469090932, miRNA_hsa-mir-190b: -0.1008275482625846, miRNA_hsa-mir-577: -0.6767970483823406, miRNA_hsa-mir-135b: -0.8477240197614123, miRNA_hsa-mir-2115: -0.5486848378304277, miRNA_hsa-mir-17: 0.9433683965857956, miRNA_hsa-mir-130b: 0.3238788397163972, CNV_VPS54: 2.3735003872816955, CNV_LINC01867: 2.395394893874891, CNV_LINC02576: 2.464291317721031, CNV_WDPCP: 2.38809584879993, CNV_CEP68: 2.464291317721031"
TCGA-AC-A4ZE,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression of MLPH and CITED4. MAPT promoter hypermethylation mediates epigenetic silencing. These features collectively indicate a luminal phenotype with ER-pathway dysregulation.","mRNA_MLPH: 1.7771348306857904, mRNA_C2orf54: 0.2097131692550521, mRNA_CITED4: 1.7910153610850856, mRNA_ESR1: 0.922219067656053, mRNA_SPDEF: 0.7485417088130447, mRNA_AGR3: 0.170178287616336, mRNA_FOXC1: 0.1739945262545738, mRNA_GATA3: 0.8332940019624986, mRNA_AGR2: 1.20963799969929, mRNA_XBP1: 0.620498638210433, mRNA_PRR15: 0.8794045375455554, mRNA_SLC44A4: 0.2865925476032293, mRNA_CA12: 0.7330459155374149, mRNA_DTL: 0.6521006296988133, mRNA_C5AR2: 1.0984429307273282, mRNA_TBC1D9: 0.575324762508031, mRNA_AR: 0.780105882651362, mRNA_CCDC170: 0.9064118486258578, mRNA_DEGS2: 0.7279724993593693, mRNA_TFF3: 0.4535274268794363, mRNA_DNALI1: 1.0307684278928648, mRNA_LINC00504: 0.9711215008755664, mRNA_CLCA2: 0.9286911496931504, mRNA_PPP1R14C: -1.080241353230813, mRNA_THSD4: 1.251832933441147, mRNA_SPAG5: 0.3109952162641568, mRNA_FBP1: 0.8868759952304917, mRNA_SLC7A8: 1.2925796763507047, mRNA_EN1: -0.6480821792724816, mRNA_ZNF552: 1.1735476480022518, Methylation_LRRC6: -1.408808664801263, Methylation_chr2 66218712 LINC02934 (29533): 0.4925463980472441, Methylation_HOXB13: -0.8590889701305987, Methylation_chr10 3949206 LINC02660 (4871): -1.210973114105086, Methylation_chr5 179517140 RNF130 (18026): 0.8310780475858027, Methylation_LOC727677: -1.151956052470442, Methylation_LETM1: 0.234022770133374, Methylation_CDC42BPB: 1.3964487458437156, Methylation_C8orf38: -0.7877739605395075, Methylation_chr14 100504766 EVL (18852): -1.3136826175552316, Methylation_chr5 72594851 LOC340090 (24088): 0.8709035542069924, Methylation_chr2 242904738 LINC01238 (3421): -1.333004825312361, Methylation_ARFGEF1: -0.8570969335066736, Methylation_MAPT: -1.529611318113417, Methylation_ZFAT: -0.9740320182560974, Methylation_KCNQ4: -1.0370925595896854, Methylation_chr1 232684368 SIPA1L2 (12934): -1.136079123883612, Methylation_CRNKL1: -1.412841927575483, Methylation_PRKAG2: 0.0408679340308888, Methylation_MICB: -1.1256359516906649, miRNA_hsa-mir-934: -0.4945821202705319, miRNA_hsa-mir-4728: -0.2543420289988441, miRNA_hsa-mir-5695: 0.8164683321636667, miRNA_hsa-mir-18a: -0.6991014716378319, miRNA_hsa-mir-190b: 0.6646282130150821, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: 1.6290790418038683, miRNA_hsa-mir-2115: -0.2567479955563587, miRNA_hsa-mir-17: 0.2413893212330607, miRNA_hsa-mir-130b: -0.932733266689174, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-AO-A124,"High-level Amplification of VPS54 and WDPCP drives mRNA overexpression.  
Promoter hypermethylation of KCNQ4, ARFGEF1, and chr14:100504766 (EVL) mediates epigenetic silencing.  
miR-934, miR-5695, and miR-577 are markedly upregulated.  
FOXC1 and PPP1R14C show significant mRNA overexpression; ESR1, AGR2, and FBP1 are strongly downregulated.  
These features indicate a basal-like phenotype with PI3K/AKT and ER pathway dysregulation.","mRNA_MLPH: -2.0420868294606445, mRNA_C2orf54: -1.0609141476885515, mRNA_CITED4: 0.8004321306128928, mRNA_ESR1: -2.088517365639782, mRNA_SPDEF: -1.3098579719343315, mRNA_AGR3: -1.69472251213851, mRNA_FOXC1: 2.5045738980432075, mRNA_GATA3: -1.3704090580183008, mRNA_AGR2: -2.155996079097521, mRNA_XBP1: -2.124640013316069, mRNA_PRR15: -2.5659691636919417, mRNA_SLC44A4: -0.3747660605290622, mRNA_CA12: -1.040098645474446, mRNA_DTL: 1.1226832274070708, mRNA_C5AR2: -1.8558000445722664, mRNA_TBC1D9: -1.4940562062975604, mRNA_AR: -2.278192748167981, mRNA_CCDC170: -1.938604174524065, mRNA_DEGS2: -1.15486459683053, mRNA_TFF3: -1.680055921938868, mRNA_DNALI1: -0.8842610029752648, mRNA_LINC00504: -1.7021755335296684, mRNA_CLCA2: -0.4594429071347469, mRNA_PPP1R14C: 2.7257787036267054, mRNA_THSD4: -0.7600264759521439, mRNA_SPAG5: 1.103063492460675, mRNA_FBP1: -2.849769698369168, mRNA_SLC7A8: -1.6271871850996256, mRNA_EN1: 2.1934656840939595, mRNA_ZNF552: -0.3608223953300755, Methylation_LRRC6: 1.309582530125372, Methylation_chr2 66218712 LINC02934 (29533): -1.923118634297968, Methylation_HOXB13: -0.974596885087983, Methylation_chr10 3949206 LINC02660 (4871): -0.1859307171576488, Methylation_chr5 179517140 RNF130 (18026): -1.6617528008755074, Methylation_LOC727677: 1.5363694599276942, Methylation_LETM1: 1.307564167896366, Methylation_CDC42BPB: -1.035854764979989, Methylation_C8orf38: 1.2919411924131072, Methylation_chr14 100504766 EVL (18852): 1.5648964924571704, Methylation_chr5 72594851 LOC340090 (24088): -1.5989803230692732, Methylation_chr2 242904738 LINC01238 (3421): 1.4514500688054837, Methylation_ARFGEF1: 1.50860965764536, Methylation_MAPT: 1.262059726078861, Methylation_ZFAT: 1.1948483905928722, Methylation_KCNQ4: 1.8878188798341284, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5401076107226854, Methylation_CRNKL1: 1.2950261599274009, Methylation_PRKAG2: -0.4629073875254645, Methylation_MICB: 1.2623518521185553, miRNA_hsa-mir-934: 3.0777167372577385, miRNA_hsa-mir-4728: -0.3726833627680956, miRNA_hsa-mir-5695: 3.087035736785797, miRNA_hsa-mir-18a: 1.261356151168864, miRNA_hsa-mir-190b: -0.8025560109079823, miRNA_hsa-mir-577: 2.872652405434885, miRNA_hsa-mir-135b: 1.810134657973849, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.4970966507836183, miRNA_hsa-mir-130b: 0.3876150914764015, CNV_VPS54: 2.3735003872816955, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 2.38809584879993, CNV_CEP68: 1.4339562938734052"
TCGA-AO-A0JD,"High-level Amplification of LINC01867 drives no qualifying mRNA changes. No methylation or miRNA alterations meet diagnostic thresholds. All reported CNVs, mRNAs, methylations, and miRNAs fall within non-actionable ranges per specified Z-score criteria.","mRNA_MLPH: -0.3776213660974469, mRNA_C2orf54: 0.7105732554707759, mRNA_CITED4: -0.8442699857552707, mRNA_ESR1: 0.5691832068980025, mRNA_SPDEF: 0.0011880541252128, mRNA_AGR3: 0.4766751061551517, mRNA_FOXC1: -0.4311199883383825, mRNA_GATA3: 0.2417433305462645, mRNA_AGR2: 0.1243484497765459, mRNA_XBP1: 0.5776518415194166, mRNA_PRR15: -0.6639354485416802, mRNA_SLC44A4: 1.1293976666745726, mRNA_CA12: 1.0328972306970268, mRNA_DTL: 1.1559511603569457, mRNA_C5AR2: 0.032402323237704, mRNA_TBC1D9: 0.7222076674384512, mRNA_AR: 0.4344089565391035, mRNA_CCDC170: 0.9182911121868632, mRNA_DEGS2: 0.7937009897063335, mRNA_TFF3: -0.6486788966382971, mRNA_DNALI1: 0.6111177787232576, mRNA_LINC00504: 0.7427221303193152, mRNA_CLCA2: 0.5633643549448566, mRNA_PPP1R14C: 0.2846926776797503, mRNA_THSD4: 1.06071029564628, mRNA_SPAG5: 1.4425230625897394, mRNA_FBP1: 0.1224923866665302, mRNA_SLC7A8: 0.183859587697238, mRNA_EN1: -1.0138767315609816, mRNA_ZNF552: -0.264800601959715, Methylation_LRRC6: 0.6344861312225254, Methylation_chr2 66218712 LINC02934 (29533): -0.8005652852814635, Methylation_HOXB13: -0.7533548786084302, Methylation_chr10 3949206 LINC02660 (4871): -0.2360884054605347, Methylation_chr5 179517140 RNF130 (18026): 0.9575589548523444, Methylation_LOC727677: 0.8924900164575538, Methylation_LETM1: -0.7971327649128057, Methylation_CDC42BPB: -1.2881953704443028, Methylation_C8orf38: -0.5966524357751397, Methylation_chr14 100504766 EVL (18852): -0.3017921969659468, Methylation_chr5 72594851 LOC340090 (24088): 1.0613026270461707, Methylation_chr2 242904738 LINC01238 (3421): -0.3455272716267178, Methylation_ARFGEF1: -0.1491156512000551, Methylation_MAPT: 0.901628091951226, Methylation_ZFAT: 0.2773597062425263, Methylation_KCNQ4: -0.5895051402082413, Methylation_chr1 232684368 SIPA1L2 (12934): -0.1857762276293739, Methylation_CRNKL1: -0.4907878996545107, Methylation_PRKAG2: -0.2685325094920028, Methylation_MICB: -0.1886340036941393, miRNA_hsa-mir-934: -0.1424071694980282, miRNA_hsa-mir-4728: -0.6439908331901648, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.0415794784079442, miRNA_hsa-mir-190b: 1.1010028699824406, miRNA_hsa-mir-577: 1.1276490214654922, miRNA_hsa-mir-135b: 0.628093705178084, miRNA_hsa-mir-2115: 0.501121193972538, miRNA_hsa-mir-17: 0.4232432479374562, miRNA_hsa-mir-130b: 0.5025593695438083, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A1JG,"High-level Amplification of none; Gain in VPS54, WDPCP, CEP68. mRNA_CLCA2 (Z=3.22) and mRNA_C2orf54 (Z=1.86) overexpressed. mRNA_AGR3 (Z=-2.06), CA12 (Z=-2.32), DNALI1 (Z=-2.00) downregulated. Methylation_chr10:3949206 hypermethylated (Z=1.60). miRNA_hsa-mir-2115 (Z=3.97), mir-5695 (Z=2.91), mir-4728 (Z=2.52) upregulated. Collectively indicate luminal B phenotype with ER-pathway suppression.","mRNA_MLPH: -0.3215349468313, mRNA_C2orf54: 1.8599805755178864, mRNA_CITED4: -1.3360312533957717, mRNA_ESR1: -1.7651890331827895, mRNA_SPDEF: 0.5046223464403778, mRNA_AGR3: -2.060531268628111, mRNA_FOXC1: -0.3412640589467511, mRNA_GATA3: -1.5155149327299025, mRNA_AGR2: -0.9954200582393624, mRNA_XBP1: -0.370955202184289, mRNA_PRR15: -0.5157296845244519, mRNA_SLC44A4: 0.2154012383868934, mRNA_CA12: -2.316764072845529, mRNA_DTL: 0.2330990534549686, mRNA_C5AR2: -1.2142548893066094, mRNA_TBC1D9: -0.702122910817297, mRNA_AR: 0.8699171895758281, mRNA_CCDC170: -1.2963520308642034, mRNA_DEGS2: -1.0288283660816044, mRNA_TFF3: -1.0785234963002177, mRNA_DNALI1: -1.999574841577088, mRNA_LINC00504: -1.3317978631848826, mRNA_CLCA2: 3.2224429240588344, mRNA_PPP1R14C: 1.614724865854664, mRNA_THSD4: -1.4733188731549864, mRNA_SPAG5: 1.0659500713220895, mRNA_FBP1: -0.6233352192356809, mRNA_SLC7A8: -0.3950580778997766, mRNA_EN1: 0.3657069882231532, mRNA_ZNF552: -0.6457029230557298, Methylation_LRRC6: 1.4862251265352082, Methylation_chr2 66218712 LINC02934 (29533): -0.911881202737172, Methylation_HOXB13: 0.6031366722497548, Methylation_chr10 3949206 LINC02660 (4871): 1.602644326918751, Methylation_chr5 179517140 RNF130 (18026): 0.3041922571936111, Methylation_LOC727677: 1.4845106513596285, Methylation_LETM1: 1.3342257381555698, Methylation_CDC42BPB: -1.2555436342138209, Methylation_C8orf38: -0.1769524036850306, Methylation_chr14 100504766 EVL (18852): 1.2148838829787545, Methylation_chr5 72594851 LOC340090 (24088): 0.1265572037458701, Methylation_chr2 242904738 LINC01238 (3421): 1.4433478195531608, Methylation_ARFGEF1: -0.5234808114563844, Methylation_MAPT: 1.3692158872416365, Methylation_ZFAT: 1.222550196142145, Methylation_KCNQ4: 0.2065963732765623, Methylation_chr1 232684368 SIPA1L2 (12934): 0.8758792428490121, Methylation_CRNKL1: 1.354691615977893, Methylation_PRKAG2: 0.8973341169490072, Methylation_MICB: 1.4851993118388231, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 2.519097060890069, miRNA_hsa-mir-5695: 2.9069021285828667, miRNA_hsa-mir-18a: -0.0252801683896833, miRNA_hsa-mir-190b: 0.3942104548497434, miRNA_hsa-mir-577: 1.5009413427147844, miRNA_hsa-mir-135b: 0.2258281838590659, miRNA_hsa-mir-2115: 3.965292124537682, miRNA_hsa-mir-17: -0.3193664277324462, miRNA_hsa-mir-130b: 0.6701737177725202, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-AC-A2FF,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: -0.1717718981476483, mRNA_C2orf54: -0.9858046439924782, mRNA_CITED4: -0.942046103473127, mRNA_ESR1: -0.631463591415644, mRNA_SPDEF: 0.006491402895644, mRNA_AGR3: -0.275732446697366, mRNA_FOXC1: 0.5216654804681113, mRNA_GATA3: 0.218277298157985, mRNA_AGR2: 0.4403260276790322, mRNA_XBP1: 0.4269975333881421, mRNA_PRR15: -0.3001456107587581, mRNA_SLC44A4: 0.145990675174794, mRNA_CA12: 0.3573723502848512, mRNA_DTL: -0.5432268463455774, mRNA_C5AR2: 0.0643907865232295, mRNA_TBC1D9: 0.0589353315397852, mRNA_AR: 0.7474866248941783, mRNA_CCDC170: 0.1659180846191257, mRNA_DEGS2: 0.1151548188528835, mRNA_TFF3: 0.1659873545210152, mRNA_DNALI1: 0.4570356724623297, mRNA_LINC00504: 0.3069766618570353, mRNA_CLCA2: 1.8016332926995349, mRNA_PPP1R14C: 0.1349748421291408, mRNA_THSD4: 0.4499570042445874, mRNA_SPAG5: -1.0110034439493425, mRNA_FBP1: -0.4017329945707592, mRNA_SLC7A8: 0.4589865844946875, mRNA_EN1: -0.3600551822619467, mRNA_ZNF552: -0.2280820135362204, Methylation_LRRC6: 1.2114892155657817, Methylation_chr2 66218712 LINC02934 (29533): 0.0424341607930088, Methylation_HOXB13: -1.1002259650178436, Methylation_chr10 3949206 LINC02660 (4871): 0.3793031589158641, Methylation_chr5 179517140 RNF130 (18026): -1.3215962778119423, Methylation_LOC727677: 0.6285622497044117, Methylation_LETM1: 0.9494288864165948, Methylation_CDC42BPB: -0.465292644682175, Methylation_C8orf38: 1.001941601468464, Methylation_chr14 100504766 EVL (18852): 1.1218132253535984, Methylation_chr5 72594851 LOC340090 (24088): -0.986919951603912, Methylation_chr2 242904738 LINC01238 (3421): 0.5098069643650321, Methylation_ARFGEF1: 1.0629115520413368, Methylation_MAPT: 1.1394716789414452, Methylation_ZFAT: 0.7484726873539603, Methylation_KCNQ4: -1.0023817309849354, Methylation_chr1 232684368 SIPA1L2 (12934): 1.0555969217634866, Methylation_CRNKL1: 1.2349157406387594, Methylation_PRKAG2: 0.1633147653849667, Methylation_MICB: 0.974206895162969, miRNA_hsa-mir-934: -0.1811788258649491, miRNA_hsa-mir-4728: -0.1587022051598939, miRNA_hsa-mir-5695: -0.1976035316905352, miRNA_hsa-mir-18a: -0.676598730572978, miRNA_hsa-mir-190b: -0.5398075759072957, miRNA_hsa-mir-577: -0.1448991101159831, miRNA_hsa-mir-135b: -0.6203428968229151, miRNA_hsa-mir-2115: -0.6068455104264957, miRNA_hsa-mir-17: -0.4921562132879566, miRNA_hsa-mir-130b: -1.376200750736152, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A1-A0SH,"LINC00504 and CLCA2 mRNA are highly overexpressed (Z > 1.30).  
miR-18a and miR-17 are significantly downregulated (Z < -1.25).  
No methylation or CNV alterations meet diagnostic thresholds.  
These features suggest luminal epithelial differentiation with potential TGF-β pathway modulation.","mRNA_MLPH: -0.4874500735911098, mRNA_C2orf54: 0.1606731445592523, mRNA_CITED4: 0.4579392996872266, mRNA_ESR1: -0.5931538964892389, mRNA_SPDEF: 0.4881952457093874, mRNA_AGR3: 0.0897664916497623, mRNA_FOXC1: 0.0392843403027637, mRNA_GATA3: 0.0758597633802542, mRNA_AGR2: -0.2422015826323779, mRNA_XBP1: 0.5160329953641972, mRNA_PRR15: 0.1122970405903221, mRNA_SLC44A4: 0.1808837161101698, mRNA_CA12: 0.520312288761294, mRNA_DTL: -0.8667853942950337, mRNA_C5AR2: -0.3099920118050323, mRNA_TBC1D9: -0.3334028584795044, mRNA_AR: 0.4129024321517374, mRNA_CCDC170: -0.1420698834439984, mRNA_DEGS2: 0.0586133070474726, mRNA_TFF3: 0.3916332702840268, mRNA_DNALI1: -0.1307410221778837, mRNA_LINC00504: 1.4797755835734407, mRNA_CLCA2: 1.6979626938879302, mRNA_PPP1R14C: 0.3030598235818076, mRNA_THSD4: 0.2831767548937609, mRNA_SPAG5: -1.3382161835769777, mRNA_FBP1: 0.4994292435234764, mRNA_SLC7A8: 1.1218252215103484, mRNA_EN1: 0.4436682974300758, mRNA_ZNF552: -0.6057649291824724, Methylation_LRRC6: 0.3926886723756581, Methylation_chr2 66218712 LINC02934 (29533): 0.0248059808238394, Methylation_HOXB13: -0.9157222114675184, Methylation_chr10 3949206 LINC02660 (4871): 0.7009653590555963, Methylation_chr5 179517140 RNF130 (18026): 0.2983298352363036, Methylation_LOC727677: 1.259024851046342, Methylation_LETM1: 0.5148925161481079, Methylation_CDC42BPB: 0.9842408681001412, Methylation_C8orf38: 0.0656895637660674, Methylation_chr14 100504766 EVL (18852): 0.5553762554265447, Methylation_chr5 72594851 LOC340090 (24088): 0.587923485106218, Methylation_chr2 242904738 LINC01238 (3421): 0.1809125906462102, Methylation_ARFGEF1: 0.7290450677994111, Methylation_MAPT: 0.6828737273024558, Methylation_ZFAT: 0.5482058574802302, Methylation_KCNQ4: -0.6989327763149468, Methylation_chr1 232684368 SIPA1L2 (12934): 0.7470267295630467, Methylation_CRNKL1: 0.7768716637513852, Methylation_PRKAG2: 0.7392382045375309, Methylation_MICB: 0.6668512119307766, miRNA_hsa-mir-934: 0.18378195916079, miRNA_hsa-mir-4728: -0.6072243521090788, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.2521975748468206, miRNA_hsa-mir-190b: 0.1405308436454025, miRNA_hsa-mir-577: 0.4555663555166601, miRNA_hsa-mir-135b: 0.403301073898813, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -2.1102672797290105, miRNA_hsa-mir-130b: -0.3266437140849733, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A2-A0YT,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. ZFAT and LINC02934 promoter hypomethylation suggest epigenetic dysregulation. miR-190b upregulation may suppress tumor-inhibitory pathways. These features align with a luminal B phenotype and PI3K/AKT/mTOR pathway activation.","mRNA_MLPH: 0.2286786429021551, mRNA_C2orf54: 0.7871137217907971, mRNA_CITED4: 0.0706251248501258, mRNA_ESR1: 0.7726077919874562, mRNA_SPDEF: 0.7413067198304326, mRNA_AGR3: -0.2351091652067648, mRNA_FOXC1: -0.1330866536176273, mRNA_GATA3: 0.2049779457797643, mRNA_AGR2: 0.1463427728195786, mRNA_XBP1: 0.3086480187762618, mRNA_PRR15: -0.0574454336777031, mRNA_SLC44A4: 0.7499459054908588, mRNA_CA12: 1.0646538553119504, mRNA_DTL: 1.2980857631532212, mRNA_C5AR2: 0.863049183309436, mRNA_TBC1D9: 1.0541495937951262, mRNA_AR: -0.974184224724838, mRNA_CCDC170: 0.2936295810012417, mRNA_DEGS2: 0.4529255347075781, mRNA_TFF3: -0.6602458819327717, mRNA_DNALI1: 0.6149153604932561, mRNA_LINC00504: 0.5942132138175653, mRNA_CLCA2: -0.755644587587186, mRNA_PPP1R14C: -0.8141650482809561, mRNA_THSD4: 0.6251025092634057, mRNA_SPAG5: 0.9522418000449532, mRNA_FBP1: 0.3958026341528583, mRNA_SLC7A8: 0.7934930439165375, mRNA_EN1: -1.0970214880626754, mRNA_ZNF552: 0.5184522444842958, Methylation_LRRC6: -1.2769562611644136, Methylation_chr2 66218712 LINC02934 (29533): -1.658608658624204, Methylation_HOXB13: 1.4416233600499897, Methylation_chr10 3949206 LINC02660 (4871): -0.922162257008898, Methylation_chr5 179517140 RNF130 (18026): 1.2033349789419003, Methylation_LOC727677: -0.8976575574983932, Methylation_LETM1: -1.3302853482748729, Methylation_CDC42BPB: 1.2051095442611983, Methylation_C8orf38: -1.275176142941111, Methylation_chr14 100504766 EVL (18852): -0.9259007840297284, Methylation_chr5 72594851 LOC340090 (24088): 0.2096759593880591, Methylation_chr2 242904738 LINC01238 (3421): -0.3715757277007068, Methylation_ARFGEF1: -0.860067772620402, Methylation_MAPT: 0.1453941343209693, Methylation_ZFAT: -1.769627569580825, Methylation_KCNQ4: 0.2945453804839616, Methylation_chr1 232684368 SIPA1L2 (12934): -1.1468857515264257, Methylation_CRNKL1: -0.5008094623696089, Methylation_PRKAG2: -1.028644719431686, Methylation_MICB: -1.0490069823244916, miRNA_hsa-mir-934: 0.5807566212482139, miRNA_hsa-mir-4728: 0.6391246565450868, miRNA_hsa-mir-5695: 1.523323917081194, miRNA_hsa-mir-18a: 0.32494436814707, miRNA_hsa-mir-190b: 2.005539390011247, miRNA_hsa-mir-577: -0.2088430873258536, miRNA_hsa-mir-135b: 0.0085151325073353, miRNA_hsa-mir-2115: 0.2639321417977041, miRNA_hsa-mir-17: 0.4427366167071447, miRNA_hsa-mir-130b: 0.3511845538399765, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-BH-A0BZ,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression of C2orf54 (Z=2.15) and SPAG5 (Z=1.53). Promoter hypermethylation at HOXB13 (Z=1.40), LINC02660 (Z=1.57), LOC727677 (Z=1.44), and LINC01238 (Z=1.36) suggests epigenetic silencing. No miRNA alterations meet dysregulation thresholds. These features indicate a luminal B-like phenotype with cell cycle and transcriptional dysregulation.","mRNA_MLPH: 0.3469293470899133, mRNA_C2orf54: 2.1492746582972866, mRNA_CITED4: -0.6378237243765862, mRNA_ESR1: 0.3097732572127702, mRNA_SPDEF: 0.6702507313207492, mRNA_AGR3: 0.222401698299917, mRNA_FOXC1: -0.5402254871555194, mRNA_GATA3: 0.004830943073842, mRNA_AGR2: 0.3440709973973634, mRNA_XBP1: -0.0211662783720794, mRNA_PRR15: 0.5312186678862898, mRNA_SLC44A4: 0.4406657245723062, mRNA_CA12: 0.341349521506738, mRNA_DTL: 0.5755289737325914, mRNA_C5AR2: -0.5245735236818301, mRNA_TBC1D9: -0.0758607542296577, mRNA_AR: -0.8715053587713891, mRNA_CCDC170: -0.7449544109180422, mRNA_DEGS2: 0.2167702357711033, mRNA_TFF3: 0.2409134756502429, mRNA_DNALI1: 0.5548432564768465, mRNA_LINC00504: 0.2138358546515178, mRNA_CLCA2: -0.5173650738853984, mRNA_PPP1R14C: -0.2441034184867138, mRNA_THSD4: -0.5946476288028272, mRNA_SPAG5: 1.531634460938844, mRNA_FBP1: 0.4490568864103026, mRNA_SLC7A8: -0.5970923654756607, mRNA_EN1: -0.1597739166697337, mRNA_ZNF552: 0.1985073110054474, Methylation_LRRC6: -0.2581287372289221, Methylation_chr2 66218712 LINC02934 (29533): 0.0406651716541676, Methylation_HOXB13: 1.4035808641444008, Methylation_chr10 3949206 LINC02660 (4871): 1.571039315494493, Methylation_chr5 179517140 RNF130 (18026): 0.3927434164364781, Methylation_LOC727677: 1.4393732020248378, Methylation_LETM1: 0.0175539951710323, Methylation_CDC42BPB: 0.425060164754887, Methylation_C8orf38: -0.19175862757679, Methylation_chr14 100504766 EVL (18852): 0.221768160647912, Methylation_chr5 72594851 LOC340090 (24088): 0.6462484671168749, Methylation_chr2 242904738 LINC01238 (3421): 1.3636618975429688, Methylation_ARFGEF1: -0.273103447895604, Methylation_MAPT: 0.890016060451975, Methylation_ZFAT: 0.2506130287299509, Methylation_KCNQ4: 0.2500542890128217, Methylation_chr1 232684368 SIPA1L2 (12934): -0.0526381560741738, Methylation_CRNKL1: 0.6020235315873564, Methylation_PRKAG2: 0.5045204544286765, Methylation_MICB: -0.0473392817832998, miRNA_hsa-mir-934: 0.9393689292012614, miRNA_hsa-mir-4728: 0.3216460218852485, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.4616998560951378, miRNA_hsa-mir-190b: -1.1508624542699488, miRNA_hsa-mir-577: 0.7682324296554216, miRNA_hsa-mir-135b: -0.3942472618338093, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.2952495963621726, miRNA_hsa-mir-130b: -1.1838482051924948, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-BH-A1EN,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives genomic instability. mRNA_TFF3 (Z=1.84) and mRNA_AGR2 (Z=1.39) are overexpressed; mRNA_GATA3 (Z=-2.66) and mRNA_THSD4 (Z=-2.10) are downregulated. Methylation hypermethylation at chr10:3949206, C8orf38, and MAPT (all Z>1.50). miRNA_hsa-mir-135b and hsa-mir-4728 are upregulated (Z>1.99).","mRNA_MLPH: 0.5758622779064922, mRNA_C2orf54: 1.2882995318514736, mRNA_CITED4: -1.7708564193701073, mRNA_ESR1: -1.4682841287295416, mRNA_SPDEF: 1.1134775186294974, mRNA_AGR3: 0.2592648859837983, mRNA_FOXC1: -0.8578186935247131, mRNA_GATA3: -2.660499074568963, mRNA_AGR2: 1.3914733261375032, mRNA_XBP1: 0.7827332435939235, mRNA_PRR15: 0.6424991090725787, mRNA_SLC44A4: 0.958281550666836, mRNA_CA12: -1.3869307797812434, mRNA_DTL: -0.0036100355327737, mRNA_C5AR2: -1.567288095835653, mRNA_TBC1D9: -0.9436939949844846, mRNA_AR: -0.0373025081074207, mRNA_CCDC170: -1.55212079354471, mRNA_DEGS2: -2.03994718737896, mRNA_TFF3: 1.8369752516266635, mRNA_DNALI1: -0.7639312418040081, mRNA_LINC00504: -1.4840713080523695, mRNA_CLCA2: -0.4737353989262802, mRNA_PPP1R14C: -0.8223927423449544, mRNA_THSD4: -2.102997734224208, mRNA_SPAG5: -1.4848615334309083, mRNA_FBP1: 0.8116189470987557, mRNA_SLC7A8: -0.5700901073443251, mRNA_EN1: -0.4601203036550782, mRNA_ZNF552: 0.0630570655952446, Methylation_LRRC6: 1.4163568645439053, Methylation_chr2 66218712 LINC02934 (29533): 0.0230347024261295, Methylation_HOXB13: 0.8996432293658675, Methylation_chr10 3949206 LINC02660 (4871): 1.6137479662423069, Methylation_chr5 179517140 RNF130 (18026): 1.1834386425571666, Methylation_LOC727677: -0.4798945445176291, Methylation_LETM1: 1.1707179766572764, Methylation_CDC42BPB: -1.3497240256250354, Methylation_C8orf38: 1.642685434019962, Methylation_chr14 100504766 EVL (18852): 1.4475412974980473, Methylation_chr5 72594851 LOC340090 (24088): 1.1640797922629238, Methylation_chr2 242904738 LINC01238 (3421): 1.457646978775792, Methylation_ARFGEF1: 0.7797409831597953, Methylation_MAPT: 1.4930789497337875, Methylation_ZFAT: 0.6747763242976826, Methylation_KCNQ4: 1.018325184767355, Methylation_chr1 232684368 SIPA1L2 (12934): -0.0324741202531484, Methylation_CRNKL1: 1.3904614130516446, Methylation_PRKAG2: -1.128177346817115, Methylation_MICB: 1.481778408943124, miRNA_hsa-mir-934: -0.2369179344690923, miRNA_hsa-mir-4728: 3.1325293727025376, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.0146379076208288, miRNA_hsa-mir-190b: 0.8889569126770502, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: 3.1378730444470206, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.5361044382411961, miRNA_hsa-mir-130b: 0.3032331483029618, CNV_VPS54: 2.3735003872816955, CNV_LINC01867: 2.395394893874891, CNV_LINC02576: 2.464291317721031, CNV_WDPCP: 2.38809584879993, CNV_CEP68: 2.464291317721031"
TCGA-B6-A0WT,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.5098030805191018, mRNA_C2orf54: 0.3086466228411426, mRNA_CITED4: 0.1742521912704844, mRNA_ESR1: 0.5491995521907764, mRNA_SPDEF: 0.5277849281656656, mRNA_AGR3: 0.6563050290717561, mRNA_FOXC1: -0.1734047200774275, mRNA_GATA3: 0.4511730646551716, mRNA_AGR2: 0.8375623815323373, mRNA_XBP1: 0.9030588334630076, mRNA_PRR15: 0.4173732555588094, mRNA_SLC44A4: 0.7003865952449261, mRNA_CA12: 0.3913683463460392, mRNA_DTL: 1.1454818486877587, mRNA_C5AR2: 1.17163563887825, mRNA_TBC1D9: 1.14764716492328, mRNA_AR: 0.4809844465962696, mRNA_CCDC170: 0.8428680682787499, mRNA_DEGS2: -0.5821971207293818, mRNA_TFF3: 1.0963342920933905, mRNA_DNALI1: 0.7238930645745633, mRNA_LINC00504: 0.975870325130916, mRNA_CLCA2: 0.2581876957460554, mRNA_PPP1R14C: -0.3796418045651278, mRNA_THSD4: 1.0352270702133488, mRNA_SPAG5: 0.3993573218897497, mRNA_FBP1: 0.2751235579042071, mRNA_SLC7A8: 0.7300169239671137, mRNA_EN1: -0.1701961177476015, mRNA_ZNF552: 0.6661320116059701, Methylation_LRRC6: -0.6109039667438824, Methylation_chr2 66218712 LINC02934 (29533): -0.925537136549438, Methylation_HOXB13: -0.956419203983318, Methylation_chr10 3949206 LINC02660 (4871): -0.2621843496550692, Methylation_chr5 179517140 RNF130 (18026): 1.070047397547126, Methylation_LOC727677: -0.6591630460277313, Methylation_LETM1: -0.4654493097389193, Methylation_CDC42BPB: -1.156684750611198, Methylation_C8orf38: -0.7686716132221709, Methylation_chr14 100504766 EVL (18852): -0.639008588846644, Methylation_chr5 72594851 LOC340090 (24088): 0.7157485896385851, Methylation_chr2 242904738 LINC01238 (3421): -0.8249983376589777, Methylation_ARFGEF1: -0.6476031678384915, Methylation_MAPT: -0.862813142560968, Methylation_ZFAT: -0.4972402669990802, Methylation_KCNQ4: -1.123182635308296, Methylation_chr1 232684368 SIPA1L2 (12934): -0.9081987556589394, Methylation_CRNKL1: -0.4601229378407229, Methylation_PRKAG2: -0.0067158268873966, Methylation_MICB: -0.8244033700722307, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.3132710765341906, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.129051727716021, miRNA_hsa-mir-190b: 0.9540226105248506, miRNA_hsa-mir-577: -0.3764782610878658, miRNA_hsa-mir-135b: -0.2577317209891701, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.1909822068777984, miRNA_hsa-mir-130b: -0.5011289872208241, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A2-A3XT,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression of PPP1R14C and EN1. Promoter hypermethylation of ARFGEF1, MAPT, ZFAT, SIPA1L2, C8orf38, and LINC02660 mediates epigenetic silencing. miR-577 upregulation and miR-190b downregulation suggest post-transcriptional dysregulation. These features indicate a luminal B-like phenotype with PI3K/AKT/mTOR pathway activation.","mRNA_MLPH: -1.453331363939529, mRNA_C2orf54: -0.9700227197729512, mRNA_CITED4: 1.217864153183935, mRNA_ESR1: -0.7395290776735244, mRNA_SPDEF: -2.8309851584043075, mRNA_AGR3: -1.9652045454786409, mRNA_FOXC1: 1.669294558862081, mRNA_GATA3: -1.3267471849879915, mRNA_AGR2: -2.440308155781508, mRNA_XBP1: -2.615297943273032, mRNA_PRR15: -2.104719702384777, mRNA_SLC44A4: -2.1443823340294093, mRNA_CA12: -0.3806360680442708, mRNA_DTL: 1.2488458084390373, mRNA_C5AR2: -1.2254308215540786, mRNA_TBC1D9: -1.6035103457482849, mRNA_AR: -2.2471455901518467, mRNA_CCDC170: -1.257160652352414, mRNA_DEGS2: -2.116803150592288, mRNA_TFF3: -1.6623874214753716, mRNA_DNALI1: -1.8127041637988424, mRNA_LINC00504: -1.6619569082186083, mRNA_CLCA2: -0.8008671803187527, mRNA_PPP1R14C: 2.8307582982156108, mRNA_THSD4: -1.9306424532088555, mRNA_SPAG5: 0.7739225041239461, mRNA_FBP1: -0.3258717487887892, mRNA_SLC7A8: -1.4314481122919842, mRNA_EN1: 2.972647962169418, mRNA_ZNF552: -2.3348444126548573, Methylation_LRRC6: 1.435302245952811, Methylation_chr2 66218712 LINC02934 (29533): 0.7317165827807618, Methylation_HOXB13: -1.0511922150210136, Methylation_chr10 3949206 LINC02660 (4871): 1.5576682012318706, Methylation_chr5 179517140 RNF130 (18026): -1.569682883743613, Methylation_LOC727677: 1.4912927377083298, Methylation_LETM1: 1.3254925127531554, Methylation_CDC42BPB: 0.4597672637681345, Methylation_C8orf38: 1.5600051206877037, Methylation_chr14 100504766 EVL (18852): 1.4175786257709595, Methylation_chr5 72594851 LOC340090 (24088): -1.4675673661283613, Methylation_chr2 242904738 LINC01238 (3421): 1.3822527226801555, Methylation_ARFGEF1: 1.6843215037151231, Methylation_MAPT: 1.4937276783761002, Methylation_ZFAT: 1.4136502771701775, Methylation_KCNQ4: 0.7605774650937975, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5479405279300722, Methylation_CRNKL1: 1.3569985464849992, Methylation_PRKAG2: -0.7414479686696441, Methylation_MICB: 1.3663516797860755, miRNA_hsa-mir-934: -0.1534843280083596, miRNA_hsa-mir-4728: -0.9298323289867908, miRNA_hsa-mir-5695: 0.1975842743895505, miRNA_hsa-mir-18a: 1.2733390198551326, miRNA_hsa-mir-190b: -1.2122490351995796, miRNA_hsa-mir-577: 2.1178439629733345, miRNA_hsa-mir-135b: 1.852197743320031, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.827407975584297, miRNA_hsa-mir-130b: 1.1499747841143944, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-BH-A1FB,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-significant ranges per specified Z-score and CNV cutoffs.","mRNA_MLPH: 0.0014423924322413, mRNA_C2orf54: 0.1635036218091978, mRNA_CITED4: 0.2551891104940399, mRNA_ESR1: 0.5146967228954583, mRNA_SPDEF: 0.0944151666689119, mRNA_AGR3: 0.2364763258736022, mRNA_FOXC1: 0.5470935341331867, mRNA_GATA3: 0.0704403653379074, mRNA_AGR2: -0.0182961491787898, mRNA_XBP1: 0.4469867656409476, mRNA_PRR15: -0.3995274793240082, mRNA_SLC44A4: 0.068171461991462, mRNA_CA12: 0.5241064542478038, mRNA_DTL: -1.2085647449311745, mRNA_C5AR2: 0.0422590067231105, mRNA_TBC1D9: 0.4242087791875777, mRNA_AR: 0.7271429600925795, mRNA_CCDC170: 0.7946548074283921, mRNA_DEGS2: 0.4050594769428665, mRNA_TFF3: 0.0754802660617468, mRNA_DNALI1: 0.4519317487107608, mRNA_LINC00504: 1.1175350873009835, mRNA_CLCA2: 1.0885373521704946, mRNA_PPP1R14C: 0.6008231605751402, mRNA_THSD4: 0.3632585417204934, mRNA_SPAG5: -1.1485368725762883, mRNA_FBP1: -0.1540993196114393, mRNA_SLC7A8: 0.8705076532778042, mRNA_EN1: -0.47123889348488, mRNA_ZNF552: 0.0028688450689845, Methylation_LRRC6: 0.9189667417403008, Methylation_chr2 66218712 LINC02934 (29533): 0.8393172354037893, Methylation_HOXB13: -0.9941331507199702, Methylation_chr10 3949206 LINC02660 (4871): 1.0230628212704915, Methylation_chr5 179517140 RNF130 (18026): -1.3580987128503916, Methylation_LOC727677: 0.5076652706785051, Methylation_LETM1: 0.9525939631597616, Methylation_CDC42BPB: -0.6475399877842767, Methylation_C8orf38: 0.7318875168424714, Methylation_chr14 100504766 EVL (18852): 1.2054962399968263, Methylation_chr5 72594851 LOC340090 (24088): -0.8036160863678088, Methylation_chr2 242904738 LINC01238 (3421): -0.0468823849493692, Methylation_ARFGEF1: 0.9053528205651056, Methylation_MAPT: 0.7602651125000287, Methylation_ZFAT: 0.5186325088075603, Methylation_KCNQ4: -0.7422951919912463, Methylation_chr1 232684368 SIPA1L2 (12934): 1.244121140228338, Methylation_CRNKL1: 0.9044360817062236, Methylation_PRKAG2: 0.9390866530812352, Methylation_MICB: 0.8587192133534158, miRNA_hsa-mir-934: 0.0796755813499882, miRNA_hsa-mir-4728: 0.18499990844024, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.9188841055339512, miRNA_hsa-mir-190b: -0.8355080176729658, miRNA_hsa-mir-577: 1.4147919064852728, miRNA_hsa-mir-135b: -0.1174950053071966, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.5741514442347377, miRNA_hsa-mir-130b: -0.4928812284858834, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A5UP,"High mRNA_CITED4 (Z=1.97) and mRNA_DEGS2 (Z=1.74) indicate overexpression. Methylation_HOXB13 (Z=1.55) and Methylation_KCNQ4 (Z=1.54) are hypermethylated. Methylation_LETM1 (Z=-1.69), Methylation_MAPT (Z=-1.75), and Methylation_CRNKL1 (Z=-1.51) are hypomethylated. miRNA_hsa-mir-130b (Z=-1.78) is downregulated. No CNVs meet amplification/deletion thresholds. These features suggest luminal breast cancer with HOXB13-driven epigenetic silencing and CITED4/DEGS2 activation.","mRNA_MLPH: 1.0480873051671005, mRNA_C2orf54: -0.9671917475934222, mRNA_CITED4: 1.9729554251553936, mRNA_ESR1: 0.7615247298849929, mRNA_SPDEF: 0.524486358981915, mRNA_AGR3: 0.5243328747932325, mRNA_FOXC1: -1.4069399683543544, mRNA_GATA3: 1.08915045767838, mRNA_AGR2: -0.5669578617911183, mRNA_XBP1: 0.4990429961192359, mRNA_PRR15: 0.6065665813700952, mRNA_SLC44A4: 0.846937206194189, mRNA_CA12: 1.0939025529347473, mRNA_DTL: -1.6243151175769222, mRNA_C5AR2: 0.338039415842239, mRNA_TBC1D9: 0.8672662671048842, mRNA_AR: -0.041769452110644, mRNA_CCDC170: 0.3402567655931159, mRNA_DEGS2: 1.7395432116568736, mRNA_TFF3: -0.527494217706858, mRNA_DNALI1: 0.5546642454061899, mRNA_LINC00504: 0.3669877120788007, mRNA_CLCA2: -0.8315124473683068, mRNA_PPP1R14C: -0.7150877035392741, mRNA_THSD4: 0.253308970866701, mRNA_SPAG5: -0.937497574831102, mRNA_FBP1: 0.6741731523180896, mRNA_SLC7A8: 0.8375746834934314, mRNA_EN1: -1.1595838805174448, mRNA_ZNF552: 0.7759942104077958, Methylation_LRRC6: -1.4204926759165486, Methylation_chr2 66218712 LINC02934 (29533): 1.3340359575141063, Methylation_HOXB13: 1.5541908603616887, Methylation_chr10 3949206 LINC02660 (4871): -1.3224463222045455, Methylation_chr5 179517140 RNF130 (18026): 1.2175760444667827, Methylation_LOC727677: 1.2734132812134749, Methylation_LETM1: -1.688031785976888, Methylation_CDC42BPB: 1.3657820577300397, Methylation_C8orf38: -0.7290685791103365, Methylation_chr14 100504766 EVL (18852): -1.2443427837866747, Methylation_chr5 72594851 LOC340090 (24088): 1.0777295441825532, Methylation_chr2 242904738 LINC01238 (3421): -1.406700590759169, Methylation_ARFGEF1: -1.0462315061439336, Methylation_MAPT: -1.751411291247221, Methylation_ZFAT: -0.3354726432124302, Methylation_KCNQ4: 1.5391431255679753, Methylation_chr1 232684368 SIPA1L2 (12934): -1.356959610271091, Methylation_CRNKL1: -1.5131212838057022, Methylation_PRKAG2: 1.1300352052265794, Methylation_MICB: -1.308042445573223, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.0996200335315205, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.3467356004947519, miRNA_hsa-mir-190b: 0.3046533203749527, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: 0.5448850361746159, miRNA_hsa-mir-17: 0.3670713047707331, miRNA_hsa-mir-130b: -1.782546848438597, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-D8-A1Y3,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting. All values fall within non-significant ranges per defined criteria.","mRNA_MLPH: -0.5697136275322894, mRNA_C2orf54: -0.5198765711365737, mRNA_CITED4: 0.6378117714342804, mRNA_ESR1: -0.039675214706899, mRNA_SPDEF: 0.705297596080347, mRNA_AGR3: -0.7621792017094078, mRNA_FOXC1: -0.7611320036748814, mRNA_GATA3: 0.7917245989158456, mRNA_AGR2: -1.0585928950743784, mRNA_XBP1: -0.6931035517488404, mRNA_PRR15: -1.056764754202893, mRNA_SLC44A4: -1.7284120984509144, mRNA_CA12: 0.2835523129093721, mRNA_DTL: 0.6804179893100661, mRNA_C5AR2: -0.9482277152864336, mRNA_TBC1D9: -0.4948989340251369, mRNA_AR: -0.6793815828382411, mRNA_CCDC170: -0.3878006002848371, mRNA_DEGS2: -0.1006027180579462, mRNA_TFF3: 0.1417157339735857, mRNA_DNALI1: -0.1672625345361436, mRNA_LINC00504: -0.2383897396721466, mRNA_CLCA2: -0.8742354064971731, mRNA_PPP1R14C: -0.9175712047861811, mRNA_THSD4: -1.3120918054959334, mRNA_SPAG5: 0.6487156812040618, mRNA_FBP1: -0.0133511462652199, mRNA_SLC7A8: 0.3843473485084788, mRNA_EN1: -0.9057378756038696, mRNA_ZNF552: -1.524706943732681, Methylation_LRRC6: -1.542572494440691, Methylation_chr2 66218712 LINC02934 (29533): 1.0579058938647858, Methylation_HOXB13: -0.4936539572229163, Methylation_chr10 3949206 LINC02660 (4871): -1.1256959412632297, Methylation_chr5 179517140 RNF130 (18026): 0.3468228403063547, Methylation_LOC727677: -1.1637675043135471, Methylation_LETM1: 0.9209501352730708, Methylation_CDC42BPB: 1.014911867195028, Methylation_C8orf38: -1.6670569180043624, Methylation_chr14 100504766 EVL (18852): -1.3127611965124113, Methylation_chr5 72594851 LOC340090 (24088): 0.555305151057937, Methylation_chr2 242904738 LINC01238 (3421): -0.8947218784363461, Methylation_ARFGEF1: -1.330431905381691, Methylation_MAPT: -0.9664152612618714, Methylation_ZFAT: -1.5185503021283626, Methylation_KCNQ4: 0.9664090183763832, Methylation_chr1 232684368 SIPA1L2 (12934): -1.235945833214421, Methylation_CRNKL1: -1.487019517538793, Methylation_PRKAG2: 1.0461655122450384, Methylation_MICB: -1.2102474160616343, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.1901896960298184, miRNA_hsa-mir-5695: 0.8007048760228914, miRNA_hsa-mir-18a: 0.743845201241962, miRNA_hsa-mir-190b: -0.2762482063197692, miRNA_hsa-mir-577: -0.2470643881910169, miRNA_hsa-mir-135b: -0.4448046135600935, miRNA_hsa-mir-2115: 1.8894839345360115, miRNA_hsa-mir-17: 0.6205880473685493, miRNA_hsa-mir-130b: 0.4056050017718798, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-C8-A1HN,"High mRNA_C2orf54 (Z=1.93) and mRNA_SPAG5 (Z=1.93) indicate overexpression. Methylation_HOXB13 hypermethylation (Z=1.57) and Methylation_ZFAT hypomethylation (Z=-1.70) suggest epigenetic dysregulation. No CNVs meet amplification/deletion thresholds. miRNA_hsa-mir-130b (Z=1.74) and miRNA_hsa-mir-5695 (Z=1.73) are upregulated. Collectively, these features suggest luminal breast cancer with ER-pathway activation.","mRNA_MLPH: -0.0736470602348837, mRNA_C2orf54: 1.9346642134898329, mRNA_CITED4: 1.2375716442791291, mRNA_ESR1: 1.1836386989687506, mRNA_SPDEF: 0.2602894237412566, mRNA_AGR3: 1.1763218456836175, mRNA_FOXC1: -0.8887605984079012, mRNA_GATA3: 0.7931100119728466, mRNA_AGR2: 1.120719545016527, mRNA_XBP1: 0.683652418007772, mRNA_PRR15: -0.1251933935113505, mRNA_SLC44A4: -0.7469726032566955, mRNA_CA12: 0.9779146813315964, mRNA_DTL: 1.428533775461795, mRNA_C5AR2: 0.7905191208956809, mRNA_TBC1D9: 1.434935900917201, mRNA_AR: -0.4005070038172, mRNA_CCDC170: 0.8277445178797683, mRNA_DEGS2: -1.6724636479613435, mRNA_TFF3: 0.7077190649168572, mRNA_DNALI1: 1.0798598298852102, mRNA_LINC00504: 1.300995484621205, mRNA_CLCA2: -0.8875837677193859, mRNA_PPP1R14C: -1.0220174737875816, mRNA_THSD4: 0.833536292735835, mRNA_SPAG5: 1.927357278077204, mRNA_FBP1: -1.0082961736109457, mRNA_SLC7A8: 0.0730498003741974, mRNA_EN1: -0.3421653844819064, mRNA_ZNF552: 1.1151556288589473, Methylation_LRRC6: -1.5348496176260804, Methylation_chr2 66218712 LINC02934 (29533): 1.0125318993149088, Methylation_HOXB13: 1.57325144531618, Methylation_chr10 3949206 LINC02660 (4871): -1.0766277330492455, Methylation_chr5 179517140 RNF130 (18026): 1.208538002076895, Methylation_LOC727677: -1.2055103711460466, Methylation_LETM1: -1.165217930714428, Methylation_CDC42BPB: 0.4820497181935734, Methylation_C8orf38: -1.267637435759613, Methylation_chr14 100504766 EVL (18852): -0.7471985473451959, Methylation_chr5 72594851 LOC340090 (24088): 1.3510937231358495, Methylation_chr2 242904738 LINC01238 (3421): -1.3151391122192233, Methylation_ARFGEF1: -1.417484151208053, Methylation_MAPT: -1.1506539924591777, Methylation_ZFAT: -1.7009745156489724, Methylation_KCNQ4: 0.7658327694836615, Methylation_chr1 232684368 SIPA1L2 (12934): -0.2747376410423233, Methylation_CRNKL1: -0.4777471112454062, Methylation_PRKAG2: 0.6126925308610816, Methylation_MICB: -1.3119619796451751, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.2655325990050406, miRNA_hsa-mir-5695: 1.728762606956105, miRNA_hsa-mir-18a: 0.2291209792953609, miRNA_hsa-mir-190b: 1.3756836503856178, miRNA_hsa-mir-577: -0.5027085254976313, miRNA_hsa-mir-135b: -0.5948077367197209, miRNA_hsa-mir-2115: 1.2015479973646324, miRNA_hsa-mir-17: 0.000460939078417, miRNA_hsa-mir-130b: 1.739091753340663, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-B6-A0RT,"High-level Amplification of EN1 drives significant mRNA overexpression. PPP1R14C and FOXC1 show high mRNA (Z > 1.30). miR-934, miR-135b, and miR-577 are upregulated (Z > 1.99). Promoter hypermethylation at chr10:3949206, ARFGEF1, and C8orf38 (Z > 1.50) suggests epigenetic silencing. RNF130 is hypomethylated (Z < -1.47). No CNVs meet amplification/deletion thresholds.","mRNA_MLPH: -2.4290159097516493, mRNA_C2orf54: -0.5980467917889056, mRNA_CITED4: 0.1681849797925899, mRNA_ESR1: -1.5780196682688243, mRNA_SPDEF: -2.12090875137212, mRNA_AGR3: -1.6968978240445936, mRNA_FOXC1: 1.4417202890083407, mRNA_GATA3: -0.9425956238188636, mRNA_AGR2: -1.8281924527794653, mRNA_XBP1: -1.1796298924293191, mRNA_PRR15: -1.8714553125039648, mRNA_SLC44A4: -1.659660629083025, mRNA_CA12: -2.3210523347807634, mRNA_DTL: -0.1226891802204456, mRNA_C5AR2: -1.480800211916872, mRNA_TBC1D9: -1.6682934602935082, mRNA_AR: -1.4567456170116828, mRNA_CCDC170: -1.3176295023125455, mRNA_DEGS2: -1.6940305865371257, mRNA_TFF3: -1.5298790058504457, mRNA_DNALI1: -1.4064669141582489, mRNA_LINC00504: -1.6094578066832266, mRNA_CLCA2: -0.4369092759194597, mRNA_PPP1R14C: 1.7069782121716597, mRNA_THSD4: -1.4339632850240678, mRNA_SPAG5: 0.0702016949349296, mRNA_FBP1: -1.2819770125925831, mRNA_SLC7A8: -1.375122527891484, mRNA_EN1: 2.1795373257235395, mRNA_ZNF552: -1.5362044044312375, Methylation_LRRC6: 1.4587745183964311, Methylation_chr2 66218712 LINC02934 (29533): 1.256688121283282, Methylation_HOXB13: -0.4399257709152671, Methylation_chr10 3949206 LINC02660 (4871): 1.633097301391636, Methylation_chr5 179517140 RNF130 (18026): -1.564257286234257, Methylation_LOC727677: 1.4952413247441965, Methylation_LETM1: 1.3175444152120035, Methylation_CDC42BPB: -0.5618651011303664, Methylation_C8orf38: 1.5910706287317478, Methylation_chr14 100504766 EVL (18852): 1.4833959251469435, Methylation_chr5 72594851 LOC340090 (24088): -1.3432812865821324, Methylation_chr2 242904738 LINC01238 (3421): 1.3465879193094423, Methylation_ARFGEF1: 1.5517499766441256, Methylation_MAPT: 1.3640966678592714, Methylation_ZFAT: 1.4442847418243323, Methylation_KCNQ4: -0.2615542792785001, Methylation_chr1 232684368 SIPA1L2 (12934): 1.269919227792232, Methylation_CRNKL1: 1.2703978929487982, Methylation_PRKAG2: 0.3967908515791448, Methylation_MICB: 1.3003818108033085, miRNA_hsa-mir-934: 3.2318322068336447, miRNA_hsa-mir-4728: -0.149713197536241, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.346646859131729, miRNA_hsa-mir-190b: -1.2489318267988567, miRNA_hsa-mir-577: 1.900234506409083, miRNA_hsa-mir-135b: 2.1255732103681564, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.9310416475526893, miRNA_hsa-mir-130b: 1.5894769525248122, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-EW-A1P8,"High-level Amplification absent; no CNV calls meet thresholds.  
FOXC1 mRNA overexpression (Z=2.12) and PPP1R14C upregulation (Z=1.94) exceed high-expression cutoff.  
XBP1, PRR15, SLC44A4, DEGS2, TFF3, AGR2 show low mRNA (Z < -1.92).  
Multiple promoters hypermethylated (ARFGEF1, SIPA1L2, C8orf38, MAPT, LOC727677, LINC02660; Z > 1.50).  
RNF130 and LOC340090 hypomethylated (Z < -1.47).  
miR-934, miR-577, miR-130b upregulated (Z > 1.99).","mRNA_MLPH: -1.7914702600245758, mRNA_C2orf54: 0.8377271189201277, mRNA_CITED4: -0.3942620673002288, mRNA_ESR1: -1.305883332704569, mRNA_SPDEF: -1.3250081602512789, mRNA_AGR3: -1.7134384871016812, mRNA_FOXC1: 2.119966610931072, mRNA_GATA3: -0.4263169203829809, mRNA_AGR2: -1.8665385978685216, mRNA_XBP1: -2.213614492970791, mRNA_PRR15: -2.34289516630863, mRNA_SLC44A4: -2.303538458916905, mRNA_CA12: -1.100866960070575, mRNA_DTL: 1.0062730795675496, mRNA_C5AR2: -1.3529369786001035, mRNA_TBC1D9: -1.6453620766156112, mRNA_AR: -0.6442144673499551, mRNA_CCDC170: -1.4401108753142644, mRNA_DEGS2: -2.040137827873513, mRNA_TFF3: -2.245683636422964, mRNA_DNALI1: -1.403242889852414, mRNA_LINC00504: -1.670015779826112, mRNA_CLCA2: -0.794569590365585, mRNA_PPP1R14C: 1.9396648076614773, mRNA_THSD4: -1.3980046069985486, mRNA_SPAG5: 0.8227568154704515, mRNA_FBP1: -0.8090119847131656, mRNA_SLC7A8: -1.8166521031454688, mRNA_EN1: 0.1639802413869349, mRNA_ZNF552: -0.4177184104196197, Methylation_LRRC6: 1.4482496450091444, Methylation_chr2 66218712 LINC02934 (29533): -0.8781564185558023, Methylation_HOXB13: -1.0731423915813258, Methylation_chr10 3949206 LINC02660 (4871): 1.5771714532754442, Methylation_chr5 179517140 RNF130 (18026): -1.692316843176522, Methylation_LOC727677: 1.5087218352638834, Methylation_LETM1: 1.288719912092256, Methylation_CDC42BPB: 0.7243015076830185, Methylation_C8orf38: 1.6406695744106317, Methylation_chr14 100504766 EVL (18852): 1.5158624392895717, Methylation_chr5 72594851 LOC340090 (24088): -1.5419081139337736, Methylation_chr2 242904738 LINC01238 (3421): 1.4536592987995902, Methylation_ARFGEF1: 1.6807514915896244, Methylation_MAPT: 1.516219959592926, Methylation_ZFAT: 1.4548010644524068, Methylation_KCNQ4: 1.225277035392193, Methylation_chr1 232684368 SIPA1L2 (12934): 1.688002430281884, Methylation_CRNKL1: 1.3964416790251704, Methylation_PRKAG2: -1.0812210072329609, Methylation_MICB: 1.55638801110361, miRNA_hsa-mir-934: 2.606638684307025, miRNA_hsa-mir-4728: 0.574049693844209, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.1983784360735024, miRNA_hsa-mir-190b: -1.1543392221845843, miRNA_hsa-mir-577: 2.0319730026094827, miRNA_hsa-mir-135b: 1.2053660068778718, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.1670333707501122, miRNA_hsa-mir-130b: 2.1802104534579527, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-EW-A424,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.981200575932636, mRNA_C2orf54: -0.0470925602033953, mRNA_CITED4: 1.0147287214344016, mRNA_ESR1: 0.0916890085667306, mRNA_SPDEF: 0.7122214259079014, mRNA_AGR3: 0.428181194901285, mRNA_FOXC1: -0.0405264741909304, mRNA_GATA3: 0.5893481396423027, mRNA_AGR2: 0.7145223082850973, mRNA_XBP1: -0.2512910435551179, mRNA_PRR15: 0.560881935526451, mRNA_SLC44A4: -0.1090695768744651, mRNA_CA12: 0.2135332012499431, mRNA_DTL: -0.411607555992675, mRNA_C5AR2: 0.4321358515235244, mRNA_TBC1D9: 0.2515997677922488, mRNA_AR: 0.523810237649962, mRNA_CCDC170: -0.4249611571707143, mRNA_DEGS2: 0.6930782952518482, mRNA_TFF3: 0.6009150715341708, mRNA_DNALI1: 0.6193315086231279, mRNA_LINC00504: 0.7020711546732575, mRNA_CLCA2: -0.1624572161639984, mRNA_PPP1R14C: -0.0706619034597047, mRNA_THSD4: -0.3446970142255341, mRNA_SPAG5: -0.256348331836745, mRNA_FBP1: 0.5772020761062896, mRNA_SLC7A8: -0.0598468519071068, mRNA_EN1: -0.1142839168449571, mRNA_ZNF552: 0.0214954619846605, Methylation_LRRC6: -0.6096440121388591, Methylation_chr2 66218712 LINC02934 (29533): 0.5332841373130015, Methylation_HOXB13: 0.2528145074155387, Methylation_chr10 3949206 LINC02660 (4871): -0.681820572701787, Methylation_chr5 179517140 RNF130 (18026): 0.806746217069323, Methylation_LOC727677: -0.1627026906575219, Methylation_LETM1: -0.8740720368558597, Methylation_CDC42BPB: 1.2471713011760817, Methylation_C8orf38: -0.2240707188324022, Methylation_chr14 100504766 EVL (18852): -0.1921752548047802, Methylation_chr5 72594851 LOC340090 (24088): 0.970972343710194, Methylation_chr2 242904738 LINC01238 (3421): -1.162018552768562, Methylation_ARFGEF1: -0.5344118711018757, Methylation_MAPT: -1.072873923939844, Methylation_ZFAT: -0.7917557466617889, Methylation_KCNQ4: -0.8919065328686091, Methylation_chr1 232684368 SIPA1L2 (12934): -0.8319626632998834, Methylation_CRNKL1: -0.8660794996152439, Methylation_PRKAG2: 1.328046112756325, Methylation_MICB: -1.215708283216138, miRNA_hsa-mir-934: -0.4696067851910274, miRNA_hsa-mir-4728: -0.8171832193757524, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.7597867878643654, miRNA_hsa-mir-190b: 0.4513537316617167, miRNA_hsa-mir-577: -0.2367596331905614, miRNA_hsa-mir-135b: -0.0142660092906386, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.3375446665505285, miRNA_hsa-mir-130b: -2.153341615308087, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-GM-A2DK,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.070738963344853, mRNA_C2orf54: -0.7910259754690095, mRNA_CITED4: -0.5204510890605127, mRNA_ESR1: 0.5030060130762488, mRNA_SPDEF: -0.0055369665946244, mRNA_AGR3: 0.7151115929140024, mRNA_FOXC1: 0.1946791176462093, mRNA_GATA3: 0.0908264925606716, mRNA_AGR2: 0.9708258784606464, mRNA_XBP1: -0.0221760354180901, mRNA_PRR15: 0.3681565571530725, mRNA_SLC44A4: 0.1442660247700694, mRNA_CA12: 0.8034495915687975, mRNA_DTL: -1.371441062687917, mRNA_C5AR2: 0.0321688637206025, mRNA_TBC1D9: -0.1180580204751678, mRNA_AR: -1.471369994507922, mRNA_CCDC170: 0.0299771475891485, mRNA_DEGS2: -0.0197062664662745, mRNA_TFF3: 0.0687581577212749, mRNA_DNALI1: 0.4075450776832582, mRNA_LINC00504: -0.2431586019770398, mRNA_CLCA2: -0.6204022261404658, mRNA_PPP1R14C: -0.8374586744162624, mRNA_THSD4: 1.0124655652100851, mRNA_SPAG5: -0.7605004577102289, mRNA_FBP1: -0.5485592553007252, mRNA_SLC7A8: -0.587706914119677, mRNA_EN1: -0.3100526477962424, mRNA_ZNF552: 0.3262481143005226, Methylation_LRRC6: 0.2028923446919052, Methylation_chr2 66218712 LINC02934 (29533): 1.2079231556190435, Methylation_HOXB13: 0.5210841263987166, Methylation_chr10 3949206 LINC02660 (4871): -0.4320209116603986, Methylation_chr5 179517140 RNF130 (18026): 0.2222990220165879, Methylation_LOC727677: -0.1558969895165744, Methylation_LETM1: -0.4156977408073698, Methylation_CDC42BPB: 0.9193902896069877, Methylation_C8orf38: 0.7213063510070716, Methylation_chr14 100504766 EVL (18852): 0.9978790660935576, Methylation_chr5 72594851 LOC340090 (24088): 0.1278346705569468, Methylation_chr2 242904738 LINC01238 (3421): -0.2855028331249052, Methylation_ARFGEF1: 0.3736561056143467, Methylation_MAPT: -0.3760976299218257, Methylation_ZFAT: -0.1376339938224259, Methylation_KCNQ4: -0.3746108464553371, Methylation_chr1 232684368 SIPA1L2 (12934): 0.7279744923381072, Methylation_CRNKL1: 0.2961868842861339, Methylation_PRKAG2: -0.6312387955357057, Methylation_MICB: 0.1354125967926284, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.4034406512117935, miRNA_hsa-mir-5695: -0.4247358032717785, miRNA_hsa-mir-18a: -0.5183169069306977, miRNA_hsa-mir-190b: -0.2021660605815586, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.8060105852743615, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.9191969488096272, miRNA_hsa-mir-130b: -0.3989094602253594, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A0GZ,"No features meet the strict diagnostic thresholds for mRNA (Z > 1.30 or Z < -1.92), methylation (Z > 1.50 or Z < -1.47), miRNA (Z > 1.99 or Z < -1.25), or CNV (deletion, gain, amplification, or high-level amplification). All values fall within non-actionable ranges.","mRNA_MLPH: 0.2946190054986625, mRNA_C2orf54: -1.025216872087228, mRNA_CITED4: 0.1469043147818908, mRNA_ESR1: 0.6778820116853806, mRNA_SPDEF: 0.4126688560445933, mRNA_AGR3: 0.7022416467930404, mRNA_FOXC1: -0.6871917649007935, mRNA_GATA3: 0.0040618651506961, mRNA_AGR2: 0.681263006083547, mRNA_XBP1: 0.3770766503667164, mRNA_PRR15: -0.0361207259705962, mRNA_SLC44A4: 0.365297114993169, mRNA_CA12: 0.6884012821400852, mRNA_DTL: -0.2047433048333428, mRNA_C5AR2: 0.1106704600342691, mRNA_TBC1D9: -0.3623387216888201, mRNA_AR: 0.1229762965303954, mRNA_CCDC170: -0.0367357139360923, mRNA_DEGS2: 0.5623039917802053, mRNA_TFF3: 1.1644717947363932, mRNA_DNALI1: 0.0913343171449437, mRNA_LINC00504: 0.3065490154085845, mRNA_CLCA2: -0.0757167993011217, mRNA_PPP1R14C: -0.318018855840963, mRNA_THSD4: -0.1497709937770835, mRNA_SPAG5: -0.3585960348437373, mRNA_FBP1: 0.2996249870768341, mRNA_SLC7A8: 0.2063271630769889, mRNA_EN1: -0.2286387740250988, mRNA_ZNF552: -0.4667955178204984, Methylation_LRRC6: -0.5765913905489577, Methylation_chr2 66218712 LINC02934 (29533): 0.578835958277627, Methylation_HOXB13: 1.6963424206515458, Methylation_chr10 3949206 LINC02660 (4871): -0.762792916813783, Methylation_chr5 179517140 RNF130 (18026): -0.7835460439454474, Methylation_LOC727677: -0.8698155286905468, Methylation_LETM1: -0.6928441564714674, Methylation_CDC42BPB: 1.407656877082767, Methylation_C8orf38: -0.1099121465254353, Methylation_chr14 100504766 EVL (18852): -0.6724854351499758, Methylation_chr5 72594851 LOC340090 (24088): 1.1875310998635622, Methylation_chr2 242904738 LINC01238 (3421): -0.86393565717638, Methylation_ARFGEF1: -0.6586144593751874, Methylation_MAPT: -0.4844667178414285, Methylation_ZFAT: -0.7972283112195329, Methylation_KCNQ4: 0.1548303558984543, Methylation_chr1 232684368 SIPA1L2 (12934): -0.9462752885377772, Methylation_CRNKL1: -0.7147451729006187, Methylation_PRKAG2: 1.259487237881386, Methylation_MICB: -0.6535950433232195, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.4780213151813825, miRNA_hsa-mir-5695: 0.5189953137639968, miRNA_hsa-mir-18a: -0.66815247010585, miRNA_hsa-mir-190b: 0.1452369958109384, miRNA_hsa-mir-577: 0.2945164060393105, miRNA_hsa-mir-135b: -0.1491822684551212, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.5812347014496284, miRNA_hsa-mir-130b: -0.5061502980418071, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AC-A6IV,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.5046658923703741, mRNA_C2orf54: -0.3317305098512023, mRNA_CITED4: -0.3468802229664105, mRNA_ESR1: 0.0894274983347418, mRNA_SPDEF: -0.1455704707127065, mRNA_AGR3: 0.4964774709892349, mRNA_FOXC1: 0.2960135895826556, mRNA_GATA3: 0.500336959327528, mRNA_AGR2: 0.8664532099249284, mRNA_XBP1: -0.576832462224545, mRNA_PRR15: -0.0134115426110845, mRNA_SLC44A4: 0.1303493047610366, mRNA_CA12: -0.0643079884835426, mRNA_DTL: -0.3921297812444683, mRNA_C5AR2: 0.2961593401285018, mRNA_TBC1D9: 0.6347059713304244, mRNA_AR: 0.1693711390059461, mRNA_CCDC170: 0.2032624062465906, mRNA_DEGS2: 0.0502441502666041, mRNA_TFF3: 0.4808735211321944, mRNA_DNALI1: 0.207175145234643, mRNA_LINC00504: 0.2395310634691871, mRNA_CLCA2: 0.3065974306417976, mRNA_PPP1R14C: -0.4593974970375371, mRNA_THSD4: 0.6136687288756293, mRNA_SPAG5: 0.0108516500993665, mRNA_FBP1: -0.478563438368123, mRNA_SLC7A8: -0.0824743632238105, mRNA_EN1: -0.0371962814297727, mRNA_ZNF552: -0.0553925088103051, Methylation_LRRC6: 1.0267279221793149, Methylation_chr2 66218712 LINC02934 (29533): 0.7474096958169248, Methylation_HOXB13: -1.010601904199084, Methylation_chr10 3949206 LINC02660 (4871): 0.1360438130482659, Methylation_chr5 179517140 RNF130 (18026): -0.18433504585475, Methylation_LOC727677: 0.5487326126149554, Methylation_LETM1: 0.4271805010853513, Methylation_CDC42BPB: 1.0155758247613065, Methylation_C8orf38: 1.3206456673558948, Methylation_chr14 100504766 EVL (18852): 0.867739359829781, Methylation_chr5 72594851 LOC340090 (24088): 0.1057856103130034, Methylation_chr2 242904738 LINC01238 (3421): 0.8687071187892077, Methylation_ARFGEF1: 0.9139252040410688, Methylation_MAPT: 1.157387519613052, Methylation_ZFAT: 0.5719697986955935, Methylation_KCNQ4: -1.0121312484989085, Methylation_chr1 232684368 SIPA1L2 (12934): 0.984567442386726, Methylation_CRNKL1: 0.8135725666832395, Methylation_PRKAG2: 0.1328893596397833, Methylation_MICB: 0.6642391626237703, miRNA_hsa-mir-934: -0.4919737113491654, miRNA_hsa-mir-4728: -0.892407603146896, miRNA_hsa-mir-5695: -0.0168856739115364, miRNA_hsa-mir-18a: -0.4031958007571952, miRNA_hsa-mir-190b: -0.5355418108207254, miRNA_hsa-mir-577: -0.6633420349218496, miRNA_hsa-mir-135b: -1.016757745663442, miRNA_hsa-mir-2115: -0.525319777783847, miRNA_hsa-mir-17: -0.2739404267128869, miRNA_hsa-mir-130b: -0.8489996032408824, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-EW-A6S9,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.2376207425623073, mRNA_C2orf54: 0.678819947738776, mRNA_CITED4: -1.6586676507038645, mRNA_ESR1: -0.4420682033206153, mRNA_SPDEF: 0.8035977988088367, mRNA_AGR3: -0.1913165437319993, mRNA_FOXC1: -0.6769100062040792, mRNA_GATA3: 0.347684892462636, mRNA_AGR2: 0.5005932000581592, mRNA_XBP1: 0.1598854565969645, mRNA_PRR15: 0.9339714419909912, mRNA_SLC44A4: 0.7788273644858315, mRNA_CA12: -0.2819818968073077, mRNA_DTL: 0.0949749473503103, mRNA_C5AR2: -0.4877385048008525, mRNA_TBC1D9: -0.0424312339671461, mRNA_AR: 0.9450661861060486, mRNA_CCDC170: -0.752992250217134, mRNA_DEGS2: 0.4199287530767686, mRNA_TFF3: 0.2576948010270701, mRNA_DNALI1: -0.1405210604463588, mRNA_LINC00504: -0.1533185507417031, mRNA_CLCA2: 0.834473593761855, mRNA_PPP1R14C: -0.3396586117845523, mRNA_THSD4: 0.7155607859138808, mRNA_SPAG5: -0.7862573532875812, mRNA_FBP1: 0.9108815728131172, mRNA_SLC7A8: 0.1566472965690007, mRNA_EN1: 0.0351160942614892, mRNA_ZNF552: -0.0212940011948392, Methylation_LRRC6: -0.8493120281775037, Methylation_chr2 66218712 LINC02934 (29533): 0.966082477886434, Methylation_HOXB13: 0.4999007291695528, Methylation_chr10 3949206 LINC02660 (4871): -0.8970263008977564, Methylation_chr5 179517140 RNF130 (18026): 0.7721428169248153, Methylation_LOC727677: -1.1111596879635923, Methylation_LETM1: 0.686355639682482, Methylation_CDC42BPB: 0.938664504436435, Methylation_C8orf38: -0.5245240727293835, Methylation_chr14 100504766 EVL (18852): -0.7723927922036381, Methylation_chr5 72594851 LOC340090 (24088): -1.19031306611919, Methylation_chr2 242904738 LINC01238 (3421): -0.7202127883740294, Methylation_ARFGEF1: -0.7585061524951454, Methylation_MAPT: -0.0648142017811189, Methylation_ZFAT: -0.5113992226073396, Methylation_KCNQ4: -1.1110304761155787, Methylation_chr1 232684368 SIPA1L2 (12934): -0.6487906234480882, Methylation_CRNKL1: -0.8242012379685525, Methylation_PRKAG2: 0.3435150673676841, Methylation_MICB: -1.3464444233530115, miRNA_hsa-mir-934: -0.2581992458511518, miRNA_hsa-mir-4728: 2.5848802585975243, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.085457182557131, miRNA_hsa-mir-190b: -0.1112996500560788, miRNA_hsa-mir-577: -0.6399490266336388, miRNA_hsa-mir-135b: -1.0478741062444128, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.6992042074117922, miRNA_hsa-mir-130b: -0.8587250833305604, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A7-A4SF,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.6840459614715215, mRNA_C2orf54: 0.9125234629584092, mRNA_CITED4: -1.429075617861716, mRNA_ESR1: 0.4666977232322271, mRNA_SPDEF: 0.7218322095749428, mRNA_AGR3: 0.5414676907023552, mRNA_FOXC1: -0.6514856741332616, mRNA_GATA3: 0.2250341589980592, mRNA_AGR2: 0.3268942423415831, mRNA_XBP1: -0.4875457624241069, mRNA_PRR15: 0.8327527215853996, mRNA_SLC44A4: 1.035790421790893, mRNA_CA12: -0.1765713933489482, mRNA_DTL: 0.6001690145282292, mRNA_C5AR2: 0.3759599757177651, mRNA_TBC1D9: -0.1417315604757351, mRNA_AR: 0.7264332216256162, mRNA_CCDC170: -0.3236725960398053, mRNA_DEGS2: 0.6211831971045755, mRNA_TFF3: -0.2266679686354895, mRNA_DNALI1: 0.6987194208376818, mRNA_LINC00504: 0.1711365595560331, mRNA_CLCA2: -0.8950940779111158, mRNA_PPP1R14C: -1.072018276014123, mRNA_THSD4: -0.1699705085996943, mRNA_SPAG5: 0.4514977370053536, mRNA_FBP1: 1.2236000246491747, mRNA_SLC7A8: 0.7919106132164174, mRNA_EN1: -0.8808520979855182, mRNA_ZNF552: 0.1518718590204414, Methylation_LRRC6: -1.2503252041936228, Methylation_chr2 66218712 LINC02934 (29533): -1.701110913620246, Methylation_HOXB13: 0.8919461734533392, Methylation_chr10 3949206 LINC02660 (4871): -1.242262508596453, Methylation_chr5 179517140 RNF130 (18026): -1.510921799642064, Methylation_LOC727677: -1.331222780148851, Methylation_LETM1: -0.7212325067602889, Methylation_CDC42BPB: 0.6426841589387231, Methylation_C8orf38: -1.3188020283957635, Methylation_chr14 100504766 EVL (18852): -1.2406911228249704, Methylation_chr5 72594851 LOC340090 (24088): -0.4960627635163313, Methylation_chr2 242904738 LINC01238 (3421): -1.4609231546909984, Methylation_ARFGEF1: -0.9663552188280464, Methylation_MAPT: -0.9093199875201609, Methylation_ZFAT: -1.4756181047240329, Methylation_KCNQ4: 1.3742834203044094, Methylation_chr1 232684368 SIPA1L2 (12934): -1.0935236405658877, Methylation_CRNKL1: -1.5412197032288628, Methylation_PRKAG2: -1.6176710520515314, Methylation_MICB: -1.4874712790641411, miRNA_hsa-mir-934: -0.2568142205580564, miRNA_hsa-mir-4728: 1.893320447883964, miRNA_hsa-mir-5695: -0.0476073504130215, miRNA_hsa-mir-18a: -0.4927102077987192, miRNA_hsa-mir-190b: 1.1363197039725843, miRNA_hsa-mir-577: 0.3934808022733639, miRNA_hsa-mir-135b: -1.09161402063474, miRNA_hsa-mir-2115: 0.0576146485193661, miRNA_hsa-mir-17: -0.3054165822848961, miRNA_hsa-mir-130b: -0.7220991299124854, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-D8-A1X6,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.5623612308073814, mRNA_C2orf54: -1.2133589416949266, mRNA_CITED4: 0.4008918797187932, mRNA_ESR1: 0.982847473319666, mRNA_SPDEF: 0.1415654825270974, mRNA_AGR3: 1.1646715440197404, mRNA_FOXC1: -0.997817953283506, mRNA_GATA3: 0.943709574129986, mRNA_AGR2: 0.1223378687760408, mRNA_XBP1: 0.9819485469634064, mRNA_PRR15: 0.2113543828169395, mRNA_SLC44A4: 0.1812605438416014, mRNA_CA12: 0.7317883856386103, mRNA_DTL: 0.1710422228887752, mRNA_C5AR2: 1.121770720319792, mRNA_TBC1D9: 0.9738821787934974, mRNA_AR: 0.1935548844170616, mRNA_CCDC170: 0.5929050418228716, mRNA_DEGS2: 1.204502454424419, mRNA_TFF3: 0.0440796542890222, mRNA_DNALI1: 1.1114401086831922, mRNA_LINC00504: 0.956457593606806, mRNA_CLCA2: -0.1466105127705856, mRNA_PPP1R14C: -1.1136120749994294, mRNA_THSD4: 0.2745007661495965, mRNA_SPAG5: -0.0257375722282233, mRNA_FBP1: 1.0951105896583857, mRNA_SLC7A8: 0.702986099005845, mRNA_EN1: -0.8092270012935293, mRNA_ZNF552: 0.212931276634457, Methylation_LRRC6: -0.9622418288831668, Methylation_chr2 66218712 LINC02934 (29533): -0.4835489830888183, Methylation_HOXB13: -1.1047679286415897, Methylation_chr10 3949206 LINC02660 (4871): -1.3126736947634714, Methylation_chr5 179517140 RNF130 (18026): 1.2342873349604622, Methylation_LOC727677: -0.8491846520799504, Methylation_LETM1: -1.3367383550873375, Methylation_CDC42BPB: 1.3016717344338895, Methylation_C8orf38: -1.6218271967776865, Methylation_chr14 100504766 EVL (18852): -1.3187908482928985, Methylation_chr5 72594851 LOC340090 (24088): 1.1576615572617392, Methylation_chr2 242904738 LINC01238 (3421): -1.2118029552197125, Methylation_ARFGEF1: -1.3937736191425982, Methylation_MAPT: -1.2907169087162107, Methylation_ZFAT: -1.252051403164927, Methylation_KCNQ4: -0.0736709889552934, Methylation_chr1 232684368 SIPA1L2 (12934): -1.195279849123678, Methylation_CRNKL1: -1.1787225506536043, Methylation_PRKAG2: 1.14045438070295, Methylation_MICB: -1.0310996248921762, miRNA_hsa-mir-934: -0.2275796632853788, miRNA_hsa-mir-4728: 0.502143373762316, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.0244021344376467, miRNA_hsa-mir-190b: 0.9081280174858748, miRNA_hsa-mir-577: -0.1852985748183361, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.205674532039105, miRNA_hsa-mir-130b: 0.5070532321162832, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-AR-A24H,"High-level Amplification of LINC01867 drives significant mRNA overexpression. HOXB13 promoter hypermethylation mediates epigenetic silencing. LETM1 and C8orf38 are hypo-methylated. miR-5695, miR-18a, miR-190b, and miR-17 are upregulated. These features collectively indicate a luminal phenotype with ER pathway dysregulation.","mRNA_MLPH: 0.8754482225631193, mRNA_C2orf54: 1.2848829170233256, mRNA_CITED4: 1.0997650265641974, mRNA_ESR1: 0.6921395041643209, mRNA_SPDEF: 0.8594226331837426, mRNA_AGR3: 0.3112714261605392, mRNA_FOXC1: -0.5335523308925972, mRNA_GATA3: 0.741907847483329, mRNA_AGR2: 1.0492737833710422, mRNA_XBP1: 0.3327297446009355, mRNA_PRR15: 0.0912355396920232, mRNA_SLC44A4: 0.134860674846587, mRNA_CA12: 0.2593021588283879, mRNA_DTL: 2.532643844360236, mRNA_C5AR2: -0.1109078935261784, mRNA_TBC1D9: 0.2188928111924287, mRNA_AR: -0.3113916450733502, mRNA_CCDC170: 1.2436588571930265, mRNA_DEGS2: -0.1832235740515381, mRNA_TFF3: -0.0097881408995892, mRNA_DNALI1: 0.971237446795862, mRNA_LINC00504: 0.5434633829285958, mRNA_CLCA2: -0.345613102569929, mRNA_PPP1R14C: -0.8725443943465271, mRNA_THSD4: 0.6498234956517915, mRNA_SPAG5: 1.7331833449025191, mRNA_FBP1: 0.8013668706699953, mRNA_SLC7A8: -0.4992931170336839, mRNA_EN1: -0.6577554833286742, mRNA_ZNF552: 0.9129638860394328, Methylation_LRRC6: -1.054896704871446, Methylation_chr2 66218712 LINC02934 (29533): 1.326699703722522, Methylation_HOXB13: 1.5186606819290314, Methylation_chr10 3949206 LINC02660 (4871): -1.3391908787945732, Methylation_chr5 179517140 RNF130 (18026): 1.2362613542301155, Methylation_LOC727677: -0.7759336952757294, Methylation_LETM1: -1.6756761971432417, Methylation_CDC42BPB: 1.206616790927956, Methylation_C8orf38: -1.535999789450078, Methylation_chr14 100504766 EVL (18852): -1.167636327339116, Methylation_chr5 72594851 LOC340090 (24088): 1.2505538142910313, Methylation_chr2 242904738 LINC01238 (3421): 1.452983137459667, Methylation_ARFGEF1: -1.324813906690601, Methylation_MAPT: 0.0038885681713891, Methylation_ZFAT: -0.3774178684180364, Methylation_KCNQ4: 1.4835240450237674, Methylation_chr1 232684368 SIPA1L2 (12934): -1.1623123242327595, Methylation_CRNKL1: -0.945963111029375, Methylation_PRKAG2: -0.8564050094195779, Methylation_MICB: -1.5105225983046071, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 1.1186269023376092, miRNA_hsa-mir-5695: 1.8154404413915848, miRNA_hsa-mir-18a: 1.2742951645605456, miRNA_hsa-mir-190b: 1.3637244310605805, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.3880514153215201, miRNA_hsa-mir-2115: 0.3857898510521351, miRNA_hsa-mir-17: 1.3582041732895933, miRNA_hsa-mir-130b: 1.1665734792535225, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 2.395394893874891, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-EW-A1J5,"High-level Amplification absent; no CNV meets amplification thresholds.  
mRNA_SLC7A8 (Z=1.55) and mRNA_ZNF552 (Z=1.38) are highly expressed.  
miRNA_hsa-mir-5695 is strongly upregulated (Z=3.43).  
No methylation sites meet hyper/hypo-methylation criteria.  
Collectively indicates luminal-like phenotype with amino acid transport (SLC7A8) and zinc-finger transcription factor (ZNF552) activation.","mRNA_MLPH: 0.8731481809511695, mRNA_C2orf54: -0.3249274536636683, mRNA_CITED4: 0.886419019182642, mRNA_ESR1: 0.5371588992406181, mRNA_SPDEF: 0.3482976058716613, mRNA_AGR3: 0.6390188413395156, mRNA_FOXC1: -0.4264188055888472, mRNA_GATA3: 0.6119910715516618, mRNA_AGR2: 0.4792532016950629, mRNA_XBP1: 0.3891747495634226, mRNA_PRR15: -0.2239841753144856, mRNA_SLC44A4: 1.0031871938896997, mRNA_CA12: 1.1275609986714004, mRNA_DTL: 0.926572173956836, mRNA_C5AR2: -0.0495907500718872, mRNA_TBC1D9: 1.062643908252732, mRNA_AR: 0.7172084536011164, mRNA_CCDC170: 0.6414225235513111, mRNA_DEGS2: 0.7784880977285761, mRNA_TFF3: -0.0903205553899471, mRNA_DNALI1: 0.8197905994700418, mRNA_LINC00504: 0.9679710492942184, mRNA_CLCA2: 0.318296308187345, mRNA_PPP1R14C: 0.081127046604422, mRNA_THSD4: 0.6904209751002439, mRNA_SPAG5: 1.1251030551853771, mRNA_FBP1: 0.3062916598424074, mRNA_SLC7A8: 1.5479191526327325, mRNA_EN1: -0.8972866882091922, mRNA_ZNF552: 1.375790236837233, Methylation_LRRC6: 0.1023291551347573, Methylation_chr2 66218712 LINC02934 (29533): -1.37031006472584, Methylation_HOXB13: -0.6973350967479899, Methylation_chr10 3949206 LINC02660 (4871): -0.3056093476580946, Methylation_chr5 179517140 RNF130 (18026): 0.7900618968218829, Methylation_LOC727677: -0.3444928329448414, Methylation_LETM1: -0.6688729629181922, Methylation_CDC42BPB: 0.9744182423506076, Methylation_C8orf38: -0.4127026825501202, Methylation_chr14 100504766 EVL (18852): -0.5493056727032194, Methylation_chr5 72594851 LOC340090 (24088): -0.9265052069546992, Methylation_chr2 242904738 LINC01238 (3421): 0.5976910159236798, Methylation_ARFGEF1: -0.4490293611080065, Methylation_MAPT: -1.0761403605740518, Methylation_ZFAT: -0.8586260047411036, Methylation_KCNQ4: 0.9619444377963822, Methylation_chr1 232684368 SIPA1L2 (12934): 0.3334716900611586, Methylation_CRNKL1: -0.6283376414320432, Methylation_PRKAG2: 0.4812749747192286, Methylation_MICB: -0.9214389863299052, miRNA_hsa-mir-934: -0.1999162602975209, miRNA_hsa-mir-4728: 0.1592756683638995, miRNA_hsa-mir-5695: 3.434485707834983, miRNA_hsa-mir-18a: -0.6941892979487955, miRNA_hsa-mir-190b: 0.858642916973563, miRNA_hsa-mir-577: -0.5541350293599167, miRNA_hsa-mir-135b: 0.6062984106832296, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.5857320078769123, miRNA_hsa-mir-130b: -0.1485686238721241, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A5UO,High-level Amplification of DTL drives significant mRNA overexpression. LETM1 and CRNKL1 promoter hypermethylation mediates epigenetic silencing. No miRNA alterations meet significance thresholds. These features collectively indicate a proliferative phenotype with cell cycle dysregulation.,"mRNA_MLPH: 1.3206172825470217, mRNA_C2orf54: -1.2748430856484352, mRNA_CITED4: -1.7963951339233335, mRNA_ESR1: 0.670240165104573, mRNA_SPDEF: 1.1240336611532755, mRNA_AGR3: 0.4197177418877374, mRNA_FOXC1: -0.9461132044660407, mRNA_GATA3: 0.6602486828360921, mRNA_AGR2: 0.6876961299853462, mRNA_XBP1: 0.3874079793970236, mRNA_PRR15: 1.3495118462891214, mRNA_SLC44A4: 0.479770073044883, mRNA_CA12: 0.7459777377885755, mRNA_DTL: 4.295543361379618, mRNA_C5AR2: 1.1364720707689282, mRNA_TBC1D9: 1.674227467254546, mRNA_AR: -0.4212206785280745, mRNA_CCDC170: -0.1940314293364235, mRNA_DEGS2: 0.9420077406720456, mRNA_TFF3: 1.1916634690459926, mRNA_DNALI1: 0.8108433312592096, mRNA_LINC00504: 0.0394644319700461, mRNA_CLCA2: -0.8950940779111158, mRNA_PPP1R14C: -1.1100943481087948, mRNA_THSD4: 2.1442527262150306, mRNA_SPAG5: 1.0696859181357203, mRNA_FBP1: 0.4563040173238296, mRNA_SLC7A8: -0.8147900380793647, mRNA_EN1: -0.8961080027213968, mRNA_ZNF552: 0.2000146318215799, Methylation_LRRC6: -1.4680614499735567, Methylation_chr2 66218712 LINC02934 (29533): -0.7599737008525975, Methylation_HOXB13: -0.9961042502780696, Methylation_chr10 3949206 LINC02660 (4871): -1.3277716829474002, Methylation_chr5 179517140 RNF130 (18026): 1.2251921463963324, Methylation_LOC727677: -1.4943479186443789, Methylation_LETM1: -1.8254651341020696, Methylation_CDC42BPB: 1.4344486311800986, Methylation_C8orf38: -0.6642045771431384, Methylation_chr14 100504766 EVL (18852): -1.64076742711042, Methylation_chr5 72594851 LOC340090 (24088): 0.8709016500608641, Methylation_chr2 242904738 LINC01238 (3421): 1.1009976803448152, Methylation_ARFGEF1: -1.298147302235818, Methylation_MAPT: -1.0608323154569737, Methylation_ZFAT: -0.8346796310473901, Methylation_KCNQ4: -0.9530581981498276, Methylation_chr1 232684368 SIPA1L2 (12934): -1.5214012768178509, Methylation_CRNKL1: -1.6561759213616971, Methylation_PRKAG2: -0.2069181371498373, Methylation_MICB: -1.48237634557576, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.0267580580802124, miRNA_hsa-mir-5695: -0.0734076393816653, miRNA_hsa-mir-18a: -0.3665000400808418, miRNA_hsa-mir-190b: 0.6945621695514766, miRNA_hsa-mir-577: -0.5212988511005895, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.6107432919336404, miRNA_hsa-mir-130b: -0.8013878962359463, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A54Y,"High mRNA_CITED4 (Z=1.76) and mRNA_DEGS2 (Z=1.20) indicate overexpression.  
ZFAT promoter hypermethylation (Z=-1.95) suggests epigenetic silencing.  
No miRNAs meet up/downregulation thresholds.  
All CNVs fall within normal range (−1.10 to −0.10).  
Collectively indicative of luminal-like phenotype with metabolic pathway activation.","mRNA_MLPH: 0.5107600179668585, mRNA_C2orf54: -0.4459399053931985, mRNA_CITED4: 1.756613219928871, mRNA_ESR1: 0.4356084645274858, mRNA_SPDEF: 0.7045769691804078, mRNA_AGR3: 0.6274728547302205, mRNA_FOXC1: -0.8056557980260927, mRNA_GATA3: 0.2914905090271553, mRNA_AGR2: -0.0297287771904623, mRNA_XBP1: -0.4546762959134298, mRNA_PRR15: -0.2436595450549075, mRNA_SLC44A4: 0.4657291631631031, mRNA_CA12: 0.4345999662108963, mRNA_DTL: 0.4766383309518812, mRNA_C5AR2: -0.219689160645996, mRNA_TBC1D9: -0.5990293195693777, mRNA_AR: -0.7643993350719089, mRNA_CCDC170: 0.0404597569605304, mRNA_DEGS2: 1.1947955674931396, mRNA_TFF3: 1.1011042399313038, mRNA_DNALI1: -1.869721361440725, mRNA_LINC00504: -0.0449349585525569, mRNA_CLCA2: -0.8624201856616196, mRNA_PPP1R14C: -1.0400449106204026, mRNA_THSD4: 0.0182345715656605, mRNA_SPAG5: 0.5296313413824664, mRNA_FBP1: -0.0876528467390515, mRNA_SLC7A8: 0.5712221331177896, mRNA_EN1: -0.7405757640750803, mRNA_ZNF552: 0.3017667441218415, Methylation_LRRC6: -1.62844269273622, Methylation_chr2 66218712 LINC02934 (29533): -0.5567664350039196, Methylation_HOXB13: -1.0171603475141875, Methylation_chr10 3949206 LINC02660 (4871): -1.27273566905739, Methylation_chr5 179517140 RNF130 (18026): 1.2073112533711203, Methylation_LOC727677: -1.3225723602172268, Methylation_LETM1: -1.5643716016385978, Methylation_CDC42BPB: 1.268628708713209, Methylation_C8orf38: 0.1477279029730862, Methylation_chr14 100504766 EVL (18852): -1.318821433689833, Methylation_chr5 72594851 LOC340090 (24088): 1.08444653735068, Methylation_chr2 242904738 LINC01238 (3421): -0.909185417869793, Methylation_ARFGEF1: -1.0914793579637572, Methylation_MAPT: -1.6537680660914795, Methylation_ZFAT: -1.9491656035503504, Methylation_KCNQ4: 1.5824075505966768, Methylation_chr1 232684368 SIPA1L2 (12934): -1.4575324063361046, Methylation_CRNKL1: -1.7603350977391816, Methylation_PRKAG2: -1.6514918894560595, Methylation_MICB: -1.5149998118941572, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.1810854601255822, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.7630118163163854, miRNA_hsa-mir-190b: 0.884856807436077, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.87486134873484, miRNA_hsa-mir-2115: 0.4900704824973741, miRNA_hsa-mir-17: 0.790277496926609, miRNA_hsa-mir-130b: 0.0327280154596284, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E2-A1LB,"High-level Amplification absent; no CNVs meet amplification thresholds.  
mRNA_C2orf54 (Z=2.35) and mRNA_CLCA2 (Z=2.10) are highly overexpressed.  
mRNA_AGR3 (Z=−2.06) and mRNA_DNALI1 (Z=−1.93) are significantly downregulated.  
HOXB13 promoter hypermethylation (Z=1.51) suggests epigenetic silencing.  
miR-4728 and miR-2115 are strongly upregulated (Z>4.48).  
Collectively indicate luminal B-like phenotype with ER-pathway suppression.","mRNA_MLPH: 0.5573564725773075, mRNA_C2orf54: 2.349781992487069, mRNA_CITED4: -1.8832953022369163, mRNA_ESR1: -1.6824405971848837, mRNA_SPDEF: 0.867583946348337, mRNA_AGR3: -2.060531268628111, mRNA_FOXC1: -1.046670129334606, mRNA_GATA3: -1.097096178301319, mRNA_AGR2: 0.1757508688433068, mRNA_XBP1: -0.398287346122816, mRNA_PRR15: 0.2391763598016, mRNA_SLC44A4: 0.4205257795280556, mRNA_CA12: -1.0721032561475985, mRNA_DTL: -0.5364632489433521, mRNA_C5AR2: -1.4254272380762845, mRNA_TBC1D9: -1.5312562892558044, mRNA_AR: 1.4042360669341902, mRNA_CCDC170: -1.5582403786175545, mRNA_DEGS2: -1.2312398087772345, mRNA_TFF3: 0.099182273651139, mRNA_DNALI1: -1.9302024987350743, mRNA_LINC00504: -1.7558974623226091, mRNA_CLCA2: 2.0963207194124616, mRNA_PPP1R14C: -0.9206429052332016, mRNA_THSD4: -0.9810599204273082, mRNA_SPAG5: 1.1850429647680107, mRNA_FBP1: -0.3960036814373512, mRNA_SLC7A8: 0.3087778852566184, mRNA_EN1: 0.0018100151814512, mRNA_ZNF552: -0.2903639035542473, Methylation_LRRC6: -0.0575397026882763, Methylation_chr2 66218712 LINC02934 (29533): 0.226258651466728, Methylation_HOXB13: 1.5061794722141124, Methylation_chr10 3949206 LINC02660 (4871): -0.1901753439281356, Methylation_chr5 179517140 RNF130 (18026): 0.502092830346031, Methylation_LOC727677: 1.458276521193108, Methylation_LETM1: 1.3218972091618268, Methylation_CDC42BPB: -1.3096274428160883, Methylation_C8orf38: -0.7899802674989321, Methylation_chr14 100504766 EVL (18852): -0.746468818492122, Methylation_chr5 72594851 LOC340090 (24088): 0.955511808479789, Methylation_chr2 242904738 LINC01238 (3421): 1.493297366515571, Methylation_ARFGEF1: -0.502678538502147, Methylation_MAPT: 1.4547745925255409, Methylation_ZFAT: 1.2155663276251072, Methylation_KCNQ4: -0.9235711027411247, Methylation_chr1 232684368 SIPA1L2 (12934): -0.2636217867799024, Methylation_CRNKL1: 1.4586644366759831, Methylation_PRKAG2: 0.928987462680277, Methylation_MICB: 0.1007655129473387, miRNA_hsa-mir-934: 0.0743693097474733, miRNA_hsa-mir-4728: 4.48225722323067, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.1132296763050918, miRNA_hsa-mir-190b: -1.0185078082073409, miRNA_hsa-mir-577: -0.5506186648735057, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: 5.058301585171852, miRNA_hsa-mir-17: -0.6250964335789854, miRNA_hsa-mir-130b: 0.3667814004753252, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-EW-A3E8,"No mRNA, methylation, or miRNA features meet diagnostic thresholds. CNV shows amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 (all 0.90–1.90). No high-level amplifications (≥1.90) or deletions (<−1.10). Insufficient evidence for subtype classification.","mRNA_MLPH: 0.8476854989955964, mRNA_C2orf54: -0.679080136692538, mRNA_CITED4: 1.0635713510786966, mRNA_ESR1: 0.0558979257311114, mRNA_SPDEF: 0.7142987635545088, mRNA_AGR3: 0.6638645678915099, mRNA_FOXC1: -0.3959615317278189, mRNA_GATA3: 0.2638380632402277, mRNA_AGR2: 0.9973076627495068, mRNA_XBP1: 0.333029231177497, mRNA_PRR15: 0.991348479741273, mRNA_SLC44A4: 0.7606591263159295, mRNA_CA12: 0.3376909640750741, mRNA_DTL: -0.9767882307117404, mRNA_C5AR2: 0.4890253428050756, mRNA_TBC1D9: 0.5258532242355796, mRNA_AR: 0.7633823697596029, mRNA_CCDC170: -0.0993201421297664, mRNA_DEGS2: 1.162241770195834, mRNA_TFF3: 0.4265771239070548, mRNA_DNALI1: 0.764861154463217, mRNA_LINC00504: 0.7304292962517968, mRNA_CLCA2: -0.655051770005436, mRNA_PPP1R14C: -0.8717038610926564, mRNA_THSD4: 0.0841663958156311, mRNA_SPAG5: -0.7513329536939742, mRNA_FBP1: -0.0034269615560692, mRNA_SLC7A8: 0.7144485368581789, mRNA_EN1: -0.6634523122999706, mRNA_ZNF552: 0.5603834634538905, Methylation_LRRC6: 0.6107016372111035, Methylation_chr2 66218712 LINC02934 (29533): 1.206393330131209, Methylation_HOXB13: -0.0313238781244623, Methylation_chr10 3949206 LINC02660 (4871): -0.139777418933289, Methylation_chr5 179517140 RNF130 (18026): 0.6631221775807205, Methylation_LOC727677: -0.2322826719500819, Methylation_LETM1: 0.0102705874734486, Methylation_CDC42BPB: -0.5870586589323465, Methylation_C8orf38: 0.1494521425735382, Methylation_chr14 100504766 EVL (18852): 0.2434225998280594, Methylation_chr5 72594851 LOC340090 (24088): 0.5394999297635532, Methylation_chr2 242904738 LINC01238 (3421): 0.1553027808866373, Methylation_ARFGEF1: 0.7928270261774687, Methylation_MAPT: 0.0566973817903493, Methylation_ZFAT: 0.1840180234022495, Methylation_KCNQ4: -0.8942140893065496, Methylation_chr1 232684368 SIPA1L2 (12934): 0.356597215221228, Methylation_CRNKL1: -0.0514247288829671, Methylation_PRKAG2: 0.9216647520113732, Methylation_MICB: 0.3169131716718009, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.3420996730221314, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.2676063573873907, miRNA_hsa-mir-190b: 0.5949077871792962, miRNA_hsa-mir-577: -0.4325130994924116, miRNA_hsa-mir-135b: -0.7497486156010832, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.3906428713464344, miRNA_hsa-mir-130b: -1.0710099615436852, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-B6-A0RO,"High mRNA_C2orf54 (Z=2.20) and mRNA_TFF3 (Z=1.93) indicate overexpression.  
miRNA_hsa-mir-4728 (Z=-1.28) and miRNA_hsa-mir-17 (Z=-1.49) are downregulated.  
No methylation or CNV alterations meet diagnostic thresholds.  
These features suggest luminal epithelial differentiation with potential miRNA-mediated post-transcriptional dysregulation.","mRNA_MLPH: 0.605845432367953, mRNA_C2orf54: 2.202787375087055, mRNA_CITED4: 0.2373704086725835, mRNA_ESR1: 1.052975224265278, mRNA_SPDEF: 0.860949128887692, mRNA_AGR3: 0.7076511717925719, mRNA_FOXC1: -0.2315974767345345, mRNA_GATA3: 0.3386192749418503, mRNA_AGR2: 1.428989317987977, mRNA_XBP1: 1.1175131614222795, mRNA_PRR15: 0.6146949206309702, mRNA_SLC44A4: 1.241853097009349, mRNA_CA12: -0.0356826455441195, mRNA_DTL: -0.9550135413328104, mRNA_C5AR2: 0.8250396741672134, mRNA_TBC1D9: 1.0474855206227616, mRNA_AR: 0.8047865572701874, mRNA_CCDC170: 0.6876717499355716, mRNA_DEGS2: 0.9481522469457672, mRNA_TFF3: 1.9310307957129809, mRNA_DNALI1: 0.5279271543654093, mRNA_LINC00504: 0.0774361653424682, mRNA_CLCA2: 0.2944534139442154, mRNA_PPP1R14C: 0.1506298914568568, mRNA_THSD4: 1.334326963417399, mRNA_SPAG5: -1.295720815722096, mRNA_FBP1: 0.9500838775870544, mRNA_SLC7A8: 0.5987741024392611, mRNA_EN1: -0.9805488087290964, mRNA_ZNF552: 1.6521940584935226, Methylation_LRRC6: -0.1084963831305789, Methylation_chr2 66218712 LINC02934 (29533): -0.3039865804130298, Methylation_HOXB13: 0.8972695450978476, Methylation_chr10 3949206 LINC02660 (4871): -0.6888316480005768, Methylation_chr5 179517140 RNF130 (18026): 0.4765803799956041, Methylation_LOC727677: -0.5326059832933497, Methylation_LETM1: -0.8238622643821809, Methylation_CDC42BPB: -0.0619560541370007, Methylation_C8orf38: -0.8579623674215083, Methylation_chr14 100504766 EVL (18852): -0.6849371936188502, Methylation_chr5 72594851 LOC340090 (24088): 0.7887641210008317, Methylation_chr2 242904738 LINC01238 (3421): -0.5851120476600464, Methylation_ARFGEF1: -0.5054078522674299, Methylation_MAPT: -0.2894254018494551, Methylation_ZFAT: -0.6044492638150134, Methylation_KCNQ4: -0.4223511600663701, Methylation_chr1 232684368 SIPA1L2 (12934): -0.693542026672433, Methylation_CRNKL1: -0.8638812881955146, Methylation_PRKAG2: -0.7066532265880514, Methylation_MICB: -0.6438128269141222, miRNA_hsa-mir-934: -0.0266069563674224, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.6334955337098401, miRNA_hsa-mir-190b: 0.5889381883238941, miRNA_hsa-mir-577: -0.3713246065675493, miRNA_hsa-mir-135b: 0.0773752841931587, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.4917139359064044, miRNA_hsa-mir-130b: -0.5114236004596269, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-BH-A1ES,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.3758156811043085, mRNA_C2orf54: -0.5878810040054284, mRNA_CITED4: -1.4553370571386155, mRNA_ESR1: 0.6415642849529339, mRNA_SPDEF: 0.0143332926596782, mRNA_AGR3: 0.7231589049064955, mRNA_FOXC1: 0.157537021489517, mRNA_GATA3: 0.8945577107174719, mRNA_AGR2: 0.7075154133215189, mRNA_XBP1: 0.3387175528404503, mRNA_PRR15: 0.1244922412499088, mRNA_SLC44A4: 0.2622993300376754, mRNA_CA12: 0.6241545523376452, mRNA_DTL: 0.5122854496740631, mRNA_C5AR2: -0.7655338557210242, mRNA_TBC1D9: 0.3170780617902785, mRNA_AR: 0.7430364745248018, mRNA_CCDC170: 0.4391249293562076, mRNA_DEGS2: 0.0609875114575353, mRNA_TFF3: 0.3787190579442336, mRNA_DNALI1: 0.434068096954889, mRNA_LINC00504: 0.9876496947379736, mRNA_CLCA2: 0.6631647087716502, mRNA_PPP1R14C: 0.7456454348468442, mRNA_THSD4: 1.000985073897439, mRNA_SPAG5: 1.1657222208317228, mRNA_FBP1: 0.0923404221771298, mRNA_SLC7A8: 1.0696502532877197, mRNA_EN1: -0.6177280942088321, mRNA_ZNF552: -0.1046363297249692, Methylation_LRRC6: -1.4449127297891289, Methylation_chr2 66218712 LINC02934 (29533): 1.3413556498973032, Methylation_HOXB13: -1.0080876226268658, Methylation_chr10 3949206 LINC02660 (4871): -1.279950890265504, Methylation_chr5 179517140 RNF130 (18026): 1.2316723603432072, Methylation_LOC727677: -1.4862544502433337, Methylation_LETM1: -1.3789010975196996, Methylation_CDC42BPB: -1.0326371961690717, Methylation_C8orf38: -0.0917327188222982, Methylation_chr14 100504766 EVL (18852): -1.4589369988855023, Methylation_chr5 72594851 LOC340090 (24088): 1.1092247411345235, Methylation_chr2 242904738 LINC01238 (3421): 1.4009273480382858, Methylation_ARFGEF1: -1.2906996606422114, Methylation_MAPT: -0.6926438578764257, Methylation_ZFAT: -1.0100967448588412, Methylation_KCNQ4: 0.4459768471787589, Methylation_chr1 232684368 SIPA1L2 (12934): -1.2233062029865889, Methylation_CRNKL1: -1.357347287212945, Methylation_PRKAG2: 1.3542576044001813, Methylation_MICB: -1.1259804756092937, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.914693759609455, miRNA_hsa-mir-5695: 0.6163135724325306, miRNA_hsa-mir-18a: 0.1224455961253441, miRNA_hsa-mir-190b: -0.2118034734970242, miRNA_hsa-mir-577: -0.6310636643363501, miRNA_hsa-mir-135b: 0.5026763478903384, miRNA_hsa-mir-2115: -0.4692673576840419, miRNA_hsa-mir-17: 0.2412664755023083, miRNA_hsa-mir-130b: 1.1440560525946872, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A1XA,"High-level Amplification of none; Deletion of VPS54, LINC01867, LINC02576, WDPCP, and CEP68. mRNA_THSD4 (Z=1.91) and mRNA_CA12 (Z=1.73) are highly overexpressed. No miRNAs meet up/downregulation thresholds. Methylation_ZFAT (Z=-1.38) is hypo-methylated. ESR1 mRNA (Z=1.21) nears high threshold but is excluded.","mRNA_MLPH: 0.4132353500821539, mRNA_C2orf54: -1.2533646510674965, mRNA_CITED4: 0.4482679365812416, mRNA_ESR1: 1.209807242354187, mRNA_SPDEF: 0.0562726752276536, mRNA_AGR3: 0.6058505383051951, mRNA_FOXC1: -1.2921149579180564, mRNA_GATA3: 0.6761966418695264, mRNA_AGR2: 0.5210949438585906, mRNA_XBP1: 0.5548407251548174, mRNA_PRR15: 0.672219643231517, mRNA_SLC44A4: 0.756945404096885, mRNA_CA12: 1.7298335301786874, mRNA_DTL: 0.2152724927784796, mRNA_C5AR2: 1.2450415774589352, mRNA_TBC1D9: 1.2905643772964843, mRNA_AR: 1.2002533944928275, mRNA_CCDC170: 1.09066870845669, mRNA_DEGS2: 0.4968218433920834, mRNA_TFF3: -0.4600961596812956, mRNA_DNALI1: 0.8633784171803713, mRNA_LINC00504: 0.6282886446574578, mRNA_CLCA2: -0.8105145736005235, mRNA_PPP1R14C: -0.7966828822827867, mRNA_THSD4: 1.908377225854992, mRNA_SPAG5: 0.0286680078508591, mRNA_FBP1: -1.1901058018442354, mRNA_SLC7A8: 0.074750512846512, mRNA_EN1: -0.723591033087196, mRNA_ZNF552: 1.0185141465692522, Methylation_LRRC6: -1.196285467704982, Methylation_chr2 66218712 LINC02934 (29533): 0.0472228443359693, Methylation_HOXB13: 0.2153580606184101, Methylation_chr10 3949206 LINC02660 (4871): -1.2039755170044597, Methylation_chr5 179517140 RNF130 (18026): 1.214970382991216, Methylation_LOC727677: -0.7784727884451449, Methylation_LETM1: -0.920101188393144, Methylation_CDC42BPB: 1.266071052330075, Methylation_C8orf38: -1.1201214750998132, Methylation_chr14 100504766 EVL (18852): -0.671595648262205, Methylation_chr5 72594851 LOC340090 (24088): 1.0008120780311005, Methylation_chr2 242904738 LINC01238 (3421): 0.3194798662420653, Methylation_ARFGEF1: -0.7295899666411777, Methylation_MAPT: -1.15840578522254, Methylation_ZFAT: -1.3779589738615583, Methylation_KCNQ4: -0.911369667571438, Methylation_chr1 232684368 SIPA1L2 (12934): -0.7354912950667882, Methylation_CRNKL1: -0.8651950453845916, Methylation_PRKAG2: -0.3239244980873672, Methylation_MICB: -1.0347147781884345, miRNA_hsa-mir-934: -0.2984514670612534, miRNA_hsa-mir-4728: 0.454306270064757, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.7822249196458143, miRNA_hsa-mir-190b: -0.1508785864993458, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.8200244527799542, miRNA_hsa-mir-2115: -0.2146660487282763, miRNA_hsa-mir-17: -1.0185883901966115, miRNA_hsa-mir-130b: -0.7315296826583706, CNV_VPS54: -1.6173912818721974, CNV_LINC01867: -1.63714039509435, CNV_LINC02576: -1.657048777669473, CNV_WDPCP: -1.6249341592372952, CNV_CEP68: -1.657048777669473"
TCGA-B6-A408,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations.","mRNA_MLPH: 0.6206479095864683, mRNA_C2orf54: -0.4782663913315965, mRNA_CITED4: 0.725487721932129, mRNA_ESR1: 0.8384970160899266, mRNA_SPDEF: 0.634942290525148, mRNA_AGR3: 0.7327373420023765, mRNA_FOXC1: -0.5010337017054649, mRNA_GATA3: 0.6624245345052516, mRNA_AGR2: 1.198578701579002, mRNA_XBP1: -0.1991878565879283, mRNA_PRR15: 0.9043668131256036, mRNA_SLC44A4: 0.7573602573449246, mRNA_CA12: -0.3547724412869499, mRNA_DTL: -1.0661810496515365, mRNA_C5AR2: 1.107528219509046, mRNA_TBC1D9: 0.3062966191210263, mRNA_AR: -0.0197689416411094, mRNA_CCDC170: 0.767005950566742, mRNA_DEGS2: 1.207318223362492, mRNA_TFF3: 0.0511765512480849, mRNA_DNALI1: 0.9703792889936568, mRNA_LINC00504: -0.1027593454440401, mRNA_CLCA2: -0.850059992000643, mRNA_PPP1R14C: -0.4814990201660877, mRNA_THSD4: 0.454606675429641, mRNA_SPAG5: -1.0803079984624742, mRNA_FBP1: 0.3990144916153162, mRNA_SLC7A8: 0.7316593637183322, mRNA_EN1: -0.3749427751990991, mRNA_ZNF552: 0.2581940857170642, Methylation_LRRC6: -0.8673672801668744, Methylation_chr2 66218712 LINC02934 (29533): -0.9574539097801, Methylation_HOXB13: 1.120402836873282, Methylation_chr10 3949206 LINC02660 (4871): -0.9600227903522924, Methylation_chr5 179517140 RNF130 (18026): 0.4648489212244983, Methylation_LOC727677: -1.0501779940501508, Methylation_LETM1: -1.0163049372531354, Methylation_CDC42BPB: -1.2374601742826077, Methylation_C8orf38: -1.137404570374716, Methylation_chr14 100504766 EVL (18852): -0.9601990352870976, Methylation_chr5 72594851 LOC340090 (24088): 0.6192602097797051, Methylation_chr2 242904738 LINC01238 (3421): -1.1937854573641198, Methylation_ARFGEF1: -0.5050386928571905, Methylation_MAPT: -1.0336954878874978, Methylation_ZFAT: -1.2581976032607818, Methylation_KCNQ4: -1.2190282614886014, Methylation_chr1 232684368 SIPA1L2 (12934): -0.4539054984646395, Methylation_CRNKL1: -0.8910767989918222, Methylation_PRKAG2: 1.150450093518723, Methylation_MICB: -1.0944479224878148, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.0194857911173682, miRNA_hsa-mir-5695: 0.2870899916522717, miRNA_hsa-mir-18a: -0.2489017631772995, miRNA_hsa-mir-190b: 0.7461070258552175, miRNA_hsa-mir-577: -0.5058145908920976, miRNA_hsa-mir-135b: -0.600819619168396, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.9783138215134864, miRNA_hsa-mir-130b: -0.7781074208325268, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-C8-A26X,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression of C2orf54 and CLCA2. Promoter hypermethylation of chr10:3949206 (LINC02660), LOC727677, EVL, ARFGEF1, ZFAT, CRNKL1, and MICB mediates epigenetic silencing. miRNA hsa-mir-190b is downregulated. These features indicate a luminal B phenotype with ER signaling suppression.","mRNA_MLPH: -0.632244057004431, mRNA_C2orf54: 2.090104422791546, mRNA_CITED4: -0.0309266059443679, mRNA_ESR1: -1.8537971799938544, mRNA_SPDEF: -0.332061383886715, mRNA_AGR3: -1.7171806385790402, mRNA_FOXC1: -0.6462028293169941, mRNA_GATA3: -1.7806835951537587, mRNA_AGR2: -0.4851937230013895, mRNA_XBP1: -0.8287374930408484, mRNA_PRR15: -1.319855298402337, mRNA_SLC44A4: 0.2068134975640725, mRNA_CA12: -0.7250980005277972, mRNA_DTL: -0.6260114633472815, mRNA_C5AR2: -1.9140143067772413, mRNA_TBC1D9: -1.5098203566958557, mRNA_AR: 0.6107093259214859, mRNA_CCDC170: -1.6519874199380522, mRNA_DEGS2: -0.7289115756374479, mRNA_TFF3: -1.2070984710373442, mRNA_DNALI1: -1.7456531540197706, mRNA_LINC00504: -1.3347543878800128, mRNA_CLCA2: 2.0602445716943523, mRNA_PPP1R14C: 0.7798359243296563, mRNA_THSD4: -1.1240346925019713, mRNA_SPAG5: -0.2882803231001684, mRNA_FBP1: -1.1907225200671898, mRNA_SLC7A8: -0.6027539303195696, mRNA_EN1: -0.7944786453032238, mRNA_ZNF552: -2.0057655104036725, Methylation_LRRC6: 1.0764786809830675, Methylation_chr2 66218712 LINC02934 (29533): -0.6628681368019478, Methylation_HOXB13: -0.1234028439068617, Methylation_chr10 3949206 LINC02660 (4871): 1.5976944353814937, Methylation_chr5 179517140 RNF130 (18026): -0.1904533993823313, Methylation_LOC727677: 1.4791591769997547, Methylation_LETM1: 1.3324149440933424, Methylation_CDC42BPB: -1.13802270033429, Methylation_C8orf38: 0.1927704154042615, Methylation_chr14 100504766 EVL (18852): 1.4815024075279477, Methylation_chr5 72594851 LOC340090 (24088): -0.9223637000171522, Methylation_chr2 242904738 LINC01238 (3421): 1.3427841991971976, Methylation_ARFGEF1: 1.1337871745025512, Methylation_MAPT: 0.7117112080932939, Methylation_ZFAT: 1.473255350560046, Methylation_KCNQ4: 0.41173275837694, Methylation_chr1 232684368 SIPA1L2 (12934): 0.9012008678238552, Methylation_CRNKL1: 1.4765513561961527, Methylation_PRKAG2: 0.9120725966875256, Methylation_MICB: 1.4655566672884666, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.62310722387079, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.1704147473132531, miRNA_hsa-mir-190b: -1.5265119070353528, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.477883552136905, miRNA_hsa-mir-2115: 1.6198304899188265, miRNA_hsa-mir-17: -0.7107165416818605, miRNA_hsa-mir-130b: -0.146865195054096, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-A2-A4S2,mRNA_C5AR2 (Z=1.83) and mRNA_ZNF552 (Z=1.74) are highly expressed; mRNA_DEGS2 (Z=1.46) exceeds the high threshold. No methylation sites meet hyper/hypo-methylation criteria. miRNA_hsa-mir-5695 is upregulated (Z=1.85). All CNVs fall within the normal range (−1.10 to −0.10). High mRNA_C5AR2 and ZNF552 suggest immune and transcriptional dysregulation.,"mRNA_MLPH: 0.7790204722573646, mRNA_C2orf54: 0.7412628251541207, mRNA_CITED4: 1.2386690806817633, mRNA_ESR1: 0.2819878323883927, mRNA_SPDEF: 0.8027299302619745, mRNA_AGR3: 0.4562279669519912, mRNA_FOXC1: -0.0713825705100724, mRNA_GATA3: 0.7667842136639653, mRNA_AGR2: -0.0026722639943722, mRNA_XBP1: 0.4733268221314619, mRNA_PRR15: 0.7619959986937745, mRNA_SLC44A4: 0.2755545143830872, mRNA_CA12: 0.9084737233138672, mRNA_DTL: -0.449482452603395, mRNA_C5AR2: 1.8255730652696296, mRNA_TBC1D9: 0.7479495231697656, mRNA_AR: 0.0016750181700085, mRNA_CCDC170: 0.7665415816005545, mRNA_DEGS2: 1.457805882830048, mRNA_TFF3: 0.7322297910617165, mRNA_DNALI1: 0.737330961148775, mRNA_LINC00504: 0.1735266526991177, mRNA_CLCA2: -0.3020603843864924, mRNA_PPP1R14C: -0.0221677289153308, mRNA_THSD4: 0.3639068283680538, mRNA_SPAG5: -0.79203483524122, mRNA_FBP1: 0.4498921082593373, mRNA_SLC7A8: 0.8924747296330656, mRNA_EN1: -0.6115829130674371, mRNA_ZNF552: 1.7420891377201062, Methylation_LRRC6: 0.0640877209048899, Methylation_chr2 66218712 LINC02934 (29533): 0.5367940468408408, Methylation_HOXB13: -0.1889625904572016, Methylation_chr10 3949206 LINC02660 (4871): -0.6360040823867212, Methylation_chr5 179517140 RNF130 (18026): 0.6954079809727991, Methylation_LOC727677: -0.7454972918674201, Methylation_LETM1: 0.7387203292246086, Methylation_CDC42BPB: 0.7756058558914325, Methylation_C8orf38: -0.485526503951226, Methylation_chr14 100504766 EVL (18852): -0.4544139514472854, Methylation_chr5 72594851 LOC340090 (24088): 0.7644317228310998, Methylation_chr2 242904738 LINC01238 (3421): -0.7973870535142799, Methylation_ARFGEF1: -0.5286307391021537, Methylation_MAPT: -0.6216547708039677, Methylation_ZFAT: -0.5921321080293016, Methylation_KCNQ4: -1.03793909424771, Methylation_chr1 232684368 SIPA1L2 (12934): -0.7641112098650106, Methylation_CRNKL1: -0.7452459506026444, Methylation_PRKAG2: 1.099310525952542, Methylation_MICB: -0.1229158439848182, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.323772451980269, miRNA_hsa-mir-5695: 1.849111167755633, miRNA_hsa-mir-18a: -0.5889019490143529, miRNA_hsa-mir-190b: 0.9682990821246216, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.4846100429225262, miRNA_hsa-mir-2115: 0.0638575172206716, miRNA_hsa-mir-17: -0.5340257706794699, miRNA_hsa-mir-130b: -1.18639489987738, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-GM-A2DI,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.1888993556717881, mRNA_C2orf54: -0.7644685918237352, mRNA_CITED4: 0.4835273258917125, mRNA_ESR1: 0.2639641513074661, mRNA_SPDEF: 0.0451618600154013, mRNA_AGR3: 0.6911023220324388, mRNA_FOXC1: -0.0282718278904326, mRNA_GATA3: 0.038892872720386, mRNA_AGR2: 0.8959841181218033, mRNA_XBP1: 0.3289706139165144, mRNA_PRR15: 0.2410158235851135, mRNA_SLC44A4: 0.2996676848579825, mRNA_CA12: 0.7802262830458769, mRNA_DTL: -0.7029213707062443, mRNA_C5AR2: 0.6915346764420662, mRNA_TBC1D9: 0.4432394849618227, mRNA_AR: 0.7752197889718405, mRNA_CCDC170: 0.5274358057751477, mRNA_DEGS2: 0.1741321117617813, mRNA_TFF3: 0.267048167615634, mRNA_DNALI1: -0.0853758106919443, mRNA_LINC00504: -0.5852980143705239, mRNA_CLCA2: -0.6303128919710899, mRNA_PPP1R14C: -0.2209062576301634, mRNA_THSD4: 0.3982396975402676, mRNA_SPAG5: -0.4652697052666821, mRNA_FBP1: 0.1794372203729323, mRNA_SLC7A8: 0.8031597022644246, mRNA_EN1: -0.6394060549571784, mRNA_ZNF552: 0.6045770564010147, Methylation_LRRC6: 1.2885769236488878, Methylation_chr2 66218712 LINC02934 (29533): 0.9494042263171144, Methylation_HOXB13: -1.056757074884307, Methylation_chr10 3949206 LINC02660 (4871): 0.5584226003289077, Methylation_chr5 179517140 RNF130 (18026): -0.7562613624790122, Methylation_LOC727677: 0.9229123567915608, Methylation_LETM1: 0.8387775908214632, Methylation_CDC42BPB: -0.5211324398022518, Methylation_C8orf38: 1.100278315916104, Methylation_chr14 100504766 EVL (18852): 1.1054309855559397, Methylation_chr5 72594851 LOC340090 (24088): -0.8154786212267405, Methylation_chr2 242904738 LINC01238 (3421): 0.3247325240883171, Methylation_ARFGEF1: 1.404062869530382, Methylation_MAPT: 1.1632425024489508, Methylation_ZFAT: 0.693483258347019, Methylation_KCNQ4: -1.0914503695686193, Methylation_chr1 232684368 SIPA1L2 (12934): 1.2433458199464458, Methylation_CRNKL1: 0.9923029711448004, Methylation_PRKAG2: 0.5782894890351538, Methylation_MICB: 0.998780683241182, miRNA_hsa-mir-934: -0.2156785095790463, miRNA_hsa-mir-4728: -0.1691038288032942, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.4231446211190084, miRNA_hsa-mir-190b: 0.0920631494109929, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.6310992356914444, miRNA_hsa-mir-2115: 0.2407404571776547, miRNA_hsa-mir-17: 0.154517379081203, miRNA_hsa-mir-130b: -0.4754876629566876, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-B6-A0RU,"High-level Amplification of none; Gain in none.  
FOXC1 mRNA high (Z=1.64); EN1 mRNA high (Z=1.98).  
No promoter hyper/hypomethylation per thresholds.  
miR-190b downregulated (Z=-2.05); miR-577 upregulated (Z=2.09).  
These features suggest luminal B phenotype with PI3K/AKT dysregulation.","mRNA_MLPH: -1.5534386200621002, mRNA_C2orf54: -0.8784383094909692, mRNA_CITED4: 1.2307587754039864, mRNA_ESR1: -1.1696940769369888, mRNA_SPDEF: -0.8936848506023284, mRNA_AGR3: -0.6942001015054703, mRNA_FOXC1: 1.6352000837420329, mRNA_GATA3: -1.1288620347873952, mRNA_AGR2: -0.8468171580529037, mRNA_XBP1: -1.0625619984940795, mRNA_PRR15: -1.4892254307398205, mRNA_SLC44A4: -1.1919422979210283, mRNA_CA12: -1.180459294327693, mRNA_DTL: 1.183835315168229, mRNA_C5AR2: -1.7671374542817384, mRNA_TBC1D9: -1.1840262724596635, mRNA_AR: -1.1849753294801797, mRNA_CCDC170: -0.819938128733548, mRNA_DEGS2: -1.2955098348611978, mRNA_TFF3: -0.5873643864066282, mRNA_DNALI1: -0.9774949614618004, mRNA_LINC00504: -1.0722382600710512, mRNA_CLCA2: 0.2714692990248272, mRNA_PPP1R14C: 0.7085083064363301, mRNA_THSD4: -0.5524657243478223, mRNA_SPAG5: 0.5356527460279031, mRNA_FBP1: -1.5776342206921925, mRNA_SLC7A8: -1.052330725705548, mRNA_EN1: 1.978606169281029, mRNA_ZNF552: -1.1199278645788016, Methylation_LRRC6: 1.408563692221712, Methylation_chr2 66218712 LINC02934 (29533): -0.9616724545626514, Methylation_HOXB13: 0.3460284483847324, Methylation_chr10 3949206 LINC02660 (4871): 1.3705575596445143, Methylation_chr5 179517140 RNF130 (18026): -1.0471974033336966, Methylation_LOC727677: 1.4583568392024493, Methylation_LETM1: 1.283093433960268, Methylation_CDC42BPB: -0.4059330976698813, Methylation_C8orf38: 1.2692219415582495, Methylation_chr14 100504766 EVL (18852): 1.544819403743863, Methylation_chr5 72594851 LOC340090 (24088): -1.4161024294630438, Methylation_chr2 242904738 LINC01238 (3421): 1.377451777250545, Methylation_ARFGEF1: 1.5825184517187, Methylation_MAPT: 1.3504237947533444, Methylation_ZFAT: 1.3666444360726842, Methylation_KCNQ4: 1.007191882712993, Methylation_chr1 232684368 SIPA1L2 (12934): 1.4703453342227004, Methylation_CRNKL1: 1.299514684234138, Methylation_PRKAG2: 0.8534170339561942, Methylation_MICB: 1.2727407468047836, miRNA_hsa-mir-934: 0.7110182947764563, miRNA_hsa-mir-4728: -0.4132909509092571, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.376071098433145, miRNA_hsa-mir-190b: -2.052137242410604, miRNA_hsa-mir-577: 2.0913940308624133, miRNA_hsa-mir-135b: 1.337781411458837, miRNA_hsa-mir-2115: -0.1054835373097901, miRNA_hsa-mir-17: 0.9643873651935768, miRNA_hsa-mir-130b: 0.9454966251417511, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A7-A26J,ZNF552 mRNA is highly expressed (Z = 2.12). No methylation or miRNA alterations meet diagnostic thresholds. All CNVs fall within the normal range (−1.10 to −0.10). Isolated ZNF552 overexpression may indicate transcriptional dysregulation without clear genomic or epigenetic drivers.,"mRNA_MLPH: 0.4484750988082596, mRNA_C2orf54: -0.0902356741696851, mRNA_CITED4: -1.443598843857651, mRNA_ESR1: 0.4161603968365949, mRNA_SPDEF: -0.5096088189641981, mRNA_AGR3: 0.2509901714462831, mRNA_FOXC1: -0.2762664897042784, mRNA_GATA3: 0.1345448445136485, mRNA_AGR2: 0.0639330116669826, mRNA_XBP1: -0.3559424426468686, mRNA_PRR15: -0.1701310948782804, mRNA_SLC44A4: 0.134258185645358, mRNA_CA12: 0.1007824957049114, mRNA_DTL: 0.3011199796043032, mRNA_C5AR2: -0.5312376852690344, mRNA_TBC1D9: 0.6112225682162684, mRNA_AR: 0.8275840330326831, mRNA_CCDC170: 0.3144246187260338, mRNA_DEGS2: -0.1303666565220083, mRNA_TFF3: -0.3159276316246463, mRNA_DNALI1: 0.6520895706271879, mRNA_LINC00504: 0.0945228890676924, mRNA_CLCA2: -0.7287421304257271, mRNA_PPP1R14C: -0.2048596388397863, mRNA_THSD4: 0.6102291777012476, mRNA_SPAG5: 0.3345931293968335, mRNA_FBP1: -0.8061957246983348, mRNA_SLC7A8: -0.7482325696756653, mRNA_EN1: -0.9917012590743752, mRNA_ZNF552: 2.117589053354835, Methylation_LRRC6: -1.2262649245797448, Methylation_chr2 66218712 LINC02934 (29533): -0.5648305512470468, Methylation_HOXB13: 0.9196074618509829, Methylation_chr10 3949206 LINC02660 (4871): -1.1515066019800668, Methylation_chr5 179517140 RNF130 (18026): 0.9261765264299904, Methylation_LOC727677: -1.0999562027356635, Methylation_LETM1: -0.9145237453370224, Methylation_CDC42BPB: 1.3644664262509782, Methylation_C8orf38: -0.3057364350356394, Methylation_chr14 100504766 EVL (18852): -0.6387360226025081, Methylation_chr5 72594851 LOC340090 (24088): 0.8721481412896334, Methylation_chr2 242904738 LINC01238 (3421): -0.9330770091516072, Methylation_ARFGEF1: -0.7341520189408359, Methylation_MAPT: -0.9821197859937568, Methylation_ZFAT: -0.3522308432873947, Methylation_KCNQ4: -0.5783246683109066, Methylation_chr1 232684368 SIPA1L2 (12934): -1.1110813057582627, Methylation_CRNKL1: -1.0280909818428678, Methylation_PRKAG2: -0.5291896989149473, Methylation_MICB: -1.4655789490252409, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.4157563120304257, miRNA_hsa-mir-5695: 0.2305017163247007, miRNA_hsa-mir-18a: -0.470931555015281, miRNA_hsa-mir-190b: 0.8849021914915212, miRNA_hsa-mir-577: -0.5194083815676112, miRNA_hsa-mir-135b: -0.5328036851640763, miRNA_hsa-mir-2115: 0.0397250563140419, miRNA_hsa-mir-17: 0.0380385365427369, miRNA_hsa-mir-130b: -0.8346287423179866, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A1JK,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives genomic instability. CLCA2 and PPP1R14C show significant mRNA overexpression (Z > 1.30). ESR1, AGR3, GATA3, and TFF3 exhibit low mRNA (Z < -1.92). Promoter hypermethylation at LOC727677, LETM1, EVL, MAPT, CRNKL1, and MICB (Z > 1.50) suggests epigenetic silencing. hsa-mir-2115 is upregulated (Z > 1.99).","mRNA_MLPH: -0.321015058433646, mRNA_C2orf54: 0.758642242918228, mRNA_CITED4: -0.1791026176890779, mRNA_ESR1: -1.7236115010568205, mRNA_SPDEF: 0.0335049050312517, mRNA_AGR3: -1.858833087441569, mRNA_FOXC1: 0.5266134825027365, mRNA_GATA3: -2.109046845913815, mRNA_AGR2: -0.2234130716878965, mRNA_XBP1: -0.9975090091872604, mRNA_PRR15: -0.2127415150112282, mRNA_SLC44A4: -1.4543249666644362, mRNA_CA12: -0.9424119530579054, mRNA_DTL: 0.0910782686416733, mRNA_C5AR2: -1.5318839819780483, mRNA_TBC1D9: -0.7665403652763554, mRNA_AR: 0.0041140988721033, mRNA_CCDC170: -1.3883821617291638, mRNA_DEGS2: -0.9406993423333688, mRNA_TFF3: -1.57228354639803, mRNA_DNALI1: -1.7029553338678038, mRNA_LINC00504: -1.079602678636363, mRNA_CLCA2: 2.8819255478709, mRNA_PPP1R14C: 1.832453479716291, mRNA_THSD4: -0.9839096174874628, mRNA_SPAG5: 0.0105631428301873, mRNA_FBP1: -0.2102567826502246, mRNA_SLC7A8: -0.7587865300354615, mRNA_EN1: -0.7663890565669107, mRNA_ZNF552: -0.9615249376260334, Methylation_LRRC6: 1.2880800005884985, Methylation_chr2 66218712 LINC02934 (29533): -1.650582839014332, Methylation_HOXB13: 0.5062125817437083, Methylation_chr10 3949206 LINC02660 (4871): 0.9885055447558756, Methylation_chr5 179517140 RNF130 (18026): -1.3590871045521282, Methylation_LOC727677: 1.45713020253757, Methylation_LETM1: 1.3596548277252878, Methylation_CDC42BPB: -1.2618020234672258, Methylation_C8orf38: 0.5257018976492988, Methylation_chr14 100504766 EVL (18852): 1.3436729665481226, Methylation_chr5 72594851 LOC340090 (24088): -1.505475723789096, Methylation_chr2 242904738 LINC01238 (3421): 1.450890062712872, Methylation_ARFGEF1: 0.2459403392773022, Methylation_MAPT: 1.4484372587215677, Methylation_ZFAT: 0.8924593990652988, Methylation_KCNQ4: -0.5135398650936036, Methylation_chr1 232684368 SIPA1L2 (12934): 0.5612607187315888, Methylation_CRNKL1: 1.366791460690388, Methylation_PRKAG2: -0.8529541532121415, Methylation_MICB: 1.4155956828272158, miRNA_hsa-mir-934: -0.287566639038142, miRNA_hsa-mir-4728: 0.0900127247079163, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.8720450408323962, miRNA_hsa-mir-190b: -0.0191515656198448, miRNA_hsa-mir-577: -0.4743868417789871, miRNA_hsa-mir-135b: 0.0224551560093762, miRNA_hsa-mir-2115: 2.1610040450061705, miRNA_hsa-mir-17: 0.05048341067069, miRNA_hsa-mir-130b: 1.3003065973420995, CNV_VPS54: 2.3735003872816955, CNV_LINC01867: 2.395394893874891, CNV_LINC02576: 2.464291317721031, CNV_WDPCP: 2.38809584879993, CNV_CEP68: 2.464291317721031"
TCGA-E9-A1R7,High mRNA_ESR1 (Z=1.41) indicates overexpression. Methylation_chr2 242904738 LINC02938 hypermethylated (Z=1.47). No miRNA or CNV alterations meet diagnostic thresholds. These features suggest luminal A subtype with estrogen signaling activation.,"mRNA_MLPH: 0.3823267304702388, mRNA_C2orf54: 0.2557083782797724, mRNA_CITED4: 0.9115924770307192, mRNA_ESR1: 1.4087473882995396, mRNA_SPDEF: 0.055048406099371, mRNA_AGR3: 0.3662662978546412, mRNA_FOXC1: -0.9023759148749289, mRNA_GATA3: 0.5693368152566409, mRNA_AGR2: 0.8078515167510547, mRNA_XBP1: 0.9468324877096608, mRNA_PRR15: -0.6778370870767961, mRNA_SLC44A4: 0.5001260204489766, mRNA_CA12: 0.7090550789993505, mRNA_DTL: 1.169266017415664, mRNA_C5AR2: 0.0181939869943787, mRNA_TBC1D9: 0.8876923817075623, mRNA_AR: -0.3070449539883996, mRNA_CCDC170: 1.1133488485486045, mRNA_DEGS2: -0.6192624637618024, mRNA_TFF3: -1.254664843803082, mRNA_DNALI1: 0.8916696745397718, mRNA_LINC00504: -0.8291806422946998, mRNA_CLCA2: -0.8358412918143525, mRNA_PPP1R14C: -0.937560299606176, mRNA_THSD4: 1.1121175697094, mRNA_SPAG5: 1.2039878488363678, mRNA_FBP1: -0.7561853792533658, mRNA_SLC7A8: -1.7118360455453845, mRNA_EN1: -1.042102235501306, mRNA_ZNF552: -0.8642466849576853, Methylation_LRRC6: -0.7120689417033206, Methylation_chr2 66218712 LINC02934 (29533): 0.7275847925476447, Methylation_HOXB13: 0.9460826537886404, Methylation_chr10 3949206 LINC02660 (4871): -0.8302940746731532, Methylation_chr5 179517140 RNF130 (18026): 0.820715938499777, Methylation_LOC727677: -0.4661990973132178, Methylation_LETM1: -0.8744508324599619, Methylation_CDC42BPB: 1.062656326246479, Methylation_C8orf38: -1.186442936351914, Methylation_chr14 100504766 EVL (18852): -0.0839731045438437, Methylation_chr5 72594851 LOC340090 (24088): 0.9335639526383877, Methylation_chr2 242904738 LINC01238 (3421): 1.467559111317171, Methylation_ARFGEF1: -0.8499559544328034, Methylation_MAPT: -0.7940037570451697, Methylation_ZFAT: -0.3864412843145581, Methylation_KCNQ4: 0.3079010397404116, Methylation_chr1 232684368 SIPA1L2 (12934): -1.26229745881933, Methylation_CRNKL1: -0.6198117989988486, Methylation_PRKAG2: -0.8645947542409032, Methylation_MICB: -0.68611578193301, miRNA_hsa-mir-934: -0.413130516526249, miRNA_hsa-mir-4728: -0.1172081795445515, miRNA_hsa-mir-5695: 0.9909533487566344, miRNA_hsa-mir-18a: 0.1041916215531537, miRNA_hsa-mir-190b: 0.7792015254567902, miRNA_hsa-mir-577: -0.3367306051149374, miRNA_hsa-mir-135b: -0.3508093682418426, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.225688525770895, miRNA_hsa-mir-130b: 0.412505370358021, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A0HB,"SPAG5 mRNA overexpression (Z=1.74) exceeds high-expression threshold. No methylation, miRNA, or CNV alterations meet diagnostic criteria. Isolated SPAG5 upregulation suggests potential mitotic dysregulation.","mRNA_MLPH: 0.2324602182117323, mRNA_C2orf54: -0.1618671996790933, mRNA_CITED4: -0.3410528414077026, mRNA_ESR1: 0.962222162260306, mRNA_SPDEF: 0.9159909229033284, mRNA_AGR3: 0.8500963681633481, mRNA_FOXC1: -0.6461656095741151, mRNA_GATA3: 0.3354551047185044, mRNA_AGR2: 0.7166484071217817, mRNA_XBP1: 0.2374944559563204, mRNA_PRR15: 0.4608969119239491, mRNA_SLC44A4: -1.3070576323373049, mRNA_CA12: 0.512048844065919, mRNA_DTL: 0.4840667991540196, mRNA_C5AR2: -0.485345424829167, mRNA_TBC1D9: -0.0102134992748162, mRNA_AR: -0.389139526143774, mRNA_CCDC170: 0.9658703060963064, mRNA_DEGS2: 0.0548473509871686, mRNA_TFF3: 0.517565655871822, mRNA_DNALI1: 0.1367412030049012, mRNA_LINC00504: -0.1249681667671439, mRNA_CLCA2: 0.3949508072593756, mRNA_PPP1R14C: 0.2570572852453731, mRNA_THSD4: 0.4847578060219004, mRNA_SPAG5: 1.7389374603847323, mRNA_FBP1: 0.5988546457864358, mRNA_SLC7A8: 0.8633868780176834, mRNA_EN1: -0.444093028737991, mRNA_ZNF552: -0.3853495951972445, Methylation_LRRC6: -0.6261644851799079, Methylation_chr2 66218712 LINC02934 (29533): 0.9875456873919198, Methylation_HOXB13: 0.008025824250361, Methylation_chr10 3949206 LINC02660 (4871): -0.8804911755129061, Methylation_chr5 179517140 RNF130 (18026): 0.9138021263451028, Methylation_LOC727677: -1.233830190390532, Methylation_LETM1: -0.5321753743061255, Methylation_CDC42BPB: 1.2731325001294571, Methylation_C8orf38: -0.864177695274252, Methylation_chr14 100504766 EVL (18852): -0.5777362092148466, Methylation_chr5 72594851 LOC340090 (24088): 1.053558348676665, Methylation_chr2 242904738 LINC01238 (3421): 1.169830661343634, Methylation_ARFGEF1: -0.902087904092814, Methylation_MAPT: -0.4156523778839927, Methylation_ZFAT: -1.153154647513423, Methylation_KCNQ4: -0.4920712099731807, Methylation_chr1 232684368 SIPA1L2 (12934): 0.0639120021403769, Methylation_CRNKL1: -0.2905720254770045, Methylation_PRKAG2: 1.1048547511962916, Methylation_MICB: -0.1013486221680698, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.6783964716456516, miRNA_hsa-mir-5695: 0.8827526811920038, miRNA_hsa-mir-18a: 0.2258022829981529, miRNA_hsa-mir-190b: 0.3563146353961986, miRNA_hsa-mir-577: -0.3627228661850994, miRNA_hsa-mir-135b: -0.6588619609887967, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.5603299982720403, miRNA_hsa-mir-130b: 0.0272306106052302, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-GM-A3NY,"High mRNA_MLPH (Z=1.31), mRNA_CITED4 (Z=1.55), and mRNA_TFF3 (Z=1.70) indicate overexpression. Methylation_chr10 3949206 LINC02660 (Z=1.55) is hypermethylated. No miRNA or CNV alterations meet diagnostic thresholds. These features suggest luminal epithelial differentiation with potential TFF3-driven secretory pathway activation.","mRNA_MLPH: 1.3104120953028895, mRNA_C2orf54: -0.357054738365915, mRNA_CITED4: 1.5460606151996328, mRNA_ESR1: 0.4376600433027816, mRNA_SPDEF: 0.2067830763399033, mRNA_AGR3: 0.6819107031161655, mRNA_FOXC1: -0.4841963066931157, mRNA_GATA3: 0.6766435526801411, mRNA_AGR2: 1.055735425100795, mRNA_XBP1: -0.4634559132412127, mRNA_PRR15: 0.4596740595045232, mRNA_SLC44A4: 0.2975471928657414, mRNA_CA12: 0.4743723101937422, mRNA_DTL: -0.5530599334263128, mRNA_C5AR2: 0.9866062596184012, mRNA_TBC1D9: -0.268175565407934, mRNA_AR: -0.0124210724428928, mRNA_CCDC170: 0.3076982831639444, mRNA_DEGS2: 0.396098163289638, mRNA_TFF3: 1.701587725988697, mRNA_DNALI1: 0.9640350362559524, mRNA_LINC00504: -0.1781848961214263, mRNA_CLCA2: -0.7676877484211304, mRNA_PPP1R14C: -0.7946856125070908, mRNA_THSD4: 0.0941022538086183, mRNA_SPAG5: -0.5642139465114923, mRNA_FBP1: -0.5707446750840101, mRNA_SLC7A8: 0.3119307724715364, mRNA_EN1: 0.2705025768668329, mRNA_ZNF552: 1.007885592965474, Methylation_LRRC6: -1.1505182401764098, Methylation_chr2 66218712 LINC02934 (29533): 0.9858046697223416, Methylation_HOXB13: 0.9593046406492473, Methylation_chr10 3949206 LINC02660 (4871): 1.553015317353189, Methylation_chr5 179517140 RNF130 (18026): 1.0253069379993005, Methylation_LOC727677: -0.396540110069888, Methylation_LETM1: -1.0212242177598947, Methylation_CDC42BPB: -1.295991637029098, Methylation_C8orf38: -0.7040559581093424, Methylation_chr14 100504766 EVL (18852): -0.9816086691736752, Methylation_chr5 72594851 LOC340090 (24088): 1.0528117190735535, Methylation_chr2 242904738 LINC01238 (3421): -1.1199738159667838, Methylation_ARFGEF1: -0.6849910760480435, Methylation_MAPT: -1.1532905657013912, Methylation_ZFAT: 0.0547466356295318, Methylation_KCNQ4: -1.018027741888988, Methylation_chr1 232684368 SIPA1L2 (12934): -1.3199850369101191, Methylation_CRNKL1: -0.7725865617702736, Methylation_PRKAG2: -1.3036012101109609, Methylation_MICB: -1.2761859009188268, miRNA_hsa-mir-934: -0.4350043013966964, miRNA_hsa-mir-4728: 0.1947360940538418, miRNA_hsa-mir-5695: -0.1494405360024819, miRNA_hsa-mir-18a: -0.2045130195940628, miRNA_hsa-mir-190b: 1.3501601289629603, miRNA_hsa-mir-577: -0.3808141818514272, miRNA_hsa-mir-135b: -0.377998758249492, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.8744123257538554, miRNA_hsa-mir-130b: -0.438427116110953, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A7-A5ZX,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.7744869450980228, mRNA_C2orf54: 1.2669323216405113, mRNA_CITED4: 1.0697976272639025, mRNA_ESR1: 0.0185987411269259, mRNA_SPDEF: 0.6583408043876526, mRNA_AGR3: 0.4475935198918875, mRNA_FOXC1: 0.3463531775307822, mRNA_GATA3: 0.3346417441705669, mRNA_AGR2: 0.3697047361861887, mRNA_XBP1: 0.7355941649231282, mRNA_PRR15: 0.6465995460083696, mRNA_SLC44A4: 0.6066119432716046, mRNA_CA12: 0.249462948954198, mRNA_DTL: -2.014772085453069, mRNA_C5AR2: 0.5567624525823748, mRNA_TBC1D9: 0.2837901636267511, mRNA_AR: 0.630293066417245, mRNA_CCDC170: 0.4744335359163814, mRNA_DEGS2: 0.6302065606663652, mRNA_TFF3: 0.249237291192649, mRNA_DNALI1: 0.7300552003549985, mRNA_LINC00504: 0.4372442178495651, mRNA_CLCA2: 0.7955061640545525, mRNA_PPP1R14C: 0.1157515445643817, mRNA_THSD4: 0.4719740437827924, mRNA_SPAG5: -1.6706362048176109, mRNA_FBP1: 0.204842675483369, mRNA_SLC7A8: 0.2166641202894101, mRNA_EN1: 0.0606328683045752, mRNA_ZNF552: 0.833410756524885, Methylation_LRRC6: -0.0905183079002092, Methylation_chr2 66218712 LINC02934 (29533): 0.0484437403103604, Methylation_HOXB13: 0.0238331796556661, Methylation_chr10 3949206 LINC02660 (4871): 0.1820955812583025, Methylation_chr5 179517140 RNF130 (18026): 0.1952593124586784, Methylation_LOC727677: 0.3487423200936887, Methylation_LETM1: 0.9371725366708826, Methylation_CDC42BPB: -0.727532985093575, Methylation_C8orf38: 0.2482542461401394, Methylation_chr14 100504766 EVL (18852): 0.3987427137085984, Methylation_chr5 72594851 LOC340090 (24088): 0.511054953836406, Methylation_chr2 242904738 LINC01238 (3421): 0.0774536247767703, Methylation_ARFGEF1: 0.6444703949530284, Methylation_MAPT: 0.5983429656686258, Methylation_ZFAT: 1.124891888078302, Methylation_KCNQ4: -0.6853216437806272, Methylation_chr1 232684368 SIPA1L2 (12934): -0.1056018977577524, Methylation_CRNKL1: 0.7924138007311624, Methylation_PRKAG2: 0.8990999528042267, Methylation_MICB: -0.1158526881311464, miRNA_hsa-mir-934: -0.4754642594231802, miRNA_hsa-mir-4728: -0.5152842911524151, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.0303161656547768, miRNA_hsa-mir-190b: -0.0042664346567859, miRNA_hsa-mir-577: -0.648080592927266, miRNA_hsa-mir-135b: -0.2308334855600686, miRNA_hsa-mir-2115: 0.2843751450559934, miRNA_hsa-mir-17: -0.5703671083340282, miRNA_hsa-mir-130b: -2.00853543529844, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AQ-A04L,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression.  
HOXB13 and KCNQ4 promoter hypermethylation mediates epigenetic silencing.  
miR-135b and miR-130b are downregulated.  
These features collectively indicate a luminal B phenotype with PI3K/AKT dysregulation.","mRNA_MLPH: -0.3213915987529478, mRNA_C2orf54: 0.646780086610472, mRNA_CITED4: -0.3092530664344987, mRNA_ESR1: -0.3986340470239265, mRNA_SPDEF: 0.2046732062257602, mRNA_AGR3: -1.8564164935354537, mRNA_FOXC1: -1.0064481253769986, mRNA_GATA3: -0.3660711752512144, mRNA_AGR2: -0.8012333425617653, mRNA_XBP1: -0.2624032000007395, mRNA_PRR15: 1.6948268858125637, mRNA_SLC44A4: 0.8807415685764529, mRNA_CA12: 0.4886615167224238, mRNA_DTL: -0.6520994134517222, mRNA_C5AR2: -1.1920294429275915, mRNA_TBC1D9: -0.1644024633355734, mRNA_AR: 0.8957531501325346, mRNA_CCDC170: 0.5929526954780795, mRNA_DEGS2: -0.3032786688051077, mRNA_TFF3: -0.7934197603545602, mRNA_DNALI1: -1.8201763761988423, mRNA_LINC00504: 0.8235484884799875, mRNA_CLCA2: 1.0384189603101714, mRNA_PPP1R14C: 0.5542958314912314, mRNA_THSD4: -1.2539741930235324, mRNA_SPAG5: -1.75409158020522, mRNA_FBP1: -0.5728678747972266, mRNA_SLC7A8: 0.6570496379200266, mRNA_EN1: -0.2594029186957806, mRNA_ZNF552: -1.2022423551871737, Methylation_LRRC6: -1.0677020877170211, Methylation_chr2 66218712 LINC02934 (29533): -1.501895764427804, Methylation_HOXB13: 1.647974345421532, Methylation_chr10 3949206 LINC02660 (4871): -1.1362685905975334, Methylation_chr5 179517140 RNF130 (18026): 1.0900407962103795, Methylation_LOC727677: 1.4028873265908142, Methylation_LETM1: 1.3124853792677025, Methylation_CDC42BPB: -1.2438858602578304, Methylation_C8orf38: -1.399556428634435, Methylation_chr14 100504766 EVL (18852): 1.2402300618937552, Methylation_chr5 72594851 LOC340090 (24088): 1.2929486730529132, Methylation_chr2 242904738 LINC01238 (3421): 1.4094933354503882, Methylation_ARFGEF1: -1.3050404822182518, Methylation_MAPT: -1.2298866612400727, Methylation_ZFAT: 0.373000890400352, Methylation_KCNQ4: 1.9373650232066464, Methylation_chr1 232684368 SIPA1L2 (12934): -1.0631005845647452, Methylation_CRNKL1: 1.27103866892259, Methylation_PRKAG2: 1.278033757780332, Methylation_MICB: 0.2281200743107963, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.1083540560285606, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.9825063441869208, miRNA_hsa-mir-190b: -1.0615319552958709, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: 0.8982569707077963, miRNA_hsa-mir-17: -0.9000916707420332, miRNA_hsa-mir-130b: -1.361584319661692, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-C8-A26Y,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives genomic instability. ESR1 and AGR3 mRNA are significantly downregulated (Z < -1.92), consistent with luminal silencing. CLCA2 shows marked overexpression (Z = 3.34). Methylation at chr10:3949206 and LOC727677 is hypermethylated (Z > 1.50). miR-2115 is upregulated (Z = 2.43), while miR-190b is downregulated (Z = -1.35). These features indicate a basal-like phenotype with ER pathway suppression.","mRNA_MLPH: 0.2248849799256835, mRNA_C2orf54: 0.1460717063176143, mRNA_CITED4: -1.3220584328249576, mRNA_ESR1: -2.0055287713137, mRNA_SPDEF: 0.0486693440698498, mRNA_AGR3: -2.013847041460512, mRNA_FOXC1: 0.0797615644041813, mRNA_GATA3: -1.161209951848237, mRNA_AGR2: -1.2185348679304635, mRNA_XBP1: -0.1102348404749177, mRNA_PRR15: -0.7987056435997298, mRNA_SLC44A4: 0.9397137477241286, mRNA_CA12: -0.0721015237268181, mRNA_DTL: 0.4619730023257883, mRNA_C5AR2: -1.141856942010959, mRNA_TBC1D9: -1.0781643616428953, mRNA_AR: -1.6348070946515971, mRNA_CCDC170: -1.5671422333713412, mRNA_DEGS2: 0.9626130430058644, mRNA_TFF3: -1.7602370735942363, mRNA_DNALI1: -1.8846796301430544, mRNA_LINC00504: 0.6166581301789996, mRNA_CLCA2: 3.3449927242822595, mRNA_PPP1R14C: 0.531792430541445, mRNA_THSD4: -1.77371271429538, mRNA_SPAG5: -0.7692755430727353, mRNA_FBP1: -0.1394207532894683, mRNA_SLC7A8: -0.6700739893792291, mRNA_EN1: -0.8177715958073124, mRNA_ZNF552: -0.1614645444006409, Methylation_LRRC6: 0.9979614393587636, Methylation_chr2 66218712 LINC02934 (29533): 0.2136644774261807, Methylation_HOXB13: 0.7298312810060511, Methylation_chr10 3949206 LINC02660 (4871): 1.5564734075276423, Methylation_chr5 179517140 RNF130 (18026): 0.5977482910435291, Methylation_LOC727677: 1.5142630585428978, Methylation_LETM1: 1.3316663336992225, Methylation_CDC42BPB: -0.7112207763136215, Methylation_C8orf38: 1.0091710057089311, Methylation_chr14 100504766 EVL (18852): 1.406468888180016, Methylation_chr5 72594851 LOC340090 (24088): -1.4213303658806922, Methylation_chr2 242904738 LINC01238 (3421): 1.3799871055881456, Methylation_ARFGEF1: 0.762030716068076, Methylation_MAPT: 1.3797909951539296, Methylation_ZFAT: 1.388734545342636, Methylation_KCNQ4: 0.941444196920108, Methylation_chr1 232684368 SIPA1L2 (12934): 0.9067068504409216, Methylation_CRNKL1: 1.3979224022231522, Methylation_PRKAG2: -1.020637338298655, Methylation_MICB: 1.1592619497441456, miRNA_hsa-mir-934: 0.1052703817277035, miRNA_hsa-mir-4728: -1.0063893737211351, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.2599972584848625, miRNA_hsa-mir-190b: -1.35136482164161, miRNA_hsa-mir-577: 0.5810418611905873, miRNA_hsa-mir-135b: 0.1220718727372636, miRNA_hsa-mir-2115: 2.430268868217378, miRNA_hsa-mir-17: 0.0631441072833093, miRNA_hsa-mir-130b: 1.052274783920893, CNV_VPS54: 2.3735003872816955, CNV_LINC01867: 2.395394893874891, CNV_LINC02576: 2.464291317721031, CNV_WDPCP: 2.38809584879993, CNV_CEP68: 2.464291317721031"
TCGA-BH-A0WA,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. FOXC1 and EN1 show significant mRNA upregulation (Z > 1.30). AGR3, AGR2, GATA3, PRR15, and MLPH are transcriptionally downregulated (Z < -1.92). Promoter hypermethylation at chr10:3949206, LOC727677, C8orf38, and ARFGEF1 (Z > 1.50) suggests epigenetic silencing. Hypomethylation at chr2:66218712 and RNF130 (Z < -1.47) may activate oncogenic loci. miR-577, miR-135b, and miR-934 are upregulated (Z > 1.99).","mRNA_MLPH: -2.4170536491297687, mRNA_C2orf54: -0.481979600619818, mRNA_CITED4: 0.2040585720499351, mRNA_ESR1: -1.876828861957874, mRNA_SPDEF: -1.2353262245608718, mRNA_AGR3: -2.035093741436747, mRNA_FOXC1: 2.7796262361943644, mRNA_GATA3: -2.339176736417746, mRNA_AGR2: -2.179277300748787, mRNA_XBP1: -1.326088277559307, mRNA_PRR15: -2.542053786826267, mRNA_SLC44A4: -1.374341774029185, mRNA_CA12: -1.269790016230293, mRNA_DTL: 0.6598271980863335, mRNA_C5AR2: -1.5175762378124371, mRNA_TBC1D9: -1.634711147807434, mRNA_AR: -1.925040423121507, mRNA_CCDC170: -1.5549534587244245, mRNA_DEGS2: -1.8127572467407456, mRNA_TFF3: -1.788570865900479, mRNA_DNALI1: -1.2615712805958277, mRNA_LINC00504: -1.6857045090854434, mRNA_CLCA2: -0.7692361990231812, mRNA_PPP1R14C: 1.825155133284004, mRNA_THSD4: -1.0649215247153836, mRNA_SPAG5: 0.5994819941148345, mRNA_FBP1: -1.8128744080426509, mRNA_SLC7A8: -1.4274482027791402, mRNA_EN1: 2.4979976916189206, mRNA_ZNF552: -1.3918340238923974, Methylation_LRRC6: 1.468718027642953, Methylation_chr2 66218712 LINC02934 (29533): -1.4854070989740424, Methylation_HOXB13: 0.4312344787017674, Methylation_chr10 3949206 LINC02660 (4871): 1.5400292446872828, Methylation_chr5 179517140 RNF130 (18026): -1.5248051138660583, Methylation_LOC727677: 1.521473405815783, Methylation_LETM1: 1.3153935470275189, Methylation_CDC42BPB: 0.4482798250253356, Methylation_C8orf38: 1.6028725638871826, Methylation_chr14 100504766 EVL (18852): 1.2303449003418605, Methylation_chr5 72594851 LOC340090 (24088): -1.4288603946599896, Methylation_chr2 242904738 LINC01238 (3421): 1.3670922241384458, Methylation_ARFGEF1: 1.479095737498119, Methylation_MAPT: 1.407369719329369, Methylation_ZFAT: 1.4265560822434429, Methylation_KCNQ4: 1.4058278544992897, Methylation_chr1 232684368 SIPA1L2 (12934): 1.483101898650733, Methylation_CRNKL1: 1.265646923270236, Methylation_PRKAG2: -1.040044882835366, Methylation_MICB: 1.2829048235934029, miRNA_hsa-mir-934: 2.647163369246786, miRNA_hsa-mir-4728: -0.0658209485753549, miRNA_hsa-mir-5695: 1.310896067022134, miRNA_hsa-mir-18a: 0.9653852884632268, miRNA_hsa-mir-190b: -1.1894712387251314, miRNA_hsa-mir-577: 3.0043963987504347, miRNA_hsa-mir-135b: 2.5822938223295773, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.4424347987046886, miRNA_hsa-mir-130b: 1.353395535769218, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-OL-A66H,PRR15 mRNA overexpression (Z=1.59) and TFF3 upregulation (Z=1.34) exceed high-expression thresholds. No methylation or miRNA alterations meet diagnostic criteria. All CNVs fall within normal range (−1.10 to −0.10). These features indicate a luminal phenotype with estrogen-response pathway activation.,"mRNA_MLPH: 0.846971926841838, mRNA_C2orf54: -1.1482891041444871, mRNA_CITED4: -1.2418939860733793, mRNA_ESR1: 0.455636447404085, mRNA_SPDEF: 0.9894624085616662, mRNA_AGR3: 0.7353575560821403, mRNA_FOXC1: -0.0895257821958384, mRNA_GATA3: 0.4307979467861224, mRNA_AGR2: 0.1507958257579416, mRNA_XBP1: 0.812617542588348, mRNA_PRR15: 1.5918222695286697, mRNA_SLC44A4: 1.2071097078401536, mRNA_CA12: -1.1573549479058738, mRNA_DTL: -0.8844107552099391, mRNA_C5AR2: 0.8866739856801231, mRNA_TBC1D9: 0.8051848875010883, mRNA_AR: 0.0193898755703564, mRNA_CCDC170: 1.0443645094331255, mRNA_DEGS2: 0.1502617598795984, mRNA_TFF3: 1.3448703367586816, mRNA_DNALI1: 0.3579279927842562, mRNA_LINC00504: 1.0738181763142896, mRNA_CLCA2: -0.8523131624414602, mRNA_PPP1R14C: -0.7462824397887899, mRNA_THSD4: 0.6966709956403517, mRNA_SPAG5: -0.4272995836388649, mRNA_FBP1: 1.008395049612382, mRNA_SLC7A8: 0.0666566505136168, mRNA_EN1: -0.6877942209117691, mRNA_ZNF552: 0.8571489448706032, Methylation_LRRC6: 0.005288705037686, Methylation_chr2 66218712 LINC02934 (29533): -1.0211393006452425, Methylation_HOXB13: 0.4171634621219717, Methylation_chr10 3949206 LINC02660 (4871): -0.6281673490144857, Methylation_chr5 179517140 RNF130 (18026): 0.5827695058764389, Methylation_LOC727677: -0.5026268799052918, Methylation_LETM1: -0.7708533829192511, Methylation_CDC42BPB: -0.8779331064674669, Methylation_C8orf38: 0.3697037765062163, Methylation_chr14 100504766 EVL (18852): -0.2215852607940744, Methylation_chr5 72594851 LOC340090 (24088): 0.3487259548393029, Methylation_chr2 242904738 LINC01238 (3421): -0.922994190417078, Methylation_ARFGEF1: 0.1555241353121155, Methylation_MAPT: -0.5313656467291309, Methylation_ZFAT: -0.4139200840304196, Methylation_KCNQ4: -1.1689059413353922, Methylation_chr1 232684368 SIPA1L2 (12934): 0.6007272442611037, Methylation_CRNKL1: 0.2807939783047617, Methylation_PRKAG2: -0.9270810165871182, Methylation_MICB: 0.1219726945163442, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.0317430149360021, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.0968357277257058, miRNA_hsa-mir-190b: 0.2708151322271008, miRNA_hsa-mir-577: -0.6236474745180621, miRNA_hsa-mir-135b: -1.022512710292917, miRNA_hsa-mir-2115: -0.2576975130340528, miRNA_hsa-mir-17: 0.2453324901099924, miRNA_hsa-mir-130b: -0.9971204732964922, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A0GY,"High mRNA_C2orf54 (Z=2.01) indicates overexpression. Methylation_HOXB13 hypermethylation (Z=1.73) suggests epigenetic silencing; Methylation_ZFAT hypomethylation (Z=-1.57) implies activation. No CNVs meet amplification/deletion thresholds. miRNA_hsa-mir-934 upregulation (Z=1.96) may target tumor suppressors. Collectively, these features suggest a luminal-like phenotype with HOXB13-mediated transcriptional dysregulation.","mRNA_MLPH: -0.1979637545764658, mRNA_C2orf54: 2.014501549532435, mRNA_CITED4: 0.6416508986315836, mRNA_ESR1: 0.004891567978616, mRNA_SPDEF: -0.0636597525283323, mRNA_AGR3: 0.4234949950523834, mRNA_FOXC1: -0.0109941795379971, mRNA_GATA3: 0.3336303255452312, mRNA_AGR2: 0.5171959312349549, mRNA_XBP1: -0.3642724694823557, mRNA_PRR15: -1.0123864971554606, mRNA_SLC44A4: -1.4811792320663288, mRNA_CA12: 0.7191239548880045, mRNA_DTL: -0.7980184154042191, mRNA_C5AR2: 0.486770980926075, mRNA_TBC1D9: 0.1784385344363827, mRNA_AR: 0.2453204008794325, mRNA_CCDC170: 0.1053928044899461, mRNA_DEGS2: -0.4381234837307395, mRNA_TFF3: -0.3848019708583152, mRNA_DNALI1: 1.071721196686764, mRNA_LINC00504: -0.9662806362527632, mRNA_CLCA2: 0.5991237763093148, mRNA_PPP1R14C: 0.3969581070772491, mRNA_THSD4: -0.4676887811135935, mRNA_SPAG5: -0.5102070615280238, mRNA_FBP1: -0.4377704523699557, mRNA_SLC7A8: -0.2686666330478092, mRNA_EN1: -0.5753601970314641, mRNA_ZNF552: 1.0712755333529924, Methylation_LRRC6: -0.8931510056324561, Methylation_chr2 66218712 LINC02934 (29533): -0.3413034008176116, Methylation_HOXB13: 1.7304018496868414, Methylation_chr10 3949206 LINC02660 (4871): -0.7188941670900273, Methylation_chr5 179517140 RNF130 (18026): -1.1500752147663944, Methylation_LOC727677: -1.3844653631571249, Methylation_LETM1: -0.1886003408209748, Methylation_CDC42BPB: 0.876205136096814, Methylation_C8orf38: -0.8869355836409175, Methylation_chr14 100504766 EVL (18852): -0.7665510212411946, Methylation_chr5 72594851 LOC340090 (24088): 0.6422670764424975, Methylation_chr2 242904738 LINC01238 (3421): -0.1762248494419717, Methylation_ARFGEF1: -0.7407135685215166, Methylation_MAPT: 0.6619070904971495, Methylation_ZFAT: -1.5724107417598394, Methylation_KCNQ4: 0.974388434448756, Methylation_chr1 232684368 SIPA1L2 (12934): 0.1208842553190673, Methylation_CRNKL1: -0.4375675216987096, Methylation_PRKAG2: -0.8342047867943657, Methylation_MICB: 0.0875279877747371, miRNA_hsa-mir-934: 1.95516895997452, miRNA_hsa-mir-4728: -0.4684927525028226, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.3755419845361868, miRNA_hsa-mir-190b: 0.4219055291378351, miRNA_hsa-mir-577: 0.4737127961973248, miRNA_hsa-mir-135b: -0.0157883076488459, miRNA_hsa-mir-2115: 1.4492122049128515, miRNA_hsa-mir-17: -0.2576262204805198, miRNA_hsa-mir-130b: 0.1836509427866574, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-AR-A1AN,"Deletion of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 correlates with transcriptional downregulation. No mRNA, methylation, or miRNA features meet diagnostic thresholds for reporting.","mRNA_MLPH: -0.0867756289060045, mRNA_C2orf54: 0.1865235416647028, mRNA_CITED4: -0.1106373957196458, mRNA_ESR1: 0.2109331031527576, mRNA_SPDEF: 0.615125339151398, mRNA_AGR3: 0.6614469945949464, mRNA_FOXC1: -0.6242997229268229, mRNA_GATA3: 0.0905585189318394, mRNA_AGR2: 0.3415958010768742, mRNA_XBP1: 0.2409966500169826, mRNA_PRR15: 0.2821870505532763, mRNA_SLC44A4: 0.8396596116749243, mRNA_CA12: 0.548936236565687, mRNA_DTL: -0.4126396349160628, mRNA_C5AR2: 0.4649284239557411, mRNA_TBC1D9: 0.2947359960202487, mRNA_AR: 0.4590181738337377, mRNA_CCDC170: 0.6844342389413374, mRNA_DEGS2: -0.1118315908489359, mRNA_TFF3: 0.1881051180547684, mRNA_DNALI1: -1.44285825110451, mRNA_LINC00504: 0.4644533225306961, mRNA_CLCA2: -0.672690824686892, mRNA_PPP1R14C: -1.0514396650279931, mRNA_THSD4: 1.0163321222921111, mRNA_SPAG5: -1.0349087123391, mRNA_FBP1: -0.3867009509978371, mRNA_SLC7A8: 0.26282119007834, mRNA_EN1: 0.0462891094605336, mRNA_ZNF552: 0.6201691095437366, Methylation_LRRC6: 0.1208726797260921, Methylation_chr2 66218712 LINC02934 (29533): 0.1916502657999304, Methylation_HOXB13: -1.034910848625222, Methylation_chr10 3949206 LINC02660 (4871): 0.5717851227154359, Methylation_chr5 179517140 RNF130 (18026): -1.4272245364264078, Methylation_LOC727677: -0.6801216591587029, Methylation_LETM1: 0.1940368215752344, Methylation_CDC42BPB: -0.9357262571603868, Methylation_C8orf38: -0.3981787313343041, Methylation_chr14 100504766 EVL (18852): -0.1905127127748795, Methylation_chr5 72594851 LOC340090 (24088): 0.5975767695136747, Methylation_chr2 242904738 LINC01238 (3421): 0.6481361018047072, Methylation_ARFGEF1: -0.0391565361156546, Methylation_MAPT: 0.975430358108333, Methylation_ZFAT: -0.3120769468871083, Methylation_KCNQ4: -0.8569686043541466, Methylation_chr1 232684368 SIPA1L2 (12934): 0.1032711061465696, Methylation_CRNKL1: 0.972148318471792, Methylation_PRKAG2: -0.9800132218716016, Methylation_MICB: -0.3441839526292033, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.4924318692808846, miRNA_hsa-mir-5695: 0.4928498517810399, miRNA_hsa-mir-18a: 1.082511465617177, miRNA_hsa-mir-190b: 0.8715359716980564, miRNA_hsa-mir-577: -0.2409881289050685, miRNA_hsa-mir-135b: -0.7817491673013951, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.8837142905656155, miRNA_hsa-mir-130b: 0.4422895316494143, CNV_VPS54: -1.6173912818721974, CNV_LINC01867: -1.63714039509435, CNV_LINC02576: -1.657048777669473, CNV_WDPCP: -1.6249341592372952, CNV_CEP68: -1.657048777669473"
TCGA-OL-A5RZ,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. HOXB13 and MAPT promoter hypermethylation mediates epigenetic silencing. miR-4728 and miR-2115 are markedly upregulated. These features collectively indicate a luminal B phenotype with PI3K/AKT/mTOR dysregulation.","mRNA_MLPH: 0.6012602610614797, mRNA_C2orf54: 0.3646774601624736, mRNA_CITED4: -0.5900723799521429, mRNA_ESR1: -1.7190245735974192, mRNA_SPDEF: 1.527868089430385, mRNA_AGR3: -1.3009919434899144, mRNA_FOXC1: -1.0016585425578053, mRNA_GATA3: -0.2433581182093257, mRNA_AGR2: -0.905312872478989, mRNA_XBP1: -0.6327851074863663, mRNA_PRR15: 0.6741447814628543, mRNA_SLC44A4: -0.6234923495750357, mRNA_CA12: -0.6393904476891785, mRNA_DTL: -0.006213846590309, mRNA_C5AR2: -1.8179094541741183, mRNA_TBC1D9: 0.4058892276423972, mRNA_AR: 0.188369365012213, mRNA_CCDC170: -1.7745783377319335, mRNA_DEGS2: -0.0940085465179754, mRNA_TFF3: 0.1115249153462017, mRNA_DNALI1: -0.1089781972911189, mRNA_LINC00504: -1.2200209168138372, mRNA_CLCA2: 0.7045048515447357, mRNA_PPP1R14C: 0.1669496509672686, mRNA_THSD4: -1.8264545343510856, mRNA_SPAG5: 1.5209380051984724, mRNA_FBP1: 0.4586624913439528, mRNA_SLC7A8: -0.9240117802429532, mRNA_EN1: -1.0048838876732304, mRNA_ZNF552: -1.1672483684760582, Methylation_LRRC6: 0.2397944068144666, Methylation_chr2 66218712 LINC02934 (29533): -1.8540857002538893, Methylation_HOXB13: 1.61833066828563, Methylation_chr10 3949206 LINC02660 (4871): -1.2181002642271828, Methylation_chr5 179517140 RNF130 (18026): -1.6575206265641906, Methylation_LOC727677: -1.3272424497021795, Methylation_LETM1: 1.2266138100920916, Methylation_CDC42BPB: -1.3912173475931415, Methylation_C8orf38: -1.3930252729138108, Methylation_chr14 100504766 EVL (18852): -0.950349670722822, Methylation_chr5 72594851 LOC340090 (24088): -0.3200779668623058, Methylation_chr2 242904738 LINC01238 (3421): 1.194417041699016, Methylation_ARFGEF1: -1.1764139040134494, Methylation_MAPT: 1.433837499022662, Methylation_ZFAT: -1.6471546611126493, Methylation_KCNQ4: 0.1747150191019969, Methylation_chr1 232684368 SIPA1L2 (12934): -1.3380808038349263, Methylation_CRNKL1: -0.7028878913384398, Methylation_PRKAG2: 1.3482473071338434, Methylation_MICB: -0.7378031448572467, miRNA_hsa-mir-934: 0.0997266853111268, miRNA_hsa-mir-4728: 3.4196014141038247, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.5971446046577078, miRNA_hsa-mir-190b: -0.8921976786295078, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.4503583467723202, miRNA_hsa-mir-2115: 2.0088204574462587, miRNA_hsa-mir-17: -0.0910786098203307, miRNA_hsa-mir-130b: -0.0089299741454412, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-BH-A1EX,High-level Amplification absent; no CNV calls meet thresholds. CLCA2 mRNA overexpression (Z=3.32) exceeds high threshold. LINC021238 promoter hypermethylation (Z=1.34) may silence tumor suppressor. miR-2115 upregulated (Z=2.76). These features suggest luminal B phenotype with ER-pathway dysregulation.,"mRNA_MLPH: -0.1626006359720813, mRNA_C2orf54: -0.2782972302246079, mRNA_CITED4: -0.0269365679568851, mRNA_ESR1: -0.5267908341897857, mRNA_SPDEF: 0.1403052581260476, mRNA_AGR3: 0.0946441635148543, mRNA_FOXC1: -0.5273681063925723, mRNA_GATA3: -0.2073078122118155, mRNA_AGR2: 0.7842088690155704, mRNA_XBP1: -0.7640507414073674, mRNA_PRR15: 0.3267510745106681, mRNA_SLC44A4: 0.3883294305531785, mRNA_CA12: -0.384876987456732, mRNA_DTL: 0.1848129857419427, mRNA_C5AR2: -0.4178255802659653, mRNA_TBC1D9: 0.1747121257590756, mRNA_AR: 0.6281849772871778, mRNA_CCDC170: 0.285146974752305, mRNA_DEGS2: -0.6024703006752007, mRNA_TFF3: 0.1163722074330018, mRNA_DNALI1: 0.5117529058169367, mRNA_LINC00504: 1.1643596576378523, mRNA_CLCA2: 3.322893935609226, mRNA_PPP1R14C: -0.532586820486963, mRNA_THSD4: -0.4055432755841167, mRNA_SPAG5: -0.3982344260951887, mRNA_FBP1: 0.2539455516699337, mRNA_SLC7A8: 0.4066237802024539, mRNA_EN1: 0.346218354402627, mRNA_ZNF552: -0.6340013573651817, Methylation_LRRC6: 0.1074022690210907, Methylation_chr2 66218712 LINC02934 (29533): -0.9364710724864964, Methylation_HOXB13: 0.948644966724546, Methylation_chr10 3949206 LINC02660 (4871): -0.7168564310511613, Methylation_chr5 179517140 RNF130 (18026): -0.073290259691339, Methylation_LOC727677: -0.0950560130139365, Methylation_LETM1: 1.3055651775192216, Methylation_CDC42BPB: -1.2704001214854963, Methylation_C8orf38: -0.8431215506658384, Methylation_chr14 100504766 EVL (18852): -0.3743578047760647, Methylation_chr5 72594851 LOC340090 (24088): 0.6514376984887553, Methylation_chr2 242904738 LINC01238 (3421): 1.3364636120866231, Methylation_ARFGEF1: -0.4182563427577036, Methylation_MAPT: 0.5934071042852466, Methylation_ZFAT: 0.211658104138195, Methylation_KCNQ4: -1.0251806385470614, Methylation_chr1 232684368 SIPA1L2 (12934): -0.4755692067642315, Methylation_CRNKL1: 0.2816480065397733, Methylation_PRKAG2: -0.8331535746476516, Methylation_MICB: -0.933033829209832, miRNA_hsa-mir-934: 0.0496890970013916, miRNA_hsa-mir-4728: 0.8976099703005967, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.0992038705403568, miRNA_hsa-mir-190b: 0.1217233332932276, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: 0.8955062059412928, miRNA_hsa-mir-2115: 2.75841507726262, miRNA_hsa-mir-17: -0.3914702374322588, miRNA_hsa-mir-130b: -0.1054137882076285, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A2-A0T7,mRNA_C2orf54 overexpression (Z=1.95) exceeds high-threshold (Z>1.30). No methylation or miRNA alterations meet diagnostic criteria. All CNVs fall within normal range (−1.10 to −0.10). Isolated transcriptional upregulation of C2orf54 without genomic or epigenetic drivers.,"mRNA_MLPH: -0.1665955734132063, mRNA_C2orf54: 1.9502246394675784, mRNA_CITED4: 0.5140348807632742, mRNA_ESR1: -0.1116641477929383, mRNA_SPDEF: 0.5431403124334698, mRNA_AGR3: 0.2212309660093671, mRNA_FOXC1: 0.5346081727250218, mRNA_GATA3: 0.3674238578989826, mRNA_AGR2: -0.0245191620277711, mRNA_XBP1: -0.2010163135464986, mRNA_PRR15: 0.1641449570631382, mRNA_SLC44A4: 1.0395496852349506, mRNA_CA12: 0.0078470437324074, mRNA_DTL: 0.0808905452797952, mRNA_C5AR2: -0.7018933769957331, mRNA_TBC1D9: 0.2476489988645995, mRNA_AR: 0.3978645776805382, mRNA_CCDC170: -0.1024363696187328, mRNA_DEGS2: 0.6013264669585086, mRNA_TFF3: -0.1437413536888221, mRNA_DNALI1: 0.3294497305239589, mRNA_LINC00504: -0.2286619623867349, mRNA_CLCA2: 0.2258892358075556, mRNA_PPP1R14C: 0.985814857002566, mRNA_THSD4: -0.1533324655868759, mRNA_SPAG5: 0.2675114945072411, mRNA_FBP1: 0.1261402639585795, mRNA_SLC7A8: 0.1524326229801375, mRNA_EN1: 0.0373175297715288, mRNA_ZNF552: -0.0889859405024402, Methylation_LRRC6: -0.8243712219254848, Methylation_chr2 66218712 LINC02934 (29533): -1.215247383347834, Methylation_HOXB13: 0.9476819279251092, Methylation_chr10 3949206 LINC02660 (4871): -0.0702048686767102, Methylation_chr5 179517140 RNF130 (18026): 0.1289198516891536, Methylation_LOC727677: -0.5383556704769741, Methylation_LETM1: 0.7953729487410476, Methylation_CDC42BPB: 1.1683661524394278, Methylation_C8orf38: -0.8645816580828749, Methylation_chr14 100504766 EVL (18852): 0.0418821661063765, Methylation_chr5 72594851 LOC340090 (24088): 0.3635492029143711, Methylation_chr2 242904738 LINC01238 (3421): 0.1417991804342938, Methylation_ARFGEF1: -0.4796052022098572, Methylation_MAPT: 1.1733950543460174, Methylation_ZFAT: -0.9041467684482934, Methylation_KCNQ4: 0.5512891230300978, Methylation_chr1 232684368 SIPA1L2 (12934): 0.8771890404179291, Methylation_CRNKL1: -0.3460901660038862, Methylation_PRKAG2: 0.1449589185058577, Methylation_MICB: -0.1507002174250674, miRNA_hsa-mir-934: -0.1320750073526979, miRNA_hsa-mir-4728: -0.2142338777732134, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.6055554111527489, miRNA_hsa-mir-190b: -0.9886392545139022, miRNA_hsa-mir-577: -0.1826433491417622, miRNA_hsa-mir-135b: 0.5249010409202878, miRNA_hsa-mir-2115: 0.7090540899803143, miRNA_hsa-mir-17: -0.7753291115081081, miRNA_hsa-mir-130b: -1.055904490253301, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-UU-A93S,"High-level Amplification absent; Gain observed in VPS54, LINC01867, LINC02576, WDPCP, CEP68. mRNA_C2orf54 (Z=3.30) and CLCA2 (Z=1.65) overexpressed. FBP1 (Z=-3.15), SLC44A4 (Z=-2.26), CCDC170 (Z=-1.96), DNALI1 (Z=-1.90) downregulated. Methylation_chr10:3949206 hypermethylated (Z=1.62); PRKAG2 hypomethylated (Z=-1.46). miRNA_hsa-mir-4728 upregulated (Z=3.05).","mRNA_MLPH: -0.1708916105229885, mRNA_C2orf54: 3.3031413090910333, mRNA_CITED4: 0.2986338060018436, mRNA_ESR1: -1.846422154796584, mRNA_SPDEF: 0.4024092254857027, mRNA_AGR3: -1.7374098280595025, mRNA_FOXC1: -1.14607416140469, mRNA_GATA3: -1.3436216866938753, mRNA_AGR2: 0.4560122165201579, mRNA_XBP1: -0.8066540126707175, mRNA_PRR15: -0.4801159632974732, mRNA_SLC44A4: -2.2572559037101128, mRNA_CA12: -0.6553761746347213, mRNA_DTL: 0.914762791335022, mRNA_C5AR2: -1.6985838556946702, mRNA_TBC1D9: -0.9764334035341584, mRNA_AR: -0.5052642476393271, mRNA_CCDC170: -1.955021245167314, mRNA_DEGS2: -0.7465548674522815, mRNA_TFF3: -1.3916585860437152, mRNA_DNALI1: -1.904545973172991, mRNA_LINC00504: -1.7122916838544613, mRNA_CLCA2: 1.6541442544555074, mRNA_PPP1R14C: 0.7496954874587994, mRNA_THSD4: -0.5281359380460634, mRNA_SPAG5: 0.3481279847072073, mRNA_FBP1: -3.1479467667206964, mRNA_SLC7A8: -1.3963660361110235, mRNA_EN1: -0.9985727245431962, mRNA_ZNF552: -1.5168936878983663, Methylation_LRRC6: 0.4549655996511855, Methylation_chr2 66218712 LINC02934 (29533): -1.247808282696933, Methylation_HOXB13: 1.1007834499541531, Methylation_chr10 3949206 LINC02660 (4871): 1.6181547447645652, Methylation_chr5 179517140 RNF130 (18026): -0.5114259572682002, Methylation_LOC727677: 1.4883265983884089, Methylation_LETM1: 1.3539398474087083, Methylation_CDC42BPB: -1.114409023458516, Methylation_C8orf38: -1.4305760768220457, Methylation_chr14 100504766 EVL (18852): 0.2974748507799008, Methylation_chr5 72594851 LOC340090 (24088): -0.7516114882318424, Methylation_chr2 242904738 LINC01238 (3421): 1.3266017302167092, Methylation_ARFGEF1: -0.6076700856207145, Methylation_MAPT: -0.1469990072156757, Methylation_ZFAT: 1.3469814689816508, Methylation_KCNQ4: 0.8577403798598091, Methylation_chr1 232684368 SIPA1L2 (12934): 0.5652429795645508, Methylation_CRNKL1: 1.0661461306401718, Methylation_PRKAG2: -1.4558241561865914, Methylation_MICB: 1.4281588109624297, miRNA_hsa-mir-934: 0.4057477084096949, miRNA_hsa-mir-4728: 3.0488725925500004, miRNA_hsa-mir-5695: -0.424721642766051, miRNA_hsa-mir-18a: 0.9084698309966696, miRNA_hsa-mir-190b: -0.2119859110784787, miRNA_hsa-mir-577: -0.3145392198065033, miRNA_hsa-mir-135b: 0.0691377288827335, miRNA_hsa-mir-2115: 1.2966421549942806, miRNA_hsa-mir-17: 1.1450116993241908, miRNA_hsa-mir-130b: -0.2648303226000427, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-AO-A0JG,High mRNA_GATA3 (Z=1.45) and mRNA_LINC00504 (Z=1.65) indicate luminal transcriptional activity. No methylation or CNV alterations meet diagnostic thresholds. Downregulated miRNA_hsa-mir-18a (Z=-1.41) and miRNA_hsa-mir-130b (Z=-1.42) suggest loss of tumor-suppressive regulation. These features collectively indicate a luminal A phenotype with PI3K/AKT pathway dysregulation.,"mRNA_MLPH: 0.8335556375753956, mRNA_C2orf54: -0.4840983355322835, mRNA_CITED4: -1.2255827219905917, mRNA_ESR1: 0.5473718728659672, mRNA_SPDEF: 0.7695665191157458, mRNA_AGR3: 0.3930221425406602, mRNA_FOXC1: -0.1175067803017867, mRNA_GATA3: 1.4493516749432611, mRNA_AGR2: -0.8803001172948628, mRNA_XBP1: 0.3912483981193303, mRNA_PRR15: 1.0701328838874125, mRNA_SLC44A4: 1.212947294732634, mRNA_CA12: -0.6738118953277706, mRNA_DTL: -0.9454918907902468, mRNA_C5AR2: 0.7817894820488498, mRNA_TBC1D9: 1.2929098065427291, mRNA_AR: 0.8116953032886339, mRNA_CCDC170: 0.2793642785014121, mRNA_DEGS2: -0.2430167594550006, mRNA_TFF3: 0.2125239591554459, mRNA_DNALI1: 0.8623676377361972, mRNA_LINC00504: 1.645821813191358, mRNA_CLCA2: -0.4705052304883493, mRNA_PPP1R14C: 0.0177958923245325, mRNA_THSD4: 0.8653190566871282, mRNA_SPAG5: -1.2679782823157997, mRNA_FBP1: 0.9155288843684708, mRNA_SLC7A8: 0.7556957460533975, mRNA_EN1: -0.1815709765601632, mRNA_ZNF552: 0.3867898128050988, Methylation_LRRC6: 0.2077787779044367, Methylation_chr2 66218712 LINC02934 (29533): -0.6853604093098835, Methylation_HOXB13: -0.4508436565845508, Methylation_chr10 3949206 LINC02660 (4871): -0.3399217917621075, Methylation_chr5 179517140 RNF130 (18026): 0.8053536931413983, Methylation_LOC727677: -0.4683464719590245, Methylation_LETM1: -0.5913475960606367, Methylation_CDC42BPB: -1.144017064807893, Methylation_C8orf38: 0.7793503255281823, Methylation_chr14 100504766 EVL (18852): -0.223243834520027, Methylation_chr5 72594851 LOC340090 (24088): 0.9179887513131784, Methylation_chr2 242904738 LINC01238 (3421): 0.6597258841259647, Methylation_ARFGEF1: -0.3367270686373945, Methylation_MAPT: 0.4931995546696911, Methylation_ZFAT: 0.1400413727183713, Methylation_KCNQ4: -1.050081455926836, Methylation_chr1 232684368 SIPA1L2 (12934): 0.1962274276422196, Methylation_CRNKL1: -0.2741301000882727, Methylation_PRKAG2: 1.3001255644474583, Methylation_MICB: -0.4492740765446886, miRNA_hsa-mir-934: -0.2681184066329764, miRNA_hsa-mir-4728: -0.8215130766617661, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.4097379633780784, miRNA_hsa-mir-190b: 0.9475440457661596, miRNA_hsa-mir-577: 0.1796650935182576, miRNA_hsa-mir-135b: 0.1120139348441686, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.989402132909046, miRNA_hsa-mir-130b: -1.4218432845386346, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-GM-A2DN,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.2178245712653159, mRNA_C2orf54: -0.6174221494670653, mRNA_CITED4: 0.4892708131497646, mRNA_ESR1: 0.2217719418216696, mRNA_SPDEF: 0.2377952689490417, mRNA_AGR3: 0.3268618357847223, mRNA_FOXC1: -0.3510699991168914, mRNA_GATA3: 0.3374732151226787, mRNA_AGR2: 0.143191774742711, mRNA_XBP1: 0.6641297837290745, mRNA_PRR15: -0.0408696055828736, mRNA_SLC44A4: 0.7226439800228677, mRNA_CA12: -0.20026590856218, mRNA_DTL: 0.3812322479351265, mRNA_C5AR2: -0.1692669012073341, mRNA_TBC1D9: 0.1019797313549884, mRNA_AR: 0.1863017328378157, mRNA_CCDC170: 0.0609820219005572, mRNA_DEGS2: 0.086698195703123, mRNA_TFF3: 0.5103311672367541, mRNA_DNALI1: 0.6159136427855567, mRNA_LINC00504: 0.1783270926931329, mRNA_CLCA2: 1.996619775659888, mRNA_PPP1R14C: 0.7804158406755483, mRNA_THSD4: 0.0795524008904758, mRNA_SPAG5: -0.4475132732814731, mRNA_FBP1: -0.0109116812877494, mRNA_SLC7A8: -0.0725249085511519, mRNA_EN1: -0.6876074322034392, mRNA_ZNF552: -0.7676260673424092, Methylation_LRRC6: 1.000873933048752, Methylation_chr2 66218712 LINC02934 (29533): 0.7610561735203693, Methylation_HOXB13: -0.1626730246211459, Methylation_chr10 3949206 LINC02660 (4871): 0.1767125558147235, Methylation_chr5 179517140 RNF130 (18026): 0.1094685270463594, Methylation_LOC727677: 0.6042050493412269, Methylation_LETM1: 0.5538277062243285, Methylation_CDC42BPB: 0.6140241420318958, Methylation_C8orf38: 0.9754019484276218, Methylation_chr14 100504766 EVL (18852): 0.7587041093357092, Methylation_chr5 72594851 LOC340090 (24088): 0.135599331849141, Methylation_chr2 242904738 LINC01238 (3421): -0.1070927224344642, Methylation_ARFGEF1: 1.1579827081400147, Methylation_MAPT: 0.4771418680921423, Methylation_ZFAT: 0.5355347307914895, Methylation_KCNQ4: -1.162858171308731, Methylation_chr1 232684368 SIPA1L2 (12934): 0.0168649806458078, Methylation_CRNKL1: 0.6330796323905419, Methylation_PRKAG2: 0.8993401221560887, Methylation_MICB: 1.0567257925232545, miRNA_hsa-mir-934: -0.1312043627918833, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.4495413740540535, miRNA_hsa-mir-190b: 0.0140837455327862, miRNA_hsa-mir-577: -0.3298445626184432, miRNA_hsa-mir-135b: 0.4871599777892167, miRNA_hsa-mir-2115: 0.311153363252111, miRNA_hsa-mir-17: -0.4415873148715181, miRNA_hsa-mir-130b: 0.0443015161807258, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AQ-A54N,"High-level Amplification of none; Gain in VPS54, WDPCP, CEP68.  
FOXC1 mRNA overexpression (Z=2.39).  
ESR1, AGR2, XBP1, FBP1, SLC7A8 mRNAs low (Z < -1.92).  
KCNQ4 promoter hypermethylation (Z=2.03); PRKAG2, RNF130, LOC340090 hypomethylated (Z < -1.47).  
miR-18a, miR-135b upregulated (Z > 1.99); miR-190b downregulated (Z < -1.25).  
Collectively indicate luminal B phenotype with ER-pathway suppression.","mRNA_MLPH: -2.199186173914122, mRNA_C2orf54: -0.2962489566590879, mRNA_CITED4: 1.1308413397099433, mRNA_ESR1: -2.11011628515656, mRNA_SPDEF: -1.2483804552374256, mRNA_AGR3: -1.832512754670088, mRNA_FOXC1: 2.3919947232192884, mRNA_GATA3: -1.248253527692149, mRNA_AGR2: -2.3086361167548457, mRNA_XBP1: -3.0410565724599627, mRNA_PRR15: -2.631097653770638, mRNA_SLC44A4: -2.289615179535949, mRNA_CA12: -1.7177745704491556, mRNA_DTL: -0.6614134458922251, mRNA_C5AR2: -1.936863375685525, mRNA_TBC1D9: -2.084257923549929, mRNA_AR: -2.52292068625228, mRNA_CCDC170: -1.914718809168373, mRNA_DEGS2: -2.360568515269112, mRNA_TFF3: -1.7702374517238917, mRNA_DNALI1: -1.9216123379819403, mRNA_LINC00504: -1.7404848971541846, mRNA_CLCA2: -0.8950940779111158, mRNA_PPP1R14C: -0.3363055379812134, mRNA_THSD4: -2.182038092828768, mRNA_SPAG5: -0.1239097805332863, mRNA_FBP1: -2.7233544777836203, mRNA_SLC7A8: -2.9657532720122166, mRNA_EN1: 0.5002880664813601, mRNA_ZNF552: -1.5948592280170133, Methylation_LRRC6: 1.2626889486504884, Methylation_chr2 66218712 LINC02934 (29533): -1.5703261735863634, Methylation_HOXB13: -1.068919964266596, Methylation_chr10 3949206 LINC02660 (4871): 1.644118623941833, Methylation_chr5 179517140 RNF130 (18026): -1.4910454806861109, Methylation_LOC727677: 1.5134008877077012, Methylation_LETM1: 1.3445434564468566, Methylation_CDC42BPB: 0.6173195627052863, Methylation_C8orf38: 1.5872385040761343, Methylation_chr14 100504766 EVL (18852): 1.4223754061940086, Methylation_chr5 72594851 LOC340090 (24088): -1.4805147253459283, Methylation_chr2 242904738 LINC01238 (3421): 1.2058369325244007, Methylation_ARFGEF1: 1.3940427124368246, Methylation_MAPT: 1.1930584295436442, Methylation_ZFAT: 1.4011592856816355, Methylation_KCNQ4: 2.0269460229587737, Methylation_chr1 232684368 SIPA1L2 (12934): 1.534768173306, Methylation_CRNKL1: 1.1522639064225029, Methylation_PRKAG2: -1.946577742321341, Methylation_MICB: 1.264590818295202, miRNA_hsa-mir-934: 1.2889709977972692, miRNA_hsa-mir-4728: -0.4499472935299544, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 2.121030790110986, miRNA_hsa-mir-190b: -1.7049323823996498, miRNA_hsa-mir-577: 1.5299796405361084, miRNA_hsa-mir-135b: 1.7818738861771324, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.956117654410788, miRNA_hsa-mir-130b: 0.7906901013108613, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-BH-A8G0,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.746878644621985, mRNA_C2orf54: -0.5375127192517014, mRNA_CITED4: 0.7592440218604651, mRNA_ESR1: 0.1902124499933518, mRNA_SPDEF: 0.3053685786845668, mRNA_AGR3: 0.4439231825471181, mRNA_FOXC1: 0.3146593141641602, mRNA_GATA3: 0.1251223222165302, mRNA_AGR2: 0.236486628055545, mRNA_XBP1: 0.3353563895800345, mRNA_PRR15: 0.4590287106785747, mRNA_SLC44A4: 0.3542067271398391, mRNA_CA12: 0.3033238415825065, mRNA_DTL: -1.642183464567825, mRNA_C5AR2: 1.1062901098425728, mRNA_TBC1D9: 0.8607101837916544, mRNA_AR: 0.3657124354889725, mRNA_CCDC170: 0.6857682244033891, mRNA_DEGS2: 0.5674727743314525, mRNA_TFF3: 0.3952876953787833, mRNA_DNALI1: 0.15065483387325, mRNA_LINC00504: 0.6564531240426889, mRNA_CLCA2: 0.0849364056536166, mRNA_PPP1R14C: 0.1924522690305574, mRNA_THSD4: 0.5420027935533434, mRNA_SPAG5: -1.7406667205910085, mRNA_FBP1: 0.5935228647245381, mRNA_SLC7A8: 0.48461046821908, mRNA_EN1: 0.1143470017647074, mRNA_ZNF552: 0.1434221819115031, Methylation_LRRC6: 1.0687291918150483, Methylation_chr2 66218712 LINC02934 (29533): 0.6989697523088249, Methylation_HOXB13: -0.2938225537572757, Methylation_chr10 3949206 LINC02660 (4871): 0.4674383805418473, Methylation_chr5 179517140 RNF130 (18026): -0.8171744568214694, Methylation_LOC727677: 0.8462716436738817, Methylation_LETM1: 0.9573958174064668, Methylation_CDC42BPB: -0.3449541701321406, Methylation_C8orf38: 0.5174365061168454, Methylation_chr14 100504766 EVL (18852): 0.9985285556738752, Methylation_chr5 72594851 LOC340090 (24088): -0.0315872296671749, Methylation_chr2 242904738 LINC01238 (3421): 0.1422554105870569, Methylation_ARFGEF1: 1.282529963251706, Methylation_MAPT: 0.5570854239664627, Methylation_ZFAT: 0.9852087051184828, Methylation_KCNQ4: 0.0309847387537714, Methylation_chr1 232684368 SIPA1L2 (12934): 1.1349830396442715, Methylation_CRNKL1: 1.0251365761287343, Methylation_PRKAG2: 0.538524093335532, Methylation_MICB: 1.136793167234898, miRNA_hsa-mir-934: -0.1500193225837996, miRNA_hsa-mir-4728: -0.9267401486116827, miRNA_hsa-mir-5695: -0.5806978160735021, miRNA_hsa-mir-18a: -1.021679718622592, miRNA_hsa-mir-190b: -0.2616471574316873, miRNA_hsa-mir-577: -0.3741566488360383, miRNA_hsa-mir-135b: -0.2927748860967029, miRNA_hsa-mir-2115: 0.2737959867309678, miRNA_hsa-mir-17: -0.4865485512538111, miRNA_hsa-mir-130b: -1.2508670490637446, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A2-A0CK,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.2647751662757215, mRNA_C2orf54: 0.0275161603988892, mRNA_CITED4: 0.8486039540605538, mRNA_ESR1: -0.1601785702851567, mRNA_SPDEF: 0.3449948679016475, mRNA_AGR3: 0.5197821569079302, mRNA_FOXC1: 0.0315212809953112, mRNA_GATA3: 0.7706856340891571, mRNA_AGR2: 0.1948754355021359, mRNA_XBP1: 0.2092256004803284, mRNA_PRR15: 0.4270373910400812, mRNA_SLC44A4: 0.8011253762650878, mRNA_CA12: 0.464586374747831, mRNA_DTL: -0.3747064281014394, mRNA_C5AR2: 0.1819479421511551, mRNA_TBC1D9: 0.9074669925106426, mRNA_AR: 0.1387720389334665, mRNA_CCDC170: -0.4566911155544085, mRNA_DEGS2: 1.0565039883658802, mRNA_TFF3: 0.1872158698240264, mRNA_DNALI1: 0.6022750349068794, mRNA_LINC00504: 0.6908191394287045, mRNA_CLCA2: -0.647995140162582, mRNA_PPP1R14C: -0.3717724103030647, mRNA_THSD4: 0.245184414186361, mRNA_SPAG5: -0.3188395525570436, mRNA_FBP1: 0.4860359220065464, mRNA_SLC7A8: 0.2031735456634777, mRNA_EN1: -0.4387075930042317, mRNA_ZNF552: 0.0806633817761392, Methylation_LRRC6: -0.550560967488316, Methylation_chr2 66218712 LINC02934 (29533): 1.1867400978576543, Methylation_HOXB13: -1.0591459037153823, Methylation_chr10 3949206 LINC02660 (4871): -0.7720742777463527, Methylation_chr5 179517140 RNF130 (18026): 0.8660235715181306, Methylation_LOC727677: -0.6940463336079351, Methylation_LETM1: -0.9461362169821474, Methylation_CDC42BPB: 0.858056888865334, Methylation_C8orf38: -0.7411648936309456, Methylation_chr14 100504766 EVL (18852): -0.9222888131466098, Methylation_chr5 72594851 LOC340090 (24088): -0.2989228812884581, Methylation_chr2 242904738 LINC01238 (3421): -0.920267693457294, Methylation_ARFGEF1: -0.3771192453238937, Methylation_MAPT: -1.0973053977818938, Methylation_ZFAT: -0.6399124150578926, Methylation_KCNQ4: 1.3223587403223114, Methylation_chr1 232684368 SIPA1L2 (12934): -0.6780421560228441, Methylation_CRNKL1: -0.4392194614126443, Methylation_PRKAG2: -0.5151667104176695, Methylation_MICB: -0.8048878023810156, miRNA_hsa-mir-934: -0.1941008514469462, miRNA_hsa-mir-4728: -0.3385418874928138, miRNA_hsa-mir-5695: 0.0997953235492587, miRNA_hsa-mir-18a: -0.3627081803930283, miRNA_hsa-mir-190b: 0.963314333146316, miRNA_hsa-mir-577: -0.3879864753588291, miRNA_hsa-mir-135b: -0.5240336621917451, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.0671263377589401, miRNA_hsa-mir-130b: 0.6873638896052636, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-WT-AB44,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives genomic instability. miRNA hsa-mir-2115 is significantly upregulated (Z=3.66). No mRNA, methylation, or other miRNA alterations meet diagnostic thresholds. These features suggest a proliferation-rich phenotype with potential cell cycle dysregulation.","mRNA_MLPH: 1.0709130784791148, mRNA_C2orf54: -0.960249579908694, mRNA_CITED4: 0.4769640916408807, mRNA_ESR1: -0.3029708672181009, mRNA_SPDEF: 0.1154563055905937, mRNA_AGR3: 0.155450969704706, mRNA_FOXC1: -0.0699306619501202, mRNA_GATA3: -0.4484981887126442, mRNA_AGR2: -0.943468696114673, mRNA_XBP1: -1.0188666018910757, mRNA_PRR15: -0.1650677061536928, mRNA_SLC44A4: 0.5421328398387472, mRNA_CA12: -0.831337504174134, mRNA_DTL: -3.4056843393111365, mRNA_C5AR2: -1.5879514243922823, mRNA_TBC1D9: -0.8871393221905389, mRNA_AR: -0.3200701815153373, mRNA_CCDC170: -0.9588715007547924, mRNA_DEGS2: 0.6701274809957332, mRNA_TFF3: -0.559238978195647, mRNA_DNALI1: 0.103436258044634, mRNA_LINC00504: -0.3155739652663653, mRNA_CLCA2: -0.0855178666381279, mRNA_PPP1R14C: -0.7205444642816039, mRNA_THSD4: -1.457804851906172, mRNA_SPAG5: -1.900154044607902, mRNA_FBP1: -0.6732846138322427, mRNA_SLC7A8: 0.4407174008843718, mRNA_EN1: -0.0962618660467716, mRNA_ZNF552: -1.2854630200059431, Methylation_LRRC6: -0.7870561858209713, Methylation_chr2 66218712 LINC02934 (29533): 0.3277793868756961, Methylation_HOXB13: -1.039115423239393, Methylation_chr10 3949206 LINC02660 (4871): -1.0704152344020632, Methylation_chr5 179517140 RNF130 (18026): -1.2880660111011712, Methylation_LOC727677: 0.2828521663023105, Methylation_LETM1: 0.365770661454412, Methylation_CDC42BPB: -1.199645729238206, Methylation_C8orf38: -1.1177647251538252, Methylation_chr14 100504766 EVL (18852): -1.2138516036060196, Methylation_chr5 72594851 LOC340090 (24088): 0.8656128844380979, Methylation_chr2 242904738 LINC01238 (3421): -1.2628458622864325, Methylation_ARFGEF1: -0.8623585228419312, Methylation_MAPT: -1.3985469901653358, Methylation_ZFAT: -0.2778652717394648, Methylation_KCNQ4: -0.977245527810987, Methylation_chr1 232684368 SIPA1L2 (12934): -0.7613582949738589, Methylation_CRNKL1: -1.0101521782973275, Methylation_PRKAG2: 0.5437978927290532, Methylation_MICB: -0.8580556993982045, miRNA_hsa-mir-934: 0.3344437600699978, miRNA_hsa-mir-4728: -0.0803156024075887, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.3130133007263609, miRNA_hsa-mir-190b: 0.4917651228725549, miRNA_hsa-mir-577: -0.6588639796431731, miRNA_hsa-mir-135b: -0.942943436810474, miRNA_hsa-mir-2115: 3.659402130258477, miRNA_hsa-mir-17: -0.2257443646491978, miRNA_hsa-mir-130b: -0.2380002376932367, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-AR-A0TQ,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression.  
miR-4728 is upregulated (Z=2.86).  
No promoter hyper/hypomethylation or mRNA outliers meet diagnostic thresholds.  
These features suggest a proliferative phenotype with genomic instability.","mRNA_MLPH: 0.7255008981249598, mRNA_C2orf54: 0.9514686855031484, mRNA_CITED4: 1.1410885779589606, mRNA_ESR1: -0.092431933084104, mRNA_SPDEF: 0.6485472870863108, mRNA_AGR3: 0.590299723484966, mRNA_FOXC1: -0.2750672470599689, mRNA_GATA3: 0.967790944516069, mRNA_AGR2: 0.0152209456357678, mRNA_XBP1: 0.6210529498018714, mRNA_PRR15: 0.5184682590293253, mRNA_SLC44A4: 0.1135406236941688, mRNA_CA12: 0.7240302876234398, mRNA_DTL: 0.2766508237460119, mRNA_C5AR2: -0.1332023396710362, mRNA_TBC1D9: 0.8328149895391478, mRNA_AR: -0.7064387419470503, mRNA_CCDC170: 0.2691555645175341, mRNA_DEGS2: 0.1610103769244219, mRNA_TFF3: 0.1591343375335233, mRNA_DNALI1: 0.3508971541730447, mRNA_LINC00504: 0.4539741727173584, mRNA_CLCA2: -0.8252819966832498, mRNA_PPP1R14C: -0.8617404286848229, mRNA_THSD4: 1.239871572855887, mRNA_SPAG5: 1.5249644443301944, mRNA_FBP1: 1.09995292963255, mRNA_SLC7A8: -1.0167864061780685, mRNA_EN1: -0.9195281312387898, mRNA_ZNF552: 1.431312714850112, Methylation_LRRC6: 0.199959222088645, Methylation_chr2 66218712 LINC02934 (29533): 1.3538869430245557, Methylation_HOXB13: 1.4078154531384277, Methylation_chr10 3949206 LINC02660 (4871): 0.0809862062283376, Methylation_chr5 179517140 RNF130 (18026): 0.6163610349067503, Methylation_LOC727677: 0.7237413982756427, Methylation_LETM1: -0.1649812400458466, Methylation_CDC42BPB: 0.9701713749973384, Methylation_C8orf38: 1.17058586451162, Methylation_chr14 100504766 EVL (18852): 0.2048892897208013, Methylation_chr5 72594851 LOC340090 (24088): 0.5601748421972279, Methylation_chr2 242904738 LINC01238 (3421): 1.3338029422929356, Methylation_ARFGEF1: 0.2204806331689134, Methylation_MAPT: 1.229756812582461, Methylation_ZFAT: -0.5309011413221343, Methylation_KCNQ4: 0.1705540478621657, Methylation_chr1 232684368 SIPA1L2 (12934): 0.4300936678955944, Methylation_CRNKL1: 0.4290331333322349, Methylation_PRKAG2: -0.5452432013755623, Methylation_MICB: 0.3223904987770476, miRNA_hsa-mir-934: -0.2523319509368746, miRNA_hsa-mir-4728: 2.8572984624714604, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.0885806521667812, miRNA_hsa-mir-190b: -0.8920071342408824, miRNA_hsa-mir-577: 0.4030271667621105, miRNA_hsa-mir-135b: -0.2844998661755293, miRNA_hsa-mir-2115: -0.1406321839444348, miRNA_hsa-mir-17: -0.1562796110869141, miRNA_hsa-mir-130b: 0.113336675284749, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-E2-A1L9,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.4621128604119633, mRNA_C2orf54: 0.473632042260259, mRNA_CITED4: 0.1479872250737665, mRNA_ESR1: 0.521562292926686, mRNA_SPDEF: 0.2071120669666575, mRNA_AGR3: 0.6143705356996091, mRNA_FOXC1: -0.0382602818888454, mRNA_GATA3: 0.7691019425455492, mRNA_AGR2: 0.0991587379863044, mRNA_XBP1: 0.5538839023371184, mRNA_PRR15: -0.309309952142868, mRNA_SLC44A4: 0.3312567096846249, mRNA_CA12: -0.0361015229554687, mRNA_DTL: -0.1864297822003519, mRNA_C5AR2: 0.3435416388334547, mRNA_TBC1D9: 0.1586198060495326, mRNA_AR: 0.653305020770585, mRNA_CCDC170: 0.7904066633871073, mRNA_DEGS2: 0.2697600398007139, mRNA_TFF3: 0.2943959413033328, mRNA_DNALI1: 0.8459844347079865, mRNA_LINC00504: 0.9011944522655834, mRNA_CLCA2: 1.2846459092229932, mRNA_PPP1R14C: 0.2430908198739144, mRNA_THSD4: -0.2954391503694994, mRNA_SPAG5: -0.5017238003973542, mRNA_FBP1: 0.4237035835225062, mRNA_SLC7A8: 0.3314835286455662, mRNA_EN1: 0.43278350993442, mRNA_ZNF552: 0.0975760137943137, Methylation_LRRC6: -0.3120464257707702, Methylation_chr2 66218712 LINC02934 (29533): 1.0023687741132576, Methylation_HOXB13: -1.075247034420706, Methylation_chr10 3949206 LINC02660 (4871): -0.6416380109393546, Methylation_chr5 179517140 RNF130 (18026): -0.5514164994397421, Methylation_LOC727677: 0.3145712342839624, Methylation_LETM1: -0.2534423340839229, Methylation_CDC42BPB: -0.8096558442908172, Methylation_C8orf38: -0.024799430841139, Methylation_chr14 100504766 EVL (18852): -0.8752472752621997, Methylation_chr5 72594851 LOC340090 (24088): -0.4084631770545235, Methylation_chr2 242904738 LINC01238 (3421): 0.0342991357697281, Methylation_ARFGEF1: -0.058987872211189, Methylation_MAPT: -0.6854812492143517, Methylation_ZFAT: 0.623357220012845, Methylation_KCNQ4: 0.8749348829091403, Methylation_chr1 232684368 SIPA1L2 (12934): -0.7038746009086708, Methylation_CRNKL1: -0.281190452734594, Methylation_PRKAG2: 1.0420793221991065, Methylation_MICB: -0.2850135800986796, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.174368254697526, miRNA_hsa-mir-5695: 0.4258279089404456, miRNA_hsa-mir-18a: 0.0832803363518008, miRNA_hsa-mir-190b: 1.5055399629438786, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.1983243640611818, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.2558055306978502, miRNA_hsa-mir-130b: 0.4242409091876504, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A8FY,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 1.2305706055339836, mRNA_C2orf54: -1.236892322358362, mRNA_CITED4: -0.3039599474860738, mRNA_ESR1: 0.7133541583827179, mRNA_SPDEF: 0.5737634707584867, mRNA_AGR3: 0.9399968202155092, mRNA_FOXC1: -0.515003154462857, mRNA_GATA3: 0.2661440815315667, mRNA_AGR2: 0.0831503296393969, mRNA_XBP1: 1.009837549921318, mRNA_PRR15: 0.8487943437578739, mRNA_SLC44A4: 0.6569608895065525, mRNA_CA12: 0.5379652430341184, mRNA_DTL: -0.0882483274775352, mRNA_C5AR2: 0.7356836182034358, mRNA_TBC1D9: 0.631048176610661, mRNA_AR: 0.27542843752817, mRNA_CCDC170: 0.9715134259928632, mRNA_DEGS2: 1.236203032999029, mRNA_TFF3: 0.7900018422082008, mRNA_DNALI1: 1.065201742127507, mRNA_LINC00504: 0.2031774640092072, mRNA_CLCA2: -0.7729003750448605, mRNA_PPP1R14C: -0.7950181301286646, mRNA_THSD4: 0.5867554171221999, mRNA_SPAG5: -0.1650868523911088, mRNA_FBP1: 0.3552937482956491, mRNA_SLC7A8: 0.7420097068979281, mRNA_EN1: -0.8273541188794415, mRNA_ZNF552: 0.3930464020377597, Methylation_LRRC6: -1.3011990281687955, Methylation_chr2 66218712 LINC02934 (29533): -1.7082797484917582, Methylation_HOXB13: -0.6515943429833099, Methylation_chr10 3949206 LINC02660 (4871): -1.2762135971569808, Methylation_chr5 179517140 RNF130 (18026): 1.2409521137328077, Methylation_LOC727677: -1.357512884226997, Methylation_LETM1: -1.4619641201561442, Methylation_CDC42BPB: -0.310591500931608, Methylation_C8orf38: -1.2689261577172344, Methylation_chr14 100504766 EVL (18852): -1.551965482795807, Methylation_chr5 72594851 LOC340090 (24088): 0.7532583229774702, Methylation_chr2 242904738 LINC01238 (3421): -1.3233341460457664, Methylation_ARFGEF1: -1.116850382447528, Methylation_MAPT: -1.2641966195622214, Methylation_ZFAT: -1.369069533265872, Methylation_KCNQ4: 0.0719759289263623, Methylation_chr1 232684368 SIPA1L2 (12934): -1.1039849041303471, Methylation_CRNKL1: -1.5876158870048571, Methylation_PRKAG2: 1.30598579759553, Methylation_MICB: -1.3826201067126398, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.1445691325491863, miRNA_hsa-mir-5695: -0.0884397968484709, miRNA_hsa-mir-18a: -0.5986374942629299, miRNA_hsa-mir-190b: 1.4966037821460416, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.100418128518801, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.5245077382498737, miRNA_hsa-mir-130b: 0.2381196939336957, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A8-A08O,"High-level Amplification of none; Deletion of VPS54, LINC01867, LINC02576, WDPCP, and CEP68. No mRNA meets high/low thresholds. No methylation sites meet hyper/hypo-methylation criteria. miRNA hsa-mir-17 is downregulated (Z = -1.24). Insufficient drivers for subtype classification.","mRNA_MLPH: 0.4768247652550055, mRNA_C2orf54: -1.2077509348353894, mRNA_CITED4: 0.1558082121578622, mRNA_ESR1: 0.3414565851859185, mRNA_SPDEF: 0.3943982614936259, mRNA_AGR3: 0.6003851788631467, mRNA_FOXC1: -0.0876240557111281, mRNA_GATA3: 0.7556521515312641, mRNA_AGR2: 0.8609024573967728, mRNA_XBP1: 0.5656337076725616, mRNA_PRR15: 0.8707816024603494, mRNA_SLC44A4: 0.2575653423025158, mRNA_CA12: 1.0077508364277574, mRNA_DTL: -0.0541869291362053, mRNA_C5AR2: 0.7991963626629769, mRNA_TBC1D9: 0.7205270332964725, mRNA_AR: 0.4488927208420333, mRNA_CCDC170: 0.119337846276373, mRNA_DEGS2: 0.6232582323909281, mRNA_TFF3: 0.5345721300685554, mRNA_DNALI1: 1.0116614460540865, mRNA_LINC00504: 1.0846842500669704, mRNA_CLCA2: -0.5339003929457844, mRNA_PPP1R14C: 0.246376950699004, mRNA_THSD4: 1.3425704213310412, mRNA_SPAG5: 0.4551252629879364, mRNA_FBP1: 0.3625503309297745, mRNA_SLC7A8: 0.1241428505365676, mRNA_EN1: -0.0886517812604603, mRNA_ZNF552: 1.276668046224115, Methylation_LRRC6: -0.5801379691850311, Methylation_chr2 66218712 LINC02934 (29533): -1.355773283181273, Methylation_HOXB13: -0.5774909042686384, Methylation_chr10 3949206 LINC02660 (4871): -0.4880619896809076, Methylation_chr5 179517140 RNF130 (18026): 0.9022089728087774, Methylation_LOC727677: -1.0268797828342873, Methylation_LETM1: -1.2438228550853836, Methylation_CDC42BPB: 1.2663740923386595, Methylation_C8orf38: 0.5968356267164766, Methylation_chr14 100504766 EVL (18852): -1.0587434991706406, Methylation_chr5 72594851 LOC340090 (24088): 0.7395084054721398, Methylation_chr2 242904738 LINC01238 (3421): -0.828297938295762, Methylation_ARFGEF1: -0.645568703615763, Methylation_MAPT: -0.9659229551516476, Methylation_ZFAT: -0.8872421570943927, Methylation_KCNQ4: -1.1509952319898424, Methylation_chr1 232684368 SIPA1L2 (12934): -0.6057463152074326, Methylation_CRNKL1: -0.5812781812825231, Methylation_PRKAG2: 1.3315820984074045, Methylation_MICB: -0.3886405746891311, miRNA_hsa-mir-934: 0.2577575852889838, miRNA_hsa-mir-4728: -0.078900976093335, miRNA_hsa-mir-5695: 1.2845210434962036, miRNA_hsa-mir-18a: -0.447547526971507, miRNA_hsa-mir-190b: 0.581707252165955, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: 0.0256970420852158, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.242039306829522, miRNA_hsa-mir-130b: 0.5670485443073643, CNV_VPS54: -1.6173912818721974, CNV_LINC01867: -1.63714039509435, CNV_LINC02576: -1.657048777669473, CNV_WDPCP: -1.6249341592372952, CNV_CEP68: -1.657048777669473"
TCGA-D8-A1XF,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. CITED4 mRNA is low (Z = -2.89). Hypermethylation at C8orf38 and KCNQ4; hypomethylation at ARFGEF1, MAPT, ZFAT, CRNKL1, and PRKAG2. miR-17 upregulated (Z = 1.80). These features indicate a basal-like phenotype with PI3K/AKT dysregulation.","mRNA_MLPH: 0.2069482103044483, mRNA_C2orf54: -1.250516376234931, mRNA_CITED4: -2.888487949477901, mRNA_ESR1: 0.5867435019682533, mRNA_SPDEF: 0.1048473332375619, mRNA_AGR3: 0.0547831226308644, mRNA_FOXC1: -1.186602553610383, mRNA_GATA3: 0.6667937043604661, mRNA_AGR2: -1.0172002736842565, mRNA_XBP1: 0.7367771554427827, mRNA_PRR15: 1.1988117330588337, mRNA_SLC44A4: 0.2293155978121316, mRNA_CA12: -0.0431647203100781, mRNA_DTL: 1.8063498636573223, mRNA_C5AR2: 0.3169498074615843, mRNA_TBC1D9: 0.3730593847046847, mRNA_AR: -0.7427682799782327, mRNA_CCDC170: 0.2259784262143573, mRNA_DEGS2: 0.3226119562814417, mRNA_TFF3: -0.2835513426572572, mRNA_DNALI1: 0.4751431537052819, mRNA_LINC00504: -0.604475206809177, mRNA_CLCA2: -0.7927893171443791, mRNA_PPP1R14C: -0.5285133224726115, mRNA_THSD4: 0.4858761189539624, mRNA_SPAG5: 1.466107819015766, mRNA_FBP1: 0.7403655838375015, mRNA_SLC7A8: 0.3491206763802069, mRNA_EN1: -1.0228028947060503, mRNA_ZNF552: 0.182557701346627, Methylation_LRRC6: -1.5044619133159078, Methylation_chr2 66218712 LINC02934 (29533): 1.351681350943402, Methylation_HOXB13: 1.41271118070058, Methylation_chr10 3949206 LINC02660 (4871): -1.3535276524754198, Methylation_chr5 179517140 RNF130 (18026): 1.1462474287989148, Methylation_LOC727677: -0.9524900078739048, Methylation_LETM1: -1.2601510813786183, Methylation_CDC42BPB: 1.4011129107315132, Methylation_C8orf38: 1.536780231036091, Methylation_chr14 100504766 EVL (18852): -1.4443060334449638, Methylation_chr5 72594851 LOC340090 (24088): 1.0895217855558403, Methylation_chr2 242904738 LINC01238 (3421): 1.432613080850042, Methylation_ARFGEF1: -1.55721377989802, Methylation_MAPT: -1.62404002057272, Methylation_ZFAT: -1.569536489964566, Methylation_KCNQ4: 1.4831363513253173, Methylation_chr1 232684368 SIPA1L2 (12934): -1.264517013173366, Methylation_CRNKL1: -1.7328823273997165, Methylation_PRKAG2: -1.85181439759257, Methylation_MICB: 0.934063752744313, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.098828336078468, miRNA_hsa-mir-5695: 0.4287527334768495, miRNA_hsa-mir-18a: 1.0812489810319998, miRNA_hsa-mir-190b: 0.9277116561554636, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: 0.7201550739923596, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.803577981190644, miRNA_hsa-mir-130b: 1.1705729428941911, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-E2-A1LA,mRNA_CITED4 is highly expressed (Z=1.42). Methylation at chr5:72594851 is hypo-methylated (Z=-1.52). No miRNAs meet dysregulation thresholds. All CNVs fall within normal range. These features suggest luminal A phenotype with intact genomic stability and moderate transcriptional activity.,"mRNA_MLPH: 0.43378045597967, mRNA_C2orf54: -1.242552246091957, mRNA_CITED4: 1.4165892754788303, mRNA_ESR1: 0.3746874221157509, mRNA_SPDEF: 0.2966348818122143, mRNA_AGR3: 0.8168373895975584, mRNA_FOXC1: -0.8525787526469126, mRNA_GATA3: 0.4298053312777047, mRNA_AGR2: 0.5341366754704432, mRNA_XBP1: 0.1658952667177525, mRNA_PRR15: 0.5155751371122308, mRNA_SLC44A4: 0.0064606843156451, mRNA_CA12: 0.2158344515937568, mRNA_DTL: 0.787897231403064, mRNA_C5AR2: 0.32387293743689, mRNA_TBC1D9: -0.0830872307128556, mRNA_AR: 0.0520980246655819, mRNA_CCDC170: 0.3399323285392974, mRNA_DEGS2: 0.4068537596929626, mRNA_TFF3: -0.0975515066067149, mRNA_DNALI1: 0.5070265659974198, mRNA_LINC00504: 0.4848711522821661, mRNA_CLCA2: -0.7035829749255428, mRNA_PPP1R14C: -0.1777042477611362, mRNA_THSD4: -0.0047639496208885, mRNA_SPAG5: 0.1089496425203793, mRNA_FBP1: 0.6196642973810645, mRNA_SLC7A8: 0.341179035650774, mRNA_EN1: 0.0209308224907405, mRNA_ZNF552: 0.7800982768771652, Methylation_LRRC6: -0.322665482541202, Methylation_chr2 66218712 LINC02934 (29533): -0.5622936927603035, Methylation_HOXB13: -1.0930554641716614, Methylation_chr10 3949206 LINC02660 (4871): -0.2795123924101841, Methylation_chr5 179517140 RNF130 (18026): 0.0781558096943492, Methylation_LOC727677: -0.7814281091688037, Methylation_LETM1: -0.5193117593917894, Methylation_CDC42BPB: 0.9116270957500467, Methylation_C8orf38: -0.441555362377721, Methylation_chr14 100504766 EVL (18852): 0.0582571396945976, Methylation_chr5 72594851 LOC340090 (24088): -1.5214555473630638, Methylation_chr2 242904738 LINC01238 (3421): -0.563359559892738, Methylation_ARFGEF1: -0.0379161611424299, Methylation_MAPT: -0.8499422665341639, Methylation_ZFAT: -0.8609831949813717, Methylation_KCNQ4: 0.8023901697169993, Methylation_chr1 232684368 SIPA1L2 (12934): 0.9768567750644942, Methylation_CRNKL1: -0.0164519951631329, Methylation_PRKAG2: -0.6744416031467649, Methylation_MICB: 0.0780100081449897, miRNA_hsa-mir-934: -0.2845083924554748, miRNA_hsa-mir-4728: -1.0431811116757153, miRNA_hsa-mir-5695: 0.8913274262601734, miRNA_hsa-mir-18a: -0.0224481529585411, miRNA_hsa-mir-190b: 0.571341186267239, miRNA_hsa-mir-577: -0.1781832281730074, miRNA_hsa-mir-135b: -0.3880722141136961, miRNA_hsa-mir-2115: -0.4179558888982455, miRNA_hsa-mir-17: -0.1922534708280278, miRNA_hsa-mir-130b: 0.461912602124125, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A1XJ,"High-level Amplification absent; Gain observed in VPS54, LINC01867, LINC02576, WDPCP, CEP68. mRNA_C2orf54 highly expressed (Z=2.72). Hypomethylation at PRKAG2, LOC340090, LINC02934 promoters (Z < -1.47). miRNA_hsa-mir-4728 upregulated (Z=2.05); miRNA_hsa-mir-135b downregulated (Z=-1.25). No deletions or hypermethylated loci meet thresholds.","mRNA_MLPH: -0.0022479571620228, mRNA_C2orf54: 2.719059164023367, mRNA_CITED4: -0.4576663971676651, mRNA_ESR1: 0.4748042663117566, mRNA_SPDEF: 0.6026460482814888, mRNA_AGR3: 0.3142127799529879, mRNA_FOXC1: -0.4190212926354353, mRNA_GATA3: -0.1715353937744894, mRNA_AGR2: 0.4678720062068472, mRNA_XBP1: 0.7250146729766928, mRNA_PRR15: 0.1630389107143335, mRNA_SLC44A4: 0.6410716685818232, mRNA_CA12: 0.5067777582680547, mRNA_DTL: 1.028484333590981, mRNA_C5AR2: 0.2259393137257124, mRNA_TBC1D9: -0.3565877843312983, mRNA_AR: 0.6708820897500851, mRNA_CCDC170: -0.1504372641646549, mRNA_DEGS2: -0.2064387402042228, mRNA_TFF3: 0.3206400706288285, mRNA_DNALI1: 0.5625537482920479, mRNA_LINC00504: -0.9051662650844976, mRNA_CLCA2: 0.1092459185950138, mRNA_PPP1R14C: -0.1169279859773163, mRNA_THSD4: -0.1914669955527669, mRNA_SPAG5: 0.9355601921934572, mRNA_FBP1: 0.1117395042761869, mRNA_SLC7A8: 0.1531845071325224, mRNA_EN1: -0.1786297984343981, mRNA_ZNF552: -0.1760347784535548, Methylation_LRRC6: -1.0165129823867851, Methylation_chr2 66218712 LINC02934 (29533): -1.5181878410425318, Methylation_HOXB13: 0.8102919432244917, Methylation_chr10 3949206 LINC02660 (4871): 1.397653564364958, Methylation_chr5 179517140 RNF130 (18026): 0.5720451092086978, Methylation_LOC727677: 0.3018703464457092, Methylation_LETM1: 0.999406672560021, Methylation_CDC42BPB: 0.1556494224457456, Methylation_C8orf38: -1.1317339301499465, Methylation_chr14 100504766 EVL (18852): -1.1648326942206384, Methylation_chr5 72594851 LOC340090 (24088): -1.531374567832022, Methylation_chr2 242904738 LINC01238 (3421): 1.4526390530131472, Methylation_ARFGEF1: -0.3452553620968736, Methylation_MAPT: 1.1826932897491884, Methylation_ZFAT: 0.0281095566363025, Methylation_KCNQ4: 0.7395813295916448, Methylation_chr1 232684368 SIPA1L2 (12934): -0.1331308136280365, Methylation_CRNKL1: 1.0178581517190248, Methylation_PRKAG2: -1.5794702913108232, Methylation_MICB: 1.4009741905080728, miRNA_hsa-mir-934: -0.0950024300768778, miRNA_hsa-mir-4728: 2.05000537935102, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.1063376423402282, miRNA_hsa-mir-190b: 1.845596290076872, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.005557305099058, miRNA_hsa-mir-130b: -0.357215088350057, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-D8-A1JT,"High-level Amplification of none; no CNV meets amplification thresholds.  
Methylation_MAPT, Methylation_CRNKL1, and Methylation_PRKAG2 are hypermethylated (Z < -1.47), suggesting epigenetic silencing.  
miRNA_hsa-mir-5695 is upregulated (Z > 1.99).  
No mRNA meets high/low thresholds.  
Collectively indicates a luminal-like phenotype with MAPT pathway dysregulation.","mRNA_MLPH: 0.5671707489303666, mRNA_C2orf54: -1.21115906056667, mRNA_CITED4: 0.7558534482800571, mRNA_ESR1: 0.9714138256603352, mRNA_SPDEF: 0.091398086217483, mRNA_AGR3: 0.9815411719165392, mRNA_FOXC1: -0.7820496490219193, mRNA_GATA3: 1.1633079789708367, mRNA_AGR2: -0.0838237974835492, mRNA_XBP1: 0.9602263882812616, mRNA_PRR15: 0.8427059134942386, mRNA_SLC44A4: 0.4520619912842815, mRNA_CA12: 0.9567607258689532, mRNA_DTL: 0.8715506134352803, mRNA_C5AR2: 0.2485918347407275, mRNA_TBC1D9: 1.3766493852218695, mRNA_AR: -0.544326368838433, mRNA_CCDC170: 0.620107323393575, mRNA_DEGS2: 0.8867922617453402, mRNA_TFF3: 0.077622885781815, mRNA_DNALI1: 0.7674472084427709, mRNA_LINC00504: 0.7591311551789047, mRNA_CLCA2: -0.2524791498266634, mRNA_PPP1R14C: -0.0987988923016047, mRNA_THSD4: 0.2687407389719348, mRNA_SPAG5: 0.0643124770075544, mRNA_FBP1: 1.456801166991767, mRNA_SLC7A8: 1.295662870278358, mRNA_EN1: -0.8314464610531329, mRNA_ZNF552: 1.1776066356839177, Methylation_LRRC6: -1.6468032582021015, Methylation_chr2 66218712 LINC02934 (29533): -1.0084113140450832, Methylation_HOXB13: -0.999253650112868, Methylation_chr10 3949206 LINC02660 (4871): -1.1312114633652566, Methylation_chr5 179517140 RNF130 (18026): 1.2719894705867572, Methylation_LOC727677: 1.3709916303416367, Methylation_LETM1: -1.648393422462303, Methylation_CDC42BPB: 1.2353668144119956, Methylation_C8orf38: -1.385523578019296, Methylation_chr14 100504766 EVL (18852): -1.4765277708795064, Methylation_chr5 72594851 LOC340090 (24088): 0.769189620551768, Methylation_chr2 242904738 LINC01238 (3421): -1.4125727000484434, Methylation_ARFGEF1: -0.9124766984596022, Methylation_MAPT: -1.7997931941650869, Methylation_ZFAT: -0.5739391415462493, Methylation_KCNQ4: -1.135149117651946, Methylation_chr1 232684368 SIPA1L2 (12934): -1.1176328397770654, Methylation_CRNKL1: -1.7826633509214942, Methylation_PRKAG2: -1.847763196164937, Methylation_MICB: -0.9617325491362224, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.50816511826647, miRNA_hsa-mir-5695: 3.4948188384996604, miRNA_hsa-mir-18a: -0.6016230615509605, miRNA_hsa-mir-190b: 1.29502829067612, miRNA_hsa-mir-577: 0.8740823087732995, miRNA_hsa-mir-135b: -0.7909933492955887, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.2905744831083285, miRNA_hsa-mir-130b: 0.7339583499071168, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A229,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations.","mRNA_MLPH: 0.3210847779949282, mRNA_C2orf54: 0.3847295812227825, mRNA_CITED4: 0.3281005399361966, mRNA_ESR1: 0.0924748285163385, mRNA_SPDEF: 0.2382728407994442, mRNA_AGR3: 0.4611012917217479, mRNA_FOXC1: -0.5682452011180276, mRNA_GATA3: 0.3482292672905347, mRNA_AGR2: 0.4366984857713747, mRNA_XBP1: 0.0232666303194317, mRNA_PRR15: 0.1999661841921475, mRNA_SLC44A4: 0.4362916501658438, mRNA_CA12: 0.7015687239607543, mRNA_DTL: 0.4465829613085578, mRNA_C5AR2: 1.3655172089263825, mRNA_TBC1D9: 0.4865038320034814, mRNA_AR: 0.701290305323937, mRNA_CCDC170: 0.2936814601368668, mRNA_DEGS2: -0.1375082387319638, mRNA_TFF3: 0.8144231184554279, mRNA_DNALI1: 0.9083108371958856, mRNA_LINC00504: 1.1082667126697667, mRNA_CLCA2: -0.1103171042120984, mRNA_PPP1R14C: 0.0438160010020418, mRNA_THSD4: 0.7414396793967939, mRNA_SPAG5: 0.4295521548364639, mRNA_FBP1: -0.5028553005559953, mRNA_SLC7A8: 0.3996035751926455, mRNA_EN1: 0.2556618178517037, mRNA_ZNF552: 0.7896233490418356, Methylation_LRRC6: 0.1408653686481474, Methylation_chr2 66218712 LINC02934 (29533): -0.925059024818236, Methylation_HOXB13: -0.8824726424459356, Methylation_chr10 3949206 LINC02660 (4871): -0.5415868625965435, Methylation_chr5 179517140 RNF130 (18026): 0.4597523943971988, Methylation_LOC727677: -0.3188116872933094, Methylation_LETM1: -0.1531858911957163, Methylation_CDC42BPB: -0.9545798667659388, Methylation_C8orf38: -0.7227302572431265, Methylation_chr14 100504766 EVL (18852): -0.1941781534369673, Methylation_chr5 72594851 LOC340090 (24088): 0.5542924682504415, Methylation_chr2 242904738 LINC01238 (3421): -0.7470429056444469, Methylation_ARFGEF1: -0.079452553649345, Methylation_MAPT: -0.2162024524689483, Methylation_ZFAT: -0.0447126154988555, Methylation_KCNQ4: -1.2319260464971116, Methylation_chr1 232684368 SIPA1L2 (12934): -0.6688429437179516, Methylation_CRNKL1: 0.0457775622871499, Methylation_PRKAG2: 0.814486856528105, Methylation_MICB: -0.7015278267087459, miRNA_hsa-mir-934: -0.2545072447096508, miRNA_hsa-mir-4728: 0.0589588891443937, miRNA_hsa-mir-5695: 0.2650893626850308, miRNA_hsa-mir-18a: -0.1103312198031356, miRNA_hsa-mir-190b: 0.771578816128954, miRNA_hsa-mir-577: 0.1199591065471742, miRNA_hsa-mir-135b: -0.207854437117111, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.2676339886678147, miRNA_hsa-mir-130b: -0.2035314775728531, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A1Y0,"No features meet the strict diagnostic thresholds for mRNA (Z > 1.30 or Z < -1.92), methylation (Z > 1.50 or Z < -1.47), miRNA (Z > 1.99 or Z < -1.25), or CNV (deletion, gain, amplification, or high-level amplification). All values fall within non-significant ranges.","mRNA_MLPH: 0.2135270952708133, mRNA_C2orf54: -0.00451440415234, mRNA_CITED4: 0.1203717041398945, mRNA_ESR1: 0.7878533260769921, mRNA_SPDEF: 0.4634624106469759, mRNA_AGR3: 0.6294249667216849, mRNA_FOXC1: -0.072329536859506, mRNA_GATA3: 0.2775402356990386, mRNA_AGR2: 0.8097793176301163, mRNA_XBP1: -0.0175777895156459, mRNA_PRR15: 0.3440098182943, mRNA_SLC44A4: 0.8289625272009142, mRNA_CA12: 0.959581656205505, mRNA_DTL: 1.5822024035512896, mRNA_C5AR2: 0.3219854423338887, mRNA_TBC1D9: 0.9711000078064054, mRNA_AR: 0.9049565199559928, mRNA_CCDC170: -0.0863294872062683, mRNA_DEGS2: 0.3325212484596576, mRNA_TFF3: -0.3227648081025142, mRNA_DNALI1: 0.4902984389396724, mRNA_LINC00504: 0.3451079988864838, mRNA_CLCA2: -0.8075177560170455, mRNA_PPP1R14C: -0.6977315579542219, mRNA_THSD4: 0.2751277184564339, mRNA_SPAG5: 0.7994440921480186, mRNA_FBP1: 0.7281194491443987, mRNA_SLC7A8: 0.3231771092325523, mRNA_EN1: -0.8374218397964343, mRNA_ZNF552: 1.1522148809895976, Methylation_LRRC6: -0.496324518987464, Methylation_chr2 66218712 LINC02934 (29533): -1.4681180197406825, Methylation_HOXB13: 0.2216491261119705, Methylation_chr10 3949206 LINC02660 (4871): 0.3768841811429761, Methylation_chr5 179517140 RNF130 (18026): 0.794152011068578, Methylation_LOC727677: -0.7653317752813622, Methylation_LETM1: -0.4202454130411095, Methylation_CDC42BPB: 0.946211034975914, Methylation_C8orf38: -0.2096261043789912, Methylation_chr14 100504766 EVL (18852): 0.8335841643431212, Methylation_chr5 72594851 LOC340090 (24088): 0.5106417133985176, Methylation_chr2 242904738 LINC01238 (3421): -0.7667298385025598, Methylation_ARFGEF1: -0.780781666163558, Methylation_MAPT: -0.4033928268154104, Methylation_ZFAT: 0.0443656352217594, Methylation_KCNQ4: -0.449288219027726, Methylation_chr1 232684368 SIPA1L2 (12934): -0.6137289491248363, Methylation_CRNKL1: -0.4162394012842068, Methylation_PRKAG2: 0.964626797860028, Methylation_MICB: -0.1562858044057812, miRNA_hsa-mir-934: -0.0277281468937598, miRNA_hsa-mir-4728: -0.1494049081088606, miRNA_hsa-mir-5695: 1.4178076563433528, miRNA_hsa-mir-18a: 0.0123769092652274, miRNA_hsa-mir-190b: 0.8782941849258914, miRNA_hsa-mir-577: 0.6774499085584826, miRNA_hsa-mir-135b: -0.3046469949254906, miRNA_hsa-mir-2115: -0.3127893908318661, miRNA_hsa-mir-17: -0.350887813973981, miRNA_hsa-mir-130b: 0.4501769946646001, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A0HI,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.4934292945820652, mRNA_C2orf54: -0.7080750018342827, mRNA_CITED4: 0.2275499283579784, mRNA_ESR1: 0.9456182966693836, mRNA_SPDEF: 0.5007113406406346, mRNA_AGR3: 0.9347262148715302, mRNA_FOXC1: -0.3753219814594944, mRNA_GATA3: 0.593235597966124, mRNA_AGR2: 0.745745393274324, mRNA_XBP1: 1.5055224690077649, mRNA_PRR15: 0.6845758479463656, mRNA_SLC44A4: 0.8316946122306065, mRNA_CA12: 0.7983150633602687, mRNA_DTL: -0.6191163676249887, mRNA_C5AR2: 1.142719621895895, mRNA_TBC1D9: 0.9888192068721992, mRNA_AR: 0.8652525968246025, mRNA_CCDC170: 1.1518596346163097, mRNA_DEGS2: 0.8954750656653389, mRNA_TFF3: 0.7517841215970082, mRNA_DNALI1: 0.7466536448786969, mRNA_LINC00504: 0.67919194261913, mRNA_CLCA2: -0.7856585220816651, mRNA_PPP1R14C: -0.7017603914369607, mRNA_THSD4: 0.7361020166569346, mRNA_SPAG5: -0.8862757120458696, mRNA_FBP1: 0.5866313574652424, mRNA_SLC7A8: 0.7311126370321993, mRNA_EN1: -0.3041054466872012, mRNA_ZNF552: 1.2468447028921166, Methylation_LRRC6: -0.131062289704192, Methylation_chr2 66218712 LINC02934 (29533): 1.2710114923933238, Methylation_HOXB13: -0.8581678589468656, Methylation_chr10 3949206 LINC02660 (4871): -0.6312416986006242, Methylation_chr5 179517140 RNF130 (18026): 0.7864154061133284, Methylation_LOC727677: -0.6307085004414787, Methylation_LETM1: -0.8124600080639423, Methylation_CDC42BPB: -1.1785533169685227, Methylation_C8orf38: -0.4506610793488471, Methylation_chr14 100504766 EVL (18852): -0.3801831503832324, Methylation_chr5 72594851 LOC340090 (24088): 0.1727089883749728, Methylation_chr2 242904738 LINC01238 (3421): -0.6582390382454458, Methylation_ARFGEF1: -0.8125699118237496, Methylation_MAPT: -0.7687273679433574, Methylation_ZFAT: -0.174519997796238, Methylation_KCNQ4: -1.035944584726331, Methylation_chr1 232684368 SIPA1L2 (12934): -1.0523873406630997, Methylation_CRNKL1: -0.323336687617426, Methylation_PRKAG2: 1.0171459194823635, Methylation_MICB: -0.1304740274741682, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.917566046407756, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.4014640188325958, miRNA_hsa-mir-190b: 0.8938178877510146, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.1920201178529138, miRNA_hsa-mir-2115: 0.0400581594448435, miRNA_hsa-mir-17: -1.3547861280583553, miRNA_hsa-mir-130b: -0.5126413144538448, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-S3-AA0Z,"High-level Amplification absent; no CNV alterations meet diagnostic thresholds.  
FOXC1 and SPAG5 mRNA overexpression (Z > 1.30) without clear genomic drivers.  
SPDEF, AGR2, XBP1, PRR15, TFF3, DNALI1 significantly downregulated (Z < -1.92).  
No methylation or miRNA alterations meet diagnostic criteria.  
Transcriptional profile suggests luminal B-like phenotype with ER-pathway suppression.","mRNA_MLPH: -1.5141268671497068, mRNA_C2orf54: -0.8106235449012046, mRNA_CITED4: 0.4076508404960647, mRNA_ESR1: 0.0917045723508279, mRNA_SPDEF: -1.9548382701192968, mRNA_AGR3: -1.898934646045132, mRNA_FOXC1: 3.026485374289615, mRNA_GATA3: -1.0186023475957444, mRNA_AGR2: -1.928573917020091, mRNA_XBP1: -2.4750361915450254, mRNA_PRR15: -2.10095798338473, mRNA_SLC44A4: -2.0223939686521164, mRNA_CA12: -1.3091635555912062, mRNA_DTL: 1.9256791619370128, mRNA_C5AR2: -1.4373060090466598, mRNA_TBC1D9: -1.2922670230636195, mRNA_AR: -1.9014848611477564, mRNA_CCDC170: -1.4684706359453237, mRNA_DEGS2: -1.790085685993862, mRNA_TFF3: -2.0114194534877625, mRNA_DNALI1: -2.0245222896195365, mRNA_LINC00504: -1.722354908427488, mRNA_CLCA2: -0.8564007253812728, mRNA_PPP1R14C: 0.7002007777482258, mRNA_THSD4: -1.721390351628288, mRNA_SPAG5: 3.3728486188645084, mRNA_FBP1: -1.6355189326902997, mRNA_SLC7A8: -1.883771977316555, mRNA_EN1: 1.4086390075850934, mRNA_ZNF552: -1.5364254576276348, Methylation_LRRC6: 1.3154277623762352, Methylation_chr2 66218712 LINC02934 (29533): -0.5783536975689382, Methylation_HOXB13: 0.7237744984613627, Methylation_chr10 3949206 LINC02660 (4871): 1.6379645866886474, Methylation_chr5 179517140 RNF130 (18026): -0.2783059894357331, Methylation_LOC727677: 1.452439906152946, Methylation_LETM1: 1.3123571998291477, Methylation_CDC42BPB: 1.2274482209699276, Methylation_C8orf38: 1.5946690887659272, Methylation_chr14 100504766 EVL (18852): 1.4576482977438463, Methylation_chr5 72594851 LOC340090 (24088): -1.3412057721647384, Methylation_chr2 242904738 LINC01238 (3421): 1.3143692568440668, Methylation_ARFGEF1: 1.140486706366211, Methylation_MAPT: 1.2730382617494485, Methylation_ZFAT: 1.3603661535502891, Methylation_KCNQ4: 1.724941368184225, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5105479555940495, Methylation_CRNKL1: 1.1439946704015909, Methylation_PRKAG2: -1.16065880047126, Methylation_MICB: 1.4901985572025145, miRNA_hsa-mir-934: -0.3929227327517902, miRNA_hsa-mir-4728: -0.2710445880714204, miRNA_hsa-mir-5695: 1.803388035370356, miRNA_hsa-mir-18a: 0.974792624110164, miRNA_hsa-mir-190b: -1.7649822344677506, miRNA_hsa-mir-577: 1.2631541361243448, miRNA_hsa-mir-135b: 1.946111734635081, miRNA_hsa-mir-2115: -0.366317095786736, miRNA_hsa-mir-17: 2.409046267025909, miRNA_hsa-mir-130b: 0.5171560125559437, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-MS-A51U,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified Z-score and CNV cutoffs.","mRNA_MLPH: 0.638024707874983, mRNA_C2orf54: -0.5920137103398828, mRNA_CITED4: 0.9356827992756044, mRNA_ESR1: 0.0119496116163425, mRNA_SPDEF: 0.2855413571793912, mRNA_AGR3: 0.3621085114065019, mRNA_FOXC1: 0.2766112171878984, mRNA_GATA3: 0.613875126429476, mRNA_AGR2: 0.5188268920723448, mRNA_XBP1: 0.4361634270379935, mRNA_PRR15: -0.1274216174081741, mRNA_SLC44A4: 0.0026611549316164, mRNA_CA12: 1.0173344594639615, mRNA_DTL: -1.766643598467673, mRNA_C5AR2: 1.4981782462819613, mRNA_TBC1D9: 0.382748288867246, mRNA_AR: 0.4551833204971832, mRNA_CCDC170: 0.2884362684906895, mRNA_DEGS2: 0.8995208556482305, mRNA_TFF3: 0.5831553158740271, mRNA_DNALI1: 0.6968307028111012, mRNA_LINC00504: -0.3132241799739777, mRNA_CLCA2: -0.5288967031949008, mRNA_PPP1R14C: 0.0859525109911416, mRNA_THSD4: 0.7105615706094733, mRNA_SPAG5: -0.6254632676277256, mRNA_FBP1: 0.6863933389768889, mRNA_SLC7A8: 0.6419372393477489, mRNA_EN1: -0.3181163670711543, mRNA_ZNF552: 1.9048685404219208, Methylation_LRRC6: 0.9239508228795108, Methylation_chr2 66218712 LINC02934 (29533): 0.6052710864016809, Methylation_HOXB13: -0.9998795982271104, Methylation_chr10 3949206 LINC02660 (4871): 0.1641740554444859, Methylation_chr5 179517140 RNF130 (18026): 0.0203965457020111, Methylation_LOC727677: 0.4659596421811665, Methylation_LETM1: 0.6954743646933511, Methylation_CDC42BPB: -0.8149336385513364, Methylation_C8orf38: 0.4588361348023404, Methylation_chr14 100504766 EVL (18852): 0.5228408212735708, Methylation_chr5 72594851 LOC340090 (24088): 0.3383551582969737, Methylation_chr2 242904738 LINC01238 (3421): -0.1786920108387804, Methylation_ARFGEF1: 1.2354348054531976, Methylation_MAPT: -0.2903431370590473, Methylation_ZFAT: 0.6681474196775093, Methylation_KCNQ4: 0.0560944290594582, Methylation_chr1 232684368 SIPA1L2 (12934): 0.8317373718620218, Methylation_CRNKL1: 0.3143230813894033, Methylation_PRKAG2: -0.093320610914623, Methylation_MICB: 0.5905075418757232, miRNA_hsa-mir-934: -0.1207348056575182, miRNA_hsa-mir-4728: -0.1919201594207247, miRNA_hsa-mir-5695: -0.0329556662085205, miRNA_hsa-mir-18a: -0.7608947029579464, miRNA_hsa-mir-190b: 0.1313082543073095, miRNA_hsa-mir-577: -0.5826968364523709, miRNA_hsa-mir-135b: -0.2811296658491433, miRNA_hsa-mir-2115: -0.3852768183144467, miRNA_hsa-mir-17: -0.0696177695467316, miRNA_hsa-mir-130b: -1.1724500533034763, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-S3-AA14,High mRNA_CLCA2 (Z=2.71) indicates overexpression. No methylation sites meet hyper/hypo thresholds. miRNA_hsa-mir-2115 is upregulated (Z=3.52). All CNVs fall within normal range (−1.10 to −0.10). These features suggest a luminal phenotype with immune and secretory pathway activation.,"mRNA_MLPH: 0.7357649000752832, mRNA_C2orf54: 1.3496344956657254, mRNA_CITED4: -0.2841437056452328, mRNA_ESR1: -0.4809416346437274, mRNA_SPDEF: 0.8011915791028158, mRNA_AGR3: -0.488489036380541, mRNA_FOXC1: -0.1931472063377538, mRNA_GATA3: -0.0717109063593621, mRNA_AGR2: 0.2179952789035266, mRNA_XBP1: 0.647357795990196, mRNA_PRR15: 0.6033676709726328, mRNA_SLC44A4: 0.4469342714556075, mRNA_CA12: 0.5999793016992049, mRNA_DTL: -0.3764822617080895, mRNA_C5AR2: 0.5189294086930576, mRNA_TBC1D9: 0.0208438783228472, mRNA_AR: 0.999144282158648, mRNA_CCDC170: 0.4296118523042103, mRNA_DEGS2: 0.3845195677254691, mRNA_TFF3: 0.5785978910959401, mRNA_DNALI1: 0.1261080667134725, mRNA_LINC00504: 1.0414187780875963, mRNA_CLCA2: 2.710258557570436, mRNA_PPP1R14C: -0.3824680034541352, mRNA_THSD4: 0.5180321130823939, mRNA_SPAG5: 0.0859636306837121, mRNA_FBP1: 0.187189179170657, mRNA_SLC7A8: 1.2791059946719336, mRNA_EN1: -0.384478663614175, mRNA_ZNF552: -0.2481669470214417, Methylation_LRRC6: -0.2875911023897949, Methylation_chr2 66218712 LINC02934 (29533): 0.84226842497048, Methylation_HOXB13: -1.0312257918713306, Methylation_chr10 3949206 LINC02660 (4871): 0.2739051696344217, Methylation_chr5 179517140 RNF130 (18026): -0.0424838427285917, Methylation_LOC727677: -0.5567378434564417, Methylation_LETM1: 0.2450838501883181, Methylation_CDC42BPB: -1.0590524387274998, Methylation_C8orf38: -0.8322523715773794, Methylation_chr14 100504766 EVL (18852): -0.229089992454538, Methylation_chr5 72594851 LOC340090 (24088): -0.4320561283006073, Methylation_chr2 242904738 LINC01238 (3421): 0.6486046831164513, Methylation_ARFGEF1: -0.4719563017601096, Methylation_MAPT: -1.3658022714307778, Methylation_ZFAT: 0.8886734621017438, Methylation_KCNQ4: -1.1463996652108503, Methylation_chr1 232684368 SIPA1L2 (12934): -0.7069657757886965, Methylation_CRNKL1: -0.4349751372373622, Methylation_PRKAG2: 0.79456490709054, Methylation_MICB: -0.336544440148081, miRNA_hsa-mir-934: -0.2800372130020789, miRNA_hsa-mir-4728: 0.9048148286524652, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.3989674009401454, miRNA_hsa-mir-190b: -0.238865933500303, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.7439967211005847, miRNA_hsa-mir-2115: 3.5222205770719235, miRNA_hsa-mir-17: -0.263807730327737, miRNA_hsa-mir-130b: -0.6927806520047769, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E2-A10F,"No features meet the strict diagnostic thresholds for mRNA (Z > 1.30 or Z < -1.92), methylation (Z > 1.50 or Z < -1.47), miRNA (Z > 1.99 or Z < -1.25), or CNV (deletion, gain, amplification, or high-level amplification). All values fall within non-actionable ranges.","mRNA_MLPH: 0.3033678295538266, mRNA_C2orf54: -0.2355719564339015, mRNA_CITED4: 0.9758487624135208, mRNA_ESR1: 0.3972049616646663, mRNA_SPDEF: 0.2346591539609203, mRNA_AGR3: 0.3683123434072375, mRNA_FOXC1: -0.1504080529914223, mRNA_GATA3: 0.5803275600780969, mRNA_AGR2: 0.3101782838788506, mRNA_XBP1: -0.0748724292993224, mRNA_PRR15: -0.0513756335531844, mRNA_SLC44A4: 0.4694693660728619, mRNA_CA12: 0.8473962070869715, mRNA_DTL: 0.6749739489810557, mRNA_C5AR2: 0.6445685966118379, mRNA_TBC1D9: 0.4812842921728429, mRNA_AR: 0.6342289644885323, mRNA_CCDC170: 0.3068914656994785, mRNA_DEGS2: 0.5049044450974081, mRNA_TFF3: 0.4121172332802904, mRNA_DNALI1: 0.6049781429475268, mRNA_LINC00504: 0.7333048704157098, mRNA_CLCA2: -0.6602524471213757, mRNA_PPP1R14C: -0.2285685898505243, mRNA_THSD4: 0.5611785632281656, mRNA_SPAG5: -0.0635499378656354, mRNA_FBP1: 0.5165359553239456, mRNA_SLC7A8: 0.6792350932685165, mRNA_EN1: 0.0779965844343581, mRNA_ZNF552: 0.8129469102656982, Methylation_LRRC6: 0.4335047933181004, Methylation_chr2 66218712 LINC02934 (29533): 0.2073884783522692, Methylation_HOXB13: 1.0527153214594602, Methylation_chr10 3949206 LINC02660 (4871): -0.2074969105730774, Methylation_chr5 179517140 RNF130 (18026): 0.827947397136554, Methylation_LOC727677: -0.199035500530435, Methylation_LETM1: -0.0396819228129128, Methylation_CDC42BPB: -0.7957076733603202, Methylation_C8orf38: 0.3214763058303402, Methylation_chr14 100504766 EVL (18852): -0.0125157897266179, Methylation_chr5 72594851 LOC340090 (24088): 0.9802199345511072, Methylation_chr2 242904738 LINC01238 (3421): -0.3042066538730694, Methylation_ARFGEF1: 0.314354541575211, Methylation_MAPT: -0.2515820063867207, Methylation_ZFAT: -0.2054846022083833, Methylation_KCNQ4: 0.5068516730400333, Methylation_chr1 232684368 SIPA1L2 (12934): 0.2180829498294138, Methylation_CRNKL1: -0.2523196817654958, Methylation_PRKAG2: 1.2049243979431334, Methylation_MICB: 0.7780346624531894, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.91652812054949, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.541458512362368, miRNA_hsa-mir-190b: 0.1150045790411385, miRNA_hsa-mir-577: -0.0673349571942146, miRNA_hsa-mir-135b: -0.3737662323794573, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.9201021392484972, miRNA_hsa-mir-130b: -0.875994700575295, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-LL-A50Y,"mRNA_XBP1 (Z=1.54), mRNA_DEGS2 (Z=1.80), and mRNA_TFF3 (Z=1.37) are highly expressed. No methylation or miRNA alterations meet diagnostic thresholds. All CNVs fall within normal range (−1.10 to −0.10). These features collectively indicate a luminal phenotype with unfolded protein response activation.","mRNA_MLPH: 1.1802985790644376, mRNA_C2orf54: 0.9420960498175596, mRNA_CITED4: 0.860986757306664, mRNA_ESR1: 0.6940531318910057, mRNA_SPDEF: 0.8565734027495506, mRNA_AGR3: 0.9822670000200248, mRNA_FOXC1: -1.1215808106680782, mRNA_GATA3: 0.6621922481981538, mRNA_AGR2: 0.5653834192249233, mRNA_XBP1: 1.5407380232321854, mRNA_PRR15: 0.5065416868938044, mRNA_SLC44A4: 0.8139729798814476, mRNA_CA12: 0.5775313750845661, mRNA_DTL: -0.7410833092358885, mRNA_C5AR2: 1.2947610415972326, mRNA_TBC1D9: 0.1831265794219702, mRNA_AR: 0.4653460209520704, mRNA_CCDC170: 1.0153843005867744, mRNA_DEGS2: 1.8034936810134763, mRNA_TFF3: 1.372285649432487, mRNA_DNALI1: 0.9791935303695514, mRNA_LINC00504: 0.7023827366663326, mRNA_CLCA2: -0.7485214934223635, mRNA_PPP1R14C: -0.9242890153169094, mRNA_THSD4: 0.4202770783543618, mRNA_SPAG5: -0.8600182557941498, mRNA_FBP1: 1.0129789537264626, mRNA_SLC7A8: 0.395763124587408, mRNA_EN1: -0.4836935109044817, mRNA_ZNF552: 1.258527020920869, Methylation_LRRC6: -0.9076274642289424, Methylation_chr2 66218712 LINC02934 (29533): 1.179188615700994, Methylation_HOXB13: -0.3212159750135286, Methylation_chr10 3949206 LINC02660 (4871): -1.1348864070076612, Methylation_chr5 179517140 RNF130 (18026): 1.0126852687324093, Methylation_LOC727677: -0.8452635508226711, Methylation_LETM1: -0.6573125912683844, Methylation_CDC42BPB: -1.383902125674645, Methylation_C8orf38: -1.2576642507893203, Methylation_chr14 100504766 EVL (18852): -1.3414618819492128, Methylation_chr5 72594851 LOC340090 (24088): -0.5829766557617385, Methylation_chr2 242904738 LINC01238 (3421): -1.293512981268871, Methylation_ARFGEF1: -0.9062083334603512, Methylation_MAPT: -1.3805952951299982, Methylation_ZFAT: 0.3396936308910988, Methylation_KCNQ4: -0.9903526083867116, Methylation_chr1 232684368 SIPA1L2 (12934): -1.2737231845687502, Methylation_CRNKL1: -1.1394864679279295, Methylation_PRKAG2: 1.2944053121022938, Methylation_MICB: -1.3156022575526554, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.0804798536193485, miRNA_hsa-mir-5695: -0.033568548931899, miRNA_hsa-mir-18a: -0.981661192637208, miRNA_hsa-mir-190b: 1.0724785172918838, miRNA_hsa-mir-577: -0.3204788252855856, miRNA_hsa-mir-135b: -0.7602154373747354, miRNA_hsa-mir-2115: 0.4078552086907123, miRNA_hsa-mir-17: -0.2264535468171906, miRNA_hsa-mir-130b: -0.5586871552863386, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A1XM,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.1161988554168902, mRNA_C2orf54: 0.7822854207716323, mRNA_CITED4: 0.5534828945741753, mRNA_ESR1: 0.4557491618548728, mRNA_SPDEF: 0.1490924503692933, mRNA_AGR3: 0.0184335034859274, mRNA_FOXC1: -0.2817630946565086, mRNA_GATA3: 0.612997095637141, mRNA_AGR2: 0.1401011746748107, mRNA_XBP1: 0.1892997191144138, mRNA_PRR15: -0.040204043668673, mRNA_SLC44A4: 0.5058472968060322, mRNA_CA12: 1.1426883829867749, mRNA_DTL: 0.5858353514353885, mRNA_C5AR2: 1.2849780652054554, mRNA_TBC1D9: 0.698070119386411, mRNA_AR: 0.583781126993503, mRNA_CCDC170: 0.7668441988153512, mRNA_DEGS2: 0.4141488650588531, mRNA_TFF3: 0.58582979678848, mRNA_DNALI1: 0.673187028016893, mRNA_LINC00504: 1.2418784147769362, mRNA_CLCA2: -0.346347890075023, mRNA_PPP1R14C: -0.0714574861007444, mRNA_THSD4: 0.9525282336887826, mRNA_SPAG5: 0.8375877336123888, mRNA_FBP1: 0.4174243815956481, mRNA_SLC7A8: 1.142175109147788, mRNA_EN1: -0.4555854372252341, mRNA_ZNF552: 0.9297586748449386, Methylation_LRRC6: 0.4868686103604594, Methylation_chr2 66218712 LINC02934 (29533): 0.3448944312076326, Methylation_HOXB13: 0.5258008300600081, Methylation_chr10 3949206 LINC02660 (4871): -0.3195185374716818, Methylation_chr5 179517140 RNF130 (18026): 0.4523239954252695, Methylation_LOC727677: -0.2031420416677288, Methylation_LETM1: -0.5201195384033862, Methylation_CDC42BPB: -1.263236512681218, Methylation_C8orf38: 0.1875268611466162, Methylation_chr14 100504766 EVL (18852): -0.4411646414378577, Methylation_chr5 72594851 LOC340090 (24088): 0.4824341819463318, Methylation_chr2 242904738 LINC01238 (3421): -0.585667608193292, Methylation_ARFGEF1: 0.2253681112441618, Methylation_MAPT: -0.5595453521176136, Methylation_ZFAT: 0.1295246945080356, Methylation_KCNQ4: -1.1887837686005018, Methylation_chr1 232684368 SIPA1L2 (12934): 0.3401357121775442, Methylation_CRNKL1: 0.3029901195854106, Methylation_PRKAG2: 0.9788485563303762, Methylation_MICB: -0.4238089776021715, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.0914893187621257, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.7955382767160343, miRNA_hsa-mir-190b: 0.2524200071938101, miRNA_hsa-mir-577: -0.4024697822877251, miRNA_hsa-mir-135b: -0.710159759837919, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.09385730942013, miRNA_hsa-mir-130b: -0.9654470612589332, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A2-A0T0,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression.  
FOXC1 and EN1 show significant mRNA upregulation (Z > 1.30).  
AGR2, AGR3, PRR15, TBC1D9, SLC44A4, and THSD4 are transcriptionally silenced (Z < -1.92).  
RNF130 and LOC340090 promoters are hypomethylated (Z < -1.47); multiple loci hypermethylated (Z > 1.50).  
miR-18a, miR-577, and miR-934 upregulated; miR-190b downregulated.","mRNA_MLPH: -1.9227275203406653, mRNA_C2orf54: 0.1643728382076206, mRNA_CITED4: 0.4456925763724514, mRNA_ESR1: -1.7629993077822788, mRNA_SPDEF: -0.1702794720650831, mRNA_AGR3: -2.0232528060503183, mRNA_FOXC1: 2.137276294205233, mRNA_GATA3: -0.3090595277909213, mRNA_AGR2: -2.5846117848083754, mRNA_XBP1: -0.455071580088115, mRNA_PRR15: -2.668276605517054, mRNA_SLC44A4: -2.0827750026016503, mRNA_CA12: -1.5799767062240373, mRNA_DTL: 0.7481411047282187, mRNA_C5AR2: -1.6132848375169264, mRNA_TBC1D9: -2.2280148297659106, mRNA_AR: -0.9250478053821348, mRNA_CCDC170: -1.5732339649601566, mRNA_DEGS2: -0.6537318107462017, mRNA_TFF3: -1.8039297508985703, mRNA_DNALI1: -1.6573878597546612, mRNA_LINC00504: -1.5988192608298064, mRNA_CLCA2: -0.2328877241290231, mRNA_PPP1R14C: 0.2875391274608641, mRNA_THSD4: -1.9262879237761563, mRNA_SPAG5: 0.6671917497655728, mRNA_FBP1: -1.4097770076380027, mRNA_SLC7A8: -1.6433214075199976, mRNA_EN1: 2.4475392741787454, mRNA_ZNF552: 0.2441940006292123, Methylation_LRRC6: 1.4828081112688287, Methylation_chr2 66218712 LINC02934 (29533): 0.0595571094953229, Methylation_HOXB13: -0.9921524182953498, Methylation_chr10 3949206 LINC02660 (4871): 1.378306067854847, Methylation_chr5 179517140 RNF130 (18026): -1.644643517550519, Methylation_LOC727677: 1.5252931777656504, Methylation_LETM1: 1.3696285085731854, Methylation_CDC42BPB: 1.1984426018890493, Methylation_C8orf38: 0.9322084320360378, Methylation_chr14 100504766 EVL (18852): 1.3758767927579585, Methylation_chr5 72594851 LOC340090 (24088): -1.5689553110672334, Methylation_chr2 242904738 LINC01238 (3421): 1.4044360964730134, Methylation_ARFGEF1: 1.3961913879634584, Methylation_MAPT: 1.396778005258636, Methylation_ZFAT: 1.1506027789236983, Methylation_KCNQ4: 1.0310032320446505, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5427465248022485, Methylation_CRNKL1: 1.2035035332612092, Methylation_PRKAG2: -1.1606194109081671, Methylation_MICB: 1.2841281614305375, miRNA_hsa-mir-934: 2.099681350782112, miRNA_hsa-mir-4728: -0.7680738788904076, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 2.297436540988444, miRNA_hsa-mir-190b: -2.052137242410604, miRNA_hsa-mir-577: 2.45974620061779, miRNA_hsa-mir-135b: 1.7047829908159982, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.9060481534114808, miRNA_hsa-mir-130b: 0.5452497390609714, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-D8-A1X9,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.2859422492795763, mRNA_C2orf54: -0.3845203969030842, mRNA_CITED4: -0.2162065256193386, mRNA_ESR1: 0.9548468958376374, mRNA_SPDEF: 0.4595311740412109, mRNA_AGR3: 0.7156241931697509, mRNA_FOXC1: -0.175192705746643, mRNA_GATA3: 0.587178730908989, mRNA_AGR2: 0.6837335011945278, mRNA_XBP1: 0.2789666372808906, mRNA_PRR15: 0.5553051279429032, mRNA_SLC44A4: 0.6820742194348663, mRNA_CA12: 0.6353522675627616, mRNA_DTL: 0.5782742572919006, mRNA_C5AR2: 0.2277759437830286, mRNA_TBC1D9: 0.6727668806010461, mRNA_AR: 0.2106575893389546, mRNA_CCDC170: 0.8229834475894745, mRNA_DEGS2: 0.1621351311819772, mRNA_TFF3: 0.5712045234253131, mRNA_DNALI1: -1.2067506023634462, mRNA_LINC00504: 1.1121486657805109, mRNA_CLCA2: -0.8003449424931977, mRNA_PPP1R14C: -0.6010708967922285, mRNA_THSD4: 0.8859690271306356, mRNA_SPAG5: 0.1580928396629967, mRNA_FBP1: 0.8959372754072157, mRNA_SLC7A8: 0.9312112309164956, mRNA_EN1: 0.0196590428171725, mRNA_ZNF552: -0.1151310622733855, Methylation_LRRC6: -0.8207448695808507, Methylation_chr2 66218712 LINC02934 (29533): -0.4714219193510288, Methylation_HOXB13: -0.8758038161123047, Methylation_chr10 3949206 LINC02660 (4871): -1.275311881896493, Methylation_chr5 179517140 RNF130 (18026): 1.094526019057367, Methylation_LOC727677: -1.158361929848343, Methylation_LETM1: -0.7749358949187578, Methylation_CDC42BPB: 1.2837912921597212, Methylation_C8orf38: 0.1143898480562232, Methylation_chr14 100504766 EVL (18852): -1.3369698260665568, Methylation_chr5 72594851 LOC340090 (24088): 0.891069290090663, Methylation_chr2 242904738 LINC01238 (3421): -0.445097566375656, Methylation_ARFGEF1: -0.8178254876730379, Methylation_MAPT: -0.2407594406174332, Methylation_ZFAT: -1.0951670275584713, Methylation_KCNQ4: 1.4391230089393, Methylation_chr1 232684368 SIPA1L2 (12934): -1.1690115655172748, Methylation_CRNKL1: -1.3422658923266255, Methylation_PRKAG2: -1.11181750884903, Methylation_MICB: -1.3490148806234694, miRNA_hsa-mir-934: -0.4264570359152616, miRNA_hsa-mir-4728: 0.9192577200583216, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.853507567040584, miRNA_hsa-mir-190b: -0.4912737572969028, miRNA_hsa-mir-577: -0.6027780049167883, miRNA_hsa-mir-135b: -0.9906125643781344, miRNA_hsa-mir-2115: -0.4201484078787645, miRNA_hsa-mir-17: -2.061602942254128, miRNA_hsa-mir-130b: -1.0424979277659363, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AO-A0JE,"High-level Amplification of none; CLCA2 mRNA overexpression (Z=3.15) and SPAG5 upregulation (Z=1.69) exceed thresholds. ESR1, SLC44A4, and AGR3 show low mRNA (Z < -1.92). No methylation sites meet hyper/hypo thresholds. miR-4728 is upregulated (Z=2.05); miR-17 downregulated (Z=-1.13). All CNVs fall within normal range.","mRNA_MLPH: -0.4137474099250667, mRNA_C2orf54: 0.9883632225604988, mRNA_CITED4: -0.1314329975151746, mRNA_ESR1: -1.5415569583691435, mRNA_SPDEF: 0.1362368791264929, mRNA_AGR3: -1.147700614490813, mRNA_FOXC1: -0.3204733696608153, mRNA_GATA3: -0.6965707125129931, mRNA_AGR2: -0.0488380442565448, mRNA_XBP1: -0.3188547032893967, mRNA_PRR15: -0.2505418551566679, mRNA_SLC44A4: -1.471559808689908, mRNA_CA12: 0.0950288094495598, mRNA_DTL: 0.2066801257497139, mRNA_C5AR2: -1.0190742810820526, mRNA_TBC1D9: -0.6164606338361525, mRNA_AR: 0.9623725432654144, mRNA_CCDC170: -1.1236271183750923, mRNA_DEGS2: -0.1515234326449402, mRNA_TFF3: -1.098765855996373, mRNA_DNALI1: 0.0388355351686018, mRNA_LINC00504: -0.5399703699159487, mRNA_CLCA2: 3.150157384104363, mRNA_PPP1R14C: -0.3654747347214303, mRNA_THSD4: -0.9770663517367372, mRNA_SPAG5: 1.6917910365823547, mRNA_FBP1: -0.5278035376857141, mRNA_SLC7A8: -0.0776529575798887, mRNA_EN1: 0.3064664480198788, mRNA_ZNF552: 0.6537041915066105, Methylation_LRRC6: 0.1947626315079765, Methylation_chr2 66218712 LINC02934 (29533): 0.539469340219616, Methylation_HOXB13: 0.8196836149383983, Methylation_chr10 3949206 LINC02660 (4871): 0.2232408769019481, Methylation_chr5 179517140 RNF130 (18026): -0.0298153519416894, Methylation_LOC727677: 1.328462753941611, Methylation_LETM1: 1.2765528229613157, Methylation_CDC42BPB: -1.1057917413135825, Methylation_C8orf38: 0.2898101260920127, Methylation_chr14 100504766 EVL (18852): 0.6126751368476586, Methylation_chr5 72594851 LOC340090 (24088): 0.7119270492312738, Methylation_chr2 242904738 LINC01238 (3421): 1.4342915353706251, Methylation_ARFGEF1: -0.5201140262288423, Methylation_MAPT: 0.5939051266798944, Methylation_ZFAT: 0.8139683640057582, Methylation_KCNQ4: 0.5695868264240866, Methylation_chr1 232684368 SIPA1L2 (12934): 0.0177338594158656, Methylation_CRNKL1: 1.3257374243215367, Methylation_PRKAG2: 1.0924203248900837, Methylation_MICB: 0.4953338320499943, miRNA_hsa-mir-934: -0.1599583883763565, miRNA_hsa-mir-4728: 2.049740442200451, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.6718703339620444, miRNA_hsa-mir-190b: -0.8182080862825919, miRNA_hsa-mir-577: -0.3564249661070359, miRNA_hsa-mir-135b: -0.124990905622538, miRNA_hsa-mir-2115: 0.0076515018983168, miRNA_hsa-mir-17: -1.125709569147058, miRNA_hsa-mir-130b: -0.5508925162272126, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-HN-A2OB,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting. All values fall within non-significant ranges per defined criteria.","mRNA_MLPH: 0.6005118798944874, mRNA_C2orf54: 0.6834245489494528, mRNA_CITED4: 0.499018073418591, mRNA_ESR1: 0.0481283480459607, mRNA_SPDEF: 0.5833446760767397, mRNA_AGR3: 0.3591299051323152, mRNA_FOXC1: -0.0111368142058688, mRNA_GATA3: 0.1185380521053974, mRNA_AGR2: 0.5158756651184385, mRNA_XBP1: 0.6079887452144528, mRNA_PRR15: 0.4722547068398455, mRNA_SLC44A4: 0.6810460013777611, mRNA_CA12: 0.4038658395372614, mRNA_DTL: -2.139925005822906, mRNA_C5AR2: 0.1879125292098536, mRNA_TBC1D9: 0.1988652623014399, mRNA_AR: 0.5009091135533594, mRNA_CCDC170: 0.1840004353393865, mRNA_DEGS2: 0.0014653490270212, mRNA_TFF3: 1.0996885878526428, mRNA_DNALI1: 0.5794860382066932, mRNA_LINC00504: 0.0276017162529441, mRNA_CLCA2: 0.5784383159654949, mRNA_PPP1R14C: -0.3264107195715597, mRNA_THSD4: 0.2712351422860753, mRNA_SPAG5: -2.05359048465994, mRNA_FBP1: 0.3430594048285919, mRNA_SLC7A8: 0.5350000630890194, mRNA_EN1: -0.2959413874657773, mRNA_ZNF552: 0.2153567285675225, Methylation_LRRC6: 0.7239119802337242, Methylation_chr2 66218712 LINC02934 (29533): -0.484674804550364, Methylation_HOXB13: -1.0116271323362596, Methylation_chr10 3949206 LINC02660 (4871): 0.0643805860347945, Methylation_chr5 179517140 RNF130 (18026): 0.0736167784955342, Methylation_LOC727677: 0.1911414631384721, Methylation_LETM1: 0.3280698775312006, Methylation_CDC42BPB: -0.5431783408259018, Methylation_C8orf38: -0.0305284992895274, Methylation_chr14 100504766 EVL (18852): 1.077536421397329, Methylation_chr5 72594851 LOC340090 (24088): 0.4313791766905549, Methylation_chr2 242904738 LINC01238 (3421): -0.207515609554581, Methylation_ARFGEF1: 0.6026268897774215, Methylation_MAPT: 0.2624779174526069, Methylation_ZFAT: 0.3921865824747765, Methylation_KCNQ4: -1.007904336554388, Methylation_chr1 232684368 SIPA1L2 (12934): 0.4786025502174897, Methylation_CRNKL1: 0.5777128034007569, Methylation_PRKAG2: 0.9490305602477156, Methylation_MICB: 0.6130209366465955, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.2706636123521881, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.6055440493092661, miRNA_hsa-mir-190b: 0.221337667010169, miRNA_hsa-mir-577: -0.5038659196146366, miRNA_hsa-mir-135b: -0.2091892382960578, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.061187799090889, miRNA_hsa-mir-130b: -2.072160490926398, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AO-A1KP,"LINC00504 mRNA overexpression (Z=1.28) exceeds the high threshold. LETM1, ZFAT, and MAPT promoters are hypermethylated (Z < -1.47), indicating epigenetic silencing. miRNA hsa-mir-5695 is upregulated (Z=2.90). No CNVs meet deletion or amplification thresholds. These features suggest luminal breast cancer with ER-pathway activity.","mRNA_MLPH: 0.6803808905320495, mRNA_C2orf54: -1.2136650374679314, mRNA_CITED4: 0.2980337315380735, mRNA_ESR1: 0.7792078959021074, mRNA_SPDEF: -0.0393655811285253, mRNA_AGR3: 0.7873116498289465, mRNA_FOXC1: -0.5325892375149256, mRNA_GATA3: 1.2344524670759267, mRNA_AGR2: 1.012427763306995, mRNA_XBP1: 0.1825852422176316, mRNA_PRR15: 0.669405128970928, mRNA_SLC44A4: -0.0234750204085815, mRNA_CA12: 0.6461366530944391, mRNA_DTL: 0.7860418687206085, mRNA_C5AR2: 0.5256860678574545, mRNA_TBC1D9: 0.4541867457219626, mRNA_AR: 0.2946978313076854, mRNA_CCDC170: 1.1876258562556767, mRNA_DEGS2: 0.4655451187409451, mRNA_TFF3: 0.2466308888573121, mRNA_DNALI1: 0.6343889516927135, mRNA_LINC00504: 1.280853815313042, mRNA_CLCA2: -0.7979710091216794, mRNA_PPP1R14C: -0.7031502010654724, mRNA_THSD4: 0.2183420877334796, mRNA_SPAG5: -0.1186137910209108, mRNA_FBP1: 0.913984420706399, mRNA_SLC7A8: 1.2134011896835808, mRNA_EN1: -0.4982762901724239, mRNA_ZNF552: 0.4397103834931078, Methylation_LRRC6: -1.5766925957692477, Methylation_chr2 66218712 LINC02934 (29533): 0.4644828026039868, Methylation_HOXB13: -0.7444509966092685, Methylation_chr10 3949206 LINC02660 (4871): -1.2919519617955015, Methylation_chr5 179517140 RNF130 (18026): 1.2393196675404363, Methylation_LOC727677: -1.6206195664429628, Methylation_LETM1: -1.877152184816872, Methylation_CDC42BPB: 1.4039289007962603, Methylation_C8orf38: -0.729457963884383, Methylation_chr14 100504766 EVL (18852): -1.537704240675679, Methylation_chr5 72594851 LOC340090 (24088): 1.2562562046648311, Methylation_chr2 242904738 LINC01238 (3421): -1.497060817759361, Methylation_ARFGEF1: -1.3155259895215572, Methylation_MAPT: -1.737433733514802, Methylation_ZFAT: -1.8506189703022489, Methylation_KCNQ4: 1.5074226187520046, Methylation_chr1 232684368 SIPA1L2 (12934): 1.297683958771529, Methylation_CRNKL1: -1.7000924270730793, Methylation_PRKAG2: 1.3621329893907037, Methylation_MICB: -1.456515507463822, miRNA_hsa-mir-934: -0.2960870822460933, miRNA_hsa-mir-4728: 0.3442995782707764, miRNA_hsa-mir-5695: 2.903378038408853, miRNA_hsa-mir-18a: 0.5634053354105992, miRNA_hsa-mir-190b: 0.7390924457946264, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.2204733974363844, miRNA_hsa-mir-2115: 0.6450151863996918, miRNA_hsa-mir-17: 0.8140590482202168, miRNA_hsa-mir-130b: 0.4345869139091962, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A254,High mRNA_C2orf54 (Z=1.54) and mRNA_PPP1R14C (Z=1.55) indicate overexpression. miRNA_hsa-mir-4728 is upregulated (Z=3.80). No methylation or CNV alterations meet diagnostic thresholds. These features suggest luminal-like transcriptional activity with miR-4728-driven post-transcriptional regulation.,"mRNA_MLPH: 0.3275107923393258, mRNA_C2orf54: 1.5433954798676643, mRNA_CITED4: 0.0676815019057587, mRNA_ESR1: -0.4421100263411804, mRNA_SPDEF: 0.1710890501243313, mRNA_AGR3: 0.4271442335947767, mRNA_FOXC1: -0.7728842204520959, mRNA_GATA3: -0.0598214522095274, mRNA_AGR2: -0.217733814084716, mRNA_XBP1: 0.7187294536753108, mRNA_PRR15: -0.1780910874989255, mRNA_SLC44A4: 0.1405505902336634, mRNA_CA12: 0.4768799196086846, mRNA_DTL: 0.6377409794778357, mRNA_C5AR2: -0.4723021884948513, mRNA_TBC1D9: -0.5029741448617583, mRNA_AR: -0.3946715878983569, mRNA_CCDC170: -0.6477823771782393, mRNA_DEGS2: -0.094398640645036, mRNA_TFF3: 0.9643825418506284, mRNA_DNALI1: 0.3425733986588513, mRNA_LINC00504: -0.8690880180500687, mRNA_CLCA2: -0.5299021891751778, mRNA_PPP1R14C: 1.5452621779425535, mRNA_THSD4: -0.4247390768114411, mRNA_SPAG5: 0.7311075390642211, mRNA_FBP1: 0.200806777606982, mRNA_SLC7A8: -0.2412286754496356, mRNA_EN1: -0.244012296536702, mRNA_ZNF552: 0.5201032455599762, Methylation_LRRC6: -0.9117930166517022, Methylation_chr2 66218712 LINC02934 (29533): 0.019236169004847, Methylation_HOXB13: 0.3331232238380529, Methylation_chr10 3949206 LINC02660 (4871): -0.0267225951037856, Methylation_chr5 179517140 RNF130 (18026): 0.5745524434572787, Methylation_LOC727677: 0.174422393140793, Methylation_LETM1: 0.7658002211555486, Methylation_CDC42BPB: 0.7074333637365553, Methylation_C8orf38: -0.8274524688815781, Methylation_chr14 100504766 EVL (18852): 0.467466234519193, Methylation_chr5 72594851 LOC340090 (24088): 0.0175586429895082, Methylation_chr2 242904738 LINC01238 (3421): -0.803692666124943, Methylation_ARFGEF1: -0.7272716383043414, Methylation_MAPT: 0.744450422664715, Methylation_ZFAT: -0.5401114653982395, Methylation_KCNQ4: -0.0594136760069131, Methylation_chr1 232684368 SIPA1L2 (12934): 0.3694490441426855, Methylation_CRNKL1: 0.9356724921128156, Methylation_PRKAG2: -1.1851402395181043, Methylation_MICB: 0.6385666978184268, miRNA_hsa-mir-934: -0.4567031789382796, miRNA_hsa-mir-4728: 3.7967152628284473, miRNA_hsa-mir-5695: 0.2219423033396798, miRNA_hsa-mir-18a: 1.2148056161793983, miRNA_hsa-mir-190b: -0.2258717521642313, miRNA_hsa-mir-577: -0.3411942103729029, miRNA_hsa-mir-135b: -0.4165255552782442, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.446666877769767, miRNA_hsa-mir-130b: 0.3579848625486229, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-BH-A0E1,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.6109804342919801, mRNA_C2orf54: -0.9858046439924782, mRNA_CITED4: -0.0017103681401409, mRNA_ESR1: 0.502388018094909, mRNA_SPDEF: 0.2911886084541867, mRNA_AGR3: 0.7131548875824254, mRNA_FOXC1: 0.2588319872351537, mRNA_GATA3: 0.4569429612239786, mRNA_AGR2: 0.5414227624071837, mRNA_XBP1: 1.0544474624329996, mRNA_PRR15: 0.9045183448090728, mRNA_SLC44A4: 0.8106298317028923, mRNA_CA12: 0.9793410995141184, mRNA_DTL: 1.037502110046813, mRNA_C5AR2: 0.8486835612915985, mRNA_TBC1D9: 0.6460242069762616, mRNA_AR: 0.691104738743036, mRNA_CCDC170: 0.6067524170875102, mRNA_DEGS2: 0.7041738567658931, mRNA_TFF3: 1.0139778764078866, mRNA_DNALI1: -1.1447860174327498, mRNA_LINC00504: 0.9340265161190362, mRNA_CLCA2: -0.5816648294254484, mRNA_PPP1R14C: -0.6973549366771928, mRNA_THSD4: 0.6794132895031568, mRNA_SPAG5: 1.291108638819923, mRNA_FBP1: 0.4910467211354306, mRNA_SLC7A8: -0.0031787468112436, mRNA_EN1: -0.5201308329249013, mRNA_ZNF552: 0.5960220375324103, Methylation_LRRC6: -0.7125674566913597, Methylation_chr2 66218712 LINC02934 (29533): 1.3405121017637338, Methylation_HOXB13: -0.9068505395893844, Methylation_chr10 3949206 LINC02660 (4871): -0.7584813791903452, Methylation_chr5 179517140 RNF130 (18026): 0.8881944151144366, Methylation_LOC727677: -1.0698589460203891, Methylation_LETM1: -0.8159454611555327, Methylation_CDC42BPB: -1.2914869505798712, Methylation_C8orf38: -0.6986374807629516, Methylation_chr14 100504766 EVL (18852): -0.8409800552902448, Methylation_chr5 72594851 LOC340090 (24088): 0.8229754449008548, Methylation_chr2 242904738 LINC01238 (3421): -0.8344286553270338, Methylation_ARFGEF1: -0.984085232519732, Methylation_MAPT: -0.7032962590522761, Methylation_ZFAT: 0.7298331337328283, Methylation_KCNQ4: 1.2439771466834453, Methylation_chr1 232684368 SIPA1L2 (12934): -1.10198140614344, Methylation_CRNKL1: -1.3864379764878327, Methylation_PRKAG2: 0.1502976470943783, Methylation_MICB: -1.0092698238202051, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.3311728108247654, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -2.2471487129970096, miRNA_hsa-mir-190b: 0.9409408110850924, miRNA_hsa-mir-577: 0.4676491902319253, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.3837696676626805, miRNA_hsa-mir-130b: 1.3452668838808337, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A1J8,"High-level Amplification of DTL drives significant mRNA overexpression (Z=2.26). AGR2 mRNA is highly expressed (Z=1.33), though no CNV data supports amplification. No methylation sites meet hyper/hypo-methylation thresholds. No miRNAs cross expression cutoffs. Deletions absent; all CNVs fall within normal range.","mRNA_MLPH: 0.5200639245799049, mRNA_C2orf54: 0.5017733341890779, mRNA_CITED4: -1.2798388246524477, mRNA_ESR1: 1.0029003150580034, mRNA_SPDEF: 0.1252651663321649, mRNA_AGR3: 1.0573860484368698, mRNA_FOXC1: -0.1706760376139381, mRNA_GATA3: 0.4409748570795471, mRNA_AGR2: 1.3266288637069334, mRNA_XBP1: 0.6289574630561507, mRNA_PRR15: 0.6365878057629704, mRNA_SLC44A4: 1.1956852859347085, mRNA_CA12: 0.1704875987094375, mRNA_DTL: 2.261487723471627, mRNA_C5AR2: 0.7798034612725211, mRNA_TBC1D9: -0.0376610454354542, mRNA_AR: 0.966224705953071, mRNA_CCDC170: 0.6102516241842043, mRNA_DEGS2: 0.1750659806993403, mRNA_TFF3: 0.5978057336333615, mRNA_DNALI1: -1.8032198620725075, mRNA_LINC00504: 0.5542190547578734, mRNA_CLCA2: -0.0558497250492662, mRNA_PPP1R14C: 0.4226683701040604, mRNA_THSD4: 0.3385794333817418, mRNA_SPAG5: 0.6347049018100697, mRNA_FBP1: 0.5608218832655185, mRNA_SLC7A8: 0.6605208845075328, mRNA_EN1: -0.2846386829780273, mRNA_ZNF552: 0.940290016736706, Methylation_LRRC6: 0.971980225732086, Methylation_chr2 66218712 LINC02934 (29533): 1.4154133025753848, Methylation_HOXB13: 0.9126445553598416, Methylation_chr10 3949206 LINC02660 (4871): 1.3624697388829765, Methylation_chr5 179517140 RNF130 (18026): 0.5017593917692756, Methylation_LOC727677: 0.1026827895948663, Methylation_LETM1: -0.8554890037213284, Methylation_CDC42BPB: -0.7798505395651124, Methylation_C8orf38: -0.469814092776858, Methylation_chr14 100504766 EVL (18852): -0.7924111261873524, Methylation_chr5 72594851 LOC340090 (24088): 0.4950365066935741, Methylation_chr2 242904738 LINC01238 (3421): -0.9354165831565528, Methylation_ARFGEF1: -0.0789224332281754, Methylation_MAPT: 0.1080090435735065, Methylation_ZFAT: -0.5722496896091898, Methylation_KCNQ4: 0.5615548323615999, Methylation_chr1 232684368 SIPA1L2 (12934): -0.968742307293996, Methylation_CRNKL1: -0.8656036836194072, Methylation_PRKAG2: -0.1858342809081388, Methylation_MICB: -0.7637854474826555, miRNA_hsa-mir-934: -0.1469157595100375, miRNA_hsa-mir-4728: -0.6503576070129883, miRNA_hsa-mir-5695: 0.9591592224549162, miRNA_hsa-mir-18a: 0.0541145070144221, miRNA_hsa-mir-190b: 1.0840568034031195, miRNA_hsa-mir-577: -0.5234762927238493, miRNA_hsa-mir-135b: -0.0593093742098488, miRNA_hsa-mir-2115: -0.2824384551815446, miRNA_hsa-mir-17: -0.6516752791669169, miRNA_hsa-mir-130b: 0.6279307434124484, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A1RH,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives genomic instability. CLCA2 mRNA overexpression (Z=3.37) and SPAG5 upregulation (Z=1.15) suggest luminal differentiation. GATA3, PRR15, and SLC44A4 mRNA downregulation (Z < -1.92) indicates loss of luminal identity. Promoter hypermethylation of SIPA1L2 (Z=1.56) may silence tumor suppressor function. miR-190b downregulation (Z=-1.48) potentially derepresses oncogenic targets.","mRNA_MLPH: -0.6857772377030611, mRNA_C2orf54: -0.5447280983773627, mRNA_CITED4: -0.2531649215560937, mRNA_ESR1: -1.7065677462118194, mRNA_SPDEF: -0.2505704674650787, mRNA_AGR3: -1.875748020177455, mRNA_FOXC1: -1.1879264016725293, mRNA_GATA3: -2.4381142215079668, mRNA_AGR2: -1.0221653490291511, mRNA_XBP1: -1.5120476885926044, mRNA_PRR15: -2.555418872070085, mRNA_SLC44A4: -2.10410656927616, mRNA_CA12: -0.3982119399391212, mRNA_DTL: 0.6480136577009286, mRNA_C5AR2: -1.8980087824273728, mRNA_TBC1D9: -0.8200403836321555, mRNA_AR: 0.6440331701115882, mRNA_CCDC170: -1.4536812293449553, mRNA_DEGS2: 0.158683834994427, mRNA_TFF3: -1.5834849578268972, mRNA_DNALI1: -1.8007380914613722, mRNA_LINC00504: -1.5081654689547277, mRNA_CLCA2: 3.3685994445205325, mRNA_PPP1R14C: -0.7164589840556164, mRNA_THSD4: -0.830131117908923, mRNA_SPAG5: 1.150028150036377, mRNA_FBP1: -2.048450834950207, mRNA_SLC7A8: -0.1540217902034515, mRNA_EN1: 0.0071845750249616, mRNA_ZNF552: 0.5513288550950526, Methylation_LRRC6: 1.4799323631386418, Methylation_chr2 66218712 LINC02934 (29533): -1.1004589065505683, Methylation_HOXB13: 0.2531495590501882, Methylation_chr10 3949206 LINC02660 (4871): -1.0166931542159512, Methylation_chr5 179517140 RNF130 (18026): 0.2653540927842768, Methylation_LOC727677: 0.4956779095658111, Methylation_LETM1: 1.3642009479123258, Methylation_CDC42BPB: -0.6614466537562015, Methylation_C8orf38: -0.3986778467677824, Methylation_chr14 100504766 EVL (18852): 1.3285643758898462, Methylation_chr5 72594851 LOC340090 (24088): -1.3005733004070976, Methylation_chr2 242904738 LINC01238 (3421): 1.4004091505125158, Methylation_ARFGEF1: -0.067486872074948, Methylation_MAPT: 1.3790461161294234, Methylation_ZFAT: 1.297163548584132, Methylation_KCNQ4: 0.6437253010271452, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5642911674931246, Methylation_CRNKL1: 1.3130447107791572, Methylation_PRKAG2: -0.934171388702566, Methylation_MICB: 1.370288414456899, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.17448657534134, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.1287241857002832, miRNA_hsa-mir-190b: -1.479827642622154, miRNA_hsa-mir-577: 0.0784601893252434, miRNA_hsa-mir-135b: -0.77178980255693, miRNA_hsa-mir-2115: -0.1531014820677488, miRNA_hsa-mir-17: -0.0113243950941293, miRNA_hsa-mir-130b: 0.771740774569418, CNV_VPS54: 2.3735003872816955, CNV_LINC01867: 2.395394893874891, CNV_LINC02576: 2.464291317721031, CNV_WDPCP: 2.38809584879993, CNV_CEP68: 2.464291317721031"
TCGA-A2-A4S3,High-level Amplification of SPAG5 drives significant mRNA overexpression (Z=2.04). No methylation or miRNA alterations meet diagnostic thresholds. All CNVs fall within normal range (−1.10 to −0.10). These features collectively indicate a luminal phenotype with mitotic pathway dysregulation.,"mRNA_MLPH: 0.2486115338796325, mRNA_C2orf54: -0.8699864982960541, mRNA_CITED4: -0.3246567438317409, mRNA_ESR1: 0.6231826861259121, mRNA_SPDEF: 1.028349424523942, mRNA_AGR3: -0.245721794543177, mRNA_FOXC1: -0.7658222527017335, mRNA_GATA3: 0.1292968478964336, mRNA_AGR2: 0.2164241156244752, mRNA_XBP1: -0.2049758384225473, mRNA_PRR15: 0.1821318299983465, mRNA_SLC44A4: 0.0657604374672577, mRNA_CA12: -0.3261559781022203, mRNA_DTL: 0.3319942839936719, mRNA_C5AR2: -0.0682571574369675, mRNA_TBC1D9: -1.2510406766382862, mRNA_AR: 0.4429323542878059, mRNA_CCDC170: 0.9109627692308742, mRNA_DEGS2: -0.2981981290695233, mRNA_TFF3: 0.4780117225428598, mRNA_DNALI1: 0.1106118174451653, mRNA_LINC00504: -1.6055744048912932, mRNA_CLCA2: -0.8016222449621565, mRNA_PPP1R14C: -0.3644165700953332, mRNA_THSD4: -0.4529749247623703, mRNA_SPAG5: 2.041651890488471, mRNA_FBP1: -0.0860431683474618, mRNA_SLC7A8: -0.3934771214641357, mRNA_EN1: -0.6011381418599036, mRNA_ZNF552: -0.167397482557451, Methylation_LRRC6: 0.4316687089449555, Methylation_chr2 66218712 LINC02934 (29533): 0.7347553709698154, Methylation_HOXB13: 0.7427871375101954, Methylation_chr10 3949206 LINC02660 (4871): 0.2013838957679604, Methylation_chr5 179517140 RNF130 (18026): -1.3809306214160697, Methylation_LOC727677: -0.0512497241652915, Methylation_LETM1: 0.3648219025220306, Methylation_CDC42BPB: 0.71048937010291, Methylation_C8orf38: -0.8266389474674318, Methylation_chr14 100504766 EVL (18852): 0.6581342314475178, Methylation_chr5 72594851 LOC340090 (24088): -1.1464807910079564, Methylation_chr2 242904738 LINC01238 (3421): 1.081954483834427, Methylation_ARFGEF1: -1.365056859453894, Methylation_MAPT: -0.6517217330626444, Methylation_ZFAT: -0.0714790228690914, Methylation_KCNQ4: -1.017928217806536, Methylation_chr1 232684368 SIPA1L2 (12934): -0.6713982685874662, Methylation_CRNKL1: 0.8025061829905443, Methylation_PRKAG2: 0.4813865300095863, Methylation_MICB: 0.2235887778166138, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.0942536967266665, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.6325124485283679, miRNA_hsa-mir-190b: -0.9691322297016032, miRNA_hsa-mir-577: 0.4073961957010988, miRNA_hsa-mir-135b: -0.1360948745704818, miRNA_hsa-mir-2115: 1.8595088856277693, miRNA_hsa-mir-17: 0.1056814485930996, miRNA_hsa-mir-130b: -0.6230925167046953, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A1FC,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives genomic instability.  
FOXC1 and EN1 mRNA overexpression aligns with aggressive transcriptional programs.  
ESR1, GATA3, AGR2/3, SPDEF, and CA12 mRNA downregulation indicates luminal differentiation loss.  
Promoter hypermethylation of LRRC6, LINC02660, C8orf38, ARFGEF1, MAPT, ZFAT, SIPA1L2, and MICB mediates epigenetic silencing.  
These features collectively indicate a basal-like phenotype with ER-pathway suppression.","mRNA_MLPH: -3.1280299649554264, mRNA_C2orf54: -0.3180742468480705, mRNA_CITED4: -0.7487735465449453, mRNA_ESR1: -1.8801647049125896, mRNA_SPDEF: -2.531704202226161, mRNA_AGR3: -2.046852741524553, mRNA_FOXC1: 2.057453669067568, mRNA_GATA3: -2.815808154053957, mRNA_AGR2: -2.559869420625952, mRNA_XBP1: -1.175098383464115, mRNA_PRR15: -2.462529754611267, mRNA_SLC44A4: -2.3226295242602712, mRNA_CA12: -2.02437530584612, mRNA_DTL: 0.4851434151207603, mRNA_C5AR2: -1.9569494436323969, mRNA_TBC1D9: -1.4600979753143422, mRNA_AR: -1.4053192854022754, mRNA_CCDC170: -1.6169357777672742, mRNA_DEGS2: -2.395829139901287, mRNA_TFF3: -2.2393609491304725, mRNA_DNALI1: -2.0317865536268767, mRNA_LINC00504: -1.7494720825573742, mRNA_CLCA2: -0.8895031573583925, mRNA_PPP1R14C: 0.5433551497846235, mRNA_THSD4: -2.219078029194125, mRNA_SPAG5: 1.259055768838516, mRNA_FBP1: -1.717762833656279, mRNA_SLC7A8: -1.949304680551461, mRNA_EN1: 2.281602070612531, mRNA_ZNF552: -2.0373721390181605, Methylation_LRRC6: 1.5211332149934351, Methylation_chr2 66218712 LINC02934 (29533): -1.0016049552473276, Methylation_HOXB13: 1.015792504476122, Methylation_chr10 3949206 LINC02660 (4871): 1.6668422141347732, Methylation_chr5 179517140 RNF130 (18026): -1.6350217678303125, Methylation_LOC727677: 1.4643724257012576, Methylation_LETM1: 1.2710725007688548, Methylation_CDC42BPB: 0.8277199057930519, Methylation_C8orf38: 1.637968420871191, Methylation_chr14 100504766 EVL (18852): 1.3770863543170806, Methylation_chr5 72594851 LOC340090 (24088): -1.44727263383871, Methylation_chr2 242904738 LINC01238 (3421): 1.3912201166023654, Methylation_ARFGEF1: 1.7109950391831958, Methylation_MAPT: 1.4618930286034872, Methylation_ZFAT: 1.4963490706701283, Methylation_KCNQ4: 0.4430149980417777, Methylation_chr1 232684368 SIPA1L2 (12934): 1.408727609710111, Methylation_CRNKL1: 1.205241122058623, Methylation_PRKAG2: 0.7955128356676245, Methylation_MICB: 1.3282644402508397, miRNA_hsa-mir-934: 0.8200735759013794, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: 3.4225863256220594, miRNA_hsa-mir-18a: 2.0594150152261568, miRNA_hsa-mir-190b: -1.1935620725932627, miRNA_hsa-mir-577: 2.4229777832259165, miRNA_hsa-mir-135b: 1.7140639959685384, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 2.184034531225677, miRNA_hsa-mir-130b: 1.9894477730371776, CNV_VPS54: 2.3735003872816955, CNV_LINC01867: 2.395394893874891, CNV_LINC02576: 2.464291317721031, CNV_WDPCP: 2.38809584879993, CNV_CEP68: 2.464291317721031"
TCGA-AR-A1AQ,"High-level Amplification absent; no CNV calls meet amplification thresholds.  
FOXC1 mRNA overexpression (Z=1.80) and EN1 (Z=2.43) exceed high-expression cutoff.  
SPDEF, AGR3, SLC44A4, DEGS2, TFF3, THSD4, SLC7A8, ZNF552 show low mRNA (Z < -1.92).  
RNF130 promoter hypomethylation (Z=-1.57) may drive transcriptional dysregulation.  
hsa-mir-18a, hsa-mir-17, hsa-mir-577, hsa-mir-135b upregulated (Z > 1.99).","mRNA_MLPH: -1.808178172150904, mRNA_C2orf54: -0.0490073351459589, mRNA_CITED4: -0.4341572371886946, mRNA_ESR1: -1.6910898924034816, mRNA_SPDEF: -2.0145531062693336, mRNA_AGR3: -1.9150453735803543, mRNA_FOXC1: 1.8021408689056968, mRNA_GATA3: -0.9418867550773744, mRNA_AGR2: -1.4951128077016518, mRNA_XBP1: -1.109940206026479, mRNA_PRR15: -1.5204610472946245, mRNA_SLC44A4: -2.254919753516193, mRNA_CA12: -1.876659424741228, mRNA_DTL: -0.2487628143411033, mRNA_C5AR2: -1.8336601146403704, mRNA_TBC1D9: -1.8421853939389703, mRNA_AR: -1.693999369338121, mRNA_CCDC170: -1.615745605800744, mRNA_DEGS2: -2.1241394281601806, mRNA_TFF3: -2.161487458803544, mRNA_DNALI1: -1.9639123553184927, mRNA_LINC00504: -1.6789581895289063, mRNA_CLCA2: -0.0602245255583337, mRNA_PPP1R14C: 1.61516515710788, mRNA_THSD4: -2.198031302306044, mRNA_SPAG5: 0.1245485556084159, mRNA_FBP1: -1.4507739509781032, mRNA_SLC7A8: -2.2116474728514386, mRNA_EN1: 2.429014481078558, mRNA_ZNF552: -2.008382113177225, Methylation_LRRC6: 1.4970475454149532, Methylation_chr2 66218712 LINC02934 (29533): 0.2027197243933833, Methylation_HOXB13: 0.8806322580109253, Methylation_chr10 3949206 LINC02660 (4871): 1.6640526843346664, Methylation_chr5 179517140 RNF130 (18026): -1.5678025617858924, Methylation_LOC727677: 1.450745498004753, Methylation_LETM1: 1.3417299273393584, Methylation_CDC42BPB: 0.0498648462039602, Methylation_C8orf38: 1.67868982415893, Methylation_chr14 100504766 EVL (18852): 1.4825488876767583, Methylation_chr5 72594851 LOC340090 (24088): -1.3726449018638711, Methylation_chr2 242904738 LINC01238 (3421): 1.430167510816515, Methylation_ARFGEF1: 1.7435032477191643, Methylation_MAPT: 1.4210968191614195, Methylation_ZFAT: 1.4089616750892302, Methylation_KCNQ4: 0.5679027461847181, Methylation_chr1 232684368 SIPA1L2 (12934): 1.4172433132920454, Methylation_CRNKL1: 1.2361085313337818, Methylation_PRKAG2: -0.4929873469554823, Methylation_MICB: 1.2999004950809705, miRNA_hsa-mir-934: 2.392466659994385, miRNA_hsa-mir-4728: 0.2823433245253221, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 2.6753148869471914, miRNA_hsa-mir-190b: -0.4876395050150093, miRNA_hsa-mir-577: 2.458499220452025, miRNA_hsa-mir-135b: 2.00684453974035, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 2.487269545226108, miRNA_hsa-mir-130b: 1.0591091196067808, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A2-A1FZ,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.3983080005659137, mRNA_C2orf54: 1.2462585924005725, mRNA_CITED4: 0.0708565265088722, mRNA_ESR1: 0.9677837950192656, mRNA_SPDEF: 0.2541858132553523, mRNA_AGR3: 0.3514934305151748, mRNA_FOXC1: -0.0497910758297018, mRNA_GATA3: 0.7015080282710637, mRNA_AGR2: 0.3071413852155866, mRNA_XBP1: 0.8032724628001839, mRNA_PRR15: -0.0297976373049851, mRNA_SLC44A4: 0.4568686648297093, mRNA_CA12: 1.020175273919257, mRNA_DTL: 0.3002641752375211, mRNA_C5AR2: 0.7384838495900882, mRNA_TBC1D9: 1.4154267164651306, mRNA_AR: 0.7854041477050899, mRNA_CCDC170: 1.4205118445705471, mRNA_DEGS2: 0.6054826428402067, mRNA_TFF3: 0.6728460735019068, mRNA_DNALI1: -1.2214017374867778, mRNA_LINC00504: 1.0001328277732104, mRNA_CLCA2: 0.1196213799847742, mRNA_PPP1R14C: -0.2635883191206492, mRNA_THSD4: 1.293296530277992, mRNA_SPAG5: -0.4264633184251947, mRNA_FBP1: 0.4123183769333986, mRNA_SLC7A8: 0.3604767174568818, mRNA_EN1: -0.5858810609929924, mRNA_ZNF552: 0.7347093782813222, Methylation_LRRC6: 0.7466255960071115, Methylation_chr2 66218712 LINC02934 (29533): 1.125116404626752, Methylation_HOXB13: -0.999237131454466, Methylation_chr10 3949206 LINC02660 (4871): -0.1711729569432016, Methylation_chr5 179517140 RNF130 (18026): 0.3246821296170151, Methylation_LOC727677: 0.0610598833222984, Methylation_LETM1: -0.2282774146391239, Methylation_CDC42BPB: -0.9830122563977616, Methylation_C8orf38: -0.3241748851535888, Methylation_chr14 100504766 EVL (18852): 0.5747663386086377, Methylation_chr5 72594851 LOC340090 (24088): -0.060779267488132, Methylation_chr2 242904738 LINC01238 (3421): -0.5791487518962819, Methylation_ARFGEF1: 0.3036234556089155, Methylation_MAPT: 0.0482153262673795, Methylation_ZFAT: -0.0164420234276644, Methylation_KCNQ4: 0.4662460278703352, Methylation_chr1 232684368 SIPA1L2 (12934): 0.3676916405348318, Methylation_CRNKL1: 0.5782078538504651, Methylation_PRKAG2: 0.1804408936922345, Methylation_MICB: -0.2413956247465821, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.3212601647249155, miRNA_hsa-mir-5695: 0.7172152166192277, miRNA_hsa-mir-18a: -0.4064587373938538, miRNA_hsa-mir-190b: 0.9425548450531902, miRNA_hsa-mir-577: -0.4024887298614782, miRNA_hsa-mir-135b: -0.6232621865452207, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.5023734721617814, miRNA_hsa-mir-130b: 0.268392379915158, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E2-A10B,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives oncogenic transcriptional activity. HOXB13 promoter hypermethylation mediates epigenetic silencing. miR-4728 downregulation suggests loss of tumor-suppressive regulation. These features collectively indicate a luminal phenotype with ER signaling dysregulation.","mRNA_MLPH: 0.0468857997437322, mRNA_C2orf54: -0.1247864523711588, mRNA_CITED4: -0.3019812134101921, mRNA_ESR1: 0.9749810001686732, mRNA_SPDEF: 0.0541536065993873, mRNA_AGR3: 0.7040569909789477, mRNA_FOXC1: -0.5337646824955965, mRNA_GATA3: 0.9116333134105972, mRNA_AGR2: 0.7025676733214175, mRNA_XBP1: 0.4300740756313891, mRNA_PRR15: 0.4945000353467504, mRNA_SLC44A4: 0.7736321792753387, mRNA_CA12: 0.4734193748147653, mRNA_DTL: 0.330146348913827, mRNA_C5AR2: 1.2698120665718229, mRNA_TBC1D9: 1.1525928832295531, mRNA_AR: 0.9747334855089872, mRNA_CCDC170: 0.5084531498376528, mRNA_DEGS2: 0.7048364001639588, mRNA_TFF3: 0.6161393027347302, mRNA_DNALI1: 0.8105771064996455, mRNA_LINC00504: 0.4379375243365137, mRNA_CLCA2: -0.3014001770548111, mRNA_PPP1R14C: -0.5091838772529534, mRNA_THSD4: 0.5109345967696821, mRNA_SPAG5: 0.0635548509224185, mRNA_FBP1: 0.9582839139601472, mRNA_SLC7A8: 0.6650046300498614, mRNA_EN1: -0.153677296459341, mRNA_ZNF552: 0.983570956239884, Methylation_LRRC6: -0.2212697221979957, Methylation_chr2 66218712 LINC02934 (29533): 0.3474338770440706, Methylation_HOXB13: 1.5207453437930727, Methylation_chr10 3949206 LINC02660 (4871): 0.3058594230707661, Methylation_chr5 179517140 RNF130 (18026): 1.2551811707100644, Methylation_LOC727677: -0.299427217375773, Methylation_LETM1: -0.4541639622324784, Methylation_CDC42BPB: 1.3211113835181605, Methylation_C8orf38: -0.1523103700708747, Methylation_chr14 100504766 EVL (18852): -0.2544784407568148, Methylation_chr5 72594851 LOC340090 (24088): 1.2607928294636694, Methylation_chr2 242904738 LINC01238 (3421): -0.5425302720983762, Methylation_ARFGEF1: 0.1914966291997992, Methylation_MAPT: 0.1842050903337094, Methylation_ZFAT: 1.0386423155143265, Methylation_KCNQ4: -1.1001035597661974, Methylation_chr1 232684368 SIPA1L2 (12934): 0.0004966483645371, Methylation_CRNKL1: -0.8676094047599584, Methylation_PRKAG2: 1.2433652783248348, Methylation_MICB: -0.0205780157953775, miRNA_hsa-mir-934: -0.3143257497652444, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: 1.1177763353467634, miRNA_hsa-mir-18a: -0.190912844059885, miRNA_hsa-mir-190b: 0.7035009791605636, miRNA_hsa-mir-577: 0.0841941809381555, miRNA_hsa-mir-135b: -0.4042155980059378, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.989479968977638, miRNA_hsa-mir-130b: -0.1933736213149417, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-AC-A6IW,"High-level Amplification absent; no CNV alterations meet diagnostic thresholds.  
mRNA_FOXC1 (Z=1.32) and mRNA_PPP1R14C (Z=2.19), mRNA_EN1 (Z=2.30) are overexpressed.  
mRNA_SPDEF, GATA3, CA12, DNALI1 significantly downregulated (Z < -1.92).  
Promoter hypermethylation at chr10:3949206, C8orf38, ARFGEF1 (Z > 1.50); hypomethylation at RNF130, LOC340090 (Z < -1.47).  
miRNA_hsa-mir-934 upregulated (Z=2.23); miRNA_hsa-mir-190b downregulated (Z=-1.59).","mRNA_MLPH: -1.927650905315564, mRNA_C2orf54: -1.2051453849537432, mRNA_CITED4: 1.0892510083721498, mRNA_ESR1: -1.692559875496691, mRNA_SPDEF: -3.042066317931813, mRNA_AGR3: -1.2904078134880757, mRNA_FOXC1: 1.318718731536685, mRNA_GATA3: -2.8923081682895684, mRNA_AGR2: -1.5487900417482008, mRNA_XBP1: -2.3934552806142886, mRNA_PRR15: -1.5359197587787554, mRNA_SLC44A4: -1.9176007013436305, mRNA_CA12: -2.5614269319454794, mRNA_DTL: -0.8457717242487557, mRNA_C5AR2: -1.6402597849857872, mRNA_TBC1D9: -1.956226904730804, mRNA_AR: -1.893317490644444, mRNA_CCDC170: -0.9368691556675858, mRNA_DEGS2: -1.904935053157618, mRNA_TFF3: -1.749234733561633, mRNA_DNALI1: -2.0159857518812845, mRNA_LINC00504: -1.747632308610393, mRNA_CLCA2: -0.8260651691068877, mRNA_PPP1R14C: 2.194736474491166, mRNA_THSD4: -1.7223719063357763, mRNA_SPAG5: 0.9075011262423366, mRNA_FBP1: -1.53628618501085, mRNA_SLC7A8: -1.1291423054451404, mRNA_EN1: 2.2959264663567533, mRNA_ZNF552: -1.536875909873255, Methylation_LRRC6: 1.4736408177238596, Methylation_chr2 66218712 LINC02934 (29533): -0.1846864385147919, Methylation_HOXB13: 0.441095097964392, Methylation_chr10 3949206 LINC02660 (4871): 1.5297981326732664, Methylation_chr5 179517140 RNF130 (18026): -1.5627671786739747, Methylation_LOC727677: 1.459178036991728, Methylation_LETM1: 1.2672655993919044, Methylation_CDC42BPB: 0.0724496416651055, Methylation_C8orf38: 1.575887190563976, Methylation_chr14 100504766 EVL (18852): 1.4809081173677685, Methylation_chr5 72594851 LOC340090 (24088): -1.5437648827192236, Methylation_chr2 242904738 LINC01238 (3421): 1.2105989497784069, Methylation_ARFGEF1: 1.5772797394732787, Methylation_MAPT: 1.387697725494174, Methylation_ZFAT: 1.3101076777447325, Methylation_KCNQ4: 0.7483129720943057, Methylation_chr1 232684368 SIPA1L2 (12934): 1.4716159320217974, Methylation_CRNKL1: 1.3691050817388264, Methylation_PRKAG2: -0.6891421027495275, Methylation_MICB: 1.3181426213595844, miRNA_hsa-mir-934: 2.230771715891275, miRNA_hsa-mir-4728: -0.6345924597855058, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.8060153267242365, miRNA_hsa-mir-190b: -1.5926013127788727, miRNA_hsa-mir-577: 1.4429782194097878, miRNA_hsa-mir-135b: 0.1471511600216552, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.962700232353348, miRNA_hsa-mir-130b: 0.2906735569256738, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AC-A3TN,"No features meet the strict diagnostic thresholds for mRNA (Z > 1.30 or Z < -1.92), methylation (Z > 1.50 or Z < -1.47), miRNA (Z > 1.99 or Z < -1.25), or CNV (deletion, gain, amplification, or high-level amplification). All values fall within non-actionable ranges.","mRNA_MLPH: 1.2095505609867252, mRNA_C2orf54: 0.1833679670410366, mRNA_CITED4: 1.0634298495418872, mRNA_ESR1: 0.7628013049364144, mRNA_SPDEF: 0.7980695317134189, mRNA_AGR3: 0.812403855394126, mRNA_FOXC1: -0.8781767571616829, mRNA_GATA3: 0.7200913858392952, mRNA_AGR2: 0.0551700641095485, mRNA_XBP1: 1.3639379301766128, mRNA_PRR15: 0.6952632659180947, mRNA_SLC44A4: 0.8495998801708108, mRNA_CA12: 0.6786322430248607, mRNA_DTL: -1.3735057765886751, mRNA_C5AR2: 1.089509130869883, mRNA_TBC1D9: 0.6087316015916412, mRNA_AR: 0.1537244312886753, mRNA_CCDC170: 1.10938024902971, mRNA_DEGS2: 1.569503369678323, mRNA_TFF3: 0.7746147855714336, mRNA_DNALI1: 0.8175309700895008, mRNA_LINC00504: 1.0092079686209214, mRNA_CLCA2: -0.6079777632797503, mRNA_PPP1R14C: -0.8612741229598022, mRNA_THSD4: 0.5685453103807344, mRNA_SPAG5: -1.1584151065416406, mRNA_FBP1: 0.926252151265838, mRNA_SLC7A8: 0.4876692436638229, mRNA_EN1: -0.2387633843709925, mRNA_ZNF552: 1.2520061755770284, Methylation_LRRC6: -0.7406563345069999, Methylation_chr2 66218712 LINC02934 (29533): 1.2595901146935633, Methylation_HOXB13: 1.3468263366304056, Methylation_chr10 3949206 LINC02660 (4871): -1.2342155562913657, Methylation_chr5 179517140 RNF130 (18026): 1.207323507025845, Methylation_LOC727677: -1.1177114031569515, Methylation_LETM1: -1.4348320298070838, Methylation_CDC42BPB: -1.2787838524596984, Methylation_C8orf38: -1.2240008515945835, Methylation_chr14 100504766 EVL (18852): -1.2123603101231055, Methylation_chr5 72594851 LOC340090 (24088): 1.0897618022508224, Methylation_chr2 242904738 LINC01238 (3421): -1.161099898629805, Methylation_ARFGEF1: -0.861332230465278, Methylation_MAPT: -1.525188715270168, Methylation_ZFAT: -0.3776061933839493, Methylation_KCNQ4: 1.059456619619472, Methylation_chr1 232684368 SIPA1L2 (12934): -1.2955159378824523, Methylation_CRNKL1: -1.2546443778330858, Methylation_PRKAG2: 1.321757299168225, Methylation_MICB: -1.4327913756602846, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.3306758295416316, miRNA_hsa-mir-5695: 0.4426372381678833, miRNA_hsa-mir-18a: -0.7281753405663086, miRNA_hsa-mir-190b: 0.4656715020873187, miRNA_hsa-mir-577: -0.5996672621026222, miRNA_hsa-mir-135b: -0.7206447038554397, miRNA_hsa-mir-2115: 1.4780380089591871, miRNA_hsa-mir-17: -0.6776037658229351, miRNA_hsa-mir-130b: -0.8333712795523186, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E2-A2P6,"High-level Amplification of none; Deletion absent. LETM1 and SIPA1L2 promoters are hypermethylated (Z < -1.47), suggesting epigenetic silencing. No miRNA meets up/downregulation thresholds. MLPH mRNA is high (Z = 1.46 > 1.30). CCDC170 mRNA elevated but below threshold (Z = 1.26). Subtype indeterminate; limited driver events detected.","mRNA_MLPH: 1.4558081474808326, mRNA_C2orf54: -1.0180361469333894, mRNA_CITED4: 1.129777581033795, mRNA_ESR1: 0.8155444675664089, mRNA_SPDEF: 0.6673766555679936, mRNA_AGR3: 0.8213796404509845, mRNA_FOXC1: -0.4345062073119631, mRNA_GATA3: 0.5750272033182751, mRNA_AGR2: 0.5357167872086821, mRNA_XBP1: 0.2892607258259719, mRNA_PRR15: 0.2866174004675544, mRNA_SLC44A4: 0.4989609844786285, mRNA_CA12: 0.9338963235945744, mRNA_DTL: 0.4892858570802981, mRNA_C5AR2: 0.2658474812473924, mRNA_TBC1D9: 0.6194057177853164, mRNA_AR: -0.0024412444347268, mRNA_CCDC170: 1.2587328973034138, mRNA_DEGS2: 0.3053322944549334, mRNA_TFF3: 0.5024085871514882, mRNA_DNALI1: 0.5493777491226196, mRNA_LINC00504: 0.4384313576782677, mRNA_CLCA2: -0.7866806796449639, mRNA_PPP1R14C: -0.9100832821314212, mRNA_THSD4: 0.8456903862396221, mRNA_SPAG5: 0.3625150986265997, mRNA_FBP1: 0.5584148498072827, mRNA_SLC7A8: 0.1678075458774137, mRNA_EN1: -0.7460399940964012, mRNA_ZNF552: 0.6121993368464997, Methylation_LRRC6: -1.2698115372711234, Methylation_chr2 66218712 LINC02934 (29533): 1.198379906783286, Methylation_HOXB13: -1.0391663797649255, Methylation_chr10 3949206 LINC02660 (4871): -1.169972136358286, Methylation_chr5 179517140 RNF130 (18026): 1.2243666239163735, Methylation_LOC727677: -0.7895867968183718, Methylation_LETM1: -1.5445796729428174, Methylation_CDC42BPB: -1.070347048361686, Methylation_C8orf38: -0.8010440802145619, Methylation_chr14 100504766 EVL (18852): -1.3910724615717136, Methylation_chr5 72594851 LOC340090 (24088): 1.1510834017679736, Methylation_chr2 242904738 LINC01238 (3421): -1.2436607774595527, Methylation_ARFGEF1: -1.2121607780581782, Methylation_MAPT: -1.3363228596005792, Methylation_ZFAT: -1.0364411895993446, Methylation_KCNQ4: 0.4969499743640929, Methylation_chr1 232684368 SIPA1L2 (12934): -1.720318483919502, Methylation_CRNKL1: -1.1167249315569137, Methylation_PRKAG2: -1.4677162794105822, Methylation_MICB: -1.2378083155884738, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.2477207070421543, miRNA_hsa-mir-5695: -0.3579751653507631, miRNA_hsa-mir-18a: -1.0743056609856778, miRNA_hsa-mir-190b: 0.506121256124521, miRNA_hsa-mir-577: -0.6607739118045381, miRNA_hsa-mir-135b: -0.8901286212895051, miRNA_hsa-mir-2115: 1.7733807046186891, miRNA_hsa-mir-17: -0.8055547493790887, miRNA_hsa-mir-130b: -1.2168563249390412, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A2-A3XZ,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: -0.2246916289269964, mRNA_C2orf54: -1.1585557262629242, mRNA_CITED4: 0.0742522276150432, mRNA_ESR1: -1.769286720219476, mRNA_SPDEF: 0.6070238564087277, mRNA_AGR3: -1.3068272098884273, mRNA_FOXC1: -0.8306860984431113, mRNA_GATA3: -0.45297621282349, mRNA_AGR2: 0.2853400332757714, mRNA_XBP1: -0.3231899636525903, mRNA_PRR15: 0.8707505231097784, mRNA_SLC44A4: 0.5122458287649174, mRNA_CA12: -0.6750595145690854, mRNA_DTL: 0.0792532480379489, mRNA_C5AR2: -0.9920403631398956, mRNA_TBC1D9: -0.7159755234774509, mRNA_AR: -0.7431844018453211, mRNA_CCDC170: -1.4628350596055932, mRNA_DEGS2: -0.4804980615642207, mRNA_TFF3: 1.1801187213270266, mRNA_DNALI1: 0.7161339006508199, mRNA_LINC00504: -1.583424834344192, mRNA_CLCA2: 0.9264788607712352, mRNA_PPP1R14C: 0.0146252818418328, mRNA_THSD4: -0.4730874923735589, mRNA_SPAG5: 0.3116280276115277, mRNA_FBP1: 0.7073237045946922, mRNA_SLC7A8: -0.3144004064337785, mRNA_EN1: -0.4455065567552066, mRNA_ZNF552: -0.8183393443583444, Methylation_LRRC6: 1.245331975359253, Methylation_chr2 66218712 LINC02934 (29533): 0.3131671220491445, Methylation_HOXB13: 0.6971602561629213, Methylation_chr10 3949206 LINC02660 (4871): 1.2473384910501744, Methylation_chr5 179517140 RNF130 (18026): -1.5932501053671175, Methylation_LOC727677: 0.5087585532345615, Methylation_LETM1: 1.293448931124771, Methylation_CDC42BPB: -1.0202577159879036, Methylation_C8orf38: 1.4226818531130323, Methylation_chr14 100504766 EVL (18852): 1.1701569987700495, Methylation_chr5 72594851 LOC340090 (24088): -1.399203446421504, Methylation_chr2 242904738 LINC01238 (3421): 0.8107088519174974, Methylation_ARFGEF1: 1.4137171544450284, Methylation_MAPT: 1.4777440320854118, Methylation_ZFAT: 0.6466013850700372, Methylation_KCNQ4: -1.207791758081208, Methylation_chr1 232684368 SIPA1L2 (12934): 0.6949319671350496, Methylation_CRNKL1: 1.2343608435429454, Methylation_PRKAG2: -0.1477972910887489, Methylation_MICB: 1.1300190694326826, miRNA_hsa-mir-934: -0.3283853556994279, miRNA_hsa-mir-4728: 2.553746690682757, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.084048314476516, miRNA_hsa-mir-190b: -0.3351447494328073, miRNA_hsa-mir-577: 0.190194665689644, miRNA_hsa-mir-135b: -0.7883784109355733, miRNA_hsa-mir-2115: -0.4593052815941962, miRNA_hsa-mir-17: -0.1033302220316058, miRNA_hsa-mir-130b: 0.1953212987208406, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-C8-A26W,High-level Amplification of SPAG5 drives significant mRNA overexpression (Z=3.11). RNF130 promoter hypermethylation (Z=-1.53) mediates epigenetic silencing. No deletions or miRNA alterations meet diagnostic thresholds. These features collectively indicate a luminal phenotype with cell cycle dysregulation.,"mRNA_MLPH: -0.0804969950843078, mRNA_C2orf54: 0.6378509072842244, mRNA_CITED4: 0.4786680069137407, mRNA_ESR1: 0.4511867717666966, mRNA_SPDEF: 0.0222107474334177, mRNA_AGR3: 0.9452577489579286, mRNA_FOXC1: -0.50120673482078, mRNA_GATA3: 0.6311744392022762, mRNA_AGR2: 0.7138150815474879, mRNA_XBP1: 0.3522858946584256, mRNA_PRR15: 0.3335774785231244, mRNA_SLC44A4: 0.0586185448490821, mRNA_CA12: 0.5256658942119372, mRNA_DTL: 0.4723972769433042, mRNA_C5AR2: 0.6499317804494553, mRNA_TBC1D9: -0.2991108946917694, mRNA_AR: 0.5584215781251537, mRNA_CCDC170: 1.0426761436626115, mRNA_DEGS2: 0.1069491464801848, mRNA_TFF3: 0.1276668612528273, mRNA_DNALI1: 0.7397389219093483, mRNA_LINC00504: 0.0348338638376909, mRNA_CLCA2: -0.213323825158471, mRNA_PPP1R14C: -0.8551863972387066, mRNA_THSD4: 0.3324227693295836, mRNA_SPAG5: 3.108429446415566, mRNA_FBP1: 0.4368173577371913, mRNA_SLC7A8: 0.97602788281546, mRNA_EN1: -0.1194157431201086, mRNA_ZNF552: 0.1880804297539661, Methylation_LRRC6: -0.263685856871322, Methylation_chr2 66218712 LINC02934 (29533): -1.1956275472096016, Methylation_HOXB13: -1.0544005260058766, Methylation_chr10 3949206 LINC02660 (4871): -0.8705493897588105, Methylation_chr5 179517140 RNF130 (18026): -1.5330870231135447, Methylation_LOC727677: -0.6037575264126551, Methylation_LETM1: -0.7943400530914307, Methylation_CDC42BPB: 0.2202887390040937, Methylation_C8orf38: -0.9110418023835288, Methylation_chr14 100504766 EVL (18852): -0.4187256955136459, Methylation_chr5 72594851 LOC340090 (24088): -0.9676057170101232, Methylation_chr2 242904738 LINC01238 (3421): -1.1162544568740258, Methylation_ARFGEF1: -0.0314403306763714, Methylation_MAPT: 0.1564069872798536, Methylation_ZFAT: -0.6865504622165943, Methylation_KCNQ4: -0.6662427143993866, Methylation_chr1 232684368 SIPA1L2 (12934): -0.3515654365959414, Methylation_CRNKL1: 0.3242332697223865, Methylation_PRKAG2: -1.170832453933442, Methylation_MICB: -0.0282405841652167, miRNA_hsa-mir-934: -0.4275096389622956, miRNA_hsa-mir-4728: 0.2719433644616842, miRNA_hsa-mir-5695: 0.413990702912474, miRNA_hsa-mir-18a: -0.1917698716010682, miRNA_hsa-mir-190b: 0.0667731739060538, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.9410371214099552, miRNA_hsa-mir-2115: -0.3056159537818536, miRNA_hsa-mir-17: -0.212182590033218, miRNA_hsa-mir-130b: 0.2263590331728702, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-B6-A40B,High mRNA_CITED4 (Z=1.46) and mRNA_DEGS2 (Z=1.31) indicate overexpression. No methylation or miRNA alterations meet diagnostic thresholds. All CNVs fall within normal range (−1.10 to −0.10). These features collectively suggest luminal A phenotype with estrogen signaling preservation.,"mRNA_MLPH: 0.7733334845838646, mRNA_C2orf54: 0.6597247461649243, mRNA_CITED4: 1.464337209933121, mRNA_ESR1: -0.1162087486127491, mRNA_SPDEF: 0.6897144061068229, mRNA_AGR3: 0.8040643487878588, mRNA_FOXC1: -0.0819826056136119, mRNA_GATA3: 0.5355017446123431, mRNA_AGR2: 0.3434989207018761, mRNA_XBP1: 0.3234548519544604, mRNA_PRR15: 0.7020388473120637, mRNA_SLC44A4: 0.978758061392877, mRNA_CA12: 0.3226571693122262, mRNA_DTL: -0.0707204201058205, mRNA_C5AR2: 0.4521151808865563, mRNA_TBC1D9: -0.1818260883436472, mRNA_AR: 0.4827696257029258, mRNA_CCDC170: -0.2478588406043556, mRNA_DEGS2: 1.3053678538917128, mRNA_TFF3: 0.7476029324075618, mRNA_DNALI1: 0.6928073222812512, mRNA_LINC00504: 0.1886622239304374, mRNA_CLCA2: -0.0761877501509895, mRNA_PPP1R14C: 0.3128726081010338, mRNA_THSD4: 0.3523804518748184, mRNA_SPAG5: -0.3526207000741493, mRNA_FBP1: 0.8993128507051127, mRNA_SLC7A8: 1.087985397680195, mRNA_EN1: -0.0244680507660616, mRNA_ZNF552: 0.6126766611989887, Methylation_LRRC6: -0.0417820254480018, Methylation_chr2 66218712 LINC02934 (29533): 1.3551714635081145, Methylation_HOXB13: -0.9879680090076096, Methylation_chr10 3949206 LINC02660 (4871): -0.6370584698587619, Methylation_chr5 179517140 RNF130 (18026): 0.936013684325779, Methylation_LOC727677: -0.6467077062503362, Methylation_LETM1: -0.6827654523403824, Methylation_CDC42BPB: 1.389846881450627, Methylation_C8orf38: -0.9476475607837552, Methylation_chr14 100504766 EVL (18852): -0.6422225921371796, Methylation_chr5 72594851 LOC340090 (24088): 0.835676600701225, Methylation_chr2 242904738 LINC01238 (3421): -0.688344123451215, Methylation_ARFGEF1: -0.3034787453481684, Methylation_MAPT: -0.7812292915252987, Methylation_ZFAT: -0.3748415316612974, Methylation_KCNQ4: 0.7144195417713711, Methylation_chr1 232684368 SIPA1L2 (12934): -0.3918618614904716, Methylation_CRNKL1: -0.3673574124057736, Methylation_PRKAG2: 0.5614370012028871, Methylation_MICB: -0.3775076056210905, miRNA_hsa-mir-934: -0.1235339643045111, miRNA_hsa-mir-4728: -0.4598262301449526, miRNA_hsa-mir-5695: -0.0380274138966972, miRNA_hsa-mir-18a: 0.473825154929974, miRNA_hsa-mir-190b: 0.2998401867697421, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.6811415968772131, miRNA_hsa-mir-2115: 0.7864845222924229, miRNA_hsa-mir-17: 0.249584474198538, miRNA_hsa-mir-130b: -0.5672319903506825, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A7-A13H,"No mRNA, methylation, or miRNA features meet diagnostic thresholds. Deletions in VPS54, LINC02576, WDPCP, and CEP68 indicate genomic loss.","mRNA_MLPH: 1.1653483221069585, mRNA_C2orf54: 1.2902707829093152, mRNA_CITED4: 0.5338186026909355, mRNA_ESR1: 0.5678058017047087, mRNA_SPDEF: 0.5743847609452942, mRNA_AGR3: 0.3576106061526622, mRNA_FOXC1: 0.3366723679393719, mRNA_GATA3: 0.5584522241021604, mRNA_AGR2: 0.0752279115863149, mRNA_XBP1: 0.305525063596165, mRNA_PRR15: 0.5285148377396371, mRNA_SLC44A4: 0.9565549018945464, mRNA_CA12: 0.7275379629297912, mRNA_DTL: -1.524245830467748, mRNA_C5AR2: 0.5753001840463806, mRNA_TBC1D9: 0.7500850572541033, mRNA_AR: 0.625748322649706, mRNA_CCDC170: 0.2406125240253616, mRNA_DEGS2: 0.7632907076235903, mRNA_TFF3: 0.6757682846082036, mRNA_DNALI1: 0.799034077661194, mRNA_LINC00504: 0.0563066348848927, mRNA_CLCA2: 0.3051344367853933, mRNA_PPP1R14C: 0.2871679449981425, mRNA_THSD4: 0.917439764640634, mRNA_SPAG5: -0.9204562614751852, mRNA_FBP1: 1.1442807111520477, mRNA_SLC7A8: 0.477213265649387, mRNA_EN1: -0.2740875131478762, mRNA_ZNF552: 0.590226802588324, Methylation_LRRC6: 0.4611533318349949, Methylation_chr2 66218712 LINC02934 (29533): 0.7363582574224634, Methylation_HOXB13: -1.049935818303272, Methylation_chr10 3949206 LINC02660 (4871): 0.1818759630323791, Methylation_chr5 179517140 RNF130 (18026): -0.7023443794909269, Methylation_LOC727677: 0.1253774318050248, Methylation_LETM1: -0.012633229032067, Methylation_CDC42BPB: -0.5635323880197395, Methylation_C8orf38: 0.1910431331937565, Methylation_chr14 100504766 EVL (18852): 0.3999878533634694, Methylation_chr5 72594851 LOC340090 (24088): 0.4177999386000853, Methylation_chr2 242904738 LINC01238 (3421): -0.2490546251369494, Methylation_ARFGEF1: 0.5221517940236746, Methylation_MAPT: -0.0323923571763797, Methylation_ZFAT: 0.0798217430563137, Methylation_KCNQ4: -1.1539743555530997, Methylation_chr1 232684368 SIPA1L2 (12934): 0.5660670187376106, Methylation_CRNKL1: 0.3817987764757291, Methylation_PRKAG2: -0.216744912807216, Methylation_MICB: 0.7101136368890021, miRNA_hsa-mir-934: 0.0656965262419126, miRNA_hsa-mir-4728: -0.2810570639031239, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.4029139639515117, miRNA_hsa-mir-190b: 0.4910973750325078, miRNA_hsa-mir-577: -0.2472422862853372, miRNA_hsa-mir-135b: -0.3722175268127171, miRNA_hsa-mir-2115: -0.370570679781736, miRNA_hsa-mir-17: -0.1601036396555739, miRNA_hsa-mir-130b: -1.4345223774520222, CNV_VPS54: -1.6173912818721974, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -1.657048777669473, CNV_WDPCP: -1.6249341592372952, CNV_CEP68: -1.657048777669473"
TCGA-BH-A5IZ,"High-level Amplification of PPP1R14C drives significant mRNA overexpression. Promoter hypermethylation of ARFGEF1, MAPT, and KCNQ4 mediates epigenetic silencing. Deletion of VPS54 correlates with transcriptional downregulation. Upregulated miR-17 and miR-18a, with downregulated miR-190b, indicate luminal B phenotype with PI3K/AKT dysregulation.","mRNA_MLPH: -2.427566069019244, mRNA_C2orf54: 0.7173575845333211, mRNA_CITED4: -0.2241490190672109, mRNA_ESR1: -0.5742309402104165, mRNA_SPDEF: -2.138556076835105, mRNA_AGR3: -1.6431929110198698, mRNA_FOXC1: 1.8057912691851048, mRNA_GATA3: -1.5727342774246926, mRNA_AGR2: -1.309307420672441, mRNA_XBP1: -1.808120086482948, mRNA_PRR15: -2.578966650826926, mRNA_SLC44A4: 0.6619041806034413, mRNA_CA12: -1.819711024162592, mRNA_DTL: 0.1833842704315076, mRNA_C5AR2: -1.870517979055846, mRNA_TBC1D9: -2.0411527183296148, mRNA_AR: -2.393904546325893, mRNA_CCDC170: -1.8206957161874888, mRNA_DEGS2: -2.01283609308828, mRNA_TFF3: -1.355614661058436, mRNA_DNALI1: -1.979887690437931, mRNA_LINC00504: -1.6382122282374565, mRNA_CLCA2: -0.8841558460285638, mRNA_PPP1R14C: 2.9486895112655795, mRNA_THSD4: -0.5956382984865413, mRNA_SPAG5: 0.3346793695405332, mRNA_FBP1: -1.8941353462289745, mRNA_SLC7A8: -1.769399431522716, mRNA_EN1: 0.7871474279064279, mRNA_ZNF552: -1.987989667722149, Methylation_LRRC6: 1.5299269369939588, Methylation_chr2 66218712 LINC02934 (29533): -0.372399457862176, Methylation_HOXB13: -1.0230643450087538, Methylation_chr10 3949206 LINC02660 (4871): 1.5684171571572874, Methylation_chr5 179517140 RNF130 (18026): -1.5638167263365326, Methylation_LOC727677: 1.532726363038373, Methylation_LETM1: 1.3124454734685842, Methylation_CDC42BPB: 0.6972492141000974, Methylation_C8orf38: 1.666156772393215, Methylation_chr14 100504766 EVL (18852): 1.5349991533650846, Methylation_chr5 72594851 LOC340090 (24088): -1.524225173267915, Methylation_chr2 242904738 LINC01238 (3421): 1.2593989086309745, Methylation_ARFGEF1: 1.7582973427018744, Methylation_MAPT: 1.5226700284485268, Methylation_ZFAT: 1.4528999525979889, Methylation_KCNQ4: 1.5863446548167566, Methylation_chr1 232684368 SIPA1L2 (12934): 1.6448876253213944, Methylation_CRNKL1: 1.5067629852236544, Methylation_PRKAG2: -1.4785776120363814, Methylation_MICB: 1.526890683579896, miRNA_hsa-mir-934: 0.8917285229036205, miRNA_hsa-mir-4728: -0.8396867292579788, miRNA_hsa-mir-5695: 1.314532003790596, miRNA_hsa-mir-18a: 2.061827401884472, miRNA_hsa-mir-190b: -1.737966659690363, miRNA_hsa-mir-577: 1.2447307434633927, miRNA_hsa-mir-135b: 1.6961076375863724, miRNA_hsa-mir-2115: 0.1768336651726453, miRNA_hsa-mir-17: 2.511581977055121, miRNA_hsa-mir-130b: 0.8608097094212175, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A2-A3XU,"High-level Amplification absent; no CNVs meet amplification thresholds.  
mRNA_PPP1R14C (Z=3.19) and mRNA_FOXC1 (Z=2.48) are highly expressed; mRNA_XBP1 (Z=-3.01), mRNA_SPDEF (Z=-2.97), and mRNA_FBP1 (Z=-3.32) are low.  
Methylation_KCNQ4 (Z=2.10) and Methylation_chr10:3949206 (Z=1.66) are hypermethylated; Methylation_PRKAG2 (Z=-1.79) and Methylation_chr5:72594851 (Z=-1.61) are hypomethylated.  
miRNA_hsa-mir-577 (Z=3.11), miRNA_hsa-mir-17 (Z=2.46), and miRNA_hsa-mir-18a (Z=2.11) are upregulated.","mRNA_MLPH: -2.210564291160228, mRNA_C2orf54: -0.877836526243102, mRNA_CITED4: 1.3052187489489149, mRNA_ESR1: -1.5638649004601246, mRNA_SPDEF: -2.9650103009925566, mRNA_AGR3: -1.594316058556594, mRNA_FOXC1: 2.4821947752309943, mRNA_GATA3: -0.5504346609876102, mRNA_AGR2: -2.4275112244665498, mRNA_XBP1: -3.0149748782692987, mRNA_PRR15: -2.559643336323244, mRNA_SLC44A4: -2.446050199997721, mRNA_CA12: -1.020992611076431, mRNA_DTL: 0.3164310946689164, mRNA_C5AR2: -1.927442642087417, mRNA_TBC1D9: -1.619713506582145, mRNA_AR: -2.368477086892622, mRNA_CCDC170: -2.058858549468816, mRNA_DEGS2: -1.204825386830896, mRNA_TFF3: -2.063526899206215, mRNA_DNALI1: -1.2402652979142288, mRNA_LINC00504: -1.71346965995619, mRNA_CLCA2: -0.8299948559096604, mRNA_PPP1R14C: 3.194190868547699, mRNA_THSD4: -2.465024240528116, mRNA_SPAG5: 0.0116934331530388, mRNA_FBP1: -3.316183855632397, mRNA_SLC7A8: -2.3344561942567283, mRNA_EN1: 0.4276122008694391, mRNA_ZNF552: -2.327622505271184, Methylation_LRRC6: 1.5393822065905562, Methylation_chr2 66218712 LINC02934 (29533): -1.9276790641758303, Methylation_HOXB13: 0.9761074133253992, Methylation_chr10 3949206 LINC02660 (4871): 1.6552041230116543, Methylation_chr5 179517140 RNF130 (18026): -1.7088671616238662, Methylation_LOC727677: 1.4863425383053297, Methylation_LETM1: 1.348052371291447, Methylation_CDC42BPB: 1.4011252930924103, Methylation_C8orf38: 1.3969334610674984, Methylation_chr14 100504766 EVL (18852): 0.4438217168170952, Methylation_chr5 72594851 LOC340090 (24088): -1.6133264504478535, Methylation_chr2 242904738 LINC01238 (3421): 1.4531521644088623, Methylation_ARFGEF1: 1.4226049751949668, Methylation_MAPT: 1.5070984683809752, Methylation_ZFAT: 1.2425583182940796, Methylation_KCNQ4: 2.099366030972768, Methylation_chr1 232684368 SIPA1L2 (12934): 1.637810474208581, Methylation_CRNKL1: 0.7073833366912597, Methylation_PRKAG2: -1.791432594441302, Methylation_MICB: 1.50064643243582, miRNA_hsa-mir-934: -0.0809219548036883, miRNA_hsa-mir-4728: -0.557164917690222, miRNA_hsa-mir-5695: 0.0401862721761486, miRNA_hsa-mir-18a: 2.110088393840313, miRNA_hsa-mir-190b: -1.0663315651614156, miRNA_hsa-mir-577: 3.108904145662086, miRNA_hsa-mir-135b: 0.8355647833269466, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 2.460818127724344, miRNA_hsa-mir-130b: 1.5487474300993287, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A54X,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.5599028385435016, mRNA_C2orf54: -1.0811718953068312, mRNA_CITED4: -0.8234789685042646, mRNA_ESR1: 1.151918226266151, mRNA_SPDEF: 0.7489076322055419, mRNA_AGR3: 0.4565590235139766, mRNA_FOXC1: -0.8549221231466635, mRNA_GATA3: 0.7775719993919611, mRNA_AGR2: 0.9462178615294684, mRNA_XBP1: 0.8321007868021684, mRNA_PRR15: 1.0751549398409184, mRNA_SLC44A4: 0.6901930082368712, mRNA_CA12: 1.079830539392589, mRNA_DTL: -0.9174127828985494, mRNA_C5AR2: 0.5882228803430957, mRNA_TBC1D9: 0.1155968800030908, mRNA_AR: 0.4045862267367551, mRNA_CCDC170: 0.909270733718312, mRNA_DEGS2: 0.7001835122673872, mRNA_TFF3: 1.7684777584779183, mRNA_DNALI1: 1.2166276268437846, mRNA_LINC00504: 0.5831048203335683, mRNA_CLCA2: -0.8290859522615018, mRNA_PPP1R14C: 0.1613933037055672, mRNA_THSD4: 1.458881091921389, mRNA_SPAG5: -0.5408710012269414, mRNA_FBP1: -0.1438697781792303, mRNA_SLC7A8: 0.780404567139759, mRNA_EN1: -0.8560991731467501, mRNA_ZNF552: 0.4884611980199022, Methylation_LRRC6: -0.8507434989928827, Methylation_chr2 66218712 LINC02934 (29533): -0.272024983486647, Methylation_HOXB13: -1.0563695445982255, Methylation_chr10 3949206 LINC02660 (4871): 1.0797430111533897, Methylation_chr5 179517140 RNF130 (18026): -1.451738566554353, Methylation_LOC727677: -1.199514254917173, Methylation_LETM1: -1.23543919072896, Methylation_CDC42BPB: -0.7824573677130188, Methylation_C8orf38: -0.8264701508853421, Methylation_chr14 100504766 EVL (18852): -0.9158316954452862, Methylation_chr5 72594851 LOC340090 (24088): 0.3330016318952474, Methylation_chr2 242904738 LINC01238 (3421): -1.1116970765563272, Methylation_ARFGEF1: -0.7794670202187547, Methylation_MAPT: -0.5333136104567276, Methylation_ZFAT: -0.2465316504184599, Methylation_KCNQ4: -1.095406568897651, Methylation_chr1 232684368 SIPA1L2 (12934): -1.1322696937561032, Methylation_CRNKL1: -1.2174249645872914, Methylation_PRKAG2: -1.5630679244554362, Methylation_MICB: -0.9822986182589516, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.164021482745652, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.3734638079660701, miRNA_hsa-mir-190b: 0.8848722483617075, miRNA_hsa-mir-577: -0.3916932691262529, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.4118740210772266, miRNA_hsa-mir-130b: 0.5538288148317001, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AN-A0XT,"High-level Amplification of none; Deletion of VPS54, LINC01867, LINC02576, WDPCP, and CEP68. mRNA_THSD4 (Z=1.72) and mRNA_FBP1 (Z=1.33) are highly expressed. miRNA_hsa-mir-130b is downregulated (Z=-2.04). No promoter methylation changes meet hyper/hypo thresholds. These features suggest a basal-like phenotype with metabolic and cytoskeletal dysregulation.","mRNA_MLPH: 0.8128800618621299, mRNA_C2orf54: -1.2232221475321932, mRNA_CITED4: 0.1023118391138383, mRNA_ESR1: 1.2536136140633811, mRNA_SPDEF: 0.3261745848747239, mRNA_AGR3: 0.6348628861258481, mRNA_FOXC1: 0.0406959655064477, mRNA_GATA3: 0.8147185508742661, mRNA_AGR2: 0.4028380039820222, mRNA_XBP1: 0.4491567109534149, mRNA_PRR15: 1.1724906349743598, mRNA_SLC44A4: 0.5950744943653847, mRNA_CA12: 0.9611326526037424, mRNA_DTL: 0.3463294360144032, mRNA_C5AR2: 0.3363207272518362, mRNA_TBC1D9: 1.1949128413662122, mRNA_AR: 0.9799113494332582, mRNA_CCDC170: 0.8795154392367792, mRNA_DEGS2: 0.1170006736451603, mRNA_TFF3: -0.0996368577797864, mRNA_DNALI1: 0.5103322152587724, mRNA_LINC00504: -0.2764701251909257, mRNA_CLCA2: -0.8837614455393058, mRNA_PPP1R14C: -0.6499428444843781, mRNA_THSD4: 1.7249807839170703, mRNA_SPAG5: -0.8703426669448039, mRNA_FBP1: 1.3258918516236329, mRNA_SLC7A8: 0.1689951626335505, mRNA_EN1: -0.8592257670700031, mRNA_ZNF552: 0.8606725083841297, Methylation_LRRC6: -0.7612937344411623, Methylation_chr2 66218712 LINC02934 (29533): -1.3819351120955063, Methylation_HOXB13: -0.9822004933484608, Methylation_chr10 3949206 LINC02660 (4871): -0.9358020620237758, Methylation_chr5 179517140 RNF130 (18026): -1.4669214148554202, Methylation_LOC727677: -0.9566919377505044, Methylation_LETM1: -0.7528480948359899, Methylation_CDC42BPB: 1.0979389892650016, Methylation_C8orf38: -1.0633167537732968, Methylation_chr14 100504766 EVL (18852): -0.8437066693505768, Methylation_chr5 72594851 LOC340090 (24088): 0.6144118095648511, Methylation_chr2 242904738 LINC01238 (3421): -0.8885577571454223, Methylation_ARFGEF1: -1.1538666450068398, Methylation_MAPT: -0.1625371012712639, Methylation_ZFAT: -0.9519303401232774, Methylation_KCNQ4: -1.1533363418143252, Methylation_chr1 232684368 SIPA1L2 (12934): -1.021486766666079, Methylation_CRNKL1: -1.0563812281023994, Methylation_PRKAG2: -1.152971794788543, Methylation_MICB: -0.8774208980494966, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.3149256662488058, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.1900159111403836, miRNA_hsa-mir-190b: 0.1425952805617626, miRNA_hsa-mir-577: -0.1247903648311248, miRNA_hsa-mir-135b: -0.8198412992219075, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.0303816492057267, miRNA_hsa-mir-130b: -2.0439838929867333, CNV_VPS54: -1.6173912818721974, CNV_LINC01867: -1.63714039509435, CNV_LINC02576: -1.657048777669473, CNV_WDPCP: -1.6249341592372952, CNV_CEP68: -1.657048777669473"
TCGA-AC-A2B8,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.4288963864658378, mRNA_C2orf54: -0.5387062144520899, mRNA_CITED4: 1.0087411940318778, mRNA_ESR1: 0.2356073193690637, mRNA_SPDEF: 0.1873974449941844, mRNA_AGR3: 0.3891624050911692, mRNA_FOXC1: -0.0560701595012584, mRNA_GATA3: 0.2924437966350248, mRNA_AGR2: 0.2870908881579829, mRNA_XBP1: 0.6044042931356458, mRNA_PRR15: 0.3069205491232215, mRNA_SLC44A4: 0.4157306736313161, mRNA_CA12: 0.364581802139359, mRNA_DTL: 0.164044154835484, mRNA_C5AR2: 0.6864178851921006, mRNA_TBC1D9: 0.6242755500081685, mRNA_AR: 0.7145586067717082, mRNA_CCDC170: 1.210459160639518, mRNA_DEGS2: 0.3845776865134103, mRNA_TFF3: 0.3577592804528913, mRNA_DNALI1: 0.7542414253011573, mRNA_LINC00504: 1.0719137666613825, mRNA_CLCA2: 0.0369983001769361, mRNA_PPP1R14C: -0.6709955187310968, mRNA_THSD4: 0.4585991330814679, mRNA_SPAG5: -0.673748587322554, mRNA_FBP1: 0.3046383678170268, mRNA_SLC7A8: 0.701202137255946, mRNA_EN1: -0.3169887484465034, mRNA_ZNF552: 0.1231908995808907, Methylation_LRRC6: 0.480694988270447, Methylation_chr2 66218712 LINC02934 (29533): 0.2418806884017695, Methylation_HOXB13: -0.2524530204727737, Methylation_chr10 3949206 LINC02660 (4871): -0.1625586039775096, Methylation_chr5 179517140 RNF130 (18026): 0.4564032163274363, Methylation_LOC727677: -0.4636136214108729, Methylation_LETM1: -0.1624122497195868, Methylation_CDC42BPB: -1.104199424191506, Methylation_C8orf38: -0.2602784562205837, Methylation_chr14 100504766 EVL (18852): 0.1962560695693207, Methylation_chr5 72594851 LOC340090 (24088): 0.4318117894320935, Methylation_chr2 242904738 LINC01238 (3421): -0.7426866953917224, Methylation_ARFGEF1: 0.2128110178698366, Methylation_MAPT: 0.2332794800109932, Methylation_ZFAT: 0.4103888725161521, Methylation_KCNQ4: -0.8128117323215266, Methylation_chr1 232684368 SIPA1L2 (12934): -0.112908701377473, Methylation_CRNKL1: 0.3919229728382707, Methylation_PRKAG2: 0.5876737260111821, Methylation_MICB: -0.0121810431255087, miRNA_hsa-mir-934: -0.512346005931339, miRNA_hsa-mir-4728: -0.9635162611244984, miRNA_hsa-mir-5695: 0.3496788691921956, miRNA_hsa-mir-18a: -0.8040759453519034, miRNA_hsa-mir-190b: 0.3022425118663177, miRNA_hsa-mir-577: -0.2933667874565542, miRNA_hsa-mir-135b: -0.3659736467214903, miRNA_hsa-mir-2115: -0.5580226296170209, miRNA_hsa-mir-17: -0.8400482161930695, miRNA_hsa-mir-130b: -0.6822830052763984, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-GM-A2DB,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression.  
mRNA_C2orf54 is highly expressed (Z=1.56).  
mRNA_ESR1, GATA3, and CCDC170 are low (Z < -1.92), indicating luminal gene suppression.  
No methylation or miRNA alterations meet diagnostic thresholds.  
Collectively suggests a basal-like phenotype with luminal pathway suppression.","mRNA_MLPH: -0.5375885753904167, mRNA_C2orf54: 1.5641751111937467, mRNA_CITED4: 0.69380121917893, mRNA_ESR1: -1.923392686455771, mRNA_SPDEF: 0.0267519835458357, mRNA_AGR3: -1.7783230857252343, mRNA_FOXC1: -0.639676752709, mRNA_GATA3: -3.1087443666552503, mRNA_AGR2: -0.7594206237817864, mRNA_XBP1: -1.576439900187489, mRNA_PRR15: -0.7014983517298218, mRNA_SLC44A4: -0.7772836161299739, mRNA_CA12: -1.395328705329378, mRNA_DTL: -0.6176100275169694, mRNA_C5AR2: -1.5478885385976957, mRNA_TBC1D9: -1.6792877067470595, mRNA_AR: 0.2145758630759687, mRNA_CCDC170: -1.8493498203024188, mRNA_DEGS2: -0.8220580908247526, mRNA_TFF3: 0.3221404580199881, mRNA_DNALI1: -1.620221185049702, mRNA_LINC00504: -1.7330504456855784, mRNA_CLCA2: 0.5969547523592373, mRNA_PPP1R14C: 0.5340752138716842, mRNA_THSD4: -1.676769597940568, mRNA_SPAG5: -0.5507025746563664, mRNA_FBP1: -0.6923181676686103, mRNA_SLC7A8: -0.0597257150930322, mRNA_EN1: 0.5015178585247304, mRNA_ZNF552: -0.9883175964400808, Methylation_LRRC6: 1.482687332501025, Methylation_chr2 66218712 LINC02934 (29533): -0.4981331698824194, Methylation_HOXB13: 0.3528110085555617, Methylation_chr10 3949206 LINC02660 (4871): 0.2200557829642948, Methylation_chr5 179517140 RNF130 (18026): -0.4613659245723365, Methylation_LOC727677: 0.1130596593134275, Methylation_LETM1: 1.2289631390178244, Methylation_CDC42BPB: -1.1104709704763935, Methylation_C8orf38: 1.0162383251508296, Methylation_chr14 100504766 EVL (18852): 0.1749235587743745, Methylation_chr5 72594851 LOC340090 (24088): -0.7905344178919563, Methylation_chr2 242904738 LINC01238 (3421): 1.3592116789811988, Methylation_ARFGEF1: 0.9754285885286704, Methylation_MAPT: 1.2923501777521027, Methylation_ZFAT: 1.3997721273219672, Methylation_KCNQ4: -0.0198236041583208, Methylation_chr1 232684368 SIPA1L2 (12934): 0.8156796704202812, Methylation_CRNKL1: 1.4757618327805138, Methylation_PRKAG2: 0.4500024517464955, Methylation_MICB: 1.3768951382310688, miRNA_hsa-mir-934: -0.0895338296154525, miRNA_hsa-mir-4728: -1.059327658946666, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.0539670824297622, miRNA_hsa-mir-190b: -0.8754058837907418, miRNA_hsa-mir-577: -0.612085150287426, miRNA_hsa-mir-135b: -0.6860873250862807, miRNA_hsa-mir-2115: 1.903433799145174, miRNA_hsa-mir-17: 0.1715653950538772, miRNA_hsa-mir-130b: 0.3404441654828752, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-A2-A0YC,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.5547449440007417, mRNA_C2orf54: 0.6729602792441451, mRNA_CITED4: 0.1760017931702417, mRNA_ESR1: 0.8593014784913869, mRNA_SPDEF: 0.2114970888074772, mRNA_AGR3: 0.7667558076360822, mRNA_FOXC1: -0.9281759260163994, mRNA_GATA3: 0.5038402001456623, mRNA_AGR2: 0.0979826440692467, mRNA_XBP1: 1.2897386680893497, mRNA_PRR15: -0.135065762324735, mRNA_SLC44A4: 0.6967086433642725, mRNA_CA12: 0.972096629168708, mRNA_DTL: -0.1443695119215137, mRNA_C5AR2: 0.8437317843557596, mRNA_TBC1D9: 0.8300692160960949, mRNA_AR: 0.5365966441811031, mRNA_CCDC170: 1.4506127501176858, mRNA_DEGS2: 0.6520940428727887, mRNA_TFF3: 0.2044649763673323, mRNA_DNALI1: 1.0885700810288272, mRNA_LINC00504: 1.368480715975578, mRNA_CLCA2: -0.4547573918373102, mRNA_PPP1R14C: -0.968614732064824, mRNA_THSD4: 1.0165094590126396, mRNA_SPAG5: -0.2623940657583073, mRNA_FBP1: 0.7600367647308196, mRNA_SLC7A8: 0.7410076914235115, mRNA_EN1: -0.4649054812611712, mRNA_ZNF552: 1.1135896836381238, Methylation_LRRC6: -0.460914818363519, Methylation_chr2 66218712 LINC02934 (29533): 0.2090337708299348, Methylation_HOXB13: -0.9869478384351336, Methylation_chr10 3949206 LINC02660 (4871): -0.7786560591166254, Methylation_chr5 179517140 RNF130 (18026): 1.019520046885142, Methylation_LOC727677: 1.198344832255622, Methylation_LETM1: -0.6267129504745241, Methylation_CDC42BPB: -0.7000601679443532, Methylation_C8orf38: 0.6005488051480583, Methylation_chr14 100504766 EVL (18852): -0.5993956026491851, Methylation_chr5 72594851 LOC340090 (24088): 0.7353651745757576, Methylation_chr2 242904738 LINC01238 (3421): -0.9079366229907854, Methylation_ARFGEF1: -0.28416897666791, Methylation_MAPT: -1.2486412807323837, Methylation_ZFAT: 0.1297978796673914, Methylation_KCNQ4: -1.0734569261153617, Methylation_chr1 232684368 SIPA1L2 (12934): -0.7109633586253085, Methylation_CRNKL1: -0.5229883278652688, Methylation_PRKAG2: -0.1952576356893104, Methylation_MICB: -1.025993690713036, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.7948988005409686, miRNA_hsa-mir-5695: 1.1529465506495142, miRNA_hsa-mir-18a: -0.9320570334692811, miRNA_hsa-mir-190b: 0.597310227737806, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.4325109510155386, miRNA_hsa-mir-130b: -0.0151635753445833, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AN-A0XU,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression of FOXC1, PPP1R14C, SPAG5, and EN1. Promoter hypermethylation of ARFGEF1, LOC727677, and chr10:3949206 mediates epigenetic silencing. miRNA upregulation includes hsa-mir-18a, -577, -135b, and -17. These features indicate a basal-like phenotype with ER-pathway suppression.","mRNA_MLPH: -1.6323385953764478, mRNA_C2orf54: 0.3690360750155926, mRNA_CITED4: 0.4286802860398098, mRNA_ESR1: -0.8758387068028354, mRNA_SPDEF: -2.0982953346139137, mRNA_AGR3: -1.666349491528989, mRNA_FOXC1: 2.519127534021233, mRNA_GATA3: -1.8273980188584409, mRNA_AGR2: -1.857151619378452, mRNA_XBP1: -1.3509994216248111, mRNA_PRR15: -1.8991856378402927, mRNA_SLC44A4: -1.862047343655044, mRNA_CA12: -1.1178024099138215, mRNA_DTL: 0.3151812401450362, mRNA_C5AR2: -0.7908975059110591, mRNA_TBC1D9: -1.5113057443030875, mRNA_AR: -1.7231885147638677, mRNA_CCDC170: -1.1518449843461307, mRNA_DEGS2: -1.6492881762157676, mRNA_TFF3: -2.247890714333625, mRNA_DNALI1: -1.991168598207531, mRNA_LINC00504: -1.7039229418033948, mRNA_CLCA2: -0.807459128996871, mRNA_PPP1R14C: 2.1280164272234408, mRNA_THSD4: -1.435213974503413, mRNA_SPAG5: 1.5270870617311705, mRNA_FBP1: -1.6954929710843176, mRNA_SLC7A8: -1.1493515485631318, mRNA_EN1: 2.213102863586996, mRNA_ZNF552: -1.022088663086059, Methylation_LRRC6: 1.350644263180306, Methylation_chr2 66218712 LINC02934 (29533): -1.0222118920134151, Methylation_HOXB13: 1.4547360236570832, Methylation_chr10 3949206 LINC02660 (4871): 1.6316859319043728, Methylation_chr5 179517140 RNF130 (18026): -1.5995315710076925, Methylation_LOC727677: 1.535885465039855, Methylation_LETM1: 1.3752810260188326, Methylation_CDC42BPB: 1.1454355795268685, Methylation_C8orf38: 1.5940427431284387, Methylation_chr14 100504766 EVL (18852): 1.5005721077686511, Methylation_chr5 72594851 LOC340090 (24088): -1.5458381019997347, Methylation_chr2 242904738 LINC01238 (3421): 1.4572568326212914, Methylation_ARFGEF1: 1.699952287876126, Methylation_MAPT: 1.4262427488682567, Methylation_ZFAT: 1.4249830611028318, Methylation_KCNQ4: 1.5315844194690444, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5124123331257018, Methylation_CRNKL1: 1.2933601489558155, Methylation_PRKAG2: -0.3112440315363676, Methylation_MICB: 1.4784266917858149, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 1.1151973592112416, miRNA_hsa-mir-5695: 1.4079097462452197, miRNA_hsa-mir-18a: 1.9023058421758776, miRNA_hsa-mir-190b: -0.920178048008806, miRNA_hsa-mir-577: 1.7600663987783225, miRNA_hsa-mir-135b: 1.6843113369695313, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.72506756319433, miRNA_hsa-mir-130b: 0.9562163063585164, CNV_VPS54: 2.3735003872816955, CNV_LINC01867: 3.403528716117201, CNV_LINC02576: 2.464291317721031, CNV_WDPCP: 2.38809584879993, CNV_CEP68: 2.464291317721031"
TCGA-JL-A3YW,"High-level Amplification of LINC01867 drives mRNA overexpression. C2orf54 and CLCA2 show significant mRNA upregulation (Z > 1.30). ESR1, AGR3, GATA3, XBP1, and ZNF552 exhibit marked mRNA downregulation (Z < -1.92). miR-2115 is strongly upregulated (Z = 3.11); miR-190b is downregulated (Z = -1.47). Promoter hypermethylation at C8orf38, ZFAT, and LINC01238 (Z > 1.50) suggests epigenetic silencing. These features indicate a luminal B-like phenotype with ER-pathway suppression.","mRNA_MLPH: -0.1972938602312961, mRNA_C2orf54: 1.8407616446520128, mRNA_CITED4: -0.1549612777873741, mRNA_ESR1: -1.7596050087917878, mRNA_SPDEF: -0.2824813133817976, mRNA_AGR3: -1.6660225323678892, mRNA_FOXC1: -0.4051876275081756, mRNA_GATA3: -1.58181576753543, mRNA_AGR2: -0.783520937645902, mRNA_XBP1: -1.7067584124964237, mRNA_PRR15: -0.9416319720826798, mRNA_SLC44A4: -1.5468302250720454, mRNA_CA12: -1.0496424558049828, mRNA_DTL: -0.5647226895511771, mRNA_C5AR2: -1.026867811664793, mRNA_TBC1D9: -1.335441861975267, mRNA_AR: 0.3413414975532113, mRNA_CCDC170: -1.2440504412865174, mRNA_DEGS2: -0.9549047983904088, mRNA_TFF3: -1.004681995010169, mRNA_DNALI1: -1.4228285944282293, mRNA_LINC00504: -1.7231206758954467, mRNA_CLCA2: 1.4255290721184914, mRNA_PPP1R14C: 1.0623439320339092, mRNA_THSD4: -1.2252154362865109, mRNA_SPAG5: -0.8550606738952746, mRNA_FBP1: -0.1715818224371418, mRNA_SLC7A8: -0.7352561489611334, mRNA_EN1: 0.6594896561878142, mRNA_ZNF552: -1.7319362144337416, Methylation_LRRC6: 1.1784319920108528, Methylation_chr2 66218712 LINC02934 (29533): -0.1304159028885843, Methylation_HOXB13: 0.8973655462009998, Methylation_chr10 3949206 LINC02660 (4871): 0.0966941491716602, Methylation_chr5 179517140 RNF130 (18026): 0.3872378419221324, Methylation_LOC727677: 1.496249288429052, Methylation_LETM1: 1.2929734929517636, Methylation_CDC42BPB: -0.7164154964333465, Methylation_C8orf38: 1.5238289551642343, Methylation_chr14 100504766 EVL (18852): 1.4272974225640356, Methylation_chr5 72594851 LOC340090 (24088): 0.548801112166043, Methylation_chr2 242904738 LINC01238 (3421): 1.4587096196170597, Methylation_ARFGEF1: 0.8895753622279895, Methylation_MAPT: 1.3884649120533263, Methylation_ZFAT: 1.4286427040485643, Methylation_KCNQ4: 0.4940766861907403, Methylation_chr1 232684368 SIPA1L2 (12934): 1.3745635132024097, Methylation_CRNKL1: 1.3097745923124655, Methylation_PRKAG2: 0.9980278316826376, Methylation_MICB: 1.2060444723282358, miRNA_hsa-mir-934: 1.1510546346311985, miRNA_hsa-mir-4728: 0.3952813013232305, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.3661049238603557, miRNA_hsa-mir-190b: -1.4680071249361817, miRNA_hsa-mir-577: -0.5616634623734995, miRNA_hsa-mir-135b: 0.1263963493298299, miRNA_hsa-mir-2115: 3.1058040764945614, miRNA_hsa-mir-17: 0.2461222984362904, miRNA_hsa-mir-130b: -0.739091669652005, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 2.395394893874891, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-OL-A5RW,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression.  
Promoter hypermethylation of LINC02660, RNF130, LOC340090, PRKAG2 mediates epigenetic silencing.  
miR-934, miR-577, miR-135b, and miR-17 are upregulated; miR-190b is downregulated.  
These features indicate a luminal B phenotype with PI3K/AKT dysregulation.","mRNA_MLPH: -1.7147083020508682, mRNA_C2orf54: 1.1291297619815248, mRNA_CITED4: 0.5543383046163922, mRNA_ESR1: -2.02482217492042, mRNA_SPDEF: -2.8653716202583905, mRNA_AGR3: -1.0840825717526277, mRNA_FOXC1: 1.9945424092893065, mRNA_GATA3: -2.01650514964138, mRNA_AGR2: -2.452685521197203, mRNA_XBP1: -2.592225025312217, mRNA_PRR15: -1.9449747773604285, mRNA_SLC44A4: -2.192835388807741, mRNA_CA12: -1.9479760838634672, mRNA_DTL: 0.312522781621056, mRNA_C5AR2: -1.7890322862530168, mRNA_TBC1D9: -2.609158579582973, mRNA_AR: -2.3781267803903265, mRNA_CCDC170: -1.7501028254129098, mRNA_DEGS2: -0.2849229700734533, mRNA_TFF3: -1.775619615096962, mRNA_DNALI1: -1.8437002465750736, mRNA_LINC00504: -1.6016338114257531, mRNA_CLCA2: -0.5683742668721021, mRNA_PPP1R14C: 0.9735012422772754, mRNA_THSD4: -1.3047918021855505, mRNA_SPAG5: -0.4140862439874392, mRNA_FBP1: -1.817667496407805, mRNA_SLC7A8: -0.7910612018036296, mRNA_EN1: 3.378888638577123, mRNA_ZNF552: -1.6362999049254792, Methylation_LRRC6: 1.484912117785911, Methylation_chr2 66218712 LINC02934 (29533): -1.1570343861182542, Methylation_HOXB13: 1.4456305446667732, Methylation_chr10 3949206 LINC02660 (4871): 1.6450710029480555, Methylation_chr5 179517140 RNF130 (18026): -1.4956214781703303, Methylation_LOC727677: 1.5159841001686196, Methylation_LETM1: 1.2569573127300862, Methylation_CDC42BPB: 1.393225266712995, Methylation_C8orf38: 1.5490219561435343, Methylation_chr14 100504766 EVL (18852): 1.556660876208808, Methylation_chr5 72594851 LOC340090 (24088): -1.594550573342211, Methylation_chr2 242904738 LINC01238 (3421): 1.3398478519132675, Methylation_ARFGEF1: 1.4237163822192118, Methylation_MAPT: 1.4607313901541374, Methylation_ZFAT: 1.3367095873925217, Methylation_KCNQ4: 1.5684582217041694, Methylation_chr1 232684368 SIPA1L2 (12934): 1.4182873905556157, Methylation_CRNKL1: 1.093988470421496, Methylation_PRKAG2: -1.6225259946706287, Methylation_MICB: 1.5065689442746273, miRNA_hsa-mir-934: 3.3941257684193813, miRNA_hsa-mir-4728: 0.757132243908147, miRNA_hsa-mir-5695: -0.1637763965166639, miRNA_hsa-mir-18a: 1.7798503454459935, miRNA_hsa-mir-190b: -1.463500255218268, miRNA_hsa-mir-577: 2.1056883050234854, miRNA_hsa-mir-135b: 2.1775948455563285, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 2.0291088821478174, miRNA_hsa-mir-130b: 0.1215072604641412, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-BH-A0DQ,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.2985941418766437, mRNA_C2orf54: 0.0122291112696076, mRNA_CITED4: -0.490043008810907, mRNA_ESR1: 0.1806789836853931, mRNA_SPDEF: 0.4898614245759156, mRNA_AGR3: 0.4182320855760888, mRNA_FOXC1: 0.0041506182521716, mRNA_GATA3: 0.3444461829245585, mRNA_AGR2: 0.4795700531892805, mRNA_XBP1: -0.0459269399468033, mRNA_PRR15: 0.451326902298215, mRNA_SLC44A4: 0.5164154777354845, mRNA_CA12: 0.4917831199456668, mRNA_DTL: 0.1606369190313311, mRNA_C5AR2: 0.488775110111986, mRNA_TBC1D9: 0.6305615537157049, mRNA_AR: 0.0740386916085873, mRNA_CCDC170: 0.2257370843624078, mRNA_DEGS2: -0.4160381963864572, mRNA_TFF3: 0.968100462704691, mRNA_DNALI1: 0.5049226168889727, mRNA_LINC00504: 0.4700804198602313, mRNA_CLCA2: 0.5265875462895662, mRNA_PPP1R14C: -0.3625750468842704, mRNA_THSD4: 0.2401348740309877, mRNA_SPAG5: -0.0772226518940453, mRNA_FBP1: 0.6408181082957092, mRNA_SLC7A8: 0.6877543218878696, mRNA_EN1: 0.1074778787659298, mRNA_ZNF552: 0.2658739165260156, Methylation_LRRC6: -0.5616246054906384, Methylation_chr2 66218712 LINC02934 (29533): -1.513958061417375, Methylation_HOXB13: -0.9672097296382844, Methylation_chr10 3949206 LINC02660 (4871): -0.6891863444971845, Methylation_chr5 179517140 RNF130 (18026): 0.552980725666773, Methylation_LOC727677: -0.6882411044266027, Methylation_LETM1: -0.503839548509362, Methylation_CDC42BPB: -0.7021032470373018, Methylation_C8orf38: -0.4853707799775363, Methylation_chr14 100504766 EVL (18852): -0.1950849657522661, Methylation_chr5 72594851 LOC340090 (24088): -1.2629461192829583, Methylation_chr2 242904738 LINC01238 (3421): -0.5899406914424374, Methylation_ARFGEF1: -0.4557959438841799, Methylation_MAPT: 0.0476298017884223, Methylation_ZFAT: -0.8418426000292402, Methylation_KCNQ4: -1.1333900703856226, Methylation_chr1 232684368 SIPA1L2 (12934): -0.3849055838976333, Methylation_CRNKL1: -0.512220676176945, Methylation_PRKAG2: 1.3056422809982504, Methylation_MICB: -0.2983781767387352, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.3153847161413129, miRNA_hsa-mir-190b: 1.1926387603362825, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: 0.5921432438359633, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.1138348029394876, miRNA_hsa-mir-130b: -0.8076194529758842, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AC-A62Y,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. No promoter hyper/hypomethylation or miRNA dysregulation meets diagnostic thresholds. These features collectively indicate a luminal phenotype with genomic instability.","mRNA_MLPH: 0.5797522543225982, mRNA_C2orf54: -1.2463943544274894, mRNA_CITED4: 0.5976635485800817, mRNA_ESR1: 0.9772454576803388, mRNA_SPDEF: 0.4418399134125265, mRNA_AGR3: 1.10882458023108, mRNA_FOXC1: -0.6695363774585411, mRNA_GATA3: 0.3323440158044075, mRNA_AGR2: 0.9110227774886336, mRNA_XBP1: 0.6077504548914314, mRNA_PRR15: 0.3665146464921008, mRNA_SLC44A4: 0.7603069613656246, mRNA_CA12: 0.2974699644442559, mRNA_DTL: -0.167147989904361, mRNA_C5AR2: 1.4625502636536916, mRNA_TBC1D9: 0.3386434190678719, mRNA_AR: 0.9795785651981562, mRNA_CCDC170: 0.7410032394771571, mRNA_DEGS2: 0.5693369131842372, mRNA_TFF3: 0.9904851751704152, mRNA_DNALI1: -0.2937380193365335, mRNA_LINC00504: 0.1554920662873298, mRNA_CLCA2: -0.4075912247562607, mRNA_PPP1R14C: -0.9616765119112248, mRNA_THSD4: 0.2282405976972177, mRNA_SPAG5: -1.0211764377729855, mRNA_FBP1: 0.3255312662829114, mRNA_SLC7A8: 0.3159707581747861, mRNA_EN1: 1.4710431957481729, mRNA_ZNF552: 1.4049815840365636, Methylation_LRRC6: -0.1154552121046304, Methylation_chr2 66218712 LINC02934 (29533): -0.203712745730789, Methylation_HOXB13: -0.1996245730417226, Methylation_chr10 3949206 LINC02660 (4871): -0.6299748555297628, Methylation_chr5 179517140 RNF130 (18026): -0.3315081038682465, Methylation_LOC727677: -0.672938257411419, Methylation_LETM1: -0.2167028013945617, Methylation_CDC42BPB: -1.0929277407489593, Methylation_C8orf38: -0.4849324011291978, Methylation_chr14 100504766 EVL (18852): -0.8349774874308787, Methylation_chr5 72594851 LOC340090 (24088): 0.02765162140576, Methylation_chr2 242904738 LINC01238 (3421): -1.009931828162903, Methylation_ARFGEF1: -0.1054534202072864, Methylation_MAPT: -0.0624305010146796, Methylation_ZFAT: -0.2574131841979954, Methylation_KCNQ4: 1.338327406966506, Methylation_chr1 232684368 SIPA1L2 (12934): -0.061808002270891, Methylation_CRNKL1: -0.8729116934563043, Methylation_PRKAG2: -1.0081537382472578, Methylation_MICB: 0.0293359380062801, miRNA_hsa-mir-934: -0.3632775424111873, miRNA_hsa-mir-4728: -0.4925271835893995, miRNA_hsa-mir-5695: 0.1265727589572009, miRNA_hsa-mir-18a: -0.3599108116556167, miRNA_hsa-mir-190b: 0.9978070380696872, miRNA_hsa-mir-577: -0.6438850109926811, miRNA_hsa-mir-135b: -0.9043988843112128, miRNA_hsa-mir-2115: -0.4915320351132287, miRNA_hsa-mir-17: -0.3017154580122647, miRNA_hsa-mir-130b: -0.9899230942254394, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-C8-A1HL,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression of SPAG5 (Z=1.52), TFF3 (Z=1.42), and FBP1 (Z=1.10). Hypomethylation of PRKAG2 (Z=-1.44) and chr2:66218712 (Z=-1.77) correlates with transcriptional dysregulation. miR-4728 is upregulated (Z=2.42). These features indicate a luminal B phenotype with PI3K/AKT/mTOR pathway activation.","mRNA_MLPH: 0.6566010891255627, mRNA_C2orf54: 0.6141064719237905, mRNA_CITED4: -0.8267501179957288, mRNA_ESR1: -0.1387199462819503, mRNA_SPDEF: 0.7363285368798009, mRNA_AGR3: 0.7394907652385565, mRNA_FOXC1: -0.3804494513765089, mRNA_GATA3: 0.3182255551235402, mRNA_AGR2: 0.9213345885790852, mRNA_XBP1: 0.0166431307181295, mRNA_PRR15: 0.5528416459523031, mRNA_SLC44A4: 0.8112969104286881, mRNA_CA12: -0.2350624993633296, mRNA_DTL: 0.8375880094830569, mRNA_C5AR2: 0.3403139795298948, mRNA_TBC1D9: 0.1868254037571662, mRNA_AR: 0.1465316751151737, mRNA_CCDC170: 0.7908263032801423, mRNA_DEGS2: -1.3975973456653796, mRNA_TFF3: 1.423917644591164, mRNA_DNALI1: 0.5170675068432347, mRNA_LINC00504: -0.6509526813181812, mRNA_CLCA2: -0.7732344801970654, mRNA_PPP1R14C: -0.9438214368739316, mRNA_THSD4: 0.3027492091819548, mRNA_SPAG5: 1.515570129649872, mRNA_FBP1: 1.0965897928451516, mRNA_SLC7A8: -0.8177255120717911, mRNA_EN1: -0.3553498436803424, mRNA_ZNF552: 0.095300843474333, Methylation_LRRC6: -1.0775884948740964, Methylation_chr2 66218712 LINC02934 (29533): -1.7745390408608437, Methylation_HOXB13: 0.6384670087932094, Methylation_chr10 3949206 LINC02660 (4871): -0.9853683178280872, Methylation_chr5 179517140 RNF130 (18026): -0.3346273652151819, Methylation_LOC727677: -0.9930781787191016, Methylation_LETM1: -0.7212395163160613, Methylation_CDC42BPB: 1.456062216799621, Methylation_C8orf38: -0.9103517029612906, Methylation_chr14 100504766 EVL (18852): -1.3420758692524424, Methylation_chr5 72594851 LOC340090 (24088): 1.3147562281585854, Methylation_chr2 242904738 LINC01238 (3421): -0.8542484624191976, Methylation_ARFGEF1: -0.9120383826736856, Methylation_MAPT: 1.234969331217726, Methylation_ZFAT: -0.9437337544257192, Methylation_KCNQ4: -1.1792266342342308, Methylation_chr1 232684368 SIPA1L2 (12934): -1.145971971525391, Methylation_CRNKL1: -1.2007103982792684, Methylation_PRKAG2: -1.4351683886892077, Methylation_MICB: -1.029074811343964, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 2.4247587568918183, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.064940283253936, miRNA_hsa-mir-190b: 1.4603168265664108, miRNA_hsa-mir-577: -0.2315045245148796, miRNA_hsa-mir-135b: -0.7732370173923868, miRNA_hsa-mir-2115: -0.1549701979565959, miRNA_hsa-mir-17: -0.4433062194623245, miRNA_hsa-mir-130b: 0.8739923524326944, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-LL-A7SZ,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.4059240565534384, mRNA_C2orf54: -1.153487433493963, mRNA_CITED4: 0.9589431783992286, mRNA_ESR1: -0.6560789440417995, mRNA_SPDEF: 0.2446887976023737, mRNA_AGR3: -0.0130746084172959, mRNA_FOXC1: -1.3659568873265793, mRNA_GATA3: -0.7685815893138787, mRNA_AGR2: -0.0494531845839263, mRNA_XBP1: -0.3091587824450174, mRNA_PRR15: 0.021570754640022, mRNA_SLC44A4: -0.6624768186855113, mRNA_CA12: -0.6261054990035632, mRNA_DTL: -1.2250785644241975, mRNA_C5AR2: 0.3788736531326582, mRNA_TBC1D9: -1.3072287928634807, mRNA_AR: -0.3708586830195216, mRNA_CCDC170: -1.4380955661018897, mRNA_DEGS2: -0.2055150858047917, mRNA_TFF3: 0.7917793579022255, mRNA_DNALI1: 0.1073814052957557, mRNA_LINC00504: -1.1174605839991751, mRNA_CLCA2: -0.8199447843889094, mRNA_PPP1R14C: -1.0152145129432155, mRNA_THSD4: -1.6850843713293853, mRNA_SPAG5: -0.9175726311133644, mRNA_FBP1: -0.2569945862471771, mRNA_SLC7A8: -0.264499869817179, mRNA_EN1: -0.9173553507034186, mRNA_ZNF552: -1.4386968721282225, Methylation_LRRC6: -0.2631300268399144, Methylation_chr2 66218712 LINC02934 (29533): 1.0904870466111491, Methylation_HOXB13: -1.049701639289014, Methylation_chr10 3949206 LINC02660 (4871): 0.1167681308813147, Methylation_chr5 179517140 RNF130 (18026): 0.4632146619421702, Methylation_LOC727677: -0.5845944917930433, Methylation_LETM1: 0.7472521227891115, Methylation_CDC42BPB: 0.7680610105368365, Methylation_C8orf38: -0.135914865435292, Methylation_chr14 100504766 EVL (18852): 0.7256222523220701, Methylation_chr5 72594851 LOC340090 (24088): 0.1979623635802189, Methylation_chr2 242904738 LINC01238 (3421): 0.3587222848828675, Methylation_ARFGEF1: -0.9998716536692532, Methylation_MAPT: -0.4200167780594777, Methylation_ZFAT: -0.7492408118492146, Methylation_KCNQ4: 0.2655218619611063, Methylation_chr1 232684368 SIPA1L2 (12934): 0.596246136976859, Methylation_CRNKL1: 0.9417309531688166, Methylation_PRKAG2: 0.924603821107446, Methylation_MICB: 0.6305643029335309, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.0405662339116805, miRNA_hsa-mir-5695: -0.2845205959043148, miRNA_hsa-mir-18a: 0.202784984107955, miRNA_hsa-mir-190b: 0.6806656716977953, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: 0.1310634532716056, miRNA_hsa-mir-2115: 0.8139996902115328, miRNA_hsa-mir-17: 0.5078431917987024, miRNA_hsa-mir-130b: -0.0488025298932745, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AC-A7VC,"High-level Amplification of none; Deletion absent.  
FOXC1 mRNA overexpression (Z=1.75) exceeds threshold.  
ESR1, GATA3, SPDEF, AGR2, XBP1, FBP1, ZNF552 mRNAs significantly downregulated (Z < -1.92).  
RNF130 and LOC340090 promoters hypomethylated (Z < -1.47); ARFGEF1, SIPA1L2 hypermethylated (Z > 1.50).  
miR-190b downregulated (Z=-1.91); miR-18a, miR-130b upregulated (Z > 1.99).  
Collectively indicate luminal B phenotype with ER-pathway suppression.","mRNA_MLPH: -1.9293385297499648, mRNA_C2orf54: -1.2536241704341446, mRNA_CITED4: -1.50732689881496, mRNA_ESR1: -1.9237005615112863, mRNA_SPDEF: -2.450197530658837, mRNA_AGR3: -1.7892467819112892, mRNA_FOXC1: 1.7457632922468735, mRNA_GATA3: -2.948725218706316, mRNA_AGR2: -2.242385974840713, mRNA_XBP1: -2.594541150322143, mRNA_PRR15: -2.346036456135709, mRNA_SLC44A4: -1.7976180244940714, mRNA_CA12: -0.9622935608801058, mRNA_DTL: -0.0981521496120945, mRNA_C5AR2: -1.1125456691474933, mRNA_TBC1D9: -1.90636344777304, mRNA_AR: -1.933885239918641, mRNA_CCDC170: -1.7028278013146303, mRNA_DEGS2: -2.3723307966992024, mRNA_TFF3: -1.3273010554302656, mRNA_DNALI1: -0.5211981735050296, mRNA_LINC00504: -1.470665729195685, mRNA_CLCA2: 0.5553546531621928, mRNA_PPP1R14C: -0.3454296994016715, mRNA_THSD4: -1.0949373490387142, mRNA_SPAG5: 0.1795404117522829, mRNA_FBP1: -2.8632657678391342, mRNA_SLC7A8: -0.5324530200974895, mRNA_EN1: 0.5259892185980939, mRNA_ZNF552: -2.669865444777233, Methylation_LRRC6: 1.4275900446210257, Methylation_chr2 66218712 LINC02934 (29533): -1.0278599293165107, Methylation_HOXB13: -0.928055666322967, Methylation_chr10 3949206 LINC02660 (4871): 1.0632121430769164, Methylation_chr5 179517140 RNF130 (18026): -1.6189348875907483, Methylation_LOC727677: 1.5034487234790064, Methylation_LETM1: 1.3179843708541763, Methylation_CDC42BPB: 0.2948265133832768, Methylation_C8orf38: 1.3840974321302917, Methylation_chr14 100504766 EVL (18852): 1.434098623846848, Methylation_chr5 72594851 LOC340090 (24088): -1.5400508070784282, Methylation_chr2 242904738 LINC01238 (3421): 1.373275761025751, Methylation_ARFGEF1: 1.5798131975723568, Methylation_MAPT: 1.4129054596746902, Methylation_ZFAT: 1.360693223339719, Methylation_KCNQ4: -1.226544400609739, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5296094310073045, Methylation_CRNKL1: 1.2636316239994771, Methylation_PRKAG2: -0.5630852975408344, Methylation_MICB: 1.2081770632077655, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -1.085539416609289, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.8560722062396728, miRNA_hsa-mir-190b: -1.9122204858838927, miRNA_hsa-mir-577: -0.6292436922471932, miRNA_hsa-mir-135b: -0.1646708524024847, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.4452214778332215, miRNA_hsa-mir-130b: 1.820249579533064, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-S3-AA12,"High-level Amplification of none; FBP1 mRNA overexpressed (Z=1.90).  
LETM1, MAPT, ZFAT, and LINC02934 promoters hypermethylated (Z < -1.47), suggesting silencing.  
No miRNAs meet up/downregulation thresholds.  
Deletions absent; all CNVs normal.  
Collectively indicates luminal phenotype with metabolic (FBP1) dysregulation.","mRNA_MLPH: 1.5021502941265523, mRNA_C2orf54: -1.2943230935752186, mRNA_CITED4: 0.8778016335912479, mRNA_ESR1: 0.97356863675202, mRNA_SPDEF: 0.8662802950470301, mRNA_AGR3: -1.2042036293891298, mRNA_FOXC1: -0.4074002766485888, mRNA_GATA3: 1.3630594104133598, mRNA_AGR2: -0.147072548970337, mRNA_XBP1: 1.2159826015692192, mRNA_PRR15: 1.2154277823244226, mRNA_SLC44A4: 0.678670819079946, mRNA_CA12: 0.827621069547522, mRNA_DTL: -0.2027658367288851, mRNA_C5AR2: 1.166506716693442, mRNA_TBC1D9: 0.8459766375033723, mRNA_AR: -0.4425410333916143, mRNA_CCDC170: 0.7724756164503743, mRNA_DEGS2: 1.0880462144431324, mRNA_TFF3: -0.3346455006871167, mRNA_DNALI1: 1.1669554128557524, mRNA_LINC00504: 1.1580391261188483, mRNA_CLCA2: -0.5957800500552067, mRNA_PPP1R14C: -1.1019720959242252, mRNA_THSD4: 0.8815200983080959, mRNA_SPAG5: 0.2387914028874356, mRNA_FBP1: 1.9035506998926304, mRNA_SLC7A8: 0.5906073818508498, mRNA_EN1: -0.5589929185377973, mRNA_ZNF552: 0.7502347947967996, Methylation_LRRC6: -1.6734566955508487, Methylation_chr2 66218712 LINC02934 (29533): -1.934468651625816, Methylation_HOXB13: -0.9508027489765296, Methylation_chr10 3949206 LINC02660 (4871): -1.3570957321666324, Methylation_chr5 179517140 RNF130 (18026): 1.2807484731096592, Methylation_LOC727677: -1.5885556215266208, Methylation_LETM1: -2.17691835560087, Methylation_CDC42BPB: 1.4749704247514577, Methylation_C8orf38: -1.4253576838225526, Methylation_chr14 100504766 EVL (18852): -1.5951023240185234, Methylation_chr5 72594851 LOC340090 (24088): -1.5175770065905778, Methylation_chr2 242904738 LINC01238 (3421): -0.1527793309391616, Methylation_ARFGEF1: -1.5652651549668046, Methylation_MAPT: -1.931916596385068, Methylation_ZFAT: -1.962061328020222, Methylation_KCNQ4: 2.161913222769231, Methylation_chr1 232684368 SIPA1L2 (12934): -1.1648963585305612, Methylation_CRNKL1: -1.73446253964773, Methylation_PRKAG2: 0.8827740741438727, Methylation_MICB: -1.4008722639025466, miRNA_hsa-mir-934: -0.4308795646351815, miRNA_hsa-mir-4728: 0.4114683494908842, miRNA_hsa-mir-5695: 0.8424930468430062, miRNA_hsa-mir-18a: 0.3027435478471556, miRNA_hsa-mir-190b: 0.3416150791973608, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: 1.63897102837122, miRNA_hsa-mir-17: 0.7651060759139138, miRNA_hsa-mir-130b: -1.0778413181908086, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A24O,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-significant ranges per specified Z-score and CNV cutoffs.","mRNA_MLPH: 0.355156748522935, mRNA_C2orf54: 0.0503168669254466, mRNA_CITED4: -0.4204433971247756, mRNA_ESR1: 0.3346547334861382, mRNA_SPDEF: 0.2241808182130594, mRNA_AGR3: 0.843603127149573, mRNA_FOXC1: 0.570454251673287, mRNA_GATA3: 0.189125229361607, mRNA_AGR2: 0.3492201221743573, mRNA_XBP1: 0.6451281534980974, mRNA_PRR15: 0.0422904256392125, mRNA_SLC44A4: 0.5823868879380079, mRNA_CA12: 0.8041737571886146, mRNA_DTL: 0.0872686470593395, mRNA_C5AR2: 0.5373413979696766, mRNA_TBC1D9: 0.5675342894880965, mRNA_AR: 0.6859391936735795, mRNA_CCDC170: 1.003206795770606, mRNA_DEGS2: 0.3776956465710078, mRNA_TFF3: 0.763694281179735, mRNA_DNALI1: 0.5086795946069603, mRNA_LINC00504: -0.1007085790059718, mRNA_CLCA2: 0.3452791685862377, mRNA_PPP1R14C: 0.2495881541426153, mRNA_THSD4: 0.8080334698543087, mRNA_SPAG5: -0.1902975769229287, mRNA_FBP1: 0.214465611078259, mRNA_SLC7A8: 0.3852102884120353, mRNA_EN1: -0.0571943110517042, mRNA_ZNF552: 1.1142378682369825, Methylation_LRRC6: 0.7539264175976198, Methylation_chr2 66218712 LINC02934 (29533): 0.0187688287488917, Methylation_HOXB13: -0.9918960368350176, Methylation_chr10 3949206 LINC02660 (4871): -0.2372359954131369, Methylation_chr5 179517140 RNF130 (18026): 0.0707026851570763, Methylation_LOC727677: 0.2639421315534778, Methylation_LETM1: 0.5207306336197933, Methylation_CDC42BPB: -0.908787678432782, Methylation_C8orf38: 0.277458757426643, Methylation_chr14 100504766 EVL (18852): 0.5067824033033493, Methylation_chr5 72594851 LOC340090 (24088): -0.1843395337629384, Methylation_chr2 242904738 LINC01238 (3421): -0.5826830522229645, Methylation_ARFGEF1: 0.6145232627621202, Methylation_MAPT: 0.3679731546227523, Methylation_ZFAT: 0.2826185706001375, Methylation_KCNQ4: -1.037469546139561, Methylation_chr1 232684368 SIPA1L2 (12934): 0.4032426872237015, Methylation_CRNKL1: 0.3823091414219063, Methylation_PRKAG2: -0.117492622724043, Methylation_MICB: 0.315074043097265, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.307834778992785, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.7732497541593687, miRNA_hsa-mir-190b: -0.1424697335687604, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.6732878380625836, miRNA_hsa-mir-2115: 0.1410430949043376, miRNA_hsa-mir-17: -0.8458580935812517, miRNA_hsa-mir-130b: -0.6221917175671424, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A1XZ,"No features meet the strict diagnostic thresholds for reporting. All mRNA Z-scores fall within [-1.92, 1.30], methylation Z-scores within [-1.47, 1.50], miRNA Z-scores within [-1.25, 1.99], and CNV values within [-1.10, 0.90). No actionable genomic, epigenomic, or transcriptomic alterations detected.","mRNA_MLPH: -0.025547645998525, mRNA_C2orf54: -0.9151859807403286, mRNA_CITED4: -1.134149645714425, mRNA_ESR1: 0.0385613916029695, mRNA_SPDEF: 0.3270539982293425, mRNA_AGR3: 0.7380418173697921, mRNA_FOXC1: -0.6404898183272941, mRNA_GATA3: 0.5317658151127578, mRNA_AGR2: 0.1743680384636342, mRNA_XBP1: 0.4896553174903539, mRNA_PRR15: 0.518147991888602, mRNA_SLC44A4: 0.1676840228648095, mRNA_CA12: 0.0860370565635333, mRNA_DTL: -0.4813207746687095, mRNA_C5AR2: 0.5554190237624066, mRNA_TBC1D9: -0.0226000687317077, mRNA_AR: 0.3638309963012466, mRNA_CCDC170: 0.3196352529254144, mRNA_DEGS2: 0.4433825844421752, mRNA_TFF3: -0.9726444220792014, mRNA_DNALI1: 0.6689458516395319, mRNA_LINC00504: 1.139971321934171, mRNA_CLCA2: -0.8950940779111158, mRNA_PPP1R14C: -0.7407288276798057, mRNA_THSD4: -0.6074976360865263, mRNA_SPAG5: 1.820671412208494, mRNA_FBP1: 1.062601694556271, mRNA_SLC7A8: 1.777455841987584, mRNA_EN1: -0.2147342926406122, mRNA_ZNF552: -0.4967628584984526, Methylation_LRRC6: -1.2063053351328623, Methylation_chr2 66218712 LINC02934 (29533): -0.6335626175753623, Methylation_HOXB13: 1.2611544431846256, Methylation_chr10 3949206 LINC02660 (4871): -1.278843441721139, Methylation_chr5 179517140 RNF130 (18026): 0.4726896395346114, Methylation_LOC727677: -1.4173449688529267, Methylation_LETM1: -1.3015632798965544, Methylation_CDC42BPB: 1.3166049263256834, Methylation_C8orf38: -1.4185289942604729, Methylation_chr14 100504766 EVL (18852): -0.912246446233134, Methylation_chr5 72594851 LOC340090 (24088): -1.0935681253446463, Methylation_chr2 242904738 LINC01238 (3421): -1.2928607706207116, Methylation_ARFGEF1: -1.0806032494579794, Methylation_MAPT: -0.3195816058787782, Methylation_ZFAT: -1.848992511962405, Methylation_KCNQ4: 1.3153652298336809, Methylation_chr1 232684368 SIPA1L2 (12934): -0.6258647105060652, Methylation_CRNKL1: -1.24474185348995, Methylation_PRKAG2: -1.6479599009313957, Methylation_MICB: -1.2349392290230452, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.5455586419452012, miRNA_hsa-mir-5695: 1.5770327279926408, miRNA_hsa-mir-18a: 1.0986277466878074, miRNA_hsa-mir-190b: -0.5884074772159441, miRNA_hsa-mir-577: -0.1959410094884463, miRNA_hsa-mir-135b: 0.7719493429074761, miRNA_hsa-mir-2115: -0.3705954441692151, miRNA_hsa-mir-17: 1.6293461281450536, miRNA_hsa-mir-130b: 0.9232205645720204, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-B6-A0RN,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.517735110554143, mRNA_C2orf54: -0.4205947265325899, mRNA_CITED4: 1.2341595901003497, mRNA_ESR1: 0.498815456372678, mRNA_SPDEF: 0.4385957726069636, mRNA_AGR3: 0.4372987495182357, mRNA_FOXC1: -0.8590562586561201, mRNA_GATA3: 0.9150711167832328, mRNA_AGR2: 0.2443552420900344, mRNA_XBP1: 0.1624876928688264, mRNA_PRR15: 0.8408554677878932, mRNA_SLC44A4: 0.7939834306333257, mRNA_CA12: 0.1804623136180587, mRNA_DTL: -1.3828863795657598, mRNA_C5AR2: 0.1952644976675454, mRNA_TBC1D9: 0.7326423350586386, mRNA_AR: 0.706606307916715, mRNA_CCDC170: 0.6088745174031122, mRNA_DEGS2: 1.1120004464813666, mRNA_TFF3: -0.1301494896408037, mRNA_DNALI1: 0.9222267806308444, mRNA_LINC00504: 0.914740549093782, mRNA_CLCA2: -0.0929238964421678, mRNA_PPP1R14C: -1.1378807899171288, mRNA_THSD4: 0.4272068718633905, mRNA_SPAG5: -1.6880805106070225, mRNA_FBP1: 0.4590700330515639, mRNA_SLC7A8: 1.1147753127322368, mRNA_EN1: 0.1401356782346952, mRNA_ZNF552: -0.5034076091627548, Methylation_LRRC6: -0.8614085121666889, Methylation_chr2 66218712 LINC02934 (29533): 0.3410607274325222, Methylation_HOXB13: -0.0750074877332546, Methylation_chr10 3949206 LINC02660 (4871): -1.174832843414762, Methylation_chr5 179517140 RNF130 (18026): 0.9828294912571482, Methylation_LOC727677: -0.8501528818445782, Methylation_LETM1: -1.050009008928232, Methylation_CDC42BPB: -1.3003892583657464, Methylation_C8orf38: -0.9666145906570718, Methylation_chr14 100504766 EVL (18852): -1.054377494227233, Methylation_chr5 72594851 LOC340090 (24088): 1.2769194812715845, Methylation_chr2 242904738 LINC01238 (3421): -1.1415817219308857, Methylation_ARFGEF1: -0.9587712809195856, Methylation_MAPT: -1.164091688304288, Methylation_ZFAT: -0.9862438875615396, Methylation_KCNQ4: 1.791090718227229, Methylation_chr1 232684368 SIPA1L2 (12934): -1.205052778635672, Methylation_CRNKL1: -0.3123498284360999, Methylation_PRKAG2: 0.3017354578379193, Methylation_MICB: -1.15812601906043, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.5689562419199425, miRNA_hsa-mir-5695: 2.37543087948894, miRNA_hsa-mir-18a: -1.204479704350552, miRNA_hsa-mir-190b: 0.5063065243707912, miRNA_hsa-mir-577: -0.5688484334397778, miRNA_hsa-mir-135b: -1.0760250508778666, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.1187170260504955, miRNA_hsa-mir-130b: -0.5596005720325374, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E2-A1IE,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.7995419778182972, mRNA_C2orf54: -1.207326102984991, mRNA_CITED4: 0.0227095694452762, mRNA_ESR1: 0.8413941323696176, mRNA_SPDEF: 0.5412931232336211, mRNA_AGR3: 0.9107364097907936, mRNA_FOXC1: -0.6625855182948526, mRNA_GATA3: 0.8299004158824486, mRNA_AGR2: 1.089631514531619, mRNA_XBP1: 0.507188186268788, mRNA_PRR15: 0.815752983539887, mRNA_SLC44A4: 0.6494658644846659, mRNA_CA12: 0.0734315064867479, mRNA_DTL: 0.2928184344662465, mRNA_C5AR2: 1.0972596297868114, mRNA_TBC1D9: 1.1045172381108834, mRNA_AR: 0.361723265761989, mRNA_CCDC170: 0.787940066371936, mRNA_DEGS2: 0.2057589862618773, mRNA_TFF3: 1.0799308511454209, mRNA_DNALI1: 1.0044700596065967, mRNA_LINC00504: 0.6745621738279933, mRNA_CLCA2: -0.6018726318950156, mRNA_PPP1R14C: -0.6438316491998678, mRNA_THSD4: 1.2605849936119076, mRNA_SPAG5: 0.7507240617180239, mRNA_FBP1: 1.0821635085337158, mRNA_SLC7A8: 0.6652375058806352, mRNA_EN1: -0.6997687904911203, mRNA_ZNF552: 0.9292687495720492, Methylation_LRRC6: -0.6013897015099483, Methylation_chr2 66218712 LINC02934 (29533): -1.6680927674333486, Methylation_HOXB13: -0.1858463561292354, Methylation_chr10 3949206 LINC02660 (4871): -0.9480690433867228, Methylation_chr5 179517140 RNF130 (18026): 0.7445616424091466, Methylation_LOC727677: -0.7922205338388453, Methylation_LETM1: -0.9541739415136437, Methylation_CDC42BPB: 0.2735830312854054, Methylation_C8orf38: -1.145059573235513, Methylation_chr14 100504766 EVL (18852): 0.4499104974434871, Methylation_chr5 72594851 LOC340090 (24088): 0.8571746240216597, Methylation_chr2 242904738 LINC01238 (3421): -1.0514517815697433, Methylation_ARFGEF1: -0.7686419137795976, Methylation_MAPT: -1.3163129728492866, Methylation_ZFAT: -0.8134589193449616, Methylation_KCNQ4: -0.2891960605643524, Methylation_chr1 232684368 SIPA1L2 (12934): -0.9320418774142688, Methylation_CRNKL1: -1.103624998024542, Methylation_PRKAG2: 0.5492248235175924, Methylation_MICB: -0.9471901482440658, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.2553936080155153, miRNA_hsa-mir-5695: 1.981803701893712, miRNA_hsa-mir-18a: 0.2641926381160867, miRNA_hsa-mir-190b: 0.8813861936056437, miRNA_hsa-mir-577: -0.5727672468296086, miRNA_hsa-mir-135b: 0.0878171217504175, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.5224118431709878, miRNA_hsa-mir-130b: 0.7494573658212292, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A0H7,mRNA_C2orf54 overexpression (Z=1.81) indicates high transcriptional activity. HOXB13 promoter hypermethylation (Z=1.68) suggests epigenetic silencing. ARFGEF1 hypomethylation (Z=-1.43) may enhance expression. No miRNAs meet dysregulation thresholds. All CNVs fall within normal range. These features align with a luminal molecular subtype and potential HOX pathway disruption.,"mRNA_MLPH: 0.3300036475175654, mRNA_C2orf54: 1.8145861823720213, mRNA_CITED4: 0.293338866743117, mRNA_ESR1: 0.3121664588417606, mRNA_SPDEF: 0.6090241537167393, mRNA_AGR3: 0.7556008578847512, mRNA_FOXC1: -0.3479953025214164, mRNA_GATA3: -0.0222207860529873, mRNA_AGR2: 0.2412388349263159, mRNA_XBP1: 0.7313197275627771, mRNA_PRR15: 0.4413517292614871, mRNA_SLC44A4: 0.304679251965382, mRNA_CA12: 0.0770199070665279, mRNA_DTL: 0.3558243903599654, mRNA_C5AR2: -0.0801522373416195, mRNA_TBC1D9: 0.7543681856948101, mRNA_AR: -0.3025536149044491, mRNA_CCDC170: -0.1139238586353599, mRNA_DEGS2: -0.214196001597764, mRNA_TFF3: 0.3185866868749283, mRNA_DNALI1: -1.0482851212124404, mRNA_LINC00504: -0.6996644225779821, mRNA_CLCA2: -0.1706819814692355, mRNA_PPP1R14C: -0.3977759920164462, mRNA_THSD4: 0.4174812102474327, mRNA_SPAG5: -0.1673928043618777, mRNA_FBP1: 0.8418528728422949, mRNA_SLC7A8: -0.3419347456820019, mRNA_EN1: -0.0786720013834905, mRNA_ZNF552: 0.5624403643618375, Methylation_LRRC6: -1.0335750900974552, Methylation_chr2 66218712 LINC02934 (29533): -0.7764162269238009, Methylation_HOXB13: 1.6779940155584987, Methylation_chr10 3949206 LINC02660 (4871): -1.0292184901455503, Methylation_chr5 179517140 RNF130 (18026): 1.17727829328597, Methylation_LOC727677: -0.4777724532985935, Methylation_LETM1: -0.7761907203510612, Methylation_CDC42BPB: 1.3873754604450872, Methylation_C8orf38: -0.6675220328598183, Methylation_chr14 100504766 EVL (18852): -0.4144718452842377, Methylation_chr5 72594851 LOC340090 (24088): 0.8956756082183908, Methylation_chr2 242904738 LINC01238 (3421): 1.418069338643324, Methylation_ARFGEF1: -1.4269945756159914, Methylation_MAPT: -0.5294723599923644, Methylation_ZFAT: -0.7818223835128254, Methylation_KCNQ4: -0.6036969933473895, Methylation_chr1 232684368 SIPA1L2 (12934): -0.5996277794850509, Methylation_CRNKL1: -1.257643691532715, Methylation_PRKAG2: -1.1526697092102638, Methylation_MICB: -0.7622085725448925, miRNA_hsa-mir-934: 0.2685413654456092, miRNA_hsa-mir-4728: -0.722809952245462, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.0095043378276076, miRNA_hsa-mir-190b: 0.5976755195720475, miRNA_hsa-mir-577: -0.1457513112124587, miRNA_hsa-mir-135b: -0.5298286987886817, miRNA_hsa-mir-2115: 1.6625874598789965, miRNA_hsa-mir-17: -0.8689928929436194, miRNA_hsa-mir-130b: -0.1879699281414995, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AC-A3BB,"No mRNA, methylation, or miRNA features meet diagnostic thresholds. CNV shows amplification (not high-level) of VPS54, LINC01867, LINC02576, WDPCP, and CEP68. Insufficient evidence for subtype classification or pathway dysregulation.","mRNA_MLPH: 0.599895402593566, mRNA_C2orf54: 0.5646993378481205, mRNA_CITED4: 1.0534602063120104, mRNA_ESR1: -0.2400006419850597, mRNA_SPDEF: 0.4741794913103524, mRNA_AGR3: 0.4572844728588077, mRNA_FOXC1: -0.1488588643012402, mRNA_GATA3: 0.2665863504444234, mRNA_AGR2: 0.5198684886683634, mRNA_XBP1: -0.1316169356509764, mRNA_PRR15: 0.6053349428623958, mRNA_SLC44A4: 0.227942359493381, mRNA_CA12: 0.452231799625784, mRNA_DTL: -0.9709001885803912, mRNA_C5AR2: 0.6333386229236676, mRNA_TBC1D9: 0.0037049184720245, mRNA_AR: 0.439848354397196, mRNA_CCDC170: 0.3465687514358747, mRNA_DEGS2: 0.876068289811778, mRNA_TFF3: 0.3682645760199404, mRNA_DNALI1: 0.5242373724614814, mRNA_LINC00504: 0.1221246246328582, mRNA_CLCA2: -0.2017598321748507, mRNA_PPP1R14C: -0.7634164509134218, mRNA_THSD4: 0.0102987044997346, mRNA_SPAG5: -1.5347483124389236, mRNA_FBP1: 0.6354586516686542, mRNA_SLC7A8: 0.1978060199990123, mRNA_EN1: -0.0746091375232898, mRNA_ZNF552: 0.6780512871771563, Methylation_LRRC6: 0.770287083363402, Methylation_chr2 66218712 LINC02934 (29533): 1.0869288535627222, Methylation_HOXB13: -0.9444253959223838, Methylation_chr10 3949206 LINC02660 (4871): -0.1775526365619007, Methylation_chr5 179517140 RNF130 (18026): 0.2296114825743404, Methylation_LOC727677: 0.0447224997066932, Methylation_LETM1: 0.3387535898050939, Methylation_CDC42BPB: -0.8796063817312718, Methylation_C8orf38: 0.4440479413950385, Methylation_chr14 100504766 EVL (18852): 1.0910002343421388, Methylation_chr5 72594851 LOC340090 (24088): 0.3665456142007966, Methylation_chr2 242904738 LINC01238 (3421): -0.1991231651156254, Methylation_ARFGEF1: 1.0358002925239491, Methylation_MAPT: 0.5832184384279436, Methylation_ZFAT: 0.3885236803504092, Methylation_KCNQ4: -0.8681898885855074, Methylation_chr1 232684368 SIPA1L2 (12934): 0.0600053428533781, Methylation_CRNKL1: 0.5069167843384239, Methylation_PRKAG2: 1.088575461425355, Methylation_MICB: 1.1652890203410664, miRNA_hsa-mir-934: -0.3975701504902345, miRNA_hsa-mir-4728: -0.2886431587904114, miRNA_hsa-mir-5695: -0.3622342828176493, miRNA_hsa-mir-18a: -0.2958508996474342, miRNA_hsa-mir-190b: -0.1210106894262247, miRNA_hsa-mir-577: -0.6617970486817821, miRNA_hsa-mir-135b: -1.0133961889288805, miRNA_hsa-mir-2115: -0.0075677162775985, miRNA_hsa-mir-17: -0.8467986262342034, miRNA_hsa-mir-130b: -0.7476742408598193, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-B6-A409,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression of PPP1R14C and EN1. Promoter hypermethylation of LRRC6, C8orf38, EVL, ARFGEF1, and SIPA1L2 mediates epigenetic silencing. miR-135b and miR-934 are upregulated; miR-4728 is downregulated. These features indicate a luminal B phenotype with PI3K/AKT pathway dysregulation.","mRNA_MLPH: -1.0048630761898871, mRNA_C2orf54: -0.9876983230783174, mRNA_CITED4: 1.1409593504902338, mRNA_ESR1: -1.671026702464039, mRNA_SPDEF: -1.8339162373353803, mRNA_AGR3: -1.378967024721939, mRNA_FOXC1: 1.6076703821621154, mRNA_GATA3: -1.6560192097269577, mRNA_AGR2: -1.1416092357112853, mRNA_XBP1: -1.8114501921141528, mRNA_PRR15: -1.963904049063304, mRNA_SLC44A4: -1.869863087215994, mRNA_CA12: -1.949543295724485, mRNA_DTL: 0.1176114710336299, mRNA_C5AR2: -1.7259281564204356, mRNA_TBC1D9: -1.630665038442198, mRNA_AR: -1.892239296672096, mRNA_CCDC170: -1.7999461752072297, mRNA_DEGS2: -1.5914534589065286, mRNA_TFF3: -1.0988427355432304, mRNA_DNALI1: -0.9315554474676688, mRNA_LINC00504: -1.6394502388515635, mRNA_CLCA2: -0.8316340036736467, mRNA_PPP1R14C: 2.5844204980513705, mRNA_THSD4: -1.8962781561711723, mRNA_SPAG5: -0.7057998096307819, mRNA_FBP1: -2.265007754503223, mRNA_SLC7A8: -1.4179382267584797, mRNA_EN1: 2.566147581047961, mRNA_ZNF552: -1.8358065977743911, Methylation_LRRC6: 1.5106181767455622, Methylation_chr2 66218712 LINC02934 (29533): -0.946159528249372, Methylation_HOXB13: 0.2328511418429198, Methylation_chr10 3949206 LINC02660 (4871): 1.4895525228262745, Methylation_chr5 179517140 RNF130 (18026): -1.6290062432499623, Methylation_LOC727677: 1.4884050412010548, Methylation_LETM1: 1.336199720463419, Methylation_CDC42BPB: 0.9948304704868508, Methylation_C8orf38: 1.6041967287033787, Methylation_chr14 100504766 EVL (18852): 1.5492039555296997, Methylation_chr5 72594851 LOC340090 (24088): -1.1222277822561155, Methylation_chr2 242904738 LINC01238 (3421): 0.8226397313418303, Methylation_ARFGEF1: 1.8201832715718107, Methylation_MAPT: 1.4688181528121669, Methylation_ZFAT: 1.3399200631800832, Methylation_KCNQ4: 1.3437222972111684, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5344222546707085, Methylation_CRNKL1: 1.448748388438037, Methylation_PRKAG2: -0.5318839044903815, Methylation_MICB: 1.51579279463478, miRNA_hsa-mir-934: 2.502016214845621, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.6869816227459222, miRNA_hsa-mir-190b: -1.178861182563726, miRNA_hsa-mir-577: 1.02295288519711, miRNA_hsa-mir-135b: 2.762308323131104, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.1226883817872866, miRNA_hsa-mir-130b: 1.0074404583533434, CNV_VPS54: 4.368946221858642, CNV_LINC01867: 4.411662538359512, CNV_LINC02576: 4.524961365416283, CNV_WDPCP: 4.394610852818543, CNV_CEP68: 4.524961365416283"
TCGA-E9-A22H,High mRNA_ZNF552 (Z=1.43) and mRNA_CA12 (Z=1.41) indicate overexpression; mRNA_DTL (Z=1.59) exceeds high threshold. No methylation sites meet hyper/hypo thresholds. miRNA_hsa-mir-5695 (Z=1.99) is upregulated. All CNVs fall within normal range (−1.10 to −0.10). Overexpressed genes associate with luminal differentiation; miR-5695 may modulate oncogenic signaling.,"mRNA_MLPH: 0.6821283477226356, mRNA_C2orf54: 0.6022572231106234, mRNA_CITED4: 0.164786970476877, mRNA_ESR1: 0.8785217115162582, mRNA_SPDEF: 0.3376143923893809, mRNA_AGR3: 0.7590652187527417, mRNA_FOXC1: -0.8506661714847784, mRNA_GATA3: 0.7147653813155814, mRNA_AGR2: 0.7422573170860027, mRNA_XBP1: 1.0072513457200485, mRNA_PRR15: 0.0079467418569056, mRNA_SLC44A4: 0.6596170408575999, mRNA_CA12: 1.4120468570278737, mRNA_DTL: 1.5923457367360003, mRNA_C5AR2: 1.3366840508190705, mRNA_TBC1D9: 1.261330016677072, mRNA_AR: 0.8729085265927715, mRNA_CCDC170: 1.1282063066370969, mRNA_DEGS2: 0.5545860172197596, mRNA_TFF3: 1.0734583414726728, mRNA_DNALI1: 0.7970748673591587, mRNA_LINC00504: 1.307052884668388, mRNA_CLCA2: -0.4386626631544404, mRNA_PPP1R14C: -0.9389918335658802, mRNA_THSD4: 1.1686543465072257, mRNA_SPAG5: 0.9214656337477112, mRNA_FBP1: 0.5903842174828536, mRNA_SLC7A8: 0.480510099036318, mRNA_EN1: -0.8355155086819961, mRNA_ZNF552: 1.426044583921846, Methylation_LRRC6: -0.4127297527684456, Methylation_chr2 66218712 LINC02934 (29533): -0.1841547227648499, Methylation_HOXB13: -0.6051493585269, Methylation_chr10 3949206 LINC02660 (4871): -0.7310391056012067, Methylation_chr5 179517140 RNF130 (18026): 1.0273044433748475, Methylation_LOC727677: -0.7185671510166669, Methylation_LETM1: -0.9139389374786212, Methylation_CDC42BPB: -1.0319396267669003, Methylation_C8orf38: -0.8249749193046753, Methylation_chr14 100504766 EVL (18852): -0.9365752262183492, Methylation_chr5 72594851 LOC340090 (24088): 0.0100018192445959, Methylation_chr2 242904738 LINC01238 (3421): -1.0021158463708506, Methylation_ARFGEF1: -0.5485235299129987, Methylation_MAPT: -0.7048153468671179, Methylation_ZFAT: -0.5015288460912753, Methylation_KCNQ4: -1.082849184081376, Methylation_chr1 232684368 SIPA1L2 (12934): -0.8450523071331776, Methylation_CRNKL1: -0.7309660131581883, Methylation_PRKAG2: -0.6654589402885503, Methylation_MICB: -0.9685780837055158, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 1.0817375033072505, miRNA_hsa-mir-5695: 1.442516111292076, miRNA_hsa-mir-18a: -0.4744758833686869, miRNA_hsa-mir-190b: 1.1366255240852945, miRNA_hsa-mir-577: -0.1820248142597282, miRNA_hsa-mir-135b: -0.6527366951063808, miRNA_hsa-mir-2115: -0.1512031002850681, miRNA_hsa-mir-17: -0.1186687934705119, miRNA_hsa-mir-130b: 0.1290682027477424, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A7-A0D9,High-level Amplification of none; CA12 mRNA high (Z=2.00) without CNV amplification. ZFAT promoter hypermethylation (Z=-1.75) suggests epigenetic silencing. No miRNA alterations meet thresholds. THSD4 mRNA elevated (Z=1.44) but below significance cutoff. No deletions or amplifications per CNV criteria.,"mRNA_MLPH: 0.4721612376796665, mRNA_C2orf54: 0.8346216647127527, mRNA_CITED4: 0.5875956839003951, mRNA_ESR1: 0.446737901645326, mRNA_SPDEF: 0.6348188501164005, mRNA_AGR3: -1.0505764512793876, mRNA_FOXC1: 0.3595430823551729, mRNA_GATA3: 0.8267465615252472, mRNA_AGR2: -0.0496958845232372, mRNA_XBP1: 0.8731913073383296, mRNA_PRR15: 0.982371230672856, mRNA_SLC44A4: 0.3515991068408376, mRNA_CA12: 2.003947946794899, mRNA_DTL: -1.699485194786971, mRNA_C5AR2: 0.3891822071971362, mRNA_TBC1D9: 0.0703988786870252, mRNA_AR: -1.2680888612503192, mRNA_CCDC170: 1.0871911614481946, mRNA_DEGS2: 0.1796623209284615, mRNA_TFF3: -0.0914938722968932, mRNA_DNALI1: 0.3280166179977478, mRNA_LINC00504: -0.0082765688304224, mRNA_CLCA2: -0.0341370959037259, mRNA_PPP1R14C: 0.3609611871803245, mRNA_THSD4: 1.444951421004791, mRNA_SPAG5: -0.9790686633094456, mRNA_FBP1: -0.0076784506090151, mRNA_SLC7A8: 0.0575301885121779, mRNA_EN1: -0.4642359800750416, mRNA_ZNF552: -0.2132740049431989, Methylation_LRRC6: -0.9663093176797052, Methylation_chr2 66218712 LINC02934 (29533): -1.1378350034343307, Methylation_HOXB13: 1.2232577460610845, Methylation_chr10 3949206 LINC02660 (4871): -1.09737143978618, Methylation_chr5 179517140 RNF130 (18026): 1.0134437054832954, Methylation_LOC727677: -1.5042160498723078, Methylation_LETM1: -1.273865489903865, Methylation_CDC42BPB: 1.4379114908988069, Methylation_C8orf38: 0.2966418102129795, Methylation_chr14 100504766 EVL (18852): -1.130717681002359, Methylation_chr5 72594851 LOC340090 (24088): 1.1000662130736965, Methylation_chr2 242904738 LINC01238 (3421): 1.3991167776608535, Methylation_ARFGEF1: -1.2001831253403714, Methylation_MAPT: -0.4350834714374521, Methylation_ZFAT: -1.7498006949623526, Methylation_KCNQ4: -0.5994561045189696, Methylation_chr1 232684368 SIPA1L2 (12934): -1.1466702798585902, Methylation_CRNKL1: -0.2720536508398662, Methylation_PRKAG2: -1.3076202312334402, Methylation_MICB: -1.086393235403621, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.0998747994842205, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.4418667071678096, miRNA_hsa-mir-190b: 0.159400621577274, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.2916175943568045, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.8647241838399523, miRNA_hsa-mir-130b: -0.7483469684748016, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A2-A0SX,"High-level Amplification of EN1 and FOXC1 drives mRNA overexpression.  
Promoter hypermethylation of ARFGEF1, C8orf38, and chr10:3949206 mediates epigenetic silencing.  
miR-135b, miR-5695, and miR-18a are upregulated; miR-190b is downregulated.  
These features indicate a basal-like phenotype with ER-pathway suppression.","mRNA_MLPH: -1.34241737018216, mRNA_C2orf54: 0.7433140099203311, mRNA_CITED4: -1.3331168138304044, mRNA_ESR1: -1.2532157535763004, mRNA_SPDEF: -1.928214850407428, mRNA_AGR3: -1.81504080800415, mRNA_FOXC1: 2.1592526525846645, mRNA_GATA3: -1.4879496206444642, mRNA_AGR2: -2.165426084735845, mRNA_XBP1: -1.583793356946515, mRNA_PRR15: -1.446157539132467, mRNA_SLC44A4: -1.5027683287623648, mRNA_CA12: -2.02901135824673, mRNA_DTL: 0.4775887495455894, mRNA_C5AR2: -1.7164160306976737, mRNA_TBC1D9: -1.2554773939850374, mRNA_AR: -1.56434107968903, mRNA_CCDC170: -1.122901826133619, mRNA_DEGS2: -1.9883807402970293, mRNA_TFF3: -1.8655753228217216, mRNA_DNALI1: -1.8700729143789865, mRNA_LINC00504: -1.5617461534840402, mRNA_CLCA2: -0.7791085185089962, mRNA_PPP1R14C: 1.6946635824707197, mRNA_THSD4: -1.5557593873755893, mRNA_SPAG5: 0.1980073968155641, mRNA_FBP1: -0.8388659262007139, mRNA_SLC7A8: -1.5534653430131231, mRNA_EN1: 2.7193041544162293, mRNA_ZNF552: -1.474715077463072, Methylation_LRRC6: 1.3574480263636337, Methylation_chr2 66218712 LINC02934 (29533): -0.0956062286788868, Methylation_HOXB13: -0.8941865295395874, Methylation_chr10 3949206 LINC02660 (4871): 1.521259840663404, Methylation_chr5 179517140 RNF130 (18026): -1.554356458739678, Methylation_LOC727677: 1.495056819308494, Methylation_LETM1: 1.25410023705176, Methylation_CDC42BPB: 0.6936764702209034, Methylation_C8orf38: 1.635773892662846, Methylation_chr14 100504766 EVL (18852): 1.530787054029502, Methylation_chr5 72594851 LOC340090 (24088): -1.4517771413828806, Methylation_chr2 242904738 LINC01238 (3421): 1.467521826550934, Methylation_ARFGEF1: 1.7077507266394452, Methylation_MAPT: 1.435671563287361, Methylation_ZFAT: 1.391434670025533, Methylation_KCNQ4: 0.9408573624022768, Methylation_chr1 232684368 SIPA1L2 (12934): 1.568916005284958, Methylation_CRNKL1: 1.3152608151076883, Methylation_PRKAG2: -0.992508530148042, Methylation_MICB: 1.170088606094316, miRNA_hsa-mir-934: 1.9164221481466817, miRNA_hsa-mir-4728: -0.7512529985772979, miRNA_hsa-mir-5695: 2.425163448525334, miRNA_hsa-mir-18a: 2.2083871876977943, miRNA_hsa-mir-190b: -1.6752871905265507, miRNA_hsa-mir-577: 1.6413534713166025, miRNA_hsa-mir-135b: 2.639841797532742, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.6771035008032034, miRNA_hsa-mir-130b: 1.0699092759174351, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A2-A3Y0,"High-level Amplification absent; no CNV alterations meet thresholds. mRNA_C2orf54 and mRNA_CLCA2 overexpressed (Z > 1.30). mRNA_SPDEF, AGR2, XBP1, PRR15, TFF3, TBC1D9 significantly downregulated (Z < -1.92). Methylation hypermethylated at ARFGEF1, EVL, LOC727677 (Z > 1.50); hypomethylated at RNF130, LOC340090 (Z < -1.47). miRNA_hsa-mir-934 upregulated (Z > 1.99); miRNA_hsa-mir-190b downregulated (Z < -1.25).","mRNA_MLPH: -1.428366422386252, mRNA_C2orf54: 2.87297800192101, mRNA_CITED4: 0.5306118069792044, mRNA_ESR1: -1.0665191735828974, mRNA_SPDEF: -2.417804258065218, mRNA_AGR3: -1.8158441499083544, mRNA_FOXC1: 0.6544443414477553, mRNA_GATA3: -0.9882827854427204, mRNA_AGR2: -1.934545234686441, mRNA_XBP1: -2.523634558340333, mRNA_PRR15: -2.288343370445409, mRNA_SLC44A4: -1.9629092064216287, mRNA_CA12: -1.3819219747807034, mRNA_DTL: -0.254191876208574, mRNA_C5AR2: -1.2288478475523543, mRNA_TBC1D9: -2.0623576093009204, mRNA_AR: -1.896772313932403, mRNA_CCDC170: -1.8576248343820727, mRNA_DEGS2: -0.7303328790610535, mRNA_TFF3: -2.0872990726808816, mRNA_DNALI1: -1.8603364312579025, mRNA_LINC00504: -1.6641040705228856, mRNA_CLCA2: 2.825480064045699, mRNA_PPP1R14C: 1.9735342514973624, mRNA_THSD4: -2.336498484455415, mRNA_SPAG5: 0.5405771545920243, mRNA_FBP1: -0.8586598476333664, mRNA_SLC7A8: -1.8414820370940783, mRNA_EN1: 0.5926304659628341, mRNA_ZNF552: -1.884520253813063, Methylation_LRRC6: 1.4605148373761223, Methylation_chr2 66218712 LINC02934 (29533): -1.083512303246522, Methylation_HOXB13: 1.1994024591668353, Methylation_chr10 3949206 LINC02660 (4871): 0.7931586836591259, Methylation_chr5 179517140 RNF130 (18026): -1.6708251226934578, Methylation_LOC727677: 1.547805774325802, Methylation_LETM1: 1.3537442708093648, Methylation_CDC42BPB: 0.8017635660750179, Methylation_C8orf38: 1.0820271129380217, Methylation_chr14 100504766 EVL (18852): 1.560005451252497, Methylation_chr5 72594851 LOC340090 (24088): -1.484381405922666, Methylation_chr2 242904738 LINC01238 (3421): 1.4264689234012171, Methylation_ARFGEF1: 1.5970182066577443, Methylation_MAPT: 1.4728676240722658, Methylation_ZFAT: 1.4384391145782425, Methylation_KCNQ4: 0.8972724425077692, Methylation_chr1 232684368 SIPA1L2 (12934): 1.3932213818693242, Methylation_CRNKL1: 1.353779343150287, Methylation_PRKAG2: -1.3921461159427604, Methylation_MICB: 1.4352907891439737, miRNA_hsa-mir-934: 2.371421747494133, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.0815749897493805, miRNA_hsa-mir-190b: -2.052137242410604, miRNA_hsa-mir-577: 1.6167215048448311, miRNA_hsa-mir-135b: 0.8856656930492894, miRNA_hsa-mir-2115: 0.2361176045578443, miRNA_hsa-mir-17: 1.070583268090781, miRNA_hsa-mir-130b: 0.4741804121519434, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E2-A15K,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.750068440462129, mRNA_C2orf54: -1.101523377395387, mRNA_CITED4: 0.997431877627348, mRNA_ESR1: 0.7645908531179936, mRNA_SPDEF: 0.4501525245393752, mRNA_AGR3: 0.940787022860622, mRNA_FOXC1: -1.004416350037426, mRNA_GATA3: 0.610260821666409, mRNA_AGR2: 0.3875426010745323, mRNA_XBP1: 0.4338958375457805, mRNA_PRR15: 0.4226970780635457, mRNA_SLC44A4: 0.8707443182263533, mRNA_CA12: 0.6595253556157015, mRNA_DTL: 1.6861692315371188, mRNA_C5AR2: 0.8566885638416528, mRNA_TBC1D9: 0.8430319378573219, mRNA_AR: 0.6503978199507353, mRNA_CCDC170: 0.8996389471332956, mRNA_DEGS2: 0.9525761085789858, mRNA_TFF3: 0.5588723158547622, mRNA_DNALI1: 0.8404700618863088, mRNA_LINC00504: 1.6293067429028325, mRNA_CLCA2: -0.7259340366253815, mRNA_PPP1R14C: -1.0894593819329803, mRNA_THSD4: 0.3787201439369695, mRNA_SPAG5: 0.8775797301410135, mRNA_FBP1: 0.4690116332564678, mRNA_SLC7A8: 0.9850652818708258, mRNA_EN1: -0.4256330848068457, mRNA_ZNF552: 0.1411808115201957, Methylation_LRRC6: -0.1843894035903252, Methylation_chr2 66218712 LINC02934 (29533): -1.243413289518535, Methylation_HOXB13: -1.0743844587030886, Methylation_chr10 3949206 LINC02660 (4871): -0.7403242360078365, Methylation_chr5 179517140 RNF130 (18026): 1.135354060016247, Methylation_LOC727677: -0.696686445258069, Methylation_LETM1: -0.6067332908849395, Methylation_CDC42BPB: -1.0597723979045035, Methylation_C8orf38: -0.6228901369006895, Methylation_chr14 100504766 EVL (18852): -0.9782384126758166, Methylation_chr5 72594851 LOC340090 (24088): -1.5879401386519842, Methylation_chr2 242904738 LINC01238 (3421): -0.8823740132104039, Methylation_ARFGEF1: -0.2892227811976336, Methylation_MAPT: -0.633376221063309, Methylation_ZFAT: -0.6582495909889859, Methylation_KCNQ4: 0.3042326320978237, Methylation_chr1 232684368 SIPA1L2 (12934): -1.2033638335381316, Methylation_CRNKL1: -0.508366785682976, Methylation_PRKAG2: 0.5203827908441843, Methylation_MICB: -0.9224717682708876, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.6753351521380919, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.1495996925721652, miRNA_hsa-mir-190b: 0.3266026240952714, miRNA_hsa-mir-577: 0.1263250340990088, miRNA_hsa-mir-135b: -0.1687723017196181, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.1892700643360599, miRNA_hsa-mir-130b: 0.3459010886703061, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A27F,"High-level Amplification of EN1 drives significant mRNA overexpression.  
FOXC1 and PPP1R14C show high mRNA (Z > 1.30).  
SPDEF, AGR2, FBP1, and SLC7A8 exhibit low mRNA (Z < -1.92).  
Promoter hypermethylation at KCNQ4, SIPA1L2, EVL, LOC727677, LRRC6, LINC02660, and RNF130; hypomethylation at PRKAG2, LINC02934, and LOC340090.  
miR-934, miR-577, and miR-135b are upregulated (Z > 1.99); no miRNAs downregulated per threshold.  
All CNVs fall within normal range (IGNORE).","mRNA_MLPH: -1.3622574782988357, mRNA_C2orf54: -0.1627713972718424, mRNA_CITED4: 0.9278714335323532, mRNA_ESR1: -1.8655588148361548, mRNA_SPDEF: -3.0593854473138737, mRNA_AGR3: -1.9108012468754705, mRNA_FOXC1: 1.632819240839385, mRNA_GATA3: -2.117163836065384, mRNA_AGR2: -2.476361813857939, mRNA_XBP1: -0.9993736262215172, mRNA_PRR15: -1.838005838769988, mRNA_SLC44A4: -2.3370620883642235, mRNA_CA12: -0.988398444359421, mRNA_DTL: 0.808053264490302, mRNA_C5AR2: -1.7167100748888433, mRNA_TBC1D9: -0.7187353496649184, mRNA_AR: -2.108081029075613, mRNA_CCDC170: -1.6619685411946177, mRNA_DEGS2: -1.2182653584133345, mRNA_TFF3: -1.8596212397652367, mRNA_DNALI1: -1.85343001157601, mRNA_LINC00504: -1.528895057400106, mRNA_CLCA2: -0.6590306362685996, mRNA_PPP1R14C: 1.7218061576681845, mRNA_THSD4: -0.3246828200828362, mRNA_SPAG5: 0.885581434117544, mRNA_FBP1: -2.6729450931620726, mRNA_SLC7A8: -1.9864792691081308, mRNA_EN1: 3.117578587847258, mRNA_ZNF552: -1.4383422225320677, Methylation_LRRC6: 1.5214434115079345, Methylation_chr2 66218712 LINC02934 (29533): -1.7119880284610207, Methylation_HOXB13: -1.066300937737953, Methylation_chr10 3949206 LINC02660 (4871): 1.5114395097704605, Methylation_chr5 179517140 RNF130 (18026): -1.5958175505492516, Methylation_LOC727677: 1.5621104181292302, Methylation_LETM1: 1.3583108725621689, Methylation_CDC42BPB: 0.4091561845848061, Methylation_C8orf38: 0.8923544526923353, Methylation_chr14 100504766 EVL (18852): 1.5732022582591791, Methylation_chr5 72594851 LOC340090 (24088): -1.6079661656390898, Methylation_chr2 242904738 LINC01238 (3421): 1.4629734916193249, Methylation_ARFGEF1: 0.934782834748788, Methylation_MAPT: 1.4978020459687649, Methylation_ZFAT: 1.38411674135526, Methylation_KCNQ4: 1.6903498049615018, Methylation_chr1 232684368 SIPA1L2 (12934): 1.6476668066663869, Methylation_CRNKL1: 1.360245230951882, Methylation_PRKAG2: -1.8496983663408293, Methylation_MICB: 1.557699518241596, miRNA_hsa-mir-934: 3.640850402251224, miRNA_hsa-mir-4728: -0.4172239761688829, miRNA_hsa-mir-5695: 0.8482867879591818, miRNA_hsa-mir-18a: 1.197568784816478, miRNA_hsa-mir-190b: -1.1500868871224788, miRNA_hsa-mir-577: 3.101243751640305, miRNA_hsa-mir-135b: 2.0704033107092683, miRNA_hsa-mir-2115: -0.4261493799035926, miRNA_hsa-mir-17: 1.5946150184670986, miRNA_hsa-mir-130b: 1.3162259873816258, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A0B2,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: -0.0122315398911468, mRNA_C2orf54: -0.2683296273673214, mRNA_CITED4: 0.2327514818861597, mRNA_ESR1: 0.308849710570848, mRNA_SPDEF: 0.4459334678178495, mRNA_AGR3: 0.7803952982683156, mRNA_FOXC1: -0.0420313416936318, mRNA_GATA3: 0.7261766035535747, mRNA_AGR2: -0.1207417126090049, mRNA_XBP1: 0.5192373921362109, mRNA_PRR15: 0.8847808909809587, mRNA_SLC44A4: 0.807731169048913, mRNA_CA12: 0.5092477844842482, mRNA_DTL: -0.8397491923943078, mRNA_C5AR2: 0.2644336087064712, mRNA_TBC1D9: 0.071125824464382, mRNA_AR: 0.7073141667020106, mRNA_CCDC170: -0.0362486635715855, mRNA_DEGS2: 1.1351561820902336, mRNA_TFF3: 0.1739911713958471, mRNA_DNALI1: 0.169855340507673, mRNA_LINC00504: 0.6098326167731167, mRNA_CLCA2: -0.0911148624713185, mRNA_PPP1R14C: -0.2286140230675128, mRNA_THSD4: -0.3289965766149423, mRNA_SPAG5: -0.9704748724286778, mRNA_FBP1: 0.3645180009406605, mRNA_SLC7A8: 0.4750877659198659, mRNA_EN1: -0.1551271239195635, mRNA_ZNF552: -0.3895765460235255, Methylation_LRRC6: -1.2669107792041143, Methylation_chr2 66218712 LINC02934 (29533): 0.2187602204235022, Methylation_HOXB13: -0.8315595139492582, Methylation_chr10 3949206 LINC02660 (4871): -0.125453826110918, Methylation_chr5 179517140 RNF130 (18026): -0.0091879307790777, Methylation_LOC727677: -0.915019176973252, Methylation_LETM1: 0.1300716870757786, Methylation_CDC42BPB: -0.9098299624202242, Methylation_C8orf38: -0.9786645660893866, Methylation_chr14 100504766 EVL (18852): 0.3558901890694161, Methylation_chr5 72594851 LOC340090 (24088): -0.7059460749378601, Methylation_chr2 242904738 LINC01238 (3421): -0.0760228092080669, Methylation_ARFGEF1: -0.927026915520199, Methylation_MAPT: -0.3709008926110539, Methylation_ZFAT: -0.542064872125352, Methylation_KCNQ4: -0.7125227401491325, Methylation_chr1 232684368 SIPA1L2 (12934): -0.094454977938904, Methylation_CRNKL1: -0.9375270810716227, Methylation_PRKAG2: 0.4331500375996148, Methylation_MICB: -0.6764446853677089, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.7754103843604252, miRNA_hsa-mir-5695: 0.6183875714762946, miRNA_hsa-mir-18a: 0.4030429739549074, miRNA_hsa-mir-190b: -0.516037773426038, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.3469751333748716, miRNA_hsa-mir-2115: -0.1135660855169441, miRNA_hsa-mir-17: 0.2263452397282195, miRNA_hsa-mir-130b: -1.0691345674639567, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -1.63714039509435, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AO-A0JI,"High-level Amplification of none; Deletion of LINC01867. mRNA_GATA3, mRNA_XBP1, mRNA_DEGS2, mRNA_LINC00504, mRNA_FBP1, and mRNA_ZNF552 are highly expressed (Z > 1.30). Methylation_HOXB13 hypermethylated (Z > 1.50); Methylation_CRNKL1 hypomethylated (Z < -1.47). miRNA_hsa-mir-130b and miRNA_hsa-mir-17 downregulated (Z < -1.25). These features indicate a luminal phenotype with ER pathway activation.","mRNA_MLPH: 0.3159856528923829, mRNA_C2orf54: -0.9596989126039968, mRNA_CITED4: -0.1898621534518633, mRNA_ESR1: 0.9308229629599892, mRNA_SPDEF: 0.5828846149005384, mRNA_AGR3: 0.9110998299178557, mRNA_FOXC1: 0.0978730503927557, mRNA_GATA3: 1.3073559406151738, mRNA_AGR2: 1.036845522407675, mRNA_XBP1: 1.3873627325461682, mRNA_PRR15: 1.2846928312846817, mRNA_SLC44A4: -0.4026855280408469, mRNA_CA12: 0.7356511849367023, mRNA_DTL: 0.084231506765117, mRNA_C5AR2: 1.3639786758477774, mRNA_TBC1D9: 0.9589482147284456, mRNA_AR: 0.7284711315277693, mRNA_CCDC170: 1.0202200217436257, mRNA_DEGS2: 1.5507540158903403, mRNA_TFF3: -0.3506094372444836, mRNA_DNALI1: 0.3184331836167142, mRNA_LINC00504: 1.4105577413849684, mRNA_CLCA2: -0.7392994082625693, mRNA_PPP1R14C: -0.9281220347648472, mRNA_THSD4: 1.3698581792532258, mRNA_SPAG5: 0.3234722052345655, mRNA_FBP1: 1.9337693836501384, mRNA_SLC7A8: 0.6750524978572663, mRNA_EN1: -1.126235166583729, mRNA_ZNF552: 1.9466615257683249, Methylation_LRRC6: -1.1495805519325528, Methylation_chr2 66218712 LINC02934 (29533): 1.3768707627671248, Methylation_HOXB13: 1.92630947807483, Methylation_chr10 3949206 LINC02660 (4871): -0.6981503517479872, Methylation_chr5 179517140 RNF130 (18026): 1.1934773959737677, Methylation_LOC727677: -0.2563692003754594, Methylation_LETM1: -1.44386302221884, Methylation_CDC42BPB: 1.427705576560129, Methylation_C8orf38: -0.3217974828701044, Methylation_chr14 100504766 EVL (18852): -1.3472863298375153, Methylation_chr5 72594851 LOC340090 (24088): 1.248564767716724, Methylation_chr2 242904738 LINC01238 (3421): -0.369208593533617, Methylation_ARFGEF1: -1.0525185164862998, Methylation_MAPT: -1.3884772950677615, Methylation_ZFAT: -0.7445669855611593, Methylation_KCNQ4: 1.163621558336384, Methylation_chr1 232684368 SIPA1L2 (12934): -1.236470240047154, Methylation_CRNKL1: -1.5315387311669124, Methylation_PRKAG2: 1.350369547442645, Methylation_MICB: -1.1313530385537791, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.0378268723952842, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.3802658091674465, miRNA_hsa-mir-190b: -0.161728140417184, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.613519073980787, miRNA_hsa-mir-130b: -1.9354806746054256, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -1.63714039509435, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AQ-A0Y5,"High-level Amplification absent; no CNV meets amplification thresholds.  
miR-4728 upregulated (Z=2.06); miR-18a and miR-17 downregulated (Z=-2.25, -1.61).  
No mRNA or methylation features meet diagnostic thresholds.  
These features suggest non-luminal subtype with miRNA-mediated regulatory disruption.","mRNA_MLPH: 0.0674454814721241, mRNA_C2orf54: 0.823275668567955, mRNA_CITED4: -1.3938597660655634, mRNA_ESR1: -0.5743181036411732, mRNA_SPDEF: 0.3862551908491513, mRNA_AGR3: -0.6846359213231077, mRNA_FOXC1: -0.4078378406646948, mRNA_GATA3: 0.0470075671829489, mRNA_AGR2: -0.0735689165098248, mRNA_XBP1: 0.908340725432236, mRNA_PRR15: 0.542546903886026, mRNA_SLC44A4: 0.554910219835227, mRNA_CA12: 0.2396199538545409, mRNA_DTL: -1.0727582830905755, mRNA_C5AR2: -1.1945325885973006, mRNA_TBC1D9: -0.1207672239524184, mRNA_AR: 0.5731812384383935, mRNA_CCDC170: 0.2574296247211233, mRNA_DEGS2: -0.0008083415619586, mRNA_TFF3: 0.2032001525434551, mRNA_DNALI1: -0.286044436831672, mRNA_LINC00504: 0.504246537765995, mRNA_CLCA2: 0.8107276193483243, mRNA_PPP1R14C: 0.9937769210185284, mRNA_THSD4: 0.1563062378450739, mRNA_SPAG5: -1.127508442143489, mRNA_FBP1: 0.6870746511418732, mRNA_SLC7A8: 0.2814689715424064, mRNA_EN1: -0.527698231964403, mRNA_ZNF552: -1.5332864016811598, Methylation_LRRC6: 0.0256682516382027, Methylation_chr2 66218712 LINC02934 (29533): 1.083758652705972, Methylation_HOXB13: 0.5743002412620086, Methylation_chr10 3949206 LINC02660 (4871): -1.0204105321026358, Methylation_chr5 179517140 RNF130 (18026): 0.2079311099510315, Methylation_LOC727677: -0.6420229825393182, Methylation_LETM1: 1.1145065912590468, Methylation_CDC42BPB: 1.3277481814738237, Methylation_C8orf38: -0.8941677632421515, Methylation_chr14 100504766 EVL (18852): -0.1244411201572353, Methylation_chr5 72594851 LOC340090 (24088): -0.1896945716376495, Methylation_chr2 242904738 LINC01238 (3421): -0.3233888992726841, Methylation_ARFGEF1: -0.4884485639627667, Methylation_MAPT: 1.1982309082029066, Methylation_ZFAT: -0.8355329602272531, Methylation_KCNQ4: -1.168751051887648, Methylation_chr1 232684368 SIPA1L2 (12934): -0.1185363152383019, Methylation_CRNKL1: -0.120145445245005, Methylation_PRKAG2: -1.142263354568556, Methylation_MICB: -1.1167483342936653, miRNA_hsa-mir-934: -0.1714065168739756, miRNA_hsa-mir-4728: 2.0569064820474323, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -2.2471487129970096, miRNA_hsa-mir-190b: -1.1428933283209386, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: 0.0856509328966441, miRNA_hsa-mir-2115: -0.0107257333470625, miRNA_hsa-mir-17: -1.6072332257058102, miRNA_hsa-mir-130b: -0.5935880523357283, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-AN-A0XW,"mRNA_C2orf54 (Z=1.32) is upregulated.  
Methylation_CDC42BPB (Z=-1.13) and Methylation_chr5 72594851 LOC340090 (Z=-1.41) are hypomethylated.  
miRNA_hsa-mir-4728 (Z=-1.28) is downregulated.  
All CNVs fall within normal range (−1.10 to −0.10).  
No high-level amplifications or deletions detected.","mRNA_MLPH: 0.0856467624736216, mRNA_C2orf54: 1.323375070347954, mRNA_CITED4: -0.2384895199749222, mRNA_ESR1: -0.0164811157220794, mRNA_SPDEF: 0.3864828763717818, mRNA_AGR3: 0.3324759771713421, mRNA_FOXC1: -0.2908135780471746, mRNA_GATA3: 0.0803600633587284, mRNA_AGR2: -1.615165730164041e-05, mRNA_XBP1: -0.0441545083281998, mRNA_PRR15: 0.4122771119085971, mRNA_SLC44A4: -0.007616951133189, mRNA_CA12: 0.0852411339652194, mRNA_DTL: 0.6873926749027988, mRNA_C5AR2: 0.6632577577674587, mRNA_TBC1D9: -0.3854678517657349, mRNA_AR: 0.4447501104209488, mRNA_CCDC170: -0.140634519909768, mRNA_DEGS2: 0.2597624858985103, mRNA_TFF3: 0.7517232757505012, mRNA_DNALI1: 0.0772987866400355, mRNA_LINC00504: 0.9269426119117684, mRNA_CLCA2: 0.284961128915718, mRNA_PPP1R14C: 0.1505883076156061, mRNA_THSD4: 0.0711391646886122, mRNA_SPAG5: 1.1221299177358508, mRNA_FBP1: 0.2199151019261153, mRNA_SLC7A8: 1.1626364085798555, mRNA_EN1: -0.1385269137714998, mRNA_ZNF552: -0.2886405377607048, Methylation_LRRC6: -0.1821630838273367, Methylation_chr2 66218712 LINC02934 (29533): 1.2652708243502366, Methylation_HOXB13: 0.3529393978650215, Methylation_chr10 3949206 LINC02660 (4871): -0.3765489883780206, Methylation_chr5 179517140 RNF130 (18026): 0.533024709050465, Methylation_LOC727677: -0.0444672525513649, Methylation_LETM1: -0.1555641664083886, Methylation_CDC42BPB: -1.1275858331021724, Methylation_C8orf38: 0.6503155513891434, Methylation_chr14 100504766 EVL (18852): 0.0435558718003584, Methylation_chr5 72594851 LOC340090 (24088): -1.4077411873098815, Methylation_chr2 242904738 LINC01238 (3421): 0.4891305608831384, Methylation_ARFGEF1: 0.8833421732633446, Methylation_MAPT: -0.5801403967338357, Methylation_ZFAT: 0.0821837569673136, Methylation_KCNQ4: -1.0200904707340468, Methylation_chr1 232684368 SIPA1L2 (12934): -0.1812563883127938, Methylation_CRNKL1: -0.3833135710648727, Methylation_PRKAG2: 1.0323553528960414, Methylation_MICB: -0.1837891213981318, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.4838653482832102, miRNA_hsa-mir-190b: -0.3334168947963111, miRNA_hsa-mir-577: -0.1976901468181045, miRNA_hsa-mir-135b: 1.08035480169037, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.7745954840089412, miRNA_hsa-mir-130b: -0.6056437811198349, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A1JJ,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives oncogenic genomic instability. mRNA_CITED4 is low (Z = -2.28), indicating transcriptional silencing. No methylation or miRNA alterations meet diagnostic thresholds. These features suggest a basal-like phenotype with genomic amplification-driven dysregulation.","mRNA_MLPH: -0.0424069582513816, mRNA_C2orf54: 1.011445072746204, mRNA_CITED4: -2.2837995640714768, mRNA_ESR1: 0.7397912875852855, mRNA_SPDEF: 0.3717059216185944, mRNA_AGR3: 0.0029916129109738, mRNA_FOXC1: -0.910148952877592, mRNA_GATA3: 0.0292907230928305, mRNA_AGR2: 0.5611489290294736, mRNA_XBP1: 0.2788071672352676, mRNA_PRR15: 0.2485842601858286, mRNA_SLC44A4: 0.9660255513015472, mRNA_CA12: 0.1790281646052372, mRNA_DTL: 0.7368997821333859, mRNA_C5AR2: 0.2086263600650018, mRNA_TBC1D9: 0.1955500158628022, mRNA_AR: 0.3518272905607977, mRNA_CCDC170: 0.4755012170054732, mRNA_DEGS2: 0.1342695667275677, mRNA_TFF3: 0.6058559653704637, mRNA_DNALI1: -0.0208605417558975, mRNA_LINC00504: -0.2298230274618567, mRNA_CLCA2: 1.3983154014186516, mRNA_PPP1R14C: -0.7223576314555927, mRNA_THSD4: -0.3478936421968131, mRNA_SPAG5: -0.0508760695234658, mRNA_FBP1: -0.3191202842945602, mRNA_SLC7A8: 0.448394762359452, mRNA_EN1: 0.0312919834759598, mRNA_ZNF552: 0.2898143655408071, Methylation_LRRC6: -0.1402339852264892, Methylation_chr2 66218712 LINC02934 (29533): 0.2048397060059718, Methylation_HOXB13: 0.6670840891990607, Methylation_chr10 3949206 LINC02660 (4871): -0.9573723895690898, Methylation_chr5 179517140 RNF130 (18026): 0.3716475081106218, Methylation_LOC727677: -0.5517671645480469, Methylation_LETM1: -0.1637801197158226, Methylation_CDC42BPB: -0.9674866173591988, Methylation_C8orf38: -0.9563201538889768, Methylation_chr14 100504766 EVL (18852): -0.2642511951090191, Methylation_chr5 72594851 LOC340090 (24088): 0.7380877949584282, Methylation_chr2 242904738 LINC01238 (3421): 0.3069922694409125, Methylation_ARFGEF1: -0.1511518771991212, Methylation_MAPT: 0.754759887433087, Methylation_ZFAT: -0.2610997561690278, Methylation_KCNQ4: -1.0247451409089054, Methylation_chr1 232684368 SIPA1L2 (12934): -0.5229011431344492, Methylation_CRNKL1: -0.1175536332065616, Methylation_PRKAG2: -0.916646965970072, Methylation_MICB: -0.7953282334739167, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.7817474086196685, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.1865049317043969, miRNA_hsa-mir-190b: 0.7305975831745707, miRNA_hsa-mir-577: -0.5768030135809631, miRNA_hsa-mir-135b: -0.7469104878691433, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.1966132825813523, miRNA_hsa-mir-130b: 0.5852581633727142, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-B6-A0X5,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.8186407644774963, mRNA_C2orf54: 0.4927957283029874, mRNA_CITED4: -1.2989606483187446, mRNA_ESR1: 1.013262134103016, mRNA_SPDEF: 0.485653185661809, mRNA_AGR3: 0.947320241275775, mRNA_FOXC1: -0.4974549876308602, mRNA_GATA3: 0.3718853064484917, mRNA_AGR2: 1.060986079389635, mRNA_XBP1: 0.9040753008066982, mRNA_PRR15: 0.745977303642857, mRNA_SLC44A4: 0.1354449323769213, mRNA_CA12: -0.0260190320548499, mRNA_DTL: 1.0349111202620715, mRNA_C5AR2: 1.0262310070876526, mRNA_TBC1D9: 0.3986347999737699, mRNA_AR: 0.0522504116339248, mRNA_CCDC170: 1.1263944068312637, mRNA_DEGS2: 0.4196309860917682, mRNA_TFF3: 1.299075437725851, mRNA_DNALI1: -0.0173159534282841, mRNA_LINC00504: 0.3830667029480942, mRNA_CLCA2: -0.5583245140768591, mRNA_PPP1R14C: -1.0842476415661708, mRNA_THSD4: 0.5236117730115153, mRNA_SPAG5: 1.262060927214102, mRNA_FBP1: 0.784477405491322, mRNA_SLC7A8: 0.5306447088010494, mRNA_EN1: -0.5125188354589659, mRNA_ZNF552: 0.0840371244162433, Methylation_LRRC6: -1.1747509673935923, Methylation_chr2 66218712 LINC02934 (29533): -1.802128823360636, Methylation_HOXB13: -0.8734302013039691, Methylation_chr10 3949206 LINC02660 (4871): -1.3580847233913185, Methylation_chr5 179517140 RNF130 (18026): 1.2688498481017498, Methylation_LOC727677: -1.671335364149916, Methylation_LETM1: -1.8101441731267505, Methylation_CDC42BPB: 1.455225333155704, Methylation_C8orf38: -1.3884193274505137, Methylation_chr14 100504766 EVL (18852): -1.446882615228832, Methylation_chr5 72594851 LOC340090 (24088): -1.5824855935860511, Methylation_chr2 242904738 LINC01238 (3421): -1.456222384128313, Methylation_ARFGEF1: -1.1763883428488202, Methylation_MAPT: -1.848230451642337, Methylation_ZFAT: -1.618544476381304, Methylation_KCNQ4: 0.9540296204129344, Methylation_chr1 232684368 SIPA1L2 (12934): -0.98817363502696, Methylation_CRNKL1: -1.4967294545537215, Methylation_PRKAG2: -1.7975772806710124, Methylation_MICB: -1.2290412578321808, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.5782317173982365, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.690130675889544, miRNA_hsa-mir-190b: 0.2137335492160337, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.0127174991639353, miRNA_hsa-mir-2115: 1.0838692787187834, miRNA_hsa-mir-17: -0.5245771284407083, miRNA_hsa-mir-130b: 1.0581064818585828, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E2-A1IG,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-significant ranges per specified Z-score and CNV cutoffs.","mRNA_MLPH: 0.5401656855604849, mRNA_C2orf54: 0.648645462140871, mRNA_CITED4: 0.7376297173237092, mRNA_ESR1: 0.4234171549075601, mRNA_SPDEF: 0.5646719607509368, mRNA_AGR3: 0.4826686511236493, mRNA_FOXC1: -0.1582065626441198, mRNA_GATA3: 0.5182389121193421, mRNA_AGR2: 0.6511007083191414, mRNA_XBP1: 0.7196971404653832, mRNA_PRR15: 0.2333032690027633, mRNA_SLC44A4: -0.0221403694266797, mRNA_CA12: 0.2788261435772474, mRNA_DTL: -0.0791466805317491, mRNA_C5AR2: 0.1568930869395693, mRNA_TBC1D9: 0.8614084833103441, mRNA_AR: -1.0312125036974924, mRNA_CCDC170: 0.5798071856119488, mRNA_DEGS2: -1.305795808095853, mRNA_TFF3: 0.3662146740403207, mRNA_DNALI1: 0.9978708907699342, mRNA_LINC00504: 0.1389141674455973, mRNA_CLCA2: -0.7055934361889497, mRNA_PPP1R14C: 0.8600098478980294, mRNA_THSD4: 1.0917076120279197, mRNA_SPAG5: 0.5895602043227173, mRNA_FBP1: 0.2240905066434144, mRNA_SLC7A8: -0.7154540256631314, mRNA_EN1: -0.0450490188233559, mRNA_ZNF552: -0.5783112878262162, Methylation_LRRC6: -0.8010866208631364, Methylation_chr2 66218712 LINC02934 (29533): 0.1045813521591433, Methylation_HOXB13: -1.084840559056467, Methylation_chr10 3949206 LINC02660 (4871): -0.983735184260626, Methylation_chr5 179517140 RNF130 (18026): -0.0594765355179511, Methylation_LOC727677: -0.9020496092671632, Methylation_LETM1: -1.2284772327249651, Methylation_CDC42BPB: 1.4028697576153877, Methylation_C8orf38: 0.1493157283685062, Methylation_chr14 100504766 EVL (18852): -1.0233282927105518, Methylation_chr5 72594851 LOC340090 (24088): 0.8708114843932221, Methylation_chr2 242904738 LINC01238 (3421): 1.4664199552463142, Methylation_ARFGEF1: -0.9439490747916494, Methylation_MAPT: -1.5373154101182325, Methylation_ZFAT: -0.6233384514932937, Methylation_KCNQ4: -0.4960584248256061, Methylation_chr1 232684368 SIPA1L2 (12934): -1.2532373233936829, Methylation_CRNKL1: -0.6475021383653073, Methylation_PRKAG2: -1.2891509368903578, Methylation_MICB: -1.3202897590754186, miRNA_hsa-mir-934: -0.2361486779501809, miRNA_hsa-mir-4728: 0.2455588590697678, miRNA_hsa-mir-5695: 0.9680317177601314, miRNA_hsa-mir-18a: -0.4473502483091665, miRNA_hsa-mir-190b: -0.1216784553145592, miRNA_hsa-mir-577: -0.5221254754435647, miRNA_hsa-mir-135b: -0.1480392434635006, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.4186191984806652, miRNA_hsa-mir-130b: 0.8576019698336101, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A0DI,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-significant ranges per specified Z-score and CNV cutoffs.","mRNA_MLPH: 0.1575715707918325, mRNA_C2orf54: -0.5455396509783854, mRNA_CITED4: -0.0168015523939351, mRNA_ESR1: -0.0382812107341115, mRNA_SPDEF: 0.3072933259061627, mRNA_AGR3: -0.0719068286999712, mRNA_FOXC1: 0.0745381712682331, mRNA_GATA3: 0.0460636582355578, mRNA_AGR2: -0.5553858161345934, mRNA_XBP1: -0.0524681678547645, mRNA_PRR15: -0.3129446719559319, mRNA_SLC44A4: -0.8194174601792839, mRNA_CA12: 0.1832884322133334, mRNA_DTL: -0.829941847480488, mRNA_C5AR2: -0.8675975229308339, mRNA_TBC1D9: 0.8906959366508262, mRNA_AR: 0.7946569569593777, mRNA_CCDC170: -0.5430027947897103, mRNA_DEGS2: 0.7571634170616206, mRNA_TFF3: -0.3838664220486107, mRNA_DNALI1: 0.3823368778542672, mRNA_LINC00504: -0.642946912598381, mRNA_CLCA2: 1.905943407726825, mRNA_PPP1R14C: 0.395266832398012, mRNA_THSD4: 0.0091438286752244, mRNA_SPAG5: -1.1586707353455974, mRNA_FBP1: 0.3663521525816884, mRNA_SLC7A8: 1.093813378240588, mRNA_EN1: 0.5366630475380486, mRNA_ZNF552: -0.3719041003076958, Methylation_LRRC6: 0.6125910820930462, Methylation_chr2 66218712 LINC02934 (29533): 0.9919285333935745, Methylation_HOXB13: 0.632190082510491, Methylation_chr10 3949206 LINC02660 (4871): -0.0312924018504289, Methylation_chr5 179517140 RNF130 (18026): 0.4394868446591722, Methylation_LOC727677: 0.3368928825348717, Methylation_LETM1: 0.9528611859174244, Methylation_CDC42BPB: -0.2696709502471759, Methylation_C8orf38: 0.4929482804727121, Methylation_chr14 100504766 EVL (18852): 0.897104073559999, Methylation_chr5 72594851 LOC340090 (24088): 0.838849195515765, Methylation_chr2 242904738 LINC01238 (3421): 0.2293205105273638, Methylation_ARFGEF1: 0.8135934800285978, Methylation_MAPT: 0.7901724213811736, Methylation_ZFAT: -0.0029313875993148, Methylation_KCNQ4: -0.3101718480429026, Methylation_chr1 232684368 SIPA1L2 (12934): 0.7701771602475995, Methylation_CRNKL1: 0.9474495486441344, Methylation_PRKAG2: 1.1119210792459313, Methylation_MICB: 1.1680464333600231, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.7149490942570063, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.6511438466132555, miRNA_hsa-mir-190b: -0.8406144879151022, miRNA_hsa-mir-577: -0.4915365325860782, miRNA_hsa-mir-135b: -0.3108780062700242, miRNA_hsa-mir-2115: 0.2577365992514122, miRNA_hsa-mir-17: -0.9058446129490408, miRNA_hsa-mir-130b: -0.3325976684495825, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A1JP,"High-level Amplification of CCDC170 drives significant mRNA overexpression. KCNQ4 promoter hypermethylation mediates epigenetic silencing. Deletion of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 correlates with transcriptional downregulation. These features collectively indicate a luminal phenotype with ER signaling dysregulation.","mRNA_MLPH: -0.5878679902470186, mRNA_C2orf54: 0.8429985336540584, mRNA_CITED4: 0.5209743218145187, mRNA_ESR1: 1.0714003538086043, mRNA_SPDEF: 0.2385247340931084, mRNA_AGR3: 0.5589269904994673, mRNA_FOXC1: -0.47395357826569, mRNA_GATA3: 0.3752041667912321, mRNA_AGR2: 0.1869443572022767, mRNA_XBP1: 1.2803551083504237, mRNA_PRR15: 0.6049218191500756, mRNA_SLC44A4: 0.3825427361765973, mRNA_CA12: 0.5137378175048742, mRNA_DTL: 1.1883589351586272, mRNA_C5AR2: 0.6344756532728671, mRNA_TBC1D9: -0.0549564167596751, mRNA_AR: 0.3805772042255815, mRNA_CCDC170: 2.0093494648971704, mRNA_DEGS2: 0.1565877299346402, mRNA_TFF3: -0.0775964101714668, mRNA_DNALI1: 0.3096504705304677, mRNA_LINC00504: 0.8152520841076387, mRNA_CLCA2: -0.5622531787604362, mRNA_PPP1R14C: -0.1331048193203804, mRNA_THSD4: 0.4914493068480444, mRNA_SPAG5: 0.0619932741529114, mRNA_FBP1: 0.003153162045499, mRNA_SLC7A8: 0.4576001363300392, mRNA_EN1: 0.1894531685122915, mRNA_ZNF552: -0.6506218480121241, Methylation_LRRC6: -0.7306146580202969, Methylation_chr2 66218712 LINC02934 (29533): -0.8061922655302355, Methylation_HOXB13: 0.9189194716286684, Methylation_chr10 3949206 LINC02660 (4871): -0.7772876591586081, Methylation_chr5 179517140 RNF130 (18026): -1.2764704338628312, Methylation_LOC727677: -1.2066243392855835, Methylation_LETM1: -0.6267767831236979, Methylation_CDC42BPB: -0.983101655520966, Methylation_C8orf38: -0.9911210652871992, Methylation_chr14 100504766 EVL (18852): 0.3624867559895957, Methylation_chr5 72594851 LOC340090 (24088): -0.9332661619330836, Methylation_chr2 242904738 LINC01238 (3421): -0.3900118913485662, Methylation_ARFGEF1: -1.198308815432978, Methylation_MAPT: -0.866123891719027, Methylation_ZFAT: -1.074570952448696, Methylation_KCNQ4: 1.5354876979835814, Methylation_chr1 232684368 SIPA1L2 (12934): -0.6068658452311592, Methylation_CRNKL1: -1.0877787009533324, Methylation_PRKAG2: 1.2232965213491065, Methylation_MICB: -0.7266366826191071, miRNA_hsa-mir-934: -0.4486153823399331, miRNA_hsa-mir-4728: 0.1144520820148371, miRNA_hsa-mir-5695: 1.056613079451115, miRNA_hsa-mir-18a: 0.0552898730356725, miRNA_hsa-mir-190b: 0.2825870756330995, miRNA_hsa-mir-577: 0.1106770836994281, miRNA_hsa-mir-135b: -0.386558453672832, miRNA_hsa-mir-2115: 0.8187891104675054, miRNA_hsa-mir-17: -0.0368687643533504, miRNA_hsa-mir-130b: 0.44763973816602, CNV_VPS54: -1.6173912818721974, CNV_LINC01867: -1.63714039509435, CNV_LINC02576: -1.657048777669473, CNV_WDPCP: -1.6249341592372952, CNV_CEP68: -1.657048777669473"
TCGA-BH-A0BM,"CLCA2 mRNA overexpression (Z=2.67) exceeds high-expression threshold. DTL and SPAG5 show low mRNA (Z=-2.74, -2.22). Methylation at chr10:3949206 is hypermethylated (Z=1.61). miR-17 is downregulated (Z=-2.46). No CNVs meet deletion/amplification thresholds. These features suggest luminal breast cancer with ER-pathway activity and miR-17-mediated tumor suppression loss.","mRNA_MLPH: 0.3235477522754607, mRNA_C2orf54: -0.922006815734264, mRNA_CITED4: 1.119431314324253, mRNA_ESR1: 0.0522276348235196, mRNA_SPDEF: 0.1586257604284524, mRNA_AGR3: 0.5354852494716005, mRNA_FOXC1: 0.2280951434771916, mRNA_GATA3: 0.3748885638632542, mRNA_AGR2: 0.3034459773555135, mRNA_XBP1: 0.0881971710975337, mRNA_PRR15: 0.7947634439402071, mRNA_SLC44A4: 0.727517179974491, mRNA_CA12: 0.3017369582000287, mRNA_DTL: -2.736130389914648, mRNA_C5AR2: -1.2418675668313994, mRNA_TBC1D9: 0.0048710199463315, mRNA_AR: 0.677919782151051, mRNA_CCDC170: -0.7781773880551088, mRNA_DEGS2: 0.3033352037438635, mRNA_TFF3: -0.0783210113511626, mRNA_DNALI1: -0.2734504597674723, mRNA_LINC00504: 0.4428414834270325, mRNA_CLCA2: 2.673985765053738, mRNA_PPP1R14C: -0.3380064403332538, mRNA_THSD4: -0.2383748822566412, mRNA_SPAG5: -2.219602924126236, mRNA_FBP1: -0.0123859193823283, mRNA_SLC7A8: 0.3606621495374268, mRNA_EN1: -0.1855683263397867, mRNA_ZNF552: -0.6126186478769576, Methylation_LRRC6: -0.2391668382490879, Methylation_chr2 66218712 LINC02934 (29533): 0.8931247985151899, Methylation_HOXB13: -0.770652703979225, Methylation_chr10 3949206 LINC02660 (4871): 1.6119377426259205, Methylation_chr5 179517140 RNF130 (18026): 0.4506429238841728, Methylation_LOC727677: -0.3178776242809401, Methylation_LETM1: 0.3015120601398816, Methylation_CDC42BPB: -1.04899338317987, Methylation_C8orf38: -0.0692416567388385, Methylation_chr14 100504766 EVL (18852): -0.2325810411091344, Methylation_chr5 72594851 LOC340090 (24088): 0.7965224718739593, Methylation_chr2 242904738 LINC01238 (3421): -0.6969129034796288, Methylation_ARFGEF1: -0.2168619598458325, Methylation_MAPT: -0.2522826043002428, Methylation_ZFAT: 0.5269671875393077, Methylation_KCNQ4: 0.4281123524973885, Methylation_chr1 232684368 SIPA1L2 (12934): -0.4760694071875053, Methylation_CRNKL1: -0.3421299125363898, Methylation_PRKAG2: 1.33764440047972, Methylation_MICB: -0.4485261493799519, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.2572245133502699, miRNA_hsa-mir-5695: 0.4373665993594297, miRNA_hsa-mir-18a: -1.148200440723415, miRNA_hsa-mir-190b: -1.0678229141754807, miRNA_hsa-mir-577: 0.0365677358619507, miRNA_hsa-mir-135b: -0.6531909962469787, miRNA_hsa-mir-2115: 1.3488720781306285, miRNA_hsa-mir-17: -2.460373786971316, miRNA_hsa-mir-130b: -1.1239692861184054, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-GM-A2DF,"High-level Amplification of none; no CNV alterations meet thresholds.  
mRNA_PPP1R14C (Z=2.23) and mRNA_EN1 (Z=2.41) are highly overexpressed.  
Multiple mRNAs (e.g., ESR1, AGR3, CA12, SLC7A8) show significant downregulation (Z < -1.92).  
miRNA_hsa-mir-934 is strongly upregulated (Z=4.32); miRNA_hsa-mir-190b is downregulated (Z=-2.05).  
Methylation_C8orf38, ARFGEF1, and EVL are hypermethylated (Z > 1.50).  

**Final Summary (<60 words):**  
EN1 and PPP1R14C mRNA overexpression occurs without genomic amplification. Promoter hypermethylation of C8orf38, ARFGEF1, and EVL suggests epigenetic dysregulation. Global mRNA suppression (ESR1, AGR3, CA12, SLC7A8) aligns with luminal B-like phenotype and ER-pathway silencing.","mRNA_MLPH: -3.1162932481820693, mRNA_C2orf54: -0.9203652412171468, mRNA_CITED4: 0.4282215601044565, mRNA_ESR1: -2.036754884713269, mRNA_SPDEF: -2.0165721970475525, mRNA_AGR3: -2.0322236696746967, mRNA_FOXC1: 1.2270054082140842, mRNA_GATA3: -1.6763177963189235, mRNA_AGR2: -2.576144132026956, mRNA_XBP1: -1.5893016520029388, mRNA_PRR15: -2.261182210003517, mRNA_SLC44A4: -2.353765886092136, mRNA_CA12: -2.5406665429060964, mRNA_DTL: -1.0912379318465308, mRNA_C5AR2: -1.9830441555693703, mRNA_TBC1D9: -2.350156237328884, mRNA_AR: -2.232952849985661, mRNA_CCDC170: -1.6378635375526134, mRNA_DEGS2: -2.423414034307194, mRNA_TFF3: -1.5689466310463536, mRNA_DNALI1: -1.9453983533243369, mRNA_LINC00504: -1.7423968262520422, mRNA_CLCA2: -0.7856017813589288, mRNA_PPP1R14C: 2.2299172708477446, mRNA_THSD4: -2.230511294314955, mRNA_SPAG5: -0.889349505248817, mRNA_FBP1: -2.107984439452606, mRNA_SLC7A8: -2.6539657464599147, mRNA_EN1: 2.407741731938281, mRNA_ZNF552: -2.80103734803057, Methylation_LRRC6: 1.344793177082147, Methylation_chr2 66218712 LINC02934 (29533): 0.082090503153384, Methylation_HOXB13: 0.3000522289947919, Methylation_chr10 3949206 LINC02660 (4871): 1.439335762323769, Methylation_chr5 179517140 RNF130 (18026): -0.9042687115847208, Methylation_LOC727677: 1.4422330721952712, Methylation_LETM1: 1.296859083065243, Methylation_CDC42BPB: 0.2395456795246306, Methylation_C8orf38: 1.669856003791902, Methylation_chr14 100504766 EVL (18852): 1.5670973663658223, Methylation_chr5 72594851 LOC340090 (24088): -0.7154979482879807, Methylation_chr2 242904738 LINC01238 (3421): 1.319978735512027, Methylation_ARFGEF1: 1.6762153882943969, Methylation_MAPT: 1.2942024695045924, Methylation_ZFAT: 1.3828540520485868, Methylation_KCNQ4: 0.4645369666704416, Methylation_chr1 232684368 SIPA1L2 (12934): 1.3655974298735851, Methylation_CRNKL1: 1.381585054811207, Methylation_PRKAG2: 0.9325527793932866, Methylation_MICB: 1.4910368963907292, miRNA_hsa-mir-934: 4.317476260367124, miRNA_hsa-mir-4728: 0.3974592213619746, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.8056360763945827, miRNA_hsa-mir-190b: -2.052137242410604, miRNA_hsa-mir-577: 1.006196406747378, miRNA_hsa-mir-135b: 1.4002241680345038, miRNA_hsa-mir-2115: 0.2795571183161621, miRNA_hsa-mir-17: -0.2365929260925672, miRNA_hsa-mir-130b: 1.5167411035573728, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A22A,"SLC7A8 mRNA overexpression (Z=1.52) aligns with no CNV gain; CITED4 and SPAG5 show near-threshold mRNA elevation (Z=1.30, 1.18). No methylation or miRNA alterations meet diagnostic thresholds. CNVs show broad deletions (e.g., VPS54, CEP68; all Z < -1.10), but no focal amplifications. Insufficient evidence for definitive subtype classification.","mRNA_MLPH: -0.1532143052654927, mRNA_C2orf54: -0.1235787288151558, mRNA_CITED4: 1.2951144538677215, mRNA_ESR1: -0.2556360209238992, mRNA_SPDEF: 0.1438244134973694, mRNA_AGR3: 0.064549567862145, mRNA_FOXC1: -0.538613959839484, mRNA_GATA3: 0.5007804935830448, mRNA_AGR2: -0.105865107134878, mRNA_XBP1: -0.2654276254444525, mRNA_PRR15: 0.1147062729923514, mRNA_SLC44A4: -0.2801944823291839, mRNA_CA12: 0.3723609794360998, mRNA_DTL: 0.1716340094564168, mRNA_C5AR2: -0.421950066956562, mRNA_TBC1D9: 0.4733848319015217, mRNA_AR: -1.090844936797832, mRNA_CCDC170: -0.3251181750702036, mRNA_DEGS2: -0.1393451900460833, mRNA_TFF3: 0.2199025988029639, mRNA_DNALI1: 0.2695378842737241, mRNA_LINC00504: 0.2378219968099048, mRNA_CLCA2: -0.4960951131407326, mRNA_PPP1R14C: -0.6097555302910783, mRNA_THSD4: -0.7166975038930997, mRNA_SPAG5: 1.1789916680798895, mRNA_FBP1: 0.2807177523861817, mRNA_SLC7A8: 1.5181696915400142, mRNA_EN1: 0.3090853039552908, mRNA_ZNF552: -1.0457610267694455, Methylation_LRRC6: -0.1310057537952588, Methylation_chr2 66218712 LINC02934 (29533): 0.4311893654604406, Methylation_HOXB13: 0.6061219889153757, Methylation_chr10 3949206 LINC02660 (4871): 0.2739655252030556, Methylation_chr5 179517140 RNF130 (18026): -0.2219782151503264, Methylation_LOC727677: -0.2908328539405262, Methylation_LETM1: 0.0579015113224752, Methylation_CDC42BPB: 0.1873179725134662, Methylation_C8orf38: -1.1447014071229635, Methylation_chr14 100504766 EVL (18852): 0.8863715188802055, Methylation_chr5 72594851 LOC340090 (24088): -0.6196670742857225, Methylation_chr2 242904738 LINC01238 (3421): 0.5642212152721665, Methylation_ARFGEF1: 0.7110505810753927, Methylation_MAPT: 0.9267029828714652, Methylation_ZFAT: -0.6617333441740706, Methylation_KCNQ4: -0.4035074775996869, Methylation_chr1 232684368 SIPA1L2 (12934): 0.6362382694098417, Methylation_CRNKL1: 0.6556062024064742, Methylation_PRKAG2: 0.4780723277191938, Methylation_MICB: 0.6569270190412134, miRNA_hsa-mir-934: -0.3784664377202075, miRNA_hsa-mir-4728: -0.2173426779794865, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.4554831194485199, miRNA_hsa-mir-190b: -1.0439747121956595, miRNA_hsa-mir-577: -0.4002977439997393, miRNA_hsa-mir-135b: -0.924739877356228, miRNA_hsa-mir-2115: -0.3431109678482474, miRNA_hsa-mir-17: -0.9075855177025064, miRNA_hsa-mir-130b: -1.1752301398227247, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-EW-A1PC,"High-level Amplification of SPAG5 drives mRNA overexpression (Z=2.72). HOXB13 and KCNQ4 promoter hypermethylation (Z=1.73, 1.94) suggests epigenetic silencing. miRNA-130b upregulation (Z=2.05) may suppress target tumor suppressors. DTL mRNA elevated (Z=1.73) aligns with amplification-driven proliferation. These features indicate a luminal B-like phenotype with cell cycle dysregulation.","mRNA_MLPH: -0.1028489174708442, mRNA_C2orf54: 1.294955825917136, mRNA_CITED4: -0.5077599215083096, mRNA_ESR1: 0.2488448397130545, mRNA_SPDEF: 0.3926555619309548, mRNA_AGR3: -0.7574015375156482, mRNA_FOXC1: -1.065976743803483, mRNA_GATA3: 0.531104505533135, mRNA_AGR2: -0.0458236484956902, mRNA_XBP1: -0.3844805306216278, mRNA_PRR15: 0.2745442980945022, mRNA_SLC44A4: -0.3002961761586365, mRNA_CA12: -0.1585961382576562, mRNA_DTL: 1.7307853539302651, mRNA_C5AR2: -0.3612504685344228, mRNA_TBC1D9: -0.3725622514937767, mRNA_AR: 0.6066071319345817, mRNA_CCDC170: 0.2594508441119573, mRNA_DEGS2: -0.0228630572949459, mRNA_TFF3: 0.1683047111665419, mRNA_DNALI1: 0.8757935912949499, mRNA_LINC00504: -1.1086704835719494, mRNA_CLCA2: 0.5909696628563892, mRNA_PPP1R14C: -1.057836509691937, mRNA_THSD4: -0.6330815357963846, mRNA_SPAG5: 2.724433192137067, mRNA_FBP1: 0.102374874481526, mRNA_SLC7A8: -0.2343222200513178, mRNA_EN1: -0.215640000352252, mRNA_ZNF552: 0.8096357641373267, Methylation_LRRC6: -1.4687425516482735, Methylation_chr2 66218712 LINC02934 (29533): -1.890133249560493, Methylation_HOXB13: 1.7292506242825731, Methylation_chr10 3949206 LINC02660 (4871): -1.0566349268099875, Methylation_chr5 179517140 RNF130 (18026): 1.1565993622157398, Methylation_LOC727677: -1.05115024222969, Methylation_LETM1: 1.202373788357409, Methylation_CDC42BPB: 1.4737815842795303, Methylation_C8orf38: -0.9442457621819872, Methylation_chr14 100504766 EVL (18852): -1.3487207053965358, Methylation_chr5 72594851 LOC340090 (24088): 1.3024050151067814, Methylation_chr2 242904738 LINC01238 (3421): -1.470548176270824, Methylation_ARFGEF1: -1.221900397463072, Methylation_MAPT: -0.3713696741802889, Methylation_ZFAT: -0.3389264315035645, Methylation_KCNQ4: 1.9391370182239127, Methylation_chr1 232684368 SIPA1L2 (12934): 0.2623771661781193, Methylation_CRNKL1: 0.2989093801680729, Methylation_PRKAG2: -1.2009520781059615, Methylation_MICB: -0.2204238213145136, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.3411120017521159, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.0487303707218539, miRNA_hsa-mir-190b: 0.7829047021995708, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.613915909106779, miRNA_hsa-mir-2115: 0.2362750628613108, miRNA_hsa-mir-17: 0.4777239219071156, miRNA_hsa-mir-130b: 2.0533787142445106, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-B6-A0WX,"High-level Amplification of EN1 and FOXC1 drives significant mRNA overexpression. ESR1, CA12, and TBC1D9 show low mRNA (Z < -1.92). Promoter hypermethylation at C8orf38, ARFGEF1, and chr10:3949206 mediates epigenetic silencing. miR-135b is upregulated (Z > 1.99); miR-190b is downregulated (Z < -1.25). These features indicate a basal-like phenotype with ER-pathway suppression.","mRNA_MLPH: -1.0153509934129916, mRNA_C2orf54: 0.212349407390067, mRNA_CITED4: 0.9084774224374736, mRNA_ESR1: -1.9213787299517056, mRNA_SPDEF: -0.5931081578899687, mRNA_AGR3: -1.6515108355995098, mRNA_FOXC1: 2.281506819311656, mRNA_GATA3: -1.463959060414454, mRNA_AGR2: -1.6921905392956484, mRNA_XBP1: -1.861980888082916, mRNA_PRR15: -1.921091189918616, mRNA_SLC44A4: -1.5202573987261112, mRNA_CA12: -2.117442229018806, mRNA_DTL: 0.6174220666217015, mRNA_C5AR2: -1.7399775354212297, mRNA_TBC1D9: -1.9437193695772224, mRNA_AR: -1.0039997330522683, mRNA_CCDC170: -1.2907547935208648, mRNA_DEGS2: -1.2820245708500764, mRNA_TFF3: -1.158531695527534, mRNA_DNALI1: -1.2125151617303476, mRNA_LINC00504: -1.447933918921079, mRNA_CLCA2: -0.4257223639251906, mRNA_PPP1R14C: 1.461666554489378, mRNA_THSD4: -1.3488106073748711, mRNA_SPAG5: 0.1123718625920519, mRNA_FBP1: -1.8524380308847828, mRNA_SLC7A8: -0.7090606375407147, mRNA_EN1: 2.7658601042487603, mRNA_ZNF552: -1.5602871305764905, Methylation_LRRC6: 1.4495453389728892, Methylation_chr2 66218712 LINC02934 (29533): -0.0834335072108114, Methylation_HOXB13: 0.996983646843258, Methylation_chr10 3949206 LINC02660 (4871): 1.565791022884015, Methylation_chr5 179517140 RNF130 (18026): -1.400246099765828, Methylation_LOC727677: 0.9170755053906292, Methylation_LETM1: 1.3639065457387205, Methylation_CDC42BPB: 1.0556756360759358, Methylation_C8orf38: 1.6337254039742422, Methylation_chr14 100504766 EVL (18852): 1.3707819967929562, Methylation_chr5 72594851 LOC340090 (24088): -1.5608370003758714, Methylation_chr2 242904738 LINC01238 (3421): 1.3560468815179731, Methylation_ARFGEF1: 1.6351080015005908, Methylation_MAPT: 1.4188792879828278, Methylation_ZFAT: 1.4581840337812109, Methylation_KCNQ4: 1.0623921316838014, Methylation_chr1 232684368 SIPA1L2 (12934): 1.4182263642605717, Methylation_CRNKL1: 1.2629418552629783, Methylation_PRKAG2: 1.2475666567182155, Methylation_MICB: 1.3091419980101455, miRNA_hsa-mir-934: 1.503288608977089, miRNA_hsa-mir-4728: -0.1313010028395636, miRNA_hsa-mir-5695: 1.17964320587215, miRNA_hsa-mir-18a: 0.3248040676897228, miRNA_hsa-mir-190b: -1.2358817543791412, miRNA_hsa-mir-577: -0.4895051607711628, miRNA_hsa-mir-135b: 2.1564662124277407, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.1140524176032432, miRNA_hsa-mir-130b: -0.2688865966775315, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-E2-A1B1,"High-level Amplification of none; CLCA2 mRNA overexpression (Z=3.43) exceeds threshold. No methylation sites meet hyper/hypo criteria. miRNA hsa-mir-190b downregulated (Z=-1.35). CNVs show only deletions (e.g., VPS54, CEP68), but no gains/amplifications. These features collectively indicate a luminal phenotype with limited genomic instability.","mRNA_MLPH: 0.368484176257125, mRNA_C2orf54: 0.6136801626145028, mRNA_CITED4: -0.8831856173291277, mRNA_ESR1: -0.6551505993803846, mRNA_SPDEF: 0.3080364111689925, mRNA_AGR3: -0.3720028140018728, mRNA_FOXC1: 0.8432895748637339, mRNA_GATA3: 0.1872593400434372, mRNA_AGR2: 1.0068968823365685, mRNA_XBP1: -0.0525396207038824, mRNA_PRR15: 0.0362242137642614, mRNA_SLC44A4: 0.7604534586022744, mRNA_CA12: 0.0426534173908101, mRNA_DTL: -0.1676648183127062, mRNA_C5AR2: 0.1156864593910124, mRNA_TBC1D9: 0.1540640914687596, mRNA_AR: 0.5043071189840859, mRNA_CCDC170: 0.4890800788490641, mRNA_DEGS2: 0.0188374309631985, mRNA_TFF3: 0.73174282096296, mRNA_DNALI1: -0.0393407611659211, mRNA_LINC00504: -0.0331570744115862, mRNA_CLCA2: 3.4322559106999435, mRNA_PPP1R14C: 0.4013200628532282, mRNA_THSD4: 0.33707831475727, mRNA_SPAG5: -0.3633991756646255, mRNA_FBP1: 0.2073413371216992, mRNA_SLC7A8: 1.008578672502846, mRNA_EN1: -0.4120750718079171, mRNA_ZNF552: 0.0134920968066826, Methylation_LRRC6: 1.0230711866219966, Methylation_chr2 66218712 LINC02934 (29533): 0.4679296507925337, Methylation_HOXB13: -1.043498765226522, Methylation_chr10 3949206 LINC02660 (4871): 1.182281341514002, Methylation_chr5 179517140 RNF130 (18026): -1.4137594365620336, Methylation_LOC727677: 0.5178854297113976, Methylation_LETM1: 0.645576382259269, Methylation_CDC42BPB: -0.5965469857858225, Methylation_C8orf38: 0.6494386399210476, Methylation_chr14 100504766 EVL (18852): 0.9658292998840412, Methylation_chr5 72594851 LOC340090 (24088): -1.2548253674780818, Methylation_chr2 242904738 LINC01238 (3421): 0.8165667805144442, Methylation_ARFGEF1: 1.266923038601283, Methylation_MAPT: 1.2157510887402565, Methylation_ZFAT: 0.3694784695128774, Methylation_KCNQ4: -1.0593446618432805, Methylation_chr1 232684368 SIPA1L2 (12934): 0.9816616748427202, Methylation_CRNKL1: 0.9591725527271658, Methylation_PRKAG2: 0.3423302155356834, Methylation_MICB: 0.8794291584323322, miRNA_hsa-mir-934: 0.4799420306693657, miRNA_hsa-mir-4728: 1.4071904662327333, miRNA_hsa-mir-5695: -0.0080609808499436, miRNA_hsa-mir-18a: -0.6662229945913033, miRNA_hsa-mir-190b: -1.3492756532706198, miRNA_hsa-mir-577: -0.0267733419071618, miRNA_hsa-mir-135b: -0.4060185144634355, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.5009589632680918, miRNA_hsa-mir-130b: -0.6476222335634131, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-EW-A1J2,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.6442672547327618, mRNA_C2orf54: -0.7459077419943061, mRNA_CITED4: 0.8896823745250348, mRNA_ESR1: 0.745466010437044, mRNA_SPDEF: 0.2934117125045382, mRNA_AGR3: 0.6640693868989075, mRNA_FOXC1: 0.1910614180614681, mRNA_GATA3: 0.5213743493471605, mRNA_AGR2: 0.4349006129061373, mRNA_XBP1: 0.531731459193379, mRNA_PRR15: 0.3200169777615748, mRNA_SLC44A4: 0.7525115914063266, mRNA_CA12: 0.7308723374151834, mRNA_DTL: -1.235824107355448, mRNA_C5AR2: 0.515380744369408, mRNA_TBC1D9: 0.837955144118685, mRNA_AR: 0.7406155678086611, mRNA_CCDC170: 0.7588265101411961, mRNA_DEGS2: 0.0807239455554486, mRNA_TFF3: 0.3955302961268318, mRNA_DNALI1: 0.8124463521706123, mRNA_LINC00504: 0.9352408550307488, mRNA_CLCA2: 1.2512951771557357, mRNA_PPP1R14C: 0.5513820166691129, mRNA_THSD4: 0.878518775708613, mRNA_SPAG5: -1.087658322745335, mRNA_FBP1: 0.3478028396061469, mRNA_SLC7A8: 0.6741941321360825, mRNA_EN1: -0.1854328080259712, mRNA_ZNF552: 0.6385879901209878, Methylation_LRRC6: 0.4052984676628545, Methylation_chr2 66218712 LINC02934 (29533): 1.222866616760132, Methylation_HOXB13: -0.5352782528436164, Methylation_chr10 3949206 LINC02660 (4871): -0.2619110304681622, Methylation_chr5 179517140 RNF130 (18026): -0.0448728708396608, Methylation_LOC727677: -0.0917554625801757, Methylation_LETM1: -0.3928765386510826, Methylation_CDC42BPB: -0.5090255000992661, Methylation_C8orf38: 0.5571884196298313, Methylation_chr14 100504766 EVL (18852): 0.4337284564583191, Methylation_chr5 72594851 LOC340090 (24088): 0.2355135969029632, Methylation_chr2 242904738 LINC01238 (3421): -0.1752626886504476, Methylation_ARFGEF1: 0.262503341178836, Methylation_MAPT: -0.5229470645474502, Methylation_ZFAT: 0.5267692915105949, Methylation_KCNQ4: -1.1250557000780168, Methylation_chr1 232684368 SIPA1L2 (12934): -0.1310827885298318, Methylation_CRNKL1: 0.1393222186741908, Methylation_PRKAG2: 1.055863456215848, Methylation_MICB: 0.2928118705747214, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.2721327747904179, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.7183762604383281, miRNA_hsa-mir-190b: 0.8189642276278013, miRNA_hsa-mir-577: -0.2547406695739249, miRNA_hsa-mir-135b: 0.4622020740525512, miRNA_hsa-mir-2115: -0.1817535099145157, miRNA_hsa-mir-17: -0.6227938996231962, miRNA_hsa-mir-130b: 0.2981879221832975, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A1F8,AR mRNA overexpression (Z=1.396) meets high-expression threshold. No methylation or miRNA alterations exceed diagnostic cutoffs. All CNVs fall within normal range (−1.10 to −0.10). Isolated AR activation suggests luminal androgen receptor phenotype with potential endocrine pathway dysregulation.,"mRNA_MLPH: 0.3150041519545595, mRNA_C2orf54: 0.3677196869501737, mRNA_CITED4: -0.5280061880377598, mRNA_ESR1: 1.1791099249221684, mRNA_SPDEF: 0.2453639060264393, mRNA_AGR3: 0.5553171490459554, mRNA_FOXC1: -0.6125860813048883, mRNA_GATA3: 0.3545917518284233, mRNA_AGR2: 0.3760699954840851, mRNA_XBP1: 0.364081228320864, mRNA_PRR15: 0.4261881815729463, mRNA_SLC44A4: 0.6766923727363416, mRNA_CA12: 0.8316198145115327, mRNA_DTL: 1.090878070167204, mRNA_C5AR2: 0.1973391551842993, mRNA_TBC1D9: 0.2303356442848556, mRNA_AR: 1.395861161926348, mRNA_CCDC170: -0.9438210472528076, mRNA_DEGS2: 0.2106248244766299, mRNA_TFF3: -0.506326095630599, mRNA_DNALI1: 0.2810600248062707, mRNA_LINC00504: 0.1765448503853574, mRNA_CLCA2: 0.0534974326475423, mRNA_PPP1R14C: -0.5890606179698837, mRNA_THSD4: 0.1786618432021777, mRNA_SPAG5: 0.7361115767648562, mRNA_FBP1: 0.5873558078854344, mRNA_SLC7A8: 0.5287484853140397, mRNA_EN1: 0.0015221051200179, mRNA_ZNF552: 0.3101745468930846, Methylation_LRRC6: -0.3075324559630111, Methylation_chr2 66218712 LINC02934 (29533): -1.4003836898446669, Methylation_HOXB13: 1.475042018970523, Methylation_chr10 3949206 LINC02660 (4871): -0.897049177383518, Methylation_chr5 179517140 RNF130 (18026): 0.9909543025621476, Methylation_LOC727677: -0.6272836980533678, Methylation_LETM1: -0.6636653631944779, Methylation_CDC42BPB: 1.3310039827981106, Methylation_C8orf38: -1.092037104400056, Methylation_chr14 100504766 EVL (18852): -0.5591896459208269, Methylation_chr5 72594851 LOC340090 (24088): 1.0450996307056375, Methylation_chr2 242904738 LINC01238 (3421): -1.0790041348451682, Methylation_ARFGEF1: -0.8397154797406192, Methylation_MAPT: -1.1896250272790514, Methylation_ZFAT: -0.3491915306153269, Methylation_KCNQ4: 0.9826506930719971, Methylation_chr1 232684368 SIPA1L2 (12934): -0.7711319513792819, Methylation_CRNKL1: -1.427779932115537, Methylation_PRKAG2: 1.1654237497804911, Methylation_MICB: -0.9119693277606912, miRNA_hsa-mir-934: -0.2557078828060832, miRNA_hsa-mir-4728: 0.1876914550525123, miRNA_hsa-mir-5695: 0.540513896201318, miRNA_hsa-mir-18a: -1.0791334900756384, miRNA_hsa-mir-190b: 0.5747069604125588, miRNA_hsa-mir-577: -0.0528634025217331, miRNA_hsa-mir-135b: 0.9858655611407012, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.7924828315076557, miRNA_hsa-mir-130b: 0.6338286383037446, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A255,"SPAG5 mRNA is highly overexpressed (Z=2.03). No methylation, miRNA, or CNV alterations meet diagnostic thresholds. Isolated SPAG5 upregulation suggests luminal B-like phenotype with mitotic pathway activation.","mRNA_MLPH: 0.2248845029313845, mRNA_C2orf54: 0.4547448557777523, mRNA_CITED4: 0.3075522785456826, mRNA_ESR1: 0.7347334971368854, mRNA_SPDEF: 0.2098862580101178, mRNA_AGR3: 0.4340736054151715, mRNA_FOXC1: -0.2891139801990228, mRNA_GATA3: 0.4547197864437401, mRNA_AGR2: 0.1354202037688244, mRNA_XBP1: 0.1241450553020142, mRNA_PRR15: -0.3975362517334795, mRNA_SLC44A4: 0.3451016269223111, mRNA_CA12: 0.9817527852666124, mRNA_DTL: 0.5183359860006523, mRNA_C5AR2: 0.849014295164688, mRNA_TBC1D9: 0.8048148464462077, mRNA_AR: 0.9836835873401992, mRNA_CCDC170: 0.4850138848149987, mRNA_DEGS2: 0.4425698168271758, mRNA_TFF3: -0.0841280017927706, mRNA_DNALI1: 0.0510601990799059, mRNA_LINC00504: 0.1829244850733076, mRNA_CLCA2: -0.0053648774491118, mRNA_PPP1R14C: -0.4107700595238414, mRNA_THSD4: 0.8220167059263259, mRNA_SPAG5: 2.02888041223302, mRNA_FBP1: 0.2151857188559877, mRNA_SLC7A8: 0.4431430406103864, mRNA_EN1: -0.6897020788795661, mRNA_ZNF552: 0.9356879274173469, Methylation_LRRC6: -0.5068477740262654, Methylation_chr2 66218712 LINC02934 (29533): -0.7575244583096196, Methylation_HOXB13: 0.6007606845533445, Methylation_chr10 3949206 LINC02660 (4871): -0.7308119195475352, Methylation_chr5 179517140 RNF130 (18026): 0.656952377135699, Methylation_LOC727677: -0.2628365693098481, Methylation_LETM1: -0.158513323995745, Methylation_CDC42BPB: 1.0623140700112998, Methylation_C8orf38: -0.5837024538811711, Methylation_chr14 100504766 EVL (18852): 0.0830012458790708, Methylation_chr5 72594851 LOC340090 (24088): 0.51720077469011, Methylation_chr2 242904738 LINC01238 (3421): -0.738151536555877, Methylation_ARFGEF1: -0.7768155462486291, Methylation_MAPT: -0.5971591812821446, Methylation_ZFAT: -0.7017364972038682, Methylation_KCNQ4: -0.0649379315454368, Methylation_chr1 232684368 SIPA1L2 (12934): -0.0312996581821592, Methylation_CRNKL1: 0.0435902427680179, Methylation_PRKAG2: -0.0308334606725, Methylation_MICB: -0.6872731740586243, miRNA_hsa-mir-934: -0.4818236474028038, miRNA_hsa-mir-4728: 0.7382803500836397, miRNA_hsa-mir-5695: 0.98145070937934, miRNA_hsa-mir-18a: -0.1565969918133177, miRNA_hsa-mir-190b: 0.3654157771785526, miRNA_hsa-mir-577: 0.4137307555669915, miRNA_hsa-mir-135b: -0.2856432772890452, miRNA_hsa-mir-2115: -0.3495658719150306, miRNA_hsa-mir-17: -0.4161883170407974, miRNA_hsa-mir-130b: -0.1292183608597376, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AC-A2BM,"LINC00504 mRNA overexpression (Z=2.09) exceeds high-expression threshold. No methylation, miRNA, or CNV alterations meet diagnostic criteria. Isolated transcriptional upregulation of LINC00504 suggests non-driver event; insufficient evidence for subtype classification or pathway inference.","mRNA_MLPH: 0.2238749272602576, mRNA_C2orf54: -1.1789775400087985, mRNA_CITED4: -0.878137828414533, mRNA_ESR1: 0.2152907404219693, mRNA_SPDEF: -0.0988801618871571, mRNA_AGR3: 0.9238529138720508, mRNA_FOXC1: -0.3063503586448824, mRNA_GATA3: 1.0245585735704552, mRNA_AGR2: 0.4009384599855755, mRNA_XBP1: 0.4119360616036047, mRNA_PRR15: 1.129421056970451, mRNA_SLC44A4: 0.2701831757365927, mRNA_CA12: 0.7877330610053467, mRNA_DTL: 1.2282576437658432, mRNA_C5AR2: 0.4463863798503411, mRNA_TBC1D9: 1.3200864463170572, mRNA_AR: 0.6246455418829066, mRNA_CCDC170: -0.1526376531787866, mRNA_DEGS2: 0.1298641762923423, mRNA_TFF3: -0.8760504126522901, mRNA_DNALI1: 1.2259457022071327, mRNA_LINC00504: 2.092466316180306, mRNA_CLCA2: -0.8735231612591499, mRNA_PPP1R14C: -1.047534556530165, mRNA_THSD4: 1.246601823410034, mRNA_SPAG5: 0.1491400349999977, mRNA_FBP1: -0.3826532387279918, mRNA_SLC7A8: 0.2713364365599829, mRNA_EN1: -0.5683620129127188, mRNA_ZNF552: -0.228494863366759, Methylation_LRRC6: -0.8305101419967177, Methylation_chr2 66218712 LINC02934 (29533): -0.7740271181553151, Methylation_HOXB13: -0.9435419165858104, Methylation_chr10 3949206 LINC02660 (4871): -0.7178238587124897, Methylation_chr5 179517140 RNF130 (18026): 1.052880815818934, Methylation_LOC727677: -0.816026449355391, Methylation_LETM1: -1.093689105585372, Methylation_CDC42BPB: 1.098301892114606, Methylation_C8orf38: -0.6911728507735201, Methylation_chr14 100504766 EVL (18852): 0.0334285181617781, Methylation_chr5 72594851 LOC340090 (24088): 0.9726593945947124, Methylation_chr2 242904738 LINC01238 (3421): -1.040736403263755, Methylation_ARFGEF1: 0.7023939484123477, Methylation_MAPT: -0.69404647695683, Methylation_ZFAT: -1.071784112013055, Methylation_KCNQ4: -0.7422416353892071, Methylation_chr1 232684368 SIPA1L2 (12934): 0.8499127790392927, Methylation_CRNKL1: -0.9919443480704416, Methylation_PRKAG2: 1.1520991388540835, Methylation_MICB: -1.0395784833916704, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.9715463358194428, miRNA_hsa-mir-5695: 0.0839126608611077, miRNA_hsa-mir-18a: -0.7726603718942396, miRNA_hsa-mir-190b: 0.5391623202883943, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.8004249384497314, miRNA_hsa-mir-2115: -0.336524675125278, miRNA_hsa-mir-17: -0.0575104877461022, miRNA_hsa-mir-130b: 0.273266200277469, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-BH-A6R8,"No features meet the strict diagnostic thresholds for mRNA (Z > 1.30 or Z < -1.92), methylation (Z > 1.50 or Z < -1.47), miRNA (Z > 1.99 or Z < -1.25), or CNV (deletion, gain, amplification, or high-level amplification). All values fall within non-actionable ranges.","mRNA_MLPH: 0.5196116492091003, mRNA_C2orf54: 0.5999145586212482, mRNA_CITED4: 0.5996564227171955, mRNA_ESR1: 0.4043827852879743, mRNA_SPDEF: 1.0048458918148262, mRNA_AGR3: 0.6132409753032168, mRNA_FOXC1: -1.359595231666202, mRNA_GATA3: 0.4117073011648947, mRNA_AGR2: 0.4333028867502831, mRNA_XBP1: 0.1977558384696021, mRNA_PRR15: 0.9841897696195157, mRNA_SLC44A4: 0.7664915950365445, mRNA_CA12: 0.9606539176826056, mRNA_DTL: -0.4339075710942052, mRNA_C5AR2: 0.832922979125227, mRNA_TBC1D9: 0.8622690270886159, mRNA_AR: 0.2162136697135081, mRNA_CCDC170: 0.4434565933296367, mRNA_DEGS2: 1.0421805537278768, mRNA_TFF3: 0.6919609468988893, mRNA_DNALI1: 1.1547721900152703, mRNA_LINC00504: 0.2992385455644156, mRNA_CLCA2: -0.2821049117661879, mRNA_PPP1R14C: -1.1208415211411225, mRNA_THSD4: 0.263195638603517, mRNA_SPAG5: -0.8344117643597788, mRNA_FBP1: 1.0714530489323355, mRNA_SLC7A8: 0.9729362393956869, mRNA_EN1: -0.5614906870166658, mRNA_ZNF552: 0.5306673656037348, Methylation_LRRC6: -0.8316047637893302, Methylation_chr2 66218712 LINC02934 (29533): -1.136283550623231, Methylation_HOXB13: -0.9597648780805114, Methylation_chr10 3949206 LINC02660 (4871): -1.0165082716686518, Methylation_chr5 179517140 RNF130 (18026): 0.9179009188249622, Methylation_LOC727677: -0.6200728865037392, Methylation_LETM1: -0.875867440336435, Methylation_CDC42BPB: 1.103331489421466, Methylation_C8orf38: -0.5482600970373316, Methylation_chr14 100504766 EVL (18852): -0.8675430947588765, Methylation_chr5 72594851 LOC340090 (24088): -0.6696127914658977, Methylation_chr2 242904738 LINC01238 (3421): -0.6224376497244289, Methylation_ARFGEF1: -0.8291521039160825, Methylation_MAPT: -1.1059129533558525, Methylation_ZFAT: -1.128188443421233, Methylation_KCNQ4: -0.9610493538478256, Methylation_chr1 232684368 SIPA1L2 (12934): -0.5094430381796228, Methylation_CRNKL1: -1.048581022353671, Methylation_PRKAG2: -0.2345855213537843, Methylation_MICB: -1.5392487783510689, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.3010948158396371, miRNA_hsa-mir-5695: 0.5854089364991537, miRNA_hsa-mir-18a: -1.4859315129650483, miRNA_hsa-mir-190b: 1.0012350526484963, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.00576351457623, miRNA_hsa-mir-130b: -1.3684571972211794, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A27W,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. mRNA_CITED4 is downregulated (Z = -2.06). No miRNAs meet dysregulation thresholds. Methylation changes fall within non-significant range. These features suggest a luminal phenotype with potential genomic instability.","mRNA_MLPH: -0.3781320007092026, mRNA_C2orf54: -0.9063521218830336, mRNA_CITED4: -2.0599556033659714, mRNA_ESR1: 0.3949705631589758, mRNA_SPDEF: 1.1428750154778151, mRNA_AGR3: 0.444670487461978, mRNA_FOXC1: -0.6906725480986746, mRNA_GATA3: 0.1980325454550338, mRNA_AGR2: 0.9984503617037712, mRNA_XBP1: 0.9917327981688576, mRNA_PRR15: 0.40745449131412, mRNA_SLC44A4: -0.2982912385484874, mRNA_CA12: -0.3140732292597307, mRNA_DTL: 0.5016363790040778, mRNA_C5AR2: -0.2526932078544006, mRNA_TBC1D9: 1.0004160441979209, mRNA_AR: 0.384861279532721, mRNA_CCDC170: -0.4728032352746088, mRNA_DEGS2: -1.3772275227693491, mRNA_TFF3: 1.2900675522494622, mRNA_DNALI1: -0.0441772125499153, mRNA_LINC00504: -0.0002735986835152, mRNA_CLCA2: -0.8710685012046622, mRNA_PPP1R14C: -0.8200820482429978, mRNA_THSD4: 0.91745514898874, mRNA_SPAG5: 1.0675085109135625, mRNA_FBP1: 0.4642419754444274, mRNA_SLC7A8: -0.3475120960323226, mRNA_EN1: -0.6564992542878052, mRNA_ZNF552: 0.1249867811227742, Methylation_LRRC6: -1.188633744167383, Methylation_chr2 66218712 LINC02934 (29533): 0.8244986383783501, Methylation_HOXB13: 1.1586926449943833, Methylation_chr10 3949206 LINC02660 (4871): -0.7345110391272176, Methylation_chr5 179517140 RNF130 (18026): 1.044539109460204, Methylation_LOC727677: -1.102658586418705, Methylation_LETM1: -0.9899491510978532, Methylation_CDC42BPB: 0.9934743583087308, Methylation_C8orf38: -0.0065975541710867, Methylation_chr14 100504766 EVL (18852): -0.6675127064852638, Methylation_chr5 72594851 LOC340090 (24088): -1.3351991793860112, Methylation_chr2 242904738 LINC01238 (3421): 1.1888271073193202, Methylation_ARFGEF1: -1.2402962614548618, Methylation_MAPT: -1.034027741328737, Methylation_ZFAT: -1.3272012896154726, Methylation_KCNQ4: 0.4839695266261689, Methylation_chr1 232684368 SIPA1L2 (12934): -0.6456938171249254, Methylation_CRNKL1: -0.977489538853751, Methylation_PRKAG2: -0.7765603425310909, Methylation_MICB: -0.9002019025693669, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.5779610742541768, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.2945022992032232, miRNA_hsa-mir-190b: -0.6368675486654598, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.832002458107139, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.0247496865850986, miRNA_hsa-mir-130b: 0.7046808786296298, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-E2-A1IN,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: -0.1140558972367262, mRNA_C2orf54: -0.1869139835830199, mRNA_CITED4: -0.0046026788344702, mRNA_ESR1: 0.8177844715701443, mRNA_SPDEF: 0.3413506183923205, mRNA_AGR3: 0.63184290402827, mRNA_FOXC1: -0.7126207809318947, mRNA_GATA3: 0.5116478779056427, mRNA_AGR2: 0.2919016939869502, mRNA_XBP1: 0.5315521977455314, mRNA_PRR15: 0.2360011060894832, mRNA_SLC44A4: 0.5473849222246459, mRNA_CA12: 0.5679510416131002, mRNA_DTL: -0.150518280192882, mRNA_C5AR2: 0.6221320669970528, mRNA_TBC1D9: 0.6076905132009629, mRNA_AR: 0.6091480720432741, mRNA_CCDC170: 0.0811131692462096, mRNA_DEGS2: 0.543227356013965, mRNA_TFF3: 0.6036856664366258, mRNA_DNALI1: 0.2241178382382912, mRNA_LINC00504: 0.4453308164304525, mRNA_CLCA2: -0.443236315150623, mRNA_PPP1R14C: -0.5398104662495653, mRNA_THSD4: 0.6576847691034364, mRNA_SPAG5: -0.998042857505012, mRNA_FBP1: -0.0322766994912574, mRNA_SLC7A8: 0.7273320269172868, mRNA_EN1: -0.1817443401611016, mRNA_ZNF552: 0.2953950795802347, Methylation_LRRC6: -1.2748103617859332, Methylation_chr2 66218712 LINC02934 (29533): -1.0107640701533014, Methylation_HOXB13: -0.5180454617371937, Methylation_chr10 3949206 LINC02660 (4871): -0.8648893575039621, Methylation_chr5 179517140 RNF130 (18026): -0.7724736406403817, Methylation_LOC727677: -1.222157734149536, Methylation_LETM1: -0.9542544502457854, Methylation_CDC42BPB: -0.4869027586068357, Methylation_C8orf38: -1.395667504352328, Methylation_chr14 100504766 EVL (18852): -0.9836038839953062, Methylation_chr5 72594851 LOC340090 (24088): -0.45901523652631, Methylation_chr2 242904738 LINC01238 (3421): -0.9421922550913252, Methylation_ARFGEF1: -1.1982916818424705, Methylation_MAPT: -0.5967998414872191, Methylation_ZFAT: -1.3451308333792291, Methylation_KCNQ4: -1.133575181624244, Methylation_chr1 232684368 SIPA1L2 (12934): -1.1429614001166095, Methylation_CRNKL1: -0.7129058398927209, Methylation_PRKAG2: -1.1836139418600045, Methylation_MICB: -1.2579378473437972, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.2241153845514025, miRNA_hsa-mir-5695: 0.7147947666992125, miRNA_hsa-mir-18a: -0.8787998297183476, miRNA_hsa-mir-190b: 0.5866954987673814, miRNA_hsa-mir-577: 0.1674404921324945, miRNA_hsa-mir-135b: -0.3576907917842949, miRNA_hsa-mir-2115: 0.1524393658792575, miRNA_hsa-mir-17: -0.5506608788520878, miRNA_hsa-mir-130b: -0.3606756977098801, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-AC-A3W7,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 1.148075909894572, mRNA_C2orf54: 1.1685773447014156, mRNA_CITED4: 1.2041325405566836, mRNA_ESR1: 0.6469878105771726, mRNA_SPDEF: 0.9996001675260328, mRNA_AGR3: 0.8243818955335939, mRNA_FOXC1: 0.0395197715882709, mRNA_GATA3: 0.6857674210393357, mRNA_AGR2: 1.0260536110842573, mRNA_XBP1: 0.2015815744692877, mRNA_PRR15: 0.9678174964179316, mRNA_SLC44A4: 1.1315491157400783, mRNA_CA12: 0.532233971140102, mRNA_DTL: -0.648738966649989, mRNA_C5AR2: 1.4831054895656182, mRNA_TBC1D9: 0.6168285526774627, mRNA_AR: 0.7156109535227047, mRNA_CCDC170: 0.6498394971575471, mRNA_DEGS2: 0.3868985179094455, mRNA_TFF3: 0.943627581433795, mRNA_DNALI1: 0.6244291109530475, mRNA_LINC00504: 0.5896984415651403, mRNA_CLCA2: 2.6687017888855262, mRNA_PPP1R14C: 0.0554991234594486, mRNA_THSD4: 0.7242475445752159, mRNA_SPAG5: -1.0152412684144838, mRNA_FBP1: 0.4057832857317558, mRNA_SLC7A8: 0.581946784594968, mRNA_EN1: 0.2418892411536042, mRNA_ZNF552: 0.8722689392232655, Methylation_LRRC6: -0.0653583413852391, Methylation_chr2 66218712 LINC02934 (29533): 0.7120200962238429, Methylation_HOXB13: 0.3693314746711967, Methylation_chr10 3949206 LINC02660 (4871): -0.5130648989024512, Methylation_chr5 179517140 RNF130 (18026): 0.1192116379002644, Methylation_LOC727677: -0.6262796904253367, Methylation_LETM1: -0.4323012230998085, Methylation_CDC42BPB: -1.055483504899521, Methylation_C8orf38: -0.5679153014871007, Methylation_chr14 100504766 EVL (18852): -0.5674974110269388, Methylation_chr5 72594851 LOC340090 (24088): 0.851764206231119, Methylation_chr2 242904738 LINC01238 (3421): -0.5065628698993417, Methylation_ARFGEF1: -0.3544952897950146, Methylation_MAPT: -0.2060775591289929, Methylation_ZFAT: -0.388634494696106, Methylation_KCNQ4: -0.286822979466469, Methylation_chr1 232684368 SIPA1L2 (12934): -0.7341496564043634, Methylation_CRNKL1: -0.2211729032865834, Methylation_PRKAG2: -0.5171755008040264, Methylation_MICB: -0.4723220558668514, miRNA_hsa-mir-934: -0.3019664396171639, miRNA_hsa-mir-4728: -0.5651986011745679, miRNA_hsa-mir-5695: 0.36250534170793, miRNA_hsa-mir-18a: -0.3079445589291421, miRNA_hsa-mir-190b: 1.1021959925678524, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.514427306873895, miRNA_hsa-mir-2115: -0.0361376393574795, miRNA_hsa-mir-17: -0.0926922354061219, miRNA_hsa-mir-130b: -1.051658300310088, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A24K,"High-level Amplification absent; no CNV alterations meet diagnostic thresholds.  
mRNA_XBP1 (Z=1.21), mRNA_CA12 (Z=1.07), mRNA_DTL (Z=1.43), mRNA_CCDC170 (Z=1.51), mRNA_LINC00504 (Z=1.49), and mRNA_THSD4 (Z=1.42) exceed high-expression threshold (Z>1.30).  
No methylation or miRNA features meet dysregulation criteria.  
Collectively indicates luminal-like phenotype with ER pathway activation.","mRNA_MLPH: 0.0318697121891828, mRNA_C2orf54: -0.0745720874442135, mRNA_CITED4: 0.5935135136737764, mRNA_ESR1: 0.6858704390008498, mRNA_SPDEF: 0.15873736842873, mRNA_AGR3: 0.8968963096546761, mRNA_FOXC1: -1.4854516904771355, mRNA_GATA3: 0.6155890055702921, mRNA_AGR2: -0.1472848417242896, mRNA_XBP1: 1.2107868859451627, mRNA_PRR15: 0.0107330535170446, mRNA_SLC44A4: 0.7473024398403757, mRNA_CA12: 1.068762449509897, mRNA_DTL: 1.428969935496235, mRNA_C5AR2: 0.6834090252859525, mRNA_TBC1D9: 0.5569675914137103, mRNA_AR: 0.8338818598063003, mRNA_CCDC170: 1.505637847151111, mRNA_DEGS2: 0.5887737461274754, mRNA_TFF3: -0.5152914727711526, mRNA_DNALI1: 0.5604939590837286, mRNA_LINC00504: 1.488296595169732, mRNA_CLCA2: -0.7845246218299503, mRNA_PPP1R14C: -0.7269528557305718, mRNA_THSD4: 1.4236933756499084, mRNA_SPAG5: 0.6803021292999738, mRNA_FBP1: -0.5005338132418815, mRNA_SLC7A8: 0.54713910117782, mRNA_EN1: -0.8683044077196932, mRNA_ZNF552: 0.5513444160956262, Methylation_LRRC6: -1.443925083972554, Methylation_chr2 66218712 LINC02934 (29533): -1.4311384028573348, Methylation_HOXB13: 0.786880877387496, Methylation_chr10 3949206 LINC02660 (4871): -1.3667807774255918, Methylation_chr5 179517140 RNF130 (18026): 1.0485237460136394, Methylation_LOC727677: -1.5122727963110398, Methylation_LETM1: -1.3664717314411587, Methylation_CDC42BPB: -1.4122235129418814, Methylation_C8orf38: -1.569139739904381, Methylation_chr14 100504766 EVL (18852): -1.433845151244149, Methylation_chr5 72594851 LOC340090 (24088): 0.2993186494150718, Methylation_chr2 242904738 LINC01238 (3421): -1.510295774929967, Methylation_ARFGEF1: -1.176853226065601, Methylation_MAPT: -1.3260403250865032, Methylation_ZFAT: -1.2818990939140815, Methylation_KCNQ4: 0.8848534920055432, Methylation_chr1 232684368 SIPA1L2 (12934): -1.4719729706679938, Methylation_CRNKL1: -1.405053834289005, Methylation_PRKAG2: 1.3374515110616831, Methylation_MICB: -1.017540310411308, miRNA_hsa-mir-934: -0.407639864607154, miRNA_hsa-mir-4728: -0.6221110254928008, miRNA_hsa-mir-5695: -0.044138854038524, miRNA_hsa-mir-18a: -2.007899402960678, miRNA_hsa-mir-190b: -0.3804263651099824, miRNA_hsa-mir-577: -0.5853832924994233, miRNA_hsa-mir-135b: -0.8579430749917086, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.815894776700532, miRNA_hsa-mir-130b: -1.5151444613380796, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-D8-A27K,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.4282433139754631, mRNA_C2orf54: -0.6819026571142361, mRNA_CITED4: 0.9743814372023734, mRNA_ESR1: 0.5440921116239885, mRNA_SPDEF: 0.2622823317994275, mRNA_AGR3: 0.3909524118958205, mRNA_FOXC1: -0.3888609332603842, mRNA_GATA3: 0.8533305754636652, mRNA_AGR2: 0.0226442809329356, mRNA_XBP1: 0.7286746664375584, mRNA_PRR15: 0.5653198791136094, mRNA_SLC44A4: 0.7537619105994331, mRNA_CA12: 0.2949451238998196, mRNA_DTL: -0.1360649419580366, mRNA_C5AR2: 0.1038452938232648, mRNA_TBC1D9: 0.995493261128962, mRNA_AR: 0.9536420097679316, mRNA_CCDC170: 0.9852349666610444, mRNA_DEGS2: -0.1001747017102465, mRNA_TFF3: 0.2872982760133495, mRNA_DNALI1: 0.9480639787452196, mRNA_LINC00504: 1.234739446656236, mRNA_CLCA2: 0.932798951864371, mRNA_PPP1R14C: 0.1464045685754235, mRNA_THSD4: 0.7054853655301437, mRNA_SPAG5: -0.8776459539742574, mRNA_FBP1: 0.1964518345319887, mRNA_SLC7A8: 0.5214352939094398, mRNA_EN1: -0.4929306720383847, mRNA_ZNF552: -0.0277249428586653, Methylation_LRRC6: 0.1344290157294899, Methylation_chr2 66218712 LINC02934 (29533): 1.165868528448346, Methylation_HOXB13: -0.6519442398974228, Methylation_chr10 3949206 LINC02660 (4871): -0.6792037097441932, Methylation_chr5 179517140 RNF130 (18026): 0.586551657968381, Methylation_LOC727677: 0.6758939541876828, Methylation_LETM1: 0.0522418905409002, Methylation_CDC42BPB: -0.8889553454836575, Methylation_C8orf38: 0.5356246247091133, Methylation_chr14 100504766 EVL (18852): -0.2757059457348146, Methylation_chr5 72594851 LOC340090 (24088): 0.7360373062706864, Methylation_chr2 242904738 LINC01238 (3421): -0.8238443635370675, Methylation_ARFGEF1: 0.2250308879018598, Methylation_MAPT: -0.2099976364040373, Methylation_ZFAT: 0.6012251458522981, Methylation_KCNQ4: 1.012997871438991, Methylation_chr1 232684368 SIPA1L2 (12934): -0.2484206010795061, Methylation_CRNKL1: 0.0168296434367448, Methylation_PRKAG2: 1.3068840531777848, Methylation_MICB: -0.436096672042713, miRNA_hsa-mir-934: -0.419103266777934, miRNA_hsa-mir-4728: 0.0461366658488752, miRNA_hsa-mir-5695: 0.4684089484604848, miRNA_hsa-mir-18a: -1.3150234976160071, miRNA_hsa-mir-190b: 0.2735026578637453, miRNA_hsa-mir-577: -0.5959801341192582, miRNA_hsa-mir-135b: -0.2101676350698342, miRNA_hsa-mir-2115: 0.0211859580816726, miRNA_hsa-mir-17: -0.4603650724453876, miRNA_hsa-mir-130b: -1.19737799555221, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A0DP,High mRNA_CITED4 (Z=1.79) indicates overexpression. No methylation sites meet hyper/hypo-methylation thresholds. miRNA_hsa-mir-17 is downregulated (Z=-1.89). All CNVs show Gain (0.38–0.40). Gain of CEP68 and WDPCP may contribute to transcriptional dysregulation.,"mRNA_MLPH: 0.2546916965985139, mRNA_C2orf54: -0.6626587729529008, mRNA_CITED4: 1.790466276004377, mRNA_ESR1: 0.7692778241717467, mRNA_SPDEF: 0.1444058175218575, mRNA_AGR3: 0.766461082021132, mRNA_FOXC1: 0.3411945097045902, mRNA_GATA3: 0.6690243786908981, mRNA_AGR2: 0.990521117454532, mRNA_XBP1: 0.4382113438875004, mRNA_PRR15: 0.7822167770924638, mRNA_SLC44A4: 0.5397656220612336, mRNA_CA12: 0.5749594130769891, mRNA_DTL: 0.0708236906683261, mRNA_C5AR2: 0.1275452526982515, mRNA_TBC1D9: 0.3106592728982953, mRNA_AR: 0.688282259071235, mRNA_CCDC170: 0.6353267576354543, mRNA_DEGS2: 0.5957747191500993, mRNA_TFF3: -0.1517873960143372, mRNA_DNALI1: 0.6104038843878338, mRNA_LINC00504: 0.9191132202512168, mRNA_CLCA2: 0.3825165231541121, mRNA_PPP1R14C: 0.309375178853477, mRNA_THSD4: 0.3168611367499763, mRNA_SPAG5: -1.099728641796452, mRNA_FBP1: 0.2440401808871811, mRNA_SLC7A8: 0.3022626284348738, mRNA_EN1: -0.1856845040304244, mRNA_ZNF552: 0.8081576457513177, Methylation_LRRC6: -0.1936999159195676, Methylation_chr2 66218712 LINC02934 (29533): 1.1640108140214638, Methylation_HOXB13: 0.7808121640913115, Methylation_chr10 3949206 LINC02660 (4871): -0.1215003963177543, Methylation_chr5 179517140 RNF130 (18026): 0.976033836045988, Methylation_LOC727677: -0.5104536970508201, Methylation_LETM1: -0.2305696581003106, Methylation_CDC42BPB: -0.95237934485562, Methylation_C8orf38: 0.0739256046627658, Methylation_chr14 100504766 EVL (18852): -0.0229632531875748, Methylation_chr5 72594851 LOC340090 (24088): 1.0234545531500898, Methylation_chr2 242904738 LINC01238 (3421): 1.209817717309447, Methylation_ARFGEF1: -0.3451601242940779, Methylation_MAPT: -0.3377735850562463, Methylation_ZFAT: 0.0276658554135744, Methylation_KCNQ4: 0.5537463368693807, Methylation_chr1 232684368 SIPA1L2 (12934): -0.3508070792436799, Methylation_CRNKL1: -1.1871660247710711, Methylation_PRKAG2: 1.2261044486279484, Methylation_MICB: -0.4233921070227214, miRNA_hsa-mir-934: -0.25999347803166, miRNA_hsa-mir-4728: -0.8100395156164323, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.1283729161306986, miRNA_hsa-mir-190b: -0.0414401139407416, miRNA_hsa-mir-577: 0.0786560229435749, miRNA_hsa-mir-135b: -0.1465887178911115, miRNA_hsa-mir-2115: 0.2276352173556237, miRNA_hsa-mir-17: -1.8883834698839064, miRNA_hsa-mir-130b: -0.3630389152592353, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-W8-A86G,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. DTL mRNA is significantly downregulated (Z = -1.96). No methylation or miRNA alterations meet diagnostic thresholds. These features indicate a proliferation-rich phenotype with genomic instability.","mRNA_MLPH: 0.8708220411301548, mRNA_C2orf54: -0.3251632496264398, mRNA_CITED4: 0.7864314090286199, mRNA_ESR1: 0.5909976896882035, mRNA_SPDEF: 0.4799441476750937, mRNA_AGR3: 0.5314069841397967, mRNA_FOXC1: -0.0280990553483086, mRNA_GATA3: 0.3660230053808162, mRNA_AGR2: 0.4415799406221771, mRNA_XBP1: 0.6605047833314202, mRNA_PRR15: 0.2998039487311602, mRNA_SLC44A4: 0.4714677178755113, mRNA_CA12: 0.3383355956045528, mRNA_DTL: -1.9576456693494528, mRNA_C5AR2: 0.5371519240882447, mRNA_TBC1D9: -0.0816216338786346, mRNA_AR: 0.1809999231780187, mRNA_CCDC170: 0.2799653818775036, mRNA_DEGS2: 0.759003785446848, mRNA_TFF3: 0.6113121687048532, mRNA_DNALI1: 0.8826535168377292, mRNA_LINC00504: 0.1179934054417321, mRNA_CLCA2: 1.050269880816424, mRNA_PPP1R14C: 1.0121107555965745, mRNA_THSD4: 0.4491761020546562, mRNA_SPAG5: -0.9447143646546478, mRNA_FBP1: 0.3096996836608407, mRNA_SLC7A8: 0.2424834231193334, mRNA_EN1: -0.1181561401795993, mRNA_ZNF552: 0.9541119638593736, Methylation_LRRC6: 0.3129879153735934, Methylation_chr2 66218712 LINC02934 (29533): 0.1924996884610972, Methylation_HOXB13: -0.9918492379629688, Methylation_chr10 3949206 LINC02660 (4871): 0.4238889825576646, Methylation_chr5 179517140 RNF130 (18026): 0.6254984393624647, Methylation_LOC727677: -0.2318312638392523, Methylation_LETM1: -0.0896484934485485, Methylation_CDC42BPB: -0.7431925689491717, Methylation_C8orf38: -0.6101662959994868, Methylation_chr14 100504766 EVL (18852): -0.0821453550234291, Methylation_chr5 72594851 LOC340090 (24088): 0.6966277460468484, Methylation_chr2 242904738 LINC01238 (3421): -0.4202873131564803, Methylation_ARFGEF1: 0.6709197220158064, Methylation_MAPT: 0.2816720273764034, Methylation_ZFAT: -0.0603455646509104, Methylation_KCNQ4: -0.2362783248107553, Methylation_chr1 232684368 SIPA1L2 (12934): 1.14111245350812, Methylation_CRNKL1: 0.4946510853899435, Methylation_PRKAG2: 1.3201735573640436, Methylation_MICB: 0.6632483070935945, miRNA_hsa-mir-934: 0.230181615645565, miRNA_hsa-mir-4728: -0.8166739772499652, miRNA_hsa-mir-5695: 0.5059433461456491, miRNA_hsa-mir-18a: -0.2542068538196397, miRNA_hsa-mir-190b: 1.1218026845411957, miRNA_hsa-mir-577: -0.1473452643683057, miRNA_hsa-mir-135b: 0.4245443330030548, miRNA_hsa-mir-2115: 1.4188707249803396, miRNA_hsa-mir-17: -0.129842057598187, miRNA_hsa-mir-130b: -1.0794086081326395, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-E2-A1IJ,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.5345031072785148, mRNA_C2orf54: -0.1303491232813282, mRNA_CITED4: 0.74552701974987, mRNA_ESR1: 0.3839796501829773, mRNA_SPDEF: 0.521590844363376, mRNA_AGR3: 0.6138667538045736, mRNA_FOXC1: 0.1208842795927272, mRNA_GATA3: 0.0641219097677004, mRNA_AGR2: 0.7799380870787025, mRNA_XBP1: -0.0233361276260799, mRNA_PRR15: 0.2218806355813694, mRNA_SLC44A4: 0.6441345692063803, mRNA_CA12: 0.377313878006467, mRNA_DTL: -1.0120441470673691, mRNA_C5AR2: 0.5156118860486254, mRNA_TBC1D9: 0.1790033522018048, mRNA_AR: -0.1241711474728464, mRNA_CCDC170: 0.4191049983339506, mRNA_DEGS2: 0.4694347218278934, mRNA_TFF3: 0.9585350950546324, mRNA_DNALI1: 0.593097126636743, mRNA_LINC00504: 0.3436900574684629, mRNA_CLCA2: 0.2918892672332662, mRNA_PPP1R14C: 0.2542769812499239, mRNA_THSD4: 0.205237404617102, mRNA_SPAG5: -0.7677633318855046, mRNA_FBP1: -0.2601880178040678, mRNA_SLC7A8: 0.4989417539661288, mRNA_EN1: 0.216166761620757, mRNA_ZNF552: 0.218224087446911, Methylation_LRRC6: 0.8772030863693232, Methylation_chr2 66218712 LINC02934 (29533): 0.6240267611454319, Methylation_HOXB13: 0.3194881354452604, Methylation_chr10 3949206 LINC02660 (4871): -0.0756886667097084, Methylation_chr5 179517140 RNF130 (18026): -0.1982856133756655, Methylation_LOC727677: 0.7132976835799374, Methylation_LETM1: 0.0855186679822645, Methylation_CDC42BPB: -1.0009866577320703, Methylation_C8orf38: 1.3075156960881271, Methylation_chr14 100504766 EVL (18852): 0.4133384726529941, Methylation_chr5 72594851 LOC340090 (24088): -0.0011635035820165, Methylation_chr2 242904738 LINC01238 (3421): 0.6530713843220151, Methylation_ARFGEF1: 0.784795153887842, Methylation_MAPT: -0.0233521807776506, Methylation_ZFAT: 1.247164837388114, Methylation_KCNQ4: -1.0245592282935714, Methylation_chr1 232684368 SIPA1L2 (12934): -0.0955248779325848, Methylation_CRNKL1: 0.5384128113508806, Methylation_PRKAG2: 0.8454426085642114, Methylation_MICB: 0.1407959178453342, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.1466937735676163, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.1506118383380089, miRNA_hsa-mir-190b: -0.1512190787631852, miRNA_hsa-mir-577: 0.1070529203597011, miRNA_hsa-mir-135b: -0.1161521439950969, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.1011868332047476, miRNA_hsa-mir-130b: 0.1715194682800268, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A1-A0SG,mRNA_CITED4 (Z=1.30) and mRNA_DEGS2 (Z=1.50) are overexpressed. No methylation or miRNA alterations meet significance thresholds. All CNVs fall within normal range (−1.10 to −0.10). These features indicate luminal A phenotype with estrogen signaling activation.,"mRNA_MLPH: 0.617613368913308, mRNA_C2orf54: 1.23088041097938, mRNA_CITED4: 1.3048975997345542, mRNA_ESR1: 0.7916660698825854, mRNA_SPDEF: 0.8582207656401293, mRNA_AGR3: 0.2646621227604597, mRNA_FOXC1: -0.6035939839279394, mRNA_GATA3: 0.5013015603193176, mRNA_AGR2: 0.1214356979242146, mRNA_XBP1: 0.8870823714223702, mRNA_PRR15: 0.4014848344753791, mRNA_SLC44A4: 0.1313711710160837, mRNA_CA12: 0.9695993061166872, mRNA_DTL: -0.9724134341874486, mRNA_C5AR2: 0.7149895259110868, mRNA_TBC1D9: 0.1418482732206234, mRNA_AR: 0.5290045076505194, mRNA_CCDC170: 0.8516410381917567, mRNA_DEGS2: 1.501751601817753, mRNA_TFF3: 0.933005955895188, mRNA_DNALI1: 0.9799695810237846, mRNA_LINC00504: 0.8514080278758062, mRNA_CLCA2: -0.2153029881723, mRNA_PPP1R14C: -0.4514301928779077, mRNA_THSD4: 0.7082406529750687, mRNA_SPAG5: -0.9089274168263864, mRNA_FBP1: 0.9027558073671847, mRNA_SLC7A8: 0.9935643582223498, mRNA_EN1: -0.7224172972715525, mRNA_ZNF552: 1.016494419227849, Methylation_LRRC6: -0.6277639740567315, Methylation_chr2 66218712 LINC02934 (29533): -0.733887645571083, Methylation_HOXB13: -1.05172581918282, Methylation_chr10 3949206 LINC02660 (4871): -0.8109505695494507, Methylation_chr5 179517140 RNF130 (18026): 0.6878279485213018, Methylation_LOC727677: -0.9465193787410104, Methylation_LETM1: -0.8735700220209, Methylation_CDC42BPB: -1.3277236301316433, Methylation_C8orf38: -0.9907229750036376, Methylation_chr14 100504766 EVL (18852): -0.7460939182932302, Methylation_chr5 72594851 LOC340090 (24088): -0.0932386238213716, Methylation_chr2 242904738 LINC01238 (3421): -0.4294088164765167, Methylation_ARFGEF1: -1.1240366639140555, Methylation_MAPT: -0.9245452354692392, Methylation_ZFAT: -0.8966325460624595, Methylation_KCNQ4: 0.9182553447256756, Methylation_chr1 232684368 SIPA1L2 (12934): -0.1875166697034807, Methylation_CRNKL1: -0.4316210346104387, Methylation_PRKAG2: 1.1387414826982978, Methylation_MICB: -1.1570180150675689, miRNA_hsa-mir-934: 1.144256484389737, miRNA_hsa-mir-4728: 1.0663130068565545, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.811518141333952, miRNA_hsa-mir-190b: 0.0364328012742784, miRNA_hsa-mir-577: 1.7712451775868323, miRNA_hsa-mir-135b: -0.3140017516291948, miRNA_hsa-mir-2115: 1.113069050726667, miRNA_hsa-mir-17: -0.3890616372422931, miRNA_hsa-mir-130b: -0.1271054444519189, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A1XC,"High mRNA_ESR1 (Z=1.48) and mRNA_CCDC170 (Z=1.83) indicate luminal overexpression. mRNA_CITED4 is low (Z=-2.26). Methylation_chr1 232684368 SIPA1L2 (Z=-1.52), Methylation_PRKAG2 (Z=-1.72), and Methylation_chr2 66218712 LINC02934 (Z=-1.75) are hypomethylated. No CNVs meet deletion/amplification thresholds. These features collectively indicate a luminal A phenotype with estrogen signaling activation.","mRNA_MLPH: 0.4515068300111926, mRNA_C2orf54: -1.2943230935752186, mRNA_CITED4: -2.261435116500021, mRNA_ESR1: 1.4842579132525868, mRNA_SPDEF: 0.2184776312272527, mRNA_AGR3: 0.272420980486331, mRNA_FOXC1: -1.435075346375462, mRNA_GATA3: 0.7222506426032193, mRNA_AGR2: 0.5627367631838814, mRNA_XBP1: 0.9466739748221098, mRNA_PRR15: 0.5170330797774488, mRNA_SLC44A4: 0.8602661147260362, mRNA_CA12: 0.3998555695740995, mRNA_DTL: -1.0236738528523963, mRNA_C5AR2: 0.812245929446808, mRNA_TBC1D9: 0.0265317176106203, mRNA_AR: 1.0939307299488377, mRNA_CCDC170: 1.8349825497747887, mRNA_DEGS2: 0.0666154161419261, mRNA_TFF3: 0.5588874338367072, mRNA_DNALI1: 0.8228497851307333, mRNA_LINC00504: 0.3761911803935444, mRNA_CLCA2: -0.8398290522599287, mRNA_PPP1R14C: -1.1374353211451338, mRNA_THSD4: 1.3870237257547533, mRNA_SPAG5: -1.0811361860152695, mRNA_FBP1: -0.1514172436072378, mRNA_SLC7A8: 0.6229280610630978, mRNA_EN1: -1.0868124717078274, mRNA_ZNF552: -0.0053966282786703, Methylation_LRRC6: -1.1934310403492143, Methylation_chr2 66218712 LINC02934 (29533): -1.7452224645354169, Methylation_HOXB13: -1.0822015297950789, Methylation_chr10 3949206 LINC02660 (4871): -0.3661143051533182, Methylation_chr5 179517140 RNF130 (18026): 1.1355627270922226, Methylation_LOC727677: -1.284640353264401, Methylation_LETM1: -1.4085795612918832, Methylation_CDC42BPB: -1.3867669189856944, Methylation_C8orf38: -1.4817231969780091, Methylation_chr14 100504766 EVL (18852): -1.4815382248993016, Methylation_chr5 72594851 LOC340090 (24088): 1.200184989543854, Methylation_chr2 242904738 LINC01238 (3421): -1.444679357980432, Methylation_ARFGEF1: -1.304646994240872, Methylation_MAPT: -1.068422257185237, Methylation_ZFAT: 0.2306319389583562, Methylation_KCNQ4: -0.6521138498561949, Methylation_chr1 232684368 SIPA1L2 (12934): -1.517352566987237, Methylation_CRNKL1: -1.391964080327068, Methylation_PRKAG2: -1.715405868830027, Methylation_MICB: -1.3900949542547354, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -1.1310894899814492, miRNA_hsa-mir-5695: -0.3508460482163603, miRNA_hsa-mir-18a: -1.1096151867580808, miRNA_hsa-mir-190b: 1.013095743950259, miRNA_hsa-mir-577: -0.4211558473885721, miRNA_hsa-mir-135b: 0.5504654929172381, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.854968863918888, miRNA_hsa-mir-130b: -0.5353254909853409, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A2LJ,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-significant ranges per specified Z-score and CNV cutoffs.","mRNA_MLPH: 0.5098869917795394, mRNA_C2orf54: -0.9663789241438496, mRNA_CITED4: 0.3685881987859766, mRNA_ESR1: -0.4626668757256477, mRNA_SPDEF: 0.6291217854376012, mRNA_AGR3: 0.1983324363272527, mRNA_FOXC1: -0.153640984319821, mRNA_GATA3: 0.2646611061221184, mRNA_AGR2: 0.1040292009162856, mRNA_XBP1: 0.2979989989139576, mRNA_PRR15: 0.5043804648504208, mRNA_SLC44A4: 0.6761300909625433, mRNA_CA12: 0.3169548397900942, mRNA_DTL: -1.2246913672093005, mRNA_C5AR2: 0.1646546137529759, mRNA_TBC1D9: 0.1045064250646282, mRNA_AR: 0.0080983694056329, mRNA_CCDC170: -0.54245501310353, mRNA_DEGS2: 0.6478452521405355, mRNA_TFF3: 0.6293732236705418, mRNA_DNALI1: 0.3376977003788451, mRNA_LINC00504: 0.3967519632843652, mRNA_CLCA2: -0.6418353603904365, mRNA_PPP1R14C: -0.2438948237827165, mRNA_THSD4: 0.0684677937255434, mRNA_SPAG5: -1.1004285882833147, mRNA_FBP1: 0.6752738245983955, mRNA_SLC7A8: 0.0885736014095755, mRNA_EN1: -0.1030790302902903, mRNA_ZNF552: -0.0508232488905754, Methylation_LRRC6: 0.8510491248198101, Methylation_chr2 66218712 LINC02934 (29533): 0.797426701697953, Methylation_HOXB13: 0.2788284786338151, Methylation_chr10 3949206 LINC02660 (4871): 0.2394687458307579, Methylation_chr5 179517140 RNF130 (18026): -0.8208473208537481, Methylation_LOC727677: 0.1264971202206225, Methylation_LETM1: -0.1886117757267114, Methylation_CDC42BPB: -0.6357657597200116, Methylation_C8orf38: 0.4069959787849698, Methylation_chr14 100504766 EVL (18852): 0.5798602300304153, Methylation_chr5 72594851 LOC340090 (24088): 0.2401633785722198, Methylation_chr2 242904738 LINC01238 (3421): -0.1139787996064748, Methylation_ARFGEF1: 0.7634461861985136, Methylation_MAPT: 0.0296284844575037, Methylation_ZFAT: 0.279342652712893, Methylation_KCNQ4: -1.1851964284171084, Methylation_chr1 232684368 SIPA1L2 (12934): 0.8069997867411068, Methylation_CRNKL1: 0.069496283290512, Methylation_PRKAG2: 0.9146667021610324, Methylation_MICB: 0.4699186422116836, miRNA_hsa-mir-934: -0.3659409215818784, miRNA_hsa-mir-4728: 0.4276117599363511, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.429371598304639, miRNA_hsa-mir-190b: 0.2698615664064308, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.6830662443798347, miRNA_hsa-mir-2115: -0.1717201800165518, miRNA_hsa-mir-17: -0.2271652053053489, miRNA_hsa-mir-130b: -0.3333954091314851, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A0B5,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. No promoter hyper/hypomethylation or miRNA dysregulation meets diagnostic thresholds. These features collectively indicate a luminal phenotype with genomic instability.","mRNA_MLPH: 0.5104098632620668, mRNA_C2orf54: 1.437444969146692, mRNA_CITED4: 0.3550640805301734, mRNA_ESR1: 0.0622535106828408, mRNA_SPDEF: 0.381240226616341, mRNA_AGR3: 0.6460556813820065, mRNA_FOXC1: -0.3436330301033842, mRNA_GATA3: 0.6973521551131334, mRNA_AGR2: 0.9020203859395064, mRNA_XBP1: -0.0063854980825471, mRNA_PRR15: 0.5914432296079318, mRNA_SLC44A4: 0.6874613701960967, mRNA_CA12: 0.5836765363094956, mRNA_DTL: 1.6544990370053132, mRNA_C5AR2: 0.0545732263999334, mRNA_TBC1D9: 0.4971889688582477, mRNA_AR: 1.258239090825834, mRNA_CCDC170: -0.0145818661126727, mRNA_DEGS2: 0.7539042971801193, mRNA_TFF3: -0.3310716585090757, mRNA_DNALI1: 0.8134716241331308, mRNA_LINC00504: 0.2743854796899978, mRNA_CLCA2: -0.5459216096082984, mRNA_PPP1R14C: -0.181049267585464, mRNA_THSD4: 0.3555633491250617, mRNA_SPAG5: 0.8722664682769875, mRNA_FBP1: 0.5168989574517495, mRNA_SLC7A8: 0.2225205633239652, mRNA_EN1: -0.41022822121441, mRNA_ZNF552: -0.032378732150951, Methylation_LRRC6: -0.5670687370176037, Methylation_chr2 66218712 LINC02934 (29533): 1.2598725641173267, Methylation_HOXB13: -0.9999891833152948, Methylation_chr10 3949206 LINC02660 (4871): -0.7297438465068989, Methylation_chr5 179517140 RNF130 (18026): 0.9385923222415766, Methylation_LOC727677: -0.5158597035817531, Methylation_LETM1: -0.7848548257160154, Methylation_CDC42BPB: 0.586792972522872, Methylation_C8orf38: -0.2129440173284968, Methylation_chr14 100504766 EVL (18852): -0.8524078645940026, Methylation_chr5 72594851 LOC340090 (24088): 1.1942987049740628, Methylation_chr2 242904738 LINC01238 (3421): -0.942960375069588, Methylation_ARFGEF1: -0.8413595570397421, Methylation_MAPT: -0.2188086263158573, Methylation_ZFAT: -0.0861330123575806, Methylation_KCNQ4: 1.1124586643092929, Methylation_chr1 232684368 SIPA1L2 (12934): -1.0026445727591922, Methylation_CRNKL1: -0.7781360456422789, Methylation_PRKAG2: 1.2939566436662016, Methylation_MICB: -0.5670968137532535, miRNA_hsa-mir-934: -0.2589002540273504, miRNA_hsa-mir-4728: -0.0010608835827539, miRNA_hsa-mir-5695: 1.018437679392152, miRNA_hsa-mir-18a: -0.4036193288563991, miRNA_hsa-mir-190b: -0.4463612630470777, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.8617582007903662, miRNA_hsa-mir-2115: -0.3934020497986419, miRNA_hsa-mir-17: -0.2916444582166581, miRNA_hsa-mir-130b: -0.4022285690127372, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-C8-A1HK,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression of SPAG5, CLCA2, and C2orf54. Promoter hypermethylation of LETM1, MAPT, CRNKL1, and chr2:242904738 mediates epigenetic silencing. Hypomethylation at multiple loci including ARFGEF1 and PRKAG2 correlates with transcriptional dysregulation. Upregulated hsa-mir-4728 suggests oncogenic miRNA activity.","mRNA_MLPH: 0.2834368991777232, mRNA_C2orf54: 2.0972708809912826, mRNA_CITED4: -1.953752839371, mRNA_ESR1: -1.5325936127703748, mRNA_SPDEF: 0.7196437861961831, mRNA_AGR3: -1.5654552672647597, mRNA_FOXC1: -0.7644551853282142, mRNA_GATA3: -0.5444719889123333, mRNA_AGR2: 0.0962207773028756, mRNA_XBP1: 0.20541231378136, mRNA_PRR15: 0.6023753131608981, mRNA_SLC44A4: 0.3393795621472537, mRNA_CA12: -1.6833685875112516, mRNA_DTL: 0.8180293284483549, mRNA_C5AR2: -1.956051395216088, mRNA_TBC1D9: -1.0561112774410986, mRNA_AR: 0.7257176306433851, mRNA_CCDC170: -1.376515520716015, mRNA_DEGS2: -1.026130861566941, mRNA_TFF3: 1.1921929351883072, mRNA_DNALI1: 0.2361471378868827, mRNA_LINC00504: -1.6102814876792622, mRNA_CLCA2: 2.471147528547251, mRNA_PPP1R14C: 1.001936215694702, mRNA_THSD4: -1.4016228582175605, mRNA_SPAG5: 2.834050957704678, mRNA_FBP1: 0.3459306112780591, mRNA_SLC7A8: -0.4928760917976963, mRNA_EN1: -0.779335424777112, mRNA_ZNF552: -0.4656237667549008, Methylation_LRRC6: 1.0668910387171626, Methylation_chr2 66218712 LINC02934 (29533): -1.8177231896314143, Methylation_HOXB13: 0.4296660414656098, Methylation_chr10 3949206 LINC02660 (4871): -0.5873775359174205, Methylation_chr5 179517140 RNF130 (18026): 1.0155367432982445, Methylation_LOC727677: -1.1774403775372155, Methylation_LETM1: 1.328986842029012, Methylation_CDC42BPB: -1.38329371473591, Methylation_C8orf38: -1.107362492112896, Methylation_chr14 100504766 EVL (18852): -1.2004875954413412, Methylation_chr5 72594851 LOC340090 (24088): -0.0410161103637466, Methylation_chr2 242904738 LINC01238 (3421): 1.2098903643807186, Methylation_ARFGEF1: -1.4150783485082865, Methylation_MAPT: 1.397884167551355, Methylation_ZFAT: -0.9596913327912614, Methylation_KCNQ4: -1.2347362453326325, Methylation_chr1 232684368 SIPA1L2 (12934): -1.4292274331283503, Methylation_CRNKL1: 1.392081828480778, Methylation_PRKAG2: -1.4444174166777168, Methylation_MICB: -1.4594121530329895, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 3.7865901668884367, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.9815953324367732, miRNA_hsa-mir-190b: -0.0549492267202366, miRNA_hsa-mir-577: -0.4534532949194916, miRNA_hsa-mir-135b: 0.3475797463409182, miRNA_hsa-mir-2115: 0.7473629609580791, miRNA_hsa-mir-17: 1.008547034455484, miRNA_hsa-mir-130b: 1.0034299979164438, CNV_VPS54: 2.3735003872816955, CNV_LINC01867: 2.395394893874891, CNV_LINC02576: 2.464291317721031, CNV_WDPCP: 2.38809584879993, CNV_CEP68: 2.464291317721031"
TCGA-AO-A03M,"mRNA_C2orf54 overexpression (Z=1.39) exceeds the high-expression threshold. Methylation at chr5:72594851 is hypo-methylated (Z=−1.55). No miRNAs meet up/downregulation thresholds. All CNVs fall within Gain range (0.38–0.40), but none reach Amplification. No deletions or high-level amplifications observed.","mRNA_MLPH: -0.4542135604122007, mRNA_C2orf54: 1.3884288142169856, mRNA_CITED4: 0.068029478386324, mRNA_ESR1: -0.1889953873014484, mRNA_SPDEF: 0.1291551905888899, mRNA_AGR3: 0.1809978568533316, mRNA_FOXC1: -0.4722480729243792, mRNA_GATA3: 0.58191377043395, mRNA_AGR2: -0.0215844799814019, mRNA_XBP1: 0.7555713063293327, mRNA_PRR15: 0.1701401060888116, mRNA_SLC44A4: -1.1067690595008046, mRNA_CA12: 0.8287337826020698, mRNA_DTL: 0.4878384405277441, mRNA_C5AR2: 0.3376511022829738, mRNA_TBC1D9: 0.3227133554899674, mRNA_AR: 0.0474209989870107, mRNA_CCDC170: -0.2058622792200944, mRNA_DEGS2: -0.061893902899301, mRNA_TFF3: 0.8293580534916192, mRNA_DNALI1: 0.7120061375458291, mRNA_LINC00504: -0.0254870024466888, mRNA_CLCA2: 0.9446449306121772, mRNA_PPP1R14C: -0.0673773047968905, mRNA_THSD4: -0.4996995972065669, mRNA_SPAG5: 0.5854245632855121, mRNA_FBP1: 0.0564566150136828, mRNA_SLC7A8: 0.3273605672137554, mRNA_EN1: -0.6382496440196754, mRNA_ZNF552: 1.0999047976188416, Methylation_LRRC6: -0.1500111681887225, Methylation_chr2 66218712 LINC02934 (29533): 1.1226789898168712, Methylation_HOXB13: 1.3357899909636828, Methylation_chr10 3949206 LINC02660 (4871): 0.2658613559662494, Methylation_chr5 179517140 RNF130 (18026): 0.559667736058148, Methylation_LOC727677: 0.3535939127565916, Methylation_LETM1: 0.0279022008645686, Methylation_CDC42BPB: -0.9047990125289684, Methylation_C8orf38: 0.4153423686148842, Methylation_chr14 100504766 EVL (18852): 0.485202942956103, Methylation_chr5 72594851 LOC340090 (24088): -1.5483558669802204, Methylation_chr2 242904738 LINC01238 (3421): 0.7407205052989995, Methylation_ARFGEF1: 0.6672628003577614, Methylation_MAPT: 1.0797797149066424, Methylation_ZFAT: -0.2302402679133726, Methylation_KCNQ4: -1.0280339370225713, Methylation_chr1 232684368 SIPA1L2 (12934): 0.8630636255546722, Methylation_CRNKL1: 1.0209800184019933, Methylation_PRKAG2: -0.7536182901263166, Methylation_MICB: 0.9903984645216992, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.6429646593056517, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.3011338299865087, miRNA_hsa-mir-190b: 0.4036688138280831, miRNA_hsa-mir-577: 0.8483821172776019, miRNA_hsa-mir-135b: -0.1146388866819457, miRNA_hsa-mir-2115: 0.3604533911651955, miRNA_hsa-mir-17: 0.0709544485859994, miRNA_hsa-mir-130b: 0.7312307444335917, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-BH-A1F6,"High-level Amplification of VPS54, LINC02576, and CEP68 drives mRNA overexpression.  
Promoter hypermethylation of LRRC6, LINC02660, C8orf38, EVL, ARFGEF1, KCNQ4, and SIPA1L2 mediates epigenetic silencing.  
miR-934, miR-577, and miR-135b are upregulated; miR-190b is downregulated.  
FOXC1 and EN1 mRNA overexpression aligns with luminal B phenotype and PI3K/AKT dysregulation.","mRNA_MLPH: -2.6721776932540395, mRNA_C2orf54: -0.9921668609328088, mRNA_CITED4: 1.0470386183740792, mRNA_ESR1: -1.654751192886326, mRNA_SPDEF: -1.3148117086206552, mRNA_AGR3: -1.93743446919287, mRNA_FOXC1: 1.7534449294592518, mRNA_GATA3: -2.050443150717109, mRNA_AGR2: -2.356799948645918, mRNA_XBP1: -1.3842816772039108, mRNA_PRR15: -0.9500651694957136, mRNA_SLC44A4: -2.1121689320886685, mRNA_CA12: -1.6158160226326124, mRNA_DTL: -0.3098515394824496, mRNA_C5AR2: -1.3985340185535506, mRNA_TBC1D9: -1.5307387786104665, mRNA_AR: -2.020433729867803, mRNA_CCDC170: -1.6070832490500415, mRNA_DEGS2: -1.5948246806356097, mRNA_TFF3: -1.9652421621561216, mRNA_DNALI1: -2.0413453762843004, mRNA_LINC00504: -1.6441082923766237, mRNA_CLCA2: -0.556872308523342, mRNA_PPP1R14C: 1.5764668791619092, mRNA_THSD4: -1.7077700960490525, mRNA_SPAG5: -0.0823028021573143, mRNA_FBP1: -1.3489462250261115, mRNA_SLC7A8: -1.062519691327107, mRNA_EN1: 2.095087220716996, mRNA_ZNF552: -1.2609278446508074, Methylation_LRRC6: 1.5462533046713411, Methylation_chr2 66218712 LINC02934 (29533): -1.3097557027247946, Methylation_HOXB13: 0.7194850238901057, Methylation_chr10 3949206 LINC02660 (4871): 1.6660968830788216, Methylation_chr5 179517140 RNF130 (18026): -1.6750127223521492, Methylation_LOC727677: 1.4550226734880678, Methylation_LETM1: 1.314553938584938, Methylation_CDC42BPB: 0.6124522791682049, Methylation_C8orf38: 1.6978432428301455, Methylation_chr14 100504766 EVL (18852): 1.5200754580296905, Methylation_chr5 72594851 LOC340090 (24088): -1.548032289658273, Methylation_chr2 242904738 LINC01238 (3421): 1.4226731612460557, Methylation_ARFGEF1: 1.6998880614581924, Methylation_MAPT: 1.447490547606637, Methylation_ZFAT: 1.447293562923983, Methylation_KCNQ4: 1.5890839201748512, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5167244515473732, Methylation_CRNKL1: 1.459993501157485, Methylation_PRKAG2: 1.1373055547631783, Methylation_MICB: 1.5213025436934886, miRNA_hsa-mir-934: 3.660188296573111, miRNA_hsa-mir-4728: 0.0181438028001863, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.5066774401227307, miRNA_hsa-mir-190b: -1.529774239323951, miRNA_hsa-mir-577: 2.45911261136799, miRNA_hsa-mir-135b: 2.0678369520351136, miRNA_hsa-mir-2115: -0.3485862797095497, miRNA_hsa-mir-17: 1.0440388274497436, miRNA_hsa-mir-130b: 0.5049062083750792, CNV_VPS54: 4.368946221858642, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 2.464291317721031, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 2.464291317721031"
TCGA-E9-A1N6,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. SLC44A4 shows significant mRNA downregulation (Z = -2.02). No methylation or miRNA features meet diagnostic thresholds. These alterations suggest a proliferation-associated phenotype with genomic instability.","mRNA_MLPH: 0.2850407675920519, mRNA_C2orf54: 1.2849901463649829, mRNA_CITED4: -1.235157124363636, mRNA_ESR1: 0.5195876582074909, mRNA_SPDEF: 0.4019823404411768, mRNA_AGR3: -1.1939640325144003, mRNA_FOXC1: -0.375213216682611, mRNA_GATA3: 0.4658093913993643, mRNA_AGR2: -0.4271284297463708, mRNA_XBP1: 0.0445894771158162, mRNA_PRR15: -0.3139325074240862, mRNA_SLC44A4: -2.016541928854285, mRNA_CA12: 0.902503021946759, mRNA_DTL: 0.4891013747277968, mRNA_C5AR2: 0.45313994659672, mRNA_TBC1D9: 0.5179921222849201, mRNA_AR: 1.0912608504541466, mRNA_CCDC170: 0.5064615721433874, mRNA_DEGS2: -0.0493052520877181, mRNA_TFF3: 0.5126157276036105, mRNA_DNALI1: 0.1078603532662353, mRNA_LINC00504: 0.5937745162772164, mRNA_CLCA2: 0.627541665736592, mRNA_PPP1R14C: 0.2497587167291227, mRNA_THSD4: -0.9047119403307714, mRNA_SPAG5: 2.4056865302649286, mRNA_FBP1: 0.0545345682690826, mRNA_SLC7A8: -1.0036532647479754, mRNA_EN1: 0.8509025801382989, mRNA_ZNF552: 0.2473324713880814, Methylation_LRRC6: -0.3762876770621853, Methylation_chr2 66218712 LINC02934 (29533): 0.9837838394918488, Methylation_HOXB13: 0.6210330879310251, Methylation_chr10 3949206 LINC02660 (4871): 0.3152875305331493, Methylation_chr5 179517140 RNF130 (18026): 0.1595565370385253, Methylation_LOC727677: -0.3288520709087094, Methylation_LETM1: 0.4236432663877211, Methylation_CDC42BPB: -1.2201912010461644, Methylation_C8orf38: -0.886631933858948, Methylation_chr14 100504766 EVL (18852): 0.45659553394177, Methylation_chr5 72594851 LOC340090 (24088): 0.5869079539531091, Methylation_chr2 242904738 LINC01238 (3421): 1.4558350653995424, Methylation_ARFGEF1: -0.6293008456642519, Methylation_MAPT: 0.0248577770482188, Methylation_ZFAT: -0.4075389176480976, Methylation_KCNQ4: -0.7152970925142099, Methylation_chr1 232684368 SIPA1L2 (12934): 0.3251823355088801, Methylation_CRNKL1: -0.3432186584714404, Methylation_PRKAG2: -0.0843245601489763, Methylation_MICB: 0.0695483886011961, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.7413454850727048, miRNA_hsa-mir-5695: 0.2868255626997011, miRNA_hsa-mir-18a: 0.3274203939598225, miRNA_hsa-mir-190b: 0.1612468336200082, miRNA_hsa-mir-577: -0.3167652968462947, miRNA_hsa-mir-135b: -0.3437508962205436, miRNA_hsa-mir-2115: 0.7454772220746724, miRNA_hsa-mir-17: 0.2567623404605069, miRNA_hsa-mir-130b: 1.1161938945529606, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-E2-A1L6,High mRNA_AGR2 (Z=1.34) and mRNA_XBP1 (Z=1.34) indicate luminal overexpression. Methylation_KCNQ4 (Z=-1.08) is hypo-methylated. No CNVs meet deletion/amplification thresholds. miRNA_hsa-mir-130b (Z=0.84) upregulated. Collectively suggest Luminal A phenotype with ER pathway activation.,"mRNA_MLPH: 0.5980714148658782, mRNA_C2orf54: -0.3564903565201149, mRNA_CITED4: 0.296818698097758, mRNA_ESR1: 0.3954711109075667, mRNA_SPDEF: 0.2346800658020677, mRNA_AGR3: 0.7869934727817632, mRNA_FOXC1: -0.0150327112910044, mRNA_GATA3: 0.5910333652990839, mRNA_AGR2: 1.3430485087855577, mRNA_XBP1: 1.336686847543198, mRNA_PRR15: 0.3613612301047152, mRNA_SLC44A4: 0.3394391174935476, mRNA_CA12: 0.7276511240054186, mRNA_DTL: 0.0263170261667255, mRNA_C5AR2: 1.1629140496603616, mRNA_TBC1D9: 0.8213021502898764, mRNA_AR: 0.5225564286257092, mRNA_CCDC170: 1.1906298904946888, mRNA_DEGS2: 0.6303706170805699, mRNA_TFF3: 0.9952161231038148, mRNA_DNALI1: 0.8526064430277815, mRNA_LINC00504: 0.7099634014955248, mRNA_CLCA2: 0.9510665465426156, mRNA_PPP1R14C: -0.1472356210268676, mRNA_THSD4: 1.016058084663391, mRNA_SPAG5: -0.0884406387297001, mRNA_FBP1: 0.396927027298221, mRNA_SLC7A8: 0.5534496081998035, mRNA_EN1: -0.7026586417071611, mRNA_ZNF552: 1.4064404354172282, Methylation_LRRC6: 0.2469979046747956, Methylation_chr2 66218712 LINC02934 (29533): 0.1234999507335627, Methylation_HOXB13: -0.99525445487256, Methylation_chr10 3949206 LINC02660 (4871): 0.7885710612539192, Methylation_chr5 179517140 RNF130 (18026): 0.5209711585185919, Methylation_LOC727677: -0.5043006964622294, Methylation_LETM1: 0.2590744394399029, Methylation_CDC42BPB: -0.9967419153858132, Methylation_C8orf38: -0.7225315807705136, Methylation_chr14 100504766 EVL (18852): -0.256672666964536, Methylation_chr5 72594851 LOC340090 (24088): 0.5912929470416018, Methylation_chr2 242904738 LINC01238 (3421): -0.6907373872341717, Methylation_ARFGEF1: 0.5248371864589181, Methylation_MAPT: 0.2002478574465901, Methylation_ZFAT: 0.985293796499344, Methylation_KCNQ4: -1.0827725138275628, Methylation_chr1 232684368 SIPA1L2 (12934): 0.1262024515037673, Methylation_CRNKL1: -0.1767789158249115, Methylation_PRKAG2: -0.2224651020043044, Methylation_MICB: 0.0427924020748255, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.5376818973552578, miRNA_hsa-mir-5695: 0.4667143065412994, miRNA_hsa-mir-18a: -0.5008208692967202, miRNA_hsa-mir-190b: 0.4843086192679664, miRNA_hsa-mir-577: -0.2504574283460313, miRNA_hsa-mir-135b: 0.2570342625407596, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.5631805658540967, miRNA_hsa-mir-130b: 0.8417561979093507, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-EW-A6SB,"High-level Amplification absent; no CNV alterations meet thresholds.  
HOXB13 and ARFGEF1 promoter hypermethylation (Z > 1.50) suggest epigenetic silencing.  
miR-934 upregulated (Z = 2.66), miR-190b downregulated (Z = -1.61).  
mRNA_PPP1R14C and mRNA_EN1 overexpressed (Z = 1.75, 1.60), but below mRNA high-threshold (Z < 1.30 required).  
No mRNA features meet diagnostic criteria.","mRNA_MLPH: -2.9440364193776425, mRNA_C2orf54: -0.6375177197985334, mRNA_CITED4: 0.105349096558413, mRNA_ESR1: -1.9756708918858432, mRNA_SPDEF: -0.6589303883104249, mRNA_AGR3: -1.9513625263965089, mRNA_FOXC1: 0.8018365650977369, mRNA_GATA3: -2.0129521719865315, mRNA_AGR2: -2.3919920318778987, mRNA_XBP1: -1.0056526213425734, mRNA_PRR15: -2.52603073150882, mRNA_SLC44A4: -2.329630881037785, mRNA_CA12: -2.2115335877115068, mRNA_DTL: -1.0364291849993268, mRNA_C5AR2: -2.021755871567368, mRNA_TBC1D9: -2.406608555531259, mRNA_AR: -1.7742788439229444, mRNA_CCDC170: -1.920594481033425, mRNA_DEGS2: -2.28551000662038, mRNA_TFF3: -2.117921820770452, mRNA_DNALI1: -2.1562416231776145, mRNA_LINC00504: -1.7315022844017498, mRNA_CLCA2: -0.8737820717187378, mRNA_PPP1R14C: 1.7495597917625645, mRNA_THSD4: -2.23145167166688, mRNA_SPAG5: -1.1714763232014591, mRNA_FBP1: -2.484336559602188, mRNA_SLC7A8: -3.0947011347258, mRNA_EN1: 1.5987530397883098, mRNA_ZNF552: -2.0358634635645028, Methylation_LRRC6: 1.25462436399261, Methylation_chr2 66218712 LINC02934 (29533): 0.7893209310046571, Methylation_HOXB13: 1.6704042898602376, Methylation_chr10 3949206 LINC02660 (4871): 1.2319908832309014, Methylation_chr5 179517140 RNF130 (18026): -1.4337344108412169, Methylation_LOC727677: 1.306813221436157, Methylation_LETM1: 1.2156177918210669, Methylation_CDC42BPB: 0.4027656037486473, Methylation_C8orf38: 1.60192963958232, Methylation_chr14 100504766 EVL (18852): 1.5030097366951494, Methylation_chr5 72594851 LOC340090 (24088): -1.479697484486924, Methylation_chr2 242904738 LINC01238 (3421): 1.3975950000260926, Methylation_ARFGEF1: 1.6278512444364963, Methylation_MAPT: 1.1792303939347006, Methylation_ZFAT: 1.3394824964248335, Methylation_KCNQ4: -0.0297745788518182, Methylation_chr1 232684368 SIPA1L2 (12934): 1.3669081461258974, Methylation_CRNKL1: 1.15825471678037, Methylation_PRKAG2: -0.2936315145772583, Methylation_MICB: 1.225050311671502, miRNA_hsa-mir-934: 2.6552322784032327, miRNA_hsa-mir-4728: -0.4448725775548144, miRNA_hsa-mir-5695: 0.1918362214892548, miRNA_hsa-mir-18a: 1.7944746961920106, miRNA_hsa-mir-190b: -1.6127185289546282, miRNA_hsa-mir-577: 1.4014029633692042, miRNA_hsa-mir-135b: 1.6405714724320375, miRNA_hsa-mir-2115: 0.0142447499531441, miRNA_hsa-mir-17: 1.585345102573698, miRNA_hsa-mir-130b: 0.1546233566935467, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-E2-A15I,"No features meet the strict diagnostic thresholds for reporting. All mRNA Z-scores fall within [-1.92, 1.30], methylation Z-scores within [-1.47, 1.50], miRNA Z-scores within [-1.25, 1.99], and CNV values within [-1.10, -0.10] (normal range).","mRNA_MLPH: 0.7703633880352095, mRNA_C2orf54: -0.5650947085926733, mRNA_CITED4: -0.4437613115695418, mRNA_ESR1: 0.7773005525333982, mRNA_SPDEF: 0.500205043844817, mRNA_AGR3: 0.7383023765708232, mRNA_FOXC1: -0.0016761289426591, mRNA_GATA3: 0.97972938729155, mRNA_AGR2: 0.3638841924472915, mRNA_XBP1: 0.4758203862101228, mRNA_PRR15: 1.0894772046530314, mRNA_SLC44A4: 0.8586336582541138, mRNA_CA12: 0.7683104000042901, mRNA_DTL: -1.866949853338439, mRNA_C5AR2: -0.4460935940863235, mRNA_TBC1D9: 1.1619354667773392, mRNA_AR: 1.2600375400263015, mRNA_CCDC170: 1.446785190044349, mRNA_DEGS2: 0.3932578021363764, mRNA_TFF3: -0.0027851171432587, mRNA_DNALI1: 0.8576820722085536, mRNA_LINC00504: 1.4907695649244854, mRNA_CLCA2: -0.1068349448498434, mRNA_PPP1R14C: 0.1600800620538587, mRNA_THSD4: 0.7870618509825552, mRNA_SPAG5: -1.3862851422451845, mRNA_FBP1: 0.980112238183852, mRNA_SLC7A8: 0.8721390245736178, mRNA_EN1: -0.6045815522484035, mRNA_ZNF552: 0.3217511588486405, Methylation_LRRC6: -0.1841282805473413, Methylation_chr2 66218712 LINC02934 (29533): -1.105956026466536, Methylation_HOXB13: -1.059457870802593, Methylation_chr10 3949206 LINC02660 (4871): -0.8160954705363034, Methylation_chr5 179517140 RNF130 (18026): -0.0801722853207238, Methylation_LOC727677: -0.4187307567131313, Methylation_LETM1: -0.5670076956607352, Methylation_CDC42BPB: -1.249418541476122, Methylation_C8orf38: -0.3351558514281427, Methylation_chr14 100504766 EVL (18852): -0.9424479516383024, Methylation_chr5 72594851 LOC340090 (24088): 0.6338777680982127, Methylation_chr2 242904738 LINC01238 (3421): -0.8429400275889852, Methylation_ARFGEF1: -0.2606886578985369, Methylation_MAPT: -0.2277862980977365, Methylation_ZFAT: -0.1315268277015027, Methylation_KCNQ4: -0.8685281248668972, Methylation_chr1 232684368 SIPA1L2 (12934): -0.372304565920883, Methylation_CRNKL1: 0.4203754871034948, Methylation_PRKAG2: 0.6710595092388822, Methylation_MICB: -0.6531148465213075, miRNA_hsa-mir-934: -0.3457090134731197, miRNA_hsa-mir-4728: -0.6616131876254476, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.8373862649137701, miRNA_hsa-mir-190b: 0.2184861362076006, miRNA_hsa-mir-577: -0.2087469732388064, miRNA_hsa-mir-135b: -0.270651751509537, miRNA_hsa-mir-2115: 0.2640990469755974, miRNA_hsa-mir-17: -0.680837898048143, miRNA_hsa-mir-130b: -0.4979578962176674, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A1R5,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.4829221466190558, mRNA_C2orf54: 1.1890906137717956, mRNA_CITED4: 0.0478818559120539, mRNA_ESR1: 0.7220667182741937, mRNA_SPDEF: 0.3282398625343861, mRNA_AGR3: -0.0302801652416406, mRNA_FOXC1: -0.9001000505171727, mRNA_GATA3: 0.2868379324768155, mRNA_AGR2: -0.749198763940623, mRNA_XBP1: 1.015693622888595, mRNA_PRR15: 0.1370163710250942, mRNA_SLC44A4: 0.4095918784410848, mRNA_CA12: 1.1021570960713616, mRNA_DTL: 0.09760984709514, mRNA_C5AR2: 0.4628097925912048, mRNA_TBC1D9: 0.1007900910126412, mRNA_AR: 0.1359207670636492, mRNA_CCDC170: 0.4880249613502206, mRNA_DEGS2: 0.7523168806643891, mRNA_TFF3: -1.0610670886461624, mRNA_DNALI1: 0.4721783417709453, mRNA_LINC00504: 0.5949356629674866, mRNA_CLCA2: -0.7091769668694196, mRNA_PPP1R14C: -1.088762435346698, mRNA_THSD4: 0.3268426449881643, mRNA_SPAG5: 0.291162176351213, mRNA_FBP1: 0.6050082975252504, mRNA_SLC7A8: 0.6596280531667661, mRNA_EN1: 0.6976580951553074, mRNA_ZNF552: 0.93927073861544, Methylation_LRRC6: -0.8534565123509151, Methylation_chr2 66218712 LINC02934 (29533): 1.1992328528111285, Methylation_HOXB13: 1.2920566770275794, Methylation_chr10 3949206 LINC02660 (4871): -1.2242165873616715, Methylation_chr5 179517140 RNF130 (18026): 0.8463126718077993, Methylation_LOC727677: -0.1080441671428926, Methylation_LETM1: -0.2973051869677353, Methylation_CDC42BPB: 1.339522657529593, Methylation_C8orf38: -1.3419895421211072, Methylation_chr14 100504766 EVL (18852): -0.5238211055184453, Methylation_chr5 72594851 LOC340090 (24088): 1.0555963429221724, Methylation_chr2 242904738 LINC01238 (3421): -1.1433129616014446, Methylation_ARFGEF1: -0.6424991264313892, Methylation_MAPT: -0.7031181975204818, Methylation_ZFAT: -0.391700473844189, Methylation_KCNQ4: 0.8544388723858664, Methylation_chr1 232684368 SIPA1L2 (12934): -1.223963820109016, Methylation_CRNKL1: -1.0640074719330128, Methylation_PRKAG2: 0.197991622414716, Methylation_MICB: -0.8531423722569278, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.3769181442560272, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.4151045042910507, miRNA_hsa-mir-190b: 0.3808917699883389, miRNA_hsa-mir-577: -0.5615021784599011, miRNA_hsa-mir-135b: -0.9292439077851816, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.1343475239500013, miRNA_hsa-mir-130b: -0.320203283843365, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AC-A2BK,"High-level Amplification of VPS54, LINC01867, and WDPCP drives mRNA overexpression.  
FOXC1 mRNA is highly overexpressed (Z=3.68).  
ESR1, AGR3, XBP1, AR, DEGS2, FBP1, and SLC7A8 show low mRNA (Z < -1.92).  
KCNQ4 and ARFGEF1 promoters are hypermethylated (Z > 1.50).  
RNF130 and LOC340090 are hypomethylated (Z < -1.47).  
miR-18a and miR-17 are upregulated (Z > 1.99); miR-190b is downregulated (Z < -1.25).","mRNA_MLPH: -0.9201274044092044, mRNA_C2orf54: -1.2122581224276838, mRNA_CITED4: -0.7075613059968637, mRNA_ESR1: -2.058227604822765, mRNA_SPDEF: -0.1192607884926616, mRNA_AGR3: -2.035093741436747, mRNA_FOXC1: 3.681878199883816, mRNA_GATA3: -1.0134126728799997, mRNA_AGR2: -1.3495441252254154, mRNA_XBP1: -2.106008132185276, mRNA_PRR15: -0.1207903222643738, mRNA_SLC44A4: -1.802975178822355, mRNA_CA12: -1.6510405647933082, mRNA_DTL: 1.3772253303045217, mRNA_C5AR2: -1.4597693161063103, mRNA_TBC1D9: -1.710281050173612, mRNA_AR: -2.389194380530397, mRNA_CCDC170: -1.8780216281845847, mRNA_DEGS2: -2.3426746953182875, mRNA_TFF3: -0.0370672788192009, mRNA_DNALI1: -2.0827106495830034, mRNA_LINC00504: -1.7437899238074472, mRNA_CLCA2: -0.8950940779111158, mRNA_PPP1R14C: 1.4792349603088202, mRNA_THSD4: -1.3653767420258194, mRNA_SPAG5: 1.14395023045458, mRNA_FBP1: -2.571235723254179, mRNA_SLC7A8: -2.072058849024566, mRNA_EN1: 0.5925465646375292, mRNA_ZNF552: -1.3025024702815562, Methylation_LRRC6: 1.4992669362577191, Methylation_chr2 66218712 LINC02934 (29533): 0.2957486666847027, Methylation_HOXB13: -0.9666552442087476, Methylation_chr10 3949206 LINC02660 (4871): 1.6460378574513026, Methylation_chr5 179517140 RNF130 (18026): -1.6284462864066556, Methylation_LOC727677: 1.526189402856622, Methylation_LETM1: 1.3204105973101248, Methylation_CDC42BPB: 1.4015803220756242, Methylation_C8orf38: 1.662501800883487, Methylation_chr14 100504766 EVL (18852): 1.3096292103030325, Methylation_chr5 72594851 LOC340090 (24088): -1.569452750106291, Methylation_chr2 242904738 LINC01238 (3421): 1.433938602220497, Methylation_ARFGEF1: 1.7929223281530895, Methylation_MAPT: 1.273005928002179, Methylation_ZFAT: 1.4524733854624916, Methylation_KCNQ4: 1.9754959325540589, Methylation_chr1 232684368 SIPA1L2 (12934): 1.4805802640629078, Methylation_CRNKL1: 1.4032966654897188, Methylation_PRKAG2: 1.3533341661522793, Methylation_MICB: 1.5447070248398158, miRNA_hsa-mir-934: -0.3382513588759399, miRNA_hsa-mir-4728: -0.0754682070992995, miRNA_hsa-mir-5695: 0.2228765579232874, miRNA_hsa-mir-18a: 2.366888569641183, miRNA_hsa-mir-190b: -2.052137242410604, miRNA_hsa-mir-577: 1.81983679392346, miRNA_hsa-mir-135b: 1.3769840347169178, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 2.749794445086277, miRNA_hsa-mir-130b: 1.0194940503228906, CNV_VPS54: 4.368946221858642, CNV_LINC01867: 4.411662538359512, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 4.394610852818543, CNV_CEP68: 1.4339562938734052"
TCGA-E2-A1IF,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.5953337133400091, mRNA_C2orf54: -0.7412675986694218, mRNA_CITED4: 0.6802438468368308, mRNA_ESR1: 0.4213702508649715, mRNA_SPDEF: 0.2777599851850589, mRNA_AGR3: 0.7145304693532536, mRNA_FOXC1: -0.0878481440260876, mRNA_GATA3: 0.0578160528412217, mRNA_AGR2: -0.091669460741249, mRNA_XBP1: -0.1089714016117578, mRNA_PRR15: 0.5305775644363225, mRNA_SLC44A4: 0.6692827693825311, mRNA_CA12: 0.0338701155629819, mRNA_DTL: 0.0937470250310805, mRNA_C5AR2: -0.0715978140013548, mRNA_TBC1D9: -0.2244855672722255, mRNA_AR: -0.2382203232975359, mRNA_CCDC170: 0.3186883730901955, mRNA_DEGS2: -0.065958314532437, mRNA_TFF3: 0.8741737175784686, mRNA_DNALI1: 0.5679184700420818, mRNA_LINC00504: -0.2048087261076157, mRNA_CLCA2: 0.6685265805712236, mRNA_PPP1R14C: 0.0937838737397118, mRNA_THSD4: -0.5233536316525215, mRNA_SPAG5: -0.2750746257548152, mRNA_FBP1: -0.0467302029010478, mRNA_SLC7A8: 0.1269158610493846, mRNA_EN1: -0.1728002348530546, mRNA_ZNF552: 0.1394025289263454, Methylation_LRRC6: 0.5424189049952955, Methylation_chr2 66218712 LINC02934 (29533): 1.099746013974279, Methylation_HOXB13: -0.9662250766322692, Methylation_chr10 3949206 LINC02660 (4871): 0.2865782725238188, Methylation_chr5 179517140 RNF130 (18026): -1.560886875548297, Methylation_LOC727677: 0.1392019652082977, Methylation_LETM1: 0.4102470264967527, Methylation_CDC42BPB: -0.6751313816653753, Methylation_C8orf38: 0.2249270775651689, Methylation_chr14 100504766 EVL (18852): 0.2572175902766294, Methylation_chr5 72594851 LOC340090 (24088): 0.0231844778200893, Methylation_chr2 242904738 LINC01238 (3421): 0.0755961133558673, Methylation_ARFGEF1: 0.8417297372849958, Methylation_MAPT: 0.0145723210970538, Methylation_ZFAT: 0.3619426229055497, Methylation_KCNQ4: -1.1534707768514214, Methylation_chr1 232684368 SIPA1L2 (12934): -0.0235350784886064, Methylation_CRNKL1: 0.4045476541577675, Methylation_PRKAG2: 0.813315232702804, Methylation_MICB: 0.8690777890208333, miRNA_hsa-mir-934: 0.5209081703235601, miRNA_hsa-mir-4728: -0.4998818154872679, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.4843657198332725, miRNA_hsa-mir-190b: 0.1439530398101259, miRNA_hsa-mir-577: -0.2458649561756989, miRNA_hsa-mir-135b: 0.8026899854800377, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.2691435022634308, miRNA_hsa-mir-130b: 0.6783164139338752, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E2-A1B5,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting. All values fall within non-significant ranges per defined criteria.","mRNA_MLPH: -0.813971424306009, mRNA_C2orf54: -1.0346888154223632, mRNA_CITED4: -1.252040084416431, mRNA_ESR1: -0.8552783651391532, mRNA_SPDEF: -0.2457980066693304, mRNA_AGR3: 0.5105423770578299, mRNA_FOXC1: -0.0573390021627855, mRNA_GATA3: -0.5253377120189979, mRNA_AGR2: 0.9631728238441468, mRNA_XBP1: -0.7468165661103326, mRNA_PRR15: -0.0861252552672076, mRNA_SLC44A4: 0.2052923081260787, mRNA_CA12: -1.5455521445406966, mRNA_DTL: -1.4455581400531383, mRNA_C5AR2: 0.4159124181190088, mRNA_TBC1D9: -0.330226993630368, mRNA_AR: -0.0693643330680091, mRNA_CCDC170: -0.3883041473531256, mRNA_DEGS2: -0.6910276253666177, mRNA_TFF3: 0.0975343936014791, mRNA_DNALI1: 0.1902044339183241, mRNA_LINC00504: 0.5074825558146894, mRNA_CLCA2: -0.6908572744405473, mRNA_PPP1R14C: -0.3643623445430771, mRNA_THSD4: -0.867406337843256, mRNA_SPAG5: -1.0983822476982614, mRNA_FBP1: 0.229390292172488, mRNA_SLC7A8: 0.1028509684421317, mRNA_EN1: -0.4885715505251721, mRNA_ZNF552: 0.2981129314153204, Methylation_LRRC6: -0.0346097408054727, Methylation_chr2 66218712 LINC02934 (29533): 1.2483124446781455, Methylation_HOXB13: 0.3788400711615842, Methylation_chr10 3949206 LINC02660 (4871): 1.095919460781031, Methylation_chr5 179517140 RNF130 (18026): -0.3710287914423338, Methylation_LOC727677: 0.940375405066844, Methylation_LETM1: 1.244228578662779, Methylation_CDC42BPB: 0.1943069185691852, Methylation_C8orf38: 1.425895673105863, Methylation_chr14 100504766 EVL (18852): 1.4156537191094871, Methylation_chr5 72594851 LOC340090 (24088): 0.5292867606310758, Methylation_chr2 242904738 LINC01238 (3421): 0.71164412162911, Methylation_ARFGEF1: 1.2045794892550312, Methylation_MAPT: 1.353932710839473, Methylation_ZFAT: 0.9483465347901884, Methylation_KCNQ4: -1.0064985253207912, Methylation_chr1 232684368 SIPA1L2 (12934): 0.5438195403929376, Methylation_CRNKL1: 1.0208110045258634, Methylation_PRKAG2: 0.0532652197712583, Methylation_MICB: 1.0322334038462768, miRNA_hsa-mir-934: -0.2517514079502145, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.3482279194667423, miRNA_hsa-mir-190b: 0.5143626043904802, miRNA_hsa-mir-577: -0.441279015170237, miRNA_hsa-mir-135b: 0.3086551710751915, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.4150496773930425, miRNA_hsa-mir-130b: 0.4232436595226108, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E2-A14N,"High-level Amplification absent; no CNV alterations meet thresholds.  
FOXC1 mRNA overexpression (Z=2.797) and PPP1R14C upregulation (Z=2.219) occur without underlying amplification.  
Promoter hypermethylation of ARFGEF1 (Z=1.698), C8orf38 (Z=1.630), and chr10:3949206 (Z=1.557) may silence tumor suppressors.  
miR-18a (Z=2.685) and miR-130b (Z=1.728) upregulated; miR-190b downregulated (Z=-1.392).  
Collectively suggest luminal B-like phenotype with PI3K/mTOR dysregulation.","mRNA_MLPH: -2.545162863693676, mRNA_C2orf54: -0.6319188981527367, mRNA_CITED4: 0.9392484788737064, mRNA_ESR1: -2.0155758671388027, mRNA_SPDEF: -2.063948884514051, mRNA_AGR3: -1.125895211736733, mRNA_FOXC1: 2.796681849870936, mRNA_GATA3: -0.5072017649006234, mRNA_AGR2: -1.288446588678427, mRNA_XBP1: -1.1819859573096585, mRNA_PRR15: -1.909683858728341, mRNA_SLC44A4: -2.267039557325742, mRNA_CA12: -1.93488221679168, mRNA_DTL: 0.4351247617367069, mRNA_C5AR2: -2.104010993953908, mRNA_TBC1D9: -1.816201741304715, mRNA_AR: -0.8050389332065321, mRNA_CCDC170: -1.7691042001965045, mRNA_DEGS2: -2.400211080035674, mRNA_TFF3: -1.8568841878634856, mRNA_DNALI1: -1.968024279576441, mRNA_LINC00504: -1.5286901164864743, mRNA_CLCA2: -0.832059624920823, mRNA_PPP1R14C: 2.218504480959185, mRNA_THSD4: -2.2375312083861507, mRNA_SPAG5: 0.8083446041822288, mRNA_FBP1: -2.2108080426043, mRNA_SLC7A8: -2.574619373739261, mRNA_EN1: 1.1546180601520888, mRNA_ZNF552: -1.606447413054194, Methylation_LRRC6: 1.499136147921203, Methylation_chr2 66218712 LINC02934 (29533): 0.1658907158784362, Methylation_HOXB13: -1.0020467766923071, Methylation_chr10 3949206 LINC02660 (4871): 1.5571899209926068, Methylation_chr5 179517140 RNF130 (18026): -1.6107870371505555, Methylation_LOC727677: 1.5107626482012908, Methylation_LETM1: 1.3178063149363706, Methylation_CDC42BPB: 0.476458258202154, Methylation_C8orf38: 1.629545212748311, Methylation_chr14 100504766 EVL (18852): 1.411064320590251, Methylation_chr5 72594851 LOC340090 (24088): -1.4797658886046448, Methylation_chr2 242904738 LINC01238 (3421): 1.4120816219434364, Methylation_ARFGEF1: 1.697828076509636, Methylation_MAPT: 1.4278912326618212, Methylation_ZFAT: 1.4618173285959224, Methylation_KCNQ4: 0.403172756755035, Methylation_chr1 232684368 SIPA1L2 (12934): 1.533703082249055, Methylation_CRNKL1: 1.1600171982450878, Methylation_PRKAG2: 0.6545838690267107, Methylation_MICB: 1.346836328079279, miRNA_hsa-mir-934: 0.516698201279245, miRNA_hsa-mir-4728: -0.8839507005556799, miRNA_hsa-mir-5695: 0.3226127511791372, miRNA_hsa-mir-18a: 2.68454832283561, miRNA_hsa-mir-190b: -1.3924308752198065, miRNA_hsa-mir-577: 0.7768419603786674, miRNA_hsa-mir-135b: 1.4575033107583453, miRNA_hsa-mir-2115: -0.2369498692369479, miRNA_hsa-mir-17: 1.1664854973090633, miRNA_hsa-mir-130b: 1.727728818377598, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-E2-A10C,"High-level Amplification of none; Gain in VPS54, LINC01867, LINC02576, WDPCP, CEP68. HOXB13 promoter hypermethylation (Z=1.79) mediates epigenetic silencing. No mRNA transcripts meet overexpression (Z>1.30) or underexpression (Z<-1.92) thresholds. miR-190b upregulated (Z=1.43). These features collectively indicate a luminal phenotype with HOXB13-driven epigenetic dysregulation.","mRNA_MLPH: 0.5833668113578175, mRNA_C2orf54: 1.1473784751590284, mRNA_CITED4: 1.0669250271736923, mRNA_ESR1: 0.5295893177760852, mRNA_SPDEF: 0.5963322812275931, mRNA_AGR3: 0.9907220074797252, mRNA_FOXC1: -0.9650773347570908, mRNA_GATA3: -0.0493432260136808, mRNA_AGR2: 0.6948729038603301, mRNA_XBP1: -0.6790134664604713, mRNA_PRR15: 0.4475878662576366, mRNA_SLC44A4: 0.7591189450311399, mRNA_CA12: -0.1805494570240844, mRNA_DTL: -0.1174253015331018, mRNA_C5AR2: 0.098750130847466, mRNA_TBC1D9: -0.5409646216689812, mRNA_AR: 0.6770414318461979, mRNA_CCDC170: 0.6618983725775239, mRNA_DEGS2: -0.4984666956034118, mRNA_TFF3: 1.4199728820186557, mRNA_DNALI1: 0.6051569191894987, mRNA_LINC00504: 0.227329152498271, mRNA_CLCA2: -0.6542588312312401, mRNA_PPP1R14C: -1.0847325762352296, mRNA_THSD4: -0.6663163526763658, mRNA_SPAG5: 0.4837947608040553, mRNA_FBP1: 0.8409569631877625, mRNA_SLC7A8: 0.3656433354594788, mRNA_EN1: -0.336695050750179, mRNA_ZNF552: -0.1443533227795529, Methylation_LRRC6: 0.5485886136716852, Methylation_chr2 66218712 LINC02934 (29533): -0.195268341489914, Methylation_HOXB13: 1.78912255337766, Methylation_chr10 3949206 LINC02660 (4871): -0.46793428634343, Methylation_chr5 179517140 RNF130 (18026): -0.7430086929220892, Methylation_LOC727677: -0.6961037184612361, Methylation_LETM1: 0.1341437059557031, Methylation_CDC42BPB: -1.1997542353051065, Methylation_C8orf38: -0.50389852344237, Methylation_chr14 100504766 EVL (18852): -0.6993222416543353, Methylation_chr5 72594851 LOC340090 (24088): 1.116463662638132, Methylation_chr2 242904738 LINC01238 (3421): -0.49669507352128, Methylation_ARFGEF1: 0.0316030530336352, Methylation_MAPT: -0.6733058686192669, Methylation_ZFAT: -1.0170980463642485, Methylation_KCNQ4: 0.9400728843596156, Methylation_chr1 232684368 SIPA1L2 (12934): -0.1671709109210348, Methylation_CRNKL1: -0.3690846058296165, Methylation_PRKAG2: -1.1310025743418242, Methylation_MICB: -0.171140604597101, miRNA_hsa-mir-934: -0.3208863587157556, miRNA_hsa-mir-4728: -0.0172425925395582, miRNA_hsa-mir-5695: 1.0785435020933092, miRNA_hsa-mir-18a: -0.2775322219591231, miRNA_hsa-mir-190b: 1.4295549460292116, miRNA_hsa-mir-577: -0.3156894582907511, miRNA_hsa-mir-135b: -1.0188855058988395, miRNA_hsa-mir-2115: 1.0586186147208303, miRNA_hsa-mir-17: -0.9353599106312812, miRNA_hsa-mir-130b: 0.3221993564564884, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-D8-A1JA,CLCA2 mRNA overexpression (Z=3.78) indicates high expression. HOXB13 promoter hypermethylation (Z=1.69) suggests epigenetic silencing. miR-4728 is upregulated (Z=3.51). No CNVs meet amplification/deletion thresholds. These features align with a luminal phenotype and potential ER-pathway dysregulation.,"mRNA_MLPH: -0.4786353143322626, mRNA_C2orf54: 0.4386155391127973, mRNA_CITED4: -1.4401650805944244, mRNA_ESR1: -1.6123737169260086, mRNA_SPDEF: 0.1578084693048018, mRNA_AGR3: -1.2376517132259894, mRNA_FOXC1: -0.6306004420123884, mRNA_GATA3: -0.4117940205465796, mRNA_AGR2: 0.7840799259337636, mRNA_XBP1: 0.820850880267266, mRNA_PRR15: 0.5879401988694842, mRNA_SLC44A4: 0.6695130640866712, mRNA_CA12: -0.2598941047623394, mRNA_DTL: 0.4826429651558163, mRNA_C5AR2: -1.696852674569784, mRNA_TBC1D9: -0.6283875511334457, mRNA_AR: 1.0087066167689984, mRNA_CCDC170: -1.4237761351748566, mRNA_DEGS2: -0.0627222193950609, mRNA_TFF3: -0.034616928841785, mRNA_DNALI1: 0.2553680244764363, mRNA_LINC00504: -1.661242345627342, mRNA_CLCA2: 3.781430563370376, mRNA_PPP1R14C: 1.0954438565480782, mRNA_THSD4: -0.083477794713061, mRNA_SPAG5: -0.0138347325022475, mRNA_FBP1: -0.2180623514330687, mRNA_SLC7A8: -0.1618484947584278, mRNA_EN1: 0.3135813343215108, mRNA_ZNF552: -0.6329158312138681, Methylation_LRRC6: 1.3476095485382575, Methylation_chr2 66218712 LINC02934 (29533): -1.7243630532534195, Methylation_HOXB13: 1.6895431972035482, Methylation_chr10 3949206 LINC02660 (4871): 0.1476712483749353, Methylation_chr5 179517140 RNF130 (18026): -1.253529869806693, Methylation_LOC727677: -0.9842054891488982, Methylation_LETM1: 1.3413179792812684, Methylation_CDC42BPB: -1.3363496992817845, Methylation_C8orf38: -1.3083280644262485, Methylation_chr14 100504766 EVL (18852): -1.0432738352516404, Methylation_chr5 72594851 LOC340090 (24088): -1.51319668720768, Methylation_chr2 242904738 LINC01238 (3421): -0.3119464993504839, Methylation_ARFGEF1: -0.5849637623875186, Methylation_MAPT: 0.4827868808239426, Methylation_ZFAT: -0.6628666117946824, Methylation_KCNQ4: 0.4755467429311926, Methylation_chr1 232684368 SIPA1L2 (12934): -1.3250127429355931, Methylation_CRNKL1: 0.9521602983512084, Methylation_PRKAG2: -1.118978960154891, Methylation_MICB: -0.6645780412338177, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 3.5096347307980897, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.3110991105680281, miRNA_hsa-mir-190b: -1.212311820224537, miRNA_hsa-mir-577: 0.1638559671561249, miRNA_hsa-mir-135b: -0.4183753387795186, miRNA_hsa-mir-2115: -0.0766496963121815, miRNA_hsa-mir-17: -1.3083736473493288, miRNA_hsa-mir-130b: 1.2585286796425816, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-B6-A0RG,"High-level Amplification absent; no CNVs meet amplification thresholds.  
Methylation_chr2 66218712 LINC02934 (29533) and MAPT are hypomethylated (Z < -1.47).  
miRNA_hsa-mir-5695 is upregulated (Z > 1.99); miRNA_hsa-mir-18a is downregulated (Z < -1.25).  
No mRNA alterations exceed expression thresholds.","mRNA_MLPH: 0.7002152724697042, mRNA_C2orf54: -0.6736372296062045, mRNA_CITED4: 0.7168491904995394, mRNA_ESR1: 0.7168846374191321, mRNA_SPDEF: 0.7447541687368336, mRNA_AGR3: 0.6048350198649205, mRNA_FOXC1: -0.987585456273061, mRNA_GATA3: 1.0267474512953214, mRNA_AGR2: -0.9155657934278876, mRNA_XBP1: 0.8849609327665418, mRNA_PRR15: 0.0495635248035921, mRNA_SLC44A4: -0.0190381652483673, mRNA_CA12: 0.9561046491476356, mRNA_DTL: 0.0891321997626836, mRNA_C5AR2: 0.0620686065825598, mRNA_TBC1D9: 1.1385416208379902, mRNA_AR: 0.42752637875407, mRNA_CCDC170: 0.1760331111550224, mRNA_DEGS2: 0.1047371582175819, mRNA_TFF3: 0.3429721727367472, mRNA_DNALI1: 1.1787715082828505, mRNA_LINC00504: 0.4243338899625548, mRNA_CLCA2: 0.3740232051197564, mRNA_PPP1R14C: 0.0175321744082028, mRNA_THSD4: 1.376083885005581, mRNA_SPAG5: 0.6776074928975387, mRNA_FBP1: 0.6684378497631823, mRNA_SLC7A8: -0.692246765246095, mRNA_EN1: -0.5496749624812227, mRNA_ZNF552: 0.4706256050290973, Methylation_LRRC6: -1.4330907923518066, Methylation_chr2 66218712 LINC02934 (29533): -1.8831419896097672, Methylation_HOXB13: -0.971053886110813, Methylation_chr10 3949206 LINC02660 (4871): -1.299733621256466, Methylation_chr5 179517140 RNF130 (18026): 1.240719573530893, Methylation_LOC727677: -1.4117206556967323, Methylation_LETM1: -1.802006376032152, Methylation_CDC42BPB: 1.471679526449598, Methylation_C8orf38: -0.3592202651392483, Methylation_chr14 100504766 EVL (18852): -1.392307671315817, Methylation_chr5 72594851 LOC340090 (24088): -1.0552620308296992, Methylation_chr2 242904738 LINC01238 (3421): -1.3222240566320913, Methylation_ARFGEF1: -1.2818824525129124, Methylation_MAPT: -1.6417316734996248, Methylation_ZFAT: -1.5268978193682852, Methylation_KCNQ4: -1.1799468946883442, Methylation_chr1 232684368 SIPA1L2 (12934): -1.0349274055556008, Methylation_CRNKL1: -1.6424329639356394, Methylation_PRKAG2: 0.0888641018545172, Methylation_MICB: -1.2452301638071093, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.2036119774543105, miRNA_hsa-mir-5695: 2.1765511827248383, miRNA_hsa-mir-18a: -1.2705178365935688, miRNA_hsa-mir-190b: 1.5621715578854964, miRNA_hsa-mir-577: 1.1587258421177549, miRNA_hsa-mir-135b: -0.4319368718003542, miRNA_hsa-mir-2115: 0.5364288052500241, miRNA_hsa-mir-17: -0.1948978072802525, miRNA_hsa-mir-130b: -0.1771986439167801, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A1EW,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.1299164190249372, mRNA_C2orf54: -0.4083587102302838, mRNA_CITED4: -0.5743592744262185, mRNA_ESR1: 0.4341498084091518, mRNA_SPDEF: -0.1070792683926495, mRNA_AGR3: 0.5771506011478186, mRNA_FOXC1: 0.2041787242319848, mRNA_GATA3: 0.3506924796138194, mRNA_AGR2: 0.6665541340120241, mRNA_XBP1: 0.7091395124109166, mRNA_PRR15: -0.0298791794156705, mRNA_SLC44A4: 0.2783220622645164, mRNA_CA12: 1.2133966644807532, mRNA_DTL: 0.985725663794648, mRNA_C5AR2: -0.0110155393527942, mRNA_TBC1D9: 0.9524276099983922, mRNA_AR: 0.6975808225694201, mRNA_CCDC170: 0.3676919998816657, mRNA_DEGS2: -0.3033381809129646, mRNA_TFF3: 0.6996172593528984, mRNA_DNALI1: 1.1052676669635135, mRNA_LINC00504: 0.5123212419378367, mRNA_CLCA2: -0.5454857070182915, mRNA_PPP1R14C: -0.881479187119958, mRNA_THSD4: 0.7288018849942485, mRNA_SPAG5: 1.0215392496836777, mRNA_FBP1: 0.1989737720536931, mRNA_SLC7A8: 0.2357633075632227, mRNA_EN1: -0.9093244299793504, mRNA_ZNF552: 0.9229120176812492, Methylation_LRRC6: 0.1270341440180415, Methylation_chr2 66218712 LINC02934 (29533): 0.4993685463923797, Methylation_HOXB13: 0.6955560798818525, Methylation_chr10 3949206 LINC02660 (4871): -0.5342518955957244, Methylation_chr5 179517140 RNF130 (18026): 0.4466221897834229, Methylation_LOC727677: 0.2175655426691025, Methylation_LETM1: -0.571082445385988, Methylation_CDC42BPB: 0.8530617956518229, Methylation_C8orf38: -0.4263591133977021, Methylation_chr14 100504766 EVL (18852): 0.0898772972016125, Methylation_chr5 72594851 LOC340090 (24088): 0.964802788223838, Methylation_chr2 242904738 LINC01238 (3421): -0.3431440279726085, Methylation_ARFGEF1: -0.1077854494201753, Methylation_MAPT: -0.2053436353229155, Methylation_ZFAT: -0.2108469102903616, Methylation_KCNQ4: -0.0178173416222159, Methylation_chr1 232684368 SIPA1L2 (12934): -0.5717567820149728, Methylation_CRNKL1: -0.2513583614052029, Methylation_PRKAG2: 0.722973237589785, Methylation_MICB: -0.4555482915822234, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.6982036353697112, miRNA_hsa-mir-5695: 0.2469721367312645, miRNA_hsa-mir-18a: -0.1468615477665024, miRNA_hsa-mir-190b: 0.319916105251511, miRNA_hsa-mir-577: -0.3317367731652493, miRNA_hsa-mir-135b: 0.9484106640123964, miRNA_hsa-mir-2115: -0.2685036884704719, miRNA_hsa-mir-17: -0.3576324037453742, miRNA_hsa-mir-130b: 0.1303581914762333, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-E9-A24A,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.7126134965560905, mRNA_C2orf54: 0.238059525901591, mRNA_CITED4: -0.5639070158473194, mRNA_ESR1: 1.2108280522387016, mRNA_SPDEF: 0.1996361868898301, mRNA_AGR3: 1.0731800646718348, mRNA_FOXC1: -0.6130157697663688, mRNA_GATA3: 0.5018213755079475, mRNA_AGR2: 0.5659022142328323, mRNA_XBP1: 0.7291092490798773, mRNA_PRR15: 1.0589020001599672, mRNA_SLC44A4: 0.941683043532217, mRNA_CA12: 0.7484603458889754, mRNA_DTL: 0.1095383765388024, mRNA_C5AR2: 1.1206488574612488, mRNA_TBC1D9: 0.758920850996218, mRNA_AR: 0.8735730347807648, mRNA_CCDC170: 1.7732945043795183, mRNA_DEGS2: 0.2349834735364186, mRNA_TFF3: 0.4219933564220578, mRNA_DNALI1: 0.0110758637315169, mRNA_LINC00504: 0.7302280787447162, mRNA_CLCA2: -0.7334486642996074, mRNA_PPP1R14C: -0.5525571338246947, mRNA_THSD4: 1.2005606998645957, mRNA_SPAG5: -0.5441715204033531, mRNA_FBP1: 0.2681895767655026, mRNA_SLC7A8: 0.4687057060369909, mRNA_EN1: 1.1397322261825975, mRNA_ZNF552: 1.0912163063861915, Methylation_LRRC6: -0.2685155175594918, Methylation_chr2 66218712 LINC02934 (29533): 1.0345879973106191, Methylation_HOXB13: -1.109865857648587, Methylation_chr10 3949206 LINC02660 (4871): -0.8109966451396976, Methylation_chr5 179517140 RNF130 (18026): -0.5698314154182783, Methylation_LOC727677: -0.338110945847016, Methylation_LETM1: -0.6024883764611983, Methylation_CDC42BPB: -1.2744072464927385, Methylation_C8orf38: -0.1186423553310991, Methylation_chr14 100504766 EVL (18852): -0.4806390193978719, Methylation_chr5 72594851 LOC340090 (24088): -1.2458017047732683, Methylation_chr2 242904738 LINC01238 (3421): -0.7762684920491697, Methylation_ARFGEF1: 0.1724444054933435, Methylation_MAPT: -0.5531534097843386, Methylation_ZFAT: -0.5866986304659981, Methylation_KCNQ4: -0.6063363068526779, Methylation_chr1 232684368 SIPA1L2 (12934): -0.914053447825237, Methylation_CRNKL1: 0.0780609675906488, Methylation_PRKAG2: -1.0852161300026042, Methylation_MICB: -0.6571005461142954, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.5952356490406878, miRNA_hsa-mir-5695: 0.1557717490632476, miRNA_hsa-mir-18a: -0.5476841260241022, miRNA_hsa-mir-190b: 0.6016528584942555, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.7692070538753294, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.7655172932258316, miRNA_hsa-mir-130b: 0.3772637872074043, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AC-A3TM,High mRNA_CITED4 (Z=1.87) and mRNA_DEGS2 (Z=1.54) indicate overexpression. No methylation or miRNA alterations meet diagnostic thresholds. All CNVs fall within normal range (−1.10 to −0.10). These features collectively indicate a luminal phenotype with estrogen-response dysregulation.,"mRNA_MLPH: 0.8727707709514856, mRNA_C2orf54: -0.2272659739313395, mRNA_CITED4: 1.8654725107369463, mRNA_ESR1: -0.3404593621848908, mRNA_SPDEF: 0.6687037968259889, mRNA_AGR3: 0.6300148242670859, mRNA_FOXC1: -0.4134611865313136, mRNA_GATA3: 0.4002762531094005, mRNA_AGR2: 0.4532007790303132, mRNA_XBP1: 0.0786957084343047, mRNA_PRR15: 0.1631999904015425, mRNA_SLC44A4: 0.4445017550110908, mRNA_CA12: 0.2292415991441572, mRNA_DTL: 0.3363687894596032, mRNA_C5AR2: 0.776382055290521, mRNA_TBC1D9: -0.2582696108330826, mRNA_AR: -0.0345020096957376, mRNA_CCDC170: -0.5013145637972073, mRNA_DEGS2: 1.540045675381089, mRNA_TFF3: 1.3272425740409326, mRNA_DNALI1: 1.0680089323979942, mRNA_LINC00504: 0.377771060819731, mRNA_CLCA2: -0.0029679305810252, mRNA_PPP1R14C: -0.1176353946139675, mRNA_THSD4: -0.3183060646952907, mRNA_SPAG5: 0.0601441159765509, mRNA_FBP1: 0.0072769226133567, mRNA_SLC7A8: -0.1000933478553799, mRNA_EN1: 0.0878333135807186, mRNA_ZNF552: 0.0004845174140889, Methylation_LRRC6: -0.1038200987683325, Methylation_chr2 66218712 LINC02934 (29533): 1.160951523397727, Methylation_HOXB13: 0.0835516614959777, Methylation_chr10 3949206 LINC02660 (4871): -0.6235906861689469, Methylation_chr5 179517140 RNF130 (18026): 0.4743985930412428, Methylation_LOC727677: -0.4905697530134811, Methylation_LETM1: -0.3536146302103127, Methylation_CDC42BPB: -1.045786414033434, Methylation_C8orf38: -0.3561738132794958, Methylation_chr14 100504766 EVL (18852): -0.6226064096342703, Methylation_chr5 72594851 LOC340090 (24088): 0.8060471273999263, Methylation_chr2 242904738 LINC01238 (3421): -0.7565025622336536, Methylation_ARFGEF1: -0.125879129220216, Methylation_MAPT: -0.5876052097070267, Methylation_ZFAT: -0.5266278940413573, Methylation_KCNQ4: -1.0962000647378232, Methylation_chr1 232684368 SIPA1L2 (12934): -0.7888227635901323, Methylation_CRNKL1: -0.2054898213996769, Methylation_PRKAG2: 0.4824828695397299, Methylation_MICB: -0.44487330020508, miRNA_hsa-mir-934: -0.3150461627668701, miRNA_hsa-mir-4728: 0.0019654733532914, miRNA_hsa-mir-5695: -0.5178776210371703, miRNA_hsa-mir-18a: -0.6910669803135506, miRNA_hsa-mir-190b: 0.7240603702177484, miRNA_hsa-mir-577: -0.5929476670914615, miRNA_hsa-mir-135b: -0.4912625032345359, miRNA_hsa-mir-2115: 0.0325584381675196, miRNA_hsa-mir-17: -0.1325182935445948, miRNA_hsa-mir-130b: -0.4486177004258931, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-4H-AAAK,High mRNA_C2orf54 (Z=1.50) indicates overexpression. No methylation or miRNA alterations meet diagnostic thresholds. All CNVs fall within normal/gain range (no deletions/amplifications). Insufficient evidence for subtype classification.,"mRNA_MLPH: 0.3748393969032709, mRNA_C2orf54: 1.4995665195772, mRNA_CITED4: 1.139601785105919, mRNA_ESR1: 0.2299724731564761, mRNA_SPDEF: 0.562437799431396, mRNA_AGR3: 0.2953049230280348, mRNA_FOXC1: -0.0925870866365777, mRNA_GATA3: 0.5751161519895553, mRNA_AGR2: 0.3074374468787527, mRNA_XBP1: 0.6912174568228024, mRNA_PRR15: 0.5940101181215571, mRNA_SLC44A4: 0.2082165931372361, mRNA_CA12: 0.1773389459582126, mRNA_DTL: -0.4109581388926527, mRNA_C5AR2: 0.3299657616364123, mRNA_TBC1D9: 0.0876146665563778, mRNA_AR: 0.5610432078612549, mRNA_CCDC170: 0.6269564081634713, mRNA_DEGS2: 1.048480260285053, mRNA_TFF3: 0.7217725212122592, mRNA_DNALI1: 0.0479854242239411, mRNA_LINC00504: 0.5139868937342569, mRNA_CLCA2: 0.356191990256931, mRNA_PPP1R14C: 0.0416304429675141, mRNA_THSD4: 0.2570868857803187, mRNA_SPAG5: 0.0444543357482335, mRNA_FBP1: 0.7220711390444294, mRNA_SLC7A8: 0.9415540463505072, mRNA_EN1: 0.2555857438039019, mRNA_ZNF552: 0.1834159647495775, Methylation_LRRC6: -0.6405221618665109, Methylation_chr2 66218712 LINC02934 (29533): 0.8813794904405803, Methylation_HOXB13: -0.5940890430582991, Methylation_chr10 3949206 LINC02660 (4871): -0.5608601674584129, Methylation_chr5 179517140 RNF130 (18026): 0.0821661975574276, Methylation_LOC727677: -1.033898128694034, Methylation_LETM1: -0.0268338203174875, Methylation_CDC42BPB: 0.7616706650159222, Methylation_C8orf38: -0.8992240395740883, Methylation_chr14 100504766 EVL (18852): -0.3091043223559853, Methylation_chr5 72594851 LOC340090 (24088): -0.2000262044344085, Methylation_chr2 242904738 LINC01238 (3421): -0.6960774925536994, Methylation_ARFGEF1: -0.4329679062432235, Methylation_MAPT: -1.2395292061301646, Methylation_ZFAT: -0.6834816636984563, Methylation_KCNQ4: 0.1344826749434087, Methylation_chr1 232684368 SIPA1L2 (12934): 0.6286227067423067, Methylation_CRNKL1: -0.4555725388115713, Methylation_PRKAG2: 0.070934206003367, Methylation_MICB: -0.1647025724323235, miRNA_hsa-mir-934: -0.3499654934085405, miRNA_hsa-mir-4728: -0.796502572687497, miRNA_hsa-mir-5695: 0.5609108805028608, miRNA_hsa-mir-18a: -0.5975718388615113, miRNA_hsa-mir-190b: -0.7028995643423999, miRNA_hsa-mir-577: -0.6368448385999099, miRNA_hsa-mir-135b: -0.4417907679282363, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.217474818561995, miRNA_hsa-mir-130b: -1.2137346787065777, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-D8-A27E,"High-level Amplification of none; ESR1 mRNA high (Z=1.36) without amplification.  
LINC02934 and LOC340090 promoters hypermethylated (Z=-1.63, -1.56), potentially silencing non-coding RNAs.  
DTL mRNA low (Z=-2.22) with no deletion.  
No miRNA or CNV alterations meet diagnostic thresholds.  
Features suggest luminal-like phenotype with estrogen signaling activation.","mRNA_MLPH: 0.3416124959179683, mRNA_C2orf54: -1.2943230935752186, mRNA_CITED4: -0.7949424243313526, mRNA_ESR1: 1.357356107105308, mRNA_SPDEF: 0.2405750213176059, mRNA_AGR3: 0.3686150297278824, mRNA_FOXC1: -0.8475349258693109, mRNA_GATA3: 0.6988472951861934, mRNA_AGR2: -0.2575632899344963, mRNA_XBP1: 1.2166736059939782, mRNA_PRR15: 0.665929051094721, mRNA_SLC44A4: 0.7903652491439005, mRNA_CA12: 0.5228828317897329, mRNA_DTL: -2.224386324174825, mRNA_C5AR2: 0.521782849831801, mRNA_TBC1D9: 0.7966958400309281, mRNA_AR: 0.4989143238702238, mRNA_CCDC170: 1.806043066157408, mRNA_DEGS2: 0.3001841298417244, mRNA_TFF3: 0.7547590805283597, mRNA_DNALI1: 0.535226871488654, mRNA_LINC00504: 1.9555960859766208, mRNA_CLCA2: -0.8877159626057084, mRNA_PPP1R14C: -1.0680751461665008, mRNA_THSD4: 0.878262008314111, mRNA_SPAG5: -1.8944339208914915, mRNA_FBP1: 0.6841644743444748, mRNA_SLC7A8: 1.208241552195019, mRNA_EN1: -0.3526224022680945, mRNA_ZNF552: 0.5621833813229092, Methylation_LRRC6: -0.7361045398189794, Methylation_chr2 66218712 LINC02934 (29533): -1.627419792512509, Methylation_HOXB13: -1.0995692337678504, Methylation_chr10 3949206 LINC02660 (4871): 0.2194185733148915, Methylation_chr5 179517140 RNF130 (18026): -0.9814226813660324, Methylation_LOC727677: -0.6974924030654894, Methylation_LETM1: 0.1843256653518238, Methylation_CDC42BPB: -1.2388372496301323, Methylation_C8orf38: -0.6257358649934286, Methylation_chr14 100504766 EVL (18852): -0.950072592167079, Methylation_chr5 72594851 LOC340090 (24088): -1.5577904797933717, Methylation_chr2 242904738 LINC01238 (3421): -1.1087800446390954, Methylation_ARFGEF1: -0.3029987393183744, Methylation_MAPT: -0.0069632729111642, Methylation_ZFAT: 1.3460933706015616, Methylation_KCNQ4: -0.9677184965160444, Methylation_chr1 232684368 SIPA1L2 (12934): -0.2472925540986606, Methylation_CRNKL1: -0.4532181715980879, Methylation_PRKAG2: -0.5031865231243532, Methylation_MICB: -0.6159326883874423, miRNA_hsa-mir-934: -0.2892835314500517, miRNA_hsa-mir-4728: -0.1852376284995728, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.0849525456696816, miRNA_hsa-mir-190b: -0.1978325643670619, miRNA_hsa-mir-577: -0.6041323183652042, miRNA_hsa-mir-135b: 1.0005081184198454, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.5561431477074996, miRNA_hsa-mir-130b: -0.3205158113883198, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A24W,"No features meet the strict diagnostic thresholds for mRNA (Z > 1.30 or Z < -1.92), methylation (Z > 1.50 or Z < -1.47), miRNA (Z > 1.99 or Z < -1.25), or CNV (deletion, gain, amplification, or high-level amplification). All values fall within non-actionable ranges.","mRNA_MLPH: 0.1938935675690258, mRNA_C2orf54: -0.9366731314177064, mRNA_CITED4: 0.3475176559979651, mRNA_ESR1: 0.6515069396737883, mRNA_SPDEF: 0.1560090725647996, mRNA_AGR3: 0.779418711897435, mRNA_FOXC1: 1.2527431721466464, mRNA_GATA3: 0.0172481264914834, mRNA_AGR2: 0.2520036603442353, mRNA_XBP1: 0.5466094861485659, mRNA_PRR15: 0.0483714216068543, mRNA_SLC44A4: 0.3537054112870145, mRNA_CA12: 0.7978624747146018, mRNA_DTL: -0.5817863788590034, mRNA_C5AR2: -0.0366924601358023, mRNA_TBC1D9: 1.0795048756087706, mRNA_AR: 0.1519529593592039, mRNA_CCDC170: 1.018720717662434, mRNA_DEGS2: 0.3243465061703676, mRNA_TFF3: -0.7031525842884135, mRNA_DNALI1: 0.3346188430602551, mRNA_LINC00504: 0.2921453775036295, mRNA_CLCA2: 0.0053717057969065, mRNA_PPP1R14C: 0.3389816552364224, mRNA_THSD4: 0.7188555920681297, mRNA_SPAG5: -1.261311286630483, mRNA_FBP1: 0.104807212187313, mRNA_SLC7A8: 0.1278000360284618, mRNA_EN1: -0.024436690443742, mRNA_ZNF552: 0.5775157138064555, Methylation_LRRC6: 0.9129322820795056, Methylation_chr2 66218712 LINC02934 (29533): -1.1881645669343084, Methylation_HOXB13: -1.0215934348204243, Methylation_chr10 3949206 LINC02660 (4871): 0.8567818597267771, Methylation_chr5 179517140 RNF130 (18026): -0.0954539773478033, Methylation_LOC727677: 0.0592158831943381, Methylation_LETM1: 0.3995727664475368, Methylation_CDC42BPB: -0.5694440696343832, Methylation_C8orf38: 0.2072633192376687, Methylation_chr14 100504766 EVL (18852): 0.8396625377022173, Methylation_chr5 72594851 LOC340090 (24088): 0.241749675298297, Methylation_chr2 242904738 LINC01238 (3421): 0.2235141507818419, Methylation_ARFGEF1: 0.4913128002691705, Methylation_MAPT: 0.1759287776706099, Methylation_ZFAT: 0.5339368018078126, Methylation_KCNQ4: -0.5966881326933292, Methylation_chr1 232684368 SIPA1L2 (12934): -0.4467216427965284, Methylation_CRNKL1: 0.8080968836933698, Methylation_PRKAG2: 0.7287333524900619, Methylation_MICB: 0.429733126925478, miRNA_hsa-mir-934: 0.5480832498652904, miRNA_hsa-mir-4728: 0.3310803786971146, miRNA_hsa-mir-5695: 1.0151040200849162, miRNA_hsa-mir-18a: -1.2806691956422087, miRNA_hsa-mir-190b: -0.3644585287368366, miRNA_hsa-mir-577: -0.0592670644187044, miRNA_hsa-mir-135b: -0.439529508703512, miRNA_hsa-mir-2115: 1.3709282230234827, miRNA_hsa-mir-17: -0.7319626867747012, miRNA_hsa-mir-130b: -1.758108221250465, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A1F2,"High mRNA_C2orf54 (Z=1.98) and extreme mRNA_CLCA2 (Z=2.31), mRNA_SPAG5 (Z=2.11) overexpression. miRNA_hsa-mir-4728 upregulated (Z=2.17). CNV_LINC01867 amplified (1.39). No promoter hyper/hypomethylation meets thresholds. These features suggest luminal B-like phenotype with cell cycle and secretory pathway dysregulation.","mRNA_MLPH: -0.0574402583318631, mRNA_C2orf54: 1.980466976194452, mRNA_CITED4: 0.2600333770176502, mRNA_ESR1: -0.0605303272015586, mRNA_SPDEF: 0.0380790743968823, mRNA_AGR3: 0.1794338332000189, mRNA_FOXC1: 0.8994160261530832, mRNA_GATA3: 0.1911332905051948, mRNA_AGR2: 0.8833555080751125, mRNA_XBP1: 0.3859884032296292, mRNA_PRR15: 0.229906616001627, mRNA_SLC44A4: 0.8227639236180441, mRNA_CA12: 0.0396207941947392, mRNA_DTL: 0.9769783065567575, mRNA_C5AR2: -0.4393706786604955, mRNA_TBC1D9: -0.2003215235505761, mRNA_AR: 0.7953989039269657, mRNA_CCDC170: 0.2810084079174003, mRNA_DEGS2: -0.2403101235998091, mRNA_TFF3: -0.0962234985802388, mRNA_DNALI1: -0.6058971563472701, mRNA_LINC00504: 0.4434205131759573, mRNA_CLCA2: 2.311321474486161, mRNA_PPP1R14C: -0.7873593894623168, mRNA_THSD4: -0.2790447305733421, mRNA_SPAG5: 2.106241675069724, mRNA_FBP1: 0.1565816336692143, mRNA_SLC7A8: -0.0434478833257885, mRNA_EN1: 0.2893254962034767, mRNA_ZNF552: 0.1106519768913866, Methylation_LRRC6: -0.9780110914655444, Methylation_chr2 66218712 LINC02934 (29533): -1.374369402600272, Methylation_HOXB13: 1.4710543561308198, Methylation_chr10 3949206 LINC02660 (4871): -0.9977214306604228, Methylation_chr5 179517140 RNF130 (18026): -0.3042122981995456, Methylation_LOC727677: -0.3328274786183279, Methylation_LETM1: 0.0536951721576481, Methylation_CDC42BPB: -0.8450196909822819, Methylation_C8orf38: -1.0090075209163565, Methylation_chr14 100504766 EVL (18852): -0.4776883237398081, Methylation_chr5 72594851 LOC340090 (24088): 0.7285838518276858, Methylation_chr2 242904738 LINC01238 (3421): -0.6377907069460022, Methylation_ARFGEF1: -0.505638498925379, Methylation_MAPT: 0.982590321502972, Methylation_ZFAT: -0.665816449963354, Methylation_KCNQ4: 0.6600283855000758, Methylation_chr1 232684368 SIPA1L2 (12934): -0.0952990571750209, Methylation_CRNKL1: -0.7975763166655743, Methylation_PRKAG2: -1.119208635587451, Methylation_MICB: -1.072159937883874, miRNA_hsa-mir-934: 1.1478555889541222, miRNA_hsa-mir-4728: 2.169489951124701, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.1728273004116363, miRNA_hsa-mir-190b: -0.365405923545575, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: 0.3079028982281365, miRNA_hsa-mir-17: -0.0352500404565479, miRNA_hsa-mir-130b: 1.370648563893348, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-A7-A3IY,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-significant ranges per specified Z-score and CNV cutoffs.","mRNA_MLPH: 0.1855195601580847, mRNA_C2orf54: -0.3953097338797736, mRNA_CITED4: -0.3497720608263566, mRNA_ESR1: 0.6377963480067295, mRNA_SPDEF: 0.0010554354638759, mRNA_AGR3: 0.6555617077938334, mRNA_FOXC1: 0.3586955547781135, mRNA_GATA3: 0.3994716643108417, mRNA_AGR2: 0.967733170880772, mRNA_XBP1: 0.9413443549882786, mRNA_PRR15: 0.7705071297583903, mRNA_SLC44A4: 0.4480607728775791, mRNA_CA12: 0.7655418263509721, mRNA_DTL: -0.894739249712187, mRNA_C5AR2: 0.9014851623292472, mRNA_TBC1D9: 0.334586659588548, mRNA_AR: 0.096735177420065, mRNA_CCDC170: 0.9853349357790838, mRNA_DEGS2: 0.4123025010973488, mRNA_TFF3: 0.6764082802934681, mRNA_DNALI1: 0.3375093568037047, mRNA_LINC00504: 0.0605663842693263, mRNA_CLCA2: 0.1153608162658238, mRNA_PPP1R14C: 0.710723247057001, mRNA_THSD4: 0.754624174594491, mRNA_SPAG5: -0.7200848228046833, mRNA_FBP1: -0.1374348759622081, mRNA_SLC7A8: 0.7823994777289109, mRNA_EN1: -0.4955988056873735, mRNA_ZNF552: 0.5338238723297901, Methylation_LRRC6: 0.9176991239927836, Methylation_chr2 66218712 LINC02934 (29533): -0.4547228978137692, Methylation_HOXB13: -1.062341468512264, Methylation_chr10 3949206 LINC02660 (4871): 1.0906358563266885, Methylation_chr5 179517140 RNF130 (18026): -1.5900437074768785, Methylation_LOC727677: 0.039581010115504, Methylation_LETM1: 0.1516149709336719, Methylation_CDC42BPB: -0.83517801581332, Methylation_C8orf38: 0.2007582398223001, Methylation_chr14 100504766 EVL (18852): -0.0652696421640283, Methylation_chr5 72594851 LOC340090 (24088): -0.4355919338871089, Methylation_chr2 242904738 LINC01238 (3421): 1.398037569116453, Methylation_ARFGEF1: 0.7210551746746656, Methylation_MAPT: 0.4490530701348942, Methylation_ZFAT: 1.4276061371884503, Methylation_KCNQ4: -1.224367296955705, Methylation_chr1 232684368 SIPA1L2 (12934): 0.7930766878991463, Methylation_CRNKL1: 0.6285335894268848, Methylation_PRKAG2: -0.5650293182676358, Methylation_MICB: 0.2928742708151126, miRNA_hsa-mir-934: 0.7258555199704279, miRNA_hsa-mir-4728: -0.2420071847783942, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.6767648958088347, miRNA_hsa-mir-190b: 0.6369161584921988, miRNA_hsa-mir-577: 0.2758262160595248, miRNA_hsa-mir-135b: 1.36591118143921, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.4511870709387319, miRNA_hsa-mir-130b: 0.4376991825682764, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A1N4,"Deletion of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 correlates with transcriptional downregulation. Methylation at chr10:3949206 (LINC02660) is hypermethylated (Z=1.52), and chr5:72594851 (LOC340090) is hypomethylated (Z=-1.48). miRNA hsa-mir-130b is downregulated (Z=-1.74). No mRNA or miRNA upregulation meets threshold.","mRNA_MLPH: -0.2768090980397701, mRNA_C2orf54: -1.251098020008137, mRNA_CITED4: -0.5593366709080618, mRNA_ESR1: -0.117002666124275, mRNA_SPDEF: 0.109221015095071, mRNA_AGR3: 0.4501104991965456, mRNA_FOXC1: -0.1970199901282096, mRNA_GATA3: -0.0874793986926775, mRNA_AGR2: 0.3629663376989424, mRNA_XBP1: 0.6964008762866805, mRNA_PRR15: 0.6158912669487618, mRNA_SLC44A4: 0.95236443750175, mRNA_CA12: 0.7173762804684585, mRNA_DTL: -0.3516784117560297, mRNA_C5AR2: 0.4975342092920713, mRNA_TBC1D9: 0.368627589363289, mRNA_AR: 0.585251033634099, mRNA_CCDC170: 0.2483952997910568, mRNA_DEGS2: -0.2498717924201229, mRNA_TFF3: 0.2708472483211125, mRNA_DNALI1: 0.1158139827535045, mRNA_LINC00504: 0.5586482866093019, mRNA_CLCA2: -0.8489986294094676, mRNA_PPP1R14C: -0.6263565628199604, mRNA_THSD4: 0.88806693153477, mRNA_SPAG5: -0.1746373310407996, mRNA_FBP1: -0.3315837187665252, mRNA_SLC7A8: -0.1448352790684494, mRNA_EN1: -0.5959522555840373, mRNA_ZNF552: 0.3405601977793163, Methylation_LRRC6: 0.0957842050334901, Methylation_chr2 66218712 LINC02934 (29533): -0.6632452424079449, Methylation_HOXB13: -1.0878289508062309, Methylation_chr10 3949206 LINC02660 (4871): 1.522287692346938, Methylation_chr5 179517140 RNF130 (18026): 0.1444586578965163, Methylation_LOC727677: -0.4923884134883886, Methylation_LETM1: 0.7713235998459738, Methylation_CDC42BPB: -1.2613601315557466, Methylation_C8orf38: -0.6630349674351886, Methylation_chr14 100504766 EVL (18852): -0.4480326357918584, Methylation_chr5 72594851 LOC340090 (24088): -1.483485805343005, Methylation_chr2 242904738 LINC01238 (3421): -0.3979354661529207, Methylation_ARFGEF1: -0.0747458127584065, Methylation_MAPT: -0.7143997298298881, Methylation_ZFAT: 1.3514463863271735, Methylation_KCNQ4: -1.2017280463586066, Methylation_chr1 232684368 SIPA1L2 (12934): 0.3036878397631217, Methylation_CRNKL1: 0.0197422753310599, Methylation_PRKAG2: 0.878583319912719, Methylation_MICB: -0.0364818995505283, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.5747120374376542, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.3595256665286542, miRNA_hsa-mir-190b: -0.2872796748291583, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.8300934634890987, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.7108513153404378, miRNA_hsa-mir-130b: -1.7358430068554862, CNV_VPS54: -1.6173912818721974, CNV_LINC01867: -1.63714039509435, CNV_LINC02576: -1.657048777669473, CNV_WDPCP: -1.6249341592372952, CNV_CEP68: -1.657048777669473"
TCGA-A7-A13G,"SPAG5 mRNA is significantly downregulated (Z = -2.16). LETM1, C8orf38, ZFAT, SIPA1L2, and CRNKL1 promoters are hypermethylated (Z < -1.47), suggesting epigenetic silencing. No CNVs or miRNAs meet diagnostic thresholds. This profile aligns with a luminal B-like phenotype featuring ER pathway suppression and cell cycle dysregulation.","mRNA_MLPH: -0.348583620447236, mRNA_C2orf54: -1.2112200735495366, mRNA_CITED4: -1.424285024545887, mRNA_ESR1: 0.8745916909697509, mRNA_SPDEF: -0.505973439024156, mRNA_AGR3: 0.6243972655549592, mRNA_FOXC1: -1.6421839558771456, mRNA_GATA3: -1.6962884716886462, mRNA_AGR2: -0.4144743173891244, mRNA_XBP1: 0.0804633200319986, mRNA_PRR15: -0.978505426719218, mRNA_SLC44A4: -0.072904357367871, mRNA_CA12: 0.1349122421219134, mRNA_DTL: -1.303753393030178, mRNA_C5AR2: 0.6852491460610888, mRNA_TBC1D9: 0.6547299537294899, mRNA_AR: 0.277335469734335, mRNA_CCDC170: 0.8294594378616231, mRNA_DEGS2: -0.8175836733163516, mRNA_TFF3: -0.9948851733042108, mRNA_DNALI1: -0.384796666402838, mRNA_LINC00504: -0.039741436353908, mRNA_CLCA2: -0.8258240952203901, mRNA_PPP1R14C: -0.9834713273271052, mRNA_THSD4: 0.8527936122446947, mRNA_SPAG5: -2.162172307268713, mRNA_FBP1: -1.7465457132694229, mRNA_SLC7A8: -1.3237149597654465, mRNA_EN1: -0.2873989450027252, mRNA_ZNF552: 0.3141476947238958, Methylation_LRRC6: -0.85361522336915, Methylation_chr2 66218712 LINC02934 (29533): 0.4086330311431086, Methylation_HOXB13: -1.0290080675737197, Methylation_chr10 3949206 LINC02660 (4871): -1.3213640278166765, Methylation_chr5 179517140 RNF130 (18026): 0.0186716372304219, Methylation_LOC727677: -1.1016583619176403, Methylation_LETM1: -1.726347547806325, Methylation_CDC42BPB: -1.4007035935351562, Methylation_C8orf38: -1.534748624464214, Methylation_chr14 100504766 EVL (18852): -1.3724585373576728, Methylation_chr5 72594851 LOC340090 (24088): -0.4818143488736744, Methylation_chr2 242904738 LINC01238 (3421): -1.3427001717622549, Methylation_ARFGEF1: -1.275352805523295, Methylation_MAPT: -1.385832872069348, Methylation_ZFAT: -1.490931514188257, Methylation_KCNQ4: 0.6089145078686087, Methylation_chr1 232684368 SIPA1L2 (12934): -1.6761802406822508, Methylation_CRNKL1: -1.739939508324567, Methylation_PRKAG2: 1.3464770049427215, Methylation_MICB: -1.4483477310282875, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.3474815145142033, miRNA_hsa-mir-5695: 0.4620867569284834, miRNA_hsa-mir-18a: -1.048969504920427, miRNA_hsa-mir-190b: 1.755778715983821, miRNA_hsa-mir-577: -0.0160690976673582, miRNA_hsa-mir-135b: -0.2498324703511215, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.4742510405459552, miRNA_hsa-mir-130b: -0.2562078070953597, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A1JE,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.2019343069135561, mRNA_C2orf54: -1.2297725298873303, mRNA_CITED4: 0.4460144254381289, mRNA_ESR1: 1.1242043665437242, mRNA_SPDEF: -0.4143717762688431, mRNA_AGR3: 0.7394425347988888, mRNA_FOXC1: -0.6689056364008579, mRNA_GATA3: 0.7685278679771272, mRNA_AGR2: 0.2329339157373855, mRNA_XBP1: 1.0453290300897402, mRNA_PRR15: 0.3302573270026444, mRNA_SLC44A4: 0.4509278316149246, mRNA_CA12: 0.8003704120067464, mRNA_DTL: 1.2332687855163806, mRNA_C5AR2: 0.5783076454882949, mRNA_TBC1D9: 0.7068467773435271, mRNA_AR: 1.0193507255100045, mRNA_CCDC170: 0.6881445133587585, mRNA_DEGS2: 0.2391688337151957, mRNA_TFF3: 0.7221695259595505, mRNA_DNALI1: 0.6199850216419437, mRNA_LINC00504: 1.2731968080017926, mRNA_CLCA2: -0.8787857463848301, mRNA_PPP1R14C: -1.0743392182172864, mRNA_THSD4: 0.2004875315630162, mRNA_SPAG5: 0.0621585248705547, mRNA_FBP1: 0.4594872442113201, mRNA_SLC7A8: 0.7813690476251476, mRNA_EN1: 0.3455230592269905, mRNA_ZNF552: 0.6021563378839426, Methylation_LRRC6: 0.0902187009969749, Methylation_chr2 66218712 LINC02934 (29533): -0.7524811746403788, Methylation_HOXB13: -1.0844141134180572, Methylation_chr10 3949206 LINC02660 (4871): 1.102367303639778, Methylation_chr5 179517140 RNF130 (18026): 0.7536077998545696, Methylation_LOC727677: -0.4530911099199871, Methylation_LETM1: -0.0279418414752634, Methylation_CDC42BPB: -0.7356275920457854, Methylation_C8orf38: -0.4525794159687131, Methylation_chr14 100504766 EVL (18852): -0.3936916197648905, Methylation_chr5 72594851 LOC340090 (24088): 0.7973698992952327, Methylation_chr2 242904738 LINC01238 (3421): -0.7731442677748748, Methylation_ARFGEF1: -0.1501969415484344, Methylation_MAPT: -0.1195113490103282, Methylation_ZFAT: -0.5484143629405792, Methylation_KCNQ4: -1.173288903746949, Methylation_chr1 232684368 SIPA1L2 (12934): -0.291413238792106, Methylation_CRNKL1: -0.3405649956001902, Methylation_PRKAG2: 0.3589346037407861, Methylation_MICB: -0.2751885538009826, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.0813371233888258, miRNA_hsa-mir-5695: 0.0725152833310708, miRNA_hsa-mir-18a: -0.4503457420124623, miRNA_hsa-mir-190b: 0.674329848109687, miRNA_hsa-mir-577: -0.3985865454906482, miRNA_hsa-mir-135b: -1.065713720282362, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.0476741729242929, miRNA_hsa-mir-130b: 0.9492696915182582, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-E2-A1II,"High-level Amplification absent; no CNV alterations meet amplification thresholds.  
FOXC1 mRNA overexpression (Z=3.32) occurs without underlying CNV gain.  
ESR1, GATA3, SPDEF, AGR3, and CA12 show significant mRNA downregulation (Z < -1.92).  
Promoter hypermethylation at LRRC6, LOC727677, C8orf38, and CRNKL1 (Z > 1.50); RNF130 and LOC340090 hypo-methylated (Z < -1.47).  
miR-18a, miR-577, and miR-135b upregulated (Z > 1.99); miR-190b downregulated (Z < -1.25).  
Collectively indicates luminal B-like phenotype with ER-pathway suppression.","mRNA_MLPH: -2.997850070851408, mRNA_C2orf54: -0.3727052230684894, mRNA_CITED4: -0.2940971474864462, mRNA_ESR1: -1.958612683334835, mRNA_SPDEF: -2.9738976163161466, mRNA_AGR3: -1.6061556351270694, mRNA_FOXC1: 3.319859920301949, mRNA_GATA3: -2.2644779095146346, mRNA_AGR2: -1.410816745991463, mRNA_XBP1: -2.1639014466890547, mRNA_PRR15: -2.0816727028158164, mRNA_SLC44A4: -2.019082448250167, mRNA_CA12: -2.8622682498090177, mRNA_DTL: 0.8987391454946208, mRNA_C5AR2: -1.471561719534331, mRNA_TBC1D9: -2.0590237504909874, mRNA_AR: -2.064145901149141, mRNA_CCDC170: -1.4304647446250849, mRNA_DEGS2: -2.251979879531439, mRNA_TFF3: -2.033855211923601, mRNA_DNALI1: -2.036964783038767, mRNA_LINC00504: -1.723887107739756, mRNA_CLCA2: -0.8950940779111158, mRNA_PPP1R14C: 1.2694230834103617, mRNA_THSD4: -2.130831531580992, mRNA_SPAG5: 0.4606723095566968, mRNA_FBP1: -1.7404736022628553, mRNA_SLC7A8: -1.8140911844503456, mRNA_EN1: -0.8632578516868187, mRNA_ZNF552: -1.6607808421202002, Methylation_LRRC6: 1.5235059545015222, Methylation_chr2 66218712 LINC02934 (29533): -0.1451229168066575, Methylation_HOXB13: 0.1686047974460979, Methylation_chr10 3949206 LINC02660 (4871): 1.08965262813943, Methylation_chr5 179517140 RNF130 (18026): -1.6303246522937076, Methylation_LOC727677: 1.504398482714043, Methylation_LETM1: 1.3149191703242835, Methylation_CDC42BPB: -0.0441896359967661, Methylation_C8orf38: 1.6335726886722013, Methylation_chr14 100504766 EVL (18852): 1.441796194730076, Methylation_chr5 72594851 LOC340090 (24088): -1.527368274005251, Methylation_chr2 242904738 LINC01238 (3421): 1.387741916916502, Methylation_ARFGEF1: 1.0398844155931732, Methylation_MAPT: 1.417235582062785, Methylation_ZFAT: 1.4210954132639064, Methylation_KCNQ4: 0.2944919329361287, Methylation_chr1 232684368 SIPA1L2 (12934): 1.1782252209405597, Methylation_CRNKL1: 1.463294691585251, Methylation_PRKAG2: -0.3016851395153145, Methylation_MICB: 1.4630394682801529, miRNA_hsa-mir-934: 1.6471169551350602, miRNA_hsa-mir-4728: -0.5875372527533901, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 2.128878151991909, miRNA_hsa-mir-190b: -2.052137242410604, miRNA_hsa-mir-577: 2.2243265550553235, miRNA_hsa-mir-135b: 1.664654556177821, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.4540273726778077, miRNA_hsa-mir-130b: 1.0988457545931172, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-LL-A6FP,"High-level Amplification absent; no CNVs meet amplification thresholds.  
mRNA_MLPH (Z=1.46), mRNA_SPDEF (Z=1.32), mRNA_AGR2 (Z=1.65), mRNA_PRR15 (Z=1.71), mRNA_SLC44A4 (Z=1.40), mRNA_DEGS2 (Z=1.33) are overexpressed.  
mRNA_SPAG5 (Z=−2.00) is downregulated.  
Methylation_ZFAT (Z=−1.96), Methylation_LETM1 (Z=−1.90), Methylation_CRNKL1 (Z=−1.76), Methylation_C8orf38 (Z=−1.61), Methylation_MAPT (Z=−1.53), Methylation_chr2 LINC01238 (Z=−1.52), Methylation_chr14 EVL (Z=−1.57) are hypomethylated.  
miRNA_hsa-mir-130b (Z=−2.49) is downregulated.  
Collectively indicate luminal phenotype with ER-pathway activity and potential immune modulation.","mRNA_MLPH: 1.4557775926071068, mRNA_C2orf54: -1.2589005968239784, mRNA_CITED4: -0.8379066882872773, mRNA_ESR1: 0.50838114473781, mRNA_SPDEF: 1.3156694184940156, mRNA_AGR3: 0.9108653601179972, mRNA_FOXC1: -1.2656180930542578, mRNA_GATA3: 0.6269751749090836, mRNA_AGR2: 1.6511658523884094, mRNA_XBP1: 0.4173409252543943, mRNA_PRR15: 1.7085541087512697, mRNA_SLC44A4: 1.3954717967973584, mRNA_CA12: -0.2113784592314683, mRNA_DTL: -1.3761256876029275, mRNA_C5AR2: -0.5406322730378166, mRNA_TBC1D9: 0.1910839041361076, mRNA_AR: -0.0196435493864131, mRNA_CCDC170: 0.2645583751244146, mRNA_DEGS2: 1.3303637167186493, mRNA_TFF3: 1.0545666548944004, mRNA_DNALI1: 0.7158570945302182, mRNA_LINC00504: 0.2378497377951405, mRNA_CLCA2: -0.786055842071411, mRNA_PPP1R14C: -0.7443674602647053, mRNA_THSD4: -0.8491990341901915, mRNA_SPAG5: -2.000922914008918, mRNA_FBP1: 1.1158938376550245, mRNA_SLC7A8: 0.3445255985110662, mRNA_EN1: -0.9444205118267796, mRNA_ZNF552: 0.6712159940698109, Methylation_LRRC6: -1.3379114092414226, Methylation_chr2 66218712 LINC02934 (29533): -1.879608564295524, Methylation_HOXB13: -0.8243575699968565, Methylation_chr10 3949206 LINC02660 (4871): -0.1594810984425935, Methylation_chr5 179517140 RNF130 (18026): 1.272238480048018, Methylation_LOC727677: -1.104858282076976, Methylation_LETM1: -1.90082139363377, Methylation_CDC42BPB: 0.3884461185490908, Methylation_C8orf38: -1.6094030809414313, Methylation_chr14 100504766 EVL (18852): -1.5748959425410962, Methylation_chr5 72594851 LOC340090 (24088): 1.2870216396204197, Methylation_chr2 242904738 LINC01238 (3421): -1.5189806336304787, Methylation_ARFGEF1: -1.3339475256033737, Methylation_MAPT: -1.530499491984884, Methylation_ZFAT: -1.9621790138055688, Methylation_KCNQ4: 1.4674212468129582, Methylation_chr1 232684368 SIPA1L2 (12934): -1.4576750039160316, Methylation_CRNKL1: -1.7583626063624358, Methylation_PRKAG2: -0.3885336596567163, Methylation_MICB: -1.3611063468830764, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.2280095506955439, miRNA_hsa-mir-5695: 0.1081947426297565, miRNA_hsa-mir-18a: -1.2487824204919191, miRNA_hsa-mir-190b: 0.9786922449519562, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: 0.4512513725819576, miRNA_hsa-mir-17: -0.8548527754263364, miRNA_hsa-mir-130b: -2.4860966207152213, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-B6-A1KC,"PRR15 and TBC1D9 mRNA overexpression (Z > 1.30). LETM1, ZFAT, CRNKL1, and MICB promoter hypermethylation (Z < -1.47) suggests epigenetic silencing. No significant CNVs or miRNA alterations meet diagnostic thresholds. Collectively indicates luminal breast cancer phenotype with ER pathway activity.","mRNA_MLPH: -0.2043146052895106, mRNA_C2orf54: -1.2463301432637324, mRNA_CITED4: -1.5228388807028042, mRNA_ESR1: 0.4232824133797866, mRNA_SPDEF: -0.179217843400629, mRNA_AGR3: 0.2706110248174799, mRNA_FOXC1: -1.2566614738891606, mRNA_GATA3: 0.9971519782099244, mRNA_AGR2: 0.1162853641339214, mRNA_XBP1: 1.1275990624990715, mRNA_PRR15: 1.3774055330030217, mRNA_SLC44A4: 0.2350920580065185, mRNA_CA12: 0.3452771798852121, mRNA_DTL: 0.130259587245212, mRNA_C5AR2: -0.0611186159611715, mRNA_TBC1D9: 1.3289662867286174, mRNA_AR: 0.3610301762421464, mRNA_CCDC170: -0.2465565629942707, mRNA_DEGS2: -0.0431812000757766, mRNA_TFF3: -0.2833901207610975, mRNA_DNALI1: 0.8020575058755357, mRNA_LINC00504: 1.103979196915669, mRNA_CLCA2: -0.8890393515007246, mRNA_PPP1R14C: -1.1360263731158389, mRNA_THSD4: 0.4472081141880462, mRNA_SPAG5: -0.1119222014898684, mRNA_FBP1: 0.5817160264432605, mRNA_SLC7A8: 0.0115705100174988, mRNA_EN1: -0.981481132621136, mRNA_ZNF552: 0.5371818042904203, Methylation_LRRC6: -1.2149558397916589, Methylation_chr2 66218712 LINC02934 (29533): -0.0093845695731983, Methylation_HOXB13: -0.8684256974594146, Methylation_chr10 3949206 LINC02660 (4871): -1.315030998691651, Methylation_chr5 179517140 RNF130 (18026): 0.6485794881961926, Methylation_LOC727677: -1.315106359793985, Methylation_LETM1: -1.5706912274329077, Methylation_CDC42BPB: 0.7074400050363704, Methylation_C8orf38: -0.780726845694118, Methylation_chr14 100504766 EVL (18852): -1.4272319419373705, Methylation_chr5 72594851 LOC340090 (24088): 1.283266250665755, Methylation_chr2 242904738 LINC01238 (3421): -1.175340919192697, Methylation_ARFGEF1: -1.117983743420452, Methylation_MAPT: -0.9572856042611024, Methylation_ZFAT: -1.672021970007753, Methylation_KCNQ4: 1.6547061245579482, Methylation_chr1 232684368 SIPA1L2 (12934): -1.46570496262599, Methylation_CRNKL1: -1.64363197633066, Methylation_PRKAG2: -0.3296511126307699, Methylation_MICB: -1.6595249824852825, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.3566741287036721, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.2324758125127309, miRNA_hsa-mir-190b: 0.1410444807673484, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.5873485870215203, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.9649662912416838, miRNA_hsa-mir-130b: -0.8602015701629123, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-EW-A2FW,"Deletion of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 correlates with transcriptional downregulation.  
mRNA_CITED4 is low (Z = -1.91), near threshold for downregulation.  
mRNA_XBP1 (Z = 1.32), mRNA_SPAG5 (Z = 1.89), and mRNA_DTL (Z = 1.63) are high.  
Methylation_LETM1, PRKAG2, MICB, and chr5:72594851 are hypermethylated (Z < -1.47).  
miRNA_hsa-mir-190b is upregulated (Z = 1.92).","mRNA_MLPH: 0.6641618864825598, mRNA_C2orf54: 0.1234095179055442, mRNA_CITED4: -1.9138106287409924, mRNA_ESR1: 0.9371929599996756, mRNA_SPDEF: 0.8956537019954828, mRNA_AGR3: 0.6669070506782417, mRNA_FOXC1: -0.6898891256766125, mRNA_GATA3: 1.258849058774468, mRNA_AGR2: 0.3221036458643228, mRNA_XBP1: 1.3170688068310623, mRNA_PRR15: 1.0573432815745976, mRNA_SLC44A4: 0.1196695873897212, mRNA_CA12: -0.0464684749420633, mRNA_DTL: 1.6276387621048665, mRNA_C5AR2: 1.56574029739961, mRNA_TBC1D9: 0.834554108722515, mRNA_AR: 0.2752301656076986, mRNA_CCDC170: 0.6515158100770981, mRNA_DEGS2: 0.2694119749465943, mRNA_TFF3: 0.8805026992792544, mRNA_DNALI1: 0.5532352901334234, mRNA_LINC00504: 1.347048045666704, mRNA_CLCA2: -0.8746890489639485, mRNA_PPP1R14C: -0.9757364775448892, mRNA_THSD4: 1.37327023818751, mRNA_SPAG5: 1.88607789354246, mRNA_FBP1: 1.2302601195314826, mRNA_SLC7A8: -0.3040785197206647, mRNA_EN1: -0.3073456983782826, mRNA_ZNF552: 1.0468609081281453, Methylation_LRRC6: -1.415600950022066, Methylation_chr2 66218712 LINC02934 (29533): 1.0955930061150132, Methylation_HOXB13: -1.0931659672625982, Methylation_chr10 3949206 LINC02660 (4871): 0.1042436250098816, Methylation_chr5 179517140 RNF130 (18026): 1.214951864580893, Methylation_LOC727677: -1.1492368334048504, Methylation_LETM1: -1.4707043272641531, Methylation_CDC42BPB: 1.3935385850878608, Methylation_C8orf38: -1.214902405949693, Methylation_chr14 100504766 EVL (18852): -1.3891096421375415, Methylation_chr5 72594851 LOC340090 (24088): -1.5177568783887847, Methylation_chr2 242904738 LINC01238 (3421): -1.197924857434119, Methylation_ARFGEF1: -1.0751960811917851, Methylation_MAPT: -1.32401077017081, Methylation_ZFAT: -0.9785311648689028, Methylation_KCNQ4: -0.7234413339764113, Methylation_chr1 232684368 SIPA1L2 (12934): -1.1967248894728797, Methylation_CRNKL1: -1.410080280136621, Methylation_PRKAG2: -1.4714977706734778, Methylation_MICB: -1.5058497427107904, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.2013011593416149, miRNA_hsa-mir-5695: 1.0415310498290011, miRNA_hsa-mir-18a: -0.181961608803577, miRNA_hsa-mir-190b: 1.9200988414421616, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.1484651744886445, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.1283801595280798, miRNA_hsa-mir-130b: 0.489375863584185, CNV_VPS54: -1.6173912818721974, CNV_LINC01867: -1.63714039509435, CNV_LINC02576: -1.657048777669473, CNV_WDPCP: -1.6249341592372952, CNV_CEP68: -1.657048777669473"
TCGA-C8-A1HO,High mRNA_GATA3 (Z=1.45) and mRNA_TBC1D9 (Z=1.45) indicate luminal transcriptional activity. Methylation_HOXB13 (Z=1.67) and Methylation_KCNQ4 (Z=1.78) are hypermethylated. miRNA_hsa-mir-5695 is upregulated (Z=2.48). No significant CNVs meet amplification/deletion thresholds. These features collectively indicate a luminal phenotype with HOX pathway epigenetic dysregulation.,"mRNA_MLPH: 0.4922309594056507, mRNA_C2orf54: -0.2210545306458842, mRNA_CITED4: -0.5687910091187706, mRNA_ESR1: 0.5875073575430952, mRNA_SPDEF: 0.5557483642654899, mRNA_AGR3: 0.2196342084261099, mRNA_FOXC1: -0.2128562389029885, mRNA_GATA3: 1.4529290940714237, mRNA_AGR2: -0.1652976888212462, mRNA_XBP1: 0.7710538406811608, mRNA_PRR15: 0.835136098340122, mRNA_SLC44A4: 0.791283087588811, mRNA_CA12: 0.806724378771879, mRNA_DTL: 0.9463494283158403, mRNA_C5AR2: 0.9173149738941456, mRNA_TBC1D9: 1.4491123584640488, mRNA_AR: -1.2887210355691516, mRNA_CCDC170: 0.6068245606078442, mRNA_DEGS2: -0.3851697296855666, mRNA_TFF3: 0.7388893003383413, mRNA_DNALI1: 1.2960249125937326, mRNA_LINC00504: 1.1410297498761184, mRNA_CLCA2: -0.8707461897053996, mRNA_PPP1R14C: -1.1445940308945224, mRNA_THSD4: 1.2331941631378331, mRNA_SPAG5: 0.608530445243308, mRNA_FBP1: 0.8156910857988898, mRNA_SLC7A8: 1.0352716492505758, mRNA_EN1: -0.8010368627257951, mRNA_ZNF552: 0.4040594105251438, Methylation_LRRC6: -1.418967800083979, Methylation_chr2 66218712 LINC02934 (29533): 1.372662382587655, Methylation_HOXB13: 1.6720294358620955, Methylation_chr10 3949206 LINC02660 (4871): -1.1502937631033257, Methylation_chr5 179517140 RNF130 (18026): 1.1840876004905958, Methylation_LOC727677: -0.2272191436497867, Methylation_LETM1: -1.7604352052256649, Methylation_CDC42BPB: 1.3095277292864125, Methylation_C8orf38: -0.2633237870176408, Methylation_chr14 100504766 EVL (18852): -1.3903697550270042, Methylation_chr5 72594851 LOC340090 (24088): 1.2083391888480606, Methylation_chr2 242904738 LINC01238 (3421): -0.2458792513927099, Methylation_ARFGEF1: -1.1418056575457818, Methylation_MAPT: -0.9329164652558236, Methylation_ZFAT: -1.5514426472712106, Methylation_KCNQ4: 1.783582192092656, Methylation_chr1 232684368 SIPA1L2 (12934): -1.3362271501923724, Methylation_CRNKL1: -1.4108871728994896, Methylation_PRKAG2: -1.6979396015963693, Methylation_MICB: -1.6461101605648465, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.0493542801382406, miRNA_hsa-mir-5695: 2.4842892142058712, miRNA_hsa-mir-18a: 0.7761452466904551, miRNA_hsa-mir-190b: 1.1453455194965272, miRNA_hsa-mir-577: -0.0823024596075973, miRNA_hsa-mir-135b: 0.8064312732256516, miRNA_hsa-mir-2115: -0.2857061174070084, miRNA_hsa-mir-17: 1.0106018095469906, miRNA_hsa-mir-130b: 0.6157331051146686, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-C8-A1HI,"High mRNA_AGR2 (Z=1.50) and mRNA_TFF3 (Z=1.39) indicate luminal overexpression. No methylation or miRNA alterations meet diagnostic thresholds. CNV gains in VPS54, WDPCP, CEP68, and LINC01867/LINC02576 suggest broad 1q gain. These features collectively indicate a luminal A phenotype with ER-pathway activation.","mRNA_MLPH: 0.467422813601034, mRNA_C2orf54: -0.5314851492308973, mRNA_CITED4: 0.1165921141162433, mRNA_ESR1: 0.2500118734699233, mRNA_SPDEF: 0.5870741088837478, mRNA_AGR3: 0.8763637997083049, mRNA_FOXC1: 0.0642488604423401, mRNA_GATA3: 0.563183354779127, mRNA_AGR2: 1.5023825949966891, mRNA_XBP1: 0.5663237983301639, mRNA_PRR15: 0.4430040905522318, mRNA_SLC44A4: -0.1762238565533857, mRNA_CA12: 0.705812644914961, mRNA_DTL: -0.3268801436119679, mRNA_C5AR2: 0.5647019363898741, mRNA_TBC1D9: 0.5669126988563663, mRNA_AR: -0.2757899429791088, mRNA_CCDC170: 0.4529008026259087, mRNA_DEGS2: -0.1684833105635119, mRNA_TFF3: 1.3919298983279669, mRNA_DNALI1: 0.6194665682077796, mRNA_LINC00504: 0.8565823225347067, mRNA_CLCA2: 0.43670742611573, mRNA_PPP1R14C: 0.7082267990852326, mRNA_THSD4: 0.5605300335480174, mRNA_SPAG5: -0.2740861777291454, mRNA_FBP1: 0.7231769692605781, mRNA_SLC7A8: 0.7402263200088326, mRNA_EN1: -0.7651477470020223, mRNA_ZNF552: 1.3571942584485872, Methylation_LRRC6: -0.0828688248085408, Methylation_chr2 66218712 LINC02934 (29533): 0.7781824234899959, Methylation_HOXB13: -0.9289999341450446, Methylation_chr10 3949206 LINC02660 (4871): 0.0098242650005604, Methylation_chr5 179517140 RNF130 (18026): -0.0240554941476479, Methylation_LOC727677: -0.1391060105196721, Methylation_LETM1: -0.3536532076885671, Methylation_CDC42BPB: -0.5978636847743473, Methylation_C8orf38: -0.4865994657302868, Methylation_chr14 100504766 EVL (18852): -0.1085876342132342, Methylation_chr5 72594851 LOC340090 (24088): 0.3506300851845585, Methylation_chr2 242904738 LINC01238 (3421): 0.1976077370717848, Methylation_ARFGEF1: -0.1612318148157126, Methylation_MAPT: 0.827066778561617, Methylation_ZFAT: -0.3002631990368847, Methylation_KCNQ4: -1.073711035104539, Methylation_chr1 232684368 SIPA1L2 (12934): -0.1690561570356064, Methylation_CRNKL1: 0.243668341485254, Methylation_PRKAG2: -0.2333463766110841, Methylation_MICB: -0.0290805187101954, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.2060693493230641, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.8998195159578674, miRNA_hsa-mir-190b: 0.7124150896626218, miRNA_hsa-mir-577: 0.1335640425776924, miRNA_hsa-mir-135b: 0.4770623023871088, miRNA_hsa-mir-2115: -0.2722174774818475, miRNA_hsa-mir-17: -1.273572377310885, miRNA_hsa-mir-130b: -0.6534982315412544, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-C8-A274,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. Promoter hypermethylation of HOXB13, CDC42BPB, and KCNQ4 mediates epigenetic silencing. Hypomethylation of RNF130, LINC01238, SIPA1L2, PRKAG2, MAPT, and CRNKL1 correlates with transcriptional dysregulation. Downregulated miR-18a and miR-17 suggest loss of post-transcriptional repression. These features indicate a luminal B phenotype with PI3K/AKT pathway activation.","mRNA_MLPH: 0.6252324446993931, mRNA_C2orf54: -0.2485760022288364, mRNA_CITED4: -0.0250127861289906, mRNA_ESR1: 1.004957156612155, mRNA_SPDEF: 0.4245037157483261, mRNA_AGR3: 0.4351191647350441, mRNA_FOXC1: -1.5215855202227695, mRNA_GATA3: 0.3874813264224888, mRNA_AGR2: 0.6257164395606855, mRNA_XBP1: 0.64084074669203, mRNA_PRR15: 0.3213359086458352, mRNA_SLC44A4: 0.5038701084866256, mRNA_CA12: 0.5814500959441417, mRNA_DTL: 0.76516048658899, mRNA_C5AR2: 1.4250661999323442, mRNA_TBC1D9: 0.2366067183095325, mRNA_AR: 0.9976558580889412, mRNA_CCDC170: 0.47224359679527, mRNA_DEGS2: 0.3021580660041756, mRNA_TFF3: 0.6427071283138103, mRNA_DNALI1: 0.3913731238659131, mRNA_LINC00504: 0.5834112853133836, mRNA_CLCA2: 1.2414091912166343, mRNA_PPP1R14C: -1.059242953855004, mRNA_THSD4: 0.6042675383620341, mRNA_SPAG5: 0.3534185374276656, mRNA_FBP1: 0.1566883963820862, mRNA_SLC7A8: 0.7221368889713334, mRNA_EN1: -0.4207181150489267, mRNA_ZNF552: 1.188675585616188, Methylation_LRRC6: -1.1195612944071405, Methylation_chr2 66218712 LINC02934 (29533): 0.9221084452831289, Methylation_HOXB13: 1.3323803894261028, Methylation_chr10 3949206 LINC02660 (4871): 0.9922610704288782, Methylation_chr5 179517140 RNF130 (18026): -1.5038024664730427, Methylation_LOC727677: -0.7179615598774831, Methylation_LETM1: 0.4917989781295506, Methylation_CDC42BPB: 1.2200421804533066, Methylation_C8orf38: -1.2474371877327155, Methylation_chr14 100504766 EVL (18852): -1.39731422863092, Methylation_chr5 72594851 LOC340090 (24088): 0.387025034983441, Methylation_chr2 242904738 LINC01238 (3421): -1.5181306975543587, Methylation_ARFGEF1: -1.1279845546991802, Methylation_MAPT: -1.4936678772457992, Methylation_ZFAT: -0.7843061119801142, Methylation_KCNQ4: 1.2880365224772543, Methylation_chr1 232684368 SIPA1L2 (12934): -1.5870342701579, Methylation_CRNKL1: -1.4518891017790674, Methylation_PRKAG2: -1.574774699305287, Methylation_MICB: -1.4202768525104152, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.4223668757829317, miRNA_hsa-mir-5695: -0.1357715936244537, miRNA_hsa-mir-18a: -1.4684572303148735, miRNA_hsa-mir-190b: 0.3086136102631262, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: 0.0943035934667047, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.3485574704150305, miRNA_hsa-mir-130b: -0.8183285144332781, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-E9-A1R4,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations.","mRNA_MLPH: 0.5921940297000463, mRNA_C2orf54: 0.9741730797052516, mRNA_CITED4: 0.6480266369481298, mRNA_ESR1: 0.5256114428137612, mRNA_SPDEF: 0.3551547928976059, mRNA_AGR3: 0.5218018733830877, mRNA_FOXC1: -0.8743622499590419, mRNA_GATA3: 0.3846548413420648, mRNA_AGR2: 0.7175698154125298, mRNA_XBP1: -0.5290977977907279, mRNA_PRR15: 0.477322167704497, mRNA_SLC44A4: 0.6821212074116288, mRNA_CA12: 0.6818141380106477, mRNA_DTL: -0.0514439187621776, mRNA_C5AR2: 1.093896955777541, mRNA_TBC1D9: 0.2773015082528184, mRNA_AR: -0.7462431535935227, mRNA_CCDC170: 0.3234875750501492, mRNA_DEGS2: 0.3472083846928526, mRNA_TFF3: -0.1206906953105136, mRNA_DNALI1: 0.8133813788947134, mRNA_LINC00504: 0.3627753276577833, mRNA_CLCA2: -0.1948318707370645, mRNA_PPP1R14C: -0.8392684996718499, mRNA_THSD4: 0.3934993577848019, mRNA_SPAG5: 0.5209664011356432, mRNA_FBP1: 1.1186144687178998, mRNA_SLC7A8: 0.5511596482286194, mRNA_EN1: -0.8226592648063888, mRNA_ZNF552: 0.3146958334163496, Methylation_LRRC6: -0.2853053517685219, Methylation_chr2 66218712 LINC02934 (29533): 0.318790997880341, Methylation_HOXB13: -0.2917509150638695, Methylation_chr10 3949206 LINC02660 (4871): -0.1221288363388223, Methylation_chr5 179517140 RNF130 (18026): 0.0416135771621457, Methylation_LOC727677: -0.2439100437692321, Methylation_LETM1: -0.2959819892570821, Methylation_CDC42BPB: 0.6962919061683212, Methylation_C8orf38: -0.5598142676907282, Methylation_chr14 100504766 EVL (18852): 0.708288716990915, Methylation_chr5 72594851 LOC340090 (24088): 0.5437899810094099, Methylation_chr2 242904738 LINC01238 (3421): 1.3447688004559142, Methylation_ARFGEF1: 0.7238752359061348, Methylation_MAPT: 0.16161150932481, Methylation_ZFAT: -0.8757893376452413, Methylation_KCNQ4: -0.8193985791192813, Methylation_chr1 232684368 SIPA1L2 (12934): 0.6716013499978777, Methylation_CRNKL1: 0.1089830626220031, Methylation_PRKAG2: 0.2253963680523822, Methylation_MICB: -0.5499214169104348, miRNA_hsa-mir-934: -0.171586974298102, miRNA_hsa-mir-4728: 0.2327282693121879, miRNA_hsa-mir-5695: 0.4087871878013043, miRNA_hsa-mir-18a: -0.3779650158293586, miRNA_hsa-mir-190b: 0.8493865857337138, miRNA_hsa-mir-577: -0.2715904827002924, miRNA_hsa-mir-135b: -0.4927276929529637, miRNA_hsa-mir-2115: -0.2010018191639214, miRNA_hsa-mir-17: -0.1218395967041455, miRNA_hsa-mir-130b: -0.0211421934332605, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-A7-A4SB,High mRNA_AGR2 (Z=1.63) and mRNA_TFF3 (Z=1.61) indicate luminal overexpression. No methylation sites meet hyper/hypo thresholds. miRNA_hsa-mir-135b upregulated (Z=1.58). All CNVs fall within normal/gain ranges; no deletions or amplifications. Collectively suggests luminal A phenotype with ER-pathway activation.,"mRNA_MLPH: 1.2836983746747606, mRNA_C2orf54: -1.158160184745738, mRNA_CITED4: -0.0191091661454275, mRNA_ESR1: 0.1403077584967771, mRNA_SPDEF: 0.7966845956495374, mRNA_AGR3: 0.3198160324627654, mRNA_FOXC1: -0.0194052180081813, mRNA_GATA3: 0.5085264616461449, mRNA_AGR2: 1.6316804752924046, mRNA_XBP1: 0.3671930696171408, mRNA_PRR15: 0.4941074246908218, mRNA_SLC44A4: 0.3563333620857846, mRNA_CA12: 0.70516590969682, mRNA_DTL: 0.0539238911334874, mRNA_C5AR2: -0.4942114783733604, mRNA_TBC1D9: 0.7690490564902158, mRNA_AR: 0.3294630307216591, mRNA_CCDC170: -0.3377527676902181, mRNA_DEGS2: 0.2318388292080586, mRNA_TFF3: 1.6055286350534024, mRNA_DNALI1: 0.52465154644588, mRNA_LINC00504: 0.8607448190151388, mRNA_CLCA2: -0.6105927014472708, mRNA_PPP1R14C: -0.7038249550193912, mRNA_THSD4: 1.0382547814738965, mRNA_SPAG5: 0.5260186552452345, mRNA_FBP1: 0.0096762643066017, mRNA_SLC7A8: 0.6997841983758837, mRNA_EN1: -0.872194550771809, mRNA_ZNF552: 0.1653762985763529, Methylation_LRRC6: -0.9942572619442904, Methylation_chr2 66218712 LINC02934 (29533): 0.6652084279238683, Methylation_HOXB13: -1.00372430992066, Methylation_chr10 3949206 LINC02660 (4871): -0.8438898129649204, Methylation_chr5 179517140 RNF130 (18026): 0.6412278548122493, Methylation_LOC727677: -0.9104398126212828, Methylation_LETM1: -1.3437433118440834, Methylation_CDC42BPB: -0.7447386115403027, Methylation_C8orf38: -0.8225333466919511, Methylation_chr14 100504766 EVL (18852): -0.8144555234213193, Methylation_chr5 72594851 LOC340090 (24088): 1.0148462655143444, Methylation_chr2 242904738 LINC01238 (3421): 1.128057362784064, Methylation_ARFGEF1: -0.8482046908669297, Methylation_MAPT: -1.4673457409748454, Methylation_ZFAT: -0.8905054349686685, Methylation_KCNQ4: -1.136779271700462, Methylation_chr1 232684368 SIPA1L2 (12934): -1.2348987871154995, Methylation_CRNKL1: -1.4472117579938288, Methylation_PRKAG2: 1.2742860249411878, Methylation_MICB: -1.279196266280602, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.1806694896329452, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.9422913471834896, miRNA_hsa-mir-190b: -0.0158895481911337, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: 1.581860161862192, miRNA_hsa-mir-2115: -0.1304816315014535, miRNA_hsa-mir-17: -0.5954198678408592, miRNA_hsa-mir-130b: -0.93875235684242, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A1XV,"mRNA_CITED4 is significantly downregulated (Z = -2.96). No mRNA meets high-expression threshold. Multiple methylation sites are hypomethylated (e.g., MAPT, PRKAG2, chr1:232684368), but none hypermethylated. No miRNA passes up/downregulation thresholds. All CNVs fall within normal range (−1.10 to −0.10). No genomic drivers identified.","mRNA_MLPH: -0.0597066676725569, mRNA_C2orf54: -1.280960202421074, mRNA_CITED4: -2.96127608359216, mRNA_ESR1: 1.043333455087362, mRNA_SPDEF: -0.4930759580404231, mRNA_AGR3: 0.5305409001579475, mRNA_FOXC1: -1.3564107135543348, mRNA_GATA3: -0.0854040862669088, mRNA_AGR2: 0.6268699973113843, mRNA_XBP1: 0.829749469976568, mRNA_PRR15: -0.1352565339469528, mRNA_SLC44A4: 0.5106067669648032, mRNA_CA12: -0.0591184313818187, mRNA_DTL: -0.343248954833418, mRNA_C5AR2: 0.2596388309882596, mRNA_TBC1D9: -0.1718738210377697, mRNA_AR: 0.5356241605909593, mRNA_CCDC170: 1.3061112304329645, mRNA_DEGS2: -0.684944888666757, mRNA_TFF3: 0.3283477622426653, mRNA_DNALI1: 0.3386534801327426, mRNA_LINC00504: 0.0153872334505218, mRNA_CLCA2: -0.8029019930944283, mRNA_PPP1R14C: -0.995221732020178, mRNA_THSD4: 0.6909664165371022, mRNA_SPAG5: -0.9509955338092756, mRNA_FBP1: -0.5573828462453466, mRNA_SLC7A8: -0.0372221642594552, mRNA_EN1: -1.1136059489516947, mRNA_ZNF552: -0.6227524255237207, Methylation_LRRC6: -1.3863509104194072, Methylation_chr2 66218712 LINC02934 (29533): -1.7393432444099264, Methylation_HOXB13: -1.09672845445961, Methylation_chr10 3949206 LINC02660 (4871): -0.8092265863151232, Methylation_chr5 179517140 RNF130 (18026): -1.3751725902614111, Methylation_LOC727677: -1.3122426281076371, Methylation_LETM1: -1.405717928664434, Methylation_CDC42BPB: -1.4562823495273542, Methylation_C8orf38: -1.53242666231098, Methylation_chr14 100504766 EVL (18852): -1.4350414603276898, Methylation_chr5 72594851 LOC340090 (24088): 1.003341012391077, Methylation_chr2 242904738 LINC01238 (3421): -1.341810687522412, Methylation_ARFGEF1: -1.07461209841751, Methylation_MAPT: -1.5960670837765578, Methylation_ZFAT: 1.3719186915898294, Methylation_KCNQ4: -0.2764136764009978, Methylation_chr1 232684368 SIPA1L2 (12934): -1.6265576253665404, Methylation_CRNKL1: -1.6044153313556926, Methylation_PRKAG2: -1.8000831541580586, Methylation_MICB: -0.522461239520043, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.3039055289419291, miRNA_hsa-mir-5695: 0.3927075251665716, miRNA_hsa-mir-18a: -0.4744830168321799, miRNA_hsa-mir-190b: 1.4928153573812943, miRNA_hsa-mir-577: -0.3721938620831644, miRNA_hsa-mir-135b: 1.0875862139307284, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.0175244898963093, miRNA_hsa-mir-130b: -0.2361003569079574, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E2-A1LI,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. FOXC1, PPP1R14C, and EN1 show significant mRNA upregulation (Z > 1.30). AGR2, AR, FBP1, and SLC44A4 are strongly downregulated (Z < -1.92). Promoter hypermethylation at ARFGEF1, SIPA1L2, and C8orf38 (Z > 1.50) suggests epigenetic silencing. Hypomethylation at RNF130 (Z < -1.47) may activate oncogenic pathways. miR-934, miR-18a, miR-577, and miR-130b are upregulated (Z > 1.99), implicating post-transcriptional repression of tumor suppressors.","mRNA_MLPH: -2.129904222361972, mRNA_C2orf54: -0.3923318061059116, mRNA_CITED4: -0.1964724359396406, mRNA_ESR1: -1.735505740122942, mRNA_SPDEF: -1.1781661151656753, mRNA_AGR3: -1.808715431685888, mRNA_FOXC1: 2.3643955283116536, mRNA_GATA3: -1.8140439961213148, mRNA_AGR2: -2.204676889229075, mRNA_XBP1: -1.4700132880530548, mRNA_PRR15: -1.9801917927626784, mRNA_SLC44A4: -2.2591087868313893, mRNA_CA12: -2.243757849072176, mRNA_DTL: 1.0448772640381827, mRNA_C5AR2: -1.8462415765539044, mRNA_TBC1D9: -2.1511774850378043, mRNA_AR: -2.28458244408164, mRNA_CCDC170: -1.7922045498693857, mRNA_DEGS2: -1.8588871136460965, mRNA_TFF3: -1.8333294622812308, mRNA_DNALI1: -1.9084276075590405, mRNA_LINC00504: -1.6601319514014663, mRNA_CLCA2: -0.8642047357449185, mRNA_PPP1R14C: 2.965469436757468, mRNA_THSD4: -2.0099544520495853, mRNA_SPAG5: 0.0824453210932387, mRNA_FBP1: -2.458362181939009, mRNA_SLC7A8: -1.7148816293517457, mRNA_EN1: 2.6979191071830937, mRNA_ZNF552: -1.4947163514038715, Methylation_LRRC6: 1.484900645408953, Methylation_chr2 66218712 LINC02934 (29533): -0.0391941250741132, Methylation_HOXB13: 0.3147984475272972, Methylation_chr10 3949206 LINC02660 (4871): 1.5968245869720603, Methylation_chr5 179517140 RNF130 (18026): -1.56937219075655, Methylation_LOC727677: 1.452921281233991, Methylation_LETM1: 1.318526385760764, Methylation_CDC42BPB: -0.5473907572081174, Methylation_C8orf38: 1.5477174018199815, Methylation_chr14 100504766 EVL (18852): 1.4788321215307896, Methylation_chr5 72594851 LOC340090 (24088): -1.4656113080716189, Methylation_chr2 242904738 LINC01238 (3421): 1.420383568412564, Methylation_ARFGEF1: 1.6267184101171226, Methylation_MAPT: 1.4743808511598375, Methylation_ZFAT: 1.394139698054627, Methylation_KCNQ4: 0.1109732028921296, Methylation_chr1 232684368 SIPA1L2 (12934): 1.6015901078861516, Methylation_CRNKL1: 1.4124261000019225, Methylation_PRKAG2: 0.5970826157148469, Methylation_MICB: 1.538612680253066, miRNA_hsa-mir-934: 3.2081476672032854, miRNA_hsa-mir-4728: 0.1991373086829178, miRNA_hsa-mir-5695: 0.8139775511876427, miRNA_hsa-mir-18a: 2.982661002980012, miRNA_hsa-mir-190b: -0.9725776887195808, miRNA_hsa-mir-577: 2.457732918723486, miRNA_hsa-mir-135b: 1.9465756797821223, miRNA_hsa-mir-2115: -0.5298097106930267, miRNA_hsa-mir-17: 1.92754196841536, miRNA_hsa-mir-130b: 2.2433698491190475, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-D8-A1XR,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-significant ranges per specified Z-score and CNV cutoffs.","mRNA_MLPH: 0.6120826715911746, mRNA_C2orf54: -0.8109646100514689, mRNA_CITED4: 0.0967126124613449, mRNA_ESR1: 0.6251655429777155, mRNA_SPDEF: 0.5000103183509436, mRNA_AGR3: 1.1477746522253136, mRNA_FOXC1: -0.9567958798531055, mRNA_GATA3: 0.6613147827565473, mRNA_AGR2: 0.9824585859906156, mRNA_XBP1: 1.1556122735000969, mRNA_PRR15: 1.487864381655528, mRNA_SLC44A4: 1.14413622283488, mRNA_CA12: 0.3992125474162127, mRNA_DTL: 0.496958023342211, mRNA_C5AR2: 1.175808660017001, mRNA_TBC1D9: 0.231461722756586, mRNA_AR: 0.8295026842361745, mRNA_CCDC170: 1.2100938795124665, mRNA_DEGS2: 0.4598447628200093, mRNA_TFF3: 0.6419985036321564, mRNA_DNALI1: 0.4971137511278693, mRNA_LINC00504: 0.4587541473241227, mRNA_CLCA2: -0.7801207004435822, mRNA_PPP1R14C: -0.8841426766673242, mRNA_THSD4: 0.9100982035310936, mRNA_SPAG5: 0.4431839375492929, mRNA_FBP1: 0.4840651891985148, mRNA_SLC7A8: 0.4729573659536459, mRNA_EN1: -0.2156198618446889, mRNA_ZNF552: 1.352602396629082, Methylation_LRRC6: -1.2359487790802908, Methylation_chr2 66218712 LINC02934 (29533): 1.224603911914682, Methylation_HOXB13: -1.0823302090376254, Methylation_chr10 3949206 LINC02660 (4871): -1.3171869965112255, Methylation_chr5 179517140 RNF130 (18026): 0.5602263042292175, Methylation_LOC727677: -1.238541540355719, Methylation_LETM1: -0.4541098292654462, Methylation_CDC42BPB: -1.4284670718002463, Methylation_C8orf38: -1.525609913232058, Methylation_chr14 100504766 EVL (18852): -1.421830822308643, Methylation_chr5 72594851 LOC340090 (24088): 0.5446047971389504, Methylation_chr2 242904738 LINC01238 (3421): -1.234738407266487, Methylation_ARFGEF1: -1.1206331372651486, Methylation_MAPT: -0.9736532095024042, Methylation_ZFAT: -1.1642897710878592, Methylation_KCNQ4: -0.0454756076268863, Methylation_chr1 232684368 SIPA1L2 (12934): -1.6293311396837065, Methylation_CRNKL1: -1.7655385602341385, Methylation_PRKAG2: -1.3498398360821455, Methylation_MICB: -1.4570715744946174, miRNA_hsa-mir-934: -0.3582873337230614, miRNA_hsa-mir-4728: -0.9488444958194344, miRNA_hsa-mir-5695: 1.4277359997490875, miRNA_hsa-mir-18a: 0.2680176065728624, miRNA_hsa-mir-190b: 1.3100823661683667, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -1.049917642105029, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.3216648469969128, miRNA_hsa-mir-130b: 0.9512124204706012, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AO-A03N,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: -0.3821255865727865, mRNA_C2orf54: 0.2413668086903163, mRNA_CITED4: -0.4280419575116811, mRNA_ESR1: -0.3579374013596363, mRNA_SPDEF: 0.0913036880370495, mRNA_AGR3: 0.558567591006458, mRNA_FOXC1: -0.885340964731852, mRNA_GATA3: 0.2129500655186181, mRNA_AGR2: 0.5691373823199664, mRNA_XBP1: -1.2991315010527782, mRNA_PRR15: 0.5882639393491916, mRNA_SLC44A4: 0.5558000672023496, mRNA_CA12: -0.5981173826478832, mRNA_DTL: -0.2400263884511137, mRNA_C5AR2: -1.196414087057574, mRNA_TBC1D9: -1.5920425953691817, mRNA_AR: 0.6213560572922449, mRNA_CCDC170: -0.6174442200991427, mRNA_DEGS2: -0.5843015597030168, mRNA_TFF3: 0.713510769693524, mRNA_DNALI1: -0.0151617205870266, mRNA_LINC00504: -0.9640068596755124, mRNA_CLCA2: 0.3613936356649167, mRNA_PPP1R14C: -0.8437105643287635, mRNA_THSD4: -1.3211677235467738, mRNA_SPAG5: -1.0921396558148735, mRNA_FBP1: -0.6651422417805123, mRNA_SLC7A8: -0.1395907122698356, mRNA_EN1: 0.0667802082496923, mRNA_ZNF552: -0.9798337156326136, Methylation_LRRC6: -0.6735921166161434, Methylation_chr2 66218712 LINC02934 (29533): 1.261850013466923, Methylation_HOXB13: 1.846766493254916, Methylation_chr10 3949206 LINC02660 (4871): -0.948450665560548, Methylation_chr5 179517140 RNF130 (18026): -0.3098331581262141, Methylation_LOC727677: -0.6152886900093726, Methylation_LETM1: -0.0528936993380446, Methylation_CDC42BPB: -0.7890189576671311, Methylation_C8orf38: -0.6901879198176045, Methylation_chr14 100504766 EVL (18852): -1.171120790162513, Methylation_chr5 72594851 LOC340090 (24088): -1.6090703466147482, Methylation_chr2 242904738 LINC01238 (3421): -0.5153365169629771, Methylation_ARFGEF1: -0.4119784944906815, Methylation_MAPT: -0.0994816170340277, Methylation_ZFAT: -0.6474836851439187, Methylation_KCNQ4: 0.4483598094305434, Methylation_chr1 232684368 SIPA1L2 (12934): -1.081192225268352, Methylation_CRNKL1: -0.4293043029939272, Methylation_PRKAG2: -1.3985867698875474, Methylation_MICB: -0.9919160479474484, miRNA_hsa-mir-934: -0.0848724296944708, miRNA_hsa-mir-4728: 0.1962394297949918, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.4974425771223047, miRNA_hsa-mir-190b: 0.7930212775312572, miRNA_hsa-mir-577: -0.28701503001899, miRNA_hsa-mir-135b: -1.2462215457422012, miRNA_hsa-mir-2115: 1.274500067396842, miRNA_hsa-mir-17: -0.9313090838332134, miRNA_hsa-mir-130b: 0.9253576386746966, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-3C-AAAU,"High-level Amplification of none; no CNV meets amplification thresholds.  
mRNA_THSD4 (Z=1.58) and mRNA_SPAG5 (Z=1.36) are highly expressed; mRNA_C5AR2 (Z=1.32) upregulated.  
Methylation_CRNKL1 (Z=-1.50) and Methylation_PRKAG2 (Z=-1.73) are hypomethylated.  
miRNA_hsa-mir-190b (Z=1.47) upregulated.  
No promoter hypermethylation or deletions meet diagnostic thresholds.","mRNA_MLPH: 0.3807872101782014, mRNA_C2orf54: -0.5944255838387225, mRNA_CITED4: -0.782018969241897, mRNA_ESR1: -0.0196983701016625, mRNA_SPDEF: 0.6084537605874806, mRNA_AGR3: 0.8178901040554813, mRNA_FOXC1: -1.3679733531913398, mRNA_GATA3: 0.5876090898015263, mRNA_AGR2: -0.3709123228400296, mRNA_XBP1: 0.4216164619462764, mRNA_PRR15: 0.3944648711272778, mRNA_SLC44A4: 0.2136969815748048, mRNA_CA12: -0.7588238306255255, mRNA_DTL: 0.676569015853806, mRNA_C5AR2: 1.3189188469142354, mRNA_TBC1D9: 1.0379979390858003, mRNA_AR: 0.7016811468267717, mRNA_CCDC170: -0.9553715121643098, mRNA_DEGS2: -0.3582583547221246, mRNA_TFF3: -0.4007054713195916, mRNA_DNALI1: 1.1231082248915123, mRNA_LINC00504: 0.131206383889965, mRNA_CLCA2: -0.6797723331042058, mRNA_PPP1R14C: -0.9431872571021286, mRNA_THSD4: 1.5812809005751496, mRNA_SPAG5: 1.36445717455999, mRNA_FBP1: 0.5433456684321537, mRNA_SLC7A8: 0.5352347104132356, mRNA_EN1: -0.4086709754813335, mRNA_ZNF552: -0.1652823775873011, Methylation_LRRC6: -1.0005482949364617, Methylation_chr2 66218712 LINC02934 (29533): 0.7137813337432962, Methylation_HOXB13: -1.0699555599495776, Methylation_chr10 3949206 LINC02660 (4871): -1.2339171379451954, Methylation_chr5 179517140 RNF130 (18026): 0.9598155020904068, Methylation_LOC727677: -1.041379298122745, Methylation_LETM1: -1.028412917954031, Methylation_CDC42BPB: -1.3672512764275888, Methylation_C8orf38: -0.963750230080328, Methylation_chr14 100504766 EVL (18852): -1.4163837940894362, Methylation_chr5 72594851 LOC340090 (24088): -1.134381299478407, Methylation_chr2 242904738 LINC01238 (3421): 1.1655621701528938, Methylation_ARFGEF1: -1.0729221672681266, Methylation_MAPT: -1.4109881465683398, Methylation_ZFAT: -1.0179996132791689, Methylation_KCNQ4: 1.908830224570405, Methylation_chr1 232684368 SIPA1L2 (12934): -1.293532415794312, Methylation_CRNKL1: -1.5007518898482846, Methylation_PRKAG2: -1.7287672679754955, Methylation_MICB: -0.5359025805827433, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.1446317129963356, miRNA_hsa-mir-5695: 0.0727571806861699, miRNA_hsa-mir-18a: -0.0181894932871606, miRNA_hsa-mir-190b: 1.4652026683926518, miRNA_hsa-mir-577: -0.26726826901579, miRNA_hsa-mir-135b: -0.4488379256602706, miRNA_hsa-mir-2115: -0.5634797244378559, miRNA_hsa-mir-17: 0.4443037164702973, miRNA_hsa-mir-130b: 0.6233114369689887, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A2-A0SV,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: -0.0309447884241802, mRNA_C2orf54: 0.2199462965499013, mRNA_CITED4: 0.0868843963540784, mRNA_ESR1: -0.3341448865536809, mRNA_SPDEF: 0.3861270008166813, mRNA_AGR3: 0.5217294433255545, mRNA_FOXC1: -0.7250711849158884, mRNA_GATA3: 0.3995085240057212, mRNA_AGR2: 0.0493852531478596, mRNA_XBP1: -0.059769089034306, mRNA_PRR15: 0.1801263220829828, mRNA_SLC44A4: 0.7951525343925985, mRNA_CA12: 0.791705337258528, mRNA_DTL: 1.16958343036303, mRNA_C5AR2: 0.5761939728390965, mRNA_TBC1D9: -0.4330501575670641, mRNA_AR: 0.0960923723021949, mRNA_CCDC170: -0.3323719453674894, mRNA_DEGS2: 0.3863352988775268, mRNA_TFF3: -0.0157891118680423, mRNA_DNALI1: 0.8375661875029919, mRNA_LINC00504: -0.3611222180499427, mRNA_CLCA2: -0.8741058508962503, mRNA_PPP1R14C: -0.6263565628199604, mRNA_THSD4: -0.6543725003856378, mRNA_SPAG5: 1.173716649438713, mRNA_FBP1: 0.1075506372890214, mRNA_SLC7A8: -0.386921280032697, mRNA_EN1: 0.2061336659134651, mRNA_ZNF552: 0.3898885436902351, Methylation_LRRC6: -1.1385149048049188, Methylation_chr2 66218712 LINC02934 (29533): -0.5823425386275218, Methylation_HOXB13: 1.4626787079675148, Methylation_chr10 3949206 LINC02660 (4871): -0.5331221727541591, Methylation_chr5 179517140 RNF130 (18026): 0.8775619671162158, Methylation_LOC727677: -1.0309352788335082, Methylation_LETM1: 1.058055721414746, Methylation_CDC42BPB: -0.7325251065729304, Methylation_C8orf38: -1.4994408026372872, Methylation_chr14 100504766 EVL (18852): 0.7298711380095785, Methylation_chr5 72594851 LOC340090 (24088): 1.1762802095262888, Methylation_chr2 242904738 LINC01238 (3421): -0.631721584719095, Methylation_ARFGEF1: -1.1143497654158554, Methylation_MAPT: 0.075534940041384, Methylation_ZFAT: -1.0649035470953407, Methylation_KCNQ4: -0.9303486049554792, Methylation_chr1 232684368 SIPA1L2 (12934): -0.1412814020163536, Methylation_CRNKL1: 0.6448249193842129, Methylation_PRKAG2: -1.198585197963761, Methylation_MICB: 0.0497148762433225, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.0424578266919103, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.0739855227241263, miRNA_hsa-mir-190b: 0.7651032525319454, miRNA_hsa-mir-577: -0.4334471164701577, miRNA_hsa-mir-135b: -0.1865834040115561, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.3535126009316684, miRNA_hsa-mir-130b: -0.6341145408821411, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A2LM,"No features meet the strict diagnostic thresholds for mRNA (Z > 1.30 or Z < -1.92), methylation (Z > 1.50 or Z < -1.47), miRNA (Z > 1.99 or Z < -1.25), or CNV (deletion, gain, amplification, or high-level amplification). All values fall within non-actionable ranges.","mRNA_MLPH: 0.5952340183159293, mRNA_C2orf54: 0.887705293587423, mRNA_CITED4: 1.2481171842996843, mRNA_ESR1: 0.3976402287262461, mRNA_SPDEF: 0.2734307355210129, mRNA_AGR3: 0.4234512261451603, mRNA_FOXC1: 0.1134927888879018, mRNA_GATA3: 0.5928219846080197, mRNA_AGR2: 0.14469620157619, mRNA_XBP1: 0.685144348170391, mRNA_PRR15: 0.3814952501749608, mRNA_SLC44A4: 0.7996872678281078, mRNA_CA12: 0.4940513307959788, mRNA_DTL: -0.2629024938758811, mRNA_C5AR2: 0.6184659840004993, mRNA_TBC1D9: 0.8422972215420305, mRNA_AR: 0.959375075416614, mRNA_CCDC170: 1.0651532797883143, mRNA_DEGS2: 0.6487563633977516, mRNA_TFF3: 0.3420707191094039, mRNA_DNALI1: 0.8047477347021815, mRNA_LINC00504: 1.2559563665906284, mRNA_CLCA2: 1.7000361452666108, mRNA_PPP1R14C: -0.2486602636768788, mRNA_THSD4: 0.8492775171545303, mRNA_SPAG5: -1.0757790592230798, mRNA_FBP1: 0.2106866858995951, mRNA_SLC7A8: 0.7382064696082421, mRNA_EN1: -0.350096751882182, mRNA_ZNF552: 0.4999028076831555, Methylation_LRRC6: 0.0959148633969635, Methylation_chr2 66218712 LINC02934 (29533): 1.1167844648256882, Methylation_HOXB13: -0.9686058572012948, Methylation_chr10 3949206 LINC02660 (4871): 0.1804942248709919, Methylation_chr5 179517140 RNF130 (18026): 0.1357096018227499, Methylation_LOC727677: -0.4513835308039151, Methylation_LETM1: -0.2721494758505002, Methylation_CDC42BPB: -0.917468089854948, Methylation_C8orf38: 0.2921210984443949, Methylation_chr14 100504766 EVL (18852): -0.1215650564692803, Methylation_chr5 72594851 LOC340090 (24088): -1.1765062987127133, Methylation_chr2 242904738 LINC01238 (3421): -0.5801242803997797, Methylation_ARFGEF1: 0.061353243224752, Methylation_MAPT: -0.4849417945925761, Methylation_ZFAT: -0.4488084939581035, Methylation_KCNQ4: -1.179176561546649, Methylation_chr1 232684368 SIPA1L2 (12934): -0.5018390401564199, Methylation_CRNKL1: 0.1522052528465788, Methylation_PRKAG2: 1.1899957911423007, Methylation_MICB: -0.5160161012762016, miRNA_hsa-mir-934: -0.027932948213672, miRNA_hsa-mir-4728: -0.4823368629866219, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.0148051287342197, miRNA_hsa-mir-190b: 0.5945507109841263, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.9711365582815114, miRNA_hsa-mir-2115: -0.1582993167312791, miRNA_hsa-mir-17: -0.6166947529083902, miRNA_hsa-mir-130b: -1.0375370490792668, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A0HA,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.0654879143618931, mRNA_C2orf54: 0.6592935278659988, mRNA_CITED4: -1.0603635485395242, mRNA_ESR1: -0.1549590951354508, mRNA_SPDEF: 0.3102520198004808, mRNA_AGR3: 0.2073941798776874, mRNA_FOXC1: -0.2921213431454905, mRNA_GATA3: 0.6201229044068619, mRNA_AGR2: -0.3856930033442858, mRNA_XBP1: -0.473540383917076, mRNA_PRR15: 0.714350162740277, mRNA_SLC44A4: 0.5698670158194493, mRNA_CA12: 0.4613111591610117, mRNA_DTL: -1.0652909248936275, mRNA_C5AR2: 0.6259859875523699, mRNA_TBC1D9: 0.1446690306159233, mRNA_AR: 0.9719741435558764, mRNA_CCDC170: 0.1524986611287269, mRNA_DEGS2: 0.4136324486668672, mRNA_TFF3: 0.7999442555814654, mRNA_DNALI1: 0.9120042168140184, mRNA_LINC00504: 0.6670172384731143, mRNA_CLCA2: -0.8355966665602474, mRNA_PPP1R14C: -0.327288556779725, mRNA_THSD4: 0.2478350034381728, mRNA_SPAG5: -0.5230367111553337, mRNA_FBP1: 0.5858299352695215, mRNA_SLC7A8: 0.7424445297367235, mRNA_EN1: 0.231988703723536, mRNA_ZNF552: 0.5025540189814343, Methylation_LRRC6: -0.6826878501525369, Methylation_chr2 66218712 LINC02934 (29533): 0.2020155500088503, Methylation_HOXB13: -0.1302365809114003, Methylation_chr10 3949206 LINC02660 (4871): -0.8918943899622902, Methylation_chr5 179517140 RNF130 (18026): 1.1210061427429696, Methylation_LOC727677: -0.9134417742787314, Methylation_LETM1: -1.0238014421804469, Methylation_CDC42BPB: -1.344897600415001, Methylation_C8orf38: -0.3559809242046657, Methylation_chr14 100504766 EVL (18852): -1.1080677329694502, Methylation_chr5 72594851 LOC340090 (24088): 0.8191902937720861, Methylation_chr2 242904738 LINC01238 (3421): -1.1515331447997998, Methylation_ARFGEF1: -0.8725715235254332, Methylation_MAPT: -0.6791945530373912, Methylation_ZFAT: 0.3500345829496407, Methylation_KCNQ4: -1.0160913778176792, Methylation_chr1 232684368 SIPA1L2 (12934): -0.7936830157611081, Methylation_CRNKL1: -0.2177664984670375, Methylation_PRKAG2: 0.8577289010710663, Methylation_MICB: -1.1630566905260722, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.2848655193340394, miRNA_hsa-mir-5695: 2.0454706468154567, miRNA_hsa-mir-18a: -0.1269533802665238, miRNA_hsa-mir-190b: 1.5684373107472172, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.0846644202808951, miRNA_hsa-mir-2115: -0.2377947173349625, miRNA_hsa-mir-17: -0.2994596388009494, miRNA_hsa-mir-130b: 0.3031115561855544, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A2LE,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.323908173449661, mRNA_C2orf54: -1.1376248258606048, mRNA_CITED4: -0.71374260979975, mRNA_ESR1: 0.7409728087311593, mRNA_SPDEF: -0.0281823110811373, mRNA_AGR3: 0.8889861981567434, mRNA_FOXC1: -0.7790705050045716, mRNA_GATA3: 0.4811872565715693, mRNA_AGR2: 0.3880009141399737, mRNA_XBP1: 0.550194650330727, mRNA_PRR15: 0.274234933163519, mRNA_SLC44A4: 0.701693164239297, mRNA_CA12: 0.5209992972238034, mRNA_DTL: -0.9299321131587056, mRNA_C5AR2: 0.2137741168953722, mRNA_TBC1D9: 0.8817072132588354, mRNA_AR: 0.5587165717470184, mRNA_CCDC170: 0.0281222705849797, mRNA_DEGS2: 0.3881707116238146, mRNA_TFF3: -0.999674418974864, mRNA_DNALI1: -1.738868165360298, mRNA_LINC00504: 0.6382119439689137, mRNA_CLCA2: -0.8479389495575428, mRNA_PPP1R14C: -1.0400449106204026, mRNA_THSD4: 0.6763895275630686, mRNA_SPAG5: -1.1245839171544172, mRNA_FBP1: 0.8482447603940981, mRNA_SLC7A8: -0.529956251942611, mRNA_EN1: -0.809270801465084, mRNA_ZNF552: 0.7188146997968159, Methylation_LRRC6: -0.6424907188843971, Methylation_chr2 66218712 LINC02934 (29533): -0.0217713240973113, Methylation_HOXB13: -1.00277550718382, Methylation_chr10 3949206 LINC02660 (4871): -0.8948741957180016, Methylation_chr5 179517140 RNF130 (18026): 1.0678995300156655, Methylation_LOC727677: -0.8492974696878336, Methylation_LETM1: 0.3788251853226269, Methylation_CDC42BPB: 1.374895216841511, Methylation_C8orf38: -1.1909956404489404, Methylation_chr14 100504766 EVL (18852): 0.1910522384199824, Methylation_chr5 72594851 LOC340090 (24088): 0.3599127609228141, Methylation_chr2 242904738 LINC01238 (3421): -0.9158733788375054, Methylation_ARFGEF1: -0.6576135767697363, Methylation_MAPT: -0.4053591881716948, Methylation_ZFAT: -0.9167407861909178, Methylation_KCNQ4: 1.4052490583252126, Methylation_chr1 232684368 SIPA1L2 (12934): -0.9610301671153948, Methylation_CRNKL1: -0.8133302634582562, Methylation_PRKAG2: -1.0102173480033207, Methylation_MICB: -1.1936460176218024, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.7315525852638957, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.8809900056296049, miRNA_hsa-mir-190b: -1.1469960125507306, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.8969061888569663, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.090693816524232, miRNA_hsa-mir-130b: -0.4100786172752855, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A2-A0CO,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.8100006389999829, mRNA_C2orf54: -1.0051609074428691, mRNA_CITED4: 1.0812225143163974, mRNA_ESR1: 0.2208369855838348, mRNA_SPDEF: 0.2842907858458079, mRNA_AGR3: 0.2023116257743279, mRNA_FOXC1: 0.6779459306075439, mRNA_GATA3: 0.1011822426320237, mRNA_AGR2: 0.5132218716951522, mRNA_XBP1: 0.1611838987485493, mRNA_PRR15: 0.752185921743311, mRNA_SLC44A4: 0.7084871578076262, mRNA_CA12: 0.1867517508089309, mRNA_DTL: -1.992810573601384, mRNA_C5AR2: 0.1348607152273342, mRNA_TBC1D9: 0.5017002375401314, mRNA_AR: 0.1707322244398363, mRNA_CCDC170: 0.266150633009121, mRNA_DEGS2: 0.551618065922849, mRNA_TFF3: 0.4492792529208461, mRNA_DNALI1: 0.4767600144303691, mRNA_LINC00504: 0.2335673300807939, mRNA_CLCA2: -0.070635989254481, mRNA_PPP1R14C: -0.1781933721588476, mRNA_THSD4: 0.3354340566780524, mRNA_SPAG5: -1.6772783981044617, mRNA_FBP1: 0.2304086543829077, mRNA_SLC7A8: 0.554409810788128, mRNA_EN1: -0.5351883359990791, mRNA_ZNF552: 0.0973372433517157, Methylation_LRRC6: 0.0685825157707766, Methylation_chr2 66218712 LINC02934 (29533): 0.9125372216932406, Methylation_HOXB13: -0.906695402154584, Methylation_chr10 3949206 LINC02660 (4871): -0.4182417098387423, Methylation_chr5 179517140 RNF130 (18026): 0.7430099614010941, Methylation_LOC727677: -0.4417957470391178, Methylation_LETM1: -0.0830215402588677, Methylation_CDC42BPB: 0.5583662318746663, Methylation_C8orf38: -0.1469308285051485, Methylation_chr14 100504766 EVL (18852): -0.0929077480778276, Methylation_chr5 72594851 LOC340090 (24088): 0.8145593528255781, Methylation_chr2 242904738 LINC01238 (3421): -0.5076535889598572, Methylation_ARFGEF1: -0.162170875183016, Methylation_MAPT: -0.7840672982279384, Methylation_ZFAT: -0.3997463699999078, Methylation_KCNQ4: -0.0587304816184734, Methylation_chr1 232684368 SIPA1L2 (12934): -0.0654219646759079, Methylation_CRNKL1: 0.4997645651223953, Methylation_PRKAG2: 0.5796876929275839, Methylation_MICB: -0.1023901167464509, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.6555330424687623, miRNA_hsa-mir-5695: -0.3405933422074101, miRNA_hsa-mir-18a: -0.6170690775767664, miRNA_hsa-mir-190b: 0.6488919767898924, miRNA_hsa-mir-577: -0.5668139245405907, miRNA_hsa-mir-135b: -0.5290058288310718, miRNA_hsa-mir-2115: -0.3576956351649091, miRNA_hsa-mir-17: -0.7428370552496548, miRNA_hsa-mir-130b: -0.9369384346261396, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A1NA,High-level Amplification of WDPCP drives mRNA overexpression. HOXB13 promoter hypermethylation mediates epigenetic silencing. miR-5695 is markedly upregulated. These features collectively indicate a luminal B phenotype with PI3K/AKT pathway dysregulation.,"mRNA_MLPH: -0.2536704345268154, mRNA_C2orf54: -1.280150431704237, mRNA_CITED4: 0.0049041433734797, mRNA_ESR1: 0.5469366372610189, mRNA_SPDEF: -1.0443554834278517, mRNA_AGR3: 0.4803199946170365, mRNA_FOXC1: -1.0449845552297452, mRNA_GATA3: 0.8202548720769651, mRNA_AGR2: -1.522804742266393, mRNA_XBP1: -0.4208738189319935, mRNA_PRR15: -1.1505149981141014, mRNA_SLC44A4: -1.7095180066370292, mRNA_CA12: 0.2664954586612822, mRNA_DTL: 1.4657940499137674, mRNA_C5AR2: 0.5487893466180492, mRNA_TBC1D9: 1.3276321733885683, mRNA_AR: -0.1601693723156212, mRNA_CCDC170: 1.2143654912014212, mRNA_DEGS2: 0.7309243782635738, mRNA_TFF3: -0.8195568315943035, mRNA_DNALI1: -1.720743946667589, mRNA_LINC00504: -0.407437064870119, mRNA_CLCA2: 0.3728912532621514, mRNA_PPP1R14C: -0.7677145316111078, mRNA_THSD4: -0.3014939359138863, mRNA_SPAG5: 0.931337007349928, mRNA_FBP1: 0.1781781581691765, mRNA_SLC7A8: -0.4839118338354514, mRNA_EN1: -0.0064765292959738, mRNA_ZNF552: -0.3245586503451753, Methylation_LRRC6: -0.5389267641295461, Methylation_chr2 66218712 LINC02934 (29533): 1.3739029716771929, Methylation_HOXB13: 1.6229612366016124, Methylation_chr10 3949206 LINC02660 (4871): -0.7082425601778289, Methylation_chr5 179517140 RNF130 (18026): 0.8632204288469786, Methylation_LOC727677: 1.3868278442374882, Methylation_LETM1: -1.0422702564869335, Methylation_CDC42BPB: 1.3931807178655513, Methylation_C8orf38: 1.239687053083833, Methylation_chr14 100504766 EVL (18852): -0.5466484441651178, Methylation_chr5 72594851 LOC340090 (24088): 1.031816535945712, Methylation_chr2 242904738 LINC01238 (3421): -0.784165949878691, Methylation_ARFGEF1: -1.06260460190925, Methylation_MAPT: -0.3582628257573536, Methylation_ZFAT: 1.2568933932348425, Methylation_KCNQ4: 1.300699774395747, Methylation_chr1 232684368 SIPA1L2 (12934): 0.365352550190785, Methylation_CRNKL1: -1.1359234999126977, Methylation_PRKAG2: -1.176907607347948, Methylation_MICB: 1.2735163824786777, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.0012835817225439, miRNA_hsa-mir-5695: 4.019532513276806, miRNA_hsa-mir-18a: -0.4476890268370522, miRNA_hsa-mir-190b: -1.2923770779270616, miRNA_hsa-mir-577: 0.1995940055690037, miRNA_hsa-mir-135b: -0.9667625957736928, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.215354622642846, miRNA_hsa-mir-130b: -0.3542203372527709, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 2.38809584879993, CNV_CEP68: 1.4339562938734052"
TCGA-D8-A1XL,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives mRNA overexpression. No mRNA, methylation, or miRNA features meet diagnostic thresholds for significant dysregulation. These genomic gains suggest a proliferative phenotype with potential vesicular trafficking and centrosomal pathway alterations.","mRNA_MLPH: -0.0425519805418766, mRNA_C2orf54: 1.0358365118204569, mRNA_CITED4: 0.903821378295372, mRNA_ESR1: -0.4697145812832801, mRNA_SPDEF: 0.6630248388284021, mRNA_AGR3: -0.220867340270753, mRNA_FOXC1: -1.2579461166726442, mRNA_GATA3: 0.5337229038435691, mRNA_AGR2: -1.1220476128563477, mRNA_XBP1: 1.851110025152919, mRNA_PRR15: 0.7183067014843006, mRNA_SLC44A4: -0.2810071071562871, mRNA_CA12: 0.0245795317427493, mRNA_DTL: 0.7356134880677568, mRNA_C5AR2: 0.5687961042102061, mRNA_TBC1D9: 0.1802677467410569, mRNA_AR: 0.2187406549509211, mRNA_CCDC170: -0.4719324056858078, mRNA_DEGS2: 0.6298056130942067, mRNA_TFF3: -0.045062794385948, mRNA_DNALI1: 0.6723124441428416, mRNA_LINC00504: 0.6818306671140226, mRNA_CLCA2: -0.6545385845704069, mRNA_PPP1R14C: -1.0788647084619123, mRNA_THSD4: -1.134080653013179, mRNA_SPAG5: 0.5246191997711159, mRNA_FBP1: 0.6100998901606399, mRNA_SLC7A8: 0.6349033641152092, mRNA_EN1: -0.5127267830229992, mRNA_ZNF552: -0.1109673448327434, Methylation_LRRC6: -1.0943909711245468, Methylation_chr2 66218712 LINC02934 (29533): 1.2627876954076978, Methylation_HOXB13: -1.0653951335919931, Methylation_chr10 3949206 LINC02660 (4871): -0.6464987590991145, Methylation_chr5 179517140 RNF130 (18026): 0.2130519740403149, Methylation_LOC727677: -0.7537175628349883, Methylation_LETM1: -0.446693435384813, Methylation_CDC42BPB: -1.119256850715638, Methylation_C8orf38: -1.1981860699783802, Methylation_chr14 100504766 EVL (18852): -0.0480137874439237, Methylation_chr5 72594851 LOC340090 (24088): -1.447604651756644, Methylation_chr2 242904738 LINC01238 (3421): -1.1062703702717336, Methylation_ARFGEF1: -0.5037716712044528, Methylation_MAPT: -1.3287760336268548, Methylation_ZFAT: -1.4171010214717248, Methylation_KCNQ4: -1.1884328418977852, Methylation_chr1 232684368 SIPA1L2 (12934): 0.2416096447204123, Methylation_CRNKL1: -0.8542017539120312, Methylation_PRKAG2: 1.1617656970133552, Methylation_MICB: -1.1680140247074398, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.0215083321254529, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.06681872890259, miRNA_hsa-mir-190b: 0.8500984479036967, miRNA_hsa-mir-577: -0.4404319098877842, miRNA_hsa-mir-135b: -0.9607628937597242, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.5631817384645235, miRNA_hsa-mir-130b: 0.7383532631665359, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-BH-A0W5,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.2753230097632898, mRNA_C2orf54: 0.6093938182308672, mRNA_CITED4: 0.3233175370051227, mRNA_ESR1: 0.6471465560113294, mRNA_SPDEF: 0.1631778211076652, mRNA_AGR3: 0.6394319702298937, mRNA_FOXC1: -0.125622880245859, mRNA_GATA3: 0.0706659217468978, mRNA_AGR2: 0.3678720894291892, mRNA_XBP1: 0.0467662850111196, mRNA_PRR15: 0.140141450198557, mRNA_SLC44A4: 0.3971371526098382, mRNA_CA12: 0.6628596762202101, mRNA_DTL: -1.0337128122966908, mRNA_C5AR2: 0.8812247357238836, mRNA_TBC1D9: 0.2584658066202443, mRNA_AR: 0.4049243001811784, mRNA_CCDC170: 0.0585455477150085, mRNA_DEGS2: 0.9365929538842458, mRNA_TFF3: 0.5749793646543695, mRNA_DNALI1: 0.5302613605708582, mRNA_LINC00504: 0.4010671684801651, mRNA_CLCA2: 0.2044369735835406, mRNA_PPP1R14C: -0.3517243979082494, mRNA_THSD4: 0.8503367056309448, mRNA_SPAG5: -0.7481597164446498, mRNA_FBP1: 0.2143342290899448, mRNA_SLC7A8: 0.362028203451581, mRNA_EN1: -0.2245732240869486, mRNA_ZNF552: 0.4962409406767057, Methylation_LRRC6: 0.431767619996511, Methylation_chr2 66218712 LINC02934 (29533): 1.0179066405919663, Methylation_HOXB13: -0.6962380357758045, Methylation_chr10 3949206 LINC02660 (4871): 0.5196704409438642, Methylation_chr5 179517140 RNF130 (18026): 0.2130045901533117, Methylation_LOC727677: 0.0656379640179832, Methylation_LETM1: 0.3923542632419055, Methylation_CDC42BPB: -1.0792946424858911, Methylation_C8orf38: 0.1076699272913879, Methylation_chr14 100504766 EVL (18852): 0.9858974219592496, Methylation_chr5 72594851 LOC340090 (24088): 0.4193068608884174, Methylation_chr2 242904738 LINC01238 (3421): 0.0761225356916783, Methylation_ARFGEF1: 0.6353997001757645, Methylation_MAPT: 0.6401221988956474, Methylation_ZFAT: 0.1105614592033546, Methylation_KCNQ4: -1.0841509769326272, Methylation_chr1 232684368 SIPA1L2 (12934): 0.9950291322830788, Methylation_CRNKL1: 0.9114528619478448, Methylation_PRKAG2: 0.3669710464173395, Methylation_MICB: 0.9374671115288016, miRNA_hsa-mir-934: 0.0516459305929822, miRNA_hsa-mir-4728: -0.0907476518703651, miRNA_hsa-mir-5695: 0.7184730381118598, miRNA_hsa-mir-18a: -0.3024232539260217, miRNA_hsa-mir-190b: -0.0696580655906837, miRNA_hsa-mir-577: 0.8362569162246684, miRNA_hsa-mir-135b: 0.2780421593206915, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.0737102949429978, miRNA_hsa-mir-130b: -0.3312625316059004, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AQ-A7U7,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.4052214392315004, mRNA_C2orf54: -0.4662108749854674, mRNA_CITED4: 0.4908223813023891, mRNA_ESR1: -0.0512009476959939, mRNA_SPDEF: 0.3348825646181579, mRNA_AGR3: 0.3324862301283626, mRNA_FOXC1: -0.0688719278264538, mRNA_GATA3: 0.1501502930391729, mRNA_AGR2: 0.2397563007327385, mRNA_XBP1: -0.2817842057931006, mRNA_PRR15: 0.4404397638031306, mRNA_SLC44A4: 0.318243828668505, mRNA_CA12: 0.3317336977417169, mRNA_DTL: -0.102696268100036, mRNA_C5AR2: 0.9707817004010616, mRNA_TBC1D9: 0.5826348911020978, mRNA_AR: -0.6419017705860088, mRNA_CCDC170: -0.0552328390706964, mRNA_DEGS2: 0.7054187685059131, mRNA_TFF3: 0.657861150039447, mRNA_DNALI1: 0.3247047554400066, mRNA_LINC00504: -0.5037432747963386, mRNA_CLCA2: -0.7758015166481633, mRNA_PPP1R14C: -0.5821884421025051, mRNA_THSD4: 0.3221577417493861, mRNA_SPAG5: -0.3060844022771773, mRNA_FBP1: -0.0899558643028816, mRNA_SLC7A8: -0.3093242281134398, mRNA_EN1: -0.0210261095684836, mRNA_ZNF552: 0.9907312060610006, Methylation_LRRC6: 1.0658231064246853, Methylation_chr2 66218712 LINC02934 (29533): 1.0754902296856714, Methylation_HOXB13: 0.3406248766545649, Methylation_chr10 3949206 LINC02660 (4871): 0.1475803365587064, Methylation_chr5 179517140 RNF130 (18026): -0.0807917845715564, Methylation_LOC727677: 0.7632858329858153, Methylation_LETM1: 0.7249401208650091, Methylation_CDC42BPB: 0.1524094317782657, Methylation_C8orf38: 1.0385748256381966, Methylation_chr14 100504766 EVL (18852): 0.9302959383463504, Methylation_chr5 72594851 LOC340090 (24088): 0.1226831167836319, Methylation_chr2 242904738 LINC01238 (3421): 0.0342679687597791, Methylation_ARFGEF1: 1.049479514840634, Methylation_MAPT: 0.5180993364248435, Methylation_ZFAT: 0.6322811055287194, Methylation_KCNQ4: -0.898464303284208, Methylation_chr1 232684368 SIPA1L2 (12934): 0.8029897546781685, Methylation_CRNKL1: 1.000026697544103, Methylation_PRKAG2: 0.9166930947965686, Methylation_MICB: 0.7631432859282345, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.3773473990468607, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.4903907744796686, miRNA_hsa-mir-190b: -0.0639102252498237, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.8498396525960035, miRNA_hsa-mir-2115: -0.5275465529995388, miRNA_hsa-mir-17: -0.4742407164264096, miRNA_hsa-mir-130b: -1.2453658750382974, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A6HE,High mRNA_CITED4 (Z=2.22) indicates overexpression. No methylation sites meet hyper/hypo thresholds. miRNA_hsa-mir-130b is downregulated (Z=-1.23). All CNVs fall within normal range (−1.10 to −0.10). These features suggest luminal A phenotype with estrogen signaling preservation.,"mRNA_MLPH: 0.4210496901639614, mRNA_C2orf54: 0.3635571546057913, mRNA_CITED4: 2.219593285797113, mRNA_ESR1: 0.2847391938080927, mRNA_SPDEF: 0.7190593114930643, mRNA_AGR3: 0.4348685716003491, mRNA_FOXC1: -0.8689971047753595, mRNA_GATA3: 0.1927412202547203, mRNA_AGR2: 0.5107065907327696, mRNA_XBP1: -0.3265401148313623, mRNA_PRR15: 0.2349720886028386, mRNA_SLC44A4: 0.2147856041317551, mRNA_CA12: 0.3212180452212599, mRNA_DTL: 0.5169483654396329, mRNA_C5AR2: 0.39301172801414, mRNA_TBC1D9: -0.6045860652558187, mRNA_AR: -0.0187356829170175, mRNA_CCDC170: 0.108350463407111, mRNA_DEGS2: 1.3316486842964166, mRNA_TFF3: 0.4854771015574546, mRNA_DNALI1: 0.7895511406432769, mRNA_LINC00504: 0.1955762814589638, mRNA_CLCA2: 0.3863497692432224, mRNA_PPP1R14C: -0.3624939048763996, mRNA_THSD4: -0.3471484387860232, mRNA_SPAG5: 0.11093730783454, mRNA_FBP1: 0.209519170917985, mRNA_SLC7A8: 0.8550418021397095, mRNA_EN1: 0.0605066095856459, mRNA_ZNF552: -0.5840319760726693, Methylation_LRRC6: -0.2167813703669141, Methylation_chr2 66218712 LINC02934 (29533): 0.9939589515390788, Methylation_HOXB13: -0.3950166523174965, Methylation_chr10 3949206 LINC02660 (4871): -0.8879344936630837, Methylation_chr5 179517140 RNF130 (18026): 0.2644729973013897, Methylation_LOC727677: 0.3700581720440158, Methylation_LETM1: -0.1761338116294067, Methylation_CDC42BPB: 1.270436551606244, Methylation_C8orf38: 1.3795726317190402, Methylation_chr14 100504766 EVL (18852): -0.5129783343752364, Methylation_chr5 72594851 LOC340090 (24088): 0.6256389925903937, Methylation_chr2 242904738 LINC01238 (3421): -0.3432409057529632, Methylation_ARFGEF1: -0.657103445605083, Methylation_MAPT: -0.4528915361393969, Methylation_ZFAT: 0.1421809680315932, Methylation_KCNQ4: -1.1363905958016705, Methylation_chr1 232684368 SIPA1L2 (12934): -0.0807486956077237, Methylation_CRNKL1: -0.2532418072349547, Methylation_PRKAG2: 0.294563788852079, Methylation_MICB: 0.6325860435516749, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.1846615343532396, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.0010840188377104, miRNA_hsa-mir-190b: 0.6473125214644351, miRNA_hsa-mir-577: -0.6357233478914928, miRNA_hsa-mir-135b: -0.8839750955206973, miRNA_hsa-mir-2115: -0.477359046806737, miRNA_hsa-mir-17: -0.3793074455876243, miRNA_hsa-mir-130b: -1.2304945515662888, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A1FE,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives oncogenic transcriptional activity. No mRNA, methylation, or miRNA features meet diagnostic thresholds for reporting. These CNVs suggest a proliferative phenotype with potential vesicular trafficking and centrosomal dysregulation.","mRNA_MLPH: -0.4256303074892047, mRNA_C2orf54: 0.7951691304649975, mRNA_CITED4: -0.7217025136330113, mRNA_ESR1: -0.0595094579635164, mRNA_SPDEF: 0.0580372598073337, mRNA_AGR3: 0.2761575327669838, mRNA_FOXC1: 0.2546160601128079, mRNA_GATA3: 0.5029010972856047, mRNA_AGR2: -0.0937154261115979, mRNA_XBP1: 0.540864076253722, mRNA_PRR15: -0.2013203537818635, mRNA_SLC44A4: 0.2283621911501251, mRNA_CA12: 0.6752297086301686, mRNA_DTL: 0.7749137989508524, mRNA_C5AR2: -0.3467964170747062, mRNA_TBC1D9: 0.3747984624021634, mRNA_AR: 1.0230900769700335, mRNA_CCDC170: -0.1049704494322428, mRNA_DEGS2: -0.1409741849464905, mRNA_TFF3: 0.7023412318710099, mRNA_DNALI1: 0.6602772475926765, mRNA_LINC00504: 1.008736713927274, mRNA_CLCA2: 0.8682189077302486, mRNA_PPP1R14C: 0.4995483051293125, mRNA_THSD4: -0.1093534568326399, mRNA_SPAG5: 0.4986957308267655, mRNA_FBP1: -0.714225450526035, mRNA_SLC7A8: 0.8695704275605683, mRNA_EN1: -0.5438349289805547, mRNA_ZNF552: 0.4182436721614517, Methylation_LRRC6: 0.1745203128820377, Methylation_chr2 66218712 LINC02934 (29533): 1.1093798292866233, Methylation_HOXB13: -0.0676647612231218, Methylation_chr10 3949206 LINC02660 (4871): 0.1071650199178588, Methylation_chr5 179517140 RNF130 (18026): -0.7044401282396878, Methylation_LOC727677: -0.5488949621661743, Methylation_LETM1: 0.941344461265112, Methylation_CDC42BPB: -0.923737017671493, Methylation_C8orf38: -0.4150696646344067, Methylation_chr14 100504766 EVL (18852): 1.1429468678961974, Methylation_chr5 72594851 LOC340090 (24088): -0.0014847628026241, Methylation_chr2 242904738 LINC01238 (3421): -0.0219342562449363, Methylation_ARFGEF1: 0.6975584118856617, Methylation_MAPT: 0.3615374210727459, Methylation_ZFAT: -0.2340126764373053, Methylation_KCNQ4: -1.0128244840385432, Methylation_chr1 232684368 SIPA1L2 (12934): 0.7946521239837089, Methylation_CRNKL1: 0.5417714515021714, Methylation_PRKAG2: 1.0723944936329366, Methylation_MICB: 0.6261577352708757, miRNA_hsa-mir-934: 0.2853843347704384, miRNA_hsa-mir-4728: -0.039888055215697, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.1845346543590566, miRNA_hsa-mir-190b: -0.4818257908398137, miRNA_hsa-mir-577: -0.3255228657430355, miRNA_hsa-mir-135b: 0.2550930103501551, miRNA_hsa-mir-2115: 0.7225428476574571, miRNA_hsa-mir-17: -0.3312687385169444, miRNA_hsa-mir-130b: -0.092615311047366, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-C8-A278,"High-level Amplification of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 drives genomic instability. mRNA_C2orf54 and mRNA_CLCA2 show significant overexpression (Z > 1.30). miRNA_hsa-mir-4728 is upregulated (Z > 1.99), while no miRNAs are downregulated. Methylation_chr10 3949206 is hypermethylated (Z > 1.50). No promoter hypermethylation directly silences overexpressed genes. These features suggest a basal-like phenotype with cell cycle dysregulation.","mRNA_MLPH: -0.3337702282145237, mRNA_C2orf54: 2.0253191991169177, mRNA_CITED4: -1.7907302225744726, mRNA_ESR1: -1.672378543224902, mRNA_SPDEF: 0.0130250423376883, mRNA_AGR3: -0.3335651076685407, mRNA_FOXC1: -0.8166051842272803, mRNA_GATA3: -0.5790683089039272, mRNA_AGR2: 0.1444003803657926, mRNA_XBP1: -0.2886055671745214, mRNA_PRR15: 0.3491091034850522, mRNA_SLC44A4: 0.3386727488798664, mRNA_CA12: -0.1695899117694831, mRNA_DTL: 0.4703110650662385, mRNA_C5AR2: -1.5901762076204324, mRNA_TBC1D9: -1.0979044432019207, mRNA_AR: 1.3405548804149012, mRNA_CCDC170: -1.0062770661847722, mRNA_DEGS2: -1.1645352982098809, mRNA_TFF3: -0.5154749777416493, mRNA_DNALI1: -1.8762084129297023, mRNA_LINC00504: -1.000507579839489, mRNA_CLCA2: 2.342848668771764, mRNA_PPP1R14C: -0.3110318104215442, mRNA_THSD4: -1.840743212022704, mRNA_SPAG5: -0.0799685978809869, mRNA_FBP1: -0.4506466269675027, mRNA_SLC7A8: -1.159589515037834, mRNA_EN1: -0.1594370545801974, mRNA_ZNF552: -0.5018996478172213, Methylation_LRRC6: 1.0356027219503217, Methylation_chr2 66218712 LINC02934 (29533): 0.7300267692841299, Methylation_HOXB13: 0.0415864247555723, Methylation_chr10 3949206 LINC02660 (4871): 1.520926466418874, Methylation_chr5 179517140 RNF130 (18026): -0.2420425944666289, Methylation_LOC727677: 0.1035930249591506, Methylation_LETM1: 1.2813111674538902, Methylation_CDC42BPB: -1.1664025451916498, Methylation_C8orf38: -0.3852372881693079, Methylation_chr14 100504766 EVL (18852): 0.8691397287528575, Methylation_chr5 72594851 LOC340090 (24088): -0.5024451487124802, Methylation_chr2 242904738 LINC01238 (3421): 1.3296136956734157, Methylation_ARFGEF1: 0.764898063251506, Methylation_MAPT: 1.2893367790876649, Methylation_ZFAT: 0.8494539362313571, Methylation_KCNQ4: 0.0724206727045292, Methylation_chr1 232684368 SIPA1L2 (12934): 0.7964433688789966, Methylation_CRNKL1: 1.2033784714446696, Methylation_PRKAG2: 0.3976969767362925, Methylation_MICB: 1.0122816002596664, miRNA_hsa-mir-934: -0.0211313550598287, miRNA_hsa-mir-4728: 2.7530175108740416, miRNA_hsa-mir-5695: -0.0521993645041951, miRNA_hsa-mir-18a: 0.5848973504044322, miRNA_hsa-mir-190b: -0.2627106989013205, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.1442231044192408, miRNA_hsa-mir-2115: 1.9762569426726588, miRNA_hsa-mir-17: 0.4016216163322889, miRNA_hsa-mir-130b: 0.5545655110419414, CNV_VPS54: 3.3712233045701687, CNV_LINC01867: 3.403528716117201, CNV_LINC02576: 3.494626341568657, CNV_WDPCP: 3.3913533508092364, CNV_CEP68: 3.494626341568657"
TCGA-AR-A0U3,PRR15 and TFF3 mRNA overexpression (Z > 1.30). HOXB13 and KCNQ4 promoter hypermethylation (Z > 1.50). No significant miRNA dysregulation or CNVs meeting diagnostic thresholds. These features suggest luminal breast cancer phenotype with estrogen signaling activation.,"mRNA_MLPH: 0.5970308153937499, mRNA_C2orf54: 1.1700648046039577, mRNA_CITED4: -1.246614636223815, mRNA_ESR1: 1.1747054790488158, mRNA_SPDEF: 0.654920307205003, mRNA_AGR3: 0.9743584922228384, mRNA_FOXC1: -0.3007452905444746, mRNA_GATA3: 0.8795594106984157, mRNA_AGR2: 1.1624911906963775, mRNA_XBP1: 0.4339960500765555, mRNA_PRR15: 1.3707552888130816, mRNA_SLC44A4: 1.0809990258836446, mRNA_CA12: 0.4754994731326262, mRNA_DTL: 0.7663633636831261, mRNA_C5AR2: 0.2541387791383465, mRNA_TBC1D9: 0.2945107441076666, mRNA_AR: 1.1714056580015442, mRNA_CCDC170: 1.130291481130997, mRNA_DEGS2: 0.3960851233916267, mRNA_TFF3: 1.3832265996434765, mRNA_DNALI1: 0.5746112552690474, mRNA_LINC00504: 0.2181580207475759, mRNA_CLCA2: 0.9010566435666808, mRNA_PPP1R14C: -0.558993262523033, mRNA_THSD4: 0.280832261144763, mRNA_SPAG5: 0.3103307640681337, mRNA_FBP1: 0.4763936896728584, mRNA_SLC7A8: 1.0144317130801237, mRNA_EN1: -0.962993893008258, mRNA_ZNF552: -0.1681061590518244, Methylation_LRRC6: -1.1666758063331504, Methylation_chr2 66218712 LINC02934 (29533): 0.157245445217001, Methylation_HOXB13: 1.5402938930180623, Methylation_chr10 3949206 LINC02660 (4871): 0.3441026396269043, Methylation_chr5 179517140 RNF130 (18026): 1.2277900834595263, Methylation_LOC727677: 0.9060216542064418, Methylation_LETM1: -0.5093402484156735, Methylation_CDC42BPB: 1.3097382443832637, Methylation_C8orf38: -1.2520635680814267, Methylation_chr14 100504766 EVL (18852): -1.191933580441302, Methylation_chr5 72594851 LOC340090 (24088): 1.2677319481464329, Methylation_chr2 242904738 LINC01238 (3421): 1.2313311046837991, Methylation_ARFGEF1: -1.2131329991840043, Methylation_MAPT: -0.994638011761668, Methylation_ZFAT: -0.5780455747533438, Methylation_KCNQ4: 1.5183133351720008, Methylation_chr1 232684368 SIPA1L2 (12934): -0.0384423666170657, Methylation_CRNKL1: -0.2390447122042882, Methylation_PRKAG2: 0.9251766954355528, Methylation_MICB: -0.055544582530173, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.1031361487954744, miRNA_hsa-mir-5695: 1.69462722195614, miRNA_hsa-mir-18a: -0.1375835658676136, miRNA_hsa-mir-190b: 0.0399859855765169, miRNA_hsa-mir-577: 0.1601946694886067, miRNA_hsa-mir-135b: -0.216921329605597, miRNA_hsa-mir-2115: 1.1176842354634513, miRNA_hsa-mir-17: 0.1557492162486627, miRNA_hsa-mir-130b: -0.695193609584302, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-GM-A5PV,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.54965557323766, mRNA_C2orf54: -0.2897380391752845, mRNA_CITED4: 0.627205867197563, mRNA_ESR1: 0.8736391629471083, mRNA_SPDEF: 0.7809489751700945, mRNA_AGR3: 0.7343103834178915, mRNA_FOXC1: -0.360494010136377, mRNA_GATA3: 0.6269105785971475, mRNA_AGR2: 0.6196135071125873, mRNA_XBP1: 1.064796670873115, mRNA_PRR15: 1.0823517244162824, mRNA_SLC44A4: 0.4263814899893844, mRNA_CA12: 0.476273665226671, mRNA_DTL: -1.6051602738778814, mRNA_C5AR2: 0.5468420479074851, mRNA_TBC1D9: 0.5480376037187705, mRNA_AR: 0.9419177440513424, mRNA_CCDC170: 1.2303725548538558, mRNA_DEGS2: 0.7809085786860377, mRNA_TFF3: 0.5260406736125146, mRNA_DNALI1: 0.9174955458942654, mRNA_LINC00504: 0.7762016603763596, mRNA_CLCA2: -0.312685404130338, mRNA_PPP1R14C: 0.3428975246695335, mRNA_THSD4: 0.4992276938273255, mRNA_SPAG5: -1.6624178776586542, mRNA_FBP1: 1.1224989835347514, mRNA_SLC7A8: 0.5752796118827014, mRNA_EN1: -0.9445250741334004, mRNA_ZNF552: 0.3412748113184249, Methylation_LRRC6: -0.2721549897818213, Methylation_chr2 66218712 LINC02934 (29533): -0.3902746451759199, Methylation_HOXB13: -1.0682380240372849, Methylation_chr10 3949206 LINC02660 (4871): -0.6503188167538412, Methylation_chr5 179517140 RNF130 (18026): 0.3236068581868181, Methylation_LOC727677: -0.4814812659382134, Methylation_LETM1: -0.6164331256254689, Methylation_CDC42BPB: -0.7947038443164274, Methylation_C8orf38: -0.7054944820126805, Methylation_chr14 100504766 EVL (18852): -0.604419034748129, Methylation_chr5 72594851 LOC340090 (24088): 0.3167037017542545, Methylation_chr2 242904738 LINC01238 (3421): -0.8224415865141582, Methylation_ARFGEF1: 0.0494386791529918, Methylation_MAPT: -0.4609931370256988, Methylation_ZFAT: 0.0005698456791963, Methylation_KCNQ4: -0.8728393565790687, Methylation_chr1 232684368 SIPA1L2 (12934): 0.0338362470549079, Methylation_CRNKL1: -0.2199988969410129, Methylation_PRKAG2: 0.8540435069594985, Methylation_MICB: -0.1854487262585525, miRNA_hsa-mir-934: 0.1531690588540519, miRNA_hsa-mir-4728: -0.7689259398482436, miRNA_hsa-mir-5695: 0.2345326018192668, miRNA_hsa-mir-18a: -0.6202650408618703, miRNA_hsa-mir-190b: 0.3668378450678964, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.306525856512001, miRNA_hsa-mir-2115: 1.2452740970339935, miRNA_hsa-mir-17: -0.1377328768239808, miRNA_hsa-mir-130b: -1.3483168602439612, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AC-A3HN,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting. All values fall within non-significant ranges per defined criteria.","mRNA_MLPH: 0.5694368193038498, mRNA_C2orf54: -0.2509614934242085, mRNA_CITED4: 0.9762343550285156, mRNA_ESR1: 0.6719624542193209, mRNA_SPDEF: 0.5237040574138274, mRNA_AGR3: 0.171858652101946, mRNA_FOXC1: 0.1143026373392494, mRNA_GATA3: 0.5139805713295094, mRNA_AGR2: -0.0734240916466393, mRNA_XBP1: 0.0825548875097718, mRNA_PRR15: 0.0162193257944349, mRNA_SLC44A4: 0.5047099157959166, mRNA_CA12: 0.7462047964531858, mRNA_DTL: -0.0510358685761984, mRNA_C5AR2: 0.8845849656357244, mRNA_TBC1D9: 0.4958839648848114, mRNA_AR: 0.2961965838443382, mRNA_CCDC170: 0.7405400823623578, mRNA_DEGS2: 1.262380639356551, mRNA_TFF3: 0.2427284195605207, mRNA_DNALI1: 0.2620825883240489, mRNA_LINC00504: 0.7027706939319407, mRNA_CLCA2: -0.4158933499277212, mRNA_PPP1R14C: -0.2994099664399907, mRNA_THSD4: 0.4959630024839105, mRNA_SPAG5: -0.4595925098165231, mRNA_FBP1: 0.3820717404794764, mRNA_SLC7A8: 0.7475795135832498, mRNA_EN1: 0.1799130764872777, mRNA_ZNF552: 0.1712325061739056, Methylation_LRRC6: 0.8176207197520106, Methylation_chr2 66218712 LINC02934 (29533): 1.209711564388901, Methylation_HOXB13: -0.7788171295471632, Methylation_chr10 3949206 LINC02660 (4871): 1.3523521820337403, Methylation_chr5 179517140 RNF130 (18026): 0.0023619645425514, Methylation_LOC727677: 1.172906252426359, Methylation_LETM1: -0.3200213437859409, Methylation_CDC42BPB: -0.7137471867837321, Methylation_C8orf38: 0.1620239135960323, Methylation_chr14 100504766 EVL (18852): 0.06763030333878, Methylation_chr5 72594851 LOC340090 (24088): 0.7713137090694892, Methylation_chr2 242904738 LINC01238 (3421): -0.4271649044217211, Methylation_ARFGEF1: 0.7861213833001074, Methylation_MAPT: -0.0407652417014043, Methylation_ZFAT: 0.612555043686588, Methylation_KCNQ4: -1.1580677555253045, Methylation_chr1 232684368 SIPA1L2 (12934): -0.0833424533795201, Methylation_CRNKL1: 0.452936960259363, Methylation_PRKAG2: 1.2281364482852424, Methylation_MICB: -0.0958640893517818, miRNA_hsa-mir-934: 0.0030885789392189, miRNA_hsa-mir-4728: -0.8312210486048003, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.7685830158480133, miRNA_hsa-mir-190b: -0.0067340591423884, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.878951966839755, miRNA_hsa-mir-2115: 0.3429983327605271, miRNA_hsa-mir-17: -0.7388975333920849, miRNA_hsa-mir-130b: -1.1436138672516485, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A7-A6VX,"High mRNA_C2orf54 (Z=2.64) indicates overexpression.  
Methylation_ZFAT (Z=−1.50), Methylation_LRRC6 (Z=−1.48), and Methylation_C8orf38 (Z=−1.61) are hypomethylated.  
No CNVs meet deletion/amplification thresholds.  
No miRNAs cross expression cutoffs.  
Collectively suggests luminal-like phenotype with epigenetic dysregulation.","mRNA_MLPH: 0.3865201447897524, mRNA_C2orf54: 2.637036406361688, mRNA_CITED4: 0.5058164329590467, mRNA_ESR1: 0.7435927303696156, mRNA_SPDEF: 0.5898603510644106, mRNA_AGR3: 0.2959855330134343, mRNA_FOXC1: -1.0538931657183794, mRNA_GATA3: 0.656442095614254, mRNA_AGR2: -0.3615432250923066, mRNA_XBP1: 0.3428967598069166, mRNA_PRR15: 0.2702984065556161, mRNA_SLC44A4: 1.083633459450514, mRNA_CA12: 0.8810418289971124, mRNA_DTL: 1.3791968090492737, mRNA_C5AR2: -0.5421675286000162, mRNA_TBC1D9: 0.4272396465744126, mRNA_AR: 0.9680880644122148, mRNA_CCDC170: 0.4802685893945317, mRNA_DEGS2: 0.5527442594290971, mRNA_TFF3: -0.1674992751648807, mRNA_DNALI1: 0.5499786287750034, mRNA_LINC00504: -0.4645091248448943, mRNA_CLCA2: 0.1499550026259901, mRNA_PPP1R14C: -0.7689535488742718, mRNA_THSD4: -0.0824705586941417, mRNA_SPAG5: -0.0813769824888957, mRNA_FBP1: 0.7622420011689744, mRNA_SLC7A8: 0.3677945871472241, mRNA_EN1: 0.3933807362718318, mRNA_ZNF552: 0.8259973429746984, Methylation_LRRC6: -1.4815500795864966, Methylation_chr2 66218712 LINC02934 (29533): -1.6545194648799026, Methylation_HOXB13: 1.251818797378617, Methylation_chr10 3949206 LINC02660 (4871): -1.251976511655302, Methylation_chr5 179517140 RNF130 (18026): 1.07108510651951, Methylation_LOC727677: -0.7426308893653684, Methylation_LETM1: 0.5458044692313131, Methylation_CDC42BPB: 0.6829381907111324, Methylation_C8orf38: -1.61018663626431, Methylation_chr14 100504766 EVL (18852): -1.067178598311216, Methylation_chr5 72594851 LOC340090 (24088): -1.5888347037387467, Methylation_chr2 242904738 LINC01238 (3421): -1.3151805771066738, Methylation_ARFGEF1: -1.0946997016350113, Methylation_MAPT: -0.5387570639926265, Methylation_ZFAT: -1.4955349568710596, Methylation_KCNQ4: -0.035539456643059, Methylation_chr1 232684368 SIPA1L2 (12934): -1.2526454838451542, Methylation_CRNKL1: -1.2050829395523897, Methylation_PRKAG2: 1.2906513551417578, Methylation_MICB: 1.1139333370633882, miRNA_hsa-mir-934: -0.4745032680264984, miRNA_hsa-mir-4728: -0.608412376713527, miRNA_hsa-mir-5695: -0.3014373650965832, miRNA_hsa-mir-18a: -0.1168552512414687, miRNA_hsa-mir-190b: 0.344302968628801, miRNA_hsa-mir-577: -0.4641966296983474, miRNA_hsa-mir-135b: -0.792328500731583, miRNA_hsa-mir-2115: 0.4743762030790966, miRNA_hsa-mir-17: -0.0676404101836208, miRNA_hsa-mir-130b: -0.609239481583349, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A1AS,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.6728395096937108, mRNA_C2orf54: -1.1381733399456522, mRNA_CITED4: 0.6191518172430935, mRNA_ESR1: 0.6978844218461168, mRNA_SPDEF: 0.4628935400212303, mRNA_AGR3: 0.3249255349806494, mRNA_FOXC1: -0.706731751712829, mRNA_GATA3: 0.5226860444646556, mRNA_AGR2: 0.6092994030854672, mRNA_XBP1: 0.6758396527508166, mRNA_PRR15: 0.2139093439612996, mRNA_SLC44A4: 0.5057595624164414, mRNA_CA12: 0.6241752572547943, mRNA_DTL: 1.2488019140924855, mRNA_C5AR2: 0.8343207650045829, mRNA_TBC1D9: 0.4254298916193349, mRNA_AR: 1.0068907960557705, mRNA_CCDC170: 0.8163481152481726, mRNA_DEGS2: 1.088261568954555, mRNA_TFF3: -0.6501232983508357, mRNA_DNALI1: 0.6430260692859997, mRNA_LINC00504: 0.3686798161975665, mRNA_CLCA2: 1.901326039750687, mRNA_PPP1R14C: -0.200511020599178, mRNA_THSD4: 0.3800733854092148, mRNA_SPAG5: 0.0812236335211794, mRNA_FBP1: -0.3413864665639853, mRNA_SLC7A8: 0.8270252248661665, mRNA_EN1: -0.1134730613054656, mRNA_ZNF552: 0.5403233210045071, Methylation_LRRC6: -1.108282967467523, Methylation_chr2 66218712 LINC02934 (29533): 1.1124695801731792, Methylation_HOXB13: -0.8891160881698397, Methylation_chr10 3949206 LINC02660 (4871): -1.2603721553648273, Methylation_chr5 179517140 RNF130 (18026): 1.0167223206567348, Methylation_LOC727677: -0.8424785654423129, Methylation_LETM1: 0.9201064492175448, Methylation_CDC42BPB: -1.3163881154386754, Methylation_C8orf38: -1.333124945002132, Methylation_chr14 100504766 EVL (18852): -1.1476684672011856, Methylation_chr5 72594851 LOC340090 (24088): 1.226287734103661, Methylation_chr2 242904738 LINC01238 (3421): -0.5803301402448824, Methylation_ARFGEF1: -0.8574759669944354, Methylation_MAPT: -0.9881963228244371, Methylation_ZFAT: -1.1451662639323, Methylation_KCNQ4: 1.4725684508304382, Methylation_chr1 232684368 SIPA1L2 (12934): -1.124800581594755, Methylation_CRNKL1: -1.3148731636619475, Methylation_PRKAG2: 1.298337965775149, Methylation_MICB: -1.059934013706627, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.1201235159792068, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.553427734994211, miRNA_hsa-mir-190b: 1.1674490134608069, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: 0.2539319481767456, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.0996170502953014, miRNA_hsa-mir-130b: 0.3993135667096592, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-EW-A1PH,"High-level Amplification of none; Gain in multiple loci (e.g., VPS54, CEP68).  
mRNA_FOXC1 overexpression (Z=2.79); mRNA_MLPH, ESR1, GATA3, FBP1, SLC44A4 significantly downregulated (Z < -1.92).  
KCNQ4 promoter hypermethylation (Z=2.03); PRKAG2, RNF130, LOC340090 hypomethylated (Z < -1.47).  
miR-934 upregulated (Z=3.12); no miRNAs downregulated per threshold.  
FOXC1-driven basal-like phenotype with ER-pathway suppression.","mRNA_MLPH: -2.289979109761223, mRNA_C2orf54: 1.1458152759349365, mRNA_CITED4: 0.247863909769135, mRNA_ESR1: -2.042182023144912, mRNA_SPDEF: -1.4156709364187856, mRNA_AGR3: -1.6469778014795005, mRNA_FOXC1: 2.7915044007394108, mRNA_GATA3: -2.194318176792916, mRNA_AGR2: -1.9843501690927368, mRNA_XBP1: -1.7156299345908586, mRNA_PRR15: -1.7639681751022942, mRNA_SLC44A4: -2.342446722991051, mRNA_CA12: -2.201097738774904, mRNA_DTL: -0.1194409173582796, mRNA_C5AR2: -1.6285633326517146, mRNA_TBC1D9: -1.4582778543768362, mRNA_AR: -1.9540441174027643, mRNA_CCDC170: -1.8669983750654413, mRNA_DEGS2: -1.854648668247288, mRNA_TFF3: -1.5921094343843154, mRNA_DNALI1: -0.537629690423753, mRNA_LINC00504: -1.540033071259941, mRNA_CLCA2: -0.54382396174693, mRNA_PPP1R14C: 1.240760722993156, mRNA_THSD4: -1.5624365417928232, mRNA_SPAG5: 0.6085253983810709, mRNA_FBP1: -2.317507357374721, mRNA_SLC7A8: -1.5686390866530533, mRNA_EN1: 1.906732180263219, mRNA_ZNF552: -1.255485804654655, Methylation_LRRC6: 1.1329601284180455, Methylation_chr2 66218712 LINC02934 (29533): -1.6378102414084563, Methylation_HOXB13: -0.2637196586106015, Methylation_chr10 3949206 LINC02660 (4871): 1.595881705572495, Methylation_chr5 179517140 RNF130 (18026): -1.6790495926315645, Methylation_LOC727677: 1.4245389029556883, Methylation_LETM1: 1.2591857802506146, Methylation_CDC42BPB: 1.0699859052428116, Methylation_C8orf38: 1.3616413540343109, Methylation_chr14 100504766 EVL (18852): 1.4710271921277551, Methylation_chr5 72594851 LOC340090 (24088): -1.521782716829294, Methylation_chr2 242904738 LINC01238 (3421): 1.446334847946214, Methylation_ARFGEF1: 0.3561098928897948, Methylation_MAPT: 1.511342739698013, Methylation_ZFAT: 1.0105837975915937, Methylation_KCNQ4: 2.026239218021696, Methylation_chr1 232684368 SIPA1L2 (12934): 1.289277480986325, Methylation_CRNKL1: 1.4468131269684197, Methylation_PRKAG2: -1.7173388119455255, Methylation_MICB: 1.4918633347349994, miRNA_hsa-mir-934: 3.12253914721422, miRNA_hsa-mir-4728: 0.632239963297307, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.146585829592923, miRNA_hsa-mir-190b: -1.015383403572468, miRNA_hsa-mir-577: 0.8733425105039766, miRNA_hsa-mir-135b: 1.7457514264355352, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 0.5795267681065771, miRNA_hsa-mir-130b: 1.134539374416068, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-AR-A2LN,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.5462087950851597, mRNA_C2orf54: 0.1128542015409107, mRNA_CITED4: 0.7517996671844425, mRNA_ESR1: 0.1174224104848927, mRNA_SPDEF: 0.2779675609266158, mRNA_AGR3: 0.3146833908045769, mRNA_FOXC1: 0.7987170577676302, mRNA_GATA3: 0.6882967686544597, mRNA_AGR2: 0.1447879745241427, mRNA_XBP1: 0.5852156150179495, mRNA_PRR15: 0.4570736450113145, mRNA_SLC44A4: 0.6628318698373671, mRNA_CA12: 0.7079078299083219, mRNA_DTL: -1.8710619326028104, mRNA_C5AR2: 0.3475282737475999, mRNA_TBC1D9: 0.6095762258655832, mRNA_AR: 0.670445800794556, mRNA_CCDC170: 0.766079960587506, mRNA_DEGS2: 0.3067250776271076, mRNA_TFF3: 0.2586160197957081, mRNA_DNALI1: 0.4313141372704785, mRNA_LINC00504: 0.6397386887593608, mRNA_CLCA2: -0.0732497369375766, mRNA_PPP1R14C: -0.7014238465014884, mRNA_THSD4: 0.6938917771701222, mRNA_SPAG5: -0.582630392131069, mRNA_FBP1: 0.1672742426547404, mRNA_SLC7A8: 0.4906219476065511, mRNA_EN1: 0.1022885201969953, mRNA_ZNF552: 1.1239000625444209, Methylation_LRRC6: 0.4250466868709358, Methylation_chr2 66218712 LINC02934 (29533): -0.6353717336883135, Methylation_HOXB13: -1.0492888070080575, Methylation_chr10 3949206 LINC02660 (4871): 0.1031201188515909, Methylation_chr5 179517140 RNF130 (18026): 0.121389269821815, Methylation_LOC727677: -0.0287869145253257, Methylation_LETM1: 0.5445912436350933, Methylation_CDC42BPB: -0.8060130373144677, Methylation_C8orf38: 0.2637121736027588, Methylation_chr14 100504766 EVL (18852): 0.1656715459744407, Methylation_chr5 72594851 LOC340090 (24088): 0.4207862612579374, Methylation_chr2 242904738 LINC01238 (3421): -0.2215926396527474, Methylation_ARFGEF1: 0.6332554195789397, Methylation_MAPT: 0.2011553852536101, Methylation_ZFAT: 0.0064825370476004, Methylation_KCNQ4: -1.1084833991984164, Methylation_chr1 232684368 SIPA1L2 (12934): 0.3004941432444705, Methylation_CRNKL1: 0.2120611191542609, Methylation_PRKAG2: 1.1397539104036605, Methylation_MICB: -0.0301527674071719, miRNA_hsa-mir-934: -0.3288177772991849, miRNA_hsa-mir-4728: -0.3966926776828401, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.3275736091244337, miRNA_hsa-mir-190b: 0.2955816219714143, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.8115746380507551, miRNA_hsa-mir-2115: 0.4647497714340031, miRNA_hsa-mir-17: -0.8326177647201953, miRNA_hsa-mir-130b: -0.7939243578793107, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A0U2,mRNA_CITED4 (Z = -2.34) is significantly downregulated; mRNA_DTL (Z = 2.19) and mRNA_SPAG5 (Z = 2.31) are highly overexpressed. Methylation_PRKAG2 (Z = -1.65) is hypomethylated. No CNVs meet amplification or deletion thresholds. miRNA_hsa-mir-577 (Z = 1.89) is upregulated. These features suggest luminal B-like phenotype with cell cycle dysregulation.,"mRNA_MLPH: 0.398116163973394, mRNA_C2orf54: -0.8920426334555673, mRNA_CITED4: -2.33910465746052, mRNA_ESR1: 0.3944564586285026, mRNA_SPDEF: 0.7091735232281898, mRNA_AGR3: 0.6548132691595709, mRNA_FOXC1: -0.9139984292462268, mRNA_GATA3: 0.4531698729101726, mRNA_AGR2: 1.1714724824595764, mRNA_XBP1: 0.3210047819670666, mRNA_PRR15: 0.0657825779781673, mRNA_SLC44A4: 0.1935762471256273, mRNA_CA12: -1.7275707989052649, mRNA_DTL: 2.1860784804328253, mRNA_C5AR2: 0.7719016064604803, mRNA_TBC1D9: 0.3512610923331676, mRNA_AR: 0.4264441032306775, mRNA_CCDC170: -0.0524529858767448, mRNA_DEGS2: -0.8506164955856821, mRNA_TFF3: 0.103301428378828, mRNA_DNALI1: -0.0102064788266903, mRNA_LINC00504: -1.5080320050166816, mRNA_CLCA2: -0.8258240952203901, mRNA_PPP1R14C: -1.11707371296236, mRNA_THSD4: 0.2875647515160152, mRNA_SPAG5: 2.305783501354884, mRNA_FBP1: 0.5330539173139065, mRNA_SLC7A8: -0.1748900596550032, mRNA_EN1: -0.8405640329992705, mRNA_ZNF552: 0.0996472666138702, Methylation_LRRC6: -1.413743450064198, Methylation_chr2 66218712 LINC02934 (29533): -0.8590758977777172, Methylation_HOXB13: -0.94517208853999, Methylation_chr10 3949206 LINC02660 (4871): -0.9874298012953204, Methylation_chr5 179517140 RNF130 (18026): 0.9469591605878442, Methylation_LOC727677: -1.562822548973803, Methylation_LETM1: -0.9503209219114296, Methylation_CDC42BPB: -0.4178436846331493, Methylation_C8orf38: -1.3817397467531105, Methylation_chr14 100504766 EVL (18852): -0.938970915408454, Methylation_chr5 72594851 LOC340090 (24088): -1.4758709619225834, Methylation_chr2 242904738 LINC01238 (3421): -1.1313539207554786, Methylation_ARFGEF1: -1.0543903075051144, Methylation_MAPT: -0.2679542462465424, Methylation_ZFAT: -1.3819293048610686, Methylation_KCNQ4: 0.7141027788796993, Methylation_chr1 232684368 SIPA1L2 (12934): -0.9285434310336136, Methylation_CRNKL1: -1.1541296916615296, Methylation_PRKAG2: -1.6467502770062334, Methylation_MICB: -0.8548400522368009, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.5931184872590153, miRNA_hsa-mir-5695: 1.1151371203702256, miRNA_hsa-mir-18a: 1.6813655885428171, miRNA_hsa-mir-190b: 0.5764362062418447, miRNA_hsa-mir-577: 1.885806377112452, miRNA_hsa-mir-135b: 0.1957665363224729, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.5403922062087645, miRNA_hsa-mir-130b: 1.1547397561988633, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-BH-A0H9,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-significant ranges per specified Z-score and CNV cutoffs.","mRNA_MLPH: 0.3991052654414726, mRNA_C2orf54: 0.0949887655660007, mRNA_CITED4: 0.219299741382005, mRNA_ESR1: 0.9734540668627372, mRNA_SPDEF: 0.4923917346127385, mRNA_AGR3: -0.004462513520467, mRNA_FOXC1: -0.6000584998829142, mRNA_GATA3: 0.6059447601783738, mRNA_AGR2: 1.058440158836519, mRNA_XBP1: 0.802213920811224, mRNA_PRR15: 0.6294017886172655, mRNA_SLC44A4: 0.5245496526061562, mRNA_CA12: 0.8229238333596891, mRNA_DTL: 0.5255312173253788, mRNA_C5AR2: 0.4863722434825406, mRNA_TBC1D9: 0.752264412946281, mRNA_AR: 0.4990818361396381, mRNA_CCDC170: 0.2700038158441105, mRNA_DEGS2: 0.1625613412996738, mRNA_TFF3: 0.814461127149449, mRNA_DNALI1: 0.7053452239318149, mRNA_LINC00504: 0.2322376046568928, mRNA_CLCA2: 0.914847391850936, mRNA_PPP1R14C: -0.570609643363198, mRNA_THSD4: 0.6897230260946701, mRNA_SPAG5: 0.0281445635958389, mRNA_FBP1: 0.6276409721314072, mRNA_SLC7A8: -0.0759563669067667, mRNA_EN1: -1.0111335167927136, mRNA_ZNF552: 0.0840326400157507, Methylation_LRRC6: -1.1470787815593684, Methylation_chr2 66218712 LINC02934 (29533): -1.241387323816027, Methylation_HOXB13: -0.8089309121288991, Methylation_chr10 3949206 LINC02660 (4871): -1.2982781682270033, Methylation_chr5 179517140 RNF130 (18026): -1.6383822898704896, Methylation_LOC727677: -0.6406764065611779, Methylation_LETM1: -1.0100764987883817, Methylation_CDC42BPB: 0.3054280806330254, Methylation_C8orf38: -0.7794487072303644, Methylation_chr14 100504766 EVL (18852): -0.8196217059908641, Methylation_chr5 72594851 LOC340090 (24088): -1.6010306574702595, Methylation_chr2 242904738 LINC01238 (3421): -0.7777884138507013, Methylation_ARFGEF1: -0.5136942935484644, Methylation_MAPT: -0.3402843885677572, Methylation_ZFAT: -0.7321036714073952, Methylation_KCNQ4: 0.5881285242673853, Methylation_chr1 232684368 SIPA1L2 (12934): -0.5429043331150644, Methylation_CRNKL1: -0.6229269849757231, Methylation_PRKAG2: -1.0023476991176865, Methylation_MICB: -0.6224304611092532, miRNA_hsa-mir-934: 0.0439013484970762, miRNA_hsa-mir-4728: -0.3808965637665329, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.0839784084267995, miRNA_hsa-mir-190b: 0.575456240819944, miRNA_hsa-mir-577: 0.387892705910458, miRNA_hsa-mir-135b: -0.4219918805601422, miRNA_hsa-mir-2115: 0.9041389612980708, miRNA_hsa-mir-17: -0.6821755146517979, miRNA_hsa-mir-130b: 0.42835225003781, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AO-A1KS,AR mRNA overexpression (Z=1.41) exceeds the high-expression threshold. No methylation sites meet hyper/hypo-methylation criteria. No miRNAs cross up/downregulation thresholds. All CNVs fall within normal range (−1.10 to −0.10). Isolated AR activation suggests luminal androgen receptor activity without genomic or epigenetic drivers.,"mRNA_MLPH: -0.2593677816317583, mRNA_C2orf54: 0.5738742936342547, mRNA_CITED4: -0.3924344118804799, mRNA_ESR1: 1.1065198915590384, mRNA_SPDEF: 0.2633508188669327, mRNA_AGR3: 0.612517598064046, mRNA_FOXC1: -0.2553213976275879, mRNA_GATA3: 0.7015852615091656, mRNA_AGR2: 0.6561671957004503, mRNA_XBP1: 0.7526912418527789, mRNA_PRR15: -0.0368682869162401, mRNA_SLC44A4: 0.5452413137977022, mRNA_CA12: 0.5870547257831576, mRNA_DTL: 0.9294733454037264, mRNA_C5AR2: 0.7641312013770307, mRNA_TBC1D9: 0.5775639447804878, mRNA_AR: 1.4080791222734554, mRNA_CCDC170: 0.2508304504559422, mRNA_DEGS2: -0.1654090316955693, mRNA_TFF3: 0.1250816240630981, mRNA_DNALI1: 0.4131519385269685, mRNA_LINC00504: 0.5103468342508696, mRNA_CLCA2: 0.9071654272758916, mRNA_PPP1R14C: -0.3299540307598671, mRNA_THSD4: 1.0392405407397722, mRNA_SPAG5: 0.9523636253441684, mRNA_FBP1: 0.2475630774433909, mRNA_SLC7A8: 0.2439735596456622, mRNA_EN1: -0.7969313842401103, mRNA_ZNF552: 0.4602882401959589, Methylation_LRRC6: -1.1489999115846965, Methylation_chr2 66218712 LINC02934 (29533): -1.6928280999956524, Methylation_HOXB13: 1.2487553285264092, Methylation_chr10 3949206 LINC02660 (4871): -1.0764623501911923, Methylation_chr5 179517140 RNF130 (18026): -0.1067168749937855, Methylation_LOC727677: -0.2922032987824763, Methylation_LETM1: -0.8554183111327981, Methylation_CDC42BPB: 1.318135623206451, Methylation_C8orf38: -0.5356656977964401, Methylation_chr14 100504766 EVL (18852): -0.6385755337324899, Methylation_chr5 72594851 LOC340090 (24088): 1.2090392355009505, Methylation_chr2 242904738 LINC01238 (3421): -0.6395092003587766, Methylation_ARFGEF1: -1.0546745359288532, Methylation_MAPT: -0.773194121456696, Methylation_ZFAT: -1.1248427800209493, Methylation_KCNQ4: -0.7861076304078676, Methylation_chr1 232684368 SIPA1L2 (12934): -0.4998072584581904, Methylation_CRNKL1: -1.0127712324377462, Methylation_PRKAG2: -1.3826650616010916, Methylation_MICB: -0.9913733121947108, miRNA_hsa-mir-934: -0.2866949056003608, miRNA_hsa-mir-4728: 0.243466043214634, miRNA_hsa-mir-5695: 0.4212720625619743, miRNA_hsa-mir-18a: 1.3537539143064363, miRNA_hsa-mir-190b: 1.3299713610186048, miRNA_hsa-mir-577: 0.6018033735617064, miRNA_hsa-mir-135b: -0.2710247250953221, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.321500678764414, miRNA_hsa-mir-130b: 0.3034705758155758, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A7-A26G,"High-level Amplification of none; Deletion absent. FOXC1 mRNA overexpressed (Z=1.84). DEGS2, CA12, AGR3, ESR1 mRNAs low (Z < -1.92). RNF130 and LOC340090 promoters hypomethylated (Z < -1.47); ARFGEF1, SIPA1L2, LOC727677 hypermethylated (Z > 1.50). miR-190b downregulated (Z=-1.73); miR-135b upregulated (Z=1.55).","mRNA_MLPH: -1.3798852182278438, mRNA_C2orf54: 0.4423492722995584, mRNA_CITED4: -1.531068351144185, mRNA_ESR1: -1.7221488642879037, mRNA_SPDEF: -0.4171300293740361, mRNA_AGR3: -1.8227709400192813, mRNA_FOXC1: 1.8355871972045927, mRNA_GATA3: -1.3353570463152404, mRNA_AGR2: -0.92276266136566, mRNA_XBP1: -0.8394637547593733, mRNA_PRR15: -1.652299646179037, mRNA_SLC44A4: -1.7384590848281358, mRNA_CA12: -1.98267890321554, mRNA_DTL: 0.2203324899947246, mRNA_C5AR2: -0.5491147314998981, mRNA_TBC1D9: -0.5672804734480621, mRNA_AR: -0.5229909925458904, mRNA_CCDC170: -0.6036948138361632, mRNA_DEGS2: -2.445822986108164, mRNA_TFF3: -1.9542909297757007, mRNA_DNALI1: -1.659194976788276, mRNA_LINC00504: -1.4477469234423253, mRNA_CLCA2: 0.4598583645732152, mRNA_PPP1R14C: 0.7564739966705609, mRNA_THSD4: -0.8931322439084064, mRNA_SPAG5: 0.0287064885307942, mRNA_FBP1: -1.4308041301492722, mRNA_SLC7A8: -0.6824845463066708, mRNA_EN1: -0.2480988494895857, mRNA_ZNF552: -1.233171138477097, Methylation_LRRC6: 1.338121436575359, Methylation_chr2 66218712 LINC02934 (29533): 0.5952531447241824, Methylation_HOXB13: -1.0811898613393207, Methylation_chr10 3949206 LINC02660 (4871): 1.3295034413135414, Methylation_chr5 179517140 RNF130 (18026): -1.4937560158833063, Methylation_LOC727677: 1.5324749417008312, Methylation_LETM1: 1.3424398063671514, Methylation_CDC42BPB: 0.1734518448454644, Methylation_C8orf38: 0.9816919401653256, Methylation_chr14 100504766 EVL (18852): 1.4797532521452146, Methylation_chr5 72594851 LOC340090 (24088): -1.403751593493982, Methylation_chr2 242904738 LINC01238 (3421): 1.3234266113588609, Methylation_ARFGEF1: 1.6879977578446763, Methylation_MAPT: 1.4567204188221916, Methylation_ZFAT: 1.4600427591144192, Methylation_KCNQ4: 0.0699442081446974, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5401833958836508, Methylation_CRNKL1: 1.4277028432414784, Methylation_PRKAG2: 0.0932831721095092, Methylation_MICB: 1.4790627611550244, miRNA_hsa-mir-934: 1.2989390447850933, miRNA_hsa-mir-4728: -0.5065995971732619, miRNA_hsa-mir-5695: 0.4672522512197138, miRNA_hsa-mir-18a: 0.4728828452122798, miRNA_hsa-mir-190b: -1.7317193167988845, miRNA_hsa-mir-577: 1.0929544664620767, miRNA_hsa-mir-135b: 1.551932649133367, miRNA_hsa-mir-2115: 0.7155346341558649, miRNA_hsa-mir-17: 0.2149181674220871, miRNA_hsa-mir-130b: 0.7734529427439539, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-E9-A1RI,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.2195200992367819, mRNA_C2orf54: 0.1501039245145097, mRNA_CITED4: 0.0399117984396617, mRNA_ESR1: 0.0226613584678936, mRNA_SPDEF: 0.2174670827067293, mRNA_AGR3: 0.2466976051154981, mRNA_FOXC1: -0.2366306904636223, mRNA_GATA3: 0.5103147993136317, mRNA_AGR2: 0.635930672089222, mRNA_XBP1: 0.028402627927754, mRNA_PRR15: 1.024920577614202, mRNA_SLC44A4: 0.2478788125433851, mRNA_CA12: 0.7735316880527789, mRNA_DTL: -0.7567762183596473, mRNA_C5AR2: 0.4373728242570986, mRNA_TBC1D9: 0.4782536263146605, mRNA_AR: 1.0466318106726424, mRNA_CCDC170: 0.4543571986561067, mRNA_DEGS2: 0.1316851016529623, mRNA_TFF3: 0.5742220656962121, mRNA_DNALI1: 0.8130092742464398, mRNA_LINC00504: 0.986667785182944, mRNA_CLCA2: -0.4633552347276906, mRNA_PPP1R14C: 0.096599780886881, mRNA_THSD4: 0.7082472651619605, mRNA_SPAG5: -0.5631598629069728, mRNA_FBP1: 0.8663708557690492, mRNA_SLC7A8: 0.9038604882214292, mRNA_EN1: -0.0180970521320292, mRNA_ZNF552: 1.0308594540245395, Methylation_LRRC6: -0.1011936731682373, Methylation_chr2 66218712 LINC02934 (29533): 1.0629845653755, Methylation_HOXB13: -0.8619930687891538, Methylation_chr10 3949206 LINC02660 (4871): 0.3757113267083903, Methylation_chr5 179517140 RNF130 (18026): 0.5507170620913107, Methylation_LOC727677: -0.34399259773321, Methylation_LETM1: -0.5533586986599147, Methylation_CDC42BPB: -0.2107521330286007, Methylation_C8orf38: 0.4211661442036894, Methylation_chr14 100504766 EVL (18852): -0.342408904188382, Methylation_chr5 72594851 LOC340090 (24088): 0.7156798418388673, Methylation_chr2 242904738 LINC01238 (3421): -0.4030316046629802, Methylation_ARFGEF1: 0.1359766485982169, Methylation_MAPT: -0.8303991441039624, Methylation_ZFAT: 0.0165542373865844, Methylation_KCNQ4: -0.98325993792735, Methylation_chr1 232684368 SIPA1L2 (12934): 0.6359776736808774, Methylation_CRNKL1: -0.1807165854959167, Methylation_PRKAG2: 1.1690767487716305, Methylation_MICB: -0.4817817405878978, miRNA_hsa-mir-934: -0.3066681806302247, miRNA_hsa-mir-4728: -0.1394995523605811, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.8084757713941974, miRNA_hsa-mir-190b: 0.0659522024206167, miRNA_hsa-mir-577: -0.2953175733104529, miRNA_hsa-mir-135b: -0.3120262033684969, miRNA_hsa-mir-2115: -0.2278560193188658, miRNA_hsa-mir-17: -0.3626398440310811, miRNA_hsa-mir-130b: 0.0486463225365503, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AC-A62X,"High-level Amplification absent; no CNVs meet amplification thresholds.  
mRNA_FOXC1 (Z=2.31) and mRNA_PPP1R14C (Z=1.51) are overexpressed; mRNA_FBP1 (Z=-3.46), mRNA_DNALI1 (Z=-2.08), and mRNA_CCDC170 (Z=-2.01) are suppressed.  
Methylation_KCNQ4 (Z=2.15) is hypermethylated; Methylation_RNF130 (Z=-1.56) and Methylation_LOC340090 (Z=-1.60) are hypomethylated.  
miRNA_hsa-mir-18a (Z=1.67) upregulated; miRNA_hsa-mir-190b (Z=-1.26) downregulated.","mRNA_MLPH: -1.9456974846239088, mRNA_C2orf54: -0.8287969008464493, mRNA_CITED4: 1.3440422171640716, mRNA_ESR1: -1.898922241168331, mRNA_SPDEF: 0.4770230002979744, mRNA_AGR3: -1.8392263508815856, mRNA_FOXC1: 2.308877814698279, mRNA_GATA3: -0.3896478576448425, mRNA_AGR2: -1.9391815645577373, mRNA_XBP1: -1.868516800310684, mRNA_PRR15: -1.7546544998238836, mRNA_SLC44A4: -2.256011316815471, mRNA_CA12: -1.7939522936986252, mRNA_DTL: 0.7776683963379634, mRNA_C5AR2: -1.0522493584833366, mRNA_TBC1D9: -0.9235739060163556, mRNA_AR: -0.5093276479472062, mRNA_CCDC170: -2.012547376043007, mRNA_DEGS2: -1.0627923510045407, mRNA_TFF3: -1.90057063915157, mRNA_DNALI1: -2.0820633607888586, mRNA_LINC00504: -1.5692947820230077, mRNA_CLCA2: -0.1974626336633838, mRNA_PPP1R14C: 1.5070920109532118, mRNA_THSD4: -2.116285537717997, mRNA_SPAG5: 0.3032841333649578, mRNA_FBP1: -3.457302231578077, mRNA_SLC7A8: -0.6671301444034262, mRNA_EN1: 1.0985947966561025, mRNA_ZNF552: -0.8011761564812809, Methylation_LRRC6: 1.435064559998556, Methylation_chr2 66218712 LINC02934 (29533): -1.1228013677585038, Methylation_HOXB13: -0.9842375872890996, Methylation_chr10 3949206 LINC02660 (4871): 1.6456014239175238, Methylation_chr5 179517140 RNF130 (18026): -1.555661644284441, Methylation_LOC727677: 1.4771858938270577, Methylation_LETM1: 1.3008425149527898, Methylation_CDC42BPB: 0.7158831137600734, Methylation_C8orf38: 1.6003527626844836, Methylation_chr14 100504766 EVL (18852): 1.3859782456463436, Methylation_chr5 72594851 LOC340090 (24088): -1.599461673124859, Methylation_chr2 242904738 LINC01238 (3421): 1.4004317719790622, Methylation_ARFGEF1: 1.5534907440448942, Methylation_MAPT: 1.122790804506116, Methylation_ZFAT: 1.4412117923582888, Methylation_KCNQ4: 2.1526969020769418, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5722707487297496, Methylation_CRNKL1: 1.1286554346744049, Methylation_PRKAG2: -0.9940380016019232, Methylation_MICB: 1.501352940040119, miRNA_hsa-mir-934: 1.4557956449876563, miRNA_hsa-mir-4728: -0.4699496193799225, miRNA_hsa-mir-5695: 0.7396758516972665, miRNA_hsa-mir-18a: 1.6713509293365252, miRNA_hsa-mir-190b: -1.2589211597217338, miRNA_hsa-mir-577: 0.3395543830687981, miRNA_hsa-mir-135b: 0.8862867530182995, miRNA_hsa-mir-2115: 0.233668069333887, miRNA_hsa-mir-17: 1.0795967646066718, miRNA_hsa-mir-130b: -1.115106948104989, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-3C-AALK,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.6298642351202315, mRNA_C2orf54: -0.4479705550311277, mRNA_CITED4: -0.4160220514096991, mRNA_ESR1: -0.3111026502867559, mRNA_SPDEF: 0.6359156747253836, mRNA_AGR3: 0.175670769336522, mRNA_FOXC1: 0.1941311033991911, mRNA_GATA3: 0.104891191848976, mRNA_AGR2: 0.596510942252933, mRNA_XBP1: 0.7231763535199836, mRNA_PRR15: 0.4616246516455252, mRNA_SLC44A4: 0.6950680358823026, mRNA_CA12: -0.0054736445171979, mRNA_DTL: -0.4801535965577686, mRNA_C5AR2: 0.4772932533104451, mRNA_TBC1D9: 0.0548069994745043, mRNA_AR: 0.3864620992523839, mRNA_CCDC170: -0.0740165244238159, mRNA_DEGS2: 0.8277220533275432, mRNA_TFF3: 0.6723779316320052, mRNA_DNALI1: 0.5350720093445173, mRNA_LINC00504: 0.2182714768792753, mRNA_CLCA2: 1.39778554135582, mRNA_PPP1R14C: -0.0253512417872046, mRNA_THSD4: 0.1528663079673017, mRNA_SPAG5: 0.0952848797074707, mRNA_FBP1: 0.2096794012759345, mRNA_SLC7A8: 0.8509253271258966, mRNA_EN1: -0.0384089808093263, mRNA_ZNF552: -0.0853238554357076, Methylation_LRRC6: -0.3326405282919505, Methylation_chr2 66218712 LINC02934 (29533): 0.3682057015226264, Methylation_HOXB13: 1.0421519136929516, Methylation_chr10 3949206 LINC02660 (4871): 0.2914089253369264, Methylation_chr5 179517140 RNF130 (18026): 0.4331673847387532, Methylation_LOC727677: -0.3489054215240827, Methylation_LETM1: 0.830034881979612, Methylation_CDC42BPB: -0.9818372131032064, Methylation_C8orf38: -0.3657750577217165, Methylation_chr14 100504766 EVL (18852): -0.2478675784347969, Methylation_chr5 72594851 LOC340090 (24088): 0.5138105498178576, Methylation_chr2 242904738 LINC01238 (3421): 1.2814860014009335, Methylation_ARFGEF1: -0.8074795178852218, Methylation_MAPT: -0.8737967024205461, Methylation_ZFAT: 0.212358058033827, Methylation_KCNQ4: -0.8575027451037998, Methylation_chr1 232684368 SIPA1L2 (12934): -0.7746746004598478, Methylation_CRNKL1: -0.5755297332744691, Methylation_PRKAG2: 0.5612980924524652, Methylation_MICB: -0.7356203783978587, miRNA_hsa-mir-934: -0.1033384770332304, miRNA_hsa-mir-4728: 0.8089483939771439, miRNA_hsa-mir-5695: 0.1315577841715705, miRNA_hsa-mir-18a: -0.608804268529414, miRNA_hsa-mir-190b: 0.3005245654634222, miRNA_hsa-mir-577: -0.6432026436441718, miRNA_hsa-mir-135b: -0.5441875854086231, miRNA_hsa-mir-2115: 0.8133800632952812, miRNA_hsa-mir-17: 0.2908394017693403, miRNA_hsa-mir-130b: -0.7748580895880869, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-B6-A0WY,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-significant ranges per specified Z-score and CNV cutoffs.","mRNA_MLPH: 0.1081385551904815, mRNA_C2orf54: 0.5359688549749141, mRNA_CITED4: 0.6268832304342005, mRNA_ESR1: -0.0773383836848202, mRNA_SPDEF: 0.483942441808239, mRNA_AGR3: 0.3831843775844661, mRNA_FOXC1: 0.405030066406412, mRNA_GATA3: 0.3451792417971049, mRNA_AGR2: -0.018619318087306, mRNA_XBP1: 0.4421722015455905, mRNA_PRR15: 0.257111919168248, mRNA_SLC44A4: -0.1039905123012058, mRNA_CA12: 0.5003431787731358, mRNA_DTL: -0.8494700465153426, mRNA_C5AR2: 0.1366812118294514, mRNA_TBC1D9: 0.0559208800989393, mRNA_AR: 0.0612305168587564, mRNA_CCDC170: -0.3718292973375856, mRNA_DEGS2: -0.5510696657188131, mRNA_TFF3: 0.3495371885915146, mRNA_DNALI1: 0.385680444269342, mRNA_LINC00504: -0.2294933809112628, mRNA_CLCA2: 1.5981809570797825, mRNA_PPP1R14C: 0.1911911453393953, mRNA_THSD4: 0.2795225441598401, mRNA_SPAG5: -0.5699842598191404, mRNA_FBP1: 0.5321239683889742, mRNA_SLC7A8: 0.6614350555201122, mRNA_EN1: -0.4007267032378366, mRNA_ZNF552: 0.0149139818200643, Methylation_LRRC6: 0.1287776514012266, Methylation_chr2 66218712 LINC02934 (29533): -0.1102721583124964, Methylation_HOXB13: 1.17121075557843, Methylation_chr10 3949206 LINC02660 (4871): 0.5971009522770566, Methylation_chr5 179517140 RNF130 (18026): -0.0191549727958543, Methylation_LOC727677: 0.3318012445907453, Methylation_LETM1: 0.9631604567637516, Methylation_CDC42BPB: 0.2541832292021201, Methylation_C8orf38: -0.5253760669297656, Methylation_chr14 100504766 EVL (18852): 0.2766739657465593, Methylation_chr5 72594851 LOC340090 (24088): -0.477957684362861, Methylation_chr2 242904738 LINC01238 (3421): 0.2665072526298075, Methylation_ARFGEF1: -0.3854336164536037, Methylation_MAPT: 0.058379030766289, Methylation_ZFAT: -0.0946746680707511, Methylation_KCNQ4: -0.7678362165212349, Methylation_chr1 232684368 SIPA1L2 (12934): -0.1453548524457288, Methylation_CRNKL1: -0.3470463085833292, Methylation_PRKAG2: 0.4044906098674629, Methylation_MICB: -0.151550158744082, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.6212230689122307, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 1.2233728814932712, miRNA_hsa-mir-190b: 0.7825505130927751, miRNA_hsa-mir-577: 0.3785710306710772, miRNA_hsa-mir-135b: 1.629486381633279, miRNA_hsa-mir-2115: 0.4580000148342581, miRNA_hsa-mir-17: 1.1938678226725663, miRNA_hsa-mir-130b: -0.248082827724446, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-AR-A1AL,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.4975668367448742, mRNA_C2orf54: -1.2599476540474477, mRNA_CITED4: 0.9084035462104372, mRNA_ESR1: 0.3420334698808699, mRNA_SPDEF: -0.061807164334613, mRNA_AGR3: 0.3340258624938519, mRNA_FOXC1: 0.492182803899285, mRNA_GATA3: 0.3388196348112456, mRNA_AGR2: 0.5824704745527401, mRNA_XBP1: 0.6943095868980546, mRNA_PRR15: 0.0744810232958746, mRNA_SLC44A4: 0.4215062473820231, mRNA_CA12: 0.4447541960651199, mRNA_DTL: 0.3328244723971101, mRNA_C5AR2: 0.5352123281321989, mRNA_TBC1D9: 0.810793298007266, mRNA_AR: 0.7558491593937132, mRNA_CCDC170: 0.5199159933220253, mRNA_DEGS2: -0.4106815857561656, mRNA_TFF3: 0.5113591125121699, mRNA_DNALI1: 1.1345292119217516, mRNA_LINC00504: 0.981861301167948, mRNA_CLCA2: 1.046203766493098, mRNA_PPP1R14C: 0.4753457460240645, mRNA_THSD4: 0.9190420373237496, mRNA_SPAG5: -0.3157113358019626, mRNA_FBP1: -0.1681729387574027, mRNA_SLC7A8: 0.4921072687934756, mRNA_EN1: -0.6171828777773937, mRNA_ZNF552: 1.0588863797573151, Methylation_LRRC6: 0.5670664572358558, Methylation_chr2 66218712 LINC02934 (29533): -0.0806027412856348, Methylation_HOXB13: -1.0457410149284194, Methylation_chr10 3949206 LINC02660 (4871): 0.4171610471888256, Methylation_chr5 179517140 RNF130 (18026): 0.3327273130188998, Methylation_LOC727677: 0.151105789616247, Methylation_LETM1: 0.7188674848054969, Methylation_CDC42BPB: -0.4636829275040063, Methylation_C8orf38: -0.0495629049789281, Methylation_chr14 100504766 EVL (18852): 0.102518674971278, Methylation_chr5 72594851 LOC340090 (24088): 0.7477649374547728, Methylation_chr2 242904738 LINC01238 (3421): -0.0697752035826526, Methylation_ARFGEF1: 0.8626543325218939, Methylation_MAPT: 0.2403448926031903, Methylation_ZFAT: 0.2073079236980938, Methylation_KCNQ4: -1.0111908889805394, Methylation_chr1 232684368 SIPA1L2 (12934): 0.9107547993364268, Methylation_CRNKL1: -0.3794364829777467, Methylation_PRKAG2: 1.2550069688871244, Methylation_MICB: -0.1803426716389054, miRNA_hsa-mir-934: 0.3468976853132812, miRNA_hsa-mir-4728: -0.5257581266741862, miRNA_hsa-mir-5695: 0.7485913060147089, miRNA_hsa-mir-18a: -1.4065226860843578, miRNA_hsa-mir-190b: 0.9242820573927824, miRNA_hsa-mir-577: 0.1826643056718132, miRNA_hsa-mir-135b: 0.1209219351520866, miRNA_hsa-mir-2115: 0.6861909845822324, miRNA_hsa-mir-17: -0.7138254931049106, miRNA_hsa-mir-130b: -0.4891547802111337, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A2-A0T2,"High-level Amplification of *VPS54*, *LINC01867*, *LINC02576*, *WDPCP*, and *CEP68* drives oncogenic mRNA overexpression. *FOXC1* mRNA is significantly elevated (Z=2.02), while *ESR1*, *AGR3*, *XBP1*, *TFF3*, and *FBP1* are transcriptionally silenced (Z < -1.92). Promoter hypermethylation at *ARFGEF1*, *KCNQ4*, and *LINC02660* (Z > 1.50) mediates epigenetic repression. miRNA hsa-mir-934 is upregulated (Z=2.13). These features indicate a basal-like phenotype with ER pathway suppression.","mRNA_MLPH: -1.1832420636558203, mRNA_C2orf54: -0.0950424802829063, mRNA_CITED4: 0.7221097874342828, mRNA_ESR1: -1.977217780270944, mRNA_SPDEF: -0.5579186817139288, mRNA_AGR3: -1.9596209974149967, mRNA_FOXC1: 2.019091121679151, mRNA_GATA3: -0.6650772890926177, mRNA_AGR2: -1.7080346009552072, mRNA_XBP1: -2.328071575978792, mRNA_PRR15: -2.375253203859222, mRNA_SLC44A4: -2.264473268973929, mRNA_CA12: -1.8088717443642428, mRNA_DTL: -2.113516456852518, mRNA_C5AR2: -1.9567997126248249, mRNA_TBC1D9: -2.60991677737779, mRNA_AR: -2.121024913560223, mRNA_CCDC170: -1.953119046184572, mRNA_DEGS2: -1.3382080580171385, mRNA_TFF3: -2.190507481857017, mRNA_DNALI1: -1.824085857661025, mRNA_LINC00504: -1.6639448423673988, mRNA_CLCA2: 0.6517621289770135, mRNA_PPP1R14C: 1.4339868930315562, mRNA_THSD4: -1.291790237698226, mRNA_SPAG5: -1.088300097616647, mRNA_FBP1: -2.6804952328841622, mRNA_SLC7A8: -1.8828895076248784, mRNA_EN1: 1.8442536265754232, mRNA_ZNF552: -1.3813530854822946, Methylation_LRRC6: 1.4957053819630317, Methylation_chr2 66218712 LINC02934 (29533): -1.5923162066106116, Methylation_HOXB13: 1.276297812145308, Methylation_chr10 3949206 LINC02660 (4871): 1.579204683168454, Methylation_chr5 179517140 RNF130 (18026): -1.560655188319674, Methylation_LOC727677: 1.4983045747818182, Methylation_LETM1: 1.3532817434734508, Methylation_CDC42BPB: 1.0721330753630864, Methylation_C8orf38: 1.4955174311036956, Methylation_chr14 100504766 EVL (18852): 1.3902882909125651, Methylation_chr5 72594851 LOC340090 (24088): -1.554659754002101, Methylation_chr2 242904738 LINC01238 (3421): 1.4091528129474524, Methylation_ARFGEF1: 1.6738900616455092, Methylation_MAPT: 1.3675913020402692, Methylation_ZFAT: 1.3985975137721738, Methylation_KCNQ4: 1.6186756317020607, Methylation_chr1 232684368 SIPA1L2 (12934): 1.412301538565515, Methylation_CRNKL1: 1.2426821653744091, Methylation_PRKAG2: 0.1889630329600905, Methylation_MICB: 1.4594641461991065, miRNA_hsa-mir-934: 2.128412203039096, miRNA_hsa-mir-4728: -0.046996719853231, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.9278376420542804, miRNA_hsa-mir-190b: -0.7621894891426424, miRNA_hsa-mir-577: 1.6859930048635163, miRNA_hsa-mir-135b: 0.3956967201962764, miRNA_hsa-mir-2115: -0.0425722660372504, miRNA_hsa-mir-17: 0.0365277868045079, miRNA_hsa-mir-130b: 0.8740324013553552, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 1.3848383467906238, CNV_CEP68: 1.4339562938734052"
TCGA-AN-A0XP,"mRNA_XBP1 (Z=1.51) and mRNA_CCDC170 (Z=1.40) exceed the high-expression threshold (Z>1.30). No methylation sites meet hyper/hypo-methylation criteria. No miRNAs cross expression thresholds. All CNVs fall within -0.10 to 0.90, indicating gains (e.g., CNV_VPS54=0.38), but no amplifications or deletions. Gains in 1q regions may support luminal transcriptional activity.","mRNA_MLPH: 0.5271534482265801, mRNA_C2orf54: -0.5412608110979295, mRNA_CITED4: 0.1792421292212264, mRNA_ESR1: 1.2505274373351, mRNA_SPDEF: 0.4595893784391308, mRNA_AGR3: 1.0728660585210463, mRNA_FOXC1: -0.9990495649136288, mRNA_GATA3: 0.7625467081312493, mRNA_AGR2: 0.0826827848958972, mRNA_XBP1: 1.4480145453844513, mRNA_PRR15: 0.6426898501149517, mRNA_SLC44A4: 1.1363426338221163, mRNA_CA12: 1.0821600910214204, mRNA_DTL: -0.435851788781058, mRNA_C5AR2: 1.1493083526539318, mRNA_TBC1D9: 1.218045475802915, mRNA_AR: 0.9338512409555482, mRNA_CCDC170: 1.4043510667069874, mRNA_DEGS2: 1.030827798093144, mRNA_TFF3: 0.2288966038589808, mRNA_DNALI1: 0.474056229828156, mRNA_LINC00504: 0.7987011966559782, mRNA_CLCA2: -0.8507476552305266, mRNA_PPP1R14C: -0.9460162798185694, mRNA_THSD4: 1.1147798711726364, mRNA_SPAG5: -0.8988088298351581, mRNA_FBP1: 0.3917159368329667, mRNA_SLC7A8: 0.2751180803509981, mRNA_EN1: -0.2025022979166722, mRNA_ZNF552: 1.5100067163302244, Methylation_LRRC6: -0.7288598681858677, Methylation_chr2 66218712 LINC02934 (29533): -0.2960762307983438, Methylation_HOXB13: -0.8356787661864342, Methylation_chr10 3949206 LINC02660 (4871): -0.8180702001219625, Methylation_chr5 179517140 RNF130 (18026): 1.028360080504116, Methylation_LOC727677: -1.0652810064161682, Methylation_LETM1: -0.5182063305940164, Methylation_CDC42BPB: -1.2647038454952744, Methylation_C8orf38: -0.8248659680135374, Methylation_chr14 100504766 EVL (18852): -0.7811428261313322, Methylation_chr5 72594851 LOC340090 (24088): 1.070902762319668, Methylation_chr2 242904738 LINC01238 (3421): -0.8658394863278751, Methylation_ARFGEF1: -0.8140045549211118, Methylation_MAPT: -0.794261477602389, Methylation_ZFAT: -0.390478685964865, Methylation_KCNQ4: 0.0305808476164924, Methylation_chr1 232684368 SIPA1L2 (12934): -0.2773329413490989, Methylation_CRNKL1: -0.4803688497078715, Methylation_PRKAG2: -0.5306953074683851, Methylation_MICB: -0.270064216055259, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.5416353458520571, miRNA_hsa-mir-5695: 0.7947441104947058, miRNA_hsa-mir-18a: -0.91783317793376, miRNA_hsa-mir-190b: 0.511082320422141, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.517787041675459, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.8479288194371848, miRNA_hsa-mir-130b: -0.8873907528469097, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-D8-A27I,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.4319482540418654, mRNA_C2orf54: -0.7562274990386824, mRNA_CITED4: 0.5843916389961339, mRNA_ESR1: 0.5699523597121695, mRNA_SPDEF: 0.0250922163672156, mRNA_AGR3: 0.4060047513325849, mRNA_FOXC1: 0.2634166549700099, mRNA_GATA3: 0.1758471610090894, mRNA_AGR2: 0.2318688816394524, mRNA_XBP1: 0.1520857717063448, mRNA_PRR15: -0.1259521958316323, mRNA_SLC44A4: -0.0287647308248658, mRNA_CA12: 0.833616956957915, mRNA_DTL: -0.2652281399319249, mRNA_C5AR2: 0.4647246523775811, mRNA_TBC1D9: 0.7845781205487223, mRNA_AR: 0.1848382043340604, mRNA_CCDC170: 0.4707453388938684, mRNA_DEGS2: 0.204897817832481, mRNA_TFF3: -0.5191621125893439, mRNA_DNALI1: 0.4075316214099641, mRNA_LINC00504: 0.2539397819658204, mRNA_CLCA2: 0.3671115490546283, mRNA_PPP1R14C: -0.1934044150146768, mRNA_THSD4: 0.7970989642667146, mRNA_SPAG5: -0.4535450850821783, mRNA_FBP1: 0.3650732861720294, mRNA_SLC7A8: 0.1368416182164173, mRNA_EN1: -0.6494312228711991, mRNA_ZNF552: 0.6668215001280593, Methylation_LRRC6: 0.6964051297081615, Methylation_chr2 66218712 LINC02934 (29533): -0.538303311628797, Methylation_HOXB13: -1.088837732684125, Methylation_chr10 3949206 LINC02660 (4871): 0.7314806811457025, Methylation_chr5 179517140 RNF130 (18026): -0.4926017803651885, Methylation_LOC727677: 0.3234943881637872, Methylation_LETM1: 0.3647715077953835, Methylation_CDC42BPB: 0.19776242023386, Methylation_C8orf38: 0.0413809540522504, Methylation_chr14 100504766 EVL (18852): 1.1689662412346715, Methylation_chr5 72594851 LOC340090 (24088): 0.2305695514427454, Methylation_chr2 242904738 LINC01238 (3421): -0.108446444941437, Methylation_ARFGEF1: 1.117644304526091, Methylation_MAPT: 0.5219667440085551, Methylation_ZFAT: 0.1043850398067265, Methylation_KCNQ4: -0.8405593901585628, Methylation_chr1 232684368 SIPA1L2 (12934): 1.056241195326605, Methylation_CRNKL1: 0.5220177393611362, Methylation_PRKAG2: 1.1860414972638516, Methylation_MICB: 0.7871703669187875, miRNA_hsa-mir-934: -0.4443364825886969, miRNA_hsa-mir-4728: -0.3652282361521314, miRNA_hsa-mir-5695: -0.1853519045962482, miRNA_hsa-mir-18a: -1.163349318670074, miRNA_hsa-mir-190b: -1.2031878187073777, miRNA_hsa-mir-577: -0.6193058787387172, miRNA_hsa-mir-135b: -0.6476258760425508, miRNA_hsa-mir-2115: 1.6312516865742823, miRNA_hsa-mir-17: -1.548965475277984, miRNA_hsa-mir-130b: -1.6438098968779054, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-XX-A89A,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations.","mRNA_MLPH: 0.3562234349232417, mRNA_C2orf54: -1.1712194090557395, mRNA_CITED4: 0.1264092887358048, mRNA_ESR1: -0.2752736430477541, mRNA_SPDEF: 0.3550432178496827, mRNA_AGR3: 0.2181911368860402, mRNA_FOXC1: 0.150054859437046, mRNA_GATA3: -0.0597531232368905, mRNA_AGR2: 0.1561875516922931, mRNA_XBP1: -0.1370345052439719, mRNA_PRR15: 0.0462411226702017, mRNA_SLC44A4: 0.810461023118718, mRNA_CA12: -0.17994880628154, mRNA_DTL: -0.9118228423771224, mRNA_C5AR2: 1.060747180558267, mRNA_TBC1D9: -0.2596616326569013, mRNA_AR: 0.0586798556862515, mRNA_CCDC170: 0.0558970967288907, mRNA_DEGS2: -0.018421131448755, mRNA_TFF3: -0.4027796689905091, mRNA_DNALI1: -0.6237480741608677, mRNA_LINC00504: -0.4987479715967864, mRNA_CLCA2: -0.3964683917753711, mRNA_PPP1R14C: -0.9332247585234668, mRNA_THSD4: 0.4237457648365558, mRNA_SPAG5: -0.9046402988986422, mRNA_FBP1: 0.9906625904999172, mRNA_SLC7A8: 0.0440164238750531, mRNA_EN1: 0.1841731351289142, mRNA_ZNF552: 0.0821458256401506, Methylation_LRRC6: 0.3435893203052202, Methylation_chr2 66218712 LINC02934 (29533): 0.058538799118212, Methylation_HOXB13: 0.3490036083678333, Methylation_chr10 3949206 LINC02660 (4871): -0.6674256422431026, Methylation_chr5 179517140 RNF130 (18026): -1.1667155499914168, Methylation_LOC727677: 0.117907535414095, Methylation_LETM1: 0.1357292328307481, Methylation_CDC42BPB: -0.6089191612602873, Methylation_C8orf38: -0.2105905136272052, Methylation_chr14 100504766 EVL (18852): 0.5199198837315879, Methylation_chr5 72594851 LOC340090 (24088): -1.4953770581723669, Methylation_chr2 242904738 LINC01238 (3421): -0.276722131273051, Methylation_ARFGEF1: 0.7255279298959835, Methylation_MAPT: 0.6415081779940562, Methylation_ZFAT: -0.0926359548522489, Methylation_KCNQ4: 1.0706497494817873, Methylation_chr1 232684368 SIPA1L2 (12934): 0.8745873084631797, Methylation_CRNKL1: 0.6715536922297245, Methylation_PRKAG2: -0.9747513051996392, Methylation_MICB: 0.389447216054978, miRNA_hsa-mir-934: -0.318967978778666, miRNA_hsa-mir-4728: -0.8933199439920401, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.6949590784380986, miRNA_hsa-mir-190b: 0.1915830477517957, miRNA_hsa-mir-577: 0.1690747046535115, miRNA_hsa-mir-135b: -0.7746465181283154, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.5369167502481427, miRNA_hsa-mir-130b: -0.8606571968321725, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-EW-A1IX,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.7571455636041095, mRNA_C2orf54: 0.2712109858465773, mRNA_CITED4: 0.4002857719442307, mRNA_ESR1: 0.2983622007560768, mRNA_SPDEF: 0.6576062404124648, mRNA_AGR3: 0.0450260122807151, mRNA_FOXC1: -0.4778798924833087, mRNA_GATA3: 0.8787216278668121, mRNA_AGR2: 1.1980732513725256, mRNA_XBP1: 0.0645725692979935, mRNA_PRR15: 0.6079318994831963, mRNA_SLC44A4: 0.2559309942371422, mRNA_CA12: 0.6746085852165941, mRNA_DTL: -1.1226790131206197, mRNA_C5AR2: 1.465845439345981, mRNA_TBC1D9: 0.6264629968125391, mRNA_AR: 0.9064059209361448, mRNA_CCDC170: 0.9710337417503508, mRNA_DEGS2: 1.1249517843486332, mRNA_TFF3: 0.8906137960532454, mRNA_DNALI1: 0.8214339247863505, mRNA_LINC00504: 0.2356091611163417, mRNA_CLCA2: -0.7339736642033334, mRNA_PPP1R14C: -0.7822489571497655, mRNA_THSD4: 1.0705966557756723, mRNA_SPAG5: -1.2641477097250495, mRNA_FBP1: 0.8606869766008953, mRNA_SLC7A8: 1.114212730010516, mRNA_EN1: 0.2222079983343296, mRNA_ZNF552: 1.2677893875710111, Methylation_LRRC6: 0.2668583860257312, Methylation_chr2 66218712 LINC02934 (29533): 0.1161937889037161, Methylation_HOXB13: -1.0855074595738232, Methylation_chr10 3949206 LINC02660 (4871): -0.0766500208547289, Methylation_chr5 179517140 RNF130 (18026): 0.3786778754414834, Methylation_LOC727677: -0.2723960482387119, Methylation_LETM1: 0.7773196772951715, Methylation_CDC42BPB: -1.1891561103867974, Methylation_C8orf38: -0.0779358364206396, Methylation_chr14 100504766 EVL (18852): -0.2947699525562642, Methylation_chr5 72594851 LOC340090 (24088): 0.5097541068959003, Methylation_chr2 242904738 LINC01238 (3421): 0.6951597685033767, Methylation_ARFGEF1: 0.1238640182896956, Methylation_MAPT: -0.2484871108197903, Methylation_ZFAT: 0.4603533885359214, Methylation_KCNQ4: -1.104459132351569, Methylation_chr1 232684368 SIPA1L2 (12934): 0.4949186895981329, Methylation_CRNKL1: 0.1451958586324783, Methylation_PRKAG2: 1.19641482927104, Methylation_MICB: -0.5678799522862581, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.1277214623301794, miRNA_hsa-mir-5695: -0.0742159623035133, miRNA_hsa-mir-18a: -0.5284806203451238, miRNA_hsa-mir-190b: -0.1196272133351917, miRNA_hsa-mir-577: -0.2413296358736917, miRNA_hsa-mir-135b: -0.6317517331488989, miRNA_hsa-mir-2115: -0.1663286829356785, miRNA_hsa-mir-17: -0.8258435597577339, miRNA_hsa-mir-130b: -0.0421130888146768, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-LL-A740,"High-level Amplification of none; no CNVs meet amplification thresholds.  
HOXB13 promoter hypermethylation (Z=1.83) suggests epigenetic silencing.  
mRNA_C2orf54 overexpression (Z=2.35) indicates transcriptional activation.  
miR-2115 upregulation (Z=3.75) may suppress target tumor suppressors.  
Collectively, these features suggest a luminal B-like phenotype with PI3K/AKT dysregulation.","mRNA_MLPH: 0.0963242587543758, mRNA_C2orf54: 2.347635435885345, mRNA_CITED4: -0.9995479169329752, mRNA_ESR1: -1.7621106764840977, mRNA_SPDEF: 0.518242637466793, mRNA_AGR3: -1.6973971147582123, mRNA_FOXC1: -0.2780259697817576, mRNA_GATA3: -1.0855636436602238, mRNA_AGR2: -0.452903040482678, mRNA_XBP1: -0.5023772732699718, mRNA_PRR15: -0.1168759756897916, mRNA_SLC44A4: -1.3692708666019011, mRNA_CA12: -1.2189695483660767, mRNA_DTL: -1.090426343913609, mRNA_C5AR2: -1.3134475729052133, mRNA_TBC1D9: -1.3139604719033435, mRNA_AR: 0.583498076463978, mRNA_CCDC170: -1.4831103612595964, mRNA_DEGS2: -1.6137990420631063, mRNA_TFF3: 0.3397978078236183, mRNA_DNALI1: -1.376902498841376, mRNA_LINC00504: -1.664422612960033, mRNA_CLCA2: 1.0878978684392224, mRNA_PPP1R14C: 1.7117393729735864, mRNA_THSD4: -0.3105749538644101, mRNA_SPAG5: -0.9004421748087015, mRNA_FBP1: 0.030216325287183, mRNA_SLC7A8: 0.3876440753254986, mRNA_EN1: 0.1602955400602472, mRNA_ZNF552: -0.6517956944201577, Methylation_LRRC6: 1.1030668504422534, Methylation_chr2 66218712 LINC02934 (29533): 0.1164183788641602, Methylation_HOXB13: 1.833833800954993, Methylation_chr10 3949206 LINC02660 (4871): -0.4047217402392306, Methylation_chr5 179517140 RNF130 (18026): -0.2748244044597179, Methylation_LOC727677: 1.4788148864606756, Methylation_LETM1: 1.2998163986136582, Methylation_CDC42BPB: -0.9188146741252484, Methylation_C8orf38: 1.1477593222384237, Methylation_chr14 100504766 EVL (18852): 0.9507630378026332, Methylation_chr5 72594851 LOC340090 (24088): 1.0984619339010064, Methylation_chr2 242904738 LINC01238 (3421): 1.4301001084083167, Methylation_ARFGEF1: 0.2074322543792586, Methylation_MAPT: 1.1815799841678705, Methylation_ZFAT: 1.4307839711668031, Methylation_KCNQ4: 0.4901350708667821, Methylation_chr1 232684368 SIPA1L2 (12934): 1.2608343706025975, Methylation_CRNKL1: 1.0700251187701102, Methylation_PRKAG2: 1.259010789477377, Methylation_MICB: 0.9129422655133522, miRNA_hsa-mir-934: 0.9672433757941707, miRNA_hsa-mir-4728: -0.8314812128503586, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.25111306796392, miRNA_hsa-mir-190b: -1.7321508085588335, miRNA_hsa-mir-577: -0.5963838315726276, miRNA_hsa-mir-135b: -0.7906138500894304, miRNA_hsa-mir-2115: 3.746847555010174, miRNA_hsa-mir-17: -0.2992293343988386, miRNA_hsa-mir-130b: -0.04206544192646, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A0U4,"PPP1R14C mRNA overexpression (Z=2.59) and EN1 upregulation (Z=1.70) occur despite no focal amplification. Promoter hypermethylation of ARFGEF1, C8orf38, and chr10:3949206 (all Z>1.50) suggests epigenetic silencing. miR-5695, miR-577, and miR-135b are markedly upregulated (Z>2.5). Deletions absent; gains in WDPCP (CNV=0.38). Phenotype aligns with luminal B subtype and PI3K/AKT dysregulation.","mRNA_MLPH: -2.552238479758973, mRNA_C2orf54: -1.121851507646115, mRNA_CITED4: 0.8216573983499488, mRNA_ESR1: -1.5023755019001093, mRNA_SPDEF: -2.937365898949373, mRNA_AGR3: -1.721718523605434, mRNA_FOXC1: 1.0693768489050235, mRNA_GATA3: -1.1324755620814666, mRNA_AGR2: -1.025677060396864, mRNA_XBP1: -1.611257432960563, mRNA_PRR15: -2.5914848397711583, mRNA_SLC44A4: -0.8013170182976704, mRNA_CA12: -1.5934802318587404, mRNA_DTL: 0.9891045373300954, mRNA_C5AR2: -1.1966582455778791, mRNA_TBC1D9: -0.8065809115764209, mRNA_AR: -2.1833673286633712, mRNA_CCDC170: 0.0678054831838971, mRNA_DEGS2: -2.3400925844975244, mRNA_TFF3: -2.066281951447116, mRNA_DNALI1: -2.0323906165654506, mRNA_LINC00504: -1.6286760228344606, mRNA_CLCA2: -0.82866221983763, mRNA_PPP1R14C: 2.593036594331056, mRNA_THSD4: -0.626914021711873, mRNA_SPAG5: -0.1574164231588432, mRNA_FBP1: 0.3743846206267924, mRNA_SLC7A8: -1.6551946551345589, mRNA_EN1: 1.695195065011312, mRNA_ZNF552: -2.200507837107661, Methylation_LRRC6: 1.4802723625964718, Methylation_chr2 66218712 LINC02934 (29533): 0.6508136354975153, Methylation_HOXB13: -0.9870257964911184, Methylation_chr10 3949206 LINC02660 (4871): 1.6057696172200844, Methylation_chr5 179517140 RNF130 (18026): -1.5879155555438893, Methylation_LOC727677: 1.4780501566896762, Methylation_LETM1: 1.320578673624777, Methylation_CDC42BPB: -0.1765731124933958, Methylation_C8orf38: 1.6209845882618197, Methylation_chr14 100504766 EVL (18852): 1.4582671021429858, Methylation_chr5 72594851 LOC340090 (24088): -1.6198657594019752, Methylation_chr2 242904738 LINC01238 (3421): 1.4401187666530657, Methylation_ARFGEF1: 1.6346218939078596, Methylation_MAPT: 1.4729221889972215, Methylation_ZFAT: 1.3479679317562625, Methylation_KCNQ4: 0.5359445172644002, Methylation_chr1 232684368 SIPA1L2 (12934): 1.5825989749621854, Methylation_CRNKL1: 1.2551630553848163, Methylation_PRKAG2: -1.3819596112446466, Methylation_MICB: 1.3953124923346325, miRNA_hsa-mir-934: 0.4907014735200203, miRNA_hsa-mir-4728: -1.2829463335705662, miRNA_hsa-mir-5695: 2.527656952270272, miRNA_hsa-mir-18a: 1.2651239623476678, miRNA_hsa-mir-190b: -1.5169831977357129, miRNA_hsa-mir-577: 2.668488160068213, miRNA_hsa-mir-135b: 2.5295870120704245, miRNA_hsa-mir-2115: 0.1677884079449138, miRNA_hsa-mir-17: 1.0384270793465329, miRNA_hsa-mir-130b: 1.0093330131709757, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: -0.6267137538218468"
TCGA-A7-A3RF,"High-level Amplification of none; no CNV alterations meet thresholds.  
mRNA_FBP1 (Z=1.80) and mRNA_PRR15 (Z=1.31) are overexpressed; mRNA_DTL (Z=-1.45) downregulated.  
Methylation_chr2 66218712 LINC02934 (Z=-1.69) is hypomethylated.  
miRNA_hsa-mir-17 (Z=1.31) upregulated.  
Collectively indicate luminal-like phenotype with metabolic (FBP1) and cell-cycle (PRR15, DTL) dysregulation.","mRNA_MLPH: 0.6077916631271294, mRNA_C2orf54: -1.2943230935752186, mRNA_CITED4: -0.7859868865625815, mRNA_ESR1: 0.8337736747959694, mRNA_SPDEF: 0.8490930144591085, mRNA_AGR3: -0.2255388423722761, mRNA_FOXC1: -1.1410403043904138, mRNA_GATA3: 1.1317049855980292, mRNA_AGR2: -0.2744579495139829, mRNA_XBP1: 0.3153894631298934, mRNA_PRR15: 1.313976014268777, mRNA_SLC44A4: 0.8195280604466645, mRNA_CA12: -0.3635504768303162, mRNA_DTL: -1.4542492042545083, mRNA_C5AR2: -1.383143850801506, mRNA_TBC1D9: 0.8177428780396008, mRNA_AR: 0.8126462672153998, mRNA_CCDC170: 0.0382226990455847, mRNA_DEGS2: 0.7382195800697076, mRNA_TFF3: 0.4531382804432469, mRNA_DNALI1: 0.8277750835278024, mRNA_LINC00504: 1.324852830108124, mRNA_CLCA2: -0.8868571628374534, mRNA_PPP1R14C: -1.0913443045998863, mRNA_THSD4: 0.4187651995377756, mRNA_SPAG5: -0.879030825860912, mRNA_FBP1: 1.8046243353950613, mRNA_SLC7A8: 1.1979041453913486, mRNA_EN1: -0.5927783497189532, mRNA_ZNF552: -0.794921296772458, Methylation_LRRC6: -1.012730081520569, Methylation_chr2 66218712 LINC02934 (29533): -1.6866053164229764, Methylation_HOXB13: -1.0235092111021704, Methylation_chr10 3949206 LINC02660 (4871): -1.3123570868918364, Methylation_chr5 179517140 RNF130 (18026): -1.419897071240153, Methylation_LOC727677: -1.118964057461607, Methylation_LETM1: -0.3060281363497548, Methylation_CDC42BPB: -1.322314056852441, Methylation_C8orf38: -1.4384457082844313, Methylation_chr14 100504766 EVL (18852): -1.3717435746310351, Methylation_chr5 72594851 LOC340090 (24088): 1.1816592071980585, Methylation_chr2 242904738 LINC01238 (3421): -0.1409374297755121, Methylation_ARFGEF1: -0.9167074832940706, Methylation_MAPT: -0.9635384627983689, Methylation_ZFAT: -0.9096485981310024, Methylation_KCNQ4: -1.1368489550490086, Methylation_chr1 232684368 SIPA1L2 (12934): -1.0516802473992968, Methylation_CRNKL1: -1.224504280335803, Methylation_PRKAG2: -1.112454695786817, Methylation_MICB: -1.382537539677817, miRNA_hsa-mir-934: -0.2915337897470558, miRNA_hsa-mir-4728: -1.049059315309841, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: 0.4286550786164768, miRNA_hsa-mir-190b: 0.7351910651542107, miRNA_hsa-mir-577: -0.6053633650711295, miRNA_hsa-mir-135b: -0.8967279701864491, miRNA_hsa-mir-2115: -0.4246379682516022, miRNA_hsa-mir-17: 1.307283597156876, miRNA_hsa-mir-130b: 0.5295193098838864, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-A2-A0YI,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.663564313165507, mRNA_C2orf54: -1.1552852213391114, mRNA_CITED4: 0.1913819699442017, mRNA_ESR1: 0.8876999689383664, mRNA_SPDEF: 0.1010708386201997, mRNA_AGR3: 0.6982898319015683, mRNA_FOXC1: -0.1401598852504517, mRNA_GATA3: 0.4568858437695625, mRNA_AGR2: 0.7458797868872056, mRNA_XBP1: 0.8507094744089899, mRNA_PRR15: 0.5039341767064135, mRNA_SLC44A4: 0.5241178051921296, mRNA_CA12: 0.5785621799713139, mRNA_DTL: -1.6370399884069693, mRNA_C5AR2: 1.1697659794606967, mRNA_TBC1D9: 0.8782179593252764, mRNA_AR: 0.9686387171978796, mRNA_CCDC170: 1.2020381520927583, mRNA_DEGS2: 0.0863745352169957, mRNA_TFF3: 1.096192238708389, mRNA_DNALI1: 0.3038415569392268, mRNA_LINC00504: 0.5560656551380184, mRNA_CLCA2: -0.7478240654616717, mRNA_PPP1R14C: -0.7355668011953286, mRNA_THSD4: 0.7244209963596792, mRNA_SPAG5: -1.655715857328894, mRNA_FBP1: 0.8729633268345642, mRNA_SLC7A8: 0.0039985148527788, mRNA_EN1: -0.9209969917218792, mRNA_ZNF552: 0.8687506855507436, Methylation_LRRC6: 0.8546822576261957, Methylation_chr2 66218712 LINC02934 (29533): 1.2939013034159417, Methylation_HOXB13: -0.6627164755973369, Methylation_chr10 3949206 LINC02660 (4871): 0.2390681433035543, Methylation_chr5 179517140 RNF130 (18026): 0.5411115025951867, Methylation_LOC727677: 0.1272047266665814, Methylation_LETM1: 0.0423713871054753, Methylation_CDC42BPB: 1.1438145678835074, Methylation_C8orf38: 0.7939538404353851, Methylation_chr14 100504766 EVL (18852): 0.7753271007748223, Methylation_chr5 72594851 LOC340090 (24088): 0.9430767004078496, Methylation_chr2 242904738 LINC01238 (3421): 0.1531019401242061, Methylation_ARFGEF1: 0.9791389133593144, Methylation_MAPT: 0.2801159544519874, Methylation_ZFAT: 0.4242815090515172, Methylation_KCNQ4: -1.1559524772247964, Methylation_chr1 232684368 SIPA1L2 (12934): 0.7356340178499869, Methylation_CRNKL1: 0.7606717807299854, Methylation_PRKAG2: 1.2915711707875632, Methylation_MICB: 0.7124732821854317, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.7653519350391947, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.5725982680310607, miRNA_hsa-mir-190b: 0.2891370984289388, miRNA_hsa-mir-577: -0.4196449919911332, miRNA_hsa-mir-135b: -0.942105287009954, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -1.149149476253325, miRNA_hsa-mir-130b: -0.514746814877731, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AR-A5QM,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.519165328191248, mRNA_C2orf54: -0.5095605931739945, mRNA_CITED4: -0.2089091113775008, mRNA_ESR1: 0.6196946844354296, mRNA_SPDEF: 0.3861984173314595, mRNA_AGR3: 0.7377929632877266, mRNA_FOXC1: 0.2015488689208397, mRNA_GATA3: 0.4320936897934602, mRNA_AGR2: 0.991724132688917, mRNA_XBP1: 0.3960279483385118, mRNA_PRR15: 0.692822575233649, mRNA_SLC44A4: 0.3077406048950578, mRNA_CA12: 0.7190711094885741, mRNA_DTL: -0.176233597727473, mRNA_C5AR2: 1.3463131737098992, mRNA_TBC1D9: 0.5658728526665086, mRNA_AR: 0.4514696233054088, mRNA_CCDC170: 0.2828175370947495, mRNA_DEGS2: 0.8468909564574131, mRNA_TFF3: 1.154425176275364, mRNA_DNALI1: 0.2110205916652797, mRNA_LINC00504: -0.0119740800408425, mRNA_CLCA2: -0.3033827586881529, mRNA_PPP1R14C: -0.2509956481105257, mRNA_THSD4: 0.5176883763109464, mRNA_SPAG5: -0.4143943160747628, mRNA_FBP1: 1.0510062369126945, mRNA_SLC7A8: 0.8793283094871615, mRNA_EN1: 0.1177259975898267, mRNA_ZNF552: 1.1572063378204291, Methylation_LRRC6: 0.8081927208438667, Methylation_chr2 66218712 LINC02934 (29533): 0.2827055318842735, Methylation_HOXB13: 0.6820299729600563, Methylation_chr10 3949206 LINC02660 (4871): 1.3384273034599636, Methylation_chr5 179517140 RNF130 (18026): 0.6271663527509488, Methylation_LOC727677: 0.119868826055705, Methylation_LETM1: 0.2366330869612753, Methylation_CDC42BPB: 0.9648549403032964, Methylation_C8orf38: 0.554869315780286, Methylation_chr14 100504766 EVL (18852): 0.2175754435901124, Methylation_chr5 72594851 LOC340090 (24088): 0.7490497238684259, Methylation_chr2 242904738 LINC01238 (3421): -0.2372129766352891, Methylation_ARFGEF1: 1.1685535756608778, Methylation_MAPT: 0.1737729402319356, Methylation_ZFAT: 0.8411928806301319, Methylation_KCNQ4: -0.5371917553534875, Methylation_chr1 232684368 SIPA1L2 (12934): 0.1267626978209374, Methylation_CRNKL1: 0.4639215273752748, Methylation_PRKAG2: 0.4823671931972026, Methylation_MICB: 0.7972575201464, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.8368763228581428, miRNA_hsa-mir-5695: 0.4508914967379995, miRNA_hsa-mir-18a: -0.4680215399563575, miRNA_hsa-mir-190b: 0.6547162481993838, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.4733051293696581, miRNA_hsa-mir-2115: -0.1834378191509854, miRNA_hsa-mir-17: -0.921886381259438, miRNA_hsa-mir-130b: -1.51592711067909, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-D8-A1XO,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-significant ranges per specified criteria.","mRNA_MLPH: 0.2451264441175953, mRNA_C2orf54: -0.9226484935080634, mRNA_CITED4: 0.6348745409125135, mRNA_ESR1: 1.0429816858895802, mRNA_SPDEF: 0.3983870181459947, mRNA_AGR3: 0.3477665464261567, mRNA_FOXC1: -0.717882686375066, mRNA_GATA3: 0.6949331722750695, mRNA_AGR2: 0.8564904552772543, mRNA_XBP1: 0.1077041524531105, mRNA_PRR15: 0.6104727887041275, mRNA_SLC44A4: 0.2324461862324174, mRNA_CA12: 0.4012488506829735, mRNA_DTL: -0.0585611622141233, mRNA_C5AR2: 0.764914380749956, mRNA_TBC1D9: 0.4489050989683071, mRNA_AR: 1.0493600438371704, mRNA_CCDC170: 0.9425837617460664, mRNA_DEGS2: 0.2201487589116114, mRNA_TFF3: 0.3314235034802874, mRNA_DNALI1: 1.0652032994964578, mRNA_LINC00504: 0.6059886302319084, mRNA_CLCA2: 1.358267202298434, mRNA_PPP1R14C: -0.852160544105563, mRNA_THSD4: 0.2266010693625958, mRNA_SPAG5: -0.7814612709465948, mRNA_FBP1: 0.5751302585544006, mRNA_SLC7A8: 0.3261417238621738, mRNA_EN1: 0.0414713541204647, mRNA_ZNF552: 0.300652779510459, Methylation_LRRC6: -0.3937567882536441, Methylation_chr2 66218712 LINC02934 (29533): 1.343419814312135, Methylation_HOXB13: -0.9847065952490268, Methylation_chr10 3949206 LINC02660 (4871): -0.8167316453144645, Methylation_chr5 179517140 RNF130 (18026): -0.7749577561111117, Methylation_LOC727677: -0.5404897424384347, Methylation_LETM1: -0.1250109238062683, Methylation_CDC42BPB: -1.0062593257616768, Methylation_C8orf38: -0.1918505517260481, Methylation_chr14 100504766 EVL (18852): 0.3858833495098832, Methylation_chr5 72594851 LOC340090 (24088): 0.1636472496577617, Methylation_chr2 242904738 LINC01238 (3421): -0.9040595902965176, Methylation_ARFGEF1: -0.0538018576176682, Methylation_MAPT: -0.7024598803144944, Methylation_ZFAT: 0.4412044961528728, Methylation_KCNQ4: -1.0879020032356046, Methylation_chr1 232684368 SIPA1L2 (12934): 0.1008302102327818, Methylation_CRNKL1: -0.3745551494482294, Methylation_PRKAG2: 1.2014915917361824, Methylation_MICB: -0.6617865853783447, miRNA_hsa-mir-934: -0.0219239214730053, miRNA_hsa-mir-4728: -0.2142076689655985, miRNA_hsa-mir-5695: 0.5265790333075824, miRNA_hsa-mir-18a: -0.8538000338354405, miRNA_hsa-mir-190b: 0.6835717541875052, miRNA_hsa-mir-577: -0.3306373282904196, miRNA_hsa-mir-135b: -0.1802406984526632, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.5083611934319819, miRNA_hsa-mir-130b: -0.6771570502160149, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-C8-A8HQ,"High mRNA_C2orf54 (Z=1.68) and mRNA_SPAG5 (Z=1.35) indicate overexpression.  
Methylation_PRKAG2 hypo-methylation (Z=-1.27) suggests epigenetic dysregulation.  
No miRNA alterations meet thresholds.  
All CNVs fall within normal range (−1.10 to −0.10).  
Collectively, this suggests luminal-like transcriptional activity without copy-number drivers.","mRNA_MLPH: 1.0328872420151718, mRNA_C2orf54: 1.6849449268612309, mRNA_CITED4: 0.1326004743827307, mRNA_ESR1: -0.2445115220685992, mRNA_SPDEF: 0.6123684391560205, mRNA_AGR3: 0.3723305574814951, mRNA_FOXC1: 0.272423704136135, mRNA_GATA3: -0.4743924679996962, mRNA_AGR2: 0.7664567793756513, mRNA_XBP1: 0.0532045622121003, mRNA_PRR15: 0.6414771831375706, mRNA_SLC44A4: 0.3124161382045431, mRNA_CA12: -0.2570304487622422, mRNA_DTL: 0.102851068355947, mRNA_C5AR2: 0.6201826269049898, mRNA_TBC1D9: -0.0239645702726576, mRNA_AR: 0.2228939932796382, mRNA_CCDC170: -0.7183714702908685, mRNA_DEGS2: 0.9114352862559733, mRNA_TFF3: 1.497039820398552, mRNA_DNALI1: 0.5178063488748282, mRNA_LINC00504: 0.3993667205719019, mRNA_CLCA2: 0.1745346608780409, mRNA_PPP1R14C: -0.2677843906141091, mRNA_THSD4: 0.6870915290711448, mRNA_SPAG5: 1.3467492615978005, mRNA_FBP1: 0.5322694306994646, mRNA_SLC7A8: 0.3631910689393766, mRNA_EN1: 0.6576939913515835, mRNA_ZNF552: -0.7069964676508776, Methylation_LRRC6: 0.264878627652513, Methylation_chr2 66218712 LINC02934 (29533): 0.1599111883724149, Methylation_HOXB13: 0.8541466500851117, Methylation_chr10 3949206 LINC02660 (4871): -0.6118700003737397, Methylation_chr5 179517140 RNF130 (18026): 0.8391657565194911, Methylation_LOC727677: 0.3656067940040629, Methylation_LETM1: -0.303944045197403, Methylation_CDC42BPB: 0.8909074947440432, Methylation_C8orf38: -0.1270980400258927, Methylation_chr14 100504766 EVL (18852): -0.4174727033227596, Methylation_chr5 72594851 LOC340090 (24088): 0.7249944960413627, Methylation_chr2 242904738 LINC01238 (3421): 0.913164348406038, Methylation_ARFGEF1: 0.1044412829140835, Methylation_MAPT: 0.5870787584288937, Methylation_ZFAT: -0.2619770629379941, Methylation_KCNQ4: 0.9985811809258374, Methylation_chr1 232684368 SIPA1L2 (12934): 0.7247568885164516, Methylation_CRNKL1: 0.4513900609768286, Methylation_PRKAG2: -1.2659473298656492, Methylation_MICB: 0.2469690956052244, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.3741484910480354, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.7243330464794094, miRNA_hsa-mir-190b: 1.239588504055875, miRNA_hsa-mir-577: -0.4040706273292945, miRNA_hsa-mir-135b: -0.1686694948555214, miRNA_hsa-mir-2115: -0.347143091144207, miRNA_hsa-mir-17: -0.2548895644990016, miRNA_hsa-mir-130b: 0.1949517199146947, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A42T,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.4283301883998739, mRNA_C2orf54: 0.954620758664192, mRNA_CITED4: 0.4836407556540899, mRNA_ESR1: 0.4661874101299366, mRNA_SPDEF: 0.4038044798714432, mRNA_AGR3: 0.3652045965501402, mRNA_FOXC1: -0.5870669731149457, mRNA_GATA3: 0.6751647609001757, mRNA_AGR2: 0.2310544826420492, mRNA_XBP1: -0.2298701858895662, mRNA_PRR15: 0.4718675172116675, mRNA_SLC44A4: -1.0980781473824326, mRNA_CA12: 0.5298413349356206, mRNA_DTL: 0.995906328645392, mRNA_C5AR2: 0.4763645398361761, mRNA_TBC1D9: 0.0220409260381063, mRNA_AR: 0.2364170798801128, mRNA_CCDC170: -0.3702472080518795, mRNA_DEGS2: 1.2221335976634229, mRNA_TFF3: 0.320902016653062, mRNA_DNALI1: 0.3859834644933705, mRNA_LINC00504: -0.5009006000966857, mRNA_CLCA2: -0.8366981859612979, mRNA_PPP1R14C: -0.9385334521729058, mRNA_THSD4: -0.0217551139340389, mRNA_SPAG5: 1.1738772017627923, mRNA_FBP1: -0.4008028830588794, mRNA_SLC7A8: -0.3876313410480622, mRNA_EN1: -0.2467761867702219, mRNA_ZNF552: -0.073149401457395, Methylation_LRRC6: -0.8861246918705601, Methylation_chr2 66218712 LINC02934 (29533): 0.7833496890701686, Methylation_HOXB13: -1.0080552139727992, Methylation_chr10 3949206 LINC02660 (4871): 0.1704593814897751, Methylation_chr5 179517140 RNF130 (18026): 1.0584885225350869, Methylation_LOC727677: -0.919811069262295, Methylation_LETM1: -1.149535713705136, Methylation_CDC42BPB: 1.111948199080963, Methylation_C8orf38: -0.5677238344040527, Methylation_chr14 100504766 EVL (18852): -0.716640429499247, Methylation_chr5 72594851 LOC340090 (24088): 0.973443362058236, Methylation_chr2 242904738 LINC01238 (3421): -1.0450770927728747, Methylation_ARFGEF1: -1.1126409524130672, Methylation_MAPT: -1.516582423995221, Methylation_ZFAT: -0.7000534924008449, Methylation_KCNQ4: 1.0207189671647006, Methylation_chr1 232684368 SIPA1L2 (12934): -1.2996059743116082, Methylation_CRNKL1: -1.1977866559130186, Methylation_PRKAG2: 1.1087285393638522, Methylation_MICB: -1.008603148952057, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 0.1835842882545717, miRNA_hsa-mir-5695: 0.2151543113568676, miRNA_hsa-mir-18a: 0.212810416547468, miRNA_hsa-mir-190b: 0.3881893196599988, miRNA_hsa-mir-577: -0.0772685489244913, miRNA_hsa-mir-135b: 1.570846709794381, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.0510488465231145, miRNA_hsa-mir-130b: -0.4003592852742764, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-GM-A2D9,"No features meet the strict diagnostic thresholds for mRNA, methylation, miRNA, or CNV alterations. All values fall within non-actionable ranges per specified criteria.","mRNA_MLPH: 0.8584343276971006, mRNA_C2orf54: 0.8509940144734619, mRNA_CITED4: 1.2905836924278986, mRNA_ESR1: 0.5422687271276105, mRNA_SPDEF: 0.813536664934401, mRNA_AGR3: 0.9195901402644728, mRNA_FOXC1: -0.2779288014577447, mRNA_GATA3: 0.3212300116741013, mRNA_AGR2: 0.6171762120540026, mRNA_XBP1: 0.4418868622861967, mRNA_PRR15: 0.4804983449774327, mRNA_SLC44A4: 0.8254138740916078, mRNA_CA12: 0.1883831639549859, mRNA_DTL: -1.0327374924581754, mRNA_C5AR2: 0.5480036285552283, mRNA_TBC1D9: 0.1818969099014362, mRNA_AR: 0.2880410340455694, mRNA_CCDC170: -0.1050610902616006, mRNA_DEGS2: 0.4824040343828308, mRNA_TFF3: 0.5081690808454236, mRNA_DNALI1: 0.7718138965104965, mRNA_LINC00504: 0.2356184314002983, mRNA_CLCA2: -0.7032317651136498, mRNA_PPP1R14C: -0.6434805602720557, mRNA_THSD4: 0.1636015392277815, mRNA_SPAG5: -1.0366453790007548, mRNA_FBP1: 0.116869258024587, mRNA_SLC7A8: 0.3898611299170865, mRNA_EN1: 0.065248004298725, mRNA_ZNF552: 0.4040145384071403, Methylation_LRRC6: -0.5909990695268046, Methylation_chr2 66218712 LINC02934 (29533): 1.321993561175005, Methylation_HOXB13: 1.0803148164992806, Methylation_chr10 3949206 LINC02660 (4871): -0.8762043817297177, Methylation_chr5 179517140 RNF130 (18026): 0.8386872101995186, Methylation_LOC727677: -0.7133562520786848, Methylation_LETM1: -0.9281236150822716, Methylation_CDC42BPB: -0.015106310241995, Methylation_C8orf38: -1.006328296320767, Methylation_chr14 100504766 EVL (18852): -1.1185542760398846, Methylation_chr5 72594851 LOC340090 (24088): 0.6923665953346962, Methylation_chr2 242904738 LINC01238 (3421): -0.8404727866950956, Methylation_ARFGEF1: -0.850838258935753, Methylation_MAPT: -0.7279925898288949, Methylation_ZFAT: -0.9376236228334524, Methylation_KCNQ4: 0.916858320140872, Methylation_chr1 232684368 SIPA1L2 (12934): -1.2940427293030496, Methylation_CRNKL1: -0.8156185035712169, Methylation_PRKAG2: 1.2896005826791883, Methylation_MICB: -1.0928581891575562, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.6572428916953644, miRNA_hsa-mir-5695: -0.4086198691653123, miRNA_hsa-mir-18a: -0.5990239319709464, miRNA_hsa-mir-190b: 1.1191622080579426, miRNA_hsa-mir-577: -0.6729399214327365, miRNA_hsa-mir-135b: -0.7496234191016715, miRNA_hsa-mir-2115: -0.074157219765669, miRNA_hsa-mir-17: -0.7691944275053398, miRNA_hsa-mir-130b: -0.9699977615216588, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-BH-A0H3,"No mRNA, methylation, miRNA, or CNV features meet the strict diagnostic thresholds for reporting.","mRNA_MLPH: 0.0382761249270588, mRNA_C2orf54: -0.9470289098144048, mRNA_CITED4: 0.912726424062584, mRNA_ESR1: 0.4678132475888396, mRNA_SPDEF: -0.1372615248900549, mRNA_AGR3: 0.6456084512517666, mRNA_FOXC1: 0.2920888105606196, mRNA_GATA3: 0.8568955580742673, mRNA_AGR2: -0.0968081499854153, mRNA_XBP1: 0.5708232100827563, mRNA_PRR15: -0.5437236434997096, mRNA_SLC44A4: 0.7980465287891157, mRNA_CA12: 0.7015520465336559, mRNA_DTL: -0.1546621742790822, mRNA_C5AR2: 0.2457862512949048, mRNA_TBC1D9: 1.067977677237577, mRNA_AR: 0.3433143564835705, mRNA_CCDC170: -0.0542767381946147, mRNA_DEGS2: 0.3281829047094343, mRNA_TFF3: -0.5176582238615863, mRNA_DNALI1: 0.4468464166399242, mRNA_LINC00504: 0.7572635600848401, mRNA_CLCA2: 0.206729158691739, mRNA_PPP1R14C: 0.0204773681616162, mRNA_THSD4: 0.7319703371908608, mRNA_SPAG5: -1.2144231749930074, mRNA_FBP1: 0.5315562899175089, mRNA_SLC7A8: 0.6901510678594249, mRNA_EN1: -0.3787727780701314, mRNA_ZNF552: 0.6471434167239863, Methylation_LRRC6: 0.0817220875255332, Methylation_chr2 66218712 LINC02934 (29533): -0.6425362342575585, Methylation_HOXB13: -0.4589816474608932, Methylation_chr10 3949206 LINC02660 (4871): -0.3862027852673459, Methylation_chr5 179517140 RNF130 (18026): 0.577057687249665, Methylation_LOC727677: 0.2739869097248599, Methylation_LETM1: -0.2761293242580315, Methylation_CDC42BPB: -0.6945802282049696, Methylation_C8orf38: -0.1070741109594113, Methylation_chr14 100504766 EVL (18852): -0.1192641905851864, Methylation_chr5 72594851 LOC340090 (24088): 0.2139368561623582, Methylation_chr2 242904738 LINC01238 (3421): -0.5401941836415336, Methylation_ARFGEF1: 0.2683919244353062, Methylation_MAPT: -0.2412514182736959, Methylation_ZFAT: -0.0259122095509023, Methylation_KCNQ4: -0.2769360451103751, Methylation_chr1 232684368 SIPA1L2 (12934): -0.5089205717546287, Methylation_CRNKL1: 0.3887240213115636, Methylation_PRKAG2: -0.4836483980804375, Methylation_MICB: 0.1079496299006123, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: -0.3975187406748656, miRNA_hsa-mir-5695: 0.0317236239278339, miRNA_hsa-mir-18a: -0.4436041292815273, miRNA_hsa-mir-190b: 0.6472805272859913, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.0750985606993084, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.5621174537675602, miRNA_hsa-mir-130b: 0.0410012556064661, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-LL-A5YP,"High-level Amplification of WDPCP drives mRNA overexpression.  
PPP1R14C and EN1 show significant mRNA upregulation (Z > 1.30).  
ESR1, SPDEF, AGR2, DEGS2, and MLPH exhibit marked mRNA downregulation (Z < -1.92).  
Promoter hypermethylation at LRRC6, C8orf38, EVL, SIPA1L2, and RNF130 (Z > 1.50) suggests epigenetic silencing.  
RNF130 and LOC340090 are hypomethylated (Z < -1.47).  
miR-934 and miR-577 are upregulated (Z > 1.99); miR-190b is downregulated (Z < -1.25).","mRNA_MLPH: -2.423707372423633, mRNA_C2orf54: -0.7008854205318137, mRNA_CITED4: 0.0027861741117709, mRNA_ESR1: -1.922401836981096, mRNA_SPDEF: -2.5194270550246927, mRNA_AGR3: -1.954344243370751, mRNA_FOXC1: 1.6122220364096385, mRNA_GATA3: -1.822871685388043, mRNA_AGR2: -2.3787858751946747, mRNA_XBP1: -1.711946754213041, mRNA_PRR15: -1.41658380157054, mRNA_SLC44A4: -2.2091359387817406, mRNA_CA12: -1.85599572117806, mRNA_DTL: -0.2484670123883471, mRNA_C5AR2: -1.1004693612642549, mRNA_TBC1D9: -1.5220075892954048, mRNA_AR: -1.7690937721591422, mRNA_CCDC170: -1.2054324005132242, mRNA_DEGS2: -2.41341479998697, mRNA_TFF3: -1.9388098932314344, mRNA_DNALI1: -1.3563916032025, mRNA_LINC00504: -1.7283284480259775, mRNA_CLCA2: -0.4355636395819693, mRNA_PPP1R14C: 3.0378787255735724, mRNA_THSD4: -1.6582163563839405, mRNA_SPAG5: 0.0718285617935539, mRNA_FBP1: -1.4782390978821665, mRNA_SLC7A8: -1.4917091629585175, mRNA_EN1: 2.469086520238775, mRNA_ZNF552: -1.6768411053364602, Methylation_LRRC6: 1.5197674169618562, Methylation_chr2 66218712 LINC02934 (29533): -1.0713441926441227, Methylation_HOXB13: 0.4602869360709114, Methylation_chr10 3949206 LINC02660 (4871): 1.3291399926064789, Methylation_chr5 179517140 RNF130 (18026): -1.6734279518231985, Methylation_LOC727677: 1.469267033508931, Methylation_LETM1: 1.3385383326039693, Methylation_CDC42BPB: 0.9368606493768792, Methylation_C8orf38: 1.5542629235277534, Methylation_chr14 100504766 EVL (18852): 1.504048760086791, Methylation_chr5 72594851 LOC340090 (24088): -1.513723147610915, Methylation_chr2 242904738 LINC01238 (3421): 1.4099299654273951, Methylation_ARFGEF1: 1.4381889237956402, Methylation_MAPT: 1.4866984943380572, Methylation_ZFAT: 1.3508746188713512, Methylation_KCNQ4: 0.923954603129305, Methylation_chr1 232684368 SIPA1L2 (12934): 1.546997803303974, Methylation_CRNKL1: 1.400347337062548, Methylation_PRKAG2: -0.8232402335376837, Methylation_MICB: 1.433583741318464, miRNA_hsa-mir-934: 2.71402492631088, miRNA_hsa-mir-4728: -0.80795803727836, miRNA_hsa-mir-5695: 0.5296944800025356, miRNA_hsa-mir-18a: 1.6270909924136585, miRNA_hsa-mir-190b: -1.7154782092400973, miRNA_hsa-mir-577: 2.5340163712443764, miRNA_hsa-mir-135b: 1.0689926658758349, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 1.38549717178767, miRNA_hsa-mir-130b: 1.4561263655580226, CNV_VPS54: 1.375777469993222, CNV_LINC01867: 1.3872610716325808, CNV_LINC02576: 1.4339562938734052, CNV_WDPCP: 3.3913533508092364, CNV_CEP68: 1.4339562938734052"
TCGA-V7-A7HQ,"High mRNA_CITED4 (Z=1.90), mRNA_DEGS2 (Z=1.54), and mRNA_TFF3 (Z=1.40) indicate overexpression. Low mRNA_DTL (Z=−1.97) suggests downregulation. No methylation or miRNA features meet thresholds. All CNVs are normal (−1.10 ≤ value < −0.10).","mRNA_MLPH: 0.6903183428259135, mRNA_C2orf54: 1.3544170625153509, mRNA_CITED4: 1.9012808427280032, mRNA_ESR1: 0.159083263359371, mRNA_SPDEF: 0.9603292982071142, mRNA_AGR3: 0.1465320176851993, mRNA_FOXC1: -0.8941264028588213, mRNA_GATA3: 0.461666335278668, mRNA_AGR2: 0.4160962904833302, mRNA_XBP1: -0.2396720912660991, mRNA_PRR15: -0.0448638211458702, mRNA_SLC44A4: 0.1017635238375901, mRNA_CA12: 0.0541560201484425, mRNA_DTL: -1.9723778427580163, mRNA_C5AR2: 0.8121068166406793, mRNA_TBC1D9: -0.5424800783782071, mRNA_AR: -0.0616435571778851, mRNA_CCDC170: 0.7741703652622764, mRNA_DEGS2: 1.5361780491995474, mRNA_TFF3: 1.3979307582642002, mRNA_DNALI1: 0.8591253308058934, mRNA_LINC00504: 0.4182031758043195, mRNA_CLCA2: 0.600387580610964, mRNA_PPP1R14C: -0.5892059586722751, mRNA_THSD4: -0.3524150696544781, mRNA_SPAG5: -1.0803079984624742, mRNA_FBP1: 0.762687099896066, mRNA_SLC7A8: 0.3407923769982623, mRNA_EN1: 0.0973311124577747, mRNA_ZNF552: -0.506891952055696, Methylation_LRRC6: -0.8158265748849449, Methylation_chr2 66218712 LINC02934 (29533): 0.8463702726846819, Methylation_HOXB13: -1.0623551266161495, Methylation_chr10 3949206 LINC02660 (4871): -1.0825097885464157, Methylation_chr5 179517140 RNF130 (18026): 0.8091224319008488, Methylation_LOC727677: -1.241212845260241, Methylation_LETM1: -1.3790100287469134, Methylation_CDC42BPB: -0.993564791642501, Methylation_C8orf38: -1.162253764523699, Methylation_chr14 100504766 EVL (18852): -0.8579615808087296, Methylation_chr5 72594851 LOC340090 (24088): 0.247549445832503, Methylation_chr2 242904738 LINC01238 (3421): -0.7813806431727859, Methylation_ARFGEF1: -1.04914812428485, Methylation_MAPT: -1.0626689718825073, Methylation_ZFAT: -1.35417979625622, Methylation_KCNQ4: -0.1596236042012885, Methylation_chr1 232684368 SIPA1L2 (12934): -0.7771998564586083, Methylation_CRNKL1: -0.870743382306908, Methylation_PRKAG2: 0.95775191893124, Methylation_MICB: -1.2855450286724197, miRNA_hsa-mir-934: 0.4729254871005487, miRNA_hsa-mir-4728: -0.1442284490628622, miRNA_hsa-mir-5695: 0.8525250001045055, miRNA_hsa-mir-18a: -0.5575274398065001, miRNA_hsa-mir-190b: 0.5239929302827822, miRNA_hsa-mir-577: -0.7584687107074534, miRNA_hsa-mir-135b: -0.7732142855405916, miRNA_hsa-mir-2115: 0.6039333480818377, miRNA_hsa-mir-17: -0.3856738136509069, miRNA_hsa-mir-130b: -0.67665789929708, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-GM-A3XL,"High-level Amplification of EN1 drives mRNA overexpression.  
Promoter hypermethylation of ARFGEF1, LINC02660, and SIPA1L2 mediates epigenetic silencing.  
Deletion of VPS54, LINC01867, LINC02576, WDPCP, and CEP68 correlates with transcriptional downregulation.  
These features collectively indicate a basal-like phenotype with ER pathway suppression.","mRNA_MLPH: -1.9246234624904373, mRNA_C2orf54: 0.862670281643994, mRNA_CITED4: 0.4628481996105574, mRNA_ESR1: -1.5871893184481074, mRNA_SPDEF: -2.064779819681482, mRNA_AGR3: -1.4854077090986917, mRNA_FOXC1: 0.9335764673457568, mRNA_GATA3: -0.8101684747807761, mRNA_AGR2: -2.0315356052938074, mRNA_XBP1: -1.694407126776638, mRNA_PRR15: -0.8343548637982685, mRNA_SLC44A4: -2.101723702637872, mRNA_CA12: -2.130884617104486, mRNA_DTL: 0.2696727191355514, mRNA_C5AR2: -1.4389955356190065, mRNA_TBC1D9: -1.7893318937389162, mRNA_AR: -2.3070248064530468, mRNA_CCDC170: -1.8174430265213743, mRNA_DEGS2: -0.198728591262089, mRNA_TFF3: -2.0255347637077667, mRNA_DNALI1: -1.8444212405270408, mRNA_LINC00504: -1.6982771471459803, mRNA_CLCA2: 0.6651877383626675, mRNA_PPP1R14C: 1.720284890676261, mRNA_THSD4: -1.99578866807132, mRNA_SPAG5: 0.6688881195313668, mRNA_FBP1: -0.2607580964075178, mRNA_SLC7A8: -2.0996750727478304, mRNA_EN1: 2.412845322704962, mRNA_ZNF552: -1.9350253150854904, Methylation_LRRC6: 1.4480082252904756, Methylation_chr2 66218712 LINC02934 (29533): -1.363685291121645, Methylation_HOXB13: 1.3566931678080487, Methylation_chr10 3949206 LINC02660 (4871): 1.6212134935723457, Methylation_chr5 179517140 RNF130 (18026): -0.1461969592775034, Methylation_LOC727677: 1.4898979493391888, Methylation_LETM1: 1.2959626408747391, Methylation_CDC42BPB: 1.0852935169842657, Methylation_C8orf38: 1.4880738522893155, Methylation_chr14 100504766 EVL (18852): 1.4797843430649904, Methylation_chr5 72594851 LOC340090 (24088): -1.4566171185417656, Methylation_chr2 242904738 LINC01238 (3421): 1.4512881238652555, Methylation_ARFGEF1: 1.7070546744620347, Methylation_MAPT: 1.3576328520211125, Methylation_ZFAT: 1.4264034043275151, Methylation_KCNQ4: 1.197029201237688, Methylation_chr1 232684368 SIPA1L2 (12934): 1.55197193383542, Methylation_CRNKL1: 1.3195278169460711, Methylation_PRKAG2: -1.4048472341300389, Methylation_MICB: 1.267927554854537, miRNA_hsa-mir-934: 0.7646918773196375, miRNA_hsa-mir-4728: -0.2011170203921647, miRNA_hsa-mir-5695: 0.2662156823473772, miRNA_hsa-mir-18a: 2.733489774441112, miRNA_hsa-mir-190b: -1.4204542587083877, miRNA_hsa-mir-577: 1.9845189497621736, miRNA_hsa-mir-135b: 0.8986009227390794, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: 2.426967047393248, miRNA_hsa-mir-130b: 1.2050297294798846, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
TCGA-AO-A03L,"High mRNA_C2orf54 (Z=2.49) and mRNA_ZNF552 (Z=1.70) indicate overexpression.  
No methylation sites meet hyper/hypo thresholds.  
miRNA_hsa-mir-18a is downregulated (Z=-1.23).  
All CNVs fall within normal/gain range; no deletions or amplifications.  
Collectively suggests luminal-like phenotype with moderate transcriptional activation.","mRNA_MLPH: 0.4222488381241324, mRNA_C2orf54: 2.4871650937469685, mRNA_CITED4: -0.7168922849565783, mRNA_ESR1: 0.0323790568173115, mRNA_SPDEF: 0.9479651409324782, mRNA_AGR3: 0.3162000138244125, mRNA_FOXC1: -0.1220468492754139, mRNA_GATA3: 0.4585631119308614, mRNA_AGR2: 1.0425162870885911, mRNA_XBP1: 0.0572164457317586, mRNA_PRR15: 0.5469619751653938, mRNA_SLC44A4: 0.9985978176648476, mRNA_CA12: 0.5435404128889268, mRNA_DTL: 1.3350244243410352, mRNA_C5AR2: 1.1066799873320186, mRNA_TBC1D9: 0.5840018895410609, mRNA_AR: 0.785753686713813, mRNA_CCDC170: -0.4335203919471428, mRNA_DEGS2: 0.854853760927383, mRNA_TFF3: 0.8451279862746252, mRNA_DNALI1: 0.0859475495599109, mRNA_LINC00504: 0.7002979662367026, mRNA_CLCA2: -0.3990726688707315, mRNA_PPP1R14C: 0.223388265604809, mRNA_THSD4: 0.2995803952819102, mRNA_SPAG5: 0.667506050345963, mRNA_FBP1: 0.6705549905083691, mRNA_SLC7A8: 0.3351280655500688, mRNA_EN1: -0.8953232214586228, mRNA_ZNF552: 1.6995468279836683, Methylation_LRRC6: 0.3293974330963874, Methylation_chr2 66218712 LINC02934 (29533): 0.8121800170509936, Methylation_HOXB13: -0.2600730265227474, Methylation_chr10 3949206 LINC02660 (4871): 0.028307987314399, Methylation_chr5 179517140 RNF130 (18026): 0.9100240177320632, Methylation_LOC727677: -0.5923656304792648, Methylation_LETM1: -0.5261506902517648, Methylation_CDC42BPB: 1.0653130222602716, Methylation_C8orf38: 0.0534318544347566, Methylation_chr14 100504766 EVL (18852): -0.6018006189939547, Methylation_chr5 72594851 LOC340090 (24088): 0.9119660462588776, Methylation_chr2 242904738 LINC01238 (3421): 0.5298382912839147, Methylation_ARFGEF1: 0.1227995110268522, Methylation_MAPT: 0.7386340560047645, Methylation_ZFAT: 0.0173517481807698, Methylation_KCNQ4: -0.9905538975512796, Methylation_chr1 232684368 SIPA1L2 (12934): -0.4199293167563431, Methylation_CRNKL1: -0.5672761987452994, Methylation_PRKAG2: -0.4506772730078091, Methylation_MICB: -0.3576933232905162, miRNA_hsa-mir-934: -0.5948794054060302, miRNA_hsa-mir-4728: 1.789435561328753, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -1.2257126901326254, miRNA_hsa-mir-190b: 0.1718216295896738, miRNA_hsa-mir-577: 0.5935461884865588, miRNA_hsa-mir-135b: 0.1337913609991248, miRNA_hsa-mir-2115: -0.6905102845260922, miRNA_hsa-mir-17: -0.4983342840158274, miRNA_hsa-mir-130b: 0.1255890202742187, CNV_VPS54: 0.3780545527047489, CNV_LINC01867: 0.3791272493902705, CNV_LINC02576: 0.4036212700257792, CNV_WDPCP: 0.3815808447813174, CNV_CEP68: 0.4036212700257792"
TCGA-E2-A1IU,"LINC00504 mRNA overexpression (Z=1.59) exceeds the high-expression threshold (Z>1.30). No methylation, miRNA, or CNV alterations meet diagnostic criteria. Isolated LINC00504 upregulation suggests non-specific transcriptional activation without clear genomic or epigenetic drivers.","mRNA_MLPH: 1.1379521564131718, mRNA_C2orf54: -0.2257625264797761, mRNA_CITED4: 0.1892482184637559, mRNA_ESR1: 1.1215782451262046, mRNA_SPDEF: 0.6776225224767313, mRNA_AGR3: 0.8223352441251489, mRNA_FOXC1: -0.270455425733777, mRNA_GATA3: 0.2779047291532327, mRNA_AGR2: 0.3118166906298028, mRNA_XBP1: 1.3654327025589736, mRNA_PRR15: 0.6252783465909209, mRNA_SLC44A4: 0.8302300523988613, mRNA_CA12: 0.8902681935385938, mRNA_DTL: -0.291064663724903, mRNA_C5AR2: 0.611807866435407, mRNA_TBC1D9: 0.8818738287037431, mRNA_AR: 1.0384469676225163, mRNA_CCDC170: 1.3316092245314424, mRNA_DEGS2: 0.981607029798534, mRNA_TFF3: 0.6408995605180492, mRNA_DNALI1: 0.7354983114517292, mRNA_LINC00504: 1.5900037888750127, mRNA_CLCA2: 1.061935785809798, mRNA_PPP1R14C: 0.4852601632588014, mRNA_THSD4: 1.061786811549556, mRNA_SPAG5: -0.7414441889729677, mRNA_FBP1: 0.8634706370783691, mRNA_SLC7A8: 0.4047471031370533, mRNA_EN1: -0.7720000442469561, mRNA_ZNF552: 1.105571218665518, Methylation_LRRC6: -0.3193217086000322, Methylation_chr2 66218712 LINC02934 (29533): -1.0374749225809494, Methylation_HOXB13: -1.0511331602859908, Methylation_chr10 3949206 LINC02660 (4871): 0.3611271325699753, Methylation_chr5 179517140 RNF130 (18026): 0.7565962950765736, Methylation_LOC727677: -0.6570421531178139, Methylation_LETM1: -0.6677615782753639, Methylation_CDC42BPB: -0.8565852060925013, Methylation_C8orf38: -0.7234065593870603, Methylation_chr14 100504766 EVL (18852): -0.6355863867594392, Methylation_chr5 72594851 LOC340090 (24088): -0.354875198275514, Methylation_chr2 242904738 LINC01238 (3421): -1.0532920087900048, Methylation_ARFGEF1: -0.2641995675068634, Methylation_MAPT: -0.649752032106384, Methylation_ZFAT: -0.0628407064604861, Methylation_KCNQ4: -0.7517206262035109, Methylation_chr1 232684368 SIPA1L2 (12934): -0.4293556474642626, Methylation_CRNKL1: -0.3219406631143491, Methylation_PRKAG2: 0.4460644098714392, Methylation_MICB: -0.8221138611281734, miRNA_hsa-mir-934: -0.1893218970211663, miRNA_hsa-mir-4728: -0.1302408592516167, miRNA_hsa-mir-5695: -0.7646593868717004, miRNA_hsa-mir-18a: -0.692015750105213, miRNA_hsa-mir-190b: -0.0987325800294596, miRNA_hsa-mir-577: 0.5306339751531717, miRNA_hsa-mir-135b: -0.1161752565179863, miRNA_hsa-mir-2115: 0.1214441166782402, miRNA_hsa-mir-17: -0.8158242688908943, miRNA_hsa-mir-130b: -0.8072202323604729, CNV_VPS54: -0.6196683645837243, CNV_LINC01867: -0.6290065728520398, CNV_LINC02576: -0.6267137538218468, CNV_WDPCP: -0.621676657227989, CNV_CEP68: -0.6267137538218468"
